<?xml version="1.0" encoding="UTF-8"?><!-- generator="podbean/5.5" -->
<rss version="2.0"
     xmlns:content="http://purl.org/rss/1.0/modules/content/"
     xmlns:atom="http://www.w3.org/2005/Atom"
     xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
     xmlns:spotify="http://www.spotify.com/ns/rss"
     xmlns:podcast="https://podcastindex.org/namespace/1.0"
    xmlns:media="http://search.yahoo.com/mrss/">

<channel>
    <title>Medicine and Science from The BMJ</title>
    <atom:link href="https://feed.podbean.com/thebmjpodcast/feed.xml" rel="self" type="application/rss+xml"/>
    <link>https://thebmjpodcast.podbean.com</link>
    <description>The BMJ brings you interviews with the people who are shaping medicine and science around the world.</description>
    <pubDate>Fri, 11 Sep 2026 17:26:55 +0000</pubDate>
    <generator>https://podbean.com/?v=5.5</generator>
    <language>en-gb</language>
        <copyright>Copyright 2023, BMJ Publishing Group</copyright>
    <category>Health &amp; Fitness:Medicine</category>
    <ttl>1440</ttl>
    <itunes:type>episodic</itunes:type>
          <itunes:summary>Leading the debate on health to engage, inform, and stimulate doctors, researchers, and other health professionals.</itunes:summary>
        <itunes:author>The BMJ</itunes:author>
	<itunes:category text="Health &amp; Fitness">
		<itunes:category text="Medicine" />
	</itunes:category>
    <itunes:owner>
        <itunes:name>The BMJ</itunes:name>
            </itunes:owner>
    	<itunes:block>No</itunes:block>
	<itunes:explicit>false</itunes:explicit>
	<itunes:new-feed-url>https://feed.podbean.com/thebmjpodcast/feed.xml</itunes:new-feed-url>
    <itunes:image href="https://pbcdn1.podbean.com/imglogo/image-logo/16196630/The-BMJ.jpg" />
    <image>
        <url>https://pbcdn1.podbean.com/imglogo/image-logo/16196630/The-BMJ.jpg</url>
        <title>Medicine and Science from The BMJ</title>
        <link>https://thebmjpodcast.podbean.com</link>
        <width>144</width>
        <height>144</height>
    </image>
    <item>
        <title>Food industry nutrition advisor conflicts, and regulation of healthcare AI</title>
        <itunes:title>Food industry nutrition advisor conflicts, and regulation of healthcare AI</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/food-industry-nutrition-advisor-conflicts-and-regulation-of-healthcare-ai/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/food-industry-nutrition-advisor-conflicts-and-regulation-of-healthcare-ai/#comments</comments>        <pubDate>Fri, 11 Sep 2026 17:26:55 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/9822c668-7786-3aa5-9221-09d7fb46a6e3</guid>
                                    <description><![CDATA[<p>Back in 2024, the BMJ revealed how more than half of the members of the UK government's Scientific Advisory Committee on Nutrition, had declared financial interests with food and drinks companies. </p>
<p>A tightening of the rules followed, but two years after our initial investigation, we have returned - and we found that nearly a third of nutrition advisors still have significant ties to the food industry.</p>
<p>Chris Van Tulleken, professor of infection and immunology at University College London, and author of the book “Ultra Processed People”, joins us to explain why he thinks ongoing industry ties are bad for the UK's health.</p>
<p> </p>
<p>Also this week. We have tight regulation of medical tech in the UK, but new AI tools don’t fit neatly into that existing process - and so the government has set up a National Commission on the Regulation of AI in Healthcare, </p>
<p> Alastair Denniston, and Henrietta Hughes, who headed that commission, join us to explain how AI should be monitored, how we can ensure it's safety, and who should be responsible when something goes wrong.</p>
<p> </p>
<p>Reading list:</p>
<p><a href='https://www.bmj.com/content/394/bmj-2026-100768'>A third of UK government’s nutrition advisers are still paid by food industry, including Coca Cola and Nestlé</a></p>
<p><a href='https://www.gov.uk/government/publications/national-commission-into-the-regulation-of-ai-in-healthcare-recommendations-for-a-future-regulatory-framework'>National Commission into the Regulation of AI in Healthcare: Recommendations for a future regulatory framework</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Back in 2024, the BMJ revealed how more than half of the members of the UK government's Scientific Advisory Committee on Nutrition, had declared financial interests with food and drinks companies. </p>
<p>A tightening of the rules followed, but two years after our initial investigation, we have returned - and we found that nearly a third of nutrition advisors still have significant ties to the food industry.</p>
<p>Chris Van Tulleken, professor of infection and immunology at University College London, and author of the book “Ultra Processed People”, joins us to explain why he thinks ongoing industry ties are bad for the UK's health.</p>
<p> </p>
<p>Also this week. We have tight regulation of medical tech in the UK, but new AI tools don’t fit neatly into that existing process - and so the government has set up a National Commission on the Regulation of AI in Healthcare, </p>
<p> Alastair Denniston, and Henrietta Hughes, who headed that commission, join us to explain how AI should be monitored, how we can ensure it's safety, and who should be responsible when something goes wrong.</p>
<p> </p>
<p>Reading list:</p>
<p><a href='https://www.bmj.com/content/394/bmj-2026-100768'>A third of UK government’s nutrition advisers are still paid by food industry, including Coca Cola and Nestlé</a></p>
<p><a href='https://www.gov.uk/government/publications/national-commission-into-the-regulation-of-ai-in-healthcare-recommendations-for-a-future-regulatory-framework'>National Commission into the Regulation of AI in Healthcare: Recommendations for a future regulatory framework</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/b6inzwefctqyi36c/med_sci_pod_11_sep_266zet7.mp3" length="54795453" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Back in 2024, the BMJ revealed how more than half of the members of the UK government's Scientific Advisory Committee on Nutrition, had declared financial interests with food and drinks companies. 
A tightening of the rules followed, but two years after our initial investigation, we have returned - and we found that nearly a third of nutrition advisors still have significant ties to the food industry.
Chris Van Tulleken, professor of infection and immunology at University College London, and author of the book “Ultra Processed People”, joins us to explain why he thinks ongoing industry ties are bad for the UK's health.
 
Also this week. We have tight regulation of medical tech in the UK, but new AI tools don’t fit neatly into that existing process - and so the government has set up a National Commission on the Regulation of AI in Healthcare, 
 Alastair Denniston, and Henrietta Hughes, who headed that commission, join us to explain how AI should be monitored, how we can ensure it's safety, and who should be responsible when something goes wrong.
 
Reading list:
A third of UK government’s nutrition advisers are still paid by food industry, including Coca Cola and Nestlé
National Commission into the Regulation of AI in Healthcare: Recommendations for a future regulatory framework]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2282</itunes:duration>
                <itunes:episode>97</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Now is a golden opportunity to change primary care</title>
        <itunes:title>Now is a golden opportunity to change primary care</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/now-is-a-golden-opportunity-to-change-primary-care/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/now-is-a-golden-opportunity-to-change-primary-care/#comments</comments>        <pubDate>Fri, 04 Sep 2026 18:23:27 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/4b44ad3b-bef4-39e5-9d21-e4959cce0a46</guid>
                                    <description><![CDATA[<p>The next few months might be an inflection point for GPs in England and Wales </p>
<p>Our strong primary care system is often credited in the success of the NHS - But changes to how that system works are currently underway. Legislation is quietly proceeding through parliament that will reorganise the way in which local care is structured, and those changes are raising concerns for GPs.</p>
<p>To talk about how we build a stronger primary care system, and stronger NHS we're joined by:</p>
<ul>
<li style="font-weight:400;">Victoria Tzortziou Brown, president of the Royal College of General Practitioners</li>
<li style="font-weight:400;">Sam Everington, a GP in East London, and a non-executive director of NHS England</li>
<li style="font-weight:400;">Kamila Hawthorne, GP in South Wales, and chair of National Academy for Social Prescribing</li>
</ul>
<p>We also take the opportunity to hear about where social prescribing fits into this new picture, and why our panel think it's important in changing the UK's health.</p>
<p>Reading list</p>
<p><a href='https://www.bmj.com/content/394/bmj-2026-100707'>Building a stronger NHS: an open letter from past and present presidents and chairs of the Royal College of General Practitioners</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The next few months might be an inflection point for GPs in England and Wales </p>
<p>Our strong primary care system is often credited in the success of the NHS - But changes to how that system works are currently underway. Legislation is quietly proceeding through parliament that will reorganise the way in which local care is structured, and those changes are raising concerns for GPs.</p>
<p>To talk about how we build a stronger primary care system, and stronger NHS we're joined by:</p>
<ul>
<li style="font-weight:400;">Victoria Tzortziou Brown, president of the Royal College of General Practitioners</li>
<li style="font-weight:400;">Sam Everington, a GP in East London, and a non-executive director of NHS England</li>
<li style="font-weight:400;">Kamila Hawthorne, GP in South Wales, and chair of National Academy for Social Prescribing</li>
</ul>
<p>We also take the opportunity to hear about where social prescribing fits into this new picture, and why our panel think it's important in changing the UK's health.</p>
<p>Reading list</p>
<p><a href='https://www.bmj.com/content/394/bmj-2026-100707'>Building a stronger NHS: an open letter from past and present presidents and chairs of the Royal College of General Practitioners</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2y8zdjgbp9qjcaij/An_opportunity_to_really_change_primary_care6ifpi.mp3" length="29812103" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The next few months might be an inflection point for GPs in England and Wales 
Our strong primary care system is often credited in the success of the NHS - But changes to how that system works are currently underway. Legislation is quietly proceeding through parliament that will reorganise the way in which local care is structured, and those changes are raising concerns for GPs.
To talk about how we build a stronger primary care system, and stronger NHS we're joined by:

Victoria Tzortziou Brown, president of the Royal College of General Practitioners
Sam Everington, a GP in East London, and a non-executive director of NHS England
Kamila Hawthorne, GP in South Wales, and chair of National Academy for Social Prescribing

We also take the opportunity to hear about where social prescribing fits into this new picture, and why our panel think it's important in changing the UK's health.
Reading list
Building a stronger NHS: an open letter from past and present presidents and chairs of the Royal College of General Practitioners]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1862</itunes:duration>
                <itunes:episode>96</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>When medical exams go wrong, &amp; CTE in the NFL</title>
        <itunes:title>When medical exams go wrong, &amp; CTE in the NFL</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/when-medical-exams-go-wrong-cte-in-the-nfl/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/when-medical-exams-go-wrong-cte-in-the-nfl/#comments</comments>        <pubDate>Fri, 28 Aug 2026 18:03:36 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/8d2c029a-9c4f-3026-85d5-4f93a277d69b</guid>
                                    <description><![CDATA[<p>In this week’s podcast we’ll be hearing a lot about exams - the bane of many doctor’s training lives, exams that determine your future are scattered through medicine and can cause a huge amount of anxiety and stress…</p>
<p> </p>
<p>John McLachlan, professor of medical education at the University of Lancashire, has carried out four reviews of medical exams. He explains what happens to the people who have been marked wrongly, why he thinks re-sits should be done differently, and why multiple choice questions are still in use.</p>
<p> </p>
<p>Over the Summer there have been extensive protests from the young people of India, the “Cockroach Janta Party” has led demonstrations across the country, sparked by allegations of cheating in India’s “NEET” exams - the federal tests taken by applicants to India's medical training.</p>
<p> </p>
<p>Rohan Krishnan, orthopaedic surgeon in Delhi, and chief of the Federation of All India Medical Association, and Kathir Karuppiah, a house surgeon in Tamil Nadu, join us to explain where India's medical admissions tests are failing students.</p>
<p> </p>
<p>We’ll also hear about new research into Chronic Traumatic Encephalopathy in NFL players.  Daniel Daneshvar is associate professor at Harvard Medical School, and he and his co-authors have examined the brains of 338 former players, with the goal of determining how many of them died with CTE neurodegeneration. He joins us to explain his findings, and what it means for competitive sports players and others who play contact sports.</p>
<p> </p>
<p>Reading list:</p>
<p> </p>
<p><a href='https://www.bmj.com/content/394/bmj-2026-100429'>“Cockroach” victory: India’s education minister resigns over medical exam scandal linked to 12 suicides</a></p>
<p> </p>
<p><a href='https://www.bmj.com/content/394/bmj-2026-100707'>Prevalence of chronic traumatic encephalopathy at death in National Football League players: retrospective population based cohort study, 2008-21</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this week’s podcast we’ll be hearing a lot about exams - the bane of many doctor’s training lives, exams that determine your future are scattered through medicine and can cause a huge amount of anxiety and stress…</p>
<p> </p>
<p>John McLachlan, professor of medical education at the University of Lancashire, has carried out four reviews of medical exams. He explains what happens to the people who have been marked wrongly, why he thinks re-sits should be done differently, and why multiple choice questions are still in use.</p>
<p> </p>
<p>Over the Summer there have been extensive protests from the young people of India, the “Cockroach Janta Party” has led demonstrations across the country, sparked by allegations of cheating in India’s “NEET” exams - the federal tests taken by applicants to India's medical training.</p>
<p> </p>
<p>Rohan Krishnan, orthopaedic surgeon in Delhi, and chief of the Federation of All India Medical Association, and Kathir Karuppiah, a house surgeon in Tamil Nadu, join us to explain where India's medical admissions tests are failing students.</p>
<p> </p>
<p>We’ll also hear about new research into Chronic Traumatic Encephalopathy in NFL players.  Daniel Daneshvar is associate professor at Harvard Medical School, and he and his co-authors have examined the brains of 338 former players, with the goal of determining how many of them died with CTE neurodegeneration. He joins us to explain his findings, and what it means for competitive sports players and others who play contact sports.</p>
<p> </p>
<p>Reading list:</p>
<p> </p>
<p><a href='https://www.bmj.com/content/394/bmj-2026-100429'>“Cockroach” victory: India’s education minister resigns over medical exam scandal linked to 12 suicides</a></p>
<p> </p>
<p><a href='https://www.bmj.com/content/394/bmj-2026-100707'>Prevalence of chronic traumatic encephalopathy at death in National Football League players: retrospective population based cohort study, 2008-21</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ezafv2ezretc6xbm/bmjpod_280826_mixdown88x8l.mp3" length="71213225" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this week’s podcast we’ll be hearing a lot about exams - the bane of many doctor’s training lives, exams that determine your future are scattered through medicine and can cause a huge amount of anxiety and stress…
 
John McLachlan, professor of medical education at the University of Lancashire, has carried out four reviews of medical exams. He explains what happens to the people who have been marked wrongly, why he thinks re-sits should be done differently, and why multiple choice questions are still in use.
 
Over the Summer there have been extensive protests from the young people of India, the “Cockroach Janta Party” has led demonstrations across the country, sparked by allegations of cheating in India’s “NEET” exams - the federal tests taken by applicants to India's medical training.
 
Rohan Krishnan, orthopaedic surgeon in Delhi, and chief of the Federation of All India Medical Association, and Kathir Karuppiah, a house surgeon in Tamil Nadu, join us to explain where India's medical admissions tests are failing students.
 
We’ll also hear about new research into Chronic Traumatic Encephalopathy in NFL players.  Daniel Daneshvar is associate professor at Harvard Medical School, and he and his co-authors have examined the brains of 338 former players, with the goal of determining how many of them died with CTE neurodegeneration. He joins us to explain his findings, and what it means for competitive sports players and others who play contact sports.
 
Reading list:
 
“Cockroach” victory: India’s education minister resigns over medical exam scandal linked to 12 suicides
 
Prevalence of chronic traumatic encephalopathy at death in National Football League players: retrospective population based cohort study, 2008-21]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2966</itunes:duration>
                <itunes:episode>95</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AI in healthcare - getting it right, and stopping it going wrong</title>
        <itunes:title>AI in healthcare - getting it right, and stopping it going wrong</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/ai-getting-it-right-and-stopping-it-going-wrong-in-healthcare/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/ai-getting-it-right-and-stopping-it-going-wrong-in-healthcare/#comments</comments>        <pubDate>Fri, 21 Aug 2026 16:35:08 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/19735a1a-650c-3486-9294-0a04ba845d76</guid>
                                    <description><![CDATA[<p>This week we’re focusing on how healthcare is using AI systems. The NHS is firmly set on a course of AI integration, with NHS England committing £10 billion of taxpayer funds to the cause over the next three years. The pressure to implement AI in our hospitals is intense. But, how can healthcare leaders know what makes for a good AI adoption strategy? Victor Montori and Jon Tilburt are physicians from the US’ Mayo Clinic. They join us to lay out what they are calling the ‘five red flags’ that any organisation needs to consider in its AI rollout.</p>
<p> </p>
<p>The UK is already having this conversation. The National Commission into the Regulation of AI in Healthcare released its initial report in June of this year. Among its findings was a call for a ‘lifecycle-based approach’ to regulation. To explain what this means, as well as how doctors can be equipped to ‘surveil’ AI systems as conditions evolve, we’re joined by the co-authors of a new BMJ editorial - Mark Ball from the University of Derby, and Elvira Perez Vallejos from the University of Nottingham.</p>
<p> </p>
<p>And lastly, we talk about a research paper from last week that sparked off some concern. Researchers at Stanford University in California have used generative AI to design novel bacteriophage viruses. But, what have these scientists actually accomplished, and how can we put the right safeguards around the technology? Simon Clarke, associate professor in cellular microbiology at the University of Reading, explains the breakthrough and lays out its real implications.</p>
<p> </p>
<p>References:</p>
<p><a href='https://www.bmj.com/content/394/bmj-2026-100589'>We can, but should we? Red flags for hasty, low integrity AI integration into healthcare</a></p>
<p><a href='https://www.bmj.com/content/394/bmj-2026-100555'>Regulating AI in healthcare: a moving target</a></p>
<p><a href='https://www.bmj.com/content/394/bmj-2026-100572'>Developments in AI designed viruses demonstrate why such research must be done in the open</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week we’re focusing on how healthcare is using AI systems. The NHS is firmly set on a course of AI integration, with NHS England committing £10 billion of taxpayer funds to the cause over the next three years. The pressure to implement AI in our hospitals is intense. But, how can healthcare leaders know what makes for a good AI adoption strategy? Victor Montori and Jon Tilburt are physicians from the US’ Mayo Clinic. They join us to lay out what they are calling the ‘five red flags’ that any organisation needs to consider in its AI rollout.</p>
<p> </p>
<p>The UK is already having this conversation. The National Commission into the Regulation of AI in Healthcare released its initial report in June of this year. Among its findings was a call for a ‘lifecycle-based approach’ to regulation. To explain what this means, as well as how doctors can be equipped to ‘surveil’ AI systems as conditions evolve, we’re joined by the co-authors of a new BMJ editorial - Mark Ball from the University of Derby, and Elvira Perez Vallejos from the University of Nottingham.</p>
<p> </p>
<p>And lastly, we talk about a research paper from last week that sparked off some concern. Researchers at Stanford University in California have used generative AI to design novel bacteriophage viruses. But, what have these scientists actually accomplished, and how can we put the right safeguards around the technology? Simon Clarke, associate professor in cellular microbiology at the University of Reading, explains the breakthrough and lays out its real implications.</p>
<p> </p>
<p>References:</p>
<p><a href='https://www.bmj.com/content/394/bmj-2026-100589'>We can, but should we? Red flags for hasty, low integrity AI integration into healthcare</a></p>
<p><a href='https://www.bmj.com/content/394/bmj-2026-100555'>Regulating AI in healthcare: a moving target</a></p>
<p><a href='https://www.bmj.com/content/394/bmj-2026-100572'>Developments in AI designed viruses demonstrate why such research must be done in the open</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fxde9k4rrmge35pn/AI_-_virus_regulation_and_implimentation7ev09.mp3" length="36971111" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week we’re focusing on how healthcare is using AI systems. The NHS is firmly set on a course of AI integration, with NHS England committing £10 billion of taxpayer funds to the cause over the next three years. The pressure to implement AI in our hospitals is intense. But, how can healthcare leaders know what makes for a good AI adoption strategy? Victor Montori and Jon Tilburt are physicians from the US’ Mayo Clinic. They join us to lay out what they are calling the ‘five red flags’ that any organisation needs to consider in its AI rollout.
 
The UK is already having this conversation. The National Commission into the Regulation of AI in Healthcare released its initial report in June of this year. Among its findings was a call for a ‘lifecycle-based approach’ to regulation. To explain what this means, as well as how doctors can be equipped to ‘surveil’ AI systems as conditions evolve, we’re joined by the co-authors of a new BMJ editorial - Mark Ball from the University of Derby, and Elvira Perez Vallejos from the University of Nottingham.
 
And lastly, we talk about a research paper from last week that sparked off some concern. Researchers at Stanford University in California have used generative AI to design novel bacteriophage viruses. But, what have these scientists actually accomplished, and how can we put the right safeguards around the technology? Simon Clarke, associate professor in cellular microbiology at the University of Reading, explains the breakthrough and lays out its real implications.
 
References:
We can, but should we? Red flags for hasty, low integrity AI integration into healthcare
Regulating AI in healthcare: a moving target
Developments in AI designed viruses demonstrate why such research must be done in the open]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2309</itunes:duration>
                <itunes:episode>94</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>New analysis on Bipolar treatment, and vaccines for malaria</title>
        <itunes:title>New analysis on Bipolar treatment, and vaccines for malaria</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/new-analysis-on-bipolar-treatment-and-vaccines-for-malaria/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/new-analysis-on-bipolar-treatment-and-vaccines-for-malaria/#comments</comments>        <pubDate>Fri, 14 Aug 2026 16:42:34 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/05831101-953c-3c9c-82a7-060696740004</guid>
                                    <description><![CDATA[<p>Bipolar disorder affects almost 40 million people worldwide, but finding the right treatment is complex, and nearly half of patients struggle to follow their prescribed treatment plans.</p>
<p> </p>
<p>In the first part of this episode, we discuss new research which aims to help patients and their doctors identify the right treatment. Michele De Prisco, psychiatrist and researcher at the Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques, joins us to discuss his team's comprehensive umbrella analysis of bipolar disorder treatment options.</p>
<p> </p>
<p>Also this week, with the malaria vaccines RTS,S and R21 passing regulatory hurdles, and becoming available for populations around the world, the fight against malaria is shifting. Gillian Turner, Principal Research Associate at the Liverpool School of Tropical Medicine, explains the logistical challenges of the malaria vaccine rollout and what steps are needed next to control the disease.</p>
<p>
Reading list:</p>
<p> </p>
<p><a href='https://www.bmj.com/content/394/bmj-2026-100216'>Evidence based interventions for bipolar disorder across phases and age groups</a></p>
<p> </p>
<p><a href='https://www.bmj.com/content/394/bmj-2026-100502'>Scaling up Malaria Vaccines in Africa</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Bipolar disorder affects almost 40 million people worldwide, but finding the right treatment is complex, and nearly half of patients struggle to follow their prescribed treatment plans.</p>
<p> </p>
<p>In the first part of this episode, we discuss new research which aims to help patients and their doctors identify the right treatment. Michele De Prisco, psychiatrist and researcher at the Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques, joins us to discuss his team's comprehensive umbrella analysis of bipolar disorder treatment options.</p>
<p> </p>
<p>Also this week, with the malaria vaccines RTS,S and R21 passing regulatory hurdles, and becoming available for populations around the world, the fight against malaria is shifting. Gillian Turner, Principal Research Associate at the Liverpool School of Tropical Medicine, explains the logistical challenges of the malaria vaccine rollout and what steps are needed next to control the disease.</p>
<p><br>
Reading list:</p>
<p> </p>
<p><a href='https://www.bmj.com/content/394/bmj-2026-100216'>Evidence based interventions for bipolar disorder across phases and age groups</a></p>
<p> </p>
<p><a href='https://www.bmj.com/content/394/bmj-2026-100502'>Scaling up Malaria Vaccines in Africa</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/va9wejdskrz4gwm8/bmjpod_140826_mixdown93kg1.mp3" length="49770379" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Bipolar disorder affects almost 40 million people worldwide, but finding the right treatment is complex, and nearly half of patients struggle to follow their prescribed treatment plans.
 
In the first part of this episode, we discuss new research which aims to help patients and their doctors identify the right treatment. Michele De Prisco, psychiatrist and researcher at the Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques, joins us to discuss his team's comprehensive umbrella analysis of bipolar disorder treatment options.
 
Also this week, with the malaria vaccines RTS,S and R21 passing regulatory hurdles, and becoming available for populations around the world, the fight against malaria is shifting. Gillian Turner, Principal Research Associate at the Liverpool School of Tropical Medicine, explains the logistical challenges of the malaria vaccine rollout and what steps are needed next to control the disease.
Reading list:
 
Evidence based interventions for bipolar disorder across phases and age groups
 
Scaling up Malaria Vaccines in Africa]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2073</itunes:duration>
                <itunes:episode>93</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>We need to understand how global market forces undermine healthcare</title>
        <itunes:title>We need to understand how global market forces undermine healthcare</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/we-need-to-understand-how-global-market-forces-undermine-healthcare/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/we-need-to-understand-how-global-market-forces-undermine-healthcare/#comments</comments>        <pubDate>Fri, 07 Aug 2026 17:49:24 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/c0f85671-06ff-3e94-84c6-438437145f55</guid>
                                    <description><![CDATA[<p>This week we focus on the external forces that shape medicine and healthcare. </p>
<p>Global health is changing, after the reduction in financing from wealthy nations, the global community are beginning to implement reforms to improve the situation. However, any change will be unsuccessful until we tackle the fundamental structures that govern outcomes, argue Daniel Bernal-Serrano and Omar Gabriel Torres Valencia from the London School of Hygiene and Tropical Medicine. They join us to explain how economic forces, wealth distribution, and market dynamics undermine health outcomes.</p>
<p>We also learn about the rapid rise in private equity financing of healthcare in the UK, and the dangers that poses to healthcare quality. Bernd Rechel is a researcher at the European Observatory on Health Systems and Policies, and explains how different countries are handling this drive for healthcare profit extraction.</p>
<p> </p>
<p>Reading list:</p>
<ul>
<li><a href='https://www.bmj.com/content/394/bmj-2026-100432'>Private equity involvement in UK healthcare</a></li>
<li><a href='https://www.bmj.com/content/394/bmj-2026-100315'>Reforming global health architecture requires confronting its political economy</a></li>
</ul>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week we focus on the external forces that shape medicine and healthcare. </p>
<p>Global health is changing, after the reduction in financing from wealthy nations, the global community are beginning to implement reforms to improve the situation. However, any change will be unsuccessful until we tackle the fundamental structures that govern outcomes, argue Daniel Bernal-Serrano and Omar Gabriel Torres Valencia from the London School of Hygiene and Tropical Medicine. They join us to explain how economic forces, wealth distribution, and market dynamics undermine health outcomes.</p>
<p>We also learn about the rapid rise in private equity financing of healthcare in the UK, and the dangers that poses to healthcare quality. Bernd Rechel is a researcher at the European Observatory on Health Systems and Policies, and explains how different countries are handling this drive for healthcare profit extraction.</p>
<p> </p>
<p>Reading list:</p>
<ul>
<li><a href='https://www.bmj.com/content/394/bmj-2026-100432'>Private equity involvement in UK healthcare</a></li>
<li><a href='https://www.bmj.com/content/394/bmj-2026-100315'>Reforming global health architecture requires confronting its political economy</a></li>
</ul>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7eyz6arusb4pv8c9/med_sci_7_aug_26bpr6r.mp3" length="41550401" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week we focus on the external forces that shape medicine and healthcare. 
Global health is changing, after the reduction in financing from wealthy nations, the global community are beginning to implement reforms to improve the situation. However, any change will be unsuccessful until we tackle the fundamental structures that govern outcomes, argue Daniel Bernal-Serrano and Omar Gabriel Torres Valencia from the London School of Hygiene and Tropical Medicine. They join us to explain how economic forces, wealth distribution, and market dynamics undermine health outcomes.
We also learn about the rapid rise in private equity financing of healthcare in the UK, and the dangers that poses to healthcare quality. Bernd Rechel is a researcher at the European Observatory on Health Systems and Policies, and explains how different countries are handling this drive for healthcare profit extraction.
 
Reading list:

Private equity involvement in UK healthcare
Reforming global health architecture requires confronting its political economy
]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2596</itunes:duration>
                <itunes:episode>92</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Are doctors afraid of death?</title>
        <itunes:title>Are doctors afraid of death?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/are-doctors-afraid-of-death/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/are-doctors-afraid-of-death/#comments</comments>        <pubDate>Fri, 31 Jul 2026 15:57:28 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/b4de69d9-7d0f-389c-8f7a-012aa0ff00d4</guid>
                                    <description><![CDATA[<p id="p-rc_1d515ade8120eec7-25">In this week's podcast - the Sensitivity of Patient Questionnaires: If you've ever asked a patient to fill out a Patient Health Questionnaire (like the PHQ-9) to assess their mental health and wondered exactly how much of a change it can actually detect, new research just published on bmj.com sets out to answer that question. We're joined by Brett Thombs, Professor in the department of Psychiatry at McGill University</p>
<p id="p-rc_1d515ade8120eec7-26">Also this week, Are Doctors Scared of Death? BMJ Careers Editor Abi Rimmer sits down in the studio with Richard Coker, Emeritus Professor of Public Health at LSHTM. Drawing from his early days as an HIV doctor during the onset of the AIDS epidemic, and later with infectious disease outbreaks in South East Asia. Professor Coker discusses the profound experiences of the end of his patients lives that shaped his new book, Timor Mortis: How We Live with Death.</p>
<p>Reading list:</p>
<p id="p-rc_1d515ade8120eec7-27"><a href='https://www.bmj.com/content/394/bmj-2026-100119'>Minimal detectable change of the Patient Health Questionnaire-9, Patient Health Questionnaire-8, and Patient Health Questionnaire-2`</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p id="p-rc_1d515ade8120eec7-25">In this week's podcast - the Sensitivity of Patient Questionnaires: If you've ever asked a patient to fill out a Patient Health Questionnaire (like the PHQ-9) to assess their mental health and wondered exactly how much of a change it can actually detect, new research just published on bmj.com sets out to answer that question. We're joined by Brett Thombs, Professor in the department of Psychiatry at McGill University</p>
<p id="p-rc_1d515ade8120eec7-26">Also this week, Are Doctors Scared of Death? BMJ Careers Editor Abi Rimmer sits down in the studio with Richard Coker, Emeritus Professor of Public Health at LSHTM. Drawing from his early days as an HIV doctor during the onset of the AIDS epidemic, and later with infectious disease outbreaks in South East Asia. Professor Coker discusses the profound experiences of the end of his patients lives that shaped his new book, <em>Timor Mortis: How We Live with Death</em>.</p>
<p>Reading list:</p>
<p id="p-rc_1d515ade8120eec7-27"><a href='https://www.bmj.com/content/394/bmj-2026-100119'>Minimal detectable change of the Patient Health Questionnaire-9, Patient Health Questionnaire-8, and Patient Health Questionnaire-2`</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/f5pswjxew9hcqdkz/Med_sci_pod_31st_July6afs1.mp3" length="71736926" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this week's podcast - the Sensitivity of Patient Questionnaires: If you've ever asked a patient to fill out a Patient Health Questionnaire (like the PHQ-9) to assess their mental health and wondered exactly how much of a change it can actually detect, new research just published on bmj.com sets out to answer that question. We're joined by Brett Thombs, Professor in the department of Psychiatry at McGill University
Also this week, Are Doctors Scared of Death? BMJ Careers Editor Abi Rimmer sits down in the studio with Richard Coker, Emeritus Professor of Public Health at LSHTM. Drawing from his early days as an HIV doctor during the onset of the AIDS epidemic, and later with infectious disease outbreaks in South East Asia. Professor Coker discusses the profound experiences of the end of his patients lives that shaped his new book, Timor Mortis: How We Live with Death.
Reading list:
Minimal detectable change of the Patient Health Questionnaire-9, Patient Health Questionnaire-8, and Patient Health Questionnaire-2`]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2988</itunes:duration>
                <itunes:episode>91</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Is Burnham's 'Manchesterism' the fix for health &amp; social care?</title>
        <itunes:title>Is Burnham's 'Manchesterism' the fix for health &amp; social care?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/what-manchesterism-and-devolved-power-might-mean-for-healthcare/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/what-manchesterism-and-devolved-power-might-mean-for-healthcare/#comments</comments>        <pubDate>Fri, 24 Jul 2026 17:27:37 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/fd9301ce-7832-3453-aefa-3a9c412beda8</guid>
                                    <description><![CDATA[<p>Known for his use of devolved powers, during his tenure as Mayor of Greater Manchester, Andy Burnham now has the opportunity to bring his local blueprint to the national stage. But what does this mean for the future of health and social care?</p>
<p>Our panel explore the deeply rooted health inequalities tied to the social determinants of health, the disconnect between local decision-making and national infrastructure, and the urgent need to extend the ability to access social care to more of England's population.</p>
<p>We're joined by</p>
<ul>
<li>
<p>Michael Marmot: Professor of Epidemiology and Public Health at University College London (UCL) and author of the landmark Marmot Review.</p>
</li>
<li>
<p>Sarah Woolnough: Chief Executive of the health think tank, The King's Fund.</p>
</li>
<li>
<p>Matt Sutton: Professor of Health Economics at the University of Manchester.</p>
</li>
</ul>
Reading List
<ul>
<li>
<p><a href='https://www.bmj.com/content/394/bmj-2026-100380'>Devolution can create new opportunities for</a><a href='https://www.bmj.com/content/394/bmj-2026-100380'> </a><a href='https://www.bmj.com/content/394/bmj-2026-100380'>better </a><a href='https://www.bmj.com/content/394/bmj-2026-100380'>health</a></p>
</li>
<li>
<p><a href='https://www.bmj.com/content/394/bmj-2026-100274'>Will devolving powers to mayors close England’s health gap?</a></p>
</li>
<li>
<p><a href='https://www.bmj.com/content/394/bmj-2026-100349'>Andy Burnham’s goal of good growth could be a health-creating mission that supports environmental action</a></p>
</li>
<li><a href='https://www.kingsfund.org.uk/insight-and-analysis/press-releases/the-kings-fund-responds-to-yvette-coopers-appointment-secretary-state-health-social-care'>The King's Fund responds to Andy Burnham’s comments on social care </a></li>
</ul>
]]></description>
                                                            <content:encoded><![CDATA[<p>Known for his use of devolved powers, during his tenure as Mayor of Greater Manchester, Andy Burnham now has the opportunity to bring his local blueprint to the national stage. But what does this mean for the future of health and social care?</p>
<p>Our panel explore the deeply rooted health inequalities tied to the social determinants of health, the disconnect between local decision-making and national infrastructure, and the urgent need to extend the ability to access social care to more of England's population.</p>
<p>We're joined by</p>
<ul>
<li>
<p>Michael Marmot: Professor of Epidemiology and Public Health at University College London (UCL) and author of the landmark Marmot Review.</p>
</li>
<li>
<p>Sarah Woolnough: Chief Executive of the health think tank, The King's Fund.</p>
</li>
<li>
<p>Matt Sutton: Professor of Health Economics at the University of Manchester.</p>
</li>
</ul>
Reading List
<ul>
<li>
<p><a href='https://www.bmj.com/content/394/bmj-2026-100380'>Devolution can create new opportunities for</a><a href='https://www.bmj.com/content/394/bmj-2026-100380'> </a><a href='https://www.bmj.com/content/394/bmj-2026-100380'>better </a><a href='https://www.bmj.com/content/394/bmj-2026-100380'>health</a></p>
</li>
<li>
<p><a href='https://www.bmj.com/content/394/bmj-2026-100274'>Will devolving powers to mayors close England’s health gap?</a></p>
</li>
<li>
<p><a href='https://www.bmj.com/content/394/bmj-2026-100349'>Andy Burnham’s goal of good growth could be a health-creating mission that supports environmental action</a></p>
</li>
<li><a href='https://www.kingsfund.org.uk/insight-and-analysis/press-releases/the-kings-fund-responds-to-yvette-coopers-appointment-secretary-state-health-social-care'>The King's Fund responds to Andy Burnham’s comments on social care </a></li>
</ul>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6j4vmnmvb7yy9uzm/Manchesterism_mixdown9kcy1.mp3" length="71624722" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Known for his use of devolved powers, during his tenure as Mayor of Greater Manchester, Andy Burnham now has the opportunity to bring his local blueprint to the national stage. But what does this mean for the future of health and social care?
Our panel explore the deeply rooted health inequalities tied to the social determinants of health, the disconnect between local decision-making and national infrastructure, and the urgent need to extend the ability to access social care to more of England's population.
We're joined by


Michael Marmot: Professor of Epidemiology and Public Health at University College London (UCL) and author of the landmark Marmot Review.


Sarah Woolnough: Chief Executive of the health think tank, The King's Fund.


Matt Sutton: Professor of Health Economics at the University of Manchester.


Reading List


Devolution can create new opportunities for better health


Will devolving powers to mayors close England’s health gap?


Andy Burnham’s goal of good growth could be a health-creating mission that supports environmental action

The King's Fund responds to Andy Burnham’s comments on social care 
]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2983</itunes:duration>
                <itunes:episode>90</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Measuring ethnicity in research, NHS job discrimination, and how medicine led evidence revolution</title>
        <itunes:title>Measuring ethnicity in research, NHS job discrimination, and how medicine led evidence revolution</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/measuring-ethnicity-in-research-nhs-job-discrimination-and-how-medicine-led-evidence-revolution/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/measuring-ethnicity-in-research-nhs-job-discrimination-and-how-medicine-led-evidence-revolution/#comments</comments>        <pubDate>Tue, 21 Jul 2026 16:25:00 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/daf386a9-b228-3955-875c-a370b86f6cef</guid>
                                    <description><![CDATA[<p>Discrimination in NHS Hiring: We examine the troubling success rates of Black and Asian doctors when applying for NHS jobs. Deputy news editor, Gareth Iacobucci speaks to Anthony Emmanushares his analysis on why discrimination persists in the medical workforce and what recent reports reveal.</p>
<p>The Ethnicity Data Gap in Research: While sex and gender are reported in 99% of trials, ethnicity is reported in only 48%. Bianca Brijnath, Professor of Health Communication in Society at La Trobe University, joins us to discuss a newly published framework aimed at standardizing the capture and reporting of ethnicity data in clinical trials.</p>
<p>The Evidence Revolution: We celebrate how evidence-based medicine (EBM) has set the gold standard for other areas of science. Mun-Keat Looi, The BMJ’s International News and Features Editor, speaks with Nature editor and science journalist Helen Pearson about her new book, Beyond Belief: How Evidence Shows What Really Works.</p>
Reading List
<p><a href='https://www.bmj.com/content/394/bmj-2026-100228'>Black and Asian doctors are up to 30 times less likely to be offered medical training posts in some specialties, data show </a></p>
<p><a href='https://www.bmj.com/content/394/bmj-2026-409503'>Measurement of ethnicity in clinical trials: Delphi survey and consensus statement</a> </p>
<p>Beyond Belief: How Evidence Shows What Really Works by Helen Pearson </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Discrimination in NHS Hiring: We examine the troubling success rates of Black and Asian doctors when applying for NHS jobs. Deputy news editor, Gareth Iacobucci speaks to Anthony Emmanushares his analysis on why discrimination persists in the medical workforce and what recent reports reveal.</p>
<p>The Ethnicity Data Gap in Research: While sex and gender are reported in 99% of trials, ethnicity is reported in only 48%. Bianca Brijnath, Professor of Health Communication in Society at La Trobe University, joins us to discuss a newly published framework aimed at standardizing the capture and reporting of ethnicity data in clinical trials.</p>
<p>The Evidence Revolution: We celebrate how evidence-based medicine (EBM) has set the gold standard for other areas of science. Mun-Keat Looi, The BMJ’s International News and Features Editor, speaks with Nature editor and science journalist Helen Pearson about her new book, Beyond Belief: How Evidence Shows What Really Works.</p>
Reading List
<p><a href='https://www.bmj.com/content/394/bmj-2026-100228'>Black and Asian doctors are up to 30 times less likely to be offered medical training posts in some specialties, data show </a></p>
<p><a href='https://www.bmj.com/content/394/bmj-2026-409503'>Measurement of ethnicity in clinical trials: Delphi survey and consensus statement</a> </p>
<p>Beyond Belief: How Evidence Shows What Really Works by Helen Pearson </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/h9nbbj9v3frqv73x/Measuring_race_and_ethnicity_in_health_mixdown9pxa8.mp3" length="66026884" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Discrimination in NHS Hiring: We examine the troubling success rates of Black and Asian doctors when applying for NHS jobs. Deputy news editor, Gareth Iacobucci speaks to Anthony Emmanushares his analysis on why discrimination persists in the medical workforce and what recent reports reveal.
The Ethnicity Data Gap in Research: While sex and gender are reported in 99% of trials, ethnicity is reported in only 48%. Bianca Brijnath, Professor of Health Communication in Society at La Trobe University, joins us to discuss a newly published framework aimed at standardizing the capture and reporting of ethnicity data in clinical trials.
The Evidence Revolution: We celebrate how evidence-based medicine (EBM) has set the gold standard for other areas of science. Mun-Keat Looi, The BMJ’s International News and Features Editor, speaks with Nature editor and science journalist Helen Pearson about her new book, Beyond Belief: How Evidence Shows What Really Works.
Reading List
Black and Asian doctors are up to 30 times less likely to be offered medical training posts in some specialties, data show 
Measurement of ethnicity in clinical trials: Delphi survey and consensus statement 
Beyond Belief: How Evidence Shows What Really Works by Helen Pearson ]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2750</itunes:duration>
                <itunes:episode>89</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hands off our data: the need for sovereignty in a connected world</title>
        <itunes:title>Hands off our data: the need for sovereignty in a connected world</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/hands-off-our-data-the-need-for-sovereignty-in-a-connected-world/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/hands-off-our-data-the-need-for-sovereignty-in-a-connected-world/#comments</comments>        <pubDate>Fri, 10 Jul 2026 16:44:33 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/e0337e37-c88d-3e10-acaf-d02747ff11fb</guid>
                                    <description><![CDATA[Who actually owns our health data once it is stored in the cloud? And how do we balance the global push for open medical research with the need to protect local populations from data extraction?
Kamran Abbasi sits down with Trudie Lang, Professor of Global Health Research at the University of Oxford and David Strain, Associate Professor of Cardiometabolic Health at the University of Exeter.
Together, they dive into the complex ethical and legal landscape of data sovereignty - unpacking the loopholes that could allow the US government access to NHS data, and how medical research in resource poorer settings can be extractive of data. They set out the case for data sovereignty, and how it could practically work while not stifling essential international research collaboration
Read the related articles on BMJ.com:
The CLOUD Act: NHS data must be safeguarded from US interests by David Strain
A commitment to act on data sharing by Kamran Abbasi
Data sharing must evolve towards data sovereignty by Trudie Lang
]]></description>
                                                            <content:encoded><![CDATA[Who actually owns our health data once it is stored in the cloud? And how do we balance the global push for open medical research with the need to protect local populations from data extraction?
Kamran Abbasi sits down with Trudie Lang, Professor of Global Health Research at the University of Oxford and David Strain, Associate Professor of Cardiometabolic Health at the University of Exeter.
Together, they dive into the complex ethical and legal landscape of data sovereignty - unpacking the loopholes that could allow the US government access to NHS data, and how medical research in resource poorer settings can be extractive of data. They set out the case for data sovereignty, and how it could practically work while not stifling essential international research collaboration
Read the related articles on BMJ.com:
The CLOUD Act: NHS data must be safeguarded from US interests by David Strain
A commitment to act on data sharing by Kamran Abbasi
Data sharing must evolve towards data sovereignty by Trudie Lang
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jzkhg4jbrstwayhg/Med_sci_pod_10th_July_-_data_sovereignty_6xsnk.mp3" length="49997986" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Who actually owns our health data once it is stored in the cloud? And how do we balance the global push for open medical research with the need to protect local populations from data extraction?
Kamran Abbasi sits down with Trudie Lang, Professor of Global Health Research at the University of Oxford and David Strain, Associate Professor of Cardiometabolic Health at the University of Exeter.
Together, they dive into the complex ethical and legal landscape of data sovereignty - unpacking the loopholes that could allow the US government access to NHS data, and how medical research in resource poorer settings can be extractive of data. They set out the case for data sovereignty, and how it could practically work while not stifling essential international research collaboration
Read the related articles on BMJ.com:
The CLOUD Act: NHS data must be safeguarded from US interests by David Strain
A commitment to act on data sharing by Kamran Abbasi
Data sharing must evolve towards data sovereignty by Trudie Lang
]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2082</itunes:duration>
                <itunes:episode>88</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>750 recommendations, and little change - why the UK keeps having maternity care reviews.</title>
        <itunes:title>750 recommendations, and little change - why the UK keeps having maternity care reviews.</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/placeholder_maternity_title/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/placeholder_maternity_title/#comments</comments>        <pubDate>Fri, 03 Jul 2026 21:37:59 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/9565b829-6298-3c0e-bf40-1a7915f19699</guid>
                                    <description><![CDATA[<p>Two NHS maternity reviews have been published over the past few weeks. The biggest ever conducted, involving nearly 2500 families, investigated services at Nottingham university hospitals NHS trust. It was led by senior midwife, Donna Ockenden, and its findings on poor and avoidable harm to babies and mothers have reverberated throughout UK healthcare.</p>
<p>This was followed immediately by publication of an independent investigation into maternity and neonatal services in England, conducted by Valerie Amos, which states that the UK's poor maternity care is "on a scale that shames our society".</p>
<p>We speak to  Kate Duhig, clinical senior lecturer at  Kings College London, and Marian Knight, professor of of maternal and child population health at the University of Oxford, about why we keep having reports saying the same thing, but little action to solve the problem.</p>
<p>As many wealthy nations have stepped back from previous aid promises, a new force has emerged to fill the gaps: private finance. David McCoy is professor of global public health at the United Nations University, and explains why turning to investment banks, wealth funds, and private equity in the pursuit of universal health coverage might cause more problems than it solves.</p>
<p> </p>
<p>Reading list:</p>
<p><a href='https://www.bmj.com/content/393/bmj-2026-210213?__cf_chl_f_tk=w90xiecd2m0tbjENJtTW.htHB3SW.7T7E0H4PVQQeuw-1783096695-1.0.1.1-zM4esi9KKkRZFGPfdVFsxVvLvMUplr.TYjognLd8fMU'>Dangers of finance capital in healthcare</a></p>
<p id="page-title" class="highwire-cite-title"><a href='https://www.bmj.com/content/393/bmj-2026-100127'>Amos maternity review: Doctors must work differently as units “no longer fit for purpose,” but report is dogged by controversy</a></p>
<p id="page-title" class="highwire-cite-title"><a href='https://www.bmj.com/content/393/bmj-2026-100083'>Nottingham maternity review: 520 mothers and babies were seriously harmed on “toxic” ward, damning inquiry finds</a></p>
<p id="page-title" class="highwire-cite-title"></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Two NHS maternity reviews have been published over the past few weeks. The biggest ever conducted, involving nearly 2500 families, investigated services at Nottingham university hospitals NHS trust. It was led by senior midwife, Donna Ockenden, and its findings on poor and avoidable harm to babies and mothers have reverberated throughout UK healthcare.</p>
<p>This was followed immediately by publication of an independent investigation into maternity and neonatal services in England, conducted by Valerie Amos, which states that the UK's poor maternity care is "on a scale that shames our society".</p>
<p>We speak to  Kate Duhig, clinical senior lecturer at  Kings College London, and Marian Knight, professor of of maternal and child population health at the University of Oxford, about why we keep having reports saying the same thing, but little action to solve the problem.</p>
<p>As many wealthy nations have stepped back from previous aid promises, a new force has emerged to fill the gaps: private finance. David McCoy is professor of global public health at the United Nations University, and explains why turning to investment banks, wealth funds, and private equity in the pursuit of universal health coverage might cause more problems than it solves.</p>
<p> </p>
<p>Reading list:</p>
<p><a href='https://www.bmj.com/content/393/bmj-2026-210213?__cf_chl_f_tk=w90xiecd2m0tbjENJtTW.htHB3SW.7T7E0H4PVQQeuw-1783096695-1.0.1.1-zM4esi9KKkRZFGPfdVFsxVvLvMUplr.TYjognLd8fMU'>Dangers of finance capital in healthcare</a></p>
<p id="page-title" class="highwire-cite-title"><a href='https://www.bmj.com/content/393/bmj-2026-100127'>Amos maternity review: Doctors must work differently as units “no longer fit for purpose,” but report is dogged by controversy</a></p>
<p id="page-title" class="highwire-cite-title"><a href='https://www.bmj.com/content/393/bmj-2026-100083'>Nottingham maternity review: 520 mothers and babies were seriously harmed on “toxic” ward, damning inquiry finds</a></p>
<p id="page-title" class="highwire-cite-title"></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7iamjz4rq4qnmcfx/med_sci_pod_-_3rd_july7iji0.mp3" length="67959104" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Two NHS maternity reviews have been published over the past few weeks. The biggest ever conducted, involving nearly 2500 families, investigated services at Nottingham university hospitals NHS trust. It was led by senior midwife, Donna Ockenden, and its findings on poor and avoidable harm to babies and mothers have reverberated throughout UK healthcare.
This was followed immediately by publication of an independent investigation into maternity and neonatal services in England, conducted by Valerie Amos, which states that the UK's poor maternity care is "on a scale that shames our society".
We speak to  Kate Duhig, clinical senior lecturer at  Kings College London, and Marian Knight, professor of of maternal and child population health at the University of Oxford, about why we keep having reports saying the same thing, but little action to solve the problem.
As many wealthy nations have stepped back from previous aid promises, a new force has emerged to fill the gaps: private finance. David McCoy is professor of global public health at the United Nations University, and explains why turning to investment banks, wealth funds, and private equity in the pursuit of universal health coverage might cause more problems than it solves.
 
Reading list:
Dangers of finance capital in healthcare
Amos maternity review: Doctors must work differently as units “no longer fit for purpose,” but report is dogged by controversy
Nottingham maternity review: 520 mothers and babies were seriously harmed on “toxic” ward, damning inquiry finds
]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2830</itunes:duration>
                <itunes:episode>87</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Children are bypassing the Australian social media ban</title>
        <itunes:title>Children are bypassing the Australian social media ban</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/children-are-bypassing-the-australian-social-media-ban/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/children-are-bypassing-the-australian-social-media-ban/#comments</comments>        <pubDate>Fri, 26 Jun 2026 15:50:20 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/a0e382d0-fc71-33bd-ad08-5ee8471b4748</guid>
                                    <description><![CDATA[<p>Australia has been in the vanguard of legislation to try and reduce the influence of social media on children and young people - their ban for under 16s was introduced on the 10th of December 2025, to great fanfare, and a lot of interest around the world.</p>
<p>But how effective are these bans at keeping children away from social media?</p>
<p>New research just published on BMJ.com has looked at that question of efficacy - finding that children are using the most simple tactics to evade the ban.</p>
<p>To dicuss what that means, we're joined by two of the authors of that research Courtney Barnes and Luke Wolfenden from the University of Newcastle, Australia.</p>
<p>We’re also joined by Amrit Purba, from the London School of Hygiene and Tropical Medicine, and Louise Holly, from the Digital Transformations for Health Lab, in Geneva, who have written commentaries to go with that research.</p>
<p> </p>
<p>Reading list</p>
<p><a href=''>Assessing early effects of Australia’s Social Media Minimum Age Act on adolescents’ social media use</a> </p>
<p><a href='https://www.bmj.com/content/393/bmj-2026-100017'>Learning from Australia’s social media age restriction policy</a>  </p>
<p><a href='https://www.bmj.com/content/393/bmj-2026-100024'>Early data from Australia indicate that social media companies can’t be relied on to protect children</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Australia has been in the vanguard of legislation to try and reduce the influence of social media on children and young people - their ban for under 16s was introduced on the 10th of December 2025, to great fanfare, and a lot of interest around the world.</p>
<p>But how effective are these bans at keeping children away from social media?</p>
<p>New research just published on BMJ.com has looked at that question of efficacy - finding that children are using the most simple tactics to evade the ban.</p>
<p>To dicuss what that means, we're joined by two of the authors of that research Courtney Barnes and Luke Wolfenden from the University of Newcastle, Australia.</p>
<p>We’re also joined by Amrit Purba, from the London School of Hygiene and Tropical Medicine, and Louise Holly, from the Digital Transformations for Health Lab, in Geneva, who have written commentaries to go with that research.</p>
<p> </p>
<p>Reading list</p>
<p><a href=''>Assessing early effects of Australia’s Social Media Minimum Age Act on adolescents’ social media use</a> </p>
<p><a href='https://www.bmj.com/content/393/bmj-2026-100017'>Learning from Australia’s social media age restriction policy</a>  </p>
<p><a href='https://www.bmj.com/content/393/bmj-2026-100024'>Early data from Australia indicate that social media companies can’t be relied on to protect children</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/exnbebjgpicibsp9/Children_are_bypassing_the_australian_social_media_ban857um.mp3" length="55334410" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Australia has been in the vanguard of legislation to try and reduce the influence of social media on children and young people - their ban for under 16s was introduced on the 10th of December 2025, to great fanfare, and a lot of interest around the world.
But how effective are these bans at keeping children away from social media?
New research just published on BMJ.com has looked at that question of efficacy - finding that children are using the most simple tactics to evade the ban.
To dicuss what that means, we're joined by two of the authors of that research Courtney Barnes and Luke Wolfenden from the University of Newcastle, Australia.
We’re also joined by Amrit Purba, from the London School of Hygiene and Tropical Medicine, and Louise Holly, from the Digital Transformations for Health Lab, in Geneva, who have written commentaries to go with that research.
 
Reading list
Assessing early effects of Australia’s Social Media Minimum Age Act on adolescents’ social media use 
Learning from Australia’s social media age restriction policy  
Early data from Australia indicate that social media companies can’t be relied on to protect children ]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2305</itunes:duration>
                <itunes:episode>86</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The £400 million blackhole for doctor training, drug ads evading regulation, and reining in AI in war</title>
        <itunes:title>The £400 million blackhole for doctor training, drug ads evading regulation, and reining in AI in war</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-400-million-blackhole-for-doctor-training-drug-ads-evading-regulation-and-reining-in-ai-in-war/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-400-million-blackhole-for-doctor-training-drug-ads-evading-regulation-and-reining-in-ai-in-war/#comments</comments>        <pubDate>Mon, 22 Jun 2026 23:59:00 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/901ac050-7a0b-3fbf-845e-f6ac10419af2</guid>
                                    <description><![CDATA[<p>The US military’s Operation “Epic Fury” highlighted the devastating cost of using artificial intelligence for rapid military planning. Thomas Adamkiewicz, associate professor at Morehouse School of Medicine, and Zulfiqar Bhutta, Robert Harding Inaugural Chair in Global Child Health at the Hospital for Sick Children, Toronto, to discuss why international humanitarian law is lagging dangerously behind technology, and why we urgently need a new era of legal frameworks to govern AI use in war.</p>
<p> </p>
<p>Direct-to-consumer (DTC) advertising of prescription medicines is strictly illegal everywhere in the world except for the United States and New Zealand. Deborah Cohen, investigative journalist, joins us to explain how global social media platforms are making borders porous, allowing Hollywood celebrities and high-profile influencers to broadcast drug endorsements directly into the feeds of UK citizens.</p>
<p> </p>
<p>Finally, Between 2020 and 2023, the UK government allocated £1.7 billion specifically intended for frontline doctor training. However, a deep-dive investigation has revealed that a staggering £400 million of that funding is completely unaccounted for - David Hutchison, paediatrics registrar, and Jonathan De Oliveira, GP trainee, join us to describe what they found.</p>
Reading List
<ul>
<li style="font-weight:400;"><a href='https://www.bmj.com/content/393/bmj-2026-351015'>AI warfare demands a new era of humanitarian law</a></li>
<li style="font-weight:400;"><a href='https://www.bmj.com/content/393/bmj-2026-590532'>Bad influencers: How social media imported US-style drug advertising to the UK</a></li>
<li style="font-weight:400;"><a href='https://url.uk.m.mimecastprotect.com/s/bp9iC9361CM0EpXHEhJcqDRM5?domain=bmj.com'>“Black hole” of medical student funding</a></li>
</ul>
]]></description>
                                                            <content:encoded><![CDATA[<p>The US military’s Operation “Epic Fury” highlighted the devastating cost of using artificial intelligence for rapid military planning. Thomas Adamkiewicz, associate professor at <em>Morehouse School of Medicine,</em> and Zulfiqar Bhutta, Robert Harding Inaugural Chair in Global Child Health at the Hospital for Sick Children, Toronto, to discuss why international humanitarian law is lagging dangerously behind technology, and why we urgently need a new era of legal frameworks to govern AI use in war.</p>
<p> </p>
<p>Direct-to-consumer (DTC) advertising of prescription medicines is strictly illegal everywhere in the world except for the United States and New Zealand. Deborah Cohen, investigative journalist, joins us to explain how global social media platforms are making borders porous, allowing Hollywood celebrities and high-profile influencers to broadcast drug endorsements directly into the feeds of UK citizens.</p>
<p> </p>
<p>Finally, Between 2020 and 2023, the UK government allocated £1.7 billion specifically intended for frontline doctor training. However, a deep-dive investigation has revealed that a staggering £400 million of that funding is completely unaccounted for - David Hutchison, paediatrics registrar, and Jonathan De Oliveira, GP trainee, join us to describe what they found.</p>
Reading List
<ul>
<li style="font-weight:400;"><a href='https://www.bmj.com/content/393/bmj-2026-351015'>AI warfare demands a new era of humanitarian law</a></li>
<li style="font-weight:400;"><a href='https://www.bmj.com/content/393/bmj-2026-590532'>Bad influencers: How social media imported US-style drug advertising to the UK</a></li>
<li style="font-weight:400;"><a href='https://url.uk.m.mimecastprotect.com/s/bp9iC9361CM0EpXHEhJcqDRM5?domain=bmj.com'>“Black hole” of medical student funding</a></li>
</ul>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7t9mygbvfwm5cfi9/bmjpod230626mixdown9b6t7.mp3" length="69630690" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The US military’s Operation “Epic Fury” highlighted the devastating cost of using artificial intelligence for rapid military planning. Thomas Adamkiewicz, associate professor at Morehouse School of Medicine, and Zulfiqar Bhutta, Robert Harding Inaugural Chair in Global Child Health at the Hospital for Sick Children, Toronto, to discuss why international humanitarian law is lagging dangerously behind technology, and why we urgently need a new era of legal frameworks to govern AI use in war.
 
Direct-to-consumer (DTC) advertising of prescription medicines is strictly illegal everywhere in the world except for the United States and New Zealand. Deborah Cohen, investigative journalist, joins us to explain how global social media platforms are making borders porous, allowing Hollywood celebrities and high-profile influencers to broadcast drug endorsements directly into the feeds of UK citizens.
 
Finally, Between 2020 and 2023, the UK government allocated £1.7 billion specifically intended for frontline doctor training. However, a deep-dive investigation has revealed that a staggering £400 million of that funding is completely unaccounted for - David Hutchison, paediatrics registrar, and Jonathan De Oliveira, GP trainee, join us to describe what they found.
Reading List

AI warfare demands a new era of humanitarian law
Bad influencers: How social media imported US-style drug advertising to the UK
“Black hole” of medical student funding
]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2900</itunes:duration>
                <itunes:episode>84</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Cancer screening: when does testing go too far?</title>
        <itunes:title>Cancer screening: when does testing go too far?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/cancer-screening-when-does-testing-go-too-far/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/cancer-screening-when-does-testing-go-too-far/#comments</comments>        <pubDate>Fri, 12 Jun 2026 15:42:42 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/b1bc0173-cc65-39cc-9635-8241bf611fbb</guid>
                                    <description><![CDATA[<p>The heated debate on prostate cancer screening boils down to one question: should men be routinely screened?</p>
<p>Two recent position statements from the UK’s national screening committee published in the BMJ show that screening decisions are steeped in complexity. </p>
<p>The benefits of screening may be easier to grasp, but the harms of overdiagnosis and overtreatment are given less attention. Can we close the divide between the public and academic discourse?</p>
<p> </p>
<p>Guest: Sian Taylor-Phillips is professor of population health at the University of Warwick and a member of the UK national screening committee.</p>
<p> </p>
<p>Further Reading:</p>
<ul>
<li><a href='https://www.bmj.com/content/393/bmj-2026-629407'>UK National Screening Committee position statement on surrogate outcomes in cancer screening trials</a></li>
<li><a href='https://www.bmj.com/content/393/bmj-2026-891902'>Prostate cancer screening: Committee rejects calls for mass testing programme despite pressure</a></li>
</ul>
<p>More interviews from the BMJ on <a href='https://www.youtube.com/playlist?list=PLiC5xPiBbjJWBrtXQTTsskfjCoMu4WyNW'>our Youtube channel</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The heated debate on prostate cancer screening boils down to one question: should men be routinely screened?</p>
<p>Two recent position statements from the UK’s national screening committee published in the BMJ show that screening decisions are steeped in complexity. </p>
<p>The benefits of screening may be easier to grasp, but the harms of overdiagnosis and overtreatment are given less attention. Can we close the divide between the public and academic discourse?</p>
<p> </p>
<p>Guest: Sian Taylor-Phillips is professor of population health at the University of Warwick and a member of the UK national screening committee.</p>
<p> </p>
<p>Further Reading:</p>
<ul>
<li><a href='https://www.bmj.com/content/393/bmj-2026-629407'>UK National Screening Committee position statement on surrogate outcomes in cancer screening trials</a></li>
<li><a href='https://www.bmj.com/content/393/bmj-2026-891902'>Prostate cancer screening: Committee rejects calls for mass testing programme despite pressure</a></li>
</ul>
<p>More interviews from the BMJ on <a href='https://www.youtube.com/playlist?list=PLiC5xPiBbjJWBrtXQTTsskfjCoMu4WyNW'>our Youtube channel</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jz8rf3d74bkhjses/bmj_120626_mix.mp3" length="35376768" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The heated debate on prostate cancer screening boils down to one question: should men be routinely screened?
Two recent position statements from the UK’s national screening committee published in the BMJ show that screening decisions are steeped in complexity. 
The benefits of screening may be easier to grasp, but the harms of overdiagnosis and overtreatment are given less attention. Can we close the divide between the public and academic discourse?
 
Guest: Sian Taylor-Phillips is professor of population health at the University of Warwick and a member of the UK national screening committee.
 
Further Reading:

UK National Screening Committee position statement on surrogate outcomes in cancer screening trials
Prostate cancer screening: Committee rejects calls for mass testing programme despite pressure

More interviews from the BMJ on our Youtube channel.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2211</itunes:duration>
                <itunes:episode>83</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Child mortality has reduced, but there are worrying trends</title>
        <itunes:title>Child mortality has reduced, but there are worrying trends</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/child-mortality-has-reduced-but-self-harm-and-violence-is-increasing/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/child-mortality-has-reduced-but-self-harm-and-violence-is-increasing/#comments</comments>        <pubDate>Sat, 06 Jun 2026 12:46:51 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/6a94857e-cc8b-3025-8027-a71a21e846e2</guid>
                                    <description><![CDATA[<p>New estimates of Global Patterns in Neonatal, Child, and Adolescent Mortality have been published - and while there has been a huge improvement, those gains are in danger - and we’re seeing worrying trends.</p>
<p> </p>
<p>Kate Strong, a Scientist at the World Health Organization and Lucia Hug, a specialist in statistics and monitoring for UNICEF, join us to explain the data - and why they are worried about our ability to measure this in the future.</p>
<p> </p>
<p>Helen Sharman is the first British Astronaut to make it to space - this week she was at the Royal College of GPs giving the General Medical Council's annual Marx lecture. She joins us to discuss how research in space might impact healthcare on Earth, and what the NHS can learn from cosmonaut teamwork. </p>
<p> </p>
<p>Finally, The government and doctors in England are not getting on well - we’ve had a series of strikes from the resident doctors, GPs are in dispute about the imposition of a new contract, and now consultants are being polled on industrial action.  BMA Consultants Committee co-chairs Shanu Dutta and Helen Neary explain why.</p>
<p> </p>
<p>Reading list</p>
<p> </p>
<p>Neonatal, Child, and Adolescent Mortality</p>
<p><a href='https://www.bmj.com/content/393/bmj-2025-088684'>Global, regional, and national levels and trends in under 5, infant, and neonatal mortality during 1990-2024 with scenario based projections to 2030</a></p>
<p><a href='https://www.bmj.com/content/393/bmj-2025-088685'>Global, regional, and national levels and trends in older child, adolescent, and youth (5-24 years) all cause mortality from 1990 to 2024: modelling study</a></p>
<p><a href='https://www.bmj.com/content/393/bmj-2025-088686'>Systematic estimates of global causes of neonatal and under 5 mortality in 2000-24: secondary data analysis using bayesian multinomial logistic regression</a></p>
<p><a href='https://www.bmj.com/content/393/bmj-2025-088687'>Estimates of global causes of death for children and adolescents aged 5-19 in 2000-24: secondary data analysis using bayesian multinomial logistic regression</a></p>
<p> </p>
<p>Full interview on YouTube:</p>
<p><a href='https://youtu.be/_OGSli923W4'>Why NHS Senior Doctors in England Are Considering Strike Action</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>New estimates of Global Patterns in Neonatal, Child, and Adolescent Mortality have been published - and while there has been a huge improvement, those gains are in danger - and we’re seeing worrying trends.</p>
<p> </p>
<p>Kate Strong, a Scientist at the World Health Organization and Lucia Hug, a specialist in statistics and monitoring for UNICEF, join us to explain the data - and why they are worried about our ability to measure this in the future.</p>
<p> </p>
<p>Helen Sharman is the first British Astronaut to make it to space - this week she was at the Royal College of GPs giving the General Medical Council's annual Marx lecture. She joins us to discuss how research in space might impact healthcare on Earth, and what the NHS can learn from cosmonaut teamwork. </p>
<p> </p>
<p>Finally, The government and doctors in England are not getting on well - we’ve had a series of strikes from the resident doctors, GPs are in dispute about the imposition of a new contract, and now consultants are being polled on industrial action.  BMA Consultants Committee co-chairs Shanu Dutta and Helen Neary explain why.</p>
<p> </p>
<p>Reading list</p>
<p> </p>
<p>Neonatal, Child, and Adolescent Mortality</p>
<p><a href='https://www.bmj.com/content/393/bmj-2025-088684'>Global, regional, and national levels and trends in under 5, infant, and neonatal mortality during 1990-2024 with scenario based projections to 2030</a></p>
<p><a href='https://www.bmj.com/content/393/bmj-2025-088685'>Global, regional, and national levels and trends in older child, adolescent, and youth (5-24 years) all cause mortality from 1990 to 2024: modelling study</a></p>
<p><a href='https://www.bmj.com/content/393/bmj-2025-088686'>Systematic estimates of global causes of neonatal and under 5 mortality in 2000-24: secondary data analysis using bayesian multinomial logistic regression</a></p>
<p><a href='https://www.bmj.com/content/393/bmj-2025-088687'>Estimates of global causes of death for children and adolescents aged 5-19 in 2000-24: secondary data analysis using bayesian multinomial logistic regression</a></p>
<p> </p>
<p>Full interview on YouTube:</p>
<p><a href='https://youtu.be/_OGSli923W4'>Why NHS Senior Doctors in England Are Considering Strike Action</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/stbhqc3cry56idzx/bmj_050626_mix.mp3" length="39406848" type="audio/mpeg"/>
        <itunes:summary><![CDATA[New estimates of Global Patterns in Neonatal, Child, and Adolescent Mortality have been published - and while there has been a huge improvement, those gains are in danger - and we’re seeing worrying trends.
 
Kate Strong, a Scientist at the World Health Organization and Lucia Hug, a specialist in statistics and monitoring for UNICEF, join us to explain the data - and why they are worried about our ability to measure this in the future.
 
Helen Sharman is the first British Astronaut to make it to space - this week she was at the Royal College of GPs giving the General Medical Council's annual Marx lecture. She joins us to discuss how research in space might impact healthcare on Earth, and what the NHS can learn from cosmonaut teamwork. 
 
Finally, The government and doctors in England are not getting on well - we’ve had a series of strikes from the resident doctors, GPs are in dispute about the imposition of a new contract, and now consultants are being polled on industrial action.  BMA Consultants Committee co-chairs Shanu Dutta and Helen Neary explain why.
 
Reading list
 
Neonatal, Child, and Adolescent Mortality
Global, regional, and national levels and trends in under 5, infant, and neonatal mortality during 1990-2024 with scenario based projections to 2030
Global, regional, and national levels and trends in older child, adolescent, and youth (5-24 years) all cause mortality from 1990 to 2024: modelling study
Systematic estimates of global causes of neonatal and under 5 mortality in 2000-24: secondary data analysis using bayesian multinomial logistic regression
Estimates of global causes of death for children and adolescents aged 5-19 in 2000-24: secondary data analysis using bayesian multinomial logistic regression
 
Full interview on YouTube:
Why NHS Senior Doctors in England Are Considering Strike Action]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2462</itunes:duration>
                <itunes:episode>82</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>How to make healthcare more human</title>
        <itunes:title>How to make healthcare more human</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/how-to-make-healthcare-more-human/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/how-to-make-healthcare-more-human/#comments</comments>        <pubDate>Fri, 29 May 2026 17:35:54 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/dac5c540-ef12-3361-a8ba-181c5a12cc83</guid>
                                    <description><![CDATA[<p>Does healthcare have a moral emergency?</p>
<p>In this episode of the Medicine and Science podcast, Kamran Abbasi sits down with healthcare leaders Maureen Bisognano, president emerita of the Institute for Healthcare Improvement and Bob Klaber, director of strategy at Imperial College Healthcare NHS Trust, to discuss why they're calling the lack of humanity in medicine an emergency.</p>
<p>We ask why this dangerous imbalance between the rational (efficiency, data, and metrics) and the relational (human connection, empathy, and listening) has developed in modern medicine. We also learn how simple changes, like asking "What matters to you?" instead of just "What's the matter?, can help us put the humanity back into healthcare.</p>
<p> </p>
<p>Reading list</p>
<p>Read the BMJ Article: <a href='https://www.bmj.com/content/393/bmj.s969'>Healthcare's moral emergency: reconnecting healthcare with its mission and purpose </a></p>
<p><a href=''>Michael West on workforce kindness</a></p>
<p><a href='https://www.mdpi.com/2227-9032/12/8/812'>Amy Edmondson on psychological safety</a></p>
<p><a href='https://ascopubs.org/doi/10.1200/JOP.2017.026195'>Len Berry on cancer care &amp; kindness</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Does healthcare have a moral emergency?</p>
<p>In this episode of the Medicine and Science podcast, Kamran Abbasi sits down with healthcare leaders Maureen Bisognano, president emerita of the Institute for Healthcare Improvement and Bob Klaber, director of strategy at Imperial College Healthcare NHS Trust, to discuss why they're calling the lack of humanity in medicine an emergency.</p>
<p>We ask why this dangerous imbalance between the rational (efficiency, data, and metrics) and the relational (human connection, empathy, and listening) has developed in modern medicine. We also learn how simple changes, like asking "What matters to you?" instead of just "What's the matter?, can help us put the humanity back into healthcare.</p>
<p> </p>
<p>Reading list</p>
<p>Read the BMJ Article: <a href='https://www.bmj.com/content/393/bmj.s969'>Healthcare's moral emergency: reconnecting healthcare with its mission and purpose </a></p>
<p><a href=''>Michael West on workforce kindness</a></p>
<p><a href='https://www.mdpi.com/2227-9032/12/8/812'>Amy Edmondson on psychological safety</a></p>
<p><a href='https://ascopubs.org/doi/10.1200/JOP.2017.026195'>Len Berry on cancer care &amp; kindness</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jpztff4gv2nf4u2r/Medicine_s_moral_emergencya6upj.mp3" length="52314739" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Does healthcare have a moral emergency?
In this episode of the Medicine and Science podcast, Kamran Abbasi sits down with healthcare leaders Maureen Bisognano, president emerita of the Institute for Healthcare Improvement and Bob Klaber, director of strategy at Imperial College Healthcare NHS Trust, to discuss why they're calling the lack of humanity in medicine an emergency.
We ask why this dangerous imbalance between the rational (efficiency, data, and metrics) and the relational (human connection, empathy, and listening) has developed in modern medicine. We also learn how simple changes, like asking "What matters to you?" instead of just "What's the matter?, can help us put the humanity back into healthcare.
 
Reading list
Read the BMJ Article: Healthcare's moral emergency: reconnecting healthcare with its mission and purpose 
Michael West on workforce kindness
Amy Edmondson on psychological safety
Len Berry on cancer care &amp; kindness
 ]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2179</itunes:duration>
                <itunes:episode>81</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>What does Wes Streeting's exit mean for the NHS modernisation bill?</title>
        <itunes:title>What does Wes Streeting's exit mean for the NHS modernisation bill?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/what-does-wes-streetings-exit-mean-for-the-nhs-modernisation-bill/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/what-does-wes-streetings-exit-mean-for-the-nhs-modernisation-bill/#comments</comments>        <pubDate>Fri, 22 May 2026 16:37:07 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/e8e026e2-e698-35c9-b444-2b0a4be8581c</guid>
                                    <description><![CDATA[<p>It has been a tumultuous time in UK health politics. UK Health Minister ,Wes Streeting, has freshly resigned. What does this mean for his newly introduced NHS Modernization Bill as it heads through Parliament?</p>
<p>Together with Hugh Alderwick, Director of Policy and Research at the Health Foundation, we unpack the bill's sweeping centralization of power, the abolition of NHS England, and the contentious role for US tech firm Palantir in the new NHS.</p>
<p>And, we explore a major milestone for women's healthcare. A condition affecting an estimated 170 million women globally has officially been renamed from Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS). Rachel Morman, Chair of the PMOS charity Verity, joins us to explain why dropping "cysts" from the name is a vital step toward recognizing this as a complex, multi-system condition, and how this co-designed change will fundamentally reshape diagnosis, treatment, and future research.</p>
<p>Further reading:</p>
<p><a href='https://www.bmj.com/content/393/bmj.s958'>Health Bill brings NHS management back into government</a></p>
<p><a href='https://www.bmj.com/content/393/bmj-2026-079749'>PMOS: What's in a name? Everything</a></p>
<p id="page-title" class="highwire-cite-title"><a href='https://www.bmj.com/content/393/bmj.s955'>PCOS name change to PMOS must be managed to avoid confusing patients, says expert</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>It has been a tumultuous time in UK health politics. UK Health Minister ,Wes Streeting, has freshly resigned. What does this mean for his newly introduced NHS Modernization Bill as it heads through Parliament?</p>
<p>Together with Hugh Alderwick, Director of Policy and Research at the Health Foundation, we unpack the bill's sweeping centralization of power, the abolition of NHS England, and the contentious role for US tech firm Palantir in the new NHS.</p>
<p>And, we explore a major milestone for women's healthcare. A condition affecting an estimated 170 million women globally has officially been renamed from Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS). Rachel Morman, Chair of the PMOS charity Verity, joins us to explain why dropping "cysts" from the name is a vital step toward recognizing this as a complex, multi-system condition, and how this co-designed change will fundamentally reshape diagnosis, treatment, and future research.</p>
<p>Further reading:</p>
<p><a href='https://www.bmj.com/content/393/bmj.s958'>Health Bill brings NHS management back into government</a></p>
<p><a href='https://www.bmj.com/content/393/bmj-2026-079749'>PMOS: What's in a name? Everything</a></p>
<p id="page-title" class="highwire-cite-title"><a href='https://www.bmj.com/content/393/bmj.s955'>PCOS name change to PMOS must be managed to avoid confusing patients, says expert</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4wuwjt65xfwz7y9t/bmjpod_220526_mixdownaf8cs.mp3" length="53147837" type="audio/mpeg"/>
        <itunes:summary><![CDATA[It has been a tumultuous time in UK health politics. UK Health Minister ,Wes Streeting, has freshly resigned. What does this mean for his newly introduced NHS Modernization Bill as it heads through Parliament?
Together with Hugh Alderwick, Director of Policy and Research at the Health Foundation, we unpack the bill's sweeping centralization of power, the abolition of NHS England, and the contentious role for US tech firm Palantir in the new NHS.
And, we explore a major milestone for women's healthcare. A condition affecting an estimated 170 million women globally has officially been renamed from Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS). Rachel Morman, Chair of the PMOS charity Verity, joins us to explain why dropping "cysts" from the name is a vital step toward recognizing this as a complex, multi-system condition, and how this co-designed change will fundamentally reshape diagnosis, treatment, and future research.
Further reading:
Health Bill brings NHS management back into government
PMOS: What's in a name? Everything
PCOS name change to PMOS must be managed to avoid confusing patients, says expert]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2214</itunes:duration>
                <itunes:episode>80</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Social media companies are using the tobacco industry playbook to addict children</title>
        <itunes:title>Social media companies are using the tobacco industry playbook to addict children</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/social-media-companies-are-using-the-tobacco-industry-playbook-to-addict-children/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/social-media-companies-are-using-the-tobacco-industry-playbook-to-addict-children/#comments</comments>        <pubDate>Fri, 15 May 2026 14:55:04 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/565121b9-50a0-3368-8c66-0ae876da8c3f</guid>
                                    <description><![CDATA[<p>Twitter was launched 20 years ago, followed quickly by the iPhone and Instagram. Today, nearly 60% of the world’s population uses social media. Medical experts are sounding the alarm on the potential for these platforms to cause systemic harm. This past year has seen large events in the legal and public health battle against tech giants, with millions of dollars awarded in damages to child victims. Why has pinning down these companies proven difficult? And, what are the parallels between the social media industry and the historical tactics of "Big Tobacco"?</p>
<p>Guests:</p>
<p>Matthew Bergman is a practicing attorney and the founder of the Social Media Victims Law Center, as well as a professor at Lewis &amp; Clark Law School in Portland, Oregon.</p>
<p>Ilona Kickbusch is an editorial board member of the BMJ and a visiting professor at the Digital Transformations for Health Lab at the University of Geneva, specializing in the commercial determinants of health.</p>
<p>Further reading:</p>
<p><a href='https://www.bmj.com/content/bmj/393/bmj.s655.full.pdf'>From tobacco to TikTok: what public health litigation history tells us about holding social media accountable</a></p>
<p><a href='https://www.bmj.com/content/bmj/393/bmj.s798.full.pdf'>What is the evidence for social media addiction?</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Twitter was launched 20 years ago, followed quickly by the iPhone and Instagram. Today, nearly 60% of the world’s population uses social media. Medical experts are sounding the alarm on the potential for these platforms to cause systemic harm. This past year has seen large events in the legal and public health battle against tech giants, with millions of dollars awarded in damages to child victims. Why has pinning down these companies proven difficult? And, what are the parallels between the social media industry and the historical tactics of "Big Tobacco"?</p>
<p>Guests:</p>
<p>Matthew Bergman is a practicing attorney and the founder of the Social Media Victims Law Center, as well as a professor at Lewis &amp; Clark Law School in Portland, Oregon.</p>
<p>Ilona Kickbusch is an editorial board member of the BMJ and a visiting professor at the Digital Transformations for Health Lab at the University of Geneva, specializing in the commercial determinants of health.</p>
<p>Further reading:</p>
<p><a href='https://www.bmj.com/content/bmj/393/bmj.s655.full.pdf'>From tobacco to TikTok: what public health litigation history tells us about holding social media accountable</a></p>
<p><a href='https://www.bmj.com/content/bmj/393/bmj.s798.full.pdf'>What is the evidence for social media addiction?</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/59t4ardmicpe4kdh/bmjpod_150526_Social_media_harms.mp3" length="71085273" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Twitter was launched 20 years ago, followed quickly by the iPhone and Instagram. Today, nearly 60% of the world’s population uses social media. Medical experts are sounding the alarm on the potential for these platforms to cause systemic harm. This past year has seen large events in the legal and public health battle against tech giants, with millions of dollars awarded in damages to child victims. Why has pinning down these companies proven difficult? And, what are the parallels between the social media industry and the historical tactics of "Big Tobacco"?
Guests:
Matthew Bergman is a practicing attorney and the founder of the Social Media Victims Law Center, as well as a professor at Lewis &amp; Clark Law School in Portland, Oregon.
Ilona Kickbusch is an editorial board member of the BMJ and a visiting professor at the Digital Transformations for Health Lab at the University of Geneva, specializing in the commercial determinants of health.
Further reading:
From tobacco to TikTok: what public health litigation history tells us about holding social media accountable
What is the evidence for social media addiction?]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2961</itunes:duration>
                <itunes:episode>79</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Revisiting the Cass Review on gender identity services, and non-invasive brain stimulation for children with autism</title>
        <itunes:title>Revisiting the Cass Review on gender identity services, and non-invasive brain stimulation for children with autism</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/revisiting-the-cass-review-on-gender-identity-services-and-non-invasive-brain-stimulation-for-children-with-autism/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/revisiting-the-cass-review-on-gender-identity-services-and-non-invasive-brain-stimulation-for-children-with-autism/#comments</comments>        <pubDate>Fri, 08 May 2026 16:51:42 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/8107d17d-d532-3d19-a766-6f96f5543c7b</guid>
                                    <description><![CDATA[<p>The BMA has released their long awaited review of the Cass report. The original report looked at the provision of NHS gender identity services for children and young people, and involved a review of the science underpinning those services. It also set out a plan to improve care for gender diverse young people. </p>
<p>We talk with David Strain of the BMA’s board of science to discuss their findings, and hear why they were critical of the Secretary of State, Wes Streeting's response to Cass’s review.

And, we hear about new research published with The BMJ that aims to help children with autism. The researchers used a non-invasive magnetic stimulation technique to target specific regions of the brain, with the goal of promoting sociality. We discuss the benefits, and how this technique might translate to treatment plans for patients.
</p>
<p>Guests:</p>
<p>David Strain is an associate professor in cardio-metabolic health at the University of Exeter and Chair of the BMA’s Board of Science.</p>
<p>Benjamin Becker is a professor of psychology and neuroscience at the University of Hong Kong, specializing in brain-based interventions for mental disorders.</p>
<p>Further reading:</p>
<p id="page-title" class="highwire-cite-title"><a href='https://www.bmj.com/content/393/bmj.s876'>Puberty blockers: BMA critique vindicates Cass review but questions government “overreach”</a></p>
<p id="page-title" class="highwire-cite-title"><a href='https://www.bmj.com/content/393/bmj.s783'>Accelerated non-invasive brain stimulation in childhood autism</a></p>
<p class="highwire-cite-title"> </p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The BMA has released their long awaited review of the Cass report. The original report looked at the provision of NHS gender identity services for children and young people, and involved a review of the science underpinning those services. It also set out a plan to improve care for gender diverse young people. </p>
<p>We talk with David Strain of the BMA’s board of science to discuss their findings, and hear why they were critical of the Secretary of State, Wes Streeting's response to Cass’s review.<br>
<br>
And, we hear about new research published with The BMJ that aims to help children with autism. The researchers used a non-invasive magnetic stimulation technique to target specific regions of the brain, with the goal of promoting sociality. We discuss the benefits, and how this technique might translate to treatment plans for patients.<br>
</p>
<p>Guests:</p>
<p>David Strain is an associate professor in cardio-metabolic health at the University of Exeter and Chair of the BMA’s Board of Science.</p>
<p>Benjamin Becker is a professor of psychology and neuroscience at the University of Hong Kong, specializing in brain-based interventions for mental disorders.</p>
<p>Further reading:</p>
<p id="page-title" class="highwire-cite-title"><a href='https://www.bmj.com/content/393/bmj.s876'>Puberty blockers: BMA critique vindicates Cass review but questions government “overreach”</a></p>
<p id="page-title" class="highwire-cite-title"><a href='https://www.bmj.com/content/393/bmj.s783'>Accelerated non-invasive brain stimulation in childhood autism</a></p>
<p class="highwire-cite-title"> </p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gx8iv9tjzgv5eqkb/bmj_080526_mixdown.mp3" length="56907955" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The BMA has released their long awaited review of the Cass report. The original report looked at the provision of NHS gender identity services for children and young people, and involved a review of the science underpinning those services. It also set out a plan to improve care for gender diverse young people. 
We talk with David Strain of the BMA’s board of science to discuss their findings, and hear why they were critical of the Secretary of State, Wes Streeting's response to Cass’s review.And, we hear about new research published with The BMJ that aims to help children with autism. The researchers used a non-invasive magnetic stimulation technique to target specific regions of the brain, with the goal of promoting sociality. We discuss the benefits, and how this technique might translate to treatment plans for patients.
Guests:
David Strain is an associate professor in cardio-metabolic health at the University of Exeter and Chair of the BMA’s Board of Science.
Benjamin Becker is a professor of psychology and neuroscience at the University of Hong Kong, specializing in brain-based interventions for mental disorders.
Further reading:
Puberty blockers: BMA critique vindicates Cass review but questions government “overreach”
Accelerated non-invasive brain stimulation in childhood autism
 
 ]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2370</itunes:duration>
                <itunes:episode>78</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The US UK trade deal will cost the NHS billions, and only serve to increase pharma profits</title>
        <itunes:title>The US UK trade deal will cost the NHS billions, and only serve to increase pharma profits</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-us-uk-trade-deal-will-cost-the-nhs-billions-and-only-serve-to-increase-pharma-profits/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-us-uk-trade-deal-will-cost-the-nhs-billions-and-only-serve-to-increase-pharma-profits/#comments</comments>        <pubDate>Fri, 01 May 2026 16:27:04 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/f7d0ad71-29cd-3bca-97fc-73d334a98a11</guid>
                                    <description><![CDATA[<p>The new trade deal struck between the UK and US came into force in April. </p>
<p>The deal will</p>
<ul>
<li>double the amount that the NHS spends on new medicines, by the end of 2036 (from 0.6 - 0.6% of GDP).</li>
<li> increase the threshold that the National Institute for Health and Care Excellence (NICE) sets for drug approvals - which will allow more to be approved, but will also allow companies to charge more for their pharmaceuticals,</li>
<li> include a change to the rebate the NHS receives, to ensure that the extra drug spend occurs.</li>
</ul>
<p>Cumulatively this will increase our drug spend by £56 billion in the next 10 years, which will have to come out of current healthcare spending - which experts are calling a catastrophe for the NHS.</p>
<p>
Joining Kamran Abbasi to discuss are Sally Gainsbury, a senior policy analyst Nuffield Trust and Karl Claxton, professor of economics at the University of York. We also hear from Francis Ruiz, policy analyst at the London School of Hygiene and Tropical Medicine.</p>
<p>
Reading list</p>
<p><a href='https://www.bmj.com/content/393/bmj.s733'>The UK government must publish a detailed impact assessment of the costs and benefits of the US-UK medicines partnership</a></p>
<p><a href='https://www.bmj.com/content/393/bmj.s755'>A budget apart: the case for ringfencing medicines in the UK</a></p>
<p> </p>
<p> </p>
<p> </p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The new trade deal struck between the UK and US came into force in April. </p>
<p>The deal will</p>
<ul>
<li>double the amount that the NHS spends on new medicines, by the end of 2036 (from 0.6 - 0.6% of GDP).</li>
<li> increase the threshold that the National Institute for Health and Care Excellence (NICE) sets for drug approvals - which will allow more to be approved, but will also allow companies to charge more for their pharmaceuticals,</li>
<li> include a change to the rebate the NHS receives, to ensure that the extra drug spend occurs.</li>
</ul>
<p>Cumulatively this will increase our drug spend by £56 billion in the next 10 years, which will have to come out of current healthcare spending - which experts are calling a catastrophe for the NHS.</p>
<p><br>
Joining Kamran Abbasi to discuss are Sally Gainsbury, a senior policy analyst Nuffield Trust and Karl Claxton, professor of economics at the University of York. We also hear from Francis Ruiz, policy analyst at the London School of Hygiene and Tropical Medicine.</p>
<p><br>
Reading list</p>
<p><a href='https://www.bmj.com/content/393/bmj.s733'>The UK government must publish a detailed impact assessment of the costs and benefits of the US-UK medicines partnership</a></p>
<p><a href='https://www.bmj.com/content/393/bmj.s755'>A budget apart: the case for ringfencing medicines in the UK</a></p>
<p> </p>
<p> </p>
<p> </p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3bx6ijxinwcmh7gj/US-UK_Trade_Deal_-_30_04_26_mixdown81b9m.mp3" length="62379025" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The new trade deal struck between the UK and US came into force in April. 
The deal will

double the amount that the NHS spends on new medicines, by the end of 2036 (from 0.6 - 0.6% of GDP).
 increase the threshold that the National Institute for Health and Care Excellence (NICE) sets for drug approvals - which will allow more to be approved, but will also allow companies to charge more for their pharmaceuticals,
 include a change to the rebate the NHS receives, to ensure that the extra drug spend occurs.

Cumulatively this will increase our drug spend by £56 billion in the next 10 years, which will have to come out of current healthcare spending - which experts are calling a catastrophe for the NHS.
Joining Kamran Abbasi to discuss are Sally Gainsbury, a senior policy analyst Nuffield Trust and Karl Claxton, professor of economics at the University of York. We also hear from Francis Ruiz, policy analyst at the London School of Hygiene and Tropical Medicine.
Reading list
The UK government must publish a detailed impact assessment of the costs and benefits of the US-UK medicines partnership
A budget apart: the case for ringfencing medicines in the UK
 
 
 
 ]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2598</itunes:duration>
                <itunes:episode>77</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>MS drug controversy, adoption outcomes in Sweden, and the multi-factorial reality of Alzheimer’s</title>
        <itunes:title>MS drug controversy, adoption outcomes in Sweden, and the multi-factorial reality of Alzheimer’s</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/ms-drug-controversy-adoption-outcomes-in-sweden-and-the-multi-factorial-reality-of-alzheimer-s/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/ms-drug-controversy-adoption-outcomes-in-sweden-and-the-multi-factorial-reality-of-alzheimer-s/#comments</comments>        <pubDate>Fri, 24 Apr 2026 15:19:08 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/f820e81d-a68d-3f3a-8b55-547df2b40f94</guid>
                                    <description><![CDATA[<p>A blockbuster MS drug undergoes FDA re-evaluation. We explore the story of Ocrelizumab, a treatment for primary progressive multiple sclerosis, following a patient petition that highlighted internal disagreements among agency reviewers regarding its efficacy.</p>
<p>We look to Sweden, where new research involving sibling pairs separated by adoption investigates how early-life environments shape long-term health and social outcomes.</p>
<p>Finally, we revisit the dominant medical narrative on Alzheimer’s disease. Why is it so difficult to move towards comprehensive treatments? Has the focus on amyloid plaques hindered our understanding of other critical factors like vascular health and social inequality?</p>

<p>Peter Doshi is a senior editor at The BMJ and an associate professor of pharmaceutical health services research at the University of Maryland.</p>
<p>Erik Peterson is an associate professor at the Karolinska Institute in Stockholm, specializing in psychiatric epidemiology and adoption studies.</p>
<p>Carol Brayne is a professor emerita of public health medicine at the University of Cambridge and a leading expert in the epidemiology of dementia.</p>
<p>Reading List:</p>
<p><a href='https://www.bmj.com/content/393/bmj.s666'>Multiple sclerosis: Could Roche's bestselling drug Ocrevus be doing more harm than good in women with primary progressive MS?</a></p>
<p><a href='https://www.bmj.com/content/393/bmj-2025-087844'>Home environment conditions during childhood and psychosocial outcomes across three generations in Sweden: population based adoption-discordant sibling comparison study</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>A blockbuster MS drug undergoes FDA re-evaluation. We explore the story of Ocrelizumab, a treatment for primary progressive multiple sclerosis, following a patient petition that highlighted internal disagreements among agency reviewers regarding its efficacy.</p>
<p>We look to Sweden, where new research involving sibling pairs separated by adoption investigates how early-life environments shape long-term health and social outcomes.</p>
<p>Finally, we revisit the dominant medical narrative on Alzheimer’s disease. Why is it so difficult to move towards comprehensive treatments? Has the focus on amyloid plaques hindered our understanding of other critical factors like vascular health and social inequality?</p>

<p>Peter Doshi is a senior editor at <em>The BMJ</em> and an associate professor of pharmaceutical health services research at the University of Maryland.</p>
<p>Erik Peterson is an associate professor at the Karolinska Institute in Stockholm, specializing in psychiatric epidemiology and adoption studies.</p>
<p>Carol Brayne is a professor emerita of public health medicine at the University of Cambridge and a leading expert in the epidemiology of dementia.</p>
<p>Reading List:</p>
<p><a href='https://www.bmj.com/content/393/bmj.s666'>Multiple sclerosis: Could Roche's bestselling drug Ocrevus be doing more harm than good in women with primary progressive MS?</a></p>
<p><a href='https://www.bmj.com/content/393/bmj-2025-087844'>Home environment conditions during childhood and psychosocial outcomes across three generations in Sweden: population based adoption-discordant sibling comparison study</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gr5vzf5x7gcb68hf/bmjpod_240426_EDIT_mixdown73hep.mp3" length="55465671" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A blockbuster MS drug undergoes FDA re-evaluation. We explore the story of Ocrelizumab, a treatment for primary progressive multiple sclerosis, following a patient petition that highlighted internal disagreements among agency reviewers regarding its efficacy.
We look to Sweden, where new research involving sibling pairs separated by adoption investigates how early-life environments shape long-term health and social outcomes.
Finally, we revisit the dominant medical narrative on Alzheimer’s disease. Why is it so difficult to move towards comprehensive treatments? Has the focus on amyloid plaques hindered our understanding of other critical factors like vascular health and social inequality?

Peter Doshi is a senior editor at The BMJ and an associate professor of pharmaceutical health services research at the University of Maryland.
Erik Peterson is an associate professor at the Karolinska Institute in Stockholm, specializing in psychiatric epidemiology and adoption studies.
Carol Brayne is a professor emerita of public health medicine at the University of Cambridge and a leading expert in the epidemiology of dementia.
Reading List:
Multiple sclerosis: Could Roche's bestselling drug Ocrevus be doing more harm than good in women with primary progressive MS?
Home environment conditions during childhood and psychosocial outcomes across three generations in Sweden: population based adoption-discordant sibling comparison study
 ]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2310</itunes:duration>
                <itunes:episode>76</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The Trump administration is an international health emergency</title>
        <itunes:title>The Trump administration is an international health emergency</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-trump-administration-is-an-international-health-emergency/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-trump-administration-is-an-international-health-emergency/#comments</comments>        <pubDate>Fri, 17 Apr 2026 16:48:26 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/50c5e076-ed71-3152-8f95-a0894cf071d2</guid>
                                    <description><![CDATA[<p>Covid 19 was the last Public Health Emergency of International Concern (PHEIC). Our guests in this podcast think that the Trump Administration should be declared the next one.</p>
<p>Joining Kamran Abbasi are, Fatima Hassan,  human rights lawyer and Director of the Health Justice Initiative in South Africa, and Matthew Herder, Director of the Health Justice Institute at Dalhousie University in Canada explain why they think that the actions and consequences of the Whitehouse meet the bar for WHO to delcare an emergency</p>
<p>We examine the global consequences of recent US policy shifts, including:</p>
<ul>
<li>
<p>The withdrawal from the World Health Organization (WHO) and its implications for international health governance.</p>
</li>
<li>
<p>Significant funding cuts to global health programs, including PEPFAR and the CDC, and how these disruptions affect life-saving HIV and TB treatments in the Global South.</p>
</li>
<li>
<p>The rise of "unhinged nationalism" in health policy, from North American measles outbreaks to the extraction of trade concessions in exchange for medical aid.</p>
</li>
<li>
<p>The role of US health leadership in fueling vaccine hesitancy and dismantling scientific research at the NIH.</p>
</li>
</ul>
<p> </p>
<p>Reading list:</p>
<ul>
<li>
<p><a href='https://www.bmj.com/content/392/bmj-2026-089474'>Trump and his administration as a public health emergency of international concern</a></p>
</li>
<li>
<p><a href='https://www.bmj.com/content/392/bmj.s528'>Why the expanded global gag rule is a deadly triple tripwire for recipients of US foreign aid</a></p>
</li>
<li>
<p><a href='https://www.bmj.com/content/393/bmj.s683'>The power of the markets: the scandal that keeps on taking</a></p>
</li>
</ul>
]]></description>
                                                            <content:encoded><![CDATA[<p>Covid 19 was the last Public Health Emergency of International Concern (PHEIC). Our guests in this podcast think that the Trump Administration should be declared the next one.</p>
<p>Joining Kamran Abbasi are, Fatima Hassan,  human rights lawyer and Director of the Health Justice Initiative in South Africa, and Matthew Herder, Director of the Health Justice Institute at Dalhousie University in Canada explain why they think that the actions and consequences of the Whitehouse meet the bar for WHO to delcare an emergency</p>
<p>We examine the global consequences of recent US policy shifts, including:</p>
<ul>
<li>
<p>The withdrawal from the World Health Organization (WHO) and its implications for international health governance.</p>
</li>
<li>
<p>Significant funding cuts to global health programs, including PEPFAR and the CDC, and how these disruptions affect life-saving HIV and TB treatments in the Global South.</p>
</li>
<li>
<p>The rise of "unhinged nationalism" in health policy, from North American measles outbreaks to the extraction of trade concessions in exchange for medical aid.</p>
</li>
<li>
<p>The role of US health leadership in fueling vaccine hesitancy and dismantling scientific research at the NIH.</p>
</li>
</ul>
<p> </p>
<p>Reading list:</p>
<ul>
<li>
<p><a href='https://www.bmj.com/content/392/bmj-2026-089474'>Trump and his administration as a public health emergency of international concern</a></p>
</li>
<li>
<p><a href='https://www.bmj.com/content/392/bmj.s528'>Why the expanded global gag rule is a deadly triple tripwire for recipients of US foreign aid</a></p>
</li>
<li>
<p><a href='https://www.bmj.com/content/393/bmj.s683'>The power of the markets: the scandal that keeps on taking</a></p>
</li>
</ul>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hsfqhgur4q2sxk5y/Trump_is_a_pheic81rqj.mp3" length="73632193" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Covid 19 was the last Public Health Emergency of International Concern (PHEIC). Our guests in this podcast think that the Trump Administration should be declared the next one.
Joining Kamran Abbasi are, Fatima Hassan,  human rights lawyer and Director of the Health Justice Initiative in South Africa, and Matthew Herder, Director of the Health Justice Institute at Dalhousie University in Canada explain why they think that the actions and consequences of the Whitehouse meet the bar for WHO to delcare an emergency
We examine the global consequences of recent US policy shifts, including:


The withdrawal from the World Health Organization (WHO) and its implications for international health governance.


Significant funding cuts to global health programs, including PEPFAR and the CDC, and how these disruptions affect life-saving HIV and TB treatments in the Global South.


The rise of "unhinged nationalism" in health policy, from North American measles outbreaks to the extraction of trade concessions in exchange for medical aid.


The role of US health leadership in fueling vaccine hesitancy and dismantling scientific research at the NIH.


 
Reading list:


Trump and his administration as a public health emergency of international concern


Why the expanded global gag rule is a deadly triple tripwire for recipients of US foreign aid


The power of the markets: the scandal that keeps on taking

]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3067</itunes:duration>
                <itunes:episode>75</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The 15th strike, and bringing compassion back to A&amp;E</title>
        <itunes:title>The 15th strike, and bringing compassion back to A&amp;E</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/bmj-14th-april/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/bmj-14th-april/#comments</comments>        <pubDate>Mon, 13 Apr 2026 21:51:12 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/1c0cdbc0-e2d5-3c30-9854-075707815eec</guid>
                                    <description><![CDATA[<p>Coming up in this week’s episode:</p>
<p id="p-rc_3dbe67634d976ea7-33">The 15th Strike: As the latest six-day walkout by resident doctors in England concludes, the BMJ's news team examines the state of the ongoing dispute over pay and training places.</p>
<p>Iain Beardsell, consultant in emergency medicine in Southampton explain why he thinks reintroducing compassion could be the key to tackling the systemic issues facing emergency departments</p>
<p>And finally, The BMA announces major changes to how it represents doctors in private practice - we hear why they think the US has some better legislation around health insurance than the UK.</p>
<p> </p>
<p>Reading list:</p>
<ul>
<li><a href='https://www.bmj.com/content/393/bmj.s699'>Resident doctor strikes: Streeting demands to “meet with the organ grinders” as latest action ends</a></li>
<li><a href='https://www.youtube.com/watch?v=NiBu9IZINkc'>The BMJ interviews Jack Fletcher </a></li>
<li><a href='https://www.bmj.com/content/393/bmj.s667'>Make compassion visible in emergency medicine again</a></li>
<li><a href='https://www.google.com/search?q=https://www.bmj.com/content/393/bmj.s204'>BMA boosts support for private practice as NHS failings prompt more patients to pay for care</a></li>
</ul>
]]></description>
                                                            <content:encoded><![CDATA[<p>Coming up in this week’s episode:</p>
<p id="p-rc_3dbe67634d976ea7-33">The 15th Strike: As the latest six-day walkout by resident doctors in England concludes, the BMJ's news team examines the state of the ongoing dispute over pay and training places.</p>
<p>Iain Beardsell, consultant in emergency medicine in Southampton explain why he thinks reintroducing compassion could be the key to tackling the systemic issues facing emergency departments</p>
<p>And finally, The BMA announces major changes to how it represents doctors in private practice - we hear why they think the US has some better legislation around health insurance than the UK.</p>
<p> </p>
<p>Reading list:</p>
<ul>
<li><a href='https://www.bmj.com/content/393/bmj.s699'>Resident doctor strikes: Streeting demands to “meet with the organ grinders” as latest action ends</a></li>
<li><a href='https://www.youtube.com/watch?v=NiBu9IZINkc'>The BMJ interviews Jack Fletcher </a></li>
<li><a href='https://www.bmj.com/content/393/bmj.s667'>Make compassion visible in emergency medicine again</a></li>
<li><a href='https://www.google.com/search?q=https://www.bmj.com/content/393/bmj.s204'>BMA boosts support for private practice as NHS failings prompt more patients to pay for care</a></li>
</ul>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/udhr45dfmdnw59ai/bmj_130426_mix.mp3" length="56665728" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Coming up in this week’s episode:
The 15th Strike: As the latest six-day walkout by resident doctors in England concludes, the BMJ's news team examines the state of the ongoing dispute over pay and training places.
Iain Beardsell, consultant in emergency medicine in Southampton explain why he thinks reintroducing compassion could be the key to tackling the systemic issues facing emergency departments
And finally, The BMA announces major changes to how it represents doctors in private practice - we hear why they think the US has some better legislation around health insurance than the UK.
 
Reading list:

Resident doctor strikes: Streeting demands to “meet with the organ grinders” as latest action ends
The BMJ interviews Jack Fletcher 
Make compassion visible in emergency medicine again
BMA boosts support for private practice as NHS failings prompt more patients to pay for care
]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2361</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The unchecked rise of shisha tobacco cafes, and making breastfeeding stick</title>
        <itunes:title>The unchecked rise of shisha tobacco cafes, and making breastfeeding stick</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/bmj-april-2nd-2026/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/bmj-april-2nd-2026/#comments</comments>        <pubDate>Fri, 03 Apr 2026 10:30:48 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/a3e15c5d-6bdd-369d-8728-ac4dd0e38c05</guid>
                                    <description><![CDATA[<p>The BMJ published a negative result this week. A new trial focuses on a peer support intervention for improving breastfeeding rates in the UK, but finds no major improvement. We hear from the lead author who tells us what went wrong, and the insights that can still be drawn from apparent ‘failures’.</p>
<p>Next we turn our eyes to shisha smoking in the UK. With shisha or “hookah” cafes on the rise, we explore the smoking habit in more detail. What are the effects on health? And why are UK laws poor at regulating the practice?</p>
<p> </p>
<p>Kate Jolly is professor of public health and primary care at the University of Birmingham.</p>
<p>Zainab Hussain is a UK-based freelance journalist writing on behalf of The BMJ.</p>
<p>Links:</p>
<ul>
<li><a href='https://www.bmj.com/content/392/bmj-2025-086558'>Peer support intervention (ABA-feed) to improve breastfeeding: UK based, multicentre, parallel group, randomised controlled trial</a></li>
<li><a href='https://www.bmj.com/content/393/bmj.r2198'>Shisha tobacco’s availability is rising. Why does UK smoking policy fail to tackle it?</a></li>
</ul>
]]></description>
                                                            <content:encoded><![CDATA[<p>The BMJ published a negative result this week. A new trial focuses on a peer support intervention for improving breastfeeding rates in the UK, but finds no major improvement. We hear from the lead author who tells us what went wrong, and the insights that can still be drawn from apparent ‘failures’.</p>
<p>Next we turn our eyes to shisha smoking in the UK. With shisha or “hookah” cafes on the rise, we explore the smoking habit in more detail. What are the effects on health? And why are UK laws poor at regulating the practice?</p>
<p> </p>
<p>Kate Jolly is professor of public health and primary care at the University of Birmingham.</p>
<p>Zainab Hussain is a UK-based freelance journalist writing on behalf of The BMJ.</p>
<p>Links:</p>
<ul>
<li><a href='https://www.bmj.com/content/392/bmj-2025-086558'>Peer support intervention (ABA-feed) to improve breastfeeding: UK based, multicentre, parallel group, randomised controlled trial</a></li>
<li><a href='https://www.bmj.com/content/393/bmj.r2198'>Shisha tobacco’s availability is rising. Why does UK smoking policy fail to tackle it?</a></li>
</ul>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rtm3k8nvdeszgzc5/bmj_0202426_mix.mp3" length="48962880" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The BMJ published a negative result this week. A new trial focuses on a peer support intervention for improving breastfeeding rates in the UK, but finds no major improvement. We hear from the lead author who tells us what went wrong, and the insights that can still be drawn from apparent ‘failures’.
Next we turn our eyes to shisha smoking in the UK. With shisha or “hookah” cafes on the rise, we explore the smoking habit in more detail. What are the effects on health? And why are UK laws poor at regulating the practice?
 
Kate Jolly is professor of public health and primary care at the University of Birmingham.
Zainab Hussain is a UK-based freelance journalist writing on behalf of The BMJ.
Links:

Peer support intervention (ABA-feed) to improve breastfeeding: UK based, multicentre, parallel group, randomised controlled trial
Shisha tobacco’s availability is rising. Why does UK smoking policy fail to tackle it?
]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2040</itunes:duration>
                <itunes:episode>74</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>New Covid inquiry findings with Dr Kevin Fong, and invasive cosmetic procedures</title>
        <itunes:title>New Covid inquiry findings with Dr Kevin Fong, and invasive cosmetic procedures</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/new-covid-inquiry-findings-with-dr-kevin-fong-and-invasive-cosmetic-procedures/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/new-covid-inquiry-findings-with-dr-kevin-fong-and-invasive-cosmetic-procedures/#comments</comments>        <pubDate>Fri, 27 Mar 2026 18:07:29 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/46857800-29cf-329b-a8aa-91e0025558e1</guid>
                                    <description><![CDATA[<p>The UK Covid Inquiry released Module Three of its findings this month. It lays out in startling detail the lived experiences of NHS staff and patients who bore through the pandemic. In the report’s words: ‘healthcare systems coped with the pandemic, but only just’.
The BMJ speaks to Kevin Fong, anaesthetist lead for major incidence planning at UCL hospitals, to break down Module Three’s most important takeaways.
And, invasive surgical cosmetic procedures are on the rise in the UK, with regulation patchy at best. From botox and fillers, to tummy tucks and breast surgeries, we hear about the gaps in patient protections that leave space for harm.

Kevin Fong is a consultant anaesthetist, broadcaster, and anaesthetist lead for major incidence planning at UCL hospitals.
Danielle Griffiths is an author and lecturer at the University of Liverpool’s School of Law.
Alexandra Mullock is an author and senior lecturer in medical law at the University of Manchester.

<a href='https://covid19.public-inquiry.uk/reports/module-3-full-report/'>UK Covid Inquiry Module Three Report</a>

<a href='https://www.bmj.com/content/392/bmj-2025-086763.full'>Regulating invasive cosmetic procedures to reduce harm | The BMJ</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The UK Covid Inquiry released Module Three of its findings this month. It lays out in startling detail the lived experiences of NHS staff and patients who bore through the pandemic. In the report’s words: ‘healthcare systems coped with the pandemic, but only just’.<br>
The BMJ speaks to Kevin Fong, anaesthetist lead for major incidence planning at UCL hospitals, to break down Module Three’s most important takeaways.<br>
And, invasive surgical cosmetic procedures are on the rise in the UK, with regulation patchy at best. From botox and fillers, to tummy tucks and breast surgeries, we hear about the gaps in patient protections that leave space for harm.<br>
<br>
Kevin Fong is a consultant anaesthetist, broadcaster, and anaesthetist lead for major incidence planning at UCL hospitals.<br>
Danielle Griffiths is an author and lecturer at the University of Liverpool’s School of Law.<br>
Alexandra Mullock is an author and senior lecturer in medical law at the University of Manchester.<br>
<br>
<a href='https://covid19.public-inquiry.uk/reports/module-3-full-report/'>UK Covid Inquiry Module Three Report</a><br>
<br>
<a href='https://www.bmj.com/content/392/bmj-2025-086763.full'>Regulating invasive cosmetic procedures to reduce harm | The BMJ</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/iqsr8t4txvh5tt9a/bmj_270326_mix.mp3" length="62886528" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The UK Covid Inquiry released Module Three of its findings this month. It lays out in startling detail the lived experiences of NHS staff and patients who bore through the pandemic. In the report’s words: ‘healthcare systems coped with the pandemic, but only just’.The BMJ speaks to Kevin Fong, anaesthetist lead for major incidence planning at UCL hospitals, to break down Module Three’s most important takeaways.And, invasive surgical cosmetic procedures are on the rise in the UK, with regulation patchy at best. From botox and fillers, to tummy tucks and breast surgeries, we hear about the gaps in patient protections that leave space for harm.Kevin Fong is a consultant anaesthetist, broadcaster, and anaesthetist lead for major incidence planning at UCL hospitals.Danielle Griffiths is an author and lecturer at the University of Liverpool’s School of Law.Alexandra Mullock is an author and senior lecturer in medical law at the University of Manchester.UK Covid Inquiry Module Three ReportRegulating invasive cosmetic procedures to reduce harm | The BMJ]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2620</itunes:duration>
                <itunes:episode>73</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>How the war in Iran will disrupt medical supplies around the world</title>
        <itunes:title>How the war in Iran will disrupt medical supplies around the world</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/how-the-war-in-iran-will-affect-medical-supplies-around-the-world/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/how-the-war-in-iran-will-affect-medical-supplies-around-the-world/#comments</comments>        <pubDate>Fri, 20 Mar 2026 19:00:15 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/277c7007-ccf8-362f-95c2-a8f553d9801c</guid>
                                    <description><![CDATA[<p>The Gulf states are not large producers of pharmaceuticals or healthcare products - but the oil they supply, and the transport infrastructure they have built, are key components in a worldwide logistical network that underpin all of the pharmaceutical and other medical consumables we use.</p>
<p>From critical NHS shortages like Bone Cement for orthopedic surgery, to persistent IV fluid supply crises plaguing Australian hospitals, we discuss how the conflict in Iran will affect fragile healthcare logistics.</p>
<p>Joining us today are </p>
<ul>
<li style="font-weight:400;">Mark Dayan, Brexit programme lead at the Nuffield Trust) on NHS procurement problems </li>
<li style="font-weight:400;">Anny Huang, doctor and journalist in Brisbane,on the three-year  IV fluid shortages in Australia.</li>
<li>Prashant Yadav a senior fellow for global health at the Council on Foreign Relations, on the potential global effects of the Iranian conflict on international supply chains.</li>
</ul>
<p>Reading list</p>
<p><a href='https://www.bmj.com/content/392/bmj.s343'>Global bone cement shortage: NHS could cancel or delay knee and hip operations</a></p>
<p><a href='https://www.bmj.com/content/392/bmj.s368'>How Australia survived a sudden shortage of IV fluids</a>
</p>
<p><a href='https://www.thinkglobalhealth.org/article/where-the-iran-war-could-disrupt-pharmaceutical-supply-chains'>Where the Iran War Could Disrupt Pharmaceutical Supply Chains</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The Gulf states are not large producers of pharmaceuticals or healthcare products - but the oil they supply, and the transport infrastructure they have built, are key components in a worldwide logistical network that underpin all of the pharmaceutical and other medical consumables we use.</p>
<p>From critical NHS shortages like Bone Cement for orthopedic surgery, to persistent IV fluid supply crises plaguing Australian hospitals, we discuss how the conflict in Iran will affect fragile healthcare logistics.</p>
<p>Joining us today are </p>
<ul>
<li style="font-weight:400;">Mark Dayan, Brexit programme lead at the Nuffield Trust) on NHS procurement problems </li>
<li style="font-weight:400;">Anny Huang, doctor and journalist in Brisbane,on the three-year  IV fluid shortages in Australia.</li>
<li>Prashant Yadav a senior fellow for global health at the Council on Foreign Relations, on the potential global effects of the Iranian conflict on international supply chains.</li>
</ul>
<p>Reading list</p>
<p><a href='https://www.bmj.com/content/392/bmj.s343'>Global bone cement shortage: NHS could cancel or delay knee and hip operations</a></p>
<p><a href='https://www.bmj.com/content/392/bmj.s368'>How Australia survived a sudden shortage of IV fluids</a><br>
</p>
<p><a href='https://www.thinkglobalhealth.org/article/where-the-iran-war-could-disrupt-pharmaceutical-supply-chains'>Where the Iran War Could Disrupt Pharmaceutical Supply Chains</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ykgegjmxyinr93ms/PODCAST_ASSEMBLY_mixdownagket.mp3" length="81251221" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The Gulf states are not large producers of pharmaceuticals or healthcare products - but the oil they supply, and the transport infrastructure they have built, are key components in a worldwide logistical network that underpin all of the pharmaceutical and other medical consumables we use.
From critical NHS shortages like Bone Cement for orthopedic surgery, to persistent IV fluid supply crises plaguing Australian hospitals, we discuss how the conflict in Iran will affect fragile healthcare logistics.
Joining us today are 

Mark Dayan, Brexit programme lead at the Nuffield Trust) on NHS procurement problems 
Anny Huang, doctor and journalist in Brisbane,on the three-year  IV fluid shortages in Australia.
Prashant Yadav a senior fellow for global health at the Council on Foreign Relations, on the potential global effects of the Iranian conflict on international supply chains.

Reading list
Global bone cement shortage: NHS could cancel or delay knee and hip operations
How Australia survived a sudden shortage of IV fluids
Where the Iran War Could Disrupt Pharmaceutical Supply Chains
 ]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2030</itunes:duration>
                <itunes:episode>72</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Is the NHS in danger of making misinformation worse?</title>
        <itunes:title>Is the NHS in danger of making misinformation worse?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/bmj-nuffield-summit-2026/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/bmj-nuffield-summit-2026/#comments</comments>        <pubDate>Fri, 13 Mar 2026 14:55:58 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/897ce4ae-6f27-38ec-932e-9dc28cb02bbc</guid>
                                    <description><![CDATA[<p>The lure of health influencers and AI chat bots is strong. More and more people are placing trust in them to answer their health problems, misplaced trust - as we know these AIs can misinform.</p>
<p>At the same time, people are struggling to access the NHS, and when they do doctors have little time or the right tools to unpick complicated science, and challenge misunderstandings.</p>
<p>So in this roundtable, we’re asking, are we in danger of the NHS making the problem of misinformation worse, and what can we do to combat that.</p>
<p>Joining Kamran Abbasi, the BMJ’s editor in chief are:</p>
<ul>
<li style="font-weight:400;">Deborah Cohen: Freelance Journalist; Senior Visiting Fellow at LSE Health</li>
<li style="font-weight:400;">Kamila Hawthorne: Chair of the National Academy for Social Prescribing</li>
<li style="font-weight:400;">Nnena Osuji: Consultant haematologist and CEO of North Middlesex University Hospital NHS Trust</li>
</ul>
<p>Chapters</p>
<ul>
<li style="font-weight:400;">[00:00] The rise of health influencers</li>
<li style="font-weight:400;">[03:55] Patient satisfaction and the NHS</li>
<li style="font-weight:400;">[05:58] The "Infodemic" and clinical impact</li>
<li style="font-weight:400;">[11:04] Digital literacy and health inequalities</li>
<li style="font-weight:400;">[16:40] Questions from the audience</li>
</ul>
<p> </p>
<p>Reading list:</p>
<ul>
<li style="font-weight:400;">Cohen D. Bad Influence: How the Internet Hijacked Our Health. Oneworld Publications; 2026.</li>
<li style="font-weight:400;"><a href='https://www.bmj.com/content/389/bmj.r659'>Satisfaction with NHS hits record low, but public still back founding principles - The BMJ</a></li>
</ul>
]]></description>
                                                            <content:encoded><![CDATA[<p>The lure of health influencers and AI chat bots is strong. More and more people are placing trust in them to answer their health problems, misplaced trust - as we know these AIs can misinform.</p>
<p>At the same time, people are struggling to access the NHS, and when they do doctors have little time or the right tools to unpick complicated science, and challenge misunderstandings.</p>
<p>So in this roundtable, we’re asking, are we in danger of the NHS making the problem of misinformation worse, and what can we do to combat that.</p>
<p>Joining Kamran Abbasi, the BMJ’s editor in chief are:</p>
<ul>
<li style="font-weight:400;">Deborah Cohen: Freelance Journalist; Senior Visiting Fellow at LSE Health</li>
<li style="font-weight:400;">Kamila Hawthorne: Chair of the National Academy for Social Prescribing</li>
<li style="font-weight:400;">Nnena Osuji: Consultant haematologist and CEO of North Middlesex University Hospital NHS Trust</li>
</ul>
<p>Chapters</p>
<ul>
<li style="font-weight:400;">[00:00] The rise of health influencers</li>
<li style="font-weight:400;">[03:55] Patient satisfaction and the NHS</li>
<li style="font-weight:400;">[05:58] The "Infodemic" and clinical impact</li>
<li style="font-weight:400;">[11:04] Digital literacy and health inequalities</li>
<li style="font-weight:400;">[16:40] Questions from the audience</li>
</ul>
<p> </p>
<p>Reading list:</p>
<ul>
<li style="font-weight:400;">Cohen D. <em>Bad Influence: How the Internet Hijacked Our Health</em>. Oneworld Publications; 2026.</li>
<li style="font-weight:400;"><a href='https://www.bmj.com/content/389/bmj.r659'>Satisfaction with NHS hits record low, but public still back founding principles - The BMJ</a></li>
</ul>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/yymm3inynxzh8d86/bmj_nuffield_mix.mp3" length="46364160" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The lure of health influencers and AI chat bots is strong. More and more people are placing trust in them to answer their health problems, misplaced trust - as we know these AIs can misinform.
At the same time, people are struggling to access the NHS, and when they do doctors have little time or the right tools to unpick complicated science, and challenge misunderstandings.
So in this roundtable, we’re asking, are we in danger of the NHS making the problem of misinformation worse, and what can we do to combat that.
Joining Kamran Abbasi, the BMJ’s editor in chief are:

Deborah Cohen: Freelance Journalist; Senior Visiting Fellow at LSE Health
Kamila Hawthorne: Chair of the National Academy for Social Prescribing
Nnena Osuji: Consultant haematologist and CEO of North Middlesex University Hospital NHS Trust

Chapters

[00:00] The rise of health influencers
[03:55] Patient satisfaction and the NHS
[05:58] The "Infodemic" and clinical impact
[11:04] Digital literacy and health inequalities
[16:40] Questions from the audience

 
Reading list:

Cohen D. Bad Influence: How the Internet Hijacked Our Health. Oneworld Publications; 2026.
Satisfaction with NHS hits record low, but public still back founding principles - The BMJ
]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2897</itunes:duration>
                <itunes:episode>71</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>What should GP's make of the new NHS contract?</title>
        <itunes:title>What should GP's make of the new NHS contract?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/what-should-gps-make-of-the-new-nhs-contract/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/what-should-gps-make-of-the-new-nhs-contract/#comments</comments>        <pubDate>Thu, 12 Mar 2026 17:21:25 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/c1f1e2eb-d702-3c00-a770-ef2152147582</guid>
                                    <description><![CDATA[<p>In this episode, Dr Katie Bramall, Chair of the BMA’s General Practitioners Committee, joins the podcast to discuss her concerns surrounding the new GP contract imposed by the UK government.</p>
<p><a href='https://www.bmj.com/content/392/bmj.s390'>GP contract overhaul: What's included and how has it been received?</a></p>
<p><a href='https://www.bmj.com/content/392/bmj.s416'>Helen Salisbury: Another imposed GP contract</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, Dr Katie Bramall, Chair of the BMA’s General Practitioners Committee, joins the podcast to discuss her concerns surrounding the new GP contract imposed by the UK government.</p>
<p><a href='https://www.bmj.com/content/392/bmj.s390'>GP contract overhaul: What's included and how has it been received?</a></p>
<p><a href='https://www.bmj.com/content/392/bmj.s416'>Helen Salisbury: Another imposed GP contract</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ckax4juz48c642zx/bmj_120326_mix_mixdown.mp3" length="39877946" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, Dr Katie Bramall, Chair of the BMA’s General Practitioners Committee, joins the podcast to discuss her concerns surrounding the new GP contract imposed by the UK government.
GP contract overhaul: What's included and how has it been received?
Helen Salisbury: Another imposed GP contract]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1661</itunes:duration>
                <itunes:episode>70</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Household air pollution, Labour’s lag on child poverty, children forced to cope with conflict</title>
        <itunes:title>Household air pollution, Labour’s lag on child poverty, children forced to cope with conflict</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/household-air-pollution-labour-s-lag-on-child-poverty-children-forced-to-cope-with-conflict/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/household-air-pollution-labour-s-lag-on-child-poverty-children-forced-to-cope-with-conflict/#comments</comments>        <pubDate>Fri, 06 Mar 2026 19:16:47 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/b21a6f39-ebe8-3dee-9a3f-647f72af7446</guid>
                                    <description><![CDATA[<p>As public health officials warn about rising emissions from urban wood burning, a BMJ investigation finds that just under a third of UK councils in high use areas have faced pressure from the stove industry to tone down or withdraw campaigns.</p>
<p>
Almost a third of UK children live in poverty. Leading expert Michael Marmot weighs in on the UK’s "steepest rise" in child poverty among OECD countries and why local government "Marmot Cities" like Coventry and Manchester are taking the lead where national policy falls short.</p>
<p>
And, a new BMJ collection has just been published on child mental health in conflict zones. 1 in 5 children globally live in conflict zones, creating a staggering mental health toll. We hear about community-led interventions.</p>
<p> </p>
<p>Reading list:</p>
<ul>
<li><a href='https://www.bmj.com/content/392/bmj.s360'>The growing threat of domestic wood burning stoves—and industry’s legal attempts to shut down clean air campaigns</a></li>
<li><a href='https://www.bmj.com/content/392/bmj.s356'>Michael Marmot: Labour has reneged on its child poverty promises</a></li>
<li><a href='https://www.bmj.com/collections/child-mental-health'>Child mental health in conflict settings</a></li>
</ul>
]]></description>
                                                            <content:encoded><![CDATA[<p>As public health officials warn about rising emissions from urban wood burning, a BMJ investigation finds that just under a third of UK councils in high use areas have faced pressure from the stove industry to tone down or withdraw campaigns.</p>
<p><br>
Almost a third of UK children live in poverty. Leading expert Michael Marmot weighs in on the UK’s "steepest rise" in child poverty among OECD countries and why local government "Marmot Cities" like Coventry and Manchester are taking the lead where national policy falls short.</p>
<p><br>
And, a new BMJ collection has just been published on child mental health in conflict zones. 1 in 5 children globally live in conflict zones, creating a staggering mental health toll. We hear about community-led interventions.</p>
<p> </p>
<p>Reading list:</p>
<ul>
<li><a href='https://www.bmj.com/content/392/bmj.s360'>The growing threat of domestic wood burning stoves—and industry’s legal attempts to shut down clean air campaigns</a></li>
<li><a href='https://www.bmj.com/content/392/bmj.s356'>Michael Marmot: Labour has reneged on its child poverty promises</a></li>
<li><a href='https://www.bmj.com/collections/child-mental-health'>Child mental health in conflict settings</a></li>
</ul>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gnsxj5j972n939yj/bmj_060326_mix.mp3" length="50484096" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As public health officials warn about rising emissions from urban wood burning, a BMJ investigation finds that just under a third of UK councils in high use areas have faced pressure from the stove industry to tone down or withdraw campaigns.
Almost a third of UK children live in poverty. Leading expert Michael Marmot weighs in on the UK’s "steepest rise" in child poverty among OECD countries and why local government "Marmot Cities" like Coventry and Manchester are taking the lead where national policy falls short.
And, a new BMJ collection has just been published on child mental health in conflict zones. 1 in 5 children globally live in conflict zones, creating a staggering mental health toll. We hear about community-led interventions.
 
Reading list:

The growing threat of domestic wood burning stoves—and industry’s legal attempts to shut down clean air campaigns
Michael Marmot: Labour has reneged on its child poverty promises
Child mental health in conflict settings
]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2103</itunes:duration>
                <itunes:episode>69</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Measles is surging in 2026. From London to Texas, why are cases hitting a 30-year high?</title>
        <itunes:title>Measles is surging in 2026. From London to Texas, why are cases hitting a 30-year high?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/measles-outbreaks-in-uk-mexico-and-north-america-is-the-disease-coming-back-bmj-interview/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/measles-outbreaks-in-uk-mexico-and-north-america-is-the-disease-coming-back-bmj-interview/#comments</comments>        <pubDate>Fri, 27 Feb 2026 19:18:42 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/e818d6eb-3aa1-3f1f-a8bf-6d43f0b4bb03</guid>
                                    <description><![CDATA[<p>In this episode, we investigate the alarming resurgence of measles across North America and the UK. While cases are falling across much of Europe and Asia, North America is seeing explosive outbreaks fueled by vaccine hesitancy and political shifts.
We break down the 2026 crisis: Why London is the epicenter and how the UK lost its "Measles Elimination Status". An in-depth look at outbreaks in Ontario, Alberta, Texas, and Mexico. How returning travelers—not migrants—are actually driving the spread. The impact of "shared clinical decision-making" and current US health leadership on vaccine access.</p>
<p>Kamran Abbasi is joined by:</p>
<p>Angela Rasmussen - Virologist, University of Saskatchewan.</p>
<p>Azeem Majeed - Professor of Primary Care and Public Health, Imperial College London.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, we investigate the alarming resurgence of measles across North America and the UK. While cases are falling across much of Europe and Asia, North America is seeing explosive outbreaks fueled by vaccine hesitancy and political shifts.<br>
We break down the 2026 crisis: Why London is the epicenter and how the UK lost its "Measles Elimination Status". An in-depth look at outbreaks in Ontario, Alberta, Texas, and Mexico. How returning travelers—not migrants—are actually driving the spread. The impact of "shared clinical decision-making" and current US health leadership on vaccine access.</p>
<p>Kamran Abbasi is joined by:</p>
<p>Angela Rasmussen - Virologist, University of Saskatchewan.</p>
<p>Azeem Majeed - Professor of Primary Care and Public Health, Imperial College London.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/52ibeija6uwt8nyu/bmj_270226_measles_roundtable.mp3" length="39906567" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, we investigate the alarming resurgence of measles across North America and the UK. While cases are falling across much of Europe and Asia, North America is seeing explosive outbreaks fueled by vaccine hesitancy and political shifts.We break down the 2026 crisis: Why London is the epicenter and how the UK lost its "Measles Elimination Status". An in-depth look at outbreaks in Ontario, Alberta, Texas, and Mexico. How returning travelers—not migrants—are actually driving the spread. The impact of "shared clinical decision-making" and current US health leadership on vaccine access.
Kamran Abbasi is joined by:
Angela Rasmussen - Virologist, University of Saskatchewan.
Azeem Majeed - Professor of Primary Care and Public Health, Imperial College London.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2494</itunes:duration>
                <itunes:episode>68</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Rethinking Cancer Survivorship and the Autism Gender Gap</title>
        <itunes:title>Rethinking Cancer Survivorship and the Autism Gender Gap</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/rethinking-cancer-survivorship-and-the-autism-gender-gap/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/rethinking-cancer-survivorship-and-the-autism-gender-gap/#comments</comments>        <pubDate>Fri, 20 Feb 2026 20:16:16 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/d37d057f-7c29-3903-86c4-bc3661646f24</guid>
                                    <description><![CDATA[<p>In this week’s episode, we challenge long-held medical narratives, starting with how the healthcare system manages life after a cancer diagnosis. While medical advancements mean more people are surviving cancer than ever before, many patients report a "cliff-edge" experience where coordinated care effectively vanishes once primary treatment ends. We are joined by Dr. Rosalind Adam, an Academic GP at the University of Aberdeen, who argues that it is time to stop viewing cancer as a discrete, one-off episode and instead integrate it into routine chronic disease management. </p>
<p>Next, we dive into a landmark study from Sweden that is overturning the conventional notion of autism as a predominantly male condition. Historically, autism has been cited as having a 4:1 male-to-female ratio, but new data suggests this gap may be a byproduct of timing rather than biology. We speak with Dr. Caroline Fyfe, a medical epidemiologist at the University of Edinburgh, and Dr. Natasha Marrus, a child psychiatrist at Washington University in St. Louis. They discuss their analysis of 2.7 million individuals, which revealed a significant female catch-up during adolescence, showing that by age 20, the diagnosis ratio approaches 1:1. The team explores why girls are so often missed in childhood and what this shift means for the future of sex-sensitive diagnostic practices.</p>
Reading List
<p>For more details on the research discussed in this episode, you can access the full papers on bmj.com:</p>
<ul>
<li style="font-weight:400;"><a href='https://www.bmj.com/content/392/bmj-2025-086624'> Cancer is a chronic disease: why don’t we treat it as one?</a> Adam R, Hogg DR, Ritchie LD, Nekhlyudov L. BMJ 2026;392:e086624.</li>
<li><a href='https://www.bmj.com/content/392/bmj-2025-084164'>Time trends in the male to female ratio for autism incidence: population based, prospectively collected, birth cohort study.</a> Fyfe C, et al. BMJ 2026;392:e084164.</li>
</ul>
<p>Please subscribe to the Medicine &amp; Science podcast on your favourite platform to get the latest episodes. If you enjoy our podcast, you can leave us a review or a comment on <a href='https://podcasts.apple.com/gb/podcast/the-bmj-podcast/id283916558'>Apple Podcasts</a>, <a href='https://open.spotify.com/show/2FKxpbvObp8W9hNT1PUMQH'>Spotify</a>, or <a href='https://www.youtube.com/@TheBMJ/podcasts'>YouTube</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this week’s episode, we challenge long-held medical narratives, starting with how the healthcare system manages life after a cancer diagnosis. While medical advancements mean more people are surviving cancer than ever before, many patients report a "cliff-edge" experience where coordinated care effectively vanishes once primary treatment ends. We are joined by Dr. Rosalind Adam, an Academic GP at the University of Aberdeen, who argues that it is time to stop viewing cancer as a discrete, one-off episode and instead integrate it into routine chronic disease management. </p>
<p>Next, we dive into a landmark study from Sweden that is overturning the conventional notion of autism as a predominantly male condition. Historically, autism has been cited as having a 4:1 male-to-female ratio, but new data suggests this gap may be a byproduct of timing rather than biology. We speak with Dr. Caroline Fyfe, a medical epidemiologist at the University of Edinburgh, and Dr. Natasha Marrus, a child psychiatrist at Washington University in St. Louis. They discuss their analysis of 2.7 million individuals, which revealed a significant female catch-up during adolescence, showing that by age 20, the diagnosis ratio approaches 1:1. The team explores why girls are so often missed in childhood and what this shift means for the future of sex-sensitive diagnostic practices.</p>
Reading List
<p>For more details on the research discussed in this episode, you can access the full papers on bmj.com:</p>
<ul>
<li style="font-weight:400;"><a href='https://www.bmj.com/content/392/bmj-2025-086624'> Cancer is a chronic disease: why don’t we treat it as one?</a> Adam R, Hogg DR, Ritchie LD, Nekhlyudov L. <em>BMJ</em> 2026;392:e086624.</li>
<li><a href='https://www.bmj.com/content/392/bmj-2025-084164'>Time trends in the male to female ratio for autism incidence: population based, prospectively collected, birth cohort study.</a> Fyfe C, et al. <em style="font-family:'-apple-system', BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Open Sans', 'Helvetica Neue', sans-serif;">BMJ</em> 2026;392:e084164.</li>
</ul>
<p>Please subscribe to the Medicine &amp; Science podcast on your favourite platform to get the latest episodes. If you enjoy our podcast, you can leave us a review or a comment on <a href='https://podcasts.apple.com/gb/podcast/the-bmj-podcast/id283916558'>Apple Podcasts</a>, <a href='https://open.spotify.com/show/2FKxpbvObp8W9hNT1PUMQH'>Spotify</a>, or <a href='https://www.youtube.com/@TheBMJ/podcasts'>YouTube</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/t5mqmjsbqv8ed4xr/bmj_200226_mix.mp3" length="40741632" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this week’s episode, we challenge long-held medical narratives, starting with how the healthcare system manages life after a cancer diagnosis. While medical advancements mean more people are surviving cancer than ever before, many patients report a "cliff-edge" experience where coordinated care effectively vanishes once primary treatment ends. We are joined by Dr. Rosalind Adam, an Academic GP at the University of Aberdeen, who argues that it is time to stop viewing cancer as a discrete, one-off episode and instead integrate it into routine chronic disease management. 
Next, we dive into a landmark study from Sweden that is overturning the conventional notion of autism as a predominantly male condition. Historically, autism has been cited as having a 4:1 male-to-female ratio, but new data suggests this gap may be a byproduct of timing rather than biology. We speak with Dr. Caroline Fyfe, a medical epidemiologist at the University of Edinburgh, and Dr. Natasha Marrus, a child psychiatrist at Washington University in St. Louis. They discuss their analysis of 2.7 million individuals, which revealed a significant female catch-up during adolescence, showing that by age 20, the diagnosis ratio approaches 1:1. The team explores why girls are so often missed in childhood and what this shift means for the future of sex-sensitive diagnostic practices.
Reading List
For more details on the research discussed in this episode, you can access the full papers on bmj.com:

 Cancer is a chronic disease: why don’t we treat it as one? Adam R, Hogg DR, Ritchie LD, Nekhlyudov L. BMJ 2026;392:e086624.
Time trends in the male to female ratio for autism incidence: population based, prospectively collected, birth cohort study. Fyfe C, et al. BMJ 2026;392:e084164.

Please subscribe to the Medicine &amp; Science podcast on your favourite platform to get the latest episodes. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts, Spotify, or YouTube.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1697</itunes:duration>
                <itunes:episode>67</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>"We see coercion the other way... People cannot let go of their dying family"  - assisted dying around the world</title>
        <itunes:title>"We see coercion the other way... People cannot let go of their dying family"  - assisted dying around the world</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/we-see-coercion-the-other-way-people-cannot-let-go-of-their-dying-family-assisted-dying-around-the-world/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/we-see-coercion-the-other-way-people-cannot-let-go-of-their-dying-family-assisted-dying-around-the-world/#comments</comments>        <pubDate>Sat, 14 Feb 2026 13:01:20 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/9eaa16dc-b3e2-3c41-8c1c-981ce5f198d9</guid>
                                    <description><![CDATA[<p>The House of Lord's amendments to England and Wales assisted dying bill might be causing a constitutional crisis. Lords have tabled 1,277 amendments—which is a record for any equivalent bill in history - and over half of those came from just seven peers.</p>
<p>This has led to accusations of "delaying tactics" or "filibustering" to run down the clock deliberately and run this bill off the road. Although some of these amendments have been described as unworkable, repetitious and unnecessary; others reflect serious, legitimate concerns, around the prevention of coercion, how to identify victims of domestic abuse and the broader impact on the disabled community, and whether it’s wise to introduce assisted dying while palliative and social care services are so stretched.</p>
<p>300 territories around the world, allow physician assisted death - so we asked experts from Canada and California to reflect on those objections, and if there is any evidence of this issues arising where they live.</p>
<p>James Downer is Professor and Head of the Division of Palliative Care at the University of Ottawa, and Catherine Forest is clinical associate professor of family medicine at the University of California San Francisco.</p>
<p> </p>
<p>Reading list:</p>
<p><a href='https://www.bmj.com/content/392/bmj.s250'>Scrutiny of the assisted dying bill is vital but obstruction in the House of Lords could mean it never becomes law</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The House of Lord's amendments to England and Wales assisted dying bill might be causing a constitutional crisis. Lords have tabled 1,277 amendments—which is a record for any equivalent bill in history - and over half of those came from just seven peers.</p>
<p>This has led to accusations of "delaying tactics" or "filibustering" to run down the clock deliberately and run this bill off the road. Although some of these amendments have been described as unworkable, repetitious and unnecessary; others reflect serious, legitimate concerns, around the prevention of coercion, how to identify victims of domestic abuse and the broader impact on the disabled community, and whether it’s wise to introduce assisted dying while palliative and social care services are so stretched.</p>
<p>300 territories around the world, allow physician assisted death - so we asked experts from Canada and California to reflect on those objections, and if there is any evidence of this issues arising where they live.</p>
<p>James Downer is Professor and Head of the Division of Palliative Care at the University of Ottawa, and Catherine Forest is clinical associate professor of family medicine at the University of California San Francisco.</p>
<p> </p>
<p>Reading list:</p>
<p><a href='https://www.bmj.com/content/392/bmj.s250'>Scrutiny of the assisted dying bill is vital but obstruction in the House of Lords could mean it never becomes law</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/g5f9fyemynkb64tf/Assisted_dying_roundtable_-_audio_version9jtpm.mp3" length="67066931" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The House of Lord's amendments to England and Wales assisted dying bill might be causing a constitutional crisis. Lords have tabled 1,277 amendments—which is a record for any equivalent bill in history - and over half of those came from just seven peers.
This has led to accusations of "delaying tactics" or "filibustering" to run down the clock deliberately and run this bill off the road. Although some of these amendments have been described as unworkable, repetitious and unnecessary; others reflect serious, legitimate concerns, around the prevention of coercion, how to identify victims of domestic abuse and the broader impact on the disabled community, and whether it’s wise to introduce assisted dying while palliative and social care services are so stretched.
300 territories around the world, allow physician assisted death - so we asked experts from Canada and California to reflect on those objections, and if there is any evidence of this issues arising where they live.
James Downer is Professor and Head of the Division of Palliative Care at the University of Ottawa, and Catherine Forest is clinical associate professor of family medicine at the University of California San Francisco.
 
Reading list:
Scrutiny of the assisted dying bill is vital but obstruction in the House of Lords could mean it never becomes law]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2794</itunes:duration>
                <itunes:episode>66</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>How the internet hijacked our health</title>
        <itunes:title>How the internet hijacked our health</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/how-the-internet-hijacked-our-health/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/how-the-internet-hijacked-our-health/#comments</comments>        <pubDate>Fri, 06 Feb 2026 13:53:58 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/3b5b8206-6ddf-3ba6-9d3a-6be0f81d989e</guid>
                                    <description><![CDATA[<p>Deborah Cohen's new book "How the internet hijacked our health" explores the profound impact of the internet on our wellbeing.</p>
<p>In this conversation with BMJ Editor, Kamran Abbasi, they discuss the ways in which online information can both empower and mislead, the role of big tech in shaping our wellbeing and the complex and disturbing ways wellness influencers are becoming more trusted than the NHS.</p>
<p>With insights drawn from extensive research and a deep understanding of the digital landscape, Deborah Cohen sheds light on the critical issues at the intersection of technology and healthcare, and challenges anyone who consumes health information online to think differently about what they're doing.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Deborah Cohen's new book "How the internet hijacked our health" explores the profound impact of the internet on our wellbeing.</p>
<p>In this conversation with BMJ Editor, Kamran Abbasi, they discuss the ways in which online information can both empower and mislead, the role of big tech in shaping our wellbeing and the complex and disturbing ways wellness influencers are becoming more trusted than the NHS.</p>
<p>With insights drawn from extensive research and a deep understanding of the digital landscape, Deborah Cohen sheds light on the critical issues at the intersection of technology and healthcare, and challenges anyone who consumes health information online to think differently about what they're doing.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gyjh9swqp75g7cjh/BMJ_Deborah_Cohen_How_the_internet_hijacked_our_health_-_edit9dj2n.mp3" length="57039235" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Deborah Cohen's new book "How the internet hijacked our health" explores the profound impact of the internet on our wellbeing.
In this conversation with BMJ Editor, Kamran Abbasi, they discuss the ways in which online information can both empower and mislead, the role of big tech in shaping our wellbeing and the complex and disturbing ways wellness influencers are becoming more trusted than the NHS.
With insights drawn from extensive research and a deep understanding of the digital landscape, Deborah Cohen sheds light on the critical issues at the intersection of technology and healthcare, and challenges anyone who consumes health information online to think differently about what they're doing.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2376</itunes:duration>
                <itunes:episode>65</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>What access to GPs tells us about the NHS 10 year plan, and online gambling</title>
        <itunes:title>What access to GPs tells us about the NHS 10 year plan, and online gambling</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/bmj-jan-30th-2026/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/bmj-jan-30th-2026/#comments</comments>        <pubDate>Sat, 31 Jan 2026 12:14:19 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/5e1e4260-e594-361a-b196-4a6125e5413a</guid>
                                    <description><![CDATA[<p>We’re 18 months into the Labour government, and their changes to the NHS are beginning to be felt. In the 10 year plan that they launched last year, they announced three planned shifts for the health service. </p>
<p>Firstly, they pledge to move care from hospitals to the community, an increased focus on prevention rather than sickness, and shift from analogue to digital with an improved NHS app where patients can access records, seek advice and control some aspects of their care. However, accessing primary care and getting a GP appointment is still a key area of concern for patients and healthcare staff. </p>
<p>In a new research paper on <a href='http://bmj.com'>bmj.com</a>, a group of researchers have performed a qualitative study asking 70 patients about their experiences of accessing primary care in England. We're joined by Hugh Alderwick and Luisa Petigrew from the Health Foundation to discuss what the findings mean for the 10 year plan.</p>
<p>Also this week, online gambling is a growing problem. The immediacy of access, combined with advertising and push notifications, and a proliferation of new gambling companies, undermines traditional ways of managing a gambling addiction.</p>
<p>A new analysis argues that these new forms of online gambling requires new forms of regulation. Spencer Murch from the University of Calgery offers some ideas on how that could work.</p>
<p> </p>
<p>Reading list</p>
<p><a href='https://www.bmj.com/content/392/bmj-2025-087367'>Experience of access to general practice in England</a></p>
<p><a href='https://www.bmj.com/content/392/bmj.s107'>Policies to increase access to general practice may have unintended consequences</a></p>
<p><a href='https://www.bmj.com/content/392/bmj-2025-086768'>Online gambling requires greater government regulation</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>We’re 18 months into the Labour government, and their changes to the NHS are beginning to be felt. In the 10 year plan that they launched last year, they announced three planned shifts for the health service. </p>
<p>Firstly, they pledge to move care from hospitals to the community, an increased focus on prevention rather than sickness, and shift from analogue to digital with an improved NHS app where patients can access records, seek advice and control some aspects of their care. However, accessing primary care and getting a GP appointment is still a key area of concern for patients and healthcare staff. </p>
<p>In a new research paper on <a href='http://bmj.com'>bmj.com</a>, a group of researchers have performed a qualitative study asking 70 patients about their experiences of accessing primary care in England. We're joined by Hugh Alderwick and Luisa Petigrew from the Health Foundation to discuss what the findings mean for the 10 year plan.</p>
<p>Also this week, online gambling is a growing problem. The immediacy of access, combined with advertising and push notifications, and a proliferation of new gambling companies, undermines traditional ways of managing a gambling addiction.</p>
<p>A new analysis argues that these new forms of online gambling requires new forms of regulation. Spencer Murch from the University of Calgery offers some ideas on how that could work.</p>
<p> </p>
<p>Reading list</p>
<p><a href='https://www.bmj.com/content/392/bmj-2025-087367'>Experience of access to general practice in England</a></p>
<p><a href='https://www.bmj.com/content/392/bmj.s107'>Policies to increase access to general practice may have unintended consequences</a></p>
<p><a href='https://www.bmj.com/content/392/bmj-2025-086768'>Online gambling requires greater government regulation</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gvs9bjxj43pny2k7/bmj_300126_mix.mp3" length="54124416" type="audio/mpeg"/>
        <itunes:summary><![CDATA[We’re 18 months into the Labour government, and their changes to the NHS are beginning to be felt. In the 10 year plan that they launched last year, they announced three planned shifts for the health service. 
Firstly, they pledge to move care from hospitals to the community, an increased focus on prevention rather than sickness, and shift from analogue to digital with an improved NHS app where patients can access records, seek advice and control some aspects of their care. However, accessing primary care and getting a GP appointment is still a key area of concern for patients and healthcare staff. 
In a new research paper on bmj.com, a group of researchers have performed a qualitative study asking 70 patients about their experiences of accessing primary care in England. We're joined by Hugh Alderwick and Luisa Petigrew from the Health Foundation to discuss what the findings mean for the 10 year plan.
Also this week, online gambling is a growing problem. The immediacy of access, combined with advertising and push notifications, and a proliferation of new gambling companies, undermines traditional ways of managing a gambling addiction.
A new analysis argues that these new forms of online gambling requires new forms of regulation. Spencer Murch from the University of Calgery offers some ideas on how that could work.
 
Reading list
Experience of access to general practice in England
Policies to increase access to general practice may have unintended consequences
Online gambling requires greater government regulation]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2255</itunes:duration>
                <itunes:episode>64</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>How much should doctors be paid? | BMJ Interviews Economist Richard Murphy</title>
        <itunes:title>How much should doctors be paid? | BMJ Interviews Economist Richard Murphy</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/is-the-nhs-unaffordable-the-economics-of-health-with-richard-murphy/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/is-the-nhs-unaffordable-the-economics-of-health-with-richard-murphy/#comments</comments>        <pubDate>Fri, 23 Jan 2026 16:15:05 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/2d3cd841-1301-3a49-bf02-957bc5271f15</guid>
                                    <description><![CDATA[<p>This interview is available in video form: <a href='https://www.youtube.com/watch?v=-yNO47EfuEM'>https://www.youtube.com/watch?v=-yNO47EfuEM</a></p>
<p>​<a href='https://www.youtube.com/@RichardJMurphy'>‪
@RichardJMurphy‬</a>, political economist and tax campaigner, joins Kamran Abbasi, Editor in Chief of The BMJ. </p>
<p>In the UK an ongoing dispute between resident doctors and the Labour Government saw doctors go on strike in mid-December. With Winter pressure piling on and cost-of-living on the rise, do doctors have a credible case of pay rises? And more broadly, how can the economic situation of the NHS be improved?</p>
<p>00:00 Introduction
01:30 Doctor Pay Claims
04:33 Inflation Measures
07:29 Affordability Crisis
09:48 Market Forces Arguments
12:52 NHS Affordability
15:00 Youth Unemployment
19:14 Political Priorities
23:10 Neoliberal Capitalism
27:35 Mixed Economy Alternative
32:32 Prescription for NHS</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This interview is available in video form: <a href='https://www.youtube.com/watch?v=-yNO47EfuEM'>https://www.youtube.com/watch?v=-yNO47EfuEM</a></p>
<p>​<a href='https://www.youtube.com/@RichardJMurphy'>‪<br>
@RichardJMurphy‬</a>, political economist and tax campaigner, joins Kamran Abbasi, Editor in Chief of The BMJ. </p>
<p>In the UK an ongoing dispute between resident doctors and the Labour Government saw doctors go on strike in mid-December. With Winter pressure piling on and cost-of-living on the rise, do doctors have a credible case of pay rises? And more broadly, how can the economic situation of the NHS be improved?</p>
<p>00:00 Introduction<br>
01:30 Doctor Pay Claims<br>
04:33 Inflation Measures<br>
07:29 Affordability Crisis<br>
09:48 Market Forces Arguments<br>
12:52 NHS Affordability<br>
15:00 Youth Unemployment<br>
19:14 Political Priorities<br>
23:10 Neoliberal Capitalism<br>
27:35 Mixed Economy Alternative<br>
32:32 Prescription for NHS</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wpkd8qtpy9gvtwym/bmj_2201626_richard_murphy.mp3" length="51460551" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This interview is available in video form: https://www.youtube.com/watch?v=-yNO47EfuEM
​‪@RichardJMurphy‬, political economist and tax campaigner, joins Kamran Abbasi, Editor in Chief of The BMJ. 
In the UK an ongoing dispute between resident doctors and the Labour Government saw doctors go on strike in mid-December. With Winter pressure piling on and cost-of-living on the rise, do doctors have a credible case of pay rises? And more broadly, how can the economic situation of the NHS be improved?
00:00 Introduction01:30 Doctor Pay Claims04:33 Inflation Measures07:29 Affordability Crisis09:48 Market Forces Arguments12:52 NHS Affordability15:00 Youth Unemployment19:14 Political Priorities23:10 Neoliberal Capitalism27:35 Mixed Economy Alternative32:32 Prescription for NHS]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2144</itunes:duration>
                <itunes:episode>63</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>GLP-1 weight regain and doctors forced out of Gaza</title>
        <itunes:title>GLP-1 weight regain and doctors forced out of Gaza</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/glp-1-weight-regain-and-doctors-forced-out-of-gaza/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/glp-1-weight-regain-and-doctors-forced-out-of-gaza/#comments</comments>        <pubDate>Mon, 12 Jan 2026 17:28:00 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/eca0ae67-2958-3f0e-a844-95d3d8f3bea5</guid>
                                    <description><![CDATA[<p>The class of GLP-1 agonist drugs including Ozempic gained a wide reputation for weight loss in 2025. However, it's well established that weight regain is a common result after people stop their doses. We report on new research which aims to quantify what is happening in the here-and-now for patients who stop using these and similar drugs.</p>
<p><a href='https://www.bmj.com/content/392/bmj-2025-085304'>Weight regain after cessation of medication for weight management: systematic review and meta-analysis</a> </p>
<p> </p>
<p>Also, The BMJ reports on news from Gaza. The Israeli government has issued new directives to strip 37 NGOs of their licences to provide essential aid to the population. This includes Médecins Sans Frontières, the charity directly supporting many of the critically important hospitals in the territory. Gaza is experiencing an especially harsh Winter and MSF warn that this measure could leave Palestinians without lifesaving medical care.</p>
<p><a href='https://www.bmj.com/content/392/bmj.s3'>Gaza: Israel moves to ban dozens of aid groups in "cynical and calculated" move</a> 
<a href='https://www.bmj.com/content/391/bmj.r2687'>Gaza in winter: 29 day old baby dies of hypothermia amid dire conditions</a>
</p>
<p> </p>
<p>The BMJ’s annual appeal is supporting the work of Médecins Sans Frontières (MSF). Around the world, MSF teams are providing maternity care, containing outbreaks, and performing vital surgeries. In areas overwhelmed by conflicts and natural disasters, more lives can be saved when we are in the right place at the right time.</p>
<p>Donate today at <a href='https://msf.org.uk/bmj-annual-appeal-2025'>https://msf.org.uk/bmj-annual-appeal-2025</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The class of GLP-1 agonist drugs including Ozempic gained a wide reputation for weight loss in 2025. However, it's well established that weight regain is a common result after people stop their doses. We report on new research which aims to quantify what is happening in the here-and-now for patients who stop using these and similar drugs.</p>
<p><a href='https://www.bmj.com/content/392/bmj-2025-085304'>Weight regain after cessation of medication for weight management: systematic review and meta-analysis</a> </p>
<p> </p>
<p>Also, The BMJ reports on news from Gaza. The Israeli government has issued new directives to strip 37 NGOs of their licences to provide essential aid to the population. This includes Médecins Sans Frontières, the charity directly supporting many of the critically important hospitals in the territory. Gaza is experiencing an especially harsh Winter and MSF warn that this measure could leave Palestinians without lifesaving medical care.</p>
<p><a href='https://www.bmj.com/content/392/bmj.s3'>Gaza: Israel moves to ban dozens of aid groups in "cynical and calculated" move</a> <br>
<a href='https://www.bmj.com/content/391/bmj.r2687'>Gaza in winter: 29 day old baby dies of hypothermia amid dire conditions</a><br>
</p>
<p> </p>
<p><em>The BMJ</em>’s annual appeal is supporting the work of Médecins Sans Frontières (MSF). Around the world, MSF teams are providing maternity care, containing outbreaks, and performing vital surgeries. In areas overwhelmed by conflicts and natural disasters, more lives can be saved when we are in the right place at the right time.</p>
<p>Donate today at <a href='https://msf.org.uk/bmj-annual-appeal-2025'>https://msf.org.uk/bmj-annual-appeal-2025</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hg9dqit2m8u24ii8/bmj_120126_mix.mp3" length="45666432" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The class of GLP-1 agonist drugs including Ozempic gained a wide reputation for weight loss in 2025. However, it's well established that weight regain is a common result after people stop their doses. We report on new research which aims to quantify what is happening in the here-and-now for patients who stop using these and similar drugs.
Weight regain after cessation of medication for weight management: systematic review and meta-analysis 
 
Also, The BMJ reports on news from Gaza. The Israeli government has issued new directives to strip 37 NGOs of their licences to provide essential aid to the population. This includes Médecins Sans Frontières, the charity directly supporting many of the critically important hospitals in the territory. Gaza is experiencing an especially harsh Winter and MSF warn that this measure could leave Palestinians without lifesaving medical care.
Gaza: Israel moves to ban dozens of aid groups in "cynical and calculated" move Gaza in winter: 29 day old baby dies of hypothermia amid dire conditions
 
The BMJ’s annual appeal is supporting the work of Médecins Sans Frontières (MSF). Around the world, MSF teams are providing maternity care, containing outbreaks, and performing vital surgeries. In areas overwhelmed by conflicts and natural disasters, more lives can be saved when we are in the right place at the right time.
Donate today at https://msf.org.uk/bmj-annual-appeal-2025]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1902</itunes:duration>
                <itunes:episode>62</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Could a Ministry for the Future solve the climate crisis? | Kim Stanley Robinson interview</title>
        <itunes:title>Could a Ministry for the Future solve the climate crisis? | Kim Stanley Robinson interview</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/could-a-ministry-for-the-future-solve-the-climate-crisis-kim-stanley-robinson-interview/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/could-a-ministry-for-the-future-solve-the-climate-crisis-kim-stanley-robinson-interview/#comments</comments>        <pubDate>Fri, 09 Jan 2026 13:40:31 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/3f1c26c1-b578-3b5c-a09b-e976f8b6a063</guid>
                                    <description><![CDATA[<p>This episode is available in video form on YouTube: <a href='https://youtu.be/1cGrD47eZSk'>https://youtu.be/1cGrD47eZSk</a> 

American science fiction author Kim Stanley Robinson joins Kamran Abbasi to discuss climate disaster, the need for political imagination, and science fiction's vision for health.</p>
<p>Kim Stanley Robinson is the acclaimed author of a trilogy of novels, exploring the terraforming and settlement of Mars. His most recent novel, 'Ministry for the Future', was published in 2020.</p>
<p>'Ministry for the Future' sets out a vision for real solutions to our climate crisis, covering global finance, the animal kingdom, rising sea levels, energy production and much more. The book imagines a Ministry that begins its work in 2025.</p>
<p>Five years after publication, with 2025 past and gone, The BMJ spoke to Robinson to explore how closely the novel's vision for the future has reflected reality.</p>
<p>01:00 BMJ's New Climate Change Initiative
01:21 Kim Stanley Robinson's Ministry for the Future
04:02 The Role of Political Violence in Climate Action
10:50 The Concept of the Carbon Coin
12:51 The Importance of Global Collaboration
27:32 The Role of Medicine in Climate Change
32:33 Youth and Climate Activism
37:53 Hope and Despair in Climate Action
41:29 Conclusion and Future Works

</p>
<p>Read more about The BMJ's climate coverage in the latest issue: https://www.bmj.com/content/392/8479</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is available in video form on YouTube: <a href='https://youtu.be/1cGrD47eZSk'>https://youtu.be/1cGrD47eZSk</a> <br>
<br>
American science fiction author Kim Stanley Robinson joins Kamran Abbasi to discuss climate disaster, the need for political imagination, and science fiction's vision for health.</p>
<p>Kim Stanley Robinson is the acclaimed author of a trilogy of novels, exploring the terraforming and settlement of Mars. His most recent novel, 'Ministry for the Future', was published in 2020.</p>
<p>'Ministry for the Future' sets out a vision for real solutions to our climate crisis, covering global finance, the animal kingdom, rising sea levels, energy production and much more. The book imagines a Ministry that begins its work in 2025.</p>
<p>Five years after publication, with 2025 past and gone, The BMJ spoke to Robinson to explore how closely the novel's vision for the future has reflected reality.</p>
<p>01:00 BMJ's New Climate Change Initiative<br>
01:21 Kim Stanley Robinson's Ministry for the Future<br>
04:02 The Role of Political Violence in Climate Action<br>
10:50 The Concept of the Carbon Coin<br>
12:51 The Importance of Global Collaboration<br>
27:32 The Role of Medicine in Climate Change<br>
32:33 Youth and Climate Activism<br>
37:53 Hope and Despair in Climate Action<br>
41:29 Conclusion and Future Works<br>
<br>
</p>
<p>Read more about The BMJ's climate coverage in the latest issue: https://www.bmj.com/content/392/8479</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/t2y5a5kmjprkjnjt/bmj_080126_KSR.mp3" length="61554387" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is available in video form on YouTube: https://youtu.be/1cGrD47eZSk American science fiction author Kim Stanley Robinson joins Kamran Abbasi to discuss climate disaster, the need for political imagination, and science fiction's vision for health.
Kim Stanley Robinson is the acclaimed author of a trilogy of novels, exploring the terraforming and settlement of Mars. His most recent novel, 'Ministry for the Future', was published in 2020.
'Ministry for the Future' sets out a vision for real solutions to our climate crisis, covering global finance, the animal kingdom, rising sea levels, energy production and much more. The book imagines a Ministry that begins its work in 2025.
Five years after publication, with 2025 past and gone, The BMJ spoke to Robinson to explore how closely the novel's vision for the future has reflected reality.
01:00 BMJ's New Climate Change Initiative01:21 Kim Stanley Robinson's Ministry for the Future04:02 The Role of Political Violence in Climate Action10:50 The Concept of the Carbon Coin12:51 The Importance of Global Collaboration27:32 The Role of Medicine in Climate Change32:33 Youth and Climate Activism37:53 Hope and Despair in Climate Action41:29 Conclusion and Future Works
Read more about The BMJ's climate coverage in the latest issue: https://www.bmj.com/content/392/8479]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2564</itunes:duration>
                <itunes:episode>61</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Christmas 2025 - neologisms, longevity and unexpected research</title>
        <itunes:title>Christmas 2025 - neologisms, longevity and unexpected research</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/christmas-2025-neologisms-longevity-and-unexpected-research/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/christmas-2025-neologisms-longevity-and-unexpected-research/#comments</comments>        <pubDate>Mon, 29 Dec 2025 15:46:52 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/cb8f47de-b155-3742-be6d-a210cee1d1dd</guid>
                                    <description><![CDATA[<p>It’s time for 2025’s festive fun!</p>
<p>Practicing medicine can be a very visceral experience - and the English language can’t always adequately capture the sights, sounds, smells. So Matt Morgan, intensivist and BMJ columnist, is creating medical neologisms, and joins us to share a few.</p>
<p>Madhvi Joshi, a GP in London, has written about longevity science, and we hear how the “biohacking” of internet influencers like Bryan Johnson is making its way into the consultation.</p>
<p>Navjoyt Ladher and Tim Feeny take us though this year’s festive research, and are joined by Anupam Bapu Jena from Harvard, who has been looking at self censorship in the time of Trump, and Melanie de Lange, from the university of Bristol, who has been investigating the impact of daylight savings time.</p>
<p>Reading list:</p>
<p>A dictionary for medicine’s unnamed moments
<a href='https://www.bmj.com/content/391/bmj.r2476'>https://www.bmj.com/content/391/bmj.r2476</a></p>
<p>Science of longevity medicine 
<a href='https://www.bmj.com/content/391/bmj.r2536'>https://www.bmj.com/content/391/bmj.r2536</a> </p>
<p>Changes in diversity language in National Institutes of Health grant awards
<a href='https://www.bmj.com/content/391/bmj-2025-087222'>https://www.bmj.com/content/391/bmj-2025-087222</a> </p>
<p>Acute effects of daylight saving time clock changes on mental and physical health in England
<a href='https://www.bmj.com/content/391/bmj-2025-085962'>https://www.bmj.com/content/391/bmj-2025-085962</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>It’s time for 2025’s festive fun!</p>
<p>Practicing medicine can be a very visceral experience - and the English language can’t always adequately capture the sights, sounds, smells. So Matt Morgan, intensivist and BMJ columnist, is creating medical neologisms, and joins us to share a few.</p>
<p>Madhvi Joshi, a GP in London, has written about longevity science, and we hear how the “biohacking” of internet influencers like Bryan Johnson is making its way into the consultation.</p>
<p>Navjoyt Ladher and Tim Feeny take us though this year’s festive research, and are joined by Anupam Bapu Jena from Harvard, who has been looking at self censorship in the time of Trump, and Melanie de Lange, from the university of Bristol, who has been investigating the impact of daylight savings time.</p>
<p>Reading list:</p>
<p>A dictionary for medicine’s unnamed moments<br>
<a href='https://www.bmj.com/content/391/bmj.r2476'>https://www.bmj.com/content/391/bmj.r2476</a></p>
<p>Science of longevity medicine <br>
<a href='https://www.bmj.com/content/391/bmj.r2536'>https://www.bmj.com/content/391/bmj.r2536</a> </p>
<p>Changes in diversity language in National Institutes of Health grant awards<br>
<a href='https://www.bmj.com/content/391/bmj-2025-087222'>https://www.bmj.com/content/391/bmj-2025-087222</a> </p>
<p>Acute effects of daylight saving time clock changes on mental and physical health in England<br>
<a href='https://www.bmj.com/content/391/bmj-2025-085962'>https://www.bmj.com/content/391/bmj-2025-085962</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kc3fjhh3jjmcdbkf/bmj_291225_mix.mp3" length="77554944" type="audio/mpeg"/>
        <itunes:summary><![CDATA[It’s time for 2025’s festive fun!
Practicing medicine can be a very visceral experience - and the English language can’t always adequately capture the sights, sounds, smells. So Matt Morgan, intensivist and BMJ columnist, is creating medical neologisms, and joins us to share a few.
Madhvi Joshi, a GP in London, has written about longevity science, and we hear how the “biohacking” of internet influencers like Bryan Johnson is making its way into the consultation.
Navjoyt Ladher and Tim Feeny take us though this year’s festive research, and are joined by Anupam Bapu Jena from Harvard, who has been looking at self censorship in the time of Trump, and Melanie de Lange, from the university of Bristol, who has been investigating the impact of daylight savings time.
Reading list:
A dictionary for medicine’s unnamed momentshttps://www.bmj.com/content/391/bmj.r2476
Science of longevity medicine https://www.bmj.com/content/391/bmj.r2536 
Changes in diversity language in National Institutes of Health grant awardshttps://www.bmj.com/content/391/bmj-2025-087222 
Acute effects of daylight saving time clock changes on mental and physical health in Englandhttps://www.bmj.com/content/391/bmj-2025-085962 ]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3231</itunes:duration>
                <itunes:episode>60</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The shadow use of Gen AI in the consultation room</title>
        <itunes:title>The shadow use of Gen AI in the consultation room</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-shadow-use-of-gen-ai-in-the-consultation-room/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-shadow-use-of-gen-ai-in-the-consultation-room/#comments</comments>        <pubDate>Tue, 16 Dec 2025 01:00:00 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/846df265-1666-31ee-ac5f-2c222647a07c</guid>
                                    <description><![CDATA[<p dir="ltr">In this episode, we hear how Generative AI is making it into the consultation room - but not through NHS endorsed routes - surveys suggest that ⅔ of doctors are using AI, for backoffice tasks - but also increasingly for information and diagnosis.</p>
<p> </p>
<p dir="ltr">David Navarro, a research fellow in generative AI at the Australian Institute of Health Innovation, Charlotte Blease, associate professor at the Participatory eHealth and Health Data Research Group at <a href='https://url.uk.m.mimecastprotect.com/s/0AieC3YRQH2KzOvSgfqFQ7iEg?domain=katalog.uu.se'>Uppsala University</a>, and Marcus Lewis, GP in London, reflect on what we know about the real way in gen AI is being used - and what “triadic care” (doctor, patient and AI) will mean for the future of the therapeutic relationship.</p>
<p> </p>
<p dir="ltr">We also hear from Teppo Järvinen, professor of orthopaedic surgery at Helsinki University, about surgical subacromial decompression - a 10 year follow up of a double blinded placebo controlled trial, confirms that surgery is no more effective than standard care. Yet surgical interventions continue - we hear why.</p>
<p> </p>
<p dir="ltr">Finally, we go to a Cholera clinic in Nigeria, where Médecins Sans Frontières are running cholera treatment centres, which you can help by donating to our Christmas appeal.</p>
<p> </p>
<p dir="ltr">Links</p>
<p dir="ltr"><a href='https://url.uk.m.mimecastprotect.com/s/h_dkC4WmQFl5KqxCxhoF4-pwe?domain=bmj.com'>Generative AI and the clinical encounter</a></p>
<p> </p>
<p dir="ltr"><a href='https://url.uk.m.mimecastprotect.com/s/INfEC5AnQi69L21hyikFkPOQb?domain=bmj.com'>The BMJ appeal 2025-26: Inside MSF’s response to cholera in Nigeria: a day in the life of an emergency doctor</a></p>
<p> </p>
<p dir="ltr"><a href='https://url.uk.m.mimecastprotect.com/s/PuTBC6YoXHymYqJc5sVF5wuQ-?domain=bmj.com'>Arthroscopic subacromial decompression versus placebo surgery for subacromial pain syndrome</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p dir="ltr">In this episode, we hear how Generative AI is making it into the consultation room - but not through NHS endorsed routes - surveys suggest that ⅔ of doctors are using AI, for backoffice tasks - but also increasingly for information and diagnosis.</p>
<p> </p>
<p dir="ltr">David Navarro, a research fellow in generative AI at the Australian Institute of Health Innovation, Charlotte Blease, associate professor at the Participatory eHealth and Health Data Research Group at <a href='https://url.uk.m.mimecastprotect.com/s/0AieC3YRQH2KzOvSgfqFQ7iEg?domain=katalog.uu.se'>Uppsala University</a>, and Marcus Lewis, GP in London, reflect on what we know about the real way in gen AI is being used - and what “triadic care” (doctor, patient and AI) will mean for the future of the therapeutic relationship.</p>
<p> </p>
<p dir="ltr">We also hear from Teppo Järvinen, professor of orthopaedic surgery at Helsinki University, about surgical subacromial decompression - a 10 year follow up of a double blinded placebo controlled trial, confirms that surgery is no more effective than standard care. Yet surgical interventions continue - we hear why.</p>
<p> </p>
<p dir="ltr">Finally, we go to a Cholera clinic in Nigeria, where Médecins Sans Frontières are running cholera treatment centres, which you can help by donating to our Christmas appeal.</p>
<p> </p>
<p dir="ltr">Links</p>
<p dir="ltr"><a href='https://url.uk.m.mimecastprotect.com/s/h_dkC4WmQFl5KqxCxhoF4-pwe?domain=bmj.com'>Generative AI and the clinical encounter</a></p>
<p> </p>
<p dir="ltr"><a href='https://url.uk.m.mimecastprotect.com/s/INfEC5AnQi69L21hyikFkPOQb?domain=bmj.com'>The BMJ appeal 2025-26: Inside MSF’s response to cholera in Nigeria: a day in the life of an emergency doctor</a></p>
<p> </p>
<p dir="ltr"><a href='https://url.uk.m.mimecastprotect.com/s/PuTBC6YoXHymYqJc5sVF5wuQ-?domain=bmj.com'>Arthroscopic subacromial decompression versus placebo surgery for subacromial pain syndrome</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kcrqykq64yiyqjms/bmj_151225_mix.mp3" length="54438912" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, we hear how Generative AI is making it into the consultation room - but not through NHS endorsed routes - surveys suggest that ⅔ of doctors are using AI, for backoffice tasks - but also increasingly for information and diagnosis.
 
David Navarro, a research fellow in generative AI at the Australian Institute of Health Innovation, Charlotte Blease, associate professor at the Participatory eHealth and Health Data Research Group at Uppsala University, and Marcus Lewis, GP in London, reflect on what we know about the real way in gen AI is being used - and what “triadic care” (doctor, patient and AI) will mean for the future of the therapeutic relationship.
 
We also hear from Teppo Järvinen, professor of orthopaedic surgery at Helsinki University, about surgical subacromial decompression - a 10 year follow up of a double blinded placebo controlled trial, confirms that surgery is no more effective than standard care. Yet surgical interventions continue - we hear why.
 
Finally, we go to a Cholera clinic in Nigeria, where Médecins Sans Frontières are running cholera treatment centres, which you can help by donating to our Christmas appeal.
 
Links
Generative AI and the clinical encounter
 
The BMJ appeal 2025-26: Inside MSF’s response to cholera in Nigeria: a day in the life of an emergency doctor
 
Arthroscopic subacromial decompression versus placebo surgery for subacromial pain syndrome]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2268</itunes:duration>
                <itunes:episode>59</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ADHD therapies, and the NHS gig economy</title>
        <itunes:title>ADHD therapies, and the NHS gig economy</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/adhd-therapies-and-the-nhs-gig-economy/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/adhd-therapies-and-the-nhs-gig-economy/#comments</comments>        <pubDate>Fri, 05 Dec 2025 01:00:00 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/450c7505-5066-3961-a5b8-756269616954</guid>
                                    <description><![CDATA[<p dir="ltr">There is an enormous amount of research on treatment for ADHD - pharmaceutical and otherwise. But not all of those trials, or meta-analyses, are of high quality; and not many compare the whole literature. </p>
<p dir="ltr">Now a new umbrella review - a review of reviews - tries to give a broad overview of the whole evidence base. Corentin Gosling, associate professor at the Université Paris Nanterre, joins us to set out the benefits and harms of ADHD therapies.</p>
<p> </p>
<p dir="ltr">Also, the BMJ’s been investigating the employment of doctors on “local” contracts in the NHS - and our latest look at this exposes what some have described as a “gig economy”, with doctors plugging rota gaps but missing out on training, development, and salary progression. Rebecca Coombes, head of journalism at The BMJ explains more.</p>
<p> </p>
<p dir="ltr">Finally, Tom Frieden is former head of the US Centers for Disease Control, and current CEO of Resolve to Save Lives - he’s written a new book on public health. He joins us to talk about what actually improves health at a population level, and why the current US administration’s approach to staffing the CDC is leaving the country open to danger.</p>
<p> </p>
<p dir="ltr">Reading list</p>
<p dir="ltr"><a href='https://url.uk.m.mimecastprotect.com/s/W5v8CVJpAFgV9VRIGfLFEuu8c?domain=bmj.com'>Benefits and harms of ADHD interventions: umbrella review and platform for shared decision making</a></p>
<p dir="ltr"><a href='https://url.uk.m.mimecastprotect.com/s/aJ0sCWWOLFD1G1WfxhgFoPOpp?domain=bmj.com'>Revealed: Thousands of NHS doctors are trapped in insecure “gig economy” contracts</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p dir="ltr">There is an enormous amount of research on treatment for ADHD - pharmaceutical and otherwise. But not all of those trials, or meta-analyses, are of high quality; and not many compare the whole literature. </p>
<p dir="ltr">Now a new umbrella review - a review of reviews - tries to give a broad overview of the whole evidence base. Corentin Gosling, associate professor at the Université Paris Nanterre, joins us to set out the benefits and harms of ADHD therapies.</p>
<p> </p>
<p dir="ltr">Also, the BMJ’s been investigating the employment of doctors on “local” contracts in the NHS - and our latest look at this exposes what some have described as a “gig economy”, with doctors plugging rota gaps but missing out on training, development, and salary progression. Rebecca Coombes, head of journalism at The BMJ explains more.</p>
<p> </p>
<p dir="ltr">Finally, Tom Frieden is former head of the US Centers for Disease Control, and current CEO of Resolve to Save Lives - he’s written a new book on public health. He joins us to talk about what actually improves health at a population level, and why the current US administration’s approach to staffing the CDC is leaving the country open to danger.</p>
<p> </p>
<p dir="ltr">Reading list</p>
<p dir="ltr"><a href='https://url.uk.m.mimecastprotect.com/s/W5v8CVJpAFgV9VRIGfLFEuu8c?domain=bmj.com'>Benefits and harms of ADHD interventions: umbrella review and platform for shared decision making</a></p>
<p dir="ltr"><a href='https://url.uk.m.mimecastprotect.com/s/aJ0sCWWOLFD1G1WfxhgFoPOpp?domain=bmj.com'>Revealed: Thousands of NHS doctors are trapped in insecure “gig economy” contracts</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/cmcjnuhgkebqcu3b/bmj_031225_mix.mp3" length="58565376" type="audio/mpeg"/>
        <itunes:summary><![CDATA[There is an enormous amount of research on treatment for ADHD - pharmaceutical and otherwise. But not all of those trials, or meta-analyses, are of high quality; and not many compare the whole literature. 
Now a new umbrella review - a review of reviews - tries to give a broad overview of the whole evidence base. Corentin Gosling, associate professor at the Université Paris Nanterre, joins us to set out the benefits and harms of ADHD therapies.
 
Also, the BMJ’s been investigating the employment of doctors on “local” contracts in the NHS - and our latest look at this exposes what some have described as a “gig economy”, with doctors plugging rota gaps but missing out on training, development, and salary progression. Rebecca Coombes, head of journalism at The BMJ explains more.
 
Finally, Tom Frieden is former head of the US Centers for Disease Control, and current CEO of Resolve to Save Lives - he’s written a new book on public health. He joins us to talk about what actually improves health at a population level, and why the current US administration’s approach to staffing the CDC is leaving the country open to danger.
 
Reading list
Benefits and harms of ADHD interventions: umbrella review and platform for shared decision making
Revealed: Thousands of NHS doctors are trapped in insecure “gig economy” contracts
 ]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2440</itunes:duration>
                <itunes:episode>57</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The Covid Inquiry - special episode</title>
        <itunes:title>The Covid Inquiry - special episode</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-covid-inquiry-special-episode/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-covid-inquiry-special-episode/#comments</comments>        <pubDate>Thu, 04 Dec 2025 12:15:00 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/b7049cb2-4284-3dcd-b41c-9454e9f38326</guid>
                                    <description><![CDATA[<p class="p1"> </p>
<p class="p2">"Damning” and “unforgivable failures” is how some papers headlines reacted to criticism of former UK prime minister Boris Johnson in the second of 10 reports from the UK Covid Inquiry.</p>
<p class="p2">Under pressure, in 2001 Boris Johnson announced a covid inquiry led by a former judge, Baroness Hallett. Each report is examining a different area of the pandemic's impact, and module 2 is about decision making and political governance.</p>
<p class="p2">The report describes inertia, toxic cultures, and an inability to learn lessons - disfunction that contributed to many extra deaths. </p>
<p class="p2">To dissect the report and discuss what needs to change, we're joined by;</p>
<ul class="ul1">
<li class="li2">Rebecca Coombes - The BMJ’s head of journalism</li>
<li class="li2">Kevin Fong - anaesthetist and lead for major incident planning at University College Hospital</li>
<li class="li2">Matthew Flinders - Professor of Politics and Public Policy at the University of Sheffield</li>
</ul>
<p class="p2"> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p class="p1"> </p>
<p class="p2">"Damning” and “unforgivable failures” is how some papers headlines reacted to criticism of former UK prime minister Boris Johnson in the second of 10 reports from the UK Covid Inquiry.</p>
<p class="p2">Under pressure, in 2001 Boris Johnson announced a covid inquiry led by a former judge, Baroness Hallett. Each report is examining a different area of the pandemic's impact, and module 2 is about decision making and political governance.</p>
<p class="p2">The report describes inertia, toxic cultures, and an inability to learn lessons - disfunction that contributed to many extra deaths. </p>
<p class="p2">To dissect the report and discuss what needs to change, we're joined by;</p>
<ul class="ul1">
<li class="li2">Rebecca Coombes - The BMJ’s head of journalism</li>
<li class="li2">Kevin Fong - anaesthetist and lead for major incident planning at University College Hospital</li>
<li class="li2">Matthew Flinders - Professor of Politics and Public Policy at the University of Sheffield</li>
</ul>
<p class="p2"> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/w88kidtjibjfx3in/med_sci_pod_covid_inquiry_81287kr4.mp3" length="44760739" type="audio/mpeg"/>
        <itunes:summary><![CDATA[ 
"Damning” and “unforgivable failures” is how some papers headlines reacted to criticism of former UK prime minister Boris Johnson in the second of 10 reports from the UK Covid Inquiry.
Under pressure, in 2001 Boris Johnson announced a covid inquiry led by a former judge, Baroness Hallett. Each report is examining a different area of the pandemic's impact, and module 2 is about decision making and political governance.
The report describes inertia, toxic cultures, and an inability to learn lessons - disfunction that contributed to many extra deaths. 
To dissect the report and discuss what needs to change, we're joined by;

Rebecca Coombes - The BMJ’s head of journalism
Kevin Fong - anaesthetist and lead for major incident planning at University College Hospital
Matthew Flinders - Professor of Politics and Public Policy at the University of Sheffield

 ]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1864</itunes:duration>
                <itunes:episode>58</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Climate, “car spreading”, and conflict</title>
        <itunes:title>Climate, “car spreading”, and conflict</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/climate-car-spreading-and-conflict/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/climate-car-spreading-and-conflict/#comments</comments>        <pubDate>Tue, 18 Nov 2025 04:00:00 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/db9cce4f-e8d9-3726-9935-7e309f7c9ec0</guid>
                                    <description><![CDATA[<p>It’s the BMJ’s annual climate issue - and in this episode, we’ll be hearing about more ways in which climate mitigation is good for health.</p>
<p> </p>
<p>Firstly, climate change is fuelling conflict, and exacerbating the impact it has on fragile healthcare systems. Andy Haines, from the London School of Hygiene and Tropical Medicine, and Barbora Sedova, from Potsdam Institute for Climate Impact Research, discuss how climate and conflict intersect, and what they think needs to be done to combat it.</p>
<p> </p>
<p>“Car spreading”, the recent tendency for cars to become bigger and heavier is not only harming the climate, but it’s also harming pedestrians.  Anthony Laverty, associate professor of public health at Imperial College London, and trauma surgeon Cleo Kenington explain why SUVs are more lethal in accidents, and why France is bucking the trend in sales.</p>
<p> </p>
<p>Finally, Jocalyn Clark, the BMJ’s international editor joins us to talk about women’s health innovation and why tech bros aren’t the people to be leading it.</p>
<p> </p>
<p>Reading list:</p>
<p> </p>
<p><a href='https://www.bmj.com/content/391/8475'>The climate issue: Brazil and the climate crisis</a></p>
<p> </p>
<p><a href='https://www.bmj.com/content/391/bmj.r1578'>Tackling the complex links between climate change, conflict, and health</a></p>
<p> </p>
<p><a href='https://www.bmj.com/content/391/bmj.r2162'>Reducing the harms from ever larger cars</a></p>
<p> </p>
<p><a href='https://www.bmj.com/collections/womens-health-innovation'>Transforming women’s health through innovation</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>It’s the BMJ’s annual climate issue - and in this episode, we’ll be hearing about more ways in which climate mitigation is good for health.</p>
<p> </p>
<p>Firstly, climate change is fuelling conflict, and exacerbating the impact it has on fragile healthcare systems. Andy Haines, from the London School of Hygiene and Tropical Medicine, and Barbora Sedova, from Potsdam Institute for Climate Impact Research, discuss how climate and conflict intersect, and what they think needs to be done to combat it.</p>
<p> </p>
<p>“Car spreading”, the recent tendency for cars to become bigger and heavier is not only harming the climate, but it’s also harming pedestrians.  Anthony Laverty, associate professor of public health at Imperial College London, and trauma surgeon Cleo Kenington explain why SUVs are more lethal in accidents, and why France is bucking the trend in sales.</p>
<p> </p>
<p>Finally, Jocalyn Clark, the BMJ’s international editor joins us to talk about women’s health innovation and why tech bros aren’t the people to be leading it.</p>
<p> </p>
<p>Reading list:</p>
<p> </p>
<p><a href='https://www.bmj.com/content/391/8475'>The climate issue: Brazil and the climate crisis</a></p>
<p> </p>
<p><a href='https://www.bmj.com/content/391/bmj.r1578'>Tackling the complex links between climate change, conflict, and health</a></p>
<p> </p>
<p><a href='https://www.bmj.com/content/391/bmj.r2162'>Reducing the harms from ever larger cars</a></p>
<p> </p>
<p><a href='https://www.bmj.com/collections/womens-health-innovation'>Transforming women’s health through innovation</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xexdihw9js4izk3f/bmj_171125_mix.mp3" length="63658368" type="audio/mpeg"/>
        <itunes:summary><![CDATA[It’s the BMJ’s annual climate issue - and in this episode, we’ll be hearing about more ways in which climate mitigation is good for health.
 
Firstly, climate change is fuelling conflict, and exacerbating the impact it has on fragile healthcare systems. Andy Haines, from the London School of Hygiene and Tropical Medicine, and Barbora Sedova, from Potsdam Institute for Climate Impact Research, discuss how climate and conflict intersect, and what they think needs to be done to combat it.
 
“Car spreading”, the recent tendency for cars to become bigger and heavier is not only harming the climate, but it’s also harming pedestrians.  Anthony Laverty, associate professor of public health at Imperial College London, and trauma surgeon Cleo Kenington explain why SUVs are more lethal in accidents, and why France is bucking the trend in sales.
 
Finally, Jocalyn Clark, the BMJ’s international editor joins us to talk about women’s health innovation and why tech bros aren’t the people to be leading it.
 
Reading list:
 
The climate issue: Brazil and the climate crisis
 
Tackling the complex links between climate change, conflict, and health
 
Reducing the harms from ever larger cars
 
Transforming women’s health through innovation]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2652</itunes:duration>
                <itunes:episode>55</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Doctors against the far right</title>
        <itunes:title>Doctors against the far right</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/doctors-against-the-far-right/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/doctors-against-the-far-right/#comments</comments>        <pubDate>Mon, 03 Nov 2025 23:30:00 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/fc79f130-d321-39a9-8937-fe2cb68dc52a</guid>
                                    <description><![CDATA[<p>Far right rallies have been held across the UK, culminating in a large parade in London where Elon Musk spoke. At the same time, politicians from across the political spectrum are following the talking points of far right parties - and shifting their policies rightward, even the Labour home secretary has said she wishes to double the period migrants have to be in the UK before they can become citizens.</p>
<p>
That has made a group of medics decide it’s time for doctors and other healthcare professionals to use their voice and speak up - against the demonisation of migrants into the UK, and for their fellow NHS staff. They are demanding that those in positions of power do so too.</p>
<p> </p>
<p>Some of those medics join us on the podcast today;</p>
<p>Alistair Stewart, consultant psychiatrist in Manchester </p>
<p>Omnya Ahmed, resident doctor in London </p>
<p>Jordan Rivera, occupational therapist in London</p>
<p> </p>
<p>Also this week, doctor, researcher, comedian and Matt Hutchinson is adding author to his list, and has released the book “Are You Really the Doctor? My Life as a Black Doctor in the NHS” - he joins Shivali Fulchand to talk about balancing all of this bits of his career - and how standup comedy has helped him maintain his career in the NHS.</p>
<p> </p>
<p>Reading list</p>
<p><a href='https://www.bmj.com/content/391/bmj.r2230'>Everybody’s business: call to all NHS staff to oppose the influence of racism and the far right</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Far right rallies have been held across the UK, culminating in a large parade in London where Elon Musk spoke. At the same time, politicians from across the political spectrum are following the talking points of far right parties - and shifting their policies rightward, even the Labour home secretary has said she wishes to double the period migrants have to be in the UK before they can become citizens.</p>
<p><br>
That has made a group of medics decide it’s time for doctors and other healthcare professionals to use their voice and speak up - against the demonisation of migrants into the UK, and for their fellow NHS staff. They are demanding that those in positions of power do so too.</p>
<p> </p>
<p>Some of those medics join us on the podcast today;</p>
<p>Alistair Stewart, consultant psychiatrist in Manchester </p>
<p>Omnya Ahmed, resident doctor in London </p>
<p>Jordan Rivera, occupational therapist in London</p>
<p> </p>
<p>Also this week, doctor, researcher, comedian and Matt Hutchinson is adding author to his list, and has released the book “Are You Really the Doctor? My Life as a Black Doctor in the NHS” - he joins Shivali Fulchand to talk about balancing all of this bits of his career - and how standup comedy has helped him maintain his career in the NHS.</p>
<p> </p>
<p>Reading list</p>
<p><a href='https://www.bmj.com/content/391/bmj.r2230'>Everybody’s business: call to all NHS staff to oppose the influence of racism and the far right</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/adxdshgxw6mpm88z/bmj_031125_mix.mp3" length="29947776" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Far right rallies have been held across the UK, culminating in a large parade in London where Elon Musk spoke. At the same time, politicians from across the political spectrum are following the talking points of far right parties - and shifting their policies rightward, even the Labour home secretary has said she wishes to double the period migrants have to be in the UK before they can become citizens.
That has made a group of medics decide it’s time for doctors and other healthcare professionals to use their voice and speak up - against the demonisation of migrants into the UK, and for their fellow NHS staff. They are demanding that those in positions of power do so too.
 
Some of those medics join us on the podcast today;
Alistair Stewart, consultant psychiatrist in Manchester 
Omnya Ahmed, resident doctor in London 
Jordan Rivera, occupational therapist in London
 
Also this week, doctor, researcher, comedian and Matt Hutchinson is adding author to his list, and has released the book “Are You Really the Doctor? My Life as a Black Doctor in the NHS” - he joins Shivali Fulchand to talk about balancing all of this bits of his career - and how standup comedy has helped him maintain his career in the NHS.
 
Reading list
Everybody’s business: call to all NHS staff to oppose the influence of racism and the far right]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1871</itunes:duration>
                <itunes:episode>54</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The shaky science of the Q-collar, exercise for osteoarthritis, and patient choice.</title>
        <itunes:title>The shaky science of the Q-collar, exercise for osteoarthritis, and patient choice.</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/bmj-oct-20th-2025/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/bmj-oct-20th-2025/#comments</comments>        <pubDate>Tue, 21 Oct 2025 06:05:34 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/7f99c193-556b-350e-bc41-bcc10aa1ad6c</guid>
                                    <description><![CDATA[<p>This week on the podcast</p>
<p>The BMJ investigates Q-COLLAR, an American device that distributors claim can reduce brain injury from contact sports. Investigators James Smoliga and Mu Yang take us through the evidence, and former NFL punter turned US bobsled team member Johnny Townsend explains what this means for sportspeople.</p>
<p>Bin Wang from Zhejiang University School of Medicine explains what the new network metaanalysis finds is the best exercise options for knee osteoarthritis</p>
<p>And, what our patient panel really think about “patient choice”.</p>
<p> </p>
<p>links</p>
<p><a href='https://www.bmj.com/content/391/bmj.r2028'>How an FDA cleared “brain protection” device built on shaky science made it to the NFL</a>
</p>
<p><a href='https://www.bmj.com/content/391/bmj-2025-085242'>Comparative efficacy and safety of exercise modalities in knee osteoarthritis</a></p>
<p><a href='https://www.bmj.com/campaign/patient-partnership'>The BMJ's patient and public partnership</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week on the podcast</p>
<p>The BMJ investigates Q-COLLAR, an American device that distributors claim can reduce brain injury from contact sports. Investigators James Smoliga and Mu Yang take us through the evidence, and former NFL punter turned US bobsled team member Johnny Townsend explains what this means for sportspeople.</p>
<p>Bin Wang from <em>Zhejiang University School of Medicine explains what the new network metaanalysis finds is</em> the best exercise options for knee osteoarthritis</p>
<p>And, what our patient panel really think about “patient choice”.</p>
<p> </p>
<p>links</p>
<p><a href='https://www.bmj.com/content/391/bmj.r2028'>How an FDA cleared “brain protection” device built on shaky science made it to the NFL</a><br>
</p>
<p><a href='https://www.bmj.com/content/391/bmj-2025-085242'>Comparative efficacy and safety of exercise modalities in knee osteoarthritis</a></p>
<p><a href='https://www.bmj.com/campaign/patient-partnership'>The BMJ's patient and public partnership</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ycdicedaeezigjkx/bmj_201025_mix.mp3" length="52089984" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week on the podcast
The BMJ investigates Q-COLLAR, an American device that distributors claim can reduce brain injury from contact sports. Investigators James Smoliga and Mu Yang take us through the evidence, and former NFL punter turned US bobsled team member Johnny Townsend explains what this means for sportspeople.
Bin Wang from Zhejiang University School of Medicine explains what the new network metaanalysis finds is the best exercise options for knee osteoarthritis
And, what our patient panel really think about “patient choice”.
 
links
How an FDA cleared “brain protection” device built on shaky science made it to the NFL
Comparative efficacy and safety of exercise modalities in knee osteoarthritis
The BMJ's patient and public partnership]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2170</itunes:duration>
                <itunes:episode>53</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The difficulty of delirium diagnosis, the lack of agency in the 10 year plan, and Gaza wounds</title>
        <itunes:title>The difficulty of delirium diagnosis, the lack of agency in the 10 year plan, and Gaza wounds</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-difficulty-of-delirium-diagnosis-the-lack-of-agency-in-the-10-year-plan-and-gaza-wounds/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-difficulty-of-delirium-diagnosis-the-lack-of-agency-in-the-10-year-plan-and-gaza-wounds/#comments</comments>        <pubDate>Tue, 07 Oct 2025 13:09:17 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/1051b55b-3bee-3303-bbe0-3d21b9bb0bae</guid>
                                    <description><![CDATA[<p>In this episode of the podcast;</p>
<p>In July this year, the Government published their 10 year health plan for England - A new analysis just published on BMJ.com takes an in depth look at the chances of that plan succeeding, and where the government needs to focus time and resources. Bob Klaber, paediatrician and director of strategy, research and innovation at Imperial College Healthcare, and Helen Salisbury, GP and columnist for the BMJ join us to discuss.</p>
<p>Journalist Chris Stoker-Walker's grandfather suffered from delirium at the end of his life, but the journey to that diagnosis was difficult - Chris joins us to talk about the impact that had on his family, and Elizabeth Sampson, professor of liaison psychiatry from Queen Mary University of London, explains why it's under-researched.</p>
<p>Finally, we've been reporting from Gaza for 2 years, and it's been very difficult to get accurate information out of the region. However, new research published on bmj.com has surveyed medics there, to document the patterns of wounding in the civilian population - to improve the medical response to the conflict. Omar El-Taji and Ameer Ali, resident doctors in the NHS join us to explain what they found.</p>
<p> </p>
<p>Reading list:</p>
<p><a href='https://www.bmj.com/content/390/bmj.r1980'>Delivering on the 10 year health plan for England</a></p>
<p><a href='https://www.bmj.com/content/391/bmj.r2003'>Why can’t we do anything about delirium?</a></p>
<p><a href='https://www.bmj.com/content/390/bmj-2025-087524'>Patterns of war related trauma in Gaza during armed conflict</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode of the podcast;</p>
<p>In July this year, the Government published their 10 year health plan for England - A new analysis just published on BMJ.com takes an in depth look at the chances of that plan succeeding, and where the government needs to focus time and resources. Bob Klaber, paediatrician and director of strategy, research and innovation at Imperial College Healthcare, and Helen Salisbury, GP and columnist for the BMJ join us to discuss.</p>
<p>Journalist Chris Stoker-Walker's grandfather suffered from delirium at the end of his life, but the journey to that diagnosis was difficult - Chris joins us to talk about the impact that had on his family, and Elizabeth Sampson, professor of liaison psychiatry from Queen Mary University of London, explains why it's under-researched.</p>
<p>Finally, we've been reporting from Gaza for 2 years, and it's been very difficult to get accurate information out of the region. However, new research published on bmj.com has surveyed medics there, to document the patterns of wounding in the civilian population - to improve the medical response to the conflict. Omar El-Taji and Ameer Ali, resident doctors in the NHS join us to explain what they found.</p>
<p> </p>
<p>Reading list:</p>
<p><a href='https://www.bmj.com/content/390/bmj.r1980'>Delivering on the 10 year health plan for England</a></p>
<p><a href='https://www.bmj.com/content/391/bmj.r2003'>Why can’t we do anything about delirium?</a></p>
<p><a href='https://www.bmj.com/content/390/bmj-2025-087524'>Patterns of war related trauma in Gaza during armed conflict</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qne67zksutyca4g3/bmj_061025.mp3" length="63701568" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode of the podcast;
In July this year, the Government published their 10 year health plan for England - A new analysis just published on BMJ.com takes an in depth look at the chances of that plan succeeding, and where the government needs to focus time and resources. Bob Klaber, paediatrician and director of strategy, research and innovation at Imperial College Healthcare, and Helen Salisbury, GP and columnist for the BMJ join us to discuss.
Journalist Chris Stoker-Walker's grandfather suffered from delirium at the end of his life, but the journey to that diagnosis was difficult - Chris joins us to talk about the impact that had on his family, and Elizabeth Sampson, professor of liaison psychiatry from Queen Mary University of London, explains why it's under-researched.
Finally, we've been reporting from Gaza for 2 years, and it's been very difficult to get accurate information out of the region. However, new research published on bmj.com has surveyed medics there, to document the patterns of wounding in the civilian population - to improve the medical response to the conflict. Omar El-Taji and Ameer Ali, resident doctors in the NHS join us to explain what they found.
 
Reading list:
Delivering on the 10 year health plan for England
Why can’t we do anything about delirium?
Patterns of war related trauma in Gaza during armed conflict
 ]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2654</itunes:duration>
                <itunes:episode>52</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Doctors still have questions about the UK's assisted dying bill</title>
        <itunes:title>Doctors still have questions about the UK's assisted dying bill</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/doctors-still-have-questions-about-the-uks-assisted-dying-bill/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/doctors-still-have-questions-about-the-uks-assisted-dying-bill/#comments</comments>        <pubDate>Mon, 22 Sep 2025 16:52:55 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/8fc32cbf-2c31-3964-9b9e-91b469af1b03</guid>
                                    <description><![CDATA[<p>In today’s episode: Assisted Dying moves closer to becoming UK law. The proposed legislation to allow people to end their own lives has moved through a second debate in the House of Lords. What do MPs and doctors think of the Bill as it stands? And, new ways to pull research findings from observation alone makes us question whether correlation really doesn’t equal causation. We find out - what is Target Trial Emulation?</p>
<p>The BMJ’s Elisabeth Mahase speaks to Labour MP Kim Leadbeater, sponsor of the Assisted Dying Bill. Why did she propose the legislation? What has been her impression of its movement through Parliament and the opposition it has faced? We also hear from Jamilla Hussain and Gareth Owen, doctors who attended a BMJ parliamentary roundtable on the topic.</p>
<p>Finally, the BMJ’s Duncan Jarvies talks to our research editors about new ways to develop evidence from observational studies. What are the limits to this new technique of causal inference?</p>
<p>Reading list</p>
<p><a href='https://www.bmj.com/content/390/bmj.r1959'>MP behind assisted dying bill warns that terminally ill people and their families are being failed, ahead of Lords debate</a></p>
<p><a href='https://www.bmj.com/content/390/bmj.r1942'>Assisted dying bill: Lords debate concerns over lack of safeguards</a></p>
<p><a href='https://www.bmj.com/content/390/bmj-2025-087179/related'>Transparent reporting of observational studies emulating a target trial: the TARGET Statement</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In today’s episode: Assisted Dying moves closer to becoming UK law. The proposed legislation to allow people to end their own lives has moved through a second debate in the House of Lords. What do MPs and doctors think of the Bill as it stands? And, new ways to pull research findings from observation alone makes us question whether correlation really doesn’t equal causation. We find out - what is Target Trial Emulation?</p>
<p>The BMJ’s Elisabeth Mahase speaks to Labour MP Kim Leadbeater, sponsor of the Assisted Dying Bill. Why did she propose the legislation? What has been her impression of its movement through Parliament and the opposition it has faced? We also hear from Jamilla Hussain and Gareth Owen, doctors who attended a BMJ parliamentary roundtable on the topic.</p>
<p>Finally, the BMJ’s Duncan Jarvies talks to our research editors about new ways to develop evidence from observational studies. What are the limits to this new technique of causal inference?</p>
<p>Reading list</p>
<p><a href='https://www.bmj.com/content/390/bmj.r1959'>MP behind assisted dying bill warns that terminally ill people and their families are being failed, ahead of Lords debate</a></p>
<p><a href='https://www.bmj.com/content/390/bmj.r1942'>Assisted dying bill: Lords debate concerns over lack of safeguards</a></p>
<p><a href='https://www.bmj.com/content/390/bmj-2025-087179/related'>Transparent reporting of observational studies emulating a target trial: the TARGET Statement</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3k7w7nmf9wc8hgxe/bmj_220925.mp3" length="54856512" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In today’s episode: Assisted Dying moves closer to becoming UK law. The proposed legislation to allow people to end their own lives has moved through a second debate in the House of Lords. What do MPs and doctors think of the Bill as it stands? And, new ways to pull research findings from observation alone makes us question whether correlation really doesn’t equal causation. We find out - what is Target Trial Emulation?
The BMJ’s Elisabeth Mahase speaks to Labour MP Kim Leadbeater, sponsor of the Assisted Dying Bill. Why did she propose the legislation? What has been her impression of its movement through Parliament and the opposition it has faced? We also hear from Jamilla Hussain and Gareth Owen, doctors who attended a BMJ parliamentary roundtable on the topic.
Finally, the BMJ’s Duncan Jarvies talks to our research editors about new ways to develop evidence from observational studies. What are the limits to this new technique of causal inference?
Reading list
MP behind assisted dying bill warns that terminally ill people and their families are being failed, ahead of Lords debate
Assisted dying bill: Lords debate concerns over lack of safeguards
Transparent reporting of observational studies emulating a target trial: the TARGET Statement]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2285</itunes:duration>
                <itunes:episode>51</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Starvation in Gaza is a multi-generational disaster</title>
        <itunes:title>Starvation in Gaza is a multi-generational disaster</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/bmj-090925/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/bmj-090925/#comments</comments>        <pubDate>Tue, 09 Sep 2025 15:45:45 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/4561f141-8f39-3b51-8baa-0bcfb14fa763</guid>
                                    <description><![CDATA[<p>In today’s episode:</p>
<ul>
<li>Rethinking how we measure the harm caused by the  arms industry</li>
<li>The life long, and multigenerational, impact of starvation in Gaza</li>
<li> What is the appropriate focus on prevention in general practice?</li>
</ul>
<p> </p>
<p>The BMJ's international editor, Jocalyn Clark talks about a new series we've just published - examining the arms industry as a commercial determinant of health. Jocalyn also speaks to Mark Bellis, from Liverpool John Moores university about why he thinks it’s time we take the impact of the arms industry on health seriously.</p>
<p>The blockade on food reaching Gaza is in place again, risking more starvation. Elizabeth Mahase, clinical reporter for the BMJ, has been finding out about the acute, chronic, and generational impact on the palestinian population. She speaks to Jonathan Wells, professor of anthropology and paediatric nutrition at University College London, and Tessa Roseboom, professor of early development and health at the University of Amsterdam, Marie McGrath former head of the Emergency Nutrition Network, and Chris McIntosh, humanitarian response advisor for the charity, Oxfam.</p>
<p>Finally, an analysis we published earlier this year made the case that "tsunami" of preventative care is destabilised the work of GPs. Helen Macdonald was at the Preventing Overdiagnosis conference and spoke to some of the authors - Minna Johansson, associate professor at University of Gothenberg, Stephen Martin, professor at UMass Chan Medical School, and Iona Heath, retired GP and former president of the RCGP.</p>
<p> </p>
<p>Reading list</p>
<p><a href='https://www.bmj.com/collections/arms-industry-health'>Arms industry as a commercial determinant of health</a>
</p>
<p><a href='https://www.bmj.com/content/390/bmj.r1607'>Starvation is a lifelong sentence: Gaza’s civilians must be protected in accordance with international humanitarian law</a></p>
<p><a href='https://www.bmj.com/content/388/bmj-2024-080811'>Sacrificing patient care for prevention: distortion of the role of general practice</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In today’s episode:</p>
<ul>
<li>Rethinking how we measure the harm caused by the  arms industry</li>
<li>The life long, and multigenerational, impact of starvation in Gaza</li>
<li> What is the appropriate focus on prevention in general practice?</li>
</ul>
<p> </p>
<p>The BMJ's international editor, Jocalyn Clark talks about a new series we've just published - examining the arms industry as a commercial determinant of health. Jocalyn also speaks to Mark Bellis, from Liverpool John Moores university about why he thinks it’s time we take the impact of the arms industry on health seriously.</p>
<p>The blockade on food reaching Gaza is in place again, risking more starvation. Elizabeth Mahase, clinical reporter for the BMJ, has been finding out about the acute, chronic, and generational impact on the palestinian population. She speaks to Jonathan Wells, professor of anthropology and paediatric nutrition at University College London, and Tessa Roseboom, professor of early development and health at the University of Amsterdam, Marie McGrath former head of the Emergency Nutrition Network, and Chris McIntosh, humanitarian response advisor for the charity, Oxfam.</p>
<p>Finally, an analysis we published earlier this year made the case that "tsunami" of preventative care is destabilised the work of GPs. Helen Macdonald was at the Preventing Overdiagnosis conference and spoke to some of the authors - Minna Johansson, associate professor at University of Gothenberg, Stephen Martin, professor at UMass Chan Medical School, and Iona Heath, retired GP and former president of the RCGP.</p>
<p> </p>
<p>Reading list</p>
<p><a href='https://www.bmj.com/collections/arms-industry-health'>Arms industry as a commercial determinant of health</a><br>
</p>
<p><a href='https://www.bmj.com/content/390/bmj.r1607'>Starvation is a lifelong sentence: Gaza’s civilians must be protected in accordance with international humanitarian law</a></p>
<p><a href='https://www.bmj.com/content/388/bmj-2024-080811'>Sacrificing patient care for prevention: distortion of the role of general practice</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5ns7winuqe3ep6ee/bmj_090925.mp3" length="52930944" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In today’s episode:

Rethinking how we measure the harm caused by the  arms industry
The life long, and multigenerational, impact of starvation in Gaza
 What is the appropriate focus on prevention in general practice?

 
The BMJ's international editor, Jocalyn Clark talks about a new series we've just published - examining the arms industry as a commercial determinant of health. Jocalyn also speaks to Mark Bellis, from Liverpool John Moores university about why he thinks it’s time we take the impact of the arms industry on health seriously.
The blockade on food reaching Gaza is in place again, risking more starvation. Elizabeth Mahase, clinical reporter for the BMJ, has been finding out about the acute, chronic, and generational impact on the palestinian population. She speaks to Jonathan Wells, professor of anthropology and paediatric nutrition at University College London, and Tessa Roseboom, professor of early development and health at the University of Amsterdam, Marie McGrath former head of the Emergency Nutrition Network, and Chris McIntosh, humanitarian response advisor for the charity, Oxfam.
Finally, an analysis we published earlier this year made the case that "tsunami" of preventative care is destabilised the work of GPs. Helen Macdonald was at the Preventing Overdiagnosis conference and spoke to some of the authors - Minna Johansson, associate professor at University of Gothenberg, Stephen Martin, professor at UMass Chan Medical School, and Iona Heath, retired GP and former president of the RCGP.
 
Reading list
Arms industry as a commercial determinant of health
Starvation is a lifelong sentence: Gaza’s civilians must be protected in accordance with international humanitarian law
Sacrificing patient care for prevention: distortion of the role of general practice
 ]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2205</itunes:duration>
                <itunes:episode>50</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>CRISPR, stemcell banking,  and a football world cup</title>
        <itunes:title>CRISPR, stemcell banking,  and a football world cup</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/crispr-stemcell-banking-and-a-football-world-cup/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/crispr-stemcell-banking-and-a-football-world-cup/#comments</comments>        <pubDate>Thu, 21 Aug 2025 08:44:42 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/36a6293b-2903-3306-9e27-9600bd0451d5</guid>
                                    <description><![CDATA[<p>CRISPR technology has revolutionised biological research, and for the first time it’s out of the lab and into the NHS, as NICE has approved its use as cost effective. Kenneth Charles, senior lecturer in haematology at the University of the West Indies explains how the treatment works, and what concerns he has about it's implementation.</p>
<p>Also this week, a new investigation on <a href='https://www.bmj.com/'>bmj.com</a> has looked at a number of British companies who are offering to collect children's teeth for stem cell extraction and storage. Freelance investigative journalist Emma Wilkinson explains the "outrageous" claims she found them making.</p>
<p>Finally - we’re finishing with the football. Team GB had a strong showing this year -  our over 25 men’s team brought the trophy home, and our womans team competed for the first time To explain more about the medical world cup we're joined by Minnan Al-Khafaji, captain of the women’s team, and Jamie Thoroughgood, captain of the men’s team.</p>
<p> </p>
<p>Read more.</p>
<p><a href='https://www.bmj.com/content/390/bmj.r1491'>Banking baby teeth: companies may be misleading parents with “outrageous claims”</a></p>
<p><a href='https://www.bmj.com/content/390/bmj.r1596'>CRISPR therapy for sickle cell disease</a></p>
<p><a href='https://www.instagram.com/gbrmedfootball/?hl=en'>Follow the British Medical Football Team on instagram</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>CRISPR technology has revolutionised biological research, and for the first time it’s out of the lab and into the NHS, as NICE has approved its use as cost effective. Kenneth Charles, senior lecturer in haematology at the University of the West Indies explains how the treatment works, and what concerns he has about it's implementation.</p>
<p>Also this week, a new investigation on <a href='https://www.bmj.com/'>bmj.com</a> has looked at a number of British companies who are offering to collect children's teeth for stem cell extraction and storage. Freelance investigative journalist Emma Wilkinson explains the "outrageous" claims she found them making.</p>
<p>Finally - we’re finishing with the football. Team GB had a strong showing this year -  our over 25 men’s team brought the trophy home, and our womans team competed for the first time To explain more about the medical world cup we're joined by Minnan Al-Khafaji, captain of the women’s team, and Jamie Thoroughgood, captain of the men’s team.</p>
<p> </p>
<p>Read more.</p>
<p><a href='https://www.bmj.com/content/390/bmj.r1491'>Banking baby teeth: companies may be misleading parents with “outrageous claims”</a></p>
<p><a href='https://www.bmj.com/content/390/bmj.r1596'>CRISPR therapy for sickle cell disease</a></p>
<p><a href='https://www.instagram.com/gbrmedfootball/?hl=en'>Follow the British Medical Football Team on instagram</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fr6ewqr4x4dubwhc/med_sci_pod_21st_aug_2025b7hsz.mp3" length="52273165" type="audio/mpeg"/>
        <itunes:summary><![CDATA[CRISPR technology has revolutionised biological research, and for the first time it’s out of the lab and into the NHS, as NICE has approved its use as cost effective. Kenneth Charles, senior lecturer in haematology at the University of the West Indies explains how the treatment works, and what concerns he has about it's implementation.
Also this week, a new investigation on bmj.com has looked at a number of British companies who are offering to collect children's teeth for stem cell extraction and storage. Freelance investigative journalist Emma Wilkinson explains the "outrageous" claims she found them making.
Finally - we’re finishing with the football. Team GB had a strong showing this year -  our over 25 men’s team brought the trophy home, and our womans team competed for the first time To explain more about the medical world cup we're joined by Minnan Al-Khafaji, captain of the women’s team, and Jamie Thoroughgood, captain of the men’s team.
 
Read more.
Banking baby teeth: companies may be misleading parents with “outrageous claims”
CRISPR therapy for sickle cell disease
Follow the British Medical Football Team on instagram]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2176</itunes:duration>
                <itunes:episode>49</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The pitfalls of home test kits</title>
        <itunes:title>The pitfalls of home test kits</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/bmj-29th-july-2025/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/bmj-29th-july-2025/#comments</comments>        <pubDate>Tue, 29 Jul 2025 17:42:47 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/f1d072ce-6f4f-3964-8666-673e78454fb7</guid>
                                    <description><![CDATA[<p>If you’ve been in a high street pharmacy or supermarket recently, chances are you’ll have seen home test kits for all sorts of indications; blood sugar level, vitamin deficiencies, thyroid function, and even some forms of cancer. </p>
<p>A new series of article in The BMJ revealing serious concerns with the reliability of these home tests, and raises questions about their regulation.</p>
<p>Jonathan Deeks, professor of Biostatistics at the University of Birmingham, joins us to discuss what these tests are, and how his team have rated their usability.</p>
<p>Also this week, the sad death of a child in Liverpool from measles highlights the growing outbreak in the UK - and this may be one of the first times many doctors have come across the infection. Frances Dutton, GP at the Small Heath Medical Practice reminds us how to recognise the sign of the infection.</p>
<p> </p>
<p>Reading list</p>
<p><a href='https://www.bmj.com/content/390/bmj-2025-085547'>Direct-to-consumer self-tests sold in the UK in 2023</a></p>
<p><a href='https://www.bmj.com/content/388/bmj-2024-079895'>How to recognise and manage measles</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>If you’ve been in a high street pharmacy or supermarket recently, chances are you’ll have seen home test kits for all sorts of indications; blood sugar level, vitamin deficiencies, thyroid function, and even some forms of cancer. </p>
<p>A new series of article in The BMJ revealing serious concerns with the reliability of these home tests, and raises questions about their regulation.</p>
<p>Jonathan Deeks, professor of Biostatistics at the University of Birmingham, joins us to discuss what these tests are, and how his team have rated their usability.</p>
<p>Also this week, the sad death of a child in Liverpool from measles highlights the growing outbreak in the UK - and this may be one of the first times many doctors have come across the infection. Frances Dutton, GP at the Small Heath Medical Practice reminds us how to recognise the sign of the infection.</p>
<p> </p>
<p>Reading list</p>
<p><a href='https://www.bmj.com/content/390/bmj-2025-085547'>Direct-to-consumer self-tests sold in the UK in 2023</a></p>
<p><a href='https://www.bmj.com/content/388/bmj-2024-079895'>How to recognise and manage measles</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kqd98hqpxm6a8mu6/bmj_290725_mix.mp3" length="40295232" type="audio/mpeg"/>
        <itunes:summary><![CDATA[If you’ve been in a high street pharmacy or supermarket recently, chances are you’ll have seen home test kits for all sorts of indications; blood sugar level, vitamin deficiencies, thyroid function, and even some forms of cancer. 
A new series of article in The BMJ revealing serious concerns with the reliability of these home tests, and raises questions about their regulation.
Jonathan Deeks, professor of Biostatistics at the University of Birmingham, joins us to discuss what these tests are, and how his team have rated their usability.
Also this week, the sad death of a child in Liverpool from measles highlights the growing outbreak in the UK - and this may be one of the first times many doctors have come across the infection. Frances Dutton, GP at the Small Heath Medical Practice reminds us how to recognise the sign of the infection.
 
Reading list
Direct-to-consumer self-tests sold in the UK in 2023
How to recognise and manage measles]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1678</itunes:duration>
                <itunes:episode>48</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The Future for Physician Associates? | Prof. Gillian Leng</title>
        <itunes:title>The Future for Physician Associates? | Prof. Gillian Leng</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-future-for-physician-associates-prof-gillian-leng/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-future-for-physician-associates-prof-gillian-leng/#comments</comments>        <pubDate>Thu, 24 Jul 2025 15:21:25 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/125feb2e-c1ab-3287-9a52-e99ca1c0ad11</guid>
                                    <description><![CDATA[<p>Professor Gillian Leng, President of the Royal Society of Medicine was asked to carry out an independent review into the role of physician and anaesthetic associates.</p>
<p>She sits down with Kamran Abbasi, editor in chief of The BMJ, to discuss her findings. In the UK, the rollout of physician associates, NHS staff who took on some of the tasks of doctors, has been both haphazard and controversial.</p>
<p>Originally copied from similar roles in the U.S., British PAs were introduced in the early 2000s. The level of clinical responsibility they were asked to take on began to vary around the country, driven mostly by the workforce needs of individual Trusts.</p>
<p>The lack of clarity about their roles lead to disquiet with doctors, worry for patients, and an increasingly toxic debate on social media.</p>
<ul>
<li>01.00 What is the Leng Review?</li>
<li>10:00 Recommendation one: Renaming</li>
<li>14:00 Recommendation two: Easier identification</li>
<li>16:00 Recommendation three: How to work?</li>
<li>20:00 Recommendation four: Diagnosis</li>
<li>25:00 Recommendation five: Oversight &amp; Regulation</li>
<li>32:00 Prescribing and ordering ionizing radiation?</li>
<li>40:00 A failure of workforce planning and vision ?</li>
<li>49:00 The NHS 10 year plan</li>
</ul>
]]></description>
                                                            <content:encoded><![CDATA[<p>Professor Gillian Leng, President of the Royal Society of Medicine was asked to carry out an independent review into the role of physician and anaesthetic associates.</p>
<p>She sits down with Kamran Abbasi, editor in chief of The BMJ, to discuss her findings. In the UK, the rollout of physician associates, NHS staff who took on some of the tasks of doctors, has been both haphazard and controversial.</p>
<p>Originally copied from similar roles in the U.S., British PAs were introduced in the early 2000s. The level of clinical responsibility they were asked to take on began to vary around the country, driven mostly by the workforce needs of individual Trusts.</p>
<p>The lack of clarity about their roles lead to disquiet with doctors, worry for patients, and an increasingly toxic debate on social media.</p>
<ul>
<li>01.00 What is the Leng Review?</li>
<li>10:00 Recommendation one: Renaming</li>
<li>14:00 Recommendation two: Easier identification</li>
<li>16:00 Recommendation three: How to work?</li>
<li>20:00 Recommendation four: Diagnosis</li>
<li>25:00 Recommendation five: Oversight &amp; Regulation</li>
<li>32:00 Prescribing and ordering ionizing radiation?</li>
<li>40:00 A failure of workforce planning and vision ?</li>
<li>49:00 The NHS 10 year plan</li>
</ul>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kk8gm66pqp6ezruf/Leng-report_pod_version72o48.mp3" length="76181754" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Professor Gillian Leng, President of the Royal Society of Medicine was asked to carry out an independent review into the role of physician and anaesthetic associates.
She sits down with Kamran Abbasi, editor in chief of The BMJ, to discuss her findings. In the UK, the rollout of physician associates, NHS staff who took on some of the tasks of doctors, has been both haphazard and controversial.
Originally copied from similar roles in the U.S., British PAs were introduced in the early 2000s. The level of clinical responsibility they were asked to take on began to vary around the country, driven mostly by the workforce needs of individual Trusts.
The lack of clarity about their roles lead to disquiet with doctors, worry for patients, and an increasingly toxic debate on social media.

01.00 What is the Leng Review?
10:00 Recommendation one: Renaming
14:00 Recommendation two: Easier identification
16:00 Recommendation three: How to work?
20:00 Recommendation four: Diagnosis
25:00 Recommendation five: Oversight &amp; Regulation
32:00 Prescribing and ordering ionizing radiation?
40:00 A failure of workforce planning and vision ?
49:00 The NHS 10 year plan
]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3173</itunes:duration>
                <itunes:episode>47</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>NHS 10 year plan dissected</title>
        <itunes:title>NHS 10 year plan dissected</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/nhs-10-year-plan-dissected/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/nhs-10-year-plan-dissected/#comments</comments>        <pubDate>Tue, 15 Jul 2025 15:13:09 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/8f5b50f6-caeb-3782-a60e-d391ab727070</guid>
                                    <description><![CDATA[<p>This week we’re focusing on the NHS.</p>
<p>On the 3rd of July the UK’s Prime Minister, Kier Starmer finally announced the NHS’ 10 year plan. His Labour government laid out a vision for where the healthcare service should head over the next decade.</p>
<p>The announcement has been met with mixed responses. The plan has some good ideas - but a lack of vision combined with scarcity of detail leave many questions about how well its aims can be implemented.</p>
<p>In this podcast we're joined by 3 experts to dissect the details of this plan</p>
<ul>
<li>Jennifer Dixon is chief executive of the Health Foundation</li>
<li>Katie Bramhall-Stainer is a working GP, and chairs the BMA’s General Practice committee.</li>
<li>David Oliver is a consultant geriatrician, and a columnist for the BMJ</li>
</ul>
<p>Reading list</p>
<p>News analysis: <a href='https://www.bmj.com/content/390/bmj.r1405'>What is the NHS 10 year plan promising and how will it be delivered?</a>
</p>
<p>Editorial: <a href='https://www.bmj.com/content/390/bmj.r1396#:~:text=The%20plan%20fleshes%20out%20the,physiotherapists%2C%20care%20workers%2C%20and%20social'>Government’s 10 year plan for the NHS in England</a>
</p>
<p>David Oliver's column: <a href='https://www.bmj.com/content/390/bmj.r1398.full'>The NHS 10 year plan—more a set of ambitions than a plan</a>
</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week we’re focusing on the NHS.</p>
<p>On the 3rd of July the UK’s Prime Minister, Kier Starmer finally announced the NHS’ 10 year plan. His Labour government laid out a vision for where the healthcare service should head over the next decade.</p>
<p>The announcement has been met with mixed responses. The plan has some good ideas - but a lack of vision combined with scarcity of detail leave many questions about how well its aims can be implemented.</p>
<p>In this podcast we're joined by 3 experts to dissect the details of this plan</p>
<ul>
<li>Jennifer Dixon is chief executive of the Health Foundation</li>
<li>Katie Bramhall-Stainer is a working GP, and chairs the BMA’s General Practice committee.</li>
<li>David Oliver is a consultant geriatrician, and a columnist for the BMJ</li>
</ul>
<p>Reading list</p>
<p>News analysis: <a href='https://www.bmj.com/content/390/bmj.r1405'>What is the NHS 10 year plan promising and how will it be delivered?</a><br>
</p>
<p>Editorial: <a href='https://www.bmj.com/content/390/bmj.r1396#:~:text=The%20plan%20fleshes%20out%20the,physiotherapists%2C%20care%20workers%2C%20and%20social'>Government’s 10 year plan for the NHS in England</a><br>
</p>
<p>David Oliver's column: <a href='https://www.bmj.com/content/390/bmj.r1398.full'>The NHS 10 year plan—more a set of ambitions than a plan</a><br>
</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ubed6735i2yu5css/10_Year_Plan_diseccted8kmol.mp3" length="61133458" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week we’re focusing on the NHS.
On the 3rd of July the UK’s Prime Minister, Kier Starmer finally announced the NHS’ 10 year plan. His Labour government laid out a vision for where the healthcare service should head over the next decade.
The announcement has been met with mixed responses. The plan has some good ideas - but a lack of vision combined with scarcity of detail leave many questions about how well its aims can be implemented.
In this podcast we're joined by 3 experts to dissect the details of this plan

Jennifer Dixon is chief executive of the Health Foundation
Katie Bramhall-Stainer is a working GP, and chairs the BMA’s General Practice committee.
David Oliver is a consultant geriatrician, and a columnist for the BMJ

Reading list
News analysis: What is the NHS 10 year plan promising and how will it be delivered?
Editorial: Government’s 10 year plan for the NHS in England
David Oliver's column: The NHS 10 year plan—more a set of ambitions than a plan]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2546</itunes:duration>
                <itunes:episode>46</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>What are doctors demanding? | New BMA Chair, Tom Dolphin</title>
        <itunes:title>What are doctors demanding? | New BMA Chair, Tom Dolphin</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/what-are-doctors-demanding-new-bma-chair-tom-dolphin/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/what-are-doctors-demanding-new-bma-chair-tom-dolphin/#comments</comments>        <pubDate>Fri, 11 Jul 2025 16:26:33 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/3c329ea4-0f90-3e67-930d-9605545c6eae</guid>
                                    <description><![CDATA[<p>Rebecca Coombes interviews Dr. Tom Dolphin, consultant anaesthetist and newly elected chair of the BMA Council.</p>
<p><a href='https://youtu.be/zSeWEwWXC1Q'>Watch this interview on our YouTube.</a></p>
<p> </p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Rebecca Coombes interviews Dr. Tom Dolphin, consultant anaesthetist and newly elected chair of the BMA Council.</p>
<p><a href='https://youtu.be/zSeWEwWXC1Q'>Watch this interview on our YouTube.</a></p>
<p> </p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fk3ybaa6y6zq4rer/bmj_110725_tom_dolphin.mp3" length="33204480" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Rebecca Coombes interviews Dr. Tom Dolphin, consultant anaesthetist and newly elected chair of the BMA Council.
Watch this interview on our YouTube.
 
 ]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2075</itunes:duration>
                <itunes:episode>45</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Time to rethink GP's advice on weightloss, and ticagrelor data doubts</title>
        <itunes:title>Time to rethink GP's advice on weightloss, and ticagrelor data doubts</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/bmj-1725/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/bmj-1725/#comments</comments>        <pubDate>Tue, 01 Jul 2025 17:14:18 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/2827941b-8362-3afc-acce-96e9a7d32355</guid>
                                    <description><![CDATA[<p>Last December, The BMJ published an investigation into the 2009 PLATO trial - exposing serious problems with that study’s data analysis and reporting.  Our follow up investigation has shown that those data problems extend to other key supporting evidence in AstraZeneca’s initial application to regulators.</p>
<p>Peter Doshi, senior editor in the BMJ’s Investigations unit, and Rita Redberg, cardiologist and Professor of Medicine at UCSF and former editor of JAMA Internal Medicine, join us to explain what this means for scientific integrity, and trust in the FDA's approval processes.</p>
<p> </p>
<p>Also in this episode. A group of international authors are arguing that weightloss advice given in primary care might actually be doing more harm than good - it’s ineffective and potentially reinforces damaging stigma. </p>
<p>To explain why they came to that conclusion we're joined by Juan Franco editor in chief of BMJ EBM, and a practicing GP in Germany, and Emma Grundtvig Gram, from the Centre for General Practice at the University of Copenhagen</p>
<p>
Reading list</p>
<p><a href='https://www.bmj.com/content/389/bmj.r1201'>Doubts over landmark heart drug trial: ticagrelor PLATO study</a>
</p>
<p><a href='https://www.bmj.com/content/389/bmj.r1201'>Ticagrelor doubts: inaccuracies uncovered in key studies for AstraZeneca’s billion dollar drug</a></p>
<p><a href='https://www.bmj.com/content/389/bmj-2025-084654'>Beyond body mass index: rethinking doctors’ advice for weight loss</a>
</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Last December, The BMJ published an investigation into the 2009 PLATO trial - exposing serious problems with that study’s data analysis and reporting.  Our follow up investigation has shown that those data problems extend to other key supporting evidence in AstraZeneca’s initial application to regulators.</p>
<p>Peter Doshi, senior editor in the BMJ’s Investigations unit, and Rita Redberg, cardiologist and Professor of Medicine at UCSF and former editor of JAMA Internal Medicine, join us to explain what this means for scientific integrity, and trust in the FDA's approval processes.</p>
<p> </p>
<p>Also in this episode. A group of international authors are arguing that weightloss advice given in primary care might actually be doing more harm than good - it’s ineffective and potentially reinforces damaging stigma. </p>
<p>To explain why they came to that conclusion we're joined by Juan Franco editor in chief of BMJ EBM, and a practicing GP in Germany, and Emma Grundtvig Gram, from the Centre for General Practice at the University of Copenhagen</p>
<p><br>
Reading list</p>
<p><a href='https://www.bmj.com/content/389/bmj.r1201'>Doubts over landmark heart drug trial: ticagrelor PLATO study</a><br>
</p>
<p><a href='https://www.bmj.com/content/389/bmj.r1201'>Ticagrelor doubts: inaccuracies uncovered in key studies for AstraZeneca’s billion dollar drug</a></p>
<p><a href='https://www.bmj.com/content/389/bmj-2025-084654'>Beyond body mass index: rethinking doctors’ advice for weight loss</a><br>
</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dz4trzsafys4cshj/bmj_010725_mix.mp3" length="48439872" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Last December, The BMJ published an investigation into the 2009 PLATO trial - exposing serious problems with that study’s data analysis and reporting.  Our follow up investigation has shown that those data problems extend to other key supporting evidence in AstraZeneca’s initial application to regulators.
Peter Doshi, senior editor in the BMJ’s Investigations unit, and Rita Redberg, cardiologist and Professor of Medicine at UCSF and former editor of JAMA Internal Medicine, join us to explain what this means for scientific integrity, and trust in the FDA's approval processes.
 
Also in this episode. A group of international authors are arguing that weightloss advice given in primary care might actually be doing more harm than good - it’s ineffective and potentially reinforces damaging stigma. 
To explain why they came to that conclusion we're joined by Juan Franco editor in chief of BMJ EBM, and a practicing GP in Germany, and Emma Grundtvig Gram, from the Centre for General Practice at the University of Copenhagen
Reading list
Doubts over landmark heart drug trial: ticagrelor PLATO study
Ticagrelor doubts: inaccuracies uncovered in key studies for AstraZeneca’s billion dollar drug
Beyond body mass index: rethinking doctors’ advice for weight loss]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2018</itunes:duration>
                <itunes:episode>44</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The plan for NHS league tables is bad, and will lead to unintended consequences</title>
        <itunes:title>The plan for NHS league tables is bad, and will lead to unintended consequences</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-plan-for-nhs-league-tables-is-bad-and-will-lead-to-unintended-consequences/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-plan-for-nhs-league-tables-is-bad-and-will-lead-to-unintended-consequences/#comments</comments>        <pubDate>Mon, 16 Jun 2025 17:21:48 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/e9286dd4-c303-37d6-a797-73ec0fa66039</guid>
                                    <description><![CDATA[<p>In this episode, we hear about ketamine addiction. It's in the news, but the rise in addiction amongst young people in the UK has caused concern for some time.  Irene Guerrini and Nicola Kalk, both addiction psychiatrists from the National Addiction Centre, join us to explain why its become a problem.</p>
<p>In November 2024 Wes Streeting, the UK’s health and social care minister, announced that he was planning to introduce league tables for hospitals - and would be linking managers' pay and continued employment to those outcomes. </p>
<p>Richard Lilford, from the University of Birmingham, Timothy Hofer, from the University of Michigan, and Ian Leistikow, an inspector at the Dutch Health and Youth Care Inspectorate, join us to explain why this is a bad idea.</p>
<p><a href='https://www.bmj.com/content/389/bmj.r1167'>Non-prescribed ketamine use is rising in the UK</a></p>
<p><a href='https://www.bmj.com/content/389/bmj-2024-083517'>Hospital league tables, targets, and performance incentives should be used with care</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, we hear about ketamine addiction. It's in the news, but the rise in addiction amongst young people in the UK has caused concern for some time.  Irene Guerrini and Nicola Kalk, both addiction psychiatrists from the National Addiction Centre, join us to explain why its become a problem.</p>
<p>In November 2024 Wes Streeting, the UK’s health and social care minister, announced that he was planning to introduce league tables for hospitals - and would be linking managers' pay and continued employment to those outcomes. </p>
<p>Richard Lilford, from the University of Birmingham, Timothy Hofer, from the University of Michigan, and Ian Leistikow, an inspector at the Dutch Health and Youth Care Inspectorate, join us to explain why this is a bad idea.</p>
<p><a href='https://www.bmj.com/content/389/bmj.r1167'>Non-prescribed ketamine use is rising in the UK</a></p>
<p><a href='https://www.bmj.com/content/389/bmj-2024-083517'>Hospital league tables, targets, and performance incentives should be used with care</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/nu3fpiirvndpaf22/bmj_160625_mix.mp3" length="37661184" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, we hear about ketamine addiction. It's in the news, but the rise in addiction amongst young people in the UK has caused concern for some time.  Irene Guerrini and Nicola Kalk, both addiction psychiatrists from the National Addiction Centre, join us to explain why its become a problem.
In November 2024 Wes Streeting, the UK’s health and social care minister, announced that he was planning to introduce league tables for hospitals - and would be linking managers' pay and continued employment to those outcomes. 
Richard Lilford, from the University of Birmingham, Timothy Hofer, from the University of Michigan, and Ian Leistikow, an inspector at the Dutch Health and Youth Care Inspectorate, join us to explain why this is a bad idea.
Non-prescribed ketamine use is rising in the UK
Hospital league tables, targets, and performance incentives should be used with care]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1569</itunes:duration>
                <itunes:episode>43</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Wellness industry lies, and preventative AI evaluation</title>
        <itunes:title>Wellness industry lies, and preventative AI evaluation</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/bmj-020525/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/bmj-020525/#comments</comments>        <pubDate>Mon, 02 Jun 2025 17:52:39 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/e0abcc58-0d1f-3b08-b80d-68af1a890687</guid>
                                    <description><![CDATA[<p>Devi Sridhar's new book  “How Not to Die  (Too Soon) - The Lies We’ve Been Sold, and the Policies That Could Save Us” is focussing on the way wellness culture ignores the societal context in which health is really created. As a trained personal trainer and professor of global public health, Devi's straddling both of those worlds, and joins us to talk about how she would tackle our lowering life expectancy.</p>
<p>Also, John Downey, from the Centre of Health Technology at Peninsula Medical School, and Martha Lee from NHS Devon Integrated Care Board, have written about Plymouth's "Living Lab" - which has been set up to test how health tech can actually work in the real world, but also (importantly, critically) how it can be properly evaluated and integrated into the NHS and social care.</p>
<p>
Reading list</p>
<p><a href='https://www.penguin.co.uk/books/458539/how-not-to-die-too-soon-by-sridhar-devi/9780241742846'>How Not to Die (Too Soon)</a>
</p>
<p><a href='https://www.bmj.com/content/389/bmj-2024-082873'>Harnessing predictive prevention to shift elderly care from hospital to community in England</a>
</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Devi Sridhar's new book  “How Not to Die  (Too Soon) - The Lies We’ve Been Sold, and the Policies That Could Save Us” is focussing on the way wellness culture ignores the societal context in which health is really created. As a trained personal trainer and professor of global public health, Devi's straddling both of those worlds, and joins us to talk about how she would tackle our lowering life expectancy.</p>
<p>Also, John Downey, from the Centre of Health Technology at Peninsula Medical School, and Martha Lee from NHS Devon Integrated Care Board, have written about Plymouth's "Living Lab" - which has been set up to test how health tech can actually work in the real world, but also (importantly, critically) how it can be properly evaluated and integrated into the NHS and social care.</p>
<p><br>
Reading list</p>
<p><a href='https://www.penguin.co.uk/books/458539/how-not-to-die-too-soon-by-sridhar-devi/9780241742846'>How Not to Die (Too Soon)</a><br>
</p>
<p><a href='https://www.bmj.com/content/389/bmj-2024-082873'>Harnessing predictive prevention to shift elderly care from hospital to community in England</a><br>
</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mx62vm3z62r57it6/bmj_020525.mp3" length="55996416" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Devi Sridhar's new book  “How Not to Die  (Too Soon) - The Lies We’ve Been Sold, and the Policies That Could Save Us” is focussing on the way wellness culture ignores the societal context in which health is really created. As a trained personal trainer and professor of global public health, Devi's straddling both of those worlds, and joins us to talk about how she would tackle our lowering life expectancy.
Also, John Downey, from the Centre of Health Technology at Peninsula Medical School, and Martha Lee from NHS Devon Integrated Care Board, have written about Plymouth's "Living Lab" - which has been set up to test how health tech can actually work in the real world, but also (importantly, critically) how it can be properly evaluated and integrated into the NHS and social care.
Reading list
How Not to Die (Too Soon)
Harnessing predictive prevention to shift elderly care from hospital to community in England]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2333</itunes:duration>
                <itunes:episode>42</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Conflict in South Asia, and simplifying GRADE.</title>
        <itunes:title>Conflict in South Asia, and simplifying GRADE.</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/conflict-in-south-asia-and-simplifying-grade/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/conflict-in-south-asia-and-simplifying-grade/#comments</comments>        <pubDate>Mon, 19 May 2025 16:03:00 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/b099ab46-3111-3e63-ab07-47a5f8b48dd0</guid>
                                    <description><![CDATA[<p>Recent escalations in the ever simmering tension between India and Pakistan brought us closer to conflict - conflict between two nuclear powers.</p>
<p>For a long time doctors have campaigned for nuclear disarmament, and Chris Zielinski, president of the World Association of Medical Editors, makes the case for returning WHO's mandate to measure the potential impact of nuclear war.</p>
<p>Also the militarization of the region is detrimental to the health and wellbeing of the populations in both India and Pakistan. co-chairs of The BMJ's South Asia editorial board, Sanjay Nagral and Zulfiqar Butta, explain why a focus on the daily material and health needs of citizens is the way to change political rhetoric in the region.</p>
<p>Gordon Guyatt, distinguished professor at McMaster University, was one of the people responsible for starting GRADE - which is a structured system for assessing the quality of evidence in systematic reviews and clinical practice guideline. Gordon thinks that process has become too complicated - so he’s now championing “Core GRADE”. He joins us to explain why.</p>
<p> </p>
<p>Reading list</p>
<p><a href='https://www.bmj.com/content/389/bmj.r881'>Ending nuclear weapons, before they end us</a>
</p>
<p><a href='https://www.bmj.com/content/389/bmj-2024-081902'>Why Core GRADE is needed: introduction to a new series in The BMJ</a>
</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Recent escalations in the ever simmering tension between India and Pakistan brought us closer to conflict - conflict between two nuclear powers.</p>
<p>For a long time doctors have campaigned for nuclear disarmament, and Chris Zielinski, president of the World Association of Medical Editors, makes the case for returning WHO's mandate to measure the potential impact of nuclear war.</p>
<p>Also the militarization of the region is detrimental to the health and wellbeing of the populations in both India and Pakistan. co-chairs of The BMJ's South Asia editorial board, Sanjay Nagral and Zulfiqar Butta, explain why a focus on the daily material and health needs of citizens is the way to change political rhetoric in the region.</p>
<p>Gordon Guyatt, distinguished professor at McMaster University, was one of the people responsible for starting GRADE - which is a structured system for assessing the quality of evidence in systematic reviews and clinical practice guideline. Gordon thinks that process has become too complicated - so he’s now championing “Core GRADE”. He joins us to explain why.</p>
<p> </p>
<p>Reading list</p>
<p><a href='https://www.bmj.com/content/389/bmj.r881'>Ending nuclear weapons, before they end us</a><br>
</p>
<p><a href='https://www.bmj.com/content/389/bmj-2024-081902'>Why Core GRADE is needed: introduction to a new series in The BMJ</a><br>
</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/68bzsd73u3ze6vkb/war_and_Core_Grade_med_sci7qsgx.mp3" length="57978158" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Recent escalations in the ever simmering tension between India and Pakistan brought us closer to conflict - conflict between two nuclear powers.
For a long time doctors have campaigned for nuclear disarmament, and Chris Zielinski, president of the World Association of Medical Editors, makes the case for returning WHO's mandate to measure the potential impact of nuclear war.
Also the militarization of the region is detrimental to the health and wellbeing of the populations in both India and Pakistan. co-chairs of The BMJ's South Asia editorial board, Sanjay Nagral and Zulfiqar Butta, explain why a focus on the daily material and health needs of citizens is the way to change political rhetoric in the region.
Gordon Guyatt, distinguished professor at McMaster University, was one of the people responsible for starting GRADE - which is a structured system for assessing the quality of evidence in systematic reviews and clinical practice guideline. Gordon thinks that process has become too complicated - so he’s now championing “Core GRADE”. He joins us to explain why.
 
Reading list
Ending nuclear weapons, before they end us
Why Core GRADE is needed: introduction to a new series in The BMJ]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2415</itunes:duration>
                <itunes:episode>41</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Malaria free China, an academic medicine revolution, and retracted data's impact</title>
        <itunes:title>Malaria free China, an academic medicine revolution, and retracted data's impact</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/bmj-7th-may/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/bmj-7th-may/#comments</comments>        <pubDate>Wed, 07 May 2025 22:04:40 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/95391732-1a41-3a28-bbea-d126bca3f883</guid>
                                    <description><![CDATA[<p>China was declared malaria free in 2021 - and we'll hear how persistence was key to their success, and what new technologies are available to help the rest of the world become malaria free, from Regina Rabinovich, director of the Malaria Elimination Initiative at the Barcelona Institute for Global Health. </p>
<p>Sonia Saxena, professor of primary care at Imperial College London, and Miguel O’Ryan, dean of the medical faculty of the University of Chile join Kamran to talk about what broke academic medicine, and why it's time for a revolution.</p>
<p>New research shows that data from retracted papers is still having an alarming effect on clinical practice. Chang Xu, Hui Liu, and Fuchen Liu from the Naval Medical University in Shanghai, and Suhail Doi from Qatar University, join us to talk about their study which has maped retracted papers impact on systematic reviews and clinical guidelines. </p>
<p> </p>
<p>Reading list</p>
<p><a href='https://www.bmj.com/collections/malaria-control-china'>Malaria control lessons from China</a></p>
<p><a href='https://www.bmj.com/content/389/bmj.r561'>Vision 2050: a revolution in academic medicine for better health for all</a></p>
<p><a href='https://www.bmj.com/content/389/bmj-2024-082068'>Investigating the impact of trial retractions on the healthcare evidence ecosystem (VITALITY Study I)</a></p>
<p>- <a href='https://www.bmj.com/content/356/bmj.j138'>An example of the BMJ's approach to updating metaanalysis after a study retraction </a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>China was declared malaria free in 2021 - and we'll hear how persistence was key to their success, and what new technologies are available to help the rest of the world become malaria free, from Regina Rabinovich, director of the Malaria Elimination Initiative at the Barcelona Institute for Global Health. </p>
<p>Sonia Saxena, professor of primary care at Imperial College London, and Miguel O’Ryan, dean of the medical faculty of the University of Chile join Kamran to talk about what broke academic medicine, and why it's time for a revolution.</p>
<p>New research shows that data from retracted papers is still having an alarming effect on clinical practice. Chang Xu, Hui Liu, and Fuchen Liu from the Naval Medical University in Shanghai, and Suhail Doi from Qatar University, join us to talk about their study which has maped retracted papers impact on systematic reviews and clinical guidelines. </p>
<p> </p>
<p>Reading list</p>
<p><a href='https://www.bmj.com/collections/malaria-control-china'>Malaria control lessons from China</a></p>
<p><a href='https://www.bmj.com/content/389/bmj.r561'>Vision 2050: a revolution in academic medicine for better health for all</a></p>
<p><a href='https://www.bmj.com/content/389/bmj-2024-082068'>Investigating the impact of trial retractions on the healthcare evidence ecosystem (VITALITY Study I)</a></p>
<p>- <a href='https://www.bmj.com/content/356/bmj.j138'>An example of the BMJ's approach to updating metaanalysis after a study retraction </a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2mmi49679fgvd9uh/bmj_070525.mp3" length="52725312" type="audio/mpeg"/>
        <itunes:summary><![CDATA[China was declared malaria free in 2021 - and we'll hear how persistence was key to their success, and what new technologies are available to help the rest of the world become malaria free, from Regina Rabinovich, director of the Malaria Elimination Initiative at the Barcelona Institute for Global Health. 
Sonia Saxena, professor of primary care at Imperial College London, and Miguel O’Ryan, dean of the medical faculty of the University of Chile join Kamran to talk about what broke academic medicine, and why it's time for a revolution.
New research shows that data from retracted papers is still having an alarming effect on clinical practice. Chang Xu, Hui Liu, and Fuchen Liu from the Naval Medical University in Shanghai, and Suhail Doi from Qatar University, join us to talk about their study which has maped retracted papers impact on systematic reviews and clinical guidelines. 
 
Reading list
Malaria control lessons from China
Vision 2050: a revolution in academic medicine for better health for all
Investigating the impact of trial retractions on the healthcare evidence ecosystem (VITALITY Study I)
- An example of the BMJ's approach to updating metaanalysis after a study retraction ]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2196</itunes:duration>
                <itunes:episode>40</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The problem of prognostication in assisted dying.</title>
        <itunes:title>The problem of prognostication in assisted dying.</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/bmj-april-23rd/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/bmj-april-23rd/#comments</comments>        <pubDate>Wed, 23 Apr 2025 16:11:00 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/b3a4ccd7-dd60-352d-9b20-15abfe20e13b</guid>
                                    <description><![CDATA[<p>The UK government is debating legislation to allow assisted dying in England and Wales, which puts doctors at the forefront of deciding if their patient will be eligible for a medically assisted death - the key criteria being a 6 month prognosis. But is making a 6 month prognosis actually clinically reliable?</p>
<p>To discuss we're joined by a panel of experts on end of life;</p>
<ul>
<li style="font-weight:400;">Scott Murray, emeritus professor of primary palliative care at the University of Edinburgh</li>
<li style="font-weight:400;">Simon Etkind, assistant professor of palliative care at the University of Cambridge</li>
<li style="font-weight:400;">Nancy Preston, professor of supportive and palliative care, Lancaster University</li>
<li style="font-weight:400;">Suzanne Ost, professor of law, Lancaster University</li>
</ul>
<p>Reading list</p>
<p><a href='https://www.bmj.com/content/388/bmj.r490'>Assisted dying and the difficulties of predicting end of life</a></p>
<p><a href='https://www.bmj.com/content/382/bmj.p1968'>Breaching the stalemate on assisted dying: it’s time to move beyond a medicalised approach</a></p>
<p> </p>
<p>Also in this episode, we dim the lights and raise the curtains - there is a public fascination with doctors who kill and the stage show turned podcast, ‘An Appointment with Murder’, takes a deep dive into the crimes of GPs John Bodkin-Adams and Harold Shipman.</p>
<p>Kamran is joined by Harry Brunjes and Andrew Johns to talk medical murder.</p>
<p><a href='https://podcasts.apple.com/gb/podcast/an-appointment-with-murder/id1810022052'>An Appointment With Murder on Apple Podcasts</a></p>
<p> </p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The UK government is debating legislation to allow assisted dying in England and Wales, which puts doctors at the forefront of deciding if their patient will be eligible for a medically assisted death - the key criteria being a 6 month prognosis. But is making a 6 month prognosis actually clinically reliable?</p>
<p>To discuss we're joined by a panel of experts on end of life;</p>
<ul>
<li style="font-weight:400;">Scott Murray, emeritus professor of primary palliative care at the University of Edinburgh</li>
<li style="font-weight:400;">Simon Etkind, assistant professor of palliative care at the University of Cambridge</li>
<li style="font-weight:400;">Nancy Preston, professor of supportive and palliative care, Lancaster University</li>
<li style="font-weight:400;">Suzanne Ost, professor of law, Lancaster University</li>
</ul>
<p>Reading list</p>
<p><a href='https://www.bmj.com/content/388/bmj.r490'>Assisted dying and the difficulties of predicting end of life</a></p>
<p><a href='https://www.bmj.com/content/382/bmj.p1968'>Breaching the stalemate on assisted dying: it’s time to move beyond a medicalised approach</a></p>
<p> </p>
<p>Also in this episode, we dim the lights and raise the curtains - there is a public fascination with doctors who kill and the stage show turned podcast, ‘An Appointment with Murder’, takes a deep dive into the crimes of GPs John Bodkin-Adams and Harold Shipman.</p>
<p>Kamran is joined by Harry Brunjes and Andrew Johns to talk medical murder.</p>
<p><a href='https://podcasts.apple.com/gb/podcast/an-appointment-with-murder/id1810022052'>An Appointment With Murder on Apple Podcasts</a></p>
<p> </p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/cysbe7evec2vd3xg/bmj_230525.mp3" length="44361792" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The UK government is debating legislation to allow assisted dying in England and Wales, which puts doctors at the forefront of deciding if their patient will be eligible for a medically assisted death - the key criteria being a 6 month prognosis. But is making a 6 month prognosis actually clinically reliable?
To discuss we're joined by a panel of experts on end of life;

Scott Murray, emeritus professor of primary palliative care at the University of Edinburgh
Simon Etkind, assistant professor of palliative care at the University of Cambridge
Nancy Preston, professor of supportive and palliative care, Lancaster University
Suzanne Ost, professor of law, Lancaster University

Reading list
Assisted dying and the difficulties of predicting end of life
Breaching the stalemate on assisted dying: it’s time to move beyond a medicalised approach
 
Also in this episode, we dim the lights and raise the curtains - there is a public fascination with doctors who kill and the stage show turned podcast, ‘An Appointment with Murder’, takes a deep dive into the crimes of GPs John Bodkin-Adams and Harold Shipman.
Kamran is joined by Harry Brunjes and Andrew Johns to talk medical murder.
An Appointment With Murder on Apple Podcasts
 
 ]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1848</itunes:duration>
                <itunes:episode>39</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Trump is trying to destroy universities - Ashish Jha, Dean of Public Health at Brown University</title>
        <itunes:title>Trump is trying to destroy universities - Ashish Jha, Dean of Public Health at Brown University</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/trump-is-trying-to-destroy-universities-ashish-jha-dean-of-public-health-at-brown-university/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/trump-is-trying-to-destroy-universities-ashish-jha-dean-of-public-health-at-brown-university/#comments</comments>        <pubDate>Fri, 11 Apr 2025 11:07:46 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/d6c8e0be-e398-355b-8242-fb61f46706e1</guid>
                                    <description><![CDATA[<p>Kamran Abbasi interviews Professor Ashish Jha, Dean of Public Health at Brown University and former COVID-19 pandemic advisor to President Biden.</p>
<p><a href='https://www.youtube.com/watch?v=ziM2mF0Yzug'>Watch this interview on our YouTube. </a></p>
<p>Trump’s second term has touched everything in the US political sphere - and health is no exception. With research funding for medicine and science weathering under Trump’s storm of cuts, how can Americans who care about public health and data navigate a course through the swells?</p>
<p>Professor Jha discusses how to resist an anti-vaccine resurgence, and comments on revisionist narratives that drive ill-conceived public health policies.</p>
<p> </p>
<ul>
<li>02:20 The MAHA movement and RFK Jnr.</li>
<li>07:40 Does evidence still matter?</li>
<li>13:35 Trump administration is helping China</li>
<li>15:10 Policymaking in Trump’s shadow</li>
<li>23:35 Where do universities go from here?</li>
<li>28:48 Censorship, research funding and academic freedom</li>
<li>33:35 Health inequalities within America</li>
<li>36:20 A resurgent anti-vax message</li>
<li>41:24 What Ashish’s got wrong about the pandemic response</li>
<li>45:31 When is enough for research data?</li>
<li>47:14 Future hope and how to pushback in smart ways</li>
</ul>
<p> </p>
<p>Reading list:</p>
<p>Professor Jha’s December 2024 editorial on the <a href='https://www.bmj.com/content/387/bmj.q2801.'>Trump admin’s plans for American healthcare coverage</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Kamran Abbasi interviews Professor Ashish Jha, Dean of Public Health at Brown University and former COVID-19 pandemic advisor to President Biden.</p>
<p><a href='https://www.youtube.com/watch?v=ziM2mF0Yzug'>Watch this interview on our YouTube. </a></p>
<p>Trump’s second term has touched everything in the US political sphere - and health is no exception. With research funding for medicine and science weathering under Trump’s storm of cuts, how can Americans who care about public health and data navigate a course through the swells?</p>
<p>Professor Jha discusses how to resist an anti-vaccine resurgence, and comments on revisionist narratives that drive ill-conceived public health policies.</p>
<p> </p>
<ul>
<li>02:20 The MAHA movement and RFK Jnr.</li>
<li>07:40 Does evidence still matter?</li>
<li>13:35 Trump administration is helping China</li>
<li>15:10 Policymaking in Trump’s shadow</li>
<li>23:35 Where do universities go from here?</li>
<li>28:48 Censorship, research funding and academic freedom</li>
<li>33:35 Health inequalities within America</li>
<li>36:20 A resurgent anti-vax message</li>
<li>41:24 What Ashish’s got wrong about the pandemic response</li>
<li>45:31 When is enough for research data?</li>
<li>47:14 Future hope and how to pushback in smart ways</li>
</ul>
<p> </p>
<p>Reading list:</p>
<p>Professor Jha’s December 2024 editorial on the <a href='https://www.bmj.com/content/387/bmj.q2801.'>Trump admin’s plans for American healthcare coverage</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7si7bzqmrdsvcux6/Science_in_Trump_s_America_with_Biden_COVID_Response_Coordinator_Ashish_Jha_The_BMJ_Podcast8et8c.mp3" length="72474468" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Kamran Abbasi interviews Professor Ashish Jha, Dean of Public Health at Brown University and former COVID-19 pandemic advisor to President Biden.
Watch this interview on our YouTube. 
Trump’s second term has touched everything in the US political sphere - and health is no exception. With research funding for medicine and science weathering under Trump’s storm of cuts, how can Americans who care about public health and data navigate a course through the swells?
Professor Jha discusses how to resist an anti-vaccine resurgence, and comments on revisionist narratives that drive ill-conceived public health policies.
 

02:20 The MAHA movement and RFK Jnr.
07:40 Does evidence still matter?
13:35 Trump administration is helping China
15:10 Policymaking in Trump’s shadow
23:35 Where do universities go from here?
28:48 Censorship, research funding and academic freedom
33:35 Health inequalities within America
36:20 A resurgent anti-vax message
41:24 What Ashish’s got wrong about the pandemic response
45:31 When is enough for research data?
47:14 Future hope and how to pushback in smart ways

 
Reading list:
Professor Jha’s December 2024 editorial on the Trump admin’s plans for American healthcare coverage ]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3019</itunes:duration>
                <itunes:episode>38</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Reducing benefits will not get disabled people back to work, and explaining overdiagnosis</title>
        <itunes:title>Reducing benefits will not get disabled people back to work, and explaining overdiagnosis</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/medicine-science-april-9th/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/medicine-science-april-9th/#comments</comments>        <pubDate>Wed, 09 Apr 2025 13:34:02 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/7cf38ed7-41d3-3315-9248-de0d27117581</guid>
                                    <description><![CDATA[<p>The UK’s chancellor has announced a £5bn cut to benefits, much of which will be borne by those on long-term disability allowance. Gerry McCartney, professor of wellbeing economy at Glasgow University explains about why these cuts will not only hurt the most vulnerable, but will be counterproductive to the government's wish to get people back to work.</p>
<p>Also, Suzanne O'Sullivan, consultant neurologist and author, joins us to talk about her new book "Age of Diagnosis". The book used clinical cases to explore the issues of medicalisation, and Suzanne explains why overdiagnosis doesn't mean that care isn't needed.</p>
<p> </p>
<p>Reading list;</p>
<p><a href='https://www.bmj.com/content/388/bmj.r593'>UK welfare reforms threaten health of the most vulnerable</a></p>
<p><a href='https://www.theguardian.com/society/2025/mar/01/the-number-of-people-with-chronic-conditions-is-soaring-are-we-less-healthy-than-we-used-to-be-or-overdiagnosing-illness'>Guardian edited extract from "The Age of Diagnosis: Sickness, Health and Why Medicine Has Gone Too Far"</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The UK’s chancellor has announced a £5bn cut to benefits, much of which will be borne by those on long-term disability allowance. Gerry McCartney, professor of wellbeing economy at Glasgow University explains about why these cuts will not only hurt the most vulnerable, but will be counterproductive to the government's wish to get people back to work.</p>
<p>Also, Suzanne O'Sullivan, consultant neurologist and author, joins us to talk about her new book "Age of Diagnosis". The book used clinical cases to explore the issues of medicalisation, and Suzanne explains why overdiagnosis doesn't mean that care isn't needed.</p>
<p> </p>
<p>Reading list;</p>
<p><a href='https://www.bmj.com/content/388/bmj.r593'>UK welfare reforms threaten health of the most vulnerable</a></p>
<p><a href='https://www.theguardian.com/society/2025/mar/01/the-number-of-people-with-chronic-conditions-is-soaring-are-we-less-healthy-than-we-used-to-be-or-overdiagnosing-illness'>Guardian edited extract from "The Age of Diagnosis: Sickness, Health and Why Medicine Has Gone Too Far"</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/myss54cs3a55mwew/Med_Sci_Pod_-_9th_April9d0dt.mp3" length="46940544" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The UK’s chancellor has announced a £5bn cut to benefits, much of which will be borne by those on long-term disability allowance. Gerry McCartney, professor of wellbeing economy at Glasgow University explains about why these cuts will not only hurt the most vulnerable, but will be counterproductive to the government's wish to get people back to work.
Also, Suzanne O'Sullivan, consultant neurologist and author, joins us to talk about her new book "Age of Diagnosis". The book used clinical cases to explore the issues of medicalisation, and Suzanne explains why overdiagnosis doesn't mean that care isn't needed.
 
Reading list;
UK welfare reforms threaten health of the most vulnerable
Guardian edited extract from "The Age of Diagnosis: Sickness, Health and Why Medicine Has Gone Too Far"
 ]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1955</itunes:duration>
                <itunes:episode>37</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>What does the death of NHS England, and the western alliance, mean for health?</title>
        <itunes:title>What does the death of NHS England, and the western alliance, mean for health?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/what-does-the-death-of-nhs-england-and-the-western-alliance-mean-for-health/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/what-does-the-death-of-nhs-england-and-the-western-alliance-mean-for-health/#comments</comments>        <pubDate>Wed, 26 Mar 2025 17:24:30 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/ed02f636-e7de-375c-991e-8e546d00711a</guid>
                                    <description><![CDATA[<p>In the UK, the prime minister has announced the disbanding of NHS England, Nigel Crisp - former chief executive of the NHS, explains why he thinks that it’s important the health service is closer to the political decision makers, and why this could be the time to really acknowledge the healthcare emergency.</p>
<p>On the international stage, the Trump administration's withdrawal from the WHO is throwing global health into disarray - Illona Kickbusch, founder of the Global Health Centre at the Graduate Institute in Geneva, joins us to explain which new alliances are emerging, why the funding that has disappeared may never be replaced, and how tech will surpass pharma when it comes to industry influence.</p>
<p>Finally, there is a triple burden of malnutrition for adolescent girls in south Asia - which creates a cycle of ill health that is hard to break. However, Zulfiqar Bhutta, chair in global child health at the Hospital for Sick Children in Toronto, thinks the region can come together to change both government and society to champion young women’s health.

Reading list:</p>
<p><a href='https://www.bmj.com/content/388/bmj.r553'>Abolishing NHS England: risks and opportunities</a></p>
<p><a href='https://www.bmj.com/nhs-commission'>https://www.bmj.com/nhs-commission</a></p>
<p><a href='https://www.bmj.com/collections/nourishing-south-asia'>https://www.bmj.com/collections/nourishing-south-asia</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In the UK, the prime minister has announced the disbanding of NHS England, Nigel Crisp - former chief executive of the NHS, explains why he thinks that it’s important the health service is closer to the political decision makers, and why this could be the time to really acknowledge the healthcare emergency.</p>
<p>On the international stage, the Trump administration's withdrawal from the WHO is throwing global health into disarray - Illona Kickbusch, founder of the Global Health Centre at the Graduate Institute in Geneva, joins us to explain which new alliances are emerging, why the funding that has disappeared may never be replaced, and how tech will surpass pharma when it comes to industry influence.</p>
<p>Finally, there is a triple burden of malnutrition for adolescent girls in south Asia - which creates a cycle of ill health that is hard to break. However, Zulfiqar Bhutta, chair in global child health at the Hospital for Sick Children in Toronto, thinks the region can come together to change both government and society to champion young women’s health.<br>
<br>
Reading list:</p>
<p><a href='https://www.bmj.com/content/388/bmj.r553'>Abolishing NHS England: risks and opportunities</a></p>
<p><a href='https://www.bmj.com/nhs-commission'>https://www.bmj.com/nhs-commission</a></p>
<p><a href='https://www.bmj.com/collections/nourishing-south-asia'>https://www.bmj.com/collections/nourishing-south-asia</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ptdbjb2x4vw9zun4/bmj_260325.mp3" length="54455616" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In the UK, the prime minister has announced the disbanding of NHS England, Nigel Crisp - former chief executive of the NHS, explains why he thinks that it’s important the health service is closer to the political decision makers, and why this could be the time to really acknowledge the healthcare emergency.
On the international stage, the Trump administration's withdrawal from the WHO is throwing global health into disarray - Illona Kickbusch, founder of the Global Health Centre at the Graduate Institute in Geneva, joins us to explain which new alliances are emerging, why the funding that has disappeared may never be replaced, and how tech will surpass pharma when it comes to industry influence.
Finally, there is a triple burden of malnutrition for adolescent girls in south Asia - which creates a cycle of ill health that is hard to break. However, Zulfiqar Bhutta, chair in global child health at the Hospital for Sick Children in Toronto, thinks the region can come together to change both government and society to champion young women’s health.Reading list:
Abolishing NHS England: risks and opportunities
https://www.bmj.com/nhs-commission
https://www.bmj.com/collections/nourishing-south-asia]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2268</itunes:duration>
                <itunes:episode>36</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The data on physician associates in the UK, and speaking up in the NHS</title>
        <itunes:title>The data on physician associates in the UK, and speaking up in the NHS</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-data-on-physician-associates-in-the-uk-and-speaking-up-in-the-nhs/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-data-on-physician-associates-in-the-uk-and-speaking-up-in-the-nhs/#comments</comments>        <pubDate>Wed, 12 Mar 2025 16:02:20 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/dc3472bf-459a-37e0-af85-e2048cc75d06</guid>
                                    <description><![CDATA[<p>We've just published a new rapid review on the safety and efficacy of physician and anaesthetic associates in the UK, which was commissioned to support the ongoing Leng review of these new roles in the NHS. Trish Greenhalgh, professor of primary care at the University of Oxford, joins us to discuss the data she found.</p>
<p>Habib Naqvi is director of the NHS Race and Health Observatory, and is holding up a mirror to the NHS on it's support for ethnic minority patients and doctors - he joins us to talk about the work they've done, and why Reform UK's manifesto pledge to disband the Observatory is a matter of pride. </p>
<p>Finally, our annual trip to the Nuffield Summit is not complete without a roundtable, this year we asked the question "What is stopping staff from speaking up?". Our panellists raised the usual issues of hierarchy and psychological safety, but also how the lack of positive change from senior leadership has habituated people into thinking "why bother".</p>
<p>Our panel;</p>
<p>Katie Bramall-Stainer, chair of the General Practice Committee of the BMA
Jugdeep Dhesi, consultant in geriatric medicine at Guys and St Thomas Hopsital
Henrietta Hughes, the UK's patient safety commissioner
Thea Stein, chief executive of the Nuffield Trust </p>
<p> </p>
<p>Reading list</p>
<p><a href='https://www.bmj.com/content/388/bmj-2025-084613'>Physician associates and anaesthetic associates in UK: rapid systematic review of recent UK based research</a></p>
<p><a href='https://www.bmj.com/content/388/bmj.r348'>Together we can challenge the racism that persists in healthcare</a></p>
<p> </p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>We've just published a new rapid review on the safety and efficacy of physician and anaesthetic associates in the UK, which was commissioned to support the ongoing Leng review of these new roles in the NHS. Trish Greenhalgh, professor of primary care at the University of Oxford, joins us to discuss the data she found.</p>
<p>Habib Naqvi is director of the NHS Race and Health Observatory, and is holding up a mirror to the NHS on it's support for ethnic minority patients and doctors - he joins us to talk about the work they've done, and why Reform UK's manifesto pledge to disband the Observatory is a matter of pride. </p>
<p>Finally, our annual trip to the Nuffield Summit is not complete without a roundtable, this year we asked the question "What is stopping staff from speaking up?". Our panellists raised the usual issues of hierarchy and psychological safety, but also how the lack of positive change from senior leadership has habituated people into thinking "why bother".</p>
<p>Our panel;</p>
<p>Katie Bramall-Stainer, chair of the General Practice Committee of the BMA<br>
Jugdeep Dhesi, consultant in geriatric medicine at Guys and St Thomas Hopsital<br>
Henrietta Hughes, the UK's patient safety commissioner<br>
Thea Stein, chief executive of the Nuffield Trust </p>
<p> </p>
<p>Reading list</p>
<p><a href='https://www.bmj.com/content/388/bmj-2025-084613'>Physician associates and anaesthetic associates in UK: rapid systematic review of recent UK based research</a></p>
<p><a href='https://www.bmj.com/content/388/bmj.r348'>Together we can challenge the racism that persists in healthcare</a></p>
<p> </p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gvsxzj4tsmyke9ue/med_sci_pod_12th_March_202567rlw.mp3" length="67746631" type="audio/mpeg"/>
        <itunes:summary><![CDATA[We've just published a new rapid review on the safety and efficacy of physician and anaesthetic associates in the UK, which was commissioned to support the ongoing Leng review of these new roles in the NHS. Trish Greenhalgh, professor of primary care at the University of Oxford, joins us to discuss the data she found.
Habib Naqvi is director of the NHS Race and Health Observatory, and is holding up a mirror to the NHS on it's support for ethnic minority patients and doctors - he joins us to talk about the work they've done, and why Reform UK's manifesto pledge to disband the Observatory is a matter of pride. 
Finally, our annual trip to the Nuffield Summit is not complete without a roundtable, this year we asked the question "What is stopping staff from speaking up?". Our panellists raised the usual issues of hierarchy and psychological safety, but also how the lack of positive change from senior leadership has habituated people into thinking "why bother".
Our panel;
Katie Bramall-Stainer, chair of the General Practice Committee of the BMAJugdeep Dhesi, consultant in geriatric medicine at Guys and St Thomas HopsitalHenrietta Hughes, the UK's patient safety commissionerThea Stein, chief executive of the Nuffield Trust 
 
Reading list
Physician associates and anaesthetic associates in UK: rapid systematic review of recent UK based research
Together we can challenge the racism that persists in healthcare
 
 ]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2822</itunes:duration>
                <itunes:episode>35</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Phil Banfield on the British Medical Association's plan to support doctors</title>
        <itunes:title>Phil Banfield on the British Medical Association's plan to support doctors</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/phil-banfield-on-the-british-medical-associations-plan-to-support-doctors/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/phil-banfield-on-the-british-medical-associations-plan-to-support-doctors/#comments</comments>        <pubDate>Wed, 05 Mar 2025 10:43:13 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/c0c6b4ae-0b51-362e-8c89-9684ee02f69f</guid>
                                    <description><![CDATA[<p>From pay restoration, to making sure there are enough training posts for resident doctors, the BMA has been busy.</p>
<p>In this podcast, Kamran Abbasi, the editor in chief of The BMJ, spoke to Phil Banfield, chair of the BMA’s council.</p>
<p> </p>
<p>They talk about the ongoing pay discussions, how the BMA is working with the new government - touching on both speciality training places, and the role of physician assistants.</p>
<p>The conversation also covers the BMA's changing strategy, which aims to empower local members to take on the fights they care about, and how the organisation is linking both their trade union and professional activities.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>From pay restoration, to making sure there are enough training posts for resident doctors, the BMA has been busy.</p>
<p>In this podcast, Kamran Abbasi, the editor in chief of The BMJ, spoke to Phil Banfield, chair of the BMA’s council.</p>
<p> </p>
<p>They talk about the ongoing pay discussions, how the BMA is working with the new government - touching on both speciality training places, and the role of physician assistants.</p>
<p>The conversation also covers the BMA's changing strategy, which aims to empower local members to take on the fights they care about, and how the organisation is linking both their trade union and professional activities.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qm2egwsuv6bedmyx/Phil_Banfield_on_the_British_Medical_Association_s_plan_to_support_doctorsaqeem.mp3" length="42331301" type="audio/mpeg"/>
        <itunes:summary><![CDATA[From pay restoration, to making sure there are enough training posts for resident doctors, the BMA has been busy.
In this podcast, Kamran Abbasi, the editor in chief of The BMJ, spoke to Phil Banfield, chair of the BMA’s council.
 
They talk about the ongoing pay discussions, how the BMA is working with the new government - touching on both speciality training places, and the role of physician assistants.
The conversation also covers the BMA's changing strategy, which aims to empower local members to take on the fights they care about, and how the organisation is linking both their trade union and professional activities.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1763</itunes:duration>
                <itunes:episode>34</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Combating disinformation, and time to stop spinal injections for chronic pain</title>
        <itunes:title>Combating disinformation, and time to stop spinal injections for chronic pain</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/combating-disinformation-and-racism-in-medicine/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/combating-disinformation-and-racism-in-medicine/#comments</comments>        <pubDate>Wed, 26 Feb 2025 10:42:32 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/177b413b-2fef-37a0-9b6d-460998a2b607</guid>
                                    <description><![CDATA[In this episode of the BMJ's Medicine and Science podcast, editor-in-chief Kamran Abbasi discusses the urgent need to tackle disinformation in health, especially in the context of the US, with Heidi Larson and Martin McKee from the London School of Hygiene and Tropical Medicine. 
 
We also hear from Jane Ballentyne, professor of anaesthesia and pain medicine at the University of Washington, about new guidelines that strongly recommend against the use of spinal injections for chronic pain - and why that recommendation might be hard for some patients and doctors to hear.
 
Finally, we revisit the progress made in addressing racism in UK medical schools over the past five years with Gareth Iacobucci, The BMJ's assistant news editor.
 
Running order
01:44 Defining Misinformation and Disinformation
04:08 Vaccines and Misinformation
05:38 Strategies to Combat Disinformation
10:04 Denialism and Its Implications
16:21 BMJ Rapid Recommendations on Spinal Injections
26:27 Racism in Medical Schools: An Update
 
Reading list
<a href='https://www.bmj.com/content/388/bmj.r179'>Spinal interventions for chronic back pain</a>
<a href='https://www.bmj.com/content/388/bmj.r312'>Racism in medical schools: are things improving?</a>]]></description>
                                                            <content:encoded><![CDATA[In this episode of the BMJ's Medicine and Science podcast, editor-in-chief Kamran Abbasi discusses the urgent need to tackle disinformation in health, especially in the context of the US, with Heidi Larson and Martin McKee from the London School of Hygiene and Tropical Medicine. 
 
We also hear from Jane Ballentyne, professor of anaesthesia and pain medicine at the University of Washington, about new guidelines that strongly recommend against the use of spinal injections for chronic pain - and why that recommendation might be hard for some patients and doctors to hear.
 
Finally, we revisit the progress made in addressing racism in UK medical schools over the past five years with Gareth Iacobucci, The BMJ's assistant news editor.
 
Running order
01:44 Defining Misinformation and Disinformation
04:08 Vaccines and Misinformation
05:38 Strategies to Combat Disinformation
10:04 Denialism and Its Implications
16:21 BMJ Rapid Recommendations on Spinal Injections
26:27 Racism in Medical Schools: An Update
 
Reading list
<a href='https://www.bmj.com/content/388/bmj.r179'>Spinal interventions for chronic back pain</a>
<a href='https://www.bmj.com/content/388/bmj.r312'>Racism in medical schools: are things improving?</a>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9pavd5ema4c4f2sb/med_and_sci_-_26th_Nov_2025b34uo.mp3" length="44905187" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode of the BMJ's Medicine and Science podcast, editor-in-chief Kamran Abbasi discusses the urgent need to tackle disinformation in health, especially in the context of the US, with Heidi Larson and Martin McKee from the London School of Hygiene and Tropical Medicine. 
 
We also hear from Jane Ballentyne, professor of anaesthesia and pain medicine at the University of Washington, about new guidelines that strongly recommend against the use of spinal injections for chronic pain - and why that recommendation might be hard for some patients and doctors to hear.
 
Finally, we revisit the progress made in addressing racism in UK medical schools over the past five years with Gareth Iacobucci, The BMJ's assistant news editor.
 
Running order
01:44 Defining Misinformation and Disinformation
04:08 Vaccines and Misinformation
05:38 Strategies to Combat Disinformation
10:04 Denialism and Its Implications
16:21 BMJ Rapid Recommendations on Spinal Injections
26:27 Racism in Medical Schools: An Update
 
Reading list
Spinal interventions for chronic back pain
Racism in medical schools: are things improving?]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1870</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Why compassion isn't just nice, it's essential</title>
        <itunes:title>Why compassion isn't just nice, it's essential</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/why-compassion-isnt-just-nice-its-essential/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/why-compassion-isnt-just-nice-its-essential/#comments</comments>        <pubDate>Fri, 21 Feb 2025 11:15:30 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/831a3d3b-f38f-3649-9930-1a0236a541fd</guid>
                                    <description><![CDATA[<p>Providing quality healthcare is demanding, often stressful, and requires sustained effort. When resources are stretched and pressure mounts, compassion can slip - but compassion is an essential tool for leaders, who need to support their teams to continue delivering the best possible care.</p>
<p> </p>
<p>In this final episode of The BMJ’s podcast series on quality of care, Rachael Hinton, BMJ Editor, speaks to three healthcare leaders. They discuss how fostering kind and compassionate leadership and care can improve morale, combat burnout, and contribute to better patient outcomes.</p>
<p> </p>
<p>01:48 Lydia Okutoyi talks compassionate leadership in Kenya</p>
<p>08:39 Pedro Delgado talks refocusing on the human factor and tools for kind leadership</p>
<p>15:02 Alexander Ansah Manu talks reaping quality of care benefits in Ghana</p>
<p> </p>
<p>This podcast was produced as part of the BMJ Collection on Quality of Care, developed in partnership with the World Health Organisation and the World Bank. Visit <a href='http://bmj.com/qualityofcare'>bmj.com/qualityofcare</a> to view the full Collection. The BMJ commissioned, edited, and published this podcast. This episode edited by Brian Kennedy.</p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Providing quality healthcare is demanding, often stressful, and requires sustained effort. When resources are stretched and pressure mounts, compassion can slip - but compassion is an essential tool for leaders, who need to support their teams to continue delivering the best possible care.</p>
<p> </p>
<p>In this final episode of The BMJ’s podcast series on quality of care, Rachael Hinton, BMJ Editor, speaks to three healthcare leaders. They discuss how fostering kind and compassionate leadership and care can improve morale, combat burnout, and contribute to better patient outcomes.</p>
<p> </p>
<p>01:48 Lydia Okutoyi talks compassionate leadership in Kenya</p>
<p>08:39 Pedro Delgado talks refocusing on the human factor and tools for kind leadership</p>
<p>15:02 Alexander Ansah Manu talks reaping quality of care benefits in Ghana</p>
<p> </p>
<p>This podcast was produced as part of the BMJ Collection on Quality of Care, developed in partnership with the World Health Organisation and the World Bank. Visit <a href='http://bmj.com/qualityofcare'>bmj.com/qualityofcare</a> to view the full Collection. The BMJ commissioned, edited, and published this podcast. This episode edited by Brian Kennedy.</p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gxztdmge8x49q33b/Quality_of_Care_3_Leadership_mixdown_LUFS.mp3" length="35059020" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Providing quality healthcare is demanding, often stressful, and requires sustained effort. When resources are stretched and pressure mounts, compassion can slip - but compassion is an essential tool for leaders, who need to support their teams to continue delivering the best possible care.
 
In this final episode of The BMJ’s podcast series on quality of care, Rachael Hinton, BMJ Editor, speaks to three healthcare leaders. They discuss how fostering kind and compassionate leadership and care can improve morale, combat burnout, and contribute to better patient outcomes.
 
01:48 Lydia Okutoyi talks compassionate leadership in Kenya
08:39 Pedro Delgado talks refocusing on the human factor and tools for kind leadership
15:02 Alexander Ansah Manu talks reaping quality of care benefits in Ghana
 
This podcast was produced as part of the BMJ Collection on Quality of Care, developed in partnership with the World Health Organisation and the World Bank. Visit bmj.com/qualityofcare to view the full Collection. The BMJ commissioned, edited, and published this podcast. This episode edited by Brian Kennedy.
 ]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1460</itunes:duration>
                <itunes:episode>33</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The industry playbook to combat public health, and FUTURE-AI</title>
        <itunes:title>The industry playbook to combat public health, and FUTURE-AI</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-industry-playbook-to-combat-public-health-and-future-ai/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-industry-playbook-to-combat-public-health-and-future-ai/#comments</comments>        <pubDate>Wed, 12 Feb 2025 10:00:00 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/13a38358-e13b-3c8c-b645-1c96fbfe90b3</guid>
                                    <description><![CDATA[<p>This week Rebecca Coombes is back with another big-food investigation, this time about fast-food giant MacDonalds subverting attempts to stop it opening stores near schools.</p>
<p>Sticking with industry behaving badly, May van Schalkwyk, from the University of Edinburgh, wonders why we haven't learn lessons from the attempts to control big tobacco companies, when it comes to other industries that harm health.</p>
<p>And finally, AI in healthcare - Karim Lekadir, from the University of Barcelona, explains new guidelines which can help evaluate which AI applications are trustworthy.</p>
<p> </p>
<p>Reading list</p>
<p><a href='https://www.bmj.com/content/388/bmj.r163'>McDonald’s triumphs over councils’ rejections of new branches</a></p>
<p><a href='https://www.bmj.com/content/388/bmj-2024-081554'>FUTURE-AI: international consensus guideline for trustworthy and deployable artificial intelligence in healthcare</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week Rebecca Coombes is back with another big-food investigation, this time about fast-food giant MacDonalds subverting attempts to stop it opening stores near schools.</p>
<p>Sticking with industry behaving badly, May van Schalkwyk, from the University of Edinburgh, wonders why we haven't learn lessons from the attempts to control big tobacco companies, when it comes to other industries that harm health.</p>
<p>And finally, AI in healthcare - Karim Lekadir, from the University of Barcelona, explains new guidelines which can help evaluate which AI applications are trustworthy.</p>
<p> </p>
<p>Reading list</p>
<p><a href='https://www.bmj.com/content/388/bmj.r163'>McDonald’s triumphs over councils’ rejections of new branches</a></p>
<p><a href='https://www.bmj.com/content/388/bmj-2024-081554'>FUTURE-AI: international consensus guideline for trustworthy and deployable artificial intelligence in healthcare</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vzmk8wishhitqevb/med_sci_pod_12th_feb_2025as2jf.mp3" length="49063444" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week Rebecca Coombes is back with another big-food investigation, this time about fast-food giant MacDonalds subverting attempts to stop it opening stores near schools.
Sticking with industry behaving badly, May van Schalkwyk, from the University of Edinburgh, wonders why we haven't learn lessons from the attempts to control big tobacco companies, when it comes to other industries that harm health.
And finally, AI in healthcare - Karim Lekadir, from the University of Barcelona, explains new guidelines which can help evaluate which AI applications are trustworthy.
 
Reading list
McDonald’s triumphs over councils’ rejections of new branches
FUTURE-AI: international consensus guideline for trustworthy and deployable artificial intelligence in healthcare]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2043</itunes:duration>
                <itunes:episode>32</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Prehabilitation before surgery, alcohol's impact on clinical care, and life after a cardiac arrest</title>
        <itunes:title>Prehabilitation before surgery, alcohol's impact on clinical care, and life after a cardiac arrest</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/prehabilitation-before-surgery-alcohols-impact-on-clinical-care-and-life-after-a-cardiac-arrest/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/prehabilitation-before-surgery-alcohols-impact-on-clinical-care-and-life-after-a-cardiac-arrest/#comments</comments>        <pubDate>Wed, 29 Jan 2025 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/4450767a-9ee5-302e-ab1b-f908a2314ea2</guid>
                                    <description><![CDATA[<p>Exercise and a better diet, prior to surgery, can improve outcomes. Daniel McIsaac, a professor of anaesthesiology from the University of Ottowa and lead author of that research, joins us to talk about getting those results into practice.</p>
<p>Julia Sinclair, professor of addiction psychiatry at the University of Southampton, explains how the NHS has lost sight of the impact alcohol consumption has on clinical care, and why we need a strategy to tackle it.</p>
<p>Finally, Matt Morgan, consultant in intensive care and BMJ columnist, has written another book - this time about patients who are revived after cardiac arrest, and the profound effect it can have on their outlook in life. </p>
<p> </p>
<p>Reading list:</p>
<p><a href='https://www.bmj.com/content/388/bmj-2024-081164'>Relative efficacy of prehabilitation interventions and their components</a></p>
<p><a href='https://www.bmj.com/content/388/bmj.r38'>UK needs national strategy to tackle alcohol related harms</a></p>
<p><a href='https://www.simonandschuster.co.uk/books/A-Second-Act/Matt-Morgan/9781398532335'>A Second Act</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Exercise and a better diet, prior to surgery, can improve outcomes. Daniel McIsaac, a professor of anaesthesiology from the University of Ottowa and lead author of that research, joins us to talk about getting those results into practice.</p>
<p>Julia Sinclair, professor of addiction psychiatry at the University of Southampton, explains how the NHS has lost sight of the impact alcohol consumption has on clinical care, and why we need a strategy to tackle it.</p>
<p>Finally, Matt Morgan, consultant in intensive care and BMJ columnist, has written another book - this time about patients who are revived after cardiac arrest, and the profound effect it can have on their outlook in life. </p>
<p> </p>
<p>Reading list:</p>
<p><a href='https://www.bmj.com/content/388/bmj-2024-081164'>Relative efficacy of prehabilitation interventions and their components</a></p>
<p><a href='https://www.bmj.com/content/388/bmj.r38'>UK needs national strategy to tackle alcohol related harms</a></p>
<p><a href='https://www.simonandschuster.co.uk/books/A-Second-Act/Matt-Morgan/9781398532335'>A Second Act</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ii82ttea7869v9qm/28_jan_assembly81q7q.mp3" length="58576927" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Exercise and a better diet, prior to surgery, can improve outcomes. Daniel McIsaac, a professor of anaesthesiology from the University of Ottowa and lead author of that research, joins us to talk about getting those results into practice.
Julia Sinclair, professor of addiction psychiatry at the University of Southampton, explains how the NHS has lost sight of the impact alcohol consumption has on clinical care, and why we need a strategy to tackle it.
Finally, Matt Morgan, consultant in intensive care and BMJ columnist, has written another book - this time about patients who are revived after cardiac arrest, and the profound effect it can have on their outlook in life. 
 
Reading list:
Relative efficacy of prehabilitation interventions and their components
UK needs national strategy to tackle alcohol related harms
A Second Act
 ]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2440</itunes:duration>
                <itunes:episode>31</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Can a deal be done to keep the US in the WHO?</title>
        <itunes:title>Can a deal be done to keep the US in the WHO?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/can-a-deal-be-done-to-keep-the-us-in-the-who/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/can-a-deal-be-done-to-keep-the-us-in-the-who/#comments</comments>        <pubDate>Fri, 24 Jan 2025 17:23:00 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/58e0176f-847a-3575-97e0-a8f2c08b31d2</guid>
                                    <description><![CDATA[<p>US President Donald Trump has signed an executive order to withdraw the US out of the WHO. This would cut funding for the UN’s medical agency by one-fifth.</p>
<p>Will they really exit, or can a deal be made? Lawrence Gostin hopes so, and as a professor of law at Georgetown, and director of the World Health Organisation Collaborating Center on National and Global Health Law, he is working with senior US and WHO officials to try and understand what reforms could be made to WHO what would allow a such a deal to be be struck.</p>
<p>Gostin also believes that the president cannot withdraw from the WHO with an executive order, but instead requires congressional approval - and is exploring the options for legal challenge to the move.</p>
<p> </p>
<p>00:00 Intro</p>
<p>01:01 US history with the WHO</p>
<p>03:31 Executive order</p>
<p>06:35 WHO’s relationship with China</p>
<p>11:14 Funding</p>
<p>12:47 Benefits to US from the WHO</p>
<p>18:05 H5N1 threat</p>
<p>19:43 World benefits from US involvement</p>
<p>21:57 A deal to be made?</p>
<p>24:55 Legal action?</p>
<p>26:37 Administration responses</p>
<p> </p>
<p>Read Professor Larry Gostin’s co-written opinion piece on the dangers of a US withdrawal from the WHO here: https://www.bmj.com/content/388/bmj.r116</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>US President Donald Trump has signed an executive order to withdraw the US out of the WHO. This would cut funding for the UN’s medical agency by one-fifth.</p>
<p>Will they really exit, or can a deal be made? Lawrence Gostin hopes so, and as a professor of law at Georgetown, and director of the World Health Organisation Collaborating Center on National and Global Health Law, he is working with senior US and WHO officials to try and understand what reforms could be made to WHO what would allow a such a deal to be be struck.</p>
<p>Gostin also believes that the president cannot withdraw from the WHO with an executive order, but instead requires congressional approval - and is exploring the options for legal challenge to the move.</p>
<p> </p>
<p>00:00 Intro</p>
<p>01:01 US history with the WHO</p>
<p>03:31 Executive order</p>
<p>06:35 WHO’s relationship with China</p>
<p>11:14 Funding</p>
<p>12:47 Benefits to US from the WHO</p>
<p>18:05 H5N1 threat</p>
<p>19:43 World benefits from US involvement</p>
<p>21:57 A deal to be made?</p>
<p>24:55 Legal action?</p>
<p>26:37 Administration responses</p>
<p> </p>
<p>Read Professor Larry Gostin’s co-written opinion piece on the dangers of a US withdrawal from the WHO here: https://www.bmj.com/content/388/bmj.r116</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/bxzmbhbaq8kjbdju/deal_to_keep_us_in_whoa7k15.mp3" length="42512069" type="audio/mpeg"/>
        <itunes:summary><![CDATA[US President Donald Trump has signed an executive order to withdraw the US out of the WHO. This would cut funding for the UN’s medical agency by one-fifth.
Will they really exit, or can a deal be made? Lawrence Gostin hopes so, and as a professor of law at Georgetown, and director of the World Health Organisation Collaborating Center on National and Global Health Law, he is working with senior US and WHO officials to try and understand what reforms could be made to WHO what would allow a such a deal to be be struck.
Gostin also believes that the president cannot withdraw from the WHO with an executive order, but instead requires congressional approval - and is exploring the options for legal challenge to the move.
 
00:00 Intro
01:01 US history with the WHO
03:31 Executive order
06:35 WHO’s relationship with China
11:14 Funding
12:47 Benefits to US from the WHO
18:05 H5N1 threat
19:43 World benefits from US involvement
21:57 A deal to be made?
24:55 Legal action?
26:37 Administration responses
 
Read Professor Larry Gostin’s co-written opinion piece on the dangers of a US withdrawal from the WHO here: https://www.bmj.com/content/388/bmj.r116]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1771</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Conviviality and TV doctors, polar bear tales, and Christmas research</title>
        <itunes:title>Conviviality and TV doctors, polar bear tales, and Christmas research</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/conviviality-and-tv-doctors-polar-bear-tales-and-christmas-research/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/conviviality-and-tv-doctors-polar-bear-tales-and-christmas-research/#comments</comments>        <pubDate>Mon, 30 Dec 2024 05:00:00 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/b7db6456-2953-3cef-8d15-932b832c6378</guid>
                                    <description><![CDATA[<p dir="ltr">In the last podcast of 2024, Richard Smith, former editor of The BMJ and head of<a href='https://ukhealthalliance.org/'> UKHACC</a> will be making the case for being more convivial. Tina Korownyk, professor of family medicine at the University of Alberta is the ghost of Christmas past for TV doctors.</p>
<p dir="ltr">Tim Feeny and Navjoyt Ladher take us through this year's Christmas research papers.</p>
<p dir="ltr">And finally, Mari Martensen, a paramedic, explains what makes being a medic in Svalbard bear-able.</p>
<p dir="ltr"> </p>
<p dir="ltr">Reading list.</p>
<ul>
<li dir="ltr"><a href='https://www.bmj.com/content/387/bmj.q2577'>The dangers of industrialisation—why we need to rebuild a convivial society</a></li>
<li dir="ltr"><a href='https://www.bmj.com/content/349/bmj.g7346'>Televised medical talk shows—what they recommend and the evidence to support their recommendations</a></li>
<li dir="ltr"><a href='https://www.bmj.com/content/387/bmj.q2417'>Christmas 2024: How to transport a polar bear, and other idiosyncrasies for Arctic emergency medical services</a></li>
<li dir="ltr"><a href='https://www.bmj.com/specialties/christmas'>The full Christmas archive</a></li>
</ul>
]]></description>
                                                            <content:encoded><![CDATA[<p dir="ltr">In the last podcast of 2024, Richard Smith, former editor of The BMJ and head of<a href='https://ukhealthalliance.org/'> UKHACC</a> will be making the case for being more convivial. Tina Korownyk, professor of family medicine at the University of Alberta is the ghost of Christmas past for TV doctors.</p>
<p dir="ltr">Tim Feeny and Navjoyt Ladher take us through this year's Christmas research papers.</p>
<p dir="ltr">And finally, Mari Martensen, a paramedic, explains what makes being a medic in Svalbard bear-able.</p>
<p dir="ltr"> </p>
<p dir="ltr">Reading list.</p>
<ul>
<li dir="ltr"><a href='https://www.bmj.com/content/387/bmj.q2577'>The dangers of industrialisation—why we need to rebuild a convivial society</a></li>
<li dir="ltr"><a href='https://www.bmj.com/content/349/bmj.g7346'>Televised medical talk shows—what they recommend and the evidence to support their recommendations</a></li>
<li dir="ltr"><a href='https://www.bmj.com/content/387/bmj.q2417'>Christmas 2024: How to transport a polar bear, and other idiosyncrasies for Arctic emergency medical services</a></li>
<li dir="ltr"><a href='https://www.bmj.com/specialties/christmas'>The full Christmas archive</a></li>
</ul>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/zybdif4ejugmn675/med_sci_281224.mp3" length="39469056" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In the last podcast of 2024, Richard Smith, former editor of The BMJ and head of UKHACC will be making the case for being more convivial. Tina Korownyk, professor of family medicine at the University of Alberta is the ghost of Christmas past for TV doctors.
Tim Feeny and Navjoyt Ladher take us through this year's Christmas research papers.
And finally, Mari Martensen, a paramedic, explains what makes being a medic in Svalbard bear-able.
 
Reading list.

The dangers of industrialisation—why we need to rebuild a convivial society
Televised medical talk shows—what they recommend and the evidence to support their recommendations
Christmas 2024: How to transport a polar bear, and other idiosyncrasies for Arctic emergency medical services
The full Christmas archive
]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2466</itunes:duration>
                <itunes:episode>29</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Big food infiltration of UK Schools, and chocolate consumption and diabetes</title>
        <itunes:title>Big food infiltration of UK Schools, and chocolate consumption and diabetes</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/bmj_161224/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/bmj_161224/#comments</comments>        <pubDate>Tue, 17 Dec 2024 13:58:56 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/6da6dd87-0348-323c-a9ee-076785408c30</guid>
                                    <description><![CDATA[<p>Conflicts of interest harm health, and a new investigation uncovers the infiltration of big food manufacturers into UK schools. Emma Wilkinson reports on that investigation. Kamran and  Rebecca Coombes, head of journalism, discuss moves to reduce industry's impact on food policy in the UK.</p>
<p>A new research paper has identified a link between eating chocolate and lower rates of diabetes. Binkai Liu, doctoral student and Qi Sun, associate professor, at the Harvard T.H. Chan School of Public Health explain what they found.</p>
<p>Finally, Sam Hutt is a doctor in the NHS, but is better known by his stage persona “Hank Wangford”. Hank performed a celebration of the NHS at Glastonbury this year, and has now released that song. He joins us to talk about what inspired him.</p>
<p> </p>
<p>Reading list</p>
<a href='https://www.bmj.com/content/387/bmj.q2661'>Food industry has infiltrated UK children’s education: stealth marketing exposed</a>
<a href='https://www.bmj.com/content/387/bmj-2023-078386'>Chocolate intake and risk of type 2 diabetes</a>
<p><a href='https://www.instagram.com/p/DCZlbf-OoxK/'>Hank Wangford</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Conflicts of interest harm health, and a new investigation uncovers the infiltration of big food manufacturers into UK schools. Emma Wilkinson reports on that investigation. Kamran and  Rebecca Coombes, head of journalism, discuss moves to reduce industry's impact on food policy in the UK.</p>
<p>A new research paper has identified a link between eating chocolate and lower rates of diabetes. Binkai Liu, doctoral student and Qi Sun, associate professor, at the Harvard T.H. Chan School of Public Health explain what they found.</p>
<p>Finally, Sam Hutt is a doctor in the NHS, but is better known by his stage persona “Hank Wangford”. Hank performed a celebration of the NHS at Glastonbury this year, and has now released that song. He joins us to talk about what inspired him.</p>
<p> </p>
<p>Reading list</p>
<a href='https://www.bmj.com/content/387/bmj.q2661'>Food industry has infiltrated UK children’s education: stealth marketing exposed</a>
<a href='https://www.bmj.com/content/387/bmj-2023-078386'>Chocolate intake and risk of type 2 diabetes</a>
<p><a href='https://www.instagram.com/p/DCZlbf-OoxK/'>Hank Wangford</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mj3ecy67jfku6hs7/bmj_161224.mp3" length="47454643" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Conflicts of interest harm health, and a new investigation uncovers the infiltration of big food manufacturers into UK schools. Emma Wilkinson reports on that investigation. Kamran and  Rebecca Coombes, head of journalism, discuss moves to reduce industry's impact on food policy in the UK.
A new research paper has identified a link between eating chocolate and lower rates of diabetes. Binkai Liu, doctoral student and Qi Sun, associate professor, at the Harvard T.H. Chan School of Public Health explain what they found.
Finally, Sam Hutt is a doctor in the NHS, but is better known by his stage persona “Hank Wangford”. Hank performed a celebration of the NHS at Glastonbury this year, and has now released that song. He joins us to talk about what inspired him.
 
Reading list
Food industry has infiltrated UK children’s education: stealth marketing exposed
Chocolate intake and risk of type 2 diabetes
Hank Wangford]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1976</itunes:duration>
                <itunes:episode>28</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>"Incredibly distressing and incredibly dangerous"- David Miliband on healthcare attacks, and staff turnover effect on patient outcomes</title>
        <itunes:title>"Incredibly distressing and incredibly dangerous"- David Miliband on healthcare attacks, and staff turnover effect on patient outcomes</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/incrediby-distresing-and-incredibly-dangerous-david-miliband-on-healthcare-attacks-and-staff-turnover-effect-on-patient-outcomes/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/incrediby-distresing-and-incredibly-dangerous-david-miliband-on-healthcare-attacks-and-staff-turnover-effect-on-patient-outcomes/#comments</comments>        <pubDate>Wed, 04 Dec 2024 11:11:35 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/8d5f4cc3-ee53-3470-8d5d-69cb89fd9a64</guid>
                                    <description><![CDATA[<p>In today’s episode, new research, which has looked at the impact staff turnover is having on patient outcomes. Giuseppe Moscelli, associate professor at the University of Surrey joins Navjoyt Ladher to explain more.</p>
<p> </p>
<p>Also, every year the BMJ has a Christmas appeal - and this year we have chosen the International Rescue Committee as our partner. To talk more about what they do, and to give us some insight into how geopolitics are affecting health we're joined David Milliband, president and chief executive officer of the International Rescue Committee, and former UK foreign secretary.</p>
<p> </p>
<p>Reading list;</p>
<p><a href='https://www.bmj.com/content/387/bmj-2024-079987'>Nurse and doctor turnover and patient outcomes in NHS acute trusts in England</a></p>
<p><a href='https://www.bmj.com/content/387/bmj.q2591'>The BMJ Appeal 2024-25: David Miliband on hospital attacks, Trump, and the International Rescue Committee in a “flammable world”</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In today’s episode, new research, which has looked at the impact staff turnover is having on patient outcomes. Giuseppe Moscelli, associate professor at the University of Surrey joins Navjoyt Ladher to explain more.</p>
<p> </p>
<p>Also, every year the BMJ has a Christmas appeal - and this year we have chosen the International Rescue Committee as our partner. To talk more about what they do, and to give us some insight into how geopolitics are affecting health we're joined David Milliband, president and chief executive officer of the International Rescue Committee, and former UK foreign secretary.</p>
<p> </p>
<p>Reading list;</p>
<p><a href='https://www.bmj.com/content/387/bmj-2024-079987'>Nurse and doctor turnover and patient outcomes in NHS acute trusts in England</a></p>
<p><a href='https://www.bmj.com/content/387/bmj.q2591'>The BMJ Appeal 2024-25: David Miliband on hospital attacks, Trump, and the International Rescue Committee in a “flammable world”</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/a8rz2w8zzb2au2fj/bmj_031224_david_miliband.mp3" length="31986432" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In today’s episode, new research, which has looked at the impact staff turnover is having on patient outcomes. Giuseppe Moscelli, associate professor at the University of Surrey joins Navjoyt Ladher to explain more.
 
Also, every year the BMJ has a Christmas appeal - and this year we have chosen the International Rescue Committee as our partner. To talk more about what they do, and to give us some insight into how geopolitics are affecting health we're joined David Milliband, president and chief executive officer of the International Rescue Committee, and former UK foreign secretary.
 
Reading list;
Nurse and doctor turnover and patient outcomes in NHS acute trusts in England
The BMJ Appeal 2024-25: David Miliband on hospital attacks, Trump, and the International Rescue Committee in a “flammable world”]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1999</itunes:duration>
                <itunes:episode>27</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>How MSF maintains neutrality in conflict zones</title>
        <itunes:title>How MSF maintains neutrality in conflict zones</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/how-msf-maintains-neutrality-in-conflict-zones/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/how-msf-maintains-neutrality-in-conflict-zones/#comments</comments>        <pubDate>Wed, 20 Nov 2024 05:00:00 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/201d3eaa-55c4-3991-ab17-bd539ac80e6b</guid>
                                    <description><![CDATA[<p>
This week we’re at the World Innovation Summit for Health, where we’re a media partner - the meeting is focussing on conflict, equity and resilience.  </p>
<p>In that vein, we’re joined by Christos Christou, international president of Médecins Sans Frontières (MSF) to talk about attacks on healthcare staff, and the difficulty and importance of maintaining neutrality in conflict zones.</p>
<p>Ara Darzi, surgeon, executive chair of the conference, and author of the recent NHS review, joins us to talk about  antimicrobial resistance, and how diagnostics and a small funding commitment could head off the problem.</p>
<p>And finally, we change our focus to the US, and hear about new research into adverse events during surgery with authors Antoine Duclos and David Bates from Harvard Medical School.</p>
<p> </p>
<p>Reading list.</p>
<p> </p>
<p><a href='https://www.bmj.com/content/387/bmj.q2491'>We need to do more to keep antibiotics working</a>
</p>
<p>WISH report - <a href='https://wish.org.qa/research-reports/?node_id=7178'>Tackling Antimicrobial Resistance: How to Keep Antibiotics Working for the Next Century</a></p>
<p><a href='https://www.bmj.com/content/387/bmj-2024-080480'>Safety of inpatient care in surgical settings: cohort study</a>
</p>
]]></description>
                                                            <content:encoded><![CDATA[<p><br>
This week we’re at the World Innovation Summit for Health, where we’re a media partner - the meeting is focussing on conflict, equity and resilience.  </p>
<p>In that vein, we’re joined by Christos Christou, international president of Médecins Sans Frontières (MSF) to talk about attacks on healthcare staff, and the difficulty and importance of maintaining neutrality in conflict zones.</p>
<p>Ara Darzi, surgeon, executive chair of the conference, and author of the recent NHS review, joins us to talk about  antimicrobial resistance, and how diagnostics and a small funding commitment could head off the problem.</p>
<p>And finally, we change our focus to the US, and hear about new research into adverse events during surgery with authors Antoine Duclos and David Bates from Harvard Medical School.</p>
<p> </p>
<p>Reading list.</p>
<p> </p>
<p><a href='https://www.bmj.com/content/387/bmj.q2491'>We need to do more to keep antibiotics working</a><br>
</p>
<p>WISH report - <a href='https://wish.org.qa/research-reports/?node_id=7178'>Tackling Antimicrobial Resistance: How to Keep Antibiotics Working for the Next Century</a></p>
<p><a href='https://www.bmj.com/content/387/bmj-2024-080480'>Safety of inpatient care in surgical settings: cohort study</a><br>
</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/cfhn3j9eex4p2n7k/BMJ_pod_1911249xw8w.mp3" length="46448077" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week we’re at the World Innovation Summit for Health, where we’re a media partner - the meeting is focussing on conflict, equity and resilience.  
In that vein, we’re joined by Christos Christou, international president of Médecins Sans Frontières (MSF) to talk about attacks on healthcare staff, and the difficulty and importance of maintaining neutrality in conflict zones.
Ara Darzi, surgeon, executive chair of the conference, and author of the recent NHS review, joins us to talk about  antimicrobial resistance, and how diagnostics and a small funding commitment could head off the problem.
And finally, we change our focus to the US, and hear about new research into adverse events during surgery with authors Antoine Duclos and David Bates from Harvard Medical School.
 
Reading list.
 
We need to do more to keep antibiotics working
WISH report - Tackling Antimicrobial Resistance: How to Keep Antibiotics Working for the Next Century
Safety of inpatient care in surgical settings: cohort study]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1934</itunes:duration>
                <itunes:episode>26</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Conflict zones, women’s health research, and reimagining palliative care</title>
        <itunes:title>Conflict zones, women’s health research, and reimagining palliative care</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/conflict-zones-women-s-health-research-and-reimagining-palliative-care/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/conflict-zones-women-s-health-research-and-reimagining-palliative-care/#comments</comments>        <pubDate>Sat, 02 Nov 2024 06:00:00 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/6f43bf61-56a6-3603-9fa8-b1be3061f6f6</guid>
                                    <description><![CDATA[<p>In this episode, we speak to the doctor overseeing the WHO’s emergency response for the eastern mediterranean region - including Gaza, Lebanon, Sudan and Yemen. Richard Brennan joins us to talk about protecting health services, and workers, in the escalating armed conflicts that are affecting the region.</p>
<p> Menaka Paranathala and Emma Rourke, from The BMJ, are on to talk about improving research into women’s health. A new UK project, MESSAGE, aims to give consideration to sex and gender in life science research.</p>
<p>Palliative care is not just for end-of-life, and rethinking how it’s integrated into every speciality is the key to improving care for patients, argue Richard Harding, Anna Peeler, and Oladayo Afolabi from the Cicely Saunders Institute.</p>
<p>Links</p>
<ul><li><a href='https://wish.org.qa/research-reports/?node_id=7165'>WISH report - Protecting Health in Armed Conflict</a></li>
<li><a href='https://www.messageproject.co.uk/'>MESSAGE (Medical Science Sex and Gender Equity) project</a></li>
<li><a href='https://www.bmj.com/content/387/bmj.q2387'>BMJ Opinion - Palliative care is an overlooked global health priority</a></li>
<li><a href='https://wish.org.qa/research-reports/?node_id=7166'>WISH report - Palliative Care</a></li>
</ul>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, we speak to the doctor overseeing the WHO’s emergency response for the eastern mediterranean region - including Gaza, Lebanon, Sudan and Yemen. Richard Brennan joins us to talk about protecting health services, and workers, in the escalating armed conflicts that are affecting the region.</p>
<p> Menaka Paranathala and Emma Rourke, from The BMJ, are on to talk about improving research into women’s health. A new UK project, MESSAGE, aims to give consideration to sex and gender in life science research.</p>
<p>Palliative care is not just for end-of-life, and rethinking how it’s integrated into every speciality is the key to improving care for patients, argue Richard Harding, Anna Peeler, and Oladayo Afolabi from the Cicely Saunders Institute.</p>
<p>Links</p>
<ul><li><a href='https://wish.org.qa/research-reports/?node_id=7165'>WISH report - Protecting Health in Armed Conflict</a></li>
<li><a href='https://www.messageproject.co.uk/'>MESSAGE (Medical Science Sex and Gender Equity) project</a></li>
<li><a href='https://www.bmj.com/content/387/bmj.q2387'>BMJ Opinion - Palliative care is an overlooked global health priority</a></li>
<li><a href='https://wish.org.qa/research-reports/?node_id=7166'>WISH report - Palliative Care</a></li>
</ul>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7xtf93q39v5yg7yk/bmj_311024_conflict_women_palliative.mp3" length="36192000" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, we speak to the doctor overseeing the WHO’s emergency response for the eastern mediterranean region - including Gaza, Lebanon, Sudan and Yemen. Richard Brennan joins us to talk about protecting health services, and workers, in the escalating armed conflicts that are affecting the region.
 Menaka Paranathala and Emma Rourke, from The BMJ, are on to talk about improving research into women’s health. A new UK project, MESSAGE, aims to give consideration to sex and gender in life science research.
Palliative care is not just for end-of-life, and rethinking how it’s integrated into every speciality is the key to improving care for patients, argue Richard Harding, Anna Peeler, and Oladayo Afolabi from the Cicely Saunders Institute.
Links
WISH report - Protecting Health in Armed Conflict
MESSAGE (Medical Science Sex and Gender Equity) project
BMJ Opinion - Palliative care is an overlooked global health priority
WISH report - Palliative Care
]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2261</itunes:duration>
                <itunes:episode>25</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Climate leadership - knowledge is power</title>
        <itunes:title>Climate leadership - knowledge is power</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/climate-leadership-knowledge-is-power/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/climate-leadership-knowledge-is-power/#comments</comments>        <pubDate>Sat, 19 Oct 2024 08:00:00 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/78dc2de5-21a1-3b07-a26f-441c50553ea1</guid>
                                    <description><![CDATA[<p>It’s an often cited statistic that if healthcare was a country, it would be the fifth largest carbon emitter. At The BMJ we want to change that, and move healthcare towards a more sustainable future. </p>
<p>In this week’s episode, we’ll hear about our annual climate edition from two of The BMJ’s editors, Sophie Cook and Juliet Dobson. </p>
<p>We’ll be diving into Cli-Fi and asking how climate fiction can galvanise our collective response to climate change. Our panel includes Howard Frumkin, professor emeritus at University of Washington. Lakshmi Krishnan, internist and Director of Medical Humanities at Georgetown university, and Sarah Grossman, journalist and author of Fire So Wild.</p>
<p>And Finally, Tereza Kasaeva, director of the WHO’s Global Tuberculosis Programme, explains how migration and food insecurity, exacerbated by climate change, are affecting TB - and why, despite effective treatment, there are still over a million deaths from the disease annually. </p>
<p> </p>
<p>Our panel's cli-fi book recommendations</p>
<ul><li><a href='https://www.goodreads.com/book/show/176823311-a-fire-so-wild?from_search=true&amp;from_srp=true&amp;qid=W0Gh2aRlqZ&amp;rank=1'>A Fire So Wild</a> - Sarah Grossman</li>
<li><a href='https://www.goodreads.com/book/show/143979888-the-last-man-by-mary-w-shelly-volume-v-1-1833-leather-bound?from_search=true&amp;from_srp=true&amp;qid=N2DBv3UsBR&amp;rank=3'>The Last Man</a> - Mary W. Shelly</li>
<li><a href='https://www.goodreads.com/book/show/19161852-the-fifth-season?from_search=true&amp;from_srp=true&amp;qid=bvoJCnbqpk&amp;rank=1'>The Broken Earth</a>  - NK Jemisin</li>
<li><a href='https://www.goodreads.com/book/show/46756.Oryx_and_Crake?ref=nav_sb_ss_1_6'>Oryx and Crake</a> - Margaret Attwood</li>
<li><a href='https://www.goodreads.com/book/show/50998056-the-ministry-for-the-future?from_search=true&amp;from_srp=true&amp;qid=3K6I4Fvb1b&amp;rank=1'>The Ministry for the Future</a> - Kim Stanley Robinson</li>
<li><a href='https://www.goodreads.com/book/show/57693171-olga-dies-dreaming?from_search=true&amp;from_srp=true&amp;qid=XccI9X0jtw&amp;rank=1'>Olga Dies Dreaming</a> - Xóchitl González</li>
<li><a href='https://www.goodreads.com/book/show/101673225-land-of-milk-and-honey?ref=nav_sb_ss_1_22'>Land of Milk and Honey</a> - C Pam Zhang</li>
<li><a href='https://www.goodreads.com/book/show/530965.The_Day_of_the_Triffids'>Day of the Triffids</a> - John Wyndham </li>
</ul>
<p> </p>
<p>Links</p>
<ul><li><a href='https://www.bmj.com/content/387/8444'>The BMJ’s annual climate issue</a></li>
<li><a href='https://www.bmj.com/content/387/bmj.q1734'>Cli-Fi—helping us manage a crisis</a></li>
<li><a href='https://www.bmj.com/content/387/bmj.q1825'>Writing towards a healthier future amid climate disaster</a></li>
<li><a href='https://wish.org.qa/research-reports/?node_id=7163'>WISH report - Tuberculosis</a></li>
</ul>
<p> </p>
<p>Lakshmi’s references</p>
<ul><li style="font-weight:400;"><a href='https://store.aamc.org/the-fundamental-role-of-the-arts-and-humanities-in-medical-education.html'>Fundamental Role of Arts and Humanities in Medical Education</a> </li>
<li style="font-weight:400;"><a href='https://mh.bmj.com/content/48/3/325'>Capable of being in uncertainties’: applied medical humanities in undergraduate medical education</a></li>
<li style="font-weight:400;"><a href='https://pmc.ncbi.nlm.nih.gov/articles/PMC3031316/'>The introduction of medical humanities in the undergraduate curriculum of Greek medical schools: challenge and necessity</a></li>
<li style="font-weight:400;"><a href='https://bmcmededuc.biomedcentral.com/articles/10.1186/s12909-023-04564-y'>The medical humanities at United States medical schools</a></li>
</ul>
]]></description>
                                                            <content:encoded><![CDATA[<p>It’s an often cited statistic that if healthcare was a country, it would be the fifth largest carbon emitter. At The BMJ we want to change that, and move healthcare towards a more sustainable future. </p>
<p>In this week’s episode, we’ll hear about our annual climate edition from two of The BMJ’s editors, Sophie Cook and Juliet Dobson. </p>
<p>We’ll be diving into Cli-Fi and asking how climate fiction can galvanise our collective response to climate change. Our panel includes Howard Frumkin, professor emeritus at University of Washington. Lakshmi Krishnan, internist and Director of Medical Humanities at Georgetown university, and Sarah Grossman, journalist and author of Fire So Wild.</p>
<p>And Finally, Tereza Kasaeva, director of the WHO’s Global Tuberculosis Programme, explains how migration and food insecurity, exacerbated by climate change, are affecting TB - and why, despite effective treatment, there are still over a million deaths from the disease annually. </p>
<p> </p>
<p>Our panel's cli-fi book recommendations</p>
<ul><li><a href='https://www.goodreads.com/book/show/176823311-a-fire-so-wild?from_search=true&amp;from_srp=true&amp;qid=W0Gh2aRlqZ&amp;rank=1'>A Fire So Wild</a> - Sarah Grossman</li>
<li><a href='https://www.goodreads.com/book/show/143979888-the-last-man-by-mary-w-shelly-volume-v-1-1833-leather-bound?from_search=true&amp;from_srp=true&amp;qid=N2DBv3UsBR&amp;rank=3'>The Last Man</a> - Mary W. Shelly</li>
<li><a href='https://www.goodreads.com/book/show/19161852-the-fifth-season?from_search=true&amp;from_srp=true&amp;qid=bvoJCnbqpk&amp;rank=1'>The Broken Earth</a>  - NK Jemisin</li>
<li><a href='https://www.goodreads.com/book/show/46756.Oryx_and_Crake?ref=nav_sb_ss_1_6'>Oryx and Crake</a> - Margaret Attwood</li>
<li><a href='https://www.goodreads.com/book/show/50998056-the-ministry-for-the-future?from_search=true&amp;from_srp=true&amp;qid=3K6I4Fvb1b&amp;rank=1'>The Ministry for the Future</a> - Kim Stanley Robinson</li>
<li><a href='https://www.goodreads.com/book/show/57693171-olga-dies-dreaming?from_search=true&amp;from_srp=true&amp;qid=XccI9X0jtw&amp;rank=1'>Olga Dies Dreaming</a> - Xóchitl González</li>
<li><a href='https://www.goodreads.com/book/show/101673225-land-of-milk-and-honey?ref=nav_sb_ss_1_22'>Land of Milk and Honey</a> - C Pam Zhang</li>
<li><a href='https://www.goodreads.com/book/show/530965.The_Day_of_the_Triffids'>Day of the Triffids</a> - John Wyndham </li>
</ul>
<p> </p>
<p>Links</p>
<ul><li><a href='https://www.bmj.com/content/387/8444'>The BMJ’s annual climate issue</a></li>
<li><a href='https://www.bmj.com/content/387/bmj.q1734'>Cli-Fi—helping us manage a crisis</a></li>
<li><a href='https://www.bmj.com/content/387/bmj.q1825'>Writing towards a healthier future amid climate disaster</a></li>
<li><a href='https://wish.org.qa/research-reports/?node_id=7163'>WISH report - Tuberculosis</a></li>
</ul>
<p> </p>
<p>Lakshmi’s references</p>
<ul><li style="font-weight:400;"><a href='https://store.aamc.org/the-fundamental-role-of-the-arts-and-humanities-in-medical-education.html'>Fundamental Role of Arts and Humanities in Medical Education</a> </li>
<li style="font-weight:400;"><a href='https://mh.bmj.com/content/48/3/325'>Capable of being in uncertainties’: applied medical humanities in undergraduate medical education</a></li>
<li style="font-weight:400;"><a href='https://pmc.ncbi.nlm.nih.gov/articles/PMC3031316/'>The introduction of medical humanities in the undergraduate curriculum of Greek medical schools: challenge and necessity</a></li>
<li style="font-weight:400;"><a href='https://bmcmededuc.biomedcentral.com/articles/10.1186/s12909-023-04564-y'>The medical humanities at United States medical schools</a></li>
</ul>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5a7g3c5am4uiwgyn/bmj_181024_climate_issue.mp3" length="39494400" type="audio/mpeg"/>
        <itunes:summary><![CDATA[It’s an often cited statistic that if healthcare was a country, it would be the fifth largest carbon emitter. At The BMJ we want to change that, and move healthcare towards a more sustainable future. 
In this week’s episode, we’ll hear about our annual climate edition from two of The BMJ’s editors, Sophie Cook and Juliet Dobson. 
We’ll be diving into Cli-Fi and asking how climate fiction can galvanise our collective response to climate change. Our panel includes Howard Frumkin, professor emeritus at University of Washington. Lakshmi Krishnan, internist and Director of Medical Humanities at Georgetown university, and Sarah Grossman, journalist and author of Fire So Wild.
And Finally, Tereza Kasaeva, director of the WHO’s Global Tuberculosis Programme, explains how migration and food insecurity, exacerbated by climate change, are affecting TB - and why, despite effective treatment, there are still over a million deaths from the disease annually. 
 
Our panel's cli-fi book recommendations
A Fire So Wild - Sarah Grossman
The Last Man - Mary W. Shelly
The Broken Earth  - NK Jemisin
Oryx and Crake - Margaret Attwood
The Ministry for the Future - Kim Stanley Robinson
Olga Dies Dreaming - Xóchitl González
Land of Milk and Honey - C Pam Zhang
Day of the Triffids - John Wyndham 
 
Links
The BMJ’s annual climate issue
Cli-Fi—helping us manage a crisis
Writing towards a healthier future amid climate disaster
WISH report - Tuberculosis
 
Lakshmi’s references
Fundamental Role of Arts and Humanities in Medical Education 
Capable of being in uncertainties’: applied medical humanities in undergraduate medical education
The introduction of medical humanities in the undergraduate curriculum of Greek medical schools: challenge and necessity
The medical humanities at United States medical schools
]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2468</itunes:duration>
                <itunes:episode>23</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Getting science into policy for gun control and NHS reform</title>
        <itunes:title>Getting science into policy for gun control and NHS reform</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/getting-science-into-policy-for-gun-control-and-nhs-reform/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/getting-science-into-policy-for-gun-control-and-nhs-reform/#comments</comments>        <pubDate>Sat, 12 Oct 2024 16:00:08 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/d53c9bca-bc1d-3d1f-9072-e275cd72680c</guid>
                                    <description><![CDATA[<p>How science can be transformed into policy?</p>
<p>One of the seemingly intractable issues when it comes to legislative change in the US is gun control.  One reason policy change is so difficult, is the US specific evidence vacuum, but that’s beginning to change. </p>
<p>We're joined by Louis Klarevas, an academic at the University of Colombia and author of the book “Rampage Nation, securing america from gun violence" and Shannon Watts, from Moms Demand Action which is a grassroots movement of Americans fighting for public safety measures that can protect people from gun violence.</p>
<p> </p>
<p>Even when there is evidence, the trade-offs needed for legislative change can still paralyse policy makers. Citizen assemblies, a form of democratic participation that asks the public for their views, has helped clarify some key healthcare issues, from assisted dying in Jersey, to abortion access in Ireland.</p>
<p>Rebecca McKee from the Institute of Government argues they could be used to fix the NHS, and joins us to explain how.</p>
<p> </p>
<p>Reading list</p>
<p><a href='https://www.bmj.com/content/386/bmj.q1984'>More gun regulation, less firearm harm</a>
</p>
<p><a href='https://www.bmj.com/content/386/bmj.q1886'>Citizens’ assemblies, health, and health policy</a></p>
<p> </p>
<p> </p>
<p> </p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>How science can be transformed into policy?</p>
<p>One of the seemingly intractable issues when it comes to legislative change in the US is gun control.  One reason policy change is so difficult, is the US specific evidence vacuum, but that’s beginning to change. </p>
<p>We're joined by Louis Klarevas, an academic at the University of Colombia and author of the book “Rampage Nation, securing america from gun violence" and Shannon Watts, from Moms Demand Action which is a grassroots movement of Americans fighting for public safety measures that can protect people from gun violence.</p>
<p> </p>
<p>Even when there is evidence, the trade-offs needed for legislative change can still paralyse policy makers. Citizen assemblies, a form of democratic participation that asks the public for their views, has helped clarify some key healthcare issues, from assisted dying in Jersey, to abortion access in Ireland.</p>
<p>Rebecca McKee from the Institute of Government argues they could be used to fix the NHS, and joins us to explain how.</p>
<p> </p>
<p>Reading list</p>
<p><a href='https://www.bmj.com/content/386/bmj.q1984'>More gun regulation, less firearm harm</a><br>
</p>
<p><a href='https://www.bmj.com/content/386/bmj.q1886'>Citizens’ assemblies, health, and health policy</a></p>
<p> </p>
<p> </p>
<p> </p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xxneu3jgtq2frztd/podcast_12th_october_89sr4.mp3" length="31107450" type="audio/mpeg"/>
        <itunes:summary><![CDATA[How science can be transformed into policy?
One of the seemingly intractable issues when it comes to legislative change in the US is gun control.  One reason policy change is so difficult, is the US specific evidence vacuum, but that’s beginning to change. 
We're joined by Louis Klarevas, an academic at the University of Colombia and author of the book “Rampage Nation, securing america from gun violence" and Shannon Watts, from Moms Demand Action which is a grassroots movement of Americans fighting for public safety measures that can protect people from gun violence.
 
Even when there is evidence, the trade-offs needed for legislative change can still paralyse policy makers. Citizen assemblies, a form of democratic participation that asks the public for their views, has helped clarify some key healthcare issues, from assisted dying in Jersey, to abortion access in Ireland.
Rebecca McKee from the Institute of Government argues they could be used to fix the NHS, and joins us to explain how.
 
Reading list
More gun regulation, less firearm harm
Citizens’ assemblies, health, and health policy
 
 
 
 ]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1294</itunes:duration>
                <itunes:episode>22</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Nutrition for health and conflicts of interests</title>
        <itunes:title>Nutrition for health and conflicts of interests</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/nutrition-for-health-and-conflicts-of-interests/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/nutrition-for-health-and-conflicts-of-interests/#comments</comments>        <pubDate>Fri, 27 Sep 2024 17:46:26 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/3dd19ea9-10b3-3781-aea1-312c3784001d</guid>
                                    <description><![CDATA[<p>Under-nutrition harms health, but so does over-nutrition. </p>
<p>The Bill and Melinda Gate’s foundation has just released their Goalkeepers' report - highlighting the detrimental impact that poor nutrition is having on children’s health.  Rasa Izadnegahdar, director of Maternal, Newborn, Child Nutrition &amp; Health at the foundation joins us to explain how they are targeting nutritional interventions.</p>
<p>Also this week, a new investigation in The BMJ has found that the UK government’s  Scientific Advisory Committee on Nutrition - the people who help guide the UK’s nutrition policy - have competing interests with the food industry. We hear from Chris van Tulleken, University College London; Rob Percival, the Soil Association; and Alison Tedstone, chair of the Association for Nutrition.</p>
<p> </p>
<p>Reading list:</p>
<p><a href='https://www.gatesfoundation.org/goalkeepers/report/2024-report/'>Goalkeepers Report 2024</a></p>
<p><a href='https://www.bmj.com/content/386/bmj.q1909'>UK government’s nutrition advisers are paid by world’s largest food companies, BMJ analysis reveals</a></p>
<p> </p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Under-nutrition harms health, but so does over-nutrition. </p>
<p>The Bill and Melinda Gate’s foundation has just released their Goalkeepers' report - highlighting the detrimental impact that poor nutrition is having on children’s health.  Rasa Izadnegahdar, director of Maternal, Newborn, Child Nutrition &amp; Health at the foundation joins us to explain how they are targeting nutritional interventions.</p>
<p>Also this week, a new investigation in <em>The BMJ </em>has found that the UK government’s  Scientific Advisory Committee on Nutrition - the people who help guide the UK’s nutrition policy - have competing interests with the food industry. We hear from Chris van Tulleken, University College London; Rob Percival, the Soil Association; and Alison Tedstone, chair of the Association for Nutrition.</p>
<p> </p>
<p>Reading list:</p>
<p><a href='https://www.gatesfoundation.org/goalkeepers/report/2024-report/'>Goalkeepers Report 2024</a></p>
<p><a href='https://www.bmj.com/content/386/bmj.q1909'>UK government’s nutrition advisers are paid by world’s largest food companies, BMJ analysis reveals</a></p>
<p> </p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9ekkn4qjwmvmqpk7/Untitled_Session_1_mixdown67gge.mp3" length="31428643" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Under-nutrition harms health, but so does over-nutrition. 
The Bill and Melinda Gate’s foundation has just released their Goalkeepers' report - highlighting the detrimental impact that poor nutrition is having on children’s health.  Rasa Izadnegahdar, director of Maternal, Newborn, Child Nutrition &amp; Health at the foundation joins us to explain how they are targeting nutritional interventions.
Also this week, a new investigation in The BMJ has found that the UK government’s  Scientific Advisory Committee on Nutrition - the people who help guide the UK’s nutrition policy - have competing interests with the food industry. We hear from Chris van Tulleken, University College London; Rob Percival, the Soil Association; and Alison Tedstone, chair of the Association for Nutrition.
 
Reading list:
Goalkeepers Report 2024
UK government’s nutrition advisers are paid by world’s largest food companies, BMJ analysis reveals
 
 ]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1309</itunes:duration>
                <itunes:episode>21</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Improving data for quality care when resources are stretched</title>
        <itunes:title>Improving data for quality care when resources are stretched</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/improving-data-for-quality-care-when-resources-are-stretched/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/improving-data-for-quality-care-when-resources-are-stretched/#comments</comments>        <pubDate>Tue, 17 Sep 2024 00:01:00 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/23eded81-9f61-3346-904a-40fe9b11602c</guid>
                                    <description><![CDATA[
There's a real drive to strengthen quality of care in facilities around the world. However, no matter where you are, improving healthcare depends on quality data—and collecting and using that data can be challenging without the time and expertise. In this podcast, we explore how different healthcare systems, especially those with limited resources, are tackling the challenge of data collection and use head-on.
 
The BMJ has partnered with the World Health Organization and the World Bank on a <a href='https://www.bmj.com/qualityofcare'>Collection on Quality of Care</a>. This podcast, the second in a series exploring themes from the Collection, features researchers and implementers from Ghana, Qatar, and the US. They share insights on improving and using data in resource-constrained environments, offering valuable perspectives relevant to healthcare systems worldwide facing similar challenges.

 
Provenance statement:
This podcast is part of a<a href='https://www.bmj.com/qualityofcare'> Collection on Quality of Care</a> proposed and funded by the World Health Organization and the World Bank. The BMJ commissioned, edited, and published the podcast. Emma Veitch, Rachael Hinton and Duncan Jarvis were the lead editors for The BMJ.]]></description>
                                                            <content:encoded><![CDATA[
There's a real drive to strengthen quality of care in facilities around the world. However, no matter where you are, improving healthcare depends on quality data—and collecting and using that data can be challenging without the time and expertise. In this podcast, we explore how different healthcare systems, especially those with limited resources, are tackling the challenge of data collection and use head-on.
 
The BMJ has partnered with the World Health Organization and the World Bank on a <a href='https://www.bmj.com/qualityofcare'>Collection on Quality of Care</a>. This podcast, the second in a series exploring themes from the Collection, features researchers and implementers from Ghana, Qatar, and the US. They share insights on improving and using data in resource-constrained environments, offering valuable perspectives relevant to healthcare systems worldwide facing similar challenges.

 
Provenance statement:
This podcast is part of a<a href='https://www.bmj.com/qualityofcare'> Collection on Quality of Care</a> proposed and funded by the World Health Organization and the World Bank. The BMJ commissioned, edited, and published the podcast. Emma Veitch, Rachael Hinton and Duncan Jarvis were the lead editors for The BMJ.]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xcvmrecawjm6swyt/QoC_ep2_Final798hw.mp3" length="33097036" type="audio/mpeg"/>
        <itunes:summary><![CDATA[
There's a real drive to strengthen quality of care in facilities around the world. However, no matter where you are, improving healthcare depends on quality data—and collecting and using that data can be challenging without the time and expertise. In this podcast, we explore how different healthcare systems, especially those with limited resources, are tackling the challenge of data collection and use head-on.
 
The BMJ has partnered with the World Health Organization and the World Bank on a Collection on Quality of Care. This podcast, the second in a series exploring themes from the Collection, features researchers and implementers from Ghana, Qatar, and the US. They share insights on improving and using data in resource-constrained environments, offering valuable perspectives relevant to healthcare systems worldwide facing similar challenges.

 
Provenance statement:
This podcast is part of a Collection on Quality of Care proposed and funded by the World Health Organization and the World Bank. The BMJ commissioned, edited, and published the podcast. Emma Veitch, Rachael Hinton and Duncan Jarvis were the lead editors for The BMJ.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1378</itunes:duration>
                <itunes:episode>20</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>GPs' industrial action, and the olympians after the games</title>
        <itunes:title>GPs' industrial action, and the olympians after the games</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/gps-industrial-action-and-the-olympians-after-the-games/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/gps-industrial-action-and-the-olympians-after-the-games/#comments</comments>        <pubDate>Mon, 09 Sep 2024 15:09:00 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/e2b72ff0-be1b-36ac-ba0a-200bc769d7a8</guid>
                                    <description><![CDATA[<p>The news that GPs in England have voted for industrial action has spooked the healthcare system - Katie Bramall-Stainer, the chair of the BMA's General Practice Committee explains what's lead to this, and why trust in the government has gone.</p>
<p>After the games, olympians and paralympians return to their normal lives - but what does that mean for their healthcare, especially in the US where insurance is expensive? Jonathan Finnoff, chief medical officer for the US Olympic and Paralympic committee joins us to explain how athletes are supported outside the games.</p>
<p> </p>
<p>Reading list;</p>
<p><a href='https://www.bmj.com/content/386/bmj.q1794'>GP leader: “If general practice is the bedrock of the NHS, then the NHS is collapsing”</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The news that GPs in England have voted for industrial action has spooked the healthcare system - Katie Bramall-Stainer, the chair of the BMA's General Practice Committee explains what's lead to this, and why trust in the government has gone.</p>
<p>After the games, olympians and paralympians return to their normal lives - but what does that mean for their healthcare, especially in the US where insurance is expensive? Jonathan Finnoff, chief medical officer for the US Olympic and Paralympic committee joins us to explain how athletes are supported outside the games.</p>
<p> </p>
<p>Reading list;</p>
<p><a href='https://www.bmj.com/content/386/bmj.q1794'>GP leader: “If general practice is the bedrock of the NHS, then the NHS is collapsing”</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/pak83kpd9xy5wd8h/BMJ_podcast_-_primary_care_industrial_action_and_athletes_health_after_the_games6r713.mp3" length="41474670" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The news that GPs in England have voted for industrial action has spooked the healthcare system - Katie Bramall-Stainer, the chair of the BMA's General Practice Committee explains what's lead to this, and why trust in the government has gone.
After the games, olympians and paralympians return to their normal lives - but what does that mean for their healthcare, especially in the US where insurance is expensive? Jonathan Finnoff, chief medical officer for the US Olympic and Paralympic committee joins us to explain how athletes are supported outside the games.
 
Reading list;
GP leader: “If general practice is the bedrock of the NHS, then the NHS is collapsing”
 ]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1727</itunes:duration>
                <itunes:episode>19</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Multi-cancer detection and NHS HIT Lists</title>
        <itunes:title>Multi-cancer detection and NHS HIT Lists</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/multi-cancer-detection-and-nhs-hit-lists/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/multi-cancer-detection-and-nhs-hit-lists/#comments</comments>        <pubDate>Wed, 14 Aug 2024 17:23:47 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/1911c0b3-9f8f-3a9e-8964-858d97c74a5f</guid>
                                    <description><![CDATA[<p>This week we're questioning the effectiveness of the Galleri Test for early cancer detection with investigation authors Margaret McCartney and Deborah Cohen. They delve into the decision-making and politics behind this test's introduction in the UK.</p>
<p>The episode also covers the growing NHS waiting list crisis and how Imran Ahmed and his team at Guy's and St. Thomas' NHS Trust are using high intensity theatre (HIT) lists to increase surgical throughput - and what other teams need to know, if a national rollout of this model is to happen.</p>
<p>Reading list</p>
<p><a href='https://www.bmj.com/content/386/bmj.q1706'>Galleri promises to detect multiple cancers—but new evidence casts doubt on this much hyped blood test</a></p>
<p><a href='https://www.bmj.com/content/386/bmj.q1621'>Are surgical HIT lists the answer to bringing down NHS waiting times?</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week we're questioning the effectiveness of the Galleri Test for early cancer detection with investigation authors Margaret McCartney and Deborah Cohen. They delve into the decision-making and politics behind this test's introduction in the UK.</p>
<p>The episode also covers the growing NHS waiting list crisis and how Imran Ahmed and his team at Guy's and St. Thomas' NHS Trust are using high intensity theatre (HIT) lists to increase surgical throughput - and what other teams need to know, if a national rollout of this model is to happen.</p>
<p>Reading list</p>
<p><a href='https://www.bmj.com/content/386/bmj.q1706'>Galleri promises to detect multiple cancers—but new evidence casts doubt on this much hyped blood test</a></p>
<p><a href='https://www.bmj.com/content/386/bmj.q1621'>Are surgical HIT lists the answer to bringing down NHS waiting times?</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/49zfybun47catjf3/the_Galleri_test_and_HIT_lists_mixdownbl5ej.mp3" length="37068242" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week we're questioning the effectiveness of the Galleri Test for early cancer detection with investigation authors Margaret McCartney and Deborah Cohen. They delve into the decision-making and politics behind this test's introduction in the UK.
The episode also covers the growing NHS waiting list crisis and how Imran Ahmed and his team at Guy's and St. Thomas' NHS Trust are using high intensity theatre (HIT) lists to increase surgical throughput - and what other teams need to know, if a national rollout of this model is to happen.
Reading list
Galleri promises to detect multiple cancers—but new evidence casts doubt on this much hyped blood test
Are surgical HIT lists the answer to bringing down NHS waiting times?]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1543</itunes:duration>
                <itunes:episode>18</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Ensuring an Olympic legacy, and fixing primary care</title>
        <itunes:title>Ensuring an Olympic legacy, and fixing primary care</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/ensuring-an-olympic-legacy/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/ensuring-an-olympic-legacy/#comments</comments>        <pubDate>Fri, 26 Jul 2024 23:55:00 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/895b1359-4498-3ba6-a22d-68f4fcc6e238</guid>
                                    <description><![CDATA[<p>The Paris games have just started - and France has made a concerted effort to ensure that this year's Olympics will have a legacy of physical activity for the whole population.</p>
<p>However, mega sporting events don't always have that effect, and Fiona Bull, head of physical activity for the WHO, joins us to explain why it's increasingly important that they do.</p>
<p>We'll also hear from Professor Sir Denis Perera Gray about how a lifetime of general practice, and why continuity needs to be at the heart of any improvement to primary care.</p>
<p>Finally, Harry Brunjes went from being a village GP to the chair of English National Opera, and explains what the two careers have in common.</p>
<p> </p>
<p>Reading list</p>
<p><a href='https://www.bmj.com/content/386/bmj.q1414'>Olympic Games: linking sports mega events to population physical activity</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The Paris games have just started - and France has made a concerted effort to ensure that this year's Olympics will have a legacy of physical activity for the whole population.</p>
<p>However, mega sporting events don't always have that effect, and Fiona Bull, head of physical activity for the WHO, joins us to explain why it's increasingly important that they do.</p>
<p>We'll also hear from Professor Sir Denis Perera Gray about how a lifetime of general practice, and why continuity needs to be at the heart of any improvement to primary care.</p>
<p>Finally, Harry Brunjes went from being a village GP to the chair of English National Opera, and explains what the two careers have in common.</p>
<p> </p>
<p>Reading list</p>
<p><a href='https://www.bmj.com/content/386/bmj.q1414'>Olympic Games: linking sports mega events to population physical activity</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5f8y25a6stjhyrxs/26th_of_july_-_olympic_legacy_mixdownb6nz3.mp3" length="56059628" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The Paris games have just started - and France has made a concerted effort to ensure that this year's Olympics will have a legacy of physical activity for the whole population.
However, mega sporting events don't always have that effect, and Fiona Bull, head of physical activity for the WHO, joins us to explain why it's increasingly important that they do.
We'll also hear from Professor Sir Denis Perera Gray about how a lifetime of general practice, and why continuity needs to be at the heart of any improvement to primary care.
Finally, Harry Brunjes went from being a village GP to the chair of English National Opera, and explains what the two careers have in common.
 
Reading list
Olympic Games: linking sports mega events to population physical activity]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2335</itunes:duration>
                <itunes:episode>17</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The patient issue</title>
        <itunes:title>The patient issue</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-patient-issue/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-patient-issue/#comments</comments>        <pubDate>Sat, 13 Jul 2024 06:00:00 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/86ddc262-d4cf-308c-959c-120fc6619c14</guid>
                                    <description><![CDATA[<p>We celebrate 10 years of patient and public partnership strategy at The BMJ with a patient-centred podcast.
We ask how should the new Labour government engage patients in shaping the future of the NHS. We also dive into the concepts of social care and peer support, and learn from Brazil's experience in social participation.</p>
<p>Highlights:</p>
<p>01:52 - The Patient "takeover"
05:43 - Social care with Charlotte Augst
19:53 - Peer support groups with Claire Reid and Partha Kar
31:48 - WHO’s resolution on social participation with Mark Barone</p>
<p>
Reading:
Editor's Choice - <a href='https://www.bmj.com/content/386/bmj.q1523'>Listening to patients at all levels of healthcare</a>, Emma Doble, patient editor

</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>We celebrate 10 years of patient and public partnership strategy at The BMJ with a patient-centred podcast.<br>
We ask how should the new Labour government engage patients in shaping the future of the NHS. We also dive into the concepts of social care and peer support, and learn from Brazil's experience in social participation.</p>
<p>Highlights:</p>
<p>01:52 - The Patient "takeover"<br>
05:43 - Social care with Charlotte Augst<br>
19:53 - Peer support groups with Claire Reid and Partha Kar<br>
31:48 - WHO’s resolution on social participation with Mark Barone</p>
<p><br>
Reading:<br>
Editor's Choice - <a href='https://www.bmj.com/content/386/bmj.q1523'>Listening to patients at all levels of healthcare</a>, Emma Doble, patient editor<br>
<br>
</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/v9wfvydut2y8y4ra/TBMJ_patient_issue_KA_ED_13July2024.mp3" length="62263904" type="audio/mpeg"/>
        <itunes:summary><![CDATA[We celebrate 10 years of patient and public partnership strategy at The BMJ with a patient-centred podcast.We ask how should the new Labour government engage patients in shaping the future of the NHS. We also dive into the concepts of social care and peer support, and learn from Brazil's experience in social participation.
Highlights:
01:52 - The Patient "takeover"05:43 - Social care with Charlotte Augst19:53 - Peer support groups with Claire Reid and Partha Kar31:48 - WHO’s resolution on social participation with Mark Barone
Reading:Editor's Choice - Listening to patients at all levels of healthcare, Emma Doble, patient editor]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2594</itunes:duration>
                <itunes:episode>16</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Extending access for breast cancer, and epidural outcomes</title>
        <itunes:title>Extending access for breast cancer, and epidural outcomes</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/extending-access-for-breast-cancer-and-epidural-outcomes/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/extending-access-for-breast-cancer-and-epidural-outcomes/#comments</comments>        <pubDate>Mon, 01 Jul 2024 13:37:46 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/aed3f034-99d9-32c3-92f9-f4ad433d73b2</guid>
                                    <description><![CDATA[<p>Women's Health, breast cancer screening, epidurals, and GP voices</p>
<p>New U.S. guideline on breast cancer screening  have been extended to women in their 40s -  Katy Bell, from the University of Sydney, and Stacy Carter, from the University of Wollongong explain why the good intention of that change wont be mirrored in outcomes - and may even induce harm.</p>
<p>Research in The BMJ shows epidurals during labour can reduce severe maternal morbidity Rachael Kearns describes why analgesia may improve those outcomes, and why some myths about epidurals may be reducing their usage.</p>
<p>Lastly,  a GP confronts the Prime Minister on the disintegration of the NHS and its effects on general practitioners.</p>
<p> </p>
<p>02:23 Breast cancer screening guidelines</p>
<p>14:00 Epidurals and maternal morbidity</p>
<p>26:42 A GP confronts the Prime Minister </p>
<p> </p>
<p>Reading list:</p>
<p><a href='https://www.bmj.com/content/385/bmj.q1353'>Breast cancer screening from age 40 in the US</a></p>
<p><a href='https://www.bmj.com/content/385/bmj-2023-077190'>Epidural analgesia during labour and severe maternal morbidity: population based study</a></p>
<p><a href='https://www.bmj.com/content/385/bmj.q1375'>GP who confronted Rishi Sunak received “hundreds” of supportive messages from doctors</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Women's Health, breast cancer screening, epidurals, and GP voices</p>
<p>New U.S. guideline on breast cancer screening  have been extended to women in their 40s -  Katy Bell, from the University of Sydney, and Stacy Carter, from the University of Wollongong explain why the good intention of that change wont be mirrored in outcomes - and may even induce harm.</p>
<p>Research in The BMJ shows epidurals during labour can reduce severe maternal morbidity Rachael Kearns describes why analgesia may improve those outcomes, and why some myths about epidurals may be reducing their usage.</p>
<p>Lastly,  a GP confronts the Prime Minister on the disintegration of the NHS and its effects on general practitioners.</p>
<p> </p>
<p>02:23 Breast cancer screening guidelines</p>
<p>14:00 Epidurals and maternal morbidity</p>
<p>26:42 A GP confronts the Prime Minister </p>
<p> </p>
<p>Reading list:</p>
<p><a href='https://www.bmj.com/content/385/bmj.q1353'>Breast cancer screening from age 40 in the US</a></p>
<p><a href='https://www.bmj.com/content/385/bmj-2023-077190'>Epidural analgesia during labour and severe maternal morbidity: population based study</a></p>
<p><a href='https://www.bmj.com/content/385/bmj.q1375'>GP who confronted Rishi Sunak received “hundreds” of supportive messages from doctors</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rijkfqqvgtjgurcr/The_BMJ_podcast_1st_July_mixdownbfk5g.mp3" length="43456325" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Women's Health, breast cancer screening, epidurals, and GP voices
New U.S. guideline on breast cancer screening  have been extended to women in their 40s -  Katy Bell, from the University of Sydney, and Stacy Carter, from the University of Wollongong explain why the good intention of that change wont be mirrored in outcomes - and may even induce harm.
Research in The BMJ shows epidurals during labour can reduce severe maternal morbidity Rachael Kearns describes why analgesia may improve those outcomes, and why some myths about epidurals may be reducing their usage.
Lastly,  a GP confronts the Prime Minister on the disintegration of the NHS and its effects on general practitioners.
 
02:23 Breast cancer screening guidelines
14:00 Epidurals and maternal morbidity
26:42 A GP confronts the Prime Minister 
 
Reading list:
Breast cancer screening from age 40 in the US
Epidural analgesia during labour and severe maternal morbidity: population based study
GP who confronted Rishi Sunak received “hundreds” of supportive messages from doctors]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1810</itunes:duration>
                <itunes:episode>15</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Large, plausible and imminent - time to take H5N1 seriously</title>
        <itunes:title>Large, plausible and imminent - time to take H5N1 seriously</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/large-plausible-and-imminent-time-to-take-h5n1-seriously/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/large-plausible-and-imminent-time-to-take-h5n1-seriously/#comments</comments>        <pubDate>Fri, 14 Jun 2024 17:31:12 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/4c4dfdd4-71b0-335e-863d-83ecfe4c403b</guid>
                                    <description><![CDATA[<p>As increasing numbers of mammalian, and human, cases of H5N1 are documented we askShould we worry about a growing threat from “bird flu”?  Wendy Barclay, from Imperial college London, and Christopher Dye, from Oxford University join us to explain why they think we should.</p>
<p>Our commission on the future of the NHS has released a manifesto for a sustainable NHS that still meets it's founding principles. Helen Salisbury, GP and BMJ columnist, joins the podcast to lay it out.</p>
<p>Finally, a musical interlude from the World Doctor's Orchestra.</p>
 
00:18 H5N1 Bird Flu: Rising Threat
15:35 The manifesto for a better NHS
27:46 World Doctors' Orchestra
 
Reading list;
BMJ Editorial - <a href='https://www.bmj.com/content/385/bmj.q1199'>Should we worry about a growing threat from “bird flu”?</a>
BMJ Opinion - <a href='https://www.bmj.com/content/385/bmj.q1307'>A manifesto for a healthier NHS, a healthier UK</a>

<a href='https://www.world-doctors-orchestra.org'>https://www.world-doctors-orchestra.org</a>
 
Stay up to date with our daily email alert - <a href='https://www.bmj.com/today'>https://www.bmj.com/today</a>
 
 ]]></description>
                                                            <content:encoded><![CDATA[<p>As increasing numbers of mammalian, and human, cases of H5N1 are documented we askShould we worry about a growing threat from “bird flu”?  Wendy Barclay, from Imperial college London, and Christopher Dye, from Oxford University join us to explain why they think we should.</p>
<p>Our commission on the future of the NHS has released a manifesto for a sustainable NHS that still meets it's founding principles. Helen Salisbury, GP and BMJ columnist, joins the podcast to lay it out.</p>
<p>Finally, a musical interlude from the World Doctor's Orchestra.</p>
 
00:18 H5N1 Bird Flu: Rising Threat
15:35 The manifesto for a better NHS
27:46 World Doctors' Orchestra
 
Reading list;
BMJ Editorial - <a href='https://www.bmj.com/content/385/bmj.q1199'>Should we worry about a growing threat from “bird flu”?</a>
BMJ Opinion - <a href='https://www.bmj.com/content/385/bmj.q1307'>A manifesto for a healthier NHS, a healthier UK</a><br>

<a href='https://www.world-doctors-orchestra.org'>https://www.world-doctors-orchestra.org</a>
 
Stay up to date with our daily email alert - <a href='https://www.bmj.com/today'>https://www.bmj.com/today</a>
 
 ]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ifpvevvk4sudyn73/14th_June_2024_mixdown9ierd.mp3" length="45624068" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As increasing numbers of mammalian, and human, cases of H5N1 are documented we askShould we worry about a growing threat from “bird flu”?  Wendy Barclay, from Imperial college London, and Christopher Dye, from Oxford University join us to explain why they think we should.
Our commission on the future of the NHS has released a manifesto for a sustainable NHS that still meets it's founding principles. Helen Salisbury, GP and BMJ columnist, joins the podcast to lay it out.
Finally, a musical interlude from the World Doctor's Orchestra.
 
00:18 H5N1 Bird Flu: Rising Threat
15:35 The manifesto for a better NHS
27:46 World Doctors' Orchestra
 
Reading list;
BMJ Editorial - Should we worry about a growing threat from “bird flu”?
BMJ Opinion - A manifesto for a healthier NHS, a healthier UK
https://www.world-doctors-orchestra.org
 
Stay up to date with our daily email alert - https://www.bmj.com/today
 
 ]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1899</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Elections and health in India, the UK, and the USA</title>
        <itunes:title>Elections and health in India, the UK, and the USA</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/electing-to-be-healthy/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/electing-to-be-healthy/#comments</comments>        <pubDate>Fri, 31 May 2024 18:00:52 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/48fb6e6d-f59f-3d6e-8246-8480ebc76a9e</guid>
                                    <description><![CDATA[
<p>In the UK, a general election has been called - and around the world, ½ the global population will be voting this year; so in this episode we’ll be talking about how elections and health intersect.</p>
<p>Firstly, what are the UK parties’ plans for health? Abi Rimmer, The BMJ's UK features editor joins us with the latest information.</p>
<p>The world’s largest democracy is polling, so how are Indian politicians talking about health?  Sanjay Nagral, surgeon and director of the Department of Surgical Gastroenterology at Jaslok Hospital &amp; Research Centre in Mumbai takes us through the campaign promises.</p>
<p>And finally, Jody Heymann is founding director of the WORLD Policy Analysis Center at UCLA and explains why this is the most consequential US election for woman's health in a generation.</p>
<p> </p>

01:30 Election Fever and NHS Plans
07:35 Impact of Elections on Health in India
21:20 Women's Health in the US Elections
 
Reading list
Feature: <a href='https://www.bmj.com/content/385/bmj.q1060'>The untold health toll of voting</a>
Editorial: <a href='https://www.bmj.com/content/385/bmj.q1050'>Workplace rights around pregnancy and childbirth</a>]]></description>
                                                            <content:encoded><![CDATA[
<p>In the UK, a general election has been called - and around the world, ½ the global population will be voting this year; so in this episode we’ll be talking about how elections and health intersect.</p>
<p>Firstly, what are the UK parties’ plans for health? Abi Rimmer,<em> The BMJ</em>'s UK features editor joins us with the latest information.</p>
<p>The world’s largest democracy is polling, so how are Indian politicians talking about health?  Sanjay Nagral, surgeon and director of the Department of Surgical Gastroenterology at Jaslok Hospital &amp; Research Centre in Mumbai takes us through the campaign promises.</p>
<p>And finally, Jody Heymann is founding director of the WORLD Policy Analysis Center at UCLA and explains why this is the most consequential US election for woman's health in a generation.</p>
<p> </p>

01:30 Election Fever and NHS Plans
07:35 Impact of Elections on Health in India
21:20 Women's Health in the US Elections
 
Reading list
Feature: <a href='https://www.bmj.com/content/385/bmj.q1060'>The untold health toll of voting</a>
Editorial: <a href='https://www.bmj.com/content/385/bmj.q1050'>Workplace rights around pregnancy and childbirth</a>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ha9mzgustdiwq92f/BMJ_pod_31st_May_2024acmj0.mp3" length="43629533" type="audio/mpeg"/>
        <itunes:summary><![CDATA[
In the UK, a general election has been called - and around the world, ½ the global population will be voting this year; so in this episode we’ll be talking about how elections and health intersect.
Firstly, what are the UK parties’ plans for health? Abi Rimmer, The BMJ's UK features editor joins us with the latest information.
The world’s largest democracy is polling, so how are Indian politicians talking about health?  Sanjay Nagral, surgeon and director of the Department of Surgical Gastroenterology at Jaslok Hospital &amp; Research Centre in Mumbai takes us through the campaign promises.
And finally, Jody Heymann is founding director of the WORLD Policy Analysis Center at UCLA and explains why this is the most consequential US election for woman's health in a generation.
 

01:30 Election Fever and NHS Plans
07:35 Impact of Elections on Health in India
21:20 Women's Health in the US Elections
 
Reading list
Feature: The untold health toll of voting
Editorial: Workplace rights around pregnancy and childbirth]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1816</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The prospect of unemployed GPs</title>
        <itunes:title>The prospect of unemployed GPs</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-prospect-of-unemployed-gps/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-prospect-of-unemployed-gps/#comments</comments>        <pubDate>Fri, 10 May 2024 17:21:27 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/72541ee4-9fb8-3a90-9b58-ebaaf4bc06df</guid>
                                    <description><![CDATA[<p>With the anticipation of a new government in the UK, shadow health secretary Wes Streeting will hit the ground running - with a winter season (and it's inevitable crisis) and ongoing industrial desputes with junior doctors. Elisabeth Mahase ask him about his plans to handle these challenges if elected.</p>
<p>We also find our selves in the puzzling situation of potential GP unemployment in the UK despite a high demand for primary care doctors, Helen Salisbury, GP and columnist for The BMJ explains how we've got into this situation.</p>
<p>Finally, Peter Doshi has been looking at the financial entanglement of FDA heads with the companies they are regulating - 9 of the previous 10 FDA heads have gone on to work for industry in some respect. He has also investigated how complex financial instruments can make these conflicts more opaque.</p>
<p>02:03 Anticipating a New Government and the NHS Winter Crisis
10:50 The Kafkaesque Dilemma of GP Unemployment
23:10 FDA Leaders' Financial Entanglements: A Deep Dive

</p>
<p>Reading list</p>
<p>
<a href='https://www.bmj.com/content/385/bmj.q992'>Workforce and winter under Labour: Wes Streeting on his plan for the NHS</a></p>
<p><a href='https://www.bmj.com/content/385/bmj.q1029'>Helen Salisbury: No jobs for GPs—we’ll be missed when we’re gone</a></p>
<p><a href=''>Revolving doors: board memberships, hedge funds, and the FDA chiefs responsible for regulating industry</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>With the anticipation of a new government in the UK, shadow health secretary Wes Streeting will hit the ground running - with a winter season (and it's inevitable crisis) and ongoing industrial desputes with junior doctors. Elisabeth Mahase ask him about his plans to handle these challenges if elected.</p>
<p>We also find our selves in the puzzling situation of potential GP unemployment in the UK despite a high demand for primary care doctors, Helen Salisbury, GP and columnist for The BMJ explains how we've got into this situation.</p>
<p>Finally, Peter Doshi has been looking at the financial entanglement of FDA heads with the companies they are regulating - 9 of the previous 10 FDA heads have gone on to work for industry in some respect. He has also investigated how complex financial instruments can make these conflicts more opaque.</p>
<p>02:03 Anticipating a New Government and the NHS Winter Crisis<br>
10:50 The Kafkaesque Dilemma of GP Unemployment<br>
23:10 FDA Leaders' Financial Entanglements: A Deep Dive<br>
<br>
</p>
<p>Reading list</p>
<p><br>
<a href='https://www.bmj.com/content/385/bmj.q992'>Workforce and winter under Labour: Wes Streeting on his plan for the NHS</a></p>
<p><a href='https://www.bmj.com/content/385/bmj.q1029'>Helen Salisbury: No jobs for GPs—we’ll be missed when we’re gone</a></p>
<p><a href=''>Revolving doors: board memberships, hedge funds, and the FDA chiefs responsible for regulating industry</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9nzfx48mw763hwhn/BMJ_pod_10_may_2024_mixdown6p97x.mp3" length="49234592" type="audio/mpeg"/>
        <itunes:summary><![CDATA[With the anticipation of a new government in the UK, shadow health secretary Wes Streeting will hit the ground running - with a winter season (and it's inevitable crisis) and ongoing industrial desputes with junior doctors. Elisabeth Mahase ask him about his plans to handle these challenges if elected.
We also find our selves in the puzzling situation of potential GP unemployment in the UK despite a high demand for primary care doctors, Helen Salisbury, GP and columnist for The BMJ explains how we've got into this situation.
Finally, Peter Doshi has been looking at the financial entanglement of FDA heads with the companies they are regulating - 9 of the previous 10 FDA heads have gone on to work for industry in some respect. He has also investigated how complex financial instruments can make these conflicts more opaque.
02:03 Anticipating a New Government and the NHS Winter Crisis10:50 The Kafkaesque Dilemma of GP Unemployment23:10 FDA Leaders' Financial Entanglements: A Deep Dive
Reading list
Workforce and winter under Labour: Wes Streeting on his plan for the NHS
Helen Salisbury: No jobs for GPs—we’ll be missed when we’re gone
Revolving doors: board memberships, hedge funds, and the FDA chiefs responsible for regulating industry]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2050</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Fixing healthcare's workforce problems</title>
        <itunes:title>Fixing healthcare's workforce problems</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/fixing-healthcares-workforce-problems/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/fixing-healthcares-workforce-problems/#comments</comments>        <pubDate>Fri, 26 Apr 2024 17:23:37 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/2c940e61-85b2-331d-a670-2695fec0ccba</guid>
                                    <description><![CDATA[<p>Where next for psychological safety? Amy Edmundson is professor of Leadership and Management at the Harvard Business School. Her work on psychological safety has underpinned so much quality improvement, and she joins us fresh of the stage at the International Forum on Quality and safety in healthcare to talk about the next steps in creating a safe work place.</p>
<p>The BMJ has published two new investigations, looking at the alcohol and tobacco industry funding of public health and education - we’ll hear how the companies who create the problems, are now styling themselves as the solution. Rebecca Coombes joins us to explain what The BMJ has found, and May van Schalkwyk, a researcher from the London School of Hygiene &amp; Tropical Medicine, explains how commercial conflicts are shaping the wrong education tactics.</p>
<p>And finally, our NHS commissioners have more recommendations - this time on workforce issues. Mary Dixon-Woods, director of THIS institute at the University of Cambridge, and Matt Morgan, intensive care consultant in Cardiff, tell the NHS to get serious about staffing.</p>
<p>
02:03 Amy Edmondson on Future Health and Psychological Safety
10:24 The Impact of Corporate Funding on Public Health
19:57 Addressing NHS Workforce Challenges: Insights and Solutions

</p>
<p>Reading list;</p>
<p>Our new podcast - <a href='https://bmjfuturehealth.podbean.com/'>Future Health</a></p>
<p>International forum keynote -  <a href='https://www.bmj.com/content/385/bmj.q948'>Medscape caves in on courses funded by tobacco giant Philip Morris, while medics fear global push into medical education</a>
Investigation - <a href='https://www.bmj.com/content/385/bmj.q851'>Big alcohol: Universities and schools urged to throw out industry-funded public health advice</a></p>
<p>Commission on the future of the NHS - <a href='https://www.bmj.com/content/384/bmj-2024-079474'>The future of the NHS depends on its workforce</a></p>
<p> </p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Where next for psychological safety? Amy Edmundson is professor of Leadership and Management at the Harvard Business School. Her work on psychological safety has underpinned so much quality improvement, and she joins us fresh of the stage at the International Forum on Quality and safety in healthcare to talk about the next steps in creating a safe work place.</p>
<p><em>The BMJ</em> has published two new investigations, looking at the alcohol and tobacco industry funding of public health and education - we’ll hear how the companies who create the problems, are now styling themselves as the solution. Rebecca Coombes joins us to explain what <em>The BMJ</em> has found, and May van Schalkwyk, a researcher from the London School of Hygiene &amp; Tropical Medicine, explains how commercial conflicts are shaping the wrong education tactics.</p>
<p>And finally, our NHS commissioners have more recommendations - this time on workforce issues. Mary Dixon-Woods, director of THIS institute at the University of Cambridge, and Matt Morgan, intensive care consultant in Cardiff, tell the NHS to get serious about staffing.</p>
<p><br>
02:03 Amy Edmondson on Future Health and Psychological Safety<br>
10:24 The Impact of Corporate Funding on Public Health<br>
19:57 Addressing NHS Workforce Challenges: Insights and Solutions<br>
<br>
</p>
<p>Reading list;</p>
<p>Our new podcast - <a href='https://bmjfuturehealth.podbean.com/'>Future Health</a></p>
<p>International forum keynote -  <a href='https://www.bmj.com/content/385/bmj.q948'>Medscape caves in on courses funded by tobacco giant Philip Morris, while medics fear global push into medical education</a><br>
Investigation - <a href='https://www.bmj.com/content/385/bmj.q851'>Big alcohol: Universities and schools urged to throw out industry-funded public health advice</a></p>
<p>Commission on the future of the NHS - <a href='https://www.bmj.com/content/384/bmj-2024-079474'>The future of the NHS depends on its workforce</a></p>
<p> </p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qd5f7biemicbfsa5/The_BMJ_podcast_-_26th_Aprilbvtxe.mp3" length="53103901" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Where next for psychological safety? Amy Edmundson is professor of Leadership and Management at the Harvard Business School. Her work on psychological safety has underpinned so much quality improvement, and she joins us fresh of the stage at the International Forum on Quality and safety in healthcare to talk about the next steps in creating a safe work place.
The BMJ has published two new investigations, looking at the alcohol and tobacco industry funding of public health and education - we’ll hear how the companies who create the problems, are now styling themselves as the solution. Rebecca Coombes joins us to explain what The BMJ has found, and May van Schalkwyk, a researcher from the London School of Hygiene &amp; Tropical Medicine, explains how commercial conflicts are shaping the wrong education tactics.
And finally, our NHS commissioners have more recommendations - this time on workforce issues. Mary Dixon-Woods, director of THIS institute at the University of Cambridge, and Matt Morgan, intensive care consultant in Cardiff, tell the NHS to get serious about staffing.
02:03 Amy Edmondson on Future Health and Psychological Safety10:24 The Impact of Corporate Funding on Public Health19:57 Addressing NHS Workforce Challenges: Insights and Solutions
Reading list;
Our new podcast - Future Health
International forum keynote -  "Learning to fail" with Amy Edmundson and Don Berwick
Investigation - Medscape caves in on courses funded by tobacco giant Philip Morris, while medics fear global push into medical educationInvestigation - Big alcohol: Universities and schools urged to throw out industry-funded public health advice
Commission on the future of the NHS - The future of the NHS depends on its workforce
 
 ]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2211</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Improving NHS gender identity services - Hilary Cass</title>
        <itunes:title>Improving NHS gender identity services - Hilary Cass</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/improving-nhs-gender-identity-services-hilary-cass/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/improving-nhs-gender-identity-services-hilary-cass/#comments</comments>        <pubDate>Fri, 12 Apr 2024 15:53:00 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/fe4b7cc8-88b6-3f5f-a31d-2d3ac0c43fe3</guid>
                                    <description><![CDATA[<p>Hilary Cass, the former president of the Royal College of Paediatrics, has spent the last 3 years collating the evidence for treatment of gender questioning young people; engaging with those young people, their families and their clinicians - all with the aim of improving NHS treatment of this complex and vulnerable group.</p>
<p>In this interview, Kamran Abbasi, editor in chief of The BMJ, speaks in depth to Cass about her review - about evidence base for transitioning, but also about the way in which the siloing of care for young trans people has failed them. </p>
<p>They discuss the need to support young people in their journey - Cass is clear that the NHS should allow young people to explore their gender, but that ultimately, that may not mean medical intervention at all. </p>
<p> </p>
<p>Reading list</p>
<p><a href='https://cass.independent-review.uk/home/publications/final-report/'>The Cass Review - final report</a></p>
<p><a href='https://adc.bmj.com/pages/gender-identity-service-series'>The systematic review and meta-analyses published in Archives of Disease in Childhood</a></p>
<p>BMJ Opinion: <a href='https://www.bmj.com/content/385/bmj.q814'>Gender medicine for children and young people is built on shaky foundations</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Hilary Cass, the former president of the Royal College of Paediatrics, has spent the last 3 years collating the evidence for treatment of gender questioning young people; engaging with those young people, their families and their clinicians - all with the aim of improving NHS treatment of this complex and vulnerable group.</p>
<p>In this interview, Kamran Abbasi, editor in chief of The BMJ, speaks in depth to Cass about her review - about evidence base for transitioning, but also about the way in which the siloing of care for young trans people has failed them. </p>
<p>They discuss the need to support young people in their journey - Cass is clear that the NHS should allow young people to explore their gender, but that ultimately, that may not mean medical intervention at all. </p>
<p> </p>
<p>Reading list</p>
<p><a href='https://cass.independent-review.uk/home/publications/final-report/'>The Cass Review - final report</a></p>
<p><a href='https://adc.bmj.com/pages/gender-identity-service-series'>The systematic review and meta-analyses published in Archives of Disease in Childhood</a></p>
<p>BMJ Opinion: <a href='https://www.bmj.com/content/385/bmj.q814'>Gender medicine for children and young people is built on shaky foundations</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rt4m8jaw4skhxaug/BMJ_podcast_-_12th_April_20247oqcf.mp3" length="54122124" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Hilary Cass, the former president of the Royal College of Paediatrics, has spent the last 3 years collating the evidence for treatment of gender questioning young people; engaging with those young people, their families and their clinicians - all with the aim of improving NHS treatment of this complex and vulnerable group.
In this interview, Kamran Abbasi, editor in chief of The BMJ, speaks in depth to Cass about her review - about evidence base for transitioning, but also about the way in which the siloing of care for young trans people has failed them. 
They discuss the need to support young people in their journey - Cass is clear that the NHS should allow young people to explore their gender, but that ultimately, that may not mean medical intervention at all. 
 
Reading list
The Cass Review - final report
The systematic review and meta-analyses published in Archives of Disease in Childhood
BMJ Opinion: Gender medicine for children and young people is built on shaky foundations]]></itunes:summary>
        <itunes:author>BMJ Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2254</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Derogation, an ultra processed food system, and catch up pay for the NHS</title>
        <itunes:title>Derogation, an ultra processed food system, and catch up pay for the NHS</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/derogation-an-ultra-processed-food-system-and-catch-up-pay-for-the-nhs/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/derogation-an-ultra-processed-food-system-and-catch-up-pay-for-the-nhs/#comments</comments>        <pubDate>Fri, 29 Mar 2024 19:00:00 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/0ccec835-4d12-3f4e-8eb4-e787e1097c86</guid>
                                    <description><![CDATA[<p>Derogation, the way in which striking doctors can be recalled to the ward to protect patient safety, was agreed by NHS England and the BMA. Now, <a href='https://www.bmj.com/content/384/bmj.q740'>new data The BMJ has uncovered</a> shows that the mechanism was rarely used - and when it was tried, was often rejected. Gareth Iacobucci explains what that means about relations between the government, the NHS, and doctors.</p>
<p>Felice Jacka, director of the Food &amp; Mood Centre at Deakin University, is one of the authors of our recent <a href='https://www.bmj.com/content/384/bmj-2023-077310'>ultra-processed foods umbrella review</a> - and joins the podcast to talk about the link between diet and health; and why goverments need to pay more attention to the food system.</p>
<p>Finally, John Appleby, senior associate at the Nuffield Trust, and Gillian Leng, dean and president elect of the Royal Society of medicine, have been<a href='https://www.bmj.com/content/384/bmj-2024-079341'> thinking about healthcare funding</a>, and how more stability is essential in securing the service's future.</p>
<p> </p>
<p>Reading list</p>
<p><a href='https://www.bmj.com/content/384/bmj.q740'>Hospital leaders warned that failure to recall striking doctors risked patient safety in some trusts, documents show</a></p>
<p><a href='https://www.bmj.com/content/384/bmj-2023-077310'>Ultra-processed food exposure and adverse health outcomes</a></p>
<p><a href='https://www.bmj.com/content/384/bmj-2024-079341'>NHS funding for a secure future</a></p>
<p> </p>
<p>Chapters</p>
00:31 Derogation and doctor strikes
06:59 Ultra processed food producers and health
13:59 Rethinking NHS funding]]></description>
                                                            <content:encoded><![CDATA[<p>Derogation, the way in which striking doctors can be recalled to the ward to protect patient safety, was agreed by NHS England and the BMA. Now, <a href='https://www.bmj.com/content/384/bmj.q740'>new data The BMJ has uncovered</a> shows that the mechanism was rarely used - and when it was tried, was often rejected. Gareth Iacobucci explains what that means about relations between the government, the NHS, and doctors.</p>
<p>Felice Jacka, director of the Food &amp; Mood Centre at Deakin University, is one of the authors of our recent <a href='https://www.bmj.com/content/384/bmj-2023-077310'>ultra-processed foods umbrella review</a> - and joins the podcast to talk about the link between diet and health; and why goverments need to pay more attention to the food system.</p>
<p>Finally, John Appleby, senior associate at the Nuffield Trust, and Gillian Leng, dean and president elect of the Royal Society of medicine, have been<a href='https://www.bmj.com/content/384/bmj-2024-079341'> thinking about healthcare funding</a>, and how more stability is essential in securing the service's future.</p>
<p> </p>
<p>Reading list</p>
<p><a href='https://www.bmj.com/content/384/bmj.q740'>Hospital leaders warned that failure to recall striking doctors risked patient safety in some trusts, documents show</a></p>
<p><a href='https://www.bmj.com/content/384/bmj-2023-077310'>Ultra-processed food exposure and adverse health outcomes</a></p>
<p><a href='https://www.bmj.com/content/384/bmj-2024-079341'>NHS funding for a secure future</a></p>
<p> </p>
<p>Chapters</p>
00:31 Derogation and doctor strikes
06:59 Ultra processed food producers and health
13:59 Rethinking NHS funding]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xr7ig7/The_BMJ_podcast_29th_March_2024_mixdown89hf9.mp3" length="42928847" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Derogation, the way in which striking doctors can be recalled to the ward to protect patient safety, was agreed by NHS England and the BMA. Now, new data The BMJ has uncovered shows that the mechanism was rarely used - and when it was tried, was often rejected. Gareth Iacobucci explains what that means about relations between the government, the NHS, and doctors.
Felice Jacka, director of the Food &amp; Mood Centre at Deakin University, is one of the authors of our recent ultra-processed foods umbrella review - and joins the podcast to talk about the link between diet and health; and why goverments need to pay more attention to the food system.
Finally, John Appleby, senior associate at the Nuffield Trust, and Gillian Leng, dean and president elect of the Royal Society of medicine, have been thinking about healthcare funding, and how more stability is essential in securing the service's future.
 
Reading list
Hospital leaders warned that failure to recall striking doctors risked patient safety in some trusts, documents show
Ultra-processed food exposure and adverse health outcomes
NHS funding for a secure future
 
Chapters
00:31 Derogation and doctor strikes
06:59 Ultra processed food producers and health
13:59 Rethinking NHS funding]]></itunes:summary>
        <itunes:author>BMJ Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1787</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The future of the clinical relationship, code sharing, and a Nye-t at the theatre</title>
        <itunes:title>The future of the clinical relationship, code sharing, and a Nye-t at the theatre</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-future-of-the-clinical-relationship-code-sharing-and-a-nye-t-at-the-theatre/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-future-of-the-clinical-relationship-code-sharing-and-a-nye-t-at-the-theatre/#comments</comments>        <pubDate>Fri, 15 Mar 2024 17:59:58 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/7ef6fd7a-699b-34e3-91df-cb7ac6f57389</guid>
                                    <description><![CDATA[In this week's podcast:
 

How AI will affect the clinician-patient relationship? Our annual Nuffield Summit roundtable asks how the promise of tech tools stacks up against reality, and how the future of the therapeutic relationship can be protected (participants below).
 

Your code is as important as your methods, which is why The BMJ now requires you to share it - Ben Goldacre and Nick De Vito, from the Bennett Institute for Applied Data Science at the University of Oxford, explain why it's so important, and how The BMJ's new data and code sharing policy could change research transparency.
 
Nye Bevin set up the NHS when the UK was in the economic doldrums, and the public's need for care was becoming an emergency - BMJ columnist Matt Morgan has helped turn that story into a play, currently showing at the National Theatre; and reflects on the parallels between now and then.
 
1:58 Nuffield Summit roundtable
17:32 New BMJ rules on data and code sharing
29:03 Aneurin "Nye" Bevan play
 
Taking part in our roundtable were:

<ul><li>
<p>Rebecca Rosen, Senior Fellow at the Nuffield Trust and GP</p>
</li>
<li>
<p>Juliet Bouverie, CEO of The Stroke Association</p>
</li>
<li>
<p>Daniel Elkeles, CEO of London Ambulance Service</p>
</li>
<li>Neil Sebire, Professor and Chief Research Information Officer at Great Ormond Street Hospital</li>
</ul>


Reading list:
<p><a href='https://www.bmj.com/content/384/bmj.q574'>How is technology changing clinician-patient relationships?</a></p>
<p><a href='https://www.bmj.com/content/384/bmj.q324'>Mandatory data and code sharing for research published by The BMJ</a></p>
<p><a href='https://www.bmj.com/content/384/bmj.q478'>Scalpels and spotlights: bringing theatre to the theatre</a></p>
]]></description>
                                                            <content:encoded><![CDATA[In this week's podcast:
 

How AI will affect the clinician-patient relationship? Our annual Nuffield Summit roundtable asks how the promise of tech tools stacks up against reality, and how the future of the therapeutic relationship can be protected (participants below).
 

Your code is as important as your methods, which is why The BMJ now requires you to share it - Ben Goldacre and Nick De Vito, from the Bennett Institute for Applied Data Science at the University of Oxford, explain why it's so important, and how The BMJ's new data and code sharing policy could change research transparency.
 
Nye Bevin set up the NHS when the UK was in the economic doldrums, and the public's need for care was becoming an emergency - BMJ columnist Matt Morgan has helped turn that story into a play, currently showing at the National Theatre; and reflects on the parallels between now and then.
 
1:58 Nuffield Summit roundtable
17:32 New BMJ rules on data and code sharing
29:03 Aneurin "Nye" Bevan play
 
Taking part in our roundtable were:

<ul><li>
<p>Rebecca Rosen, Senior Fellow at the Nuffield Trust and GP</p>
</li>
<li>
<p>Juliet Bouverie, CEO of The Stroke Association</p>
</li>
<li>
<p>Daniel Elkeles, CEO of London Ambulance Service</p>
</li>
<li>Neil Sebire, Professor and Chief Research Information Officer at Great Ormond Street Hospital</li>
</ul>


Reading list:
<p><a href='https://www.bmj.com/content/384/bmj.q574'>How is technology changing clinician-patient relationships?</a></p>
<p><a href='https://www.bmj.com/content/384/bmj.q324'>Mandatory data and code sharing for research published by The BMJ</a></p>
<p><a href='https://www.bmj.com/content/384/bmj.q478'>Scalpels and spotlights: bringing theatre to the theatre</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vbbmkd/BMJ_podcast_15th_March_2024.mp3" length="35399794" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this week's podcast:
 

How AI will affect the clinician-patient relationship? Our annual Nuffield Summit roundtable asks how the promise of tech tools stacks up against reality, and how the future of the therapeutic relationship can be protected (participants below).
 

Your code is as important as your methods, which is why The BMJ now requires you to share it - Ben Goldacre and Nick De Vito, from the Bennett Institute for Applied Data Science at the University of Oxford, explain why it's so important, and how The BMJ's new data and code sharing policy could change research transparency.
 
Nye Bevin set up the NHS when the UK was in the economic doldrums, and the public's need for care was becoming an emergency - BMJ columnist Matt Morgan has helped turn that story into a play, currently showing at the National Theatre; and reflects on the parallels between now and then.
 
1:58 Nuffield Summit roundtable
17:32 New BMJ rules on data and code sharing
29:03 Aneurin "Nye" Bevan play
 
Taking part in our roundtable were:


Rebecca Rosen, Senior Fellow at the Nuffield Trust and GP


Juliet Bouverie, CEO of The Stroke Association


Daniel Elkeles, CEO of London Ambulance Service

Neil Sebire, Professor and Chief Research Information Officer at Great Ormond Street Hospital


Reading list:
How is technology changing clinician-patient relationships?
Mandatory data and code sharing for research published by The BMJ
Scalpels and spotlights: bringing theatre to the theatre
]]></itunes:summary>
        <itunes:author>BMJ Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2212</itunes:duration>
                <itunes:episode>14</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Retracting abortion papers, deafness in the clinic, and 70 years of a medical orchestra</title>
        <itunes:title>Retracting abortion papers, deafness in the clinic, and 70 years of a medical orchestra</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/retracting-abortion-papers-deafness-in-the-clinic-and-70-years-of-a-medical-orchestra/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/retracting-abortion-papers-deafness-in-the-clinic-and-70-years-of-a-medical-orchestra/#comments</comments>        <pubDate>Fri, 01 Mar 2024 20:23:23 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/52a0b69b-d0db-3691-a7e1-41ba6c094629</guid>
                                    <description><![CDATA[<p>The U.S. Supreme Court is hearing a case on the approval of mifepristone for medical abortion - a case which could change the availability of the drug in the US, and which hinges on papers linking abortion to mental distress. However, those papers are contested (including a paper published by BMJ), and some have been retracted already - Julia Littell and Antonia Biggs tell us how that science is being used in court, and why retraction is essential.</p>
<p>Awakening from anaesthetic is difficult enough, but imagine you're three and only communicate through sign language - which no one can understand. We hear from Kirsten, a mother who thinks everyone should learn at least a few key sign language phrases.</p>
<p>Finally, the London Medical Orchestra is turning 70 - having had their start in The BMJ's letters pages. Stuart Delve and Peter Gough help explain the orchestra's longevity.</p>
<p class="p1"> </p>
<p class="p1">01:00 The Supreme Court Case on Medical Abortion</p>
<p class="p1">10:27 The Role of Journal Editors in Scientific Integrity</p>
<p class="p1">19:54 The Impact of Deafness on Patient Experience</p>
<p class="p1">30:57 The Joy of Music in a Medical Career: London Medical Orchestra</p>
<p class="p1"> </p>
<p class="p1">References</p>
<p class="p1"><a href='https://www.bmj.com/content/384/bmj-2023-076518'>Analysis: Correcting the scientific record on abortion and mental health outcomes</a>
</p>
<p class="p1"><a href='https://www.bmj.com/content/384/bmj.p2615'>WYPIT: The importance of British Sign Language</a></p>
<p class="p1"><a href='https://www.instagram.com/justmecameil/'>Asha's instagram for BSL tips</a></p>
<p class="p1"><a href='https://www.lmo.org.uk/70th'>London Medical Orchestra's 70th anniversary concert - 6:30pm, Sun, 10 Mar 2024</a></p>
<p class="p1"> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The U.S. Supreme Court is hearing a case on the approval of mifepristone for medical abortion - a case which could change the availability of the drug in the US, and which hinges on papers linking abortion to mental distress. However, those papers are contested (including a paper published by BMJ), and some have been retracted already - Julia Littell and Antonia Biggs tell us how that science is being used in court, and why retraction is essential.</p>
<p>Awakening from anaesthetic is difficult enough, but imagine you're three and only communicate through sign language - which no one can understand. We hear from Kirsten, a mother who thinks everyone should learn at least a few key sign language phrases.</p>
<p>Finally, the London Medical Orchestra is turning 70 - having had their start in The BMJ's letters pages. Stuart Delve and Peter Gough help explain the orchestra's longevity.</p>
<p class="p1"> </p>
<p class="p1">01:00 The Supreme Court Case on Medical Abortion</p>
<p class="p1">10:27 The Role of Journal Editors in Scientific Integrity</p>
<p class="p1">19:54 The Impact of Deafness on Patient Experience</p>
<p class="p1">30:57 The Joy of Music in a Medical Career: London Medical Orchestra</p>
<p class="p1"> </p>
<p class="p1">References</p>
<p class="p1"><a href='https://www.bmj.com/content/384/bmj-2023-076518'>Analysis: Correcting the scientific record on abortion and mental health outcomes</a><br>
</p>
<p class="p1"><a href='https://www.bmj.com/content/384/bmj.p2615'>WYPIT: The importance of British Sign Language</a></p>
<p class="p1"><a href='https://www.instagram.com/justmecameil/'>Asha's instagram for BSL tips</a></p>
<p class="p1"><a href='https://www.lmo.org.uk/70th'>London Medical Orchestra's 70th anniversary concert - 6:30pm, Sun, 10 Mar 2024</a></p>
<p class="p1"> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7pfrtb/BMJ_podcast_1st_March_2024_mixdownb3n5b.mp3" length="55724059" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The U.S. Supreme Court is hearing a case on the approval of mifepristone for medical abortion - a case which could change the availability of the drug in the US, and which hinges on papers linking abortion to mental distress. However, those papers are contested (including a paper published by BMJ), and some have been retracted already - Julia Littell and Antonia Biggs tell us how that science is being used in court, and why retraction is essential.
Awakening from anaesthetic is difficult enough, but imagine you're three and only communicate through sign language - which no one can understand. We hear from Kirsten, a mother who thinks everyone should learn at least a few key sign language phrases.
Finally, the London Medical Orchestra is turning 70 - having had their start in The BMJ's letters pages. Stuart Delve and Peter Gough help explain the orchestra's longevity.
 
01:00 The Supreme Court Case on Medical Abortion
10:27 The Role of Journal Editors in Scientific Integrity
19:54 The Impact of Deafness on Patient Experience
30:57 The Joy of Music in a Medical Career: London Medical Orchestra
 
References
Analysis: Correcting the scientific record on abortion and mental health outcomes
WYPIT: The importance of British Sign Language
Asha's instagram for BSL tips
London Medical Orchestra's 70th anniversary concert - 6:30pm, Sun, 10 Mar 2024
 ]]></itunes:summary>
        <itunes:author>BMJ Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2321</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Heidi Larson on misinformation, the right exercise to reduce depression, and Breathtaking TV</title>
        <itunes:title>Heidi Larson on misinformation, the right exercise to reduce depression, and Breathtaking TV</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/heidi-larson-on-misinformation-the-right-exercise-to-reduce-depression-and-breathtaking-tv/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/heidi-larson-on-misinformation-the-right-exercise-to-reduce-depression-and-breathtaking-tv/#comments</comments>        <pubDate>Fri, 16 Feb 2024 17:46:43 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/3094cb89-3314-3c84-b70a-2e1a62451d95</guid>
                                    <description><![CDATA[<p>Social media, and the rate at which the online world is changing, is worrying - especially the speed at which health disinformation can speed around the globe. We look to tech companies for a solution to the problems of their own making - but Heidi Larson, director of the Vaccine Confidence Project, and professor of anthropology, risk and decision science at LSHTM, joins us to explain why we should be cautious about focussing our attention there.</p>
<p>Next on the podcast, research just published in The BMJ looks at the efficacy of exercise at controlling depressive symptoms - but helps finally answer the key question - which exercise works best. Lead author, Michael Noetel, senior lecturer in psychology at the University of Queensland, joins us to explain the research, and how well exercise stacks up against pharmacological treatments.</p>
<p>Finally, while it’s tempting to try and put the pandemic behind us, its effects linger - and many healthcare staff are still dealing with their experience of that time. Rachel Clarke, a palliative care doctor in the UK, joins us to explain why she has felt the need to document the pandemic, first in a book and now in a new TV drama set to air in the UK next week. </p>
<p> </p>
<p>06:15  Heidi Larson on vaccine confidence and social media</p>
<p>15:31 Exploring the effectiveness of exercise for depression</p>
<p>26:56 Rachel Clark on seeing her experiences reflected on screen</p>
<p> </p>
<p>Reading list</p>
<p><a href='https://www.bmj.com/social-media-influencing-vaccination'>BMJ Collection: How are social media influencing vaccination</a></p>
<p><a href='https://www.bmj.com/content/384/bmj.p2987'>Feature: Medical misinformation on social media—are the platforms equipped to be the judge?</a></p>
<p><a href='https://www.bmj.com/content/384/bmj-2023-075847'>Research: Effect of exercise for depression</a></p>
<p> </p>
<p> </p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Social media, and the rate at which the online world is changing, is worrying - especially the speed at which health disinformation can speed around the globe. We look to tech companies for a solution to the problems of their own making - but Heidi Larson, director of the Vaccine Confidence Project, and professor of anthropology, risk and decision science at LSHTM, joins us to explain why we should be cautious about focussing our attention there.</p>
<p>Next on the podcast, research just published in The BMJ looks at the efficacy of exercise at controlling depressive symptoms - but helps finally answer the key question - which exercise works best. Lead author, Michael Noetel, senior lecturer in psychology at the University of Queensland, joins us to explain the research, and how well exercise stacks up against pharmacological treatments.</p>
<p>Finally, while it’s tempting to try and put the pandemic behind us, its effects linger - and many healthcare staff are still dealing with their experience of that time. Rachel Clarke, a palliative care doctor in the UK, joins us to explain why she has felt the need to document the pandemic, first in a book and now in a new TV drama set to air in the UK next week. </p>
<p> </p>
<p>06:15  Heidi Larson on vaccine confidence and social media</p>
<p>15:31 Exploring the effectiveness of exercise for depression</p>
<p>26:56 Rachel Clark on seeing her experiences reflected on screen</p>
<p> </p>
<p>Reading list</p>
<p><a href='https://www.bmj.com/social-media-influencing-vaccination'>BMJ Collection: How are social media influencing vaccination</a></p>
<p><a href='https://www.bmj.com/content/384/bmj.p2987'>Feature: Medical misinformation on social media—are the platforms equipped to be the judge?</a></p>
<p><a href='https://www.bmj.com/content/384/bmj-2023-075847'>Research: Effect of exercise for depression</a></p>
<p> </p>
<p> </p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/n7m9az/The_BMJ_podcast_-_16_Feb_2478eon.mp3" length="83242541" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Social media, and the rate at which the online world is changing, is worrying - especially the speed at which health disinformation can speed around the globe. We look to tech companies for a solution to the problems of their own making - but Heidi Larson, director of the Vaccine Confidence Project, and professor of anthropology, risk and decision science at LSHTM, joins us to explain why we should be cautious about focussing our attention there.
Next on the podcast, research just published in The BMJ looks at the efficacy of exercise at controlling depressive symptoms - but helps finally answer the key question - which exercise works best. Lead author, Michael Noetel, senior lecturer in psychology at the University of Queensland, joins us to explain the research, and how well exercise stacks up against pharmacological treatments.
Finally, while it’s tempting to try and put the pandemic behind us, its effects linger - and many healthcare staff are still dealing with their experience of that time. Rachel Clarke, a palliative care doctor in the UK, joins us to explain why she has felt the need to document the pandemic, first in a book and now in a new TV drama set to air in the UK next week. 
 
06:15  Heidi Larson on vaccine confidence and social media
15:31 Exploring the effectiveness of exercise for depression
26:56 Rachel Clark on seeing her experiences reflected on screen
 
Reading list
BMJ Collection: How are social media influencing vaccination
Feature: Medical misinformation on social media—are the platforms equipped to be the judge?
Research: Effect of exercise for depression
 
 
 ]]></itunes:summary>
        <itunes:author>BMJ Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2080</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog16196630/The-BMJ-Podcast-Icon.png" />    </item>
    <item>
        <title>A health and care emergency, the US constitutional weakness for pandemic response, ActionAid in conflict zones</title>
        <itunes:title>A health and care emergency, the US constitutional weakness for pandemic response, ActionAid in conflict zones</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/a-health-and-care-emergency-the-us-constitutional-weakness-for-pandemic-response-actionaid-in-conflict-zones/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/a-health-and-care-emergency-the-us-constitutional-weakness-for-pandemic-response-actionaid-in-conflict-zones/#comments</comments>        <pubDate>Fri, 02 Feb 2024 17:59:55 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/76386833-b5e1-3cae-a426-9db3c6f6a038</guid>
                                    <description><![CDATA[
<p>With a new logo, and new music, comes a revamped The BMJ Podcast.</p>
<p>Every two weeks we’ll be bringing you a magazine style show, more variety and perspectives on medicine, health, and wellbeing.</p>
In this episode:
<ul><li style="font-weight:400;">Former chief executive of the NHS, Nigel Crisp, explaining why the UK is  facing a national health and care emergency (01:22)</li>
<li style="font-weight:400;">The guest editors of our US covid series, Gavin Yamey and Ana Diez Roux, discuss the US pandemic response, and how problems are built into the US constitution (19:48)</li>
<li style="font-weight:400;">How The BMJ’s ActionAid appeal will help people in Gaza, Syria and Somalia (33:06)</li>
</ul>

 
Reading list:
<ul><li class="stack gap-1"><a href='https://www.bmj.com/nhs-commission'>The BMJ Commission on the Future of the NHS</a></li>
<li class="stack gap-1"><a href='https://www.bmj.com/collections/us-covid-series'>US covid-19 lessons for future health protection and preparedness</a></li>
<li class="stack gap-1"><a href='https://www.bmj.com/content/384/bmj.q39'>The BMJ Appeal 2023-24: ActionAid offers immediate and long term help</a></li>
</ul>
]]></description>
                                                            <content:encoded><![CDATA[
<p>With a new logo, and new music, comes a revamped <em>The BMJ Podcast</em>.</p>
<p>Every two weeks we’ll be bringing you a magazine style show, more variety and perspectives on medicine, health, and wellbeing.</p>
In this episode:<br>
<ul><li style="font-weight:400;">Former chief executive of the NHS, Nigel Crisp, explaining why the UK is  facing a national health and care emergency (01:22)</li>
<li style="font-weight:400;">The guest editors of our US covid series, Gavin Yamey and Ana Diez Roux, discuss the US pandemic response, and how problems are built into the US constitution (19:48)</li>
<li style="font-weight:400;">How The BMJ’s ActionAid appeal will help people in Gaza, Syria and Somalia (33:06)</li>
</ul>

 
Reading list:
<ul><li class="stack gap-1"><a href='https://www.bmj.com/nhs-commission'>The BMJ Commission on the Future of the NHS</a></li>
<li class="stack gap-1"><a href='https://www.bmj.com/collections/us-covid-series'>US covid-19 lessons for future health protection and preparedness</a></li>
<li class="stack gap-1"><a href='https://www.bmj.com/content/384/bmj.q39'>The BMJ Appeal 2023-24: ActionAid offers immediate and long term help</a></li>
</ul>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/k7vak4/2nd_of_Feb_mixdownb4eg8.mp3" length="57308779" type="audio/mpeg"/>
        <itunes:summary><![CDATA[
With a new logo, and new music, comes a revamped The BMJ Podcast.
Every two weeks we’ll be bringing you a magazine style show, more variety and perspectives on medicine, health, and wellbeing.
In this episode:Former chief executive of the NHS, Nigel Crisp, explaining why the UK is  facing a national health and care emergency (01:22)
The guest editors of our US covid series, Gavin Yamey and Ana Diez Roux, discuss the US pandemic response, and how problems are built into the US constitution (19:48)
How The BMJ’s ActionAid appeal will help people in Gaza, Syria and Somalia (33:06)

 
Reading list:
The BMJ Commission on the Future of the NHS
US covid-19 lessons for future health protection and preparedness
The BMJ Appeal 2023-24: ActionAid offers immediate and long term help
]]></itunes:summary>
        <itunes:author>BMJ Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2386</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog16196630/Screenshot_2024-02-02_at_174645_4serfu.png" />    </item>
    <item>
        <title>Christmas 2023 - performing medicine, and prescribing nature</title>
        <itunes:title>Christmas 2023 - performing medicine, and prescribing nature</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/christmas-2023-performing-medicine-and-prescribing-nature/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/christmas-2023-performing-medicine-and-prescribing-nature/#comments</comments>        <pubDate>Fri, 22 Dec 2023 19:11:55 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/3c7cc790-a5ff-305a-ae55-22756d7f6fa6</guid>
                                    <description><![CDATA[<p> </p>
<p>In this festive edition of the BMJ podcast, we hear about what medicine can learn from music, when it comes to giving a convincing performance, and how we can grow an evidence base for nature prescribing.</p>
<p> </p>
<p>Professors Roger Kneebone and Aaron William of the Centre for Performance Science raise the curtain on the performance of medicine, and we hear what your consultation technique could learn from a hairstylist.</p>
<p> </p>
<p>Ruth Garside, Professor of Evidence Synthesis, Kerryn Husk, Associate Professor of Health Sciences and Edward Chapman from the Health and Environment Public Engagement Group then discuss 'nature prescribing', and wonder about how to balance maintaining the joy derived from nature and yet create an evidence base for the medicinal benefits associated with it.</p>
<p> </p>
<p>Reading list</p>
<p><a href='https://www.bmj.com/content/383/bmj.p2710'>Medicine: a performing art</a></p>
<p><a href='https://www.bmj.com/content/383/bmj.p2745'>Nature prescribing</a></p>
<p> </p>
<p> </p>
<p>00:13 Introduction to the BMJ Podcast
00:36 Exploring the Themes of the Christmas Edition
01:38 The Intersection of Medicine and Performance
02:33 The Art and Science of Performance in Medicine
05:04 The Role of Performance in Music
06:29 The Similarities Between Medicine and Music
08:06 The Role of Experiential Learning in Performance
14:11 The Impact of Audience on Performance
19:04 The Benefits of Nature and Green Prescribing
24:52 The Challenges of Measuring the Impact of Nature Prescribing
30:37 The Community's Engagement with Nature Prescribing
33:01 Conclusion and Farewell</p>
]]></description>
                                                            <content:encoded><![CDATA[<p> </p>
<p>In this festive edition of the BMJ podcast, we hear about what medicine can learn from music, when it comes to giving a convincing performance, and how we can grow an evidence base for nature prescribing.</p>
<p> </p>
<p>Professors Roger Kneebone and Aaron William of the Centre for Performance Science raise the curtain on the performance of medicine, and we hear what your consultation technique could learn from a hairstylist.</p>
<p> </p>
<p>Ruth Garside, Professor of Evidence Synthesis, Kerryn Husk, Associate Professor of Health Sciences and Edward Chapman from the Health and Environment Public Engagement Group then discuss 'nature prescribing', and wonder about how to balance maintaining the joy derived from nature and yet create an evidence base for the medicinal benefits associated with it.</p>
<p> </p>
<p>Reading list</p>
<p><a href='https://www.bmj.com/content/383/bmj.p2710'>Medicine: a performing art</a></p>
<p><a href='https://www.bmj.com/content/383/bmj.p2745'>Nature prescribing</a></p>
<p> </p>
<p> </p>
<p>00:13 Introduction to the BMJ Podcast<br>
00:36 Exploring the Themes of the Christmas Edition<br>
01:38 The Intersection of Medicine and Performance<br>
02:33 The Art and Science of Performance in Medicine<br>
05:04 The Role of Performance in Music<br>
06:29 The Similarities Between Medicine and Music<br>
08:06 The Role of Experiential Learning in Performance<br>
14:11 The Impact of Audience on Performance<br>
19:04 The Benefits of Nature and Green Prescribing<br>
24:52 The Challenges of Measuring the Impact of Nature Prescribing<br>
30:37 The Community's Engagement with Nature Prescribing<br>
33:01 Conclusion and Farewell</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hhcdaq/Christmas_2023_-_Performing_medicine_and_prescribing_nature84mgq.mp3" length="48372617" type="audio/mpeg"/>
        <itunes:summary><![CDATA[ 
In this festive edition of the BMJ podcast, we hear about what medicine can learn from music, when it comes to giving a convincing performance, and how we can grow an evidence base for nature prescribing.
 
Professors Roger Kneebone and Aaron William of the Centre for Performance Science raise the curtain on the performance of medicine, and we hear what your consultation technique could learn from a hairstylist.
 
Ruth Garside, Professor of Evidence Synthesis, Kerryn Husk, Associate Professor of Health Sciences and Edward Chapman from the Health and Environment Public Engagement Group then discuss 'nature prescribing', and wonder about how to balance maintaining the joy derived from nature and yet create an evidence base for the medicinal benefits associated with it.
 
Reading list
Medicine: a performing art
Nature prescribing
 
 
00:13 Introduction to the BMJ Podcast00:36 Exploring the Themes of the Christmas Edition01:38 The Intersection of Medicine and Performance02:33 The Art and Science of Performance in Medicine05:04 The Role of Performance in Music06:29 The Similarities Between Medicine and Music08:06 The Role of Experiential Learning in Performance14:11 The Impact of Audience on Performance19:04 The Benefits of Nature and Green Prescribing24:52 The Challenges of Measuring the Impact of Nature Prescribing30:37 The Community's Engagement with Nature Prescribing33:01 Conclusion and Farewell]]></itunes:summary>
        <itunes:author>BMJ Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2014</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Oxytocin, clinical outcomes, and patient choice, in resource constrained settings</title>
        <itunes:title>Oxytocin, clinical outcomes, and patient choice, in resource constrained settings</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/oxytocin-clinical-outcomes-and-patient-choice-in-resource-constrained-settings/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/oxytocin-clinical-outcomes-and-patient-choice-in-resource-constrained-settings/#comments</comments>        <pubDate>Thu, 21 Dec 2023 17:35:08 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/0c09f772-ab3b-3e72-9537-4304e86e449c</guid>
                                    <description><![CDATA[<p>There’s an inherent tension between creating quality standards that are very clinically focussed, and standards which are very patient centred - especially in settings where clinical outcomes can be compromised by basic lack of resources. </p>
<p>The use of oxytocin to prevent bleeding after birth is an example of this - WHO quality guidelines clearly measure and incentivise use of the drug, but in more wealthy healthcare systems, adherence patient preference is the key measure.</p>
<p>How can we ensure that less wealthy healthcare systems are also patient centred?</p>
<p> </p>
<p>Our guests for this discussion;</p>
<p>Nana Twum-Danso, ​senior vice president, Institute for Healthcare Improvement (IHI)</p>
<p>Paul Dsane-Aidoo, health specialist, UNICEF Ghana</p>
<p>Keith Cloete, head of department at Western Cape Government: Health</p>
<p>Hosted by Emma Veitch, Collections editor for The BMJ</p>
<p> </p>
<p>This podcast is part of The BMJ Quality of Care collection, in collaboration with the World Health Organization and the World Bank, which offers critical thinking on both the unfinished agenda and emerging priorities for improving quality of care in low- and middle-income countries.</p>
<p>

</p>
<p>00:00 Introduction to the podcast</p>
<p>00:48 Introduction of experts and their backgrounds</p>
<p>02:54 Challenges in healthcare systems: south africa's perspective</p>
<p>04:15 The importance of patient-centred care</p>
<p>04:56 The role of data in improving quality of care</p>
<p>06:11 Community engagement and feedback in healthcare</p>
<p>07:58 Tackling global disparities in healthcare</p>
<p>08:41 Balancing clinical outcomes and patient-centred care</p>
<p>10:58 Addressing inequities in healthcare</p>
<p>22:43 The role of governance in improving quality of care</p>
<p>32:56 Overcoming resource constraints in healthcare</p>
<p>36:22 The need for system redesign in healthcare</p>
<p>37:18 Adapting to changing times in healthcare</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>There’s an inherent tension between creating quality standards that are very clinically focussed, and standards which are very patient centred - especially in settings where clinical outcomes can be compromised by basic lack of resources. </p>
<p>The use of oxytocin to prevent bleeding after birth is an example of this - WHO quality guidelines clearly measure and incentivise use of the drug, but in more wealthy healthcare systems, adherence patient preference is the key measure.</p>
<p>How can we ensure that less wealthy healthcare systems are also patient centred?</p>
<p> </p>
<p>Our guests for this discussion;</p>
<p>Nana Twum-Danso, ​senior vice president, Institute for Healthcare Improvement (IHI)</p>
<p>Paul Dsane-Aidoo, health specialist, UNICEF Ghana</p>
<p>Keith Cloete, head of department at Western Cape Government: Health</p>
<p>Hosted by Emma Veitch, Collections editor for The BMJ</p>
<p> </p>
<p>This podcast is part of The BMJ Quality of Care collection, in collaboration with the World Health Organization and the World Bank, which offers critical thinking on both the unfinished agenda and emerging priorities for improving quality of care in low- and middle-income countries.</p>
<p><br>
<br>
</p>
<p>00:00 Introduction to the podcast</p>
<p>00:48 Introduction of experts and their backgrounds</p>
<p>02:54 Challenges in healthcare systems: south africa's perspective</p>
<p>04:15 The importance of patient-centred care</p>
<p>04:56 The role of data in improving quality of care</p>
<p>06:11 Community engagement and feedback in healthcare</p>
<p>07:58 Tackling global disparities in healthcare</p>
<p>08:41 Balancing clinical outcomes and patient-centred care</p>
<p>10:58 Addressing inequities in healthcare</p>
<p>22:43 The role of governance in improving quality of care</p>
<p>32:56 Overcoming resource constraints in healthcare</p>
<p>36:22 The need for system redesign in healthcare</p>
<p>37:18 Adapting to changing times in healthcare</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9hg6fk/Quality_in_a_resource_constrained_context_mixdownapq27.mp3" length="57001412" type="audio/mpeg"/>
        <itunes:summary><![CDATA[There’s an inherent tension between creating quality standards that are very clinically focussed, and standards which are very patient centred - especially in settings where clinical outcomes can be compromised by basic lack of resources. 
The use of oxytocin to prevent bleeding after birth is an example of this - WHO quality guidelines clearly measure and incentivise use of the drug, but in more wealthy healthcare systems, adherence patient preference is the key measure.
How can we ensure that less wealthy healthcare systems are also patient centred?
 
Our guests for this discussion;
Nana Twum-Danso, ​senior vice president, Institute for Healthcare Improvement (IHI)
Paul Dsane-Aidoo, health specialist, UNICEF Ghana
Keith Cloete, head of department at Western Cape Government: Health
Hosted by Emma Veitch, Collections editor for The BMJ
 
This podcast is part of The BMJ Quality of Care collection, in collaboration with the World Health Organization and the World Bank, which offers critical thinking on both the unfinished agenda and emerging priorities for improving quality of care in low- and middle-income countries.

00:00 Introduction to the podcast
00:48 Introduction of experts and their backgrounds
02:54 Challenges in healthcare systems: south africa's perspective
04:15 The importance of patient-centred care
04:56 The role of data in improving quality of care
06:11 Community engagement and feedback in healthcare
07:58 Tackling global disparities in healthcare
08:41 Balancing clinical outcomes and patient-centred care
10:58 Addressing inequities in healthcare
22:43 The role of governance in improving quality of care
32:56 Overcoming resource constraints in healthcare
36:22 The need for system redesign in healthcare
37:18 Adapting to changing times in healthcare]]></itunes:summary>
        <itunes:author>BMJ Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2374</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Social connection is essential for health; supporting adolescent health and wellbeing</title>
        <itunes:title>Social connection is essential for health; supporting adolescent health and wellbeing</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/social-connection-is-essential-for-health-supporting-adolescent-health-and-wellbeing/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/social-connection-is-essential-for-health-supporting-adolescent-health-and-wellbeing/#comments</comments>        <pubDate>Thu, 14 Dec 2023 21:18:35 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/289c14a7-8e7d-3659-b0d8-38cb99b77cb7</guid>
                                    <description><![CDATA[<p>In this specially curated three-part podcast series from The BMJ, we explore the importance of community and connection to foster adolescent wellbeing.</p>
<p> </p>
<p>The discussion covers athe  wide array of issues young people face, with a particular focus on the unique challenges of adolescence from a social perspective. The episode unpacks the significance of having supportive relationships within families, schools, and communities and the influence of these relationships on the mental and behavioural health outcomes of adolescents. </p>
<p> </p>
<p>It also explores the impact of digitalization on adolescent connection, with discussions on how to balance online interactions with offline engagements. Importantly, it highlights the need for further research into understanding digital and social media interactions and their influence on the health and wellbeing of adolescents in a rapidly evolving digital landscape.</p>
<p> </p>
<p>Our guests:</p>
<p>Ulises Ariel Vélez Gauna, Transmitiendo Diversidad</p>
<p>Flavia Bustreo, Fondation Botnar </p>
<p>Richard Dzikunu, YIELD Hub</p>
<p>Shelani Palihawadana, Young Experts Tech for Health.</p>
<p>Joanna Lai, United Nations International Children’s Emergency Fund (UNICEFUnicef)</p>
<p>Hosted by Adam Levy</p>
<p>

</p>
<p>Supported by the Fondation Botnar and PMNCH, the Partnership for Maternal, Newborn, and Child Health. <a href='https://www.bmj.com/adolescent-wellbeing'>Read the full cCollection of articles showing the importance of investing in adolescent wellbeing</a>.</p>
<p>

</p>
<p>00:04 Introduction to the podcast series</p>
<p>00:36 Understanding adolescence from a social perspective</p>
<p>01:00 The impact of community and connection on adolescents</p>
<p>01:07 Personal experiences: growing up as an LGBT+ teenager</p>
<p>01:38 The role of supportive relationships in adolescents' lives</p>
<p>02:05 The importance of connectedness in adolescence and beyond</p>
<p>03:27 Treating safe spaces for LGBT+ adolescents</p>
<p>05:23 The unique role of community during adolescence</p>
<p>07:02 The impact of political landscape on LGBT+ community</p>
<p>07:54 The importance of community and connectedness: expert opinions</p>
<p>08:56 The interconnection of social, health, and educational well-being</p>
<p>12:14 The role of digital technology in adolescents' lives</p>
<p>16:56 The importance of investing in adolescents' well-being</p>
<p>43:18 The role of schools in fostering connectedness</p>
<p>45:41 Conclusion: personal reflections on connectedness</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this specially curated three-part podcast series from The BMJ, we explore the importance of community and connection to foster adolescent wellbeing.</p>
<p> </p>
<p>The discussion covers athe  wide array of issues young people face, with a particular focus on the unique challenges of adolescence from a social perspective. The episode unpacks the significance of having supportive relationships within families, schools, and communities and the influence of these relationships on the mental and behavioural health outcomes of adolescents. </p>
<p> </p>
<p>It also explores the impact of digitalization on adolescent connection, with discussions on how to balance online interactions with offline engagements. Importantly, it highlights the need for further research into understanding digital and social media interactions and their influence on the health and wellbeing of adolescents in a rapidly evolving digital landscape.</p>
<p> </p>
<p>Our guests:</p>
<p>Ulises Ariel Vélez Gauna, Transmitiendo Diversidad</p>
<p>Flavia Bustreo, Fondation Botnar </p>
<p>Richard Dzikunu, YIELD Hub</p>
<p>Shelani Palihawadana, Young Experts Tech for Health.</p>
<p>Joanna Lai, United Nations International Children’s Emergency Fund (UNICEFUnicef)</p>
<p>Hosted by Adam Levy</p>
<p><br>
<br>
</p>
<p>Supported by the Fondation Botnar and PMNCH, the Partnership for Maternal, Newborn, and Child Health. <a href='https://www.bmj.com/adolescent-wellbeing'>Read the full cCollection of articles showing the importance of investing in adolescent wellbeing</a>.</p>
<p><br>
<br>
</p>
<p>00:04 Introduction to the podcast series</p>
<p>00:36 Understanding adolescence from a social perspective</p>
<p>01:00 The impact of community and connection on adolescents</p>
<p>01:07 Personal experiences: growing up as an LGBT+ teenager</p>
<p>01:38 The role of supportive relationships in adolescents' lives</p>
<p>02:05 The importance of connectedness in adolescence and beyond</p>
<p>03:27 Treating safe spaces for LGBT+ adolescents</p>
<p>05:23 The unique role of community during adolescence</p>
<p>07:02 The impact of political landscape on LGBT+ community</p>
<p>07:54 The importance of community and connectedness: expert opinions</p>
<p>08:56 The interconnection of social, health, and educational well-being</p>
<p>12:14 The role of digital technology in adolescents' lives</p>
<p>16:56 The importance of investing in adolescents' well-being</p>
<p>43:18 The role of schools in fostering connectedness</p>
<p>45:41 Conclusion: personal reflections on connectedness</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/iucgq7/BMJ_Episode_1_V99w0hb.mp3" length="69691212" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this specially curated three-part podcast series from The BMJ, we explore the importance of community and connection to foster adolescent wellbeing.
 
The discussion covers athe  wide array of issues young people face, with a particular focus on the unique challenges of adolescence from a social perspective. The episode unpacks the significance of having supportive relationships within families, schools, and communities and the influence of these relationships on the mental and behavioural health outcomes of adolescents. 
 
It also explores the impact of digitalization on adolescent connection, with discussions on how to balance online interactions with offline engagements. Importantly, it highlights the need for further research into understanding digital and social media interactions and their influence on the health and wellbeing of adolescents in a rapidly evolving digital landscape.
 
Our guests:
Ulises Ariel Vélez Gauna, Transmitiendo Diversidad
Flavia Bustreo, Fondation Botnar 
Richard Dzikunu, YIELD Hub
Shelani Palihawadana, Young Experts Tech for Health.
Joanna Lai, United Nations International Children’s Emergency Fund (UNICEFUnicef)
Hosted by Adam Levy

Supported by the Fondation Botnar and PMNCH, the Partnership for Maternal, Newborn, and Child Health. Read the full cCollection of articles showing the importance of investing in adolescent wellbeing.

00:04 Introduction to the podcast series
00:36 Understanding adolescence from a social perspective
01:00 The impact of community and connection on adolescents
01:07 Personal experiences: growing up as an LGBT+ teenager
01:38 The role of supportive relationships in adolescents' lives
02:05 The importance of connectedness in adolescence and beyond
03:27 Treating safe spaces for LGBT+ adolescents
05:23 The unique role of community during adolescence
07:02 The impact of political landscape on LGBT+ community
07:54 The importance of community and connectedness: expert opinions
08:56 The interconnection of social, health, and educational well-being
12:14 The role of digital technology in adolescents' lives
16:56 The importance of investing in adolescents' well-being
43:18 The role of schools in fostering connectedness
45:41 Conclusion: personal reflections on connectedness]]></itunes:summary>
        <itunes:author>BMJ Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2887</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Give children control; supporting adolescent health and wellbeing</title>
        <itunes:title>Give children control; supporting adolescent health and wellbeing</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/give-children-control-supporting-adolescent-health-and-wellbeing/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/give-children-control-supporting-adolescent-health-and-wellbeing/#comments</comments>        <pubDate>Thu, 14 Dec 2023 21:18:25 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/7335304f-36c1-32ef-a453-cbde08573ae6</guid>
                                    <description><![CDATA[<p>This is the second episode of a special three-part podcast series that delves into adolescent health and wellbeing, focusing on creating a positive trajectory of health from a young age.</p>
<p> </p>
<p>The podcast explores physical and mental health issues affecting young people globally, particularly in sexual and reproductive health. We hear how young people are excluded from decisions about their own health, and how grassroots groups around the world are empowering them to take responsibility for their own wellbeing.</p>
<p> </p>
<p>We also hear how young people are becoming leaders in social movements, from tackling structural racism to improving nutrition in schools, and how their unique perspectives are vital in making those changes.</p>
<p> </p>
<p>Our guests:</p>
<p>Natasha Salifyanji Kaoma, Copper Rose Zambia</p>
<p>Alaa Murabit, The Bill and Melinda Gates Foundation</p>
<p>Donald Bundy, London School of Hygiene and Tropical Medicine</p>
<p>Anshu Banerjee, World Health Organisation</p>
<p>Dev Sharma, Bite Back 2030</p>
<p>Hosted by Adam Levy</p>
<p>

</p>
<p>Supported by the Fondation Botnar and PMNCH, the Partnership for Maternal, Newborn, and Child Health. <a href='https://www.bmj.com/adolescent-wellbeing'>Read the full cCollection of articles showing the importance of investing in adolescent wellbeing</a>.</p>
<p>


</p>
<p>00:05 Introduction to adolescent health</p>
<p>01:00 Young womens’ menstrual health</p>
<p>02:11 Discussion on candid pride project</p>
<p>03:29 Importance of sexual and reproductive health</p>
<p>04:49 The role of young people in health advocacy</p>
<p>06:17 The epidemiology of early health and lifecourse</p>
<p>10:08 Impact of adolescent health on future generations</p>
<p>18:29 How young people become activists</p>
<p>28:51 Advocacy for women in Libya</p>
<p>28:54 Global forum for adolescents</p>
<p>40:15 Success stories </p>
<p>44:54 Conclusion and preview of next episode</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This is the second episode of a special three-part podcast series that delves into adolescent health and wellbeing, focusing on creating a positive trajectory of health from a young age.</p>
<p> </p>
<p>The podcast explores physical and mental health issues affecting young people globally, particularly in sexual and reproductive health. We hear how young people are excluded from decisions about their own health, and how grassroots groups around the world are empowering them to take responsibility for their own wellbeing.</p>
<p> </p>
<p>We also hear how young people are becoming leaders in social movements, from tackling structural racism to improving nutrition in schools, and how their unique perspectives are vital in making those changes.</p>
<p> </p>
<p>Our guests:</p>
<p>Natasha Salifyanji Kaoma, Copper Rose Zambia</p>
<p>Alaa Murabit, The Bill and Melinda Gates Foundation</p>
<p>Donald Bundy, London School of Hygiene and Tropical Medicine</p>
<p>Anshu Banerjee, World Health Organisation</p>
<p>Dev Sharma, Bite Back 2030</p>
<p>Hosted by Adam Levy</p>
<p><br>
<br>
</p>
<p>Supported by the Fondation Botnar and PMNCH, the Partnership for Maternal, Newborn, and Child Health. <a href='https://www.bmj.com/adolescent-wellbeing'>Read the full cCollection of articles showing the importance of investing in adolescent wellbeing</a>.</p>
<p><br>
<br>
<br>
</p>
<p>00:05 Introduction to adolescent health</p>
<p>01:00 Young womens’ menstrual health</p>
<p>02:11 Discussion on candid pride project</p>
<p>03:29 Importance of sexual and reproductive health</p>
<p>04:49 The role of young people in health advocacy</p>
<p>06:17 The epidemiology of early health and lifecourse</p>
<p>10:08 Impact of adolescent health on future generations</p>
<p>18:29 How young people become activists</p>
<p>28:51 Advocacy for women in Libya</p>
<p>28:54 Global forum for adolescents</p>
<p>40:15 Success stories </p>
<p>44:54 Conclusion and preview of next episode</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xj2y94/BMJ_Episode_2_V57nt5e.mp3" length="66743616" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This is the second episode of a special three-part podcast series that delves into adolescent health and wellbeing, focusing on creating a positive trajectory of health from a young age.
 
The podcast explores physical and mental health issues affecting young people globally, particularly in sexual and reproductive health. We hear how young people are excluded from decisions about their own health, and how grassroots groups around the world are empowering them to take responsibility for their own wellbeing.
 
We also hear how young people are becoming leaders in social movements, from tackling structural racism to improving nutrition in schools, and how their unique perspectives are vital in making those changes.
 
Our guests:
Natasha Salifyanji Kaoma, Copper Rose Zambia
Alaa Murabit, The Bill and Melinda Gates Foundation
Donald Bundy, London School of Hygiene and Tropical Medicine
Anshu Banerjee, World Health Organisation
Dev Sharma, Bite Back 2030
Hosted by Adam Levy

Supported by the Fondation Botnar and PMNCH, the Partnership for Maternal, Newborn, and Child Health. Read the full cCollection of articles showing the importance of investing in adolescent wellbeing.

00:05 Introduction to adolescent health
01:00 Young womens’ menstrual health
02:11 Discussion on candid pride project
03:29 Importance of sexual and reproductive health
04:49 The role of young people in health advocacy
06:17 The epidemiology of early health and lifecourse
10:08 Impact of adolescent health on future generations
18:29 How young people become activists
28:51 Advocacy for women in Libya
28:54 Global forum for adolescents
40:15 Success stories 
44:54 Conclusion and preview of next episode]]></itunes:summary>
        <itunes:author>BMJ Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2729</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>It’s time for an educational revolution; supporting adolescent health and wellbeing</title>
        <itunes:title>It’s time for an educational revolution; supporting adolescent health and wellbeing</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/it-s-time-for-an-educational-revolution-ssupporting-adolescent-health-and-wellbeing/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/it-s-time-for-an-educational-revolution-ssupporting-adolescent-health-and-wellbeing/#comments</comments>        <pubDate>Thu, 14 Dec 2023 21:18:13 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/7f103bf3-8d55-3ff9-9a1b-0b564008f321</guid>
                                    <description><![CDATA[<p>In the final episode of this three-part podcast series from The BMJ, we dive into the vital topic of education for adolescents and how it influences the course of life. </p>
<p> </p>
<p>This podcast explores barriers, burdens and possibilities of change in the educational system to better support young people, and how the traditional system of schooling is failing to equip young people with the skills and knowledge to lead healthy lives.</p>
<p> </p>
<p>We also hear how the value of informal education and its impact on subjects ranging from health to gender equality, and that learning isn’t limited to young people, and the intergenerational benefits of education and its role in shaping societal norms and individual health. </p>
<p> </p>
<p>Our guests;</p>
<p> </p>
<p>Maziko Matemvu, Uwale</p>
<p>Joanna Herat, UNESCO</p>
<p>Janani Vijayaraghavan, Plan Canada</p>
<p>Atika Ajra Ayon, Plan International</p>
<p>Stefan Germann, Fondation Botnar </p>
<p>Hosted by Adam Levy</p>
<p> </p>
<p>Supported by the Fondation Botnar and PMNCH, the Partnership for Maternal, Newborn, and Child Health. <a href='https://www.bmj.com/adolescent-wellbeing'>Read the full cCollection of articles showing the importance of investing in adolescent wellbeing</a>.</p>
<p>

</p>
<p>00:03 Introduction to the podcast</p>
<p>00:11 The importance of education for adolescents</p>
<p>03:26 The role of education in health and wellbeing</p>
<p>04:43 The impact of education on society</p>
<p>10:21 The power of peer education</p>
<p>11:15 The role of media in education</p>
<p>12:31 The importance of meaningful engagement in education</p>
<p>14:45 The impact of education on health</p>
<p>17:48 The challenges in access to education</p>
<p>26:25 The role of education in combating child marriage</p>
<p>36:37 The impact of climate change on education</p>
<p>44:53 The role of education in mental wellbeing</p>
<p>45:59 Conclusion of the podcast</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In the final episode of this three-part podcast series from The BMJ, we dive into the vital topic of education for adolescents and how it influences the course of life. </p>
<p> </p>
<p>This podcast explores barriers, burdens and possibilities of change in the educational system to better support young people, and how the traditional system of schooling is failing to equip young people with the skills and knowledge to lead healthy lives.</p>
<p> </p>
<p>We also hear how the value of informal education and its impact on subjects ranging from health to gender equality, and that learning isn’t limited to young people, and the intergenerational benefits of education and its role in shaping societal norms and individual health. </p>
<p> </p>
<p>Our guests;</p>
<p> </p>
<p>Maziko Matemvu, Uwale</p>
<p>Joanna Herat, UNESCO</p>
<p>Janani Vijayaraghavan, Plan Canada</p>
<p>Atika Ajra Ayon, Plan International</p>
<p>Stefan Germann, Fondation Botnar </p>
<p>Hosted by Adam Levy</p>
<p> </p>
<p>Supported by the Fondation Botnar and PMNCH, the Partnership for Maternal, Newborn, and Child Health. <a href='https://www.bmj.com/adolescent-wellbeing'>Read the full cCollection of articles showing the importance of investing in adolescent wellbeing</a>.</p>
<p><br>
<br>
</p>
<p>00:03 Introduction to the podcast</p>
<p>00:11 The importance of education for adolescents</p>
<p>03:26 The role of education in health and wellbeing</p>
<p>04:43 The impact of education on society</p>
<p>10:21 The power of peer education</p>
<p>11:15 The role of media in education</p>
<p>12:31 The importance of meaningful engagement in education</p>
<p>14:45 The impact of education on health</p>
<p>17:48 The challenges in access to education</p>
<p>26:25 The role of education in combating child marriage</p>
<p>36:37 The impact of climate change on education</p>
<p>44:53 The role of education in mental wellbeing</p>
<p>45:59 Conclusion of the podcast</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3qqnki/BMJ_Episode_3_V36ttmm.mp3" length="68091398" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In the final episode of this three-part podcast series from The BMJ, we dive into the vital topic of education for adolescents and how it influences the course of life. 
 
This podcast explores barriers, burdens and possibilities of change in the educational system to better support young people, and how the traditional system of schooling is failing to equip young people with the skills and knowledge to lead healthy lives.
 
We also hear how the value of informal education and its impact on subjects ranging from health to gender equality, and that learning isn’t limited to young people, and the intergenerational benefits of education and its role in shaping societal norms and individual health. 
 
Our guests;
 
Maziko Matemvu, Uwale
Joanna Herat, UNESCO
Janani Vijayaraghavan, Plan Canada
Atika Ajra Ayon, Plan International
Stefan Germann, Fondation Botnar 
Hosted by Adam Levy
 
Supported by the Fondation Botnar and PMNCH, the Partnership for Maternal, Newborn, and Child Health. Read the full cCollection of articles showing the importance of investing in adolescent wellbeing.

00:03 Introduction to the podcast
00:11 The importance of education for adolescents
03:26 The role of education in health and wellbeing
04:43 The impact of education on society
10:21 The power of peer education
11:15 The role of media in education
12:31 The importance of meaningful engagement in education
14:45 The impact of education on health
17:48 The challenges in access to education
26:25 The role of education in combating child marriage
36:37 The impact of climate change on education
44:53 The role of education in mental wellbeing
45:59 Conclusion of the podcast]]></itunes:summary>
        <itunes:author>BMJ Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2787</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Insulin without refrigeration and the complexities of consent</title>
        <itunes:title>Insulin without refrigeration and the complexities of consent</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/insulin-without-refrigeration-and-the-complexities-of-consent/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/insulin-without-refrigeration-and-the-complexities-of-consent/#comments</comments>        <pubDate>Tue, 12 Dec 2023 09:26:26 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/de8fed97-9a9f-3294-aa28-7d9b1fea47c5</guid>
                                    <description><![CDATA[<p class="p1">The December edition of the Talk Evidence podcast discusses the complexities of seeking consent from patients who are part of large data sets, and some new research to help patients living with diabetes in places without certain power supplies.</p>
<p class="p1">First patient consent and data - in the UK,  two stories that have made the public worry about the use of their health data. Firstly the news that UK biobank, who hold a lot of genomic and health data, allowed research by an insurance company, and second that the NHS has entered a contract with Palentir to do analysis on NHS data.</p>
<p class="p1">Natalie Banner, director of ethics at Genomics England has been thinking hard about putting patients at the centre of decision making about their data, and explains why she thinks a sole reliance on a consent model falls short.</p>
<p class="p1">Next, uncertain power supplies, such as in conflict or disaster zones, means uncertain refrigeration. Hard enough for most people to survive, but if you need to keep your insulin cold, it can be lifethreatening. However a new cochrane review has found good news about the thermostability of insulin at room temperature.</p>
<p class="p1">We ask Phillipa Boulle, MSF Intersectional NCD Working Group Leader and Cyrine Farhat,is  a global diabetes advocate based in Lebanon, how this will affect care for patients around the world.</p>
<p class="p1"> </p>
<p class="p1">Reading list</p>
<p class="p2"><a href='https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015385.pub2/full'>Thermal stability and storage of human insulin</a></p>
<p class="p1"> </p>
<p class="p1">Outline</p>
<p class="p1"> </p>
<p class="p1">00:06 introduction and overview</p>
<p class="p1">00:24 the challenge of seeking consent in big data sets</p>
<p class="p1">01:34 understanding consent issues in large datasets</p>
<p class="p1">01:52 the role of participant panels in data accountability</p>
<p class="p1">02:44 the complexity of public attitudes towards data use</p>
<p class="p1">04:54 the importance of transparency and engagement in data use</p>
<p class="p1">05:48 the impact of external factors on public trust in data use</p>
<p class="p1">07:49 the ethical challenges of using health data</p>
<p class="p1">09:17 the limitations of consent in ethical discussions</p>
<p class="p1">09:23 the need for more conversation about group benefits, risks, and harms</p>
<p class="p1">10:41 the role of governance in ethical decision making</p>
<p class="p1">12:05 discussion on the interview with natalie banner</p>
<p class="p1">14:59 the challenge of managing chronic conditions in disaster zones</p>
<p class="p1">15:15 the impact of temperature and storage conditions on insulin</p>
<p class="p1">17:32 interview with Philippa Boulle from medecins sans frontieres</p>
<p class="p1">29:10 interview with Cyrine Farhat, a person living with diabetes in lebanon</p>
<p class="p1">36:18 discussion on the interviews and the challenges of diabetes management</p>
]]></description>
                                                            <content:encoded><![CDATA[<p class="p1">The December edition of the Talk Evidence podcast discusses the complexities of seeking consent from patients who are part of large data sets, and some new research to help patients living with diabetes in places without certain power supplies.</p>
<p class="p1">First patient consent and data - in the UK,  two stories that have made the public worry about the use of their health data. Firstly the news that UK biobank, who hold a lot of genomic and health data, allowed research by an insurance company, and second that the NHS has entered a contract with Palentir to do analysis on NHS data.</p>
<p class="p1">Natalie Banner, director of ethics at Genomics England has been thinking hard about putting patients at the centre of decision making about their data, and explains why she thinks a sole reliance on a consent model falls short.</p>
<p class="p1">Next, uncertain power supplies, such as in conflict or disaster zones, means uncertain refrigeration. Hard enough for most people to survive, but if you need to keep your insulin cold, it can be lifethreatening. However a new cochrane review has found good news about the thermostability of insulin at room temperature.</p>
<p class="p1">We ask Phillipa Boulle, MSF Intersectional NCD Working Group Leader and Cyrine Farhat,is  a global diabetes advocate based in Lebanon, how this will affect care for patients around the world.</p>
<p class="p1"> </p>
<p class="p1">Reading list</p>
<p class="p2"><a href='https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015385.pub2/full'>Thermal stability and storage of human insulin</a></p>
<p class="p1"> </p>
<p class="p1">Outline</p>
<p class="p1"> </p>
<p class="p1">00:06 introduction and overview</p>
<p class="p1">00:24 the challenge of seeking consent in big data sets</p>
<p class="p1">01:34 understanding consent issues in large datasets</p>
<p class="p1">01:52 the role of participant panels in data accountability</p>
<p class="p1">02:44 the complexity of public attitudes towards data use</p>
<p class="p1">04:54 the importance of transparency and engagement in data use</p>
<p class="p1">05:48 the impact of external factors on public trust in data use</p>
<p class="p1">07:49 the ethical challenges of using health data</p>
<p class="p1">09:17 the limitations of consent in ethical discussions</p>
<p class="p1">09:23 the need for more conversation about group benefits, risks, and harms</p>
<p class="p1">10:41 the role of governance in ethical decision making</p>
<p class="p1">12:05 discussion on the interview with natalie banner</p>
<p class="p1">14:59 the challenge of managing chronic conditions in disaster zones</p>
<p class="p1">15:15 the impact of temperature and storage conditions on insulin</p>
<p class="p1">17:32 interview with Philippa Boulle from medecins sans frontieres</p>
<p class="p1">29:10 interview with Cyrine Farhat, a person living with diabetes in lebanon</p>
<p class="p1">36:18 discussion on the interviews and the challenges of diabetes management</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/w4g6jg/Talk_evidence_70_v29148r.mp3" length="38905823" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The December edition of the Talk Evidence podcast discusses the complexities of seeking consent from patients who are part of large data sets, and some new research to help patients living with diabetes in places without certain power supplies.
First patient consent and data - in the UK,  two stories that have made the public worry about the use of their health data. Firstly the news that UK biobank, who hold a lot of genomic and health data, allowed research by an insurance company, and second that the NHS has entered a contract with Palentir to do analysis on NHS data.
Natalie Banner, director of ethics at Genomics England has been thinking hard about putting patients at the centre of decision making about their data, and explains why she thinks a sole reliance on a consent model falls short.
Next, uncertain power supplies, such as in conflict or disaster zones, means uncertain refrigeration. Hard enough for most people to survive, but if you need to keep your insulin cold, it can be lifethreatening. However a new cochrane review has found good news about the thermostability of insulin at room temperature.
We ask Phillipa Boulle, MSF Intersectional NCD Working Group Leader and Cyrine Farhat,is  a global diabetes advocate based in Lebanon, how this will affect care for patients around the world.
 
Reading list
Thermal stability and storage of human insulin
 
Outline
 
00:06 introduction and overview
00:24 the challenge of seeking consent in big data sets
01:34 understanding consent issues in large datasets
01:52 the role of participant panels in data accountability
02:44 the complexity of public attitudes towards data use
04:54 the importance of transparency and engagement in data use
05:48 the impact of external factors on public trust in data use
07:49 the ethical challenges of using health data
09:17 the limitations of consent in ethical discussions
09:23 the need for more conversation about group benefits, risks, and harms
10:41 the role of governance in ethical decision making
12:05 discussion on the interview with natalie banner
14:59 the challenge of managing chronic conditions in disaster zones
15:15 the impact of temperature and storage conditions on insulin
17:32 interview with Philippa Boulle from medecins sans frontieres
29:10 interview with Cyrine Farhat, a person living with diabetes in lebanon
36:18 discussion on the interviews and the challenges of diabetes management]]></itunes:summary>
        <itunes:author>BMJ Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2431</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The future of the winter ’flu season</title>
        <itunes:title>The future of the winter ’flu season</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-future-of-the-winter-flu-season/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-future-of-the-winter-flu-season/#comments</comments>        <pubDate>Fri, 01 Dec 2023 18:23:05 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/53adc07f-9e74-3010-b123-94109aa8514e</guid>
                                    <description><![CDATA[<p>We were accepting of an increase in deaths every winter 'flu season, but Ashish Jha thinks that is not longer a tenable position.</p>
<p>Lessons he learned during his time as the White House Covid-19 coordinator have convinced him we should be taking a different approach to the winter season.</p>
<p>In this interview with Mun-Keat Looi, The BMJ's international features editor, we hear about living with COVID, the future of antivirals, vaccines, and surveillance. They talk about long COVID, the investment required to fight future outbreaks effectively, and the role of the US in the global health response.</p>
<p> </p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>We were accepting of an increase in deaths every winter 'flu season, but Ashish Jha thinks that is not longer a tenable position.</p>
<p>Lessons he learned during his time as the White House Covid-19 coordinator have convinced him we should be taking a different approach to the winter season.</p>
<p>In this interview with Mun-Keat Looi, The BMJ's international features editor, we hear about living with COVID, the future of antivirals, vaccines, and surveillance. They talk about long COVID, the investment required to fight future outbreaks effectively, and the role of the US in the global health response.</p>
<p> </p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/z9czup/Ashish_Jha_final8701d.mp3" length="55455977" type="audio/mpeg"/>
        <itunes:summary><![CDATA[We were accepting of an increase in deaths every winter 'flu season, but Ashish Jha thinks that is not longer a tenable position.
Lessons he learned during his time as the White House Covid-19 coordinator have convinced him we should be taking a different approach to the winter season.
In this interview with Mun-Keat Looi, The BMJ's international features editor, we hear about living with COVID, the future of antivirals, vaccines, and surveillance. They talk about long COVID, the investment required to fight future outbreaks effectively, and the role of the US in the global health response.
 
 ]]></itunes:summary>
        <itunes:author>BMJ Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2310</itunes:duration>
                <itunes:episode>13</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Low carb and cancer screening</title>
        <itunes:title>Low carb and cancer screening</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/low-carb-and-cancer-screening/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/low-carb-and-cancer-screening/#comments</comments>        <pubDate>Mon, 06 Nov 2023 11:46:40 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/b275a06d-5515-3562-8fe2-1a3741b357f1</guid>
                                    <description><![CDATA[<p>Each episode of Talk Evidence we take a dive into an issue or paper which is in the news, with a little help from some knowledgeable guests to help us to understand what it all means for clinical care, policy, or research. </p>
<p> </p>
<p>In this episode:</p>
<p>Helen Macdonald take a deep dive into cancer screening tests, prompted by a paper in JAMA which showed most have no effect on all cause mortality, and news that the NHS is evaluating a single test which screens for 50 common cancers - we ask Barry Kramer, former director of the Division of Cancer Prevention, at the U.S. National Cancer Institute to help explain how to hold those two pieces of knowledge.</p>
<p>Juan Franco has been looking into diet and obesity, prompted by new research in The BMJ and a new Cochrane review, looking at the role of low glycemic index foods in weightloss - we ask <a href='mailto:khadijachekima@gmail.com'>Khadidja Chekima</a>, nutritional researcher at Taylor’s University in Malaysia, to define low GI foods, and why it’s so hard to research their role in diet and weightloss </p>
<p> </p>
<p>Reading list;</p>
<p>JAMA research - <a href='https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2808648'>Estimated Lifetime Gained With Cancer Screening Tests; A Meta-Analysis of Randomized Clinical Trials</a></p>
<p>The BMJ news - <a href='https://www.bmj.com/content/383/bmj.p2268'>Clinicians raise concerns over pilot of blood test for multiple cancers</a></p>
<p>The BMJ research - <a href='https://www.bmj.com/content/382/bmj-2022-073939'>Association between changes in carbohydrate intake and long term weight changes: prospective cohort study</a></p>
<p>Cochrane review -<a href='https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005105.pub3/full'> Low glycaemic index or low glycaemic load diets for people with overweight or obesity</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Each episode of Talk Evidence we take a dive into an issue or paper which is in the news, with a little help from some knowledgeable guests to help us to understand what it all means for clinical care, policy, or research. </p>
<p> </p>
<p>In this episode:</p>
<p>Helen Macdonald take a deep dive into cancer screening tests, prompted by a paper in JAMA which showed most have no effect on all cause mortality, and news that the NHS is evaluating a single test which screens for 50 common cancers - we ask Barry Kramer, former <em>director of the Division of Cancer Prevention, at the U.S. National Cancer Institute</em> to help explain how to hold those two pieces of knowledge.</p>
<p>Juan Franco has been looking into diet and obesity, prompted by new research in <em>The BMJ</em> and a new Cochrane review, looking at the role of low glycemic index foods in weightloss - we ask <a href='mailto:khadijachekima@gmail.com'>Khadidja Chekima</a>, nutritional researcher at Taylor’s University in Malaysia, to define low GI foods, and why it’s so hard to research their role in diet and weightloss </p>
<p> </p>
<p>Reading list;</p>
<p>JAMA research - <a href='https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2808648'>Estimated Lifetime Gained With Cancer Screening Tests; A Meta-Analysis of Randomized Clinical Trials</a></p>
<p>The BMJ news - <a href='https://www.bmj.com/content/383/bmj.p2268'>Clinicians raise concerns over pilot of blood test for multiple cancers</a></p>
<p>The BMJ research - <a href='https://www.bmj.com/content/382/bmj-2022-073939'>Association between changes in carbohydrate intake and long term weight changes: prospective cohort study</a></p>
<p>Cochrane review -<a href='https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005105.pub3/full'> Low glycaemic index or low glycaemic load diets for people with overweight or obesity</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9wxv98/TE_-_69_carbs_and_cancer_screeninga2d05.mp3" length="32032484" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Each episode of Talk Evidence we take a dive into an issue or paper which is in the news, with a little help from some knowledgeable guests to help us to understand what it all means for clinical care, policy, or research. 
 
In this episode:
Helen Macdonald take a deep dive into cancer screening tests, prompted by a paper in JAMA which showed most have no effect on all cause mortality, and news that the NHS is evaluating a single test which screens for 50 common cancers - we ask Barry Kramer, former director of the Division of Cancer Prevention, at the U.S. National Cancer Institute to help explain how to hold those two pieces of knowledge.
Juan Franco has been looking into diet and obesity, prompted by new research in The BMJ and a new Cochrane review, looking at the role of low glycemic index foods in weightloss - we ask Khadidja Chekima, nutritional researcher at Taylor’s University in Malaysia, to define low GI foods, and why it’s so hard to research their role in diet and weightloss 
 
Reading list;
JAMA research - Estimated Lifetime Gained With Cancer Screening Tests; A Meta-Analysis of Randomized Clinical Trials
The BMJ news - Clinicians raise concerns over pilot of blood test for multiple cancers
The BMJ research - Association between changes in carbohydrate intake and long term weight changes: prospective cohort study
Cochrane review - Low glycaemic index or low glycaemic load diets for people with overweight or obesity]]></itunes:summary>
        <itunes:author>BMJ Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2002</itunes:duration>
                <itunes:episode>12</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Decolonising health and medicine: Episode 5 - Getting our house in order: Decolonising the British Medical Association</title>
        <itunes:title>Decolonising health and medicine: Episode 5 - Getting our house in order: Decolonising the British Medical Association</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/decolonising-health-and-medicine-episode-6-getting-our-house-in-order-decolonising-the-british-medical-association/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/decolonising-health-and-medicine-episode-6-getting-our-house-in-order-decolonising-the-british-medical-association/#comments</comments>        <pubDate>Tue, 17 Oct 2023 11:25:26 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/f4e46758-d938-35cc-bf1f-daca4d865a60</guid>
                                    <description><![CDATA[<p>Organisational and student leaders explore the responsibilities of the British Medical Association and The BMJ to understand and respond to its colonial history.</p>
<p>Our panel</p>
<ul><li>Kamran Abassi, editor in chief, The BMJ, London, UK</li>
<li>Omolara Akinnawonu, Foundation year doctor, Essex, UK, and outgoing co-chair of the BMA medical students committee</li>
<li>Latifa Patel, elected chair of the UK BMA's Representative Body and BMA EDI lead</li>
<li>Host - Navjoyt Ladher, clinical editor for The BMJ</li>
<li> </li>
</ul>
]]></description>
                                                            <content:encoded><![CDATA[<p>Organisational and student leaders explore the responsibilities of the British Medical Association and The BMJ to understand and respond to its colonial history.</p>
<p>Our panel</p>
<ul><li>Kamran Abassi, editor in chief, The BMJ, London, UK</li>
<li>Omolara Akinnawonu, Foundation year doctor, Essex, UK, and outgoing co-chair of the BMA medical students committee</li>
<li>Latifa Patel, elected chair of the UK BMA's Representative Body and BMA EDI lead</li>
<li>Host - Navjoyt Ladher, clinical editor for The BMJ</li>
<li> </li>
</ul>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/55vamb/Decolonising_health_-_EP_58a2k0.mp3" length="66586940" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Organisational and student leaders explore the responsibilities of the British Medical Association and The BMJ to understand and respond to its colonial history.
Our panel
Kamran Abassi, editor in chief, The BMJ, London, UK
Omolara Akinnawonu, Foundation year doctor, Essex, UK, and outgoing co-chair of the BMA medical students committee
Latifa Patel, elected chair of the UK BMA's Representative Body and BMA EDI lead
Host - Navjoyt Ladher, clinical editor for The BMJ
 
]]></itunes:summary>
        <itunes:author>BMJ Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2773</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Decolonising health and medicine: Episode 4 - How to transform global health institutions born of colonial eras</title>
        <itunes:title>Decolonising health and medicine: Episode 4 - How to transform global health institutions born of colonial eras</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/decolonising-health-and-medicine-episode-4-how-to-transform-global-health-institutions-born-of-colonial-eras/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/decolonising-health-and-medicine-episode-4-how-to-transform-global-health-institutions-born-of-colonial-eras/#comments</comments>        <pubDate>Tue, 17 Oct 2023 11:25:14 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/334951fb-8fd9-3d46-ab10-a7d467d05f2e</guid>
                                    <description><![CDATA[<p>Leaders from academic and funding organisations discuss the transformative change required to overcome extractive and inequitable research practices in global health, and the need for examining power and privilege within traditional research institutions.</p>
<p>Our panel</p>
<ul><li>Samuel Oti, senior program specialist, International Development Research Centre, Ottawa, Canada, and member of the Global Health Decolonization Movement in Africa (GHDM-Africa)</li>
<li>Muneera Rasheed, clinical psychologist and behaviour scientist and former faculty, Aga Khan University, Karachi, Pakistan</li>
<li>Liam Smeeth, professor of clinical epidemiology and director of the London School of Hygiene and Tropical Medicine, London, UK</li>
<li>Angela Obasi, senior clinical lecturer, Liverpool School of Tropical Medicine, UK</li>
<li>Seye Abimbola, editor of BMJ Global Health, and health systems researcher from Nigeria currently based at the University of Sydney, Australia</li>
<li>Jocalyn Clark, international editor, The BMJ, London, UK</li>
<li>Host - Navjoyt Ladher, clinical editor for The BMJ</li>
<li> </li>
</ul>
]]></description>
                                                            <content:encoded><![CDATA[<p>Leaders from academic and funding organisations discuss the transformative change required to overcome extractive and inequitable research practices in global health, and the need for examining power and privilege within traditional research institutions.</p>
<p>Our panel</p>
<ul><li>Samuel Oti, senior program specialist, International Development Research Centre, Ottawa, Canada, and member of the Global Health Decolonization Movement in Africa (GHDM-Africa)</li>
<li>Muneera Rasheed, clinical psychologist and behaviour scientist and former faculty, Aga Khan University, Karachi, Pakistan</li>
<li>Liam Smeeth, professor of clinical epidemiology and director of the London School of Hygiene and Tropical Medicine, London, UK</li>
<li>Angela Obasi, senior clinical lecturer, Liverpool School of Tropical Medicine, UK</li>
<li>Seye Abimbola, editor of BMJ Global Health, and health systems researcher from Nigeria currently based at the University of Sydney, Australia</li>
<li>Jocalyn Clark, international editor, The BMJ, London, UK</li>
<li>Host - Navjoyt Ladher, clinical editor for The BMJ</li>
<li> </li>
</ul>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/snsgq6/Ep_4_research7datz.mp3" length="77739671" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Leaders from academic and funding organisations discuss the transformative change required to overcome extractive and inequitable research practices in global health, and the need for examining power and privilege within traditional research institutions.
Our panel
Samuel Oti, senior program specialist, International Development Research Centre, Ottawa, Canada, and member of the Global Health Decolonization Movement in Africa (GHDM-Africa)
Muneera Rasheed, clinical psychologist and behaviour scientist and former faculty, Aga Khan University, Karachi, Pakistan
Liam Smeeth, professor of clinical epidemiology and director of the London School of Hygiene and Tropical Medicine, London, UK
Angela Obasi, senior clinical lecturer, Liverpool School of Tropical Medicine, UK
Seye Abimbola, editor of BMJ Global Health, and health systems researcher from Nigeria currently based at the University of Sydney, Australia
Jocalyn Clark, international editor, The BMJ, London, UK
Host - Navjoyt Ladher, clinical editor for The BMJ
 
]]></itunes:summary>
        <itunes:author>BMJ Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3238</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Decolonising health and medicine: Episode 3 - Common terrains of anti-colonial and feminist approaches to the politics of health</title>
        <itunes:title>Decolonising health and medicine: Episode 3 - Common terrains of anti-colonial and feminist approaches to the politics of health</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/decolonising-health-and-medicin-episode-3-common-terrains-of-anti-colonial-and-feminist-approaches-to-the-politics-of-health/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/decolonising-health-and-medicin-episode-3-common-terrains-of-anti-colonial-and-feminist-approaches-to-the-politics-of-health/#comments</comments>        <pubDate>Tue, 17 Oct 2023 11:25:02 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/e0d8ed2b-b60d-3662-8d37-9deda185f5ec</guid>
                                    <description><![CDATA[<p>International health leaders discuss how feminist and decolonial advocates in health face similar resistance and attempts to sow divisiveness, and how they can join forces to promote health equity and justice for all.</p>
<p>Our panel</p>
<ul><li>Raewyn Connell, sociologist and professor emerita at the University of Sydney, Australia</li>
<li>Sarah Hawkes, professor of global public health and director of the Centre for Gender and Global Health, University College London, UK</li>
<li>Sanjoy Bhattacharya, head of the school of history and professor of medical and global health histories, University of Leeds, UK</li>
<li>Asha George, professor and South African research chair in health systems, complexity, and social change, University of the Western Cape, South Africa</li>
<li>Host - Navjoyt Ladher, clinical editor for The BMJ</li>
<li> </li>
</ul>
]]></description>
                                                            <content:encoded><![CDATA[<p>International health leaders discuss how feminist and decolonial advocates in health face similar resistance and attempts to sow divisiveness, and how they can join forces to promote health equity and justice for all.</p>
<p>Our panel</p>
<ul><li>Raewyn Connell, sociologist and professor emerita at the University of Sydney, Australia</li>
<li>Sarah Hawkes, professor of global public health and director of the Centre for Gender and Global Health, University College London, UK</li>
<li>Sanjoy Bhattacharya, head of the school of history and professor of medical and global health histories, University of Leeds, UK</li>
<li>Asha George, professor and South African research chair in health systems, complexity, and social change, University of the Western Cape, South Africa</li>
<li>Host - Navjoyt Ladher, clinical editor for The BMJ</li>
<li> </li>
</ul>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4prxbk/episode_3_decolonising_and_gender6irep.mp3" length="72203625" type="audio/mpeg"/>
        <itunes:summary><![CDATA[International health leaders discuss how feminist and decolonial advocates in health face similar resistance and attempts to sow divisiveness, and how they can join forces to promote health equity and justice for all.
Our panel
Raewyn Connell, sociologist and professor emerita at the University of Sydney, Australia
Sarah Hawkes, professor of global public health and director of the Centre for Gender and Global Health, University College London, UK
Sanjoy Bhattacharya, head of the school of history and professor of medical and global health histories, University of Leeds, UK
Asha George, professor and South African research chair in health systems, complexity, and social change, University of the Western Cape, South Africa
Host - Navjoyt Ladher, clinical editor for The BMJ
 
]]></itunes:summary>
        <itunes:author>BMJ Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3007</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Decolonising health and medicine: Episode 2 - Looking back to move forward: missing histories of the decolonisation agenda</title>
        <itunes:title>Decolonising health and medicine: Episode 2 - Looking back to move forward: missing histories of the decolonisation agenda</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/decolonising-health-and-medicine-episode-2-looking-back-to-move-forward-missing-histories-of-the-decolonisation-agenda/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/decolonising-health-and-medicine-episode-2-looking-back-to-move-forward-missing-histories-of-the-decolonisation-agenda/#comments</comments>        <pubDate>Tue, 17 Oct 2023 11:24:47 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/65dbc699-e9b5-3f47-b58b-18157f2e7eac</guid>
                                    <description><![CDATA[<p>Experts discuss how failing to confront colonial pasts is linked to present lack of progress in global health equity, why health leaders need historical educations, and how, for Indigenous peoples, it’s not just a colonial history but a colonial present.</p>
<p>Our panel</p>
<ul><li>Seye Abimbola, editor of BMJ Global Health, and health systems researcher from Nigeria currently based at the University of Sydney, Australia</li>
<li>Catherine Kyobutungi, Ugandan epidemiologist and executive director of the African Population and Health Research Center, Nairobi, Kenya</li>
<li>Sanjoy Bhattacharya, head of the school of history and professor of medical and global health histories, University of Leeds, UK</li>
<li>Chelsea Watego, professor of Indigenous Health at Queensland University of Technology, Australia</li>
<li>Host - Navjoyt Ladher, clinical editor for The BMJ</li>
</ul>
]]></description>
                                                            <content:encoded><![CDATA[<p>Experts discuss how failing to confront colonial pasts is linked to present lack of progress in global health equity, why health leaders need historical educations, and how, for Indigenous peoples, it’s not just a colonial history but a colonial present.</p>
<p>Our panel</p>
<ul><li>Seye Abimbola, editor of BMJ Global Health, and health systems researcher from Nigeria currently based at the University of Sydney, Australia</li>
<li>Catherine Kyobutungi, Ugandan epidemiologist and executive director of the African Population and Health Research Center, Nairobi, Kenya</li>
<li>Sanjoy Bhattacharya, head of the school of history and professor of medical and global health histories, University of Leeds, UK</li>
<li>Chelsea Watego, professor of Indigenous Health at Queensland University of Technology, Australia</li>
<li>Host - Navjoyt Ladher, clinical editor for The BMJ</li>
</ul>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6nz657/Decolonising_health_-_ep_2_-_history7vicl.mp3" length="77149382" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Experts discuss how failing to confront colonial pasts is linked to present lack of progress in global health equity, why health leaders need historical educations, and how, for Indigenous peoples, it’s not just a colonial history but a colonial present.
Our panel
Seye Abimbola, editor of BMJ Global Health, and health systems researcher from Nigeria currently based at the University of Sydney, Australia
Catherine Kyobutungi, Ugandan epidemiologist and executive director of the African Population and Health Research Center, Nairobi, Kenya
Sanjoy Bhattacharya, head of the school of history and professor of medical and global health histories, University of Leeds, UK
Chelsea Watego, professor of Indigenous Health at Queensland University of Technology, Australia
Host - Navjoyt Ladher, clinical editor for The BMJ
]]></itunes:summary>
        <itunes:author>BMJ Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3212</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Decolonising health and medicine: Episode 1 - The colonial legacy in clinical medicine</title>
        <itunes:title>Decolonising health and medicine: Episode 1 - The colonial legacy in clinical medicine</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/decolonising-health-and-medicine-episode-1-the-colonial-legacy-in-clinical-medicine/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/decolonising-health-and-medicine-episode-1-the-colonial-legacy-in-clinical-medicine/#comments</comments>        <pubDate>Tue, 17 Oct 2023 11:24:31 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/441ecb76-8cf5-33ee-b3d2-078f48762bb6</guid>
                                    <description><![CDATA[<p>Healthcare leaders discuss the ways in which colonial-era bias and eugenics persist in today’s medical education and clinical practice in the UK and beyond, and what meaningful change is required to overcome racial and other healthcare inequalities</p>
<p>Our panel</p>
<ul><li>Annabel Sowemimo, sexual and reproductive health registrar and part-time PhD student and Harold Moody Scholar at King’s College London, UK</li>
<li>Thirusha Naidu, head of clinical psychology, King Dinuzulu Hospital, and associate professor, Department of Behavioural Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa</li>
<li>Subhadra Das, UK based researcher and storyteller who specialises in the history and philosophy of science, particularly scientific racism and eugenics</li>
<li>Amali Lokugamage, honorary associate professor, Institute of Women's Health, University College London, and consultant obstetrician and gynaecologist, Whittington Hospital, London, UK</li>
<li>Host - Richard Hurley, collections editor at The BMJ</li>
</ul>
]]></description>
                                                            <content:encoded><![CDATA[<p>Healthcare leaders discuss the ways in which colonial-era bias and eugenics persist in today’s medical education and clinical practice in the UK and beyond, and what meaningful change is required to overcome racial and other healthcare inequalities</p>
<p>Our panel</p>
<ul><li>Annabel Sowemimo, sexual and reproductive health registrar and part-time PhD student and Harold Moody Scholar at King’s College London, UK</li>
<li>Thirusha Naidu, head of clinical psychology, King Dinuzulu Hospital, and associate professor, Department of Behavioural Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa</li>
<li>Subhadra Das, UK based researcher and storyteller who specialises in the history and philosophy of science, particularly scientific racism and eugenics</li>
<li>Amali Lokugamage, honorary associate professor, Institute of Women's Health, University College London, and consultant obstetrician and gynaecologist, Whittington Hospital, London, UK</li>
<li>Host - Richard Hurley, collections editor at The BMJ</li>
</ul>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gyxpa8/Decolonising_health_ep_1_-_clinical_care951ch.mp3" length="74714877" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Healthcare leaders discuss the ways in which colonial-era bias and eugenics persist in today’s medical education and clinical practice in the UK and beyond, and what meaningful change is required to overcome racial and other healthcare inequalities
Our panel
Annabel Sowemimo, sexual and reproductive health registrar and part-time PhD student and Harold Moody Scholar at King’s College London, UK
Thirusha Naidu, head of clinical psychology, King Dinuzulu Hospital, and associate professor, Department of Behavioural Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa
Subhadra Das, UK based researcher and storyteller who specialises in the history and philosophy of science, particularly scientific racism and eugenics
Amali Lokugamage, honorary associate professor, Institute of Women's Health, University College London, and consultant obstetrician and gynaecologist, Whittington Hospital, London, UK
Host - Richard Hurley, collections editor at The BMJ
]]></itunes:summary>
        <itunes:author>BMJ Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3111</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Planet centred care - How to talk about this stuff</title>
        <itunes:title>Planet centred care - How to talk about this stuff</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/how-to-talk-about-this-stuff/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/how-to-talk-about-this-stuff/#comments</comments>        <pubDate>Sat, 14 Oct 2023 17:58:22 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/a7a6cd95-5ac6-364f-9209-7926d4ccc365</guid>
                                    <description><![CDATA[<p>We’ve heard throughout the series from people who have a passion for sustainability, and have successfully made changes in their organisations to reduce the planetary impact of their work. In doing so, they will have recruited other people who have a similar outlook - but they will have also convinced people who aren’t prioritising sustainability.</p>
<p> </p>
<p>In this last podcast of the series, we’re delving into that - how to talk to colleagues and patients, in ways which connect with their own needs and preferences.</p>
<p> </p>
<p>To help with that, we’re joined by David Pencheon, director of the Sustainable Development Unit for NHS England, who’s been successfully talking about these issues for years, and Kate Wylie, executive director of Doctors for the Environment Australia.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>We’ve heard throughout the series from people who have a passion for sustainability, and have successfully made changes in their organisations to reduce the planetary impact of their work. In doing so, they will have recruited other people who have a similar outlook - but they will have also convinced people who aren’t prioritising sustainability.</p>
<p> </p>
<p>In this last podcast of the series, we’re delving into that - how to talk to colleagues and patients, in ways which connect with their own needs and preferences.</p>
<p> </p>
<p>To help with that, we’re joined by David Pencheon, director of the Sustainable Development Unit for NHS England, who’s been successfully talking about these issues for years, and Kate Wylie, executive director of Doctors for the Environment Australia.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/yji5c6/PCC_ep6_v39fbki.mp3" length="51201152" type="audio/mpeg"/>
        <itunes:summary><![CDATA[We’ve heard throughout the series from people who have a passion for sustainability, and have successfully made changes in their organisations to reduce the planetary impact of their work. In doing so, they will have recruited other people who have a similar outlook - but they will have also convinced people who aren’t prioritising sustainability.
 
In this last podcast of the series, we’re delving into that - how to talk to colleagues and patients, in ways which connect with their own needs and preferences.
 
To help with that, we’re joined by David Pencheon, director of the Sustainable Development Unit for NHS England, who’s been successfully talking about these issues for years, and Kate Wylie, executive director of Doctors for the Environment Australia.]]></itunes:summary>
        <itunes:author>BMJ Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3200</itunes:duration>
                <itunes:episode>11</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog16196630/planet-centred-care-pod-art-wst.jpg" />    </item>
    <item>
        <title>Planet centred care - Why doing less can be hard</title>
        <itunes:title>Planet centred care - Why doing less can be hard</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/why-doing-less-can-be-hard/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/why-doing-less-can-be-hard/#comments</comments>        <pubDate>Fri, 06 Oct 2023 11:08:24 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/2a8edc37-f51f-3dda-941e-36ea2462ccfd</guid>
                                    <description><![CDATA[<p>One element of sustainable healthcare is simply reducing the amount of healthcare you’re doing by not doing the things that are of no value to patients. However, how do we do this in practice? And why is it often so hard? What is the role of fear in this discussion? These are all questions we will discuss in this episode.  </p>
<p> </p>
<p>To help us with this we’ll be joined by <a href='https://www2.psy.unsw.edu.au/Users/BNewell/'>Prof Ben Newell </a>(cognitive psychologist from University of New South Wales, whose research interest includes judgement and decision making). and Dr <a href='https://twitter.com/chartierlucas'>Lucas Chartier,  </a>emergency medicine physician at the University Health Network in Toronto.</p>
<p>Ben Newell also has also recently released a book, <a href='https://mitpress.mit.edu/9780262546195/open-minded/'>Open Minded</a>, co-authored with David Shanks on the role of the unconscious mind in our decisions making </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>One element of sustainable healthcare is simply reducing the amount of healthcare you’re doing by not doing the things that are of no value to patients. However, how do we do this in practice? And why is it often so hard? What is the role of fear in this discussion? These are all questions we will discuss in this episode.  </p>
<p> </p>
<p>To help us with this we’ll be joined by <a href='https://www2.psy.unsw.edu.au/Users/BNewell/'>Prof Ben Newell </a>(cognitive psychologist from University of New South Wales, whose research interest includes judgement and decision making). and Dr <a href='https://twitter.com/chartierlucas'>Lucas Chartier,  </a>emergency medicine physician at the University Health Network in Toronto.</p>
<p>Ben Newell also has also recently released a book, <a href='https://mitpress.mit.edu/9780262546195/open-minded/'>Open Minded</a>, co-authored with David Shanks on the role of the unconscious mind in our decisions making </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/q39de5/PCC_ep5_v47ffw3.mp3" length="47778176" type="audio/mpeg"/>
        <itunes:summary><![CDATA[One element of sustainable healthcare is simply reducing the amount of healthcare you’re doing by not doing the things that are of no value to patients. However, how do we do this in practice? And why is it often so hard? What is the role of fear in this discussion? These are all questions we will discuss in this episode.  
 
To help us with this we’ll be joined by Prof Ben Newell (cognitive psychologist from University of New South Wales, whose research interest includes judgement and decision making). and Dr Lucas Chartier,  emergency medicine physician at the University Health Network in Toronto.
Ben Newell also has also recently released a book, Open Minded, co-authored with David Shanks on the role of the unconscious mind in our decisions making ]]></itunes:summary>
        <itunes:author>BMJ Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2986</itunes:duration>
                <itunes:episode>10</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog16196630/planet-centred-care-pod-art-wst.jpg" />    </item>
    <item>
        <title>Planet centred care - Sustainable healthcare is better for patients</title>
        <itunes:title>Planet centred care - Sustainable healthcare is better for patients</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/sustainable-healthcare-is-better-for-patients/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/sustainable-healthcare-is-better-for-patients/#comments</comments>        <pubDate>Mon, 02 Oct 2023 07:53:45 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/beedd84e-792d-30b5-b588-9d1385d310ef</guid>
                                    <description><![CDATA[<p>Acting on climate change is often framed as having to give stuff up, to cost more money, to make sacrifices. Yet in healthcare we find the opposite can often be true: there are many actions we can take which reduce the carbon footprint of healthcare which actually end up with better outcomes for our patients. In this episode, we hear from two examples of that. </p>
<p>Singing for breathing is a type of social prescribing to help people with chronic lung disease manage their breathlessness, reducing their need to be reliant on healthcare to do this, while also finding joy and a sense of community. Stephen is one patient who has benefited from this service, and will tell us more about the impact it had on his life. </p>
<p>In another example, Lynn Riddell, an HIV consultant will tell us how a change in their clinical pathway helped a cohort of patients reduce the amount of travelling to and from the clinic, still manage their condition safely and give them back precious time and control. </p>
<p> </p>
<p>https://www.bartscharity.org.uk/our-news/singing-sessions-to-improve-patients-lung-health/</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Acting on climate change is often framed as having to give stuff up, to cost more money, to make sacrifices. Yet in healthcare we find the opposite can often be true: there are many actions we can take which reduce the carbon footprint of healthcare which actually end up with better outcomes for our patients. In this episode, we hear from two examples of that. </p>
<p>Singing for breathing is a type of social prescribing to help people with chronic lung disease manage their breathlessness, reducing their need to be reliant on healthcare to do this, while also finding joy and a sense of community. Stephen is one patient who has benefited from this service, and will tell us more about the impact it had on his life. </p>
<p>In another example, Lynn Riddell, an HIV consultant will tell us how a change in their clinical pathway helped a cohort of patients reduce the amount of travelling to and from the clinic, still manage their condition safely and give them back precious time and control. </p>
<p> </p>
<p>https://www.bartscharity.org.uk/our-news/singing-sessions-to-improve-patients-lung-health/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/m96qat/Copy_of_PCC_ep3_v4apm1r.mp3" length="36581120" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Acting on climate change is often framed as having to give stuff up, to cost more money, to make sacrifices. Yet in healthcare we find the opposite can often be true: there are many actions we can take which reduce the carbon footprint of healthcare which actually end up with better outcomes for our patients. In this episode, we hear from two examples of that. 
Singing for breathing is a type of social prescribing to help people with chronic lung disease manage their breathlessness, reducing their need to be reliant on healthcare to do this, while also finding joy and a sense of community. Stephen is one patient who has benefited from this service, and will tell us more about the impact it had on his life. 
In another example, Lynn Riddell, an HIV consultant will tell us how a change in their clinical pathway helped a cohort of patients reduce the amount of travelling to and from the clinic, still manage their condition safely and give them back precious time and control. 
 
https://www.bartscharity.org.uk/our-news/singing-sessions-to-improve-patients-lung-health/]]></itunes:summary>
        <itunes:author>BMJ Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2286</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog16196630/planet-centred-care-pod-art-wst.jpg" />    </item>
    <item>
        <title>Planet centred care - Sustainable healthcare is good for staff</title>
        <itunes:title>Planet centred care - Sustainable healthcare is good for staff</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/sustainable-healthcare-is-good-for-staff/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/sustainable-healthcare-is-good-for-staff/#comments</comments>        <pubDate>Fri, 22 Sep 2023 17:27:00 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/41a1696a-2590-3153-b905-f725e17bdc3f</guid>
                                    <description><![CDATA[<p>Ooops! If you listened to episode 3 when it first came out you may have realised that the title didn't quite match the content. We've just updated the title and the show notes below, and stay tuned for when we'll be soon releasing an episode on how sustainable healthcare can be good for patients.</p>
<p> </p>
<p>In a system where healthcare workers are continually described as overworked and burnt out, how can we expect them to find the time to act on the climate? In this episode we turn that assumption on its head, and, in fact, show how acting to reduce the environmental impact of healthcare can help staff find joy in their work again. Our two guests today are Tracy Lyons, founder of Pharmacy Declares and medicines optimisation pharmacist in Dorset, UK, and David Smith, general surgeon at North York General Hospital in Toronto, Canada.</p>
<p> </p>
<p>The very worst thing is sometimes to have a problem you feel you can’t solve, and action mitigates anxiety: these are two of the many lessons that came out of today’s episode. We also touch on the different levels that you can start to take action at: from the small and tangible to influencing change at a system level. </p>
<p> </p>
<p>Related links:</p>
<p><a href='https://cascadescanada.ca/'>https://cascadescanada.ca/</a> </p>
<p><a href='https://www.pharmacydeclares.co.uk/'>https://www.pharmacydeclares.co.uk/</a> </p>
<p><a href='https://twitter.com/TLyons00'>https://twitter.com/TLyons00 </a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p><em>Ooops! If you listened to episode 3 when it first came out you may have realised that the title didn't quite match the content. We've just updated the title and the show notes below, and stay tuned for when we'll be soon releasing an episode on how sustainable healthcare can be good for patients.</em></p>
<p> </p>
<p>In a system where healthcare workers are continually described as overworked and burnt out, how can we expect them to find the time to act on the climate? In this episode we turn that assumption on its head, and, in fact, show how acting to reduce the environmental impact of healthcare can help staff find joy in their work again. Our two guests today are Tracy Lyons, founder of Pharmacy Declares and medicines optimisation pharmacist in Dorset, UK, and David Smith, general surgeon at North York General Hospital in Toronto, Canada.</p>
<p> </p>
<p>The very worst thing is sometimes to have a problem you feel you can’t solve, and action mitigates anxiety: these are two of the many lessons that came out of today’s episode. We also touch on the different levels that you can start to take action at: from the small and tangible to influencing change at a system level. </p>
<p> </p>
<p>Related links:</p>
<p><a href='https://cascadescanada.ca/'>https://cascadescanada.ca/</a> </p>
<p><a href='https://www.pharmacydeclares.co.uk/'>https://www.pharmacydeclares.co.uk/</a> </p>
<p><a href='https://twitter.com/TLyons00'>https://twitter.com/TLyons00 </a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/t43dis/PCC_ep4bu1pw.mp3" length="52997888" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Ooops! If you listened to episode 3 when it first came out you may have realised that the title didn't quite match the content. We've just updated the title and the show notes below, and stay tuned for when we'll be soon releasing an episode on how sustainable healthcare can be good for patients.
 
In a system where healthcare workers are continually described as overworked and burnt out, how can we expect them to find the time to act on the climate? In this episode we turn that assumption on its head, and, in fact, show how acting to reduce the environmental impact of healthcare can help staff find joy in their work again. Our two guests today are Tracy Lyons, founder of Pharmacy Declares and medicines optimisation pharmacist in Dorset, UK, and David Smith, general surgeon at North York General Hospital in Toronto, Canada.
 
The very worst thing is sometimes to have a problem you feel you can’t solve, and action mitigates anxiety: these are two of the many lessons that came out of today’s episode. We also touch on the different levels that you can start to take action at: from the small and tangible to influencing change at a system level. 
 
Related links:
https://cascadescanada.ca/ 
https://www.pharmacydeclares.co.uk/ 
https://twitter.com/TLyons00  ]]></itunes:summary>
        <itunes:author>BMJ Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3312</itunes:duration>
                <itunes:episode>9</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog16196630/planet-centred-care-pod-art-wst.jpg" />    </item>
    <item>
        <title>Talking overdiagnosis</title>
        <itunes:title>Talking overdiagnosis</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talking-overdiagnosis/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talking-overdiagnosis/#comments</comments>        <pubDate>Sat, 16 Sep 2023 15:18:41 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/d3c44a7b-a371-30f6-9139-9ad5da4fd173</guid>
                                    <description><![CDATA[<p>In this month's Talk Evidence, Helen and Juan are reporting from Preventing Overdiagnosis - the conference that raises issues of diagnostic accuracy, and asks if starting the process of medicalisation is always the right thing to do for patients.</p>
<p> </p>
<p>In this episode, they talk about home testing, sustainability and screening. They're also joined by two guests to talk about the overdiagnosis of obesity - when that label is stigmatising and there seem to be few successful treatments that medicine can offer, and the need to educate students in the concepts of overdiagnosis and too much medicine, to create a culture change in medicine.</p>
<p> </p>
<p>Links;</p>
<p><a href='https://www.cebm.ox.ac.uk/upcoming-events/preventing-overdiagnosis'>The Preventing Overdiagnosis conference</a></p>
<p><a href='https://ebm.bmj.com/content/early/2023/07/20/bmjebm-2023-112266'>The BMJ EBM papers on choosing wisely.</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this month's Talk Evidence, Helen and Juan are reporting from Preventing Overdiagnosis - the conference that raises issues of diagnostic accuracy, and asks if starting the process of medicalisation is always the right thing to do for patients.</p>
<p> </p>
<p>In this episode, they talk about home testing, sustainability and screening. They're also joined by two guests to talk about the overdiagnosis of obesity - when that label is stigmatising and there seem to be few successful treatments that medicine can offer, and the need to educate students in the concepts of overdiagnosis and too much medicine, to create a culture change in medicine.</p>
<p> </p>
<p>Links;</p>
<p><a href='https://www.cebm.ox.ac.uk/upcoming-events/preventing-overdiagnosis'>The Preventing Overdiagnosis conference</a></p>
<p><a href='https://ebm.bmj.com/content/early/2023/07/20/bmjebm-2023-112266'>The BMJ EBM papers on choosing wisely.</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mj77df/Talk_evidence_69aedwl.mp3" length="34185319" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this month's Talk Evidence, Helen and Juan are reporting from Preventing Overdiagnosis - the conference that raises issues of diagnostic accuracy, and asks if starting the process of medicalisation is always the right thing to do for patients.
 
In this episode, they talk about home testing, sustainability and screening. They're also joined by two guests to talk about the overdiagnosis of obesity - when that label is stigmatising and there seem to be few successful treatments that medicine can offer, and the need to educate students in the concepts of overdiagnosis and too much medicine, to create a culture change in medicine.
 
Links;
The Preventing Overdiagnosis conference
The BMJ EBM papers on choosing wisely.
 ]]></itunes:summary>
        <itunes:author>BMJ Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2136</itunes:duration>
                <itunes:episode>8</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog16196630/talk-evidence_w6cx97.jpg" />    </item>
    <item>
        <title>Planet centred care - It’s all about working together</title>
        <itunes:title>Planet centred care - It’s all about working together</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/planet-centred-care-it-s-all-about-working-together/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/planet-centred-care-it-s-all-about-working-together/#comments</comments>        <pubDate>Thu, 31 Aug 2023 23:00:00 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/ea25bc7a-2357-3b3c-9459-ba916c45ad8d</guid>
                                    <description><![CDATA[<p>Healthcare is a complex system, and if we want to make changes such as those needed for sustainable healthcare, we need to work across multiple teams, and make sure we hear everyone’s voice, including our patients’. In this episode we’ll discuss how we can communicate and work with those different groups, and some novel ways of getting the message across from T-rexes worth of plastic gloves to art made out of surgical waste.</p>
<p> </p>
<p>Guests for this episode:</p>
<p>Nicola Wilson, lead clinical educator, Great Ormond Street Children’s hospital, and Maria Koijck, artist and former patient. You can read more about the Gloves are Off project here <a href='https://www.gosh.nhs.uk/news/gloves-are-off/'>https://www.gosh.nhs.uk/news/gloves-are-off/ </a> </p>
<p>You can see Maria’s film here: <a href='https://www.mariakoijck.com/'>https://www.mariakoijck.com/</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Healthcare is a complex system, and if we want to make changes such as those needed for sustainable healthcare, we need to work across multiple teams, and make sure we hear everyone’s voice, including our patients’. In this episode we’ll discuss how we can communicate and work with those different groups, and some novel ways of getting the message across from T-rexes worth of plastic gloves to art made out of surgical waste.</p>
<p> </p>
<p>Guests for this episode:</p>
<p>Nicola Wilson, lead clinical educator, Great Ormond Street Children’s hospital, and Maria Koijck, artist and former patient. You can read more about the Gloves are Off project here <a href='https://www.gosh.nhs.uk/news/gloves-are-off/'>https://www.gosh.nhs.uk/news/gloves-are-off/ </a> </p>
<p>You can see Maria’s film here: <a href='https://www.mariakoijck.com/'>https://www.mariakoijck.com/</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/aktk8u/Copy_of_PCC_ep2_v69pss5.mp3" length="40923008" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Healthcare is a complex system, and if we want to make changes such as those needed for sustainable healthcare, we need to work across multiple teams, and make sure we hear everyone’s voice, including our patients’. In this episode we’ll discuss how we can communicate and work with those different groups, and some novel ways of getting the message across from T-rexes worth of plastic gloves to art made out of surgical waste.
 
Guests for this episode:
Nicola Wilson, lead clinical educator, Great Ormond Street Children’s hospital, and Maria Koijck, artist and former patient. You can read more about the Gloves are Off project here https://www.gosh.nhs.uk/news/gloves-are-off/  
You can see Maria’s film here: https://www.mariakoijck.com/]]></itunes:summary>
        <itunes:author>BMJ Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2557</itunes:duration>
                <itunes:episode>7</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog16196630/planet-centred-care-pod-art-wst.jpg" />    </item>
    <item>
        <title>Planet centred care - Greening the gaze</title>
        <itunes:title>Planet centred care - Greening the gaze</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/planet-centred-care-greening-the-gaze/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/planet-centred-care-greening-the-gaze/#comments</comments>        <pubDate>Thu, 31 Aug 2023 23:00:00 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/171a9580-eaae-3654-8752-992ef5bef3ea</guid>
                                    <description><![CDATA[<p>Planet centred care is new podcast series for the BMJ exploring issues related to environmentally sustainable healthcare, aimed at all clinicians, and anyone working in healthcare, who want to make sure they can continue to help patients while not harming the planet. </p>
<p>In this episode we’ll discuss that first radicalising moment. That moment where you start to see all the things you can do to make healthcare more sustainable and how it is hard to un-see that. For everyone, that moment may come from a different place, or different perspective. </p>
<p>Our guests for this episode: </p>
<p>Gareth Murcutt who was at first reluctant until he saw the size of the impact he could make; Gwen Sims whose eyes were opened by moving health systems (and continents) and Alifia Chakera who didn’t expect to find a huge sustainability saving so close to home when she took up a new clinical role before the pandemic. </p>
<p>Hosts: </p>
<p>Loren De Freitas and Florence Wedmore, the BMJ</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Planet centred care is new podcast series for the BMJ exploring issues related to environmentally sustainable healthcare, aimed at all clinicians, and anyone working in healthcare, who want to make sure they can continue to help patients while not harming the planet. </p>
<p>In this episode we’ll discuss that first radicalising moment. That moment where you start to see all the things you can do to make healthcare more sustainable and how it is hard to un-see that. For everyone, that moment may come from a different place, or different perspective. </p>
<p>Our guests for this episode: </p>
<p>Gareth Murcutt who was at first reluctant until he saw the size of the impact he could make; Gwen Sims whose eyes were opened by moving health systems (and continents) and Alifia Chakera who didn’t expect to find a huge sustainability saving so close to home when she took up a new clinical role before the pandemic. </p>
<p>Hosts: </p>
<p>Loren De Freitas and Florence Wedmore, the BMJ</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wz5pfi/Copy_of_PCC_ep1_v89qfos.mp3" length="43369472" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Planet centred care is new podcast series for the BMJ exploring issues related to environmentally sustainable healthcare, aimed at all clinicians, and anyone working in healthcare, who want to make sure they can continue to help patients while not harming the planet. 
In this episode we’ll discuss that first radicalising moment. That moment where you start to see all the things you can do to make healthcare more sustainable and how it is hard to un-see that. For everyone, that moment may come from a different place, or different perspective. 
Our guests for this episode: 
Gareth Murcutt who was at first reluctant until he saw the size of the impact he could make; Gwen Sims whose eyes were opened by moving health systems (and continents) and Alifia Chakera who didn’t expect to find a huge sustainability saving so close to home when she took up a new clinical role before the pandemic. 
Hosts: 
Loren De Freitas and Florence Wedmore, the BMJ]]></itunes:summary>
        <itunes:author>BMJ Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2710</itunes:duration>
                <itunes:episode>6</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog16196630/planet-centred-care-pod-art-wst.jpg" />    </item>
    <item>
        <title>The problem with trainees - The GMC’s National Training Survey results data</title>
        <itunes:title>The problem with trainees - The GMC’s National Training Survey results data</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-problem-with-trainees-the-gmc-s-national-training-survey-results-data/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-problem-with-trainees-the-gmc-s-national-training-survey-results-data/#comments</comments>        <pubDate>Thu, 17 Aug 2023 11:26:45 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/c18c9f50-69b5-366e-be4d-3e66e2feaade</guid>
                                    <description><![CDATA[<p>In our final episode of this season, we're going quantitative, with the newly released data on how trainees in the UK are faring.</p>
<p>Each year the UK's General Medical Council, the doctor's regulator, surveys trainees in the NHS to ask them questions about stress and burnout, harassment and discrimination, and how well supported they feel in their training. They also ask trainers about the same things.</p>
<p>Unsurprisingly, the year the results look bad - with increasing levels of burnout across the board, but particularly in new trainees. At the same time trainers are feeling unable to use their time supporting learning, and instead are propping up the system.</p>
<p>To discuss this, Clara Munro and Ayisha Ashmore are joined by Colin Melville, medical director, and director of education and standards, at the GMC. </p>
<p> </p>
<p>All the data discussed, and the interactive tool that Colin mentions, are available on the GMC's <a href='https://www.gmc-uk.org/education/how-we-quality-assure-medical-education-and-training/evidence-data-and-intelligence/national-training-surveys'>National training survey 2023 results</a> page.</p>
<p> </p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In our final episode of this season, we're going quantitative, with the newly released data on how trainees in the UK are faring.</p>
<p>Each year the UK's General Medical Council, the doctor's regulator, surveys trainees in the NHS to ask them questions about stress and burnout, harassment and discrimination, and how well supported they feel in their training. They also ask trainers about the same things.</p>
<p>Unsurprisingly, the year the results look bad - with increasing levels of burnout across the board, but particularly in new trainees. At the same time trainers are feeling unable to use their time supporting learning, and instead are propping up the system.</p>
<p>To discuss this, Clara Munro and Ayisha Ashmore are joined by Colin Melville, medical director, and director of education and standards, at the GMC. </p>
<p> </p>
<p>All the data discussed, and the interactive tool that Colin mentions, are available on the GMC's <a href='https://www.gmc-uk.org/education/how-we-quality-assure-medical-education-and-training/evidence-data-and-intelligence/national-training-surveys'>National training survey 2023 results</a> page.</p>
<p> </p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/44vy94/DI_ep12_v2abkq7.mp3" length="47755136" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In our final episode of this season, we're going quantitative, with the newly released data on how trainees in the UK are faring.
Each year the UK's General Medical Council, the doctor's regulator, surveys trainees in the NHS to ask them questions about stress and burnout, harassment and discrimination, and how well supported they feel in their training. They also ask trainers about the same things.
Unsurprisingly, the year the results look bad - with increasing levels of burnout across the board, but particularly in new trainees. At the same time trainers are feeling unable to use their time supporting learning, and instead are propping up the system.
To discuss this, Clara Munro and Ayisha Ashmore are joined by Colin Melville, medical director, and director of education and standards, at the GMC. 
 
All the data discussed, and the interactive tool that Colin mentions, are available on the GMC's National training survey 2023 results page.
 
 ]]></itunes:summary>
        <itunes:author>BMJ Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2984</itunes:duration>
                <itunes:episode>5</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Ensuring the integrity of research, and the future of AI as authors</title>
        <itunes:title>Ensuring the integrity of research, and the future of AI as authors</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/ensuring-the-integrity-of-research-and-the-future-of-ai-as-authors/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/ensuring-the-integrity-of-research-and-the-future-of-ai-as-authors/#comments</comments>        <pubDate>Sat, 05 Aug 2023 11:02:49 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/32a1fceb-575c-3625-b829-359383d058a1</guid>
                                    <description><![CDATA[<p>In this month's Talk Evidence, we're getting a little meta - how do we keep an eye on research to make sure it's done with integrity. Helen Macdonald is BMJ's Publication ethics and content integrity editor - and we quiz her about what that actually means on a day to day basis.</p>
<p>Ensuring the integrity of research could be made both easier, and harder, by the ascendance of large language models, Ian Mulvany, BMJ's chief technology officer joins us to talk about how we can harness the power of this new technology.</p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this month's Talk Evidence, we're getting a little meta - how do we keep an eye on research to make sure it's done with integrity. Helen Macdonald is BMJ's Publication ethics and content integrity editor - and we quiz her about what that actually means on a day to day basis.</p>
<p>Ensuring the integrity of research could be made both easier, and harder, by the ascendance of large language models, Ian Mulvany, BMJ's chief technology officer joins us to talk about how we can harness the power of this new technology.</p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/inxk8x/TE_68_mixdown9d2wr.mp3" length="64431556" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this month's Talk Evidence, we're getting a little meta - how do we keep an eye on research to make sure it's done with integrity. Helen Macdonald is BMJ's Publication ethics and content integrity editor - and we quiz her about what that actually means on a day to day basis.
Ensuring the integrity of research could be made both easier, and harder, by the ascendance of large language models, Ian Mulvany, BMJ's chief technology officer joins us to talk about how we can harness the power of this new technology.
 ]]></itunes:summary>
        <itunes:author>BMJ Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2684</itunes:duration>
                <itunes:episode>4</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Taking on the van Tullekens; how Margaret McCartney changed their minds about COIs</title>
        <itunes:title>Taking on the van Tullekens; how Margaret McCartney changed their minds about COIs</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/taking-on-the-van-tullekens-how-margaret-mccartney-changed-their-minds-about-cois/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/taking-on-the-van-tullekens-how-margaret-mccartney-changed-their-minds-about-cois/#comments</comments>        <pubDate>Fri, 28 Jul 2023 17:00:55 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/028057dd-b22f-37ca-8b0b-f98b7d80bcdb</guid>
                                    <description><![CDATA[<p>They're the trusted public figures of the medical profession, but many of the most famous medics in the UK will have been approached by, and accepted money from, companies wishing to promote their products - and the public will never know.</p>
<p>To talk about conflicts of interest in media doctors, we’re joined by two of the most recognisable medics on our screens - Chris and Xand van Tulleken, and the GP who persuaded them to think about what they receive cash for, Margaret McCartney.</p>
<p>Read our investigation into how the UK's <a href='https://www.bmj.com/content/382/bmj.p1658'>medical royal colleges receive millions from drug and medical devices companies</a> and Margaret McCartney's plea that <a href='https://www.bmj.com/content/382/bmj.p1646'>“You have to be above reproach”: why doctors need to get better at managing their conflicts of interest</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>They're the trusted public figures of the medical profession, but many of the most famous medics in the UK will have been approached by, and accepted money from, companies wishing to promote their products - and the public will never know.</p>
<p>To talk about conflicts of interest in media doctors, we’re joined by two of the most recognisable medics on our screens - Chris and Xand van Tulleken, and the GP who persuaded them to think about what they receive cash for, Margaret McCartney.</p>
<p>Read our investigation into how the UK's <a href='https://www.bmj.com/content/382/bmj.p1658'>medical royal colleges receive millions from drug and medical devices companies</a> and Margaret McCartney's plea that <a href='https://www.bmj.com/content/382/bmj.p1646'>“You have to be above reproach”: why doctors need to get better at managing their conflicts of interest</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5yn32p/COIs_mixdown.mp3" length="77614292" type="audio/mpeg"/>
        <itunes:summary><![CDATA[They're the trusted public figures of the medical profession, but many of the most famous medics in the UK will have been approached by, and accepted money from, companies wishing to promote their products - and the public will never know.
To talk about conflicts of interest in media doctors, we’re joined by two of the most recognisable medics on our screens - Chris and Xand van Tulleken, and the GP who persuaded them to think about what they receive cash for, Margaret McCartney.
Read our investigation into how the UK's medical royal colleges receive millions from drug and medical devices companies and Margaret McCartney's plea that “You have to be above reproach”: why doctors need to get better at managing their conflicts of interest]]></itunes:summary>
        <itunes:author>BMJ Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3231</itunes:duration>
                <itunes:episode>3</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Talk Evidence - post pandemic pruning, breast cancer screening, and orphan drugs</title>
        <itunes:title>Talk Evidence - post pandemic pruning, breast cancer screening, and orphan drugs</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-post-pandemic-pruning-breast-cancer-screening-and-orphan-drugs/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-post-pandemic-pruning-breast-cancer-screening-and-orphan-drugs/#comments</comments>        <pubDate>Fri, 30 Jun 2023 16:38:10 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/87281829-1646-326b-bbac-3029714868a9</guid>
                                    <description><![CDATA[<p>In this episode of Talk Evidence,  Helen Macdonald, Joe Ross, and Juan Franco are back to update us on what's happening in the world of medical evidence.</p>
<p>Firstly, the news about the end of the covid-19 pandemic was trumpeted, but the changes to research funding have been more quite - and the team discuss what this means for ongoing work to understand the effects of covid, but also in terms of preparedness for the next pandemic.</p>
<p>Next, breast cancer screening recommendations, in the USA, have been reduced from women over the age of 50, to those over the age of 40. We discuss the modelling study which lead to that recommendation change, and what the consequence may be in terms of overdiagnosis.</p>
<p>Finally, 40 years ago, the U.S. Orphan Drug act was passed to encourage the development of treatments for rare conditions - but new research looks at how many clinically useful drugs have come onto market, and an analysis examines the way in which the system could be gamed by narrowing disease definitions to create small populations of patients.</p>
<p> </p>
<p>Reading list</p>
<p><a href='https://www.bmj.com/content/381/bmj.p1157'>Is the UK losing its world leading covid surveillance network just when it needs it most?</a></p>
<p><a href='https://www.bmj.com/content/381/bmj.p1077'>Breast cancer: US recommends women start screening at 40</a></p>
<p><a href='https://www.bmj.com/content/381/bmj-2022-073242'>FDA approval, clinical trial evidence, efficacy, epidemiology, and price for non-orphan and ultra-rare, rare, and common orphan cancer drug indications</a></p>
<p> </p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode of Talk Evidence,  Helen Macdonald, Joe Ross, and Juan Franco are back to update us on what's happening in the world of medical evidence.</p>
<p>Firstly, the news about the end of the covid-19 pandemic was trumpeted, but the changes to research funding have been more quite - and the team discuss what this means for ongoing work to understand the effects of covid, but also in terms of preparedness for the next pandemic.</p>
<p>Next, breast cancer screening recommendations, in the USA, have been reduced from women over the age of 50, to those over the age of 40. We discuss the modelling study which lead to that recommendation change, and what the consequence may be in terms of overdiagnosis.</p>
<p>Finally, 40 years ago, the U.S. Orphan Drug act was passed to encourage the development of treatments for rare conditions - but new research looks at how many clinically useful drugs have come onto market, and an analysis examines the way in which the system could be gamed by narrowing disease definitions to create small populations of patients.</p>
<p> </p>
<p>Reading list</p>
<p><a href='https://www.bmj.com/content/381/bmj.p1157'>Is the UK losing its world leading covid surveillance network just when it needs it most?</a></p>
<p><a href='https://www.bmj.com/content/381/bmj.p1077'>Breast cancer: US recommends women start screening at 40</a></p>
<p><a href='https://www.bmj.com/content/381/bmj-2022-073242'>FDA approval, clinical trial evidence, efficacy, epidemiology, and price for non-orphan and ultra-rare, rare, and common orphan cancer drug indications</a></p>
<p> </p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/j3arzh/TE_66_mixdownbppoq.mp3" length="52910968" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode of Talk Evidence,  Helen Macdonald, Joe Ross, and Juan Franco are back to update us on what's happening in the world of medical evidence.
Firstly, the news about the end of the covid-19 pandemic was trumpeted, but the changes to research funding have been more quite - and the team discuss what this means for ongoing work to understand the effects of covid, but also in terms of preparedness for the next pandemic.
Next, breast cancer screening recommendations, in the USA, have been reduced from women over the age of 50, to those over the age of 40. We discuss the modelling study which lead to that recommendation change, and what the consequence may be in terms of overdiagnosis.
Finally, 40 years ago, the U.S. Orphan Drug act was passed to encourage the development of treatments for rare conditions - but new research looks at how many clinically useful drugs have come onto market, and an analysis examines the way in which the system could be gamed by narrowing disease definitions to create small populations of patients.
 
Reading list
Is the UK losing its world leading covid surveillance network just when it needs it most?
Breast cancer: US recommends women start screening at 40
FDA approval, clinical trial evidence, efficacy, epidemiology, and price for non-orphan and ultra-rare, rare, and common orphan cancer drug indications
 
 ]]></itunes:summary>
        <itunes:author>BMJ Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2203</itunes:duration>
                <itunes:episode>2</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pride in healthcare</title>
        <itunes:title>Pride in healthcare</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/pride-in-healthcare/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/pride-in-healthcare/#comments</comments>        <pubDate>Sun, 18 Jun 2023 11:12:45 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/56699a66-95d9-3934-b859-f88e7e759faa</guid>
                                    <description><![CDATA[<p>We're in pride month, and this year the celebration of LGBT+ people seems to be increasingly contentious.  Healthcare's treatment of queer people has improved hugely since the days when being gay was considered a mental disorder, and would end a doctor's career - but that doesn't mean that everything is equal.</p>
<p>In this episode of Doctor Informed, we're hearing from two doctors who are out and proud at work, about what  it's been like to be queer in medicine, and what good allyship looks like.</p>
<p>Our Guests</p>
<p>Michael Farqhuar is consultant in sleep medicine at the Evelina London Children's Hospital, he also helped set up the<a href='https://www.evelinalondon.nhs.uk/about-us/who-we-are/NHS-Rainbow-Badges.aspx'> NHS Rainbow badge scheme.</a></p>
<p>Greta McLachlan is a general surgical trainee, and member of the <a href='https://www.rcseng.ac.uk/careers-in-surgery/prism/'>Royal College of Surgeon's Pride in Surgery Forum</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>We're in pride month, and this year the celebration of LGBT+ people seems to be increasingly contentious.  Healthcare's treatment of queer people has improved hugely since the days when being gay was considered a mental disorder, and would end a doctor's career - but that doesn't mean that everything is equal.</p>
<p>In this episode of Doctor Informed, we're hearing from two doctors who are out and proud at work, about what  it's been like to be queer in medicine, and what good allyship looks like.</p>
<p>Our Guests</p>
<p>Michael Farqhuar is consultant in sleep medicine at the Evelina London Children's Hospital, he also helped set up the<a href='https://www.evelinalondon.nhs.uk/about-us/who-we-are/NHS-Rainbow-Badges.aspx'> NHS Rainbow badge scheme.</a></p>
<p>Greta McLachlan is a general surgical trainee, and member of the <a href='https://www.rcseng.ac.uk/careers-in-surgery/prism/'>Royal College of Surgeon's Pride in Surgery Forum</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xsyu55/lgbt_health_mixdown6f3ga.mp3" length="68658883" type="audio/mpeg"/>
        <itunes:summary>The road to equality isn’t a straight path, and discrimination against LGBT+ people in society is reflected in healthcare - In this episode we’ll hear from queer guests what it was like to train in passively homophobic environments, and how all healthcare staff can be better allies.</itunes:summary>
        <itunes:author>BMJ Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2859</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Doctor Informed - surviving in scrubs</title>
        <itunes:title>Doctor Informed - surviving in scrubs</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/doctor-informed-surviving-in-scrubs/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/doctor-informed-surviving-in-scrubs/#comments</comments>        <pubDate>Fri, 26 May 2023 17:21:18 +0000</pubDate>
        <guid isPermaLink="false">thebmjpodcast.podbean.com/2b579f92-414f-38ae-8d81-8e90f674f2e1</guid>
                                    <description><![CDATA[<p>The culture which allows sexism to perpetuate in healthcare is no better illustrated than by <a href='https://www.bmj.com/me-too-investigation'>The BMJ's investigation into sexual abuse in the NHS.</a></p>
<p>However, The BMJ are not the first organisation to highlight the problems - <a href='https://survivinginscrubsorg.wordpress.com/'>Surviving in Scrubs</a>  have been collating stories of sexism in healthcare, and making waves about the issues for a while.</p>
<p>In this episode of Doctor Informed, Clara Munro is joined by the founders of Surviving in Scrubs, to discuss their campaign, how to create a culture of zero tolerance for sexism at the ward level, and why they think sexism should be a professional issue.</p>
<p>Our guests;</p>
<p>Becky Cox is an academic GP researching domestic abuse and GP specialist in gynaecology in Oxford.</p>
<p>Chelcie Jewitt is an emergency medicine trainee in Liverpool.</p>
<p>Bron Biddle, founder of Ambulance Voices, and an employee in the ambulance service.</p>
<p> </p>
<p>Links;</p>
<p><a href='https://www.bmj.com/me-too-investigation'>https://www.bmj.com/me-too-investigation</a></p>
<p><a href='https://podcasts.apple.com/gb/podcast/doctor-informed-medicines-me-too-moments/id1591957881?i=1000556171773'>Previous Doctor Informed interview with Baroness Helena Kennedy</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The culture which allows sexism to perpetuate in healthcare is no better illustrated than by <a href='https://www.bmj.com/me-too-investigation'><em>The BMJ's</em> investigation into sexual abuse in the NHS.</a></p>
<p>However, <em>The BMJ </em>are not the first organisation to highlight the problems - <a href='https://survivinginscrubsorg.wordpress.com/'>Surviving in Scrubs</a>  have been collating stories of sexism in healthcare, and making waves about the issues for a while.</p>
<p>In this episode of Doctor Informed, Clara Munro is joined by the founders of Surviving in Scrubs, to discuss their campaign, how to create a culture of zero tolerance for sexism at the ward level, and why they think sexism should be a professional issue.</p>
<p>Our guests;</p>
<p>Becky Cox is an academic GP researching domestic abuse and GP specialist in gynaecology in Oxford.</p>
<p>Chelcie Jewitt is an emergency medicine trainee in Liverpool.</p>
<p>Bron Biddle, founder of Ambulance Voices, and an employee in the ambulance service.</p>
<p> </p>
<p>Links;</p>
<p><a href='https://www.bmj.com/me-too-investigation'>https://www.bmj.com/me-too-investigation</a></p>
<p><a href='https://podcasts.apple.com/gb/podcast/doctor-informed-medicines-me-too-moments/id1591957881?i=1000556171773'>Previous Doctor Informed interview with Baroness Helena Kennedy</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/c957u9/DIep10.mp3" length="57659035" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The culture which allows sexism to perpetuate in healthcare is no better illustrated than by The BMJ's investigation into sexual abuse in the NHS.
However, The BMJ are not the first organisation to highlight the problems - Surviving in Scrubs  have been collating stories of sexism in healthcare, and making waves about the issues for a while.
In this episode of Doctor Informed, Clara Munro is joined by the founders of Surviving in Scrubs, to discuss their campaign, how to create a culture of zero tolerance for sexism at the ward level, and why they think sexism should be a professional issue.
Our guests;
Becky Cox is an academic GP researching domestic abuse and GP specialist in gynaecology in Oxford.
Chelcie Jewitt is an emergency medicine trainee in Liverpool.
Bron Biddle, founder of Ambulance Voices, and an employee in the ambulance service.
 
Links;
https://www.bmj.com/me-too-investigation
Previous Doctor Informed interview with Baroness Helena Kennedy]]></itunes:summary>
        <itunes:author>BMJ Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3603</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog16196630/Doctor-informed-no-THIS.jpg" />    </item>
    <item>
        <title>Talk Evidence - cloning, reporting, and disseminating</title>
        <itunes:title>Talk Evidence - cloning, reporting, and disseminating</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-cloning-reporting-and-disseminating/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-cloning-reporting-and-disseminating/#comments</comments>        <pubDate>Fri, 05 May 2023 18:11:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-cloning-reporting-and-diseminating</guid>
                                    <description><![CDATA[Helen Macdonald, Juan Franco, and Joe Ross are back with our monthly update on the world of evidence based medicine.

This episode delves into new methodologies which can use observational data to emulate trial data.  We discuss a new systematic review and meta-analysis of RCTs for surgical treatment of sciatica.  There is elaboration and explanation of the CONSORT Harms 2022 statement - and we'll be asking if it goes far enough. Finally, the old chestnut of surrogate endpoints in cancer treatment trials - are benefits communicated to patients accurately?

Reading list;
Nirmatrelvir and risk of hospital admission or death in adults with covid-19: emulation of a randomized target trial using electronic health records - https://www.bmj.com/content/381/bmj-2022-073312

Surgical versus non-surgical treatment for sciatica
https://www.bmj.com/content/381/bmj-2022-070730


CONSORT Harms 2022 statement, explanation, and elaboration
https://www.bmj.com/content/381/bmj-2022-073725

Funders crack down on unpublished clinical trials—but is it enough?
https://www.bmj.com/content/381/bmj.p840

Communication of anticancer drug benefits and related uncertainties to patients and clinicians
<p>https://www.bmj.com/content/380/bmj-2022-073711</p>
]]></description>
                                                            <content:encoded><![CDATA[Helen Macdonald, Juan Franco, and Joe Ross are back with our monthly update on the world of evidence based medicine.

This episode delves into new methodologies which can use observational data to emulate trial data.  We discuss a new systematic review and meta-analysis of RCTs for surgical treatment of sciatica.  There is elaboration and explanation of the CONSORT Harms 2022 statement - and we'll be asking if it goes far enough. Finally, the old chestnut of surrogate endpoints in cancer treatment trials - are benefits communicated to patients accurately?

Reading list;
Nirmatrelvir and risk of hospital admission or death in adults with covid-19: emulation of a randomized target trial using electronic health records - https://www.bmj.com/content/381/bmj-2022-073312

Surgical versus non-surgical treatment for sciatica
https://www.bmj.com/content/381/bmj-2022-070730


CONSORT Harms 2022 statement, explanation, and elaboration
https://www.bmj.com/content/381/bmj-2022-073725

Funders crack down on unpublished clinical trials—but is it enough?
https://www.bmj.com/content/381/bmj.p840

Communication of anticancer drug benefits and related uncertainties to patients and clinicians
<p>https://www.bmj.com/content/380/bmj-2022-073711</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2rat9n/stream_1507371109-bmjgroup-talk-evidence-cloning-reporting-and-diseminating.mp3" length="67637240" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Helen Macdonald, Juan Franco, and Joe Ross are back with our monthly update on the world of evidence based medicine.

This episode delves into new methodologies which can use observational data to emulate trial data.  We discuss a new systematic review and meta-analysis of RCTs for surgical treatment of sciatica.  There is elaboration and explanation of the CONSORT Harms 2022 statement - and we'll be asking if it goes far enough. Finally, the old chestnut of surrogate endpoints in cancer treatment trials - are benefits communicated to patients accurately?

Reading list;
Nirmatrelvir and risk of hospital admission or death in adults with covid-19: emulation of a randomized target trial using electronic health records - https://www.bmj.com/content/381/bmj-2022-073312

Surgical versus non-surgical treatment for sciatica
https://www.bmj.com/content/381/bmj-2022-070730


CONSORT Harms 2022 statement, explanation, and elaboration
https://www.bmj.com/content/381/bmj-2022-073725

Funders crack down on unpublished clinical trials—but is it enough?
https://www.bmj.com/content/381/bmj.p840

Communication of anticancer drug benefits and related uncertainties to patients and clinicians
https://www.bmj.com/content/380/bmj-2022-073711]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2822</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Addiction in doctors</title>
        <itunes:title>Addiction in doctors</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/addiction-in-doctors/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/addiction-in-doctors/#comments</comments>        <pubDate>Fri, 21 Apr 2023 16:46:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/addiction-in-doctors</guid>
                                    <description><![CDATA[Everyone has coping mechanisms, but sometimes those ways of coping become problem behaviours - addictions.

In this episode of Doctor Informed, we're focussing on how to spot the signs that you may be sliding into addiction, how to have conversations with friends and colleagues if you worry about their behaviour, and how seeking treatment is the best way to avoid GMC scrutiny.

Joining Clara Munro are Liz Croton and Zaid Al-Najjar, GPs who work for NHS Practitioner health - a mental health and addiction service specifically for health professionals. They are also joined by Ruth Mayall, a retired consultant anaesthetist who has experienced addiction herself, and has contributed to the Association of Anaesthetists guidance on drug and alcohol abuse.

Some resources mentioned in the podcast;

NHS Practitioner Health
https://www.practitionerhealth.nhs.uk/

The Sick Doctor's Trust
http://sick-doctors-trust.co.uk/

British Doctors & Dentists Group
https://www.bddg.org/

Substance use disorder in the anaesthetist
https://anaesthetists.org/Home/Resources-publications/Guidelines/Substance-use-disorder-in-the-anaesthetist

Substance abuse in anaesthetists
<p>https://academic.oup.com/bjaed/article/16/7/236/2196385?login=false</p>
]]></description>
                                                            <content:encoded><![CDATA[Everyone has coping mechanisms, but sometimes those ways of coping become problem behaviours - addictions.

In this episode of Doctor Informed, we're focussing on how to spot the signs that you may be sliding into addiction, how to have conversations with friends and colleagues if you worry about their behaviour, and how seeking treatment is the best way to avoid GMC scrutiny.

Joining Clara Munro are Liz Croton and Zaid Al-Najjar, GPs who work for NHS Practitioner health - a mental health and addiction service specifically for health professionals. They are also joined by Ruth Mayall, a retired consultant anaesthetist who has experienced addiction herself, and has contributed to the Association of Anaesthetists guidance on drug and alcohol abuse.

Some resources mentioned in the podcast;

NHS Practitioner Health
https://www.practitionerhealth.nhs.uk/

The Sick Doctor's Trust
http://sick-doctors-trust.co.uk/

British Doctors & Dentists Group
https://www.bddg.org/

Substance use disorder in the anaesthetist
https://anaesthetists.org/Home/Resources-publications/Guidelines/Substance-use-disorder-in-the-anaesthetist

Substance abuse in anaesthetists
<p>https://academic.oup.com/bjaed/article/16/7/236/2196385?login=false</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4fmlso/stream_1497699652-bmjgroup-addiction-in-doctors.mp3" length="56827520" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Everyone has coping mechanisms, but sometimes those ways of coping become problem behaviours - addictions.

In this episode of Doctor Informed, we're focussing on how to spot the signs that you may be sliding into addiction, how to have conversations with friends and colleagues if you worry about their behaviour, and how seeking treatment is the best way to avoid GMC scrutiny.

Joining Clara Munro are Liz Croton and Zaid Al-Najjar, GPs who work for NHS Practitioner health - a mental health and addiction service specifically for health professionals. They are also joined by Ruth Mayall, a retired consultant anaesthetist who has experienced addiction herself, and has contributed to the Association of Anaesthetists guidance on drug and alcohol abuse.

Some resources mentioned in the podcast;

NHS Practitioner Health
https://www.practitionerhealth.nhs.uk/

The Sick Doctor's Trust
http://sick-doctors-trust.co.uk/

British Doctors & Dentists Group
https://www.bddg.org/

Substance use disorder in the anaesthetist
https://anaesthetists.org/Home/Resources-publications/Guidelines/Substance-use-disorder-in-the-anaesthetist

Substance abuse in anaesthetists
https://academic.oup.com/bjaed/article/16/7/236/2196385?login=false]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3552</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence - automatic approval, evidence apps, and pay for performance data</title>
        <itunes:title>Talk Evidence - automatic approval, evidence apps, and pay for performance data</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-automatic-approval-evidence-apps-and-pay-for-performance-data-1684835529/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-automatic-approval-evidence-apps-and-pay-for-performance-data-1684835529/#comments</comments>        <pubDate>Thu, 30 Mar 2023 11:10:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-automatic-approval-evidence-apps-and-pay-for-performance-data</guid>
                                    <description><![CDATA[In this month’s Talk Evidence, Helen Macdonald, Juan Franco and Joseph Ross are back to talk us through some of the latest research, 

They’ll talk about pay-for-perfomance schemes, and whether the data they routinely collect is measuring outcomes or  tickboxes. They’ll also talk about a new analysis published on bmj.com which suggests ways in which that data could be better.


We’re also by Huseyin Naci, associate professor of health policy at the London School of Economics and Political Science, who will tell us about proposed changes to drug regulation in the UK - and we discuss research which has linked speedier regulatory approval to more adverse advents in post marketing studies.

Finally, we talk about point of care apps. The availability of medical information in the clinic has changed practice, but how good is that information? We hear about research which has evaluated those point of care apps (including BMJ’s Best Practice app) and rates them against different criteria.


Reading list

Estimated impact from the withdrawal of primary care financial incentives on selected indicators of quality of care in Scotland 
https://www.bmj.com/content/380/bmj-2022-072098
How can we improve the quality of data collected in general practice?
https://www.bmj.com/content/380/bmj-2022-071950#


UK to give “near automatic sign off” for treatments approved by “trusted” regulators
https://www.bmj.com/content/380/bmj.p633


Smartphone apps for point-of-care information summaries
<p>https://ebm.bmj.com/content/early/2023/03/14/bmjebm-2022-112146</p>
]]></description>
                                                            <content:encoded><![CDATA[In this month’s Talk Evidence, Helen Macdonald, Juan Franco and Joseph Ross are back to talk us through some of the latest research, 

They’ll talk about pay-for-perfomance schemes, and whether the data they routinely collect is measuring outcomes or  tickboxes. They’ll also talk about a new analysis published on bmj.com which suggests ways in which that data could be better.


We’re also by Huseyin Naci, associate professor of health policy at the London School of Economics and Political Science, who will tell us about proposed changes to drug regulation in the UK - and we discuss research which has linked speedier regulatory approval to more adverse advents in post marketing studies.

Finally, we talk about point of care apps. The availability of medical information in the clinic has changed practice, but how good is that information? We hear about research which has evaluated those point of care apps (including BMJ’s Best Practice app) and rates them against different criteria.


Reading list

Estimated impact from the withdrawal of primary care financial incentives on selected indicators of quality of care in Scotland 
https://www.bmj.com/content/380/bmj-2022-072098
How can we improve the quality of data collected in general practice?
https://www.bmj.com/content/380/bmj-2022-071950#


UK to give “near automatic sign off” for treatments approved by “trusted” regulators
https://www.bmj.com/content/380/bmj.p633


Smartphone apps for point-of-care information summaries
<p>https://ebm.bmj.com/content/early/2023/03/14/bmjebm-2022-112146</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wjesmt/stream_1481000683-bmjgroup-talk-evidence-automatic-approval-evidence-apps-and-pay-for-performance-data.mp3" length="56844994" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this month’s Talk Evidence, Helen Macdonald, Juan Franco and Joseph Ross are back to talk us through some of the latest research, 

They’ll talk about pay-for-perfomance schemes, and whether the data they routinely collect is measuring outcomes or  tickboxes. They’ll also talk about a new analysis published on bmj.com which suggests ways in which that data could be better.


We’re also by Huseyin Naci, associate professor of health policy at the London School of Economics and Political Science, who will tell us about proposed changes to drug regulation in the UK - and we discuss research which has linked speedier regulatory approval to more adverse advents in post marketing studies.

Finally, we talk about point of care apps. The availability of medical information in the clinic has changed practice, but how good is that information? We hear about research which has evaluated those point of care apps (including BMJ’s Best Practice app) and rates them against different criteria.


Reading list

Estimated impact from the withdrawal of primary care financial incentives on selected indicators of quality of care in Scotland 
https://www.bmj.com/content/380/bmj-2022-072098
How can we improve the quality of data collected in general practice?
https://www.bmj.com/content/380/bmj-2022-071950#


UK to give “near automatic sign off” for treatments approved by “trusted” regulators
https://www.bmj.com/content/380/bmj.p633


Smartphone apps for point-of-care information summaries
https://ebm.bmj.com/content/early/2023/03/14/bmjebm-2022-112146]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2372</itunes:duration>
                                    </item>
    <item>
        <title>Nappuccinos and circadian rhythms</title>
        <itunes:title>Nappuccinos and circadian rhythms</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/nappuccinos-and-circadian-rhythms/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/nappuccinos-and-circadian-rhythms/#comments</comments>        <pubDate>Fri, 24 Mar 2023 18:41:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/nappuccinos-and-circadian-rhythms</guid>
                                    <description><![CDATA[Fatigue can have as much of an affect in your ability to function as alcohol, and yet while you would be chastised for drinking before appearing on the ward, hospitals have systematically removed the spaces where tired clinicians can rest and recover.

The Royal College of Anaesthetists have been campaigning to raise awareness of the dangers of fatigue, and it seems that anaesthetic trainees have benefitted from that, with sleep pods and flexible schedules - but other specialties are lagging behind.

In this podcast, Roo McCrossan, a consultant anaesthetist joins our host Clara Munro, a surgical trainee, and Ayesha Ashmore, obstetric trainee, to talk about how to fight fatigue. They discuss circadian rhythms, what to eat, nappuccinos, and why trusts should make more sleeping spaces.

For more information about fighting fatigue;
<p>https://anaesthetists.org/Home/Wellbeing-support/Fatigue/-Fight-Fatigue-download-our-information-packs</p>
]]></description>
                                                            <content:encoded><![CDATA[Fatigue can have as much of an affect in your ability to function as alcohol, and yet while you would be chastised for drinking before appearing on the ward, hospitals have systematically removed the spaces where tired clinicians can rest and recover.

The Royal College of Anaesthetists have been campaigning to raise awareness of the dangers of fatigue, and it seems that anaesthetic trainees have benefitted from that, with sleep pods and flexible schedules - but other specialties are lagging behind.

In this podcast, Roo McCrossan, a consultant anaesthetist joins our host Clara Munro, a surgical trainee, and Ayesha Ashmore, obstetric trainee, to talk about how to fight fatigue. They discuss circadian rhythms, what to eat, nappuccinos, and why trusts should make more sleeping spaces.

For more information about fighting fatigue;
<p>https://anaesthetists.org/Home/Wellbeing-support/Fatigue/-Fight-Fatigue-download-our-information-packs</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/t0kpjf/stream_1476749296-bmjgroup-nappuccinos-and-circadian-rhythms.mp3" length="50627456" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Fatigue can have as much of an affect in your ability to function as alcohol, and yet while you would be chastised for drinking before appearing on the ward, hospitals have systematically removed the spaces where tired clinicians can rest and recover.

The Royal College of Anaesthetists have been campaigning to raise awareness of the dangers of fatigue, and it seems that anaesthetic trainees have benefitted from that, with sleep pods and flexible schedules - but other specialties are lagging behind.

In this podcast, Roo McCrossan, a consultant anaesthetist joins our host Clara Munro, a surgical trainee, and Ayesha Ashmore, obstetric trainee, to talk about how to fight fatigue. They discuss circadian rhythms, what to eat, nappuccinos, and why trusts should make more sleeping spaces.

For more information about fighting fatigue;
https://anaesthetists.org/Home/Wellbeing-support/Fatigue/-Fight-Fatigue-download-our-information-packs]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3176</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Why guideline authors need to pay attention to doctor’s time</title>
        <itunes:title>Why guideline authors need to pay attention to doctor’s time</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/why-guideline-authors-need-to-pay-attention-to-doctor-s-time/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/why-guideline-authors-need-to-pay-attention-to-doctor-s-time/#comments</comments>        <pubDate>Fri, 10 Mar 2023 18:25:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/time-needed-to-treat-with-minna-johansson</guid>
                                    <description><![CDATA[We're bringing you an episode of the BMJ's podcast for primary care, Deep Breath In, which we think you'll enjoy.

How long would it take GPs to enact all of the guideline recommendations that they might be expected too? Far more GP hours than exist in any healthcare system; but as medicine has turned its attention to primary prevention, and expanded the populations whose health we seek to improve, those guidelines are taking up more and more time.

A recent analysis in The BMJ has proposed the concept of “Time Needed to Treat” - and implores guideline makers to take account consultation time as a precious, finite, resource when thinking about their recommendations.

In this episode of Deep Breath In, we’re joined by Minna Johansson, family doctor and director Global Center for Sustainable Healthcare, who co-authored that analysis to talk about how the concept has gone down, and what it might mean for rethinking what primary care is supposed to do.

Reading list:
Guidelines should consider clinicians’ time needed to treat
<p>https://www.bmj.com/content/380/bmj-2022-072953</p>
]]></description>
                                                            <content:encoded><![CDATA[We're bringing you an episode of the BMJ's podcast for primary care, Deep Breath In, which we think you'll enjoy.

How long would it take GPs to enact all of the guideline recommendations that they might be expected too? Far more GP hours than exist in any healthcare system; but as medicine has turned its attention to primary prevention, and expanded the populations whose health we seek to improve, those guidelines are taking up more and more time.

A recent analysis in The BMJ has proposed the concept of “Time Needed to Treat” - and implores guideline makers to take account consultation time as a precious, finite, resource when thinking about their recommendations.

In this episode of Deep Breath In, we’re joined by Minna Johansson, family doctor and director Global Center for Sustainable Healthcare, who co-authored that analysis to talk about how the concept has gone down, and what it might mean for rethinking what primary care is supposed to do.

Reading list:
Guidelines should consider clinicians’ time needed to treat
<p>https://www.bmj.com/content/380/bmj-2022-072953</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ary6ic/stream_1466113720-bmjgroup-time-needed-to-treat-with-minna-johansson.mp3" length="64113943" type="audio/mpeg"/>
        <itunes:summary><![CDATA[We're bringing you an episode of the BMJ's podcast for primary care, Deep Breath In, which we think you'll enjoy.

How long would it take GPs to enact all of the guideline recommendations that they might be expected too? Far more GP hours than exist in any healthcare system; but as medicine has turned its attention to primary prevention, and expanded the populations whose health we seek to improve, those guidelines are taking up more and more time.

A recent analysis in The BMJ has proposed the concept of “Time Needed to Treat” - and implores guideline makers to take account consultation time as a precious, finite, resource when thinking about their recommendations.

In this episode of Deep Breath In, we’re joined by Minna Johansson, family doctor and director Global Center for Sustainable Healthcare, who co-authored that analysis to talk about how the concept has gone down, and what it might mean for rethinking what primary care is supposed to do.

Reading list:
Guidelines should consider clinicians’ time needed to treat
https://www.bmj.com/content/380/bmj-2022-072953]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2675</itunes:duration>
                                    </item>
    <item>
        <title>Nuffield Summit 2023 - healthcare needs flexible working</title>
        <itunes:title>Nuffield Summit 2023 - healthcare needs flexible working</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/nuffield-summit-2023-healthcare-needs-flexible-working/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/nuffield-summit-2023-healthcare-needs-flexible-working/#comments</comments>        <pubDate>Fri, 03 Mar 2023 18:14:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/nuffield-summit-2023-healthcare-needs-flexible-working</guid>
                                    <description><![CDATA[As workforce gaps in the NHS, and other healthcare systems around the world widen, the need to improve staff retention has become an ever more pressing concern. Yet work-life balance issues continue to drive staff away from the service.

What is the imperative to get flexible working right, and what can be done to remove the barriers facing healthcare workers seeking to change the way they work?

Joining us in the discussion are;
Kamran Abbasi, editor in chief of The BMJ
Rachel Hutchings, fellow at the Nuffield Trust
Sarah Sweeney, interim chief executive, National Voices
Farzana Hussain, a GP in Newham, London
Thea Stein, chief executive of Leeds Community Healthcare NHS Trust

<p>The report that Rachel Hutchings has authors is summaried in a BMJ feature -  Challenges of combining a career in surgery with parenting https://www.bmj.com/content/380/bmj.p449</p>
]]></description>
                                                            <content:encoded><![CDATA[As workforce gaps in the NHS, and other healthcare systems around the world widen, the need to improve staff retention has become an ever more pressing concern. Yet work-life balance issues continue to drive staff away from the service.

What is the imperative to get flexible working right, and what can be done to remove the barriers facing healthcare workers seeking to change the way they work?

Joining us in the discussion are;
Kamran Abbasi, editor in chief of The BMJ
Rachel Hutchings, fellow at the Nuffield Trust
Sarah Sweeney, interim chief executive, National Voices
Farzana Hussain, a GP in Newham, London
Thea Stein, chief executive of Leeds Community Healthcare NHS Trust

<p>The report that Rachel Hutchings has authors is summaried in a BMJ feature -  Challenges of combining a career in surgery with parenting https://www.bmj.com/content/380/bmj.p449</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vq4zzr/stream_1460675560-bmjgroup-nuffield-summit-2023-healthcare-needs-flexible-working.mp3" length="63815201" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As workforce gaps in the NHS, and other healthcare systems around the world widen, the need to improve staff retention has become an ever more pressing concern. Yet work-life balance issues continue to drive staff away from the service.

What is the imperative to get flexible working right, and what can be done to remove the barriers facing healthcare workers seeking to change the way they work?

Joining us in the discussion are;
Kamran Abbasi, editor in chief of The BMJ
Rachel Hutchings, fellow at the Nuffield Trust
Sarah Sweeney, interim chief executive, National Voices
Farzana Hussain, a GP in Newham, London
Thea Stein, chief executive of Leeds Community Healthcare NHS Trust

The report that Rachel Hutchings has authors is summaried in a BMJ feature -  Challenges of combining a career in surgery with parenting https://www.bmj.com/content/380/bmj.p449]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2661</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence - masks, chronic pain, and baby milk formulae claims</title>
        <itunes:title>Talk Evidence - masks, chronic pain, and baby milk formulae claims</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-masks-chronic-pain-and-baby-milk-formulae-claims/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-masks-chronic-pain-and-baby-milk-formulae-claims/#comments</comments>        <pubDate>Fri, 24 Feb 2023 23:46:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-masks-chronic-pain-and-baby-milk-formulae-claims</guid>
                                    <description><![CDATA[In this episode of Talk Evidence, Helen Macdonald is joined by Juan Franco and Joe Ross, to bring you the newest evidence in The BMJ.

First, chronic pain. As prescribers move away from opioids, Juan finds an overview of systematic reviews asking whether anti-depressants might help. 

Joe finds new research on the link between six healthy lifestyle markers and cognitive decline. 

Helen looks at a trial to reduce prescribing among older people with suspected urinary tract infection or UTI.

Juan has a nuanced take on the updated evidence on masks to reduce the spread of respiratory viruses. 

Finally, an international group of researchers traced the health claims made about infant formula milk back to the evidence or lack of it 

Reading list:
Efficacy, safety, and tolerability of antidepressants for pain in adults
https://www.bmj.com/content/380/bmj-2022-072415

Association between healthy lifestyle and memory decline in older adults
https://www.bmj.com/content/380/bmj-2022-072691

Effect of a multifaceted antibiotic stewardship intervention to improve antibiotic prescribing for suspected urinary tract infections in frail older adults 
https://www.bmj.com/content/380/bmj-2022-072319

Physical interventions to interrupt or reduce the spread of respiratory viruses
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006207.pub6/full

Health and nutrition claims for infant formula
<p>https://www.bmj.com/content/380/bmj-2022-071075</p>
]]></description>
                                                            <content:encoded><![CDATA[In this episode of Talk Evidence, Helen Macdonald is joined by Juan Franco and Joe Ross, to bring you the newest evidence in The BMJ.

First, chronic pain. As prescribers move away from opioids, Juan finds an overview of systematic reviews asking whether anti-depressants might help. 

Joe finds new research on the link between six healthy lifestyle markers and cognitive decline. 

Helen looks at a trial to reduce prescribing among older people with suspected urinary tract infection or UTI.

Juan has a nuanced take on the updated evidence on masks to reduce the spread of respiratory viruses. 

Finally, an international group of researchers traced the health claims made about infant formula milk back to the evidence or lack of it 

Reading list:
Efficacy, safety, and tolerability of antidepressants for pain in adults
https://www.bmj.com/content/380/bmj-2022-072415

Association between healthy lifestyle and memory decline in older adults
https://www.bmj.com/content/380/bmj-2022-072691

Effect of a multifaceted antibiotic stewardship intervention to improve antibiotic prescribing for suspected urinary tract infections in frail older adults 
https://www.bmj.com/content/380/bmj-2022-072319

Physical interventions to interrupt or reduce the spread of respiratory viruses
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006207.pub6/full

Health and nutrition claims for infant formula
<p>https://www.bmj.com/content/380/bmj-2022-071075</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/pibg6x/stream_1455254077-bmjgroup-talk-evidence-masks-chronic-pain-and-baby-milk-formulae-claims.mp3" length="54652618" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode of Talk Evidence, Helen Macdonald is joined by Juan Franco and Joe Ross, to bring you the newest evidence in The BMJ.

First, chronic pain. As prescribers move away from opioids, Juan finds an overview of systematic reviews asking whether anti-depressants might help. 

Joe finds new research on the link between six healthy lifestyle markers and cognitive decline. 

Helen looks at a trial to reduce prescribing among older people with suspected urinary tract infection or UTI.

Juan has a nuanced take on the updated evidence on masks to reduce the spread of respiratory viruses. 

Finally, an international group of researchers traced the health claims made about infant formula milk back to the evidence or lack of it 

Reading list:
Efficacy, safety, and tolerability of antidepressants for pain in adults
https://www.bmj.com/content/380/bmj-2022-072415

Association between healthy lifestyle and memory decline in older adults
https://www.bmj.com/content/380/bmj-2022-072691

Effect of a multifaceted antibiotic stewardship intervention to improve antibiotic prescribing for suspected urinary tract infections in frail older adults 
https://www.bmj.com/content/380/bmj-2022-072319

Physical interventions to interrupt or reduce the spread of respiratory viruses
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006207.pub6/full

Health and nutrition claims for infant formula
https://www.bmj.com/content/380/bmj-2022-071075]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2280</itunes:duration>
                                    </item>
    <item>
        <title>Got grit?</title>
        <itunes:title>Got grit?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/got-grit-1684835535/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/got-grit-1684835535/#comments</comments>        <pubDate>Fri, 10 Feb 2023 17:26:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/got-grit</guid>
                                    <description><![CDATA[Grit is one of those concepts (like the dreaded resilience) that has a specific meaning, but has become a buzzword in healthcare.
It’s the ability to persevere in the pursuit of a goal, in the face of obstacles - and it’s something all doctors have. 

However that trait has benefits and drawbacks. It’s not necessarily fixed, but will depend on context, and it is measurable but not a very helpful measure in isolation.

In this episode, Clara Munro is joined by Declan Murphy and Ayisha Ashmore - and they sit down with neurourgeon and researcher Simone Betchen, who has measured grit in women surgeons, and helps them understand their grit scores.

Reading list
Grit in surgeons
<p>https://pubmed.ncbi.nlm.nih.gov/34218313/</p>
]]></description>
                                                            <content:encoded><![CDATA[Grit is one of those concepts (like the dreaded resilience) that has a specific meaning, but has become a buzzword in healthcare.
It’s the ability to persevere in the pursuit of a goal, in the face of obstacles - and it’s something all doctors have. 

However that trait has benefits and drawbacks. It’s not necessarily fixed, but will depend on context, and it is measurable but not a very helpful measure in isolation.

In this episode, Clara Munro is joined by Declan Murphy and Ayisha Ashmore - and they sit down with neurourgeon and researcher Simone Betchen, who has measured grit in women surgeons, and helps them understand their grit scores.

Reading list
Grit in surgeons
<p>https://pubmed.ncbi.nlm.nih.gov/34218313/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/cx2jsr/stream_1444182604-bmjgroup-got-grit.mp3" length="51368960" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Grit is one of those concepts (like the dreaded resilience) that has a specific meaning, but has become a buzzword in healthcare.
It’s the ability to persevere in the pursuit of a goal, in the face of obstacles - and it’s something all doctors have. 

However that trait has benefits and drawbacks. It’s not necessarily fixed, but will depend on context, and it is measurable but not a very helpful measure in isolation.

In this episode, Clara Munro is joined by Declan Murphy and Ayisha Ashmore - and they sit down with neurourgeon and researcher Simone Betchen, who has measured grit in women surgeons, and helps them understand their grit scores.

Reading list
Grit in surgeons
https://pubmed.ncbi.nlm.nih.gov/34218313/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3211</itunes:duration>
                                    </item>
    <item>
        <title>Is it time for the Beano to drop the junk food brands?</title>
        <itunes:title>Is it time for the Beano to drop the junk food brands?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/is-it-time-for-the-beano-to-drop-the-junk-food-brands/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/is-it-time-for-the-beano-to-drop-the-junk-food-brands/#comments</comments>        <pubDate>Sat, 04 Feb 2023 10:20:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/is-it-time-for-the-beano-to-drop-the-junk-food-brands</guid>
                                    <description><![CDATA[Claire Mulrenan, specialist registrar in public health, and Mark Petticrew, professor of public health evaluation, both working at the London School of Hygiene and Tropical medicine were surprised to see high-fat, high-salt fast food brands being featured heavily on the website of one of the UK's most beloved children's comics.
In this podcast, they describe why they think that is harmful, and why the Beano should think again about its editorial policies, to protect children's health.
<p>To read the full investigation: www.bmj.com/content/380/bmj.p197</p>
]]></description>
                                                            <content:encoded><![CDATA[Claire Mulrenan, specialist registrar in public health, and Mark Petticrew, professor of public health evaluation, both working at the London School of Hygiene and Tropical medicine were surprised to see high-fat, high-salt fast food brands being featured heavily on the website of one of the UK's most beloved children's comics.
In this podcast, they describe why they think that is harmful, and why the Beano should think again about its editorial policies, to protect children's health.
<p>To read the full investigation: www.bmj.com/content/380/bmj.p197</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xoam6c/stream_1439574679-bmjgroup-is-it-time-for-the-beano-to-drop-the-junk-food-brands.mp3" length="25285360" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Claire Mulrenan, specialist registrar in public health, and Mark Petticrew, professor of public health evaluation, both working at the London School of Hygiene and Tropical medicine were surprised to see high-fat, high-salt fast food brands being featured heavily on the website of one of the UK's most beloved children's comics.
In this podcast, they describe why they think that is harmful, and why the Beano should think again about its editorial policies, to protect children's health.
To read the full investigation: www.bmj.com/content/380/bmj.p197]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1054</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence - excess deaths, the ONS, and the healthcare crisis</title>
        <itunes:title>Talk Evidence - excess deaths, the ONS, and the healthcare crisis</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-excess-deaths-the-ons-and-the-healthcare-crisis/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-excess-deaths-the-ons-and-the-healthcare-crisis/#comments</comments>        <pubDate>Fri, 27 Jan 2023 16:37:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-excess-deaths-the-ons-and-the-healthcare-crisis</guid>
                                    <description><![CDATA[In this week's episode, we're focusing on covid and the ongoing crisis in the NHS.

Helen Macdonald, Juan Franco and Joseph Ross cast their evidence seeking eyes over research into outcomes as well as the workload of doctors.

Firstly, Joe tells us about a new big data study into longer term outcomes after mild covid-19, how those ongoing symptoms relate to long covid, and how often they resolve themselves.

Juan looks back to his homeland to see what Argentina which was very early to offer children vaccinations against covid-19. He tells us how a new study design can help understand how effective different combinations of vaccines were.

Joe has a Danish registry paper, which links people's employment status after a MI, explains how that gives us an insight into morbidity following that event.

Helen looks at a new analysis which outlines the concept of "time needed to treat" - a measure of how much time it would take a clinician to actually carry out a guideline - and you'd be surprised how much GP time would be swallowed by a "brief" intervention to reduce inactivity in their patients.

Finally, the data on excess mortality in the UK has been up for debate recently - our health minister calling into question the Office of National Statistic's data. We hear from Nazrul Islam, Associate professor of medical statistics, advisor to the ONS and BMJ research editor, who has some bad news for him.

Reading list:
Long covid outcomes at one year after mild SARS-CoV-2 infection
https://www.bmj.com/content/380/bmj-2022-072529

Effectiveness of mRNA-1273, BNT162b2, and BBIBP-CorV vaccines against infection and mortality in children in Argentina, during predominance of delta and omicron covid-19 variants
https://www.bmj.com/content/379/bmj-2022-073070


Guidelines should consider clinicians’ time needed to treat
https://www.bmj.com/content/380/bmj-2022-072953

Expanding the measurement of overdiagnosis in the context of disease precursors and risk factors
https://ebm.bmj.com/content/early/2023/01/10/bmjebm-2022-112117

Excess deaths associated with covid-19 pandemic in 2020
<p>https://www.bmj.com/content/373/bmj.n1137.abstract</p>
]]></description>
                                                            <content:encoded><![CDATA[In this week's episode, we're focusing on covid and the ongoing crisis in the NHS.

Helen Macdonald, Juan Franco and Joseph Ross cast their evidence seeking eyes over research into outcomes as well as the workload of doctors.

Firstly, Joe tells us about a new big data study into longer term outcomes after mild covid-19, how those ongoing symptoms relate to long covid, and how often they resolve themselves.

Juan looks back to his homeland to see what Argentina which was very early to offer children vaccinations against covid-19. He tells us how a new study design can help understand how effective different combinations of vaccines were.

Joe has a Danish registry paper, which links people's employment status after a MI, explains how that gives us an insight into morbidity following that event.

Helen looks at a new analysis which outlines the concept of "time needed to treat" - a measure of how much time it would take a clinician to actually carry out a guideline - and you'd be surprised how much GP time would be swallowed by a "brief" intervention to reduce inactivity in their patients.

Finally, the data on excess mortality in the UK has been up for debate recently - our health minister calling into question the Office of National Statistic's data. We hear from Nazrul Islam, Associate professor of medical statistics, advisor to the ONS and BMJ research editor, who has some bad news for him.

Reading list:
Long covid outcomes at one year after mild SARS-CoV-2 infection
https://www.bmj.com/content/380/bmj-2022-072529

Effectiveness of mRNA-1273, BNT162b2, and BBIBP-CorV vaccines against infection and mortality in children in Argentina, during predominance of delta and omicron covid-19 variants
https://www.bmj.com/content/379/bmj-2022-073070


Guidelines should consider clinicians’ time needed to treat
https://www.bmj.com/content/380/bmj-2022-072953

Expanding the measurement of overdiagnosis in the context of disease precursors and risk factors
https://ebm.bmj.com/content/early/2023/01/10/bmjebm-2022-112117

Excess deaths associated with covid-19 pandemic in 2020
<p>https://www.bmj.com/content/373/bmj.n1137.abstract</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/009t6x/stream_1433867491-bmjgroup-talk-evidence-excess-deaths-the-ons-and-the-healthcare-crisis.mp3" length="50026369" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this week's episode, we're focusing on covid and the ongoing crisis in the NHS.

Helen Macdonald, Juan Franco and Joseph Ross cast their evidence seeking eyes over research into outcomes as well as the workload of doctors.

Firstly, Joe tells us about a new big data study into longer term outcomes after mild covid-19, how those ongoing symptoms relate to long covid, and how often they resolve themselves.

Juan looks back to his homeland to see what Argentina which was very early to offer children vaccinations against covid-19. He tells us how a new study design can help understand how effective different combinations of vaccines were.

Joe has a Danish registry paper, which links people's employment status after a MI, explains how that gives us an insight into morbidity following that event.

Helen looks at a new analysis which outlines the concept of "time needed to treat" - a measure of how much time it would take a clinician to actually carry out a guideline - and you'd be surprised how much GP time would be swallowed by a "brief" intervention to reduce inactivity in their patients.

Finally, the data on excess mortality in the UK has been up for debate recently - our health minister calling into question the Office of National Statistic's data. We hear from Nazrul Islam, Associate professor of medical statistics, advisor to the ONS and BMJ research editor, who has some bad news for him.

Reading list:
Long covid outcomes at one year after mild SARS-CoV-2 infection
https://www.bmj.com/content/380/bmj-2022-072529

Effectiveness of mRNA-1273, BNT162b2, and BBIBP-CorV vaccines against infection and mortality in children in Argentina, during predominance of delta and omicron covid-19 variants
https://www.bmj.com/content/379/bmj-2022-073070


Guidelines should consider clinicians’ time needed to treat
https://www.bmj.com/content/380/bmj-2022-072953

Expanding the measurement of overdiagnosis in the context of disease precursors and risk factors
https://ebm.bmj.com/content/early/2023/01/10/bmjebm-2022-112117

Excess deaths associated with covid-19 pandemic in 2020
https://www.bmj.com/content/373/bmj.n1137.abstract]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3127</itunes:duration>
                                    </item>
    <item>
        <title>Formal Training Pathways, are they really all that?</title>
        <itunes:title>Formal Training Pathways, are they really all that?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/formal-training-pathways-are-they-really-all-that/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/formal-training-pathways-are-they-really-all-that/#comments</comments>        <pubDate>Fri, 06 Jan 2023 17:59:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/formal-training-pathways-are-they-really-all-that</guid>
                                    <description><![CDATA[One size doesn’t fit all - so what are the alternative career paths of doctors in the NHS? The treadmill of medical school, to foundation training, to specialist training, to a consultant position takes years and is not very trainee-centric in it’s design.

So are there other ways for doctors to be able to work in the NHS, still progress their career, but also tailor the job to themselves? And what are the drawbacks of trying to do that?

<p>In this podcast, Clara Munro is joined by Flo Wedmore and new panelist Jason Ramsingh, a surgical trainee in Newcastle. They speak to Rob Fleming an SAS (speciality and associate specialist) doctor in anaesthetics.</p>
]]></description>
                                                            <content:encoded><![CDATA[One size doesn’t fit all - so what are the alternative career paths of doctors in the NHS? The treadmill of medical school, to foundation training, to specialist training, to a consultant position takes years and is not very trainee-centric in it’s design.

So are there other ways for doctors to be able to work in the NHS, still progress their career, but also tailor the job to themselves? And what are the drawbacks of trying to do that?

<p>In this podcast, Clara Munro is joined by Flo Wedmore and new panelist Jason Ramsingh, a surgical trainee in Newcastle. They speak to Rob Fleming an SAS (speciality and associate specialist) doctor in anaesthetics.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/r3wyeu/stream_1418124427-bmjgroup-formal-training-pathways-are-they-really-all-that.mp3" length="56848256" type="audio/mpeg"/>
        <itunes:summary><![CDATA[One size doesn’t fit all - so what are the alternative career paths of doctors in the NHS? The treadmill of medical school, to foundation training, to specialist training, to a consultant position takes years and is not very trainee-centric in it’s design.

So are there other ways for doctors to be able to work in the NHS, still progress their career, but also tailor the job to themselves? And what are the drawbacks of trying to do that?

In this podcast, Clara Munro is joined by Flo Wedmore and new panelist Jason Ramsingh, a surgical trainee in Newcastle. They speak to Rob Fleming an SAS (speciality and associate specialist) doctor in anaesthetics.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3553</itunes:duration>
                                    </item>
    <item>
        <title>Conflict and food global food insecurity</title>
        <itunes:title>Conflict and food global food insecurity</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/conflict-and-food-global-food-insecurity/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/conflict-and-food-global-food-insecurity/#comments</comments>        <pubDate>Sat, 31 Dec 2022 16:47:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/conflict-and-food-global-food-insecurity</guid>
                                    <description><![CDATA[As we gear up for the winter in the northern hemisphere, the need to stay warm and eat well is pressing - but in 2022, there are global pressures working against us. 

Russia invaded Ukraine, and the subsequent restrictions on exports from both of those countries is being felt in terms of fuel costs - but also food costs. At the same time, this year has seen droughts and flooding which have affected global food production, as well as continuing restrictions around covid and economic activity. 

All of these factors are working together to increase food insecurity.

Our Guests;
Sheryl Hendricks, professor of food security at the University of Pretoria
Renzo Guinto, chief planetary doctor at PH Lab
<p>Tim Benton, director of the Environment and Society Programme at Chatham House.</p>
]]></description>
                                                            <content:encoded><![CDATA[As we gear up for the winter in the northern hemisphere, the need to stay warm and eat well is pressing - but in 2022, there are global pressures working against us. 

Russia invaded Ukraine, and the subsequent restrictions on exports from both of those countries is being felt in terms of fuel costs - but also food costs. At the same time, this year has seen droughts and flooding which have affected global food production, as well as continuing restrictions around covid and economic activity. 

All of these factors are working together to increase food insecurity.

Our Guests;
Sheryl Hendricks, professor of food security at the University of Pretoria
Renzo Guinto, chief planetary doctor at PH Lab
<p>Tim Benton, director of the Environment and Society Programme at Chatham House.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/z54jtf/stream_1413804322-bmjgroup-conflict-and-food-global-food-insecurity.mp3" length="43041017" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As we gear up for the winter in the northern hemisphere, the need to stay warm and eat well is pressing - but in 2022, there are global pressures working against us. 

Russia invaded Ukraine, and the subsequent restrictions on exports from both of those countries is being felt in terms of fuel costs - but also food costs. At the same time, this year has seen droughts and flooding which have affected global food production, as well as continuing restrictions around covid and economic activity. 

All of these factors are working together to increase food insecurity.

Our Guests;
Sheryl Hendricks, professor of food security at the University of Pretoria
Renzo Guinto, chief planetary doctor at PH Lab
Tim Benton, director of the Environment and Society Programme at Chatham House.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2690</itunes:duration>
                                    </item>
    <item>
        <title>Talking evidence at Christmas</title>
        <itunes:title>Talking evidence at Christmas</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talking-evidence-at-christmas/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talking-evidence-at-christmas/#comments</comments>        <pubDate>Wed, 21 Dec 2022 11:52:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talking-evidence-at-christmas</guid>
                                    <description><![CDATA[It's almost time for the Christmas edition of the BMJ to hit your doormats, and in this festive edition of Talk Evidence we're going to be talking Christmas research.

Joining Helen and Juan, we have Tim Feeney, BMJ research editor and researcher into Surgical outcomes at Boston University.

<p>In this episode we'll be hearing about the health of footballers, and if a career in the sport predisposes Swedish players to substance use disorders. We'll hear about the performance of BMJ’s editors, when it comes to assessing the impact of a paper. We'll find out if AI algorithms can pass UK radiology exams, misinformation and a belief that everything causes cancer, and finally, some tips from BMJ’s statisticians to set the world right</p>
]]></description>
                                                            <content:encoded><![CDATA[It's almost time for the Christmas edition of the BMJ to hit your doormats, and in this festive edition of Talk Evidence we're going to be talking Christmas research.

Joining Helen and Juan, we have Tim Feeney, BMJ research editor and researcher into Surgical outcomes at Boston University.

<p>In this episode we'll be hearing about the health of footballers, and if a career in the sport predisposes Swedish players to substance use disorders. We'll hear about the performance of BMJ’s editors, when it comes to assessing the impact of a paper. We'll find out if AI algorithms can pass UK radiology exams, misinformation and a belief that everything causes cancer, and finally, some tips from BMJ’s statisticians to set the world right</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/iun8h7/stream_1407325957-bmjgroup-talking-evidence-at-christmas.mp3" length="33096514" type="audio/mpeg"/>
        <itunes:summary><![CDATA[It's almost time for the Christmas edition of the BMJ to hit your doormats, and in this festive edition of Talk Evidence we're going to be talking Christmas research.

Joining Helen and Juan, we have Tim Feeney, BMJ research editor and researcher into Surgical outcomes at Boston University.

In this episode we'll be hearing about the health of footballers, and if a career in the sport predisposes Swedish players to substance use disorders. We'll hear about the performance of BMJ’s editors, when it comes to assessing the impact of a paper. We'll find out if AI algorithms can pass UK radiology exams, misinformation and a belief that everything causes cancer, and finally, some tips from BMJ’s statisticians to set the world right]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2069</itunes:duration>
                                    </item>
    <item>
        <title>DNACPR</title>
        <itunes:title>DNACPR</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/dnacpr/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/dnacpr/#comments</comments>        <pubDate>Wed, 14 Dec 2022 12:28:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/dnacpr</guid>
                                    <description><![CDATA[In this episode of the Dr. Informed podcast, the topic of discussion is death and dying, and how to involve patients in DNACPR decisions.

The panel discuss the importance of doctors having discussions with patients about end-of-life care as a way of creating the best possible death for patients. The conversation also touches on the challenges that doctors may face when having these difficult discussions and they give some advice on how they to overcome them.

Joining Clara are;
Mark Taubert, palliative care consultant, and national chair of future care planning for the Welsh Government
Kat Shelley, an anaesthetics trainee, who has stage four breast cancer, and is receiving palliative care
Lucy-Anne Frank, an elderly care consultant.

The article "Do not resuscitate me in Barbados" is published by BMJ Supportive and Palliative Care, and is free to access at;
<p>https://spcare.bmj.com/content/11/3/310</p>
]]></description>
                                                            <content:encoded><![CDATA[In this episode of the Dr. Informed podcast, the topic of discussion is death and dying, and how to involve patients in DNACPR decisions.

The panel discuss the importance of doctors having discussions with patients about end-of-life care as a way of creating the best possible death for patients. The conversation also touches on the challenges that doctors may face when having these difficult discussions and they give some advice on how they to overcome them.

Joining Clara are;
Mark Taubert, palliative care consultant, and national chair of future care planning for the Welsh Government
Kat Shelley, an anaesthetics trainee, who has stage four breast cancer, and is receiving palliative care
Lucy-Anne Frank, an elderly care consultant.

The article "Do not resuscitate me in Barbados" is published by BMJ Supportive and Palliative Care, and is free to access at;
<p>https://spcare.bmj.com/content/11/3/310</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jsls0h/stream_1402516930-bmjgroup-dnacpr.mp3" length="58365056" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode of the Dr. Informed podcast, the topic of discussion is death and dying, and how to involve patients in DNACPR decisions.

The panel discuss the importance of doctors having discussions with patients about end-of-life care as a way of creating the best possible death for patients. The conversation also touches on the challenges that doctors may face when having these difficult discussions and they give some advice on how they to overcome them.

Joining Clara are;
Mark Taubert, palliative care consultant, and national chair of future care planning for the Welsh Government
Kat Shelley, an anaesthetics trainee, who has stage four breast cancer, and is receiving palliative care
Lucy-Anne Frank, an elderly care consultant.

The article "Do not resuscitate me in Barbados" is published by BMJ Supportive and Palliative Care, and is free to access at;
https://spcare.bmj.com/content/11/3/310]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3648</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence - endometriosis, falling, and better EBM</title>
        <itunes:title>Talk Evidence - endometriosis, falling, and better EBM</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-endometriosis-falling-and-better-ebm/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-endometriosis-falling-and-better-ebm/#comments</comments>        <pubDate>Fri, 02 Dec 2022 14:11:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-endometriosis-falling-and-better-ebm</guid>
                                    <description><![CDATA[In this month's episode, Helen Juan and Joe delve into the clinical - with a new review of endometriosis, and why the difficulty in diagnosis has lead to a dearth of evidence and attention on the condition.

Joe tells us about a risk prediction tool that could be useful in helping to mitigate some of the problems of antihypertensive treatments.

We're also having a geek out about a group of papers we've published lately, on how well evidence is created, maintained, and diseminated.

Reading list;


Development and external validation of a risk prediction model for falls in patients with an indication for antihypertensive treatment: retrospective cohort study
https://www.bmj.com/content/379/bmj-2022-070918

Pathophysiology, diagnosis, and management of endometriosis
https://www.bmj.com/content/379/bmj-2022-070750


Effective knowledge mobilisation: creating environments for quick generation, dissemination, and use of evidence
https://www.bmj.com/content/379/bmj-2022-070195

Consistency of covid-19 trial preprints with published reports and impact for decision making: retrospective review 
https://bmjmedicine.bmj.com/content/1/1/e000309

Changing patterns in reporting and sharing of review data in systematic reviews with meta-analysis of the effects of interventions: a meta-research study from the REPRISE project
<p>https://www.medrxiv.org/content/10.1101/2022.04.11.22273688v2</p>
]]></description>
                                                            <content:encoded><![CDATA[In this month's episode, Helen Juan and Joe delve into the clinical - with a new review of endometriosis, and why the difficulty in diagnosis has lead to a dearth of evidence and attention on the condition.

Joe tells us about a risk prediction tool that could be useful in helping to mitigate some of the problems of antihypertensive treatments.

We're also having a geek out about a group of papers we've published lately, on how well evidence is created, maintained, and diseminated.

Reading list;


Development and external validation of a risk prediction model for falls in patients with an indication for antihypertensive treatment: retrospective cohort study
https://www.bmj.com/content/379/bmj-2022-070918

Pathophysiology, diagnosis, and management of endometriosis
https://www.bmj.com/content/379/bmj-2022-070750


Effective knowledge mobilisation: creating environments for quick generation, dissemination, and use of evidence
https://www.bmj.com/content/379/bmj-2022-070195

Consistency of covid-19 trial preprints with published reports and impact for decision making: retrospective review 
https://bmjmedicine.bmj.com/content/1/1/e000309

Changing patterns in reporting and sharing of review data in systematic reviews with meta-analysis of the effects of interventions: a meta-research study from the REPRISE project
<p>https://www.medrxiv.org/content/10.1101/2022.04.11.22273688v2</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ilskfk/stream_1394794615-bmjgroup-talk-evidence-endometriosis-falling-and-better-ebm.mp3" length="45732257" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this month's episode, Helen Juan and Joe delve into the clinical - with a new review of endometriosis, and why the difficulty in diagnosis has lead to a dearth of evidence and attention on the condition.

Joe tells us about a risk prediction tool that could be useful in helping to mitigate some of the problems of antihypertensive treatments.

We're also having a geek out about a group of papers we've published lately, on how well evidence is created, maintained, and diseminated.

Reading list;


Development and external validation of a risk prediction model for falls in patients with an indication for antihypertensive treatment: retrospective cohort study
https://www.bmj.com/content/379/bmj-2022-070918

Pathophysiology, diagnosis, and management of endometriosis
https://www.bmj.com/content/379/bmj-2022-070750


Effective knowledge mobilisation: creating environments for quick generation, dissemination, and use of evidence
https://www.bmj.com/content/379/bmj-2022-070195

Consistency of covid-19 trial preprints with published reports and impact for decision making: retrospective review 
https://bmjmedicine.bmj.com/content/1/1/e000309

Changing patterns in reporting and sharing of review data in systematic reviews with meta-analysis of the effects of interventions: a meta-research study from the REPRISE project
https://www.medrxiv.org/content/10.1101/2022.04.11.22273688v2]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2858</itunes:duration>
                                    </item>
    <item>
        <title>#MedTwitter - a force for good or evil?</title>
        <itunes:title>#MedTwitter - a force for good or evil?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/medtwitter-a-force-for-good-or-evil/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/medtwitter-a-force-for-good-or-evil/#comments</comments>        <pubDate>Tue, 22 Nov 2022 10:43:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/med-twitter-a-force-for-good-or-evil</guid>
                                    <description><![CDATA[#MedTwitter consists of an online community of researchers, health practitioners and students who have created an open source decentralised forum for information sharing, medical education and professional networking. #MedTwitter also provides a space for publications to be shared and promoted. While many will credit Twitter with giving a voice to clinicians, it also comes with challenges, the potential for abuse, or the spread of misinformation.

Joining Clara to discuss are;

Jonathan Guckian, a dermatology registrar in Leeds, and director of social media and communications at the Association for the Study of Medical Education (ASMI).

Flo Wedmore, a medical registrar and NHS sustainability fellow

<p>Declan Murphy, an academic medical fellow S2 in ophthalmology in Newcastle, and former Sharp Scratch panelist.</p>
]]></description>
                                                            <content:encoded><![CDATA[#MedTwitter consists of an online community of researchers, health practitioners and students who have created an open source decentralised forum for information sharing, medical education and professional networking. #MedTwitter also provides a space for publications to be shared and promoted. While many will credit Twitter with giving a voice to clinicians, it also comes with challenges, the potential for abuse, or the spread of misinformation.

Joining Clara to discuss are;

Jonathan Guckian, a dermatology registrar in Leeds, and director of social media and communications at the Association for the Study of Medical Education (ASMI).

Flo Wedmore, a medical registrar and NHS sustainability fellow

<p>Declan Murphy, an academic medical fellow S2 in ophthalmology in Newcastle, and former Sharp Scratch panelist.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/1pbk17/stream_1388155543-bmjgroup-med-twitter-a-force-for-good-or-evil.mp3" length="50944256" type="audio/mpeg"/>
        <itunes:summary><![CDATA[#MedTwitter consists of an online community of researchers, health practitioners and students who have created an open source decentralised forum for information sharing, medical education and professional networking. #MedTwitter also provides a space for publications to be shared and promoted. While many will credit Twitter with giving a voice to clinicians, it also comes with challenges, the potential for abuse, or the spread of misinformation.

Joining Clara to discuss are;

Jonathan Guckian, a dermatology registrar in Leeds, and director of social media and communications at the Association for the Study of Medical Education (ASMI).

Flo Wedmore, a medical registrar and NHS sustainability fellow

Declan Murphy, an academic medical fellow S2 in ophthalmology in Newcastle, and former Sharp Scratch panelist.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3184</itunes:duration>
                                    </item>
    <item>
        <title>WISH 2022 - Antimicrobial resistance, and workforce wellbeing</title>
        <itunes:title>WISH 2022 - Antimicrobial resistance, and workforce wellbeing</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/wish-2022-antimicrobial-resistance-and-workforce-wellbeing/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/wish-2022-antimicrobial-resistance-and-workforce-wellbeing/#comments</comments>        <pubDate>Fri, 11 Nov 2022 19:07:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/wish-2022-antimicrobial-resistance-and-workforce-wellbeing</guid>
                                    <description><![CDATA[Last month, saw the WISH 2022 - the World Innovation Summit for Health, where experts from around the world came and presented their ideas.

In this podcast we'll hear from Dame Sally Davies, the UK’s Special Envoy on Antimicrobial Resistance - she explains how covid, and treatment uncertainty, put paid to conservative prescribing; and what innovations in microbial treatment are on the horizon.

Following that, James Campbell, director of the health workforce department at the WHO, who joins us to talk about new data they have on the wellbeing, and why the international market for healthcare staff is no longer the simple solution for vacancies.

<p>The BMJ's collections we mentioned are on empowering and engaging patients (https://www.bmj.com/empowering-and-engaging-patients) and food security and health in a changing environment (https://www.bmj.com/food-security-and-health-in-a-changing-environment)</p>
]]></description>
                                                            <content:encoded><![CDATA[Last month, saw the WISH 2022 - the World Innovation Summit for Health, where experts from around the world came and presented their ideas.

In this podcast we'll hear from Dame Sally Davies, the UK’s Special Envoy on Antimicrobial Resistance - she explains how covid, and treatment uncertainty, put paid to conservative prescribing; and what innovations in microbial treatment are on the horizon.

Following that, James Campbell, director of the health workforce department at the WHO, who joins us to talk about new data they have on the wellbeing, and why the international market for healthcare staff is no longer the simple solution for vacancies.

<p>The BMJ's collections we mentioned are on empowering and engaging patients (https://www.bmj.com/empowering-and-engaging-patients) and food security and health in a changing environment (https://www.bmj.com/food-security-and-health-in-a-changing-environment)</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/heski5/stream_1381099222-bmjgroup-wish-2022-antimicrobial-resistance-and-workforce-wellbeing.mp3" length="41441070" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Last month, saw the WISH 2022 - the World Innovation Summit for Health, where experts from around the world came and presented their ideas.

In this podcast we'll hear from Dame Sally Davies, the UK’s Special Envoy on Antimicrobial Resistance - she explains how covid, and treatment uncertainty, put paid to conservative prescribing; and what innovations in microbial treatment are on the horizon.

Following that, James Campbell, director of the health workforce department at the WHO, who joins us to talk about new data they have on the wellbeing, and why the international market for healthcare staff is no longer the simple solution for vacancies.

The BMJ's collections we mentioned are on empowering and engaging patients (https://www.bmj.com/empowering-and-engaging-patients) and food security and health in a changing environment (https://www.bmj.com/food-security-and-health-in-a-changing-environment)]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2590</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence - Diabetes data, colonoscopies, and researchers behaving badly</title>
        <itunes:title>Talk Evidence - Diabetes data, colonoscopies, and researchers behaving badly</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-diabetes-data-colonoscopies-and-researchers-behaving-badly/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-diabetes-data-colonoscopies-and-researchers-behaving-badly/#comments</comments>        <pubDate>Wed, 02 Nov 2022 10:44:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/diabetes-data-colonoscopies-and-researchers-behaving-badly</guid>
                                    <description><![CDATA[In this month's Talk Evidence, Helen Macdonald, The BMJ's research integrity editor, is joined again by Juan Franco, editor in chief of BMJ EBM, and Joe Ross, US research editor. 

They're straying beyond the pages of The BMJ, and discussing an NEJM paper about colonoscopy for colorectal cancer screening. 

We have a listener request, asking about evidence for England's " NHS Diabetes Prevention Programme" - what do we know about how lifestyle interventions work at a population level? Juan puts on his Cochrane hat to answer the query.

We stay with diabetes, and Joe tells us about his research trying to see if routinely collected observational data could be used to match the outcomes of an RCT into drug treatments. 

Finally, Helen updates us about what she's been doing about a case of plagiarism in one of BMJ's journals - and what that means for researchers who are writing in multiple journals about their work.

Reading list

Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death
https://www.nejm.org/doi/full/10.1056/NEJMoa2208375

Emulating the GRADE trial using real world data: retrospective comparative effectiveness study
https://www.bmj.com/content/379/bmj-2022-070717

Expression of concern about content of which Dr Paul McCrory is a single author
<p>https://bjsm.bmj.com/content/early/2022/10/11/bjsports-2022-106408eoc</p>
]]></description>
                                                            <content:encoded><![CDATA[In this month's Talk Evidence, Helen Macdonald, The BMJ's research integrity editor, is joined again by Juan Franco, editor in chief of BMJ EBM, and Joe Ross, US research editor. 

They're straying beyond the pages of The BMJ, and discussing an NEJM paper about colonoscopy for colorectal cancer screening. 

We have a listener request, asking about evidence for England's " NHS Diabetes Prevention Programme" - what do we know about how lifestyle interventions work at a population level? Juan puts on his Cochrane hat to answer the query.

We stay with diabetes, and Joe tells us about his research trying to see if routinely collected observational data could be used to match the outcomes of an RCT into drug treatments. 

Finally, Helen updates us about what she's been doing about a case of plagiarism in one of BMJ's journals - and what that means for researchers who are writing in multiple journals about their work.

Reading list

Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death
https://www.nejm.org/doi/full/10.1056/NEJMoa2208375

Emulating the GRADE trial using real world data: retrospective comparative effectiveness study
https://www.bmj.com/content/379/bmj-2022-070717

Expression of concern about content of which Dr Paul McCrory is a single author
<p>https://bjsm.bmj.com/content/early/2022/10/11/bjsports-2022-106408eoc</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/bc1hhg/stream_1374851470-bmjgroup-diabetes-data-colonoscopies-and-researchers-behaving-badly.mp3" length="44397295" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this month's Talk Evidence, Helen Macdonald, The BMJ's research integrity editor, is joined again by Juan Franco, editor in chief of BMJ EBM, and Joe Ross, US research editor. 

They're straying beyond the pages of The BMJ, and discussing an NEJM paper about colonoscopy for colorectal cancer screening. 

We have a listener request, asking about evidence for England's " NHS Diabetes Prevention Programme" - what do we know about how lifestyle interventions work at a population level? Juan puts on his Cochrane hat to answer the query.

We stay with diabetes, and Joe tells us about his research trying to see if routinely collected observational data could be used to match the outcomes of an RCT into drug treatments. 

Finally, Helen updates us about what she's been doing about a case of plagiarism in one of BMJ's journals - and what that means for researchers who are writing in multiple journals about their work.

Reading list

Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death
https://www.nejm.org/doi/full/10.1056/NEJMoa2208375

Emulating the GRADE trial using real world data: retrospective comparative effectiveness study
https://www.bmj.com/content/379/bmj-2022-070717

Expression of concern about content of which Dr Paul McCrory is a single author
https://bjsm.bmj.com/content/early/2022/10/11/bjsports-2022-106408eoc]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2775</itunes:duration>
                                    </item>
    <item>
        <title>Doctor informed - sustainability isn’t just waste management</title>
        <itunes:title>Doctor informed - sustainability isn’t just waste management</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/doctor-informed-sustainability-isn-t-just-waste-management/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/doctor-informed-sustainability-isn-t-just-waste-management/#comments</comments>        <pubDate>Wed, 26 Oct 2022 13:44:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/doctor-informed-sustainability-isnt-just-waste-management</guid>
                                    <description><![CDATA[In this episode of Doctor Informed, we're talking sustainability. The BMJ has a special edition on the climate crisis, and finding hope amid dispair - and we want to help our listeners with some of that. Clara is joined by three of the NHS's sustainability fellows, Florence, Who is a medical registrar, Emily a paedatrics trainee, and Li, an anaesthetics trainee

For more on the climate crisis, read The BMJ's special edition
<p>https://www.bmj.com/content/379/8356</p>
]]></description>
                                                            <content:encoded><![CDATA[In this episode of Doctor Informed, we're talking sustainability. The BMJ has a special edition on the climate crisis, and finding hope amid dispair - and we want to help our listeners with some of that. Clara is joined by three of the NHS's sustainability fellows, Florence, Who is a medical registrar, Emily a paedatrics trainee, and Li, an anaesthetics trainee

For more on the climate crisis, read The BMJ's special edition
<p>https://www.bmj.com/content/379/8356</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/zt6cit/stream_1370450218-bmjgroup-doctor-informed-sustainability-isnt-just-waste-management.mp3" length="53573888" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode of Doctor Informed, we're talking sustainability. The BMJ has a special edition on the climate crisis, and finding hope amid dispair - and we want to help our listeners with some of that. Clara is joined by three of the NHS's sustainability fellows, Florence, Who is a medical registrar, Emily a paedatrics trainee, and Li, an anaesthetics trainee

For more on the climate crisis, read The BMJ's special edition
https://www.bmj.com/content/379/8356]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3348</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence - Inquiring about covid, burnout, and marginal data</title>
        <itunes:title>Talk Evidence - Inquiring about covid, burnout, and marginal data</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-inquiring-about-covid-burnout-and-marginal-data/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-inquiring-about-covid-burnout-and-marginal-data/#comments</comments>        <pubDate>Wed, 12 Oct 2022 17:40:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/inquiring-about-covid-burnout-and-marginal-data</guid>
                                    <description><![CDATA[It's October's Talk Evidence, and  that means the autumn is upon us including those autumnal viruses. Here in the UK covid is on the rise, and Joe Ross is looking at some research on how good those elusive lateral flows are at detecting infection among people with symptoms of covid.

Juan will give us an update on the covid inquiry, the collection of analysis articles The BMJ is publishing looking at the interface of evidence and policy in our decisions about how to handle the pandemic.

Since the pandemic moral among clinicians in many health systems has fallen even further, workloads have spiralled. Coupled with other problems with workforce planning and investment in health and healthcare, this is increasing burnout -  with a consequential impact on patient care. Helen will tell us about new research which is trying to put some numbers to how much clinican burnout effects patient outcomes

Finally, we're turning to a very clinical topic that we don't often cover in Talk Evidence - oncology, and some interesting insights into clearance margins in cancer surgery.


Reading list

Diagnostic accuracy of covid-19 rapid antigen tests with unsupervised self-sampling in people with symptoms in the omicron period
https://www.bmj.com/content/378/bmj-2022-071215

Guided by the science? Questions for the UK’s covid-19 public inquiry
https://www.bmj.com/content/378/bmj.o2066

 
Associations of physician burnout with career engagement and quality of patient care
https://www.bmj.com/content/378/bmj-2022-070442

Margin status and survival outcomes after breast cancer conservation surgery
<p>https://www.bmj.com/content/378/bmj-2022-070346</p>
]]></description>
                                                            <content:encoded><![CDATA[It's October's Talk Evidence, and  that means the autumn is upon us including those autumnal viruses. Here in the UK covid is on the rise, and Joe Ross is looking at some research on how good those elusive lateral flows are at detecting infection among people with symptoms of covid.

Juan will give us an update on the covid inquiry, the collection of analysis articles The BMJ is publishing looking at the interface of evidence and policy in our decisions about how to handle the pandemic.

Since the pandemic moral among clinicians in many health systems has fallen even further, workloads have spiralled. Coupled with other problems with workforce planning and investment in health and healthcare, this is increasing burnout -  with a consequential impact on patient care. Helen will tell us about new research which is trying to put some numbers to how much clinican burnout effects patient outcomes

Finally, we're turning to a very clinical topic that we don't often cover in Talk Evidence - oncology, and some interesting insights into clearance margins in cancer surgery.


Reading list

Diagnostic accuracy of covid-19 rapid antigen tests with unsupervised self-sampling in people with symptoms in the omicron period
https://www.bmj.com/content/378/bmj-2022-071215

Guided by the science? Questions for the UK’s covid-19 public inquiry
https://www.bmj.com/content/378/bmj.o2066

 
Associations of physician burnout with career engagement and quality of patient care
https://www.bmj.com/content/378/bmj-2022-070442

Margin status and survival outcomes after breast cancer conservation surgery
<p>https://www.bmj.com/content/378/bmj-2022-070346</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/op7tub/stream_1361774377-bmjgroup-inquiring-about-covid-burnout-and-marginal-data.mp3" length="35060923" type="audio/mpeg"/>
        <itunes:summary><![CDATA[It's October's Talk Evidence, and  that means the autumn is upon us including those autumnal viruses. Here in the UK covid is on the rise, and Joe Ross is looking at some research on how good those elusive lateral flows are at detecting infection among people with symptoms of covid.

Juan will give us an update on the covid inquiry, the collection of analysis articles The BMJ is publishing looking at the interface of evidence and policy in our decisions about how to handle the pandemic.

Since the pandemic moral among clinicians in many health systems has fallen even further, workloads have spiralled. Coupled with other problems with workforce planning and investment in health and healthcare, this is increasing burnout -  with a consequential impact on patient care. Helen will tell us about new research which is trying to put some numbers to how much clinican burnout effects patient outcomes

Finally, we're turning to a very clinical topic that we don't often cover in Talk Evidence - oncology, and some interesting insights into clearance margins in cancer surgery.


Reading list

Diagnostic accuracy of covid-19 rapid antigen tests with unsupervised self-sampling in people with symptoms in the omicron period
https://www.bmj.com/content/378/bmj-2022-071215

Guided by the science? Questions for the UK’s covid-19 public inquiry
https://www.bmj.com/content/378/bmj.o2066

 
Associations of physician burnout with career engagement and quality of patient care
https://www.bmj.com/content/378/bmj-2022-070442

Margin status and survival outcomes after breast cancer conservation surgery
https://www.bmj.com/content/378/bmj-2022-070346]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2191</itunes:duration>
                                    </item>
    <item>
        <title>Doctor Informed - the generational divide</title>
        <itunes:title>Doctor Informed - the generational divide</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/doctor-informed-the-generational-divide/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/doctor-informed-the-generational-divide/#comments</comments>        <pubDate>Tue, 27 Sep 2022 16:29:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/doctor-informed-the-generational-divide</guid>
                                    <description><![CDATA[It's zoomers vs boomers on this week's Doctor Informed, as we assemble a multigenerational team to talk about the "good old days" and if the youth of today are really snowflakes.

<p>Clara Munro is joined by Nikki Nabavi, a medical student at Manchester University and a regular on Sharp Scratch (The BMJ's student podcast); Ayisha Ashmoore, an trainee in obstetrics and gynaecology, in the East Midlands; and Alastair Munro, a retired professor of oncology (and Clara's dad).</p>
]]></description>
                                                            <content:encoded><![CDATA[It's zoomers vs boomers on this week's Doctor Informed, as we assemble a multigenerational team to talk about the "good old days" and if the youth of today are really snowflakes.

<p>Clara Munro is joined by Nikki Nabavi, a medical student at Manchester University and a regular on Sharp Scratch (The BMJ's student podcast); Ayisha Ashmoore, an trainee in obstetrics and gynaecology, in the East Midlands; and Alastair Munro, a retired professor of oncology (and Clara's dad).</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/1jx82y/stream_1352015992-bmjgroup-doctor-informed-the-generational-divide.mp3" length="51868733" type="audio/mpeg"/>
        <itunes:summary><![CDATA[It's zoomers vs boomers on this week's Doctor Informed, as we assemble a multigenerational team to talk about the "good old days" and if the youth of today are really snowflakes.

Clara Munro is joined by Nikki Nabavi, a medical student at Manchester University and a regular on Sharp Scratch (The BMJ's student podcast); Ayisha Ashmoore, an trainee in obstetrics and gynaecology, in the East Midlands; and Alastair Munro, a retired professor of oncology (and Clara's dad).]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3242</itunes:duration>
                                    </item>
    <item>
        <title>Doctor Informed - what to expect from an inquest</title>
        <itunes:title>Doctor Informed - what to expect from an inquest</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/doctor-informed-what-to-expect-from-an-inquest/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/doctor-informed-what-to-expect-from-an-inquest/#comments</comments>        <pubDate>Mon, 12 Sep 2022 16:27:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/doctor-informed-what-to-expect-from-an-inquest</guid>
                                    <description><![CDATA[In our new season of Doctor Important, we'll be discussing topics that are not always talked about, and today, by popular request of our listners, we're talking about Coroner's Court and inquests - two things that strike terror into doctors, but are often not as bad as you may fear.

Our panel;
Clara Munro is a surgical trainee in the North East Deanery.
She's joined by her colleage Katie Strong, another surgical trainee. We also have returning to Doctor Informed Ayisha Ashmore, an Obs and Gynae registrar in the East Midlands.

<p>Our Expert guest this week is Beth Walker, a former palliative care registrar who now works as an advisor for Medical Protection.</p>
]]></description>
                                                            <content:encoded><![CDATA[In our new season of Doctor Important, we'll be discussing topics that are not always talked about, and today, by popular request of our listners, we're talking about Coroner's Court and inquests - two things that strike terror into doctors, but are often not as bad as you may fear.

Our panel;
Clara Munro is a surgical trainee in the North East Deanery.
She's joined by her colleage Katie Strong, another surgical trainee. We also have returning to Doctor Informed Ayisha Ashmore, an Obs and Gynae registrar in the East Midlands.

<p>Our Expert guest this week is Beth Walker, a former palliative care registrar who now works as an advisor for Medical Protection.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6hrwyp/stream_1342525120-bmjgroup-doctor-informed-what-to-expect-from-an-inquest.mp3" length="79938040" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In our new season of Doctor Important, we'll be discussing topics that are not always talked about, and today, by popular request of our listners, we're talking about Coroner's Court and inquests - two things that strike terror into doctors, but are often not as bad as you may fear.

Our panel;
Clara Munro is a surgical trainee in the North East Deanery.
She's joined by her colleage Katie Strong, another surgical trainee. We also have returning to Doctor Informed Ayisha Ashmore, an Obs and Gynae registrar in the East Midlands.

Our Expert guest this week is Beth Walker, a former palliative care registrar who now works as an advisor for Medical Protection.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3335</itunes:duration>
                                    </item>
    <item>
        <title>Series 1 wrap up</title>
        <itunes:title>Series 1 wrap up</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/series-1-wrap-up/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/series-1-wrap-up/#comments</comments>        <pubDate>Mon, 05 Sep 2022 17:54:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/series-1-wrap-up</guid>
                                    <description><![CDATA[This is our last episode of series 1 of Doctor Informed, and with it we're coming full circle. Clara will be talking to our first two guests, Mary Dixon-Woods and Bill Kirkup, having now heard from all of our other experts over this series. 

In this first series, we've learned about speaking out, team work, compassionate leadership  - all the things that are needed to help clinicians challenge the status quo,  So in this episode, we'll be asking Mary how much she thinks things have changed, and Bill how he manages a career challenging the healthcare system.

Our guests

Mary Dixon-Woods is director of THIS Institute, and a Health Foundation Professor of Healthcare Improvement Studies in the Department of Public Health and Primary Care at the University of Cambridge. Her work is concerned with generating a high quality evidence-base to support the organisation, quality and safety of care delivered to patients.

For links to the work that Mary talked about visit https://www.thisinstitute.cam.ac.uk/

<p>Bill Kirkup is a clinician turned investigator - he led investigations into failings at a maternity and neonatal unit in Morcambe Bay, into the Oxford paediatric cardiac surgery unit and into Jimmy Savile’s involvement with Broadmoor Hospital. He was also a member of the Hillsborough Independent Panel</p>
]]></description>
                                                            <content:encoded><![CDATA[This is our last episode of series 1 of Doctor Informed, and with it we're coming full circle. Clara will be talking to our first two guests, Mary Dixon-Woods and Bill Kirkup, having now heard from all of our other experts over this series. 

In this first series, we've learned about speaking out, team work, compassionate leadership  - all the things that are needed to help clinicians challenge the status quo,  So in this episode, we'll be asking Mary how much she thinks things have changed, and Bill how he manages a career challenging the healthcare system.

Our guests

Mary Dixon-Woods is director of THIS Institute, and a Health Foundation Professor of Healthcare Improvement Studies in the Department of Public Health and Primary Care at the University of Cambridge. Her work is concerned with generating a high quality evidence-base to support the organisation, quality and safety of care delivered to patients.

For links to the work that Mary talked about visit https://www.thisinstitute.cam.ac.uk/

<p>Bill Kirkup is a clinician turned investigator - he led investigations into failings at a maternity and neonatal unit in Morcambe Bay, into the Oxford paediatric cardiac surgery unit and into Jimmy Savile’s involvement with Broadmoor Hospital. He was also a member of the Hillsborough Independent Panel</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/bvf90a/stream_1338199453-bmjgroup-series-1-wrap-up.mp3" length="59177537" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This is our last episode of series 1 of Doctor Informed, and with it we're coming full circle. Clara will be talking to our first two guests, Mary Dixon-Woods and Bill Kirkup, having now heard from all of our other experts over this series. 

In this first series, we've learned about speaking out, team work, compassionate leadership  - all the things that are needed to help clinicians challenge the status quo,  So in this episode, we'll be asking Mary how much she thinks things have changed, and Bill how he manages a career challenging the healthcare system.

Our guests

Mary Dixon-Woods is director of THIS Institute, and a Health Foundation Professor of Healthcare Improvement Studies in the Department of Public Health and Primary Care at the University of Cambridge. Her work is concerned with generating a high quality evidence-base to support the organisation, quality and safety of care delivered to patients.

For links to the work that Mary talked about visit https://www.thisinstitute.cam.ac.uk/

Bill Kirkup is a clinician turned investigator - he led investigations into failings at a maternity and neonatal unit in Morcambe Bay, into the Oxford paediatric cardiac surgery unit and into Jimmy Savile’s involvement with Broadmoor Hospital. He was also a member of the Hillsborough Independent Panel]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2469</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence - a new way of understanding antidepressant effectiveness</title>
        <itunes:title>Talk Evidence - a new way of understanding antidepressant effectiveness</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-a-new-way-of-understanding-antidepressant-effectiveness/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-a-new-way-of-understanding-antidepressant-effectiveness/#comments</comments>        <pubDate>Wed, 24 Aug 2022 17:44:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-a-new-way-of-understanding-antidepressant-effectiveness</guid>
                                    <description><![CDATA[In this week's episode, Joe Ross, professor of medicine at Yale, and The BMJ's US research editor, and Juan Franco, researcher at Heinrich-Heine-Universität and editor in chief of BMJ EBM are in the hot-seat.

They will discuss new research on the effectiveness of antidepressants - based on all the individual patient data submitted to the FDA between 1979 and now. 

We'll take a look at a study of industry sponsorship of cost effectiveness analysis, and seeing similar patters of publication bias to RCTs.

And finally we'll be talking about new research on the ongoing, and emergent pandemics - covid and monkeypox.

Reading listResponse to acute monotherapy for major depressive disorder in randomized, placebo controlled trials submitted to the US Food and Drug Administration: individual participant data analysis
https://www.bmj.com/content/378/bmj-2021-067606)
 
Using individual participant data to improve network meta-analysis projects
https://ebm.bmj.com/content/early/2022/08/10/bmjebm-2022-111931 
 
Industry sponsorship bias in cost effectiveness analysis: registry based analysis
https://www.bmj.com/content/377/bmj-2021-069573
 
Clinical features and novel presentations of human monkeypox in a central London centre during the 2022 outbreak https://www.bmj.com/content/378/bmj-2022-072410
 
Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada:
<p>https://www.bmj.com/content/378/bmj-2022-071502</p>
]]></description>
                                                            <content:encoded><![CDATA[In this week's episode, Joe Ross, professor of medicine at Yale, and The BMJ's US research editor, and Juan Franco, researcher at Heinrich-Heine-Universität and editor in chief of BMJ EBM are in the hot-seat.

They will discuss new research on the effectiveness of antidepressants - based on all the individual patient data submitted to the FDA between 1979 and now. 

We'll take a look at a study of industry sponsorship of cost effectiveness analysis, and seeing similar patters of publication bias to RCTs.

And finally we'll be talking about new research on the ongoing, and emergent pandemics - covid and monkeypox.

Reading listResponse to acute monotherapy for major depressive disorder in randomized, placebo controlled trials submitted to the US Food and Drug Administration: individual participant data analysis
https://www.bmj.com/content/378/bmj-2021-067606)
 
Using individual participant data to improve network meta-analysis projects
https://ebm.bmj.com/content/early/2022/08/10/bmjebm-2022-111931 
 
Industry sponsorship bias in cost effectiveness analysis: registry based analysis
https://www.bmj.com/content/377/bmj-2021-069573
 
Clinical features and novel presentations of human monkeypox in a central London centre during the 2022 outbreak https://www.bmj.com/content/378/bmj-2022-072410
 
Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada:
<p>https://www.bmj.com/content/378/bmj-2022-071502</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qjcr3i/stream_1330532464-bmjgroup-talk-evidence-a-new-way-of-understanding-antidepressant-effectiveness.mp3" length="40623541" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this week's episode, Joe Ross, professor of medicine at Yale, and The BMJ's US research editor, and Juan Franco, researcher at Heinrich-Heine-Universität and editor in chief of BMJ EBM are in the hot-seat.

They will discuss new research on the effectiveness of antidepressants - based on all the individual patient data submitted to the FDA between 1979 and now. 

We'll take a look at a study of industry sponsorship of cost effectiveness analysis, and seeing similar patters of publication bias to RCTs.

And finally we'll be talking about new research on the ongoing, and emergent pandemics - covid and monkeypox.

Reading listResponse to acute monotherapy for major depressive disorder in randomized, placebo controlled trials submitted to the US Food and Drug Administration: individual participant data analysis
https://www.bmj.com/content/378/bmj-2021-067606)
 
Using individual participant data to improve network meta-analysis projects
https://ebm.bmj.com/content/early/2022/08/10/bmjebm-2022-111931 
 
Industry sponsorship bias in cost effectiveness analysis: registry based analysis
https://www.bmj.com/content/377/bmj-2021-069573
 
Clinical features and novel presentations of human monkeypox in a central London centre during the 2022 outbreak https://www.bmj.com/content/378/bmj-2022-072410
 
Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada:
https://www.bmj.com/content/378/bmj-2022-071502]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2539</itunes:duration>
                                    </item>
    <item>
        <title>Reflecting on a crisis</title>
        <itunes:title>Reflecting on a crisis</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/reflecting-on-a-crisis/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/reflecting-on-a-crisis/#comments</comments>        <pubDate>Tue, 09 Aug 2022 09:52:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/reflecting-on-a-crisis</guid>
                                    <description><![CDATA[Previous Doctor Informed episodes have discussed how to prevent patient safety issues from occurring, but sometimes situations are beyond anyone's control - like COVID.

It can be hard to look back, especially if difficult decisions and compromises were made, including ones we did not completely agree with, or if there could be criticism of the way we responded. We ask how individual doctors, teams, and organisations could respond to and recover from major problems?

In this episode, we're joined by Annelieke Driessen, a THIS Institute fellow and medical anthropologist. She is a research fellow at the University of Oxford and honorary assistant professor in medical anthropology at the London School of Hygiene and Tropical Medicine, who has spent hours listening to and understanding patient experiences of ICU during the pandemic. We'll also hear from Dominque Allwood, Chief Medical Officer at UCL Partners, and Director of Population Health at Imperial College Healthcare NHS Trust, who focuses on creating positive change in healthcare.

 
<p>The research Annelieke Driessen discussed, and the full versions of the patient interviews that are included in the podcast are available at https://healthtalk.org/Experiences-of-Covid-19-and-Intensive-Care/overview</p>
]]></description>
                                                            <content:encoded><![CDATA[Previous Doctor Informed episodes have discussed how to prevent patient safety issues from occurring, but sometimes situations are beyond anyone's control - like COVID.

It can be hard to look back, especially if difficult decisions and compromises were made, including ones we did not completely agree with, or if there could be criticism of the way we responded. We ask how individual doctors, teams, and organisations could respond to and recover from major problems?

In this episode, we're joined by Annelieke Driessen, a THIS Institute fellow and medical anthropologist. She is a research fellow at the University of Oxford and honorary assistant professor in medical anthropology at the London School of Hygiene and Tropical Medicine, who has spent hours listening to and understanding patient experiences of ICU during the pandemic. We'll also hear from Dominque Allwood, Chief Medical Officer at UCL Partners, and Director of Population Health at Imperial College Healthcare NHS Trust, who focuses on creating positive change in healthcare.

 
<p>The research Annelieke Driessen discussed, and the full versions of the patient interviews that are included in the podcast are available at https://healthtalk.org/Experiences-of-Covid-19-and-Intensive-Care/overview</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/l9pb9r/stream_1320617917-bmjgroup-reflecting-on-a-crisis.mp3" length="51715342" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Previous Doctor Informed episodes have discussed how to prevent patient safety issues from occurring, but sometimes situations are beyond anyone's control - like COVID.

It can be hard to look back, especially if difficult decisions and compromises were made, including ones we did not completely agree with, or if there could be criticism of the way we responded. We ask how individual doctors, teams, and organisations could respond to and recover from major problems?

In this episode, we're joined by Annelieke Driessen, a THIS Institute fellow and medical anthropologist. She is a research fellow at the University of Oxford and honorary assistant professor in medical anthropology at the London School of Hygiene and Tropical Medicine, who has spent hours listening to and understanding patient experiences of ICU during the pandemic. We'll also hear from Dominque Allwood, Chief Medical Officer at UCL Partners, and Director of Population Health at Imperial College Healthcare NHS Trust, who focuses on creating positive change in healthcare.

 
The research Annelieke Driessen discussed, and the full versions of the patient interviews that are included in the podcast are available at https://healthtalk.org/Experiences-of-Covid-19-and-Intensive-Care/overview]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3232</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence - shoulders, knees, and woes</title>
        <itunes:title>Talk Evidence - shoulders, knees, and woes</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-shoulders-knees-and-woes/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-shoulders-knees-and-woes/#comments</comments>        <pubDate>Sun, 31 Jul 2022 15:42:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-shoulders-knees-and-woes</guid>
                                    <description><![CDATA[In this episode, Juan Franco, editor in chief of BMJ EBM, and Helen Macdonald, The BMJ's research integrity editor, sit down to discuss what's new in the world of evidence.

Firstly, last week they went to the first EBM Live conference for two years - and report back on what happened when the evidence community got back together.

We have two research papers looking at knees and shoulders, and finding out about the balance of risks and benefits.

In covid news, we're still finding new symptoms associated with infection, 2.5 years after the pandemic started. We'll also hear how complex it is to research vaccine efficacy now.

Reading list:
Smell and taste dysfunction after covid-19 https://www.bmj.com/content/378/bmj.o1653

Serious adverse event rates and reoperation after arthroscopic shoulder surgery
https://www.bmj.com/content/378/bmj-2021-069901

Viscosupplementation for knee osteoarthritis
https://www.bmj.com/content/378/bmj-2022-069722

Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose
<p>https://www.bmj.com/content/378/bmj-2022-071249</p>
]]></description>
                                                            <content:encoded><![CDATA[In this episode, Juan Franco, editor in chief of BMJ EBM, and Helen Macdonald, The BMJ's research integrity editor, sit down to discuss what's new in the world of evidence.

Firstly, last week they went to the first EBM Live conference for two years - and report back on what happened when the evidence community got back together.

We have two research papers looking at knees and shoulders, and finding out about the balance of risks and benefits.

In covid news, we're still finding new symptoms associated with infection, 2.5 years after the pandemic started. We'll also hear how complex it is to research vaccine efficacy now.

Reading list:
Smell and taste dysfunction after covid-19 https://www.bmj.com/content/378/bmj.o1653

Serious adverse event rates and reoperation after arthroscopic shoulder surgery
https://www.bmj.com/content/378/bmj-2021-069901

Viscosupplementation for knee osteoarthritis
https://www.bmj.com/content/378/bmj-2022-069722

Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose
<p>https://www.bmj.com/content/378/bmj-2022-071249</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/1sry5s/stream_1315224307-bmjgroup-talk-evidence-shoulders-knees-and-woes.mp3" length="36239986" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, Juan Franco, editor in chief of BMJ EBM, and Helen Macdonald, The BMJ's research integrity editor, sit down to discuss what's new in the world of evidence.

Firstly, last week they went to the first EBM Live conference for two years - and report back on what happened when the evidence community got back together.

We have two research papers looking at knees and shoulders, and finding out about the balance of risks and benefits.

In covid news, we're still finding new symptoms associated with infection, 2.5 years after the pandemic started. We'll also hear how complex it is to research vaccine efficacy now.

Reading list:
Smell and taste dysfunction after covid-19 https://www.bmj.com/content/378/bmj.o1653

Serious adverse event rates and reoperation after arthroscopic shoulder surgery
https://www.bmj.com/content/378/bmj-2021-069901

Viscosupplementation for knee osteoarthritis
https://www.bmj.com/content/378/bmj-2022-069722

Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose
https://www.bmj.com/content/378/bmj-2022-071249]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2265</itunes:duration>
                                    </item>
    <item>
        <title>Diabetes in Ukraine - supporting NCDs in a conflict zone</title>
        <itunes:title>Diabetes in Ukraine - supporting NCDs in a conflict zone</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/diabetes-in-ukraine-supporting-ncds-in-a-conflict-zone/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/diabetes-in-ukraine-supporting-ncds-in-a-conflict-zone/#comments</comments>        <pubDate>Mon, 18 Jul 2022 11:13:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/ukraine-supporting-ncds-conflict</guid>
                                    <description><![CDATA[As the Russian invasion of Ukraine continues, living under the uncertainty has become the new normal for thousands of patients with diabetes who are dependant on insulin.

Supporting patients with non-communicable disease is the reality of all disaster situations now, and that added layer of complexity makes coordinating responses even harder.

In this podcast, we'll hear how people with diabetes are being supported in Ukraine, and what is being done to improve things, despite the continued fighting.

Our guests;
Iryna Vlasenko, Vice President of the International Diabetes Federation
Slim Slama, unit head for NCD management at the WHO
<p>Yaroslav Diakunchak, family physician in Brovary, Kyiv.</p>
]]></description>
                                                            <content:encoded><![CDATA[As the Russian invasion of Ukraine continues, living under the uncertainty has become the new normal for thousands of patients with diabetes who are dependant on insulin.

Supporting patients with non-communicable disease is the reality of all disaster situations now, and that added layer of complexity makes coordinating responses even harder.

In this podcast, we'll hear how people with diabetes are being supported in Ukraine, and what is being done to improve things, despite the continued fighting.

Our guests;
Iryna Vlasenko, Vice President of the International Diabetes Federation
Slim Slama, unit head for NCD management at the WHO
<p>Yaroslav Diakunchak, family physician in Brovary, Kyiv.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2kfr3a/stream_1307238208-bmjgroup-ukraine-supporting-ncds-conflict.mp3" length="61057661" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As the Russian invasion of Ukraine continues, living under the uncertainty has become the new normal for thousands of patients with diabetes who are dependant on insulin.

Supporting patients with non-communicable disease is the reality of all disaster situations now, and that added layer of complexity makes coordinating responses even harder.

In this podcast, we'll hear how people with diabetes are being supported in Ukraine, and what is being done to improve things, despite the continued fighting.

Our guests;
Iryna Vlasenko, Vice President of the International Diabetes Federation
Slim Slama, unit head for NCD management at the WHO
Yaroslav Diakunchak, family physician in Brovary, Kyiv.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2543</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence - political persuasion and mortality, too much medicine</title>
        <itunes:title>Talk Evidence - political persuasion and mortality, too much medicine</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-political-persuasion-and-mortality-too-much-medicine/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-political-persuasion-and-mortality-too-much-medicine/#comments</comments>        <pubDate>Fri, 17 Jun 2022 16:45:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-political-persuasion-and-mortality-too-much-medicine</guid>
                                    <description><![CDATA[In this week's episode, Helen Macdonald is joined by Joseph Ross, US research editor for The BMJ, and Juan Franco, editor of BMJ EBM.

They begin by discussing a review of obesity interventions in primary care, and Joe wonders if GPs are really the best people to tackle the issue.
https://www.bmj.com/content/377/bmj-2021-069719 

Cervical screening in the UK now includes HPV testing, and they look at research which examines whether this could mean longer periods between screening tests.
https://www.bmj.com/content/377/bmj-2021-068776 

They all enjoy a new State of the Art Review into Revascularization in stable coronary artery disease.
https://www.bmj.com/content/377/bmj-2021-067085

Juan and Joe look at a review into combinations of covid-19 vaccinations - and wonder whether we'll ever see more trials to fit into this meta-analysis. 
https://www.bmj.com/content/377/bmj-2022-069989

Finally, they find out how your political persuasion has affected mortality in the US, with new research that links Republican and Democrat voters with differential changes in mortality.
<p>https://www.bmj.com/content/377/bmj-2021-069308</p>
]]></description>
                                                            <content:encoded><![CDATA[In this week's episode, Helen Macdonald is joined by Joseph Ross, US research editor for The BMJ, and Juan Franco, editor of BMJ EBM.

They begin by discussing a review of obesity interventions in primary care, and Joe wonders if GPs are really the best people to tackle the issue.
https://www.bmj.com/content/377/bmj-2021-069719 

Cervical screening in the UK now includes HPV testing, and they look at research which examines whether this could mean longer periods between screening tests.
https://www.bmj.com/content/377/bmj-2021-068776 

They all enjoy a new State of the Art Review into Revascularization in stable coronary artery disease.
https://www.bmj.com/content/377/bmj-2021-067085

Juan and Joe look at a review into combinations of covid-19 vaccinations - and wonder whether we'll ever see more trials to fit into this meta-analysis. 
https://www.bmj.com/content/377/bmj-2022-069989

Finally, they find out how your political persuasion has affected mortality in the US, with new research that links Republican and Democrat voters with differential changes in mortality.
<p>https://www.bmj.com/content/377/bmj-2021-069308</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ponja2/stream_1289462392-bmjgroup-talk-evidence-political-persuasion-and-mortality-too-much-medicine.mp3" length="39454510" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this week's episode, Helen Macdonald is joined by Joseph Ross, US research editor for The BMJ, and Juan Franco, editor of BMJ EBM.

They begin by discussing a review of obesity interventions in primary care, and Joe wonders if GPs are really the best people to tackle the issue.
https://www.bmj.com/content/377/bmj-2021-069719 

Cervical screening in the UK now includes HPV testing, and they look at research which examines whether this could mean longer periods between screening tests.
https://www.bmj.com/content/377/bmj-2021-068776 

They all enjoy a new State of the Art Review into Revascularization in stable coronary artery disease.
https://www.bmj.com/content/377/bmj-2021-067085

Juan and Joe look at a review into combinations of covid-19 vaccinations - and wonder whether we'll ever see more trials to fit into this meta-analysis. 
https://www.bmj.com/content/377/bmj-2022-069989

Finally, they find out how your political persuasion has affected mortality in the US, with new research that links Republican and Democrat voters with differential changes in mortality.
https://www.bmj.com/content/377/bmj-2021-069308]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2466</itunes:duration>
                                    </item>
    <item>
        <title>Violence against GPs  with Adam Janjua, Marcela Schilderman, and Anita Bignell</title>
        <itunes:title>Violence against GPs  with Adam Janjua, Marcela Schilderman, and Anita Bignell</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/violence-against-gps-with-adam-janjua-marcela-schilderman-and-anita-bignell/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/violence-against-gps-with-adam-janjua-marcela-schilderman-and-anita-bignell/#comments</comments>        <pubDate>Mon, 13 Jun 2022 12:59:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/violence-against-gps</guid>
                                    <description><![CDATA[A recent investigation, by The BMJ, showed a worrying increase in incidence of violence, directed to wards GPs, and reported to the police. In this episode of Deep Breath in, Tom and Jenny are joined by Gareth Iacobucci, assistant news editor for The BMJ who broke the story.

They'll hear from a GP affected, and get some advice on preventing violence, and deescalation, from two mental health experts, who deal with the most agitated patients. 

Our guests:
Adam Janjua, a GP in Fleetwood, Lancashire.
Marcela Schilderman, a consultant psychiatrist at South London and the Maudsley NHS Foundation Trust 
and Anita Bignell, a mental health nurse, at South London and the Maudsley NHS Foundation Trust

Reading list
Violent incidents at GP surgeries double in five years, BMJ investigation finds
<p>https://www.bmj.com/content/377/bmj.o1333</p>
]]></description>
                                                            <content:encoded><![CDATA[A recent investigation, by The BMJ, showed a worrying increase in incidence of violence, directed to wards GPs, and reported to the police. In this episode of Deep Breath in, Tom and Jenny are joined by Gareth Iacobucci, assistant news editor for The BMJ who broke the story.

They'll hear from a GP affected, and get some advice on preventing violence, and deescalation, from two mental health experts, who deal with the most agitated patients. 

Our guests:
Adam Janjua, a GP in Fleetwood, Lancashire.
Marcela Schilderman, a consultant psychiatrist at South London and the Maudsley NHS Foundation Trust 
and Anita Bignell, a mental health nurse, at South London and the Maudsley NHS Foundation Trust

Reading list
Violent incidents at GP surgeries double in five years, BMJ investigation finds
<p>https://www.bmj.com/content/377/bmj.o1333</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xc5k15/stream_1286536777-bmjgroup-violence-against-gps.mp3" length="50416325" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A recent investigation, by The BMJ, showed a worrying increase in incidence of violence, directed to wards GPs, and reported to the police. In this episode of Deep Breath in, Tom and Jenny are joined by Gareth Iacobucci, assistant news editor for The BMJ who broke the story.

They'll hear from a GP affected, and get some advice on preventing violence, and deescalation, from two mental health experts, who deal with the most agitated patients. 

Our guests:
Adam Janjua, a GP in Fleetwood, Lancashire.
Marcela Schilderman, a consultant psychiatrist at South London and the Maudsley NHS Foundation Trust 
and Anita Bignell, a mental health nurse, at South London and the Maudsley NHS Foundation Trust

Reading list
Violent incidents at GP surgeries double in five years, BMJ investigation finds
https://www.bmj.com/content/377/bmj.o1333]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3151</itunes:duration>
                                    </item>
    <item>
        <title>”But it’s always been done that way”</title>
        <itunes:title>”But it’s always been done that way”</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/but-it-s-always-been-done-that-way/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/but-it-s-always-been-done-that-way/#comments</comments>        <pubDate>Mon, 30 May 2022 16:30:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/but-its-aways-been-done-that-way</guid>
                                    <description><![CDATA[In Doctor Informed, we've been hearing a lot about the problems of healthcare, but we also want to talk about solutions. Whatever we're going to do to fix healthcare, whether that's bullying, or burnout, or patient safety - it's going to require change. And change is hard.

 

In this episode Clara Munro is joined by Graham Martin, director of research at THIS Institute. They discuss the dreaded phrase "But it's always been done this way", and why failing is the path to success, and the true importance of listening.

 

Our guests;

Penny Pereira, Q managing director at the Health Foundation. Q helps promote improvement within the health and care system, encouraging and supporting a wide range of people to effectively lead improvement. https://www.health.org.uk/about-the-health-foundation/our-people/q-and-q-labs-team

<p>Moira Durbridge, director of safety and risk at University Hospitals of Leicester NHS Trust. Moira trained as a nurse, and continues to work clinically, as well as her role in leading her Trust's change.</p>
]]></description>
                                                            <content:encoded><![CDATA[In Doctor Informed, we've been hearing a lot about the problems of healthcare, but we also want to talk about solutions. Whatever we're going to do to fix healthcare, whether that's bullying, or burnout, or patient safety - it's going to require change. And change is hard.

 

In this episode Clara Munro is joined by Graham Martin, director of research at THIS Institute. They discuss the dreaded phrase "But it's always been done this way", and why failing is the path to success, and the true importance of listening.

 

Our guests;

Penny Pereira, Q managing director at the Health Foundation. Q helps promote improvement within the health and care system, encouraging and supporting a wide range of people to effectively lead improvement. https://www.health.org.uk/about-the-health-foundation/our-people/q-and-q-labs-team

<p>Moira Durbridge, director of safety and risk at University Hospitals of Leicester NHS Trust. Moira trained as a nurse, and continues to work clinically, as well as her role in leading her Trust's change.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5utedi/stream_1277938258-bmjgroup-but-its-aways-been-done-that-way.mp3" length="48692661" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In Doctor Informed, we've been hearing a lot about the problems of healthcare, but we also want to talk about solutions. Whatever we're going to do to fix healthcare, whether that's bullying, or burnout, or patient safety - it's going to require change. And change is hard.

 

In this episode Clara Munro is joined by Graham Martin, director of research at THIS Institute. They discuss the dreaded phrase "But it's always been done this way", and why failing is the path to success, and the true importance of listening.

 

Our guests;

Penny Pereira, Q managing director at the Health Foundation. Q helps promote improvement within the health and care system, encouraging and supporting a wide range of people to effectively lead improvement. https://www.health.org.uk/about-the-health-foundation/our-people/q-and-q-labs-team

Moira Durbridge, director of safety and risk at University Hospitals of Leicester NHS Trust. Moira trained as a nurse, and continues to work clinically, as well as her role in leading her Trust's change.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3043</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence - evidence in Roe vs Wade, MI treatment variation, and tribal methodologies</title>
        <itunes:title>Talk Evidence - evidence in Roe vs Wade, MI treatment variation, and tribal methodologies</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-evidence-in-roe-vs-wade-mi-treatment-variation-and-tribal-methodologies/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-evidence-in-roe-vs-wade-mi-treatment-variation-and-tribal-methodologies/#comments</comments>        <pubDate>Mon, 23 May 2022 16:44:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-may-2022</guid>
                                    <description><![CDATA[Helen Macdonald, The BMJ's research integrity editor is back with another episode, and this week is joined by Joe Ross, professor of medicine and public health at Yale, and US research editor for The BMJ, and Juan Franco, editor in chief of BMJ EBM, and Professor at the  Instituto Universitario Hospital Italiano de Buenos Aires

In this episode they discuss;

The US supreme court looks set to overturn Roe v Wade, creating a patchwork of abortion provision across the U.S.  We consider the role which evidence might play in documenting how health is affected by that decision, and whether medical evidence is being used at all in the debate.

We'll give you a quick update on treatment for Covid-19

We know that trials are needed for new treatments, but in the face of an exponentially growing amount of observational data, is it time for a shift in that certainty? Joe tells us about his research into whether trials and observational studies of three drugs in covid produce the same answer? 

And finally, treatment variation - it's one of the things that helped kick-start the EBM revolution, but there's still much to learn. Juan describes some new research which examines how countries stack up when you compare their handling of and outcomes of a common condition such as a myocardial infarction.

Reading list;

Navigating Loss of Abortion Services — A Large Academic Medical Center Prepares for the Overturn of Roe v. Wade
https://www.nejm.org/doi/full/10.1056/NEJMp2206246.

A living WHO guideline on drugs for covid-19
https://www.bmj.com/content/370/bmj.m3379

Agreement of treatment effects from observational studies and randomized controlled trials evaluating hydroxychloroquine, lopinavir-ritonavir, or dexamethasone for covid-19
https://www.bmj.com/content/377/bmj-2021-069400

Variation in revascularisation use and outcomes of patients in hospital with acute myocardial infarction across six high income countries
<p>https://www.bmj.com/content/377/bmj-2021-069164</p>
]]></description>
                                                            <content:encoded><![CDATA[Helen Macdonald, The BMJ's research integrity editor is back with another episode, and this week is joined by Joe Ross, professor of medicine and public health at Yale, and US research editor for The BMJ, and Juan Franco, editor in chief of BMJ EBM, and Professor at the  Instituto Universitario Hospital Italiano de Buenos Aires

In this episode they discuss;

The US supreme court looks set to overturn Roe v Wade, creating a patchwork of abortion provision across the U.S.  We consider the role which evidence might play in documenting how health is affected by that decision, and whether medical evidence is being used at all in the debate.

We'll give you a quick update on treatment for Covid-19

We know that trials are needed for new treatments, but in the face of an exponentially growing amount of observational data, is it time for a shift in that certainty? Joe tells us about his research into whether trials and observational studies of three drugs in covid produce the same answer? 

And finally, treatment variation - it's one of the things that helped kick-start the EBM revolution, but there's still much to learn. Juan describes some new research which examines how countries stack up when you compare their handling of and outcomes of a common condition such as a myocardial infarction.

Reading list;

Navigating Loss of Abortion Services — A Large Academic Medical Center Prepares for the Overturn of Roe v. Wade
https://www.nejm.org/doi/full/10.1056/NEJMp2206246.

A living WHO guideline on drugs for covid-19
https://www.bmj.com/content/370/bmj.m3379

Agreement of treatment effects from observational studies and randomized controlled trials evaluating hydroxychloroquine, lopinavir-ritonavir, or dexamethasone for covid-19
https://www.bmj.com/content/377/bmj-2021-069400

Variation in revascularisation use and outcomes of patients in hospital with acute myocardial infarction across six high income countries
<p>https://www.bmj.com/content/377/bmj-2021-069164</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xzajey/stream_1273752073-bmjgroup-talk-evidence-may-2022.mp3" length="44480887" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Helen Macdonald, The BMJ's research integrity editor is back with another episode, and this week is joined by Joe Ross, professor of medicine and public health at Yale, and US research editor for The BMJ, and Juan Franco, editor in chief of BMJ EBM, and Professor at the  Instituto Universitario Hospital Italiano de Buenos Aires

In this episode they discuss;

The US supreme court looks set to overturn Roe v Wade, creating a patchwork of abortion provision across the U.S.  We consider the role which evidence might play in documenting how health is affected by that decision, and whether medical evidence is being used at all in the debate.

We'll give you a quick update on treatment for Covid-19

We know that trials are needed for new treatments, but in the face of an exponentially growing amount of observational data, is it time for a shift in that certainty? Joe tells us about his research into whether trials and observational studies of three drugs in covid produce the same answer? 

And finally, treatment variation - it's one of the things that helped kick-start the EBM revolution, but there's still much to learn. Juan describes some new research which examines how countries stack up when you compare their handling of and outcomes of a common condition such as a myocardial infarction.

Reading list;

Navigating Loss of Abortion Services — A Large Academic Medical Center Prepares for the Overturn of Roe v. Wade
https://www.nejm.org/doi/full/10.1056/NEJMp2206246.

A living WHO guideline on drugs for covid-19
https://www.bmj.com/content/370/bmj.m3379

Agreement of treatment effects from observational studies and randomized controlled trials evaluating hydroxychloroquine, lopinavir-ritonavir, or dexamethasone for covid-19
https://www.bmj.com/content/377/bmj-2021-069400

Variation in revascularisation use and outcomes of patients in hospital with acute myocardial infarction across six high income countries
https://www.bmj.com/content/377/bmj-2021-069164]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2780</itunes:duration>
                                    </item>
    <item>
        <title>Get political, for health’s sake</title>
        <itunes:title>Get political, for health’s sake</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/get-political-for-health-s-sake/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/get-political-for-health-s-sake/#comments</comments>        <pubDate>Fri, 13 May 2022 17:53:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/get-political-for-healths-sake</guid>
                                    <description><![CDATA[The influence of public health on politics, at least at the beginning of the pandemic, had never been stronger - but now it seems as hard to persuade politicians to pay attention as ever, yet political will is essential in making different sectors work together to create a healthier world.

In this podcast, The BMJ's editor in chief, Kamran Abbasi is joined by Shyama Kuruvilla, senior strategic adviser at World Health Organization, and Kent Buse, director of the global healthier societies program at The George Institute for Global Health.

They discuss examples of where multisectoral working has managed to bridge the gaps between sectors, and how healthcare needs to get political to make that success more widespread.

<p>This is part of the collection "The world we want: Actions towards a sustainable, fairer and healthier society" - https://www.bmj.com/pmac-2022</p>
]]></description>
                                                            <content:encoded><![CDATA[The influence of public health on politics, at least at the beginning of the pandemic, had never been stronger - but now it seems as hard to persuade politicians to pay attention as ever, yet political will is essential in making different sectors work together to create a healthier world.

In this podcast, The BMJ's editor in chief, Kamran Abbasi is joined by Shyama Kuruvilla, senior strategic adviser at World Health Organization, and Kent Buse, director of the global healthier societies program at The George Institute for Global Health.

They discuss examples of where multisectoral working has managed to bridge the gaps between sectors, and how healthcare needs to get political to make that success more widespread.

<p>This is part of the collection "The world we want: Actions towards a sustainable, fairer and healthier society" - https://www.bmj.com/pmac-2022</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/girre0/stream_1267784563-bmjgroup-get-political-for-healths-sake.mp3" length="54484926" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The influence of public health on politics, at least at the beginning of the pandemic, had never been stronger - but now it seems as hard to persuade politicians to pay attention as ever, yet political will is essential in making different sectors work together to create a healthier world.

In this podcast, The BMJ's editor in chief, Kamran Abbasi is joined by Shyama Kuruvilla, senior strategic adviser at World Health Organization, and Kent Buse, director of the global healthier societies program at The George Institute for Global Health.

They discuss examples of where multisectoral working has managed to bridge the gaps between sectors, and how healthcare needs to get political to make that success more widespread.

This is part of the collection "The world we want: Actions towards a sustainable, fairer and healthier society" - https://www.bmj.com/pmac-2022]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2273</itunes:duration>
                                    </item>
    <item>
        <title>Deep Breath In - what’s in store for general practice in the UK</title>
        <itunes:title>Deep Breath In - what’s in store for general practice in the UK</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/deep-breath-in-what-s-in-store-for-general-practice-in-the-uk/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/deep-breath-in-what-s-in-store-for-general-practice-in-the-uk/#comments</comments>        <pubDate>Sat, 30 Apr 2022 10:11:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/deep-breath-in-whats-in-store-for-general-practice-in-the-uk</guid>
                                    <description><![CDATA[This is a special episode of our podcast for GP's, Deep Breath In, where we tackle the everyday challenges of being a GP.

With the focus on covid, and the pressure on hospitals, it may be easy to overlook what’s happening in general practice in the UK - but changes are afoot. Our new health secretary Sajid Javid doesn’t seem to like our long standing GP practice arrangement, NHS England has imposed new weekend working arrangements on the already stretched service, and the workforce pressures continue.

In this episode of Deep Breath In, our GP panel of Tom Nolan, Navjoyt Ladher, and Jenny Rasanathan are joined by Gareth Iacobucci, The BMJ’s assistant news editor, to give them the lowdown on what’s happening around primary care, who some of the key players are, and what his predictions for 2022.

You can find Deep Breath In on all major podcast apps
<p>https://www.bmj.com/podcasts/deepbreathin</p>
]]></description>
                                                            <content:encoded><![CDATA[This is a special episode of our podcast for GP's, Deep Breath In, where we tackle the everyday challenges of being a GP.

With the focus on covid, and the pressure on hospitals, it may be easy to overlook what’s happening in general practice in the UK - but changes are afoot. Our new health secretary Sajid Javid doesn’t seem to like our long standing GP practice arrangement, NHS England has imposed new weekend working arrangements on the already stretched service, and the workforce pressures continue.

In this episode of Deep Breath In, our GP panel of Tom Nolan, Navjoyt Ladher, and Jenny Rasanathan are joined by Gareth Iacobucci, The BMJ’s assistant news editor, to give them the lowdown on what’s happening around primary care, who some of the key players are, and what his predictions for 2022.

You can find Deep Breath In on all major podcast apps
<p>https://www.bmj.com/podcasts/deepbreathin</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/77jrml/stream_1259830897-bmjgroup-deep-breath-in-whats-in-store-for-general-practice-in-the-uk.mp3" length="42011584" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This is a special episode of our podcast for GP's, Deep Breath In, where we tackle the everyday challenges of being a GP.

With the focus on covid, and the pressure on hospitals, it may be easy to overlook what’s happening in general practice in the UK - but changes are afoot. Our new health secretary Sajid Javid doesn’t seem to like our long standing GP practice arrangement, NHS England has imposed new weekend working arrangements on the already stretched service, and the workforce pressures continue.

In this episode of Deep Breath In, our GP panel of Tom Nolan, Navjoyt Ladher, and Jenny Rasanathan are joined by Gareth Iacobucci, The BMJ’s assistant news editor, to give them the lowdown on what’s happening around primary care, who some of the key players are, and what his predictions for 2022.

You can find Deep Breath In on all major podcast apps
https://www.bmj.com/podcasts/deepbreathin]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2626</itunes:duration>
                                    </item>
    <item>
        <title>Creativity and wellbeing</title>
        <itunes:title>Creativity and wellbeing</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/creativity-and-wellbeing/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/creativity-and-wellbeing/#comments</comments>        <pubDate>Fri, 22 Apr 2022 12:07:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/creativity-and-wellbeing</guid>
                                    <description><![CDATA[Paula Redmond, clinical psychologist who supports healthcare workers experiencing burnout and other difficulties related to their job. Before this, she worked for the NHS until she experienced bullying, and a lack of support from her organisation, which made her strike out on her own.

In this wellbeing podcast, she describes the way in which her experience of bullying affected her, and how she used the creative process to help her move on. 

She and Cat Chatfield discuss what creativity actually is, and why small projects can be just as useful as big complex ones - depending upon what you need at the time.

Futher reading:
a Blog series on bullying in healthcare: https://drpaularedmond.com/category/bullying_in_healthcare/page/2/
<p>a mindful embroidery craftivism project ("Do no harm but take no shit") https://drpaularedmond.com/donoharm/</p>
]]></description>
                                                            <content:encoded><![CDATA[Paula Redmond, clinical psychologist who supports healthcare workers experiencing burnout and other difficulties related to their job. Before this, she worked for the NHS until she experienced bullying, and a lack of support from her organisation, which made her strike out on her own.

In this wellbeing podcast, she describes the way in which her experience of bullying affected her, and how she used the creative process to help her move on. 

She and Cat Chatfield discuss what creativity actually is, and why small projects can be just as useful as big complex ones - depending upon what you need at the time.

Futher reading:
a Blog series on bullying in healthcare: https://drpaularedmond.com/category/bullying_in_healthcare/page/2/
<p>a mindful embroidery craftivism project ("Do no harm but take no shit") https://drpaularedmond.com/donoharm/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4sos4e/stream_1254951247-bmjgroup-creativity-and-wellbeing.mp3" length="34489154" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Paula Redmond, clinical psychologist who supports healthcare workers experiencing burnout and other difficulties related to their job. Before this, she worked for the NHS until she experienced bullying, and a lack of support from her organisation, which made her strike out on her own.

In this wellbeing podcast, she describes the way in which her experience of bullying affected her, and how she used the creative process to help her move on. 

She and Cat Chatfield discuss what creativity actually is, and why small projects can be just as useful as big complex ones - depending upon what you need at the time.

Futher reading:
a Blog series on bullying in healthcare: https://drpaularedmond.com/category/bullying_in_healthcare/page/2/
a mindful embroidery craftivism project ("Do no harm but take no shit") https://drpaularedmond.com/donoharm/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2156</itunes:duration>
                                    </item>
    <item>
        <title>Quality improvement and wellbeing are inextricably linked</title>
        <itunes:title>Quality improvement and wellbeing are inextricably linked</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/quality-improvement-and-wellbeing-are-inextricably-linked/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/quality-improvement-and-wellbeing-are-inextricably-linked/#comments</comments>        <pubDate>Fri, 15 Apr 2022 16:55:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/quality-improvement-and-wellbeing-are-inextricably-linked</guid>
                                    <description><![CDATA[Over the course of the last few years, the BMJ has published a series of articles in our Quality Improvement series - aiming to give those new to improvement science a good grasp of how to think about changing things in healthcare.

Then covid-19 came along, and it seemed like all of healthcare was now aimed at just surviving in the face of the pandemic, and all thoughts of quality improvement projects went out the window... But did they?

Cat Chatfield, is joined by Will Warburton, former director of quality improvement at the Health Foundation, and advisor on the series.

<p>To read all of the open access articles mentioned in the discussion, visit https://www.bmj.com/quality-improvement</p>
]]></description>
                                                            <content:encoded><![CDATA[Over the course of the last few years, the BMJ has published a series of articles in our Quality Improvement series - aiming to give those new to improvement science a good grasp of how to think about changing things in healthcare.

Then covid-19 came along, and it seemed like all of healthcare was now aimed at just surviving in the face of the pandemic, and all thoughts of quality improvement projects went out the window... But did they?

Cat Chatfield, is joined by Will Warburton, former director of quality improvement at the Health Foundation, and advisor on the series.

<p>To read all of the open access articles mentioned in the discussion, visit https://www.bmj.com/quality-improvement</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/x9jvu3/stream_1250831437-bmjgroup-quality-improvement-and-wellbeing-are-inextricably-linked.mp3" length="26958784" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Over the course of the last few years, the BMJ has published a series of articles in our Quality Improvement series - aiming to give those new to improvement science a good grasp of how to think about changing things in healthcare.

Then covid-19 came along, and it seemed like all of healthcare was now aimed at just surviving in the face of the pandemic, and all thoughts of quality improvement projects went out the window... But did they?

Cat Chatfield, is joined by Will Warburton, former director of quality improvement at the Health Foundation, and advisor on the series.

To read all of the open access articles mentioned in the discussion, visit https://www.bmj.com/quality-improvement]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1685</itunes:duration>
                                    </item>
    <item>
        <title>Doctor Informed - Medicine’s me too moments</title>
        <itunes:title>Doctor Informed - Medicine’s me too moments</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/doctor-informed-medicine-s-me-too-moments/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/doctor-informed-medicine-s-me-too-moments/#comments</comments>        <pubDate>Mon, 04 Apr 2022 10:19:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/doctor-informed-medicines-me-too-moments</guid>
                                    <description><![CDATA[In this episode we’re going to be talking about misogyny in surgery, recent revelations about sexual harassment in the theatre have emerged - but these behaviours have been endemic for a while, even as the profession seemed to ignore them.

Joining Clara Munro is Baroness Helena Kenned, the author of a recent report into diversity in medicine, who, as a barrister, has long worked on discrimination cases.

The reports mentioned in the episode are from the Royal College of Surgeons;

<p>https://www.rcseng.ac.uk/about-the-rcs/about-our-mission/diversity-review-2021/</p>
]]></description>
                                                            <content:encoded><![CDATA[In this episode we’re going to be talking about misogyny in surgery, recent revelations about sexual harassment in the theatre have emerged - but these behaviours have been endemic for a while, even as the profession seemed to ignore them.

Joining Clara Munro is Baroness Helena Kenned, the author of a recent report into diversity in medicine, who, as a barrister, has long worked on discrimination cases.

The reports mentioned in the episode are from the Royal College of Surgeons;

<p>https://www.rcseng.ac.uk/about-the-rcs/about-our-mission/diversity-review-2021/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/b23c3q/stream_1243944166-bmjgroup-doctor-informed-medicines-me-too-moments.mp3" length="40987584" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode we’re going to be talking about misogyny in surgery, recent revelations about sexual harassment in the theatre have emerged - but these behaviours have been endemic for a while, even as the profession seemed to ignore them.

Joining Clara Munro is Baroness Helena Kenned, the author of a recent report into diversity in medicine, who, as a barrister, has long worked on discrimination cases.

The reports mentioned in the episode are from the Royal College of Surgeons;

https://www.rcseng.ac.uk/about-the-rcs/about-our-mission/diversity-review-2021/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2562</itunes:duration>
                                    </item>
    <item>
        <title>Covid vaccine safety, Methenamine hippurate, and intersectionality</title>
        <itunes:title>Covid vaccine safety, Methenamine hippurate, and intersectionality</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/covid-vaccine-safety-methenamine-hippurate-and-intersectionality/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/covid-vaccine-safety-methenamine-hippurate-and-intersectionality/#comments</comments>        <pubDate>Wed, 30 Mar 2022 18:08:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/covid-vaccine-safety-methenamine-hippurate-and-intersectionality</guid>
                                    <description><![CDATA[In this episode of Talk Evidence, Helen Macdonald, the BMJ’s research integrity editor is joined by Joe Ross, US research editor, and Juan Franco, editor in chief of BMJEBM, to talk about all things evidence.

Joe gives us an update about covid, including new research on safety of the vaccine  Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events
https://www.bmj.com/content/376/bmj-2021-068373

Juan updates us on a potential new prophylactic for recurrent UTIs, Methenamine hippurate, which could be an alternative to antibiotics.
Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women
https://www.bmj.com/content/376/bmj-2021-0068229

Helen tells us about some research which evaluates the way in which intersecting identities combine to make students experience of medical school more difficult.
Marginalized identities, mistreatment, discrimination, and burnout among US medical students
<p>https://www.bmj.com/content/376/bmj-2021-065984</p>
]]></description>
                                                            <content:encoded><![CDATA[In this episode of Talk Evidence, Helen Macdonald, the BMJ’s research integrity editor is joined by Joe Ross, US research editor, and Juan Franco, editor in chief of BMJEBM, to talk about all things evidence.

Joe gives us an update about covid, including new research on safety of the vaccine  Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events
https://www.bmj.com/content/376/bmj-2021-068373

Juan updates us on a potential new prophylactic for recurrent UTIs, Methenamine hippurate, which could be an alternative to antibiotics.
Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women
https://www.bmj.com/content/376/bmj-2021-0068229

Helen tells us about some research which evaluates the way in which intersecting identities combine to make students experience of medical school more difficult.
Marginalized identities, mistreatment, discrimination, and burnout among US medical students
<p>https://www.bmj.com/content/376/bmj-2021-065984</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/snpy4p/stream_1241471788-bmjgroup-covid-vaccine-safety-methenamine-hippurate-and-intersectionality.mp3" length="36059009" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode of Talk Evidence, Helen Macdonald, the BMJ’s research integrity editor is joined by Joe Ross, US research editor, and Juan Franco, editor in chief of BMJEBM, to talk about all things evidence.

Joe gives us an update about covid, including new research on safety of the vaccine  Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events
https://www.bmj.com/content/376/bmj-2021-068373

Juan updates us on a potential new prophylactic for recurrent UTIs, Methenamine hippurate, which could be an alternative to antibiotics.
Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women
https://www.bmj.com/content/376/bmj-2021-0068229

Helen tells us about some research which evaluates the way in which intersecting identities combine to make students experience of medical school more difficult.
Marginalized identities, mistreatment, discrimination, and burnout among US medical students
https://www.bmj.com/content/376/bmj-2021-065984]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2254</itunes:duration>
                                    </item>
    <item>
        <title>Wellbeing - hot food on a night shift</title>
        <itunes:title>Wellbeing - hot food on a night shift</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/wellbeing-hot-food-on-a-night-shift/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/wellbeing-hot-food-on-a-night-shift/#comments</comments>        <pubDate>Thu, 24 Mar 2022 12:46:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/wellbeing-hot-food-on-a-night-shift</guid>
                                    <description><![CDATA[The issue of food on nightshifts is a perennial grumble in the NHS, and though it might seem trivial, what does it say of an organisation if they demand their staff work when they're hungry, and what is the onward implication for that on patient care?

<p>To discuss all of these issues, we're joined by Neely Mozawala, a community specialist diabetes podiatrist, and Sahlia Saliha Mahmood-Ahmed, a gastroenterologist who have started the #24hrhotfoodfortheNHS campaign.</p>
]]></description>
                                                            <content:encoded><![CDATA[The issue of food on nightshifts is a perennial grumble in the NHS, and though it might seem trivial, what does it say of an organisation if they demand their staff work when they're hungry, and what is the onward implication for that on patient care?

<p>To discuss all of these issues, we're joined by Neely Mozawala, a community specialist diabetes podiatrist, and Sahlia Saliha Mahmood-Ahmed, a gastroenterologist who have started the #24hrhotfoodfortheNHS campaign.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rlgzzf/stream_1237911220-bmjgroup-wellbeing-hot-food-on-a-night-shift.mp3" length="21992175" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The issue of food on nightshifts is a perennial grumble in the NHS, and though it might seem trivial, what does it say of an organisation if they demand their staff work when they're hungry, and what is the onward implication for that on patient care?

To discuss all of these issues, we're joined by Neely Mozawala, a community specialist diabetes podiatrist, and Sahlia Saliha Mahmood-Ahmed, a gastroenterologist who have started the #24hrhotfoodfortheNHS campaign.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1374</itunes:duration>
                                    </item>
    <item>
        <title>Everyone’s going to make a mistake</title>
        <itunes:title>Everyone’s going to make a mistake</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/everyone-s-going-to-make-a-mistake/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/everyone-s-going-to-make-a-mistake/#comments</comments>        <pubDate>Thu, 17 Mar 2022 14:01:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/everyones-going-to-make-a-mistake</guid>
                                    <description><![CDATA[Medicine is complex, and as a doctor you won't always do the right thing - but you can prepare yourself for when mistakes happen, both emotionally and logistically.

In this episode of Doctor Informed, Clara Munro is joined by Susanna Stamford, a patient who was on the receiving end of a mistake, which catalysed her interest in patient safety. We're also joined by Anthea Martin, from Medical Protection, who dispels some myths about saying sorry. Ayisha Ashmore returns to the pod to digest the lessons from our experts.

Futher reading:
The video that Susanna mentioned is available to watch on youtube
<p>bitly.com/ManagingAdverseEvents</p>
]]></description>
                                                            <content:encoded><![CDATA[Medicine is complex, and as a doctor you won't always do the right thing - but you can prepare yourself for when mistakes happen, both emotionally and logistically.

In this episode of Doctor Informed, Clara Munro is joined by Susanna Stamford, a patient who was on the receiving end of a mistake, which catalysed her interest in patient safety. We're also joined by Anthea Martin, from Medical Protection, who dispels some myths about saying sorry. Ayisha Ashmore returns to the pod to digest the lessons from our experts.

Futher reading:
The video that Susanna mentioned is available to watch on youtube
<p>bitly.com/ManagingAdverseEvents</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2qi2mo/stream_1233924085-bmjgroup-everyones-going-to-make-a-mistake.mp3" length="49483440" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Medicine is complex, and as a doctor you won't always do the right thing - but you can prepare yourself for when mistakes happen, both emotionally and logistically.

In this episode of Doctor Informed, Clara Munro is joined by Susanna Stamford, a patient who was on the receiving end of a mistake, which catalysed her interest in patient safety. We're also joined by Anthea Martin, from Medical Protection, who dispels some myths about saying sorry. Ayisha Ashmore returns to the pod to digest the lessons from our experts.

Futher reading:
The video that Susanna mentioned is available to watch on youtube
bitly.com/ManagingAdverseEvents]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3093</itunes:duration>
                                    </item>
    <item>
        <title>Solving retention to support workforce recovery</title>
        <itunes:title>Solving retention to support workforce recovery</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/solving-retention-to-support-workforce-recovery/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/solving-retention-to-support-workforce-recovery/#comments</comments>        <pubDate>Fri, 11 Mar 2022 18:21:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-bmj-nuffield-trust-roundtable-2022-solving-retention-to-support-workforce-recovery</guid>
                                    <description><![CDATA[The covid-19 pandemic has stretched healthcare staff like never before. As part of the 2022 Nuffield Trust summit, The BMJ hosted a roundtable discussion looking at why workers leave the NHS and how staff wellbeing and retention can be improved. 

Joining us to discuss are:
Kamran Abbasi, editor in chief, The BMJ
Billy Palmer, senior fellow, Nuffield Trust
Lucina Rolewicz, researcher, Nuffield Trust
Mark Britnell, global healthcare expert and senior partner, KPMG International
Neil Greenburg, consultant occupational and forensic psychiatrist, King's College London's centre for military health research
Rose Penfold, National Institute for Clinical Research academic clinical fellow in geriatrics
Rammya Mathew, GP and quality improvement lead for Islington GP Federation
Partha Kar, diabetes consultant and NHS England's national advisor for diabetes
Danny Mortimer, chief executive of NHS Employers

<p>The Nuffield Trust report, "The Long Goodbye" which was discussed in this roundtable is available here - https://www.nuffieldtrust.org.uk/resource/the-long-goodbye-exploring-rates-of-staff-leaving-the-nhs-and-social-care</p>
]]></description>
                                                            <content:encoded><![CDATA[The covid-19 pandemic has stretched healthcare staff like never before. As part of the 2022 Nuffield Trust summit, The BMJ hosted a roundtable discussion looking at why workers leave the NHS and how staff wellbeing and retention can be improved. 

Joining us to discuss are:
Kamran Abbasi, editor in chief, The BMJ
Billy Palmer, senior fellow, Nuffield Trust
Lucina Rolewicz, researcher, Nuffield Trust
Mark Britnell, global healthcare expert and senior partner, KPMG International
Neil Greenburg, consultant occupational and forensic psychiatrist, King's College London's centre for military health research
Rose Penfold, National Institute for Clinical Research academic clinical fellow in geriatrics
Rammya Mathew, GP and quality improvement lead for Islington GP Federation
Partha Kar, diabetes consultant and NHS England's national advisor for diabetes
Danny Mortimer, chief executive of NHS Employers

<p>The Nuffield Trust report, "The Long Goodbye" which was discussed in this roundtable is available here - https://www.nuffieldtrust.org.uk/resource/the-long-goodbye-exploring-rates-of-staff-leaving-the-nhs-and-social-care</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ov84ur/stream_1230619906-bmjgroup-the-bmj-nuffield-trust-roundtable-2022-solving-retention-to-support-workforce-recovery.mp3" length="84659315" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The covid-19 pandemic has stretched healthcare staff like never before. As part of the 2022 Nuffield Trust summit, The BMJ hosted a roundtable discussion looking at why workers leave the NHS and how staff wellbeing and retention can be improved. 

Joining us to discuss are:
Kamran Abbasi, editor in chief, The BMJ
Billy Palmer, senior fellow, Nuffield Trust
Lucina Rolewicz, researcher, Nuffield Trust
Mark Britnell, global healthcare expert and senior partner, KPMG International
Neil Greenburg, consultant occupational and forensic psychiatrist, King's College London's centre for military health research
Rose Penfold, National Institute for Clinical Research academic clinical fellow in geriatrics
Rammya Mathew, GP and quality improvement lead for Islington GP Federation
Partha Kar, diabetes consultant and NHS England's national advisor for diabetes
Danny Mortimer, chief executive of NHS Employers

The Nuffield Trust report, "The Long Goodbye" which was discussed in this roundtable is available here - https://www.nuffieldtrust.org.uk/resource/the-long-goodbye-exploring-rates-of-staff-leaving-the-nhs-and-social-care]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3532</itunes:duration>
                                    </item>
    <item>
        <title>Rural healthcare in a pandemic</title>
        <itunes:title>Rural healthcare in a pandemic</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/rural-healthcare-in-a-pandemic/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/rural-healthcare-in-a-pandemic/#comments</comments>        <pubDate>Mon, 07 Mar 2022 15:09:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/rural-healthcare-in-a-pandemic</guid>
                                    <description><![CDATA[In this episode of the podcast we’re going to be talking about rural healthcare - and specifically the difficulties that distance, demographics, and funding have introduced into the world’s covid-19 response.

Rural regions made vulnerable by limited healthcare infrastructure, lower rates of vaccination, and opposition to government policies are the new frontlines in the pandemic, but support systems have not adjusted to the growing rural needs for health education, testing, vaccination, and treatment. 

<p>Michael Forster Rothbart, Kata Karáth, and Lungelo Ndhlovu report from the US, Ecuador, and Zimbabwe</p>
]]></description>
                                                            <content:encoded><![CDATA[In this episode of the podcast we’re going to be talking about rural healthcare - and specifically the difficulties that distance, demographics, and funding have introduced into the world’s covid-19 response.

Rural regions made vulnerable by limited healthcare infrastructure, lower rates of vaccination, and opposition to government policies are the new frontlines in the pandemic, but support systems have not adjusted to the growing rural needs for health education, testing, vaccination, and treatment. 

<p>Michael Forster Rothbart, Kata Karáth, and Lungelo Ndhlovu report from the US, Ecuador, and Zimbabwe</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kuus1j/stream_1228009927-bmjgroup-rural-healthcare-in-a-pandemic.mp3" length="39728847" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode of the podcast we’re going to be talking about rural healthcare - and specifically the difficulties that distance, demographics, and funding have introduced into the world’s covid-19 response.

Rural regions made vulnerable by limited healthcare infrastructure, lower rates of vaccination, and opposition to government policies are the new frontlines in the pandemic, but support systems have not adjusted to the growing rural needs for health education, testing, vaccination, and treatment. 

Michael Forster Rothbart, Kata Karáth, and Lungelo Ndhlovu report from the US, Ecuador, and Zimbabwe]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1657</itunes:duration>
                                    </item>
    <item>
        <title>The blame game</title>
        <itunes:title>The blame game</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-blame-game-1684835573/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-blame-game-1684835573/#comments</comments>        <pubDate>Fri, 25 Feb 2022 13:29:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-blame-game</guid>
                                    <description><![CDATA[In previous episodes of Doctor Informed, we've talked about the importance of speaking out, but the culture in your organisation might not always make that easy, especially if you feel something has gone wrong and you might be blamed for it. 

Blame culture, no blame culture, just culture - there are many terms which are used to describe the environment in which individuals and teams work, the feel within a team and an organisation. In this episode we'll explore what they mean, why blame can be detrimental to patient safety, and give some tips on how to investigate problems without throwing blame around.

Our guests in this episode;

Joselle Wright - Deputy Director of Midwifery, Gynaecology and Sexual Health at Walsall Healthcare NHS Trust

<p>Susanna Stanford, who became involved in patient safety after experience of a spinal anaesthetic failing during a c-section in 2010. She is an ambassador for the Clinical Human Factors Group.</p>
]]></description>
                                                            <content:encoded><![CDATA[In previous episodes of Doctor Informed, we've talked about the importance of speaking out, but the culture in your organisation might not always make that easy, especially if you feel something has gone wrong and you might be blamed for it. 

Blame culture, no blame culture, just culture - there are many terms which are used to describe the environment in which individuals and teams work, the feel within a team and an organisation. In this episode we'll explore what they mean, why blame can be detrimental to patient safety, and give some tips on how to investigate problems without throwing blame around.

Our guests in this episode;

Joselle Wright - Deputy Director of Midwifery, Gynaecology and Sexual Health at Walsall Healthcare NHS Trust

<p>Susanna Stanford, who became involved in patient safety after experience of a spinal anaesthetic failing during a c-section in 2010. She is an ambassador for the Clinical Human Factors Group.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8xqvcb/stream_1222338700-bmjgroup-the-blame-game.mp3" length="49763473" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In previous episodes of Doctor Informed, we've talked about the importance of speaking out, but the culture in your organisation might not always make that easy, especially if you feel something has gone wrong and you might be blamed for it. 

Blame culture, no blame culture, just culture - there are many terms which are used to describe the environment in which individuals and teams work, the feel within a team and an organisation. In this episode we'll explore what they mean, why blame can be detrimental to patient safety, and give some tips on how to investigate problems without throwing blame around.

Our guests in this episode;

Joselle Wright - Deputy Director of Midwifery, Gynaecology and Sexual Health at Walsall Healthcare NHS Trust

Susanna Stanford, who became involved in patient safety after experience of a spinal anaesthetic failing during a c-section in 2010. She is an ambassador for the Clinical Human Factors Group.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3110</itunes:duration>
                                    </item>
    <item>
        <title>Learning to listen</title>
        <itunes:title>Learning to listen</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/learning-to-listen-1684835574/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/learning-to-listen-1684835574/#comments</comments>        <pubDate>Fri, 04 Feb 2022 17:35:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/learning-to-listen</guid>
                                    <description><![CDATA[In previous episodes of Doctor Informed, we've talked about the importance of speaking out, and how to do that better, but as you progress through your medical career, you will become the person to whom those with problems will turn. 

In this episode we will explore listening. As a senior clinician, how can you make the space in your work to be a good listener, when what you hear might not be what you want to hear?

Our guests;
Megan Reitz is a professor of Leadership and Dialogue at Hult Business School.
John Higgins is research director at The Right Conversation.

Reading
Speaking truth to power: why leaders cannot hear what they need to hear 
<p>https://bmjleader.bmj.com/content/5/4/270</p>
]]></description>
                                                            <content:encoded><![CDATA[In previous episodes of Doctor Informed, we've talked about the importance of speaking out, and how to do that better, but as you progress through your medical career, you will become the person to whom those with problems will turn. 

In this episode we will explore listening. As a senior clinician, how can you make the space in your work to be a good listener, when what you hear might not be what you want to hear?

Our guests;
Megan Reitz is a professor of Leadership and Dialogue at Hult Business School.
John Higgins is research director at The Right Conversation.

Reading
Speaking truth to power: why leaders cannot hear what they need to hear 
<p>https://bmjleader.bmj.com/content/5/4/270</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7vv25g/stream_1209874909-bmjgroup-learning-to-listen.mp3" length="45504469" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In previous episodes of Doctor Informed, we've talked about the importance of speaking out, and how to do that better, but as you progress through your medical career, you will become the person to whom those with problems will turn. 

In this episode we will explore listening. As a senior clinician, how can you make the space in your work to be a good listener, when what you hear might not be what you want to hear?

Our guests;
Megan Reitz is a professor of Leadership and Dialogue at Hult Business School.
John Higgins is research director at The Right Conversation.

Reading
Speaking truth to power: why leaders cannot hear what they need to hear 
https://bmjleader.bmj.com/content/5/4/270]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2844</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence - isolation periods, openness, and environmental impacts</title>
        <itunes:title>Talk Evidence - isolation periods, openness, and environmental impacts</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-isolation-periods-openness-and-environmental-impacts/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-isolation-periods-openness-and-environmental-impacts/#comments</comments>        <pubDate>Fri, 28 Jan 2022 17:35:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-isolation-periods-openness-and-environmental-impacts</guid>
                                    <description><![CDATA[In the first Talk Evidence of 2022, we'll be asking about the evidence for isolation - now that isolation periods are being reduced, or even stopped in the event of a negative lateral flow test, we'll find out what data that's based on, and if it's appropriate. 

Vaccinations and treatments for covid-19 have been the one major success story of the pandemic, but that doesn't mean we should abandon the principles of openness and transparency when it comes to scrutinising the data - we'll hear what access to the data which underlies regulatory approval could do now.

Finally, the impacts of climate change were set out in a WHO report in November last year - and recent weather seems to underline their conclusions. We'll discuss new evidence linking the environment and health, and ask what clinicians can do with that.

Reading list:
Mitigating isolation: The use of rapid antigen testing to reduce the impact of self-isolation periods
https://www.medrxiv.org/content/10.1101/2021.12.23.21268326v1.full.pdf

Covid-19 vaccines and treatments: we must have raw data, now
https://www.bmj.com/content/376/bmj.o102

WHO report: Climate change and health
https://www.who.int/news-room/fact-sheets/detail/climate-change-and-health

Ambient heat and risks of emergency department visits among adults in the United States: time stratified case crossover study
https://www.bmj.com/content/375/bmj-2021-065653

Residential exposure to transportation noise in Denmark and incidence of dementia: national cohort study
https://www.bmj.com/content/374/bmj.n1954

Long term exposure to low level air pollution and mortality in eight European cohorts within the ELAPSE project: pooled analysis
<p>https://www.bmj.com/content/374/bmj.n1904</p>
]]></description>
                                                            <content:encoded><![CDATA[In the first Talk Evidence of 2022, we'll be asking about the evidence for isolation - now that isolation periods are being reduced, or even stopped in the event of a negative lateral flow test, we'll find out what data that's based on, and if it's appropriate. 

Vaccinations and treatments for covid-19 have been the one major success story of the pandemic, but that doesn't mean we should abandon the principles of openness and transparency when it comes to scrutinising the data - we'll hear what access to the data which underlies regulatory approval could do now.

Finally, the impacts of climate change were set out in a WHO report in November last year - and recent weather seems to underline their conclusions. We'll discuss new evidence linking the environment and health, and ask what clinicians can do with that.

Reading list:
Mitigating isolation: The use of rapid antigen testing to reduce the impact of self-isolation periods
https://www.medrxiv.org/content/10.1101/2021.12.23.21268326v1.full.pdf

Covid-19 vaccines and treatments: we must have raw data, now
https://www.bmj.com/content/376/bmj.o102

WHO report: Climate change and health
https://www.who.int/news-room/fact-sheets/detail/climate-change-and-health

Ambient heat and risks of emergency department visits among adults in the United States: time stratified case crossover study
https://www.bmj.com/content/375/bmj-2021-065653

Residential exposure to transportation noise in Denmark and incidence of dementia: national cohort study
https://www.bmj.com/content/374/bmj.n1954

Long term exposure to low level air pollution and mortality in eight European cohorts within the ELAPSE project: pooled analysis
<p>https://www.bmj.com/content/374/bmj.n1904</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/n1gshu/stream_1205560120-bmjgroup-talk-evidence-isolation-periods-openness-and-environmental-impacts.mp3" length="33715094" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In the first Talk Evidence of 2022, we'll be asking about the evidence for isolation - now that isolation periods are being reduced, or even stopped in the event of a negative lateral flow test, we'll find out what data that's based on, and if it's appropriate. 

Vaccinations and treatments for covid-19 have been the one major success story of the pandemic, but that doesn't mean we should abandon the principles of openness and transparency when it comes to scrutinising the data - we'll hear what access to the data which underlies regulatory approval could do now.

Finally, the impacts of climate change were set out in a WHO report in November last year - and recent weather seems to underline their conclusions. We'll discuss new evidence linking the environment and health, and ask what clinicians can do with that.

Reading list:
Mitigating isolation: The use of rapid antigen testing to reduce the impact of self-isolation periods
https://www.medrxiv.org/content/10.1101/2021.12.23.21268326v1.full.pdf

Covid-19 vaccines and treatments: we must have raw data, now
https://www.bmj.com/content/376/bmj.o102

WHO report: Climate change and health
https://www.who.int/news-room/fact-sheets/detail/climate-change-and-health

Ambient heat and risks of emergency department visits among adults in the United States: time stratified case crossover study
https://www.bmj.com/content/375/bmj-2021-065653

Residential exposure to transportation noise in Denmark and incidence of dementia: national cohort study
https://www.bmj.com/content/374/bmj.n1954

Long term exposure to low level air pollution and mortality in eight European cohorts within the ELAPSE project: pooled analysis
https://www.bmj.com/content/374/bmj.n1904]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2107</itunes:duration>
                                    </item>
    <item>
        <title>Why is it so hard to speak out about patient safety?</title>
        <itunes:title>Why is it so hard to speak out about patient safety?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/why-is-it-so-hard-to-speak-out-about-patient-safety/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/why-is-it-so-hard-to-speak-out-about-patient-safety/#comments</comments>        <pubDate>Fri, 21 Jan 2022 10:54:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/why-is-it-so-hard-to-speak-out-about-patient-safety</guid>
                                    <description><![CDATA[In the previous episodes of Doctor Informed, we've heard why it's so important to talk about patient safety concerns, and some of the mechanisms that allow hospital staff to raise them, but knowing why and how doesn't always make it easier to speak out. 

In this episode we're exploring the concept of a voiceable concern – identifying what counts as a concern, and what counts as an occasion for voice by an individual, is not a straightforward matter of applying objective criteria- for example how do you tell if you're witnessing poor practice, or just something that lies outside your area of understanding? Or how do you know if the common practice in this particular ward is actually an outlier when looking at other hospitals?

Our guests this week;
Mary Dixon-Woods is director of THIS Institute, and a Health Foundation Professor of Healthcare Improvement Studies in the Department of Public Health and Primary Care at the University of Cambridge. Her work is concerned with generating a high quality evidence-base to support the organisation, quality and safety of care delivered to patients.

Zoe Fritz is a consultant in acute medicine at Cambridge University Hospitals NHS Foundation Trust, she is also a Wellcome Fellow in society and ethics at THIS Institute, investigating how we communicate and record uncertainty around diagnosis.

Reading:
https://pubmed.ncbi.nlm.nih.gov/34978470/

www.bmj.com/podcasts/doctorinformed/
<p>https://www.thisinstitute.cam.ac.uk/podcast/</p>
]]></description>
                                                            <content:encoded><![CDATA[In the previous episodes of Doctor Informed, we've heard why it's so important to talk about patient safety concerns, and some of the mechanisms that allow hospital staff to raise them, but knowing why and how doesn't always make it easier to speak out. 

In this episode we're exploring the concept of a voiceable concern – identifying what counts as a concern, and what counts as an occasion for voice by an individual, is not a straightforward matter of applying objective criteria- for example how do you tell if you're witnessing poor practice, or just something that lies outside your area of understanding? Or how do you know if the common practice in this particular ward is actually an outlier when looking at other hospitals?

Our guests this week;
Mary Dixon-Woods is director of THIS Institute, and a Health Foundation Professor of Healthcare Improvement Studies in the Department of Public Health and Primary Care at the University of Cambridge. Her work is concerned with generating a high quality evidence-base to support the organisation, quality and safety of care delivered to patients.

Zoe Fritz is a consultant in acute medicine at Cambridge University Hospitals NHS Foundation Trust, she is also a Wellcome Fellow in society and ethics at THIS Institute, investigating how we communicate and record uncertainty around diagnosis.

Reading:
https://pubmed.ncbi.nlm.nih.gov/34978470/

www.bmj.com/podcasts/doctorinformed/
<p>https://www.thisinstitute.cam.ac.uk/podcast/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/12x499/stream_1200802450-bmjgroup-why-is-it-so-hard-to-speak-out-about-patient-safety.mp3" length="35842506" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In the previous episodes of Doctor Informed, we've heard why it's so important to talk about patient safety concerns, and some of the mechanisms that allow hospital staff to raise them, but knowing why and how doesn't always make it easier to speak out. 

In this episode we're exploring the concept of a voiceable concern – identifying what counts as a concern, and what counts as an occasion for voice by an individual, is not a straightforward matter of applying objective criteria- for example how do you tell if you're witnessing poor practice, or just something that lies outside your area of understanding? Or how do you know if the common practice in this particular ward is actually an outlier when looking at other hospitals?

Our guests this week;
Mary Dixon-Woods is director of THIS Institute, and a Health Foundation Professor of Healthcare Improvement Studies in the Department of Public Health and Primary Care at the University of Cambridge. Her work is concerned with generating a high quality evidence-base to support the organisation, quality and safety of care delivered to patients.

Zoe Fritz is a consultant in acute medicine at Cambridge University Hospitals NHS Foundation Trust, she is also a Wellcome Fellow in society and ethics at THIS Institute, investigating how we communicate and record uncertainty around diagnosis.

Reading:
https://pubmed.ncbi.nlm.nih.gov/34978470/

www.bmj.com/podcasts/doctorinformed/
https://www.thisinstitute.cam.ac.uk/podcast/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2240</itunes:duration>
                                    </item>
    <item>
        <title>US Assistant Secretary of Health, Rachel Levine</title>
        <itunes:title>US Assistant Secretary of Health, Rachel Levine</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/us-assistant-secretary-of-health-rachel-levine/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/us-assistant-secretary-of-health-rachel-levine/#comments</comments>        <pubDate>Sat, 15 Jan 2022 13:03:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/us-assistant-secretary-of-health-rachel-levine</guid>
                                    <description><![CDATA[Rachel Levine Trained as a paediatrician, before becoming firstly the state of Pennsylvania's Physician General, then its Health Secretary.

During president Joe Biden's administration, she was nominated to become the U.S.'s assistant secretary of health. That lead to her becoming a four-star admiral in the U.S. Public Health Service Commissioned Corps, and thus the  first openly transgender four-star officer in the US.

In this podcast, we discussed the pandemic - but also wider problems affecting Americans' health, notably climate change, inequality and the opioid crisis. We also discuss the health and care of LGBT+ people, in the U.S, and around the world.

<p>This interview was recorded on the 16th of December 2021.</p>
]]></description>
                                                            <content:encoded><![CDATA[Rachel Levine Trained as a paediatrician, before becoming firstly the state of Pennsylvania's Physician General, then its Health Secretary.

During president Joe Biden's administration, she was nominated to become the U.S.'s assistant secretary of health. That lead to her becoming a four-star admiral in the U.S. Public Health Service Commissioned Corps, and thus the  first openly transgender four-star officer in the US.

In this podcast, we discussed the pandemic - but also wider problems affecting Americans' health, notably climate change, inequality and the opioid crisis. We also discuss the health and care of LGBT+ people, in the U.S, and around the world.

<p>This interview was recorded on the 16th of December 2021.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mbt2t5/stream_1197009703-bmjgroup-us-assistant-secretary-of-health-rachel-levine.mp3" length="23666101" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Rachel Levine Trained as a paediatrician, before becoming firstly the state of Pennsylvania's Physician General, then its Health Secretary.

During president Joe Biden's administration, she was nominated to become the U.S.'s assistant secretary of health. That lead to her becoming a four-star admiral in the U.S. Public Health Service Commissioned Corps, and thus the  first openly transgender four-star officer in the US.

In this podcast, we discussed the pandemic - but also wider problems affecting Americans' health, notably climate change, inequality and the opioid crisis. We also discuss the health and care of LGBT+ people, in the U.S, and around the world.

This interview was recorded on the 16th of December 2021.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1479</itunes:duration>
                                    </item>
    <item>
        <title>Talking Christmas Evidence 2021</title>
        <itunes:title>Talking Christmas Evidence 2021</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talking-christmas-evidence-2021/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talking-christmas-evidence-2021/#comments</comments>        <pubDate>Wed, 22 Dec 2021 09:43:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talking-christmas-evidence-2021</guid>
                                    <description><![CDATA[The BMJ has special criteria for considering Christmas research: first it should make you laugh, and then it should make you think. 

In this festive episode of the Talk Evidence podcast, our regular panel of Helen Macdonald and Joe Ross are again joined by Juan Franco,
editor in chief of BMJ Evidence Based Medicine. 

<p>They’ll give you a peek into what makes for good Christmas research, and why what may seem silly on the surface has a deeper meaning.</p>
]]></description>
                                                            <content:encoded><![CDATA[The BMJ has special criteria for considering Christmas research: first it should make you laugh, and then it should make you think. 

In this festive episode of the Talk Evidence podcast, our regular panel of Helen Macdonald and Joe Ross are again joined by Juan Franco,
editor in chief of BMJ Evidence Based Medicine. 

<p>They’ll give you a peek into what makes for good Christmas research, and why what may seem silly on the surface has a deeper meaning.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/c2s7cd/stream_1182821356-bmjgroup-talking-christmas-evidence-2021.mp3" length="32452021" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The BMJ has special criteria for considering Christmas research: first it should make you laugh, and then it should make you think. 

In this festive episode of the Talk Evidence podcast, our regular panel of Helen Macdonald and Joe Ross are again joined by Juan Franco,
editor in chief of BMJ Evidence Based Medicine. 

They’ll give you a peek into what makes for good Christmas research, and why what may seem silly on the surface has a deeper meaning.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2028</itunes:duration>
                                    </item>
    <item>
        <title>Who is responsible for patient safety?</title>
        <itunes:title>Who is responsible for patient safety?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/who-is-responsible-for-patient-safety/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/who-is-responsible-for-patient-safety/#comments</comments>        <pubDate>Thu, 16 Dec 2021 18:20:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/who-is-in-responsible-for-patient-safety-mixdown</guid>
                                    <description><![CDATA[As clinicians, we're all taught that patient safety is everyone's responsibility - but on the ground it can be hard to know how to most effectively report concerns, especially if you're not sure how those concerns will be received.

In this episode of Doctor Informed, Clara Munro is joined by Ayisha Ashmore, and they ask "who is actually responsible for patient safety?"

To answer that we're joined by 2 guests

Bill Kirkup, independent investigator who has worked on the reports into failings in Mid-Staffordshire, and Gosport. 

<p>Henrietta Hughes - GP, and the NHS's first guardian, Henrietta championed the creation of freedom-to-speak-up guardians in the English NHS, to ensure that clinicians are able to freely speak out.</p>
]]></description>
                                                            <content:encoded><![CDATA[As clinicians, we're all taught that patient safety is everyone's responsibility - but on the ground it can be hard to know how to most effectively report concerns, especially if you're not sure how those concerns will be received.

In this episode of Doctor Informed, Clara Munro is joined by Ayisha Ashmore, and they ask "who is actually responsible for patient safety?"

To answer that we're joined by 2 guests

Bill Kirkup, independent investigator who has worked on the reports into failings in Mid-Staffordshire, and Gosport. 

<p>Henrietta Hughes - GP, and the NHS's first guardian, Henrietta championed the creation of freedom-to-speak-up guardians in the English NHS, to ensure that clinicians are able to freely speak out.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/eluvxh/stream_1179073156-bmjgroup-who-is-in-responsible-for-patient-safety-mixdown.mp3" length="39937252" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As clinicians, we're all taught that patient safety is everyone's responsibility - but on the ground it can be hard to know how to most effectively report concerns, especially if you're not sure how those concerns will be received.

In this episode of Doctor Informed, Clara Munro is joined by Ayisha Ashmore, and they ask "who is actually responsible for patient safety?"

To answer that we're joined by 2 guests

Bill Kirkup, independent investigator who has worked on the reports into failings in Mid-Staffordshire, and Gosport. 

Henrietta Hughes - GP, and the NHS's first guardian, Henrietta championed the creation of freedom-to-speak-up guardians in the English NHS, to ensure that clinicians are able to freely speak out.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2496</itunes:duration>
                                    </item>
    <item>
        <title>Exit interview with Fiona Godlee</title>
        <itunes:title>Exit interview with Fiona Godlee</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/exit-interview-with-fiona-godlee/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/exit-interview-with-fiona-godlee/#comments</comments>        <pubDate>Wed, 15 Dec 2021 17:56:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/exit-interview-with-fiona-godlee</guid>
                                    <description><![CDATA[Fiona Godlee is stepping down as Editor-in-Chief of The BMJ after 16 years in the position.

She was the first female editor of the journal, and over her tenure has seen a lot of changes - both to the publication she's run, and to the wider world of medicine.

To mark her departure, Helen Macdonald sat down with Fiona to ask her a bit about those early days at the journal, on her view of women taking leadership roles in medicine, on her thoughts about some of the big issues facing science, and what is coming next.

<p>Note from the editor; apologies for the audio quality in the first half.</p>
]]></description>
                                                            <content:encoded><![CDATA[Fiona Godlee is stepping down as Editor-in-Chief of The BMJ after 16 years in the position.

She was the first female editor of the journal, and over her tenure has seen a lot of changes - both to the publication she's run, and to the wider world of medicine.

To mark her departure, Helen Macdonald sat down with Fiona to ask her a bit about those early days at the journal, on her view of women taking leadership roles in medicine, on her thoughts about some of the big issues facing science, and what is coming next.

<p>Note from the editor; apologies for the audio quality in the first half.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/1ute7r/stream_1178418886-bmjgroup-exit-interview-with-fiona-godlee.mp3" length="62991673" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Fiona Godlee is stepping down as Editor-in-Chief of The BMJ after 16 years in the position.

She was the first female editor of the journal, and over her tenure has seen a lot of changes - both to the publication she's run, and to the wider world of medicine.

To mark her departure, Helen Macdonald sat down with Fiona to ask her a bit about those early days at the journal, on her view of women taking leadership roles in medicine, on her thoughts about some of the big issues facing science, and what is coming next.

Note from the editor; apologies for the audio quality in the first half.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2628</itunes:duration>
                                    </item>
    <item>
        <title>Covid and conflict In South Asia</title>
        <itunes:title>Covid and conflict In South Asia</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/covid-and-conflict-in-south-asia/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/covid-and-conflict-in-south-asia/#comments</comments>        <pubDate>Fri, 10 Dec 2021 18:52:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/covid-and-conflict-in-south-asia</guid>
                                    <description><![CDATA[In this second podcast focussing on the covid response in South Asia, we’re focussing on the intersection of conflict and covid in the region. The pandemic has highlighted the underlying weaknesses in many health systems - but could it also be used as a catalyst for change, and be a step towards easing tensions?

To discuss this,  Kamran Abbasi, executive editor of The BMJ, is joined by Zulfiqar Bhutta, head of the Institute for Global Health and Development, Aga Khan University, and Arun Mitra senior vice president of Indian Doctors for Peace & Development.

To read more;
Conflict, extremism, resilience and peace in South Asia; can covid-19 provide a bridge for peace and rapprochement?
<p>https://www.bmj.com/content/375/BMJ-2021-067384</p>
]]></description>
                                                            <content:encoded><![CDATA[In this second podcast focussing on the covid response in South Asia, we’re focussing on the intersection of conflict and covid in the region. The pandemic has highlighted the underlying weaknesses in many health systems - but could it also be used as a catalyst for change, and be a step towards easing tensions?

To discuss this,  Kamran Abbasi, executive editor of The BMJ, is joined by Zulfiqar Bhutta, head of the Institute for Global Health and Development, Aga Khan University, and Arun Mitra senior vice president of Indian Doctors for Peace & Development.

To read more;
Conflict, extremism, resilience and peace in South Asia; can covid-19 provide a bridge for peace and rapprochement?
<p>https://www.bmj.com/content/375/BMJ-2021-067384</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/prs1nf/stream_1175631178-bmjgroup-covid-and-conflict-in-south-asia.mp3" length="37681109" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this second podcast focussing on the covid response in South Asia, we’re focussing on the intersection of conflict and covid in the region. The pandemic has highlighted the underlying weaknesses in many health systems - but could it also be used as a catalyst for change, and be a step towards easing tensions?

To discuss this,  Kamran Abbasi, executive editor of The BMJ, is joined by Zulfiqar Bhutta, head of the Institute for Global Health and Development, Aga Khan University, and Arun Mitra senior vice president of Indian Doctors for Peace & Development.

To read more;
Conflict, extremism, resilience and peace in South Asia; can covid-19 provide a bridge for peace and rapprochement?
https://www.bmj.com/content/375/BMJ-2021-067384]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2355</itunes:duration>
                                    </item>
    <item>
        <title>Life Support - Being a compassionate colleague</title>
        <itunes:title>Life Support - Being a compassionate colleague</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/life-support-being-a-compassionate-colleague/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/life-support-being-a-compassionate-colleague/#comments</comments>        <pubDate>Tue, 30 Nov 2021 17:47:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/life-support-being-a-compassionate-colleague</guid>
                                    <description><![CDATA[In this episode of Doctor Informed, Clara Munro is joined by Ayisha Ashmore - and they're getting to grips with being a compassionate colleague.

While the topic might seem warm and fuzzy, there's some good hard science to suggest that compassionate leadership at every level of healthcare can make a huge difference to staff, and improve patient outcomes. 

Most people innately have the skills need to be compassionate colleagues - but often the pressures of the job can make it the lowest of priorities in our everyday interactions.

Our two guests this week think that's wrong though - and say that compassionate leadership is one of the most important things to get right. 

Joining us are, Michael West, senior fellow at The King's Fund and professor of Work and Organisational Psychology at Lancaster, and Bob Klaber, consultant general paediatrician and director of strategy, research and innovation at Imperial College Healthcare NHS Trust

Michael has written the book on compassionate leadership in health and social care  - https://tinyurl.com/vh55mker.

You can read more about Bob's work in his blog - https://www.imperial.nhs.uk/about-us/blog/how-acts-of-kindness-can-improve-care-and-strengthen-teams

<p>Ayisha has written about putting some of this all into practice in a maternity setting - https://bmjleader.bmj.com/content/early/2021/11/25/leader-2021-000449</p>
]]></description>
                                                            <content:encoded><![CDATA[In this episode of Doctor Informed, Clara Munro is joined by Ayisha Ashmore - and they're getting to grips with being a compassionate colleague.

While the topic might seem warm and fuzzy, there's some good hard science to suggest that compassionate leadership at every level of healthcare can make a huge difference to staff, and improve patient outcomes. 

Most people innately have the skills need to be compassionate colleagues - but often the pressures of the job can make it the lowest of priorities in our everyday interactions.

Our two guests this week think that's wrong though - and say that compassionate leadership is one of the most important things to get right. 

Joining us are, Michael West, senior fellow at The King's Fund and professor of Work and Organisational Psychology at Lancaster, and Bob Klaber, consultant general paediatrician and director of strategy, research and innovation at Imperial College Healthcare NHS Trust

Michael has written the book on compassionate leadership in health and social care  - https://tinyurl.com/vh55mker.

You can read more about Bob's work in his blog - https://www.imperial.nhs.uk/about-us/blog/how-acts-of-kindness-can-improve-care-and-strengthen-teams

<p>Ayisha has written about putting some of this all into practice in a maternity setting - https://bmjleader.bmj.com/content/early/2021/11/25/leader-2021-000449</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/j588yj/stream_1169392522-bmjgroup-life-support-being-a-compassionate-colleague.mp3" length="70906514" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode of Doctor Informed, Clara Munro is joined by Ayisha Ashmore - and they're getting to grips with being a compassionate colleague.

While the topic might seem warm and fuzzy, there's some good hard science to suggest that compassionate leadership at every level of healthcare can make a huge difference to staff, and improve patient outcomes. 

Most people innately have the skills need to be compassionate colleagues - but often the pressures of the job can make it the lowest of priorities in our everyday interactions.

Our two guests this week think that's wrong though - and say that compassionate leadership is one of the most important things to get right. 

Joining us are, Michael West, senior fellow at The King's Fund and professor of Work and Organisational Psychology at Lancaster, and Bob Klaber, consultant general paediatrician and director of strategy, research and innovation at Imperial College Healthcare NHS Trust

Michael has written the book on compassionate leadership in health and social care  - https://tinyurl.com/vh55mker.

You can read more about Bob's work in his blog - https://www.imperial.nhs.uk/about-us/blog/how-acts-of-kindness-can-improve-care-and-strengthen-teams

Ayisha has written about putting some of this all into practice in a maternity setting - https://bmjleader.bmj.com/content/early/2021/11/25/leader-2021-000449]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2958</itunes:duration>
                                    </item>
    <item>
        <title>Wellbeing - feeling addicted to your phone?</title>
        <itunes:title>Wellbeing - feeling addicted to your phone?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/wellbeing-feeling-addicted-to-your-phone/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/wellbeing-feeling-addicted-to-your-phone/#comments</comments>        <pubDate>Fri, 26 Nov 2021 12:53:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/wellbeing-feeling-addicted-to-your-phone</guid>
                                    <description><![CDATA[In the wellbeing podcast, the dread topic of phone usage has come up again - how social media, and an "always on" culture can affect our wellbeing.

But knowing that, and changing our behaviour are two different things - so to give some advice on reducing our reliance on phones, Abi and Cat are joined by Nidhi Gupta, assistant professor of pediatrics at Vanderbilt University Medical Center, who's been using techniques from behavioural addiction to help with device usage.

For more from Nidhi, visit https://phreedom.net/

Some of the research that Nidhi mentions
https://publications.aap.org/pediatrics/article/138/5/e20162591/60503/Media-and-Young-Minds

A randomized trial of the effects of reducing television viewing and computer use on body mass index in young children
https://pubmed.ncbi.nlm.nih.gov/18316661/

Distraction: an assessment of smartphone usage in health care work settings
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437811/

Treatment Considerations in Internet and Video Game Addiction
https://pubmed.ncbi.nlm.nih.gov/29502754/

The Smartphone Addiction Scale: Development and Validation of a Short Version for Adolescents
<p>https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0083558</p>
]]></description>
                                                            <content:encoded><![CDATA[In the wellbeing podcast, the dread topic of phone usage has come up again - how social media, and an "always on" culture can affect our wellbeing.

But knowing that, and changing our behaviour are two different things - so to give some advice on reducing our reliance on phones, Abi and Cat are joined by Nidhi Gupta, assistant professor of pediatrics at Vanderbilt University Medical Center, who's been using techniques from behavioural addiction to help with device usage.

For more from Nidhi, visit https://phreedom.net/

Some of the research that Nidhi mentions
https://publications.aap.org/pediatrics/article/138/5/e20162591/60503/Media-and-Young-Minds

A randomized trial of the effects of reducing television viewing and computer use on body mass index in young children
https://pubmed.ncbi.nlm.nih.gov/18316661/

Distraction: an assessment of smartphone usage in health care work settings
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437811/

Treatment Considerations in Internet and Video Game Addiction
https://pubmed.ncbi.nlm.nih.gov/29502754/

The Smartphone Addiction Scale: Development and Validation of a Short Version for Adolescents
<p>https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0083558</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/0ydld6/stream_1167202663-bmjgroup-wellbeing-feeling-addicted-to-your-phone.mp3" length="34362513" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In the wellbeing podcast, the dread topic of phone usage has come up again - how social media, and an "always on" culture can affect our wellbeing.

But knowing that, and changing our behaviour are two different things - so to give some advice on reducing our reliance on phones, Abi and Cat are joined by Nidhi Gupta, assistant professor of pediatrics at Vanderbilt University Medical Center, who's been using techniques from behavioural addiction to help with device usage.

For more from Nidhi, visit https://phreedom.net/

Some of the research that Nidhi mentions
https://publications.aap.org/pediatrics/article/138/5/e20162591/60503/Media-and-Young-Minds

A randomized trial of the effects of reducing television viewing and computer use on body mass index in young children
https://pubmed.ncbi.nlm.nih.gov/18316661/

Distraction: an assessment of smartphone usage in health care work settings
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437811/

Treatment Considerations in Internet and Video Game Addiction
https://pubmed.ncbi.nlm.nih.gov/29502754/

The Smartphone Addiction Scale: Development and Validation of a Short Version for Adolescents
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0083558]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2148</itunes:duration>
                                    </item>
    <item>
        <title>Doctor Informed - The patterns which emerge</title>
        <itunes:title>Doctor Informed - The patterns which emerge</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/doctor-informed-the-patterns-which-emerge/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/doctor-informed-the-patterns-which-emerge/#comments</comments>        <pubDate>Tue, 16 Nov 2021 10:59:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/doctor-informed-the-patterns-which-emerge</guid>
                                    <description><![CDATA[When you hear the reports from a major patient safety issue, it will be shocking to hear how they have played out - but the patterns in behaviour, of people and institutions which have gone disastrously wrong, can be seen throughout healthcare.

As this first series of Doctor Informed unfolds, we'll be exploring these patterns, and bring you evidence and expertise on tackling them - Doctor Informed is about going beyond medical knowledge to make you the best doctor you can be.

In this first episode we're talking to experts who have seen these patterns firsthand, and whose work is all about tackling them;

Bill Kirkup is a clinician turned investigator - he's led investigations into failings at a maternity and neonatal unit in Morcambe Bay, into the Oxford paediatric cardiac surgery unit and  into Jimmy Savile’s involvement with Broadmoor Hospital. He was also a member of the Hillsborough Independent Panel

<p>Mary Dixon-Woods is director of THIS Insitute, and a Health Foundation Professor of Healthcare Improvement Studies in the Department of Public Health and Primary Care at the University of Cambridge. Her work  is concerned with generating a high quality evidence-base to support the organisation, quality and safety of care delivered to patients.</p>
]]></description>
                                                            <content:encoded><![CDATA[When you hear the reports from a major patient safety issue, it will be shocking to hear how they have played out - but the patterns in behaviour, of people and institutions which have gone disastrously wrong, can be seen throughout healthcare.

As this first series of Doctor Informed unfolds, we'll be exploring these patterns, and bring you evidence and expertise on tackling them - Doctor Informed is about going beyond medical knowledge to make you the best doctor you can be.

In this first episode we're talking to experts who have seen these patterns firsthand, and whose work is all about tackling them;

Bill Kirkup is a clinician turned investigator - he's led investigations into failings at a maternity and neonatal unit in Morcambe Bay, into the Oxford paediatric cardiac surgery unit and  into Jimmy Savile’s involvement with Broadmoor Hospital. He was also a member of the Hillsborough Independent Panel

<p>Mary Dixon-Woods is director of THIS Insitute, and a Health Foundation Professor of Healthcare Improvement Studies in the Department of Public Health and Primary Care at the University of Cambridge. Her work  is concerned with generating a high quality evidence-base to support the organisation, quality and safety of care delivered to patients.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/m8sr1y/stream_1160902885-bmjgroup-doctor-informed-the-patterns-which-emerge.mp3" length="45348699" type="audio/mpeg"/>
        <itunes:summary><![CDATA[When you hear the reports from a major patient safety issue, it will be shocking to hear how they have played out - but the patterns in behaviour, of people and institutions which have gone disastrously wrong, can be seen throughout healthcare.

As this first series of Doctor Informed unfolds, we'll be exploring these patterns, and bring you evidence and expertise on tackling them - Doctor Informed is about going beyond medical knowledge to make you the best doctor you can be.

In this first episode we're talking to experts who have seen these patterns firsthand, and whose work is all about tackling them;

Bill Kirkup is a clinician turned investigator - he's led investigations into failings at a maternity and neonatal unit in Morcambe Bay, into the Oxford paediatric cardiac surgery unit and  into Jimmy Savile’s involvement with Broadmoor Hospital. He was also a member of the Hillsborough Independent Panel

Mary Dixon-Woods is director of THIS Insitute, and a Health Foundation Professor of Healthcare Improvement Studies in the Department of Public Health and Primary Care at the University of Cambridge. Her work  is concerned with generating a high quality evidence-base to support the organisation, quality and safety of care delivered to patients.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1889</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence - Bones, nutrition, pain relief, and overdiagnosis.</title>
        <itunes:title>Talk Evidence - Bones, nutrition, pain relief, and overdiagnosis.</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-bones-nutrition-pain-relief-and-overdiagnosis/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-bones-nutrition-pain-relief-and-overdiagnosis/#comments</comments>        <pubDate>Fri, 05 Nov 2021 19:16:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-bones-nutrition-pain-relief-and-overdiagnosis</guid>
                                    <description><![CDATA[In this month’s Talk evidence, we’re going back to our roots and avoiding covid - so sit back and listen to Helen Macdonald and Joe Ross discuss a new nutrition study to prevent fractures in older adults by eating dairy, and a meta-analysis which helps you choose pain relief medications for management of osteoarthritis.

We’ll hear from Steven Woloshin about the virtual Overdiagnosis conference, and why he’s so excited about a new category in the National Library of Medicine.

Finally, we have a study on urinary retention and risk of cancer that has been over 25 years in the making.


Reading list;

Effect of dietary sources of calcium and protein on hip fractures and falls in older adults in residential care
https://www.bmj.com/content/375/bmj.n2364

Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis
https://www.bmj.com/content/375/bmj.n2321

To access the webinars Steven was talking about.
https://www.preventingoverdiagnosis.net/

Acute urinary retention and risk of cancer
https://www.bmj.com/content/375/bmj.n2305

<p>Podcast listener survey. Please let us know how we could improve the podcasts for you, and your specialty - https://linktr.ee/BMJsurvey</p>
]]></description>
                                                            <content:encoded><![CDATA[In this month’s Talk evidence, we’re going back to our roots and avoiding covid - so sit back and listen to Helen Macdonald and Joe Ross discuss a new nutrition study to prevent fractures in older adults by eating dairy, and a meta-analysis which helps you choose pain relief medications for management of osteoarthritis.

We’ll hear from Steven Woloshin about the virtual Overdiagnosis conference, and why he’s so excited about a new category in the National Library of Medicine.

Finally, we have a study on urinary retention and risk of cancer that has been over 25 years in the making.


Reading list;

Effect of dietary sources of calcium and protein on hip fractures and falls in older adults in residential care
https://www.bmj.com/content/375/bmj.n2364

Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis
https://www.bmj.com/content/375/bmj.n2321

To access the webinars Steven was talking about.
https://www.preventingoverdiagnosis.net/

Acute urinary retention and risk of cancer
https://www.bmj.com/content/375/bmj.n2305

<p>Podcast listener survey. Please let us know how we could improve the podcasts for you, and your specialty - https://linktr.ee/BMJsurvey</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9x4x1l/stream_1154598709-bmjgroup-talk-evidence-bones-nutrition-pain-relief-and-overdiagnosis.mp3" length="44282774" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this month’s Talk evidence, we’re going back to our roots and avoiding covid - so sit back and listen to Helen Macdonald and Joe Ross discuss a new nutrition study to prevent fractures in older adults by eating dairy, and a meta-analysis which helps you choose pain relief medications for management of osteoarthritis.

We’ll hear from Steven Woloshin about the virtual Overdiagnosis conference, and why he’s so excited about a new category in the National Library of Medicine.

Finally, we have a study on urinary retention and risk of cancer that has been over 25 years in the making.


Reading list;

Effect of dietary sources of calcium and protein on hip fractures and falls in older adults in residential care
https://www.bmj.com/content/375/bmj.n2364

Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis
https://www.bmj.com/content/375/bmj.n2321

To access the webinars Steven was talking about.
https://www.preventingoverdiagnosis.net/

Acute urinary retention and risk of cancer
https://www.bmj.com/content/375/bmj.n2305

Podcast listener survey. Please let us know how we could improve the podcasts for you, and your specialty - https://linktr.ee/BMJsurvey]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2768</itunes:duration>
                                    </item>
    <item>
        <title>Introducing Doctor Informed</title>
        <itunes:title>Introducing Doctor Informed</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/introducing-doctor-informed/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/introducing-doctor-informed/#comments</comments>        <pubDate>Sun, 24 Oct 2021 18:15:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/introducting-doctor-informed</guid>
                                    <description><![CDATA[Doctor Informed is a new podcast for hospital doctors, from The BMJ - created in collaboration with THIS Institute, and sponsored by Medical Protection.

Medical expertise is fundamental to the practice of medicine. But other skills and knowledge are important too. Doctor Informed gives the inside story on the evidence about giving the best care and having positive relationships with patients and colleagues.

In this trailer, meet two of the hosts of Doctor Informed - Clara Munro, a surgical trainee in the North East Deanery, and Jenni Burt, senior social scientist at THIS Institute.

<p>www.bmj.com/podcasts/doctorinformed</p>
]]></description>
                                                            <content:encoded><![CDATA[Doctor Informed is a new podcast for hospital doctors, from The BMJ - created in collaboration with THIS Institute, and sponsored by Medical Protection.

Medical expertise is fundamental to the practice of medicine. But other skills and knowledge are important too. Doctor Informed gives the inside story on the evidence about giving the best care and having positive relationships with patients and colleagues.

In this trailer, meet two of the hosts of Doctor Informed - Clara Munro, a surgical trainee in the North East Deanery, and Jenni Burt, senior social scientist at THIS Institute.

<p>www.bmj.com/podcasts/doctorinformed</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dbudey/stream_1147237867-bmjgroup-introducting-doctor-informed.mp3" length="13621288" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Doctor Informed is a new podcast for hospital doctors, from The BMJ - created in collaboration with THIS Institute, and sponsored by Medical Protection.

Medical expertise is fundamental to the practice of medicine. But other skills and knowledge are important too. Doctor Informed gives the inside story on the evidence about giving the best care and having positive relationships with patients and colleagues.

In this trailer, meet two of the hosts of Doctor Informed - Clara Munro, a surgical trainee in the North East Deanery, and Jenni Burt, senior social scientist at THIS Institute.

www.bmj.com/podcasts/doctorinformed]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>851</itunes:duration>
                                    </item>
    <item>
        <title>Wellbeing - QI approach to improving your wellbeing</title>
        <itunes:title>Wellbeing - QI approach to improving your wellbeing</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/wellbeing-qi-approach-to-improving-your-wellbeing/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/wellbeing-qi-approach-to-improving-your-wellbeing/#comments</comments>        <pubDate>Sun, 24 Oct 2021 17:36:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/wellbeing-qi-approach-to-improving-your-wellbeing</guid>
                                    <description><![CDATA[It's easy to decide to do something like exercise, or a hobby to improve your wellbeing, but actually following through and make that a regular part of your week can be much harder.

In this podcast, Pedro Delgado, vice president of the Institute for Healthcare Improvement, joins Abi and Cat to explain how he turned some of the QI methodology he's been taught over the years on himself, and improved his wellbeing during the pandemic.

<p>www.bmj.com/wellbeing</p>
]]></description>
                                                            <content:encoded><![CDATA[It's easy to decide to do something like exercise, or a hobby to improve your wellbeing, but actually following through and make that a regular part of your week can be much harder.

In this podcast, Pedro Delgado, vice president of the Institute for Healthcare Improvement, joins Abi and Cat to explain how he turned some of the QI methodology he's been taught over the years on himself, and improved his wellbeing during the pandemic.

<p>www.bmj.com/wellbeing</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/r7ow3l/stream_1147218223-bmjgroup-wellbeing-qi-approach-to-improving-your-wellbeing.mp3" length="41212864" type="audio/mpeg"/>
        <itunes:summary><![CDATA[It's easy to decide to do something like exercise, or a hobby to improve your wellbeing, but actually following through and make that a regular part of your week can be much harder.

In this podcast, Pedro Delgado, vice president of the Institute for Healthcare Improvement, joins Abi and Cat to explain how he turned some of the QI methodology he's been taught over the years on himself, and improved his wellbeing during the pandemic.

www.bmj.com/wellbeing]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2576</itunes:duration>
                                    </item>
    <item>
        <title>Covid in south Asia - India and Nepal</title>
        <itunes:title>Covid in south Asia - India and Nepal</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/covid-in-south-asia-india-and-nepal/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/covid-in-south-asia-india-and-nepal/#comments</comments>        <pubDate>Sun, 17 Oct 2021 09:43:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/covid-in-south-asia-india-and-nepal</guid>
                                    <description><![CDATA[In this podcast series, Kamran Abbasi, executive editor of The BMJ will convene experts from South Asia to discuss how the pandemic has affected the region, how measures like lock-down and vaccination have been handled, and the impact of the pandemic on the social determinants of health.

In this first podcast, we're focussing on India and Nepal, and are joined by;

Srinath Reddy, president of the Public Health Foundation of India. 

Biraj Swain, who works in global development in Asia and East Africa, is a senior media critic

and Buddha Basnyat, director of the Oxford University Clinical Research Unit in Nepal. 

For more covid coverage

<p>www.bmj.com/coronavirus</p>
]]></description>
                                                            <content:encoded><![CDATA[In this podcast series, Kamran Abbasi, executive editor of The BMJ will convene experts from South Asia to discuss how the pandemic has affected the region, how measures like lock-down and vaccination have been handled, and the impact of the pandemic on the social determinants of health.

In this first podcast, we're focussing on India and Nepal, and are joined by;

Srinath Reddy, president of the Public Health Foundation of India. 

Biraj Swain, who works in global development in Asia and East Africa, is a senior media critic

and Buddha Basnyat, director of the Oxford University Clinical Research Unit in Nepal. 

For more covid coverage

<p>www.bmj.com/coronavirus</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/df094t/stream_1143220138-bmjgroup-covid-in-south-asia-india-and-nepal.mp3" length="77229903" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast series, Kamran Abbasi, executive editor of The BMJ will convene experts from South Asia to discuss how the pandemic has affected the region, how measures like lock-down and vaccination have been handled, and the impact of the pandemic on the social determinants of health.

In this first podcast, we're focussing on India and Nepal, and are joined by;

Srinath Reddy, president of the Public Health Foundation of India. 

Biraj Swain, who works in global development in Asia and East Africa, is a senior media critic

and Buddha Basnyat, director of the Oxford University Clinical Research Unit in Nepal. 

For more covid coverage

www.bmj.com/coronavirus]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3217</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence - testing for respiratory tract infections, cannabis for pain, &amp; covid outcomes</title>
        <itunes:title>Talk Evidence - testing for respiratory tract infections, cannabis for pain, &amp; covid outcomes</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-testing-for-respiratory-tract-infections-cannabis-for-pain-covid-outcomes/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-testing-for-respiratory-tract-infections-cannabis-for-pain-covid-outcomes/#comments</comments>        <pubDate>Wed, 29 Sep 2021 17:50:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-testing-for-respiratory-tract-infections-cannabis-for-pain-and-covid-outcomes</guid>
                                    <description><![CDATA[This week our regular panelists, Helen Macdonald and Joe Ross, are joined by Juan Franco, editor in chief of BMJ Evidence Based Medicine - to take a primary care focussed look at what's been happening in the world of evidence.

On this week’s episode. 
As kids go back to school, winter bugs surge and pressure mounts on health services we look at two trials which aimed to use reduce antibiotic prescribing for respiratory tract infections in nursing homes and primary care

Juan brings us an update on prescribing medicinal cannabis for pain, based on a recent BMJ rapid recommendation article and linked systematic review and meta-analysis

And finally, in covid news, how likely are you to be admitted or die from covid after one or two SARS-CoV 2 vaccinations?

Reading list
Effect of C reactive protein point-of-care testing on antibiotic prescribing for lower respiratory tract infections in nursing home residents - https://www.bmj.com/content/374/bmj.n2198

Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care - https://www.bmj.com/content/374/bmj.n2132

Medical cannabis or cannabinoids for chronic pain - https://www.bmj.com/content/374/bmj.n2040

<p>Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination - https://www.bmj.com/content/374/bmj.n2244</p>
]]></description>
                                                            <content:encoded><![CDATA[This week our regular panelists, Helen Macdonald and Joe Ross, are joined by Juan Franco, editor in chief of BMJ Evidence Based Medicine - to take a primary care focussed look at what's been happening in the world of evidence.

On this week’s episode. 
As kids go back to school, winter bugs surge and pressure mounts on health services we look at two trials which aimed to use reduce antibiotic prescribing for respiratory tract infections in nursing homes and primary care

Juan brings us an update on prescribing medicinal cannabis for pain, based on a recent BMJ rapid recommendation article and linked systematic review and meta-analysis

And finally, in covid news, how likely are you to be admitted or die from covid after one or two SARS-CoV 2 vaccinations?

Reading list
Effect of C reactive protein point-of-care testing on antibiotic prescribing for lower respiratory tract infections in nursing home residents - https://www.bmj.com/content/374/bmj.n2198

Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care - https://www.bmj.com/content/374/bmj.n2132

Medical cannabis or cannabinoids for chronic pain - https://www.bmj.com/content/374/bmj.n2040

<p>Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination - https://www.bmj.com/content/374/bmj.n2244</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/auukty/stream_1133179222-bmjgroup-talk-evidence-testing-for-respiratory-tract-infections-cannabis-for-pain-and-covid-outcomes.mp3" length="28048821" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week our regular panelists, Helen Macdonald and Joe Ross, are joined by Juan Franco, editor in chief of BMJ Evidence Based Medicine - to take a primary care focussed look at what's been happening in the world of evidence.

On this week’s episode. 
As kids go back to school, winter bugs surge and pressure mounts on health services we look at two trials which aimed to use reduce antibiotic prescribing for respiratory tract infections in nursing homes and primary care

Juan brings us an update on prescribing medicinal cannabis for pain, based on a recent BMJ rapid recommendation article and linked systematic review and meta-analysis

And finally, in covid news, how likely are you to be admitted or die from covid after one or two SARS-CoV 2 vaccinations?

Reading list
Effect of C reactive protein point-of-care testing on antibiotic prescribing for lower respiratory tract infections in nursing home residents - https://www.bmj.com/content/374/bmj.n2198

Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care - https://www.bmj.com/content/374/bmj.n2132

Medical cannabis or cannabinoids for chronic pain - https://www.bmj.com/content/374/bmj.n2040

Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination - https://www.bmj.com/content/374/bmj.n2244]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1753</itunes:duration>
                                    </item>
    <item>
        <title>Wellbeing - tired or fatigued, and why the difference might matter</title>
        <itunes:title>Wellbeing - tired or fatigued, and why the difference might matter</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/wellbeing-tired-or-fatigued-and-why-the-difference-might-matter/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/wellbeing-tired-or-fatigued-and-why-the-difference-might-matter/#comments</comments>        <pubDate>Fri, 24 Sep 2021 09:41:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/wellbeing-are-you-tired-or-fatigued</guid>
                                    <description><![CDATA[There has been a lot of work on the way in which surgeon's are affected by tiredness - and the whole medical workforce can probably relate to their experience.

But there's a difference between tiredness and fatigue, and that difference might be important in understanding what's happening in your own life.

<p>Dale Whelehan is a physiotherapist, and PhD candidate at Trinity college Dublin, where he is investigating behavioural psychology and the effect of tiredness and fatigue on surgeons - in this podcast he describes how he thinks about those two things, what we know about the effect on wellbeing, and some strategies which might help manage them.</p>
]]></description>
                                                            <content:encoded><![CDATA[There has been a lot of work on the way in which surgeon's are affected by tiredness - and the whole medical workforce can probably relate to their experience.

But there's a difference between tiredness and fatigue, and that difference might be important in understanding what's happening in your own life.

<p>Dale Whelehan is a physiotherapist, and PhD candidate at Trinity college Dublin, where he is investigating behavioural psychology and the effect of tiredness and fatigue on surgeons - in this podcast he describes how he thinks about those two things, what we know about the effect on wellbeing, and some strategies which might help manage them.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/tlzou0/stream_1130288380-bmjgroup-wellbeing-are-you-tired-or-fatigued.mp3" length="39944776" type="audio/mpeg"/>
        <itunes:summary><![CDATA[There has been a lot of work on the way in which surgeon's are affected by tiredness - and the whole medical workforce can probably relate to their experience.

But there's a difference between tiredness and fatigue, and that difference might be important in understanding what's happening in your own life.

Dale Whelehan is a physiotherapist, and PhD candidate at Trinity college Dublin, where he is investigating behavioural psychology and the effect of tiredness and fatigue on surgeons - in this podcast he describes how he thinks about those two things, what we know about the effect on wellbeing, and some strategies which might help manage them.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2497</itunes:duration>
                                    </item>
    <item>
        <title>The future of Afghan healthcare</title>
        <itunes:title>The future of Afghan healthcare</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-future-of-afghan-healthcare/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-future-of-afghan-healthcare/#comments</comments>        <pubDate>Sat, 18 Sep 2021 11:22:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-future-of-afghan-healthcare</guid>
                                    <description><![CDATA[The infrastructure of Afghanistan healthcare is under threat, as international agencies who run clinics withdraw from the country. At the same time, some of the healthcare workforce are leaving the country, while those who remain face the prospect of their wages drying up as the economy of the country collapses.

<p>But there remain people dedicated to providing healthcare, and in this podcast we hear from, Wais Mohammad Qarani,  president of the Afghanistan Midwifery and Nurses Council, about what changes might be seen under the new regime, and what needs to be done to support care in the country.</p>
]]></description>
                                                            <content:encoded><![CDATA[The infrastructure of Afghanistan healthcare is under threat, as international agencies who run clinics withdraw from the country. At the same time, some of the healthcare workforce are leaving the country, while those who remain face the prospect of their wages drying up as the economy of the country collapses.

<p>But there remain people dedicated to providing healthcare, and in this podcast we hear from, Wais Mohammad Qarani,  president of the Afghanistan Midwifery and Nurses Council, about what changes might be seen under the new regime, and what needs to be done to support care in the country.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/x69zog/stream_1126871854-bmjgroup-the-future-of-afghan-healthcare.mp3" length="18721226" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The infrastructure of Afghanistan healthcare is under threat, as international agencies who run clinics withdraw from the country. At the same time, some of the healthcare workforce are leaving the country, while those who remain face the prospect of their wages drying up as the economy of the country collapses.

But there remain people dedicated to providing healthcare, and in this podcast we hear from, Wais Mohammad Qarani,  president of the Afghanistan Midwifery and Nurses Council, about what changes might be seen under the new regime, and what needs to be done to support care in the country.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1170</itunes:duration>
                                    </item>
    <item>
        <title>Healthcare In Afghanistan Now</title>
        <itunes:title>Healthcare In Afghanistan Now</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/healthcare-in-afghanistan-now/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/healthcare-in-afghanistan-now/#comments</comments>        <pubDate>Thu, 09 Sep 2021 13:34:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/healthcare-in-afghanistan-now</guid>
                                    <description><![CDATA[The final evacuation planes have left Kabul airport, and Afghanistan’s government have ceded power to the Taliban. 

Amongst the international community, worries about what that transition of power means for the people of Afghanistan have centred around the rights of women, access to education for the whole population, and the continuing prosperity of the country… However what this means for health is still uncertain.

Nadia Akseer is an Afghan scientist and epidemiologist, now working at John's Hopkins Bloomberg School of Public Health and who has published extensively the health of her home country 

Reading list;
Achieving maternal and child health gains in Afghanistan
https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(16)30002-X/fulltext

Association of Exposure to Civil Conflict With Maternal Resilience and Maternal and Child Health and Health System Performance in Afghanistan
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2754253

Coverage and inequalities in maternal and child health interventions in Afghanistan
https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-016-3406-1

Geospatial inequalities and determinants of nutritional status among women and children in Afghanistan
<p>https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(18)30025-1/fulltext</p>
]]></description>
                                                            <content:encoded><![CDATA[The final evacuation planes have left Kabul airport, and Afghanistan’s government have ceded power to the Taliban. 

Amongst the international community, worries about what that transition of power means for the people of Afghanistan have centred around the rights of women, access to education for the whole population, and the continuing prosperity of the country… However what this means for health is still uncertain.

Nadia Akseer is an Afghan scientist and epidemiologist, now working at John's Hopkins Bloomberg School of Public Health and who has published extensively the health of her home country 

Reading list;
Achieving maternal and child health gains in Afghanistan
https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(16)30002-X/fulltext

Association of Exposure to Civil Conflict With Maternal Resilience and Maternal and Child Health and Health System Performance in Afghanistan
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2754253

Coverage and inequalities in maternal and child health interventions in Afghanistan
https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-016-3406-1

Geospatial inequalities and determinants of nutritional status among women and children in Afghanistan
<p>https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(18)30025-1/fulltext</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/09za27/stream_1121657212-bmjgroup-healthcare-in-afghanistan-now.mp3" length="25839071" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The final evacuation planes have left Kabul airport, and Afghanistan’s government have ceded power to the Taliban. 

Amongst the international community, worries about what that transition of power means for the people of Afghanistan have centred around the rights of women, access to education for the whole population, and the continuing prosperity of the country… However what this means for health is still uncertain.

Nadia Akseer is an Afghan scientist and epidemiologist, now working at John's Hopkins Bloomberg School of Public Health and who has published extensively the health of her home country 

Reading list;
Achieving maternal and child health gains in Afghanistan
https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(16)30002-X/fulltext

Association of Exposure to Civil Conflict With Maternal Resilience and Maternal and Child Health and Health System Performance in Afghanistan
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2754253

Coverage and inequalities in maternal and child health interventions in Afghanistan
https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-016-3406-1

Geospatial inequalities and determinants of nutritional status among women and children in Afghanistan
https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(18)30025-1/fulltext]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1615</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence - real world vaccine data, GP records and CVD</title>
        <itunes:title>Talk Evidence - real world vaccine data, GP records and CVD</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-real-world-vaccine-data-gp-records-and-cvd/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-real-world-vaccine-data-gp-records-and-cvd/#comments</comments>        <pubDate>Fri, 03 Sep 2021 16:31:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-real-world-vaccine-data-gp-records-and-cvd</guid>
                                    <description><![CDATA[In this month's Talk Evidence, Helen Macdonald and Joe Ross are back with a wry look at the world of Evidence Based Medicine.

They give us a round up of real world data emerging to address various uncertainties about vaccinations against covid

Helen has an update on NHS Digital’s project to extract GP coding for planning of healthcare and research, and talks to Natalie Banner from Understanding Patient Data, to find out what the public really cares about.

Finally, as routine care must go on a clinical review on cardiovascular disease in older adults introduces us to geroscience.


Reading list

Vaccines;
Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study - https://doi.org/10.1136/bmj.n1943 

Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study -  https://doi.org/10.1136/bmj.n2015

Associations of BNT162b2 vaccination with SARS-CoV-2 infection and hospital admission and death with covid-19 in nursing homes and healthcare workers in Catalonia: prospective cohort study
https://doi.org/10.1136/bmj.n1868

Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study - https://doi.org/10.1136/bmj.n1931 

CVD
<p>Cardiovascular care of older adults - https://doi.org/10.1136/bmj.n1593</p>
]]></description>
                                                            <content:encoded><![CDATA[In this month's Talk Evidence, Helen Macdonald and Joe Ross are back with a wry look at the world of Evidence Based Medicine.

They give us a round up of real world data emerging to address various uncertainties about vaccinations against covid

Helen has an update on NHS Digital’s project to extract GP coding for planning of healthcare and research, and talks to Natalie Banner from Understanding Patient Data, to find out what the public really cares about.

Finally, as routine care must go on a clinical review on cardiovascular disease in older adults introduces us to geroscience.


Reading list

Vaccines;
Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study - https://doi.org/10.1136/bmj.n1943 

Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study -  https://doi.org/10.1136/bmj.n2015

Associations of BNT162b2 vaccination with SARS-CoV-2 infection and hospital admission and death with covid-19 in nursing homes and healthcare workers in Catalonia: prospective cohort study
https://doi.org/10.1136/bmj.n1868

Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study - https://doi.org/10.1136/bmj.n1931 

CVD
<p>Cardiovascular care of older adults - https://doi.org/10.1136/bmj.n1593</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/yk7qmd/stream_1118261149-bmjgroup-talk-evidence-real-world-vaccine-data-gp-records-and-cvd.mp3" length="42125269" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this month's Talk Evidence, Helen Macdonald and Joe Ross are back with a wry look at the world of Evidence Based Medicine.

They give us a round up of real world data emerging to address various uncertainties about vaccinations against covid

Helen has an update on NHS Digital’s project to extract GP coding for planning of healthcare and research, and talks to Natalie Banner from Understanding Patient Data, to find out what the public really cares about.

Finally, as routine care must go on a clinical review on cardiovascular disease in older adults introduces us to geroscience.


Reading list

Vaccines;
Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study - https://doi.org/10.1136/bmj.n1943 

Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study -  https://doi.org/10.1136/bmj.n2015

Associations of BNT162b2 vaccination with SARS-CoV-2 infection and hospital admission and death with covid-19 in nursing homes and healthcare workers in Catalonia: prospective cohort study
https://doi.org/10.1136/bmj.n1868

Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study - https://doi.org/10.1136/bmj.n1931 

CVD
Cardiovascular care of older adults - https://doi.org/10.1136/bmj.n1593]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2633</itunes:duration>
                                    </item>
    <item>
        <title>Junior doctors improving hospital wellbeing</title>
        <itunes:title>Junior doctors improving hospital wellbeing</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/junior-doctors-improving-hospital-wellbeing/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/junior-doctors-improving-hospital-wellbeing/#comments</comments>        <pubDate>Fri, 27 Aug 2021 14:14:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/junior-doctors-improving-hospital-wellbeing</guid>
                                    <description><![CDATA[The Midlands Charter, is a set of principles that hospitals in the midlands region of England have signed up to, to improve the health and wellbeing of trainees working in the area. It was created in a huge collaboration of  trainees, NHS England, Health Education England and the GMC. 

Dan Smith is a junior doctor at Nottingham University Hospitals NHS Trust, and one of the authors of that charter. He joins us to explain how they're QI thinking to improve doctors wellbeing, and how other areas can follow their lead.

Read the full charter:
https://www.england.nhs.uk/midlands/information-for-professionals/nhs-midlands-charter/

To join the collaborative
<p>https://future.nhs.uk/MidlandsCharter/grouphome</p>
]]></description>
                                                            <content:encoded><![CDATA[The Midlands Charter, is a set of principles that hospitals in the midlands region of England have signed up to, to improve the health and wellbeing of trainees working in the area. It was created in a huge collaboration of  trainees, NHS England, Health Education England and the GMC. 

Dan Smith is a junior doctor at Nottingham University Hospitals NHS Trust, and one of the authors of that charter. He joins us to explain how they're QI thinking to improve doctors wellbeing, and how other areas can follow their lead.

Read the full charter:
https://www.england.nhs.uk/midlands/information-for-professionals/nhs-midlands-charter/

To join the collaborative
<p>https://future.nhs.uk/MidlandsCharter/grouphome</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mgadeq/stream_1114031449-bmjgroup-junior-doctors-improving-hospital-wellbeing.mp3" length="37600861" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The Midlands Charter, is a set of principles that hospitals in the midlands region of England have signed up to, to improve the health and wellbeing of trainees working in the area. It was created in a huge collaboration of  trainees, NHS England, Health Education England and the GMC. 

Dan Smith is a junior doctor at Nottingham University Hospitals NHS Trust, and one of the authors of that charter. He joins us to explain how they're QI thinking to improve doctors wellbeing, and how other areas can follow their lead.

Read the full charter:
https://www.england.nhs.uk/midlands/information-for-professionals/nhs-midlands-charter/

To join the collaborative
https://future.nhs.uk/MidlandsCharter/grouphome]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2350</itunes:duration>
                                    </item>
    <item>
        <title>Wellbeing - scheduling and burnout</title>
        <itunes:title>Wellbeing - scheduling and burnout</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/wellbeing-scheduling-and-burnout/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/wellbeing-scheduling-and-burnout/#comments</comments>        <pubDate>Fri, 13 Aug 2021 15:24:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/wellbeing-rota-ing-and-burnout</guid>
                                    <description><![CDATA[Rota gaps are a big problem when it comes to loading stress on the medical workforce, and there is big pressure to spread the workforce as evenly as possible across wards and shifts.

However the tyranny of the rota - especially when changing rotations or working across multiple sites, means that often doctors personal wishes, or big life events are not taken into account.

The dehumanising status of becoming just a number in the system is not helping people have the kind of fulfilling careers that encourages people to stay within the workforce, and helps guard them from burnout.

So how do we square that circle? Anas Nader, CEO of Patchwork Health, joins us to talk about why his own burnout lead him to try and fix the rota problem - and where he has got to now.

Findout more at: https://www.patchwork.health/

<p>Note - BMJ company has invested in patchwork health</p>
]]></description>
                                                            <content:encoded><![CDATA[Rota gaps are a big problem when it comes to loading stress on the medical workforce, and there is big pressure to spread the workforce as evenly as possible across wards and shifts.

However the tyranny of the rota - especially when changing rotations or working across multiple sites, means that often doctors personal wishes, or big life events are not taken into account.

The dehumanising status of becoming just a number in the system is not helping people have the kind of fulfilling careers that encourages people to stay within the workforce, and helps guard them from burnout.

So how do we square that circle? Anas Nader, CEO of Patchwork Health, joins us to talk about why his own burnout lead him to try and fix the rota problem - and where he has got to now.

Findout more at: https://www.patchwork.health/

<p>Note - BMJ company has invested in patchwork health</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mbcixn/stream_1105405432-bmjgroup-wellbeing-rota-ing-and-burnout.mp3" length="31301798" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Rota gaps are a big problem when it comes to loading stress on the medical workforce, and there is big pressure to spread the workforce as evenly as possible across wards and shifts.

However the tyranny of the rota - especially when changing rotations or working across multiple sites, means that often doctors personal wishes, or big life events are not taken into account.

The dehumanising status of becoming just a number in the system is not helping people have the kind of fulfilling careers that encourages people to stay within the workforce, and helps guard them from burnout.

So how do we square that circle? Anas Nader, CEO of Patchwork Health, joins us to talk about why his own burnout lead him to try and fix the rota problem - and where he has got to now.

Findout more at: https://www.patchwork.health/

Note - BMJ company has invested in patchwork health]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1956</itunes:duration>
                                    </item>
    <item>
        <title>Women’s health and gender inequalities - Legislating for change</title>
        <itunes:title>Women’s health and gender inequalities - Legislating for change</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/women-s-health-and-gender-inequalities-legislating-for-change/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/women-s-health-and-gender-inequalities-legislating-for-change/#comments</comments>        <pubDate>Thu, 05 Aug 2021 19:50:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/womens-health-and-gender-inequalities-legislating-for-change</guid>
                                    <description><![CDATA[It's been 25 years since the declaration on the rights of women, was signed in Beijing - and in that time the landscape of health car inequity has changed. To celebrate we created 3 podcasts, in collaboration with The WHO and UN University, as part of the collection on Women’s Health and Gender Inequalities

www.bmj.com/gender

In these podcasts we'll be hosting conversations between women early in, and some who are more advanced in, their careers - doctors, researchers, legislators and campaigners, all working towards building a future in which women can thrive.

As well as these in depth discussions, you will hear some shorter interviews from experts who have written for the collection. These give you a flavour of the bigger discussions going on in global health when it comes to gender equity - so keep an ear out for those during the discussions.

In this podcast, we're joined by lawyer and activist Hina Jilani, who has been campaigning for women's rights in her native Pakistan for her whole life. 

She and her sister set up the first female law firm in the country, she established a refuge for women who were fleeing violence and abuse, she was one of the founders of the Human Rights Commission of Pakistan, and is now an advocate on the country's Supreme Court. She is also one of The Elders.

Hina talks about her career, how she has pulled the various levers of change - lobbying for legislation, legal challenge, and protest - to improve the lives of women in Pakistan.

<p>The additional interviews are from; Lia Quatrapella, Asha George, and Veloshnee Govender</p>
]]></description>
                                                            <content:encoded><![CDATA[It's been 25 years since the declaration on the rights of women, was signed in Beijing - and in that time the landscape of health car inequity has changed. To celebrate we created 3 podcasts, in collaboration with The WHO and UN University, as part of the collection on Women’s Health and Gender Inequalities

www.bmj.com/gender

In these podcasts we'll be hosting conversations between women early in, and some who are more advanced in, their careers - doctors, researchers, legislators and campaigners, all working towards building a future in which women can thrive.

As well as these in depth discussions, you will hear some shorter interviews from experts who have written for the collection. These give you a flavour of the bigger discussions going on in global health when it comes to gender equity - so keep an ear out for those during the discussions.

In this podcast, we're joined by lawyer and activist Hina Jilani, who has been campaigning for women's rights in her native Pakistan for her whole life. 

She and her sister set up the first female law firm in the country, she established a refuge for women who were fleeing violence and abuse, she was one of the founders of the Human Rights Commission of Pakistan, and is now an advocate on the country's Supreme Court. She is also one of The Elders.

Hina talks about her career, how she has pulled the various levers of change - lobbying for legislation, legal challenge, and protest - to improve the lives of women in Pakistan.

<p>The additional interviews are from; Lia Quatrapella, Asha George, and Veloshnee Govender</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/tfmiuj/stream_1100842966-bmjgroup-womens-health-and-gender-inequalities-legislating-for-change.mp3" length="43807972" type="audio/mpeg"/>
        <itunes:summary><![CDATA[It's been 25 years since the declaration on the rights of women, was signed in Beijing - and in that time the landscape of health car inequity has changed. To celebrate we created 3 podcasts, in collaboration with The WHO and UN University, as part of the collection on Women’s Health and Gender Inequalities

www.bmj.com/gender

In these podcasts we'll be hosting conversations between women early in, and some who are more advanced in, their careers - doctors, researchers, legislators and campaigners, all working towards building a future in which women can thrive.

As well as these in depth discussions, you will hear some shorter interviews from experts who have written for the collection. These give you a flavour of the bigger discussions going on in global health when it comes to gender equity - so keep an ear out for those during the discussions.

In this podcast, we're joined by lawyer and activist Hina Jilani, who has been campaigning for women's rights in her native Pakistan for her whole life. 

She and her sister set up the first female law firm in the country, she established a refuge for women who were fleeing violence and abuse, she was one of the founders of the Human Rights Commission of Pakistan, and is now an advocate on the country's Supreme Court. She is also one of The Elders.

Hina talks about her career, how she has pulled the various levers of change - lobbying for legislation, legal challenge, and protest - to improve the lives of women in Pakistan.

The additional interviews are from; Lia Quatrapella, Asha George, and Veloshnee Govender]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2738</itunes:duration>
                                    </item>
    <item>
        <title>Wellbeing - surveying the mental health of NHS staff</title>
        <itunes:title>Wellbeing - surveying the mental health of NHS staff</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/wellbeing-surveying-the-mental-health-of-nhs-staff/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/wellbeing-surveying-the-mental-health-of-nhs-staff/#comments</comments>        <pubDate>Fri, 30 Jul 2021 14:26:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/wellbeing-an-nhs-wellbeing-survey</guid>
                                    <description><![CDATA[In the wellbeing podcast, we have had a lot of personal experience of the pandemic, and schemes to support staff - but always we've wanted to know if there's research which can tell us how universal those experiences have been.

In this podcast, Abi and Cat are joined by Danielle Lamb, senior research fellow at University College London, and Sam Gnanapragasam, clinical fellow in psychiatry at South London and the Maudsley NHS Trust. Danielle and Sam are both investigators on NHS Check - a representative survey of NHS staff about their mental wellbeing during covid-19.

<p>https://nhscheck.org/</p>
]]></description>
                                                            <content:encoded><![CDATA[In the wellbeing podcast, we have had a lot of personal experience of the pandemic, and schemes to support staff - but always we've wanted to know if there's research which can tell us how universal those experiences have been.

In this podcast, Abi and Cat are joined by Danielle Lamb, senior research fellow at University College London, and Sam Gnanapragasam, clinical fellow in psychiatry at South London and the Maudsley NHS Trust. Danielle and Sam are both investigators on NHS Check - a representative survey of NHS staff about their mental wellbeing during covid-19.

<p>https://nhscheck.org/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ir3yg0/stream_1097070757-bmjgroup-wellbeing-an-nhs-wellbeing-survey.mp3" length="31399600" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In the wellbeing podcast, we have had a lot of personal experience of the pandemic, and schemes to support staff - but always we've wanted to know if there's research which can tell us how universal those experiences have been.

In this podcast, Abi and Cat are joined by Danielle Lamb, senior research fellow at University College London, and Sam Gnanapragasam, clinical fellow in psychiatry at South London and the Maudsley NHS Trust. Danielle and Sam are both investigators on NHS Check - a representative survey of NHS staff about their mental wellbeing during covid-19.

https://nhscheck.org/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1962</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence - Freedom Day</title>
        <itunes:title>Talk Evidence - Freedom Day</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-freedom-day/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-freedom-day/#comments</comments>        <pubDate>Wed, 21 Jul 2021 15:53:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-freedom-day</guid>
                                    <description><![CDATA[The 19th of July in the UK saw the relaxation of covid rules that have been in place for 18 months - social distancing requirements in venues, mask wearing in public will no longer be legally mandated.

There are a lot of questions about what this will mean for the pandemic, and in this episode of Talk Evidence Helen MacDonald, Joe Ross and Duncan Jarvies are joined by Iain Buchan, professor of public health in Liverpool, who has been involved in 2 key studies on covid transmission. 

Firstly, lateral flow tests - the big questions has been how well do they work in the wild - and how well do they have to work, to be useful in test trace and isolate? Iain tells us about new research into the innova test.

Secondly, events - the football has shown that events can still be a big source of transmission, and the UK government put in place a number of trial events, all carefully monitored by public health researchers - Iain tells us about one nightclub test in Liverpool, and what we can glean from it.

Reading list;

Performance of the Innova SARS-CoV-2 antigen rapid lateral flow test in the Liverpool asymptomatic testing pilot: population based cohort study
https://www.bmj.com/content/374/bmj.n1637

The UK government's events programme
https://www.gov.uk/government/publications/events-research-programme-phase-i-findings/events-research-programme-phase-i-findings#findings
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/979461/S1195_Science_framework_for_opening_up_group_events.pdf

Effect of the covid-19 pandemic in 2020 on life expectancy across populations in the USA and other high income countries: simulations of provisional mortality data
https://www.bmj.com/content/373/bmj.n1343

Optimizing Therapy to Prevent Avoidable Hospital Admissions in Multimorbid Older Adults (OPERAM): cluster randomised controlled trial
https://www.bmj.com/content/374/bmj.n1585

Efficacy, acceptability, and safety of muscle relaxants for adults with non-specific low back pain: systematic review and meta-analysis
<p>https://www.bmj.com/content/374/bmj.n1446</p>
]]></description>
                                                            <content:encoded><![CDATA[The 19th of July in the UK saw the relaxation of covid rules that have been in place for 18 months - social distancing requirements in venues, mask wearing in public will no longer be legally mandated.

There are a lot of questions about what this will mean for the pandemic, and in this episode of Talk Evidence Helen MacDonald, Joe Ross and Duncan Jarvies are joined by Iain Buchan, professor of public health in Liverpool, who has been involved in 2 key studies on covid transmission. 

Firstly, lateral flow tests - the big questions has been how well do they work in the wild - and how well do they have to work, to be useful in test trace and isolate? Iain tells us about new research into the innova test.

Secondly, events - the football has shown that events can still be a big source of transmission, and the UK government put in place a number of trial events, all carefully monitored by public health researchers - Iain tells us about one nightclub test in Liverpool, and what we can glean from it.

Reading list;

Performance of the Innova SARS-CoV-2 antigen rapid lateral flow test in the Liverpool asymptomatic testing pilot: population based cohort study
https://www.bmj.com/content/374/bmj.n1637

The UK government's events programme
https://www.gov.uk/government/publications/events-research-programme-phase-i-findings/events-research-programme-phase-i-findings#findings
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/979461/S1195_Science_framework_for_opening_up_group_events.pdf

Effect of the covid-19 pandemic in 2020 on life expectancy across populations in the USA and other high income countries: simulations of provisional mortality data
https://www.bmj.com/content/373/bmj.n1343

Optimizing Therapy to Prevent Avoidable Hospital Admissions in Multimorbid Older Adults (OPERAM): cluster randomised controlled trial
https://www.bmj.com/content/374/bmj.n1585

Efficacy, acceptability, and safety of muscle relaxants for adults with non-specific low back pain: systematic review and meta-analysis
<p>https://www.bmj.com/content/374/bmj.n1446</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/e8cfuy/stream_1091559850-bmjgroup-talk-evidence-freedom-day.mp3" length="45831731" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The 19th of July in the UK saw the relaxation of covid rules that have been in place for 18 months - social distancing requirements in venues, mask wearing in public will no longer be legally mandated.

There are a lot of questions about what this will mean for the pandemic, and in this episode of Talk Evidence Helen MacDonald, Joe Ross and Duncan Jarvies are joined by Iain Buchan, professor of public health in Liverpool, who has been involved in 2 key studies on covid transmission. 

Firstly, lateral flow tests - the big questions has been how well do they work in the wild - and how well do they have to work, to be useful in test trace and isolate? Iain tells us about new research into the innova test.

Secondly, events - the football has shown that events can still be a big source of transmission, and the UK government put in place a number of trial events, all carefully monitored by public health researchers - Iain tells us about one nightclub test in Liverpool, and what we can glean from it.

Reading list;

Performance of the Innova SARS-CoV-2 antigen rapid lateral flow test in the Liverpool asymptomatic testing pilot: population based cohort study
https://www.bmj.com/content/374/bmj.n1637

The UK government's events programme
https://www.gov.uk/government/publications/events-research-programme-phase-i-findings/events-research-programme-phase-i-findings#findings
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/979461/S1195_Science_framework_for_opening_up_group_events.pdf

Effect of the covid-19 pandemic in 2020 on life expectancy across populations in the USA and other high income countries: simulations of provisional mortality data
https://www.bmj.com/content/373/bmj.n1343

Optimizing Therapy to Prevent Avoidable Hospital Admissions in Multimorbid Older Adults (OPERAM): cluster randomised controlled trial
https://www.bmj.com/content/374/bmj.n1585

Efficacy, acceptability, and safety of muscle relaxants for adults with non-specific low back pain: systematic review and meta-analysis
https://www.bmj.com/content/374/bmj.n1446]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2864</itunes:duration>
                                    </item>
    <item>
        <title>Women’s health and gender inequalities - The science of women’s health</title>
        <itunes:title>Women’s health and gender inequalities - The science of women’s health</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/women-s-health-and-gender-inequalities-the-science-of-women-s-health/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/women-s-health-and-gender-inequalities-the-science-of-women-s-health/#comments</comments>        <pubDate>Thu, 15 Jul 2021 13:01:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/womens-health-and-gender-inequalities-the-science-of-womens-health</guid>
                                    <description><![CDATA[It's been 25 years since the declaration on the rights of women, was signed in Beijing - and in that time the landscape of health car inequity has changed. To celebrate we created 3 podcasts, in collaboration with The WHO and UN University, as part of the collection on Women’s Health and Gender Inequalities

www.bmj.com/gender

In these podcasts we'll be hosting conversations between women early in, and some who are more advanced in, their careers - doctors, researchers, legislators and campaigners, all working towards building a future in which women can thrive.

As well as these in depth discussions, you will hear some shorter interviews from experts who have written for the collection. These give you a flavour of the bigger discussions going on in global health when it comes to gender equity - so keep an ear out for those during the discussions.

In this first podcast, Lulit Yonas Mengesha talks to Cara Tannenbaum

Lulit Yonas Mengesha is right at the beginning of her medical career, she's a medical student in Ethiopia, but has already become passionate about woman's health

Cara Tannenbaum is is Scientific Director of the Institute of Gender and Health at the Canadian Institutes of Health Research.

Lulit and Cara discuss how women have been excluded from healthcare research - and how that affects practice today, how there are gaps in our understanding of basic biology, as well as how different life experiences affect outcomes.

<p>The additional interviews are from; Lavanya Vijayasingham, Claudia Lopes, and Claire Wenham</p>
]]></description>
                                                            <content:encoded><![CDATA[It's been 25 years since the declaration on the rights of women, was signed in Beijing - and in that time the landscape of health car inequity has changed. To celebrate we created 3 podcasts, in collaboration with The WHO and UN University, as part of the collection on Women’s Health and Gender Inequalities

www.bmj.com/gender

In these podcasts we'll be hosting conversations between women early in, and some who are more advanced in, their careers - doctors, researchers, legislators and campaigners, all working towards building a future in which women can thrive.

As well as these in depth discussions, you will hear some shorter interviews from experts who have written for the collection. These give you a flavour of the bigger discussions going on in global health when it comes to gender equity - so keep an ear out for those during the discussions.

In this first podcast, Lulit Yonas Mengesha talks to Cara Tannenbaum

Lulit Yonas Mengesha is right at the beginning of her medical career, she's a medical student in Ethiopia, but has already become passionate about woman's health

Cara Tannenbaum is is Scientific Director of the Institute of Gender and Health at the Canadian Institutes of Health Research.

Lulit and Cara discuss how women have been excluded from healthcare research - and how that affects practice today, how there are gaps in our understanding of basic biology, as well as how different life experiences affect outcomes.

<p>The additional interviews are from; Lavanya Vijayasingham, Claudia Lopes, and Claire Wenham</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/75uctb/stream_1087975864-bmjgroup-womens-health-and-gender-inequalities-the-science-of-womens-health.mp3" length="48697677" type="audio/mpeg"/>
        <itunes:summary><![CDATA[It's been 25 years since the declaration on the rights of women, was signed in Beijing - and in that time the landscape of health car inequity has changed. To celebrate we created 3 podcasts, in collaboration with The WHO and UN University, as part of the collection on Women’s Health and Gender Inequalities

www.bmj.com/gender

In these podcasts we'll be hosting conversations between women early in, and some who are more advanced in, their careers - doctors, researchers, legislators and campaigners, all working towards building a future in which women can thrive.

As well as these in depth discussions, you will hear some shorter interviews from experts who have written for the collection. These give you a flavour of the bigger discussions going on in global health when it comes to gender equity - so keep an ear out for those during the discussions.

In this first podcast, Lulit Yonas Mengesha talks to Cara Tannenbaum

Lulit Yonas Mengesha is right at the beginning of her medical career, she's a medical student in Ethiopia, but has already become passionate about woman's health

Cara Tannenbaum is is Scientific Director of the Institute of Gender and Health at the Canadian Institutes of Health Research.

Lulit and Cara discuss how women have been excluded from healthcare research - and how that affects practice today, how there are gaps in our understanding of basic biology, as well as how different life experiences affect outcomes.

The additional interviews are from; Lavanya Vijayasingham, Claudia Lopes, and Claire Wenham]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3044</itunes:duration>
                                    </item>
    <item>
        <title>Wellbeing - the need for culturally aware support</title>
        <itunes:title>Wellbeing - the need for culturally aware support</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/wellbeing-the-need-for-culturally-aware-support/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/wellbeing-the-need-for-culturally-aware-support/#comments</comments>        <pubDate>Thu, 08 Jul 2021 09:53:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/wellbeing-the-need-for-culturally-aware-support</guid>
                                    <description><![CDATA[We know the pandemic has disproportionately affected the NHS workers who come from a ethnic minorities, we also know that doctors from an ethnic minority face additional barriers to accessing support - so how well have the various support schemes put in place during the pandemic helped those doctors from ethnic minorities?

Dammie Olubawale, medical student and grants and partnerships manager at Melanin Medics, joins us to talk about a fund they've created specifically to help doctors of black African and Caribbean heritage, to access support tailored to them.

Dammie explains some of the reasons which doctors, particularly from that heritage, may be more reluctant to access support - and how organisations large and small need to think about tailoring their wellbeing initiatives to include all staff.

To access the melanin medics wellbeing fund visit
<p>https://www.melaninmedics.com/wellbeing-fund</p>
]]></description>
                                                            <content:encoded><![CDATA[We know the pandemic has disproportionately affected the NHS workers who come from a ethnic minorities, we also know that doctors from an ethnic minority face additional barriers to accessing support - so how well have the various support schemes put in place during the pandemic helped those doctors from ethnic minorities?

Dammie Olubawale, medical student and grants and partnerships manager at Melanin Medics, joins us to talk about a fund they've created specifically to help doctors of black African and Caribbean heritage, to access support tailored to them.

Dammie explains some of the reasons which doctors, particularly from that heritage, may be more reluctant to access support - and how organisations large and small need to think about tailoring their wellbeing initiatives to include all staff.

To access the melanin medics wellbeing fund visit
<p>https://www.melaninmedics.com/wellbeing-fund</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8p9fe3/stream_1083741616-bmjgroup-wellbeing-the-need-for-culturally-aware-support.mp3" length="21152913" type="audio/mpeg"/>
        <itunes:summary><![CDATA[We know the pandemic has disproportionately affected the NHS workers who come from a ethnic minorities, we also know that doctors from an ethnic minority face additional barriers to accessing support - so how well have the various support schemes put in place during the pandemic helped those doctors from ethnic minorities?

Dammie Olubawale, medical student and grants and partnerships manager at Melanin Medics, joins us to talk about a fund they've created specifically to help doctors of black African and Caribbean heritage, to access support tailored to them.

Dammie explains some of the reasons which doctors, particularly from that heritage, may be more reluctant to access support - and how organisations large and small need to think about tailoring their wellbeing initiatives to include all staff.

To access the melanin medics wellbeing fund visit
https://www.melaninmedics.com/wellbeing-fund]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1322</itunes:duration>
                                    </item>
    <item>
        <title>Women’s health and gender inequalities - Campaigning for change</title>
        <itunes:title>Women’s health and gender inequalities - Campaigning for change</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/women-s-health-and-gender-inequalities-campaigning-for-change/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/women-s-health-and-gender-inequalities-campaigning-for-change/#comments</comments>        <pubDate>Mon, 28 Jun 2021 09:09:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/womens-health-and-gender-inequities-campaigning-for-change</guid>
                                    <description><![CDATA[It's been 25 years since the declaration on the rights of women, was signed in Beijing - and in that time the landscape of health car inequity has changed. To celebrate we created 3 podcasts, in collaboration with The WHO and UN University, as part of the collection on Women’s Health and Gender Inequalities

https://www.bmj.com/gender

In these podcasts we'll be hosting conversations between women early in, and some who are more advanced in, their careers - doctors, researchers, legislators and campaigners, all working towards building a future in which women can thrive.

As well as these in depth discussions, you will hear some shorter interviews from experts who have written for the collection. These give you a flavour of the bigger discussions going on in global health when it comes to gender equity - so keep an ear out for those during the discussions.

In this first podcast, Adrienne Germaine talks to Fila Magnus.

Adrienne starter her career as an activist for women's health in the 1970s, and went on to become president of the  International Women's Health Coalition

Fila Magnus is Director of Communications at the International Youth Alliance for Family Planning, and was born in the same year as the Declaration was signed.

Fila and Adrienne discuss campaigning, now and then, and how the work that led to the declaration can be built on, but is never over...

<p>The additional interviews are from; Emma Fulu, Sheena Hadi, Oswaldo Montoya, and Claudia Garcia-Moreno.</p>
]]></description>
                                                            <content:encoded><![CDATA[It's been 25 years since the declaration on the rights of women, was signed in Beijing - and in that time the landscape of health car inequity has changed. To celebrate we created 3 podcasts, in collaboration with The WHO and UN University, as part of the collection on Women’s Health and Gender Inequalities

https://www.bmj.com/gender

In these podcasts we'll be hosting conversations between women early in, and some who are more advanced in, their careers - doctors, researchers, legislators and campaigners, all working towards building a future in which women can thrive.

As well as these in depth discussions, you will hear some shorter interviews from experts who have written for the collection. These give you a flavour of the bigger discussions going on in global health when it comes to gender equity - so keep an ear out for those during the discussions.

In this first podcast, Adrienne Germaine talks to Fila Magnus.

Adrienne starter her career as an activist for women's health in the 1970s, and went on to become president of the  International Women's Health Coalition

Fila Magnus is Director of Communications at the International Youth Alliance for Family Planning, and was born in the same year as the Declaration was signed.

Fila and Adrienne discuss campaigning, now and then, and how the work that led to the declaration can be built on, but is never over...

<p>The additional interviews are from; Emma Fulu, Sheena Hadi, Oswaldo Montoya, and Claudia Garcia-Moreno.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/21rw22/stream_1077365218-bmjgroup-womens-health-and-gender-inequities-campaigning-for-change.mp3" length="46184070" type="audio/mpeg"/>
        <itunes:summary><![CDATA[It's been 25 years since the declaration on the rights of women, was signed in Beijing - and in that time the landscape of health car inequity has changed. To celebrate we created 3 podcasts, in collaboration with The WHO and UN University, as part of the collection on Women’s Health and Gender Inequalities

https://www.bmj.com/gender

In these podcasts we'll be hosting conversations between women early in, and some who are more advanced in, their careers - doctors, researchers, legislators and campaigners, all working towards building a future in which women can thrive.

As well as these in depth discussions, you will hear some shorter interviews from experts who have written for the collection. These give you a flavour of the bigger discussions going on in global health when it comes to gender equity - so keep an ear out for those during the discussions.

In this first podcast, Adrienne Germaine talks to Fila Magnus.

Adrienne starter her career as an activist for women's health in the 1970s, and went on to become president of the  International Women's Health Coalition

Fila Magnus is Director of Communications at the International Youth Alliance for Family Planning, and was born in the same year as the Declaration was signed.

Fila and Adrienne discuss campaigning, now and then, and how the work that led to the declaration can be built on, but is never over...

The additional interviews are from; Emma Fulu, Sheena Hadi, Oswaldo Montoya, and Claudia Garcia-Moreno.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2886</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence - GP data, excess mortality and FDA approval</title>
        <itunes:title>Talk Evidence - GP data, excess mortality and FDA approval</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-gp-data-excess-mortality-and-fda-approval/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-gp-data-excess-mortality-and-fda-approval/#comments</comments>        <pubDate>Sun, 20 Jun 2021 11:07:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-gp-data-excess-mortality-and-fda-approval</guid>
                                    <description><![CDATA[In this Talk Evidence, Helen Macdonald, Joe Ross and Duncan Jarvies discuss what's going on in the world of EBM.

Firstly, a while ago on the podcast, we concluded that excess mortality would be the best way to measure the impact of the pandemic - and now a new paper looks at different country's excess mortalitites over the past year. We're joined by author Nazrul Islam Physician-Epidemiologist at the University of Oxford (and a research editor for The BMJ) to talk about why comparisons may still not be sensible.

Read the full research here - https://www.bmj.com/content/373/bmj.n1137

The Delta variant is dominating headlines, and infections in the UK now - but until recently the Alpha one was ascendent, and new research has helped characterise how the mortality rate of that variant differed from previous viruses.  We discuss how that research was done.

Read the full research - https://www.bmj.com/content/372/bmj.n579

GP data in the UK - the planned cut-off for granting access to your GP data for researchers has been extended, but there are still a lot of questions remaining. Helen has tried to find out some basic answers, and is still confused.

Finally, the FDA has approved a new drug for treatment of dementia - and researchers (and the FDA's own panel of experts) are up in arms. Joe Ross tells us why he thinks the decision was the wrong one, and why patients may be harmed because of it. 

<p>https://edition.cnn.com/2021/06/17/opinions/biogen-alzheimers-drug-opinion-ramachandra-ross/index.html</p>
]]></description>
                                                            <content:encoded><![CDATA[In this Talk Evidence, Helen Macdonald, Joe Ross and Duncan Jarvies discuss what's going on in the world of EBM.

Firstly, a while ago on the podcast, we concluded that excess mortality would be the best way to measure the impact of the pandemic - and now a new paper looks at different country's excess mortalitites over the past year. We're joined by author Nazrul Islam Physician-Epidemiologist at the University of Oxford (and a research editor for The BMJ) to talk about why comparisons may still not be sensible.

Read the full research here - https://www.bmj.com/content/373/bmj.n1137

The Delta variant is dominating headlines, and infections in the UK now - but until recently the Alpha one was ascendent, and new research has helped characterise how the mortality rate of that variant differed from previous viruses.  We discuss how that research was done.

Read the full research - https://www.bmj.com/content/372/bmj.n579

GP data in the UK - the planned cut-off for granting access to your GP data for researchers has been extended, but there are still a lot of questions remaining. Helen has tried to find out some basic answers, and is still confused.

Finally, the FDA has approved a new drug for treatment of dementia - and researchers (and the FDA's own panel of experts) are up in arms. Joe Ross tells us why he thinks the decision was the wrong one, and why patients may be harmed because of it. 

<p>https://edition.cnn.com/2021/06/17/opinions/biogen-alzheimers-drug-opinion-ramachandra-ross/index.html</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/zmxt8j/stream_1072281943-bmjgroup-talk-evidence-gp-data-excess-mortality-and-fda-approval.mp3" length="49533595" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this Talk Evidence, Helen Macdonald, Joe Ross and Duncan Jarvies discuss what's going on in the world of EBM.

Firstly, a while ago on the podcast, we concluded that excess mortality would be the best way to measure the impact of the pandemic - and now a new paper looks at different country's excess mortalitites over the past year. We're joined by author Nazrul Islam Physician-Epidemiologist at the University of Oxford (and a research editor for The BMJ) to talk about why comparisons may still not be sensible.

Read the full research here - https://www.bmj.com/content/373/bmj.n1137

The Delta variant is dominating headlines, and infections in the UK now - but until recently the Alpha one was ascendent, and new research has helped characterise how the mortality rate of that variant differed from previous viruses.  We discuss how that research was done.

Read the full research - https://www.bmj.com/content/372/bmj.n579

GP data in the UK - the planned cut-off for granting access to your GP data for researchers has been extended, but there are still a lot of questions remaining. Helen has tried to find out some basic answers, and is still confused.

Finally, the FDA has approved a new drug for treatment of dementia - and researchers (and the FDA's own panel of experts) are up in arms. Joe Ross tells us why he thinks the decision was the wrong one, and why patients may be harmed because of it. 

https://edition.cnn.com/2021/06/17/opinions/biogen-alzheimers-drug-opinion-ramachandra-ross/index.html]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3096</itunes:duration>
                                    </item>
    <item>
        <title>Wellbeing - are men worse at sounding the alarm about their mental health?</title>
        <itunes:title>Wellbeing - are men worse at sounding the alarm about their mental health?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/wellbeing-are-men-worse-at-sounding-the-alarm-about-their-mental-health/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/wellbeing-are-men-worse-at-sounding-the-alarm-about-their-mental-health/#comments</comments>        <pubDate>Fri, 04 Jun 2021 15:51:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/wellbeing-are-men-worse-at-sounding-the-alarm-about-their-mental-health</guid>
                                    <description><![CDATA[We've been bringing you stories of doctors wellbeing for a while in the podcast, but we noticed a pattern. Woman would come on and talk about their own difficulties, men would talk about other peoples - so we wanted to dive into that a bit, and called out on twitter for men who would be willing to open up to our listeners about their own mental health.

This interview is with Zeshan Quereshi - registrar in paediatrics, author and TedX talker. In this conversation we talk about why it is that men are particularly disinclined to open up about their difficulties at work, and what Zeshan has done to try and support his own.

Zeshan's TedX talk
<p>https://www.youtube.com/watch?v=uctoTk64GVM</p>
]]></description>
                                                            <content:encoded><![CDATA[We've been bringing you stories of doctors wellbeing for a while in the podcast, but we noticed a pattern. Woman would come on and talk about their own difficulties, men would talk about other peoples - so we wanted to dive into that a bit, and called out on twitter for men who would be willing to open up to our listeners about their own mental health.

This interview is with Zeshan Quereshi - registrar in paediatrics, author and TedX talker. In this conversation we talk about why it is that men are particularly disinclined to open up about their difficulties at work, and what Zeshan has done to try and support his own.

Zeshan's TedX talk
<p>https://www.youtube.com/watch?v=uctoTk64GVM</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/abr23d/stream_1062021682-bmjgroup-wellbeing-are-men-worse-at-sounding-the-alarm-about-their-mental-health.mp3" length="32551078" type="audio/mpeg"/>
        <itunes:summary><![CDATA[We've been bringing you stories of doctors wellbeing for a while in the podcast, but we noticed a pattern. Woman would come on and talk about their own difficulties, men would talk about other peoples - so we wanted to dive into that a bit, and called out on twitter for men who would be willing to open up to our listeners about their own mental health.

This interview is with Zeshan Quereshi - registrar in paediatrics, author and TedX talker. In this conversation we talk about why it is that men are particularly disinclined to open up about their difficulties at work, and what Zeshan has done to try and support his own.

Zeshan's TedX talk
https://www.youtube.com/watch?v=uctoTk64GVM]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2034</itunes:duration>
                                    </item>
    <item>
        <title>Coronavirus Second Wave - wrapping up the UK’s response</title>
        <itunes:title>Coronavirus Second Wave - wrapping up the UK’s response</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/coronavirus-second-wave-wrapping-up-the-uk-s-response/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/coronavirus-second-wave-wrapping-up-the-uk-s-response/#comments</comments>        <pubDate>Fri, 28 May 2021 16:24:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/coronavirus-second-wave-wrapping-up-a-the-uks-response</guid>
                                    <description><![CDATA[Finally it seems that life might return to normal in the UK, as the vaccination efforts continue apace, and despite concern about increasingly spreading variants, our hospitals are not being overwhelmed.

Because of this, we are changing our approach to covering the pandemic - and taking this second wave podcast to pastures new, but before that, in this last episode we’re going to look backwards and forwards, at the UK’s response.

On the panel today are

Matt Morgan, consultant in critical care, Nisreen Alwan, associate professor in public health, Partha Kar, consultant in diabetes, and Helen Salisbury, GP.

<p>www.bmj.com/coronavirus</p>
]]></description>
                                                            <content:encoded><![CDATA[Finally it seems that life might return to normal in the UK, as the vaccination efforts continue apace, and despite concern about increasingly spreading variants, our hospitals are not being overwhelmed.

Because of this, we are changing our approach to covering the pandemic - and taking this second wave podcast to pastures new, but before that, in this last episode we’re going to look backwards and forwards, at the UK’s response.

On the panel today are

Matt Morgan, consultant in critical care, Nisreen Alwan, associate professor in public health, Partha Kar, consultant in diabetes, and Helen Salisbury, GP.

<p>www.bmj.com/coronavirus</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gusnja/stream_1057440697-bmjgroup-coronavirus-second-wave-wrapping-up-a-the-uks-response.mp3" length="50756126" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Finally it seems that life might return to normal in the UK, as the vaccination efforts continue apace, and despite concern about increasingly spreading variants, our hospitals are not being overwhelmed.

Because of this, we are changing our approach to covering the pandemic - and taking this second wave podcast to pastures new, but before that, in this last episode we’re going to look backwards and forwards, at the UK’s response.

On the panel today are

Matt Morgan, consultant in critical care, Nisreen Alwan, associate professor in public health, Partha Kar, consultant in diabetes, and Helen Salisbury, GP.

www.bmj.com/coronavirus]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3172</itunes:duration>
                                    </item>
    <item>
        <title>Wellbeing - Questions to ask yourself, if you think medicine may no longer be for you</title>
        <itunes:title>Wellbeing - Questions to ask yourself, if you think medicine may no longer be for you</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/wellbeing-questions-to-ask-yourself-if-you-think-medicine-may-no-longer-be-for-you/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/wellbeing-questions-to-ask-yourself-if-you-think-medicine-may-no-longer-be-for-you/#comments</comments>        <pubDate>Fri, 21 May 2021 14:19:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/questions-to-ask-yourself-if-you-think-medicine-may-no-longer-be-for-you</guid>
                                    <description><![CDATA[The pandemic has wrought a lot of change, not least to doctors relationship to their careers. While still loving the patient interaction, we're increasingly hearing that doctors are disillusioned with the other aspects of medicine.

If you're feeling that way, there are ways to structure your thinking to help you make sense of your career. In this podcast Claire Kaye, former portfolio GP and now coach, explains how she went about deciding medicine wasn't for her, and how she helps doctors go through that process too.

You can find Claire at
https://www.drclairekaye.com/
<p>https://www.instagram.com/drclairekaye_executivecoaching/</p>
]]></description>
                                                            <content:encoded><![CDATA[The pandemic has wrought a lot of change, not least to doctors relationship to their careers. While still loving the patient interaction, we're increasingly hearing that doctors are disillusioned with the other aspects of medicine.

If you're feeling that way, there are ways to structure your thinking to help you make sense of your career. In this podcast Claire Kaye, former portfolio GP and now coach, explains how she went about deciding medicine wasn't for her, and how she helps doctors go through that process too.

You can find Claire at
https://www.drclairekaye.com/
<p>https://www.instagram.com/drclairekaye_executivecoaching/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/pqt8rx/stream_1052923780-bmjgroup-questions-to-ask-yourself-if-you-think-medicine-may-no-longer-be-for-you.mp3" length="40538696" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The pandemic has wrought a lot of change, not least to doctors relationship to their careers. While still loving the patient interaction, we're increasingly hearing that doctors are disillusioned with the other aspects of medicine.

If you're feeling that way, there are ways to structure your thinking to help you make sense of your career. In this podcast Claire Kaye, former portfolio GP and now coach, explains how she went about deciding medicine wasn't for her, and how she helps doctors go through that process too.

You can find Claire at
https://www.drclairekaye.com/
https://www.instagram.com/drclairekaye_executivecoaching/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2534</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence covid-19 update - Research on vaccine safety, treatment for dementia</title>
        <itunes:title>Talk Evidence covid-19 update - Research on vaccine safety, treatment for dementia</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-research-on-vaccine-safety-treatment-for-dementia/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-research-on-vaccine-safety-treatment-for-dementia/#comments</comments>        <pubDate>Fri, 14 May 2021 17:15:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-covid-19-update-research-on-vaccine-safety-treatment-for-dementia</guid>
                                    <description><![CDATA[In this week's Talk Evidence, Joe Ross, BMJ editor and professor at Yale again joins Helen Macdonald to talk about emerging evidence on Covid-19.

They also welcome to the podcast Juan Franco, family physician in Buenos Aires, and professor at the Instituto Universitario Hospital Italiano, and new editor-in-chief of BMJ Evidence Based Medicine.

This week, the team bring you updates on;

Post-covid syndrome in individuals admitted to hospital with covid-19 - how are people with long covid faring.

Finally published research from Scandinavia on the risk of thrombotic events after administration of the Oxford-AstraZeneca vaccine - how big is the risk, and what does that mean for the overall benefit of that vaccine.

How difficult the UK population found it to understand and stick to the rules with our test, trace and isolate system - and some of the questions that this raises for this public health approach.

and finally, research that showed non-drug interventions are as good as pharmaceuticals at treating people with depression and dementia - and the holistic effect that alleviating depression can have.


Full reading list
Ayoubkhani, Daniel, Kamlesh Khunti, Vahé Nafilyan, Thomas Maddox, Ben Humberstone, Ian Diamond, and Amitava Banerjee. 2021. “Post-Covid Syndrome in Individuals Admitted to Hospital with Covid-19: Retrospective Cohort Study.” BMJ  372 (March): n693.
https://www.bmj.com/content/372/bmj.n693


Pottegård, Anton, Lars Christian Lund, Øystein Karlstad, Jesper Dahl, Morten Andersen, Jesper Hallas, Øjvind Lidegaard, et al. 2021. “Arterial Events, Venous Thromboembolism, Thrombocytopenia, and Bleeding after Vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: Population Based Cohort Study.” BMJ  373 (May): n1114.
https://www.bmj.com/content/373/bmj.n1114

Smith, Louise E., Henry W. W. Potts, Richard Amlôt, Nicola T. Fear, Susan Michie, and G. James Rubin. 2021. “Adherence to the Test, Trace, and Isolate System in the UK: Results from 37 Nationally Representative Surveys.” BMJ  372 (March): n608.
https://www.bmj.com/content/372/bmj.n608

Watt, Jennifer A., Zahra Goodarzi, Areti Angeliki Veroniki, Vera Nincic, Paul A. Khan, Marco Ghassemi, Yonda Lai, et al. 2021. “Comparative Efficacy of Interventions for Reducing Symptoms of Depression in People with Dementia: Systematic Review and Network Meta-Analysis.” BMJ  372 (March): n532.
<p>https://www.bmj.com/content/372/bmj.n532</p>
]]></description>
                                                            <content:encoded><![CDATA[In this week's Talk Evidence, Joe Ross, BMJ editor and professor at Yale again joins Helen Macdonald to talk about emerging evidence on Covid-19.

They also welcome to the podcast Juan Franco, family physician in Buenos Aires, and professor at the Instituto Universitario Hospital Italiano, and new editor-in-chief of BMJ Evidence Based Medicine.

This week, the team bring you updates on;

Post-covid syndrome in individuals admitted to hospital with covid-19 - how are people with long covid faring.

Finally published research from Scandinavia on the risk of thrombotic events after administration of the Oxford-AstraZeneca vaccine - how big is the risk, and what does that mean for the overall benefit of that vaccine.

How difficult the UK population found it to understand and stick to the rules with our test, trace and isolate system - and some of the questions that this raises for this public health approach.

and finally, research that showed non-drug interventions are as good as pharmaceuticals at treating people with depression and dementia - and the holistic effect that alleviating depression can have.


Full reading list
Ayoubkhani, Daniel, Kamlesh Khunti, Vahé Nafilyan, Thomas Maddox, Ben Humberstone, Ian Diamond, and Amitava Banerjee. 2021. “Post-Covid Syndrome in Individuals Admitted to Hospital with Covid-19: Retrospective Cohort Study.” BMJ  372 (March): n693.
https://www.bmj.com/content/372/bmj.n693


Pottegård, Anton, Lars Christian Lund, Øystein Karlstad, Jesper Dahl, Morten Andersen, Jesper Hallas, Øjvind Lidegaard, et al. 2021. “Arterial Events, Venous Thromboembolism, Thrombocytopenia, and Bleeding after Vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: Population Based Cohort Study.” BMJ  373 (May): n1114.
https://www.bmj.com/content/373/bmj.n1114

Smith, Louise E., Henry W. W. Potts, Richard Amlôt, Nicola T. Fear, Susan Michie, and G. James Rubin. 2021. “Adherence to the Test, Trace, and Isolate System in the UK: Results from 37 Nationally Representative Surveys.” BMJ  372 (March): n608.
https://www.bmj.com/content/372/bmj.n608

Watt, Jennifer A., Zahra Goodarzi, Areti Angeliki Veroniki, Vera Nincic, Paul A. Khan, Marco Ghassemi, Yonda Lai, et al. 2021. “Comparative Efficacy of Interventions for Reducing Symptoms of Depression in People with Dementia: Systematic Review and Network Meta-Analysis.” BMJ  372 (March): n532.
<p>https://www.bmj.com/content/372/bmj.n532</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/s37r6z/stream_1048810561-bmjgroup-talk-evidence-covid-19-update-research-on-vaccine-safety-treatment-for-dementia.mp3" length="45238229" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this week's Talk Evidence, Joe Ross, BMJ editor and professor at Yale again joins Helen Macdonald to talk about emerging evidence on Covid-19.

They also welcome to the podcast Juan Franco, family physician in Buenos Aires, and professor at the Instituto Universitario Hospital Italiano, and new editor-in-chief of BMJ Evidence Based Medicine.

This week, the team bring you updates on;

Post-covid syndrome in individuals admitted to hospital with covid-19 - how are people with long covid faring.

Finally published research from Scandinavia on the risk of thrombotic events after administration of the Oxford-AstraZeneca vaccine - how big is the risk, and what does that mean for the overall benefit of that vaccine.

How difficult the UK population found it to understand and stick to the rules with our test, trace and isolate system - and some of the questions that this raises for this public health approach.

and finally, research that showed non-drug interventions are as good as pharmaceuticals at treating people with depression and dementia - and the holistic effect that alleviating depression can have.


Full reading list
Ayoubkhani, Daniel, Kamlesh Khunti, Vahé Nafilyan, Thomas Maddox, Ben Humberstone, Ian Diamond, and Amitava Banerjee. 2021. “Post-Covid Syndrome in Individuals Admitted to Hospital with Covid-19: Retrospective Cohort Study.” BMJ  372 (March): n693.
https://www.bmj.com/content/372/bmj.n693


Pottegård, Anton, Lars Christian Lund, Øystein Karlstad, Jesper Dahl, Morten Andersen, Jesper Hallas, Øjvind Lidegaard, et al. 2021. “Arterial Events, Venous Thromboembolism, Thrombocytopenia, and Bleeding after Vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: Population Based Cohort Study.” BMJ  373 (May): n1114.
https://www.bmj.com/content/373/bmj.n1114

Smith, Louise E., Henry W. W. Potts, Richard Amlôt, Nicola T. Fear, Susan Michie, and G. James Rubin. 2021. “Adherence to the Test, Trace, and Isolate System in the UK: Results from 37 Nationally Representative Surveys.” BMJ  372 (March): n608.
https://www.bmj.com/content/372/bmj.n608

Watt, Jennifer A., Zahra Goodarzi, Areti Angeliki Veroniki, Vera Nincic, Paul A. Khan, Marco Ghassemi, Yonda Lai, et al. 2021. “Comparative Efficacy of Interventions for Reducing Symptoms of Depression in People with Dementia: Systematic Review and Network Meta-Analysis.” BMJ  372 (March): n532.
https://www.bmj.com/content/372/bmj.n532]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2827</itunes:duration>
                                    </item>
    <item>
        <title>Roopa Dhatt - Getting woman into leadership positions in healthcare</title>
        <itunes:title>Roopa Dhatt - Getting woman into leadership positions in healthcare</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/roopa-dhatt-getting-woman-into-leadership-positions-in-healthcare/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/roopa-dhatt-getting-woman-into-leadership-positions-in-healthcare/#comments</comments>        <pubDate>Fri, 07 May 2021 16:13:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/roopa-dhatt-getting-woman-into-leadership-positions-in-healthcare</guid>
                                    <description><![CDATA[This interview is part of our BMJ interview series, where we talk to the people who are changing medicine. The series thus far has been a bit male dominated - reflecting the leadership in medicine at the moment, if not the actual workforce.

One woman who's planning to change that is Roopa Dhatt, executive director of Woman in Global Health - a new grassroots organistion which is making waves with its demand for equality of representation for woman in global health decision making.

<p>In this interview, we talk to Dr Dhatt about the genesis of Woman in Global Health, and how they've managed to cement real commitment from the WHO. We also discuss how her experience of being Indian and American has shaped her understanding of equality in medicine, and how the covid-19 pandemic has highlighted the way in which women are discounted.</p>
]]></description>
                                                            <content:encoded><![CDATA[This interview is part of our BMJ interview series, where we talk to the people who are changing medicine. The series thus far has been a bit male dominated - reflecting the leadership in medicine at the moment, if not the actual workforce.

One woman who's planning to change that is Roopa Dhatt, executive director of Woman in Global Health - a new grassroots organistion which is making waves with its demand for equality of representation for woman in global health decision making.

<p>In this interview, we talk to Dr Dhatt about the genesis of Woman in Global Health, and how they've managed to cement real commitment from the WHO. We also discuss how her experience of being Indian and American has shaped her understanding of equality in medicine, and how the covid-19 pandemic has highlighted the way in which women are discounted.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/abythr/stream_1044629899-bmjgroup-roopa-dhatt-getting-woman-into-leadership-positions-in-healthcare.mp3" length="36082415" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This interview is part of our BMJ interview series, where we talk to the people who are changing medicine. The series thus far has been a bit male dominated - reflecting the leadership in medicine at the moment, if not the actual workforce.

One woman who's planning to change that is Roopa Dhatt, executive director of Woman in Global Health - a new grassroots organistion which is making waves with its demand for equality of representation for woman in global health decision making.

In this interview, we talk to Dr Dhatt about the genesis of Woman in Global Health, and how they've managed to cement real commitment from the WHO. We also discuss how her experience of being Indian and American has shaped her understanding of equality in medicine, and how the covid-19 pandemic has highlighted the way in which women are discounted.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2255</itunes:duration>
                                    </item>
    <item>
        <title>Wellbeing - Humanising medicine</title>
        <itunes:title>Wellbeing - Humanising medicine</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/wellbeing-humanising-medicine/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/wellbeing-humanising-medicine/#comments</comments>        <pubDate>Thu, 29 Apr 2021 16:58:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/wellbeing-humanising-medicine</guid>
                                    <description><![CDATA[In medicine, a lot of work has been done to encourage person centred care - but can that maxim be extended to the people working within the healthcare system?

Subodh Dave has just been elected as dean of the Royal College of Psychiatrists, and joins us fresh from talking at the International conference on physician health to speak about his ambition to humanise medicine.

In this podcast, Subodh, Abi and Cat discuss what lessons from the pandemic need to remain, why at this time it's really important to look out for your colleague with family overseas, and how ice cream trucks meant much more than a cold treat.

<p>www.bmj.com/wellbeing</p>
]]></description>
                                                            <content:encoded><![CDATA[In medicine, a lot of work has been done to encourage person centred care - but can that maxim be extended to the people working within the healthcare system?

Subodh Dave has just been elected as dean of the Royal College of Psychiatrists, and joins us fresh from talking at the International conference on physician health to speak about his ambition to humanise medicine.

In this podcast, Subodh, Abi and Cat discuss what lessons from the pandemic need to remain, why at this time it's really important to look out for your colleague with family overseas, and how ice cream trucks meant much more than a cold treat.

<p>www.bmj.com/wellbeing</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7lf5qi/stream_1039243993-bmjgroup-wellbeing-humanising-medicine.mp3" length="24880691" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In medicine, a lot of work has been done to encourage person centred care - but can that maxim be extended to the people working within the healthcare system?

Subodh Dave has just been elected as dean of the Royal College of Psychiatrists, and joins us fresh from talking at the International conference on physician health to speak about his ambition to humanise medicine.

In this podcast, Subodh, Abi and Cat discuss what lessons from the pandemic need to remain, why at this time it's really important to look out for your colleague with family overseas, and how ice cream trucks meant much more than a cold treat.

www.bmj.com/wellbeing]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1555</itunes:duration>
                                    </item>
    <item>
        <title>Wellbeing - After shielding</title>
        <itunes:title>Wellbeing - After shielding</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/wellbeing-after-shielding/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/wellbeing-after-shielding/#comments</comments>        <pubDate>Thu, 22 Apr 2021 17:19:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/wellbeing-after-shielding</guid>
                                    <description><![CDATA[On this wellbeing podcast, Abi and Cat are joined by Emma Lishman, a clinical psychologist and part of the North Bristol NHS Trust's staff wellbeing team.Emma helps doctors return to training after a break - be that for maternity leave, or covid-19.  

Emma describes some of the fears that doctors who have been shielding have expressed coming back onto the ward, the ways in which teams may inadvertently make those worse, and the problems with complying with risk assessments in the face of staffing pressures.

Wellbeing podcasts have focused a lot on the importance of openness about mental health in the NHS, but in this podcast, you'll also hear how reluctant clinicians are to discuss physical health problems - and why the taboo around all aspects of illhealth needs to be tackled.

For more wellbeing
<p>https://www.bmj.com/wellbeing</p>
]]></description>
                                                            <content:encoded><![CDATA[On this wellbeing podcast, Abi and Cat are joined by Emma Lishman, a clinical psychologist and part of the North Bristol NHS Trust's staff wellbeing team.Emma helps doctors return to training after a break - be that for maternity leave, or covid-19.  

Emma describes some of the fears that doctors who have been shielding have expressed coming back onto the ward, the ways in which teams may inadvertently make those worse, and the problems with complying with risk assessments in the face of staffing pressures.

Wellbeing podcasts have focused a lot on the importance of openness about mental health in the NHS, but in this podcast, you'll also hear how reluctant clinicians are to discuss physical health problems - and why the taboo around all aspects of illhealth needs to be tackled.

For more wellbeing
<p>https://www.bmj.com/wellbeing</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vs5za5/stream_1034742814-bmjgroup-wellbeing-after-shielding.mp3" length="42880103" type="audio/mpeg"/>
        <itunes:summary><![CDATA[On this wellbeing podcast, Abi and Cat are joined by Emma Lishman, a clinical psychologist and part of the North Bristol NHS Trust's staff wellbeing team.Emma helps doctors return to training after a break - be that for maternity leave, or covid-19.  

Emma describes some of the fears that doctors who have been shielding have expressed coming back onto the ward, the ways in which teams may inadvertently make those worse, and the problems with complying with risk assessments in the face of staffing pressures.

Wellbeing podcasts have focused a lot on the importance of openness about mental health in the NHS, but in this podcast, you'll also hear how reluctant clinicians are to discuss physical health problems - and why the taboo around all aspects of illhealth needs to be tackled.

For more wellbeing
https://www.bmj.com/wellbeing]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2680</itunes:duration>
                                    </item>
    <item>
        <title>Coronavirus second wave - headaches abound</title>
        <itunes:title>Coronavirus second wave - headaches abound</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/coronavirus-second-wave-headaches-abound/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/coronavirus-second-wave-headaches-abound/#comments</comments>        <pubDate>Wed, 14 Apr 2021 11:00:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/second-wave-12th-april</guid>
                                    <description><![CDATA[Recorded on Tuesday 13th of April, as the shops open in the UK, and England is heading to the beer gardens. The roll out of the vaccination programme has completed its first phase, and second doses have been given to the most vulnerable people - and now the under 50s are starting to get their first doses.

In this podcast, Duncan Jarvies, multimedia editor for The BMJ, talks to; Partha Kar, consultant in diabetes and endocrinology in Portsmouth, Matt Morgan, a consultant in a intensive care medicine in Cardiff, and Helen Salisbury, GP in Oxfordshire.

<p>The genomicc trial Matt mentions is  still recruiting - if you're interested more detail is available here https://genomicc.org/</p>
]]></description>
                                                            <content:encoded><![CDATA[Recorded on Tuesday 13th of April, as the shops open in the UK, and England is heading to the beer gardens. The roll out of the vaccination programme has completed its first phase, and second doses have been given to the most vulnerable people - and now the under 50s are starting to get their first doses.

In this podcast, Duncan Jarvies, multimedia editor for The BMJ, talks to; Partha Kar, consultant in diabetes and endocrinology in Portsmouth, Matt Morgan, a consultant in a intensive care medicine in Cardiff, and Helen Salisbury, GP in Oxfordshire.

<p>The genomicc trial Matt mentions is  still recruiting - if you're interested more detail is available here https://genomicc.org/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/pl7ejq/stream_1029279280-bmjgroup-second-wave-12th-april.mp3" length="63336446" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Recorded on Tuesday 13th of April, as the shops open in the UK, and England is heading to the beer gardens. The roll out of the vaccination programme has completed its first phase, and second doses have been given to the most vulnerable people - and now the under 50s are starting to get their first doses.

In this podcast, Duncan Jarvies, multimedia editor for The BMJ, talks to; Partha Kar, consultant in diabetes and endocrinology in Portsmouth, Matt Morgan, a consultant in a intensive care medicine in Cardiff, and Helen Salisbury, GP in Oxfordshire.

The genomicc trial Matt mentions is  still recruiting - if you're interested more detail is available here https://genomicc.org/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2642</itunes:duration>
                                    </item>
    <item>
        <title>Measure the broader impacts of healthcare</title>
        <itunes:title>Measure the broader impacts of healthcare</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/measure-the-broader-impacts-of-healthcare/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/measure-the-broader-impacts-of-healthcare/#comments</comments>        <pubDate>Sat, 10 Apr 2021 12:15:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/measure-the-broader-impacts-of-healthcare</guid>
                                    <description><![CDATA[The synergistic linking of increasing health and wealth is broadly accepted - it's an integral part of the thinking between the Sustainable Development Goals, and the World Bank's call for universal healthcare as a way of boosting a country's economy.

But the quantification of that link - the extent to which a particular health intervention, has broader economic impacts, is actually pretty poorly understood.

In this podcast, we hear from some economists, who have an idea about how we could - fairly easily - measure those impacts at the same time we measure clinical efficacy.

Joining us are,  Dean Jamison, professor emeritus of global health at the University of Washington
Osondu Ogbuoji,  assistant research professor at Duke Global Health Insitute.
Till Bärnighausen, director of the Heidelberg Institute of Global Health 
Sebastian Vollmer, professor of development economics at the University of Göttingen

<p>The collection that prompted this discussion is "Health, Wealth and Profits" - https://www.bmj.com/health-wealth-profits</p>
]]></description>
                                                            <content:encoded><![CDATA[The synergistic linking of increasing health and wealth is broadly accepted - it's an integral part of the thinking between the Sustainable Development Goals, and the World Bank's call for universal healthcare as a way of boosting a country's economy.

But the quantification of that link - the extent to which a particular health intervention, has broader economic impacts, is actually pretty poorly understood.

In this podcast, we hear from some economists, who have an idea about how we could - fairly easily - measure those impacts at the same time we measure clinical efficacy.

Joining us are,  Dean Jamison, professor emeritus of global health at the University of Washington
Osondu Ogbuoji,  assistant research professor at Duke Global Health Insitute.
Till Bärnighausen, director of the Heidelberg Institute of Global Health 
Sebastian Vollmer, professor of development economics at the University of Göttingen

<p>The collection that prompted this discussion is "Health, Wealth and Profits" - https://www.bmj.com/health-wealth-profits</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rk2uoq/stream_1026553480-bmjgroup-measure-the-broader-impacts-of-healthcare.mp3" length="36278438" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The synergistic linking of increasing health and wealth is broadly accepted - it's an integral part of the thinking between the Sustainable Development Goals, and the World Bank's call for universal healthcare as a way of boosting a country's economy.

But the quantification of that link - the extent to which a particular health intervention, has broader economic impacts, is actually pretty poorly understood.

In this podcast, we hear from some economists, who have an idea about how we could - fairly easily - measure those impacts at the same time we measure clinical efficacy.

Joining us are,  Dean Jamison, professor emeritus of global health at the University of Washington
Osondu Ogbuoji,  assistant research professor at Duke Global Health Insitute.
Till Bärnighausen, director of the Heidelberg Institute of Global Health 
Sebastian Vollmer, professor of development economics at the University of Göttingen

The collection that prompted this discussion is "Health, Wealth and Profits" - https://www.bmj.com/health-wealth-profits]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2267</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence - children and covid, varients of concern, ivormectin update</title>
        <itunes:title>Talk Evidence - children and covid, varients of concern, ivormectin update</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-children-and-covid-varients-of-concern-ivormectin-update/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-children-and-covid-varients-of-concern-ivormectin-update/#comments</comments>        <pubDate>Fri, 02 Apr 2021 15:31:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-children-and-covid-varients-of-concern-ivormectin-update</guid>
                                    <description><![CDATA[The evidence geekery continues, and this week Helen Macdonald and Duncan Jarvies are joined again by Joe Ross, The BMJ's US research editor, and professor of medicine and public health at Yale.

This week we update you on treatment - the WHO's guidelines for covid and ivermectin, and why they're not ready to recommend it's use in treatment, and prophylactic anticoagulation treatment.

We hear about two papers from the UK and Switzerland which look at children and covid, and we pick up on varients of concern and long covid.

Reading list.
Association between living with children and outcomes from covid-19: OpenSAFELY cohort study of 12 million adults in England
https://www.bmj.com/content/372/bmj.n628

Clustering and longitudinal change in SARS-CoV-2 seroprevalence in school children in the canton of Zurich, Switzerland: prospective cohort study of 55 schools
https://www.bmj.com/content/372/bmj.n616

Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study
https://www.bmj.com/content/372/bmj.n579

Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study
https://www.bmj.com/content/372/bmj.n311

Editorial - Prophylactic anticoagulation for patients in hospital with covid-19
https://www.bmj.com/content/372/bmj.n487

Living with Covid19 – Second review - Informative and accessible health and care research
<p>https://evidence.nihr.ac.uk/themedreview/living-with-covid19-second-review/</p>
]]></description>
                                                            <content:encoded><![CDATA[The evidence geekery continues, and this week Helen Macdonald and Duncan Jarvies are joined again by Joe Ross, The BMJ's US research editor, and professor of medicine and public health at Yale.

This week we update you on treatment - the WHO's guidelines for covid and ivermectin, and why they're not ready to recommend it's use in treatment, and prophylactic anticoagulation treatment.

We hear about two papers from the UK and Switzerland which look at children and covid, and we pick up on varients of concern and long covid.

Reading list.
Association between living with children and outcomes from covid-19: OpenSAFELY cohort study of 12 million adults in England
https://www.bmj.com/content/372/bmj.n628

Clustering and longitudinal change in SARS-CoV-2 seroprevalence in school children in the canton of Zurich, Switzerland: prospective cohort study of 55 schools
https://www.bmj.com/content/372/bmj.n616

Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study
https://www.bmj.com/content/372/bmj.n579

Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study
https://www.bmj.com/content/372/bmj.n311

Editorial - Prophylactic anticoagulation for patients in hospital with covid-19
https://www.bmj.com/content/372/bmj.n487

Living with Covid19 – Second review - Informative and accessible health and care research
<p>https://evidence.nihr.ac.uk/themedreview/living-with-covid19-second-review/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6bzgjh/stream_1021065244-bmjgroup-talk-evidence-children-and-covid-varients-of-concern-ivormectin-update.mp3" length="31218206" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The evidence geekery continues, and this week Helen Macdonald and Duncan Jarvies are joined again by Joe Ross, The BMJ's US research editor, and professor of medicine and public health at Yale.

This week we update you on treatment - the WHO's guidelines for covid and ivermectin, and why they're not ready to recommend it's use in treatment, and prophylactic anticoagulation treatment.

We hear about two papers from the UK and Switzerland which look at children and covid, and we pick up on varients of concern and long covid.

Reading list.
Association between living with children and outcomes from covid-19: OpenSAFELY cohort study of 12 million adults in England
https://www.bmj.com/content/372/bmj.n628

Clustering and longitudinal change in SARS-CoV-2 seroprevalence in school children in the canton of Zurich, Switzerland: prospective cohort study of 55 schools
https://www.bmj.com/content/372/bmj.n616

Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study
https://www.bmj.com/content/372/bmj.n579

Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study
https://www.bmj.com/content/372/bmj.n311

Editorial - Prophylactic anticoagulation for patients in hospital with covid-19
https://www.bmj.com/content/372/bmj.n487

Living with Covid19 – Second review - Informative and accessible health and care research
https://evidence.nihr.ac.uk/themedreview/living-with-covid19-second-review/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1951</itunes:duration>
                                    </item>
    <item>
        <title>Coronavirus second wave - vaccination roll out changes, uncertainty about long covid</title>
        <itunes:title>Coronavirus second wave - vaccination roll out changes, uncertainty about long covid</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/coronavirus-second-wave-vaccination-roll-out-changes-uncertainty-about-long-covid/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/coronavirus-second-wave-vaccination-roll-out-changes-uncertainty-about-long-covid/#comments</comments>        <pubDate>Thu, 25 Mar 2021 09:42:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/2nd-wave-23rd-march</guid>
                                    <description><![CDATA[In the UK, phase 2 of our coronavirus vaccination strategy may be delayed by supply problems, at the same time many GPs, who carried out the majority of the first vaccination phases, are declining to take on the addition burden and are trying to return to normal clinical work. 

<p>In this podcast, Duncan Jarvies, multimedia editor for The BMJ, talks to the full panel; Partha Kar, consultant in diabetes and endocrinology in Portsmouth, Matt Morgan, a consultant in a intensive care medicine in Cardiff, Helen Salisbury, GP in Oxfordshire, and Nisreen Alwan, public health consultant in Southampton.</p>
]]></description>
                                                            <content:encoded><![CDATA[In the UK, phase 2 of our coronavirus vaccination strategy may be delayed by supply problems, at the same time many GPs, who carried out the majority of the first vaccination phases, are declining to take on the addition burden and are trying to return to normal clinical work. 

<p>In this podcast, Duncan Jarvies, multimedia editor for The BMJ, talks to the full panel; Partha Kar, consultant in diabetes and endocrinology in Portsmouth, Matt Morgan, a consultant in a intensive care medicine in Cardiff, Helen Salisbury, GP in Oxfordshire, and Nisreen Alwan, public health consultant in Southampton.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hke7jd/stream_1015966858-bmjgroup-2nd-wave-23rd-march.mp3" length="70875376" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In the UK, phase 2 of our coronavirus vaccination strategy may be delayed by supply problems, at the same time many GPs, who carried out the majority of the first vaccination phases, are declining to take on the addition burden and are trying to return to normal clinical work. 

In this podcast, Duncan Jarvies, multimedia editor for The BMJ, talks to the full panel; Partha Kar, consultant in diabetes and endocrinology in Portsmouth, Matt Morgan, a consultant in a intensive care medicine in Cardiff, Helen Salisbury, GP in Oxfordshire, and Nisreen Alwan, public health consultant in Southampton.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2957</itunes:duration>
                                    </item>
    <item>
        <title>Wellbeing - Put yourself first</title>
        <itunes:title>Wellbeing - Put yourself first</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/wellbeing-put-yourself-first/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/wellbeing-put-yourself-first/#comments</comments>        <pubDate>Thu, 18 Mar 2021 17:46:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/wellbeing-put-yourself-first</guid>
                                    <description><![CDATA[In this Wellbeing podcast, sponsored by medical protection, Abi Rimmer and Cat Chatfield talk to Susanna Petche and Reina Popat, GPs and members of First You - an organisation of healthcare workers, promoting wellbeing in the NHS.
<p>They discuss why it is that clinicians learn to subjugate their own wellbeing to their patients', and the ways in which working in the healthcare system perpetuate that. They discuss how systemic change can come through individual action, and how peers can band together to support each other.</p>
]]></description>
                                                            <content:encoded><![CDATA[In this Wellbeing podcast, sponsored by medical protection, Abi Rimmer and Cat Chatfield talk to Susanna Petche and Reina Popat, GPs and members of First You - an organisation of healthcare workers, promoting wellbeing in the NHS.
<p>They discuss why it is that clinicians learn to subjugate their own wellbeing to their patients', and the ways in which working in the healthcare system perpetuate that. They discuss how systemic change can come through individual action, and how peers can band together to support each other.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/637upv/stream_1010612029-bmjgroup-wellbeing-put-yourself-first.mp3" length="41331564" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this Wellbeing podcast, sponsored by medical protection, Abi Rimmer and Cat Chatfield talk to Susanna Petche and Reina Popat, GPs and members of First You - an organisation of healthcare workers, promoting wellbeing in the NHS.
They discuss why it is that clinicians learn to subjugate their own wellbeing to their patients', and the ways in which working in the healthcare system perpetuate that. They discuss how systemic change can come through individual action, and how peers can band together to support each other.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2583</itunes:duration>
                                    </item>
    <item>
        <title>What should ”following the science” mean for government policy?</title>
        <itunes:title>What should ”following the science” mean for government policy?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/what-should-following-the-science-mean-for-government-policy/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/what-should-following-the-science-mean-for-government-policy/#comments</comments>        <pubDate>Mon, 15 Mar 2021 21:29:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/what-should-following-the-science-mean-for-government-policy</guid>
                                    <description><![CDATA[This round table, recorded at the nuffield summit 2021, asks what does following the science actually mean - do ministers understand the nuance of the science in the pandemic, and how does uncertainty get interpreted through the lens of ideology and the power of compelling stories.

Taking part are:
Kamran Abassi, executive editor of The BMJ
Partha Kar, consultant in diabetes and endocrinology
Deborah Cohen, health correspondent for BBC Newsnight
Tom Sasse, associate director at the Institute for Government
Christina Pagel, professor of Operational Research at University College London
Matt Morgan, intensive care consultant
Andy McKeon, chair of the Nuffield Trust
Isobel Hardman, assistant editor of The Spectator
Mary Dixon-Woods, director of This Institute
Ben Page, chief executive of Ipsos MORI
Alexandra Freeman, executive director of the Winton Centre for Risk & Evidence Communication
Will Moy, chief executive of Full Fact
<p>Nigel Edwards, chief executive of the Nuffield Trust</p>
]]></description>
                                                            <content:encoded><![CDATA[This round table, recorded at the nuffield summit 2021, asks what does following the science actually mean - do ministers understand the nuance of the science in the pandemic, and how does uncertainty get interpreted through the lens of ideology and the power of compelling stories.

Taking part are:
Kamran Abassi, executive editor of The BMJ
Partha Kar, consultant in diabetes and endocrinology
Deborah Cohen, health correspondent for BBC Newsnight
Tom Sasse, associate director at the Institute for Government
Christina Pagel, professor of Operational Research at University College London
Matt Morgan, intensive care consultant
Andy McKeon, chair of the Nuffield Trust
Isobel Hardman, assistant editor of The Spectator
Mary Dixon-Woods, director of This Institute
Ben Page, chief executive of Ipsos MORI
Alexandra Freeman, executive director of the Winton Centre for Risk & Evidence Communication
Will Moy, chief executive of Full Fact
<p>Nigel Edwards, chief executive of the Nuffield Trust</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ihaob1/stream_1008069196-bmjgroup-what-should-following-the-science-mean-for-government-policy.mp3" length="56385200" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This round table, recorded at the nuffield summit 2021, asks what does following the science actually mean - do ministers understand the nuance of the science in the pandemic, and how does uncertainty get interpreted through the lens of ideology and the power of compelling stories.

Taking part are:
Kamran Abassi, executive editor of The BMJ
Partha Kar, consultant in diabetes and endocrinology
Deborah Cohen, health correspondent for BBC Newsnight
Tom Sasse, associate director at the Institute for Government
Christina Pagel, professor of Operational Research at University College London
Matt Morgan, intensive care consultant
Andy McKeon, chair of the Nuffield Trust
Isobel Hardman, assistant editor of The Spectator
Mary Dixon-Woods, director of This Institute
Ben Page, chief executive of Ipsos MORI
Alexandra Freeman, executive director of the Winton Centre for Risk & Evidence Communication
Will Moy, chief executive of Full Fact
Nigel Edwards, chief executive of the Nuffield Trust]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3524</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence - Inside the JCVI, and the key to grading evidence</title>
        <itunes:title>Talk Evidence - Inside the JCVI, and the key to grading evidence</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-inside-the-jcvi-and-the-key-to-grading-evidence/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-inside-the-jcvi-and-the-key-to-grading-evidence/#comments</comments>        <pubDate>Fri, 12 Mar 2021 20:07:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-inside-the-jcvi-and-the-key-to-grading-evidence</guid>
                                    <description><![CDATA[In a slightly different talk evidence, Helen Macdonald and Duncan Jarvies are bringing you a couple, of in depth interviews,

Firstly, Anthony Harnden, GP, academic and member of the UK's Joint Committee on Vaccination and Immunisation takes us inside their decision making, and explains what evidence they look at, how they assess it, and what the next year of vaccination may look like.

Also in this episode, Gordon Guyatt, one of the founders of EBM, joins us to talk about Grade - the framework in which evidence for guidelines can be assessed - and explains why the most important thing is not the RCTs, but being very clear about what the guideline is supposed to achieve.

https://www.gov.uk/government/groups/joint-committee-on-vaccination-and-immunisation

<p>https://www.gradeworkinggroup.org/</p>
]]></description>
                                                            <content:encoded><![CDATA[In a slightly different talk evidence, Helen Macdonald and Duncan Jarvies are bringing you a couple, of in depth interviews,

Firstly, Anthony Harnden, GP, academic and member of the UK's Joint Committee on Vaccination and Immunisation takes us inside their decision making, and explains what evidence they look at, how they assess it, and what the next year of vaccination may look like.

Also in this episode, Gordon Guyatt, one of the founders of EBM, joins us to talk about Grade - the framework in which evidence for guidelines can be assessed - and explains why the most important thing is not the RCTs, but being very clear about what the guideline is supposed to achieve.

https://www.gov.uk/government/groups/joint-committee-on-vaccination-and-immunisation

<p>https://www.gradeworkinggroup.org/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3r4qs9/stream_1005665569-bmjgroup-talk-evidence-inside-the-jcvi-and-the-key-to-grading-evidence.mp3" length="53345801" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In a slightly different talk evidence, Helen Macdonald and Duncan Jarvies are bringing you a couple, of in depth interviews,

Firstly, Anthony Harnden, GP, academic and member of the UK's Joint Committee on Vaccination and Immunisation takes us inside their decision making, and explains what evidence they look at, how they assess it, and what the next year of vaccination may look like.

Also in this episode, Gordon Guyatt, one of the founders of EBM, joins us to talk about Grade - the framework in which evidence for guidelines can be assessed - and explains why the most important thing is not the RCTs, but being very clear about what the guideline is supposed to achieve.

https://www.gov.uk/government/groups/joint-committee-on-vaccination-and-immunisation

https://www.gradeworkinggroup.org/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3334</itunes:duration>
                                    </item>
    <item>
        <title>Stephen Thomas - Behind the scenes in the Pfizer vaccine trial</title>
        <itunes:title>Stephen Thomas - Behind the scenes in the Pfizer vaccine trial</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/stephen-thomas-behind-the-scenes-in-the-pfizer-vaccine-trial/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/stephen-thomas-behind-the-scenes-in-the-pfizer-vaccine-trial/#comments</comments>        <pubDate>Mon, 08 Mar 2021 18:12:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/stephen-thomas-behind-the-scenes-in-the-pfizer-vaccine-trial</guid>
                                    <description><![CDATA[Never has the spotlight been as strong on a clinical trial as that on the Pfizer BioNTech vaccine, the first approved for covid-19. 

In this interview, Joanne Silberner spoke to its lead principal investigator, Stephen Thomas chief of infectious diseases at SUNY Upstate Medical University, New York, became the lead principal investigator for one of the most closely watched clinical trials in history.

They discuss the moment the positive results came through, what will happen to the people who are still enrolled in the trial, but got a placebo dose, and why the trial was designed in the way it was.

<p>www.bmj.com/coronavirus</p>
]]></description>
                                                            <content:encoded><![CDATA[Never has the spotlight been as strong on a clinical trial as that on the Pfizer BioNTech vaccine, the first approved for covid-19. 

In this interview, Joanne Silberner spoke to its lead principal investigator, Stephen Thomas chief of infectious diseases at SUNY Upstate Medical University, New York, became the lead principal investigator for one of the most closely watched clinical trials in history.

They discuss the moment the positive results came through, what will happen to the people who are still enrolled in the trial, but got a placebo dose, and why the trial was designed in the way it was.

<p>www.bmj.com/coronavirus</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/586u9a/stream_1001532403-bmjgroup-stephen-thomas-behind-the-scenes-in-the-pfizer-vaccine-trial.mp3" length="31259584" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Never has the spotlight been as strong on a clinical trial as that on the Pfizer BioNTech vaccine, the first approved for covid-19. 

In this interview, Joanne Silberner spoke to its lead principal investigator, Stephen Thomas chief of infectious diseases at SUNY Upstate Medical University, New York, became the lead principal investigator for one of the most closely watched clinical trials in history.

They discuss the moment the positive results came through, what will happen to the people who are still enrolled in the trial, but got a placebo dose, and why the trial was designed in the way it was.

www.bmj.com/coronavirus]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1954</itunes:duration>
                                    </item>
    <item>
        <title>Coronavirus second wave - cancelled surgery, increasing waiting lists</title>
        <itunes:title>Coronavirus second wave - cancelled surgery, increasing waiting lists</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/coronavirus-second-wave-cancelled-surgery-increasing-waiting-lists/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/coronavirus-second-wave-cancelled-surgery-increasing-waiting-lists/#comments</comments>        <pubDate>Wed, 03 Mar 2021 18:23:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/second-wave-podcast-surgery</guid>
                                    <description><![CDATA[Many surgeries have been cancelled during the pandemic, with good reason, as early data showed the increase in mortality associated with a coronavirus infection, but now waiting lists grow, and there are questions about how the NHS will pick up the slack.

In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to the full panel; Partha Kar, consultant in diabetes and endocrinology in Portsmouth, Matt Morgan, a consultant in a intensive care medicine in Cardiff, Helen Salisbury, GP in Oxfordshire,  and Nisreen Alwan, public health consultant in Southampton.

They are joined by Mary Venn, research fellow, and honorary surgical registrar in London, who's been looking into the pandemic's effect on surgery. For more on that research:

http://nihrglobalsurgery.org/surgeryduringcovid

<p>To register for our covid known unknowns webinar - https://www.bmj.com/covid-19-webinars</p>
]]></description>
                                                            <content:encoded><![CDATA[Many surgeries have been cancelled during the pandemic, with good reason, as early data showed the increase in mortality associated with a coronavirus infection, but now waiting lists grow, and there are questions about how the NHS will pick up the slack.

In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to the full panel; Partha Kar, consultant in diabetes and endocrinology in Portsmouth, Matt Morgan, a consultant in a intensive care medicine in Cardiff, Helen Salisbury, GP in Oxfordshire,  and Nisreen Alwan, public health consultant in Southampton.

They are joined by Mary Venn, research fellow, and honorary surgical registrar in London, who's been looking into the pandemic's effect on surgery. For more on that research:

http://nihrglobalsurgery.org/surgeryduringcovid

<p>To register for our covid known unknowns webinar - https://www.bmj.com/covid-19-webinars</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/pzov2r/stream_997956193-bmjgroup-second-wave-podcast-surgery.mp3" length="41491225" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Many surgeries have been cancelled during the pandemic, with good reason, as early data showed the increase in mortality associated with a coronavirus infection, but now waiting lists grow, and there are questions about how the NHS will pick up the slack.

In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to the full panel; Partha Kar, consultant in diabetes and endocrinology in Portsmouth, Matt Morgan, a consultant in a intensive care medicine in Cardiff, Helen Salisbury, GP in Oxfordshire,  and Nisreen Alwan, public health consultant in Southampton.

They are joined by Mary Venn, research fellow, and honorary surgical registrar in London, who's been looking into the pandemic's effect on surgery. For more on that research:

http://nihrglobalsurgery.org/surgeryduringcovid

To register for our covid known unknowns webinar - https://www.bmj.com/covid-19-webinars]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2593</itunes:duration>
                                    </item>
    <item>
        <title>Wellbeing - speaking out about mental health in the NHS</title>
        <itunes:title>Wellbeing - speaking out about mental health in the NHS</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/wellbeing-speaking-out-about-mental-health-in-the-nhs/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/wellbeing-speaking-out-about-mental-health-in-the-nhs/#comments</comments>        <pubDate>Fri, 26 Feb 2021 13:07:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/wellbeing-speaking-out-about-mental-health-in-the-nhs</guid>
                                    <description><![CDATA[Ashling Lillis is a now consultant in acute medicine at Whittington Health NHS Trust, but she was almost a consultant in intensive care medicine - but a mental health crisis just 6 months before she qualified made her reassess her career, and choose a different path.

In this podcast, Ash talks to Abi and Cat about the difficulty many doctors have when discussing their mental health - and how speaking out about her own experiences, has encouraged others to talk to her privately - and opened her eyes to the extent of the problem in the NHS.

<p>www.bmj.com/wellbeing</p>
]]></description>
                                                            <content:encoded><![CDATA[Ashling Lillis is a now consultant in acute medicine at Whittington Health NHS Trust, but she was almost a consultant in intensive care medicine - but a mental health crisis just 6 months before she qualified made her reassess her career, and choose a different path.

In this podcast, Ash talks to Abi and Cat about the difficulty many doctors have when discussing their mental health - and how speaking out about her own experiences, has encouraged others to talk to her privately - and opened her eyes to the extent of the problem in the NHS.

<p>www.bmj.com/wellbeing</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/d67z99/stream_993522937-bmjgroup-wellbeing-speaking-out-about-mental-health-in-the-nhs.mp3" length="43249579" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Ashling Lillis is a now consultant in acute medicine at Whittington Health NHS Trust, but she was almost a consultant in intensive care medicine - but a mental health crisis just 6 months before she qualified made her reassess her career, and choose a different path.

In this podcast, Ash talks to Abi and Cat about the difficulty many doctors have when discussing their mental health - and how speaking out about her own experiences, has encouraged others to talk to her privately - and opened her eyes to the extent of the problem in the NHS.

www.bmj.com/wellbeing]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2703</itunes:duration>
                                    </item>
    <item>
        <title>The BMJ Interview - Jeremy Farrar; sharing the vaccine is enlightened self interest</title>
        <itunes:title>The BMJ Interview - Jeremy Farrar; sharing the vaccine is enlightened self interest</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-bmj-interview-jeremy-farrar-sharing-the-vaccine-is-enlightened-self-interest/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-bmj-interview-jeremy-farrar-sharing-the-vaccine-is-enlightened-self-interest/#comments</comments>        <pubDate>Fri, 19 Feb 2021 16:23:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-bmj-interview-jeremy-farrar-sharing-the-vaccine-is-enlightened-self-interest</guid>
                                    <description><![CDATA[Jeremy Farrar, is director of the Wellcome Trust, as well as advisor to the government on SAGE. Trained as a medic and with a PhD in neuro-immunology, he was a professor of Tropical Medicine and Global health at the University of Oxford.

In this podcast, he tells us why he thinks that vaccine nationalism is a very short-termist response the pandemic, and why he's bullish about new variants of the SARS-CoV-2 virus.

<p>www.bmj.com/coronavirus</p>
]]></description>
                                                            <content:encoded><![CDATA[Jeremy Farrar, is director of the Wellcome Trust, as well as advisor to the government on SAGE. Trained as a medic and with a PhD in neuro-immunology, he was a professor of Tropical Medicine and Global health at the University of Oxford.

In this podcast, he tells us why he thinks that vaccine nationalism is a very short-termist response the pandemic, and why he's bullish about new variants of the SARS-CoV-2 virus.

<p>www.bmj.com/coronavirus</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/zvyr4z/stream_988909057-bmjgroup-the-bmj-interview-jeremy-farrar-sharing-the-vaccine-is-enlightened-self-interest.mp3" length="31955486" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Jeremy Farrar, is director of the Wellcome Trust, as well as advisor to the government on SAGE. Trained as a medic and with a PhD in neuro-immunology, he was a professor of Tropical Medicine and Global health at the University of Oxford.

In this podcast, he tells us why he thinks that vaccine nationalism is a very short-termist response the pandemic, and why he's bullish about new variants of the SARS-CoV-2 virus.

www.bmj.com/coronavirus]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1997</itunes:duration>
                                    </item>
    <item>
        <title>Corona virus second wave - Palliative care, and online abuse</title>
        <itunes:title>Corona virus second wave - Palliative care, and online abuse</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/corona-virus-second-wave-palliative-care-and-online-abuse/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/corona-virus-second-wave-palliative-care-and-online-abuse/#comments</comments>        <pubDate>Wed, 17 Feb 2021 12:13:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/corona-virus-second-wave-palliative-care-and-online-abuse</guid>
                                    <description><![CDATA[In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to; Partha Kar, consultant in diabetes and endocrinology in Portsmouth, Helen Salisbury, GP in Oxfordshire, and Nisreen Alwan, public health consultant in Southampton. This week our special guest is Rachel Clarke, author and palliative care specialist. 

<p>The panel discuss how end of life care has changed in the pandemic, and how clinicians have become targets of abuse on social media, for speaking out about things like masks and hospital capacity.</p>
]]></description>
                                                            <content:encoded><![CDATA[In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to; Partha Kar, consultant in diabetes and endocrinology in Portsmouth, Helen Salisbury, GP in Oxfordshire, and Nisreen Alwan, public health consultant in Southampton. This week our special guest is Rachel Clarke, author and palliative care specialist. 

<p>The panel discuss how end of life care has changed in the pandemic, and how clinicians have become targets of abuse on social media, for speaking out about things like masks and hospital capacity.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/k9d1u7/stream_987348811-bmjgroup-corona-virus-second-wave-palliative-care-and-online-abuse.mp3" length="41208266" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to; Partha Kar, consultant in diabetes and endocrinology in Portsmouth, Helen Salisbury, GP in Oxfordshire, and Nisreen Alwan, public health consultant in Southampton. This week our special guest is Rachel Clarke, author and palliative care specialist. 

The panel discuss how end of life care has changed in the pandemic, and how clinicians have become targets of abuse on social media, for speaking out about things like masks and hospital capacity.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2575</itunes:duration>
                                    </item>
    <item>
        <title>Wellbeing special - A post vaccination mindfullness moment</title>
        <itunes:title>Wellbeing special - A post vaccination mindfullness moment</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/wellbeing-special-a-post-vaccination-mindfullness-moment/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/wellbeing-special-a-post-vaccination-mindfullness-moment/#comments</comments>        <pubDate>Fri, 12 Feb 2021 17:49:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/wellbeing-special-a-post-vaccination-mindfullness-moment</guid>
                                    <description><![CDATA[The observation period, after receiving a covid-19 vaccination may be the only 15 minutes someone in the NHS might get all day.

In this podcast, we're joined again by Chris Bu, psychiatry trainee who has previously spoken to us about how Burmese Buddhism helped him in his training. 

He takes us through a guided mindfullness meditation, tailored to that post-vaccination period, to help you make the most of your observation time.

<p>www.bmj.com/wellbeing</p>
]]></description>
                                                            <content:encoded><![CDATA[The observation period, after receiving a covid-19 vaccination may be the only 15 minutes someone in the NHS might get all day.

In this podcast, we're joined again by Chris Bu, psychiatry trainee who has previously spoken to us about how Burmese Buddhism helped him in his training. 

He takes us through a guided mindfullness meditation, tailored to that post-vaccination period, to help you make the most of your observation time.

<p>www.bmj.com/wellbeing</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/356cff/stream_984282247-bmjgroup-wellbeing-special-a-post-vaccination-mindfullness-moment.mp3" length="15910680" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The observation period, after receiving a covid-19 vaccination may be the only 15 minutes someone in the NHS might get all day.

In this podcast, we're joined again by Chris Bu, psychiatry trainee who has previously spoken to us about how Burmese Buddhism helped him in his training. 

He takes us through a guided mindfullness meditation, tailored to that post-vaccination period, to help you make the most of your observation time.

www.bmj.com/wellbeing]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>663</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence - re-hospitalistion for covid-19, remote hypertension intervention</title>
        <itunes:title>Talk Evidence - re-hospitalistion for covid-19, remote hypertension intervention</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-re-hospitalistion-for-covid-19-remote-hypertension-intervention/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-re-hospitalistion-for-covid-19-remote-hypertension-intervention/#comments</comments>        <pubDate>Fri, 12 Feb 2021 11:51:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-re-hospitalistion-for-covid-19-remote-blood-pressure-treatment</guid>
                                    <description><![CDATA[The evidence geekery continues, and this week Helen Macdonald and Duncan Jarvies are joined by Joe Ross, The BMJ's US research editor, and professor of medicine and public health at Yale.

This week we pick up on a preprint in medRxiv, which has been attracting attention on social media - it tries to look at the longer term effects of covid hospitalisation.

Joe explains why he thinks propensity matching can be summarised as "doing your best".

Finally, as more and more care moves remotely, we discuss a trial on a digital intervention to help manage poorly controlled hypertension remotely.

Reading list:
Epidemiology of post-COVID syndrome following hospitalisation with
coronavirus: a retrospective cohort study
https://www.medrxiv.org/content/10.1101/2021.01.15.21249885v1.full.pdf

Home and Online Management and Evaluation of Blood Pressure (HOME BP) using a digital intervention in poorly controlled hypertension: randomised controlled trial
<p>https://www.bmj.com/content/372/bmj.m4858</p>
]]></description>
                                                            <content:encoded><![CDATA[The evidence geekery continues, and this week Helen Macdonald and Duncan Jarvies are joined by Joe Ross, The BMJ's US research editor, and professor of medicine and public health at Yale.

This week we pick up on a preprint in medRxiv, which has been attracting attention on social media - it tries to look at the longer term effects of covid hospitalisation.

Joe explains why he thinks propensity matching can be summarised as "doing your best".

Finally, as more and more care moves remotely, we discuss a trial on a digital intervention to help manage poorly controlled hypertension remotely.

Reading list:
Epidemiology of post-COVID syndrome following hospitalisation with
coronavirus: a retrospective cohort study
https://www.medrxiv.org/content/10.1101/2021.01.15.21249885v1.full.pdf

Home and Online Management and Evaluation of Blood Pressure (HOME BP) using a digital intervention in poorly controlled hypertension: randomised controlled trial
<p>https://www.bmj.com/content/372/bmj.m4858</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fx4rsc/stream_984075949-bmjgroup-talk-evidence-re-hospitalistion-for-covid-19-remote-blood-pressure-treatment.mp3" length="39830528" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The evidence geekery continues, and this week Helen Macdonald and Duncan Jarvies are joined by Joe Ross, The BMJ's US research editor, and professor of medicine and public health at Yale.

This week we pick up on a preprint in medRxiv, which has been attracting attention on social media - it tries to look at the longer term effects of covid hospitalisation.

Joe explains why he thinks propensity matching can be summarised as "doing your best".

Finally, as more and more care moves remotely, we discuss a trial on a digital intervention to help manage poorly controlled hypertension remotely.

Reading list:
Epidemiology of post-COVID syndrome following hospitalisation with
coronavirus: a retrospective cohort study
https://www.medrxiv.org/content/10.1101/2021.01.15.21249885v1.full.pdf

Home and Online Management and Evaluation of Blood Pressure (HOME BP) using a digital intervention in poorly controlled hypertension: randomised controlled trial
https://www.bmj.com/content/372/bmj.m4858]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2489</itunes:duration>
                                    </item>
    <item>
        <title>Neil Greenberg on tackling PTSD in the NHS</title>
        <itunes:title>Neil Greenberg on tackling PTSD in the NHS</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/neil-greenberg-on-tackling-ptsd-in-the-nhs/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/neil-greenberg-on-tackling-ptsd-in-the-nhs/#comments</comments>        <pubDate>Tue, 09 Feb 2021 17:59:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/neil-greenberg-on-tackling-ptsd-in-the-nhs</guid>
                                    <description><![CDATA[Neil Greenberg is a psychiatrist, and professor of Defence Mental Health at King's College London. He spent 23 in the military, and now continues to work with them on things like peer led traumatic stress support packages.

A recent survey of NHS staff showed disturbing signs that covid-19 has caused a widespread trauma in staff, so in this podcast we talked to Neil about trauma and moral injury, what some of the warning signs are, and what individuals and organisations can do to help their colleagues.

<p>www.bmj.com/wellbeing</p>
]]></description>
                                                            <content:encoded><![CDATA[Neil Greenberg is a psychiatrist, and professor of Defence Mental Health at King's College London. He spent 23 in the military, and now continues to work with them on things like peer led traumatic stress support packages.

A recent survey of NHS staff showed disturbing signs that covid-19 has caused a widespread trauma in staff, so in this podcast we talked to Neil about trauma and moral injury, what some of the warning signs are, and what individuals and organisations can do to help their colleagues.

<p>www.bmj.com/wellbeing</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/clusil/stream_982185016-bmjgroup-neil-greenberg-on-tackling-ptsd-in-the-nhs.mp3" length="56510644" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Neil Greenberg is a psychiatrist, and professor of Defence Mental Health at King's College London. He spent 23 in the military, and now continues to work with them on things like peer led traumatic stress support packages.

A recent survey of NHS staff showed disturbing signs that covid-19 has caused a widespread trauma in staff, so in this podcast we talked to Neil about trauma and moral injury, what some of the warning signs are, and what individuals and organisations can do to help their colleagues.

www.bmj.com/wellbeing]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2354</itunes:duration>
                                    </item>
    <item>
        <title>The BMJ interview - Jeremy Hunt MP</title>
        <itunes:title>The BMJ interview - Jeremy Hunt MP</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-bmj-interview-jeremy-hunt-mp/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-bmj-interview-jeremy-hunt-mp/#comments</comments>        <pubDate>Mon, 08 Feb 2021 19:27:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-bmj-interview-jeremy-hunt-mp</guid>
                                    <description><![CDATA[Jeremy Hunt probably needs no introduction to our audience - the UK's longest serving health minister, he now chairs Westminster's Health and Social Care Committee - the powerful committee that holds the government to account for its policy choices.

<p>In this interview Gareth Iacobucci asks Hunt if he regrets his decision to impose the contract on junior doctors which lead to their industrial action, how  workforce issues have left the NHS in a poor state to deal with a health emergency. They also talk about the potential for a public enquiry into the government's handling of the pandemic, and what an upcoming committee report into the same issue might find.</p>
]]></description>
                                                            <content:encoded><![CDATA[Jeremy Hunt probably needs no introduction to our audience - the UK's longest serving health minister, he now chairs Westminster's Health and Social Care Committee - the powerful committee that holds the government to account for its policy choices.

<p>In this interview Gareth Iacobucci asks Hunt if he regrets his decision to impose the contract on junior doctors which lead to their industrial action, how  workforce issues have left the NHS in a poor state to deal with a health emergency. They also talk about the potential for a public enquiry into the government's handling of the pandemic, and what an upcoming committee report into the same issue might find.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/pqz65t/stream_981590131-bmjgroup-the-bmj-interview-jeremy-hunt-mp.mp3" length="41134288" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Jeremy Hunt probably needs no introduction to our audience - the UK's longest serving health minister, he now chairs Westminster's Health and Social Care Committee - the powerful committee that holds the government to account for its policy choices.

In this interview Gareth Iacobucci asks Hunt if he regrets his decision to impose the contract on junior doctors which lead to their industrial action, how  workforce issues have left the NHS in a poor state to deal with a health emergency. They also talk about the potential for a public enquiry into the government's handling of the pandemic, and what an upcoming committee report into the same issue might find.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2571</itunes:duration>
                                    </item>
    <item>
        <title>Coronavirus second wave - The NHS one year on</title>
        <itunes:title>Coronavirus second wave - The NHS one year on</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/coronavirus-second-wave-the-nhs-one-year-on/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/coronavirus-second-wave-the-nhs-one-year-on/#comments</comments>        <pubDate>Thu, 04 Feb 2021 10:33:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/coronavirus-second-wave-the-nhs-one-year-on</guid>
                                    <description><![CDATA[The "public health emergency of international concern" was issued by the WHO a year and a lifetime ago. As the UK ramps up testing for the South African virus variant, and is full steam ahead on vaccination, we look back at what we've learned in that time.

In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to; Partha Kar, consultant in diabetes and endocrinology in Portsmouth, Matt Morgan, a consultant in a intensive care medicine in Cardiff, and Helen Salisbury, GP in Oxfordshire.

They talk about working in the NHS at the moment, the utility of international comparisons, and their remaining questions about vaccination regimes.

<p>www.bmj.com/coronavirus</p>
]]></description>
                                                            <content:encoded><![CDATA[The "public health emergency of international concern" was issued by the WHO a year and a lifetime ago. As the UK ramps up testing for the South African virus variant, and is full steam ahead on vaccination, we look back at what we've learned in that time.

In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to; Partha Kar, consultant in diabetes and endocrinology in Portsmouth, Matt Morgan, a consultant in a intensive care medicine in Cardiff, and Helen Salisbury, GP in Oxfordshire.

They talk about working in the NHS at the moment, the utility of international comparisons, and their remaining questions about vaccination regimes.

<p>www.bmj.com/coronavirus</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/tqll0x/stream_978841759-bmjgroup-coronavirus-second-wave-the-nhs-one-year-on.mp3" length="39000606" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The "public health emergency of international concern" was issued by the WHO a year and a lifetime ago. As the UK ramps up testing for the South African virus variant, and is full steam ahead on vaccination, we look back at what we've learned in that time.

In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to; Partha Kar, consultant in diabetes and endocrinology in Portsmouth, Matt Morgan, a consultant in a intensive care medicine in Cardiff, and Helen Salisbury, GP in Oxfordshire.

They talk about working in the NHS at the moment, the utility of international comparisons, and their remaining questions about vaccination regimes.

www.bmj.com/coronavirus]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2438</itunes:duration>
                                    </item>
    <item>
        <title>The BMJ interview - Tom Frieden, former CDC director on why we thought we were prepared</title>
        <itunes:title>The BMJ interview - Tom Frieden, former CDC director on why we thought we were prepared</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-bmj-interview-tom-frieden-former-cdc-director-on-why-we-thought-we-were-prepared/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-bmj-interview-tom-frieden-former-cdc-director-on-why-we-thought-we-were-prepared/#comments</comments>        <pubDate>Tue, 02 Feb 2021 18:06:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-bmj-interview-tom-frieden</guid>
                                    <description><![CDATA[It’s been just over a year since the WHO declared the pandemic a “Public Health Emergency of International Concern” - if you cast your mind back to then, the news was full of reassurances about how prepared the UK and the USA were for a pandemic.

Now a year later, with the benefit of hindsight, that confidence was wildly overstated - but why was that, what is the gap between that theoretical readiness, and reality.
 
In this podcast we're joined by talking to Tom Frieden - former director of the Centres for Disease Control and Prevention, under President Obama, and who has a long history of public health leadership. 

He talks about the gap between the apparatus to do something, the the political will to do that. Why data have been lacking, and the interaction between a infectious and non-infectious diseases.

<p>www.bmj.com/coronavirus</p>
]]></description>
                                                            <content:encoded><![CDATA[It’s been just over a year since the WHO declared the pandemic a “Public Health Emergency of International Concern” - if you cast your mind back to then, the news was full of reassurances about how prepared the UK and the USA were for a pandemic.

Now a year later, with the benefit of hindsight, that confidence was wildly overstated - but why was that, what is the gap between that theoretical readiness, and reality.
 
In this podcast we're joined by talking to Tom Frieden - former director of the Centres for Disease Control and Prevention, under President Obama, and who has a long history of public health leadership. 

He talks about the gap between the apparatus to do something, the the political will to do that. Why data have been lacking, and the interaction between a infectious and non-infectious diseases.

<p>www.bmj.com/coronavirus</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ta371q/stream_977783419-bmjgroup-the-bmj-interview-tom-frieden.mp3" length="35608449" type="audio/mpeg"/>
        <itunes:summary><![CDATA[It’s been just over a year since the WHO declared the pandemic a “Public Health Emergency of International Concern” - if you cast your mind back to then, the news was full of reassurances about how prepared the UK and the USA were for a pandemic.

Now a year later, with the benefit of hindsight, that confidence was wildly overstated - but why was that, what is the gap between that theoretical readiness, and reality.
 
In this podcast we're joined by talking to Tom Frieden - former director of the Centres for Disease Control and Prevention, under President Obama, and who has a long history of public health leadership. 

He talks about the gap between the apparatus to do something, the the political will to do that. Why data have been lacking, and the interaction between a infectious and non-infectious diseases.

www.bmj.com/coronavirus]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2226</itunes:duration>
                                    </item>
    <item>
        <title>Coronavirus second wave - 100,000 deaths</title>
        <itunes:title>Coronavirus second wave - 100,000 deaths</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/coronavirus-second-wave-100000-deaths/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/coronavirus-second-wave-100000-deaths/#comments</comments>        <pubDate>Wed, 27 Jan 2021 15:50:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/coronavirus-second-wave-100000-deaths</guid>
                                    <description><![CDATA[Recorded on the 26th January 2021

The UK has become, officially, the worst performing country in terms of Covid-19 deaths, per head of population - and the number of people in hospital is still higher than at any point in the pandemic.

In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to; Partha Kar, consultant in diabetes and endocrinology in Portsmouth, Matt Morgan, a consultant in a intensive care medicine in Cardiff, and Helen Salisbury, GP in Oxfordshire.

<p>They talk about working in the NHS at the moment, and the challenges in things like oxygen and vaccine supplies. How the pandemic has exposed a gap in general medicine, and the importance of challenging poor responses at all levels.</p>
]]></description>
                                                            <content:encoded><![CDATA[Recorded on the 26th January 2021

The UK has become, officially, the worst performing country in terms of Covid-19 deaths, per head of population - and the number of people in hospital is still higher than at any point in the pandemic.

In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to; Partha Kar, consultant in diabetes and endocrinology in Portsmouth, Matt Morgan, a consultant in a intensive care medicine in Cardiff, and Helen Salisbury, GP in Oxfordshire.

<p>They talk about working in the NHS at the moment, and the challenges in things like oxygen and vaccine supplies. How the pandemic has exposed a gap in general medicine, and the importance of challenging poor responses at all levels.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/uf2qz7/stream_973813792-bmjgroup-coronavirus-second-wave-100000-deaths.mp3" length="39847809" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Recorded on the 26th January 2021

The UK has become, officially, the worst performing country in terms of Covid-19 deaths, per head of population - and the number of people in hospital is still higher than at any point in the pandemic.

In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to; Partha Kar, consultant in diabetes and endocrinology in Portsmouth, Matt Morgan, a consultant in a intensive care medicine in Cardiff, and Helen Salisbury, GP in Oxfordshire.

They talk about working in the NHS at the moment, and the challenges in things like oxygen and vaccine supplies. How the pandemic has exposed a gap in general medicine, and the importance of challenging poor responses at all levels.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2490</itunes:duration>
                                    </item>
    <item>
        <title>Coronavirus second wave - The view from the front line</title>
        <itunes:title>Coronavirus second wave - The view from the front line</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/coronavirus-second-wave-the-view-from-the-front-line/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/coronavirus-second-wave-the-view-from-the-front-line/#comments</comments>        <pubDate>Wed, 20 Jan 2021 18:28:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/coronavirus-second-wave-the-view-from-the-front-line</guid>
                                    <description><![CDATA[In the UK, over 37,000 people are in hospital with covid-19, and the NHS comes closer than ever to being overwhelmed - though 4 million people have received their first dose of the vaccine, we are warned that things will get worse before they get better.

In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to; Partha Kar, consultant in diabetes and endocrinology in Portsmouth, Matt Morgan, a consultant in a intensive care medicine in Cardiff, Helen Salisbury, GP in Oxfordshire, and Nisreen Alwan, public health consultant in Southampton, about the pressure on hospitals, why GPs are questioning the need for max vaccination centres, and why the public health approach can't be just lockdown and vaccinations.

<p>www.bmj.com/coronavirus</p>
]]></description>
                                                            <content:encoded><![CDATA[In the UK, over 37,000 people are in hospital with covid-19, and the NHS comes closer than ever to being overwhelmed - though 4 million people have received their first dose of the vaccine, we are warned that things will get worse before they get better.

In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to; Partha Kar, consultant in diabetes and endocrinology in Portsmouth, Matt Morgan, a consultant in a intensive care medicine in Cardiff, Helen Salisbury, GP in Oxfordshire, and Nisreen Alwan, public health consultant in Southampton, about the pressure on hospitals, why GPs are questioning the need for max vaccination centres, and why the public health approach can't be just lockdown and vaccinations.

<p>www.bmj.com/coronavirus</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/48zbil/stream_969388846-bmjgroup-coronavirus-second-wave-the-view-from-the-front-line.mp3" length="49553657" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In the UK, over 37,000 people are in hospital with covid-19, and the NHS comes closer than ever to being overwhelmed - though 4 million people have received their first dose of the vaccine, we are warned that things will get worse before they get better.

In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to; Partha Kar, consultant in diabetes and endocrinology in Portsmouth, Matt Morgan, a consultant in a intensive care medicine in Cardiff, Helen Salisbury, GP in Oxfordshire, and Nisreen Alwan, public health consultant in Southampton, about the pressure on hospitals, why GPs are questioning the need for max vaccination centres, and why the public health approach can't be just lockdown and vaccinations.

www.bmj.com/coronavirus]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3097</itunes:duration>
                                    </item>
    <item>
        <title>The BMJ interview: Fixing America’s covid response in the Biden era</title>
        <itunes:title>The BMJ interview: Fixing America’s covid response in the Biden era</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-bmj-interview-fixing-america-s-covid-response-in-the-biden-era/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-bmj-interview-fixing-america-s-covid-response-in-the-biden-era/#comments</comments>        <pubDate>Tue, 19 Jan 2021 12:35:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-bmj-interview-fixing-americas-covid-response-in-the-biden-era</guid>
                                    <description><![CDATA[US president elect Joe Biden wasted no time in appointing a special advisory board of experts to guide America out of its coronavirus crisis. 

One of those experts is Celine Gounder, an infectious diseases epidemiologist who has worked on Ebola, tuberculosis, and HIV in Africa and South America. She’s a clinical assistant professor of medicine and infectious diseases at New York University’s School of Medicine, as well as an active writer and podcast host, including of Epidemic

In this podcast she talks to Joanne Silberner about the ways in which the taskforce is helping prepare for action immediately after the inauguration, what the big challenges they need to tackle are, and how they plan to rebuild trust in the U.S. covid response.

<p>https://www.bmj.com/content/372/bmj.n33</p>
]]></description>
                                                            <content:encoded><![CDATA[US president elect Joe Biden wasted no time in appointing a special advisory board of experts to guide America out of its coronavirus crisis. 

One of those experts is Celine Gounder, an infectious diseases epidemiologist who has worked on Ebola, tuberculosis, and HIV in Africa and South America. She’s a clinical assistant professor of medicine and infectious diseases at New York University’s School of Medicine, as well as an active writer and podcast host, including of Epidemic

In this podcast she talks to Joanne Silberner about the ways in which the taskforce is helping prepare for action immediately after the inauguration, what the big challenges they need to tackle are, and how they plan to rebuild trust in the U.S. covid response.

<p>https://www.bmj.com/content/372/bmj.n33</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4el9is/stream_968463460-bmjgroup-the-bmj-interview-fixing-americas-covid-response-in-the-biden-era.mp3" length="27653014" type="audio/mpeg"/>
        <itunes:summary><![CDATA[US president elect Joe Biden wasted no time in appointing a special advisory board of experts to guide America out of its coronavirus crisis. 

One of those experts is Celine Gounder, an infectious diseases epidemiologist who has worked on Ebola, tuberculosis, and HIV in Africa and South America. She’s a clinical assistant professor of medicine and infectious diseases at New York University’s School of Medicine, as well as an active writer and podcast host, including of Epidemic

In this podcast she talks to Joanne Silberner about the ways in which the taskforce is helping prepare for action immediately after the inauguration, what the big challenges they need to tackle are, and how they plan to rebuild trust in the U.S. covid response.

https://www.bmj.com/content/372/bmj.n33]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1728</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence - Lateral flow tests update, not the best public health approach</title>
        <itunes:title>Talk Evidence - Lateral flow tests update, not the best public health approach</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-lateral-flow-tests-update-not-the-best-public-health-approach/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-lateral-flow-tests-update-not-the-best-public-health-approach/#comments</comments>        <pubDate>Sat, 16 Jan 2021 17:54:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-lateral-flow-tests-update-not-the-best-public-health-approach</guid>
                                    <description><![CDATA[In this episode of Talk Evidence, Jon Deeks, professor of biostatistics at the University of Birmingham, returns to the pod with an update on lateral flow tests - and why the government plan for using them in asymptomatic screening for covid-19 doesn't follow the science.

We're also joined by Allyson Pollock, clinical professor of public health at Newcastle University, and author of a recent editorial in The BMJ about asymptomatic transmission of SARS-CoV-2. She explains why she thinks supporting social isolation is the missing piece of our approach to tackling the pandemic.

Covid-19 INNOVA testing in schools: don’t just test, evaluate
https://blogs.bmj.com/bmj/2021/01/12/covid-19-innova-testing-in-schools-dont-just-test-evaluate/

Asymptomatic transmission of covid-19
<p>https://www.bmj.com/content/371/bmj.m4851</p>
]]></description>
                                                            <content:encoded><![CDATA[In this episode of Talk Evidence, Jon Deeks, professor of biostatistics at the University of Birmingham, returns to the pod with an update on lateral flow tests - and why the government plan for using them in asymptomatic screening for covid-19 doesn't follow the science.

We're also joined by Allyson Pollock, clinical professor of public health at Newcastle University, and author of a recent editorial in The BMJ about asymptomatic transmission of SARS-CoV-2. She explains why she thinks supporting social isolation is the missing piece of our approach to tackling the pandemic.

Covid-19 INNOVA testing in schools: don’t just test, evaluate
https://blogs.bmj.com/bmj/2021/01/12/covid-19-innova-testing-in-schools-dont-just-test-evaluate/

Asymptomatic transmission of covid-19
<p>https://www.bmj.com/content/371/bmj.m4851</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kbhmdo/stream_966867874-bmjgroup-talk-evidence-lateral-flow-tests-update-not-the-best-public-health-approach.mp3" length="40421249" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode of Talk Evidence, Jon Deeks, professor of biostatistics at the University of Birmingham, returns to the pod with an update on lateral flow tests - and why the government plan for using them in asymptomatic screening for covid-19 doesn't follow the science.

We're also joined by Allyson Pollock, clinical professor of public health at Newcastle University, and author of a recent editorial in The BMJ about asymptomatic transmission of SARS-CoV-2. She explains why she thinks supporting social isolation is the missing piece of our approach to tackling the pandemic.

Covid-19 INNOVA testing in schools: don’t just test, evaluate
https://blogs.bmj.com/bmj/2021/01/12/covid-19-innova-testing-in-schools-dont-just-test-evaluate/

Asymptomatic transmission of covid-19
https://www.bmj.com/content/371/bmj.m4851]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2526</itunes:duration>
                                    </item>
    <item>
        <title>The BMJ Interview - Andrew Pollard on the Oxford/Astra Zeneca vaccine</title>
        <itunes:title>The BMJ Interview - Andrew Pollard on the Oxford/Astra Zeneca vaccine</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-bmj-interview-andrew-pollard-on-the-oxfordastra-zeneca-vaccine/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-bmj-interview-andrew-pollard-on-the-oxfordastra-zeneca-vaccine/#comments</comments>        <pubDate>Thu, 14 Jan 2021 16:26:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-bmj-interview-andrew-pollard-on-the-oxfordastra-zeneca-vaccine</guid>
                                    <description><![CDATA[Andrew Pollard is Director of the Oxford Vaccines Group - who, along with Astra Zeneca, have developed an modified adenovirus vaccine for SARS-CoV-2.

In this interview we talk to him about the development of that vaccine - what he thinks about the UK government's plan to increase the interval between doses; if he worries about a mutating virus and vaccine escape; and how the university came to make a deal with a commercial company to provide cost-price vaccinations for the world.

<p>www.bmj.com/coronavirus</p>
]]></description>
                                                            <content:encoded><![CDATA[Andrew Pollard is Director of the Oxford Vaccines Group - who, along with Astra Zeneca, have developed an modified adenovirus vaccine for SARS-CoV-2.

In this interview we talk to him about the development of that vaccine - what he thinks about the UK government's plan to increase the interval between doses; if he worries about a mutating virus and vaccine escape; and how the university came to make a deal with a commercial company to provide cost-price vaccinations for the world.

<p>www.bmj.com/coronavirus</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/136b5f/stream_965491573-bmjgroup-the-bmj-interview-andrew-pollard-on-the-oxfordastra-zeneca-vaccine.mp3" length="43000475" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Andrew Pollard is Director of the Oxford Vaccines Group - who, along with Astra Zeneca, have developed an modified adenovirus vaccine for SARS-CoV-2.

In this interview we talk to him about the development of that vaccine - what he thinks about the UK government's plan to increase the interval between doses; if he worries about a mutating virus and vaccine escape; and how the university came to make a deal with a commercial company to provide cost-price vaccinations for the world.

www.bmj.com/coronavirus]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2688</itunes:duration>
                                    </item>
    <item>
        <title>Wellbeing - where to turn for emotional support during the pandemic</title>
        <itunes:title>Wellbeing - where to turn for emotional support during the pandemic</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/wellbeing-where-to-turn-for-emotional-support-during-the-pandemic/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/wellbeing-where-to-turn-for-emotional-support-during-the-pandemic/#comments</comments>        <pubDate>Tue, 12 Jan 2021 17:20:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/where-to-turn-for-emotional-support-during-the-pandemic</guid>
                                    <description><![CDATA[The Samaritans have traditionally been there for people in a crisis, those who are on the verge of ending their life by suicide - but during this pandemic, with the personal toll of caring for covid-19 patients, they are also here to provide emotional support for NHS staff however they are feeling.

In this podcast, Ben Phillips, head of service programmes for Samaritans joins us to explain how being listened to can help - and how to tactfully point your colleagues towards that emotional help if you feel they need it.

If you need support at this time you can call 0800 069 6222
<p>or visit https://www.samaritans.org/how-we-can-help/health-and-care/</p>
]]></description>
                                                            <content:encoded><![CDATA[The Samaritans have traditionally been there for people in a crisis, those who are on the verge of ending their life by suicide - but during this pandemic, with the personal toll of caring for covid-19 patients, they are also here to provide emotional support for NHS staff however they are feeling.

In this podcast, Ben Phillips, head of service programmes for Samaritans joins us to explain how being listened to can help - and how to tactfully point your colleagues towards that emotional help if you feel they need it.

If you need support at this time you can call 0800 069 6222
<p>or visit https://www.samaritans.org/how-we-can-help/health-and-care/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/zjbzl7/stream_964295218-bmjgroup-where-to-turn-for-emotional-support-during-the-pandemic.mp3" length="26112834" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The Samaritans have traditionally been there for people in a crisis, those who are on the verge of ending their life by suicide - but during this pandemic, with the personal toll of caring for covid-19 patients, they are also here to provide emotional support for NHS staff however they are feeling.

In this podcast, Ben Phillips, head of service programmes for Samaritans joins us to explain how being listened to can help - and how to tactfully point your colleagues towards that emotional help if you feel they need it.

If you need support at this time you can call 0800 069 6222
or visit https://www.samaritans.org/how-we-can-help/health-and-care/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1632</itunes:duration>
                                    </item>
    <item>
        <title>Food aid - helping providers support the health of their users</title>
        <itunes:title>Food aid - helping providers support the health of their users</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/food-aid-helping-providers-support-the-health-of-their-users/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/food-aid-helping-providers-support-the-health-of-their-users/#comments</comments>        <pubDate>Fri, 08 Jan 2021 18:37:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/food-aid-helping-providers-support-the-health-of-their-users</guid>
                                    <description><![CDATA[The growth in the need for food aid, in the UK, has been staggering. That's why The BMJ has chosen the Independent Food Aid Network (IFAN) as its annual charity appeal.

Nutritional guidelines which work for everyone is difficult, even harder for food aid providers who have to factor in things like long term storage, reduced access to fresh produce and in some cases the inability to afford the electricity to cook with.

In this podcast, Sabine Goodwin, IFAN's coordinator is joined by Isabel Rice, dietician at the charity Centrepoint, and Dee Woods, co-chair of IFAN and who co-runs Granville Community Kitchen, a food aid provider in London.

Please time the time to donate at;
<p>https://www.foodaidnetwork.org.uk/bmj</p>
]]></description>
                                                            <content:encoded><![CDATA[The growth in the need for food aid, in the UK, has been staggering. That's why The BMJ has chosen the Independent Food Aid Network (IFAN) as its annual charity appeal.

Nutritional guidelines which work for everyone is difficult, even harder for food aid providers who have to factor in things like long term storage, reduced access to fresh produce and in some cases the inability to afford the electricity to cook with.

In this podcast, Sabine Goodwin, IFAN's coordinator is joined by Isabel Rice, dietician at the charity Centrepoint, and Dee Woods, co-chair of IFAN and who co-runs Granville Community Kitchen, a food aid provider in London.

Please time the time to donate at;
<p>https://www.foodaidnetwork.org.uk/bmj</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vsjrsb/stream_961945357-bmjgroup-food-aid-helping-providers-support-the-health-of-their-users.mp3" length="17637876" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The growth in the need for food aid, in the UK, has been staggering. That's why The BMJ has chosen the Independent Food Aid Network (IFAN) as its annual charity appeal.

Nutritional guidelines which work for everyone is difficult, even harder for food aid providers who have to factor in things like long term storage, reduced access to fresh produce and in some cases the inability to afford the electricity to cook with.

In this podcast, Sabine Goodwin, IFAN's coordinator is joined by Isabel Rice, dietician at the charity Centrepoint, and Dee Woods, co-chair of IFAN and who co-runs Granville Community Kitchen, a food aid provider in London.

Please time the time to donate at;
https://www.foodaidnetwork.org.uk/bmj]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1102</itunes:duration>
                                    </item>
    <item>
        <title>Coronavirus second wave - The UK’s fourth lockdown</title>
        <itunes:title>Coronavirus second wave - The UK’s fourth lockdown</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/coronavirus-second-wave-the-uk-s-fourth-lockdown/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/coronavirus-second-wave-the-uk-s-fourth-lockdown/#comments</comments>        <pubDate>Wed, 06 Jan 2021 11:48:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/corona-virus-second-wave-the-uks-fourth-lockdown</guid>
                                    <description><![CDATA[Recorded Tuesday 5th Jan 2021

As the UK enters lockdown, again, schools are closed, the NHS struggles under the surge of cases, new variants of SARS-COV-2 virus stalk the world, and vaccination programmes make a faltering start.

In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to Matt Morgan, a consultant in a intensive care medicine in Cardiff, Helen Salisbury, GP in Oxfordshire, and Nisreen Alwan, public health consultant in Southampton, about the pressure on critical care, England's vaccination roll out, the closure of schools and why communication is undermining trust in the vaccines.

All the BMJ's corona virus coverage is currently free to access
<p>www.bmj.com/coronavirus</p>
]]></description>
                                                            <content:encoded><![CDATA[Recorded Tuesday 5th Jan 2021

As the UK enters lockdown, again, schools are closed, the NHS struggles under the surge of cases, new variants of SARS-COV-2 virus stalk the world, and vaccination programmes make a faltering start.

In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to Matt Morgan, a consultant in a intensive care medicine in Cardiff, Helen Salisbury, GP in Oxfordshire, and Nisreen Alwan, public health consultant in Southampton, about the pressure on critical care, England's vaccination roll out, the closure of schools and why communication is undermining trust in the vaccines.

All the BMJ's corona virus coverage is currently free to access
<p>www.bmj.com/coronavirus</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/e4yidv/stream_960330787-bmjgroup-corona-virus-second-wave-the-uks-fourth-lockdown.mp3" length="48321096" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Recorded Tuesday 5th Jan 2021

As the UK enters lockdown, again, schools are closed, the NHS struggles under the surge of cases, new variants of SARS-COV-2 virus stalk the world, and vaccination programmes make a faltering start.

In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to Matt Morgan, a consultant in a intensive care medicine in Cardiff, Helen Salisbury, GP in Oxfordshire, and Nisreen Alwan, public health consultant in Southampton, about the pressure on critical care, England's vaccination roll out, the closure of schools and why communication is undermining trust in the vaccines.

All the BMJ's corona virus coverage is currently free to access
www.bmj.com/coronavirus]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3020</itunes:duration>
                                    </item>
    <item>
        <title>Listening is the first part of research</title>
        <itunes:title>Listening is the first part of research</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/listening-is-the-first-part-of-research/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/listening-is-the-first-part-of-research/#comments</comments>        <pubDate>Tue, 05 Jan 2021 10:39:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/listening-is-the-first-part-of-research</guid>
                                    <description><![CDATA[The BMJ has long campaigned for better patient and public participation in research, making the case that it leads to better outcomes for patients and for society - but an article published in the Christmas edition of The BMJ goes further than that - and talks about the insights that participants in research provide- insights that the academic team would never be able to have themselves.

In this podcast, Seb Crutch a professor of neuropsychology, and Martin Rossor, national director for dementia research - who have been involved in neurological research as academics, and also by Valerie Mansfield, who’s a member of a patient support group, discuss how the scientific establishment can recognise those invaluable insights.

Read the full article:
<p>https://www.bmj.com/content/371/bmj.m4478</p>
]]></description>
                                                            <content:encoded><![CDATA[The BMJ has long campaigned for better patient and public participation in research, making the case that it leads to better outcomes for patients and for society - but an article published in the Christmas edition of The BMJ goes further than that - and talks about the insights that participants in research provide- insights that the academic team would never be able to have themselves.

In this podcast, Seb Crutch a professor of neuropsychology, and Martin Rossor, national director for dementia research - who have been involved in neurological research as academics, and also by Valerie Mansfield, who’s a member of a patient support group, discuss how the scientific establishment can recognise those invaluable insights.

Read the full article:
<p>https://www.bmj.com/content/371/bmj.m4478</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/widhbj/stream_959663398-bmjgroup-listening-is-the-first-part-of-research.mp3" length="25755061" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The BMJ has long campaigned for better patient and public participation in research, making the case that it leads to better outcomes for patients and for society - but an article published in the Christmas edition of The BMJ goes further than that - and talks about the insights that participants in research provide- insights that the academic team would never be able to have themselves.

In this podcast, Seb Crutch a professor of neuropsychology, and Martin Rossor, national director for dementia research - who have been involved in neurological research as academics, and also by Valerie Mansfield, who’s a member of a patient support group, discuss how the scientific establishment can recognise those invaluable insights.

Read the full article:
https://www.bmj.com/content/371/bmj.m4478]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1610</itunes:duration>
                                    </item>
    <item>
        <title>A (non-systematic) evidence review of 2020</title>
        <itunes:title>A (non-systematic) evidence review of 2020</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/a-non-systematic-evidence-review-of-2020/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/a-non-systematic-evidence-review-of-2020/#comments</comments>        <pubDate>Sun, 03 Jan 2021 09:43:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/an-evidence-review-of-2020</guid>
                                    <description><![CDATA[As 2021 hoves into view, we look back at a year of extraordinary evidence.

Helen Macdonald is joined by Joe Ross, one of The BMJ's research editors, as well as a researcher at Yale.

<p>They discuss the way in which clinical pre-prints have become an important part of the research ecosystem, especially during the pandemic, and pick up on some of the non-coronavirus things you might have missed in the deluge of data.</p>
]]></description>
                                                            <content:encoded><![CDATA[As 2021 hoves into view, we look back at a year of extraordinary evidence.

Helen Macdonald is joined by Joe Ross, one of The BMJ's research editors, as well as a researcher at Yale.

<p>They discuss the way in which clinical pre-prints have become an important part of the research ecosystem, especially during the pandemic, and pick up on some of the non-coronavirus things you might have missed in the deluge of data.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/63qft2/stream_958539166-bmjgroup-an-evidence-review-of-2020.mp3" length="52040398" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As 2021 hoves into view, we look back at a year of extraordinary evidence.

Helen Macdonald is joined by Joe Ross, one of The BMJ's research editors, as well as a researcher at Yale.

They discuss the way in which clinical pre-prints have become an important part of the research ecosystem, especially during the pandemic, and pick up on some of the non-coronavirus things you might have missed in the deluge of data.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2171</itunes:duration>
                                    </item>
    <item>
        <title>The Deep Breath talking wellbeing evidence round-up of the year.</title>
        <itunes:title>The Deep Breath talking wellbeing evidence round-up of the year.</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-deep-breath-talking-wellbeing-evidence-round-up-of-the-year/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-deep-breath-talking-wellbeing-evidence-round-up-of-the-year/#comments</comments>        <pubDate>Fri, 01 Jan 2021 12:29:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-deep-breath-talking-wellbeing-evidence-round-up-of-the-year</guid>
                                    <description><![CDATA[In this end-of-year podcast from Deep Breath In, we're bringing you a light hearted look back at 2020, and trying to remember some of the non-covid-19 medicine that has crossed our desks.

This festive quiz features the deep breath in gang, as well as Cat Chatfield from the Wellbeing podcast, and Helen Macdonald from our Talk Evidence podcasts.

Reading list;
Thyroid disease assessment and management: summary of NICE guidance
https://www.bmj.com/content/368/bmj.m41

Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline
https://www.bmj.com/content/365/bmj.l2006

Judd Brewer's advice for coping with burnout
<p>https://drjud.com/</p>
]]></description>
                                                            <content:encoded><![CDATA[In this end-of-year podcast from Deep Breath In, we're bringing you a light hearted look back at 2020, and trying to remember some of the non-covid-19 medicine that has crossed our desks.

This festive quiz features the deep breath in gang, as well as Cat Chatfield from the Wellbeing podcast, and Helen Macdonald from our Talk Evidence podcasts.

Reading list;
Thyroid disease assessment and management: summary of NICE guidance
https://www.bmj.com/content/368/bmj.m41

Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline
https://www.bmj.com/content/365/bmj.l2006

Judd Brewer's advice for coping with burnout
<p>https://drjud.com/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/35i0hh/stream_957615745-bmjgroup-the-deep-breath-talking-wellbeing-evidence-round-up-of-the-year.mp3" length="62446026" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this end-of-year podcast from Deep Breath In, we're bringing you a light hearted look back at 2020, and trying to remember some of the non-covid-19 medicine that has crossed our desks.

This festive quiz features the deep breath in gang, as well as Cat Chatfield from the Wellbeing podcast, and Helen Macdonald from our Talk Evidence podcasts.

Reading list;
Thyroid disease assessment and management: summary of NICE guidance
https://www.bmj.com/content/368/bmj.m41

Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline
https://www.bmj.com/content/365/bmj.l2006

Judd Brewer's advice for coping with burnout
https://drjud.com/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3903</itunes:duration>
                                    </item>
    <item>
        <title>Talking Christmas evidence - how Christmas research is chosen</title>
        <itunes:title>Talking Christmas evidence - how Christmas research is chosen</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talking-christmas-evidence-how-christmas-research-is-chosen/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talking-christmas-evidence-how-christmas-research-is-chosen/#comments</comments>        <pubDate>Mon, 28 Dec 2020 13:41:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talking-christmas-evidence-how-christmas-research-is-chosen</guid>
                                    <description><![CDATA[If you've had time to digest this year's Christmas edition of The BMJ, you might have wondered how those papers get into The BMJ.

Well in this Talk Evidence podcast, Helen Macdonald, UK research editor at The BMJ talks to two of her research team colleagues, John Fletcher and Tim Feeney, as they talk through why they chose their favourite papers.

Toxicological analysis of George’s marvellous medicine
https://www.bmj.com/content/371/bmj.m4467

Does medicine run in the family—evidence from three generations of physicians in Sweden
https://www.bmj.com/content/371/bmj.m4453

The time to act is now
<p>https://www.bmj.com/content/371/bmj.m4143</p>
]]></description>
                                                            <content:encoded><![CDATA[If you've had time to digest this year's Christmas edition of The BMJ, you might have wondered how those papers get into The BMJ.

Well in this Talk Evidence podcast, Helen Macdonald, UK research editor at The BMJ talks to two of her research team colleagues, John Fletcher and Tim Feeney, as they talk through why they chose their favourite papers.

Toxicological analysis of George’s marvellous medicine
https://www.bmj.com/content/371/bmj.m4467

Does medicine run in the family—evidence from three generations of physicians in Sweden
https://www.bmj.com/content/371/bmj.m4453

The time to act is now
<p>https://www.bmj.com/content/371/bmj.m4143</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/pm6e63/stream_955363684-bmjgroup-talking-christmas-evidence-how-christmas-research-is-chosen.mp3" length="38114432" type="audio/mpeg"/>
        <itunes:summary><![CDATA[If you've had time to digest this year's Christmas edition of The BMJ, you might have wondered how those papers get into The BMJ.

Well in this Talk Evidence podcast, Helen Macdonald, UK research editor at The BMJ talks to two of her research team colleagues, John Fletcher and Tim Feeney, as they talk through why they chose their favourite papers.

Toxicological analysis of George’s marvellous medicine
https://www.bmj.com/content/371/bmj.m4467

Does medicine run in the family—evidence from three generations of physicians in Sweden
https://www.bmj.com/content/371/bmj.m4453

The time to act is now
https://www.bmj.com/content/371/bmj.m4143]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2382</itunes:duration>
                                    </item>
    <item>
        <title>Wellbeing - Human factors, and Christmas Logistics</title>
        <itunes:title>Wellbeing - Human factors, and Christmas Logistics</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/wellbeing-human-factors-and-christmas-logistics/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/wellbeing-human-factors-and-christmas-logistics/#comments</comments>        <pubDate>Thu, 24 Dec 2020 17:47:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/wellbeing-human-factors-and-christmas-logistics</guid>
                                    <description><![CDATA[How do human behaviours affect patient outcomes? And what has that got to do with Christmas?

Graham Shaw, director of Critical Factors, and Peter Brennan, a maxillofacial surgeon in Portsmouth, join us to explain what human factors are, why they’re not a bigger part of medical training, and talk about their importance as the NHS comes under greater and greater pressure because of the surge in covid-19 cases.

They also offer a word of advice to Santa, about making sure a festive never-event never happens.

<p>www.bmj.com/wellbeing</p>
]]></description>
                                                            <content:encoded><![CDATA[How do human behaviours affect patient outcomes? And what has that got to do with Christmas?

Graham Shaw, director of Critical Factors, and Peter Brennan, a maxillofacial surgeon in Portsmouth, join us to explain what human factors are, why they’re not a bigger part of medical training, and talk about their importance as the NHS comes under greater and greater pressure because of the surge in covid-19 cases.

They also offer a word of advice to Santa, about making sure a festive never-event never happens.

<p>www.bmj.com/wellbeing</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/stft7t/stream_953598739-bmjgroup-wellbeing-human-factors-and-christmas-logistics.mp3" length="40841716" type="audio/mpeg"/>
        <itunes:summary><![CDATA[How do human behaviours affect patient outcomes? And what has that got to do with Christmas?

Graham Shaw, director of Critical Factors, and Peter Brennan, a maxillofacial surgeon in Portsmouth, join us to explain what human factors are, why they’re not a bigger part of medical training, and talk about their importance as the NHS comes under greater and greater pressure because of the surge in covid-19 cases.

They also offer a word of advice to Santa, about making sure a festive never-event never happens.

www.bmj.com/wellbeing]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2553</itunes:duration>
                                    </item>
    <item>
        <title>Food insecurity in the 6th largest economy</title>
        <itunes:title>Food insecurity in the 6th largest economy</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/food-insecurity-in-the-6th-largest-economy/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/food-insecurity-in-the-6th-largest-economy/#comments</comments>        <pubDate>Wed, 23 Dec 2020 14:28:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/food-insecurity-in-the-6th-largest-economy</guid>
                                    <description><![CDATA[Every year, the BMJ has a charity appeal - we’ve regularly focused on organisations like MSF, or Lifebox - providing support to areas of the world which don’t have good healthcare provision… This year though, covid-19 has changed everything - and we’re focussed inwards, on the UK. 

With growing unemployment, sections of the population being laid off, and with the well documented delays in receiving universal credit - food insecurity has become a major issue in the sixth largest economy in the world.

In this podcast Martin Caraher, emeritus professor of food and health policy at City University of London, explains how this crisis is a long time coming, and the result of the inattention of successive governments to the issue of hunger.

We also hear from Sabine Goodwin, coordinator of the Independent Food Aid Network, the recipients of this years award funds, about how the their network is being affected by the covid-19 pandemic, and how your money will be used to  supports food banks, and advocate for their obsolescence  

Donate the the Independent Food Aid Network here:
<p>https://www.foodaidnetwork.org.uk/bmj</p>
]]></description>
                                                            <content:encoded><![CDATA[Every year, the BMJ has a charity appeal - we’ve regularly focused on organisations like MSF, or Lifebox - providing support to areas of the world which don’t have good healthcare provision… This year though, covid-19 has changed everything - and we’re focussed inwards, on the UK. 

With growing unemployment, sections of the population being laid off, and with the well documented delays in receiving universal credit - food insecurity has become a major issue in the sixth largest economy in the world.

In this podcast Martin Caraher, emeritus professor of food and health policy at City University of London, explains how this crisis is a long time coming, and the result of the inattention of successive governments to the issue of hunger.

We also hear from Sabine Goodwin, coordinator of the Independent Food Aid Network, the recipients of this years award funds, about how the their network is being affected by the covid-19 pandemic, and how your money will be used to  supports food banks, and advocate for their obsolescence  

Donate the the Independent Food Aid Network here:
<p>https://www.foodaidnetwork.org.uk/bmj</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4x2h3v/stream_952863640-bmjgroup-food-insecurity-in-the-6th-largest-economy.mp3" length="27184900" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Every year, the BMJ has a charity appeal - we’ve regularly focused on organisations like MSF, or Lifebox - providing support to areas of the world which don’t have good healthcare provision… This year though, covid-19 has changed everything - and we’re focussed inwards, on the UK. 

With growing unemployment, sections of the population being laid off, and with the well documented delays in receiving universal credit - food insecurity has become a major issue in the sixth largest economy in the world.

In this podcast Martin Caraher, emeritus professor of food and health policy at City University of London, explains how this crisis is a long time coming, and the result of the inattention of successive governments to the issue of hunger.

We also hear from Sabine Goodwin, coordinator of the Independent Food Aid Network, the recipients of this years award funds, about how the their network is being affected by the covid-19 pandemic, and how your money will be used to  supports food banks, and advocate for their obsolescence  

Donate the the Independent Food Aid Network here:
https://www.foodaidnetwork.org.uk/bmj]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1699</itunes:duration>
                                    </item>
    <item>
        <title>The soundscape of a hospital</title>
        <itunes:title>The soundscape of a hospital</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-soundscape-of-a-hospital/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-soundscape-of-a-hospital/#comments</comments>        <pubDate>Tue, 22 Dec 2020 15:52:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-sounds-of-a-ward</guid>
                                    <description><![CDATA[Until hear death in 2019, Annabel  and her husband James Weaver, spent a lot of time together in hospitals - in patient and outpatient wards, waiting in makeshift waiting rooms in corridors and atriums. And while you or I might notice things about the way in which the hospital looks - James and Annabel noticed the way in which is sounded.

James is perusing a PhD at Queen Mary University of London into acoustics and the intelligibility of sound - and in this podcast we delve into the sound of a hospital, and why it can make communication between staff and patients so hard.

Read James's Christmas article, The sound of medicine
<p>https://www.bmj.com/content/371/bmj.m4682</p>
]]></description>
                                                            <content:encoded><![CDATA[Until hear death in 2019, Annabel  and her husband James Weaver, spent a lot of time together in hospitals - in patient and outpatient wards, waiting in makeshift waiting rooms in corridors and atriums. And while you or I might notice things about the way in which the hospital looks - James and Annabel noticed the way in which is sounded.

James is perusing a PhD at Queen Mary University of London into acoustics and the intelligibility of sound - and in this podcast we delve into the sound of a hospital, and why it can make communication between staff and patients so hard.

Read James's Christmas article, The sound of medicine
<p>https://www.bmj.com/content/371/bmj.m4682</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/yog9lb/stream_952324483-bmjgroup-the-sounds-of-a-ward.mp3" length="43863561" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Until hear death in 2019, Annabel  and her husband James Weaver, spent a lot of time together in hospitals - in patient and outpatient wards, waiting in makeshift waiting rooms in corridors and atriums. And while you or I might notice things about the way in which the hospital looks - James and Annabel noticed the way in which is sounded.

James is perusing a PhD at Queen Mary University of London into acoustics and the intelligibility of sound - and in this podcast we delve into the sound of a hospital, and why it can make communication between staff and patients so hard.

Read James's Christmas article, The sound of medicine
https://www.bmj.com/content/371/bmj.m4682]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2741</itunes:duration>
                                    </item>
    <item>
        <title>Rob Poynton wants you to pause</title>
        <itunes:title>Rob Poynton wants you to pause</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/rob-poynton-wants-you-to-pause/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/rob-poynton-wants-you-to-pause/#comments</comments>        <pubDate>Fri, 18 Dec 2020 13:25:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/rob-poynton-wants-you-to-pause</guid>
                                    <description><![CDATA[Robert Poynton is an associate fellow of the Saïd Business School at the University of Oxford, and author of books designed to help people work in ways which help both their career and wellbeing.

In this wellbeing podcast, we focus on "Do Pause; you are not a to do list" - a book that Cat has had on her to do list for months.

Rob explain to us what the concept of "pausing" is, and why he thinks a small gesture can have a significant effect on our ability to deal with the stresses of day to day work life.

Rob's books are available on Bookshop

Do Pause
https://uk.bookshop.org/a/98/9781907974632

Do Improvise
<p>https://uk.bookshop.org/a/98/9781907974014</p>
]]></description>
                                                            <content:encoded><![CDATA[Robert Poynton is an associate fellow of the Saïd Business School at the University of Oxford, and author of books designed to help people work in ways which help both their career and wellbeing.

In this wellbeing podcast, we focus on "Do Pause; you are not a to do list" - a book that Cat has had on her to do list for months.

Rob explain to us what the concept of "pausing" is, and why he thinks a small gesture can have a significant effect on our ability to deal with the stresses of day to day work life.

Rob's books are available on Bookshop

Do Pause
https://uk.bookshop.org/a/98/9781907974632

Do Improvise
<p>https://uk.bookshop.org/a/98/9781907974014</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8u8bco/stream_950028814-bmjgroup-rob-poynton-wants-you-to-pause.mp3" length="37225115" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Robert Poynton is an associate fellow of the Saïd Business School at the University of Oxford, and author of books designed to help people work in ways which help both their career and wellbeing.

In this wellbeing podcast, we focus on "Do Pause; you are not a to do list" - a book that Cat has had on her to do list for months.

Rob explain to us what the concept of "pausing" is, and why he thinks a small gesture can have a significant effect on our ability to deal with the stresses of day to day work life.

Rob's books are available on Bookshop

Do Pause
https://uk.bookshop.org/a/98/9781907974632

Do Improvise
https://uk.bookshop.org/a/98/9781907974014]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2327</itunes:duration>
                                    </item>
    <item>
        <title>Coronavirus second wave - Should we cancel Christmas?</title>
        <itunes:title>Coronavirus second wave - Should we cancel Christmas?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/coronavirus-second-wave-should-we-cancel-christmas/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/coronavirus-second-wave-should-we-cancel-christmas/#comments</comments>        <pubDate>Wed, 16 Dec 2020 11:06:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/corona-virus-second-wave-should-we-cancel-christmas</guid>
                                    <description><![CDATA[As London and some neighbouring counties move up to tier 3, and Germany, Italy and The Netherlands impose tighter restrictions over over the coming days of Christmas, in this podcast we ask - should Christmas gatherings be cancelled?

In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to Matt Morgan, a consultant in a intensive care medicine in Cardiff, and Helen Salisbury, GP in Oxfordshire.

They're joined by Mike Tildesley, reader in mathematics at Warwick School of Life Sciences, who models infectious disease spread.

They discuss why the key to controlling is pruning network connections - but why that concept hasn't been well explained to the public, what's happening in Cardiff, where ICU is running at 120% capacity, and how the vaccine roll out is being coordinated in primary care.

For more on the pandemic
<p>www.bmj.com/coronavirus</p>
]]></description>
                                                            <content:encoded><![CDATA[As London and some neighbouring counties move up to tier 3, and Germany, Italy and The Netherlands impose tighter restrictions over over the coming days of Christmas, in this podcast we ask - should Christmas gatherings be cancelled?

In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to Matt Morgan, a consultant in a intensive care medicine in Cardiff, and Helen Salisbury, GP in Oxfordshire.

They're joined by Mike Tildesley, reader in mathematics at Warwick School of Life Sciences, who models infectious disease spread.

They discuss why the key to controlling is pruning network connections - but why that concept hasn't been well explained to the public, what's happening in Cardiff, where ICU is running at 120% capacity, and how the vaccine roll out is being coordinated in primary care.

For more on the pandemic
<p>www.bmj.com/coronavirus</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/idh03e/stream_948485455-bmjgroup-corona-virus-second-wave-should-we-cancel-christmas.mp3" length="46478314" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As London and some neighbouring counties move up to tier 3, and Germany, Italy and The Netherlands impose tighter restrictions over over the coming days of Christmas, in this podcast we ask - should Christmas gatherings be cancelled?

In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to Matt Morgan, a consultant in a intensive care medicine in Cardiff, and Helen Salisbury, GP in Oxfordshire.

They're joined by Mike Tildesley, reader in mathematics at Warwick School of Life Sciences, who models infectious disease spread.

They discuss why the key to controlling is pruning network connections - but why that concept hasn't been well explained to the public, what's happening in Cardiff, where ICU is running at 120% capacity, and how the vaccine roll out is being coordinated in primary care.

For more on the pandemic
www.bmj.com/coronavirus]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2905</itunes:duration>
                                    </item>
    <item>
        <title>Inside a vaccine trial</title>
        <itunes:title>Inside a vaccine trial</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/inside-a-vaccine-trial/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/inside-a-vaccine-trial/#comments</comments>        <pubDate>Mon, 14 Dec 2020 10:04:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/inside-a-vaccine-trial</guid>
                                    <description><![CDATA[The last few weeks we’ve been feverish in our coverage of vaccines - the evidence base for them is, how they’ve been evaluated and licensed, and who’s going to get them first.  

But what we’ve not covered much is what it’s like to do, and take part in, a vaccine trial.

<p>In this special podcast, we’re going to hear from John Wright, director of the Bradford Institute of Health Research. He’s been keeping a “doctors diary” for BBC radio, and in this podcast we’re doing a deeper dive into that - and finding out about the people working on, and volunteering to test, a corona virus vaccine.</p>
]]></description>
                                                            <content:encoded><![CDATA[The last few weeks we’ve been feverish in our coverage of vaccines - the evidence base for them is, how they’ve been evaluated and licensed, and who’s going to get them first.  

But what we’ve not covered much is what it’s like to do, and take part in, a vaccine trial.

<p>In this special podcast, we’re going to hear from John Wright, director of the Bradford Institute of Health Research. He’s been keeping a “doctors diary” for BBC radio, and in this podcast we’re doing a deeper dive into that - and finding out about the people working on, and volunteering to test, a corona virus vaccine.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/uyjrlz/stream_947153149-bmjgroup-inside-a-vaccine-trial.mp3" length="28953285" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The last few weeks we’ve been feverish in our coverage of vaccines - the evidence base for them is, how they’ve been evaluated and licensed, and who’s going to get them first.  

But what we’ve not covered much is what it’s like to do, and take part in, a vaccine trial.

In this special podcast, we’re going to hear from John Wright, director of the Bradford Institute of Health Research. He’s been keeping a “doctors diary” for BBC radio, and in this podcast we’re doing a deeper dive into that - and finding out about the people working on, and volunteering to test, a corona virus vaccine.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1810</itunes:duration>
                                    </item>
    <item>
        <title>Talk evidence covid-19 update - poor public messaging, and vaccine approval data</title>
        <itunes:title>Talk evidence covid-19 update - poor public messaging, and vaccine approval data</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-poor-public-messaging-and-vaccine-approval-data/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-poor-public-messaging-and-vaccine-approval-data/#comments</comments>        <pubDate>Fri, 11 Dec 2020 19:23:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-covid-19-update-poor-public-messaging-and-vaccine-approval-data</guid>
                                    <description><![CDATA[The vaccines are being rolled out - but approval is still on an emergency basis, and the evidence underpinning those decisions is only just becoming available for scrutiny.

In this podcast we talk to Baruch Fischhoff, professor at Carnegie Mellon University and expert on public health communication about how that messaging should be done.

Peter Doshi, associate editor at The BMJ, and vaccine regulation researcher also joins us to talk about the data now released on the vaccine trials - what questions does it raise, and what are the next steps for researching safety.

<p>For more on The BMJ's covid-19 coverage www.bmj.com/coronavirus</p>
]]></description>
                                                            <content:encoded><![CDATA[The vaccines are being rolled out - but approval is still on an emergency basis, and the evidence underpinning those decisions is only just becoming available for scrutiny.

In this podcast we talk to Baruch Fischhoff, professor at Carnegie Mellon University and expert on public health communication about how that messaging should be done.

Peter Doshi, associate editor at The BMJ, and vaccine regulation researcher also joins us to talk about the data now released on the vaccine trials - what questions does it raise, and what are the next steps for researching safety.

<p>For more on The BMJ's covid-19 coverage www.bmj.com/coronavirus</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/bdtgck/stream_945771463-bmjgroup-talk-evidence-covid-19-update-poor-public-messaging-and-vaccine-approval-data.mp3" length="45102810" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The vaccines are being rolled out - but approval is still on an emergency basis, and the evidence underpinning those decisions is only just becoming available for scrutiny.

In this podcast we talk to Baruch Fischhoff, professor at Carnegie Mellon University and expert on public health communication about how that messaging should be done.

Peter Doshi, associate editor at The BMJ, and vaccine regulation researcher also joins us to talk about the data now released on the vaccine trials - what questions does it raise, and what are the next steps for researching safety.

For more on The BMJ's covid-19 coverage www.bmj.com/coronavirus]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2819</itunes:duration>
                                    </item>
    <item>
        <title>Coronavirus second wave - the vaccine’s here, but the pandemic isn’t over</title>
        <itunes:title>Coronavirus second wave - the vaccine’s here, but the pandemic isn’t over</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/coronavirus-second-wave-the-vaccine-s-here-but-the-pandemic-isn-t-over/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/coronavirus-second-wave-the-vaccine-s-here-but-the-pandemic-isn-t-over/#comments</comments>        <pubDate>Tue, 08 Dec 2020 17:24:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/corona-virus-second-wave-the-vaccines-here-but-the-pandemic-isnt-over</guid>
                                    <description><![CDATA[As the first people outside of a trial have started receiving Pfizer's sars-cov-2 vaccine, including Matt, but that's not the end of the story for the pandemic, there are still logistics of rollout, plus treating those who have already contracted the disease.

In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to Matt Morgan, a consultant in a intensive care medicine in Cardiff, and Helen Salisbury, GP in Oxfordshire.

They discuss why it's impossible to get the vaccine into care homes, because of the need for very low temperature storage, why the survival rate in ICU has gone down, and how messaging on the non-vaccine ways of preventing spread need to be tightened up, especially now.

For more of The BMJ’s covid-19 coverage.
<p>www.bmj.com/coronavirus</p>
]]></description>
                                                            <content:encoded><![CDATA[As the first people outside of a trial have started receiving Pfizer's sars-cov-2 vaccine, including Matt, but that's not the end of the story for the pandemic, there are still logistics of rollout, plus treating those who have already contracted the disease.

In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to Matt Morgan, a consultant in a intensive care medicine in Cardiff, and Helen Salisbury, GP in Oxfordshire.

They discuss why it's impossible to get the vaccine into care homes, because of the need for very low temperature storage, why the survival rate in ICU has gone down, and how messaging on the non-vaccine ways of preventing spread need to be tightened up, especially now.

For more of The BMJ’s covid-19 coverage.
<p>www.bmj.com/coronavirus</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/sgs0da/stream_943756816-bmjgroup-corona-virus-second-wave-the-vaccines-here-but-the-pandemic-isnt-over.mp3" length="49614679" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As the first people outside of a trial have started receiving Pfizer's sars-cov-2 vaccine, including Matt, but that's not the end of the story for the pandemic, there are still logistics of rollout, plus treating those who have already contracted the disease.

In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to Matt Morgan, a consultant in a intensive care medicine in Cardiff, and Helen Salisbury, GP in Oxfordshire.

They discuss why it's impossible to get the vaccine into care homes, because of the need for very low temperature storage, why the survival rate in ICU has gone down, and how messaging on the non-vaccine ways of preventing spread need to be tightened up, especially now.

For more of The BMJ’s covid-19 coverage.
www.bmj.com/coronavirus]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3101</itunes:duration>
                                    </item>
    <item>
        <title>Lockdown lessons from an Antarctic winter</title>
        <itunes:title>Lockdown lessons from an Antarctic winter</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/lockdown-lessons-from-an-antarctic-winter/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/lockdown-lessons-from-an-antarctic-winter/#comments</comments>        <pubDate>Fri, 04 Dec 2020 13:51:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/lockdown-lessons-from-an-antarctic-winter</guid>
                                    <description><![CDATA[Anne Hicks, is an emergency medicine consultant in Plymouth, and for 16 years was the medical director for the British Antarctic Survey (she stepped down last year).

The British Antarctic Survey operates all through the antarctic winter - where for 90 days, the sun sets and plunges their base into cold and darkness.  So who better to give us some advice on coping with the strict covid-19 rules during our winter period.

Anne talks to Cat Chatfield about the ways in which structure, even the seemingly small and arbitrary, can help, how to spot signs of someone struggling, and how the lack of daylight affects teams working at the bottom of the world.

<p>https://www.bmj.com/wellbeing</p>
]]></description>
                                                            <content:encoded><![CDATA[Anne Hicks, is an emergency medicine consultant in Plymouth, and for 16 years was the medical director for the British Antarctic Survey (she stepped down last year).

The British Antarctic Survey operates all through the antarctic winter - where for 90 days, the sun sets and plunges their base into cold and darkness.  So who better to give us some advice on coping with the strict covid-19 rules during our winter period.

Anne talks to Cat Chatfield about the ways in which structure, even the seemingly small and arbitrary, can help, how to spot signs of someone struggling, and how the lack of daylight affects teams working at the bottom of the world.

<p>https://www.bmj.com/wellbeing</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/e86l4k/stream_941326585-bmjgroup-lockdown-lessons-from-an-antarctic-winter.mp3" length="32668106" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Anne Hicks, is an emergency medicine consultant in Plymouth, and for 16 years was the medical director for the British Antarctic Survey (she stepped down last year).

The British Antarctic Survey operates all through the antarctic winter - where for 90 days, the sun sets and plunges their base into cold and darkness.  So who better to give us some advice on coping with the strict covid-19 rules during our winter period.

Anne talks to Cat Chatfield about the ways in which structure, even the seemingly small and arbitrary, can help, how to spot signs of someone struggling, and how the lack of daylight affects teams working at the bottom of the world.

https://www.bmj.com/wellbeing]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2042</itunes:duration>
                                    </item>
    <item>
        <title>Corona virus second wave - Fears for tiers</title>
        <itunes:title>Corona virus second wave - Fears for tiers</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/corona-virus-second-wave-fears-for-tiers/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/corona-virus-second-wave-fears-for-tiers/#comments</comments>        <pubDate>Wed, 02 Dec 2020 11:13:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/corona-virus-second-wave-fears-for-tiers</guid>
                                    <description><![CDATA[As the first vaccine for corona virus is approved, and England joins the other nations of the UK outside of full lockdown, we are all entering tiers of restrictions - variable across the country, which will continue until that vaccine coverage is enough to slow transmission in the community.

In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to Matt Morgan, a consultant in a intensive care medicine in Cardiff, and Helen Salisbury, GP in Oxfordshire, and are re-joined by  Karl Friston, neurologist and member of iSAGE. 

They discuss what we know about the efficacy of these tiers, and how they interact with things like track and trace, and the mass testing taking place in Liverpool.


For more of The BMJ’s covid-19 coverage.
<p>www.bmj.com/coronavirus</p>
]]></description>
                                                            <content:encoded><![CDATA[As the first vaccine for corona virus is approved, and England joins the other nations of the UK outside of full lockdown, we are all entering tiers of restrictions - variable across the country, which will continue until that vaccine coverage is enough to slow transmission in the community.

In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to Matt Morgan, a consultant in a intensive care medicine in Cardiff, and Helen Salisbury, GP in Oxfordshire, and are re-joined by  Karl Friston, neurologist and member of iSAGE. 

They discuss what we know about the efficacy of these tiers, and how they interact with things like track and trace, and the mass testing taking place in Liverpool.


For more of The BMJ’s covid-19 coverage.
<p>www.bmj.com/coronavirus</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/bu7wcz/stream_939882883-bmjgroup-corona-virus-second-wave-fears-for-tiers.mp3" length="66192357" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As the first vaccine for corona virus is approved, and England joins the other nations of the UK outside of full lockdown, we are all entering tiers of restrictions - variable across the country, which will continue until that vaccine coverage is enough to slow transmission in the community.

In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to Matt Morgan, a consultant in a intensive care medicine in Cardiff, and Helen Salisbury, GP in Oxfordshire, and are re-joined by  Karl Friston, neurologist and member of iSAGE. 

They discuss what we know about the efficacy of these tiers, and how they interact with things like track and trace, and the mass testing taking place in Liverpool.


For more of The BMJ’s covid-19 coverage.
www.bmj.com/coronavirus]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2762</itunes:duration>
                                    </item>
    <item>
        <title>Calum Semple - the efficacy of mass testing in Liverpool</title>
        <itunes:title>Calum Semple - the efficacy of mass testing in Liverpool</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/calum-semple-the-efficacy-of-mass-testing-in-liverpool/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/calum-semple-the-efficacy-of-mass-testing-in-liverpool/#comments</comments>        <pubDate>Tue, 01 Dec 2020 13:52:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/calum-semple-the-efficacy-of-mass-testing-in-liverpool</guid>
                                    <description><![CDATA[The government has decided to pursue a strategy of mass-testing in Liverpool, in a pilot to see what effect that has on containment of corona virus.

A lot of criticism has been levelled at the scheme, from the sensitivity of  the lateral flow test used, to whether this is screening and should be referred to the national screening committee to be evaluated.

Calum Semple, professor of  child health and outbreak medicine at the University of Liverpool is evaluating the project, and joins us to explain what we can understand from this - how initial data shows the new testing regime is reaching more of the population, and why he thinks this is a public health intervention, not a personal screening test.

<p>www.bmj.com/coronavirus</p>
]]></description>
                                                            <content:encoded><![CDATA[The government has decided to pursue a strategy of mass-testing in Liverpool, in a pilot to see what effect that has on containment of corona virus.

A lot of criticism has been levelled at the scheme, from the sensitivity of  the lateral flow test used, to whether this is screening and should be referred to the national screening committee to be evaluated.

Calum Semple, professor of  child health and outbreak medicine at the University of Liverpool is evaluating the project, and joins us to explain what we can understand from this - how initial data shows the new testing regime is reaching more of the population, and why he thinks this is a public health intervention, not a personal screening test.

<p>www.bmj.com/coronavirus</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/le5rl2/stream_939294640-bmjgroup-calum-semple-the-efficacy-of-mass-testing-in-liverpool.mp3" length="57309163" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The government has decided to pursue a strategy of mass-testing in Liverpool, in a pilot to see what effect that has on containment of corona virus.

A lot of criticism has been levelled at the scheme, from the sensitivity of  the lateral flow test used, to whether this is screening and should be referred to the national screening committee to be evaluated.

Calum Semple, professor of  child health and outbreak medicine at the University of Liverpool is evaluating the project, and joins us to explain what we can understand from this - how initial data shows the new testing regime is reaching more of the population, and why he thinks this is a public health intervention, not a personal screening test.

www.bmj.com/coronavirus]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2391</itunes:duration>
                                    </item>
    <item>
        <title>Why the government is being sued over PPE contracts</title>
        <itunes:title>Why the government is being sued over PPE contracts</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/why-the-government-is-being-sued-over-ppe-contracts/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/why-the-government-is-being-sued-over-ppe-contracts/#comments</comments>        <pubDate>Thu, 26 Nov 2020 13:16:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/why-the-government-is-being-sued-over-ppe-contracts</guid>
                                    <description><![CDATA[The BMJ is a champion of openness and transparency in research, in clinical practice and in health policy.

However, if you’ve kept and eye on the journals recently, you’ll have seen that governments have been less diligent about keeping an eye on competing interests than they should be.

In this podcast we’re joined by Jolyon Maugham QC - one of the founding members of the Good Law Project, who have successfully litigated against the government on Brexit, and are now turning their eyes to procurement during the pandemic.

Jo talks to Kamran Abbasi about how big the contracts have been, how the UK’s system lacks the checks and balances to prevent a government from forging ahead, and if cronyism and corruption have damaged the pandemic response

<p>www.bmj.com/coronavirus</p>
]]></description>
                                                            <content:encoded><![CDATA[The BMJ is a champion of openness and transparency in research, in clinical practice and in health policy.

However, if you’ve kept and eye on the journals recently, you’ll have seen that governments have been less diligent about keeping an eye on competing interests than they should be.

In this podcast we’re joined by Jolyon Maugham QC - one of the founding members of the Good Law Project, who have successfully litigated against the government on Brexit, and are now turning their eyes to procurement during the pandemic.

Jo talks to Kamran Abbasi about how big the contracts have been, how the UK’s system lacks the checks and balances to prevent a government from forging ahead, and if cronyism and corruption have damaged the pandemic response

<p>www.bmj.com/coronavirus</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/bc0yez/stream_936420883-bmjgroup-why-the-government-is-being-sued-over-ppe-contracts.mp3" length="69830349" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The BMJ is a champion of openness and transparency in research, in clinical practice and in health policy.

However, if you’ve kept and eye on the journals recently, you’ll have seen that governments have been less diligent about keeping an eye on competing interests than they should be.

In this podcast we’re joined by Jolyon Maugham QC - one of the founding members of the Good Law Project, who have successfully litigated against the government on Brexit, and are now turning their eyes to procurement during the pandemic.

Jo talks to Kamran Abbasi about how big the contracts have been, how the UK’s system lacks the checks and balances to prevent a government from forging ahead, and if cronyism and corruption have damaged the pandemic response

www.bmj.com/coronavirus]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2908</itunes:duration>
                                    </item>
    <item>
        <title>Coronavirus second wave - recentring patients in our covid-19 response</title>
        <itunes:title>Coronavirus second wave - recentring patients in our covid-19 response</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/coronavirus-second-wave-recentring-patients-in-our-covid-19-response/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/coronavirus-second-wave-recentring-patients-in-our-covid-19-response/#comments</comments>        <pubDate>Tue, 24 Nov 2020 18:37:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/corona-virus-second-wave-recentring-patients-in-our-covid-19-response</guid>
                                    <description><![CDATA[As further promising news emerges of vaccine effectiveness, although still with no data published, and as plans emerge for the return home of university students and limited festive winter celebrations.

But as we talked about in the last podcast, there needs to be a concerted effort to re-centre patients and the public within the decisions made about how the NHS will treat covid patients and those with continuing healthcare conditions impacted by the pandemic.

National Voices, a coalition of charities that stands for patient centred care, have been talking to patients about what matters to people during COVID-19 and beyond, and have written a report with some clear recommendations to health and care leaders and professionals.

In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to Matt Morgan, a consultant in a intensive care medicine in Cardiff, and Helen Salisbury, GP in Oxfordshire, and Nisreen Alwan, associate professor in public health at the University of Southampton.

They are joined by Charlotte Augst, Chief Executive of national voices to talk about that report; why some patients have felt abandoned; how covid has accelerated the conversation about rationing; and why now is the time to rebuild services around patient needs.

<p>www.bmj.com/coronavirus</p>
]]></description>
                                                            <content:encoded><![CDATA[As further promising news emerges of vaccine effectiveness, although still with no data published, and as plans emerge for the return home of university students and limited festive winter celebrations.

But as we talked about in the last podcast, there needs to be a concerted effort to re-centre patients and the public within the decisions made about how the NHS will treat covid patients and those with continuing healthcare conditions impacted by the pandemic.

National Voices, a coalition of charities that stands for patient centred care, have been talking to patients about what matters to people during COVID-19 and beyond, and have written a report with some clear recommendations to health and care leaders and professionals.

In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to Matt Morgan, a consultant in a intensive care medicine in Cardiff, and Helen Salisbury, GP in Oxfordshire, and Nisreen Alwan, associate professor in public health at the University of Southampton.

They are joined by Charlotte Augst, Chief Executive of national voices to talk about that report; why some patients have felt abandoned; how covid has accelerated the conversation about rationing; and why now is the time to rebuild services around patient needs.

<p>www.bmj.com/coronavirus</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/aaf5hi/stream_935356291-bmjgroup-corona-virus-second-wave-recentring-patients-in-our-covid-19-response.mp3" length="49360978" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As further promising news emerges of vaccine effectiveness, although still with no data published, and as plans emerge for the return home of university students and limited festive winter celebrations.

But as we talked about in the last podcast, there needs to be a concerted effort to re-centre patients and the public within the decisions made about how the NHS will treat covid patients and those with continuing healthcare conditions impacted by the pandemic.

National Voices, a coalition of charities that stands for patient centred care, have been talking to patients about what matters to people during COVID-19 and beyond, and have written a report with some clear recommendations to health and care leaders and professionals.

In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to Matt Morgan, a consultant in a intensive care medicine in Cardiff, and Helen Salisbury, GP in Oxfordshire, and Nisreen Alwan, associate professor in public health at the University of Southampton.

They are joined by Charlotte Augst, Chief Executive of national voices to talk about that report; why some patients have felt abandoned; how covid has accelerated the conversation about rationing; and why now is the time to rebuild services around patient needs.

www.bmj.com/coronavirus]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3085</itunes:duration>
                                    </item>
    <item>
        <title>Talk evidence covid-19 update - uncertainty in treatment, uncertainty in prevention</title>
        <itunes:title>Talk evidence covid-19 update - uncertainty in treatment, uncertainty in prevention</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-uncertainty-in-treatment-uncertainty-in-prevention/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-uncertainty-in-treatment-uncertainty-in-prevention/#comments</comments>        <pubDate>Sat, 21 Nov 2020 13:12:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-covid-19-update-uncertainty-in-treatment-uncertainty-in-prevention</guid>
                                    <description><![CDATA[Uncertainty abounds - even as we get better data on treatments, with the big RCTs beginning to report, and new trials on masks, the evidence remains uncertain, in both the statistical realm (confidence intervals crossing 0) and in what to do in the face of that continuing lack of clear effect.

As always Helen Macdonald and Duncan Jarvies are looking at the evidence, and this week are joined by John Brodersen, professor of general practice at the University of Copenhagen.

Helen talks to Bram Rochwerg, methodology lead on the WHO treatment guidelines for covid, about why their latest review has stopped recommending remdesivir for covid-19 treatment.

John tells us about the Danmask study - what question it was actually trying to answer.

We also discuss the ways in which there is a tendency to express certainty where there is none, and why distrusting simple solutions to complex problems is a good rule of thumb.


Reading list:
A living WHO guideline on drugs for covid-19
https://www.bmj.com/content/370/bmj.m3379

Covid-19’s known unknowns
https://www.bmj.com/content/371/bmj.m3979

Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers
<p>https://www.acpjournals.org/doi/10.7326/M20-6817</p>
]]></description>
                                                            <content:encoded><![CDATA[Uncertainty abounds - even as we get better data on treatments, with the big RCTs beginning to report, and new trials on masks, the evidence remains uncertain, in both the statistical realm (confidence intervals crossing 0) and in what to do in the face of that continuing lack of clear effect.

As always Helen Macdonald and Duncan Jarvies are looking at the evidence, and this week are joined by John Brodersen, professor of general practice at the University of Copenhagen.

Helen talks to Bram Rochwerg, methodology lead on the WHO treatment guidelines for covid, about why their latest review has stopped recommending remdesivir for covid-19 treatment.

John tells us about the Danmask study - what question it was actually trying to answer.

We also discuss the ways in which there is a tendency to express certainty where there is none, and why distrusting simple solutions to complex problems is a good rule of thumb.


Reading list:
A living WHO guideline on drugs for covid-19
https://www.bmj.com/content/370/bmj.m3379

Covid-19’s known unknowns
https://www.bmj.com/content/371/bmj.m3979

Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers
<p>https://www.acpjournals.org/doi/10.7326/M20-6817</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/afsx76/stream_933424855-bmjgroup-talk-evidence-covid-19-update-uncertainty-in-treatment-uncertainty-in-prevention.mp3" length="32375953" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Uncertainty abounds - even as we get better data on treatments, with the big RCTs beginning to report, and new trials on masks, the evidence remains uncertain, in both the statistical realm (confidence intervals crossing 0) and in what to do in the face of that continuing lack of clear effect.

As always Helen Macdonald and Duncan Jarvies are looking at the evidence, and this week are joined by John Brodersen, professor of general practice at the University of Copenhagen.

Helen talks to Bram Rochwerg, methodology lead on the WHO treatment guidelines for covid, about why their latest review has stopped recommending remdesivir for covid-19 treatment.

John tells us about the Danmask study - what question it was actually trying to answer.

We also discuss the ways in which there is a tendency to express certainty where there is none, and why distrusting simple solutions to complex problems is a good rule of thumb.


Reading list:
A living WHO guideline on drugs for covid-19
https://www.bmj.com/content/370/bmj.m3379

Covid-19’s known unknowns
https://www.bmj.com/content/371/bmj.m3979

Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers
https://www.acpjournals.org/doi/10.7326/M20-6817]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2023</itunes:duration>
                                    </item>
    <item>
        <title>Wellbeing - What we’ve learned from treating doctors</title>
        <itunes:title>Wellbeing - What we’ve learned from treating doctors</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/wellbeing-what-we-ve-learned-from-treating-doctors/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/wellbeing-what-we-ve-learned-from-treating-doctors/#comments</comments>        <pubDate>Fri, 20 Nov 2020 13:01:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/wellbeing-what-weve-learned-from-treating-doctors</guid>
                                    <description><![CDATA[Clare Gerada and Zaid Al-Najjar have been treating doctors for a while now, through the NHS Practitioner Programme. 

In that time they have noticed some themes in the issues that bring doctors to them, from isolation to stress. 

In this podcast they reflect on what they've learned about the problems that affect doctors, and how covid-19 has exacerbated some, and surprisingly reduced others.

Their book Beneath the White Coat: Doctors, Their Minds and Mental Health is out now
<p>https://www.routledge.com/Beneath-the-White-Coat-Doctors-Their-Minds-and-Mental-Health/Gerada/p/book/9781138499737</p>
]]></description>
                                                            <content:encoded><![CDATA[Clare Gerada and Zaid Al-Najjar have been treating doctors for a while now, through the NHS Practitioner Programme. 

In that time they have noticed some themes in the issues that bring doctors to them, from isolation to stress. 

In this podcast they reflect on what they've learned about the problems that affect doctors, and how covid-19 has exacerbated some, and surprisingly reduced others.

Their book Beneath the White Coat: Doctors, Their Minds and Mental Health is out now
<p>https://www.routledge.com/Beneath-the-White-Coat-Doctors-Their-Minds-and-Mental-Health/Gerada/p/book/9781138499737</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/p3tics/stream_932834338-bmjgroup-wellbeing-what-weve-learned-from-treating-doctors.mp3" length="28640234" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Clare Gerada and Zaid Al-Najjar have been treating doctors for a while now, through the NHS Practitioner Programme. 

In that time they have noticed some themes in the issues that bring doctors to them, from isolation to stress. 

In this podcast they reflect on what they've learned about the problems that affect doctors, and how covid-19 has exacerbated some, and surprisingly reduced others.

Their book Beneath the White Coat: Doctors, Their Minds and Mental Health is out now
https://www.routledge.com/Beneath-the-White-Coat-Doctors-Their-Minds-and-Mental-Health/Gerada/p/book/9781138499737]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1790</itunes:duration>
                                    </item>
    <item>
        <title>Coronavirus second wave - vaccines, how ready is the needle to hit the arm?</title>
        <itunes:title>Coronavirus second wave - vaccines, how ready is the needle to hit the arm?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/coronavirus-second-wave-vaccines-how-ready-is-the-needle-to-hit-the-arm/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/coronavirus-second-wave-vaccines-how-ready-is-the-needle-to-hit-the-arm/#comments</comments>        <pubDate>Tue, 17 Nov 2020 19:21:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/corona-virus-second-wave-ready-for-the-needle-hit-the-arm</guid>
                                    <description><![CDATA[Covid-19 continues its grip on the Northern Hemisphere alongside news of a vaccine trial showing real success at first glance. In this second wave update, we explore the latest issues with healthcare professionals from primary care, secondary care, and public health, and discuss what is happening in their field, and put their questions to experts.
In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to Matt Morgan, a consultant in a intensive care medicine in Cardiff, and Helen Salisbury, GP in Oxfordshire, and Nisreen Alwan, associate professor in public health at the University of Southampton.
They are joined by Katrina Pollock, senior clinical research fellow in vaccinology at Imperial College London, to talk about: the three vaccines in the news; why different groups may require different vaccines; and how to choose who to get the vaccination first.

<p>www.bmj.com/coronavirus</p>
]]></description>
                                                            <content:encoded><![CDATA[Covid-19 continues its grip on the Northern Hemisphere alongside news of a vaccine trial showing real success at first glance. In this second wave update, we explore the latest issues with healthcare professionals from primary care, secondary care, and public health, and discuss what is happening in their field, and put their questions to experts.
In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to Matt Morgan, a consultant in a intensive care medicine in Cardiff, and Helen Salisbury, GP in Oxfordshire, and Nisreen Alwan, associate professor in public health at the University of Southampton.
They are joined by Katrina Pollock, senior clinical research fellow in vaccinology at Imperial College London, to talk about: the three vaccines in the news; why different groups may require different vaccines; and how to choose who to get the vaccination first.

<p>www.bmj.com/coronavirus</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/31isu2/stream_931050145-bmjgroup-corona-virus-second-wave-ready-for-the-needle-hit-the-arm.mp3" length="55368723" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Covid-19 continues its grip on the Northern Hemisphere alongside news of a vaccine trial showing real success at first glance. In this second wave update, we explore the latest issues with healthcare professionals from primary care, secondary care, and public health, and discuss what is happening in their field, and put their questions to experts.
In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to Matt Morgan, a consultant in a intensive care medicine in Cardiff, and Helen Salisbury, GP in Oxfordshire, and Nisreen Alwan, associate professor in public health at the University of Southampton.
They are joined by Katrina Pollock, senior clinical research fellow in vaccinology at Imperial College London, to talk about: the three vaccines in the news; why different groups may require different vaccines; and how to choose who to get the vaccination first.

www.bmj.com/coronavirus]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3461</itunes:duration>
                                    </item>
    <item>
        <title>How well did hospitals perform for their staff during covid?</title>
        <itunes:title>How well did hospitals perform for their staff during covid?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/how-well-did-hospitals-perform-for-their-staff-during-covid/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/how-well-did-hospitals-perform-for-their-staff-during-covid/#comments</comments>        <pubDate>Fri, 13 Nov 2020 12:47:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/how-well-did-hospitals-perform-for-their-staff-during-covid</guid>
                                    <description><![CDATA[In the first wave of covid-19, hospitals started to reconfigure space and services, to provide rest areas and food for staff, to help them cope with the surge in patients.

Michael West, professor professor of work and organisational psychology at Lancaster University Management School, returns to the podcast to talk about how well those changes helped staff - and what needs to be done, now that a second wave is hitting, to make sure those essential services don't disappear.

<p>www.bmj.com/wellbeing</p>
]]></description>
                                                            <content:encoded><![CDATA[In the first wave of covid-19, hospitals started to reconfigure space and services, to provide rest areas and food for staff, to help them cope with the surge in patients.

Michael West, professor professor of work and organisational psychology at Lancaster University Management School, returns to the podcast to talk about how well those changes helped staff - and what needs to be done, now that a second wave is hitting, to make sure those essential services don't disappear.

<p>www.bmj.com/wellbeing</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/44hkvc/stream_928572454-bmjgroup-how-well-did-hospitals-perform-for-their-staff-during-covid.mp3" length="32343770" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In the first wave of covid-19, hospitals started to reconfigure space and services, to provide rest areas and food for staff, to help them cope with the surge in patients.

Michael West, professor professor of work and organisational psychology at Lancaster University Management School, returns to the podcast to talk about how well those changes helped staff - and what needs to be done, now that a second wave is hitting, to make sure those essential services don't disappear.

www.bmj.com/wellbeing]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2021</itunes:duration>
                                    </item>
    <item>
        <title>Coronavirus second wave - viral transmission and a vaccine announcement</title>
        <itunes:title>Coronavirus second wave - viral transmission and a vaccine announcement</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/coronavirus-second-wave-viral-transmission-and-a-vaccine-announcement/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/coronavirus-second-wave-viral-transmission-and-a-vaccine-announcement/#comments</comments>        <pubDate>Wed, 11 Nov 2020 15:13:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/coronavirus-second-wave-viral-transmission-and-a-vaccine-announcement</guid>
                                    <description><![CDATA[Covid-19 continues its grip on the Northern Hemisphere alongside news of a vaccine trial showing real success at first glance. In this second wave update, we explore the latest issues with healthcare professionals from primary care, secondary care, and public health, and discuss what is happening in their field, and put their questions to experts.

In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to Alison Pittard, a consultant in anaesthesia and intensive care medicine in Leeds, and Helen Salisbury, GP in Oxfordshire, and Nisreen Alwan, associate professor in public health at the University of Southampton.

They are joined by Müge Çevik, an infectious diseases researcher at the University of St Andrews, to talk about: what’s happening with track and trace and how to make it work better; transmission and asymptomatic spread, in particular hospital-acquired infections; views on the news of Pfizer’s vaccine; and reaction to US presidential election. 

<p>www.bmj.com/coronavirus</p>
]]></description>
                                                            <content:encoded><![CDATA[Covid-19 continues its grip on the Northern Hemisphere alongside news of a vaccine trial showing real success at first glance. In this second wave update, we explore the latest issues with healthcare professionals from primary care, secondary care, and public health, and discuss what is happening in their field, and put their questions to experts.

In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to Alison Pittard, a consultant in anaesthesia and intensive care medicine in Leeds, and Helen Salisbury, GP in Oxfordshire, and Nisreen Alwan, associate professor in public health at the University of Southampton.

They are joined by Müge Çevik, an infectious diseases researcher at the University of St Andrews, to talk about: what’s happening with track and trace and how to make it work better; transmission and asymptomatic spread, in particular hospital-acquired infections; views on the news of Pfizer’s vaccine; and reaction to US presidential election. 

<p>www.bmj.com/coronavirus</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/lnn043/stream_927339274-bmjgroup-coronavirus-second-wave-viral-transmission-and-a-vaccine-announcement.mp3" length="49119392" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Covid-19 continues its grip on the Northern Hemisphere alongside news of a vaccine trial showing real success at first glance. In this second wave update, we explore the latest issues with healthcare professionals from primary care, secondary care, and public health, and discuss what is happening in their field, and put their questions to experts.

In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to Alison Pittard, a consultant in anaesthesia and intensive care medicine in Leeds, and Helen Salisbury, GP in Oxfordshire, and Nisreen Alwan, associate professor in public health at the University of Southampton.

They are joined by Müge Çevik, an infectious diseases researcher at the University of St Andrews, to talk about: what’s happening with track and trace and how to make it work better; transmission and asymptomatic spread, in particular hospital-acquired infections; views on the news of Pfizer’s vaccine; and reaction to US presidential election. 

www.bmj.com/coronavirus]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3077</itunes:duration>
                                    </item>
    <item>
        <title>A lump in the throat with Nick Hamilton, Deonne Dersch-Mills and Bonnie Kaplan</title>
        <itunes:title>A lump in the throat with Nick Hamilton, Deonne Dersch-Mills and Bonnie Kaplan</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/a-lump-in-the-throat-with-nick-hamilton-deonne-dersch-mills-and-bonnie-kaplan/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/a-lump-in-the-throat-with-nick-hamilton-deonne-dersch-mills-and-bonnie-kaplan/#comments</comments>        <pubDate>Thu, 05 Nov 2020 16:51:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/a-lump-in-the-throat-with-nick-hamilton-deonne-dersch-mills-and-bonnie-kaplan</guid>
                                    <description><![CDATA[A lump in the throat is a classic GP presentation, but one that often causes a lot of worry. Many people are struggling with high levels of anxiety anyway at the moment, and this may manifest physical symptoms, such as fatigue, insomnia and dysphagia.

In this week’s episode, we discuss how to differentiate between causes of a lump in the throat: is my patient experiencing laryngopharyngeal reflux, or could it be cancer? How do we reassure distressed patients when we need to refer them on for imaging, or a consultation with a specialist, before we can rule out a malignant cause? 

We also talk about how to manage a patient who has difficulty swallowing pills, and the challenges of getting children, in particular, to take medication.

 Our guests:
Nick Hamilton is a clinical lecturer in otorhinolaryngology at UCL, and also works as a specialist registrar in otorhinolaryngology head and neck surgery at North Thames Deanery, London. 

Deonne Dersch-Mills is the clinical practice leader for pharmacy for paediatrics & neonatology with Alberta Health Services. She is based at Alberta Children’s Hospital, Calgary. 

<p>Bonnie J. Kaplan is a semi-retired research psychologist, and professor emerita from the Cumming School of Medicine, Calgary.</p>
]]></description>
                                                            <content:encoded><![CDATA[A lump in the throat is a classic GP presentation, but one that often causes a lot of worry. Many people are struggling with high levels of anxiety anyway at the moment, and this may manifest physical symptoms, such as fatigue, insomnia and dysphagia.

In this week’s episode, we discuss how to differentiate between causes of a lump in the throat: is my patient experiencing laryngopharyngeal reflux, or could it be cancer? How do we reassure distressed patients when we need to refer them on for imaging, or a consultation with a specialist, before we can rule out a malignant cause? 

We also talk about how to manage a patient who has difficulty swallowing pills, and the challenges of getting children, in particular, to take medication.

 Our guests:
Nick Hamilton is a clinical lecturer in otorhinolaryngology at UCL, and also works as a specialist registrar in otorhinolaryngology head and neck surgery at North Thames Deanery, London. 

Deonne Dersch-Mills is the clinical practice leader for pharmacy for paediatrics & neonatology with Alberta Health Services. She is based at Alberta Children’s Hospital, Calgary. 

<p>Bonnie J. Kaplan is a semi-retired research psychologist, and professor emerita from the Cumming School of Medicine, Calgary.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ciyy2p/stream_923843707-bmjgroup-a-lump-in-the-throat-with-nick-hamilton-deonne-dersch-mills-and-bonnie-kaplan.mp3" length="56350928" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A lump in the throat is a classic GP presentation, but one that often causes a lot of worry. Many people are struggling with high levels of anxiety anyway at the moment, and this may manifest physical symptoms, such as fatigue, insomnia and dysphagia.

In this week’s episode, we discuss how to differentiate between causes of a lump in the throat: is my patient experiencing laryngopharyngeal reflux, or could it be cancer? How do we reassure distressed patients when we need to refer them on for imaging, or a consultation with a specialist, before we can rule out a malignant cause? 

We also talk about how to manage a patient who has difficulty swallowing pills, and the challenges of getting children, in particular, to take medication.

 Our guests:
Nick Hamilton is a clinical lecturer in otorhinolaryngology at UCL, and also works as a specialist registrar in otorhinolaryngology head and neck surgery at North Thames Deanery, London. 

Deonne Dersch-Mills is the clinical practice leader for pharmacy for paediatrics & neonatology with Alberta Health Services. She is based at Alberta Children’s Hospital, Calgary. 

Bonnie J. Kaplan is a semi-retired research psychologist, and professor emerita from the Cumming School of Medicine, Calgary.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3522</itunes:duration>
                                    </item>
    <item>
        <title>Coronavirus second wave - Making the lockdown work</title>
        <itunes:title>Coronavirus second wave - Making the lockdown work</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/coronavirus-second-wave-making-the-lockdown-work/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/coronavirus-second-wave-making-the-lockdown-work/#comments</comments>        <pubDate>Tue, 03 Nov 2020 18:36:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/corona-virus-second-wave-making-the-lockdown-work</guid>
                                    <description><![CDATA[As the second spike in covid-19 cases grows, we want to take stock of what's happening in the NHS. In these second wave updates, clinicians from primary care, secondary care, and public health, discuss what is happening in their field, and put questions to experts.

In this podcast, Fiona Godlee, editor in chief of The BMJ talks to Matt Morgan, consultant in intensive care medicine in Cardiff and Helen Salisbury, GP in Oxfordshire, and Nisreen Alwan, associate professor in public health at the University of Southampton.

They are joined by Andrew Hayward, professor of infectious disease epidemiology and inclusion health research, to talk about the lockdown in England, why the message should be clearer, what needs to be done to make the lockdown work, and how doctors are braced for the upcoming surge in cases.

<p>https://www.bmj.com/coronavirus</p>
]]></description>
                                                            <content:encoded><![CDATA[As the second spike in covid-19 cases grows, we want to take stock of what's happening in the NHS. In these second wave updates, clinicians from primary care, secondary care, and public health, discuss what is happening in their field, and put questions to experts.

In this podcast, Fiona Godlee, editor in chief of The BMJ talks to Matt Morgan, consultant in intensive care medicine in Cardiff and Helen Salisbury, GP in Oxfordshire, and Nisreen Alwan, associate professor in public health at the University of Southampton.

They are joined by Andrew Hayward, professor of infectious disease epidemiology and inclusion health research, to talk about the lockdown in England, why the message should be clearer, what needs to be done to make the lockdown work, and how doctors are braced for the upcoming surge in cases.

<p>https://www.bmj.com/coronavirus</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6mznvc/stream_922809169-bmjgroup-corona-virus-second-wave-making-the-lockdown-work.mp3" length="55751156" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As the second spike in covid-19 cases grows, we want to take stock of what's happening in the NHS. In these second wave updates, clinicians from primary care, secondary care, and public health, discuss what is happening in their field, and put questions to experts.

In this podcast, Fiona Godlee, editor in chief of The BMJ talks to Matt Morgan, consultant in intensive care medicine in Cardiff and Helen Salisbury, GP in Oxfordshire, and Nisreen Alwan, associate professor in public health at the University of Southampton.

They are joined by Andrew Hayward, professor of infectious disease epidemiology and inclusion health research, to talk about the lockdown in England, why the message should be clearer, what needs to be done to make the lockdown work, and how doctors are braced for the upcoming surge in cases.

https://www.bmj.com/coronavirus]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3484</itunes:duration>
                                    </item>
    <item>
        <title>Talk evidence covid-19 update - talking risk, remdesivir, and relevant research</title>
        <itunes:title>Talk evidence covid-19 update - talking risk, remdesivir, and relevant research</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-talking-risk-remdesivir-and-relevant-research/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-talking-risk-remdesivir-and-relevant-research/#comments</comments>        <pubDate>Fri, 30 Oct 2020 18:58:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-covid-19-update-talking-risk-remdesivir-and-relevant-research</guid>
                                    <description><![CDATA[In this talk evidence covid-19 update, we’re taking on risk - how do you figure out your individual risk of dying from the disease? Try QCovid, but remember that it’s figuring out your risk back in April.

When it comes to talking about risk, very few people actually engage with the number, so Alex Freeman from the Winton Centre for Risk and Evidence Communication at the University of Cambridge joins us to describe their research into more effective ways of presenting it.

Huseyin Naci, from the London School of Economics, returns to the podcast to talk to us about the problems of pulling all the trial data together, and where covid-19 has made people work together most effectively in tackling that issue.


Reading list;

Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults
https://www.bmj.com/content/371/bmj.m3731


Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results
https://www.medrxiv.org/content/10.1101/2020.10.15.20209817v1

Producing and using timely comparative evidence on drugs: lessons from clinical trials for covid-19
<p>https://www.bmj.com/content/371/bmj.m3869.full</p>
]]></description>
                                                            <content:encoded><![CDATA[In this talk evidence covid-19 update, we’re taking on risk - how do you figure out your individual risk of dying from the disease? Try QCovid, but remember that it’s figuring out your risk back in April.

When it comes to talking about risk, very few people actually engage with the number, so Alex Freeman from the Winton Centre for Risk and Evidence Communication at the University of Cambridge joins us to describe their research into more effective ways of presenting it.

Huseyin Naci, from the London School of Economics, returns to the podcast to talk to us about the problems of pulling all the trial data together, and where covid-19 has made people work together most effectively in tackling that issue.


Reading list;

Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults
https://www.bmj.com/content/371/bmj.m3731


Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results
https://www.medrxiv.org/content/10.1101/2020.10.15.20209817v1

Producing and using timely comparative evidence on drugs: lessons from clinical trials for covid-19
<p>https://www.bmj.com/content/371/bmj.m3869.full</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8sf0ta/stream_920509159-bmjgroup-talk-evidence-covid-19-update-talking-risk-remdesivir-and-relevant-research.mp3" length="39760874" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this talk evidence covid-19 update, we’re taking on risk - how do you figure out your individual risk of dying from the disease? Try QCovid, but remember that it’s figuring out your risk back in April.

When it comes to talking about risk, very few people actually engage with the number, so Alex Freeman from the Winton Centre for Risk and Evidence Communication at the University of Cambridge joins us to describe their research into more effective ways of presenting it.

Huseyin Naci, from the London School of Economics, returns to the podcast to talk to us about the problems of pulling all the trial data together, and where covid-19 has made people work together most effectively in tackling that issue.


Reading list;

Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults
https://www.bmj.com/content/371/bmj.m3731


Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results
https://www.medrxiv.org/content/10.1101/2020.10.15.20209817v1

Producing and using timely comparative evidence on drugs: lessons from clinical trials for covid-19
https://www.bmj.com/content/371/bmj.m3869.full]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2485</itunes:duration>
                                    </item>
    <item>
        <title>Chris Whitty on the challenge of winter, lockdown, and following the science</title>
        <itunes:title>Chris Whitty on the challenge of winter, lockdown, and following the science</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/chris-whitty-on-the-challenge-of-winter-lockdown-and-following-the-science/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/chris-whitty-on-the-challenge-of-winter-lockdown-and-following-the-science/#comments</comments>        <pubDate>Thu, 29 Oct 2020 17:12:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/chris-whitty-on-the-challenge-of-winter-lockdown-and-following-the-science</guid>
                                    <description><![CDATA[Chris Whitty probably needs no introduction to our UK audience - he's the chief medical advisor to the UK government, has played a pivotal role in shaping the country's response to Covid-19.

He rarely does interviews - so in this conversation we wanted to ask him the questions that matter to clinicians, about how the pandemic will impact them over the winter. 

This was recorded yesterday, just before the announcement of the strict lockdowns in France and Germany.

For more covid-19 coverage
<p>www.bmj.com/coronavirus</p>
]]></description>
                                                            <content:encoded><![CDATA[Chris Whitty probably needs no introduction to our UK audience - he's the chief medical advisor to the UK government, has played a pivotal role in shaping the country's response to Covid-19.

He rarely does interviews - so in this conversation we wanted to ask him the questions that matter to clinicians, about how the pandemic will impact them over the winter. 

This was recorded yesterday, just before the announcement of the strict lockdowns in France and Germany.

For more covid-19 coverage
<p>www.bmj.com/coronavirus</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/f3ywfk/stream_919740763-bmjgroup-chris-whitty-on-the-challenge-of-winter-lockdown-and-following-the-science.mp3" length="37034944" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Chris Whitty probably needs no introduction to our UK audience - he's the chief medical advisor to the UK government, has played a pivotal role in shaping the country's response to Covid-19.

He rarely does interviews - so in this conversation we wanted to ask him the questions that matter to clinicians, about how the pandemic will impact them over the winter. 

This was recorded yesterday, just before the announcement of the strict lockdowns in France and Germany.

For more covid-19 coverage
www.bmj.com/coronavirus]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2315</itunes:duration>
                                    </item>
    <item>
        <title>Coronavirus second wave - what the modelling say about slowing transmission</title>
        <itunes:title>Coronavirus second wave - what the modelling say about slowing transmission</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/coronavirus-second-wave-what-the-modelling-say-about-slowing-transmission/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/coronavirus-second-wave-what-the-modelling-say-about-slowing-transmission/#comments</comments>        <pubDate>Tue, 27 Oct 2020 19:47:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/corona-virus-second-wave-what-does-the-modelling-say-about-slowing-transmission</guid>
                                    <description><![CDATA[As the world sees an upsurge in infections, this "second wave" feels different to the first - we have a much better understanding of the biology of the virus, in hospitals, guidelines for treatment have been rapidly developed... and the pipeline of research to improve that has been created. 

But a lot of questions remain - particularly about the dynamics of the spread of respiratory viruses.

Which brings us onto this episode - in these weekly discussions, clinicians from across the healthservice and I will be joined by experts, so we can find out more about the issues that really matter to frontline staff.

Joining us today are BMJ columnists, Matt Morgan, consultant in intensive care medicine in Cardiff and Helen Salisbury, GP in Oxfordshire. We also have The BMJ authors, Nisreen Alwan, consultant in public health, in Southampton and Karl Friston, neurologist and member of iSAGE

For more of The BMJ’s covid-19 coverage.

<p>www.bmj.com/coronavirus</p>
]]></description>
                                                            <content:encoded><![CDATA[As the world sees an upsurge in infections, this "second wave" feels different to the first - we have a much better understanding of the biology of the virus, in hospitals, guidelines for treatment have been rapidly developed... and the pipeline of research to improve that has been created. 

But a lot of questions remain - particularly about the dynamics of the spread of respiratory viruses.

Which brings us onto this episode - in these weekly discussions, clinicians from across the healthservice and I will be joined by experts, so we can find out more about the issues that really matter to frontline staff.

Joining us today are BMJ columnists, Matt Morgan, consultant in intensive care medicine in Cardiff and Helen Salisbury, GP in Oxfordshire. We also have The BMJ authors, Nisreen Alwan, consultant in public health, in Southampton and Karl Friston, neurologist and member of iSAGE

For more of The BMJ’s covid-19 coverage.

<p>www.bmj.com/coronavirus</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/b5k2mw/stream_918587377-bmjgroup-corona-virus-second-wave-what-does-the-modelling-say-about-slowing-transmission.mp3" length="43926673" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As the world sees an upsurge in infections, this "second wave" feels different to the first - we have a much better understanding of the biology of the virus, in hospitals, guidelines for treatment have been rapidly developed... and the pipeline of research to improve that has been created. 

But a lot of questions remain - particularly about the dynamics of the spread of respiratory viruses.

Which brings us onto this episode - in these weekly discussions, clinicians from across the healthservice and I will be joined by experts, so we can find out more about the issues that really matter to frontline staff.

Joining us today are BMJ columnists, Matt Morgan, consultant in intensive care medicine in Cardiff and Helen Salisbury, GP in Oxfordshire. We also have The BMJ authors, Nisreen Alwan, consultant in public health, in Southampton and Karl Friston, neurologist and member of iSAGE

For more of The BMJ’s covid-19 coverage.

www.bmj.com/coronavirus]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2745</itunes:duration>
                                    </item>
    <item>
        <title>Deep Breath In - EUPD with Leisha Davies, Soumitra Burman-Roy and Marie Stella McClure</title>
        <itunes:title>Deep Breath In - EUPD with Leisha Davies, Soumitra Burman-Roy and Marie Stella McClure</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/deep-breath-in-eupd-with-leisha-davies-soumitra-burman-roy-and-marie-stella-mcclure/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/deep-breath-in-eupd-with-leisha-davies-soumitra-burman-roy-and-marie-stella-mcclure/#comments</comments>        <pubDate>Thu, 22 Oct 2020 14:21:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/deep-breath-in-eupd-with-leisha-davies-soumitra-burman-roy-and-marie-stella-mcclure</guid>
                                    <description><![CDATA[Personality disorder is often referred to as the “Cinderella” diagnosis of mental health. Around 1 in 20 people is estimated to have a personality disorder, and it is a neglected and under-resourced area of our healthcare system. In this week’s episode, we discuss the stigma surrounding personality disorder, which can often manifest itself in high levels of anxiety for both patients and GPs, when it comes to diagnosing and managing it, and how to help a patient come to terms with their diagnosis. 

With suicidal ideation being experienced by many people with a personality disorder on a regular basis, we also talk about how we may best manage a situation of a patient in crisis presenting in primary care.

Our guests:

Leisha Davies is a clinical psychologist, originally from South Africa, who currently works in private practice.

Soumitra Burman-Roy is a consultant psychiatrist at the South London and Maudsley NHS Foundation Trust. He also works for Maudsley Learning, an organisation which provides mental health training for primary care.

<p>Marie Stella McClure, who was diagnosed with borderline personality disorder at the age of 38, is the author of ‘Borderline: a Memoir’, a book about her life and experiences of BPD.</p>
]]></description>
                                                            <content:encoded><![CDATA[Personality disorder is often referred to as the “Cinderella” diagnosis of mental health. Around 1 in 20 people is estimated to have a personality disorder, and it is a neglected and under-resourced area of our healthcare system. In this week’s episode, we discuss the stigma surrounding personality disorder, which can often manifest itself in high levels of anxiety for both patients and GPs, when it comes to diagnosing and managing it, and how to help a patient come to terms with their diagnosis. 

With suicidal ideation being experienced by many people with a personality disorder on a regular basis, we also talk about how we may best manage a situation of a patient in crisis presenting in primary care.

Our guests:

Leisha Davies is a clinical psychologist, originally from South Africa, who currently works in private practice.

Soumitra Burman-Roy is a consultant psychiatrist at the South London and Maudsley NHS Foundation Trust. He also works for Maudsley Learning, an organisation which provides mental health training for primary care.

<p>Marie Stella McClure, who was diagnosed with borderline personality disorder at the age of 38, is the author of ‘Borderline: a Memoir’, a book about her life and experiences of BPD.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ye7sgf/stream_916060175-bmjgroup-deep-breath-in-eupd-with-leisha-davies-soumitra-burman-roy-and-marie-stella-mcclure.mp3" length="56677354" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Personality disorder is often referred to as the “Cinderella” diagnosis of mental health. Around 1 in 20 people is estimated to have a personality disorder, and it is a neglected and under-resourced area of our healthcare system. In this week’s episode, we discuss the stigma surrounding personality disorder, which can often manifest itself in high levels of anxiety for both patients and GPs, when it comes to diagnosing and managing it, and how to help a patient come to terms with their diagnosis. 

With suicidal ideation being experienced by many people with a personality disorder on a regular basis, we also talk about how we may best manage a situation of a patient in crisis presenting in primary care.

Our guests:

Leisha Davies is a clinical psychologist, originally from South Africa, who currently works in private practice.

Soumitra Burman-Roy is a consultant psychiatrist at the South London and Maudsley NHS Foundation Trust. He also works for Maudsley Learning, an organisation which provides mental health training for primary care.

Marie Stella McClure, who was diagnosed with borderline personality disorder at the age of 38, is the author of ‘Borderline: a Memoir’, a book about her life and experiences of BPD.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3542</itunes:duration>
                                    </item>
    <item>
        <title>Second wave updates - How it’s affecting practice now</title>
        <itunes:title>Second wave updates - How it’s affecting practice now</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/second-wave-updates-how-it-s-affecting-practice-now/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/second-wave-updates-how-it-s-affecting-practice-now/#comments</comments>        <pubDate>Wed, 21 Oct 2020 14:27:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/second-wave-updates-how-its-affecting-practice-now</guid>
                                    <description><![CDATA[As the second spike in covid-19 cases grows, we want to take stock of what's happening in the NHS.  In these second wave updates, clinicians from primary care, secondary care, and public health, discuss what is happening in their field, and put questions to experts.

In this podcast, Fiona Godlee, editor in chief of The BMJ talks to Matt Morgan, consultant in intensive care medicine in Cardiff and Helen Salisbury, GP in Oxfordshire - they discuss how full hospitals are getting, how many covid-19 cases are presenting in primary care, and how treating patients has fared as the pandemic hots up.

<p>For more on covid-19 visit https://www.bmj.com/coronavirus</p>
]]></description>
                                                            <content:encoded><![CDATA[As the second spike in covid-19 cases grows, we want to take stock of what's happening in the NHS.  In these second wave updates, clinicians from primary care, secondary care, and public health, discuss what is happening in their field, and put questions to experts.

In this podcast, Fiona Godlee, editor in chief of The BMJ talks to Matt Morgan, consultant in intensive care medicine in Cardiff and Helen Salisbury, GP in Oxfordshire - they discuss how full hospitals are getting, how many covid-19 cases are presenting in primary care, and how treating patients has fared as the pandemic hots up.

<p>For more on covid-19 visit https://www.bmj.com/coronavirus</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/e00swk/stream_915454480-bmjgroup-second-wave-updates-how-its-affecting-practice-now.mp3" length="30349269" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As the second spike in covid-19 cases grows, we want to take stock of what's happening in the NHS.  In these second wave updates, clinicians from primary care, secondary care, and public health, discuss what is happening in their field, and put questions to experts.

In this podcast, Fiona Godlee, editor in chief of The BMJ talks to Matt Morgan, consultant in intensive care medicine in Cardiff and Helen Salisbury, GP in Oxfordshire - they discuss how full hospitals are getting, how many covid-19 cases are presenting in primary care, and how treating patients has fared as the pandemic hots up.

For more on covid-19 visit https://www.bmj.com/coronavirus]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1897</itunes:duration>
                                    </item>
    <item>
        <title>Wellbeing - Dreading the second wave</title>
        <itunes:title>Wellbeing - Dreading the second wave</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/wellbeing-dreading-the-second-wave/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/wellbeing-dreading-the-second-wave/#comments</comments>        <pubDate>Tue, 20 Oct 2020 10:02:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/wellbeing-dreading-the-second-wave-mixdown</guid>
                                    <description><![CDATA[The "second wave" of covid is hitting the UK, and clinicians are anticipating a spike in demand in the NHS. The inevitability of that is weighing on NHS staff's minds.

In this podcast, Cormac Doyle, a retired senior army officer, who specialises in military mental health/ veterans and support other with psychological trauma, returns to the podcast to talk about his experience of deployment in the military, and how individuals and their employers can make the inevitability of a second wave less daunting.

<p>For more wellbeing from The BMJ - https://www.bmj.com/wellbeing</p>
]]></description>
                                                            <content:encoded><![CDATA[The "second wave" of covid is hitting the UK, and clinicians are anticipating a spike in demand in the NHS. The inevitability of that is weighing on NHS staff's minds.

In this podcast, Cormac Doyle, a retired senior army officer, who specialises in military mental health/ veterans and support other with psychological trauma, returns to the podcast to talk about his experience of deployment in the military, and how individuals and their employers can make the inevitability of a second wave less daunting.

<p>For more wellbeing from The BMJ - https://www.bmj.com/wellbeing</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/996ppl/stream_914682181-bmjgroup-wellbeing-dreading-the-second-wave-mixdown.mp3" length="30888018" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The "second wave" of covid is hitting the UK, and clinicians are anticipating a spike in demand in the NHS. The inevitability of that is weighing on NHS staff's minds.

In this podcast, Cormac Doyle, a retired senior army officer, who specialises in military mental health/ veterans and support other with psychological trauma, returns to the podcast to talk about his experience of deployment in the military, and how individuals and their employers can make the inevitability of a second wave less daunting.

For more wellbeing from The BMJ - https://www.bmj.com/wellbeing]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1930</itunes:duration>
                                    </item>
    <item>
        <title>Economics for Drs - what you need to know to understand UBI and a jobs guarantee</title>
        <itunes:title>Economics for Drs - what you need to know to understand UBI and a jobs guarantee</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/economics-for-drs-what-you-need-to-know-to-understand-ubi-and-a-jobs-guarantee/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/economics-for-drs-what-you-need-to-know-to-understand-ubi-and-a-jobs-guarantee/#comments</comments>        <pubDate>Fri, 16 Oct 2020 11:15:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/economics-for-drs-what-you-need-to-know-to-understand-ubi-and-a-jobs-gurantee</guid>
                                    <description><![CDATA[As the economic fall out of covid-19 starts to bite, attention is turning to how the state can support everyone - especially if the pandemic turns into a depression.

Universal basic income, and a jobs guarantee are two of the potential mechanisms a country could deploy, both with different effects on people's health and wellbeing.

In this podcast, Martin Hensher, associate professor of health system financing and organisation at Deakin university in Australia, and author of the new analysis "Covid-19, unemployment, and health: time for deeper solutions?" joins us to get you up to speed on the economic thought behind these two schemes.

Read the full analysis;
<p>https://www.bmj.com/content/371/bmj.m3687</p>
]]></description>
                                                            <content:encoded><![CDATA[As the economic fall out of covid-19 starts to bite, attention is turning to how the state can support everyone - especially if the pandemic turns into a depression.

Universal basic income, and a jobs guarantee are two of the potential mechanisms a country could deploy, both with different effects on people's health and wellbeing.

In this podcast, Martin Hensher, associate professor of health system financing and organisation at Deakin university in Australia, and author of the new analysis "Covid-19, unemployment, and health: time for deeper solutions?" joins us to get you up to speed on the economic thought behind these two schemes.

Read the full analysis;
<p>https://www.bmj.com/content/371/bmj.m3687</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3bv0py/stream_911596648-bmjgroup-economics-for-drs-what-you-need-to-know-to-understand-ubi-and-a-jobs-gurantee.mp3" length="31305559" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As the economic fall out of covid-19 starts to bite, attention is turning to how the state can support everyone - especially if the pandemic turns into a depression.

Universal basic income, and a jobs guarantee are two of the potential mechanisms a country could deploy, both with different effects on people's health and wellbeing.

In this podcast, Martin Hensher, associate professor of health system financing and organisation at Deakin university in Australia, and author of the new analysis "Covid-19, unemployment, and health: time for deeper solutions?" joins us to get you up to speed on the economic thought behind these two schemes.

Read the full analysis;
https://www.bmj.com/content/371/bmj.m3687]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1957</itunes:duration>
                                    </item>
    <item>
        <title>Coughing kids with Tim Spector and Edward Snelson</title>
        <itunes:title>Coughing kids with Tim Spector and Edward Snelson</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/coughing-kids-with-tim-spector-and-edward-snelson/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/coughing-kids-with-tim-spector-and-edward-snelson/#comments</comments>        <pubDate>Thu, 08 Oct 2020 14:06:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/coughing-kids-with-tim-spector-and-ed-snelson</guid>
                                    <description><![CDATA[Persistent coughing in children is always a challenge, both for parents trying to describe and measure the cough, and for doctors making a diagnosis. In the current climate, this is all the more difficult, seeing as a continual cough is one of the major symptoms of COVID-19. UK Government guidance advises that anyone with a persistent cough should get a coronavirus test. But with the reopening of schools and the beginning of the cold & flu season both coinciding with a national shortage of tests available, should we all err on the side of caution and try to get a test at the first sign of a cough or sniffle, or can the data on cold virus symptoms help parents and GPs make an informed judgement on the likelihood that their child’s cough indicates COVID?

Our guests:
Tim Spector is a professor of Genetic Epidemiology, and director of the TwinsUK Registry, at King’s College London.

<p>Edward Snelson is a paediatrician in the paediatric emergency department at Sheffield Children’s Hospital.</p>
]]></description>
                                                            <content:encoded><![CDATA[Persistent coughing in children is always a challenge, both for parents trying to describe and measure the cough, and for doctors making a diagnosis. In the current climate, this is all the more difficult, seeing as a continual cough is one of the major symptoms of COVID-19. UK Government guidance advises that anyone with a persistent cough should get a coronavirus test. But with the reopening of schools and the beginning of the cold & flu season both coinciding with a national shortage of tests available, should we all err on the side of caution and try to get a test at the first sign of a cough or sniffle, or can the data on cold virus symptoms help parents and GPs make an informed judgement on the likelihood that their child’s cough indicates COVID?

Our guests:
Tim Spector is a professor of Genetic Epidemiology, and director of the TwinsUK Registry, at King’s College London.

<p>Edward Snelson is a paediatrician in the paediatric emergency department at Sheffield Children’s Hospital.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/b7kune/stream_907082458-bmjgroup-coughing-kids-with-tim-spector-and-ed-snelson.mp3" length="41439398" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Persistent coughing in children is always a challenge, both for parents trying to describe and measure the cough, and for doctors making a diagnosis. In the current climate, this is all the more difficult, seeing as a continual cough is one of the major symptoms of COVID-19. UK Government guidance advises that anyone with a persistent cough should get a coronavirus test. But with the reopening of schools and the beginning of the cold & flu season both coinciding with a national shortage of tests available, should we all err on the side of caution and try to get a test at the first sign of a cough or sniffle, or can the data on cold virus symptoms help parents and GPs make an informed judgement on the likelihood that their child’s cough indicates COVID?

Our guests:
Tim Spector is a professor of Genetic Epidemiology, and director of the TwinsUK Registry, at King’s College London.

Edward Snelson is a paediatrician in the paediatric emergency department at Sheffield Children’s Hospital.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2590</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence covid-19 update - antigen testing and developing non drug evidence</title>
        <itunes:title>Talk Evidence covid-19 update - antigen testing and developing non drug evidence</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-antigen-testing-and-developing-non-drug-evidence/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-antigen-testing-and-developing-non-drug-evidence/#comments</comments>        <pubDate>Mon, 05 Oct 2020 13:03:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-covid-19-update-antigen-testing-and-developing-non-drug-evidence</guid>
                                    <description><![CDATA[In this Talk Evidence covid-19 update, Jon Deeks, professor of biostatistics at the University of Birmingham gives us an update on testing technology. Will the point of care tests make a different to big live events, and how research and regulation need to change to tame the testing wild west.

<p>Paul Glasziou, professor of evidence based practice at at Bond University has set up a new collaboration to try and get better at creating evidence for non-drug/vaccine control of pandemics - and ponders why we're good at drug research, but terrible at other kinds.</p>
]]></description>
                                                            <content:encoded><![CDATA[In this Talk Evidence covid-19 update, Jon Deeks, professor of biostatistics at the University of Birmingham gives us an update on testing technology. Will the point of care tests make a different to big live events, and how research and regulation need to change to tame the testing wild west.

<p>Paul Glasziou, professor of evidence based practice at at Bond University has set up a new collaboration to try and get better at creating evidence for non-drug/vaccine control of pandemics - and ponders why we're good at drug research, but terrible at other kinds.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9agprs/stream_904979302-bmjgroup-talk-evidence-covid-19-update-antigen-testing-and-developing-non-drug-evidence.mp3" length="44278784" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this Talk Evidence covid-19 update, Jon Deeks, professor of biostatistics at the University of Birmingham gives us an update on testing technology. Will the point of care tests make a different to big live events, and how research and regulation need to change to tame the testing wild west.

Paul Glasziou, professor of evidence based practice at at Bond University has set up a new collaboration to try and get better at creating evidence for non-drug/vaccine control of pandemics - and ponders why we're good at drug research, but terrible at other kinds.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2767</itunes:duration>
                                    </item>
    <item>
        <title>A way for healthcare to become net-zero for carbon</title>
        <itunes:title>A way for healthcare to become net-zero for carbon</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/a-way-for-healthcare-to-become-net-zero-for-carbon/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/a-way-for-healthcare-to-become-net-zero-for-carbon/#comments</comments>        <pubDate>Fri, 02 Oct 2020 18:03:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/a-way-for-healthcare-to-become-net-zero-for-carbon</guid>
                                    <description><![CDATA[David Pencheon, Renee Salas and Ed Maibach join us to talk about how healthcare can, and should, take leadership on climate change.

With a few exceptions, the healthcare industry lags behind in efforts to reduce carbon emissions - in this podcast, we'll discuss why that is, why now is the time to take decarbonisation seriously, and why Covid-19 is a hindrance, but also a potential pivot point for change.


A pathway to net zero emissions for healthcare
https://www.bmj.com/content/371/bmj.m3785

For more on health and climate change
<p>https://www.bmj.com/campaign/climate-change</p>
]]></description>
                                                            <content:encoded><![CDATA[David Pencheon, Renee Salas and Ed Maibach join us to talk about how healthcare can, and should, take leadership on climate change.

With a few exceptions, the healthcare industry lags behind in efforts to reduce carbon emissions - in this podcast, we'll discuss why that is, why now is the time to take decarbonisation seriously, and why Covid-19 is a hindrance, but also a potential pivot point for change.


A pathway to net zero emissions for healthcare
https://www.bmj.com/content/371/bmj.m3785

For more on health and climate change
<p>https://www.bmj.com/campaign/climate-change</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/tx0e13/stream_903548365-bmjgroup-a-way-for-healthcare-to-become-net-zero-for-carbon.mp3" length="38587662" type="audio/mpeg"/>
        <itunes:summary><![CDATA[David Pencheon, Renee Salas and Ed Maibach join us to talk about how healthcare can, and should, take leadership on climate change.

With a few exceptions, the healthcare industry lags behind in efforts to reduce carbon emissions - in this podcast, we'll discuss why that is, why now is the time to take decarbonisation seriously, and why Covid-19 is a hindrance, but also a potential pivot point for change.


A pathway to net zero emissions for healthcare
https://www.bmj.com/content/371/bmj.m3785

For more on health and climate change
https://www.bmj.com/campaign/climate-change]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2412</itunes:duration>
                                    </item>
    <item>
        <title>’Flu vaccine season - with Nikki Turner and Jeff Kwong</title>
        <itunes:title>’Flu vaccine season - with Nikki Turner and Jeff Kwong</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/flu-vaccine-season-with-nikki-turner-and-jeff-kwong/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/flu-vaccine-season-with-nikki-turner-and-jeff-kwong/#comments</comments>        <pubDate>Thu, 24 Sep 2020 16:00:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/flu-season-with-nikki-turner-and-jeff-kwong</guid>
                                    <description><![CDATA[With the annual flu season looming, GPs are anticipating a frenzy of vaccinations, perhaps more so than ever this year.

As so many 'flu and respiratory viruses circulate every year, and as the 'flu vaccine is for one strain of influenza only, is the vaccine worth getting, and what are the risks associated with vaccinating vs. not vaccinating?

 In this week’s episode, we discuss the high vaccine uptake in New Zealand, and the role that social distancing for COVID-19 may have played in their low numbers of seasonal flu. 

We also talk about whether or not the message we give to patients about the benefits and risks of vaccination is transparent enough, and how we might communicate better with them to allow them to make an informed decision. 

We feel pressure to increase vaccination rates, because we believe we are protecting people, but does the evidence support that?

Our guests:

Nikki Turner is the director of the Immunisation Advisory Centre (IMAC) at the university of Auckland. She is an academic general practitioner, and a professor at the university.

<p>Jeff Kwong is a professor at the University of Toronto, and the interim director of the Centre for Vaccine Preventable Diseases at the university’s Dalla Lana School of Public Health.</p>
]]></description>
                                                            <content:encoded><![CDATA[With the annual flu season looming, GPs are anticipating a frenzy of vaccinations, perhaps more so than ever this year.

As so many 'flu and respiratory viruses circulate every year, and as the 'flu vaccine is for one strain of influenza only, is the vaccine worth getting, and what are the risks associated with vaccinating vs. not vaccinating?

 In this week’s episode, we discuss the high vaccine uptake in New Zealand, and the role that social distancing for COVID-19 may have played in their low numbers of seasonal flu. 

We also talk about whether or not the message we give to patients about the benefits and risks of vaccination is transparent enough, and how we might communicate better with them to allow them to make an informed decision. 

We feel pressure to increase vaccination rates, because we believe we are protecting people, but does the evidence support that?

Our guests:

Nikki Turner is the director of the Immunisation Advisory Centre (IMAC) at the university of Auckland. She is an academic general practitioner, and a professor at the university.

<p>Jeff Kwong is a professor at the University of Toronto, and the interim director of the Centre for Vaccine Preventable Diseases at the university’s Dalla Lana School of Public Health.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/16lv2y/stream_898886485-bmjgroup-flu-season-with-nikki-turner-and-jeff-kwong.mp3" length="55784593" type="audio/mpeg"/>
        <itunes:summary><![CDATA[With the annual flu season looming, GPs are anticipating a frenzy of vaccinations, perhaps more so than ever this year.

As so many 'flu and respiratory viruses circulate every year, and as the 'flu vaccine is for one strain of influenza only, is the vaccine worth getting, and what are the risks associated with vaccinating vs. not vaccinating?

 In this week’s episode, we discuss the high vaccine uptake in New Zealand, and the role that social distancing for COVID-19 may have played in their low numbers of seasonal flu. 

We also talk about whether or not the message we give to patients about the benefits and risks of vaccination is transparent enough, and how we might communicate better with them to allow them to make an informed decision. 

We feel pressure to increase vaccination rates, because we believe we are protecting people, but does the evidence support that?

Our guests:

Nikki Turner is the director of the Immunisation Advisory Centre (IMAC) at the university of Auckland. She is an academic general practitioner, and a professor at the university.

Jeff Kwong is a professor at the University of Toronto, and the interim director of the Centre for Vaccine Preventable Diseases at the university’s Dalla Lana School of Public Health.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3487</itunes:duration>
                                    </item>
    <item>
        <title>Talk evidence covid-19 update - covid in kids, and the winter cold season</title>
        <itunes:title>Talk evidence covid-19 update - covid in kids, and the winter cold season</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-covid-in-kids-and-the-winter-cold-season/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-covid-in-kids-and-the-winter-cold-season/#comments</comments>        <pubDate>Wed, 23 Sep 2020 15:42:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-covid-19-update-covid-in-kids-and-the-winter-cold-season</guid>
                                    <description><![CDATA[This episode was recorded on 18 September - just before the news came out about the new lockdown measures. We’ll hear Carl and Helen’s thoughts, but we also want to hear a broad range of views - so get in touch at bmj.com/podcasts.


(1.15) The kids are back in school, and people are worried about the infection spreading. Helen takes us through the ISCARIC data on children's symptoms and outcomes from covid-19.

(5.50) David Ludwig, professor of pediatrics at Harvard Medical School and BMJ editor, joins us to give an overview of paediatric covid.

(15.30) Carl has thoughts about the spread of covid, and how it seems to be mirroring other respiratory illnesses.

<p>(18.00) We wonder about the evidence for the "rule of six"</p>
]]></description>
                                                            <content:encoded><![CDATA[This episode was recorded on 18 September - just before the news came out about the new lockdown measures. We’ll hear Carl and Helen’s thoughts, but we also want to hear a broad range of views - so get in touch at bmj.com/podcasts.


(1.15) The kids are back in school, and people are worried about the infection spreading. Helen takes us through the ISCARIC data on children's symptoms and outcomes from covid-19.

(5.50) David Ludwig, professor of pediatrics at Harvard Medical School and BMJ editor, joins us to give an overview of paediatric covid.

(15.30) Carl has thoughts about the spread of covid, and how it seems to be mirroring other respiratory illnesses.

<p>(18.00) We wonder about the evidence for the "rule of six"</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/o1bs2p/stream_898253785-bmjgroup-talk-evidence-covid-19-update-covid-in-kids-and-the-winter-cold-season.mp3" length="25691264" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode was recorded on 18 September - just before the news came out about the new lockdown measures. We’ll hear Carl and Helen’s thoughts, but we also want to hear a broad range of views - so get in touch at bmj.com/podcasts.


(1.15) The kids are back in school, and people are worried about the infection spreading. Helen takes us through the ISCARIC data on children's symptoms and outcomes from covid-19.

(5.50) David Ludwig, professor of pediatrics at Harvard Medical School and BMJ editor, joins us to give an overview of paediatric covid.

(15.30) Carl has thoughts about the spread of covid, and how it seems to be mirroring other respiratory illnesses.

(18.00) We wonder about the evidence for the "rule of six"]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1606</itunes:duration>
                                    </item>
    <item>
        <title>Nudge it</title>
        <itunes:title>Nudge it</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/nudge-it/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/nudge-it/#comments</comments>        <pubDate>Mon, 21 Sep 2020 17:43:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/nudge-it</guid>
                                    <description><![CDATA[Nudging seemed to be all the rage a few years ago - a way of changing individual behaviours to help people make better choices, about their diet, exercise and other habits.

A lot of hype ensued, the UK government under Tony Blair even set up a “nudge unit” - but questions were asked about the efficacy of the approaches used, confusion about what a nudge actually was, and how to turn it into actual scalable change have followed the discipline.

In this podcast Craig Fox, behavioural scientist at UCLA, and author of a new analysis “Details matter: predicting when nudging clinicians will succeed or fail” joins us to explain why he thinks nudging could work in medicine.

https://www.bmj.com/content/370/bmj.m3256

To register for your free online place at BMJ Live 2020 visit
<p>https://live.bmj.com/</p>
]]></description>
                                                            <content:encoded><![CDATA[Nudging seemed to be all the rage a few years ago - a way of changing individual behaviours to help people make better choices, about their diet, exercise and other habits.

A lot of hype ensued, the UK government under Tony Blair even set up a “nudge unit” - but questions were asked about the efficacy of the approaches used, confusion about what a nudge actually was, and how to turn it into actual scalable change have followed the discipline.

In this podcast Craig Fox, behavioural scientist at UCLA, and author of a new analysis “Details matter: predicting when nudging clinicians will succeed or fail” joins us to explain why he thinks nudging could work in medicine.

https://www.bmj.com/content/370/bmj.m3256

To register for your free online place at BMJ Live 2020 visit
<p>https://live.bmj.com/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kjbtso/stream_897068887-bmjgroup-nudge-it.mp3" length="26100714" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Nudging seemed to be all the rage a few years ago - a way of changing individual behaviours to help people make better choices, about their diet, exercise and other habits.

A lot of hype ensued, the UK government under Tony Blair even set up a “nudge unit” - but questions were asked about the efficacy of the approaches used, confusion about what a nudge actually was, and how to turn it into actual scalable change have followed the discipline.

In this podcast Craig Fox, behavioural scientist at UCLA, and author of a new analysis “Details matter: predicting when nudging clinicians will succeed or fail” joins us to explain why he thinks nudging could work in medicine.

https://www.bmj.com/content/370/bmj.m3256

To register for your free online place at BMJ Live 2020 visit
https://live.bmj.com/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1631</itunes:duration>
                                    </item>
    <item>
        <title>Anthony Fauci - on changing science, long-covid, and political intrusion into health agencies</title>
        <itunes:title>Anthony Fauci - on changing science, long-covid, and political intrusion into health agencies</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/anthony-fauci-on-changing-science-long-covid-and-political-intrusion-into-health-agencies/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/anthony-fauci-on-changing-science-long-covid-and-political-intrusion-into-health-agencies/#comments</comments>        <pubDate>Fri, 18 Sep 2020 16:34:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/anthony-fauci-on-changins-science-long-covid-and-political-intrusion-into-health-agencies</guid>
                                    <description><![CDATA[Dr Anthony Fauci needs no introduction, as head of the NIAID for almost four decades, and the U.S. government's leading advisor on infectious diseases, and leader in the country's response to Covid-19.

In this interview with The BMJ, Dr Fauci covers parallels in his experience in the HIV/AIDS crisis with this latest public health emergency. He talks about how his understanding of Covid-19 has changed.

We also tackle the reports of political intrusion into the CDC and, address worries about the rush toward a vaccine in time for the November elections.

For more from The BMJ's covid coverage, all available for free
<p>https://www.bmj.com/coronavirus</p>
]]></description>
                                                            <content:encoded><![CDATA[Dr Anthony Fauci needs no introduction, as head of the NIAID for almost four decades, and the U.S. government's leading advisor on infectious diseases, and leader in the country's response to Covid-19.

In this interview with The BMJ, Dr Fauci covers parallels in his experience in the HIV/AIDS crisis with this latest public health emergency. He talks about how his understanding of Covid-19 has changed.

We also tackle the reports of political intrusion into the CDC and, address worries about the rush toward a vaccine in time for the November elections.

For more from The BMJ's covid coverage, all available for free
<p>https://www.bmj.com/coronavirus</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/zxbsnp/stream_895514659-bmjgroup-anthony-fauci-on-changins-science-long-covid-and-political-intrusion-into-health-agencies.mp3" length="31729788" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Dr Anthony Fauci needs no introduction, as head of the NIAID for almost four decades, and the U.S. government's leading advisor on infectious diseases, and leader in the country's response to Covid-19.

In this interview with The BMJ, Dr Fauci covers parallels in his experience in the HIV/AIDS crisis with this latest public health emergency. He talks about how his understanding of Covid-19 has changed.

We also tackle the reports of political intrusion into the CDC and, address worries about the rush toward a vaccine in time for the November elections.

For more from The BMJ's covid coverage, all available for free
https://www.bmj.com/coronavirus]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1983</itunes:duration>
                                    </item>
    <item>
        <title>Talking about obesity with Stephanie deGiorgio and Naveed Sattar</title>
        <itunes:title>Talking about obesity with Stephanie deGiorgio and Naveed Sattar</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talking-about-obesity-with-stephanie-degiorgio-and-naveed-sattar/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talking-about-obesity-with-stephanie-degiorgio-and-naveed-sattar/#comments</comments>        <pubDate>Thu, 10 Sep 2020 08:41:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talking-about-obesity-with-stephanie-digirogio-and-naveen-sattar</guid>
                                    <description><![CDATA[Fatphobia has been described as society’s last ‘ism’. Whilst our understanding of weight and health has changed over time, there is still a stigma towards people who are overweight or obese, and an assumption that they must be unhealthy, and unhealthy by choice. However, the correlation between weight and health may not be as clear cut as our societal biases would lead us to believe, and, therefore, the challenge for GPs is to make a conscious efforts to overcome our preconceptions so that they may provide the best support for our obese patients. This week, we discuss the need for a zero tolerance towards fat shaming at an organisational level, and how we can make GP practices more accessible for this group of patients. We also talk about retraining the palette in order to sustain weight loss, and our duty to lobby for better community-based weight management services.

Our guests:

Stephanie deGiorgio is a GP, and the clinical lead in the UTC at Queen Elizabeth The Queen Mother Hospital, Margate. She has a special interest in obesity.

<p>Naveed Sattar is a professor of Metabolic Medicine at the University of Glasgow. His main research concerns investigating the prevention, causes and management of diabetes, heart disease and obesity.</p>
]]></description>
                                                            <content:encoded><![CDATA[Fatphobia has been described as society’s last ‘ism’. Whilst our understanding of weight and health has changed over time, there is still a stigma towards people who are overweight or obese, and an assumption that they must be unhealthy, and unhealthy by choice. However, the correlation between weight and health may not be as clear cut as our societal biases would lead us to believe, and, therefore, the challenge for GPs is to make a conscious efforts to overcome our preconceptions so that they may provide the best support for our obese patients. This week, we discuss the need for a zero tolerance towards fat shaming at an organisational level, and how we can make GP practices more accessible for this group of patients. We also talk about retraining the palette in order to sustain weight loss, and our duty to lobby for better community-based weight management services.

Our guests:

Stephanie deGiorgio is a GP, and the clinical lead in the UTC at Queen Elizabeth The Queen Mother Hospital, Margate. She has a special interest in obesity.

<p>Naveed Sattar is a professor of Metabolic Medicine at the University of Glasgow. His main research concerns investigating the prevention, causes and management of diabetes, heart disease and obesity.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/frvm4m/stream_890799583-bmjgroup-talking-about-obesity-with-stephanie-digirogio-and-naveen-sattar.mp3" length="85443026" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Fatphobia has been described as society’s last ‘ism’. Whilst our understanding of weight and health has changed over time, there is still a stigma towards people who are overweight or obese, and an assumption that they must be unhealthy, and unhealthy by choice. However, the correlation between weight and health may not be as clear cut as our societal biases would lead us to believe, and, therefore, the challenge for GPs is to make a conscious efforts to overcome our preconceptions so that they may provide the best support for our obese patients. This week, we discuss the need for a zero tolerance towards fat shaming at an organisational level, and how we can make GP practices more accessible for this group of patients. We also talk about retraining the palette in order to sustain weight loss, and our duty to lobby for better community-based weight management services.

Our guests:

Stephanie deGiorgio is a GP, and the clinical lead in the UTC at Queen Elizabeth The Queen Mother Hospital, Margate. She has a special interest in obesity.

Naveed Sattar is a professor of Metabolic Medicine at the University of Glasgow. His main research concerns investigating the prevention, causes and management of diabetes, heart disease and obesity.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3564</itunes:duration>
                                    </item>
    <item>
        <title>Wellbeing - Mask shaming</title>
        <itunes:title>Wellbeing - Mask shaming</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/wellbeing-mask-shaming/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/wellbeing-mask-shaming/#comments</comments>        <pubDate>Sat, 05 Sep 2020 12:18:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/wellbeing-mask-shaming</guid>
                                    <description><![CDATA[The social norms that guide our behaviour in the world aren’t often quick to change - but the imperative to wear a mask in public has rapidly taken hold, establish by law, but policed by the public.

Mask shaming is a new phenomenon, but in this podcast, Brandy Schillace, author, historian and editor in chief of Medical Humanities (a BMJ journal) joins Cat and Abi to discuss how ineffective shaming is as a tool for behaviour change, and what mask-shaming reveals about the ways in which society treats those who are seen as non-conforming. 

For more on The BMJ’s wellbeing campaign
<p>www.bmj.com/wellbeing</p>
]]></description>
                                                            <content:encoded><![CDATA[The social norms that guide our behaviour in the world aren’t often quick to change - but the imperative to wear a mask in public has rapidly taken hold, establish by law, but policed by the public.

Mask shaming is a new phenomenon, but in this podcast, Brandy Schillace, author, historian and editor in chief of Medical Humanities (a BMJ journal) joins Cat and Abi to discuss how ineffective shaming is as a tool for behaviour change, and what mask-shaming reveals about the ways in which society treats those who are seen as non-conforming. 

For more on The BMJ’s wellbeing campaign
<p>www.bmj.com/wellbeing</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wxopb5/stream_888203986-bmjgroup-wellbeing-mask-shaming.mp3" length="43128381" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The social norms that guide our behaviour in the world aren’t often quick to change - but the imperative to wear a mask in public has rapidly taken hold, establish by law, but policed by the public.

Mask shaming is a new phenomenon, but in this podcast, Brandy Schillace, author, historian and editor in chief of Medical Humanities (a BMJ journal) joins Cat and Abi to discuss how ineffective shaming is as a tool for behaviour change, and what mask-shaming reveals about the ways in which society treats those who are seen as non-conforming. 

For more on The BMJ’s wellbeing campaign
www.bmj.com/wellbeing]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1799</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence Covid-19 Update - Lockdown, a spoonful of honey, and weight loss</title>
        <itunes:title>Talk Evidence Covid-19 Update - Lockdown, a spoonful of honey, and weight loss</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-lockdown-a-spoonful-of-honey-and-weight-loss/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-lockdown-a-spoonful-of-honey-and-weight-loss/#comments</comments>        <pubDate>Fri, 28 Aug 2020 07:47:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-lockdown-a-spoonful-of-honey-and-weight-loss</guid>
                                    <description><![CDATA[There are have been local lockdowns in the UK, in places such as Oldham, Birmingham, Manchester – but what is the criteria for making that decision?

In the non-Covid world: does honey alleviate symptoms in upper-respiratory tract infections? When does unexpected weight-loss warrant further investigation for cancer in primary care?

<p>Plus, in the light of findings from the Cumberlege review of safety in medical devices, the team discuss the issue of doctors’ declaration of interests.</p>
]]></description>
                                                            <content:encoded><![CDATA[There are have been local lockdowns in the UK, in places such as Oldham, Birmingham, Manchester – but what is the criteria for making that decision?

In the non-Covid world: does honey alleviate symptoms in upper-respiratory tract infections? When does unexpected weight-loss warrant further investigation for cancer in primary care?

<p>Plus, in the light of findings from the Cumberlege review of safety in medical devices, the team discuss the issue of doctors’ declaration of interests.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ouxs22/stream_883414699-bmjgroup-talk-evidence-lockdown-a-spoonful-of-honey-and-weight-loss.mp3" length="31705472" type="audio/mpeg"/>
        <itunes:summary><![CDATA[There are have been local lockdowns in the UK, in places such as Oldham, Birmingham, Manchester – but what is the criteria for making that decision?

In the non-Covid world: does honey alleviate symptoms in upper-respiratory tract infections? When does unexpected weight-loss warrant further investigation for cancer in primary care?

Plus, in the light of findings from the Cumberlege review of safety in medical devices, the team discuss the issue of doctors’ declaration of interests.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1982</itunes:duration>
                                    </item>
    <item>
        <title>Time For A Pill Check With Anne McGregor And Tara Stein</title>
        <itunes:title>Time For A Pill Check With Anne McGregor And Tara Stein</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/time-for-a-pill-check-with-anne-mcgregor-and-tara-stein/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/time-for-a-pill-check-with-anne-mcgregor-and-tara-stein/#comments</comments>        <pubDate>Fri, 28 Aug 2020 07:23:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/time-for-a-pill-check-with-anne-mcgregor-and-tara-stein</guid>
                                    <description><![CDATA[Contraceptive pill check-up appointments used to be simple and straightforward for GPs, and frequently felt like a welcome reprieve from more complex consultations. However, there’s often more to them these days, especially given the rise in tailored regimens, with more and more women moving away from the standard of 21 pills followed by a 7-day break. 

In this week’s episode, we discuss common misconceptions around the pill cycle compared with a woman’s natural cycle, the various side effects caused by taking an oestrogen-dominant versus a progesterone-dominant pill, and the purely arbitrary nature of the standard regimen. How do we ensure that our patients are able to make an informed choice on their method of contraception, and how do we avoid the risk of contraceptive coercion?

Our guests:

Anne MacGregor is a professor, working in Secual ans Reproductive Healthcare at Barts Health NHS Trust. She is a specialist in women’s health, and also in headaches and migraines.

<p>Tara Stein is a Family Medicine doctor at Montefiore Medical Center, and the Clinical Curriculum Manager for RHEDI – Reproductive Health Education in Family Medicine.</p>
]]></description>
                                                            <content:encoded><![CDATA[Contraceptive pill check-up appointments used to be simple and straightforward for GPs, and frequently felt like a welcome reprieve from more complex consultations. However, there’s often more to them these days, especially given the rise in tailored regimens, with more and more women moving away from the standard of 21 pills followed by a 7-day break. 

In this week’s episode, we discuss common misconceptions around the pill cycle compared with a woman’s natural cycle, the various side effects caused by taking an oestrogen-dominant versus a progesterone-dominant pill, and the purely arbitrary nature of the standard regimen. How do we ensure that our patients are able to make an informed choice on their method of contraception, and how do we avoid the risk of contraceptive coercion?

Our guests:

Anne MacGregor is a professor, working in Secual ans Reproductive Healthcare at Barts Health NHS Trust. She is a specialist in women’s health, and also in headaches and migraines.

<p>Tara Stein is a Family Medicine doctor at Montefiore Medical Center, and the Clinical Curriculum Manager for RHEDI – Reproductive Health Education in Family Medicine.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/s47p3q/stream_883408204-bmjgroup-time-for-a-pill-check-with-anne-mcgregor-and-tara-stein.mp3" length="56210911" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Contraceptive pill check-up appointments used to be simple and straightforward for GPs, and frequently felt like a welcome reprieve from more complex consultations. However, there’s often more to them these days, especially given the rise in tailored regimens, with more and more women moving away from the standard of 21 pills followed by a 7-day break. 

In this week’s episode, we discuss common misconceptions around the pill cycle compared with a woman’s natural cycle, the various side effects caused by taking an oestrogen-dominant versus a progesterone-dominant pill, and the purely arbitrary nature of the standard regimen. How do we ensure that our patients are able to make an informed choice on their method of contraception, and how do we avoid the risk of contraceptive coercion?

Our guests:

Anne MacGregor is a professor, working in Secual ans Reproductive Healthcare at Barts Health NHS Trust. She is a specialist in women’s health, and also in headaches and migraines.

Tara Stein is a Family Medicine doctor at Montefiore Medical Center, and the Clinical Curriculum Manager for RHEDI – Reproductive Health Education in Family Medicine.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3513</itunes:duration>
                                    </item>
    <item>
        <title>Wellbeing – The joy of socks</title>
        <itunes:title>Wellbeing – The joy of socks</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/wellbeing-%e2%80%93-the-joy-of-socks/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/wellbeing-%e2%80%93-the-joy-of-socks/#comments</comments>        <pubDate>Fri, 21 Aug 2020 13:50:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/wellbeing-the-joy-of-socks</guid>
                                    <description><![CDATA[In Australia, a staggering 25% of doctors have had thoughts of suicide in the past 12 months, a recent survey said. Mental health problems are higher in medicine than any other job – and yet healthcare professionals are still stigmatised for seeking help. Partly in response to his own struggles, Geoff Toogood, a cardiologist in Melbourne, started an ingenious campaign called CrazySocks4Docs to highlight the issue. 

<p>https://www.crazysocks4docs.com.au/</p>
]]></description>
                                                            <content:encoded><![CDATA[In Australia, a staggering 25% of doctors have had thoughts of suicide in the past 12 months, a recent survey said. Mental health problems are higher in medicine than any other job – and yet healthcare professionals are still stigmatised for seeking help. Partly in response to his own struggles, Geoff Toogood, a cardiologist in Melbourne, started an ingenious campaign called CrazySocks4Docs to highlight the issue. 

<p>https://www.crazysocks4docs.com.au/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/r2ibjb/stream_879624361-bmjgroup-wellbeing-the-joy-of-socks.mp3" length="28345472" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In Australia, a staggering 25% of doctors have had thoughts of suicide in the past 12 months, a recent survey said. Mental health problems are higher in medicine than any other job – and yet healthcare professionals are still stigmatised for seeking help. Partly in response to his own struggles, Geoff Toogood, a cardiologist in Melbourne, started an ingenious campaign called CrazySocks4Docs to highlight the issue. 

https://www.crazysocks4docs.com.au/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1772</itunes:duration>
                                    </item>
    <item>
        <title>What Do We Know About Long Covid</title>
        <itunes:title>What Do We Know About Long Covid</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/what-do-we-know-about-long-covid/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/what-do-we-know-about-long-covid/#comments</comments>        <pubDate>Thu, 20 Aug 2020 09:19:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/what-do-we-know-about-long-covid</guid>
                                    <description><![CDATA[Trisha Greenhalgh, professor of primary care health sciences at the University of Oxford has been a powerhouse of covid-19 evidence synthesis. She pulled together advice on doing remote consultations, on wearing masks to prevent spread, and a host of other information.

She’s now turning her attention to “long-covid” - as we learn more about the disease, it’s becoming apparent that it’s not just an acute infection, patients are reporting chronic long term consequences of having the virus.

In this podcast, she describes what we know about long-covid, where the uncertainty lies, and what clinicians should be doing to help patients who are experiencing the symptoms.
 
Management of post-acute covid-19 in primary care 
<p>https://www.bmj.com/content/370/bmj.m3026</p>
]]></description>
                                                            <content:encoded><![CDATA[Trisha Greenhalgh, professor of primary care health sciences at the University of Oxford has been a powerhouse of covid-19 evidence synthesis. She pulled together advice on doing remote consultations, on wearing masks to prevent spread, and a host of other information.

She’s now turning her attention to “long-covid” - as we learn more about the disease, it’s becoming apparent that it’s not just an acute infection, patients are reporting chronic long term consequences of having the virus.

In this podcast, she describes what we know about long-covid, where the uncertainty lies, and what clinicians should be doing to help patients who are experiencing the symptoms.
 
Management of post-acute covid-19 in primary care 
<p>https://www.bmj.com/content/370/bmj.m3026</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6glial/stream_878915599-bmjgroup-what-do-we-know-about-long-covid.mp3" length="27756250" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Trisha Greenhalgh, professor of primary care health sciences at the University of Oxford has been a powerhouse of covid-19 evidence synthesis. She pulled together advice on doing remote consultations, on wearing masks to prevent spread, and a host of other information.

She’s now turning her attention to “long-covid” - as we learn more about the disease, it’s becoming apparent that it’s not just an acute infection, patients are reporting chronic long term consequences of having the virus.

In this podcast, she describes what we know about long-covid, where the uncertainty lies, and what clinicians should be doing to help patients who are experiencing the symptoms.
 
Management of post-acute covid-19 in primary care 
https://www.bmj.com/content/370/bmj.m3026]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1735</itunes:duration>
                                    </item>
    <item>
        <title>Talk evidence covid-19 update - Living meta-analysis and covid uncertainty</title>
        <itunes:title>Talk evidence covid-19 update - Living meta-analysis and covid uncertainty</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-living-meta-analysis-and-covid-uncertainty/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-living-meta-analysis-and-covid-uncertainty/#comments</comments>        <pubDate>Sat, 15 Aug 2020 11:37:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-living-meta-analyses-and-covid-uncertainty</guid>
                                    <description><![CDATA[1.00) Carl has been looking at PCR testing, and explains why it picks up both viable SARS-cov-2, but also fragments of it’s RNA - leading to potential over diagnosis.


(8.50 ) What did the Living systematic review and accompanying guidelines say about treatment options for covid-19


(14.35) Helen talks to Reed Siemieniuk,  general internist from McMaster University, about creating a living network meta-analysis, to try and synthesis all the evidence on covid-19


(22.48) Helen also talks to Bram Rochwerg, associate professor  at McMaster University and 
consultant intensivist at Hamilton Health Sciences,  about turning the outcomes of a meta-analysis into guidelines, and why at the moment they’re still calling for more evidence on Remdesivir 



(30.08) Finally, there are worries about the uncertainty expressed in the living review - and in the way in which we communicate that. Helen goes back to Reed to find out how the review might evolve in the future.


(33.50)  Covid isn’t just an acute disease, there is emerging consensus that it’s systemic effects lead to long term problems for some patients - but there’s a lot of uncertainty there. 

(38.40) Carl talks about the IMMDS review and his involvement in it - and what recommendations we’ll be covering in future Talk Evidence programmes.


Reading list:
Drug treatments for covid-19: living systematic review and network meta-analysis -https://www.bmj.com/content/370/bmj.m2980

Remdesivir for severe covid-19: a clinical practice guideline - https://www.bmj.com/content/370/bmj.m2924

<p>Management of post-acute covid-19 in primary care - https://www.bmj.com/content/370/bmj.m3026</p>
]]></description>
                                                            <content:encoded><![CDATA[1.00) Carl has been looking at PCR testing, and explains why it picks up both viable SARS-cov-2, but also fragments of it’s RNA - leading to potential over diagnosis.


(8.50 ) What did the Living systematic review and accompanying guidelines say about treatment options for covid-19


(14.35) Helen talks to Reed Siemieniuk,  general internist from McMaster University, about creating a living network meta-analysis, to try and synthesis all the evidence on covid-19


(22.48) Helen also talks to Bram Rochwerg, associate professor  at McMaster University and 
consultant intensivist at Hamilton Health Sciences,  about turning the outcomes of a meta-analysis into guidelines, and why at the moment they’re still calling for more evidence on Remdesivir 



(30.08) Finally, there are worries about the uncertainty expressed in the living review - and in the way in which we communicate that. Helen goes back to Reed to find out how the review might evolve in the future.


(33.50)  Covid isn’t just an acute disease, there is emerging consensus that it’s systemic effects lead to long term problems for some patients - but there’s a lot of uncertainty there. 

(38.40) Carl talks about the IMMDS review and his involvement in it - and what recommendations we’ll be covering in future Talk Evidence programmes.


Reading list:
Drug treatments for covid-19: living systematic review and network meta-analysis -https://www.bmj.com/content/370/bmj.m2980

Remdesivir for severe covid-19: a clinical practice guideline - https://www.bmj.com/content/370/bmj.m2924

<p>Management of post-acute covid-19 in primary care - https://www.bmj.com/content/370/bmj.m3026</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/n93cxy/stream_876231682-bmjgroup-talk-evidence-living-meta-analyses-and-covid-uncertainty.mp3" length="41616194" type="audio/mpeg"/>
        <itunes:summary><![CDATA[1.00) Carl has been looking at PCR testing, and explains why it picks up both viable SARS-cov-2, but also fragments of it’s RNA - leading to potential over diagnosis.


(8.50 ) What did the Living systematic review and accompanying guidelines say about treatment options for covid-19


(14.35) Helen talks to Reed Siemieniuk,  general internist from McMaster University, about creating a living network meta-analysis, to try and synthesis all the evidence on covid-19


(22.48) Helen also talks to Bram Rochwerg, associate professor  at McMaster University and 
consultant intensivist at Hamilton Health Sciences,  about turning the outcomes of a meta-analysis into guidelines, and why at the moment they’re still calling for more evidence on Remdesivir 



(30.08) Finally, there are worries about the uncertainty expressed in the living review - and in the way in which we communicate that. Helen goes back to Reed to find out how the review might evolve in the future.


(33.50)  Covid isn’t just an acute disease, there is emerging consensus that it’s systemic effects lead to long term problems for some patients - but there’s a lot of uncertainty there. 

(38.40) Carl talks about the IMMDS review and his involvement in it - and what recommendations we’ll be covering in future Talk Evidence programmes.


Reading list:
Drug treatments for covid-19: living systematic review and network meta-analysis -https://www.bmj.com/content/370/bmj.m2980

Remdesivir for severe covid-19: a clinical practice guideline - https://www.bmj.com/content/370/bmj.m2924

Management of post-acute covid-19 in primary care - https://www.bmj.com/content/370/bmj.m3026]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2601</itunes:duration>
                                    </item>
    <item>
        <title>Thinking about vitamin D with Andrew Grey and Tom Chatfield</title>
        <itunes:title>Thinking about vitamin D with Andrew Grey and Tom Chatfield</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/thinking-about-vitamin-d-with-andrew-grey-and-tom-chatfield/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/thinking-about-vitamin-d-with-andrew-grey-and-tom-chatfield/#comments</comments>        <pubDate>Thu, 13 Aug 2020 14:00:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/thinking-about-vitamin-d-with-andrew-grey-and-tom-chatfield</guid>
                                    <description><![CDATA[Interest in vitamin D, and it’s association with a range of health outcomes continues - at least if the regular flurry of papers on the subject that are submitted to The BMJ are anything to go by, and with Covid-19, interest has piqued again.

GPs are regularly asked to prescribe it, and to test for deficiencies. Low levels of vitamin D are associated with a large number of health outcomes, but, given the high costs and low accuracy of tests, would it be easier just to recommend taking supplements without testing vitamin levels first, taking a “won’t hurt but might help” approach? If so, should we all be taking them, and would doing so help to prevent against COVID-19?

Our guests:

Andrew Grey is an endocrinologist and an associate professor of Medicine at the University of Auckland.

<p>Tom Chatfield is a philosopher, author and broadcaster, whose work looks at humans and technology, as well as cognitive biases.</p>
]]></description>
                                                            <content:encoded><![CDATA[Interest in vitamin D, and it’s association with a range of health outcomes continues - at least if the regular flurry of papers on the subject that are submitted to The BMJ are anything to go by, and with Covid-19, interest has piqued again.

GPs are regularly asked to prescribe it, and to test for deficiencies. Low levels of vitamin D are associated with a large number of health outcomes, but, given the high costs and low accuracy of tests, would it be easier just to recommend taking supplements without testing vitamin levels first, taking a “won’t hurt but might help” approach? If so, should we all be taking them, and would doing so help to prevent against COVID-19?

Our guests:

Andrew Grey is an endocrinologist and an associate professor of Medicine at the University of Auckland.

<p>Tom Chatfield is a philosopher, author and broadcaster, whose work looks at humans and technology, as well as cognitive biases.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/alvp0s/stream_875094142-bmjgroup-thinking-about-vitamin-d-with-andrew-grey-and-tom-chatfield.mp3" length="58253060" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Interest in vitamin D, and it’s association with a range of health outcomes continues - at least if the regular flurry of papers on the subject that are submitted to The BMJ are anything to go by, and with Covid-19, interest has piqued again.

GPs are regularly asked to prescribe it, and to test for deficiencies. Low levels of vitamin D are associated with a large number of health outcomes, but, given the high costs and low accuracy of tests, would it be easier just to recommend taking supplements without testing vitamin levels first, taking a “won’t hurt but might help” approach? If so, should we all be taking them, and would doing so help to prevent against COVID-19?

Our guests:

Andrew Grey is an endocrinologist and an associate professor of Medicine at the University of Auckland.

Tom Chatfield is a philosopher, author and broadcaster, whose work looks at humans and technology, as well as cognitive biases.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3641</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence covid-19 update - How well have physical distancing measures worked?</title>
        <itunes:title>Talk Evidence covid-19 update - How well have physical distancing measures worked?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-how-well-have-physical-distancing-measures-worked/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-how-well-have-physical-distancing-measures-worked/#comments</comments>        <pubDate>Fri, 31 Jul 2020 16:33:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-physical-distancing</guid>
                                    <description><![CDATA[Fresh outbreaks of covid in Europe and a wave of infections in the United States have been in the news this week, highlighting the renewed need for social distancing – but to what extent?

In this edition, we explore the real-world evidence for physical distancing measures as well as the research into whether or not facemasks make us behave more recklessly.

<p>We also discuss the non-covid themes of research transparency and a BMJ investigation into the lucrative business of orphan drugs.</p>
]]></description>
                                                            <content:encoded><![CDATA[Fresh outbreaks of covid in Europe and a wave of infections in the United States have been in the news this week, highlighting the renewed need for social distancing – but to what extent?

In this edition, we explore the real-world evidence for physical distancing measures as well as the research into whether or not facemasks make us behave more recklessly.

<p>We also discuss the non-covid themes of research transparency and a BMJ investigation into the lucrative business of orphan drugs.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7kjd84/stream_867954490-bmjgroup-talk-evidence-physical-distancing.mp3" length="39049472" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Fresh outbreaks of covid in Europe and a wave of infections in the United States have been in the news this week, highlighting the renewed need for social distancing – but to what extent?

In this edition, we explore the real-world evidence for physical distancing measures as well as the research into whether or not facemasks make us behave more recklessly.

We also discuss the non-covid themes of research transparency and a BMJ investigation into the lucrative business of orphan drugs.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2441</itunes:duration>
                                    </item>
    <item>
        <title>“Trust me, I’m a GP” with Karen Praeter and Rhea Boyd</title>
        <itunes:title>“Trust me, I’m a GP” with Karen Praeter and Rhea Boyd</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/trust-me-i-m-a-gp-with-karen-praeter-and-rhea-boyd/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/trust-me-i-m-a-gp-with-karen-praeter-and-rhea-boyd/#comments</comments>        <pubDate>Fri, 31 Jul 2020 14:28:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/trust-me-im-a-gp-with-karen-praeter-and-rhea-boyd</guid>
                                    <description><![CDATA[In light of the publication of the Independent Medicines and Medical Devices Safety Review (the Cumberlege report) in early July, which assessed the use of vaginal mesh, sodium valproate and Primodos and their associated under-acknowledged complications, this week we discuss trust between patients and doctors, and how that relationship of trust can break down when patients feel that their concerns and their pain are not being recognised and supported. We talk about the influence of racial inequalities on trust and healthcare outcomes, GPs being an advocate for their patients, and we ask what structural changes to the healthcare system need to happen to allow us to spend more time with our patients and build up that trusting relationship with them?

Our guests:

Karen Praeter works on the admin team of Sling the Mesh, a campaign which raises awareness of the risks of having a vaginal mesh implant, having joined two years after her own mesh implant operation in 2015 which led to painful complications.

<p>Rhea Boyd is a paediatrician at the Palo Alto Medical Foundation in California, and she is also a public health advocate and scholar.</p>
]]></description>
                                                            <content:encoded><![CDATA[In light of the publication of the Independent Medicines and Medical Devices Safety Review (the Cumberlege report) in early July, which assessed the use of vaginal mesh, sodium valproate and Primodos and their associated under-acknowledged complications, this week we discuss trust between patients and doctors, and how that relationship of trust can break down when patients feel that their concerns and their pain are not being recognised and supported. We talk about the influence of racial inequalities on trust and healthcare outcomes, GPs being an advocate for their patients, and we ask what structural changes to the healthcare system need to happen to allow us to spend more time with our patients and build up that trusting relationship with them?

Our guests:

Karen Praeter works on the admin team of Sling the Mesh, a campaign which raises awareness of the risks of having a vaginal mesh implant, having joined two years after her own mesh implant operation in 2015 which led to painful complications.

<p>Rhea Boyd is a paediatrician at the Palo Alto Medical Foundation in California, and she is also a public health advocate and scholar.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2tngk8/stream_867894196-bmjgroup-trust-me-im-a-gp-with-karen-praeter-and-rhea-boyd.mp3" length="70780548" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In light of the publication of the Independent Medicines and Medical Devices Safety Review (the Cumberlege report) in early July, which assessed the use of vaginal mesh, sodium valproate and Primodos and their associated under-acknowledged complications, this week we discuss trust between patients and doctors, and how that relationship of trust can break down when patients feel that their concerns and their pain are not being recognised and supported. We talk about the influence of racial inequalities on trust and healthcare outcomes, GPs being an advocate for their patients, and we ask what structural changes to the healthcare system need to happen to allow us to spend more time with our patients and build up that trusting relationship with them?

Our guests:

Karen Praeter works on the admin team of Sling the Mesh, a campaign which raises awareness of the risks of having a vaginal mesh implant, having joined two years after her own mesh implant operation in 2015 which led to painful complications.

Rhea Boyd is a paediatrician at the Palo Alto Medical Foundation in California, and she is also a public health advocate and scholar.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2953</itunes:duration>
                                    </item>
    <item>
        <title>Wellbeing – addiction during lockdown</title>
        <itunes:title>Wellbeing – addiction during lockdown</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/wellbeing-%e2%80%93-addiction-during-lockdown/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/wellbeing-%e2%80%93-addiction-during-lockdown/#comments</comments>        <pubDate>Thu, 30 Jul 2020 09:12:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/wellbeing-addiction-during-lockdown</guid>
                                    <description><![CDATA[<p>Lockdown has been such a stressful period that many healthcare professionals developed abnormal behaviours to cope. Addiction is one such behaviour, be it to a substance – alcohol for example – or any other obsessive activity like exercise. Dr Caroline Walker, an NHS psychiatrist and therapist who has personal experience of addiction discusses the harmful behaviours to look out for and what to do about them.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Lockdown has been such a stressful period that many healthcare professionals developed abnormal behaviours to cope. Addiction is one such behaviour, be it to a substance – alcohol for example – or any other obsessive activity like exercise. Dr Caroline Walker, an NHS psychiatrist and therapist who has personal experience of addiction discusses the harmful behaviours to look out for and what to do about them.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/v8dglh/stream_867031888-bmjgroup-wellbeing-addiction-during-lockdown.mp3" length="24977024" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Lockdown has been such a stressful period that many healthcare professionals developed abnormal behaviours to cope. Addiction is one such behaviour, be it to a substance – alcohol for example – or any other obsessive activity like exercise. Dr Caroline Walker, an NHS psychiatrist and therapist who has personal experience of addiction discusses the harmful behaviours to look out for and what to do about them.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1561</itunes:duration>
                                    </item>
    <item>
        <title>Marian Knight - Improving obstetric outcomes with a single dose of antibiotics</title>
        <itunes:title>Marian Knight - Improving obstetric outcomes with a single dose of antibiotics</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/marian-knight-improving-obstetric-outcomes-with-a-single-dose-of-antibiotics/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/marian-knight-improving-obstetric-outcomes-with-a-single-dose-of-antibiotics/#comments</comments>        <pubDate>Sat, 25 Jul 2020 14:43:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/marian-knight-improving-obstetric-outcomes-with-a-single-dose-of-antibiotics</guid>
                                    <description><![CDATA[This time of year we would usually be doing some podcasts from the BMJ awards - but the pandemic has delayed our plans.

We’re still working on acknowledging some of the best medicine from around the UK, but in the meantime we’ve decided to give out the awards for outstanding contribution to health, and research paper of the year.

In the following interview, Fiona Godlee - the BMJ’s editor in chief, talks to Marian Knight, lead author of the ANODE trial - The BMJ's research paper of the year.

<p>For more about The BMJ Awards categories and previous winners; https://thebmjawards.bmj.com/</p>
]]></description>
                                                            <content:encoded><![CDATA[This time of year we would usually be doing some podcasts from the BMJ awards - but the pandemic has delayed our plans.

We’re still working on acknowledging some of the best medicine from around the UK, but in the meantime we’ve decided to give out the awards for outstanding contribution to health, and research paper of the year.

In the following interview, Fiona Godlee - the BMJ’s editor in chief, talks to Marian Knight, lead author of the ANODE trial - The BMJ's research paper of the year.

<p>For more about The BMJ Awards categories and previous winners; https://thebmjawards.bmj.com/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xe5vkz/stream_864385342-bmjgroup-marian-knight-improving-obstetric-outcomes-with-a-single-dose-of-antibiotics.mp3" length="20236328" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This time of year we would usually be doing some podcasts from the BMJ awards - but the pandemic has delayed our plans.

We’re still working on acknowledging some of the best medicine from around the UK, but in the meantime we’ve decided to give out the awards for outstanding contribution to health, and research paper of the year.

In the following interview, Fiona Godlee - the BMJ’s editor in chief, talks to Marian Knight, lead author of the ANODE trial - The BMJ's research paper of the year.

For more about The BMJ Awards categories and previous winners; https://thebmjawards.bmj.com/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1265</itunes:duration>
                                    </item>
    <item>
        <title>David Pencheon - measuring the climate impact of the NHS</title>
        <itunes:title>David Pencheon - measuring the climate impact of the NHS</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/david-pencheon-measuring-the-climate-impact-of-the-nhs/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/david-pencheon-measuring-the-climate-impact-of-the-nhs/#comments</comments>        <pubDate>Sat, 25 Jul 2020 14:41:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/david-pencheon-measuring-the-climate-impact-of-the-nhs</guid>
                                    <description><![CDATA[This time of year we would usually be doing some podcasts from the BMJ awards - but the pandemic has delayed our plans.

We’re still working on acknowledging some of the best medicine from around the UK, but in the meantime we’ve decided to give out the awards for outstanding contribution to health, and research paper of the year.

In the following interview, Fiona Godlee - the BMJ’s editor in chief, talks to David Pencheon, director of the NHS sustainability unit about his work.

<p>For more about The BMJ Awards categories and previous winners; https://thebmjawards.bmj.com/</p>
]]></description>
                                                            <content:encoded><![CDATA[This time of year we would usually be doing some podcasts from the BMJ awards - but the pandemic has delayed our plans.

We’re still working on acknowledging some of the best medicine from around the UK, but in the meantime we’ve decided to give out the awards for outstanding contribution to health, and research paper of the year.

In the following interview, Fiona Godlee - the BMJ’s editor in chief, talks to David Pencheon, director of the NHS sustainability unit about his work.

<p>For more about The BMJ Awards categories and previous winners; https://thebmjawards.bmj.com/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dq2k8t/stream_864384796-bmjgroup-david-pencheon-measuring-the-climate-impact-of-the-nhs.mp3" length="30213850" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This time of year we would usually be doing some podcasts from the BMJ awards - but the pandemic has delayed our plans.

We’re still working on acknowledging some of the best medicine from around the UK, but in the meantime we’ve decided to give out the awards for outstanding contribution to health, and research paper of the year.

In the following interview, Fiona Godlee - the BMJ’s editor in chief, talks to David Pencheon, director of the NHS sustainability unit about his work.

For more about The BMJ Awards categories and previous winners; https://thebmjawards.bmj.com/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1888</itunes:duration>
                                    </item>
    <item>
        <title>Covid public health - Data is fundamental</title>
        <itunes:title>Covid public health - Data is fundamental</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/covid-public-health-data-is-fundamental/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/covid-public-health-data-is-fundamental/#comments</comments>        <pubDate>Wed, 22 Jul 2020 19:01:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/covid-public-health-data-is-fundamental</guid>
                                    <description><![CDATA[As the pandemic play out, we’ve seen ways in which the collection of covid data - and it’s sharing, has been flawed, with reports in the UK that local authorities haven't got granular data, and in the US that the CDC is being circumvented for data reporting.

<p>Kathleen Bachynski, assistant professor of public health at Muhlenburgh College, and Sridhar Venkatapuram, director of global health education & training at King's College London join us to discuss why data is fundamental to the social contract between the public and their government, and why undermining it is so dangerous.</p>
]]></description>
                                                            <content:encoded><![CDATA[As the pandemic play out, we’ve seen ways in which the collection of covid data - and it’s sharing, has been flawed, with reports in the UK that local authorities haven't got granular data, and in the US that the CDC is being circumvented for data reporting.

<p>Kathleen Bachynski, assistant professor of public health at Muhlenburgh College, and Sridhar Venkatapuram, director of global health education & training at King's College London join us to discuss why data is fundamental to the social contract between the public and their government, and why undermining it is so dangerous.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/oec72v/stream_862638559-bmjgroup-covid-public-health-data-is-fundamental.mp3" length="29892021" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As the pandemic play out, we’ve seen ways in which the collection of covid data - and it’s sharing, has been flawed, with reports in the UK that local authorities haven't got granular data, and in the US that the CDC is being circumvented for data reporting.

Kathleen Bachynski, assistant professor of public health at Muhlenburgh College, and Sridhar Venkatapuram, director of global health education & training at King's College London join us to discuss why data is fundamental to the social contract between the public and their government, and why undermining it is so dangerous.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1868</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence covid-19 update - How will we know if a vaccine works?</title>
        <itunes:title>Talk Evidence covid-19 update - How will we know if a vaccine works?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-how-will-we-know-if-a-vaccine-works/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-how-will-we-know-if-a-vaccine-works/#comments</comments>        <pubDate>Fri, 17 Jul 2020 16:48:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-covid-19-update-how-will-we-know-if-a-vaccine-works</guid>
                                    <description><![CDATA[Vaccines have been in the news this week - but when you dig into the stories, it turns out that the hype is about phase 1 trials. We're a long way from being sure any of the 150 possible vaccines being developed actually work. 

In this talk evidence we're talking to a researcher, a regulator, and a manufacturer about the way in covid-19 is upending normal vaccine development, which hurdles they'll have to reach to get onto the market, and how we'll know which one to choose when they are there.

This week

(1.10) We said that covid would have a knock-on effect on other treatments, and Helen looks at some research into acute coronary syndrome admissions in the UK.

(6.53) Peter Doshi, assistant professor of pharmaceutical health services research at the University of Maryland School of Pharmacy and an editor for The BMJ, tells us what to watch out for in the PICO for a vaccine study.

(15.20) Marco Cavaleri, head of Biological Health Threats and Vaccines Strategy at the European Medicines Agency, explains what regulators are looking for when thinking about licencing a vaccine - and how covid has made different agencies around the world align their requirements.

(22.22) Philip Cruz, UK head of vaccines at GSK, explains how a manufacturer tests their vaccines, and how they use adaptive study design to past regulatory hurdles and provide information for those choosing which vaccine to use.


Reading list

Lancet paper - COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31356-8/fulltext

ONS Data - Deaths registered weekly in England and Wales, provisional: week ending 3 July 2020
https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsregisteredweeklyinenglandandwalesprovisional/latest

The BMJ editorial - Vaccines, convalescent plasma, and monoclonal antibodies for covid-19
https://www.bmj.com/content/370/bmj.m2722

WHO report - Draft landscape of COVID-19 candidate vaccines
https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines

Research Methods & Reporting
The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design
<p>https://www.bmj.com/content/369/bmj.m115</p>
]]></description>
                                                            <content:encoded><![CDATA[Vaccines have been in the news this week - but when you dig into the stories, it turns out that the hype is about phase 1 trials. We're a long way from being sure any of the 150 possible vaccines being developed actually work. 

In this talk evidence we're talking to a researcher, a regulator, and a manufacturer about the way in covid-19 is upending normal vaccine development, which hurdles they'll have to reach to get onto the market, and how we'll know which one to choose when they are there.

This week

(1.10) We said that covid would have a knock-on effect on other treatments, and Helen looks at some research into acute coronary syndrome admissions in the UK.

(6.53) Peter Doshi, assistant professor of pharmaceutical health services research at the University of Maryland School of Pharmacy and an editor for The BMJ, tells us what to watch out for in the PICO for a vaccine study.

(15.20) Marco Cavaleri, head of Biological Health Threats and Vaccines Strategy at the European Medicines Agency, explains what regulators are looking for when thinking about licencing a vaccine - and how covid has made different agencies around the world align their requirements.

(22.22) Philip Cruz, UK head of vaccines at GSK, explains how a manufacturer tests their vaccines, and how they use adaptive study design to past regulatory hurdles and provide information for those choosing which vaccine to use.


Reading list

Lancet paper - COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31356-8/fulltext

ONS Data - Deaths registered weekly in England and Wales, provisional: week ending 3 July 2020
https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsregisteredweeklyinenglandandwalesprovisional/latest

The BMJ editorial - Vaccines, convalescent plasma, and monoclonal antibodies for covid-19
https://www.bmj.com/content/370/bmj.m2722

WHO report - Draft landscape of COVID-19 candidate vaccines
https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines

Research Methods & Reporting
The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design
<p>https://www.bmj.com/content/369/bmj.m115</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/c7k8g3/stream_859820056-bmjgroup-talk-evidence-covid-19-update-how-will-we-know-if-a-vaccine-works.mp3" length="35662366" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Vaccines have been in the news this week - but when you dig into the stories, it turns out that the hype is about phase 1 trials. We're a long way from being sure any of the 150 possible vaccines being developed actually work. 

In this talk evidence we're talking to a researcher, a regulator, and a manufacturer about the way in covid-19 is upending normal vaccine development, which hurdles they'll have to reach to get onto the market, and how we'll know which one to choose when they are there.

This week

(1.10) We said that covid would have a knock-on effect on other treatments, and Helen looks at some research into acute coronary syndrome admissions in the UK.

(6.53) Peter Doshi, assistant professor of pharmaceutical health services research at the University of Maryland School of Pharmacy and an editor for The BMJ, tells us what to watch out for in the PICO for a vaccine study.

(15.20) Marco Cavaleri, head of Biological Health Threats and Vaccines Strategy at the European Medicines Agency, explains what regulators are looking for when thinking about licencing a vaccine - and how covid has made different agencies around the world align their requirements.

(22.22) Philip Cruz, UK head of vaccines at GSK, explains how a manufacturer tests their vaccines, and how they use adaptive study design to past regulatory hurdles and provide information for those choosing which vaccine to use.


Reading list

Lancet paper - COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31356-8/fulltext

ONS Data - Deaths registered weekly in England and Wales, provisional: week ending 3 July 2020
https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsregisteredweeklyinenglandandwalesprovisional/latest

The BMJ editorial - Vaccines, convalescent plasma, and monoclonal antibodies for covid-19
https://www.bmj.com/content/370/bmj.m2722

WHO report - Draft landscape of COVID-19 candidate vaccines
https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines

Research Methods & Reporting
The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design
https://www.bmj.com/content/369/bmj.m115]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2229</itunes:duration>
                                    </item>
    <item>
        <title>Tackling racism with Annabel Sowemimo, Shani Scott and Joan Saddler OBE</title>
        <itunes:title>Tackling racism with Annabel Sowemimo, Shani Scott and Joan Saddler OBE</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/tackling-racism-with-annabel-sowemimo-shani-scott-and-joan-saddler-obe/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/tackling-racism-with-annabel-sowemimo-shani-scott-and-joan-saddler-obe/#comments</comments>        <pubDate>Thu, 16 Jul 2020 17:02:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/tackling-racism-with-annabel-sowemimo-shani-scott-and-joan-saddler-obe</guid>
                                    <description><![CDATA[The signs and symptoms of racism have long permeated our society, and are embedded in our clinical practice and medical education. Recent events in the US, including the murder of George Floyd, have brought the Black Lives Matter movement to the fore of public consciousness, and have sparked outrage and protests in countries around the world. COVID-19 has exposed the inequalities in our healthcare systems, as the virus has had a disproportionate impact on some ethnic minority communities. In this week’s episode, we discuss colonial undertones to contraception policy-making, how doctors remaining silent on racial issues are seen as complicit, and the lack of diversity in learning resources used in medical schools. How can we use the current climate as a teaching moment to engage with people, clinicians and patients, about their experiences of healthcare? And how do we begin to make reparations in medicine for centuries of institutionalised racism? 

Our guests:
Annabel Sowemimo is a community Sexual & Reproductive Health registrar, working in Leicester. She is also the founder of Decolonising Contraception and a trustee for Medact charity. 
Shani Scott works as a general internist at Montefiore Medical Center in the Bronx. She is an associate program director for the Moses-Weiler Internal Medicine Residency Program, and is also the co-director of Diversity & Inclusion for the Department of Medicine at Montefiore Medical Center. 
Joan Saddler OBE is the director of partnerships and equality at the NHS Confederation, and the co-chair of the NHS Equality & Diversity Council. She was awarded an OBE in 2007 for services to health and diversity. 

Resources mentioned by Jenny:

NEJM Perspective, "How Medical Education is Missing the Bull's-eye" by LaShyra Nolen
https://www.nejm.org/doi/full/10.1056/NEJMp1915891
 
America Did What?! Podcast with Blair Imani & Kate Robards 
Episode 1: Redlining and the GI Bill 
<p>https://www.stitcher.com/podcast/america-did-what</p>
]]></description>
                                                            <content:encoded><![CDATA[The signs and symptoms of racism have long permeated our society, and are embedded in our clinical practice and medical education. Recent events in the US, including the murder of George Floyd, have brought the Black Lives Matter movement to the fore of public consciousness, and have sparked outrage and protests in countries around the world. COVID-19 has exposed the inequalities in our healthcare systems, as the virus has had a disproportionate impact on some ethnic minority communities. In this week’s episode, we discuss colonial undertones to contraception policy-making, how doctors remaining silent on racial issues are seen as complicit, and the lack of diversity in learning resources used in medical schools. How can we use the current climate as a teaching moment to engage with people, clinicians and patients, about their experiences of healthcare? And how do we begin to make reparations in medicine for centuries of institutionalised racism? 

Our guests:
Annabel Sowemimo is a community Sexual & Reproductive Health registrar, working in Leicester. She is also the founder of Decolonising Contraception and a trustee for Medact charity. 
Shani Scott works as a general internist at Montefiore Medical Center in the Bronx. She is an associate program director for the Moses-Weiler Internal Medicine Residency Program, and is also the co-director of Diversity & Inclusion for the Department of Medicine at Montefiore Medical Center. 
Joan Saddler OBE is the director of partnerships and equality at the NHS Confederation, and the co-chair of the NHS Equality & Diversity Council. She was awarded an OBE in 2007 for services to health and diversity. 

Resources mentioned by Jenny:

NEJM Perspective, "How Medical Education is Missing the Bull's-eye" by LaShyra Nolen
https://www.nejm.org/doi/full/10.1056/NEJMp1915891
 
America Did What?! Podcast with Blair Imani & Kate Robards 
Episode 1: Redlining and the GI Bill 
<p>https://www.stitcher.com/podcast/america-did-what</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/w4z403/stream_859073707-bmjgroup-tackling-racism-with-annabel-sowemimo-shani-scott-and-joan-saddler-obe.mp3" length="60510457" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The signs and symptoms of racism have long permeated our society, and are embedded in our clinical practice and medical education. Recent events in the US, including the murder of George Floyd, have brought the Black Lives Matter movement to the fore of public consciousness, and have sparked outrage and protests in countries around the world. COVID-19 has exposed the inequalities in our healthcare systems, as the virus has had a disproportionate impact on some ethnic minority communities. In this week’s episode, we discuss colonial undertones to contraception policy-making, how doctors remaining silent on racial issues are seen as complicit, and the lack of diversity in learning resources used in medical schools. How can we use the current climate as a teaching moment to engage with people, clinicians and patients, about their experiences of healthcare? And how do we begin to make reparations in medicine for centuries of institutionalised racism? 

Our guests:
Annabel Sowemimo is a community Sexual & Reproductive Health registrar, working in Leicester. She is also the founder of Decolonising Contraception and a trustee for Medact charity. 
Shani Scott works as a general internist at Montefiore Medical Center in the Bronx. She is an associate program director for the Moses-Weiler Internal Medicine Residency Program, and is also the co-director of Diversity & Inclusion for the Department of Medicine at Montefiore Medical Center. 
Joan Saddler OBE is the director of partnerships and equality at the NHS Confederation, and the co-chair of the NHS Equality & Diversity Council. She was awarded an OBE in 2007 for services to health and diversity. 

Resources mentioned by Jenny:

NEJM Perspective, "How Medical Education is Missing the Bull's-eye" by LaShyra Nolen
https://www.nejm.org/doi/full/10.1056/NEJMp1915891
 
America Did What?! Podcast with Blair Imani & Kate Robards 
Episode 1: Redlining and the GI Bill 
https://www.stitcher.com/podcast/america-did-what]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3782</itunes:duration>
                                    </item>
    <item>
        <title>Making the drug and device system fit for patients</title>
        <itunes:title>Making the drug and device system fit for patients</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/making-the-drug-and-device-system-fit-for-patients/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/making-the-drug-and-device-system-fit-for-patients/#comments</comments>        <pubDate>Wed, 15 Jul 2020 19:09:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-cumberledge-report-mixdown</guid>
                                    <description><![CDATA[A series of medical scandals prompted Jeremy Hunt, former UK health secretary to launch the Independent Medicines and Medical Devices Safety Review - with the explicit aim of  strengthening the patient voice in order to help build a "system that listens, hears and acts – with speed, compassion and proportionality"

That report is out, and describes a system that does anything but.

In this podcast, Sir Cyril Chantler, the review's vice chair discusses their recommendations, for better regulation, transparency and patient advocacy in the use of medicines and medical devices.

Read the full report:
https://www.immdsreview.org.uk/

The BMJ report into what we must learn from mesh
<p>https://www.bmj.com/content/363/bmj.k4254</p>
]]></description>
                                                            <content:encoded><![CDATA[A series of medical scandals prompted Jeremy Hunt, former UK health secretary to launch the Independent Medicines and Medical Devices Safety Review - with the explicit aim of  strengthening the patient voice in order to help build a "system that listens, hears and acts – with speed, compassion and proportionality"

That report is out, and describes a system that does anything but.

In this podcast, Sir Cyril Chantler, the review's vice chair discusses their recommendations, for better regulation, transparency and patient advocacy in the use of medicines and medical devices.

Read the full report:
https://www.immdsreview.org.uk/

The BMJ report into what we must learn from mesh
<p>https://www.bmj.com/content/363/bmj.k4254</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/sz3wpm/stream_858549088-bmjgroup-the-cumberledge-report-mixdown.mp3" length="28266578" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A series of medical scandals prompted Jeremy Hunt, former UK health secretary to launch the Independent Medicines and Medical Devices Safety Review - with the explicit aim of  strengthening the patient voice in order to help build a "system that listens, hears and acts – with speed, compassion and proportionality"

That report is out, and describes a system that does anything but.

In this podcast, Sir Cyril Chantler, the review's vice chair discusses their recommendations, for better regulation, transparency and patient advocacy in the use of medicines and medical devices.

Read the full report:
https://www.immdsreview.org.uk/

The BMJ report into what we must learn from mesh
https://www.bmj.com/content/363/bmj.k4254]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1767</itunes:duration>
                                    </item>
    <item>
        <title>What are the chances of an American vaccine?</title>
        <itunes:title>What are the chances of an American vaccine?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/what-are-the-chances-of-an-american-vaccine/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/what-are-the-chances-of-an-american-vaccine/#comments</comments>        <pubDate>Fri, 10 Jul 2020 14:15:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/covid-19-in-the-us-what-are-the-chances-of-rolling-out-a-vaccine-soon</guid>
                                    <description><![CDATA[US President Donald Trump has been pushing hard for an American vaccine against Covid-19. He's named the  program Operation Warp Speed, which has many people worried that safety tests will be rushed.

What are the prospects for an American vaccine against Covid-19? If the US is first, will it make its vaccines available to other countries?  And what if it's not first? 

Three American vaccine experts talk with the BMJ about prospects for an American vaccine against the new coronavirus.

Joining us are;
Nicole Lurrie - senior lecturer at Harvard Medical School and a strategic adviser to the foundation working on global vaccines, CEPI.

Paul Offit - professor at the University of Pennsylvania, and co inventor of a rotavirus vaccine.

<p>Prashant Yadav - senior fellow at the Centre for Global Development and a lecturer at Harvard Medical School.</p>
]]></description>
                                                            <content:encoded><![CDATA[US President Donald Trump has been pushing hard for an American vaccine against Covid-19. He's named the  program Operation Warp Speed, which has many people worried that safety tests will be rushed.

What are the prospects for an American vaccine against Covid-19? If the US is first, will it make its vaccines available to other countries?  And what if it's not first? 

Three American vaccine experts talk with the BMJ about prospects for an American vaccine against the new coronavirus.

Joining us are;
Nicole Lurrie - senior lecturer at Harvard Medical School and a strategic adviser to the foundation working on global vaccines, CEPI.

Paul Offit - professor at the University of Pennsylvania, and co inventor of a rotavirus vaccine.

<p>Prashant Yadav - senior fellow at the Centre for Global Development and a lecturer at Harvard Medical School.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/tsxw4a/stream_855596737-bmjgroup-covid-19-in-the-us-what-are-the-chances-of-rolling-out-a-vaccine-soon.mp3" length="35045040" type="audio/mpeg"/>
        <itunes:summary><![CDATA[US President Donald Trump has been pushing hard for an American vaccine against Covid-19. He's named the  program Operation Warp Speed, which has many people worried that safety tests will be rushed.

What are the prospects for an American vaccine against Covid-19? If the US is first, will it make its vaccines available to other countries?  And what if it's not first? 

Three American vaccine experts talk with the BMJ about prospects for an American vaccine against the new coronavirus.

Joining us are;
Nicole Lurrie - senior lecturer at Harvard Medical School and a strategic adviser to the foundation working on global vaccines, CEPI.

Paul Offit - professor at the University of Pennsylvania, and co inventor of a rotavirus vaccine.

Prashant Yadav - senior fellow at the Centre for Global Development and a lecturer at Harvard Medical School.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2190</itunes:duration>
                                    </item>
    <item>
        <title>Wellbeing – how to say no</title>
        <itunes:title>Wellbeing – how to say no</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/wellbeing-%e2%80%93-how-to-say-no/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/wellbeing-%e2%80%93-how-to-say-no/#comments</comments>        <pubDate>Wed, 08 Jul 2020 10:00:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/wellbeing-how-to-say-no</guid>
                                    <description><![CDATA[We all know that healthcare professionals are stretching themselves to provide the care that’s needed right now. But there are instances when you might find yourself out of your comfort zone or being pushed too hard or fast. When is it ok to say no to these demands?

We spoke to Kate Burnett who educates NHS staff on empowerment about how to voice your position clearly and how to reconcile the guilt you might feel of letting the side down.

<p>www.bmj.com/wellbeing</p>
]]></description>
                                                            <content:encoded><![CDATA[We all know that healthcare professionals are stretching themselves to provide the care that’s needed right now. But there are instances when you might find yourself out of your comfort zone or being pushed too hard or fast. When is it ok to say no to these demands?

We spoke to Kate Burnett who educates NHS staff on empowerment about how to voice your position clearly and how to reconcile the guilt you might feel of letting the side down.

<p>www.bmj.com/wellbeing</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/f2vdj8/stream_854183080-bmjgroup-wellbeing-how-to-say-no.mp3" length="33209984" type="audio/mpeg"/>
        <itunes:summary><![CDATA[We all know that healthcare professionals are stretching themselves to provide the care that’s needed right now. But there are instances when you might find yourself out of your comfort zone or being pushed too hard or fast. When is it ok to say no to these demands?

We spoke to Kate Burnett who educates NHS staff on empowerment about how to voice your position clearly and how to reconcile the guilt you might feel of letting the side down.

www.bmj.com/wellbeing]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2076</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence covid-19 update -  drop in excess deaths, HIV drugs, academic promotion</title>
        <itunes:title>Talk Evidence covid-19 update -  drop in excess deaths, HIV drugs, academic promotion</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-drop-in-excess-deaths-hiv-drugs-academic-promotion/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-drop-in-excess-deaths-hiv-drugs-academic-promotion/#comments</comments>        <pubDate>Fri, 03 Jul 2020 18:57:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-covid-19-update-drop-in-excess-deaths-hiv-drugs-academic-promotion</guid>
                                    <description><![CDATA[In this week's Talk Evidence we're hearing about how the death rate has dropped below average, disappointment about HIV drugs for covid-19 treatment, a trial to reduce polypharmacy, and why academic promotions matter to everyone else.

1.35 - Carl gives us one of his death updates

3.30 - Helen asks if it’s finally time to be able to do the international comparisons we’ve been waiting for?

16.10 - New research suggests that extreme PPE prevents transmission - but PPE came with a whole range of other viral suppression measures, and they all work together.

21.30 - The Recovery trial has said that  lopinavir-ritonavir isn’t effective against covid - enough for them to stop the arm of that trial. We talk about this and more treatment evidence.

24.00 - Can a digital intervention reduce poly pharmacy? A new trial on bmj.com says no, but we talk about the composite endpoint and the way the trial is powered.

<p>36.25 - Why academic promotion matters to non academics</p>
]]></description>
                                                            <content:encoded><![CDATA[In this week's Talk Evidence we're hearing about how the death rate has dropped below average, disappointment about HIV drugs for covid-19 treatment, a trial to reduce polypharmacy, and why academic promotions matter to everyone else.

1.35 - Carl gives us one of his death updates

3.30 - Helen asks if it’s finally time to be able to do the international comparisons we’ve been waiting for?

16.10 - New research suggests that extreme PPE prevents transmission - but PPE came with a whole range of other viral suppression measures, and they all work together.

21.30 - The Recovery trial has said that  lopinavir-ritonavir isn’t effective against covid - enough for them to stop the arm of that trial. We talk about this and more treatment evidence.

24.00 - Can a digital intervention reduce poly pharmacy? A new trial on bmj.com says no, but we talk about the composite endpoint and the way the trial is powered.

<p>36.25 - Why academic promotion matters to non academics</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dmcmk7/stream_851662960-bmjgroup-talk-evidence-covid-19-update-drop-in-excess-deaths-hiv-drugs-academic-promotion.mp3" length="43066095" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this week's Talk Evidence we're hearing about how the death rate has dropped below average, disappointment about HIV drugs for covid-19 treatment, a trial to reduce polypharmacy, and why academic promotions matter to everyone else.

1.35 - Carl gives us one of his death updates

3.30 - Helen asks if it’s finally time to be able to do the international comparisons we’ve been waiting for?

16.10 - New research suggests that extreme PPE prevents transmission - but PPE came with a whole range of other viral suppression measures, and they all work together.

21.30 - The Recovery trial has said that  lopinavir-ritonavir isn’t effective against covid - enough for them to stop the arm of that trial. We talk about this and more treatment evidence.

24.00 - Can a digital intervention reduce poly pharmacy? A new trial on bmj.com says no, but we talk about the composite endpoint and the way the trial is powered.

36.25 - Why academic promotion matters to non academics]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2692</itunes:duration>
                                    </item>
    <item>
        <title>Lowering the shield with Julia Marcus and Carol Liddle</title>
        <itunes:title>Lowering the shield with Julia Marcus and Carol Liddle</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/lowering-the-shield-with-julia-marcus-and-carol-liddle/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/lowering-the-shield-with-julia-marcus-and-carol-liddle/#comments</comments>        <pubDate>Thu, 02 Jul 2020 13:44:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/lowering-the-shield-with-julia-marcus-and-carol-liddle</guid>
                                    <description><![CDATA[The relaxation of the COVID-19 lockdown regulations is raising a lot of questions, both for doctors and for patients. This week, we discuss how the lack of clarity and coherence in public health messages over the past few months has caused anxiety and confusion for our patients, especially those who have been told to shield. We talk about GPs tailoring shielding advice to suit the individuals they treat, the politicisation of mask wearing, and the flaws of ‘abstinence-only’ health messaging. How do we balance prompting overall health, rather than just working to prevent disease, and how do we start taking baby steps towards returning to normality?

Our guests:
Julia Marcus is an infectious disease epidemiologist and Assistant Professor at Harvard Medical School’s Department of Population Medicine . She is also an HIV researcher. 

Carol Liddle, a COPD patient, is a patient advocate on the panel for NACAP (National asthma and COPD audit), as well as a patient representative for the Taskforce for Lung Health, which is run by the British Lung Foundation.

<p>Tom, Navjoyt and Jenny mentioned some resources they have found useful while looking at racism in medicine - which we have compiled into this document https://bit.ly/DBIRacismResources</p>
]]></description>
                                                            <content:encoded><![CDATA[The relaxation of the COVID-19 lockdown regulations is raising a lot of questions, both for doctors and for patients. This week, we discuss how the lack of clarity and coherence in public health messages over the past few months has caused anxiety and confusion for our patients, especially those who have been told to shield. We talk about GPs tailoring shielding advice to suit the individuals they treat, the politicisation of mask wearing, and the flaws of ‘abstinence-only’ health messaging. How do we balance prompting overall health, rather than just working to prevent disease, and how do we start taking baby steps towards returning to normality?

Our guests:
Julia Marcus is an infectious disease epidemiologist and Assistant Professor at Harvard Medical School’s Department of Population Medicine . She is also an HIV researcher. 

Carol Liddle, a COPD patient, is a patient advocate on the panel for NACAP (National asthma and COPD audit), as well as a patient representative for the Taskforce for Lung Health, which is run by the British Lung Foundation.

<p>Tom, Navjoyt and Jenny mentioned some resources they have found useful while looking at racism in medicine - which we have compiled into this document https://bit.ly/DBIRacismResources</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/buqgho/stream_850840531-bmjgroup-lowering-the-shield-with-julia-marcus-and-carol-liddle.mp3" length="52233612" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The relaxation of the COVID-19 lockdown regulations is raising a lot of questions, both for doctors and for patients. This week, we discuss how the lack of clarity and coherence in public health messages over the past few months has caused anxiety and confusion for our patients, especially those who have been told to shield. We talk about GPs tailoring shielding advice to suit the individuals they treat, the politicisation of mask wearing, and the flaws of ‘abstinence-only’ health messaging. How do we balance prompting overall health, rather than just working to prevent disease, and how do we start taking baby steps towards returning to normality?

Our guests:
Julia Marcus is an infectious disease epidemiologist and Assistant Professor at Harvard Medical School’s Department of Population Medicine . She is also an HIV researcher. 

Carol Liddle, a COPD patient, is a patient advocate on the panel for NACAP (National asthma and COPD audit), as well as a patient representative for the Taskforce for Lung Health, which is run by the British Lung Foundation.

Tom, Navjoyt and Jenny mentioned some resources they have found useful while looking at racism in medicine - which we have compiled into this document https://bit.ly/DBIRacismResources]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3265</itunes:duration>
                                    </item>
    <item>
        <title>David Michaels - Doubt is an industry tactic</title>
        <itunes:title>David Michaels - Doubt is an industry tactic</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/david-michaels-doubt-is-an-industry-tactic/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/david-michaels-doubt-is-an-industry-tactic/#comments</comments>        <pubDate>Wed, 01 Jul 2020 10:05:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/david-michaels-doubt-is-an-industry-tactic</guid>
                                    <description><![CDATA[For a long time, the BMJ has been interested in conflicts of interest and how that skews the research base. 

We also heard in our podcast on "Big Tan" that science is being used to sow seeds of doubt into the association between sunbeds and skin cancer, by scrutinizing the minutiae of a research paper, but ignoring it's bigger message.

Now it's all just happening in medicine. This is an industry tactic. And to talk about that we're joined by David Michaels - who was the longest serving head of the Occupational Safety and Health Administration, and  an epidemiologist and professor at the George Washington University School of Public Health.

Read The BMJ's collection - Commercial influence in health: from transparency to independence
https://www.bmj.com/commercial-influence

To find out more from David, plus his two books on the influence of industry
<p>https://www.drdavidmichaels.com/</p>
]]></description>
                                                            <content:encoded><![CDATA[For a long time, the BMJ has been interested in conflicts of interest and how that skews the research base. 

We also heard in our podcast on "Big Tan" that science is being used to sow seeds of doubt into the association between sunbeds and skin cancer, by scrutinizing the minutiae of a research paper, but ignoring it's bigger message.

Now it's all just happening in medicine. This is an industry tactic. And to talk about that we're joined by David Michaels - who was the longest serving head of the Occupational Safety and Health Administration, and  an epidemiologist and professor at the George Washington University School of Public Health.

Read The BMJ's collection - Commercial influence in health: from transparency to independence
https://www.bmj.com/commercial-influence

To find out more from David, plus his two books on the influence of industry
<p>https://www.drdavidmichaels.com/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/esf5yj/stream_850142443-bmjgroup-david-michaels-doubt-is-an-industry-tactic.mp3" length="36211564" type="audio/mpeg"/>
        <itunes:summary><![CDATA[For a long time, the BMJ has been interested in conflicts of interest and how that skews the research base. 

We also heard in our podcast on "Big Tan" that science is being used to sow seeds of doubt into the association between sunbeds and skin cancer, by scrutinizing the minutiae of a research paper, but ignoring it's bigger message.

Now it's all just happening in medicine. This is an industry tactic. And to talk about that we're joined by David Michaels - who was the longest serving head of the Occupational Safety and Health Administration, and  an epidemiologist and professor at the George Washington University School of Public Health.

Read The BMJ's collection - Commercial influence in health: from transparency to independence
https://www.bmj.com/commercial-influence

To find out more from David, plus his two books on the influence of industry
https://www.drdavidmichaels.com/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2263</itunes:duration>
                                    </item>
    <item>
        <title>Covid-19 in the U.S. - returning to work in a pandemic</title>
        <itunes:title>Covid-19 in the U.S. - returning to work in a pandemic</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/covid-19-in-the-us-returning-to-work-in-a-pandemic/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/covid-19-in-the-us-returning-to-work-in-a-pandemic/#comments</comments>        <pubDate>Fri, 26 Jun 2020 13:22:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/covid-19-in-the-us-returning-to-work-in-a-pandemic</guid>
                                    <description><![CDATA[In the third part of our series of podcasts “Corona Virus as Seen Through a US Lens,” features editor for The BMJ, Joanne Silberner, talks to Dr. Adeline Goss about the experience of being a new mom and a hospital resident during the crisis. 

In The BMJ, Dr Goss recently wrote about the challenges facing medical residents as they deal with working during the virus.  

When she went on maternity leave a few months ago, nothing seemed amiss, beyond the normal stress of being a new mom. But when she returned to full time work on June 1, everything had changed. Goss kept an audio diary of her experience preparing and going back to work and we hear some of that during the podcast.

<p>For more of The BMJ's covid-19 coverage www.bmj.com/coronavirus</p>
]]></description>
                                                            <content:encoded><![CDATA[In the third part of our series of podcasts “Corona Virus as Seen Through a US Lens,” features editor for The BMJ, Joanne Silberner, talks to Dr. Adeline Goss about the experience of being a new mom and a hospital resident during the crisis. 

In The BMJ, Dr Goss recently wrote about the challenges facing medical residents as they deal with working during the virus.  

When she went on maternity leave a few months ago, nothing seemed amiss, beyond the normal stress of being a new mom. But when she returned to full time work on June 1, everything had changed. Goss kept an audio diary of her experience preparing and going back to work and we hear some of that during the podcast.

<p>For more of The BMJ's covid-19 coverage www.bmj.com/coronavirus</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/b6n14x/stream_847299532-bmjgroup-covid-19-in-the-us-returning-to-work-in-a-pandemic.mp3" length="17614470" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In the third part of our series of podcasts “Corona Virus as Seen Through a US Lens,” features editor for The BMJ, Joanne Silberner, talks to Dr. Adeline Goss about the experience of being a new mom and a hospital resident during the crisis. 

In The BMJ, Dr Goss recently wrote about the challenges facing medical residents as they deal with working during the virus.  

When she went on maternity leave a few months ago, nothing seemed amiss, beyond the normal stress of being a new mom. But when she returned to full time work on June 1, everything had changed. Goss kept an audio diary of her experience preparing and going back to work and we hear some of that during the podcast.

For more of The BMJ's covid-19 coverage www.bmj.com/coronavirus]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1101</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence covid-19 update - dexamethosone, testing, rehabilitation after covid.</title>
        <itunes:title>Talk Evidence covid-19 update - dexamethosone, testing, rehabilitation after covid.</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-dexamethosone-testing-rehabilitation-after-covid/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-dexamethosone-testing-rehabilitation-after-covid/#comments</comments>        <pubDate>Thu, 25 Jun 2020 10:23:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-covid-19-update-dexamethosone-testing-rehabilitation-after-covid</guid>
                                    <description><![CDATA[This week we're looking beyond the press release for dexamethasone, the long awaited review of antibody testing, and how well people are recovering after surviving acute covid-19.


(2.36) The preprint for dexamethasone is finally out - considerably after the press release. Carl digs into it to find out how good the news actually is.

(8.49) There are a couple of newly published systematic reviews on antibody testing, so we return to our testing guru Jon Deeks - professor of biostatistics at the University of Birmingham to give us an update.

(23.52)Covid-19, it became apparent as the pandemic grew, was more than a respiratory disease - there are systemic effects on almost all organs. As people are recovering from the worst ravages of the disease, the long term consequences of those effects are becoming more clear - Lynne Turner-Stokes, professor of rehabilitation medicine at King's College London.

Reading list;

Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report
https://www.medrxiv.org/content/10.1101/2020.06.22.20137273v1

Cochrane review of antibody tests for covid-19
DOI: 10.1002/14651858.CD013652

British society of rehabilitation medicine guidelines for rehab after covid-19.
<p>https://www.bsrm.org.uk/downloads/covid-19bsrmissue1-published-27-4-2020.pdf</p>
]]></description>
                                                            <content:encoded><![CDATA[This week we're looking beyond the press release for dexamethasone, the long awaited review of antibody testing, and how well people are recovering after surviving acute covid-19.


(2.36) The preprint for dexamethasone is finally out - considerably after the press release. Carl digs into it to find out how good the news actually is.

(8.49) There are a couple of newly published systematic reviews on antibody testing, so we return to our testing guru Jon Deeks - professor of biostatistics at the University of Birmingham to give us an update.

(23.52)Covid-19, it became apparent as the pandemic grew, was more than a respiratory disease - there are systemic effects on almost all organs. As people are recovering from the worst ravages of the disease, the long term consequences of those effects are becoming more clear - Lynne Turner-Stokes, professor of rehabilitation medicine at King's College London.

Reading list;

Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report
https://www.medrxiv.org/content/10.1101/2020.06.22.20137273v1

Cochrane review of antibody tests for covid-19
DOI: 10.1002/14651858.CD013652

British society of rehabilitation medicine guidelines for rehab after covid-19.
<p>https://www.bsrm.org.uk/downloads/covid-19bsrmissue1-published-27-4-2020.pdf</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/cmwnb3/stream_846450262-bmjgroup-talk-evidence-covid-19-update-dexamethosone-testing-rehabilitation-after-covid.mp3" length="37803008" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week we're looking beyond the press release for dexamethasone, the long awaited review of antibody testing, and how well people are recovering after surviving acute covid-19.


(2.36) The preprint for dexamethasone is finally out - considerably after the press release. Carl digs into it to find out how good the news actually is.

(8.49) There are a couple of newly published systematic reviews on antibody testing, so we return to our testing guru Jon Deeks - professor of biostatistics at the University of Birmingham to give us an update.

(23.52)Covid-19, it became apparent as the pandemic grew, was more than a respiratory disease - there are systemic effects on almost all organs. As people are recovering from the worst ravages of the disease, the long term consequences of those effects are becoming more clear - Lynne Turner-Stokes, professor of rehabilitation medicine at King's College London.

Reading list;

Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report
https://www.medrxiv.org/content/10.1101/2020.06.22.20137273v1

Cochrane review of antibody tests for covid-19
DOI: 10.1002/14651858.CD013652

British society of rehabilitation medicine guidelines for rehab after covid-19.
https://www.bsrm.org.uk/downloads/covid-19bsrmissue1-published-27-4-2020.pdf]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2363</itunes:duration>
                                    </item>
    <item>
        <title>Mala Rao on the UK’s new race in health observatory</title>
        <itunes:title>Mala Rao on the UK’s new race in health observatory</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/mala-rao-on-the-uk-s-new-race-in-health-observatory/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/mala-rao-on-the-uk-s-new-race-in-health-observatory/#comments</comments>        <pubDate>Wed, 17 Jun 2020 16:33:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/mala-rao-on-the-uks-new-race-in-health-observatory</guid>
                                    <description><![CDATA[Earlier this year, the bmj published a racism in medicine issue - the issue was guest edited by Lord Victor Adebowale, chief executive of the NHS Confederation and Professor Mala Rao, professor of public health at Imperial College London.

At the event to launch the issue, they managed to persuade Simon Stephens , chief executive of the NHS, to put money into a “race in health observatory”

Mala joins us to talk about what that observatory is going to do, how it will maintain independence, it's role in synthesising, commissioning and implementing research, and where the organisation might begin in tackling the issue.

Reading list
NHS launches Race and Health Observatory after BMJ’s call to end inequalities
https://www.bmj.com/content/369/bmj.m2191

The BMJ's racism in medicine issue (free to access)
https://www.bmj.com/racism-in-medicine

Interview with Yvonne Coghill
https://podcasts.apple.com/us/podcast/yvonne-coghill-is-trying-to-fix-racism-in-the-nhs/id283916558?i=1000466962555

Interview with David Williams
<p>https://podcasts.apple.com/tr/podcast/david-williams-everyday-discrimination-is-independent/id283916558?i=1000465493980</p>
]]></description>
                                                            <content:encoded><![CDATA[Earlier this year, the bmj published a racism in medicine issue - the issue was guest edited by Lord Victor Adebowale, chief executive of the NHS Confederation and Professor Mala Rao, professor of public health at Imperial College London.

At the event to launch the issue, they managed to persuade Simon Stephens , chief executive of the NHS, to put money into a “race in health observatory”

Mala joins us to talk about what that observatory is going to do, how it will maintain independence, it's role in synthesising, commissioning and implementing research, and where the organisation might begin in tackling the issue.

Reading list
NHS launches Race and Health Observatory after BMJ’s call to end inequalities
https://www.bmj.com/content/369/bmj.m2191

The BMJ's racism in medicine issue (free to access)
https://www.bmj.com/racism-in-medicine

Interview with Yvonne Coghill
https://podcasts.apple.com/us/podcast/yvonne-coghill-is-trying-to-fix-racism-in-the-nhs/id283916558?i=1000466962555

Interview with David Williams
<p>https://podcasts.apple.com/tr/podcast/david-williams-everyday-discrimination-is-independent/id283916558?i=1000465493980</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6vlega/stream_841867672-bmjgroup-mala-rao-on-the-uks-new-race-in-health-observatory.mp3" length="23428283" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Earlier this year, the bmj published a racism in medicine issue - the issue was guest edited by Lord Victor Adebowale, chief executive of the NHS Confederation and Professor Mala Rao, professor of public health at Imperial College London.

At the event to launch the issue, they managed to persuade Simon Stephens , chief executive of the NHS, to put money into a “race in health observatory”

Mala joins us to talk about what that observatory is going to do, how it will maintain independence, it's role in synthesising, commissioning and implementing research, and where the organisation might begin in tackling the issue.

Reading list
NHS launches Race and Health Observatory after BMJ’s call to end inequalities
https://www.bmj.com/content/369/bmj.m2191

The BMJ's racism in medicine issue (free to access)
https://www.bmj.com/racism-in-medicine

Interview with Yvonne Coghill
https://podcasts.apple.com/us/podcast/yvonne-coghill-is-trying-to-fix-racism-in-the-nhs/id283916558?i=1000466962555

Interview with David Williams
https://podcasts.apple.com/tr/podcast/david-williams-everyday-discrimination-is-independent/id283916558?i=1000465493980]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1464</itunes:duration>
                                    </item>
    <item>
        <title>Resetting General Practice with Martin Marshall, Jenny Doust and Toyin Ajayi</title>
        <itunes:title>Resetting General Practice with Martin Marshall, Jenny Doust and Toyin Ajayi</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/resetting-general-practice-with-martin-marshall-jenny-doust-and-toyin-ajayi/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/resetting-general-practice-with-martin-marshall-jenny-doust-and-toyin-ajayi/#comments</comments>        <pubDate>Wed, 17 Jun 2020 13:34:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/resetting-general-practice-after-covid</guid>
                                    <description><![CDATA[In this week’s episode, our focus is on what the post-COVID world of general practice might look like. The pandemic has exposed the inequalities in our social and healthcare systems, but has also given GPs some much-needed headspace to reflect on changes to make going forward. Will we be able to turn general practice off and on again, like a faulty computer? Will we just drift back to the status quo, or will we seize this opportunity to shake up the old routines in order to redefine the role of the GP and to benefit the ever-evolving needs of our patients?

Our guests:

Martin Marshall is Chair of the Royal College of General Practitioners, a professor of Healthcare Improvement at UCL, and a GP practising in East London. 

Jenny Doust is a Clinical Professorial Research Fellow at the School of Public Health at the University of Queensland, and practises as a GP in Brisbane.

Toyin Ajayi is Chief Health Officer, and co-founder, of Cityblock Health, which is a New York-based health and social services company delivering personalised healthcare to marginalised communities.

<p>Tom, Navjoyt and Jenny mentioned some resources they have found useful while looking at racism in medicine - which we have compiled into this document https://bit.ly/DBIRacismResources</p>
]]></description>
                                                            <content:encoded><![CDATA[In this week’s episode, our focus is on what the post-COVID world of general practice might look like. The pandemic has exposed the inequalities in our social and healthcare systems, but has also given GPs some much-needed headspace to reflect on changes to make going forward. Will we be able to turn general practice off and on again, like a faulty computer? Will we just drift back to the status quo, or will we seize this opportunity to shake up the old routines in order to redefine the role of the GP and to benefit the ever-evolving needs of our patients?

Our guests:

Martin Marshall is Chair of the Royal College of General Practitioners, a professor of Healthcare Improvement at UCL, and a GP practising in East London. 

Jenny Doust is a Clinical Professorial Research Fellow at the School of Public Health at the University of Queensland, and practises as a GP in Brisbane.

Toyin Ajayi is Chief Health Officer, and co-founder, of Cityblock Health, which is a New York-based health and social services company delivering personalised healthcare to marginalised communities.

<p>Tom, Navjoyt and Jenny mentioned some resources they have found useful while looking at racism in medicine - which we have compiled into this document https://bit.ly/DBIRacismResources</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/l1uylk/stream_841780621-bmjgroup-resetting-general-practice-after-covid.mp3" length="63670647" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this week’s episode, our focus is on what the post-COVID world of general practice might look like. The pandemic has exposed the inequalities in our social and healthcare systems, but has also given GPs some much-needed headspace to reflect on changes to make going forward. Will we be able to turn general practice off and on again, like a faulty computer? Will we just drift back to the status quo, or will we seize this opportunity to shake up the old routines in order to redefine the role of the GP and to benefit the ever-evolving needs of our patients?

Our guests:

Martin Marshall is Chair of the Royal College of General Practitioners, a professor of Healthcare Improvement at UCL, and a GP practising in East London. 

Jenny Doust is a Clinical Professorial Research Fellow at the School of Public Health at the University of Queensland, and practises as a GP in Brisbane.

Toyin Ajayi is Chief Health Officer, and co-founder, of Cityblock Health, which is a New York-based health and social services company delivering personalised healthcare to marginalised communities.

Tom, Navjoyt and Jenny mentioned some resources they have found useful while looking at racism in medicine - which we have compiled into this document https://bit.ly/DBIRacismResources]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3979</itunes:duration>
                                    </item>
    <item>
        <title>The corona virus pandemic in South America</title>
        <itunes:title>The corona virus pandemic in South America</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-corona-virus-pandemic-in-south-america/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-corona-virus-pandemic-in-south-america/#comments</comments>        <pubDate>Mon, 15 Jun 2020 13:18:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-corona-virus-pandemic-in-south-america</guid>
                                    <description><![CDATA[At the end of May, the WHO said that South America has become the new epicentre of the covid-19 pandemic. 

The majority of those with covid are in Brazil - not entirely surprising given it is the most populous - but in neighbouring Peru, numbers are growing too.

And it’s to Peru that we turn to talk to our guest today, Valerie Paz-Soldan is a social scientist and director of the Tulane Health Office for Latin America - part of the university’s school of public health and tropical medicine.

She joins us to talk about the pattern of the virus in Peru in particular, but elsewhere in the region, and how the pandemic is overwhelming an already stressed healthcare system.

<p>https://www.bmj.com/coronavirus</p>
]]></description>
                                                            <content:encoded><![CDATA[At the end of May, the WHO said that South America has become the new epicentre of the covid-19 pandemic. 

The majority of those with covid are in Brazil - not entirely surprising given it is the most populous - but in neighbouring Peru, numbers are growing too.

And it’s to Peru that we turn to talk to our guest today, Valerie Paz-Soldan is a social scientist and director of the Tulane Health Office for Latin America - part of the university’s school of public health and tropical medicine.

She joins us to talk about the pattern of the virus in Peru in particular, but elsewhere in the region, and how the pandemic is overwhelming an already stressed healthcare system.

<p>https://www.bmj.com/coronavirus</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5xsxu1/stream_840547075-bmjgroup-the-corona-virus-pandemic-in-south-america.mp3" length="19416292" type="audio/mpeg"/>
        <itunes:summary><![CDATA[At the end of May, the WHO said that South America has become the new epicentre of the covid-19 pandemic. 

The majority of those with covid are in Brazil - not entirely surprising given it is the most populous - but in neighbouring Peru, numbers are growing too.

And it’s to Peru that we turn to talk to our guest today, Valerie Paz-Soldan is a social scientist and director of the Tulane Health Office for Latin America - part of the university’s school of public health and tropical medicine.

She joins us to talk about the pattern of the virus in Peru in particular, but elsewhere in the region, and how the pandemic is overwhelming an already stressed healthcare system.

https://www.bmj.com/coronavirus]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1213</itunes:duration>
                                    </item>
    <item>
        <title>Wellbeing  - the art of the staycation</title>
        <itunes:title>Wellbeing  - the art of the staycation</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/wellbeing-the-art-of-the-staycation/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/wellbeing-the-art-of-the-staycation/#comments</comments>        <pubDate>Mon, 15 Jun 2020 11:46:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/wellbeing-the-art-of-the-staycation</guid>
                                    <description><![CDATA[<p>n normal times, around this time we’d start thinking about weekend breaks and summer holidays abroad. More than most healthcare staff and other key workers are in dire need of time out. Given the uncertainties around foreign travel, how can we recreate in some way that holiday feeling. Simon Calder, travel correspondent for The Independent newspaper, offers his staycation tips and alternative travel advice.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>n normal times, around this time we’d start thinking about weekend breaks and summer holidays abroad. More than most healthcare staff and other key workers are in dire need of time out. Given the uncertainties around foreign travel, how can we recreate in some way that holiday feeling. Simon Calder, travel correspondent for The Independent newspaper, offers his staycation tips and alternative travel advice.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xqnc76/stream_840510160-bmjgroup-wellbeing-the-art-of-the-staycation.mp3" length="20259968" type="audio/mpeg"/>
        <itunes:summary><![CDATA[n normal times, around this time we’d start thinking about weekend breaks and summer holidays abroad. More than most healthcare staff and other key workers are in dire need of time out. Given the uncertainties around foreign travel, how can we recreate in some way that holiday feeling. Simon Calder, travel correspondent for The Independent newspaper, offers his staycation tips and alternative travel advice.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1266</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence covid-19 update - surgisphere data, and protests in a pandemic</title>
        <itunes:title>Talk Evidence covid-19 update - surgisphere data, and protests in a pandemic</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-surgisphere-data-and-protests-in-a-pandemic/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-surgisphere-data-and-protests-in-a-pandemic/#comments</comments>        <pubDate>Fri, 12 Jun 2020 17:57:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-covid-19-update-surgisphere-data-and-protests-in-a-pandemic</guid>
                                    <description><![CDATA[This week, we’re asking questions about surgisphere data, and how it might have got into such high impact journals, we’re also talking about the protests around the world about structural racism - and how they intersect with the covid pandemic.

(1.39) Helen and Carl talk about the data underlying the newly retracted papers on hydroxychloroquine and ace-inhibitors or ARBs and covid.

(7.45) Fiona Godlee, the BMJ’s editor in chief, comes onto the pod to talk about retractions, and why they’re often called for, an rarely done.

(25.10) We talk about the protests, and Carl gives us his opinion on the risk of covid transmission during them (spoiler; he thinks it’s low)

(37.40) Sonia Saxena, professor of primary care at Imperial College London gives her verdict on the Public Health England report into this disproportionate effect of covid on ethnic minorities in the UK, and pushes back against it being a biological instead of a sociological determination.

Reading list:

Sonia’s analysis into transforming the health system for the UK’s multiethnic population https://www.bmj.com/content/368/bmj.m268

 News Analysis - Covid-19: PHE review has failed ethnic minorities, leaders tell BMJ
https://www.bmj.com/content/369/bmj.m2264

The PHE report into the disparate risk of covid to ethnic minorities
<p>https://www.gov.uk/government/publications/covid-19-review-of-disparities-in-risks-and-outcomes</p>
]]></description>
                                                            <content:encoded><![CDATA[This week, we’re asking questions about surgisphere data, and how it might have got into such high impact journals, we’re also talking about the protests around the world about structural racism - and how they intersect with the covid pandemic.

(1.39) Helen and Carl talk about the data underlying the newly retracted papers on hydroxychloroquine and ace-inhibitors or ARBs and covid.

(7.45) Fiona Godlee, the BMJ’s editor in chief, comes onto the pod to talk about retractions, and why they’re often called for, an rarely done.

(25.10) We talk about the protests, and Carl gives us his opinion on the risk of covid transmission during them (spoiler; he thinks it’s low)

(37.40) Sonia Saxena, professor of primary care at Imperial College London gives her verdict on the Public Health England report into this disproportionate effect of covid on ethnic minorities in the UK, and pushes back against it being a biological instead of a sociological determination.

Reading list:

Sonia’s analysis into transforming the health system for the UK’s multiethnic population https://www.bmj.com/content/368/bmj.m268

 News Analysis - Covid-19: PHE review has failed ethnic minorities, leaders tell BMJ
https://www.bmj.com/content/369/bmj.m2264

The PHE report into the disparate risk of covid to ethnic minorities
<p>https://www.gov.uk/government/publications/covid-19-review-of-disparities-in-risks-and-outcomes</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/95lznz/stream_839045809-bmjgroup-talk-evidence-covid-19-update-surgisphere-data-and-protests-in-a-pandemic.mp3" length="47871372" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week, we’re asking questions about surgisphere data, and how it might have got into such high impact journals, we’re also talking about the protests around the world about structural racism - and how they intersect with the covid pandemic.

(1.39) Helen and Carl talk about the data underlying the newly retracted papers on hydroxychloroquine and ace-inhibitors or ARBs and covid.

(7.45) Fiona Godlee, the BMJ’s editor in chief, comes onto the pod to talk about retractions, and why they’re often called for, an rarely done.

(25.10) We talk about the protests, and Carl gives us his opinion on the risk of covid transmission during them (spoiler; he thinks it’s low)

(37.40) Sonia Saxena, professor of primary care at Imperial College London gives her verdict on the Public Health England report into this disproportionate effect of covid on ethnic minorities in the UK, and pushes back against it being a biological instead of a sociological determination.

Reading list:

Sonia’s analysis into transforming the health system for the UK’s multiethnic population https://www.bmj.com/content/368/bmj.m268

 News Analysis - Covid-19: PHE review has failed ethnic minorities, leaders tell BMJ
https://www.bmj.com/content/369/bmj.m2264

The PHE report into the disparate risk of covid to ethnic minorities
https://www.gov.uk/government/publications/covid-19-review-of-disparities-in-risks-and-outcomes]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2992</itunes:duration>
                                    </item>
    <item>
        <title>Wellbeing - how Burmese Buddhism can help</title>
        <itunes:title>Wellbeing - how Burmese Buddhism can help</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/wellbeing-how-burmese-buddhism-can-help/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/wellbeing-how-burmese-buddhism-can-help/#comments</comments>        <pubDate>Wed, 10 Jun 2020 10:53:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/wellbeing-how-burmese-buddhism-can-help</guid>
                                    <description><![CDATA[<p>How might Burmese Buddhism help deal with pandemic stress? Christopher Bu drew on his familial heritage and the tradition of practicing mindfulness to cope with the stresses of studying to be a doctor. He invites us to consider how the same techniques might be useful psychological tool for all healthcare workers during this challenging time.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>How might Burmese Buddhism help deal with pandemic stress? Christopher Bu drew on his familial heritage and the tradition of practicing mindfulness to cope with the stresses of studying to be a doctor. He invites us to consider how the same techniques might be useful psychological tool for all healthcare workers during this challenging time.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5shbe7/stream_837508684-bmjgroup-wellbeing-how-burmese-buddhism-can-help.mp3" length="27259904" type="audio/mpeg"/>
        <itunes:summary><![CDATA[How might Burmese Buddhism help deal with pandemic stress? Christopher Bu drew on his familial heritage and the tradition of practicing mindfulness to cope with the stresses of studying to be a doctor. He invites us to consider how the same techniques might be useful psychological tool for all healthcare workers during this challenging time.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1704</itunes:duration>
                                    </item>
    <item>
        <title>Talk evidence covid-19 update - second wave and care home failings</title>
        <itunes:title>Talk evidence covid-19 update - second wave and care home failings</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-second-wave-and-care-home-failings/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-second-wave-and-care-home-failings/#comments</comments>        <pubDate>Mon, 08 Jun 2020 11:54:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-covid-19-update-second-wave-and-care-home-failings</guid>
                                    <description><![CDATA[In this episode of Talk Evidence, we'll be finding out if second waves are inevitable (or even a thing), how the UK's failure to protect it's care homes is symbolic of a neglected part of public life, and why those papers on hydroxychloroquine were retracted.

This is Talk Evidence - the podcast for evidence based medicine, where research, guidance and practice are debated and demystified.

Helen Macdonald, UK research editor for The BMJ, and Carl Heneghan, professor of EBM at the University of Oxford and editor of BMJ EBM, talk about some of the latest developments in the world of evidence, and what they mean.

This week:

2.00 - Helen looking into a second wave - and finds out from Tom Jefferson, an epidemiologist with the Cochrane Collaboration's acute respiratory infections group, that a "wave" might be a misnomer.

12.00 - Mary Daly,  professor of sociology and social policy at the University of Oxford, tells us where the UK went wrong with care homes, and what we’d need to do to stop it happening again.

31.20 - Carl and Helen discuss those hydroxy chloroquine papers, now retracted. This was recorded before that happened, but we decided to keep this section in, because they talk about the reasons the papers should be viewed with caution, and the importance of scrutiny of the data.

Reading list:
The talk from Mary Daly at Green Templeton College.
<p>https://www.gtc.ox.ac.uk/news-and-events/event/covid-19-and-care-homes-what-went-wrong-and-why/</p>
]]></description>
                                                            <content:encoded><![CDATA[In this episode of Talk Evidence, we'll be finding out if second waves are inevitable (or even a thing), how the UK's failure to protect it's care homes is symbolic of a neglected part of public life, and why those papers on hydroxychloroquine were retracted.

This is Talk Evidence - the podcast for evidence based medicine, where research, guidance and practice are debated and demystified.

Helen Macdonald, UK research editor for The BMJ, and Carl Heneghan, professor of EBM at the University of Oxford and editor of BMJ EBM, talk about some of the latest developments in the world of evidence, and what they mean.

This week:

2.00 - Helen looking into a second wave - and finds out from Tom Jefferson, an epidemiologist with the Cochrane Collaboration's acute respiratory infections group, that a "wave" might be a misnomer.

12.00 - Mary Daly,  professor of sociology and social policy at the University of Oxford, tells us where the UK went wrong with care homes, and what we’d need to do to stop it happening again.

31.20 - Carl and Helen discuss those hydroxy chloroquine papers, now retracted. This was recorded before that happened, but we decided to keep this section in, because they talk about the reasons the papers should be viewed with caution, and the importance of scrutiny of the data.

Reading list:
The talk from Mary Daly at Green Templeton College.
<p>https://www.gtc.ox.ac.uk/news-and-events/event/covid-19-and-care-homes-what-went-wrong-and-why/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8bhawt/stream_836265241-bmjgroup-talk-evidence-covid-19-update-second-wave-and-care-home-failings.mp3" length="43406732" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode of Talk Evidence, we'll be finding out if second waves are inevitable (or even a thing), how the UK's failure to protect it's care homes is symbolic of a neglected part of public life, and why those papers on hydroxychloroquine were retracted.

This is Talk Evidence - the podcast for evidence based medicine, where research, guidance and practice are debated and demystified.

Helen Macdonald, UK research editor for The BMJ, and Carl Heneghan, professor of EBM at the University of Oxford and editor of BMJ EBM, talk about some of the latest developments in the world of evidence, and what they mean.

This week:

2.00 - Helen looking into a second wave - and finds out from Tom Jefferson, an epidemiologist with the Cochrane Collaboration's acute respiratory infections group, that a "wave" might be a misnomer.

12.00 - Mary Daly,  professor of sociology and social policy at the University of Oxford, tells us where the UK went wrong with care homes, and what we’d need to do to stop it happening again.

31.20 - Carl and Helen discuss those hydroxy chloroquine papers, now retracted. This was recorded before that happened, but we decided to keep this section in, because they talk about the reasons the papers should be viewed with caution, and the importance of scrutiny of the data.

Reading list:
The talk from Mary Daly at Green Templeton College.
https://www.gtc.ox.ac.uk/news-and-events/event/covid-19-and-care-homes-what-went-wrong-and-why/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2713</itunes:duration>
                                    </item>
    <item>
        <title>Counting the ways Donald Trump failed in the pandemic</title>
        <itunes:title>Counting the ways Donald Trump failed in the pandemic</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/counting-the-ways-donald-trump-failed-in-the-pandemic/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/counting-the-ways-donald-trump-failed-in-the-pandemic/#comments</comments>        <pubDate>Fri, 05 Jun 2020 13:26:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/counting-the-ways-donald-trump-failed-in-the-pandemic</guid>
                                    <description><![CDATA[The Trump administration was left a playbook for pandemics when they entered the Whitehouse, but even before covid-19 was a threat systematically dismantled the public health protections put in place to follow that playbook.

In this podcast, Nicole Lurie, Gavin Yamey and Gregg Gonsalves talk about how the US response to public health was mismanaged, how it has become politicized, and what that playbook suggested should have been done. They also talk about rebuilding public health in the US after this is all over.

Our guests;
Nicole Lurie, former Assistant Secretary for Preparedness and Response under the Obama administration, senior clinical lecturer at Harvard Medical School and advisor to the Coalition for Epidemic Preparedness Innovation
Gavin Yamey,  professor of global health and public policy at Duke University
Gregg Gonsalves, assistant professor of epidemiology at Yale School of Public Health.

<p>This podcast is hosted by Joanne Silberner.</p>
]]></description>
                                                            <content:encoded><![CDATA[The Trump administration was left a playbook for pandemics when they entered the Whitehouse, but even before covid-19 was a threat systematically dismantled the public health protections put in place to follow that playbook.

In this podcast, Nicole Lurie, Gavin Yamey and Gregg Gonsalves talk about how the US response to public health was mismanaged, how it has become politicized, and what that playbook suggested should have been done. They also talk about rebuilding public health in the US after this is all over.

Our guests;
Nicole Lurie, former Assistant Secretary for Preparedness and Response under the Obama administration, senior clinical lecturer at Harvard Medical School and advisor to the Coalition for Epidemic Preparedness Innovation
Gavin Yamey,  professor of global health and public policy at Duke University
Gregg Gonsalves, assistant professor of epidemiology at Yale School of Public Health.

<p>This podcast is hosted by Joanne Silberner.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/riyrff/stream_834626002-bmjgroup-counting-the-ways-donald-trump-failed-in-the-pandemic.mp3" length="30986239" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The Trump administration was left a playbook for pandemics when they entered the Whitehouse, but even before covid-19 was a threat systematically dismantled the public health protections put in place to follow that playbook.

In this podcast, Nicole Lurie, Gavin Yamey and Gregg Gonsalves talk about how the US response to public health was mismanaged, how it has become politicized, and what that playbook suggested should have been done. They also talk about rebuilding public health in the US after this is all over.

Our guests;
Nicole Lurie, former Assistant Secretary for Preparedness and Response under the Obama administration, senior clinical lecturer at Harvard Medical School and advisor to the Coalition for Epidemic Preparedness Innovation
Gavin Yamey,  professor of global health and public policy at Duke University
Gregg Gonsalves, assistant professor of epidemiology at Yale School of Public Health.

This podcast is hosted by Joanne Silberner.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1937</itunes:duration>
                                    </item>
    <item>
        <title>Testing times with James McCormack and Jess Watson</title>
        <itunes:title>Testing times with James McCormack and Jess Watson</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/testing-times-with-james-mccormack-and-jess-watson/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/testing-times-with-james-mccormack-and-jess-watson/#comments</comments>        <pubDate>Thu, 04 Jun 2020 10:39:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/testing-times-with-james-mccormack-and-jess-watson</guid>
                                    <description><![CDATA[For GPs, testing patients is their “bread and butter”. This week, we discuss the “better safe than sorry” attitude towards testing, which is so common among doctors – are we guilty of over-testing purely out of force of habit, or are we worried about missing something vital, and therefore find reassurance in doing them? How should we interpret test results, and how do these results affect the way we manage our patients? And, with the huge focus on COVID-19 testing in the media, how do we communicate the current risks and uncertainties surrounding it to our patients?

Our guests:
James McCormack is a professor in the Faculty of Pharmaceutical Sciences at the University of British Columbia, and the co-host of a popular weekly podcast called Best Science (BS) Medicine podcast. His work focuses on helping healthcare professionals to understand medical data, by taking the best available evidence and making it as simple and practical as possible.

Jess Watson is a GP, working in Bristol, and an expert on medical testing. She is a researcher with an interest in the use of diagnostic tests in primary care, specifically inflammatory marker blood tests.

Reading list:
James's BS Medicine Podcast 
https://therapeuticseducation.org/

Jess's Practice Pointer - Interpreting a covid-19 test result
<p>https://www.bmj.com/content/369/bmj.m1808</p>
]]></description>
                                                            <content:encoded><![CDATA[For GPs, testing patients is their “bread and butter”. This week, we discuss the “better safe than sorry” attitude towards testing, which is so common among doctors – are we guilty of over-testing purely out of force of habit, or are we worried about missing something vital, and therefore find reassurance in doing them? How should we interpret test results, and how do these results affect the way we manage our patients? And, with the huge focus on COVID-19 testing in the media, how do we communicate the current risks and uncertainties surrounding it to our patients?

Our guests:
James McCormack is a professor in the Faculty of Pharmaceutical Sciences at the University of British Columbia, and the co-host of a popular weekly podcast called Best Science (BS) Medicine podcast. His work focuses on helping healthcare professionals to understand medical data, by taking the best available evidence and making it as simple and practical as possible.

Jess Watson is a GP, working in Bristol, and an expert on medical testing. She is a researcher with an interest in the use of diagnostic tests in primary care, specifically inflammatory marker blood tests.

Reading list:
James's BS Medicine Podcast 
https://therapeuticseducation.org/

Jess's Practice Pointer - Interpreting a covid-19 test result
<p>https://www.bmj.com/content/369/bmj.m1808</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/k8gg98/stream_833885062-bmjgroup-testing-times-with-james-mccormack-and-jess-watson.mp3" length="49526908" type="audio/mpeg"/>
        <itunes:summary><![CDATA[For GPs, testing patients is their “bread and butter”. This week, we discuss the “better safe than sorry” attitude towards testing, which is so common among doctors – are we guilty of over-testing purely out of force of habit, or are we worried about missing something vital, and therefore find reassurance in doing them? How should we interpret test results, and how do these results affect the way we manage our patients? And, with the huge focus on COVID-19 testing in the media, how do we communicate the current risks and uncertainties surrounding it to our patients?

Our guests:
James McCormack is a professor in the Faculty of Pharmaceutical Sciences at the University of British Columbia, and the co-host of a popular weekly podcast called Best Science (BS) Medicine podcast. His work focuses on helping healthcare professionals to understand medical data, by taking the best available evidence and making it as simple and practical as possible.

Jess Watson is a GP, working in Bristol, and an expert on medical testing. She is a researcher with an interest in the use of diagnostic tests in primary care, specifically inflammatory marker blood tests.

Reading list:
James's BS Medicine Podcast 
https://therapeuticseducation.org/

Jess's Practice Pointer - Interpreting a covid-19 test result
https://www.bmj.com/content/369/bmj.m1808]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3095</itunes:duration>
                                    </item>
    <item>
        <title>Talk evidence covid-19 update - remdesivir redux, the overwhelming volume of research</title>
        <itunes:title>Talk evidence covid-19 update - remdesivir redux, the overwhelming volume of research</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-remdesivir-redux-the-overwhelming-volume-of-research/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-remdesivir-redux-the-overwhelming-volume-of-research/#comments</comments>        <pubDate>Wed, 03 Jun 2020 09:45:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-covid-19-update-remdesivir-redux-the-overwhelming-volume-of-research</guid>
                                    <description><![CDATA[That remdesivir study has finally been published - what does it say and is it as independant as claimed. Also, as the world's focus turned to covid, so have researchers - and they've produced over 15000 papers. How can we sift through the flood of research and know what's any good?

(2.30) Helen Macdonald talks to Elizabeth Loder about the volume of research we're seeing, and why journals and peer reviewers are struggling to check it all.

(8.15) The study on remdesivir has been published - the trial was stopped early, and the primary outcome switched - we talk about how that increases uncertainty over the results, and could actually delay the treatment.

(26.50) We hear from a couple fo readers who wanted to correct us about averages, means, medians.

Reading list:
The US NIH AID study on remdesivir, published 22nd May in the New England Journal of Medicine

Research - preliminary report https://www.nejm.org/doi/full/10.1056/NEJMoa2007764
NEJM - looking at the dose duration https://www.nejm.org/doi/full/10.1056/NEJMoa2015301
<p>Editorial - an important first step https://www.nejm.org/doi/full/10.1056/NEJMe2018715</p>
]]></description>
                                                            <content:encoded><![CDATA[That remdesivir study has finally been published - what does it say and is it as independant as claimed. Also, as the world's focus turned to covid, so have researchers - and they've produced over 15000 papers. How can we sift through the flood of research and know what's any good?

(2.30) Helen Macdonald talks to Elizabeth Loder about the volume of research we're seeing, and why journals and peer reviewers are struggling to check it all.

(8.15) The study on remdesivir has been published - the trial was stopped early, and the primary outcome switched - we talk about how that increases uncertainty over the results, and could actually delay the treatment.

(26.50) We hear from a couple fo readers who wanted to correct us about averages, means, medians.

Reading list:
The US NIH AID study on remdesivir, published 22nd May in the New England Journal of Medicine

Research - preliminary report https://www.nejm.org/doi/full/10.1056/NEJMoa2007764
NEJM - looking at the dose duration https://www.nejm.org/doi/full/10.1056/NEJMoa2015301
<p>Editorial - an important first step https://www.nejm.org/doi/full/10.1056/NEJMe2018715</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/a7rvfl/stream_833251252-bmjgroup-talk-evidence-covid-19-update-remdesivir-redux-the-overwhelming-volume-of-research.mp3" length="44729306" type="audio/mpeg"/>
        <itunes:summary><![CDATA[That remdesivir study has finally been published - what does it say and is it as independant as claimed. Also, as the world's focus turned to covid, so have researchers - and they've produced over 15000 papers. How can we sift through the flood of research and know what's any good?

(2.30) Helen Macdonald talks to Elizabeth Loder about the volume of research we're seeing, and why journals and peer reviewers are struggling to check it all.

(8.15) The study on remdesivir has been published - the trial was stopped early, and the primary outcome switched - we talk about how that increases uncertainty over the results, and could actually delay the treatment.

(26.50) We hear from a couple fo readers who wanted to correct us about averages, means, medians.

Reading list:
The US NIH AID study on remdesivir, published 22nd May in the New England Journal of Medicine

Research - preliminary report https://www.nejm.org/doi/full/10.1056/NEJMoa2007764
NEJM - looking at the dose duration https://www.nejm.org/doi/full/10.1056/NEJMoa2015301
Editorial - an important first step https://www.nejm.org/doi/full/10.1056/NEJMe2018715]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1866</itunes:duration>
                                    </item>
    <item>
        <title>Ray Moynihan - Declarations of interest in healthcare leaders</title>
        <itunes:title>Ray Moynihan - Declarations of interest in healthcare leaders</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/ray-moynihan-declarations-of-interest-in-healthcare-leaders/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/ray-moynihan-declarations-of-interest-in-healthcare-leaders/#comments</comments>        <pubDate>Fri, 29 May 2020 10:58:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/ray-moynighan-declarations-of-interest-in-healthcare-leaders</guid>
                                    <description><![CDATA[*Non covid content alert* 

While the last couple of months have been covid-19 focused, the work of the beforetimes carries on - including a topic the BMJ is perennially interested in, industry funding of medics.

Ray Moynihan, researcher at Bond University, has been looking at financial ties between some healthcare association leaders, and industry, in the US, and reports that in new research published this week in The BMJ.

Read the full open access research;

<p>Financial ties between leaders of influential US professional medical associations and industry: cross sectional study - https://www.bmj.com/content/369/bmj.m1505</p>
]]></description>
                                                            <content:encoded><![CDATA[*Non covid content alert* 

While the last couple of months have been covid-19 focused, the work of the beforetimes carries on - including a topic the BMJ is perennially interested in, industry funding of medics.

Ray Moynihan, researcher at Bond University, has been looking at financial ties between some healthcare association leaders, and industry, in the US, and reports that in new research published this week in The BMJ.

Read the full open access research;

<p>Financial ties between leaders of influential US professional medical associations and industry: cross sectional study - https://www.bmj.com/content/369/bmj.m1505</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kqgr3y/stream_830402818-bmjgroup-ray-moynighan-declarations-of-interest-in-healthcare-leaders.mp3" length="20934320" type="audio/mpeg"/>
        <itunes:summary><![CDATA[*Non covid content alert* 

While the last couple of months have been covid-19 focused, the work of the beforetimes carries on - including a topic the BMJ is perennially interested in, industry funding of medics.

Ray Moynihan, researcher at Bond University, has been looking at financial ties between some healthcare association leaders, and industry, in the US, and reports that in new research published this week in The BMJ.

Read the full open access research;

Financial ties between leaders of influential US professional medical associations and industry: cross sectional study - https://www.bmj.com/content/369/bmj.m1505]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1308</itunes:duration>
                                    </item>
    <item>
        <title>Wellbeing – how to write a wellbeing prescription</title>
        <itunes:title>Wellbeing – how to write a wellbeing prescription</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/wellbeing-%e2%80%93-how-to-write-a-wellbeing-prescription/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/wellbeing-%e2%80%93-how-to-write-a-wellbeing-prescription/#comments</comments>        <pubDate>Wed, 27 May 2020 18:21:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/wellbeing-how-to-write-a-wellbeing-prescription</guid>
                                    <description><![CDATA[How might stress affect your performance as a healthcare worker? 

That’s the question that Mark Stacey, a consultant obstetric anaesthetist in Cardiff, has been interested in for the past 10 years. He saw similarities in the aviation industry, which uses a theory of human factors to explain why things go wrong when humans interact with complex systems. 

Stress was a major culprit, in both aerospace and medicine, so he began to explore wellbeing as a way to reduce stress and, in turn, reduce adverse events. He has developed the idea of writing yourself a wellbeing prescription, which includes practical techniques such as the Baker’s Dozen and a gratitude diary.

Useful tools

Bakers Dozen https://www.cardiff.ac.uk/__data/assets/pdf_file/0003/808950/Bakers-Dozen-Toolkit.pdf

<p>A 30 day plan that Mark has put together http://www.cardiffandvaleuhb.wales.nhs.uk/improving-resilience-in-anaesthesia</p>
]]></description>
                                                            <content:encoded><![CDATA[How might stress affect your performance as a healthcare worker? 

That’s the question that Mark Stacey, a consultant obstetric anaesthetist in Cardiff, has been interested in for the past 10 years. He saw similarities in the aviation industry, which uses a theory of human factors to explain why things go wrong when humans interact with complex systems. 

Stress was a major culprit, in both aerospace and medicine, so he began to explore wellbeing as a way to reduce stress and, in turn, reduce adverse events. He has developed the idea of writing yourself a wellbeing prescription, which includes practical techniques such as the Baker’s Dozen and a gratitude diary.

Useful tools

Bakers Dozen https://www.cardiff.ac.uk/__data/assets/pdf_file/0003/808950/Bakers-Dozen-Toolkit.pdf

<p>A 30 day plan that Mark has put together http://www.cardiffandvaleuhb.wales.nhs.uk/improving-resilience-in-anaesthesia</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/e8yo8i/stream_829233589-bmjgroup-wellbeing-how-to-write-a-wellbeing-prescription.mp3" length="26489984" type="audio/mpeg"/>
        <itunes:summary><![CDATA[How might stress affect your performance as a healthcare worker? 

That’s the question that Mark Stacey, a consultant obstetric anaesthetist in Cardiff, has been interested in for the past 10 years. He saw similarities in the aviation industry, which uses a theory of human factors to explain why things go wrong when humans interact with complex systems. 

Stress was a major culprit, in both aerospace and medicine, so he began to explore wellbeing as a way to reduce stress and, in turn, reduce adverse events. He has developed the idea of writing yourself a wellbeing prescription, which includes practical techniques such as the Baker’s Dozen and a gratitude diary.

Useful tools

Bakers Dozen https://www.cardiff.ac.uk/__data/assets/pdf_file/0003/808950/Bakers-Dozen-Toolkit.pdf

A 30 day plan that Mark has put together http://www.cardiffandvaleuhb.wales.nhs.uk/improving-resilience-in-anaesthesia]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1656</itunes:duration>
                                    </item>
    <item>
        <title>Public health response to covid-19 - data integrity and the importance of international comparison</title>
        <itunes:title>Public health response to covid-19 - data integrity and the importance of international comparison</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/public-health-response-to-covid-19-data-integrity-and-the-importance-of-international-comparison/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/public-health-response-to-covid-19-data-integrity-and-the-importance-of-international-comparison/#comments</comments>        <pubDate>Tue, 26 May 2020 17:26:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/public-health-response-to-covid-19-data-integrity-and-the-importance-of-international-comparison</guid>
                                    <description><![CDATA[This last week has seen questions raised about the integrity of some of the epidemiological data being produced by US states, and as rates continue to grow in some countries international comparisons are being questioned.

To discuss the implication of that are;

Sridhar Venkatapuram 
associate professor global health & philosophy at King's College London 
Kathleen Bachynski
Assistant professor of public health at Muhlenberg College

Martin Mckee
<p>Professor of European health at the London School of Hygiene and Tropical Medicine</p>
]]></description>
                                                            <content:encoded><![CDATA[This last week has seen questions raised about the integrity of some of the epidemiological data being produced by US states, and as rates continue to grow in some countries international comparisons are being questioned.

To discuss the implication of that are;

Sridhar Venkatapuram 
associate professor global health & philosophy at King's College London 
Kathleen Bachynski
Assistant professor of public health at Muhlenberg College

Martin Mckee
<p>Professor of European health at the London School of Hygiene and Tropical Medicine</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mse9vv/stream_828533554-bmjgroup-public-health-response-to-covid-19-data-integrity-and-the-importance-of-international-comparison.mp3" length="43250415" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This last week has seen questions raised about the integrity of some of the epidemiological data being produced by US states, and as rates continue to grow in some countries international comparisons are being questioned.

To discuss the implication of that are;

Sridhar Venkatapuram 
associate professor global health & philosophy at King's College London 
Kathleen Bachynski
Assistant professor of public health at Muhlenberg College

Martin Mckee
Professor of European health at the London School of Hygiene and Tropical Medicine]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2703</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence covid-19 update - strategies to end lockdown, more testing</title>
        <itunes:title>Talk Evidence covid-19 update - strategies to end lockdown, more testing</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-strategies-to-end-lockdown-more-testing/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-strategies-to-end-lockdown-more-testing/#comments</comments>        <pubDate>Fri, 22 May 2020 18:18:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-strategies-to-end-lockdown-more-testing</guid>
                                    <description><![CDATA[This week we're focussing on what kind of information we need to be able to collect and use as the country transitions out of lockdown - and why local lockdowns may be here for some time.

We also hear about the new antibody tests which are available in the UK - are they actually a game changer?


(2.00) Helen explains what some new evidence says about hydroxychloroquine (spoiler; don’t take it for covid-19)

(6.40) *Non covid alert* - Carl tells us about new research on compressions stockings for thromboprophylaxis, and the importance of doing research on non-pharmacological interventions

(10.30) David Nabarro, Special Envoy of WHO Director-General on COVID19,

(28.00) Helen goes back to Jon Deeks, professor of biostatistics at Birmingham, to find out more about these “accurate” tests for covid, endorsed by the government this week.


Reading list:

Clinical efficacy of hydroxychloroquine in patients with covid-19
https://www.bmj.com/content/369/bmj.m1844

Hydroxychloroquine in patients with mainly mild to moderate covid-19
https://www.bmj.com/content/369/bmj.m1849

David Nabarro’s website, with daily briefings 
https://www.4sd.info/

News Covid-19: Two antibody tests are “highly specific” but vary in sensitivity, evaluations find
<p>https://www.bmj.com/content/369/bmj.m2066</p>
]]></description>
                                                            <content:encoded><![CDATA[This week we're focussing on what kind of information we need to be able to collect and use as the country transitions out of lockdown - and why local lockdowns may be here for some time.

We also hear about the new antibody tests which are available in the UK - are they actually a game changer?


(2.00) Helen explains what some new evidence says about hydroxychloroquine (spoiler; don’t take it for covid-19)

(6.40) *Non covid alert* - Carl tells us about new research on compressions stockings for thromboprophylaxis, and the importance of doing research on non-pharmacological interventions

(10.30) David Nabarro, Special Envoy of WHO Director-General on COVID19,

(28.00) Helen goes back to Jon Deeks, professor of biostatistics at Birmingham, to find out more about these “accurate” tests for covid, endorsed by the government this week.


Reading list:

Clinical efficacy of hydroxychloroquine in patients with covid-19
https://www.bmj.com/content/369/bmj.m1844

Hydroxychloroquine in patients with mainly mild to moderate covid-19
https://www.bmj.com/content/369/bmj.m1849

David Nabarro’s website, with daily briefings 
https://www.4sd.info/

News Covid-19: Two antibody tests are “highly specific” but vary in sensitivity, evaluations find
<p>https://www.bmj.com/content/369/bmj.m2066</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hi7q1j/stream_825975370-bmjgroup-talk-evidence-strategies-to-end-lockdown-more-testing.mp3" length="44508032" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week we're focussing on what kind of information we need to be able to collect and use as the country transitions out of lockdown - and why local lockdowns may be here for some time.

We also hear about the new antibody tests which are available in the UK - are they actually a game changer?


(2.00) Helen explains what some new evidence says about hydroxychloroquine (spoiler; don’t take it for covid-19)

(6.40) *Non covid alert* - Carl tells us about new research on compressions stockings for thromboprophylaxis, and the importance of doing research on non-pharmacological interventions

(10.30) David Nabarro, Special Envoy of WHO Director-General on COVID19,

(28.00) Helen goes back to Jon Deeks, professor of biostatistics at Birmingham, to find out more about these “accurate” tests for covid, endorsed by the government this week.


Reading list:

Clinical efficacy of hydroxychloroquine in patients with covid-19
https://www.bmj.com/content/369/bmj.m1844

Hydroxychloroquine in patients with mainly mild to moderate covid-19
https://www.bmj.com/content/369/bmj.m1849

David Nabarro’s website, with daily briefings 
https://www.4sd.info/

News Covid-19: Two antibody tests are “highly specific” but vary in sensitivity, evaluations find
https://www.bmj.com/content/369/bmj.m2066]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2782</itunes:duration>
                                    </item>
    <item>
        <title>Talking about dying from covid with Scott Murray and Katherine Shear</title>
        <itunes:title>Talking about dying from covid with Scott Murray and Katherine Shear</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talking-about-dying-from-covid-with-scott-murray-and-katherine-shear/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talking-about-dying-from-covid-with-scott-murray-and-katherine-shear/#comments</comments>        <pubDate>Thu, 21 May 2020 16:39:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talking-about-dying-from-covid-with-scott-murray-and-katherine-shear</guid>
                                    <description><![CDATA[With COVID-19 still ongoing, and at the forefront of the minds of doctors, patients and members of the public alike, difficult conversations are taking place - GPs are encouraged to talk about death with those who might not be ready to discuss it, and families are losing loved ones without being able to say goodbye. In this episode, we also look at survivor guilt, the range of emotions that grieving encompasses, and how to address the potentially thorny subject of advance care planning with COVID-19 patients.

Our guests:
Katherine Shear, internist and psychiatrist, is Director of The Center for Complicated Grief at Columbia University’s School of Social Work. She has been involved in research into treatments for grief for over 20 years.

Scott Murray, a recently retired GP, has key interests in disease trajectory and advance care planning. He led the first Primary Palliative Care Research Group and he chairs the International Primary Palliative Care Network. He advocates high-quality palliative care for everyone.

<p>This week's deep breath out is the Viral Counterpoint of the Coronavirus Spike Protein (2019-nCoV) - https://soundcloud.com/user-275864738/viral-counterpoint-of-the-coronavirus-spike-protein-2019-ncov</p>
]]></description>
                                                            <content:encoded><![CDATA[With COVID-19 still ongoing, and at the forefront of the minds of doctors, patients and members of the public alike, difficult conversations are taking place - GPs are encouraged to talk about death with those who might not be ready to discuss it, and families are losing loved ones without being able to say goodbye. In this episode, we also look at survivor guilt, the range of emotions that grieving encompasses, and how to address the potentially thorny subject of advance care planning with COVID-19 patients.

Our guests:
Katherine Shear, internist and psychiatrist, is Director of The Center for Complicated Grief at Columbia University’s School of Social Work. She has been involved in research into treatments for grief for over 20 years.

Scott Murray, a recently retired GP, has key interests in disease trajectory and advance care planning. He led the first Primary Palliative Care Research Group and he chairs the International Primary Palliative Care Network. He advocates high-quality palliative care for everyone.

<p>This week's deep breath out is the Viral Counterpoint of the Coronavirus Spike Protein (2019-nCoV) - https://soundcloud.com/user-275864738/viral-counterpoint-of-the-coronavirus-spike-protein-2019-ncov</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/m5kigr/stream_825195070-bmjgroup-talking-about-dying-from-covid-with-scott-murray-and-katherine-shear.mp3" length="52483133" type="audio/mpeg"/>
        <itunes:summary><![CDATA[With COVID-19 still ongoing, and at the forefront of the minds of doctors, patients and members of the public alike, difficult conversations are taking place - GPs are encouraged to talk about death with those who might not be ready to discuss it, and families are losing loved ones without being able to say goodbye. In this episode, we also look at survivor guilt, the range of emotions that grieving encompasses, and how to address the potentially thorny subject of advance care planning with COVID-19 patients.

Our guests:
Katherine Shear, internist and psychiatrist, is Director of The Center for Complicated Grief at Columbia University’s School of Social Work. She has been involved in research into treatments for grief for over 20 years.

Scott Murray, a recently retired GP, has key interests in disease trajectory and advance care planning. He led the first Primary Palliative Care Research Group and he chairs the International Primary Palliative Care Network. He advocates high-quality palliative care for everyone.

This week's deep breath out is the Viral Counterpoint of the Coronavirus Spike Protein (2019-nCoV) - https://soundcloud.com/user-275864738/viral-counterpoint-of-the-coronavirus-spike-protein-2019-ncov]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3280</itunes:duration>
                                    </item>
    <item>
        <title>Pandemics from history - how they inform our response now</title>
        <itunes:title>Pandemics from history - how they inform our response now</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/pandemics-from-history-how-they-inform-our-response-now/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/pandemics-from-history-how-they-inform-our-response-now/#comments</comments>        <pubDate>Thu, 21 May 2020 11:48:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/pandemics-from-history-how-they-inform-our-response-now</guid>
                                    <description><![CDATA[Does history count as a non-pharmaceutical intervention? Much of our view on what to do in this pandemic has been influenced by the 1917 Spanish 'flu outbreak - even though covid-19 seems to be acting differently.

In this podcast, we talk to Howard Markel, a professor of pediatrics at Michigan, as well as professor in the history of medicine. He's written books on quarantines and epidemics, and was  part of a team that did the medical and historical work that first showed the value of flattening the curve. 

This is the first of 4 podcasts from our US colleagues, looking at the disease in that country, which will be published over the next 2 months.

For more on covid-19
<p>www.bmj.com/coronavirus</p>
]]></description>
                                                            <content:encoded><![CDATA[Does history count as a non-pharmaceutical intervention? Much of our view on what to do in this pandemic has been influenced by the 1917 Spanish 'flu outbreak - even though covid-19 seems to be acting differently.

In this podcast, we talk to Howard Markel, a professor of pediatrics at Michigan, as well as professor in the history of medicine. He's written books on quarantines and epidemics, and was  part of a team that did the medical and historical work that first showed the value of flattening the curve. 

This is the first of 4 podcasts from our US colleagues, looking at the disease in that country, which will be published over the next 2 months.

For more on covid-19
<p>www.bmj.com/coronavirus</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/c40ddf/stream_825055363-bmjgroup-pandemics-from-history-how-they-inform-our-response-now.mp3" length="22191123" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Does history count as a non-pharmaceutical intervention? Much of our view on what to do in this pandemic has been influenced by the 1917 Spanish 'flu outbreak - even though covid-19 seems to be acting differently.

In this podcast, we talk to Howard Markel, a professor of pediatrics at Michigan, as well as professor in the history of medicine. He's written books on quarantines and epidemics, and was  part of a team that did the medical and historical work that first showed the value of flattening the curve. 

This is the first of 4 podcasts from our US colleagues, looking at the disease in that country, which will be published over the next 2 months.

For more on covid-19
www.bmj.com/coronavirus]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1387</itunes:duration>
                                    </item>
    <item>
        <title>Adam Kucharski, using viral epidemiology to combat fake news</title>
        <itunes:title>Adam Kucharski, using viral epidemiology to combat fake news</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/adam-kucharski-using-viral-epidemiology-to-combat-fake-news/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/adam-kucharski-using-viral-epidemiology-to-combat-fake-news/#comments</comments>        <pubDate>Tue, 19 May 2020 17:42:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/using-viral-epidemiology-to-combat-fake-news</guid>
                                    <description><![CDATA[Hydroxychloroquine is in the news again - as Trump and some news organisations are pushing it as a treatment, despite evidence (published in The BMJ) showing it lacks efficacy, and has a load of potential negative effects - including arrhythmias.

We know that kind of information spreads online - particularly through social media, but how does it do that?

In this podcast we talk to Adam Kucharski, and epidemiologist from the London School of Hygiene and Tropical Medicine, who has used disease modelling tools to look at fake news spread, and has some ideas about creating an online social distance.

<p>For more covid coverage www.bmj.com/coronavirus</p>
]]></description>
                                                            <content:encoded><![CDATA[Hydroxychloroquine is in the news again - as Trump and some news organisations are pushing it as a treatment, despite evidence (published in The BMJ) showing it lacks efficacy, and has a load of potential negative effects - including arrhythmias.

We know that kind of information spreads online - particularly through social media, but how does it do that?

In this podcast we talk to Adam Kucharski, and epidemiologist from the London School of Hygiene and Tropical Medicine, who has used disease modelling tools to look at fake news spread, and has some ideas about creating an online social distance.

<p>For more covid coverage www.bmj.com/coronavirus</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/1smapi/stream_823904926-bmjgroup-using-viral-epidemiology-to-combat-fake-news.mp3" length="15281004" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Hydroxychloroquine is in the news again - as Trump and some news organisations are pushing it as a treatment, despite evidence (published in The BMJ) showing it lacks efficacy, and has a load of potential negative effects - including arrhythmias.

We know that kind of information spreads online - particularly through social media, but how does it do that?

In this podcast we talk to Adam Kucharski, and epidemiologist from the London School of Hygiene and Tropical Medicine, who has used disease modelling tools to look at fake news spread, and has some ideas about creating an online social distance.

For more covid coverage www.bmj.com/coronavirus]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>955</itunes:duration>
                                    </item>
    <item>
        <title>Talk evidence covid-19 update - answering questions with big data</title>
        <itunes:title>Talk evidence covid-19 update - answering questions with big data</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-answering-questions-with-big-data/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-answering-questions-with-big-data/#comments</comments>        <pubDate>Sun, 17 May 2020 11:03:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-covid-19-update-answering-questions-with-big-data</guid>
                                    <description><![CDATA[Big data is being crunched to help us tackle some of the enormous amount of uncertainty about covid-19, what the symptoms are, fatality rate, treatment options, things we shouldn't be doing.

In these podcasts, we're going to try to get away from the headlines and talk about what we need to know - to hopefully give you some insight into these issues.

This week.

(3.10) Calum Semple, professor of outbreak medicine at the University of Liverpool talks about the ISARIC project - predesigned research brought off the shelf and deployed during a pandemic.

(14.20) Ben Goldacre, doctor, researcher and director of the EBM datalab at the University of Oxford, joins us to talk about how his team have managed to pull together records from 40% of NHS patients to look for patterns in covid-19 morbidity and mortality.

Reading list

OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.
https://www.medrxiv.org/content/10.1101/2020.05.06.20092999v1

Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol
<p>https://www.medrxiv.org/content/10.1101/2020.04.23.20076042v1</p>
]]></description>
                                                            <content:encoded><![CDATA[Big data is being crunched to help us tackle some of the enormous amount of uncertainty about covid-19, what the symptoms are, fatality rate, treatment options, things we shouldn't be doing.

In these podcasts, we're going to try to get away from the headlines and talk about what we need to know - to hopefully give you some insight into these issues.

This week.

(3.10) Calum Semple, professor of outbreak medicine at the University of Liverpool talks about the ISARIC project - predesigned research brought off the shelf and deployed during a pandemic.

(14.20) Ben Goldacre, doctor, researcher and director of the EBM datalab at the University of Oxford, joins us to talk about how his team have managed to pull together records from 40% of NHS patients to look for patterns in covid-19 morbidity and mortality.

Reading list

OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.
https://www.medrxiv.org/content/10.1101/2020.05.06.20092999v1

Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol
<p>https://www.medrxiv.org/content/10.1101/2020.04.23.20076042v1</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/yv3g2t/stream_822261286-bmjgroup-talk-evidence-covid-19-update-answering-questions-with-big-data.mp3" length="36858368" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Big data is being crunched to help us tackle some of the enormous amount of uncertainty about covid-19, what the symptoms are, fatality rate, treatment options, things we shouldn't be doing.

In these podcasts, we're going to try to get away from the headlines and talk about what we need to know - to hopefully give you some insight into these issues.

This week.

(3.10) Calum Semple, professor of outbreak medicine at the University of Liverpool talks about the ISARIC project - predesigned research brought off the shelf and deployed during a pandemic.

(14.20) Ben Goldacre, doctor, researcher and director of the EBM datalab at the University of Oxford, joins us to talk about how his team have managed to pull together records from 40% of NHS patients to look for patterns in covid-19 morbidity and mortality.

Reading list

OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.
https://www.medrxiv.org/content/10.1101/2020.05.06.20092999v1

Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol
https://www.medrxiv.org/content/10.1101/2020.04.23.20076042v1]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2304</itunes:duration>
                                    </item>
    <item>
        <title>Soumya Swaminathan - WHO’s chief scientist is trying to fix research during a pandemic</title>
        <itunes:title>Soumya Swaminathan - WHO’s chief scientist is trying to fix research during a pandemic</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/soumya-swaminathan-who-s-chief-scientist-is-trying-to-fix-research-during-a-pandemic/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/soumya-swaminathan-who-s-chief-scientist-is-trying-to-fix-research-during-a-pandemic/#comments</comments>        <pubDate>Thu, 14 May 2020 17:55:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/soumya-swaminathan-whos-chief-scientist-is-trying-to-fix-research-during-a-pandemic</guid>
                                    <description><![CDATA[If you’re a regular listener to our podcasts, you’ll have heard how Covid is exposing the cracks in our systems of healthcare - from showing how poorly provisioned elderly social care is, to how antibody testing issues have exposing how innovation is uncoordinated and driven by the worst bits of the free market.

In this podcast we talked to Soumya Swaminathan, the WHO’s first Chief scientist, and ask about how the world’s foremost normative body for health tackle some of this issues.

<p>We talk about agenda setting - and how the WHO is trying to prioritise neglected areas of research, how they’re starting to set standards for evidence driven by public rather than commercial priorities, and how, if and when a vaccine for corona virus is finally created - they can help it be distributed equitably, rather than to those with the most money to spend.</p>
]]></description>
                                                            <content:encoded><![CDATA[If you’re a regular listener to our podcasts, you’ll have heard how Covid is exposing the cracks in our systems of healthcare - from showing how poorly provisioned elderly social care is, to how antibody testing issues have exposing how innovation is uncoordinated and driven by the worst bits of the free market.

In this podcast we talked to Soumya Swaminathan, the WHO’s first Chief scientist, and ask about how the world’s foremost normative body for health tackle some of this issues.

<p>We talk about agenda setting - and how the WHO is trying to prioritise neglected areas of research, how they’re starting to set standards for evidence driven by public rather than commercial priorities, and how, if and when a vaccine for corona virus is finally created - they can help it be distributed equitably, rather than to those with the most money to spend.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/j0iz33/stream_820493722-bmjgroup-soumya-swaminathan-whos-chief-scientist-is-trying-to-fix-research-during-a-pandemic.mp3" length="42859555" type="audio/mpeg"/>
        <itunes:summary><![CDATA[If you’re a regular listener to our podcasts, you’ll have heard how Covid is exposing the cracks in our systems of healthcare - from showing how poorly provisioned elderly social care is, to how antibody testing issues have exposing how innovation is uncoordinated and driven by the worst bits of the free market.

In this podcast we talked to Soumya Swaminathan, the WHO’s first Chief scientist, and ask about how the world’s foremost normative body for health tackle some of this issues.

We talk about agenda setting - and how the WHO is trying to prioritise neglected areas of research, how they’re starting to set standards for evidence driven by public rather than commercial priorities, and how, if and when a vaccine for corona virus is finally created - they can help it be distributed equitably, rather than to those with the most money to spend.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1788</itunes:duration>
                                    </item>
    <item>
        <title>Wellbeing – how to deal with the post-emergency crash</title>
        <itunes:title>Wellbeing – how to deal with the post-emergency crash</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/wellbeing-%e2%80%93-how-to-deal-with-the-post-emergency-crash/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/wellbeing-%e2%80%93-how-to-deal-with-the-post-emergency-crash/#comments</comments>        <pubDate>Wed, 13 May 2020 18:20:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/wellbeing-how-to-deal-with-the-post-emergency-crash</guid>
                                    <description><![CDATA[The first peak of the pandemic has passed, the situation in hospitals is more manageable. While healthcare workers are preparing for the long haul, Abi and Cat discuss how to deal with this period of post-crisis crash.

In this podcast, we speak to Ali Milani, a former Labour politician who ran against Prime Minister Boris Johnson in his London constituency during the 2019 election. How might Milani’s experience of a year-long campaign and fallout compare to the current post-emergency stage of Covid-19?

www.bmj.com/wellbeing
<p>www.bmj.com/coronavirus</p>
]]></description>
                                                            <content:encoded><![CDATA[The first peak of the pandemic has passed, the situation in hospitals is more manageable. While healthcare workers are preparing for the long haul, Abi and Cat discuss how to deal with this period of post-crisis crash.

In this podcast, we speak to Ali Milani, a former Labour politician who ran against Prime Minister Boris Johnson in his London constituency during the 2019 election. How might Milani’s experience of a year-long campaign and fallout compare to the current post-emergency stage of Covid-19?

www.bmj.com/wellbeing
<p>www.bmj.com/coronavirus</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/loif5y/stream_819757453-bmjgroup-wellbeing-how-to-deal-with-the-post-emergency-crash.mp3" length="26455808" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The first peak of the pandemic has passed, the situation in hospitals is more manageable. While healthcare workers are preparing for the long haul, Abi and Cat discuss how to deal with this period of post-crisis crash.

In this podcast, we speak to Ali Milani, a former Labour politician who ran against Prime Minister Boris Johnson in his London constituency during the 2019 election. How might Milani’s experience of a year-long campaign and fallout compare to the current post-emergency stage of Covid-19?

www.bmj.com/wellbeing
www.bmj.com/coronavirus]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1654</itunes:duration>
                                    </item>
    <item>
        <title>Public health response - Lifting thelockdown</title>
        <itunes:title>Public health response - Lifting thelockdown</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/public-health-response-lifting-thelockdown/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/public-health-response-lifting-thelockdown/#comments</comments>        <pubDate>Tue, 12 May 2020 16:40:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/public-health-response-lifting-the-lockdown</guid>
                                    <description><![CDATA[We’re at the point in the pandemic that restrictions on the way people live and work are being relaxed around the world, but how that changes safety for the population is very different depending on your demographic - will you have to work with other people, will you have to take public transport to work, and can you wear a mask in public safely?

To talk about the importance of not neglecting those most affected by covid-19 we’re joined by Kathleen Bachynski, assistant professor of public health at Muhlenberg College and Sridhar Venkatapuram, associate professor global Health & philosophy at King's College London

For all The BMJ's covid coverage
<p>www.bmj.com/coronavirus</p>
]]></description>
                                                            <content:encoded><![CDATA[We’re at the point in the pandemic that restrictions on the way people live and work are being relaxed around the world, but how that changes safety for the population is very different depending on your demographic - will you have to work with other people, will you have to take public transport to work, and can you wear a mask in public safely?

To talk about the importance of not neglecting those most affected by covid-19 we’re joined by Kathleen Bachynski, assistant professor of public health at Muhlenberg College and Sridhar Venkatapuram, associate professor global Health & philosophy at King's College London

For all The BMJ's covid coverage
<p>www.bmj.com/coronavirus</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/m63eby/stream_818982424-bmjgroup-public-health-response-lifting-the-lockdown.mp3" length="34089168" type="audio/mpeg"/>
        <itunes:summary><![CDATA[We’re at the point in the pandemic that restrictions on the way people live and work are being relaxed around the world, but how that changes safety for the population is very different depending on your demographic - will you have to work with other people, will you have to take public transport to work, and can you wear a mask in public safely?

To talk about the importance of not neglecting those most affected by covid-19 we’re joined by Kathleen Bachynski, assistant professor of public health at Muhlenberg College and Sridhar Venkatapuram, associate professor global Health & philosophy at King's College London

For all The BMJ's covid coverage
www.bmj.com/coronavirus]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2131</itunes:duration>
                                    </item>
    <item>
        <title>Talk evidence covid-19 update - natural history of covid, include patients in guidelines</title>
        <itunes:title>Talk evidence covid-19 update - natural history of covid, include patients in guidelines</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-natural-history-of-covid-include-patients-in-guidelines/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-natural-history-of-covid-include-patients-in-guidelines/#comments</comments>        <pubDate>Sat, 09 May 2020 09:13:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-covid-19-update-natural-history-of-covid</guid>
                                    <description><![CDATA[For the next few months Talk Evidence is going to focus on the new corona virus pandemic. There is an enormous amount of uncertainty about the disease, what the symptoms are, fatality rate, treatment options, things we shouldn't be doing.

We're going to try to get away from the headlines and talk about what we need to know - to hopefully give you some insight into these issues.

This week:

(1.20) Carl gives us an update on the England and Wales admission data.

(3.00) Helen talks about ways in which spread and severity of infection amongst household contacts.

(8.20) We talk natural history of covid-19, and Harlan Krumholz, cardiologist at Yale, tells us what we know, and why it's difficult to have a full picture at the moment.

(15.10) Helen picks up on a study from Tim Spectre and colleagues using an app to track cases.

(20.00) Henry Scowcroft, one of The BMJ's patient editor, who also works for Cancer Research UK, joins us to talk about patients who are taking part in clinical trials, and how this is affecting them. He also touches on the thin patient participation in the design of covid treatment guidelines.

(24.10) Carl talks rapidity of publishing, and where researchers should most target their evidence outreach.

Reading list:
Reducing risks from coronavirus transmission in the home
https://www.bmj.com/content/369/bmj.m1728

Rapid implementation of mobile technology for real-time
epidemiology of COVID-19
https://science.sciencemag.org/content/sci/early/2020/05/04/science.abc0473.full.pdf

The BMJ Public and Patient participation twitter chat
<p>https://twitter.com/hashtag/BMJdebate</p>
]]></description>
                                                            <content:encoded><![CDATA[For the next few months Talk Evidence is going to focus on the new corona virus pandemic. There is an enormous amount of uncertainty about the disease, what the symptoms are, fatality rate, treatment options, things we shouldn't be doing.

We're going to try to get away from the headlines and talk about what we need to know - to hopefully give you some insight into these issues.

This week:

(1.20) Carl gives us an update on the England and Wales admission data.

(3.00) Helen talks about ways in which spread and severity of infection amongst household contacts.

(8.20) We talk natural history of covid-19, and Harlan Krumholz, cardiologist at Yale, tells us what we know, and why it's difficult to have a full picture at the moment.

(15.10) Helen picks up on a study from Tim Spectre and colleagues using an app to track cases.

(20.00) Henry Scowcroft, one of The BMJ's patient editor, who also works for Cancer Research UK, joins us to talk about patients who are taking part in clinical trials, and how this is affecting them. He also touches on the thin patient participation in the design of covid treatment guidelines.

(24.10) Carl talks rapidity of publishing, and where researchers should most target their evidence outreach.

Reading list:
Reducing risks from coronavirus transmission in the home
https://www.bmj.com/content/369/bmj.m1728

Rapid implementation of mobile technology for real-time
epidemiology of COVID-19
https://science.sciencemag.org/content/sci/early/2020/05/04/science.abc0473.full.pdf

The BMJ Public and Patient participation twitter chat
<p>https://twitter.com/hashtag/BMJdebate</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/givup4/stream_816800788-bmjgroup-talk-evidence-covid-19-update-natural-history-of-covid.mp3" length="31847552" type="audio/mpeg"/>
        <itunes:summary><![CDATA[For the next few months Talk Evidence is going to focus on the new corona virus pandemic. There is an enormous amount of uncertainty about the disease, what the symptoms are, fatality rate, treatment options, things we shouldn't be doing.

We're going to try to get away from the headlines and talk about what we need to know - to hopefully give you some insight into these issues.

This week:

(1.20) Carl gives us an update on the England and Wales admission data.

(3.00) Helen talks about ways in which spread and severity of infection amongst household contacts.

(8.20) We talk natural history of covid-19, and Harlan Krumholz, cardiologist at Yale, tells us what we know, and why it's difficult to have a full picture at the moment.

(15.10) Helen picks up on a study from Tim Spectre and colleagues using an app to track cases.

(20.00) Henry Scowcroft, one of The BMJ's patient editor, who also works for Cancer Research UK, joins us to talk about patients who are taking part in clinical trials, and how this is affecting them. He also touches on the thin patient participation in the design of covid treatment guidelines.

(24.10) Carl talks rapidity of publishing, and where researchers should most target their evidence outreach.

Reading list:
Reducing risks from coronavirus transmission in the home
https://www.bmj.com/content/369/bmj.m1728

Rapid implementation of mobile technology for real-time
epidemiology of COVID-19
https://science.sciencemag.org/content/sci/early/2020/05/04/science.abc0473.full.pdf

The BMJ Public and Patient participation twitter chat
https://twitter.com/hashtag/BMJdebate]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1991</itunes:duration>
                                    </item>
    <item>
        <title>Wellbeing – coping with Covid fatigue</title>
        <itunes:title>Wellbeing – coping with Covid fatigue</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/wellbeing-%e2%80%93-coping-with-covid-fatigue/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/wellbeing-%e2%80%93-coping-with-covid-fatigue/#comments</comments>        <pubDate>Fri, 08 May 2020 10:00:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/wellbeing-coping-with-covid-fatigue</guid>
                                    <description><![CDATA[We are more than six weeks into the lockdown and if you were to gauge the mood of the nation, it would be one of fatigue. It started as an all-hands-on-deck emergency situation, but it now transpires that the current work situation for healthcare professionals is not going to change any time soon. 

This is a marathon rather than a sprint. So how can we better look after ourselves to cope with this new realisation? In this podcast we speak to Dr Caroline Walker, an NHS-based psychiatrist and therapist.

Wait til the end for Caroline's simple technique she uses to help when feeling overwhelmed.

Read Caroline and Clare Gerada's opinion piece
<p>https://blogs.bmj.com/bmj/2020/03/31/extraordinary-times-coping-psychologically-through-the-impact-of-covid-19/</p>
]]></description>
                                                            <content:encoded><![CDATA[We are more than six weeks into the lockdown and if you were to gauge the mood of the nation, it would be one of fatigue. It started as an all-hands-on-deck emergency situation, but it now transpires that the current work situation for healthcare professionals is not going to change any time soon. 

This is a marathon rather than a sprint. So how can we better look after ourselves to cope with this new realisation? In this podcast we speak to Dr Caroline Walker, an NHS-based psychiatrist and therapist.

Wait til the end for Caroline's simple technique she uses to help when feeling overwhelmed.

Read Caroline and Clare Gerada's opinion piece
<p>https://blogs.bmj.com/bmj/2020/03/31/extraordinary-times-coping-psychologically-through-the-impact-of-covid-19/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/sd8q3g/stream_816135391-bmjgroup-wellbeing-coping-with-covid-fatigue.mp3" length="23019776" type="audio/mpeg"/>
        <itunes:summary><![CDATA[We are more than six weeks into the lockdown and if you were to gauge the mood of the nation, it would be one of fatigue. It started as an all-hands-on-deck emergency situation, but it now transpires that the current work situation for healthcare professionals is not going to change any time soon. 

This is a marathon rather than a sprint. So how can we better look after ourselves to cope with this new realisation? In this podcast we speak to Dr Caroline Walker, an NHS-based psychiatrist and therapist.

Wait til the end for Caroline's simple technique she uses to help when feeling overwhelmed.

Read Caroline and Clare Gerada's opinion piece
https://blogs.bmj.com/bmj/2020/03/31/extraordinary-times-coping-psychologically-through-the-impact-of-covid-19/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1439</itunes:duration>
                                    </item>
    <item>
        <title>Coping with Covid with Monica Schoch-Spana and Jud Brewer</title>
        <itunes:title>Coping with Covid with Monica Schoch-Spana and Jud Brewer</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/coping-with-covid-with-monica-schoch-spana-and-jud-brewer/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/coping-with-covid-with-monica-schoch-spana-and-jud-brewer/#comments</comments>        <pubDate>Wed, 06 May 2020 23:27:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/coping-with-covid-with-monica-schoch-spana-and-jud-brewer</guid>
                                    <description><![CDATA[In this week’s episode, we discuss bystander guilt, convergence, brain hacks and “how you can sneeze on someone’s brain from anywhere in the world”. How can GPs cope with the myriad worries around treating patients during the current pandemic, both on the frontline and in general practice? How do we recognise and break unhelpful anxious behaviour habits and stop fixating on the news?

Our guests: 
Monica Schoch-Spana is a medical anthropologist and a Senior Scholar at Johns Hopkins Center for Public Health. She specialises in crisis and risk communication, community resilience to disaster, public engagement in policy-making and public health emergency preparedness.

Jud Brewer is an addiction psychiatrist and neuroscientist, specialising in anxiety and habit change. He is the Director of Research and Innovation at Brown University’s Mindfulness Center, an associate professor of behavioural and social sciences at the School of Public Health at Brown, as well as of psychiatry at the university’s medical school.

Reading list: 
Monica's blog on the psychological impacts of covid-19  https://blogs.scientificamerican.com/observations/covid-19s-psychosocial-impacts/

Jud's article in the New York Times https://www.nytimes.com/2020/03/13/well/mind/a-brain-hack-to-break-the-coronavirus-anxiety-cycle.html

GP course: https://drjud.com/health-care-provider-course/

Youtube animation of the NYTimes article: https://www.youtube.com/watch?v=900cOKCADIk&feature=youtu.be

<p>Youtube coronavirus daily videos: https://www.youtube.com/watch?v=w4NwsyXRbNw&list=PL6sRqjtLfiTTni7oXKpSj2cQ9290lkpKH</p>
]]></description>
                                                            <content:encoded><![CDATA[In this week’s episode, we discuss bystander guilt, convergence, brain hacks and “how you can sneeze on someone’s brain from anywhere in the world”. How can GPs cope with the myriad worries around treating patients during the current pandemic, both on the frontline and in general practice? How do we recognise and break unhelpful anxious behaviour habits and stop fixating on the news?

Our guests: 
Monica Schoch-Spana is a medical anthropologist and a Senior Scholar at Johns Hopkins Center for Public Health. She specialises in crisis and risk communication, community resilience to disaster, public engagement in policy-making and public health emergency preparedness.

Jud Brewer is an addiction psychiatrist and neuroscientist, specialising in anxiety and habit change. He is the Director of Research and Innovation at Brown University’s Mindfulness Center, an associate professor of behavioural and social sciences at the School of Public Health at Brown, as well as of psychiatry at the university’s medical school.

Reading list: 
Monica's blog on the psychological impacts of covid-19  https://blogs.scientificamerican.com/observations/covid-19s-psychosocial-impacts/

Jud's article in the New York Times https://www.nytimes.com/2020/03/13/well/mind/a-brain-hack-to-break-the-coronavirus-anxiety-cycle.html

GP course: https://drjud.com/health-care-provider-course/

Youtube animation of the NYTimes article: https://www.youtube.com/watch?v=900cOKCADIk&feature=youtu.be

<p>Youtube coronavirus daily videos: https://www.youtube.com/watch?v=w4NwsyXRbNw&list=PL6sRqjtLfiTTni7oXKpSj2cQ9290lkpKH</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/bh3gmb/stream_815142820-bmjgroup-coping-with-covid-with-monica-schoch-spana-and-jud-brewer.mp3" length="46862000" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this week’s episode, we discuss bystander guilt, convergence, brain hacks and “how you can sneeze on someone’s brain from anywhere in the world”. How can GPs cope with the myriad worries around treating patients during the current pandemic, both on the frontline and in general practice? How do we recognise and break unhelpful anxious behaviour habits and stop fixating on the news?

Our guests: 
Monica Schoch-Spana is a medical anthropologist and a Senior Scholar at Johns Hopkins Center for Public Health. She specialises in crisis and risk communication, community resilience to disaster, public engagement in policy-making and public health emergency preparedness.

Jud Brewer is an addiction psychiatrist and neuroscientist, specialising in anxiety and habit change. He is the Director of Research and Innovation at Brown University’s Mindfulness Center, an associate professor of behavioural and social sciences at the School of Public Health at Brown, as well as of psychiatry at the university’s medical school.

Reading list: 
Monica's blog on the psychological impacts of covid-19  https://blogs.scientificamerican.com/observations/covid-19s-psychosocial-impacts/

Jud's article in the New York Times https://www.nytimes.com/2020/03/13/well/mind/a-brain-hack-to-break-the-coronavirus-anxiety-cycle.html

GP course: https://drjud.com/health-care-provider-course/

Youtube animation of the NYTimes article: https://www.youtube.com/watch?v=900cOKCADIk&feature=youtu.be

Youtube coronavirus daily videos: https://www.youtube.com/watch?v=w4NwsyXRbNw&list=PL6sRqjtLfiTTni7oXKpSj2cQ9290lkpKH]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2929</itunes:duration>
                                    </item>
    <item>
        <title>Frontline stories - caring for non-covid patients</title>
        <itunes:title>Frontline stories - caring for non-covid patients</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/frontline-stories-caring-for-non-covid-patients/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/frontline-stories-caring-for-non-covid-patients/#comments</comments>        <pubDate>Tue, 05 May 2020 19:32:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/frontline-stories-caring-for-non-covid-patients</guid>
                                    <description><![CDATA[As the pandemic plays out - hospitals are reconfigured to increase critical care capacity, outpatient clinics become virtual, and elective procedures delayed.

How are these affecting care for those who are in hospital but don't have covid-19? 
 
In this podcast, Matt Morgan,honorary senior research fellow at Cardiff University, consultant in intensive care medicine and Partha Kar, consultant in diabetes and endocrinology in Portsmouth, join us to discuss how their working week is changing.

Read the BMJ's columns
<p>https://www.bmj.com/uk/news/views%20%26amp%3B%20reviews</p>
]]></description>
                                                            <content:encoded><![CDATA[As the pandemic plays out - hospitals are reconfigured to increase critical care capacity, outpatient clinics become virtual, and elective procedures delayed.

How are these affecting care for those who are in hospital but don't have covid-19? 
 
In this podcast, Matt Morgan,honorary senior research fellow at Cardiff University, consultant in intensive care medicine and Partha Kar, consultant in diabetes and endocrinology in Portsmouth, join us to discuss how their working week is changing.

Read the BMJ's columns
<p>https://www.bmj.com/uk/news/views%20%26amp%3B%20reviews</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gtrmn6/stream_814297039-bmjgroup-frontline-stories-caring-for-non-covid-patients.mp3" length="19208567" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As the pandemic plays out - hospitals are reconfigured to increase critical care capacity, outpatient clinics become virtual, and elective procedures delayed.

How are these affecting care for those who are in hospital but don't have covid-19? 
 
In this podcast, Matt Morgan,honorary senior research fellow at Cardiff University, consultant in intensive care medicine and Partha Kar, consultant in diabetes and endocrinology in Portsmouth, join us to discuss how their working week is changing.

Read the BMJ's columns
https://www.bmj.com/uk/news/views%20%26amp%3B%20reviews]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1201</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence covid-19 update - lack of testing transparency, how to give good debate</title>
        <itunes:title>Talk Evidence covid-19 update - lack of testing transparency, how to give good debate</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-lack-of-testing-transparency-how-to-give-good-debate/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-lack-of-testing-transparency-how-to-give-good-debate/#comments</comments>        <pubDate>Mon, 04 May 2020 16:25:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-covid-19-update-lack-of-testing-transparency-how-to-give-good-debate</guid>
                                    <description><![CDATA[For the next few months Talk Evidence is going to focus on the new corona virus pandemic. There is an enormous amount of uncertainty about the disease, what the symptoms are, fatality rate, treatment options, things we shouldn't be doing.

We're going to try to get away from the headlines and talk about what we need to know - to hopefully give you some insight into these issues.

This week:
(1.10) Carl gives us an update on the UK's figures, and how deaths outside are now being counted.

(2.10) When the pandemic slows down, and normal services resume - what should we start doing first? Helen picks up some evidence on what they might be.

(6.05) There's a signal that covid-19 may be causing coagulopathies in some patients, and Helen picks up on a listeners request for more information. 

(11.22) John Deeks, professor of Biostatistics at the University of Birmingham, is leading a Cochrane initiative into examining the evidence around testing, and rivals Carl's rant when he explains how some research is being done behind a veil of confidentiality.

<p>(35.27) When there's a lot of uncertainty, and the stakes are very high, then tempers can flare. Vinay Prasad, hematologist-oncologist in the US, and host of Plenary Sessions podcast, joins us to talk about having a good, respectful, scientific debate.</p>
]]></description>
                                                            <content:encoded><![CDATA[For the next few months Talk Evidence is going to focus on the new corona virus pandemic. There is an enormous amount of uncertainty about the disease, what the symptoms are, fatality rate, treatment options, things we shouldn't be doing.

We're going to try to get away from the headlines and talk about what we need to know - to hopefully give you some insight into these issues.

This week:
(1.10) Carl gives us an update on the UK's figures, and how deaths outside are now being counted.

(2.10) When the pandemic slows down, and normal services resume - what should we start doing first? Helen picks up some evidence on what they might be.

(6.05) There's a signal that covid-19 may be causing coagulopathies in some patients, and Helen picks up on a listeners request for more information. 

(11.22) John Deeks, professor of Biostatistics at the University of Birmingham, is leading a Cochrane initiative into examining the evidence around testing, and rivals Carl's rant when he explains how some research is being done behind a veil of confidentiality.

<p>(35.27) When there's a lot of uncertainty, and the stakes are very high, then tempers can flare. Vinay Prasad, hematologist-oncologist in the US, and host of Plenary Sessions podcast, joins us to talk about having a good, respectful, scientific debate.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/lyivkl/stream_813407962-bmjgroup-talk-evidence-covid-19-update-lack-of-testing-transparency-how-to-give-good-debate.mp3" length="41897481" type="audio/mpeg"/>
        <itunes:summary><![CDATA[For the next few months Talk Evidence is going to focus on the new corona virus pandemic. There is an enormous amount of uncertainty about the disease, what the symptoms are, fatality rate, treatment options, things we shouldn't be doing.

We're going to try to get away from the headlines and talk about what we need to know - to hopefully give you some insight into these issues.

This week:
(1.10) Carl gives us an update on the UK's figures, and how deaths outside are now being counted.

(2.10) When the pandemic slows down, and normal services resume - what should we start doing first? Helen picks up some evidence on what they might be.

(6.05) There's a signal that covid-19 may be causing coagulopathies in some patients, and Helen picks up on a listeners request for more information. 

(11.22) John Deeks, professor of Biostatistics at the University of Birmingham, is leading a Cochrane initiative into examining the evidence around testing, and rivals Carl's rant when he explains how some research is being done behind a veil of confidentiality.

(35.27) When there's a lot of uncertainty, and the stakes are very high, then tempers can flare. Vinay Prasad, hematologist-oncologist in the US, and host of Plenary Sessions podcast, joins us to talk about having a good, respectful, scientific debate.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2619</itunes:duration>
                                    </item>
    <item>
        <title>Wellbeing – how one junior doctor found a way to support frontline staff</title>
        <itunes:title>Wellbeing – how one junior doctor found a way to support frontline staff</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/wellbeing-%e2%80%93-how-one-junior-doctor-found-a-way-to-support-frontline-staff/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/wellbeing-%e2%80%93-how-one-junior-doctor-found-a-way-to-support-frontline-staff/#comments</comments>        <pubDate>Wed, 29 Apr 2020 17:17:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/wellbeing-how-one-junior-doctor-found-a-way-to-support-frontline-staff</guid>
                                    <description><![CDATA[How can we help frontline clinicians? Sometimes medics may feel uneasy or even guilty and that they could be doing more. That was what a junior doctor in Abergavenny in Wales felt and she did something about it.

<p>In this podcast, we speak to Josie Cheetham about how she started her initiative to provide support boxes in hospitals for her colleagues working at the frontline, and how that initiative inspired others and mushroomed across the UK.</p>
]]></description>
                                                            <content:encoded><![CDATA[How can we help frontline clinicians? Sometimes medics may feel uneasy or even guilty and that they could be doing more. That was what a junior doctor in Abergavenny in Wales felt and she did something about it.

<p>In this podcast, we speak to Josie Cheetham about how she started her initiative to provide support boxes in hospitals for her colleagues working at the frontline, and how that initiative inspired others and mushroomed across the UK.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kb10rn/stream_809892481-bmjgroup-wellbeing-how-one-junior-doctor-found-a-way-to-support-frontline-staff.mp3" length="30715520" type="audio/mpeg"/>
        <itunes:summary><![CDATA[How can we help frontline clinicians? Sometimes medics may feel uneasy or even guilty and that they could be doing more. That was what a junior doctor in Abergavenny in Wales felt and she did something about it.

In this podcast, we speak to Josie Cheetham about how she started her initiative to provide support boxes in hospitals for her colleagues working at the frontline, and how that initiative inspired others and mushroomed across the UK.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1920</itunes:duration>
                                    </item>
    <item>
        <title>Public Health Vs The Economy</title>
        <itunes:title>Public Health Vs The Economy</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/public-health-vs-the-economy-1684835745/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/public-health-vs-the-economy-1684835745/#comments</comments>        <pubDate>Tue, 28 Apr 2020 17:49:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/public-health-vs-the-economy</guid>
                                    <description><![CDATA[Around the world, as the covid pandemic plays out, and some countries are starting to ease their restrictions, this narrative of the economy and public health being opposing weights on a set of scales keeps returning - they need to be balanced.
 
But before this, a healthy population is very much seen as being supportive of the economy. So is a pandemic different, or is that dichotomy false.

Joining us to discuss are;

Martin Mckee, professor of european health at LSHTM
Kathleen Bachynski, assistant professor of public health at Muhlenberg College
<p>Sridhar Venkatapuram, associate professor global Health & philosophy at King's College London</p>
]]></description>
                                                            <content:encoded><![CDATA[Around the world, as the covid pandemic plays out, and some countries are starting to ease their restrictions, this narrative of the economy and public health being opposing weights on a set of scales keeps returning - they need to be balanced.
 
But before this, a healthy population is very much seen as being supportive of the economy. So is a pandemic different, or is that dichotomy false.

Joining us to discuss are;

Martin Mckee, professor of european health at LSHTM
Kathleen Bachynski, assistant professor of public health at Muhlenberg College
<p>Sridhar Venkatapuram, associate professor global Health & philosophy at King's College London</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/41nx1w/stream_809112217-bmjgroup-public-health-vs-the-economy.mp3" length="46938487" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Around the world, as the covid pandemic plays out, and some countries are starting to ease their restrictions, this narrative of the economy and public health being opposing weights on a set of scales keeps returning - they need to be balanced.
 
But before this, a healthy population is very much seen as being supportive of the economy. So is a pandemic different, or is that dichotomy false.

Joining us to discuss are;

Martin Mckee, professor of european health at LSHTM
Kathleen Bachynski, assistant professor of public health at Muhlenberg College
Sridhar Venkatapuram, associate professor global Health & philosophy at King's College London]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2934</itunes:duration>
                                    </item>
    <item>
        <title>Frontline stories - working as a GP during covid</title>
        <itunes:title>Frontline stories - working as a GP during covid</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/frontline-stories-working-as-a-gp-during-covid/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/frontline-stories-working-as-a-gp-during-covid/#comments</comments>        <pubDate>Mon, 27 Apr 2020 16:56:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/working-as-a-gp-during-covid-there-are-some-positives</guid>
                                    <description><![CDATA[As the pandemic plays out - the way in which doctors in the UK practice is changing, hospitals are reconfigured to increase critical care capacity, GPs are working from home and doing their day to day work remotely. 
 
Some of the changes have come at the detriment of staff and patient wellbeing but covid-19 has also helped cut through some of the inertia to get welcome changes done.

<p>In this podcast, Helen Salisbury, GP in Oxfordshire, and Clare Gerada, GP in south London, join us to talk about the way in which general practice has changed, and how they and their teams are experiencing that.</p>
]]></description>
                                                            <content:encoded><![CDATA[As the pandemic plays out - the way in which doctors in the UK practice is changing, hospitals are reconfigured to increase critical care capacity, GPs are working from home and doing their day to day work remotely. 
 
Some of the changes have come at the detriment of staff and patient wellbeing but covid-19 has also helped cut through some of the inertia to get welcome changes done.

<p>In this podcast, Helen Salisbury, GP in Oxfordshire, and Clare Gerada, GP in south London, join us to talk about the way in which general practice has changed, and how they and their teams are experiencing that.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/r2ws2w/stream_808310650-bmjgroup-working-as-a-gp-during-covid-there-are-some-positives.mp3" length="20248449" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As the pandemic plays out - the way in which doctors in the UK practice is changing, hospitals are reconfigured to increase critical care capacity, GPs are working from home and doing their day to day work remotely. 
 
Some of the changes have come at the detriment of staff and patient wellbeing but covid-19 has also helped cut through some of the inertia to get welcome changes done.

In this podcast, Helen Salisbury, GP in Oxfordshire, and Clare Gerada, GP in south London, join us to talk about the way in which general practice has changed, and how they and their teams are experiencing that.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1266</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence covid-19 update - covid ethics, waste and a minimum RCT size</title>
        <itunes:title>Talk Evidence covid-19 update - covid ethics, waste and a minimum RCT size</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-covid-ethics-waste-and-a-minimum-rct-size/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-covid-ethics-waste-and-a-minimum-rct-size/#comments</comments>        <pubDate>Fri, 24 Apr 2020 16:19:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-ethics-waste-and-a-minimum-rct-size</guid>
                                    <description><![CDATA[For the next few months Talk Evidence is going to focus on the new corona virus pandemic.

There is an enormous amount of uncertainty about the disease, what the symptoms are, fatality rate, treatment options, things we shouldn't be doing.

We're going to try to get away from the headlines and talk about what we need to know - to hopefully give you some insight into these issues.

This week:

(1.00) Carl gives us an update on the UK’s covid-19 related mortality

(7.40) When the evidence is uncertain, and the outcomes so massive, then the ethical dimensions of decisions become even more apparent. Helen talks ethics in guidelines with Julian Sheather, advisor on ethics and human rights to the BMA and MSF.

(25.37) Update on covid-19 research, looking at viral particle shedding.

<p>(29.24) We’ve mentioned the potential wasted effort in covid-19 research, and Helen speaks to Paul Glaziou, director of the Institute for Evidence Based Research at Bond University, about the waste he’s already seen, and ways in which it could be avoided.</p>
]]></description>
                                                            <content:encoded><![CDATA[For the next few months Talk Evidence is going to focus on the new corona virus pandemic.

There is an enormous amount of uncertainty about the disease, what the symptoms are, fatality rate, treatment options, things we shouldn't be doing.

We're going to try to get away from the headlines and talk about what we need to know - to hopefully give you some insight into these issues.

This week:

(1.00) Carl gives us an update on the UK’s covid-19 related mortality

(7.40) When the evidence is uncertain, and the outcomes so massive, then the ethical dimensions of decisions become even more apparent. Helen talks ethics in guidelines with Julian Sheather, advisor on ethics and human rights to the BMA and MSF.

(25.37) Update on covid-19 research, looking at viral particle shedding.

<p>(29.24) We’ve mentioned the potential wasted effort in covid-19 research, and Helen speaks to Paul Glaziou, director of the Institute for Evidence Based Research at Bond University, about the waste he’s already seen, and ways in which it could be avoided.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/whvts9/stream_806204092-bmjgroup-talk-evidence-ethics-waste-and-a-minimum-rct-size.mp3" length="45507394" type="audio/mpeg"/>
        <itunes:summary><![CDATA[For the next few months Talk Evidence is going to focus on the new corona virus pandemic.

There is an enormous amount of uncertainty about the disease, what the symptoms are, fatality rate, treatment options, things we shouldn't be doing.

We're going to try to get away from the headlines and talk about what we need to know - to hopefully give you some insight into these issues.

This week:

(1.00) Carl gives us an update on the UK’s covid-19 related mortality

(7.40) When the evidence is uncertain, and the outcomes so massive, then the ethical dimensions of decisions become even more apparent. Helen talks ethics in guidelines with Julian Sheather, advisor on ethics and human rights to the BMA and MSF.

(25.37) Update on covid-19 research, looking at viral particle shedding.

(29.24) We’ve mentioned the potential wasted effort in covid-19 research, and Helen speaks to Paul Glaziou, director of the Institute for Evidence Based Research at Bond University, about the waste he’s already seen, and ways in which it could be avoided.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2844</itunes:duration>
                                    </item>
    <item>
        <title>Teleconsulting with Trish Greenhalgh and Fiona Stevenson</title>
        <itunes:title>Teleconsulting with Trish Greenhalgh and Fiona Stevenson</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/teleconsulting-with-trish-greenhalgh-and-fiona-stevenson/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/teleconsulting-with-trish-greenhalgh-and-fiona-stevenson/#comments</comments>        <pubDate>Wed, 22 Apr 2020 17:41:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/teleconsulting-with-trish-greenhalgh-and-fiona-stevenson</guid>
                                    <description><![CDATA[A new podcast from The BMJ, to help GP's feel more connected, heard, and supported.

Subscribe on;
Apple podcasts - https://bit.ly/applepodsDBI
Spotify - https://bit.ly/spotifyDBI
Google podcasts - https://bit.ly/googlepodsDBI

In our first episode, we discuss the highs and lows of video consultations, and how coronavirus has altered the landscape of business as usual for GPs. How will this change affect our relationships with our patients? How do we cope with frustrating technical issues? Are we more likely to miss a crucial diagnosis if we can’t rely on physical examinations? And, finally, are teleconsultations the future of GP practice?

Our guests:

Trish Greenhalgh is a former GP of 30 years who is now Professor of Primary Care Health Sciences at the University of Oxford. Trish is a leading researcher on video consultations.
Fiona Stevenson is a medical sociologist and researcher based at UCL. She is the co-director of their e-health unit. 

Deep Breath Out - the Rob Auton Daily Podcast https://play.acast.com/s/robautonpodcast

<p>https://www.bmj.com/podcasts/deepbreathin</p>
]]></description>
                                                            <content:encoded><![CDATA[A new podcast from The BMJ, to help GP's feel more connected, heard, and supported.

Subscribe on;
Apple podcasts - https://bit.ly/applepodsDBI
Spotify - https://bit.ly/spotifyDBI
Google podcasts - https://bit.ly/googlepodsDBI

In our first episode, we discuss the highs and lows of video consultations, and how coronavirus has altered the landscape of business as usual for GPs. How will this change affect our relationships with our patients? How do we cope with frustrating technical issues? Are we more likely to miss a crucial diagnosis if we can’t rely on physical examinations? And, finally, are teleconsultations the future of GP practice?

Our guests:

Trish Greenhalgh is a former GP of 30 years who is now Professor of Primary Care Health Sciences at the University of Oxford. Trish is a leading researcher on video consultations.
Fiona Stevenson is a medical sociologist and researcher based at UCL. She is the co-director of their e-health unit. 

Deep Breath Out - the Rob Auton Daily Podcast https://play.acast.com/s/robautonpodcast

<p>https://www.bmj.com/podcasts/deepbreathin</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wiwjts/stream_804697405-bmjgroup-teleconsulting-with-trish-greenhalgh-and-fiona-stevenson.mp3" length="44559881" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A new podcast from The BMJ, to help GP's feel more connected, heard, and supported.

Subscribe on;
Apple podcasts - https://bit.ly/applepodsDBI
Spotify - https://bit.ly/spotifyDBI
Google podcasts - https://bit.ly/googlepodsDBI

In our first episode, we discuss the highs and lows of video consultations, and how coronavirus has altered the landscape of business as usual for GPs. How will this change affect our relationships with our patients? How do we cope with frustrating technical issues? Are we more likely to miss a crucial diagnosis if we can’t rely on physical examinations? And, finally, are teleconsultations the future of GP practice?

Our guests:

Trish Greenhalgh is a former GP of 30 years who is now Professor of Primary Care Health Sciences at the University of Oxford. Trish is a leading researcher on video consultations.
Fiona Stevenson is a medical sociologist and researcher based at UCL. She is the co-director of their e-health unit. 

Deep Breath Out - the Rob Auton Daily Podcast https://play.acast.com/s/robautonpodcast

https://www.bmj.com/podcasts/deepbreathin]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2785</itunes:duration>
                                    </item>
    <item>
        <title>Feeling the fear with Iona Heath and Danielle Ofri</title>
        <itunes:title>Feeling the fear with Iona Heath and Danielle Ofri</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/feeling-the-fear-with-iona-heath-and-danielle-ofri/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/feeling-the-fear-with-iona-heath-and-danielle-ofri/#comments</comments>        <pubDate>Wed, 22 Apr 2020 17:11:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/feeling-the-fear-with-iona-heath-and-danielle-ofri</guid>
                                    <description><![CDATA[A new podcast from The BMJ, to help GP's feel more connected, heard, and supported.

Subscribe on;
Apple podcasts - https://bit.ly/applepodsDBI
Spotify - https://bit.ly/spotifyDBI
Google podcasts - https://bit.ly/googlepodsDBI
This week, our topic is fear: we try to get a better understanding of fear, how it affects all of us as clinicians for better or for worse, and the impact that fear has on the ways in which we approach our patients & practice. Does fear distort our judgement, and increase the likelihood of blundering, or does a healthy dose of fear help to keep us grounded?

Our guests:

Iona Heath is a former GP and president of the Royal College of GPs.
Danielle Ofri is an internist at Bellevue Hospital in New York, and Clinical Professor of Medicine at NYU School of Medicine. She has written several books on topics such as medical error and how doctors’ emotions affect their practice.

The Deep Breath Out -  The bees of Brockwell Park Surgery

<p>https://www.bmj.com/podcasts/deepbreathin</p>
]]></description>
                                                            <content:encoded><![CDATA[A new podcast from The BMJ, to help GP's feel more connected, heard, and supported.

Subscribe on;
Apple podcasts - https://bit.ly/applepodsDBI
Spotify - https://bit.ly/spotifyDBI
Google podcasts - https://bit.ly/googlepodsDBI
This week, our topic is fear: we try to get a better understanding of fear, how it affects all of us as clinicians for better or for worse, and the impact that fear has on the ways in which we approach our patients & practice. Does fear distort our judgement, and increase the likelihood of blundering, or does a healthy dose of fear help to keep us grounded?

Our guests:

Iona Heath is a former GP and president of the Royal College of GPs.
Danielle Ofri is an internist at Bellevue Hospital in New York, and Clinical Professor of Medicine at NYU School of Medicine. She has written several books on topics such as medical error and how doctors’ emotions affect their practice.

The Deep Breath Out -  The bees of Brockwell Park Surgery

<p>https://www.bmj.com/podcasts/deepbreathin</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5xowqk/stream_804676594-bmjgroup-feeling-the-fear-with-iona-heath-and-danielle-ofri.mp3" length="47980041" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A new podcast from The BMJ, to help GP's feel more connected, heard, and supported.

Subscribe on;
Apple podcasts - https://bit.ly/applepodsDBI
Spotify - https://bit.ly/spotifyDBI
Google podcasts - https://bit.ly/googlepodsDBI
This week, our topic is fear: we try to get a better understanding of fear, how it affects all of us as clinicians for better or for worse, and the impact that fear has on the ways in which we approach our patients & practice. Does fear distort our judgement, and increase the likelihood of blundering, or does a healthy dose of fear help to keep us grounded?

Our guests:

Iona Heath is a former GP and president of the Royal College of GPs.
Danielle Ofri is an internist at Bellevue Hospital in New York, and Clinical Professor of Medicine at NYU School of Medicine. She has written several books on topics such as medical error and how doctors’ emotions affect their practice.

The Deep Breath Out -  The bees of Brockwell Park Surgery

https://www.bmj.com/podcasts/deepbreathin]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2999</itunes:duration>
                                    </item>
    <item>
        <title>Wellbeing – advice from a military medic to frontline clinicians</title>
        <itunes:title>Wellbeing – advice from a military medic to frontline clinicians</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/wellbeing-%e2%80%93-advice-from-a-military-medic-to-frontline-clinicians/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/wellbeing-%e2%80%93-advice-from-a-military-medic-to-frontline-clinicians/#comments</comments>        <pubDate>Wed, 22 Apr 2020 11:53:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/wellbeing-advice-from-a-military-medic-to-frontline-clinicians</guid>
                                    <description><![CDATA[There is no doubt that anxiety levels that clinicians are feeling during this pandemic are high. 

One military medic believes the current situation is comparable to his experience when posted during British campaigns in Afghanistan and Iraq.  Cormac Doyle offers advice on how to deal with high-stress conditions, both in a work and at home, as well as how to negate the future effects of post-traumatic stress disorder. 

<p>One strategy he supports is using Bilatural Stimulation using music, one example of which called “Strength Within” can be found here shorturl.at/fgrSW.</p>
]]></description>
                                                            <content:encoded><![CDATA[There is no doubt that anxiety levels that clinicians are feeling during this pandemic are high. 

One military medic believes the current situation is comparable to his experience when posted during British campaigns in Afghanistan and Iraq.  Cormac Doyle offers advice on how to deal with high-stress conditions, both in a work and at home, as well as how to negate the future effects of post-traumatic stress disorder. 

<p>One strategy he supports is using Bilatural Stimulation using music, one example of which called “Strength Within” can be found here shorturl.at/fgrSW.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dmhwmk/stream_804487024-bmjgroup-wellbeing-advice-from-a-military-medic-to-frontline-clinicians.mp3" length="33238784" type="audio/mpeg"/>
        <itunes:summary><![CDATA[There is no doubt that anxiety levels that clinicians are feeling during this pandemic are high. 

One military medic believes the current situation is comparable to his experience when posted during British campaigns in Afghanistan and Iraq.  Cormac Doyle offers advice on how to deal with high-stress conditions, both in a work and at home, as well as how to negate the future effects of post-traumatic stress disorder. 

One strategy he supports is using Bilatural Stimulation using music, one example of which called “Strength Within” can be found here shorturl.at/fgrSW.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2077</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence covid-19 update - Remdesivir, care homes, and death data</title>
        <itunes:title>Talk Evidence covid-19 update - Remdesivir, care homes, and death data</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-remdesivir-care-homes-and-death-data/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-remdesivir-care-homes-and-death-data/#comments</comments>        <pubDate>Fri, 17 Apr 2020 15:00:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-remdesivir-care-homes-and-death-data</guid>
                                    <description><![CDATA[For the next few months Talk Evidence is going to focus on the new corona virus pandemic.

There is an enormous amount of uncertainty about the disease, what the symptoms are, fatality rate, treatment options, things we shouldn't be doing.

We're going to try to get away from the headlines and talk about what we need to know - to hopefully give you some insight into these issues.

This week:

(3.14) Jeff Aronson from Oxford University explains why remdesivir is a potential therapeutic, but is pessimistic about the quality of the studies being done on it

(13.22) Carl explains why smoking cessation is still a key public health priority under covid-19

(16.30) Helen talks care homes, and interviews Mona Koshkouei, from Oxford University, about the research which shows staff are the main vector of infection.

(27.20) David Spiegelhalter, professor of public understanding of risk, looks at the new data on excess deaths in the UK - and the difficulties with reporting that underlie it.  Carl explains how deaths track infections, and why uncertainty there makes it hard to calcuate the case fatality rate (And why that is not a good measure to use in a pandemic)


Reading list.

Compassionate Use of Remdesivir for Patients with Severe Covid-19
https://www.nejm.org/doi/full/10.1056/NEJMoa2007016

How can pandemic spreads be contained in care homes?
https://www.cebm.net/covid-19/how-can-pandemic-spreads-be-contained-in-care-homes/

Covid-19: Death rate in England and Wales reaches record high because of covid-19
<p>https://www.bmj.com/node/1024784.full</p>
]]></description>
                                                            <content:encoded><![CDATA[For the next few months Talk Evidence is going to focus on the new corona virus pandemic.

There is an enormous amount of uncertainty about the disease, what the symptoms are, fatality rate, treatment options, things we shouldn't be doing.

We're going to try to get away from the headlines and talk about what we need to know - to hopefully give you some insight into these issues.

This week:

(3.14) Jeff Aronson from Oxford University explains why remdesivir is a potential therapeutic, but is pessimistic about the quality of the studies being done on it

(13.22) Carl explains why smoking cessation is still a key public health priority under covid-19

(16.30) Helen talks care homes, and interviews Mona Koshkouei, from Oxford University, about the research which shows staff are the main vector of infection.

(27.20) David Spiegelhalter, professor of public understanding of risk, looks at the new data on excess deaths in the UK - and the difficulties with reporting that underlie it.  Carl explains how deaths track infections, and why uncertainty there makes it hard to calcuate the case fatality rate (And why that is not a good measure to use in a pandemic)


Reading list.

Compassionate Use of Remdesivir for Patients with Severe Covid-19
https://www.nejm.org/doi/full/10.1056/NEJMoa2007016

How can pandemic spreads be contained in care homes?
https://www.cebm.net/covid-19/how-can-pandemic-spreads-be-contained-in-care-homes/

Covid-19: Death rate in England and Wales reaches record high because of covid-19
<p>https://www.bmj.com/node/1024784.full</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/f3uyn3/stream_800865592-bmjgroup-talk-evidence-remdesivir-care-homes-and-death-data.mp3" length="74764885" type="audio/mpeg"/>
        <itunes:summary><![CDATA[For the next few months Talk Evidence is going to focus on the new corona virus pandemic.

There is an enormous amount of uncertainty about the disease, what the symptoms are, fatality rate, treatment options, things we shouldn't be doing.

We're going to try to get away from the headlines and talk about what we need to know - to hopefully give you some insight into these issues.

This week:

(3.14) Jeff Aronson from Oxford University explains why remdesivir is a potential therapeutic, but is pessimistic about the quality of the studies being done on it

(13.22) Carl explains why smoking cessation is still a key public health priority under covid-19

(16.30) Helen talks care homes, and interviews Mona Koshkouei, from Oxford University, about the research which shows staff are the main vector of infection.

(27.20) David Spiegelhalter, professor of public understanding of risk, looks at the new data on excess deaths in the UK - and the difficulties with reporting that underlie it.  Carl explains how deaths track infections, and why uncertainty there makes it hard to calcuate the case fatality rate (And why that is not a good measure to use in a pandemic)


Reading list.

Compassionate Use of Remdesivir for Patients with Severe Covid-19
https://www.nejm.org/doi/full/10.1056/NEJMoa2007016

How can pandemic spreads be contained in care homes?
https://www.cebm.net/covid-19/how-can-pandemic-spreads-be-contained-in-care-homes/

Covid-19: Death rate in England and Wales reaches record high because of covid-19
https://www.bmj.com/node/1024784.full]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3119</itunes:duration>
                                    </item>
    <item>
        <title>Wellbeing - some advice for telehealth in secondary care</title>
        <itunes:title>Wellbeing - some advice for telehealth in secondary care</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/wellbeing-some-advice-for-telehealth-in-secondary-care/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/wellbeing-some-advice-for-telehealth-in-secondary-care/#comments</comments>        <pubDate>Thu, 16 Apr 2020 18:30:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/telehealth-in-secondary-care</guid>
                                    <description><![CDATA[We’ve published info on Telehealth in primary care - and have been overwhelmed by the response from GPs who are finding it useful. 

But it’s not only primary care that is dramatically shifting to remote care - routine hospital care is moving online too, so we’ve asked Rowena McCash - GP and out of hours triage trainer joins us to give some tips on how to change your communication for the situation.

She explains safety netting in telephone triage, note taking, and why there are some advantages to working that way.


www.bmj.com/coronavirus
<p>www.bmj.com/wellbeing</p>
]]></description>
                                                            <content:encoded><![CDATA[We’ve published info on Telehealth in primary care - and have been overwhelmed by the response from GPs who are finding it useful. 

But it’s not only primary care that is dramatically shifting to remote care - routine hospital care is moving online too, so we’ve asked Rowena McCash - GP and out of hours triage trainer joins us to give some tips on how to change your communication for the situation.

She explains safety netting in telephone triage, note taking, and why there are some advantages to working that way.


www.bmj.com/coronavirus
<p>www.bmj.com/wellbeing</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/y51epr/stream_800236552-bmjgroup-telehealth-in-secondary-care.mp3" length="23427584" type="audio/mpeg"/>
        <itunes:summary><![CDATA[We’ve published info on Telehealth in primary care - and have been overwhelmed by the response from GPs who are finding it useful. 

But it’s not only primary care that is dramatically shifting to remote care - routine hospital care is moving online too, so we’ve asked Rowena McCash - GP and out of hours triage trainer joins us to give some tips on how to change your communication for the situation.

She explains safety netting in telephone triage, note taking, and why there are some advantages to working that way.


www.bmj.com/coronavirus
www.bmj.com/wellbeing]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1464</itunes:duration>
                                    </item>
    <item>
        <title>Front line stories - How corona is changing acute care</title>
        <itunes:title>Front line stories - How corona is changing acute care</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/front-line-stories-how-corona-is-changing-acute-care/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/front-line-stories-how-corona-is-changing-acute-care/#comments</comments>        <pubDate>Tue, 14 Apr 2020 22:33:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/front-line-stories-how-corona-is-changing-acute-care</guid>
                                    <description><![CDATA[As we cover the covid-19 outbreak, we want to hear some of the stories from the frontline - And who better to heart of what this pandemic is doing to the profession in the UK, than some of the people who write regularly for The BMJ?

In this first one, we wanted to look specifically at acute care - those at the sharp end of the response, so we're joined by David Oliver, consultant in geriatrics and internal medicine, and Matt Morgan, consultant in intensive care medicine.

Read the columns
https://blogs.bmj.com/bmj/category/columnists/matt-morgan/
https://blogs.bmj.com/bmj/category/columnists/david-oliver/

For more free information on covid-19
<p>www.bmj.com/coronavirus</p>
]]></description>
                                                            <content:encoded><![CDATA[As we cover the covid-19 outbreak, we want to hear some of the stories from the frontline - And who better to heart of what this pandemic is doing to the profession in the UK, than some of the people who write regularly for The BMJ?

In this first one, we wanted to look specifically at acute care - those at the sharp end of the response, so we're joined by David Oliver, consultant in geriatrics and internal medicine, and Matt Morgan, consultant in intensive care medicine.

Read the columns
https://blogs.bmj.com/bmj/category/columnists/matt-morgan/
https://blogs.bmj.com/bmj/category/columnists/david-oliver/

For more free information on covid-19
<p>www.bmj.com/coronavirus</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ohrmxl/stream_798842077-bmjgroup-front-line-stories-how-corona-is-changing-acute-care.mp3" length="34845674" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As we cover the covid-19 outbreak, we want to hear some of the stories from the frontline - And who better to heart of what this pandemic is doing to the profession in the UK, than some of the people who write regularly for The BMJ?

In this first one, we wanted to look specifically at acute care - those at the sharp end of the response, so we're joined by David Oliver, consultant in geriatrics and internal medicine, and Matt Morgan, consultant in intensive care medicine.

Read the columns
https://blogs.bmj.com/bmj/category/columnists/matt-morgan/
https://blogs.bmj.com/bmj/category/columnists/david-oliver/

For more free information on covid-19
www.bmj.com/coronavirus]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2178</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence covid-19 update - hydroxy/chloroquinine, prognostic models and facemaskss</title>
        <itunes:title>Talk Evidence covid-19 update - hydroxy/chloroquinine, prognostic models and facemaskss</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-hydroxychloroquinine-prognostic-models-and-facemaskss/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-hydroxychloroquinine-prognostic-models-and-facemaskss/#comments</comments>        <pubDate>Mon, 13 Apr 2020 20:39:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-covid-19-update-hydroxychloroquinine-prognostic-models-and-facemaskss</guid>
                                    <description><![CDATA[For the next few months Talk Evidence is going to focus on the new corona virus pandemic. 

There is an enormous amount of uncertainty about the disease, what the symptoms are, fatality rate, treatment options, things we shouldn't be doing.

We're going to try to get away from the headlines and talk about what we need to know - to hopefully give you some insight into these issues.

This week:

 (2.24) - Hydroxychloroquinine/chloroquinine - Robin Ferner, honorary professor of clinical pharmacology at the University of Birmingham explains why is it a potential therapeutic for covid-19, and why is it being hyped.

(12.45) - We use prognostic models to make treatment decisions, but they have to be well conducted. Lots of them are being created for covid-19, but their quality isn’t great. Statisticians Laure Wynants  Maastricht University and Maarten van Smeden from Utrecht University have done a systematic review of these models, and explain what’s needed for them to be useful.

(26.30) PPE - specifically facemasks. What does the evidence say about their use by the public, and does the precautionary principle hold 

Reading list:
COVID-19 rapid guideline: managing suspected or confirmed pneumonia in adults in the community
https://www.nice.org.uk/guidance/ng165/chapter/4-Managing-suspected-or-confirmed-pneumonia

Chloroquine and hydroxychloroquine in covid-19
https://www.bmj.com/content/369/bmj.m1432

Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal
https://www.bmj.com/content/369/bmj.m1328

What is the efficacy of standard face masks compared to respirator masks in preventing COVID-type respiratory illnesses in primary care staff?
<p>https://www.cebm.net/covid-19/what-is-the-efficacy-of-standard-face-masks-compared-to-respirator-masks-in-preventing-covid-type-respiratory-illnesses-in-primary-care-staff/</p>
]]></description>
                                                            <content:encoded><![CDATA[For the next few months Talk Evidence is going to focus on the new corona virus pandemic. 

There is an enormous amount of uncertainty about the disease, what the symptoms are, fatality rate, treatment options, things we shouldn't be doing.

We're going to try to get away from the headlines and talk about what we need to know - to hopefully give you some insight into these issues.

This week:

 (2.24) - Hydroxychloroquinine/chloroquinine - Robin Ferner, honorary professor of clinical pharmacology at the University of Birmingham explains why is it a potential therapeutic for covid-19, and why is it being hyped.

(12.45) - We use prognostic models to make treatment decisions, but they have to be well conducted. Lots of them are being created for covid-19, but their quality isn’t great. Statisticians Laure Wynants  Maastricht University and Maarten van Smeden from Utrecht University have done a systematic review of these models, and explain what’s needed for them to be useful.

(26.30) PPE - specifically facemasks. What does the evidence say about their use by the public, and does the precautionary principle hold 

Reading list:
COVID-19 rapid guideline: managing suspected or confirmed pneumonia in adults in the community
https://www.nice.org.uk/guidance/ng165/chapter/4-Managing-suspected-or-confirmed-pneumonia

Chloroquine and hydroxychloroquine in covid-19
https://www.bmj.com/content/369/bmj.m1432

Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal
https://www.bmj.com/content/369/bmj.m1328

What is the efficacy of standard face masks compared to respirator masks in preventing COVID-type respiratory illnesses in primary care staff?
<p>https://www.cebm.net/covid-19/what-is-the-efficacy-of-standard-face-masks-compared-to-respirator-masks-in-preventing-covid-type-respiratory-illnesses-in-primary-care-staff/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/u82e3w/stream_797792260-bmjgroup-talk-evidence-covid-19-update-hydroxychloroquinine-prognostic-models-and-facemaskss.mp3" length="35722880" type="audio/mpeg"/>
        <itunes:summary><![CDATA[For the next few months Talk Evidence is going to focus on the new corona virus pandemic. 

There is an enormous amount of uncertainty about the disease, what the symptoms are, fatality rate, treatment options, things we shouldn't be doing.

We're going to try to get away from the headlines and talk about what we need to know - to hopefully give you some insight into these issues.

This week:

 (2.24) - Hydroxychloroquinine/chloroquinine - Robin Ferner, honorary professor of clinical pharmacology at the University of Birmingham explains why is it a potential therapeutic for covid-19, and why is it being hyped.

(12.45) - We use prognostic models to make treatment decisions, but they have to be well conducted. Lots of them are being created for covid-19, but their quality isn’t great. Statisticians Laure Wynants  Maastricht University and Maarten van Smeden from Utrecht University have done a systematic review of these models, and explain what’s needed for them to be useful.

(26.30) PPE - specifically facemasks. What does the evidence say about their use by the public, and does the precautionary principle hold 

Reading list:
COVID-19 rapid guideline: managing suspected or confirmed pneumonia in adults in the community
https://www.nice.org.uk/guidance/ng165/chapter/4-Managing-suspected-or-confirmed-pneumonia

Chloroquine and hydroxychloroquine in covid-19
https://www.bmj.com/content/369/bmj.m1432

Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal
https://www.bmj.com/content/369/bmj.m1328

What is the efficacy of standard face masks compared to respirator masks in preventing COVID-type respiratory illnesses in primary care staff?
https://www.cebm.net/covid-19/what-is-the-efficacy-of-standard-face-masks-compared-to-respirator-masks-in-preventing-covid-type-respiratory-illnesses-in-primary-care-staff/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2233</itunes:duration>
                                    </item>
    <item>
        <title>The public health response to covid - 19</title>
        <itunes:title>The public health response to covid - 19</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-public-health-response-to-covid-19-1684835756/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-public-health-response-to-covid-19-1684835756/#comments</comments>        <pubDate>Sun, 12 Apr 2020 19:40:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-public-health-response-to-covid-19</guid>
                                    <description><![CDATA[As part of our response to the covid-19 pandemic, we’re going to be running a series of discussions with experts about some of the big issues arising from the virus.
 
In this one, we’re asking about the public health response to an outbreak - what’s necessary, and is it possible to go to far. 
 
Joining us are
Martin Mckee - professor of european health at the London Schoole fo Hygiene and Tropical Medicine

Kathleen Bachynski - assistant professor of public health at Muhlenberg College

Sridhar Venkatapura - associate professor global health & philosophy at 
King's College London 

www.bmj.com/podcasts
<p>www.bmj.com/coronavirus</p>
]]></description>
                                                            <content:encoded><![CDATA[As part of our response to the covid-19 pandemic, we’re going to be running a series of discussions with experts about some of the big issues arising from the virus.
 
In this one, we’re asking about the public health response to an outbreak - what’s necessary, and is it possible to go to far. 
 
Joining us are
Martin Mckee - professor of european health at the London Schoole fo Hygiene and Tropical Medicine

Kathleen Bachynski - assistant professor of public health at Muhlenberg College

Sridhar Venkatapura - associate professor global health & philosophy at 
King's College London 

www.bmj.com/podcasts
<p>www.bmj.com/coronavirus</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/0vo6tm/stream_796972276-bmjgroup-the-public-health-response-to-covid-19.mp3" length="37334621" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As part of our response to the covid-19 pandemic, we’re going to be running a series of discussions with experts about some of the big issues arising from the virus.
 
In this one, we’re asking about the public health response to an outbreak - what’s necessary, and is it possible to go to far. 
 
Joining us are
Martin Mckee - professor of european health at the London Schoole fo Hygiene and Tropical Medicine

Kathleen Bachynski - assistant professor of public health at Muhlenberg College

Sridhar Venkatapura - associate professor global health & philosophy at 
King's College London 

www.bmj.com/podcasts
www.bmj.com/coronavirus]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2333</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence covid-19 update - pneumonia, guidelines, preprints and testing</title>
        <itunes:title>Talk Evidence covid-19 update - pneumonia, guidelines, preprints and testing</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-pneumonia-guidelines-preprints-and-testing/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-pneumonia-guidelines-preprints-and-testing/#comments</comments>        <pubDate>Thu, 09 Apr 2020 09:53:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-covid-19-update-pneumonia</guid>
                                    <description><![CDATA[For the next few months Talk Evidence is going to focus on the new corona virus pandemic.

There is an enormous amount of uncertainty about the disease, what the symptoms are, fatality rate, treatment options, things we shouldn't be doing.

We're going to try to get away from the headlines and talk about what we need to know - to hopefully give you some insight into these issues.

This week

5.00 - Carl gives us an update about pneumonia in primary care, should you give antibiotics when you're not sure if it's bacterial or viral

10.00 - The importance and difficulty of making guidelines now

15.00 - We hear from guideline maker Per Vandvik, about making guidance.

21.40 - Preprint servers for medicine are showing their use in this fast changing situation. Joseph Ross from Yale School of Medicine, and one of The BMJ's research editors, talks to us about the kind of information we're seeing on medRxiv.

31.10 - Testing. What are the tests, and when do we want specificity, and when do we want sensitivity. Nick Beeching from the Liverpool School of Tropical Medicine joins us to explain.

Reading list:
www.bmj.com/coronavirus

Rapidly managing pneumonia in older people during a pandemic
https://www.cebm.net/covid-19/rapidly-managing-pneumonia-in-older-people-during-a-pandemic/

https://www.medrxiv.org/

Covid-19: testing times
<p>https://www.bmj.com/content/369/bmj.m1403</p>
]]></description>
                                                            <content:encoded><![CDATA[For the next few months Talk Evidence is going to focus on the new corona virus pandemic.

There is an enormous amount of uncertainty about the disease, what the symptoms are, fatality rate, treatment options, things we shouldn't be doing.

We're going to try to get away from the headlines and talk about what we need to know - to hopefully give you some insight into these issues.

This week

5.00 - Carl gives us an update about pneumonia in primary care, should you give antibiotics when you're not sure if it's bacterial or viral

10.00 - The importance and difficulty of making guidelines now

15.00 - We hear from guideline maker Per Vandvik, about making guidance.

21.40 - Preprint servers for medicine are showing their use in this fast changing situation. Joseph Ross from Yale School of Medicine, and one of The BMJ's research editors, talks to us about the kind of information we're seeing on medRxiv.

31.10 - Testing. What are the tests, and when do we want specificity, and when do we want sensitivity. Nick Beeching from the Liverpool School of Tropical Medicine joins us to explain.

Reading list:
www.bmj.com/coronavirus

Rapidly managing pneumonia in older people during a pandemic
https://www.cebm.net/covid-19/rapidly-managing-pneumonia-in-older-people-during-a-pandemic/

https://www.medrxiv.org/

Covid-19: testing times
<p>https://www.bmj.com/content/369/bmj.m1403</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gntbfl/stream_794397142-bmjgroup-talk-evidence-covid-19-update-pneumonia.mp3" length="41404160" type="audio/mpeg"/>
        <itunes:summary><![CDATA[For the next few months Talk Evidence is going to focus on the new corona virus pandemic.

There is an enormous amount of uncertainty about the disease, what the symptoms are, fatality rate, treatment options, things we shouldn't be doing.

We're going to try to get away from the headlines and talk about what we need to know - to hopefully give you some insight into these issues.

This week

5.00 - Carl gives us an update about pneumonia in primary care, should you give antibiotics when you're not sure if it's bacterial or viral

10.00 - The importance and difficulty of making guidelines now

15.00 - We hear from guideline maker Per Vandvik, about making guidance.

21.40 - Preprint servers for medicine are showing their use in this fast changing situation. Joseph Ross from Yale School of Medicine, and one of The BMJ's research editors, talks to us about the kind of information we're seeing on medRxiv.

31.10 - Testing. What are the tests, and when do we want specificity, and when do we want sensitivity. Nick Beeching from the Liverpool School of Tropical Medicine joins us to explain.

Reading list:
www.bmj.com/coronavirus

Rapidly managing pneumonia in older people during a pandemic
https://www.cebm.net/covid-19/rapidly-managing-pneumonia-in-older-people-during-a-pandemic/

https://www.medrxiv.org/

Covid-19: testing times
https://www.bmj.com/content/369/bmj.m1403]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2588</itunes:duration>
                                    </item>
    <item>
        <title>Wellbeing - Some advice on working in PPE</title>
        <itunes:title>Wellbeing - Some advice on working in PPE</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/wellbeing-some-advice-on-working-in-ppe/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/wellbeing-some-advice-on-working-in-ppe/#comments</comments>        <pubDate>Wed, 08 Apr 2020 17:38:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/wellbeing-some-advice-on-ppe</guid>
                                    <description><![CDATA[Wellbeing might not seem the obvious place to talk about PPE - but lack of appropriate PPE is causing healthcare staff a great deal of stress now.

Mary Brindle is a pediatric surgeon and the director of The EQuIS (Efficiency Quality Innovation and Safety) Research platform at Alberta Children’s hospital.

In this podcast she reflects on the use of PPE, talks a little about the culture of it - and how overuse by one person can amply the concerns of others, the effect on patients of seeing their carers in protective equipment (especially children), and the importance of communication when you can't see colleagues faces anymore.

www.bmj.com/wellbeing
<p>www.bmj.com/coronavirus</p>
]]></description>
                                                            <content:encoded><![CDATA[Wellbeing might not seem the obvious place to talk about PPE - but lack of appropriate PPE is causing healthcare staff a great deal of stress now.

Mary Brindle is a pediatric surgeon and the director of The EQuIS (Efficiency Quality Innovation and Safety) Research platform at Alberta Children’s hospital.

In this podcast she reflects on the use of PPE, talks a little about the culture of it - and how overuse by one person can amply the concerns of others, the effect on patients of seeing their carers in protective equipment (especially children), and the importance of communication when you can't see colleagues faces anymore.

www.bmj.com/wellbeing
<p>www.bmj.com/coronavirus</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ugyfys/stream_793914448-bmjgroup-wellbeing-some-advice-on-ppe.mp3" length="32615552" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Wellbeing might not seem the obvious place to talk about PPE - but lack of appropriate PPE is causing healthcare staff a great deal of stress now.

Mary Brindle is a pediatric surgeon and the director of The EQuIS (Efficiency Quality Innovation and Safety) Research platform at Alberta Children’s hospital.

In this podcast she reflects on the use of PPE, talks a little about the culture of it - and how overuse by one person can amply the concerns of others, the effect on patients of seeing their carers in protective equipment (especially children), and the importance of communication when you can't see colleagues faces anymore.

www.bmj.com/wellbeing
www.bmj.com/coronavirus]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2038</itunes:duration>
                                    </item>
    <item>
        <title>Look after yourself during covid-19</title>
        <itunes:title>Look after yourself during covid-19</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/look-after-yourself-during-covid-19/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/look-after-yourself-during-covid-19/#comments</comments>        <pubDate>Tue, 07 Apr 2020 14:44:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/look-after-yourself-during-covid-19</guid>
                                    <description><![CDATA[Continuing our series on wellbeing during the pandemic, in this podcast we speak to Occupational Psychologist Roxane Gervais about how doctors can look after themselves during the covid-19 pandemic. 

We discuss the importance of reaching out to friends and family during this difficult time, how to deal with the loss of control, as well how to tackle feelings of guilt when you are unable to work clinically.

For more wellbeing content
www.bmj.com/wellbeing

For more on covid-19
<p>www.bmj.com/coronavirus</p>
]]></description>
                                                            <content:encoded><![CDATA[Continuing our series on wellbeing during the pandemic, in this podcast we speak to Occupational Psychologist Roxane Gervais about how doctors can look after themselves during the covid-19 pandemic. 

We discuss the importance of reaching out to friends and family during this difficult time, how to deal with the loss of control, as well how to tackle feelings of guilt when you are unable to work clinically.

For more wellbeing content
www.bmj.com/wellbeing

For more on covid-19
<p>www.bmj.com/coronavirus</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4b5jsi/stream_793044754-bmjgroup-look-after-yourself-during-covid-19.mp3" length="33614336" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Continuing our series on wellbeing during the pandemic, in this podcast we speak to Occupational Psychologist Roxane Gervais about how doctors can look after themselves during the covid-19 pandemic. 

We discuss the importance of reaching out to friends and family during this difficult time, how to deal with the loss of control, as well how to tackle feelings of guilt when you are unable to work clinically.

For more wellbeing content
www.bmj.com/wellbeing

For more on covid-19
www.bmj.com/coronavirus]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2101</itunes:duration>
                                    </item>
    <item>
        <title>WHO’s response to covid-19</title>
        <itunes:title>WHO’s response to covid-19</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/who-s-response-to-covid-19/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/who-s-response-to-covid-19/#comments</comments>        <pubDate>Sun, 05 Apr 2020 17:01:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/whos-response-to-covid-19</guid>
                                    <description><![CDATA[We knew a pandemic was coming at some point - it’s kind of why we have the WHO. We have had various smaller scale tests of the international response to an infectious disease outbreak - Ebola in west africa being the most recent.

After that, reports criticised the WHO's response - citing problems around the swiftness of their action, the lack of coordination between countries, and the platforms for knowledge sharing. Is the agency doing any better in Covid-19?

<p>Suerie Moon is co-director of the Global Health Centre at the Graduate Institute of International and Development studies in Geneva, and author of one of those critical reports which was published in The BMJ. She joins us to assess how the WHO is responding.</p>
]]></description>
                                                            <content:encoded><![CDATA[We knew a pandemic was coming at some point - it’s kind of why we have the WHO. We have had various smaller scale tests of the international response to an infectious disease outbreak - Ebola in west africa being the most recent.

After that, reports criticised the WHO's response - citing problems around the swiftness of their action, the lack of coordination between countries, and the platforms for knowledge sharing. Is the agency doing any better in Covid-19?

<p>Suerie Moon is co-director of the Global Health Centre at the Graduate Institute of International and Development studies in Geneva, and author of one of those critical reports which was published in The BMJ. She joins us to assess how the WHO is responding.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ep51wm/stream_791507857-bmjgroup-whos-response-to-covid-19.mp3" length="31540034" type="audio/mpeg"/>
        <itunes:summary><![CDATA[We knew a pandemic was coming at some point - it’s kind of why we have the WHO. We have had various smaller scale tests of the international response to an infectious disease outbreak - Ebola in west africa being the most recent.

After that, reports criticised the WHO's response - citing problems around the swiftness of their action, the lack of coordination between countries, and the platforms for knowledge sharing. Is the agency doing any better in Covid-19?

Suerie Moon is co-director of the Global Health Centre at the Graduate Institute of International and Development studies in Geneva, and author of one of those critical reports which was published in The BMJ. She joins us to assess how the WHO is responding.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1971</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence covid-19 update - Confused symptoms, fatality rate uncertainty, Iceland’s testing</title>
        <itunes:title>Talk Evidence covid-19 update - Confused symptoms, fatality rate uncertainty, Iceland’s testing</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-confused-symptoms-fatality-rate-uncertainty-iceland-s-testing/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-covid-19-update-confused-symptoms-fatality-rate-uncertainty-iceland-s-testing/#comments</comments>        <pubDate>Fri, 27 Mar 2020 16:14:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-covid-19-update-confused-symptoms-fatality-rate-uncertainty-icelands-testing</guid>
                                    <description><![CDATA[For the next few months Talk Evidence is going to focus on the new corona virus pandemic.  

There is an enormous amount of uncertainty about the disease, what the symptoms are, fatality rate, treatment options, things we shouldn't be doing. 

We're going to try to get away from the headlines and talk about what we need to know - to hopefully give you some insight into these issues.

This week

3.50 - There is a lot of confusion around symptoms, we hear what Carl's review of the case studies has found, and why he thinks fever and persistent dry cough may not be a sign of all cases.

10.30 - where are we with research into antiviral treatment

17.30 - John Ioannidis has expressed concerns about the quality data used in modelling and therefore our pandemic response. We hear what his concerns are, and what needs to be done to answer them.

<p>29.10 - Iceland is the only country attempting to do population level screening, we hear from Kári Stefánsson, CEO of deCODE genetics which is working with the Icelandic government to allow everyone to access testing for the virus.</p>
]]></description>
                                                            <content:encoded><![CDATA[For the next few months Talk Evidence is going to focus on the new corona virus pandemic.  

There is an enormous amount of uncertainty about the disease, what the symptoms are, fatality rate, treatment options, things we shouldn't be doing. 

We're going to try to get away from the headlines and talk about what we need to know - to hopefully give you some insight into these issues.

This week

3.50 - There is a lot of confusion around symptoms, we hear what Carl's review of the case studies has found, and why he thinks fever and persistent dry cough may not be a sign of all cases.

10.30 - where are we with research into antiviral treatment

17.30 - John Ioannidis has expressed concerns about the quality data used in modelling and therefore our pandemic response. We hear what his concerns are, and what needs to be done to answer them.

<p>29.10 - Iceland is the only country attempting to do population level screening, we hear from Kári Stefánsson, CEO of deCODE genetics which is working with the Icelandic government to allow everyone to access testing for the virus.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/isk3xq/stream_784645906-bmjgroup-talk-evidence-covid-19-update-confused-symptoms-fatality-rate-uncertainty-icelands-testing.mp3" length="38475649" type="audio/mpeg"/>
        <itunes:summary><![CDATA[For the next few months Talk Evidence is going to focus on the new corona virus pandemic.  

There is an enormous amount of uncertainty about the disease, what the symptoms are, fatality rate, treatment options, things we shouldn't be doing. 

We're going to try to get away from the headlines and talk about what we need to know - to hopefully give you some insight into these issues.

This week

3.50 - There is a lot of confusion around symptoms, we hear what Carl's review of the case studies has found, and why he thinks fever and persistent dry cough may not be a sign of all cases.

10.30 - where are we with research into antiviral treatment

17.30 - John Ioannidis has expressed concerns about the quality data used in modelling and therefore our pandemic response. We hear what his concerns are, and what needs to be done to answer them.

29.10 - Iceland is the only country attempting to do population level screening, we hear from Kári Stefánsson, CEO of deCODE genetics which is working with the Icelandic government to allow everyone to access testing for the virus.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2405</itunes:duration>
                                    </item>
    <item>
        <title>Organisational kindness during covid-19</title>
        <itunes:title>Organisational kindness during covid-19</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/organisational-kindness-during-covid-19/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/organisational-kindness-during-covid-19/#comments</comments>        <pubDate>Thu, 26 Mar 2020 11:52:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/organisational-kindness-during-covid-19</guid>
                                    <description><![CDATA[Reports from Italy, and more recently from the U.S. show the strain the healthcare system is under during this pandemic. 

We know that staff will step up in an emergency, but this isn’t a fire or a bombing, this is going to last for months. So how can organisations be proactive in supporting staff, and how can leaders try to mitigate the inevitable burnout.

In this podcast, Michael West, professor of organisational psychology at Lancaster university, and author of the GMC report “Caring for doctors, caring for patients” joins us to talk about what compassionate leadership looks like in a time of covid-19.


Resources
www.bmj.com/coronavirus
www.bmj.com/wellbeing
www.bmj.com/podcasts

<p>https://www.gmc-uk.org/-/media/documents/caring-for-doctors-caring-for-patients_pdf-80706341.pdf</p>
]]></description>
                                                            <content:encoded><![CDATA[Reports from Italy, and more recently from the U.S. show the strain the healthcare system is under during this pandemic. 

We know that staff will step up in an emergency, but this isn’t a fire or a bombing, this is going to last for months. So how can organisations be proactive in supporting staff, and how can leaders try to mitigate the inevitable burnout.

In this podcast, Michael West, professor of organisational psychology at Lancaster university, and author of the GMC report “Caring for doctors, caring for patients” joins us to talk about what compassionate leadership looks like in a time of covid-19.


Resources
www.bmj.com/coronavirus
www.bmj.com/wellbeing
www.bmj.com/podcasts

<p>https://www.gmc-uk.org/-/media/documents/caring-for-doctors-caring-for-patients_pdf-80706341.pdf</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ytulfh/stream_783648598-bmjgroup-organisational-kindness-during-covid-19.mp3" length="24582268" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Reports from Italy, and more recently from the U.S. show the strain the healthcare system is under during this pandemic. 

We know that staff will step up in an emergency, but this isn’t a fire or a bombing, this is going to last for months. So how can organisations be proactive in supporting staff, and how can leaders try to mitigate the inevitable burnout.

In this podcast, Michael West, professor of organisational psychology at Lancaster university, and author of the GMC report “Caring for doctors, caring for patients” joins us to talk about what compassionate leadership looks like in a time of covid-19.


Resources
www.bmj.com/coronavirus
www.bmj.com/wellbeing
www.bmj.com/podcasts

https://www.gmc-uk.org/-/media/documents/caring-for-doctors-caring-for-patients_pdf-80706341.pdf]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1536</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence - testing under the microscope and opioid prescription</title>
        <itunes:title>Talk Evidence - testing under the microscope and opioid prescription</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-testing-under-the-microscope-and-opioid-prescription/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-testing-under-the-microscope-and-opioid-prescription/#comments</comments>        <pubDate>Fri, 20 Mar 2020 20:08:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-testing-under-the-microscope-and-opioid-prescription</guid>
                                    <description><![CDATA[This edition of talk evidence was recorded before the big increase in covid-19 infections in the UK, and then delayed by some self isolation. We'll be back with more evidence on the pandemic very soon.

As always Duncan Jarvies is joined by Helen Macdonald (resting GP and editor at The BMJ) and Carl Heneghan (active GP, director of Oxford University’s CEBM and editor of BMJ Evidence).

in this episode
(1.01) Helen talks about variation in prescription of opioids - do 1% of clinician really prescribe the vast majority of the drug?

(8.45) Carl tells us that its time papers (in this case a lung screening one) really present absolute numbers.

(17.30) Carl explains how a spoonfull (less) of salt helps the blood pressure go down

(21.25) Helen puts test results under a microscope, and finds out that they may vary.

(33.20) What do conflicts of interest in tanning papers mean for wider science?

(48.05) Carl has a "super-rant" about smartphone apps for skin cancer - and a sensitivity of 0.


Reading list:
Opioid prescribing patterns among medical providers in the United States, 2003-17: retrospective, observational study
https://www.bmj.com/content/368/bmj.l6968

Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial
https://www.nejm.org/doi/full/10.1056/NEJMoa1911793


Effect of dose and duration of reduction in dietary sodium on blood pressure levels
https://www.bmj.com/content/368/bmj.m315

Your results may vary: the imprecision of medical measurements
https://www.bmj.com/content/368/bmj.m149

Association between financial links to indoor tanning industry and conclusions of published studies on indoor tanning: systematic review
https://www.bmj.com/content/368/bmj.m7

Algorithm based smartphone apps to assess risk of skin cancer in adults: systematic review of diagnostic accuracy studies
<p>https://www.bmj.com/content/368/bmj.m127</p>
]]></description>
                                                            <content:encoded><![CDATA[This edition of talk evidence was recorded before the big increase in covid-19 infections in the UK, and then delayed by some self isolation. We'll be back with more evidence on the pandemic very soon.

As always Duncan Jarvies is joined by Helen Macdonald (resting GP and editor at The BMJ) and Carl Heneghan (active GP, director of Oxford University’s CEBM and editor of BMJ Evidence).

in this episode
(1.01) Helen talks about variation in prescription of opioids - do 1% of clinician really prescribe the vast majority of the drug?

(8.45) Carl tells us that its time papers (in this case a lung screening one) really present absolute numbers.

(17.30) Carl explains how a spoonfull (less) of salt helps the blood pressure go down

(21.25) Helen puts test results under a microscope, and finds out that they may vary.

(33.20) What do conflicts of interest in tanning papers mean for wider science?

(48.05) Carl has a "super-rant" about smartphone apps for skin cancer - and a sensitivity of 0.


Reading list:
Opioid prescribing patterns among medical providers in the United States, 2003-17: retrospective, observational study
https://www.bmj.com/content/368/bmj.l6968

Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial
https://www.nejm.org/doi/full/10.1056/NEJMoa1911793


Effect of dose and duration of reduction in dietary sodium on blood pressure levels
https://www.bmj.com/content/368/bmj.m315

Your results may vary: the imprecision of medical measurements
https://www.bmj.com/content/368/bmj.m149

Association between financial links to indoor tanning industry and conclusions of published studies on indoor tanning: systematic review
https://www.bmj.com/content/368/bmj.m7

Algorithm based smartphone apps to assess risk of skin cancer in adults: systematic review of diagnostic accuracy studies
<p>https://www.bmj.com/content/368/bmj.m127</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/k9926z/stream_779844103-bmjgroup-talk-evidence-testing-under-the-microscope-and-opioid-prescription.mp3" length="52449697" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This edition of talk evidence was recorded before the big increase in covid-19 infections in the UK, and then delayed by some self isolation. We'll be back with more evidence on the pandemic very soon.

As always Duncan Jarvies is joined by Helen Macdonald (resting GP and editor at The BMJ) and Carl Heneghan (active GP, director of Oxford University’s CEBM and editor of BMJ Evidence).

in this episode
(1.01) Helen talks about variation in prescription of opioids - do 1% of clinician really prescribe the vast majority of the drug?

(8.45) Carl tells us that its time papers (in this case a lung screening one) really present absolute numbers.

(17.30) Carl explains how a spoonfull (less) of salt helps the blood pressure go down

(21.25) Helen puts test results under a microscope, and finds out that they may vary.

(33.20) What do conflicts of interest in tanning papers mean for wider science?

(48.05) Carl has a "super-rant" about smartphone apps for skin cancer - and a sensitivity of 0.


Reading list:
Opioid prescribing patterns among medical providers in the United States, 2003-17: retrospective, observational study
https://www.bmj.com/content/368/bmj.l6968

Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial
https://www.nejm.org/doi/full/10.1056/NEJMoa1911793


Effect of dose and duration of reduction in dietary sodium on blood pressure levels
https://www.bmj.com/content/368/bmj.m315

Your results may vary: the imprecision of medical measurements
https://www.bmj.com/content/368/bmj.m149

Association between financial links to indoor tanning industry and conclusions of published studies on indoor tanning: systematic review
https://www.bmj.com/content/368/bmj.m7

Algorithm based smartphone apps to assess risk of skin cancer in adults: systematic review of diagnostic accuracy studies
https://www.bmj.com/content/368/bmj.m127]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3278</itunes:duration>
                                    </item>
    <item>
        <title>For a greener NHS - a call for evidence</title>
        <itunes:title>For a greener NHS - a call for evidence</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/for-a-greener-nhs-a-call-for-evidence/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/for-a-greener-nhs-a-call-for-evidence/#comments</comments>        <pubDate>Sat, 14 Mar 2020 12:46:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/for-a-greener-nhs-a-call-for-submissions</guid>
                                    <description><![CDATA[The NHS is a world leader in sustainable healthcare - and it's the staff who have have been leading the charge.

The For A Greener NHS campaign is asking everyone who has made a change to the way they work, to submit evidence and help shape the whole organisation's response to the climate emergency.

In this podcast, Isobel Braithwaite, public health registrar & academic clinical fellow at UCL, and Sandy Robertson, LTFT Emergency Medicine Trainee and Chair of RCEM environmental specialist interest group, join us to explain what they're doing, and what kind of evidence is needed.

For more on the For A Greener NHS campaign
https://www.england.nhs.uk/greenernhs/

To submit evidence
<p>https://www.engage.england.nhs.uk/survey/nhs-net-zero/</p>
]]></description>
                                                            <content:encoded><![CDATA[The NHS is a world leader in sustainable healthcare - and it's the staff who have have been leading the charge.

The For A Greener NHS campaign is asking everyone who has made a change to the way they work, to submit evidence and help shape the whole organisation's response to the climate emergency.

In this podcast, Isobel Braithwaite, public health registrar & academic clinical fellow at UCL, and Sandy Robertson, LTFT Emergency Medicine Trainee and Chair of RCEM environmental specialist interest group, join us to explain what they're doing, and what kind of evidence is needed.

For more on the For A Greener NHS campaign
https://www.england.nhs.uk/greenernhs/

To submit evidence
<p>https://www.engage.england.nhs.uk/survey/nhs-net-zero/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wjtlde/stream_775968889-bmjgroup-for-a-greener-nhs-a-call-for-submissions.mp3" length="16734666" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The NHS is a world leader in sustainable healthcare - and it's the staff who have have been leading the charge.

The For A Greener NHS campaign is asking everyone who has made a change to the way they work, to submit evidence and help shape the whole organisation's response to the climate emergency.

In this podcast, Isobel Braithwaite, public health registrar & academic clinical fellow at UCL, and Sandy Robertson, LTFT Emergency Medicine Trainee and Chair of RCEM environmental specialist interest group, join us to explain what they're doing, and what kind of evidence is needed.

For more on the For A Greener NHS campaign
https://www.england.nhs.uk/greenernhs/

To submit evidence
https://www.engage.england.nhs.uk/survey/nhs-net-zero/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1046</itunes:duration>
                                    </item>
    <item>
        <title>Cycling - Does the health benefit outweigh the accident risk (in the UK)</title>
        <itunes:title>Cycling - Does the health benefit outweigh the accident risk (in the UK)</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/cycling-does-the-health-benefit-outweigh-the-accident-risk-in-the-uk/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/cycling-does-the-health-benefit-outweigh-the-accident-risk-in-the-uk/#comments</comments>        <pubDate>Thu, 12 Mar 2020 16:22:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/cycling-does-the-health-benefit-outweigh-the-accident-risk-in-the-uk</guid>
                                    <description><![CDATA[We all know we should be doing more exercise, and one way to do that is by active commuting - journeying to work on foot or by bike.

One thing preventing people from taking up cycling is the fear of being involved in road traffic accidents, and that the risk isn't worth the benefit of the extra exercise. It’s even more confusing when air pollution has to be taken into account.

Joining us to discuss new research into that risk/benefit calculation are 
Paul Welsh, a Senior Lecturer, and Carlos Celis, a research fellow, both  Institute of Cardiovascular & Medical Sciences at the University of Glasgow.

Read their open access research - Association of injury related hospital admissions with commuting by bicycle in the UK: prospective population based study
<p>https://www.bmj.com/content/368/bmj.m336</p>
]]></description>
                                                            <content:encoded><![CDATA[We all know we should be doing more exercise, and one way to do that is by active commuting - journeying to work on foot or by bike.

One thing preventing people from taking up cycling is the fear of being involved in road traffic accidents, and that the risk isn't worth the benefit of the extra exercise. It’s even more confusing when air pollution has to be taken into account.

Joining us to discuss new research into that risk/benefit calculation are 
Paul Welsh, a Senior Lecturer, and Carlos Celis, a research fellow, both  Institute of Cardiovascular & Medical Sciences at the University of Glasgow.

Read their open access research - Association of injury related hospital admissions with commuting by bicycle in the UK: prospective population based study
<p>https://www.bmj.com/content/368/bmj.m336</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vm5skp/stream_775010692-bmjgroup-cycling-does-the-health-benefit-outweigh-the-accident-risk-in-the-uk.mp3" length="21854666" type="audio/mpeg"/>
        <itunes:summary><![CDATA[We all know we should be doing more exercise, and one way to do that is by active commuting - journeying to work on foot or by bike.

One thing preventing people from taking up cycling is the fear of being involved in road traffic accidents, and that the risk isn't worth the benefit of the extra exercise. It’s even more confusing when air pollution has to be taken into account.

Joining us to discuss new research into that risk/benefit calculation are 
Paul Welsh, a Senior Lecturer, and Carlos Celis, a research fellow, both  Institute of Cardiovascular & Medical Sciences at the University of Glasgow.

Read their open access research - Association of injury related hospital admissions with commuting by bicycle in the UK: prospective population based study
https://www.bmj.com/content/368/bmj.m336]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1366</itunes:duration>
                                    </item>
    <item>
        <title>Why we are failing patients with multimorbidity</title>
        <itunes:title>Why we are failing patients with multimorbidity</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/why-we-are-failing-patients-with-multimorbidity/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/why-we-are-failing-patients-with-multimorbidity/#comments</comments>        <pubDate>Thu, 05 Mar 2020 14:54:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/why-we-are-failing-patients-with-multimorbidity</guid>
                                    <description><![CDATA[We know that the number of people living with multiple health conditions is rising year on year, and yet training, guidelines, organisations and physical spaces in healthcare still largely focus on single diseases or organ systems.

The means that patients in the NHS are often treated as if their conditions exist in isolation, and that their care lacks coordination, and isn't as good as it should be.

To look at why patients with multiple conditions pose a challenge to the NHS, and what we can do to improve the care they receive, we’re joined by

Louella Vaughan, acute physician and senior clinical fellow at the Nuffield Trust
Jihad Malasi, GP and clinical chair of Thanet CCG
Rammya Mathew, GP and a quality improvement lead and columnist for The BMJ
<p>and David Oliver, consultant in geriatrics, clinical vice president of the RCP and  columnist for The BMJ</p>
]]></description>
                                                            <content:encoded><![CDATA[We know that the number of people living with multiple health conditions is rising year on year, and yet training, guidelines, organisations and physical spaces in healthcare still largely focus on single diseases or organ systems.

The means that patients in the NHS are often treated as if their conditions exist in isolation, and that their care lacks coordination, and isn't as good as it should be.

To look at why patients with multiple conditions pose a challenge to the NHS, and what we can do to improve the care they receive, we’re joined by

Louella Vaughan, acute physician and senior clinical fellow at the Nuffield Trust
Jihad Malasi, GP and clinical chair of Thanet CCG
Rammya Mathew, GP and a quality improvement lead and columnist for The BMJ
<p>and David Oliver, consultant in geriatrics, clinical vice president of the RCP and  columnist for The BMJ</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/r5xp86/stream_771176869-bmjgroup-why-we-are-failing-patients-with-multimorbidity.mp3" length="57876897" type="audio/mpeg"/>
        <itunes:summary><![CDATA[We know that the number of people living with multiple health conditions is rising year on year, and yet training, guidelines, organisations and physical spaces in healthcare still largely focus on single diseases or organ systems.

The means that patients in the NHS are often treated as if their conditions exist in isolation, and that their care lacks coordination, and isn't as good as it should be.

To look at why patients with multiple conditions pose a challenge to the NHS, and what we can do to improve the care they receive, we’re joined by

Louella Vaughan, acute physician and senior clinical fellow at the Nuffield Trust
Jihad Malasi, GP and clinical chair of Thanet CCG
Rammya Mathew, GP and a quality improvement lead and columnist for The BMJ
and David Oliver, consultant in geriatrics, clinical vice president of the RCP and  columnist for The BMJ]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3617</itunes:duration>
                                    </item>
    <item>
        <title>Yvonne Coghill is trying to fix racism in the NHS</title>
        <itunes:title>Yvonne Coghill is trying to fix racism in the NHS</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/yvonne-coghill-is-trying-to-fix-racism-in-the-nhs-1684835769/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/yvonne-coghill-is-trying-to-fix-racism-in-the-nhs-1684835769/#comments</comments>        <pubDate>Fri, 28 Feb 2020 11:59:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/yvonne-coghill-is-trying-to-fix-racism-in-the-nhs</guid>
                                    <description><![CDATA[In this week's special episode of Sharp Scratch, we've got something a little different for you! Last week the panel talked microaggressions, so this week we're hearing from an expert guest who is leading the work the NHS is doing to combat inequality in healthcare.

If you like this special edition, let us know on Facebook, Instagram or Twitter using #SharpScratch

This week's special guest:

Yvonne Coghill, CBE is the director of Workforce Race Equality Standard (WRES) at NHS England and NHS Improvement. Yvonne has over 20 years’ experience in nursing, before taking up operational and strategic leadership posts. 

During her 40 plus years career, she has held a wide variety of clinical and managerial roles at the Department for Health and NHS Leadership Academy. In 2013 she was voted by colleagues in the NHS as one of the top 50 most inspirational women, one of the top 50 most inspirational nurse leaders and one of the top 50 black and minority ethnic (BME) pioneers, two years in a row.  

In July 2015 Yvonne joined NHS England as director for WRES Implementation. She was awarded an Order of the British Empire for services to healthcare in 2010 and Commander of the British Empire in 2018. Yvonne was elected deputy president of the Royal College of Nursing (RCN) in November 2018.

Some of the resources Yvonne mentions during the interview:

https://www.england.nhs.uk/2020/02/nhs-publishes-new-workforce-race-equality-data-ahead-of-nhs-and-race-summit/

https://www.england.nhs.uk/about/equality/equality-hub/equality-standard/resources/

<p>https://www.england.nhs.uk/2019/01/race-equality/</p>
]]></description>
                                                            <content:encoded><![CDATA[In this week's special episode of Sharp Scratch, we've got something a little different for you! Last week the panel talked microaggressions, so this week we're hearing from an expert guest who is leading the work the NHS is doing to combat inequality in healthcare.

If you like this special edition, let us know on Facebook, Instagram or Twitter using #SharpScratch

This week's special guest:

Yvonne Coghill, CBE is the director of Workforce Race Equality Standard (WRES) at NHS England and NHS Improvement. Yvonne has over 20 years’ experience in nursing, before taking up operational and strategic leadership posts. 

During her 40 plus years career, she has held a wide variety of clinical and managerial roles at the Department for Health and NHS Leadership Academy. In 2013 she was voted by colleagues in the NHS as one of the top 50 most inspirational women, one of the top 50 most inspirational nurse leaders and one of the top 50 black and minority ethnic (BME) pioneers, two years in a row.  

In July 2015 Yvonne joined NHS England as director for WRES Implementation. She was awarded an Order of the British Empire for services to healthcare in 2010 and Commander of the British Empire in 2018. Yvonne was elected deputy president of the Royal College of Nursing (RCN) in November 2018.

Some of the resources Yvonne mentions during the interview:

https://www.england.nhs.uk/2020/02/nhs-publishes-new-workforce-race-equality-data-ahead-of-nhs-and-race-summit/

https://www.england.nhs.uk/about/equality/equality-hub/equality-standard/resources/

<p>https://www.england.nhs.uk/2019/01/race-equality/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ksy6lp/stream_767929390-bmjgroup-yvonne-coghill-is-trying-to-fix-racism-in-the-nhs.mp3" length="70207418" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this week's special episode of Sharp Scratch, we've got something a little different for you! Last week the panel talked microaggressions, so this week we're hearing from an expert guest who is leading the work the NHS is doing to combat inequality in healthcare.

If you like this special edition, let us know on Facebook, Instagram or Twitter using #SharpScratch

This week's special guest:

Yvonne Coghill, CBE is the director of Workforce Race Equality Standard (WRES) at NHS England and NHS Improvement. Yvonne has over 20 years’ experience in nursing, before taking up operational and strategic leadership posts. 

During her 40 plus years career, she has held a wide variety of clinical and managerial roles at the Department for Health and NHS Leadership Academy. In 2013 she was voted by colleagues in the NHS as one of the top 50 most inspirational women, one of the top 50 most inspirational nurse leaders and one of the top 50 black and minority ethnic (BME) pioneers, two years in a row.  

In July 2015 Yvonne joined NHS England as director for WRES Implementation. She was awarded an Order of the British Empire for services to healthcare in 2010 and Commander of the British Empire in 2018. Yvonne was elected deputy president of the Royal College of Nursing (RCN) in November 2018.

Some of the resources Yvonne mentions during the interview:

https://www.england.nhs.uk/2020/02/nhs-publishes-new-workforce-race-equality-data-ahead-of-nhs-and-race-summit/

https://www.england.nhs.uk/about/equality/equality-hub/equality-standard/resources/

https://www.england.nhs.uk/2019/01/race-equality/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2929</itunes:duration>
                                    </item>
    <item>
        <title>Born equal - the launch of The BMJ special issue on race in medicine</title>
        <itunes:title>Born equal - the launch of The BMJ special issue on race in medicine</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/born-equal-the-launch-of-the-bmj-special-issue-on-race-in-medicine/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/born-equal-the-launch-of-the-bmj-special-issue-on-race-in-medicine/#comments</comments>        <pubDate>Fri, 21 Feb 2020 18:18:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/born-equal-the-launch-of-the-bmj-special-issue-on-race-in-medicine</guid>
                                    <description><![CDATA[Last week the BMJ published it’s first special edition into Racism in Medicine. The issues tacked ranged from differential attainment in medical school, to the physiological effects that experiencing everyday discrimination has. 

The issue was guest edited by Victor Adebowale, the Chief Executive of the social care enterprise Turning Point, and Mala Rao, Professor of Public Health, at Imperial College London - and they, along with Simon Stevens, chief executive of the NHS, Chand Nagpul Chair of council of the BMA, and the Olalade Obedare, medical student from Nottingham University Medical School, talked at the event.

<p>www.bmj.com/racism-in-health.</p>
]]></description>
                                                            <content:encoded><![CDATA[Last week the BMJ published it’s first special edition into Racism in Medicine. The issues tacked ranged from differential attainment in medical school, to the physiological effects that experiencing everyday discrimination has. 

The issue was guest edited by Victor Adebowale, the Chief Executive of the social care enterprise Turning Point, and Mala Rao, Professor of Public Health, at Imperial College London - and they, along with Simon Stevens, chief executive of the NHS, Chand Nagpul Chair of council of the BMA, and the Olalade Obedare, medical student from Nottingham University Medical School, talked at the event.

<p>www.bmj.com/racism-in-health.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wlj49k/stream_764423365-bmjgroup-born-equal-the-launch-of-the-bmj-special-issue-on-race-in-medicine.mp3" length="27318229" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Last week the BMJ published it’s first special edition into Racism in Medicine. The issues tacked ranged from differential attainment in medical school, to the physiological effects that experiencing everyday discrimination has. 

The issue was guest edited by Victor Adebowale, the Chief Executive of the social care enterprise Turning Point, and Mala Rao, Professor of Public Health, at Imperial College London - and they, along with Simon Stevens, chief executive of the NHS, Chand Nagpul Chair of council of the BMA, and the Olalade Obedare, medical student from Nottingham University Medical School, talked at the event.

www.bmj.com/racism-in-health.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1707</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence - Building an evidence base for covid-19</title>
        <itunes:title>Talk Evidence - Building an evidence base for covid-19</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-building-an-evidence-base-for-covid-19/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-building-an-evidence-base-for-covid-19/#comments</comments>        <pubDate>Mon, 17 Feb 2020 15:22:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-building-an-evidence-base-for-covid-19</guid>
                                    <description><![CDATA[We're taking a break from the usual Talk Evidence to focus on the new corona virus that has emerged in China.

With a brand new disease, we have to build our evidence base from scratch - basic virology, epidemiology, pathogenicity, transmissibility, and ultimately treatment are all unknowns.

In this episode of Talk Evidence, we're trying to get away from the headlines and talk about what we need to know - to hopefully give you some insight into these issues.

(8.00) Peter Openshaw, professor of experimental medicine at Imperial College London, talks to us about the pathogenicity of covid-19

(17.30) Wendy Barclay, head of the Department of Infectious Disease at Imperial College London, describes what can change the R0 of a viral disease.

(20.50) Raina MacIntyre, professor of biosecurity at the Kirby Institute at the University of New South Wales, talks to us about how effective masks are at preventing spread of viruses.

(30.00) We discuss treatment options in the face of massive uncertainty.

<p>To read more about covid-19 and to keep up to date with the disease visit https://www.bmj.com/coronavirus where all of the information on the disease if freely available.</p>
]]></description>
                                                            <content:encoded><![CDATA[We're taking a break from the usual Talk Evidence to focus on the new corona virus that has emerged in China.

With a brand new disease, we have to build our evidence base from scratch - basic virology, epidemiology, pathogenicity, transmissibility, and ultimately treatment are all unknowns.

In this episode of Talk Evidence, we're trying to get away from the headlines and talk about what we need to know - to hopefully give you some insight into these issues.

(8.00) Peter Openshaw, professor of experimental medicine at Imperial College London, talks to us about the pathogenicity of covid-19

(17.30) Wendy Barclay, head of the Department of Infectious Disease at Imperial College London, describes what can change the R0 of a viral disease.

(20.50) Raina MacIntyre, professor of biosecurity at the Kirby Institute at the University of New South Wales, talks to us about how effective masks are at preventing spread of viruses.

(30.00) We discuss treatment options in the face of massive uncertainty.

<p>To read more about covid-19 and to keep up to date with the disease visit https://www.bmj.com/coronavirus where all of the information on the disease if freely available.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9ra7pz/stream_762167875-bmjgroup-talk-evidence-building-an-evidence-base-for-covid-19.mp3" length="43140492" type="audio/mpeg"/>
        <itunes:summary><![CDATA[We're taking a break from the usual Talk Evidence to focus on the new corona virus that has emerged in China.

With a brand new disease, we have to build our evidence base from scratch - basic virology, epidemiology, pathogenicity, transmissibility, and ultimately treatment are all unknowns.

In this episode of Talk Evidence, we're trying to get away from the headlines and talk about what we need to know - to hopefully give you some insight into these issues.

(8.00) Peter Openshaw, professor of experimental medicine at Imperial College London, talks to us about the pathogenicity of covid-19

(17.30) Wendy Barclay, head of the Department of Infectious Disease at Imperial College London, describes what can change the R0 of a viral disease.

(20.50) Raina MacIntyre, professor of biosecurity at the Kirby Institute at the University of New South Wales, talks to us about how effective masks are at preventing spread of viruses.

(30.00) We discuss treatment options in the face of massive uncertainty.

To read more about covid-19 and to keep up to date with the disease visit https://www.bmj.com/coronavirus where all of the information on the disease if freely available.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2696</itunes:duration>
                                    </item>
    <item>
        <title>David Williams - everyday discrimination is an independent predictor of mortality</title>
        <itunes:title>David Williams - everyday discrimination is an independent predictor of mortality</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/david-williams-everyday-discrimination-is-an-independent-predictor-of-mortality/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/david-williams-everyday-discrimination-is-an-independent-predictor-of-mortality/#comments</comments>        <pubDate>Thu, 13 Feb 2020 12:44:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/david-williams-everyday-discrimination-is-an-independent-predictor-of-mortality</guid>
                                    <description><![CDATA[There comes a tipping point in all campaigns when the evidence is overwhelming and the only way to proceed is with action. According to David Williams, it’s time to tackle the disproportionate effects of race on patients in the UK.

David Williams, from Harvard University, developed the Everyday Discrimination Scale that, in 1997, launched a new scientific approach to assessing social influences, such as racism, on health. 

He’s shown that people who experience every day acts of discrimination— like getting poorer service in a bank or a restaurant, or being treated with less courtesy—will over time have worse health outcomes, including higher rates of heart disease, lower life expectancy, and greater infant mortality.

In this podcast he is interviewed by Lilian Anekwe, assistant news editor
for New Scientist.

Read Lilian's article on tackling racism in the NHS
https://www.bmj.com/content/368/bmj.m341

And all of the special issue on racism in medicine
<p>https://www.bmj.com/racism-in-medicine</p>
]]></description>
                                                            <content:encoded><![CDATA[There comes a tipping point in all campaigns when the evidence is overwhelming and the only way to proceed is with action. According to David Williams, it’s time to tackle the disproportionate effects of race on patients in the UK.

David Williams, from Harvard University, developed the Everyday Discrimination Scale that, in 1997, launched a new scientific approach to assessing social influences, such as racism, on health. 

He’s shown that people who experience every day acts of discrimination— like getting poorer service in a bank or a restaurant, or being treated with less courtesy—will over time have worse health outcomes, including higher rates of heart disease, lower life expectancy, and greater infant mortality.

In this podcast he is interviewed by Lilian Anekwe, assistant news editor
for New Scientist.

Read Lilian's article on tackling racism in the NHS
https://www.bmj.com/content/368/bmj.m341

And all of the special issue on racism in medicine
<p>https://www.bmj.com/racism-in-medicine</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/o6q9ea/stream_759865162-bmjgroup-david-williams-everyday-discrimination-is-an-independent-predictor-of-mortality.mp3" length="50544639" type="audio/mpeg"/>
        <itunes:summary><![CDATA[There comes a tipping point in all campaigns when the evidence is overwhelming and the only way to proceed is with action. According to David Williams, it’s time to tackle the disproportionate effects of race on patients in the UK.

David Williams, from Harvard University, developed the Everyday Discrimination Scale that, in 1997, launched a new scientific approach to assessing social influences, such as racism, on health. 

He’s shown that people who experience every day acts of discrimination— like getting poorer service in a bank or a restaurant, or being treated with less courtesy—will over time have worse health outcomes, including higher rates of heart disease, lower life expectancy, and greater infant mortality.

In this podcast he is interviewed by Lilian Anekwe, assistant news editor
for New Scientist.

Read Lilian's article on tackling racism in the NHS
https://www.bmj.com/content/368/bmj.m341

And all of the special issue on racism in medicine
https://www.bmj.com/racism-in-medicine]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3159</itunes:duration>
                                    </item>
    <item>
        <title>Big Tan - Is  the sunbed industry targeting research?</title>
        <itunes:title>Big Tan - Is  the sunbed industry targeting research?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/big-tan-is-the-sunbed-industry-targeting-research/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/big-tan-is-the-sunbed-industry-targeting-research/#comments</comments>        <pubDate>Mon, 10 Feb 2020 17:42:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/big-tan-is-the-sunbed-industry-targeting-research</guid>
                                    <description><![CDATA[In 2012, Eleni Linos, professor of dermatology at Stanford university, published a systematic review and meta-analysis of the link between non-melanoma cancer and sun-beds.

That bit of pretty standard research, and a particular rapid response to it, has kicked of years of work - and in this podcast I talk to Eleni and her colleagues Stanton Glantz, and Yogi Hendlin about what they’ve uncovered.

Reading list:
Association between financial links to indoor tanning industry and conclusions of published studies on indoor tanning
https://www.bmj.com/content/368/bmj.m7

Indoor tanning and non-melanoma skin cancer: systematic review and meta-analysis
<p>https://www.bmj.com/content/345/bmj.e5909</p>
]]></description>
                                                            <content:encoded><![CDATA[In 2012, Eleni Linos, professor of dermatology at Stanford university, published a systematic review and meta-analysis of the link between non-melanoma cancer and sun-beds.

That bit of pretty standard research, and a particular rapid response to it, has kicked of years of work - and in this podcast I talk to Eleni and her colleagues Stanton Glantz, and Yogi Hendlin about what they’ve uncovered.

Reading list:
Association between financial links to indoor tanning industry and conclusions of published studies on indoor tanning
https://www.bmj.com/content/368/bmj.m7

Indoor tanning and non-melanoma skin cancer: systematic review and meta-analysis
<p>https://www.bmj.com/content/345/bmj.e5909</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/nh5wan/stream_758329537-bmjgroup-big-tan-is-the-sunbed-industry-targeting-research.mp3" length="28160834" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In 2012, Eleni Linos, professor of dermatology at Stanford university, published a systematic review and meta-analysis of the link between non-melanoma cancer and sun-beds.

That bit of pretty standard research, and a particular rapid response to it, has kicked of years of work - and in this podcast I talk to Eleni and her colleagues Stanton Glantz, and Yogi Hendlin about what they’ve uncovered.

Reading list:
Association between financial links to indoor tanning industry and conclusions of published studies on indoor tanning
https://www.bmj.com/content/368/bmj.m7

Indoor tanning and non-melanoma skin cancer: systematic review and meta-analysis
https://www.bmj.com/content/345/bmj.e5909]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1760</itunes:duration>
                                    </item>
    <item>
        <title>Writing a good outpatient letter means addressing it to the patient</title>
        <itunes:title>Writing a good outpatient letter means addressing it to the patient</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/writing-a-good-outpatient-letter-means-addressing-it-to-the-patient/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/writing-a-good-outpatient-letter-means-addressing-it-to-the-patient/#comments</comments>        <pubDate>Fri, 07 Feb 2020 11:31:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/writing-a-good-outpatient-letter-means-addressing-it-to-the-patient</guid>
                                    <description><![CDATA[In many countries (including the UK and Australia) it is still common practice for hospital doctors to write letters to patients’ general practitioners (GPs) following outpatient consultations, and for patients to receive copies of these letters. 

However, Hugh Rayner, consultant nephrologist, and Peter Rees, former Chair of the Academy of Medical Royal Colleges' lay patient committee, suggest that hospital doctors who have changed their practice to include writing letters directly to patients have more patient centred consultations and experience smoother handovers with other members of their multidisciplinary teams.

<p>Read their article explaining what makes for a good outpatient letter; https://www.bmj.com/content/368/bmj.m24</p>
]]></description>
                                                            <content:encoded><![CDATA[In many countries (including the UK and Australia) it is still common practice for hospital doctors to write letters to patients’ general practitioners (GPs) following outpatient consultations, and for patients to receive copies of these letters. 

However, Hugh Rayner, consultant nephrologist, and Peter Rees, former Chair of the Academy of Medical Royal Colleges' lay patient committee, suggest that hospital doctors who have changed their practice to include writing letters directly to patients have more patient centred consultations and experience smoother handovers with other members of their multidisciplinary teams.

<p>Read their article explaining what makes for a good outpatient letter; https://www.bmj.com/content/368/bmj.m24</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/miinh9/stream_756591220-bmjgroup-writing-a-good-outpatient-letter-means-addressing-it-to-the-patient.mp3" length="23774771" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In many countries (including the UK and Australia) it is still common practice for hospital doctors to write letters to patients’ general practitioners (GPs) following outpatient consultations, and for patients to receive copies of these letters. 

However, Hugh Rayner, consultant nephrologist, and Peter Rees, former Chair of the Academy of Medical Royal Colleges' lay patient committee, suggest that hospital doctors who have changed their practice to include writing letters directly to patients have more patient centred consultations and experience smoother handovers with other members of their multidisciplinary teams.

Read their article explaining what makes for a good outpatient letter; https://www.bmj.com/content/368/bmj.m24]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1486</itunes:duration>
                                    </item>
    <item>
        <title>QI and improvement are not synonyms</title>
        <itunes:title>QI and improvement are not synonyms</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/qi-and-improvement-are-not-synonyms/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/qi-and-improvement-are-not-synonyms/#comments</comments>        <pubDate>Fri, 31 Jan 2020 18:17:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/qi-and-improvement-are-not-synonyms</guid>
                                    <description><![CDATA[In October 2019, Mary Dixon-Woods, director of the THIS Institute, dedicated to healthcare improvement. In that she explained how she believed healthcare improvement could be improved.

The essay took the position that "Quality Improvement" isn't necessarily the best way to improve healthcare, and that more rigour needs to be brought to the field. 

That paper has created a great deal of discussion, so in this podcast we wanted to go back to Mary and ask her what she thinks about improvement, and how we can practically put into place some of the things she calls for.

Read the full essay:
https://www.bmj.com/content/367/bmj.l5514

And the rest of our healthcare improvement series:
<p>https://www.bmj.com/quality-improvement</p>
]]></description>
                                                            <content:encoded><![CDATA[In October 2019, Mary Dixon-Woods, director of the THIS Institute, dedicated to healthcare improvement. In that she explained how she believed healthcare improvement could be improved.

The essay took the position that "Quality Improvement" isn't necessarily the best way to improve healthcare, and that more rigour needs to be brought to the field. 

That paper has created a great deal of discussion, so in this podcast we wanted to go back to Mary and ask her what she thinks about improvement, and how we can practically put into place some of the things she calls for.

Read the full essay:
https://www.bmj.com/content/367/bmj.l5514

And the rest of our healthcare improvement series:
<p>https://www.bmj.com/quality-improvement</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/li0gfx/stream_752848051-bmjgroup-qi-and-improvement-are-not-synonyms.mp3" length="43364936" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In October 2019, Mary Dixon-Woods, director of the THIS Institute, dedicated to healthcare improvement. In that she explained how she believed healthcare improvement could be improved.

The essay took the position that "Quality Improvement" isn't necessarily the best way to improve healthcare, and that more rigour needs to be brought to the field. 

That paper has created a great deal of discussion, so in this podcast we wanted to go back to Mary and ask her what she thinks about improvement, and how we can practically put into place some of the things she calls for.

Read the full essay:
https://www.bmj.com/content/367/bmj.l5514

And the rest of our healthcare improvement series:
https://www.bmj.com/quality-improvement]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2710</itunes:duration>
                                    </item>
    <item>
        <title>Prevalence and treatment of  precocious puberty</title>
        <itunes:title>Prevalence and treatment of  precocious puberty</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/prevalence-and-treatment-of-precocious-puberty/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/prevalence-and-treatment-of-precocious-puberty/#comments</comments>        <pubDate>Tue, 28 Jan 2020 17:19:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/intervention-or-watchful-waiting-for-precocious-puberty</guid>
                                    <description><![CDATA[Precocious puberty, that is puberty that starts before age 8 in girls and 9 in boys seems to be on the rise, but whether that’s because of an increase in incidence, or greater attention is unknown - what we do know that precocious puberty in girls is commonly idiopathic, while in boys is a red flag for pathology. But either way ther first point of call is the GP.

In this podcast, Steven Bradley GP, and Neil Lawrence, paediatric trainee join us to discuss how common precocious puberty is, how GPs should respond to a family presenting with it, and if intimate examination is actually warranted in primary care. 

Read the full practice pointer:
<p>https://www.bmj.com/content/368/bmj.l6597</p>
]]></description>
                                                            <content:encoded><![CDATA[Precocious puberty, that is puberty that starts before age 8 in girls and 9 in boys seems to be on the rise, but whether that’s because of an increase in incidence, or greater attention is unknown - what we do know that precocious puberty in girls is commonly idiopathic, while in boys is a red flag for pathology. But either way ther first point of call is the GP.

In this podcast, Steven Bradley GP, and Neil Lawrence, paediatric trainee join us to discuss how common precocious puberty is, how GPs should respond to a family presenting with it, and if intimate examination is actually warranted in primary care. 

Read the full practice pointer:
<p>https://www.bmj.com/content/368/bmj.l6597</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/n3bjni/stream_751086805-bmjgroup-intervention-or-watchful-waiting-for-precocious-puberty.mp3" length="32785553" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Precocious puberty, that is puberty that starts before age 8 in girls and 9 in boys seems to be on the rise, but whether that’s because of an increase in incidence, or greater attention is unknown - what we do know that precocious puberty in girls is commonly idiopathic, while in boys is a red flag for pathology. But either way ther first point of call is the GP.

In this podcast, Steven Bradley GP, and Neil Lawrence, paediatric trainee join us to discuss how common precocious puberty is, how GPs should respond to a family presenting with it, and if intimate examination is actually warranted in primary care. 

Read the full practice pointer:
https://www.bmj.com/content/368/bmj.l6597]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2049</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence - Sepsis, talc and blindsided by blinding</title>
        <itunes:title>Talk Evidence - Sepsis, talc and blindsided by blinding</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-sepsis-talc-and-blindsided-by-blinding/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-sepsis-talc-and-blindsided-by-blinding/#comments</comments>        <pubDate>Wed, 22 Jan 2020 17:40:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-sepsis-talc-and-blindsided-by-blinding</guid>
                                    <description><![CDATA[Welcome to the festive talk evidence, giving you a little EBM to take you into the new year. As always Duncan Jarvies is joined by Helen Macdonald (resting GP and editor at The BMJ) and Carl Heneghan (active GP, director of Oxford University’s CEBM and editor of BMJ Evidence)*

This month:

(1.20) Carl tells us about new research on treating sepsis with steroids that might inform practice.

(4.58)Proscribing of prophylactic PPIs or H2-blockers for intensive care patients.

(11.00) Carl wonders if we can actually rule out an increased risk of ovarian cancer with the use of talc.

(17.46) Helen drops and EBM bombshell - is all the work needed to blind participants in a double blind randomised control trial actually worth it?

(33.00) Helen is annoyed about a press release from the department of health, and kicks of 2020 by stealing Carl's rant spot.


Reading list:

Corticosteroids for Treating Sepsis in Children and Adults
https://pubmed.ncbi.nlm.nih.gov/31808551-corticosteroids-for-treating-sepsis-in-children-and-adults/?dopt=Abstract

 Gastrointestinal bleeding prophylaxis for critically ill patients: a clinical practice guideline
https://www.bmj.com/content/368/bmj.l6722

Association of Powder Use in the Genital Area With Risk of Ovarian Cancer.
https://www.ncbi.nlm.nih.gov/pubmed/31910280

Blinding
Fool’s gold? Why blinded trials are not always best
https://www.bmj.com/content/368/bmj.l6228

Impact of blinding on estimated treatment effects in randomised clinical trials
https://www.bmj.com/content/368/bmj.l6802


<p>*quick note to say sorry about the sound quality on Duncan's microphone - we had a technical glitch (he was left alone to record).</p>
]]></description>
                                                            <content:encoded><![CDATA[Welcome to the festive talk evidence, giving you a little EBM to take you into the new year. As always Duncan Jarvies is joined by Helen Macdonald (resting GP and editor at The BMJ) and Carl Heneghan (active GP, director of Oxford University’s CEBM and editor of BMJ Evidence)*

This month:

(1.20) Carl tells us about new research on treating sepsis with steroids that might inform practice.

(4.58)Proscribing of prophylactic PPIs or H2-blockers for intensive care patients.

(11.00) Carl wonders if we can actually rule out an increased risk of ovarian cancer with the use of talc.

(17.46) Helen drops and EBM bombshell - is all the work needed to blind participants in a double blind randomised control trial actually worth it?

(33.00) Helen is annoyed about a press release from the department of health, and kicks of 2020 by stealing Carl's rant spot.


Reading list:

Corticosteroids for Treating Sepsis in Children and Adults
https://pubmed.ncbi.nlm.nih.gov/31808551-corticosteroids-for-treating-sepsis-in-children-and-adults/?dopt=Abstract

 Gastrointestinal bleeding prophylaxis for critically ill patients: a clinical practice guideline
https://www.bmj.com/content/368/bmj.l6722

Association of Powder Use in the Genital Area With Risk of Ovarian Cancer.
https://www.ncbi.nlm.nih.gov/pubmed/31910280

Blinding
Fool’s gold? Why blinded trials are not always best
https://www.bmj.com/content/368/bmj.l6228

Impact of blinding on estimated treatment effects in randomised clinical trials
https://www.bmj.com/content/368/bmj.l6802


<p>*quick note to say sorry about the sound quality on Duncan's microphone - we had a technical glitch (he was left alone to record).</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/cxd1yj/stream_747699133-bmjgroup-talk-evidence-sepsis-talc-and-blindsided-by-blinding.mp3" length="39463424" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Welcome to the festive talk evidence, giving you a little EBM to take you into the new year. As always Duncan Jarvies is joined by Helen Macdonald (resting GP and editor at The BMJ) and Carl Heneghan (active GP, director of Oxford University’s CEBM and editor of BMJ Evidence)*

This month:

(1.20) Carl tells us about new research on treating sepsis with steroids that might inform practice.

(4.58)Proscribing of prophylactic PPIs or H2-blockers for intensive care patients.

(11.00) Carl wonders if we can actually rule out an increased risk of ovarian cancer with the use of talc.

(17.46) Helen drops and EBM bombshell - is all the work needed to blind participants in a double blind randomised control trial actually worth it?

(33.00) Helen is annoyed about a press release from the department of health, and kicks of 2020 by stealing Carl's rant spot.


Reading list:

Corticosteroids for Treating Sepsis in Children and Adults
https://pubmed.ncbi.nlm.nih.gov/31808551-corticosteroids-for-treating-sepsis-in-children-and-adults/?dopt=Abstract

 Gastrointestinal bleeding prophylaxis for critically ill patients: a clinical practice guideline
https://www.bmj.com/content/368/bmj.l6722

Association of Powder Use in the Genital Area With Risk of Ovarian Cancer.
https://www.ncbi.nlm.nih.gov/pubmed/31910280

Blinding
Fool’s gold? Why blinded trials are not always best
https://www.bmj.com/content/368/bmj.l6228

Impact of blinding on estimated treatment effects in randomised clinical trials
https://www.bmj.com/content/368/bmj.l6802


*quick note to say sorry about the sound quality on Duncan's microphone - we had a technical glitch (he was left alone to record).]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2467</itunes:duration>
                                    </item>
    <item>
        <title>Surviving childhood cancer treatment</title>
        <itunes:title>Surviving childhood cancer treatment</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/surviving-childhood-cancer-treatment/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/surviving-childhood-cancer-treatment/#comments</comments>        <pubDate>Tue, 21 Jan 2020 13:21:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/surviving-childhood-cancer-treatment</guid>
                                    <description><![CDATA[In a British cohort, 30% of patients who had survived childhood cancer had died within 45 years of diagnosis; only 6% were expected to have died. 

51% had developed a new primary cancer,  but a 26% died of cardiovascular disease - thought to be caused by their treatment. Consequently, efforts to reduce long term mortality have focused on reducing exposure to the most toxic aspects of anticancer treatment, including radiotherapy.

In this podcast we’re joined by  Daniel Mulrooney, associate professor in the Division of Cancer Survivorship, at St Jude Children’s Research Hospital and one of the authors of the paper Major cardiac events for adult survivors of childhood cancer diagnosed between 1970 and 1999: report from the Childhood Cancer Survivor Study cohort


Read the full research:

<p>https://www.bmj.com/content/368/bmj.l6794</p>
]]></description>
                                                            <content:encoded><![CDATA[In a British cohort, 30% of patients who had survived childhood cancer had died within 45 years of diagnosis; only 6% were expected to have died. 

51% had developed a new primary cancer,  but a 26% died of cardiovascular disease - thought to be caused by their treatment. Consequently, efforts to reduce long term mortality have focused on reducing exposure to the most toxic aspects of anticancer treatment, including radiotherapy.

In this podcast we’re joined by  Daniel Mulrooney, associate professor in the Division of Cancer Survivorship, at St Jude Children’s Research Hospital and one of the authors of the paper Major cardiac events for adult survivors of childhood cancer diagnosed between 1970 and 1999: report from the Childhood Cancer Survivor Study cohort


Read the full research:

<p>https://www.bmj.com/content/368/bmj.l6794</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/se6w9h/stream_747033085-bmjgroup-surviving-childhood-cancer-treatment.mp3" length="23712913" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In a British cohort, 30% of patients who had survived childhood cancer had died within 45 years of diagnosis; only 6% were expected to have died. 

51% had developed a new primary cancer,  but a 26% died of cardiovascular disease - thought to be caused by their treatment. Consequently, efforts to reduce long term mortality have focused on reducing exposure to the most toxic aspects of anticancer treatment, including radiotherapy.

In this podcast we’re joined by  Daniel Mulrooney, associate professor in the Division of Cancer Survivorship, at St Jude Children’s Research Hospital and one of the authors of the paper Major cardiac events for adult survivors of childhood cancer diagnosed between 1970 and 1999: report from the Childhood Cancer Survivor Study cohort


Read the full research:

https://www.bmj.com/content/368/bmj.l6794]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1482</itunes:duration>
                                    </item>
    <item>
        <title>Is it possible to have fair pricing for medicines</title>
        <itunes:title>Is it possible to have fair pricing for medicines</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/is-it-possible-to-have-fair-pricing-for-medicines/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/is-it-possible-to-have-fair-pricing-for-medicines/#comments</comments>        <pubDate>Fri, 17 Jan 2020 17:50:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/is-it-possible-to-have-fair-pricing-for-medicines</guid>
                                    <description><![CDATA[Is it possible to have a fair price for medicines? Yes, according to a new collection just published on bmj.com.

The authors set out to evaluate how we could improve the functioning of the market for medicines, to honestly compensate industry for innovation, whilst allowing the poorest to afford them.

Suerie Moon, co-director of global health at the Graduate Institute of Geneva joins us to explain what's wrong with how we decided what to pay for medicine's now, and how we could change that.

Read the full collection:
<p>https://www.bmj.com/fair-pricing</p>
]]></description>
                                                            <content:encoded><![CDATA[Is it possible to have a fair price for medicines? Yes, according to a new collection just published on bmj.com.

The authors set out to evaluate how we could improve the functioning of the market for medicines, to honestly compensate industry for innovation, whilst allowing the poorest to afford them.

Suerie Moon, co-director of global health at the Graduate Institute of Geneva joins us to explain what's wrong with how we decided what to pay for medicine's now, and how we could change that.

Read the full collection:
<p>https://www.bmj.com/fair-pricing</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/x7micp/stream_745053640-bmjgroup-is-it-possible-to-have-fair-pricing-for-medicines.mp3" length="37820603" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Is it possible to have a fair price for medicines? Yes, according to a new collection just published on bmj.com.

The authors set out to evaluate how we could improve the functioning of the market for medicines, to honestly compensate industry for innovation, whilst allowing the poorest to afford them.

Suerie Moon, co-director of global health at the Graduate Institute of Geneva joins us to explain what's wrong with how we decided what to pay for medicine's now, and how we could change that.

Read the full collection:
https://www.bmj.com/fair-pricing]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1577</itunes:duration>
                                    </item>
    <item>
        <title>Michael West - GMC Report On Wellbeing</title>
        <itunes:title>Michael West - GMC Report On Wellbeing</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/michael-west-gmc-report-on-wellbeing/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/michael-west-gmc-report-on-wellbeing/#comments</comments>        <pubDate>Fri, 10 Jan 2020 15:02:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/michael-west-gmc-report-on-wellbeing-mixdown</guid>
                                    <description><![CDATA[Michael West is professor of organisational psychology, at Lancaster University, and co-author of a new GMC report into the wellbeing of NHS staff.

The review he led together with the clinical psychiatrist Denise Coia, focused on primary interventions related to workplace factors and the systems that doctors work in, rather than secondary interventions such as resilience training.

In this podcast interview, he describes what he found - and talks about how low wellbeing is amongst doctors, why the command and control nature of some management teams has increased the problem, and why he has hope because of some of the good practice he sees in NHS organisations.

Read the full report:
<p>https://www.gmc-uk.org/-/media/documents/caring-for-doctors-caring-for-patients_pdf-80706341.pdf</p>
]]></description>
                                                            <content:encoded><![CDATA[Michael West is professor of organisational psychology, at Lancaster University, and co-author of a new GMC report into the wellbeing of NHS staff.

The review he led together with the clinical psychiatrist Denise Coia, focused on primary interventions related to workplace factors and the systems that doctors work in, rather than secondary interventions such as resilience training.

In this podcast interview, he describes what he found - and talks about how low wellbeing is amongst doctors, why the command and control nature of some management teams has increased the problem, and why he has hope because of some of the good practice he sees in NHS organisations.

Read the full report:
<p>https://www.gmc-uk.org/-/media/documents/caring-for-doctors-caring-for-patients_pdf-80706341.pdf</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/r0jyx0/stream_741332473-bmjgroup-michael-west-gmc-report-on-wellbeing-mixdown.mp3" length="36981863" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Michael West is professor of organisational psychology, at Lancaster University, and co-author of a new GMC report into the wellbeing of NHS staff.

The review he led together with the clinical psychiatrist Denise Coia, focused on primary interventions related to workplace factors and the systems that doctors work in, rather than secondary interventions such as resilience training.

In this podcast interview, he describes what he found - and talks about how low wellbeing is amongst doctors, why the command and control nature of some management teams has increased the problem, and why he has hope because of some of the good practice he sees in NHS organisations.

Read the full report:
https://www.gmc-uk.org/-/media/documents/caring-for-doctors-caring-for-patients_pdf-80706341.pdf]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2311</itunes:duration>
                                    </item>
    <item>
        <title>From dance class to social prescription - starting and evaluating an idea</title>
        <itunes:title>From dance class to social prescription - starting and evaluating an idea</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/from-dance-class-to-social-prescription-starting-and-evaluating-an-idea/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/from-dance-class-to-social-prescription-starting-and-evaluating-an-idea/#comments</comments>        <pubDate>Tue, 07 Jan 2020 10:47:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/how-to-do-social-prescribing</guid>
                                    <description><![CDATA[If you read the Christmas BMJ in the last few weeks, you might have noticed a lot around art and health - the way in which engagement in arts can help in prevention and treatment, but can also  affect those more nebulous things which really matter to patients - loneliness, self expression, being connected to the wider community.

That obviously links to social prescribing, which looks like it’s going to be one of the big changes to medicine which will happen in near future.

In this podcast we hear from Simon Opher, a GP in gloucestershire who has had artists and poets in residence in his surgery, and has experience of setting up services which link art and health - and we discuss how to do that practically. SImon makes it sound easy, but also has a few tips for GPs out there who have an idea about a non-medical service that could help their patients, but doesn’t yet exist.

We’ll also be talking to Helen Stokes Lampard, former chair of the Royal College of Surgeons and head of the new National Academy for Social Prescribing - as services bloom, how do we know what actually works?

Helen is sceptical that our current ways of evaluating an intervention are going to be inadequate to look at the much more messy world of social prescribing, with it’s localisation, multitude of influences, and difficult to measure outcomes.


Reading list:
Previous BMJ podcast on social prescribing
https://podcasts.apple.com/no/podcast/social-prescribing/id283916558?i=1000446265663

Clinical update on social prescribing
<p>https://www.bmj.com/content/364/bmj.l1285</p>
]]></description>
                                                            <content:encoded><![CDATA[If you read the Christmas BMJ in the last few weeks, you might have noticed a lot around art and health - the way in which engagement in arts can help in prevention and treatment, but can also  affect those more nebulous things which really matter to patients - loneliness, self expression, being connected to the wider community.

That obviously links to social prescribing, which looks like it’s going to be one of the big changes to medicine which will happen in near future.

In this podcast we hear from Simon Opher, a GP in gloucestershire who has had artists and poets in residence in his surgery, and has experience of setting up services which link art and health - and we discuss how to do that practically. SImon makes it sound easy, but also has a few tips for GPs out there who have an idea about a non-medical service that could help their patients, but doesn’t yet exist.

We’ll also be talking to Helen Stokes Lampard, former chair of the Royal College of Surgeons and head of the new National Academy for Social Prescribing - as services bloom, how do we know what actually works?

Helen is sceptical that our current ways of evaluating an intervention are going to be inadequate to look at the much more messy world of social prescribing, with it’s localisation, multitude of influences, and difficult to measure outcomes.


Reading list:
Previous BMJ podcast on social prescribing
https://podcasts.apple.com/no/podcast/social-prescribing/id283916558?i=1000446265663

Clinical update on social prescribing
<p>https://www.bmj.com/content/364/bmj.l1285</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/82bqg1/stream_739623871-bmjgroup-how-to-do-social-prescribing.mp3" length="39844048" type="audio/mpeg"/>
        <itunes:summary><![CDATA[If you read the Christmas BMJ in the last few weeks, you might have noticed a lot around art and health - the way in which engagement in arts can help in prevention and treatment, but can also  affect those more nebulous things which really matter to patients - loneliness, self expression, being connected to the wider community.

That obviously links to social prescribing, which looks like it’s going to be one of the big changes to medicine which will happen in near future.

In this podcast we hear from Simon Opher, a GP in gloucestershire who has had artists and poets in residence in his surgery, and has experience of setting up services which link art and health - and we discuss how to do that practically. SImon makes it sound easy, but also has a few tips for GPs out there who have an idea about a non-medical service that could help their patients, but doesn’t yet exist.

We’ll also be talking to Helen Stokes Lampard, former chair of the Royal College of Surgeons and head of the new National Academy for Social Prescribing - as services bloom, how do we know what actually works?

Helen is sceptical that our current ways of evaluating an intervention are going to be inadequate to look at the much more messy world of social prescribing, with it’s localisation, multitude of influences, and difficult to measure outcomes.


Reading list:
Previous BMJ podcast on social prescribing
https://podcasts.apple.com/no/podcast/social-prescribing/id283916558?i=1000446265663

Clinical update on social prescribing
https://www.bmj.com/content/364/bmj.l1285]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2490</itunes:duration>
                                    </item>
    <item>
        <title>Editors pick of education in 2019</title>
        <itunes:title>Editors pick of education in 2019</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/editors-pick-of-education-in-2019/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/editors-pick-of-education-in-2019/#comments</comments>        <pubDate>Fri, 03 Jan 2020 14:58:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/editors-pick-of-education-in-2019</guid>
                                    <description><![CDATA[If you’re lucky enough to not be back at work, you might be feeling like you need to quickly refresh your medical knowledge - and this podcast  the BMJ’s education editors take you on a whistlestop tour through the BMJ’s education articles of 2019.

Tom Nolan (GP in London) is joined by Navjoyt Ladher (GP in London), Anita Jain (GP in India) and Jenny Rasanathan (GP in Phnom Penh).

Our reading list:
Please don’t call me mum
https://www.bmj.com/content/367/bmj.l5373

Which emollients are effective and acceptable for eczema in children?
https://www.bmj.com/content/367/bmj.l5882

Pre-eclampsia: pathophysiology and clinical implications
https://www.bmj.com/content/366/bmj.l2381

A borderline HbA1c result
<p>https://www.bmj.com/content/365/bmj.l1361</p>
]]></description>
                                                            <content:encoded><![CDATA[If you’re lucky enough to not be back at work, you might be feeling like you need to quickly refresh your medical knowledge - and this podcast  the BMJ’s education editors take you on a whistlestop tour through the BMJ’s education articles of 2019.

Tom Nolan (GP in London) is joined by Navjoyt Ladher (GP in London), Anita Jain (GP in India) and Jenny Rasanathan (GP in Phnom Penh).

Our reading list:
Please don’t call me mum
https://www.bmj.com/content/367/bmj.l5373

Which emollients are effective and acceptable for eczema in children?
https://www.bmj.com/content/367/bmj.l5882

Pre-eclampsia: pathophysiology and clinical implications
https://www.bmj.com/content/366/bmj.l2381

A borderline HbA1c result
<p>https://www.bmj.com/content/365/bmj.l1361</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2n0ov4/stream_737852491-bmjgroup-editors-pick-of-education-in-2019.mp3" length="28388204" type="audio/mpeg"/>
        <itunes:summary><![CDATA[If you’re lucky enough to not be back at work, you might be feeling like you need to quickly refresh your medical knowledge - and this podcast  the BMJ’s education editors take you on a whistlestop tour through the BMJ’s education articles of 2019.

Tom Nolan (GP in London) is joined by Navjoyt Ladher (GP in London), Anita Jain (GP in India) and Jenny Rasanathan (GP in Phnom Penh).

Our reading list:
Please don’t call me mum
https://www.bmj.com/content/367/bmj.l5373

Which emollients are effective and acceptable for eczema in children?
https://www.bmj.com/content/367/bmj.l5882

Pre-eclampsia: pathophysiology and clinical implications
https://www.bmj.com/content/366/bmj.l2381

A borderline HbA1c result
https://www.bmj.com/content/365/bmj.l1361]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1774</itunes:duration>
                                    </item>
    <item>
        <title>Talk Xmas Evidence</title>
        <itunes:title>Talk Xmas Evidence</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-xmas-evidence/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-xmas-evidence/#comments</comments>        <pubDate>Tue, 31 Dec 2019 14:52:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-xmas-evidence</guid>
                                    <description><![CDATA[Welcome to the festive talk evidence, giving you a little EBM to take you into the new year.  As always Duncan Jarvies is joined by Helen Macdonald (resting GP and editor at The BMJ) and Carl Heneghan (active GP, director of Oxford University’s CEBM and editor of BMJ Evidence) 

This month:

(2.00) Helen look back at a Christmas article, which investigates a very common superstition in hospitals.

(7.55) Carl has his pick of the top 100 altimetric most influential papers of the year.

(12.40) We find out all about the preventing overdiagnosis conference which happened earlier in December.

(34.15) Helen has her annual rant about misogeny in medicine.



Reading list:
Q fever—the superstition of avoiding the word “quiet” as a coping mechanism
https://www.bmj.com/content/367/bmj.l6446

Altimetric Top 100
https://www.altmetric.com/top100/2019/

Fiona Godlee’s keynote at Preventing Overdiagnosis
https://www.preventingoverdiagnosis.net/

Gender differences in how scientists present the importance of their research: observational study
<p>https://www.bmj.com/content/367/bmj.l6573</p>
]]></description>
                                                            <content:encoded><![CDATA[Welcome to the festive talk evidence, giving you a little EBM to take you into the new year.  As always Duncan Jarvies is joined by Helen Macdonald (resting GP and editor at The BMJ) and Carl Heneghan (active GP, director of Oxford University’s CEBM and editor of BMJ Evidence) 

This month:

(2.00) Helen look back at a Christmas article, which investigates a very common superstition in hospitals.

(7.55) Carl has his pick of the top 100 altimetric most influential papers of the year.

(12.40) We find out all about the preventing overdiagnosis conference which happened earlier in December.

(34.15) Helen has her annual rant about misogeny in medicine.



Reading list:
Q fever—the superstition of avoiding the word “quiet” as a coping mechanism
https://www.bmj.com/content/367/bmj.l6446

Altimetric Top 100
https://www.altmetric.com/top100/2019/

Fiona Godlee’s keynote at Preventing Overdiagnosis
https://www.preventingoverdiagnosis.net/

Gender differences in how scientists present the importance of their research: observational study
<p>https://www.bmj.com/content/367/bmj.l6573</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/irajh0/stream_736322539-bmjgroup-talk-xmas-evidence.mp3" length="42195486" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Welcome to the festive talk evidence, giving you a little EBM to take you into the new year.  As always Duncan Jarvies is joined by Helen Macdonald (resting GP and editor at The BMJ) and Carl Heneghan (active GP, director of Oxford University’s CEBM and editor of BMJ Evidence) 

This month:

(2.00) Helen look back at a Christmas article, which investigates a very common superstition in hospitals.

(7.55) Carl has his pick of the top 100 altimetric most influential papers of the year.

(12.40) We find out all about the preventing overdiagnosis conference which happened earlier in December.

(34.15) Helen has her annual rant about misogeny in medicine.



Reading list:
Q fever—the superstition of avoiding the word “quiet” as a coping mechanism
https://www.bmj.com/content/367/bmj.l6446

Altimetric Top 100
https://www.altmetric.com/top100/2019/

Fiona Godlee’s keynote at Preventing Overdiagnosis
https://www.preventingoverdiagnosis.net/

Gender differences in how scientists present the importance of their research: observational study
https://www.bmj.com/content/367/bmj.l6573]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2637</itunes:duration>
                                    </item>
    <item>
        <title>The need for (psychiatrists’) speed</title>
        <itunes:title>The need for (psychiatrists’) speed</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-need-for-psychiatrists-speed/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-need-for-psychiatrists-speed/#comments</comments>        <pubDate>Fri, 20 Dec 2019 16:22:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-need-for-psychiatrists-speed</guid>
                                    <description><![CDATA[The internecine takes on medical specialty are a common thread in the Christmas BMJ, and this year we're doing it through the lens of driving. Which speciality speeds the most, who has the nicest cars?

André Zimerman, soon to be cardiologist, and researcher lets us know - and also why you can't rely on being a doctor to get off a speeding ticket. At least in Florida.

Read the full article:
<p>https://www.bmj.com/content/367/bmj.l6354</p>
]]></description>
                                                            <content:encoded><![CDATA[The internecine takes on medical specialty are a common thread in the Christmas BMJ, and this year we're doing it through the lens of driving. Which speciality speeds the most, who has the nicest cars?

André Zimerman, soon to be cardiologist, and researcher lets us know - and also why you can't rely on being a doctor to get off a speeding ticket. At least in Florida.

Read the full article:
<p>https://www.bmj.com/content/367/bmj.l6354</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/i6noyh/stream_731487400-bmjgroup-the-need-for-psychiatrists-speed.mp3" length="15237119" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The internecine takes on medical specialty are a common thread in the Christmas BMJ, and this year we're doing it through the lens of driving. Which speciality speeds the most, who has the nicest cars?

André Zimerman, soon to be cardiologist, and researcher lets us know - and also why you can't rely on being a doctor to get off a speeding ticket. At least in Florida.

Read the full article:
https://www.bmj.com/content/367/bmj.l6354]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>952</itunes:duration>
                                    </item>
    <item>
        <title>Talking up your research - Sex makes a difference</title>
        <itunes:title>Talking up your research - Sex makes a difference</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talking-up-your-research-sex-makes-a-difference/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talking-up-your-research-sex-makes-a-difference/#comments</comments>        <pubDate>Fri, 20 Dec 2019 15:50:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talking-up-your-research-sex-makes-a-difference</guid>
                                    <description><![CDATA[As editors, we feel like we’re spending a lot of time taking the superlatives out from articles - amazing, novel, important… But new research on BMJ.com suggests that we might not be doing that great a job, and that for some reason, papers authored by men tend to have more of them - because men put more in, or maybe a bias against woman writing in that way.

Marc Lerchenmueller, assistant professor at the University of Mannheim joins us to talk about how they did the research, and what it means for women's careers.

Read the full article
<p>https://www.bmj.com/content/367/bmj.l6573</p>
]]></description>
                                                            <content:encoded><![CDATA[As editors, we feel like we’re spending a lot of time taking the superlatives out from articles - amazing, novel, important… But new research on BMJ.com suggests that we might not be doing that great a job, and that for some reason, papers authored by men tend to have more of them - because men put more in, or maybe a bias against woman writing in that way.

Marc Lerchenmueller, assistant professor at the University of Mannheim joins us to talk about how they did the research, and what it means for women's careers.

Read the full article
<p>https://www.bmj.com/content/367/bmj.l6573</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/g7790r/stream_731468749-bmjgroup-talking-up-your-research-sex-makes-a-difference.mp3" length="22433122" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As editors, we feel like we’re spending a lot of time taking the superlatives out from articles - amazing, novel, important… But new research on BMJ.com suggests that we might not be doing that great a job, and that for some reason, papers authored by men tend to have more of them - because men put more in, or maybe a bias against woman writing in that way.

Marc Lerchenmueller, assistant professor at the University of Mannheim joins us to talk about how they did the research, and what it means for women's careers.

Read the full article
https://www.bmj.com/content/367/bmj.l6573]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1402</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence - digital clubbing, osteoarthritis &amp; sustainable EBM</title>
        <itunes:title>Talk Evidence - digital clubbing, osteoarthritis &amp; sustainable EBM</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-digital-clubbing-osteoarthritis-sustainable-ebm/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-digital-clubbing-osteoarthritis-sustainable-ebm/#comments</comments>        <pubDate>Mon, 16 Dec 2019 19:36:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-digital-clubbing-osteoarthritis-sustainable-ebm</guid>
                                    <description><![CDATA[We’re back for the December Talk Evidence, and this month we’re being very digital

Firstly,(1.20) Helen tells us about arthritic fingers - should we be using prednisolone for treatment when people have painful osteoarthritis of the hand

Then (13.30) Carl gets us all to check our fingers for clubbing, and we find out how useful it is as a test for lung cancer

(23.10) Minna Johansson GP and Cochrane Sweden researcher explains why EBM needs to take into account sustainability, and why that isn’t just carbon footprint.

(33.50) We talk AF and the Apple Watch - and why drop out is going to be a massive problem for the kind of big studies that they’re attempting to do with new consumer smart devices.


This month's reading:
Results of a 6-week treatment with 10 mg prednisolone in patients with hand osteoarthritis (HOPE)
https://www.sciencedirect.com/science/article/pii/S0140673619324894?via%3Dihub

Cancer research UK - finger clubbing and mesothelioma
https://www.cancerresearchuk.org/about-cancer/mesothelioma/symptoms/finger-clubbing

Cochrane launches new Sustainable Healthcare Field, in Lund
https://sweden.cochrane.org/news/cochrane-launches-new-sustainable-healthcare-field-lund

Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation
<p>https://www.nejm.org/doi/full/10.1056/NEJMoa1901183</p>
]]></description>
                                                            <content:encoded><![CDATA[We’re back for the December Talk Evidence, and this month we’re being very digital

Firstly,(1.20) Helen tells us about arthritic fingers - should we be using prednisolone for treatment when people have painful osteoarthritis of the hand

Then (13.30) Carl gets us all to check our fingers for clubbing, and we find out how useful it is as a test for lung cancer

(23.10) Minna Johansson GP and Cochrane Sweden researcher explains why EBM needs to take into account sustainability, and why that isn’t just carbon footprint.

(33.50) We talk AF and the Apple Watch - and why drop out is going to be a massive problem for the kind of big studies that they’re attempting to do with new consumer smart devices.


This month's reading:
Results of a 6-week treatment with 10 mg prednisolone in patients with hand osteoarthritis (HOPE)
https://www.sciencedirect.com/science/article/pii/S0140673619324894?via%3Dihub

Cancer research UK - finger clubbing and mesothelioma
https://www.cancerresearchuk.org/about-cancer/mesothelioma/symptoms/finger-clubbing

Cochrane launches new Sustainable Healthcare Field, in Lund
https://sweden.cochrane.org/news/cochrane-launches-new-sustainable-healthcare-field-lund

Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation
<p>https://www.nejm.org/doi/full/10.1056/NEJMoa1901183</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/147bs8/stream_728813572-bmjgroup-talk-evidence-digital-clubbing-osteoarthritis-sustainable-ebm.mp3" length="62797867" type="audio/mpeg"/>
        <itunes:summary><![CDATA[We’re back for the December Talk Evidence, and this month we’re being very digital

Firstly,(1.20) Helen tells us about arthritic fingers - should we be using prednisolone for treatment when people have painful osteoarthritis of the hand

Then (13.30) Carl gets us all to check our fingers for clubbing, and we find out how useful it is as a test for lung cancer

(23.10) Minna Johansson GP and Cochrane Sweden researcher explains why EBM needs to take into account sustainability, and why that isn’t just carbon footprint.

(33.50) We talk AF and the Apple Watch - and why drop out is going to be a massive problem for the kind of big studies that they’re attempting to do with new consumer smart devices.


This month's reading:
Results of a 6-week treatment with 10 mg prednisolone in patients with hand osteoarthritis (HOPE)
https://www.sciencedirect.com/science/article/pii/S0140673619324894?via%3Dihub

Cancer research UK - finger clubbing and mesothelioma
https://www.cancerresearchuk.org/about-cancer/mesothelioma/symptoms/finger-clubbing

Cochrane launches new Sustainable Healthcare Field, in Lund
https://sweden.cochrane.org/news/cochrane-launches-new-sustainable-healthcare-field-lund

Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation
https://www.nejm.org/doi/full/10.1056/NEJMoa1901183]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2618</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence - Talking about harms</title>
        <itunes:title>Talk Evidence - Talking about harms</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-talking-about-harms/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-talking-about-harms/#comments</comments>        <pubDate>Fri, 13 Dec 2019 18:18:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-talking-about-harms</guid>
                                    <description><![CDATA[In this special edition of talk evidence, Helen Macdonald and Carl Henneghan talk about creating an evidence base from harms.

<p>We hear from a member of the pubic who experienced harm from a drug, and now advises the FDA. A former regulator who explains why reporting harms is so important. And finally, an investigative journalist who explains what "ghost management" is.</p>
]]></description>
                                                            <content:encoded><![CDATA[In this special edition of talk evidence, Helen Macdonald and Carl Henneghan talk about creating an evidence base from harms.

<p>We hear from a member of the pubic who experienced harm from a drug, and now advises the FDA. A former regulator who explains why reporting harms is so important. And finally, an investigative journalist who explains what "ghost management" is.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/03hlz4/stream_727401478-bmjgroup-talk-evidence-talking-about-harms.mp3" length="50093720" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this special edition of talk evidence, Helen Macdonald and Carl Henneghan talk about creating an evidence base from harms.

We hear from a member of the pubic who experienced harm from a drug, and now advises the FDA. A former regulator who explains why reporting harms is so important. And finally, an investigative journalist who explains what "ghost management" is.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2089</itunes:duration>
                                    </item>
    <item>
        <title>Behind the campaign promises - Doctors in parliament</title>
        <itunes:title>Behind the campaign promises - Doctors in parliament</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/behind-the-campaign-promises-doctors-in-parliament/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/behind-the-campaign-promises-doctors-in-parliament/#comments</comments>        <pubDate>Mon, 09 Dec 2019 18:52:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/behind-the-campaign-promises-doctors-in-parliament</guid>
                                    <description><![CDATA[The UK general election is happening this week, and you’ve probably made your mind up which MP you’re voting for already - and maybe the NHS has influenced that decision. 

This year has seen an increase in the number of doctors running for parliament, and in this podcast we find out what motivates doctors to step away from clinical practice, and why their voice on national issues is important to guide the health of their patients.

<p>We’re joined by Louise Irving, gp and former parliamentary candidate for the NHS action party, and Andy Cowper, editor of Health Policy Insight</p>
]]></description>
                                                            <content:encoded><![CDATA[The UK general election is happening this week, and you’ve probably made your mind up which MP you’re voting for already - and maybe the NHS has influenced that decision. 

This year has seen an increase in the number of doctors running for parliament, and in this podcast we find out what motivates doctors to step away from clinical practice, and why their voice on national issues is important to guide the health of their patients.

<p>We’re joined by Louise Irving, gp and former parliamentary candidate for the NHS action party, and Andy Cowper, editor of Health Policy Insight</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/twtlz9/stream_725314018-bmjgroup-behind-the-campaign-promises-doctors-in-parliament.mp3" length="46761386" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The UK general election is happening this week, and you’ve probably made your mind up which MP you’re voting for already - and maybe the NHS has influenced that decision. 

This year has seen an increase in the number of doctors running for parliament, and in this podcast we find out what motivates doctors to step away from clinical practice, and why their voice on national issues is important to guide the health of their patients.

We’re joined by Louise Irving, gp and former parliamentary candidate for the NHS action party, and Andy Cowper, editor of Health Policy Insight]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1951</itunes:duration>
                                    </item>
    <item>
        <title>Behind the campaign promises - what the NHS means for the election</title>
        <itunes:title>Behind the campaign promises - what the NHS means for the election</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/behind-the-campaign-promises-what-the-nhs-means-for-the-election/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/behind-the-campaign-promises-what-the-nhs-means-for-the-election/#comments</comments>        <pubDate>Thu, 05 Dec 2019 19:09:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/behind-the-campaign-promises-what-the-nhs-means-for-the-election</guid>
                                    <description><![CDATA[UK general election has been called - polling day is on the 12th of December, and from now until then we’re going to be bringing you a weekly election-themed podcast.

We want to help you make sense of the promises and pledges, claims and counter-claims, that are being made around healthcare and the NHS out on the campaign trail.

This week we're focussing on what the NHS means to the election, from people who have been inside the political process and know about how campaign promises are made. We talk about retail pledges, and why spending claims which don't cause real change might come back to bite politicians. 

Joining us are Sally Warren, director of policy at The King's Fund,
Siva Anandaciva, chief analyst at The King's Fund and Bill Morgan, former policy advisor and founding partner of Incisive Health

www.kingsfund.org.uk/Podcast‎
<p>https://www.kingsfund.org.uk/topics/general-election-2019</p>
]]></description>
                                                            <content:encoded><![CDATA[UK general election has been called - polling day is on the 12th of December, and from now until then we’re going to be bringing you a weekly election-themed podcast.

We want to help you make sense of the promises and pledges, claims and counter-claims, that are being made around healthcare and the NHS out on the campaign trail.

This week we're focussing on what the NHS means to the election, from people who have been inside the political process and know about how campaign promises are made. We talk about retail pledges, and why spending claims which don't cause real change might come back to bite politicians. 

Joining us are Sally Warren, director of policy at The King's Fund,
Siva Anandaciva, chief analyst at The King's Fund and Bill Morgan, former policy advisor and founding partner of Incisive Health

www.kingsfund.org.uk/Podcast‎
<p>https://www.kingsfund.org.uk/topics/general-election-2019</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/45bxfz/stream_723270832-bmjgroup-behind-the-campaign-promises-what-the-nhs-means-for-the-election.mp3" length="49808102" type="audio/mpeg"/>
        <itunes:summary><![CDATA[UK general election has been called - polling day is on the 12th of December, and from now until then we’re going to be bringing you a weekly election-themed podcast.

We want to help you make sense of the promises and pledges, claims and counter-claims, that are being made around healthcare and the NHS out on the campaign trail.

This week we're focussing on what the NHS means to the election, from people who have been inside the political process and know about how campaign promises are made. We talk about retail pledges, and why spending claims which don't cause real change might come back to bite politicians. 

Joining us are Sally Warren, director of policy at The King's Fund,
Siva Anandaciva, chief analyst at The King's Fund and Bill Morgan, former policy advisor and founding partner of Incisive Health

www.kingsfund.org.uk/Podcast‎
https://www.kingsfund.org.uk/topics/general-election-2019]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2077</itunes:duration>
                                    </item>
    <item>
        <title>Behind the campaign promises - Health beyond the NHS</title>
        <itunes:title>Behind the campaign promises - Health beyond the NHS</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/behind-the-campaign-promises-health-beyond-the-nhs/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/behind-the-campaign-promises-health-beyond-the-nhs/#comments</comments>        <pubDate>Sat, 30 Nov 2019 09:10:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/behind-the-campaign-promises-health-beyond-the-nhs</guid>
                                    <description><![CDATA[A UK general election has been called - polling day is on the 12th of December, and from now until then we’re going to be bringing you a weekly election-themed podcast.

We want to help you make sense of the promises and pledges, claims and counter-claims, that are being made around healthcare and the NHS out on the campaign trail.

This week we're focussing on health beyond the NHS - public health spending, and pledges to tackle air pollution and climate change. To discuss we're joined by Jennifer Dixon, chief executive of the Health Foundation, and Nicky Philpott, director of the  UK Health Alliance on Climate Change.

Reading list
The BMJ's 2019 election coverage
https://www.bmj.com/content/general-election-2019

Health Foundation report: Mortality and life expectancy trends in the UK
https://www.health.org.uk/publications/reports/mortality-and-life-expectancy-trends-in-the-uk

UK Health Alliance on Climate Change general election briefing
<p>http://www.ukhealthalliance.org/general-election-briefing/</p>
]]></description>
                                                            <content:encoded><![CDATA[A UK general election has been called - polling day is on the 12th of December, and from now until then we’re going to be bringing you a weekly election-themed podcast.

We want to help you make sense of the promises and pledges, claims and counter-claims, that are being made around healthcare and the NHS out on the campaign trail.

This week we're focussing on health beyond the NHS - public health spending, and pledges to tackle air pollution and climate change. To discuss we're joined by Jennifer Dixon, chief executive of the Health Foundation, and Nicky Philpott, director of the  UK Health Alliance on Climate Change.

Reading list
The BMJ's 2019 election coverage
https://www.bmj.com/content/general-election-2019

Health Foundation report: Mortality and life expectancy trends in the UK
https://www.health.org.uk/publications/reports/mortality-and-life-expectancy-trends-in-the-uk

UK Health Alliance on Climate Change general election briefing
<p>http://www.ukhealthalliance.org/general-election-briefing/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/pk2e60/stream_720662437-bmjgroup-behind-the-campaign-promises-health-beyond-the-nhs.mp3" length="56281983" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A UK general election has been called - polling day is on the 12th of December, and from now until then we’re going to be bringing you a weekly election-themed podcast.

We want to help you make sense of the promises and pledges, claims and counter-claims, that are being made around healthcare and the NHS out on the campaign trail.

This week we're focussing on health beyond the NHS - public health spending, and pledges to tackle air pollution and climate change. To discuss we're joined by Jennifer Dixon, chief executive of the Health Foundation, and Nicky Philpott, director of the  UK Health Alliance on Climate Change.

Reading list
The BMJ's 2019 election coverage
https://www.bmj.com/content/general-election-2019

Health Foundation report: Mortality and life expectancy trends in the UK
https://www.health.org.uk/publications/reports/mortality-and-life-expectancy-trends-in-the-uk

UK Health Alliance on Climate Change general election briefing
http://www.ukhealthalliance.org/general-election-briefing/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2348</itunes:duration>
                                    </item>
    <item>
        <title>Behind the campaign promises - Health and social care spending</title>
        <itunes:title>Behind the campaign promises - Health and social care spending</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/behind-the-campaign-promises-health-and-social-care-spending/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/behind-the-campaign-promises-health-and-social-care-spending/#comments</comments>        <pubDate>Fri, 22 Nov 2019 16:21:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/behind-the-campaign-promises-health-and-social-care-spending</guid>
                                    <description><![CDATA[A UK general election has been called - polling day is on the 12th of December, and from now until then we’re going to be bringing you a weekly election-themed podcast.

We want to help you make sense of the promises and pledges, claims and counter-claims, that are being made around healthcare and the NHS out on the campaign trail.

This week we're focussing on spending pledges. NHS budgets have not been keeping up with healthcare demand, and social care is in dire financial straits. David Oliver, consultant physician in Berkshire and author of the weekly BMJ “Acute perspective” column, and Hugh Alderwick, assistant director of policy at the Health Foundation.

Reading list
Acute perspective column
https://blogs.bmj.com/bmj/category/columnists/david-oliver/

Health Foundations analysis of spending
https://www.health.org.uk/news-and-comment/blogsf




<p>talk through what the parties are promising</p>
]]></description>
                                                            <content:encoded><![CDATA[A UK general election has been called - polling day is on the 12th of December, and from now until then we’re going to be bringing you a weekly election-themed podcast.

We want to help you make sense of the promises and pledges, claims and counter-claims, that are being made around healthcare and the NHS out on the campaign trail.

This week we're focussing on spending pledges. NHS budgets have not been keeping up with healthcare demand, and social care is in dire financial straits. David Oliver, consultant physician in Berkshire and author of the weekly BMJ “Acute perspective” column, and Hugh Alderwick, assistant director of policy at the Health Foundation.

Reading list
Acute perspective column
https://blogs.bmj.com/bmj/category/columnists/david-oliver/

Health Foundations analysis of spending
https://www.health.org.uk/news-and-comment/blogsf




<p>talk through what the parties are promising</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/1tni6f/stream_716936980-bmjgroup-behind-the-campaign-promises-health-and-social-care-spending.mp3" length="39867663" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A UK general election has been called - polling day is on the 12th of December, and from now until then we’re going to be bringing you a weekly election-themed podcast.

We want to help you make sense of the promises and pledges, claims and counter-claims, that are being made around healthcare and the NHS out on the campaign trail.

This week we're focussing on spending pledges. NHS budgets have not been keeping up with healthcare demand, and social care is in dire financial straits. David Oliver, consultant physician in Berkshire and author of the weekly BMJ “Acute perspective” column, and Hugh Alderwick, assistant director of policy at the Health Foundation.

Reading list
Acute perspective column
https://blogs.bmj.com/bmj/category/columnists/david-oliver/

Health Foundations analysis of spending
https://www.health.org.uk/news-and-comment/blogsf




talk through what the parties are promising]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1663</itunes:duration>
                                    </item>
    <item>
        <title>Behind the campaign promises - GP numbers, and appointment slots</title>
        <itunes:title>Behind the campaign promises - GP numbers, and appointment slots</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/behind-the-campaign-promises-gp-numbers-and-appointment-slots/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/behind-the-campaign-promises-gp-numbers-and-appointment-slots/#comments</comments>        <pubDate>Fri, 15 Nov 2019 16:59:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/behind-the-campaign-promises-gp-numbers-and-appointment-slots</guid>
                                    <description><![CDATA[A UK general election has been called - polling day is on the 12th of December, and from now until then we’re going to be bringing you a weekly election-themed podcast. 

We want to help you make sense of the promises and pledges, claims and counter-claims, that are being made around healthcare and the NHS out on the campaign trail.

This week has seen pledges about GP numbers, so we're focussing on primary care - and are joined by two GPs, Clare Gerada, co chair of the NHS Assembly, and former chair of the Royal College of GPs, and Rebecca Rosen, who is also a senior fellow at the Nuffield Trust.

Reading list:
Health, wellbeing, and care should be top of everyone’s political agenda
https://www.bmj.com/content/367/bmj.l6503

Labour pledges to outspend Conservatives on health with £26bn NHS “rescue plan”
https://www.bmj.com/content/367/bmj.l6537

Tories promise 6000 extra GPs by 2024
https://www.bmj.com/content/367/bmj.l6463

Is the number of GPs falling across the UK?
<p>https://www.nuffieldtrust.org.uk/news-item/is-the-number-of-gps-falling-across-the-uk</p>
]]></description>
                                                            <content:encoded><![CDATA[A UK general election has been called - polling day is on the 12th of December, and from now until then we’re going to be bringing you a weekly election-themed podcast. 

We want to help you make sense of the promises and pledges, claims and counter-claims, that are being made around healthcare and the NHS out on the campaign trail.

This week has seen pledges about GP numbers, so we're focussing on primary care - and are joined by two GPs, Clare Gerada, co chair of the NHS Assembly, and former chair of the Royal College of GPs, and Rebecca Rosen, who is also a senior fellow at the Nuffield Trust.

Reading list:
Health, wellbeing, and care should be top of everyone’s political agenda
https://www.bmj.com/content/367/bmj.l6503

Labour pledges to outspend Conservatives on health with £26bn NHS “rescue plan”
https://www.bmj.com/content/367/bmj.l6537

Tories promise 6000 extra GPs by 2024
https://www.bmj.com/content/367/bmj.l6463

Is the number of GPs falling across the UK?
<p>https://www.nuffieldtrust.org.uk/news-item/is-the-number-of-gps-falling-across-the-uk</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/t9jr7i/stream_713314069-bmjgroup-behind-the-campaign-promises-gp-numbers-and-appointment-slots.mp3" length="44133105" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A UK general election has been called - polling day is on the 12th of December, and from now until then we’re going to be bringing you a weekly election-themed podcast. 

We want to help you make sense of the promises and pledges, claims and counter-claims, that are being made around healthcare and the NHS out on the campaign trail.

This week has seen pledges about GP numbers, so we're focussing on primary care - and are joined by two GPs, Clare Gerada, co chair of the NHS Assembly, and former chair of the Royal College of GPs, and Rebecca Rosen, who is also a senior fellow at the Nuffield Trust.

Reading list:
Health, wellbeing, and care should be top of everyone’s political agenda
https://www.bmj.com/content/367/bmj.l6503

Labour pledges to outspend Conservatives on health with £26bn NHS “rescue plan”
https://www.bmj.com/content/367/bmj.l6537

Tories promise 6000 extra GPs by 2024
https://www.bmj.com/content/367/bmj.l6463

Is the number of GPs falling across the UK?
https://www.nuffieldtrust.org.uk/news-item/is-the-number-of-gps-falling-across-the-uk]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1841</itunes:duration>
                                    </item>
    <item>
        <title>Reversing our preconceptions about where innovation comes from</title>
        <itunes:title>Reversing our preconceptions about where innovation comes from</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/reversing-our-preconceptions-about-where-innovation-comes-from/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/reversing-our-preconceptions-about-where-innovation-comes-from/#comments</comments>        <pubDate>Thu, 14 Nov 2019 16:51:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/reversing-our-preconceptions-about-where-innovation-comes-from</guid>
                                    <description><![CDATA[Reverse innovation may sound like some attempt to return to the dark ages - but it has a specific meaning, especially when it comes to med-tech. It’s about where we look for innovation - and overturning our preconceived ideas of where new ideas come from.

Mark Skopec, and Matthew Harris - both from Imperial College London are two of the authors of a new analysis, setting out to highlight those preconceptions, and creating new routes to bring innovation into the NHS.

Read the analysis:
<p>https://www.bmj.com/content/367/bmj.l6205</p>
]]></description>
                                                            <content:encoded><![CDATA[Reverse innovation may sound like some attempt to return to the dark ages - but it has a specific meaning, especially when it comes to med-tech. It’s about where we look for innovation - and overturning our preconceived ideas of where new ideas come from.

Mark Skopec, and Matthew Harris - both from Imperial College London are two of the authors of a new analysis, setting out to highlight those preconceptions, and creating new routes to bring innovation into the NHS.

Read the analysis:
<p>https://www.bmj.com/content/367/bmj.l6205</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/byoezi/stream_712800538-bmjgroup-reversing-our-preconceptions-about-where-innovation-comes-from.mp3" length="33153317" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Reverse innovation may sound like some attempt to return to the dark ages - but it has a specific meaning, especially when it comes to med-tech. It’s about where we look for innovation - and overturning our preconceived ideas of where new ideas come from.

Mark Skopec, and Matthew Harris - both from Imperial College London are two of the authors of a new analysis, setting out to highlight those preconceptions, and creating new routes to bring innovation into the NHS.

Read the analysis:
https://www.bmj.com/content/367/bmj.l6205]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1383</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence - aggravating acronyms, a time to prescribe, and screening (again)</title>
        <itunes:title>Talk Evidence - aggravating acronyms, a time to prescribe, and screening (again)</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-aggravating-acronyms-a-time-to-prescribe-and-screening-again/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-aggravating-acronyms-a-time-to-prescribe-and-screening-again/#comments</comments>        <pubDate>Mon, 11 Nov 2019 11:51:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-november-2019-acronyms-timing-of-dose-and-screening</guid>
                                    <description><![CDATA[Talk Evidence is back, with your monthly take on the world of EBM with Duncan Jarvies and GPs Carl Heneghan (also director for the Centre of Evidence Based Medicine at the University of Oxford) and Helen Macdonald (also The BMJ's UK research Editor).
This month Helen talks about the messy business of colon cancer screening - which modality is best, and in what population is it actually effective (1.40)
Carl talks about how the Netherlands did the right research at the right time to stop a new pregnancy scan before it became routine (10.35)
The Rant: acronyms in research papers (17.45)
Mini Rant: politicisation of the NHS, and Carl pitches for yet another job (25.15)
Research in the news has talked about the importance of when drugs are taken, to maximise efficacy. Melvin Lobo, cardiologist specialising in hypertension joins us to explain that research and why we seem to have forgotten about that effect.
 
Reading list:
Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline
https://www.bmj.com/content/367/bmj.l5515

Effectiveness of routine third trimester ultrasonography to reduce adverse perinatal outcomes in low risk pregnancy (the IRIS study): nationwide, pragmatic, multicentre, stepped wedge cluster randomised trial
https://www.bmj.com/content/367/bmj.l5517

Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial
<p>https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehz754/5602478</p>
]]></description>
                                                            <content:encoded><![CDATA[Talk Evidence is back, with your monthly take on the world of EBM with Duncan Jarvies and GPs Carl Heneghan (also director for the Centre of Evidence Based Medicine at the University of Oxford) and Helen Macdonald (also The BMJ's UK research Editor).
This month Helen talks about the messy business of colon cancer screening - which modality is best, and in what population is it actually effective (1.40)
Carl talks about how the Netherlands did the right research at the right time to stop a new pregnancy scan before it became routine (10.35)
The Rant: acronyms in research papers (17.45)
Mini Rant: politicisation of the NHS, and Carl pitches for yet another job (25.15)
Research in the news has talked about the importance of when drugs are taken, to maximise efficacy. Melvin Lobo, cardiologist specialising in hypertension joins us to explain that research and why we seem to have forgotten about that effect.
 
Reading list:
Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline
https://www.bmj.com/content/367/bmj.l5515

Effectiveness of routine third trimester ultrasonography to reduce adverse perinatal outcomes in low risk pregnancy (the IRIS study): nationwide, pragmatic, multicentre, stepped wedge cluster randomised trial
https://www.bmj.com/content/367/bmj.l5517

Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial
<p>https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehz754/5602478</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/pyfwhm/stream_711046090-bmjgroup-talk-evidence-november-2019-acronyms-timing-of-dose-and-screening.mp3" length="38751084" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Talk Evidence is back, with your monthly take on the world of EBM with Duncan Jarvies and GPs Carl Heneghan (also director for the Centre of Evidence Based Medicine at the University of Oxford) and Helen Macdonald (also The BMJ's UK research Editor).
This month Helen talks about the messy business of colon cancer screening - which modality is best, and in what population is it actually effective (1.40)
Carl talks about how the Netherlands did the right research at the right time to stop a new pregnancy scan before it became routine (10.35)
The Rant: acronyms in research papers (17.45)
Mini Rant: politicisation of the NHS, and Carl pitches for yet another job (25.15)
Research in the news has talked about the importance of when drugs are taken, to maximise efficacy. Melvin Lobo, cardiologist specialising in hypertension joins us to explain that research and why we seem to have forgotten about that effect.
 
Reading list:
Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline
https://www.bmj.com/content/367/bmj.l5515

Effectiveness of routine third trimester ultrasonography to reduce adverse perinatal outcomes in low risk pregnancy (the IRIS study): nationwide, pragmatic, multicentre, stepped wedge cluster randomised trial
https://www.bmj.com/content/367/bmj.l5517

Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial
https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehz754/5602478]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2422</itunes:duration>
                                    </item>
    <item>
        <title>Creating a speak out culture</title>
        <itunes:title>Creating a speak out culture</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/creating-a-speak-out-culture/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/creating-a-speak-out-culture/#comments</comments>        <pubDate>Thu, 07 Nov 2019 17:00:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/creating-a-speak-out-culture</guid>
                                    <description><![CDATA[Giving staff the confidence to speak out is important in healthcare - It's a key aspect of the WHO patient safety checklist, decreasing incidence of medical error, but it's also important to stop incidents of harassment and abuse which undermine staff and increase burnout. 

Creating that culture is a difficult task, but two hospitals in the southern hemisphere have been trying to do do that by putting in place ways which support staff in making complaints when they wouldn't normally feel confident to do so.

In this podcast we hear from Alex Sia, CEO of KK hospital Singapore, Jeanette Conley, medical executive at Adventist Healthcare in Sydney and Mark O”Brien, medical director of the Cognitive Institute, who talk about their challenges and successes in changing the way they work.

For more on burnout;
https://podcasts.apple.com/co/podcast/burnout-dont-try-to-make-canary-in-coal-mine-more-resilient/id283916558?i=1000446459269

<p>http://www.bmj.com/wellbeing</p>
]]></description>
                                                            <content:encoded><![CDATA[Giving staff the confidence to speak out is important in healthcare - It's a key aspect of the WHO patient safety checklist, decreasing incidence of medical error, but it's also important to stop incidents of harassment and abuse which undermine staff and increase burnout. 

Creating that culture is a difficult task, but two hospitals in the southern hemisphere have been trying to do do that by putting in place ways which support staff in making complaints when they wouldn't normally feel confident to do so.

In this podcast we hear from Alex Sia, CEO of KK hospital Singapore, Jeanette Conley, medical executive at Adventist Healthcare in Sydney and Mark O”Brien, medical director of the Cognitive Institute, who talk about their challenges and successes in changing the way they work.

For more on burnout;
https://podcasts.apple.com/co/podcast/burnout-dont-try-to-make-canary-in-coal-mine-more-resilient/id283916558?i=1000446459269

<p>http://www.bmj.com/wellbeing</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/my4ezn/stream_709291375-bmjgroup-creating-a-speak-out-culture.mp3" length="39813587" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Giving staff the confidence to speak out is important in healthcare - It's a key aspect of the WHO patient safety checklist, decreasing incidence of medical error, but it's also important to stop incidents of harassment and abuse which undermine staff and increase burnout. 

Creating that culture is a difficult task, but two hospitals in the southern hemisphere have been trying to do do that by putting in place ways which support staff in making complaints when they wouldn't normally feel confident to do so.

In this podcast we hear from Alex Sia, CEO of KK hospital Singapore, Jeanette Conley, medical executive at Adventist Healthcare in Sydney and Mark O”Brien, medical director of the Cognitive Institute, who talk about their challenges and successes in changing the way they work.

For more on burnout;
https://podcasts.apple.com/co/podcast/burnout-dont-try-to-make-canary-in-coal-mine-more-resilient/id283916558?i=1000446459269

http://www.bmj.com/wellbeing]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1660</itunes:duration>
                                    </item>
    <item>
        <title>Creating support for doctors in the NHS</title>
        <itunes:title>Creating support for doctors in the NHS</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/creating-support-for-doctors-in-the-nhs/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/creating-support-for-doctors-in-the-nhs/#comments</comments>        <pubDate>Tue, 05 Nov 2019 10:50:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/creating-support-for-doctors-in-the-nhs</guid>
                                    <description><![CDATA[The NHS Practitioner Health Programme - once only for doctors in London, now it’s being rolled out across the NHS to provide the largest, publicly funded, comprehensive physician health service, in the world.

However, while helping the individual is essential, systemic change needs to be made to support doctors in our healthcare system.

Clare Gerada, GP and medical director of NHS PHP joins us to talk about how the expanded service will work, and what role regulation and inspections should play in wellbeing.

For more on the NHS PHP
https://blogs.bmj.com/bmj/2019/10/31/clare-gerada-protecting-practitioners-health/
020 3049 4505
<p>https://php.nhs.uk/</p>
]]></description>
                                                            <content:encoded><![CDATA[The NHS Practitioner Health Programme - once only for doctors in London, now it’s being rolled out across the NHS to provide the largest, publicly funded, comprehensive physician health service, in the world.

However, while helping the individual is essential, systemic change needs to be made to support doctors in our healthcare system.

Clare Gerada, GP and medical director of NHS PHP joins us to talk about how the expanded service will work, and what role regulation and inspections should play in wellbeing.

For more on the NHS PHP
https://blogs.bmj.com/bmj/2019/10/31/clare-gerada-protecting-practitioners-health/
020 3049 4505
<p>https://php.nhs.uk/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/l3gaj8/stream_708154945-bmjgroup-creating-support-for-doctors-in-the-nhs.mp3" length="26435041" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The NHS Practitioner Health Programme - once only for doctors in London, now it’s being rolled out across the NHS to provide the largest, publicly funded, comprehensive physician health service, in the world.

However, while helping the individual is essential, systemic change needs to be made to support doctors in our healthcare system.

Clare Gerada, GP and medical director of NHS PHP joins us to talk about how the expanded service will work, and what role regulation and inspections should play in wellbeing.

For more on the NHS PHP
https://blogs.bmj.com/bmj/2019/10/31/clare-gerada-protecting-practitioners-health/
020 3049 4505
https://php.nhs.uk/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1102</itunes:duration>
                                    </item>
    <item>
        <title>Nudging the calories off your order</title>
        <itunes:title>Nudging the calories off your order</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/nudging-the-calories-off-your-order/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/nudging-the-calories-off-your-order/#comments</comments>        <pubDate>Thu, 31 Oct 2019 17:25:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/nudging-the-calories-off-your-order</guid>
                                    <description><![CDATA[There has been a lot of noise made about calorie counts on labels - the idea being it’s one of those things that might nudge people to make healthier choices.

So much so that in 2018, in the USA, it became mandatory for food chains with more than 20 outlets to label the calories in their food.

But the effectiveness of that is hard to gauge - it’s relied on reporting from customers, which leads to an incomplete picture. The really killer data would be from the chains themselves, but they’re reluctant to share that widely.

That's where new research comes in - and we're joined in the podcast by Joshua Petimar,  postdoctoral researcher at the Harvard T.H. Chan School of Public Health, and Jason Block, associate professor at Harvard Pilgrim Healthcare Institute & Harvard Medical School, to discuss what they've done.

Read the full research:
<p>https://www.bmj.com/content/367/bmj.l5837</p>
]]></description>
                                                            <content:encoded><![CDATA[There has been a lot of noise made about calorie counts on labels - the idea being it’s one of those things that might nudge people to make healthier choices.

So much so that in 2018, in the USA, it became mandatory for food chains with more than 20 outlets to label the calories in their food.

But the effectiveness of that is hard to gauge - it’s relied on reporting from customers, which leads to an incomplete picture. The really killer data would be from the chains themselves, but they’re reluctant to share that widely.

That's where new research comes in - and we're joined in the podcast by Joshua Petimar,  postdoctoral researcher at the Harvard T.H. Chan School of Public Health, and Jason Block, associate professor at Harvard Pilgrim Healthcare Institute & Harvard Medical School, to discuss what they've done.

Read the full research:
<p>https://www.bmj.com/content/367/bmj.l5837</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/03eis5/stream_705993520-bmjgroup-nudging-the-calories-off-your-order.mp3" length="36808334" type="audio/mpeg"/>
        <itunes:summary><![CDATA[There has been a lot of noise made about calorie counts on labels - the idea being it’s one of those things that might nudge people to make healthier choices.

So much so that in 2018, in the USA, it became mandatory for food chains with more than 20 outlets to label the calories in their food.

But the effectiveness of that is hard to gauge - it’s relied on reporting from customers, which leads to an incomplete picture. The really killer data would be from the chains themselves, but they’re reluctant to share that widely.

That's where new research comes in - and we're joined in the podcast by Joshua Petimar,  postdoctoral researcher at the Harvard T.H. Chan School of Public Health, and Jason Block, associate professor at Harvard Pilgrim Healthcare Institute & Harvard Medical School, to discuss what they've done.

Read the full research:
https://www.bmj.com/content/367/bmj.l5837]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1535</itunes:duration>
                                    </item>
    <item>
        <title>Testing for TB is only skin deep</title>
        <itunes:title>Testing for TB is only skin deep</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/testing-for-tb-is-only-skin-deep/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/testing-for-tb-is-only-skin-deep/#comments</comments>        <pubDate>Fri, 25 Oct 2019 18:36:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/testing-for-tb-is-only-skin-deep</guid>
                                    <description><![CDATA[A TB infection can take two forms, active and latent. Active disease is transmissible, and causes the damage to the lungs which makes TB one of the biggest killers in the world.

In the latent form, the bacteria Mycobacterium tuberculosis is quiescent and can stay that way for years until it becomes active and causes those clinical signs.

Testing for the active version of the disease is done directly, but when it comes to latency, we use the tuberculin skin test to see if someone has an immunological response - and when that happens we consider them to have latent disease.

However, in this podcast Lalita Ramakrishnan, professor of immunology and infectious diseases at the University of Cambridge; Paul Edelstein, professor of pathology and laboratory medicine at the University of Pennsylvania; and Marcel Behr, professor of medicine at McGill University question that conclusion.

Read their full analysis:
https://www.bmj.com/content/367/bmj.l5770/

Their previous analysis:
https://www.bmj.com/content/362/bmj.k2738.abstract

<p>And search for their previous podcast - "Have we misunderstood TB's timeline?"</p>
]]></description>
                                                            <content:encoded><![CDATA[A TB infection can take two forms, active and latent. Active disease is transmissible, and causes the damage to the lungs which makes TB one of the biggest killers in the world.

In the latent form, the bacteria Mycobacterium tuberculosis is quiescent and can stay that way for years until it becomes active and causes those clinical signs.

Testing for the active version of the disease is done directly, but when it comes to latency, we use the tuberculin skin test to see if someone has an immunological response - and when that happens we consider them to have latent disease.

However, in this podcast Lalita Ramakrishnan, professor of immunology and infectious diseases at the University of Cambridge; Paul Edelstein, professor of pathology and laboratory medicine at the University of Pennsylvania; and Marcel Behr, professor of medicine at McGill University question that conclusion.

Read their full analysis:
https://www.bmj.com/content/367/bmj.l5770/

Their previous analysis:
https://www.bmj.com/content/362/bmj.k2738.abstract

<p>And search for their previous podcast - "Have we misunderstood TB's timeline?"</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4c54l6/stream_701690335-bmjgroup-testing-for-tb-is-only-skin-deep.mp3" length="43190819" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A TB infection can take two forms, active and latent. Active disease is transmissible, and causes the damage to the lungs which makes TB one of the biggest killers in the world.

In the latent form, the bacteria Mycobacterium tuberculosis is quiescent and can stay that way for years until it becomes active and causes those clinical signs.

Testing for the active version of the disease is done directly, but when it comes to latency, we use the tuberculin skin test to see if someone has an immunological response - and when that happens we consider them to have latent disease.

However, in this podcast Lalita Ramakrishnan, professor of immunology and infectious diseases at the University of Cambridge; Paul Edelstein, professor of pathology and laboratory medicine at the University of Pennsylvania; and Marcel Behr, professor of medicine at McGill University question that conclusion.

Read their full analysis:
https://www.bmj.com/content/367/bmj.l5770/

Their previous analysis:
https://www.bmj.com/content/362/bmj.k2738.abstract

And search for their previous podcast - "Have we misunderstood TB's timeline?"]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1801</itunes:duration>
                                    </item>
    <item>
        <title>20 Arnav Agarwal</title>
        <itunes:title>20 Arnav Agarwal</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/20-arnav-agarwal/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/20-arnav-agarwal/#comments</comments>        <pubDate>Tue, 22 Oct 2019 22:59:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/therecodo/20-arnav-agarwal</guid>
                                    <description><![CDATA[<p>This week, Dr Arnav Agarwal joins Ray to share the perspective and experiences of a young, recently graduated doctor working in a busy, metropolitan hospital. Despite the long shifts and demanding environment, Arnav makes time and space to reflect on work, life and mortality through his thought-provoking poetry and volunteer work.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week, Dr Arnav Agarwal joins Ray to share the perspective and experiences of a young, recently graduated doctor working in a busy, metropolitan hospital. Despite the long shifts and demanding environment, Arnav makes time and space to reflect on work, life and mortality through his thought-provoking poetry and volunteer work.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/x6g9p7/stream_700298617-bmjgroup-20-arnav-agarwal.mp3" length="32837380" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week, Dr Arnav Agarwal joins Ray to share the perspective and experiences of a young, recently graduated doctor working in a busy, metropolitan hospital. Despite the long shifts and demanding environment, Arnav makes time and space to reflect on work, life and mortality through his thought-provoking poetry and volunteer work.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2052</itunes:duration>
                                    </item>
    <item>
        <title>19 Marion Nestle</title>
        <itunes:title>19 Marion Nestle</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/19-marion-nestle/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/19-marion-nestle/#comments</comments>        <pubDate>Tue, 22 Oct 2019 22:30:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/therecodo/19-marion-nestle</guid>
                                    <description><![CDATA[<p>This week, Ray ventures into the notoriously complex field of nutrition with special guest, Professor Marion Nestle. Named by Forbes as one of the world's most powerful foodies, Marion’s stellar career spans five decades of research, teaching, advocacy work and the publication of countless prize-winning books.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week, Ray ventures into the notoriously complex field of nutrition with special guest, Professor Marion Nestle. Named by Forbes as one of the world's most powerful foodies, Marion’s stellar career spans five decades of research, teaching, advocacy work and the publication of countless prize-winning books.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/t5fslo/stream_700287658-bmjgroup-19-marion-nestle.mp3" length="26503626" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week, Ray ventures into the notoriously complex field of nutrition with special guest, Professor Marion Nestle. Named by Forbes as one of the world's most powerful foodies, Marion’s stellar career spans five decades of research, teaching, advocacy work and the publication of countless prize-winning books.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1656</itunes:duration>
                                    </item>
    <item>
        <title>Statins for primary prevention - How good is the evidence</title>
        <itunes:title>Statins for primary prevention - How good is the evidence</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/statins-for-primary-prevention-how-good-is-the-evidence/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/statins-for-primary-prevention-how-good-is-the-evidence/#comments</comments>        <pubDate>Mon, 21 Oct 2019 10:12:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/statins-for-primary-prevention-how-good-is-the-evidence</guid>
                                    <description><![CDATA[Statins are now the most commonly used drug in the UK and one of the most commonly used medicines in the world, but debate remains about their use for primary prevention for people without cardiovascular disease.

Paula Byrne from the National University of Ireland Galway, joins us to talk about the evidence of benefit for low risk individuals, and what needs to be done to finally answer the questions about efficacy and harms.

Read the full analysis:
<p>https://www.bmj.com/content/367/bmj.l5674</p>
]]></description>
                                                            <content:encoded><![CDATA[Statins are now the most commonly used drug in the UK and one of the most commonly used medicines in the world, but debate remains about their use for primary prevention for people without cardiovascular disease.

Paula Byrne from the National University of Ireland Galway, joins us to talk about the evidence of benefit for low risk individuals, and what needs to be done to finally answer the questions about efficacy and harms.

Read the full analysis:
<p>https://www.bmj.com/content/367/bmj.l5674</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vzbs62/stream_699478291-bmjgroup-statins-for-primary-prevention-how-good-is-the-evidence.mp3" length="30899716" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Statins are now the most commonly used drug in the UK and one of the most commonly used medicines in the world, but debate remains about their use for primary prevention for people without cardiovascular disease.

Paula Byrne from the National University of Ireland Galway, joins us to talk about the evidence of benefit for low risk individuals, and what needs to be done to finally answer the questions about efficacy and harms.

Read the full analysis:
https://www.bmj.com/content/367/bmj.l5674]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1289</itunes:duration>
                                    </item>
    <item>
        <title>Ancestry DNA tests can over or under estimate genetic disease risk</title>
        <itunes:title>Ancestry DNA tests can over or under estimate genetic disease risk</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/ancestry-dna-tests-can-over-or-under-estimate-genetic-disease-risk/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/ancestry-dna-tests-can-over-or-under-estimate-genetic-disease-risk/#comments</comments>        <pubDate>Thu, 17 Oct 2019 14:36:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/ancestry-dna-tests-can-over-or-under-estimate-genetic-disease-risk</guid>
                                    <description><![CDATA[Direct-to-consumer genetic tests are sold online and in shops as a way to “find out what your DNA says". 

They insights into ancestry or disease risks; others claim to provide information on personality, athletic ability, and child talent. However, interpretation of genetic data is complex and context dependent, and DTC genetic tests may produce false positive and false negative results.

Rachel Horton, clinical training fellow,  Anneke Lucassen, chair of British Society of Genetic Medicine, and Jude Hayward the RCGP clinical champion for genomics join us to discuss how this deluge of genetic data is affecting patients, GPs and clinical geneticists in the NHS.

Read the full article:
<p>https://www.bmj.com/content/367/bmj.l5688</p>
]]></description>
                                                            <content:encoded><![CDATA[Direct-to-consumer genetic tests are sold online and in shops as a way to “find out what your DNA says". 

They insights into ancestry or disease risks; others claim to provide information on personality, athletic ability, and child talent. However, interpretation of genetic data is complex and context dependent, and DTC genetic tests may produce false positive and false negative results.

Rachel Horton, clinical training fellow,  Anneke Lucassen, chair of British Society of Genetic Medicine, and Jude Hayward the RCGP clinical champion for genomics join us to discuss how this deluge of genetic data is affecting patients, GPs and clinical geneticists in the NHS.

Read the full article:
<p>https://www.bmj.com/content/367/bmj.l5688</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4yqu60/stream_697736866-bmjgroup-ancestry-dna-tests-can-over-or-under-estimate-genetic-disease-risk.mp3" length="52491922" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Direct-to-consumer genetic tests are sold online and in shops as a way to “find out what your DNA says". 

They insights into ancestry or disease risks; others claim to provide information on personality, athletic ability, and child talent. However, interpretation of genetic data is complex and context dependent, and DTC genetic tests may produce false positive and false negative results.

Rachel Horton, clinical training fellow,  Anneke Lucassen, chair of British Society of Genetic Medicine, and Jude Hayward the RCGP clinical champion for genomics join us to discuss how this deluge of genetic data is affecting patients, GPs and clinical geneticists in the NHS.

Read the full article:
https://www.bmj.com/content/367/bmj.l5688]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2189</itunes:duration>
                                    </item>
    <item>
        <title>How Blockchain could improve clinical trial transparency</title>
        <itunes:title>How Blockchain could improve clinical trial transparency</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/how-blockchain-could-improve-clinical-trial-transparency/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/how-blockchain-could-improve-clinical-trial-transparency/#comments</comments>        <pubDate>Sat, 12 Oct 2019 13:06:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/how-bockchain-could-improve-clinical-trial-transparency</guid>
                                    <description><![CDATA[Blockchain is the digital technology that underpins cryptocurrencies such as bitcoin, and has been proposed as the digital panacea of our times. 

But Leeza Osipenko, from the London School of Economics, has thought about how it could actually be used in clinical trials, and what else would need to change in our regulatory environment to make that work.

Read her full essay:
<p>https://www.bmj.com/content/367/bmj.l5561</p>
]]></description>
                                                            <content:encoded><![CDATA[Blockchain is the digital technology that underpins cryptocurrencies such as bitcoin, and has been proposed as the digital panacea of our times. 

But Leeza Osipenko, from the London School of Economics, has thought about how it could actually be used in clinical trials, and what else would need to change in our regulatory environment to make that work.

Read her full essay:
<p>https://www.bmj.com/content/367/bmj.l5561</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ntznlj/stream_694668445-bmjgroup-how-bockchain-could-improve-clinical-trial-transparency.mp3" length="32751514" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Blockchain is the digital technology that underpins cryptocurrencies such as bitcoin, and has been proposed as the digital panacea of our times. 

But Leeza Osipenko, from the London School of Economics, has thought about how it could actually be used in clinical trials, and what else would need to change in our regulatory environment to make that work.

Read her full essay:
https://www.bmj.com/content/367/bmj.l5561]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1366</itunes:duration>
                                    </item>
    <item>
        <title>A new way to look at behaviour change in UK GPs</title>
        <itunes:title>A new way to look at behaviour change in UK GPs</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/a-new-way-to-look-at-behaviour-change-in-uk-gps/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/a-new-way-to-look-at-behaviour-change-in-uk-gps/#comments</comments>        <pubDate>Tue, 08 Oct 2019 14:52:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/a-new-way-to-look-at-behaviour-change-in-uk-gps</guid>
                                    <description><![CDATA[In quality improvement, measurement is seen as a key driver of change - how well do you know you’re doing, if you can’t actually measure it.

So, when something changes in the NHS (say a new guideline) how can you tell how quickly that’s filtering down to the front line.

Ben goldacre, from the Nuffield Department of Primary Care Health Sciences at the University of Oxford, joins us to talk about a new proof of concept published on bmj.com, which uses NHS prescribing data to analyse how change propagated through GP practices.

Read the full open access research:
https://www.bmj.com/content/367/bmj.l5205

<p>https://openprescribing.net/</p>
]]></description>
                                                            <content:encoded><![CDATA[In quality improvement, measurement is seen as a key driver of change - how well do you know you’re doing, if you can’t actually measure it.

So, when something changes in the NHS (say a new guideline) how can you tell how quickly that’s filtering down to the front line.

Ben goldacre, from the Nuffield Department of Primary Care Health Sciences at the University of Oxford, joins us to talk about a new proof of concept published on bmj.com, which uses NHS prescribing data to analyse how change propagated through GP practices.

Read the full open access research:
https://www.bmj.com/content/367/bmj.l5205

<p>https://openprescribing.net/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qsu1nf/stream_692775577-bmjgroup-a-new-way-to-look-at-behaviour-change-in-uk-gps.mp3" length="29863182" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In quality improvement, measurement is seen as a key driver of change - how well do you know you’re doing, if you can’t actually measure it.

So, when something changes in the NHS (say a new guideline) how can you tell how quickly that’s filtering down to the front line.

Ben goldacre, from the Nuffield Department of Primary Care Health Sciences at the University of Oxford, joins us to talk about a new proof of concept published on bmj.com, which uses NHS prescribing data to analyse how change propagated through GP practices.

Read the full open access research:
https://www.bmj.com/content/367/bmj.l5205

https://openprescribing.net/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1866</itunes:duration>
                                    </item>
    <item>
        <title>17 Liam Mannix</title>
        <itunes:title>17 Liam Mannix</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/17-liam-mannix/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/17-liam-mannix/#comments</comments>        <pubDate>Tue, 08 Oct 2019 01:01:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/therecodo/liam-mannix</guid>
                                    <description><![CDATA[<p>Our latest series kicks off with Australia’s multi-award-winning health and science reporter, Liam Mannix. He joins Ray to share his insights into the role and impact of evidence, advocacy and investigative reporting in today’s ever-changing media landscape.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Our latest series kicks off with Australia’s multi-award-winning health and science reporter, Liam Mannix. He joins Ray to share his insights into the role and impact of evidence, advocacy and investigative reporting in today’s ever-changing media landscape.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/l9smh1/stream_692514127-bmjgroup-liam-mannix.mp3" length="29973523" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Our latest series kicks off with Australia’s multi-award-winning health and science reporter, Liam Mannix. He joins Ray to share his insights into the role and impact of evidence, advocacy and investigative reporting in today’s ever-changing media landscape.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1873</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence - eating less, drinking less, drug approval data</title>
        <itunes:title>Talk Evidence - eating less, drinking less, drug approval data</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-eating-less-drinking-less-drug-approval-data/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-eating-less-drinking-less-drug-approval-data/#comments</comments>        <pubDate>Fri, 04 Oct 2019 16:41:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-eating-less-drinking-less-drug-approval-data</guid>
                                    <description><![CDATA[Talk Evidence is back, with your monthly take on the world of EBM with Duncan Jarvies and GPs Carl Heneghan (also director for the Centre of Evidence Based Medicine at the University of Oxford) and Helen Macdonald (also The BMJ's UK research Editor).

This month Carl talks about evidence that restricting your diet might improve health at a population level (1.50)

Helen talks about the data on a drop in alcohol consumption amongst Scots (7.04)

A listener questions the team about their take on Tramadol (13.45)

Helen talks about the problems with the trials we use to regulate drugs (18.00)

And Carl explains why drug shortages aren't just a Brexit problem (31.30)

Reading list:

two years of calorie restriction and cardiometabolic risk (CALERIE): exploratory outcomes of a multicentre, phase 2, randomised controlled trial
https://www.sciencedirect.com/science/article/pii/S2213858719301512?via%3Dihub

Immediate impact of minimum unit pricing on alcohol purchases in Scotland: controlled interrupted time series analysis for 2015-18
https://www.bmj.com/content/366/bmj.l5274

Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis
https://www.bmj.com/content/366/bmj.l5221

Crisis in the supply of medicines
<p>https://www.bmj.com/content/367/bmj.l5841</p>
]]></description>
                                                            <content:encoded><![CDATA[Talk Evidence is back, with your monthly take on the world of EBM with Duncan Jarvies and GPs Carl Heneghan (also director for the Centre of Evidence Based Medicine at the University of Oxford) and Helen Macdonald (also The BMJ's UK research Editor).

This month Carl talks about evidence that restricting your diet might improve health at a population level (1.50)

Helen talks about the data on a drop in alcohol consumption amongst Scots (7.04)

A listener questions the team about their take on Tramadol (13.45)

Helen talks about the problems with the trials we use to regulate drugs (18.00)

And Carl explains why drug shortages aren't just a Brexit problem (31.30)

Reading list:

two years of calorie restriction and cardiometabolic risk (CALERIE): exploratory outcomes of a multicentre, phase 2, randomised controlled trial
https://www.sciencedirect.com/science/article/pii/S2213858719301512?via%3Dihub

Immediate impact of minimum unit pricing on alcohol purchases in Scotland: controlled interrupted time series analysis for 2015-18
https://www.bmj.com/content/366/bmj.l5274

Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis
https://www.bmj.com/content/366/bmj.l5221

Crisis in the supply of medicines
<p>https://www.bmj.com/content/367/bmj.l5841</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/pvqmud/stream_691031731-bmjgroup-talk-evidence-eating-less-drinking-less-drug-approval-data.mp3" length="35559548" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Talk Evidence is back, with your monthly take on the world of EBM with Duncan Jarvies and GPs Carl Heneghan (also director for the Centre of Evidence Based Medicine at the University of Oxford) and Helen Macdonald (also The BMJ's UK research Editor).

This month Carl talks about evidence that restricting your diet might improve health at a population level (1.50)

Helen talks about the data on a drop in alcohol consumption amongst Scots (7.04)

A listener questions the team about their take on Tramadol (13.45)

Helen talks about the problems with the trials we use to regulate drugs (18.00)

And Carl explains why drug shortages aren't just a Brexit problem (31.30)

Reading list:

two years of calorie restriction and cardiometabolic risk (CALERIE): exploratory outcomes of a multicentre, phase 2, randomised controlled trial
https://www.sciencedirect.com/science/article/pii/S2213858719301512?via%3Dihub

Immediate impact of minimum unit pricing on alcohol purchases in Scotland: controlled interrupted time series analysis for 2015-18
https://www.bmj.com/content/366/bmj.l5274

Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis
https://www.bmj.com/content/366/bmj.l5221

Crisis in the supply of medicines
https://www.bmj.com/content/367/bmj.l5841]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2223</itunes:duration>
                                    </item>
    <item>
        <title>18 David Tovey</title>
        <itunes:title>18 David Tovey</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/18-david-tovey/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/18-david-tovey/#comments</comments>        <pubDate>Wed, 02 Oct 2019 06:49:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/therecodo/17-david-tovey</guid>
                                    <description><![CDATA[<p>After ten years at the helm of the Cochrane Library, Dr David Tovey recently stepped down as Editor-in-Chief. This week he joins Ray to reflect on Cochrane’s past, present and future and share some of the challenges and rewards of leading one of the world’s largest and most trusted health research networks.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>After ten years at the helm of the Cochrane Library, Dr David Tovey recently stepped down as Editor-in-Chief. This week he joins Ray to reflect on Cochrane’s past, present and future and share some of the challenges and rewards of leading one of the world’s largest and most trusted health research networks.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9fx3ru/stream_689857945-bmjgroup-17-david-tovey.mp3" length="28189256" type="audio/mpeg"/>
        <itunes:summary><![CDATA[After ten years at the helm of the Cochrane Library, Dr David Tovey recently stepped down as Editor-in-Chief. This week he joins Ray to reflect on Cochrane’s past, present and future and share some of the challenges and rewards of leading one of the world’s largest and most trusted health research networks.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1762</itunes:duration>
                                    </item>
    <item>
        <title>Minimum unit pricing in Scotland</title>
        <itunes:title>Minimum unit pricing in Scotland</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/minimum-unit-pricing-in-scotland/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/minimum-unit-pricing-in-scotland/#comments</comments>        <pubDate>Thu, 26 Sep 2019 17:47:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/minimum-unit-pricing-in-scotland</guid>
                                    <description><![CDATA[On the 1st of May, 2018 Scotland was the first country to try a new way of reducing alcohol consumption in its population. It introduced a minimum unit prices for alcohol. 

Now new research just published on BMJ.com is looking at the effect of that price increase - and measuring how well it has achieved the goal of reducing drinking in Scots.

Peter Anderson, professor of alcohol studies at Newcastle University explains how well the result matched the expectation, and if the result targeted just lower earners, or all high volume drinkers.

Read the full research:
<p>https://www.bmj.com/content/366/bmj.l5274</p>
]]></description>
                                                            <content:encoded><![CDATA[On the 1st of May, 2018 Scotland was the first country to try a new way of reducing alcohol consumption in its population. It introduced a minimum unit prices for alcohol. 

Now new research just published on BMJ.com is looking at the effect of that price increase - and measuring how well it has achieved the goal of reducing drinking in Scots.

Peter Anderson, professor of alcohol studies at Newcastle University explains how well the result matched the expectation, and if the result targeted just lower earners, or all high volume drinkers.

Read the full research:
<p>https://www.bmj.com/content/366/bmj.l5274</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2810hq/stream_687218701-bmjgroup-minimum-unit-pricing-in-scotland.mp3" length="16514402" type="audio/mpeg"/>
        <itunes:summary><![CDATA[On the 1st of May, 2018 Scotland was the first country to try a new way of reducing alcohol consumption in its population. It introduced a minimum unit prices for alcohol. 

Now new research just published on BMJ.com is looking at the effect of that price increase - and measuring how well it has achieved the goal of reducing drinking in Scots.

Peter Anderson, professor of alcohol studies at Newcastle University explains how well the result matched the expectation, and if the result targeted just lower earners, or all high volume drinkers.

Read the full research:
https://www.bmj.com/content/366/bmj.l5274]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1032</itunes:duration>
                                    </item>
    <item>
        <title>Climate change will make universal health coverage precarious</title>
        <itunes:title>Climate change will make universal health coverage precarious</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/climate-change-will-make-universal-health-coverage-precarious/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/climate-change-will-make-universal-health-coverage-precarious/#comments</comments>        <pubDate>Tue, 24 Sep 2019 14:26:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/climate-change-will-make-universal-health-coverage-precarious</guid>
                                    <description><![CDATA[The BMJ in partnership with The Harvard Global Health Institute has launched a collection of articles exploring how to achieve effective universal health coverage (UHC). The collection highlights the importance of quality in UHC, potential finance models, how best to incentivise stakeholders, and some of the barriers to true UHC.

One of those barriers, and it’s a big one, is climate change - patterns of disease will change, both communicable and non-communicable, cataclysmic weather will disrupt systems, and the economic impact is going to challenge our ability to pay for healthcare.

But even against that backdrop, Ashish Jha, and  Rene Salas - aren't totally pessimistic. They join us to talk about the intersection between climate and health, and where effective change can be made.


Climate change threatens the achievement of effective universal healthcare
https://www.bmj.com/content/366/bmj.l5302

Universal health coverage collection
<p>https://www.bmj.com/universal-health-coverage</p>
]]></description>
                                                            <content:encoded><![CDATA[The BMJ in partnership with The Harvard Global Health Institute has launched a collection of articles exploring how to achieve effective universal health coverage (UHC). The collection highlights the importance of quality in UHC, potential finance models, how best to incentivise stakeholders, and some of the barriers to true UHC.

One of those barriers, and it’s a big one, is climate change - patterns of disease will change, both communicable and non-communicable, cataclysmic weather will disrupt systems, and the economic impact is going to challenge our ability to pay for healthcare.

But even against that backdrop, Ashish Jha, and  Rene Salas - aren't totally pessimistic. They join us to talk about the intersection between climate and health, and where effective change can be made.


Climate change threatens the achievement of effective universal healthcare
https://www.bmj.com/content/366/bmj.l5302

Universal health coverage collection
<p>https://www.bmj.com/universal-health-coverage</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6oe06l/stream_686081545-bmjgroup-climate-change-will-make-universal-health-coverage-precarious.mp3" length="39081690" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The BMJ in partnership with The Harvard Global Health Institute has launched a collection of articles exploring how to achieve effective universal health coverage (UHC). The collection highlights the importance of quality in UHC, potential finance models, how best to incentivise stakeholders, and some of the barriers to true UHC.

One of those barriers, and it’s a big one, is climate change - patterns of disease will change, both communicable and non-communicable, cataclysmic weather will disrupt systems, and the economic impact is going to challenge our ability to pay for healthcare.

But even against that backdrop, Ashish Jha, and  Rene Salas - aren't totally pessimistic. They join us to talk about the intersection between climate and health, and where effective change can be made.


Climate change threatens the achievement of effective universal healthcare
https://www.bmj.com/content/366/bmj.l5302

Universal health coverage collection
https://www.bmj.com/universal-health-coverage]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2443</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence  - Recurrent VTE, CRP testing for COPD, CMO report, and a consultation</title>
        <itunes:title>Talk Evidence  - Recurrent VTE, CRP testing for COPD, CMO report, and a consultation</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-recurrent-vte-crp-testing-for-copd-cmo-report-and-a-consultation/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-recurrent-vte-crp-testing-for-copd-cmo-report-and-a-consultation/#comments</comments>        <pubDate>Mon, 23 Sep 2019 10:21:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-recurrent-vte-crp-testing-for-copd-cmo-report-and-a-consultation</guid>
                                    <description><![CDATA[Helen talks about new research on prevention of recurrent VTE - and Carl things the evidence goes further, and we can extend prophylaxis for a year. 

13.00 - CRP testing for antibiotic prescription in COPD exacerbations, should we start doing it in primary care settings - and what will that mean. We also hear from Chris Butler, one of the trialists, who explains why being very clear about what you actually want to measure is important in study design.


26.50 - Carl wants you to read the Chief Medical Officer’s report, and we hear from Cathrine Falconer, who edited it, about how they put the recommendations together.



32.50 - Helen thinks that a new consultation from the UK government is collecting evidence in an unsystematic way, and that it’s an opportunity for listeners to submit some good evidence.


Reading list:

Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event
https://www.bmj.com/content/366/bmj.l4363

C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations
https://www.nejm.org/doi/10.1056/NEJMoa1803185


Chief Medical Officer annual report 2019: partnering for progress
https://www.gov.uk/government/publications/chief-medical-officer-annual-report-2019-partnering-for-progress

Advancing our health: prevention in the 2020s – consultation document
<p>https://www.gov.uk/government/consultations/advancing-our-health-prevention-in-the-2020s/advancing-our-health-prevention-in-the-2020s-consultation-document</p>
]]></description>
                                                            <content:encoded><![CDATA[Helen talks about new research on prevention of recurrent VTE - and Carl things the evidence goes further, and we can extend prophylaxis for a year. 

13.00 - CRP testing for antibiotic prescription in COPD exacerbations, should we start doing it in primary care settings - and what will that mean. We also hear from Chris Butler, one of the trialists, who explains why being very clear about what you actually want to measure is important in study design.


26.50 - Carl wants you to read the Chief Medical Officer’s report, and we hear from Cathrine Falconer, who edited it, about how they put the recommendations together.



32.50 - Helen thinks that a new consultation from the UK government is collecting evidence in an unsystematic way, and that it’s an opportunity for listeners to submit some good evidence.


Reading list:

Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event
https://www.bmj.com/content/366/bmj.l4363

C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations
https://www.nejm.org/doi/10.1056/NEJMoa1803185


Chief Medical Officer annual report 2019: partnering for progress
https://www.gov.uk/government/publications/chief-medical-officer-annual-report-2019-partnering-for-progress

Advancing our health: prevention in the 2020s – consultation document
<p>https://www.gov.uk/government/consultations/advancing-our-health-prevention-in-the-2020s/advancing-our-health-prevention-in-the-2020s-consultation-document</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/r5ndvo/stream_685418494-bmjgroup-talk-evidence-recurrent-vte-crp-testing-for-copd-cmo-report-and-a-consultation.mp3" length="40615600" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Helen talks about new research on prevention of recurrent VTE - and Carl things the evidence goes further, and we can extend prophylaxis for a year. 

13.00 - CRP testing for antibiotic prescription in COPD exacerbations, should we start doing it in primary care settings - and what will that mean. We also hear from Chris Butler, one of the trialists, who explains why being very clear about what you actually want to measure is important in study design.


26.50 - Carl wants you to read the Chief Medical Officer’s report, and we hear from Cathrine Falconer, who edited it, about how they put the recommendations together.



32.50 - Helen thinks that a new consultation from the UK government is collecting evidence in an unsystematic way, and that it’s an opportunity for listeners to submit some good evidence.


Reading list:

Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event
https://www.bmj.com/content/366/bmj.l4363

C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations
https://www.nejm.org/doi/10.1056/NEJMoa1803185


Chief Medical Officer annual report 2019: partnering for progress
https://www.gov.uk/government/publications/chief-medical-officer-annual-report-2019-partnering-for-progress

Advancing our health: prevention in the 2020s – consultation document
https://www.gov.uk/government/consultations/advancing-our-health-prevention-in-the-2020s/advancing-our-health-prevention-in-the-2020s-consultation-document]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2539</itunes:duration>
                                    </item>
    <item>
        <title>Cancer drug trials used for regulatory approval are at risk of bias</title>
        <itunes:title>Cancer drug trials used for regulatory approval are at risk of bias</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/cancer-drug-trials-used-for-regulatory-approval-are-at-risk-of-bias/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/cancer-drug-trials-used-for-regulatory-approval-are-at-risk-of-bias/#comments</comments>        <pubDate>Thu, 19 Sep 2019 14:09:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/cancer-drug-trials-used-for-regulatory-approval-are-at-risk-of-bias</guid>
                                    <description><![CDATA[Around half of trials that supported new cancer drug approvals in Europe between 2014 and 2016 were judged to be at high risk of bias, in a new study. 

Huseyin Naci,assistant professor of health policy a the London School of Economics joins us to talk about why potential bias may mean potential exaggeration of treatment effects, and could be costing our health systems a great deal of money.

Read the full research:
https://www.bmj.com/content/366/bmj.l5221

Listen on apple podcasts:
<p> https://podcasts.apple.com/gb/podcast/the-bmj-podcast/id283916558?mt=2&app=podcast</p>
]]></description>
                                                            <content:encoded><![CDATA[Around half of trials that supported new cancer drug approvals in Europe between 2014 and 2016 were judged to be at high risk of bias, in a new study. 

Huseyin Naci,assistant professor of health policy a the London School of Economics joins us to talk about why potential bias may mean potential exaggeration of treatment effects, and could be costing our health systems a great deal of money.

Read the full research:
https://www.bmj.com/content/366/bmj.l5221

Listen on apple podcasts:
<p> https://podcasts.apple.com/gb/podcast/the-bmj-podcast/id283916558?mt=2&app=podcast</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/b454w1/stream_683335544-bmjgroup-cancer-drug-trials-used-for-regulatory-approval-are-at-risk-of-bias.mp3" length="39064865" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Around half of trials that supported new cancer drug approvals in Europe between 2014 and 2016 were judged to be at high risk of bias, in a new study. 

Huseyin Naci,assistant professor of health policy a the London School of Economics joins us to talk about why potential bias may mean potential exaggeration of treatment effects, and could be costing our health systems a great deal of money.

Read the full research:
https://www.bmj.com/content/366/bmj.l5221

Listen on apple podcasts:
 https://podcasts.apple.com/gb/podcast/the-bmj-podcast/id283916558?mt=2&app=podcast]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1629</itunes:duration>
                                    </item>
    <item>
        <title>Brexit - Planning for medicine shortages</title>
        <itunes:title>Brexit - Planning for medicine shortages</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/brexit-planning-for-medicine-shortages/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/brexit-planning-for-medicine-shortages/#comments</comments>        <pubDate>Fri, 13 Sep 2019 18:22:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/brexit-planning-for-medicine-shortages</guid>
                                    <description><![CDATA[This week we saw the release of the much awaited Yellowhammer documents from the government, documents which outline some of the risks involved with Britain’s sudden departure from the EU. The documents themselves outline that there are risks to the supply of medicines - but do not set out the detail of how those risks have been mitigated, and what doctors and patients should do to plan for the possibility.

<p>In this podcast we hear from Andrew Goddard , president of the Royal College of Physicians, and Sandra Gidley, president of the Royal Pharmaceutical Society. We also have a statement from the Royal College of Radiologists.</p>
]]></description>
                                                            <content:encoded><![CDATA[This week we saw the release of the much awaited Yellowhammer documents from the government, documents which outline some of the risks involved with Britain’s sudden departure from the EU. The documents themselves outline that there are risks to the supply of medicines - but do not set out the detail of how those risks have been mitigated, and what doctors and patients should do to plan for the possibility.

<p>In this podcast we hear from Andrew Goddard , president of the Royal College of Physicians, and Sandra Gidley, president of the Royal Pharmaceutical Society. We also have a statement from the Royal College of Radiologists.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/oeh54j/stream_680669519-bmjgroup-brexit-planning-for-medicine-shortages.mp3" length="30975790" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week we saw the release of the much awaited Yellowhammer documents from the government, documents which outline some of the risks involved with Britain’s sudden departure from the EU. The documents themselves outline that there are risks to the supply of medicines - but do not set out the detail of how those risks have been mitigated, and what doctors and patients should do to plan for the possibility.

In this podcast we hear from Andrew Goddard , president of the Royal College of Physicians, and Sandra Gidley, president of the Royal Pharmaceutical Society. We also have a statement from the Royal College of Radiologists.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1936</itunes:duration>
                                    </item>
    <item>
        <title>Vaping deaths - does this change what we think about public health messages</title>
        <itunes:title>Vaping deaths - does this change what we think about public health messages</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/vaping-deaths-does-this-change-what-we-think-about-public-health-messages/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/vaping-deaths-does-this-change-what-we-think-about-public-health-messages/#comments</comments>        <pubDate>Thu, 12 Sep 2019 16:58:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/vaping-deaths-does-this-change-what-we-think-about-public-health-messages</guid>
                                    <description><![CDATA[This week the Trump administration has banned the sale of flavoured vapes in the USA.

The reason for that is the sudden rash of cases of pulmonary disease, including deaths, linked to vaping. The mechanism by which vaping may be causing damage to the lungs is as yet unclear, and our understanding is hampered by the heterogeneous nature of the compounds involved and the mechanisms of delivery.

David Hammond, professor in the school of public health and health systems at the University of Waterloo in Canada, is author of a recent editorial about vaping and joins us to discuss what this means for public health.

Outbreak of pulmonary diseases linked to vaping
<p>https://www.bmj.com/content/366/bmj.l5445</p>
]]></description>
                                                            <content:encoded><![CDATA[This week the Trump administration has banned the sale of flavoured vapes in the USA.

The reason for that is the sudden rash of cases of pulmonary disease, including deaths, linked to vaping. The mechanism by which vaping may be causing damage to the lungs is as yet unclear, and our understanding is hampered by the heterogeneous nature of the compounds involved and the mechanisms of delivery.

David Hammond, professor in the school of public health and health systems at the University of Waterloo in Canada, is author of a recent editorial about vaping and joins us to discuss what this means for public health.

Outbreak of pulmonary diseases linked to vaping
<p>https://www.bmj.com/content/366/bmj.l5445</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/lvyf45/stream_680143994-bmjgroup-vaping-deaths-does-this-change-what-we-think-about-public-health-messages.mp3" length="18855785" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week the Trump administration has banned the sale of flavoured vapes in the USA.

The reason for that is the sudden rash of cases of pulmonary disease, including deaths, linked to vaping. The mechanism by which vaping may be causing damage to the lungs is as yet unclear, and our understanding is hampered by the heterogeneous nature of the compounds involved and the mechanisms of delivery.

David Hammond, professor in the school of public health and health systems at the University of Waterloo in Canada, is author of a recent editorial about vaping and joins us to discuss what this means for public health.

Outbreak of pulmonary diseases linked to vaping
https://www.bmj.com/content/366/bmj.l5445]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>786</itunes:duration>
                                    </item>
    <item>
        <title>Extending the UK’s sugar tax to snacks</title>
        <itunes:title>Extending the UK’s sugar tax to snacks</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/extending-the-uk-s-sugar-tax-to-snacks/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/extending-the-uk-s-sugar-tax-to-snacks/#comments</comments>        <pubDate>Fri, 06 Sep 2019 11:54:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/extending-the-uks-sugar-tax-to-snacks</guid>
                                    <description><![CDATA[In the UK, for just over a year, we've been paying the "Soft Drinks Industry Levy" - a tax on sugary beverages intended to reduce our consumption of free sugars.

That was based on taxes that had happened in other countries, however, in the UK high sugar snacks, such as confectionery, cakes, and biscuits make a greater contribution to intakes of free sugars as well as energy than sugar sweetened beverages.

Now new research models what extending the sugar tax to those snacks would do to our energy intake, and then onto the BMI of the nation.

Pauline Scheelbeek, assistant professor in nutritional and environmental epidemiology at the London School of Hygiene and Tropical Medicine joins us to explain how they modelled that, and what the outcome might be

Read the full open access research:
<p>https://www.bmj.com/content/366/bmj.l4786</p>
]]></description>
                                                            <content:encoded><![CDATA[In the UK, for just over a year, we've been paying the "Soft Drinks Industry Levy" - a tax on sugary beverages intended to reduce our consumption of free sugars.

That was based on taxes that had happened in other countries, however, in the UK high sugar snacks, such as confectionery, cakes, and biscuits make a greater contribution to intakes of free sugars as well as energy than sugar sweetened beverages.

Now new research models what extending the sugar tax to those snacks would do to our energy intake, and then onto the BMI of the nation.

Pauline Scheelbeek, assistant professor in nutritional and environmental epidemiology at the London School of Hygiene and Tropical Medicine joins us to explain how they modelled that, and what the outcome might be

Read the full open access research:
<p>https://www.bmj.com/content/366/bmj.l4786</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/f3emf1/stream_677152374-bmjgroup-extending-the-uks-sugar-tax-to-snacks.mp3" length="36010502" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In the UK, for just over a year, we've been paying the "Soft Drinks Industry Levy" - a tax on sugary beverages intended to reduce our consumption of free sugars.

That was based on taxes that had happened in other countries, however, in the UK high sugar snacks, such as confectionery, cakes, and biscuits make a greater contribution to intakes of free sugars as well as energy than sugar sweetened beverages.

Now new research models what extending the sugar tax to those snacks would do to our energy intake, and then onto the BMI of the nation.

Pauline Scheelbeek, assistant professor in nutritional and environmental epidemiology at the London School of Hygiene and Tropical Medicine joins us to explain how they modelled that, and what the outcome might be

Read the full open access research:
https://www.bmj.com/content/366/bmj.l4786]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1502</itunes:duration>
                                    </item>
    <item>
        <title>The government is lacking detail over Brexit planning</title>
        <itunes:title>The government is lacking detail over Brexit planning</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-government-is-lacking-detail-over-brexit-planning/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-government-is-lacking-detail-over-brexit-planning/#comments</comments>        <pubDate>Wed, 04 Sep 2019 17:43:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-lack-of-planning-for-brexit</guid>
                                    <description><![CDATA[Brexit.

Who knows what’s going to happen in the next few weeks, months, years - the uncertainty is high.

In the face of that, you’d hope that the government was doing all it could to plan for any eventuality - let alone for a massive, country altering one like suddenly crashing out without a deal - but Martin McKee, professor of public health at the London School of Hygiene and Tropical Medicine, and David Nicholl, Consultant Neurologist, don’t think that’s the case.


In the debate about Brexit, increasingly we’re hearing about the impact on health in the UK - and in increasingly doomed ways. But what about across the rest of Europe? Natasha Azzopardi Muscat, president of the European Public Health Association, explains a little about what Brexit means for the whole of European public health.


Assessing the health effects of a “no deal” Brexit:
<p>https://www.bmj.com/content/366/bmj.l5300</p>
]]></description>
                                                            <content:encoded><![CDATA[Brexit.

Who knows what’s going to happen in the next few weeks, months, years - the uncertainty is high.

In the face of that, you’d hope that the government was doing all it could to plan for any eventuality - let alone for a massive, country altering one like suddenly crashing out without a deal - but Martin McKee, professor of public health at the London School of Hygiene and Tropical Medicine, and David Nicholl, Consultant Neurologist, don’t think that’s the case.


In the debate about Brexit, increasingly we’re hearing about the impact on health in the UK - and in increasingly doomed ways. But what about across the rest of Europe? Natasha Azzopardi Muscat, president of the European Public Health Association, explains a little about what Brexit means for the whole of European public health.


Assessing the health effects of a “no deal” Brexit:
<p>https://www.bmj.com/content/366/bmj.l5300</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ezifkq/stream_676305974-bmjgroup-the-lack-of-planning-for-brexit.mp3" length="52982435" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Brexit.

Who knows what’s going to happen in the next few weeks, months, years - the uncertainty is high.

In the face of that, you’d hope that the government was doing all it could to plan for any eventuality - let alone for a massive, country altering one like suddenly crashing out without a deal - but Martin McKee, professor of public health at the London School of Hygiene and Tropical Medicine, and David Nicholl, Consultant Neurologist, don’t think that’s the case.


In the debate about Brexit, increasingly we’re hearing about the impact on health in the UK - and in increasingly doomed ways. But what about across the rest of Europe? Natasha Azzopardi Muscat, president of the European Public Health Association, explains a little about what Brexit means for the whole of European public health.


Assessing the health effects of a “no deal” Brexit:
https://www.bmj.com/content/366/bmj.l5300]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2210</itunes:duration>
                                    </item>
    <item>
        <title>Tackling burnout in The Netherlands</title>
        <itunes:title>Tackling burnout in The Netherlands</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/tackling-burnout-in-the-netherlands/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/tackling-burnout-in-the-netherlands/#comments</comments>        <pubDate>Fri, 30 Aug 2019 16:35:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/tackling-burnout-in-the-netherlands</guid>
                                    <description><![CDATA[We heard a few podcasts ago about burnout - what it is, and why it should be thought of as a systems issue. Now a project in the Netherlands is trying to investigate who it is that is particularly at risk of burnout, and hopes to test whether individually tailored coaching and counselling can help those who are experiencing the symptoms change the way they’re working.

Karel Scheepstra is a psychiatrist and researcher in the Amsterdam University Medical Centre, and joins us to discuss what we know about burnout in Dutch doctors, and what this new research hopes to uncover.

For more from our wellbeing campaign;
<p>www.bmj.com/wellbeing</p>
]]></description>
                                                            <content:encoded><![CDATA[We heard a few podcasts ago about burnout - what it is, and why it should be thought of as a systems issue. Now a project in the Netherlands is trying to investigate who it is that is particularly at risk of burnout, and hopes to test whether individually tailored coaching and counselling can help those who are experiencing the symptoms change the way they’re working.

Karel Scheepstra is a psychiatrist and researcher in the Amsterdam University Medical Centre, and joins us to discuss what we know about burnout in Dutch doctors, and what this new research hopes to uncover.

For more from our wellbeing campaign;
<p>www.bmj.com/wellbeing</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5harvl/stream_673323746-bmjgroup-tackling-burnout-in-the-netherlands.mp3" length="35021566" type="audio/mpeg"/>
        <itunes:summary><![CDATA[We heard a few podcasts ago about burnout - what it is, and why it should be thought of as a systems issue. Now a project in the Netherlands is trying to investigate who it is that is particularly at risk of burnout, and hopes to test whether individually tailored coaching and counselling can help those who are experiencing the symptoms change the way they’re working.

Karel Scheepstra is a psychiatrist and researcher in the Amsterdam University Medical Centre, and joins us to discuss what we know about burnout in Dutch doctors, and what this new research hopes to uncover.

For more from our wellbeing campaign;
www.bmj.com/wellbeing]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1460</itunes:duration>
                                    </item>
    <item>
        <title>Physical activity and mortality - ”The least active quartile did less than 5 minute per day”</title>
        <itunes:title>Physical activity and mortality - ”The least active quartile did less than 5 minute per day”</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/physical-activity-and-mortality-the-least-active-quartile-did-less-than-5-minute-per-day/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/physical-activity-and-mortality-the-least-active-quartile-did-less-than-5-minute-per-day/#comments</comments>        <pubDate>Fri, 23 Aug 2019 14:29:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/physical-activity-and-mortality-the-least-active-quartile-did-less-than-5-minute-per-day</guid>
                                    <description><![CDATA[We know that exercise is good for you - the WHO recommends at least 150 minutes of moderate intensity or 75 minutes of vigorous intensity aerobic physical activity each week.

That recommendation is built on evidence that relied on self reporting that may underestimate the amount of lower intensity exercise those people were doing, and at the sometime overestimate the overall amount.

That makes new research, published on bmj.com particularly interesting - it pulls together the published data on outcomes for measured activity, where study participants were given an accelerometer to wear.

Ulf Ekelund, from the Department of Sports Medicine at the Norwegian School of Sport Sciences, joins us to discuss what they found, and what that means for those recommendations.

Read the open access research:
<p>https://www.bmj.com/content/366/bmj.l4570</p>
]]></description>
                                                            <content:encoded><![CDATA[We know that exercise is good for you - the WHO recommends at least 150 minutes of moderate intensity or 75 minutes of vigorous intensity aerobic physical activity each week.

That recommendation is built on evidence that relied on self reporting that may underestimate the amount of lower intensity exercise those people were doing, and at the sometime overestimate the overall amount.

That makes new research, published on bmj.com particularly interesting - it pulls together the published data on outcomes for measured activity, where study participants were given an accelerometer to wear.

Ulf Ekelund, from the Department of Sports Medicine at the Norwegian School of Sport Sciences, joins us to discuss what they found, and what that means for those recommendations.

Read the open access research:
<p>https://www.bmj.com/content/366/bmj.l4570</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/j86n66/stream_669974066-bmjgroup-physical-activity-and-mortality-the-least-active-quartile-did-less-than-5-minute-per-day.mp3" length="32109945" type="audio/mpeg"/>
        <itunes:summary><![CDATA[We know that exercise is good for you - the WHO recommends at least 150 minutes of moderate intensity or 75 minutes of vigorous intensity aerobic physical activity each week.

That recommendation is built on evidence that relied on self reporting that may underestimate the amount of lower intensity exercise those people were doing, and at the sometime overestimate the overall amount.

That makes new research, published on bmj.com particularly interesting - it pulls together the published data on outcomes for measured activity, where study participants were given an accelerometer to wear.

Ulf Ekelund, from the Department of Sports Medicine at the Norwegian School of Sport Sciences, joins us to discuss what they found, and what that means for those recommendations.

Read the open access research:
https://www.bmj.com/content/366/bmj.l4570]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1337</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence - Tramadol, medical harm, and alexa</title>
        <itunes:title>Talk Evidence - Tramadol, medical harm, and alexa</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-tramadol-medical-harm-and-alexa/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-tramadol-medical-harm-and-alexa/#comments</comments>        <pubDate>Wed, 21 Aug 2019 10:49:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-tramadol-medical-harm-and-alexa</guid>
                                    <description><![CDATA[Welcome back to Talk Evidence - where Helen Macdonald and Carl Heneghan take you through what's happening in the world of Evidence. 

This month we'll be discussing  tramadol being prescripted postoperatively, and a new EBM verdict says that should change(1.36). How much preventable harm does healthcare causes (11.20. A canadian project to help policy makers get the evidence they need (16.55) 

One of our listeners thinks "Simple" GPs are anything but (28.30) - and we'll be asking Alexa about our health queries.

Reading list

Treating postoperative pain? Avoid tramadol, long-acting opioid analgesics and long-term use
 https://ebm.bmj.com/content/early/2019/08/16/bmjebm-2019-111236

Prevalence, severity, and nature of preventable patient harm across medical care settings
https://www.bmj.com/content/366/bmj.l4185

Helen Salisbury: “Alexa, can you do my job for me?”
<p>https://www.bmj.com/content/366/bmj.l4719</p>
]]></description>
                                                            <content:encoded><![CDATA[Welcome back to Talk Evidence - where Helen Macdonald and Carl Heneghan take you through what's happening in the world of Evidence. 

This month we'll be discussing  tramadol being prescripted postoperatively, and a new EBM verdict says that should change(1.36). How much preventable harm does healthcare causes (11.20. A canadian project to help policy makers get the evidence they need (16.55) 

One of our listeners thinks "Simple" GPs are anything but (28.30) - and we'll be asking Alexa about our health queries.

Reading list

Treating postoperative pain? Avoid tramadol, long-acting opioid analgesics and long-term use
 https://ebm.bmj.com/content/early/2019/08/16/bmjebm-2019-111236

Prevalence, severity, and nature of preventable patient harm across medical care settings
https://www.bmj.com/content/366/bmj.l4185

Helen Salisbury: “Alexa, can you do my job for me?”
<p>https://www.bmj.com/content/366/bmj.l4719</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/odtxap/stream_668916185-bmjgroup-talk-evidence-tramadol-medical-harm-and-alexa.mp3" length="59718044" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Welcome back to Talk Evidence - where Helen Macdonald and Carl Heneghan take you through what's happening in the world of Evidence. 

This month we'll be discussing  tramadol being prescripted postoperatively, and a new EBM verdict says that should change(1.36). How much preventable harm does healthcare causes (11.20. A canadian project to help policy makers get the evidence they need (16.55) 

One of our listeners thinks "Simple" GPs are anything but (28.30) - and we'll be asking Alexa about our health queries.

Reading list

Treating postoperative pain? Avoid tramadol, long-acting opioid analgesics and long-term use
 https://ebm.bmj.com/content/early/2019/08/16/bmjebm-2019-111236

Prevalence, severity, and nature of preventable patient harm across medical care settings
https://www.bmj.com/content/366/bmj.l4185

Helen Salisbury: “Alexa, can you do my job for me?”
https://www.bmj.com/content/366/bmj.l4719]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2488</itunes:duration>
                                    </item>
    <item>
        <title>Gottfried Hirnschall is optimistic about ending the HIV epidemic</title>
        <itunes:title>Gottfried Hirnschall is optimistic about ending the HIV epidemic</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/gottfried-hirnschall-is-optimistic-about-ending-the-hiv-epidemic/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/gottfried-hirnschall-is-optimistic-about-ending-the-hiv-epidemic/#comments</comments>        <pubDate>Thu, 15 Aug 2019 16:45:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/gottfried-hirnschall-is-optimistic-about-ending-the-hiv-epidemic</guid>
                                    <description><![CDATA[In 2001, Gottfried Hirnschall joined the WHO to work on the global response to HIV/AIDs, 18 years later he just retired as the director of WHO’s department for HIV and Hepatitis.

The intervening period, almost half the time we’ve been aware of the disease the fight against the infection has been characterised by scientific breakthroughs, and disappointments - but the people mobilised against the virus have changed the way the world funds global health, the way patients are included in research agendas, and saved lives.

<p>Gottfried spoke to us during his post retirement holiday in France, and talked about his experiences, and what the legacy of HIV/AIDs will be.</p>
]]></description>
                                                            <content:encoded><![CDATA[In 2001, Gottfried Hirnschall joined the WHO to work on the global response to HIV/AIDs, 18 years later he just retired as the director of WHO’s department for HIV and Hepatitis.

The intervening period, almost half the time we’ve been aware of the disease the fight against the infection has been characterised by scientific breakthroughs, and disappointments - but the people mobilised against the virus have changed the way the world funds global health, the way patients are included in research agendas, and saved lives.

<p>Gottfried spoke to us during his post retirement holiday in France, and talked about his experiences, and what the legacy of HIV/AIDs will be.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/p844c3/stream_666257126-bmjgroup-gottfried-hirnschall-is-optimistic-about-ending-the-hiv-epidemic.mp3" length="68042681" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In 2001, Gottfried Hirnschall joined the WHO to work on the global response to HIV/AIDs, 18 years later he just retired as the director of WHO’s department for HIV and Hepatitis.

The intervening period, almost half the time we’ve been aware of the disease the fight against the infection has been characterised by scientific breakthroughs, and disappointments - but the people mobilised against the virus have changed the way the world funds global health, the way patients are included in research agendas, and saved lives.

Gottfried spoke to us during his post retirement holiday in France, and talked about his experiences, and what the legacy of HIV/AIDs will be.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2834</itunes:duration>
                                    </item>
    <item>
        <title>Burnout - Don’t try to make the canary in the coal mine more resilient</title>
        <itunes:title>Burnout - Don’t try to make the canary in the coal mine more resilient</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/burnout-don-t-try-to-make-the-canary-in-the-coal-mine-more-resilient/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/burnout-don-t-try-to-make-the-canary-in-the-coal-mine-more-resilient/#comments</comments>        <pubDate>Thu, 08 Aug 2019 16:59:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/burnout-dont-try-and-make-the-canary-in-the-coal-mine-more-resilliant</guid>
                                    <description><![CDATA[Burnout is a problem in healthcare - it’s a problem for individuals, those who experience it and decide to leave a career they formerly loved, but it’s also a problem for our healthcare system. Burnout is associated with an increase in medical errors, and poor quality of care. Fundamentally it’s a patient safety issue.

But, unlike other patient safety issues we tend to think about it, and try to prevent it, at an individual not systems level. 

However, Anthony Montgomery from the University of Macedonia, and Christina Maslach, from the University of California, Berkeley, urge us to start treating burnout as a systems issue. We hear about how we can spot burnout, and what can be done to try and mitigate it.

Read their full analysis
Burnout in healthcare: the case for organisational change
<p>https://www.bmj.com/content/366/bmj.l4774</p>
]]></description>
                                                            <content:encoded><![CDATA[Burnout is a problem in healthcare - it’s a problem for individuals, those who experience it and decide to leave a career they formerly loved, but it’s also a problem for our healthcare system. Burnout is associated with an increase in medical errors, and poor quality of care. Fundamentally it’s a patient safety issue.

But, unlike other patient safety issues we tend to think about it, and try to prevent it, at an individual not systems level. 

However, Anthony Montgomery from the University of Macedonia, and Christina Maslach, from the University of California, Berkeley, urge us to start treating burnout as a systems issue. We hear about how we can spot burnout, and what can be done to try and mitigate it.

Read their full analysis
Burnout in healthcare: the case for organisational change
<p>https://www.bmj.com/content/366/bmj.l4774</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rfby8p/stream_663002105-bmjgroup-burnout-dont-try-and-make-the-canary-in-the-coal-mine-more-resilliant.mp3" length="74320684" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Burnout is a problem in healthcare - it’s a problem for individuals, those who experience it and decide to leave a career they formerly loved, but it’s also a problem for our healthcare system. Burnout is associated with an increase in medical errors, and poor quality of care. Fundamentally it’s a patient safety issue.

But, unlike other patient safety issues we tend to think about it, and try to prevent it, at an individual not systems level. 

However, Anthony Montgomery from the University of Macedonia, and Christina Maslach, from the University of California, Berkeley, urge us to start treating burnout as a systems issue. We hear about how we can spot burnout, and what can be done to try and mitigate it.

Read their full analysis
Burnout in healthcare: the case for organisational change
https://www.bmj.com/content/366/bmj.l4774]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3096</itunes:duration>
                                    </item>
    <item>
        <title>Sustainable health</title>
        <itunes:title>Sustainable health</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/sustainable-health/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/sustainable-health/#comments</comments>        <pubDate>Fri, 02 Aug 2019 16:49:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/sustainable-health</guid>
                                    <description><![CDATA[The UK has just seen it’s hottest July on record, including the highest ever temperature recorded.  With climate change in the forefront of our minds, it’s timely that we have two editorials on the sustainability and health.

Michael Depledge, emeritus professor of environment and human health at University of Exeter Medical School, and author of the editorial Time and Tide, explains how closely the oceans and seas are linked to human health.

Also Gillian Leng, deputy chief executive and director of health and social care at NICE has ideas about what the NHS can do to become more sustainable, and how we could evaluate the impact treatments have on the planet.

Read the two editorials
Time and tide - https://www.bmj.com/content/366/bmj.l4671
<p>A more sustainable NHS - https://www.bmj.com/content/366/bmj.l4930</p>
]]></description>
                                                            <content:encoded><![CDATA[The UK has just seen it’s hottest July on record, including the highest ever temperature recorded.  With climate change in the forefront of our minds, it’s timely that we have two editorials on the sustainability and health.

Michael Depledge, emeritus professor of environment and human health at University of Exeter Medical School, and author of the editorial Time and Tide, explains how closely the oceans and seas are linked to human health.

Also Gillian Leng, deputy chief executive and director of health and social care at NICE has ideas about what the NHS can do to become more sustainable, and how we could evaluate the impact treatments have on the planet.

Read the two editorials
Time and tide - https://www.bmj.com/content/366/bmj.l4671
<p>A more sustainable NHS - https://www.bmj.com/content/366/bmj.l4930</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/cqqxtk/stream_660181322-bmjgroup-sustainable-health.mp3" length="48681978" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The UK has just seen it’s hottest July on record, including the highest ever temperature recorded.  With climate change in the forefront of our minds, it’s timely that we have two editorials on the sustainability and health.

Michael Depledge, emeritus professor of environment and human health at University of Exeter Medical School, and author of the editorial Time and Tide, explains how closely the oceans and seas are linked to human health.

Also Gillian Leng, deputy chief executive and director of health and social care at NICE has ideas about what the NHS can do to become more sustainable, and how we could evaluate the impact treatments have on the planet.

Read the two editorials
Time and tide - https://www.bmj.com/content/366/bmj.l4671
A more sustainable NHS - https://www.bmj.com/content/366/bmj.l4930]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2030</itunes:duration>
                                    </item>
    <item>
        <title>Patient’s rights in research - moving beyond participation</title>
        <itunes:title>Patient’s rights in research - moving beyond participation</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/patient-s-rights-in-research-moving-beyond-participation/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/patient-s-rights-in-research-moving-beyond-participation/#comments</comments>        <pubDate>Thu, 25 Jul 2019 14:54:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/patients-rights-in-research-moving-beyond-participation</guid>
                                    <description><![CDATA[At EBM live recently, we ran a workshop with researchers, patients and clinicians to talk about patient rights in research - should patients be setting the full research agenda? Should they be full participants and authors?

Helen Macdonald, BMJ’s UK research editor and co-host of our talk evidence podcast sat down to Paul Wicks, researcher and patient, and Emma Cartwright, The BMJ's What your patient is thinking editor, to reflect on what the workshop uncovered - and where we should be moving to next.

Read more about the BMJ's patient and public partnership: https://www.bmj.com/campaign/patient-partnership

Go to EBM live in Toronto in 2020
<p>https://ebmlive.org/ebmlive-2020/</p>
]]></description>
                                                            <content:encoded><![CDATA[At EBM live recently, we ran a workshop with researchers, patients and clinicians to talk about patient rights in research - should patients be setting the full research agenda? Should they be full participants and authors?

Helen Macdonald, BMJ’s UK research editor and co-host of our talk evidence podcast sat down to Paul Wicks, researcher and patient, and Emma Cartwright, The BMJ's What your patient is thinking editor, to reflect on what the workshop uncovered - and where we should be moving to next.

Read more about the BMJ's patient and public partnership: https://www.bmj.com/campaign/patient-partnership

Go to EBM live in Toronto in 2020
<p>https://ebmlive.org/ebmlive-2020/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/klj1x6/stream_656221085-bmjgroup-patients-rights-in-research-moving-beyond-participation.mp3" length="44635620" type="audio/mpeg"/>
        <itunes:summary><![CDATA[At EBM live recently, we ran a workshop with researchers, patients and clinicians to talk about patient rights in research - should patients be setting the full research agenda? Should they be full participants and authors?

Helen Macdonald, BMJ’s UK research editor and co-host of our talk evidence podcast sat down to Paul Wicks, researcher and patient, and Emma Cartwright, The BMJ's What your patient is thinking editor, to reflect on what the workshop uncovered - and where we should be moving to next.

Read more about the BMJ's patient and public partnership: https://www.bmj.com/campaign/patient-partnership

Go to EBM live in Toronto in 2020
https://ebmlive.org/ebmlive-2020/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1859</itunes:duration>
                                    </item>
    <item>
        <title>Cannabinoid Hyperemesis Syndrome</title>
        <itunes:title>Cannabinoid Hyperemesis Syndrome</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/cannabinoid-hyperemesis-syndrome-1684835829/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/cannabinoid-hyperemesis-syndrome-1684835829/#comments</comments>        <pubDate>Fri, 19 Jul 2019 15:47:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/cannabinoid-hyperemesis-syndrome</guid>
                                    <description><![CDATA[Cannabinoid hyperemesis syndrome is a relatively newly recognised condition - but, according to one study, can account for up to 6% of patients presenting to emergency departments. 

The causal mechanism is as yet unclear - but currently the only known way to prevent the syndrome is for the patient to stop their cannabis use.

Yaniv Chocron, chief resident at Lausanne University Hospital, Lausanne, Switzerland talks us through spotting the condition, and what we think might be the mechanism of action.

Read the full easily missed article:
<p>https://www.bmj.com/content/366/bmj.l4336</p>
]]></description>
                                                            <content:encoded><![CDATA[Cannabinoid hyperemesis syndrome is a relatively newly recognised condition - but, according to one study, can account for up to 6% of patients presenting to emergency departments. 

The causal mechanism is as yet unclear - but currently the only known way to prevent the syndrome is for the patient to stop their cannabis use.

Yaniv Chocron, chief resident at Lausanne University Hospital, Lausanne, Switzerland talks us through spotting the condition, and what we think might be the mechanism of action.

Read the full easily missed article:
<p>https://www.bmj.com/content/366/bmj.l4336</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3sto3g/stream_653519111-bmjgroup-cannabinoid-hyperemesis-syndrome.mp3" length="25727017" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Cannabinoid hyperemesis syndrome is a relatively newly recognised condition - but, according to one study, can account for up to 6% of patients presenting to emergency departments. 

The causal mechanism is as yet unclear - but currently the only known way to prevent the syndrome is for the patient to stop their cannabis use.

Yaniv Chocron, chief resident at Lausanne University Hospital, Lausanne, Switzerland talks us through spotting the condition, and what we think might be the mechanism of action.

Read the full easily missed article:
https://www.bmj.com/content/366/bmj.l4336]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1072</itunes:duration>
                                    </item>
    <item>
        <title>Fighting bad science in Austria</title>
        <itunes:title>Fighting bad science in Austria</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/fighting-bad-science-in-austria/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/fighting-bad-science-in-austria/#comments</comments>        <pubDate>Wed, 17 Jul 2019 16:29:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/fighting-bad-science-in-austria</guid>
                                    <description><![CDATA[Cochrane Austria have been asking the public what they'd like to know about health. Not whether the latest drug is more efficacious, but whether glacier stone power cures hangovers.

Gerald Gartlehner, director of the Cochrane Austria Centre joins us to explain what they do, and how their evidence has been received.

Read more about the project (in German):
<p>https://www.medizin-transparent.at/</p>
]]></description>
                                                            <content:encoded><![CDATA[Cochrane Austria have been asking the public what they'd like to know about health. Not whether the latest drug is more efficacious, but whether glacier stone power cures hangovers.

Gerald Gartlehner, director of the Cochrane Austria Centre joins us to explain what they do, and how their evidence has been received.

Read more about the project (in German):
<p>https://www.medizin-transparent.at/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/bjleta/stream_652516100-bmjgroup-fighting-bad-science-in-austria.mp3" length="22951236" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Cochrane Austria have been asking the public what they'd like to know about health. Not whether the latest drug is more efficacious, but whether glacier stone power cures hangovers.

Gerald Gartlehner, director of the Cochrane Austria Centre joins us to explain what they do, and how their evidence has been received.

Read more about the project (in German):
https://www.medizin-transparent.at/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>957</itunes:duration>
                                    </item>
    <item>
        <title>Fertility awareness based methods for pregnancy prevention</title>
        <itunes:title>Fertility awareness based methods for pregnancy prevention</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/fertility-awareness-based-methods-for-pregnancy-prevention/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/fertility-awareness-based-methods-for-pregnancy-prevention/#comments</comments>        <pubDate>Sat, 13 Jul 2019 17:38:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/fertility-awareness-based-methods-for-pregnancy-prevention</guid>
                                    <description><![CDATA[Fertility awareness based methods of contraception are increasingly being used for pregnancy prevention. In the US, the proportion of contraceptive users who choose such methods has grown from 1% in 2008 to approximately 3% in 2014. 

Relative to other methods of pregnancy prevention, however, substantial misinformation exists around fertility awareness based methods of contraception, particularly about the effectiveness of specific methods and how to use them. 

Rachel Urrutia, assistant professor of Obstetrics and Gynecology at the, University of North Carolina,  and Chelsea Polis, senior research scientist at the Guttmacher Institute join us to describe the various fertility awareness based methods, and the evidence base behind all the options available.


Read the  full clinical update
<p>https://www.bmj.com/content/366/bmj.l4245</p>
]]></description>
                                                            <content:encoded><![CDATA[Fertility awareness based methods of contraception are increasingly being used for pregnancy prevention. In the US, the proportion of contraceptive users who choose such methods has grown from 1% in 2008 to approximately 3% in 2014. 

Relative to other methods of pregnancy prevention, however, substantial misinformation exists around fertility awareness based methods of contraception, particularly about the effectiveness of specific methods and how to use them. 

Rachel Urrutia, assistant professor of Obstetrics and Gynecology at the, University of North Carolina,  and Chelsea Polis, senior research scientist at the Guttmacher Institute join us to describe the various fertility awareness based methods, and the evidence base behind all the options available.


Read the  full clinical update
<p>https://www.bmj.com/content/366/bmj.l4245</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mdt5of/stream_650637317-bmjgroup-fertility-awareness-based-methods-for-pregnancy-prevention.mp3" length="54046409" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Fertility awareness based methods of contraception are increasingly being used for pregnancy prevention. In the US, the proportion of contraceptive users who choose such methods has grown from 1% in 2008 to approximately 3% in 2014. 

Relative to other methods of pregnancy prevention, however, substantial misinformation exists around fertility awareness based methods of contraception, particularly about the effectiveness of specific methods and how to use them. 

Rachel Urrutia, assistant professor of Obstetrics and Gynecology at the, University of North Carolina,  and Chelsea Polis, senior research scientist at the Guttmacher Institute join us to describe the various fertility awareness based methods, and the evidence base behind all the options available.


Read the  full clinical update
https://www.bmj.com/content/366/bmj.l4245]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2254</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence - smoking, gloves and transparency</title>
        <itunes:title>Talk Evidence - smoking, gloves and transparency</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-smoking-gloves-and-transparency/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-smoking-gloves-and-transparency/#comments</comments>        <pubDate>Wed, 10 Jul 2019 11:11:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-smoking-gloves-and-transparency</guid>
                                    <description><![CDATA[This month we have some more feedback from our listeners (2.20)

Carl says it's time to start smoking cessation (or stop the reduction in funding for smoking reduction) (11.40) and marvels at how pretty Richard Doll's seminal smoking paper is.

It's gloves off for infection control (22.20) 

Andrew George, a non-executive director of the Health Research Authority joins us to talk about their consultation on research transparency, and explains how you can get involved (27.04)

And we talk about a new tool for rating the transparency of pharma companies (37.40)

Reading list:

Impact of the WHO Framework Convention on Tobacco Control on global cigarette consumption
https://www.bmj.com/content/365/bmj.l2287

Sixty seconds on . . . gloves off
https://www.bmj.com/content/366/bmj.l4498

HRA transparency consultation
https://www.hra.nhs.uk/about-us/consultations/make-it-public/our-vision-research-transparency/

Sharing of clinical trial data and results reporting practices among large pharmaceutical companies
<p>https://www.bmj.com/content/366/bmj.l4217</p>
]]></description>
                                                            <content:encoded><![CDATA[This month we have some more feedback from our listeners (2.20)

Carl says it's time to start smoking cessation (or stop the reduction in funding for smoking reduction) (11.40) and marvels at how pretty Richard Doll's seminal smoking paper is.

It's gloves off for infection control (22.20) 

Andrew George, a non-executive director of the Health Research Authority joins us to talk about their consultation on research transparency, and explains how you can get involved (27.04)

And we talk about a new tool for rating the transparency of pharma companies (37.40)

Reading list:

Impact of the WHO Framework Convention on Tobacco Control on global cigarette consumption
https://www.bmj.com/content/365/bmj.l2287

Sixty seconds on . . . gloves off
https://www.bmj.com/content/366/bmj.l4498

HRA transparency consultation
https://www.hra.nhs.uk/about-us/consultations/make-it-public/our-vision-research-transparency/

Sharing of clinical trial data and results reporting practices among large pharmaceutical companies
<p>https://www.bmj.com/content/366/bmj.l4217</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rrrmyg/stream_649044047-bmjgroup-talk-evidence-smoking-gloves-and-transparency.mp3" length="44662699" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This month we have some more feedback from our listeners (2.20)

Carl says it's time to start smoking cessation (or stop the reduction in funding for smoking reduction) (11.40) and marvels at how pretty Richard Doll's seminal smoking paper is.

It's gloves off for infection control (22.20) 

Andrew George, a non-executive director of the Health Research Authority joins us to talk about their consultation on research transparency, and explains how you can get involved (27.04)

And we talk about a new tool for rating the transparency of pharma companies (37.40)

Reading list:

Impact of the WHO Framework Convention on Tobacco Control on global cigarette consumption
https://www.bmj.com/content/365/bmj.l2287

Sixty seconds on . . . gloves off
https://www.bmj.com/content/366/bmj.l4498

HRA transparency consultation
https://www.hra.nhs.uk/about-us/consultations/make-it-public/our-vision-research-transparency/

Sharing of clinical trial data and results reporting practices among large pharmaceutical companies
https://www.bmj.com/content/366/bmj.l4217]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2792</itunes:duration>
                                    </item>
    <item>
        <title>I have never encountered an organisation as vicious in its treatment of whistleblowers as the NHS</title>
        <itunes:title>I have never encountered an organisation as vicious in its treatment of whistleblowers as the NHS</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/i-have-never-encountered-an-organisation-as-vicious-in-its-treatment-of-whistleblowers-as-the-nhs/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/i-have-never-encountered-an-organisation-as-vicious-in-its-treatment-of-whistleblowers-as-the-nhs/#comments</comments>        <pubDate>Thu, 04 Jul 2019 10:23:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/i-have-never-encountered-an-organisation-as-vicious-in-its-treatment-of-whistleblowers-as-the-nhs</guid>
                                    <description><![CDATA[Margaret Heffernan has thought a lot about whistleblowing, and why companies don't respond well to it. She wrote the "Book Wilful Blindness: Why We Ignore the Obvious at our Peril". 

In this podcast she talks about how culture, and groupthink, leads to a culture where whistleblowers are ignored, and why the NHS needs to change the way it treats people who try and call out poor care.

<p>This was recorded at Risky Business - https://www.riskybusiness.events/ where you can find our more about the conference and watch previous talks.</p>
]]></description>
                                                            <content:encoded><![CDATA[Margaret Heffernan has thought a lot about whistleblowing, and why companies don't respond well to it. She wrote the "Book Wilful Blindness: Why We Ignore the Obvious at our Peril". 

In this podcast she talks about how culture, and groupthink, leads to a culture where whistleblowers are ignored, and why the NHS needs to change the way it treats people who try and call out poor care.

<p>This was recorded at Risky Business - https://www.riskybusiness.events/ where you can find our more about the conference and watch previous talks.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vjijyx/stream_646104453-bmjgroup-i-have-never-encountered-an-organisation-as-vicious-in-its-treatment-of-whistleblowers-as-the-nhs.mp3" length="41710336" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Margaret Heffernan has thought a lot about whistleblowing, and why companies don't respond well to it. She wrote the "Book Wilful Blindness: Why We Ignore the Obvious at our Peril". 

In this podcast she talks about how culture, and groupthink, leads to a culture where whistleblowers are ignored, and why the NHS needs to change the way it treats people who try and call out poor care.

This was recorded at Risky Business - https://www.riskybusiness.events/ where you can find our more about the conference and watch previous talks.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1739</itunes:duration>
                                    </item>
    <item>
        <title>After Grenfell</title>
        <itunes:title>After Grenfell</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/after-grenfell-1684835835/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/after-grenfell-1684835835/#comments</comments>        <pubDate>Mon, 01 Jul 2019 12:00:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/after-grenfell</guid>
                                    <description><![CDATA[It's been just over two years since a fire broke out in Grenfell tower, in west London, claiming the lives of 72 residents. 223 people survived, thanks to the work of the fire brigade and health care.

In this podcast we hear from Andrew Roe, assistant commissioner at London Fire Brigade, and Anu Mitra, consultant emergency physician at St Mary's hospital - they talk about the support which has been provided, and where more needs to be done to help frontline staff cope with the horrors of the job.

<p>The interviews were recorded at Risky Business - https://www.riskybusiness.events/ - where you can find out more about the Risk in healthcare.</p>
]]></description>
                                                            <content:encoded><![CDATA[It's been just over two years since a fire broke out in Grenfell tower, in west London, claiming the lives of 72 residents. 223 people survived, thanks to the work of the fire brigade and health care.

In this podcast we hear from Andrew Roe, assistant commissioner at London Fire Brigade, and Anu Mitra, consultant emergency physician at St Mary's hospital - they talk about the support which has been provided, and where more needs to be done to help frontline staff cope with the horrors of the job.

<p>The interviews were recorded at Risky Business - https://www.riskybusiness.events/ - where you can find out more about the Risk in healthcare.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/nva935/stream_644626611-bmjgroup-after-grenfell.mp3" length="20440292" type="audio/mpeg"/>
        <itunes:summary><![CDATA[It's been just over two years since a fire broke out in Grenfell tower, in west London, claiming the lives of 72 residents. 223 people survived, thanks to the work of the fire brigade and health care.

In this podcast we hear from Andrew Roe, assistant commissioner at London Fire Brigade, and Anu Mitra, consultant emergency physician at St Mary's hospital - they talk about the support which has been provided, and where more needs to be done to help frontline staff cope with the horrors of the job.

The interviews were recorded at Risky Business - https://www.riskybusiness.events/ - where you can find out more about the Risk in healthcare.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1278</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence - Z drugs, subclinical hypothyroidism and Drazen’s dozen</title>
        <itunes:title>Talk Evidence - Z drugs, subclinical hypothyroidism and Drazen’s dozen</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-z-drugs-subclinical-hypothyroidism-and-drazen-s-dozen/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-z-drugs-subclinical-hypothyroidism-and-drazen-s-dozen/#comments</comments>        <pubDate>Tue, 25 Jun 2019 16:58:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-z-drugs</guid>
                                    <description><![CDATA[This week on the podcast, (2.02) a listener asks, when we suggest something to stop, should we suggest an alternative instead?

(8.24) Helen tells us to stop putting people on treatment for subclinical hypothyroidism, but what does that mean for people who are already receiving thyroxine?

(20.55) Carl has a black box warning about z drugs, and wonders what the alternative for sleep are.

(30.11) Finally the NEJM has published Jeff Drazen's dozen most influential papers - but not a systematic review amongst them. Cue the rant.

Reading list:
Rapid rec on subclinical hypothyroidism 
https://www.bmj.com/content/365/bmj.l2006

Temporal trends in use of tests in UK primary care, 2000-15
https://www.bmj.com/content/363/bmj.k4666

Black box warning for z-drugs
https://www.bmj.com/content/365/bmj.l2165

Drazen's dozen
<p>https://cdn.nejm.org/pdf/Drazens-Dozen.pdf</p>
]]></description>
                                                            <content:encoded><![CDATA[This week on the podcast, (2.02) a listener asks, when we suggest something to stop, should we suggest an alternative instead?

(8.24) Helen tells us to stop putting people on treatment for subclinical hypothyroidism, but what does that mean for people who are already receiving thyroxine?

(20.55) Carl has a black box warning about z drugs, and wonders what the alternative for sleep are.

(30.11) Finally the NEJM has published Jeff Drazen's dozen most influential papers - but not a systematic review amongst them. Cue the rant.

Reading list:
Rapid rec on subclinical hypothyroidism 
https://www.bmj.com/content/365/bmj.l2006

Temporal trends in use of tests in UK primary care, 2000-15
https://www.bmj.com/content/363/bmj.k4666

Black box warning for z-drugs
https://www.bmj.com/content/365/bmj.l2165

Drazen's dozen
<p>https://cdn.nejm.org/pdf/Drazens-Dozen.pdf</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3kbv83/stream_641924466-bmjgroup-talk-evidence-z-drugs.mp3" length="64425768" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week on the podcast, (2.02) a listener asks, when we suggest something to stop, should we suggest an alternative instead?

(8.24) Helen tells us to stop putting people on treatment for subclinical hypothyroidism, but what does that mean for people who are already receiving thyroxine?

(20.55) Carl has a black box warning about z drugs, and wonders what the alternative for sleep are.

(30.11) Finally the NEJM has published Jeff Drazen's dozen most influential papers - but not a systematic review amongst them. Cue the rant.

Reading list:
Rapid rec on subclinical hypothyroidism 
https://www.bmj.com/content/365/bmj.l2006

Temporal trends in use of tests in UK primary care, 2000-15
https://www.bmj.com/content/363/bmj.k4666

Black box warning for z-drugs
https://www.bmj.com/content/365/bmj.l2165

Drazen's dozen
https://cdn.nejm.org/pdf/Drazens-Dozen.pdf]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2688</itunes:duration>
                                    </item>
    <item>
        <title>Did international accord on tobacco reduce smoking?</title>
        <itunes:title>Did international accord on tobacco reduce smoking?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/did-international-accord-on-tobacco-reduce-smoking/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/did-international-accord-on-tobacco-reduce-smoking/#comments</comments>        <pubDate>Thu, 20 Jun 2019 10:51:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/did-international-accord-on-tobacco-reduce-smoking</guid>
                                    <description><![CDATA[WHO Director-General Dr. Tedros recently said  “Since it came into force 13 years ago, the Framework Convention on Tobacco Control remains one of the world’s most powerful tools for promoting public health,”. 

But is it? 

That’s what a to studies just published on bmj.com try and investigate - one of which pulls together all the data we have on smoking rates, from 1970 to 2015, and then a quasi-experimental study which tries to model what the effect of the FCTC has had.

Steven Hoffman, and Matthieu Poirier from the Global Strategy Lab at York University join us to explain what their research means, and why it’s time to double down on our attempts to reduce smoking.

Read the open access research:
https://www.bmj.com/content/365/bmj.l2287
<p>https://www.bmj.com/content/365/bmj.l2231</p>
]]></description>
                                                            <content:encoded><![CDATA[WHO Director-General Dr. Tedros recently said  “Since it came into force 13 years ago, the Framework Convention on Tobacco Control remains one of the world’s most powerful tools for promoting public health,”. 

But is it? 

That’s what a to studies just published on bmj.com try and investigate - one of which pulls together all the data we have on smoking rates, from 1970 to 2015, and then a quasi-experimental study which tries to model what the effect of the FCTC has had.

Steven Hoffman, and Matthieu Poirier from the Global Strategy Lab at York University join us to explain what their research means, and why it’s time to double down on our attempts to reduce smoking.

Read the open access research:
https://www.bmj.com/content/365/bmj.l2287
<p>https://www.bmj.com/content/365/bmj.l2231</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9njqyn/stream_639455331-bmjgroup-did-international-accord-on-tobacco-reduce-smoking.mp3" length="50818433" type="audio/mpeg"/>
        <itunes:summary><![CDATA[WHO Director-General Dr. Tedros recently said  “Since it came into force 13 years ago, the Framework Convention on Tobacco Control remains one of the world’s most powerful tools for promoting public health,”. 

But is it? 

That’s what a to studies just published on bmj.com try and investigate - one of which pulls together all the data we have on smoking rates, from 1970 to 2015, and then a quasi-experimental study which tries to model what the effect of the FCTC has had.

Steven Hoffman, and Matthieu Poirier from the Global Strategy Lab at York University join us to explain what their research means, and why it’s time to double down on our attempts to reduce smoking.

Read the open access research:
https://www.bmj.com/content/365/bmj.l2287
https://www.bmj.com/content/365/bmj.l2231]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2119</itunes:duration>
                                    </item>
    <item>
        <title>Working as a team, and combating stress, in space</title>
        <itunes:title>Working as a team, and combating stress, in space</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/working-as-a-team-and-combating-stress-in-space/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/working-as-a-team-and-combating-stress-in-space/#comments</comments>        <pubDate>Tue, 18 Jun 2019 15:04:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/working-as-a-team-and-combating-stress-in-space</guid>
                                    <description><![CDATA[Nicole Stott is an engineer, aquanaut and one of the 220 astronauts to have lived and worked on the International Space Station.

In a confined space, under huge pressure, with no way out, it's important that teams maintain healthy dynamics, and individuals can manage their stress adequately, and in this podcast Nicole explains a little about living on the ISS and how she coped for 91 days.

Read more about the Space Art Foundation:
https://www.bmj.com/content/365/bmj.l4244

More from Risky Business
<p>https://www.riskybusiness.events/</p>
]]></description>
                                                            <content:encoded><![CDATA[Nicole Stott is an engineer, aquanaut and one of the 220 astronauts to have lived and worked on the International Space Station.

In a confined space, under huge pressure, with no way out, it's important that teams maintain healthy dynamics, and individuals can manage their stress adequately, and in this podcast Nicole explains a little about living on the ISS and how she coped for 91 days.

Read more about the Space Art Foundation:
https://www.bmj.com/content/365/bmj.l4244

More from Risky Business
<p>https://www.riskybusiness.events/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/477ltv/stream_638546742-bmjgroup-working-as-a-team-and-combating-stress-in-space.mp3" length="22836675" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Nicole Stott is an engineer, aquanaut and one of the 220 astronauts to have lived and worked on the International Space Station.

In a confined space, under huge pressure, with no way out, it's important that teams maintain healthy dynamics, and individuals can manage their stress adequately, and in this podcast Nicole explains a little about living on the ISS and how she coped for 91 days.

Read more about the Space Art Foundation:
https://www.bmj.com/content/365/bmj.l4244

More from Risky Business
https://www.riskybusiness.events/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>952</itunes:duration>
                                    </item>
    <item>
        <title>Thoroughly and deliberately targeted;  Doctors in Syria</title>
        <itunes:title>Thoroughly and deliberately targeted;  Doctors in Syria</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/thoroughly-and-deliberately-targeted-doctors-in-syria/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/thoroughly-and-deliberately-targeted-doctors-in-syria/#comments</comments>        <pubDate>Fri, 14 Jun 2019 18:08:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/thoroughly-and-deliberately-targeted-doctors-in-syria</guid>
                                    <description><![CDATA[As Syria enters its ninth year of conflict, doctors are struggling to provide health care to a badly damaged country.

While dealing with medicine shortages, mass casualties and everything that comes with working in a warzone, healthcare facilities and their staff are also facing an unprecedented number of targeted and often repeated attacks. 

According to a new report, there were 257 recorded attacks on hospitals, medical transportation and healthcare workers in Syria in 2018. And despite these attacks being illegal under international law, they are becoming the new normal.

<p>In this podcast, Elisabeth Mahase talks to Feras Fares, a gynaecologist from Syria, Len Rubenstein, chair of the Safeguarding Health in Conflict Coalition, and Declan Barry, an Irish pediatrician who worked with MSF in Syria in 2013.</p>
]]></description>
                                                            <content:encoded><![CDATA[As Syria enters its ninth year of conflict, doctors are struggling to provide health care to a badly damaged country.

While dealing with medicine shortages, mass casualties and everything that comes with working in a warzone, healthcare facilities and their staff are also facing an unprecedented number of targeted and often repeated attacks. 

According to a new report, there were 257 recorded attacks on hospitals, medical transportation and healthcare workers in Syria in 2018. And despite these attacks being illegal under international law, they are becoming the new normal.

<p>In this podcast, Elisabeth Mahase talks to Feras Fares, a gynaecologist from Syria, Len Rubenstein, chair of the Safeguarding Health in Conflict Coalition, and Declan Barry, an Irish pediatrician who worked with MSF in Syria in 2013.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8n69fa/stream_636701988-bmjgroup-thoroughly-and-deliberately-targeted-doctors-in-syria.mp3" length="24312931" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As Syria enters its ninth year of conflict, doctors are struggling to provide health care to a badly damaged country.

While dealing with medicine shortages, mass casualties and everything that comes with working in a warzone, healthcare facilities and their staff are also facing an unprecedented number of targeted and often repeated attacks. 

According to a new report, there were 257 recorded attacks on hospitals, medical transportation and healthcare workers in Syria in 2018. And despite these attacks being illegal under international law, they are becoming the new normal.

In this podcast, Elisabeth Mahase talks to Feras Fares, a gynaecologist from Syria, Len Rubenstein, chair of the Safeguarding Health in Conflict Coalition, and Declan Barry, an Irish pediatrician who worked with MSF in Syria in 2013.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1014</itunes:duration>
                                    </item>
    <item>
        <title>Planning for the unplannable</title>
        <itunes:title>Planning for the unplannable</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/planning-for-the-unplannable/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/planning-for-the-unplannable/#comments</comments>        <pubDate>Tue, 11 Jun 2019 17:13:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/planning-for-the-unplannable</guid>
                                    <description><![CDATA[Hi impact, low probability events are a planners nightmare. You know that you need to think about them, but how can you prioritise which event - terrorist attack, natural disaster, disease outbreak, deserves attention - and how can you sell the risks of that, but not oversell them?

Risky business is a conference where some of these kind of things can be discussed - how do we think about risk, how do we plan for it - at this year’s conference we heard from one of the men who rescued the boys from a cave in Thailand, the fireman in charge of Grenfell, and the medical teams responding to the three latest terrorist attacks in the UK.

In this podcast we talk to Amy Pope, former advisor to the Whitehouse during president Obama’s tenure. There she was charged with thinking about these high impact, low probability events.

More from Risky Business
<p>https://www.riskybusiness.events/</p>
]]></description>
                                                            <content:encoded><![CDATA[Hi impact, low probability events are a planners nightmare. You know that you need to think about them, but how can you prioritise which event - terrorist attack, natural disaster, disease outbreak, deserves attention - and how can you sell the risks of that, but not oversell them?

Risky business is a conference where some of these kind of things can be discussed - how do we think about risk, how do we plan for it - at this year’s conference we heard from one of the men who rescued the boys from a cave in Thailand, the fireman in charge of Grenfell, and the medical teams responding to the three latest terrorist attacks in the UK.

In this podcast we talk to Amy Pope, former advisor to the Whitehouse during president Obama’s tenure. There she was charged with thinking about these high impact, low probability events.

More from Risky Business
<p>https://www.riskybusiness.events/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/0nmou6/stream_635131632-bmjgroup-planning-for-the-unplannable.mp3" length="36393594" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Hi impact, low probability events are a planners nightmare. You know that you need to think about them, but how can you prioritise which event - terrorist attack, natural disaster, disease outbreak, deserves attention - and how can you sell the risks of that, but not oversell them?

Risky business is a conference where some of these kind of things can be discussed - how do we think about risk, how do we plan for it - at this year’s conference we heard from one of the men who rescued the boys from a cave in Thailand, the fireman in charge of Grenfell, and the medical teams responding to the three latest terrorist attacks in the UK.

In this podcast we talk to Amy Pope, former advisor to the Whitehouse during president Obama’s tenure. There she was charged with thinking about these high impact, low probability events.

More from Risky Business
https://www.riskybusiness.events/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1518</itunes:duration>
                                    </item>
    <item>
        <title>What Matters To You Day</title>
        <itunes:title>What Matters To You Day</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/what-matters-to-you-day/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/what-matters-to-you-day/#comments</comments>        <pubDate>Thu, 06 Jun 2019 07:02:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/what-matters-to-you-day</guid>
                                    <description><![CDATA[It's What Matters To You day - #wmty - and in this podcast Anya de Iongh, The BMJ's patient editor, and Joe Fraser, author of Joe's Diabetes who works at NHS England on personalised care, get together to discuss what personalised care actually means, how it changes the ways in which patients and health professionals interact, and how it can be practically done.

We also hear from three people who are making personalised care actually happen

Jo McGoldrick is a health coach who works at Lions Health GP Practice in Dudley. 
Joanne Appleton is a Commissioning Manager for Personalised Care at Gloucester CCG 
<p>Jono Broad lives with long term health conditions and is involved in regional and QI work around personalised care.</p>
]]></description>
                                                            <content:encoded><![CDATA[It's What Matters To You day - #wmty - and in this podcast Anya de Iongh, The BMJ's patient editor, and Joe Fraser, author of Joe's Diabetes who works at NHS England on personalised care, get together to discuss what personalised care actually means, how it changes the ways in which patients and health professionals interact, and how it can be practically done.

We also hear from three people who are making personalised care actually happen

Jo McGoldrick is a health coach who works at Lions Health GP Practice in Dudley. 
Joanne Appleton is a Commissioning Manager for Personalised Care at Gloucester CCG 
<p>Jono Broad lives with long term health conditions and is involved in regional and QI work around personalised care.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9d3w3f/stream_632507565-bmjgroup-what-matters-to-you-day.mp3" length="52958641" type="audio/mpeg"/>
        <itunes:summary><![CDATA[It's What Matters To You day - #wmty - and in this podcast Anya de Iongh, The BMJ's patient editor, and Joe Fraser, author of Joe's Diabetes who works at NHS England on personalised care, get together to discuss what personalised care actually means, how it changes the ways in which patients and health professionals interact, and how it can be practically done.

We also hear from three people who are making personalised care actually happen

Jo McGoldrick is a health coach who works at Lions Health GP Practice in Dudley. 
Joanne Appleton is a Commissioning Manager for Personalised Care at Gloucester CCG 
Jono Broad lives with long term health conditions and is involved in regional and QI work around personalised care.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2210</itunes:duration>
                                    </item>
    <item>
        <title>Tech and the NHS - A tale of two cultures</title>
        <itunes:title>Tech and the NHS - A tale of two cultures</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/tech-and-the-nhs-a-tale-of-two-cultures/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/tech-and-the-nhs-a-tale-of-two-cultures/#comments</comments>        <pubDate>Mon, 03 Jun 2019 17:31:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/tech-and-the-nhs-a-tale-of-two-cultures</guid>
                                    <description><![CDATA[The NHS is about caring for people, free at the point of care, creating a safety net which catches the most vulnerable. Tech has been defined by the facebook maxim "move fast, break things" - looking to disrupt a sector, get investment and move on. 

We want to be able to harness the potential utility of digital tech in the NHS - but how can those two cultures be reconciled, and what salutary lessons should we learn from other industries (pharmaceuticals, devices) before we embark on these new ventures.


In this podcast we hear from;
Neil Sebire, Chief Research Information Officer and Director, Great Ormond Street Hospital Digital Research, Informatics and Virtual Environments (DRIVE) Unit 
Dr Ramani Moonesinghe, Professor and Head of Centre for Perioperative Medicine, University College London
<p>Indra Joshi, Digital Health and Artificial Intelligence Clinical Lead at the newly formed NHS X</p>
]]></description>
                                                            <content:encoded><![CDATA[The NHS is about caring for people, free at the point of care, creating a safety net which catches the most vulnerable. Tech has been defined by the facebook maxim "move fast, break things" - looking to disrupt a sector, get investment and move on. 

We want to be able to harness the potential utility of digital tech in the NHS - but how can those two cultures be reconciled, and what salutary lessons should we learn from other industries (pharmaceuticals, devices) before we embark on these new ventures.


In this podcast we hear from;
Neil Sebire, Chief Research Information Officer and Director, Great Ormond Street Hospital Digital Research, Informatics and Virtual Environments (DRIVE) Unit 
Dr Ramani Moonesinghe, Professor and Head of Centre for Perioperative Medicine, University College London
<p>Indra Joshi, Digital Health and Artificial Intelligence Clinical Lead at the newly formed NHS X</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fh06pk/stream_630983982-bmjgroup-tech-and-the-nhs-a-tale-of-two-cultures.mp3" length="47233697" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The NHS is about caring for people, free at the point of care, creating a safety net which catches the most vulnerable. Tech has been defined by the facebook maxim "move fast, break things" - looking to disrupt a sector, get investment and move on. 

We want to be able to harness the potential utility of digital tech in the NHS - but how can those two cultures be reconciled, and what salutary lessons should we learn from other industries (pharmaceuticals, devices) before we embark on these new ventures.


In this podcast we hear from;
Neil Sebire, Chief Research Information Officer and Director, Great Ormond Street Hospital Digital Research, Informatics and Virtual Environments (DRIVE) Unit 
Dr Ramani Moonesinghe, Professor and Head of Centre for Perioperative Medicine, University College London
Indra Joshi, Digital Health and Artificial Intelligence Clinical Lead at the newly formed NHS X]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1970</itunes:duration>
                                    </item>
    <item>
        <title>Finding out who funds patient groups</title>
        <itunes:title>Finding out who funds patient groups</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/finding-out-who-funds-patient-groups/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/finding-out-who-funds-patient-groups/#comments</comments>        <pubDate>Wed, 29 May 2019 16:32:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/finding-out-who-funds-patient-groups</guid>
                                    <description><![CDATA[We’ve been banging the drum about transparency of payment to doctors for years - we’ve even put a moratorium on financial conflicts of interest in the authors of any of our education articles. Not because we think that all doctors who receive money from industry are being influenced to push their agenda - but because we have no way of telling when that’s happening…

At the same time, and rightly, patient groups are becoming more involved in setting things like research priorities, and in guideline development - and we’re campaigning to increase that involvement. but as that involvement increases, it’s also important to make sure that potential industry influence is made transparent.

Piotr Ozieranski, is an assistant professor at the Department of Social and Policy Sciences at the University of Bath and one of the authors of a new analysis which attempts to build a picture of industry funding of UK patient groups.

Read the full analysis:
<p>https://www.bmj.com/content/365/bmj.l1806</p>
]]></description>
                                                            <content:encoded><![CDATA[We’ve been banging the drum about transparency of payment to doctors for years - we’ve even put a moratorium on financial conflicts of interest in the authors of any of our education articles. Not because we think that all doctors who receive money from industry are being influenced to push their agenda - but because we have no way of telling when that’s happening…

At the same time, and rightly, patient groups are becoming more involved in setting things like research priorities, and in guideline development - and we’re campaigning to increase that involvement. but as that involvement increases, it’s also important to make sure that potential industry influence is made transparent.

Piotr Ozieranski, is an assistant professor at the Department of Social and Policy Sciences at the University of Bath and one of the authors of a new analysis which attempts to build a picture of industry funding of UK patient groups.

Read the full analysis:
<p>https://www.bmj.com/content/365/bmj.l1806</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4uzzuy/stream_628474152-bmjgroup-finding-out-who-funds-patient-groups.mp3" length="29585979" type="audio/mpeg"/>
        <itunes:summary><![CDATA[We’ve been banging the drum about transparency of payment to doctors for years - we’ve even put a moratorium on financial conflicts of interest in the authors of any of our education articles. Not because we think that all doctors who receive money from industry are being influenced to push their agenda - but because we have no way of telling when that’s happening…

At the same time, and rightly, patient groups are becoming more involved in setting things like research priorities, and in guideline development - and we’re campaigning to increase that involvement. but as that involvement increases, it’s also important to make sure that potential industry influence is made transparent.

Piotr Ozieranski, is an assistant professor at the Department of Social and Policy Sciences at the University of Bath and one of the authors of a new analysis which attempts to build a picture of industry funding of UK patient groups.

Read the full analysis:
https://www.bmj.com/content/365/bmj.l1806]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1233</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence - cancer causing food, prostate cancer and disease definitions</title>
        <itunes:title>Talk Evidence - cancer causing food, prostate cancer and disease definitions</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-cancer-causing-food-prostate-cancer-and-disease-definitions/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-cancer-causing-food-prostate-cancer-and-disease-definitions/#comments</comments>        <pubDate>Sat, 25 May 2019 12:11:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-cancer-causing-food-prostate-cancer-and-disease-definitions</guid>
                                    <description><![CDATA[Helen Macdonald and Carl Heneghan are back again talking about what's happened in the world of evidence this month.

(1.05) Carl rants about bacon causing cancer

(7.10) Helen talks about prostate cancer, and we hear from the author of the research paper which won Research Paper Of The Year at the BMJ awards.

We also cover disease definition  and a call to have GPs more involved in that process, (24.12)and a new call for papers into conflicts of interest (29.40)

Reading list:
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.
https://www.ncbi.nlm.nih.gov/pubmed/29552975?dopt=Abstract


Reforming disease definitions: a new primary care led, people-centred approach
https://ebm.bmj.com/content/early/2019/04/11/bmjebm-2018-111148

Commercial interests, transparency, and independence: a call for submissions
<p>https://www.bmj.com/content/365/bmj.l1706</p>
]]></description>
                                                            <content:encoded><![CDATA[Helen Macdonald and Carl Heneghan are back again talking about what's happened in the world of evidence this month.

(1.05) Carl rants about bacon causing cancer

(7.10) Helen talks about prostate cancer, and we hear from the author of the research paper which won Research Paper Of The Year at the BMJ awards.

We also cover disease definition  and a call to have GPs more involved in that process, (24.12)and a new call for papers into conflicts of interest (29.40)

Reading list:
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.
https://www.ncbi.nlm.nih.gov/pubmed/29552975?dopt=Abstract


Reforming disease definitions: a new primary care led, people-centred approach
https://ebm.bmj.com/content/early/2019/04/11/bmjebm-2018-111148

Commercial interests, transparency, and independence: a call for submissions
<p>https://www.bmj.com/content/365/bmj.l1706</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/taim1c/stream_626372430-bmjgroup-talk-evidence-cancer-causing-food-prostate-cancer-and-disease-definitions.mp3" length="34012928" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Helen Macdonald and Carl Heneghan are back again talking about what's happened in the world of evidence this month.

(1.05) Carl rants about bacon causing cancer

(7.10) Helen talks about prostate cancer, and we hear from the author of the research paper which won Research Paper Of The Year at the BMJ awards.

We also cover disease definition  and a call to have GPs more involved in that process, (24.12)and a new call for papers into conflicts of interest (29.40)

Reading list:
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.
https://www.ncbi.nlm.nih.gov/pubmed/29552975?dopt=Abstract


Reforming disease definitions: a new primary care led, people-centred approach
https://ebm.bmj.com/content/early/2019/04/11/bmjebm-2018-111148

Commercial interests, transparency, and independence: a call for submissions
https://www.bmj.com/content/365/bmj.l1706]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2126</itunes:duration>
                                    </item>
    <item>
        <title>What caused the drop in stroke mortality in the UK</title>
        <itunes:title>What caused the drop in stroke mortality in the UK</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/what-caused-the-drop-in-stroke-mortality-in-the-uk/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/what-caused-the-drop-in-stroke-mortality-in-the-uk/#comments</comments>        <pubDate>Thu, 23 May 2019 10:12:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/what-caused-the-drop-in-stroke-mortality-in-the-uk</guid>
                                    <description><![CDATA[Stroke mortality rates have been declining in almost every country, and that reduction could result from a decline in disease occurrence or a decline in case fatality, or both. Broadly - is that decline down to better treatment or better prevention.

Olena Seminog, a researcher, and and Mike Rayner, professor of population health, both from the Nuffield Department of Population Health at the University of Oxford, join us to discuss their study which has used a large database to try and determine what has most affected stroke mortality.

Read the full open access research paper:
<p>https://www.bmj.com/content/365/bmj.l1778</p>
]]></description>
                                                            <content:encoded><![CDATA[Stroke mortality rates have been declining in almost every country, and that reduction could result from a decline in disease occurrence or a decline in case fatality, or both. Broadly - is that decline down to better treatment or better prevention.

Olena Seminog, a researcher, and and Mike Rayner, professor of population health, both from the Nuffield Department of Population Health at the University of Oxford, join us to discuss their study which has used a large database to try and determine what has most affected stroke mortality.

Read the full open access research paper:
<p>https://www.bmj.com/content/365/bmj.l1778</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/58j41b/stream_625212333-bmjgroup-what-caused-the-drop-in-stroke-mortality-in-the-uk.mp3" length="33698159" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Stroke mortality rates have been declining in almost every country, and that reduction could result from a decline in disease occurrence or a decline in case fatality, or both. Broadly - is that decline down to better treatment or better prevention.

Olena Seminog, a researcher, and and Mike Rayner, professor of population health, both from the Nuffield Department of Population Health at the University of Oxford, join us to discuss their study which has used a large database to try and determine what has most affected stroke mortality.

Read the full open access research paper:
https://www.bmj.com/content/365/bmj.l1778]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1405</itunes:duration>
                                    </item>
    <item>
        <title>Helping parents with children who display challenging behaviour</title>
        <itunes:title>Helping parents with children who display challenging behaviour</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/helping-parents-with-children-who-display-challenging-behaviour/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/helping-parents-with-children-who-display-challenging-behaviour/#comments</comments>        <pubDate>Fri, 17 May 2019 14:50:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/helping-parents-with-children-how-display-challenging-behaviour</guid>
                                    <description><![CDATA[Looking after a young child is hard enough, but when that child has learning difficulties and displays challenging behaviour - the burden on parents can be extreme.

That behaviour may prompt a visit to the doctor, and in this podcast we’re talking about how parents can be supported in that - what services are available. We’ll also be discussing what is normal behaviour, and what might prompt a referral to a specialist team for further assessment.

In this podcast we're joined by 2 of the authors of a recent practice pointer - Managing challenging behaviour in children with possible learning disability. Angela Hassiotis - professor of psychiatry of intellectual disability at University College London and  Michael Absoud - consultant in paediatric neurodisability at the Evelina London Children’s Hospital.

We also have Rebecca - mother of a child who displayed some of these behaviours, and is actually a parent/carer case worker supporting families of children with disabilities.

Read the full practice article:
<p>https://www.bmj.com/content/365/bmj.l1663</p>
]]></description>
                                                            <content:encoded><![CDATA[Looking after a young child is hard enough, but when that child has learning difficulties and displays challenging behaviour - the burden on parents can be extreme.

That behaviour may prompt a visit to the doctor, and in this podcast we’re talking about how parents can be supported in that - what services are available. We’ll also be discussing what is normal behaviour, and what might prompt a referral to a specialist team for further assessment.

In this podcast we're joined by 2 of the authors of a recent practice pointer - Managing challenging behaviour in children with possible learning disability. Angela Hassiotis - professor of psychiatry of intellectual disability at University College London and  Michael Absoud - consultant in paediatric neurodisability at the Evelina London Children’s Hospital.

We also have Rebecca - mother of a child who displayed some of these behaviours, and is actually a parent/carer case worker supporting families of children with disabilities.

Read the full practice article:
<p>https://www.bmj.com/content/365/bmj.l1663</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9pmg2n/stream_622131306-bmjgroup-helping-parents-with-children-how-display-challenging-behaviour.mp3" length="64683108" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Looking after a young child is hard enough, but when that child has learning difficulties and displays challenging behaviour - the burden on parents can be extreme.

That behaviour may prompt a visit to the doctor, and in this podcast we’re talking about how parents can be supported in that - what services are available. We’ll also be discussing what is normal behaviour, and what might prompt a referral to a specialist team for further assessment.

In this podcast we're joined by 2 of the authors of a recent practice pointer - Managing challenging behaviour in children with possible learning disability. Angela Hassiotis - professor of psychiatry of intellectual disability at University College London and  Michael Absoud - consultant in paediatric neurodisability at the Evelina London Children’s Hospital.

We also have Rebecca - mother of a child who displayed some of these behaviours, and is actually a parent/carer case worker supporting families of children with disabilities.

Read the full practice article:
https://www.bmj.com/content/365/bmj.l1663]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2697</itunes:duration>
                                    </item>
    <item>
        <title>Tackling gambling</title>
        <itunes:title>Tackling gambling</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/tackling-gambling/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/tackling-gambling/#comments</comments>        <pubDate>Fri, 10 May 2019 14:38:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/tackling-gambling-as-a-public-health-problem</guid>
                                    <description><![CDATA[In the UK we have a complex relationship with gambling, the government licences the national lottery, and uses profit from that to fund our art and museum sector - horse racing is a national TV event, and we've seen a proliferation of betting shops on our high streets. 

At the same time, there's increasing acceptance that gambling causes problems for some people - to the extent that it's been termed a "hidden epidemic" and a public health problem. And it's to that point that the authors of a new analysis have written in the BMJ - if we see gambling as a public health problem, why aren't we treating it as such.

To talk about that, we're joined in the studio by Heather Wardle - Wellcome humanities and social science research fellow at the LSHTM.

Read the full analysis:
<p>https://www.bmj.com/content/365/bmj.l1807</p>
]]></description>
                                                            <content:encoded><![CDATA[In the UK we have a complex relationship with gambling, the government licences the national lottery, and uses profit from that to fund our art and museum sector - horse racing is a national TV event, and we've seen a proliferation of betting shops on our high streets. 

At the same time, there's increasing acceptance that gambling causes problems for some people - to the extent that it's been termed a "hidden epidemic" and a public health problem. And it's to that point that the authors of a new analysis have written in the BMJ - if we see gambling as a public health problem, why aren't we treating it as such.

To talk about that, we're joined in the studio by Heather Wardle - Wellcome humanities and social science research fellow at the LSHTM.

Read the full analysis:
<p>https://www.bmj.com/content/365/bmj.l1807</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/yfyxly/stream_618591783-bmjgroup-tackling-gambling-as-a-public-health-problem.mp3" length="29585955" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In the UK we have a complex relationship with gambling, the government licences the national lottery, and uses profit from that to fund our art and museum sector - horse racing is a national TV event, and we've seen a proliferation of betting shops on our high streets. 

At the same time, there's increasing acceptance that gambling causes problems for some people - to the extent that it's been termed a "hidden epidemic" and a public health problem. And it's to that point that the authors of a new analysis have written in the BMJ - if we see gambling as a public health problem, why aren't we treating it as such.

To talk about that, we're joined in the studio by Heather Wardle - Wellcome humanities and social science research fellow at the LSHTM.

Read the full analysis:
https://www.bmj.com/content/365/bmj.l1807]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1234</itunes:duration>
                                    </item>
    <item>
        <title>The sex lives of married Brits</title>
        <itunes:title>The sex lives of married Brits</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-sex-lives-of-married-brits/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-sex-lives-of-married-brits/#comments</comments>        <pubDate>Thu, 09 May 2019 09:49:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-sex-lives-of-married-brits</guid>
                                    <description><![CDATA[The National Surveys of Sexual Attitudes and Lifestyles is a deep look into the sex lives of us brits - and has been running now for 30 years, giving us some longitudinal data about the way in which those sex lives have changed. The latest paper to be published, based on that data, looks at the frequency of sex - how often different groups are having sex on a weekly basis, and has reported a drop in that frequency for some groups.

Joining us to talk about the research, and why we're having less sex, is  Kaye Wellings, Professor of Sexual and Reproductive Health at the London School of Hygiene and Tropical Medicine.

Read the full open access research:
<p>https://www.bmj.com/content/365/bmj.l1525</p>
]]></description>
                                                            <content:encoded><![CDATA[The National Surveys of Sexual Attitudes and Lifestyles is a deep look into the sex lives of us brits - and has been running now for 30 years, giving us some longitudinal data about the way in which those sex lives have changed. The latest paper to be published, based on that data, looks at the frequency of sex - how often different groups are having sex on a weekly basis, and has reported a drop in that frequency for some groups.

Joining us to talk about the research, and why we're having less sex, is  Kaye Wellings, Professor of Sexual and Reproductive Health at the London School of Hygiene and Tropical Medicine.

Read the full open access research:
<p>https://www.bmj.com/content/365/bmj.l1525</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/utok1u/stream_617927751-bmjgroup-the-sex-lives-of-married-brits.mp3" length="23860034" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The National Surveys of Sexual Attitudes and Lifestyles is a deep look into the sex lives of us brits - and has been running now for 30 years, giving us some longitudinal data about the way in which those sex lives have changed. The latest paper to be published, based on that data, looks at the frequency of sex - how often different groups are having sex on a weekly basis, and has reported a drop in that frequency for some groups.

Joining us to talk about the research, and why we're having less sex, is  Kaye Wellings, Professor of Sexual and Reproductive Health at the London School of Hygiene and Tropical Medicine.

Read the full open access research:
https://www.bmj.com/content/365/bmj.l1525]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1491</itunes:duration>
                                    </item>
    <item>
        <title>Doctors and extinction rebellion</title>
        <itunes:title>Doctors and extinction rebellion</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/doctors-and-extinction-rebellion/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/doctors-and-extinction-rebellion/#comments</comments>        <pubDate>Fri, 03 May 2019 16:39:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/doctors-and-extinction-rebellion</guid>
                                    <description><![CDATA[Starting in the middle of April, the group “Extinction Rebellion” have organised a series of non-violent direct action protests. Most notably bringing central London to a standstill - but these events are now continuing around the country.

Predictably, they have received a lot of criticism - they have also received a lot of support - amongst those arrested at the protests have been a few doctors, despite reservations that some may have for the impact on their careers. 

In this podcast, we'll hear from three people who have decided to support extinction rebellion, about why they do, and what the medical community's support might mean for climate change.

We're joined by Rowan Williams, Master of Magdalene College, Cambridge and former Archbishop of Canterbury - the principle leader of the church of England. Robin Stott, retired physician and campaigner, and Alex Armitage, paediatric trainee.

Schoolchildren’s activism is a lesson for health professionals
https://www.bmj.com/content/365/bmj.l1938

Just 11 years to avert disaster
<p>https://www.bmj.com/content/365/bmj.l1801</p>
]]></description>
                                                            <content:encoded><![CDATA[Starting in the middle of April, the group “Extinction Rebellion” have organised a series of non-violent direct action protests. Most notably bringing central London to a standstill - but these events are now continuing around the country.

Predictably, they have received a lot of criticism - they have also received a lot of support - amongst those arrested at the protests have been a few doctors, despite reservations that some may have for the impact on their careers. 

In this podcast, we'll hear from three people who have decided to support extinction rebellion, about why they do, and what the medical community's support might mean for climate change.

We're joined by Rowan Williams, Master of Magdalene College, Cambridge and former Archbishop of Canterbury - the principle leader of the church of England. Robin Stott, retired physician and campaigner, and Alex Armitage, paediatric trainee.

Schoolchildren’s activism is a lesson for health professionals
https://www.bmj.com/content/365/bmj.l1938

Just 11 years to avert disaster
<p>https://www.bmj.com/content/365/bmj.l1801</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/982shj/stream_615221247-bmjgroup-doctors-and-extinction-rebellion.mp3" length="48561781" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Starting in the middle of April, the group “Extinction Rebellion” have organised a series of non-violent direct action protests. Most notably bringing central London to a standstill - but these events are now continuing around the country.

Predictably, they have received a lot of criticism - they have also received a lot of support - amongst those arrested at the protests have been a few doctors, despite reservations that some may have for the impact on their careers. 

In this podcast, we'll hear from three people who have decided to support extinction rebellion, about why they do, and what the medical community's support might mean for climate change.

We're joined by Rowan Williams, Master of Magdalene College, Cambridge and former Archbishop of Canterbury - the principle leader of the church of England. Robin Stott, retired physician and campaigner, and Alex Armitage, paediatric trainee.

Schoolchildren’s activism is a lesson for health professionals
https://www.bmj.com/content/365/bmj.l1938

Just 11 years to avert disaster
https://www.bmj.com/content/365/bmj.l1801]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2025</itunes:duration>
                                    </item>
    <item>
        <title>Introducing Sharp Scratch - our new podcast for students and junior doctors</title>
        <itunes:title>Introducing Sharp Scratch - our new podcast for students and junior doctors</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/introducing-sharp-scratch-our-new-podcast-for-students-and-junior-doctors/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/introducing-sharp-scratch-our-new-podcast-for-students-and-junior-doctors/#comments</comments>        <pubDate>Fri, 26 Apr 2019 16:22:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/introducing-sharp-scratch-our-new-podcast-for-students-and-junior-doctors</guid>
                                    <description><![CDATA[Here's a taster for our new student podcast - Sharp Scratch. We're talking about the hidden curriculum, things you need to know to function as a doctor, but are rarely formally taught. 

This is a taster - if you enjoy, subscribe! https://podcasts.apple.com/gb/podcast/student-bmj-podcast/id331561304


Sharp Scratch episode 1: Surviving the night shift.

Why nights shifts mess with your brain, how astronauts will cope with the time difference on Mars, and the power of frozen grapes when you need a boost.

Join medical students Laura, Ryhan, Declan, and newly qualified doctor Chidera as we figure out how to survive the night shift. Featuring a guest interview with NASA researcher Erin, leader of the Fatigue Countermeasures Group.

<p>https://www.bmj.com/sharpscratch</p>
]]></description>
                                                            <content:encoded><![CDATA[Here's a taster for our new student podcast - Sharp Scratch. We're talking about the hidden curriculum, things you need to know to function as a doctor, but are rarely formally taught. 

This is a taster - if you enjoy, subscribe! https://podcasts.apple.com/gb/podcast/student-bmj-podcast/id331561304


Sharp Scratch episode 1: Surviving the night shift.

Why nights shifts mess with your brain, how astronauts will cope with the time difference on Mars, and the power of frozen grapes when you need a boost.

Join medical students Laura, Ryhan, Declan, and newly qualified doctor Chidera as we figure out how to survive the night shift. Featuring a guest interview with NASA researcher Erin, leader of the Fatigue Countermeasures Group.

<p>https://www.bmj.com/sharpscratch</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/b66wqh/stream_611810079-bmjgroup-introducing-sharp-scratch-our-new-podcast-for-students-and-junior-doctors.mp3" length="62540397" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Here's a taster for our new student podcast - Sharp Scratch. We're talking about the hidden curriculum, things you need to know to function as a doctor, but are rarely formally taught. 

This is a taster - if you enjoy, subscribe! https://podcasts.apple.com/gb/podcast/student-bmj-podcast/id331561304


Sharp Scratch episode 1: Surviving the night shift.

Why nights shifts mess with your brain, how astronauts will cope with the time difference on Mars, and the power of frozen grapes when you need a boost.

Join medical students Laura, Ryhan, Declan, and newly qualified doctor Chidera as we figure out how to survive the night shift. Featuring a guest interview with NASA researcher Erin, leader of the Fatigue Countermeasures Group.

https://www.bmj.com/sharpscratch]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2606</itunes:duration>
                                    </item>
    <item>
        <title>Gypsy and Traveller health</title>
        <itunes:title>Gypsy and Traveller health</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/gypsy-and-traveller-health/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/gypsy-and-traveller-health/#comments</comments>        <pubDate>Wed, 24 Apr 2019 14:15:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/gypsy-and-traveller-health</guid>
                                    <description><![CDATA[In the UK, there's an ethnic group that is surprisingly large, but often overlooked by society, and formal healthcare services. The gypsy traveller community have poorer health outcomes because of systemic issues around access to health and education. 

In this podcast we're joined by Michelle Gavin and Samson Rattigan, who both work for Friend's Families and Travellers - and who have have been working hard in East Sussex to bridge the gap between the  healthcare system and those who identify as gypsies or travellers, and explain some of the simple ways in which GPs and hospitals can support this neglected group.

<p>https://www.gypsy-traveller.org/</p>
]]></description>
                                                            <content:encoded><![CDATA[In the UK, there's an ethnic group that is surprisingly large, but often overlooked by society, and formal healthcare services. The gypsy traveller community have poorer health outcomes because of systemic issues around access to health and education. 

In this podcast we're joined by Michelle Gavin and Samson Rattigan, who both work for Friend's Families and Travellers - and who have have been working hard in East Sussex to bridge the gap between the  healthcare system and those who identify as gypsies or travellers, and explain some of the simple ways in which GPs and hospitals can support this neglected group.

<p>https://www.gypsy-traveller.org/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/t7yab1/stream_610719507-bmjgroup-gypsy-and-traveller-health.mp3" length="39589363" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In the UK, there's an ethnic group that is surprisingly large, but often overlooked by society, and formal healthcare services. The gypsy traveller community have poorer health outcomes because of systemic issues around access to health and education. 

In this podcast we're joined by Michelle Gavin and Samson Rattigan, who both work for Friend's Families and Travellers - and who have have been working hard in East Sussex to bridge the gap between the  healthcare system and those who identify as gypsies or travellers, and explain some of the simple ways in which GPs and hospitals can support this neglected group.

https://www.gypsy-traveller.org/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1652</itunes:duration>
                                    </item>
    <item>
        <title>Could open access have unintended consequences?</title>
        <itunes:title>Could open access have unintended consequences?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/could-open-access-have-unintended-consequences/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/could-open-access-have-unintended-consequences/#comments</comments>        <pubDate>Fri, 19 Apr 2019 11:43:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/could-open-access-have-unintended-consequences</guid>
                                    <description><![CDATA[An “author pays” publishing model is the only fair way to make biomedical research findings accessible to all, say David Sanders, professor of gastroenterology at Sheffield University, but James Ashton and worries that it can lead to bias in the evidence base towards commercially driven results - as those are the researchers who can pay for open access fees.  Dave deBronkart just wants patients to have access to key research.

Read the full head to head:
<p>https://www.bmj.com/content/365/bmj.l1544</p>
]]></description>
                                                            <content:encoded><![CDATA[An “author pays” publishing model is the only fair way to make biomedical research findings accessible to all, say David Sanders, professor of gastroenterology at Sheffield University, but James Ashton and worries that it can lead to bias in the evidence base towards commercially driven results - as those are the researchers who can pay for open access fees.  Dave deBronkart just wants patients to have access to key research.

Read the full head to head:
<p>https://www.bmj.com/content/365/bmj.l1544</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mr3tr4/stream_608316843-bmjgroup-could-open-access-have-unintended-consequences.mp3" length="32586263" type="audio/mpeg"/>
        <itunes:summary><![CDATA[An “author pays” publishing model is the only fair way to make biomedical research findings accessible to all, say David Sanders, professor of gastroenterology at Sheffield University, but James Ashton and worries that it can lead to bias in the evidence base towards commercially driven results - as those are the researchers who can pay for open access fees.  Dave deBronkart just wants patients to have access to key research.

Read the full head to head:
https://www.bmj.com/content/365/bmj.l1544]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1359</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence - health checks, abx courses and p-values</title>
        <itunes:title>Talk Evidence - health checks, abx courses and p-values</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-health-checks-abx-courses-and-p-values/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-health-checks-abx-courses-and-p-values/#comments</comments>        <pubDate>Wed, 17 Apr 2019 16:57:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-health-checks-abx-courses-and-p-values</guid>
                                    <description><![CDATA[Helen Macdonald and Carl Heneghan are back again talking about what's happened in the world of evidence this month.

(1.20) Carl grinds his gears over general health checks, with an update in the Cochrane Library.

(9.15) Helen is surprised by new research which looks at over prescription of antibiotics - but this time because the courses prescribed are far longer than guidelines suggest.

(22.30) What is the true 99th centile of high sensitivity cardiac troponin in hospital patients?

(29.02) Is it time to abandon statistical significance and be aware of the  problem of the transposed conditional.

Reading list:
General health checks in adults for reducing morbidity and mortality from disease - https://www.ncbi.nlm.nih.gov/pubmed/30699470?dopt=Abstract

Duration of antibiotic treatment for common infections in English primary care -https://www.bmj.com/content/364/bmj.l440

True 99th centile of high sensitivity cardiac troponin for hospital patients - https://www.bmj.com/content/364/bmj.l440

Significant debate - https://www.nature.com/magazine-assets/d41586-019-00874-8/d41586-019-00874-8.pdf

The false positive risk: a proposal concerning what to do about p-values -  https://www.youtube.com/watch?v=jZWgijUnIxI
<p>http://www.onemol.org.uk/?page_id=456</p>
]]></description>
                                                            <content:encoded><![CDATA[Helen Macdonald and Carl Heneghan are back again talking about what's happened in the world of evidence this month.

(1.20) Carl grinds his gears over general health checks, with an update in the Cochrane Library.

(9.15) Helen is surprised by new research which looks at over prescription of antibiotics - but this time because the courses prescribed are far longer than guidelines suggest.

(22.30) What is the true 99th centile of high sensitivity cardiac troponin in hospital patients?

(29.02) Is it time to abandon statistical significance and be aware of the  problem of the transposed conditional.

Reading list:
General health checks in adults for reducing morbidity and mortality from disease - https://www.ncbi.nlm.nih.gov/pubmed/30699470?dopt=Abstract

Duration of antibiotic treatment for common infections in English primary care -https://www.bmj.com/content/364/bmj.l440

True 99th centile of high sensitivity cardiac troponin for hospital patients - https://www.bmj.com/content/364/bmj.l440

Significant debate - https://www.nature.com/magazine-assets/d41586-019-00874-8/d41586-019-00874-8.pdf

The false positive risk: a proposal concerning what to do about p-values -  https://www.youtube.com/watch?v=jZWgijUnIxI
<p>http://www.onemol.org.uk/?page_id=456</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/agqmq1/stream_607420683-bmjgroup-talk-evidence-health-checks-abx-courses-and-p-values.mp3" length="68854850" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Helen Macdonald and Carl Heneghan are back again talking about what's happened in the world of evidence this month.

(1.20) Carl grinds his gears over general health checks, with an update in the Cochrane Library.

(9.15) Helen is surprised by new research which looks at over prescription of antibiotics - but this time because the courses prescribed are far longer than guidelines suggest.

(22.30) What is the true 99th centile of high sensitivity cardiac troponin in hospital patients?

(29.02) Is it time to abandon statistical significance and be aware of the  problem of the transposed conditional.

Reading list:
General health checks in adults for reducing morbidity and mortality from disease - https://www.ncbi.nlm.nih.gov/pubmed/30699470?dopt=Abstract

Duration of antibiotic treatment for common infections in English primary care -https://www.bmj.com/content/364/bmj.l440

True 99th centile of high sensitivity cardiac troponin for hospital patients - https://www.bmj.com/content/364/bmj.l440

Significant debate - https://www.nature.com/magazine-assets/d41586-019-00874-8/d41586-019-00874-8.pdf

The false positive risk: a proposal concerning what to do about p-values -  https://www.youtube.com/watch?v=jZWgijUnIxI
http://www.onemol.org.uk/?page_id=456]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2873</itunes:duration>
                                    </item>
    <item>
        <title>Capital punishment, my sixth great grandfather, and me</title>
        <itunes:title>Capital punishment, my sixth great grandfather, and me</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/capital-punishment-my-sixth-great-grandfather-and-me/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/capital-punishment-my-sixth-great-grandfather-and-me/#comments</comments>        <pubDate>Tue, 09 Apr 2019 16:49:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/capital-punishment-my-sixth-great-grandfather-and-me</guid>
                                    <description><![CDATA[On the 7th of June, 1753, Dr Archibald Cameron was executed at Tyburn. "The body, after hanging twenty minutes, was cut down: it was not quartered; but the heart was taken out and burnt. "

250 years later, his sixth great grandson, Robert Syned found himself deeply involved in the process of execution, as an expert witness in a case about the use of a new drug for lethal injection in the USA.

<p>In this podcast, Robert joins us to talk about the dearth of evidence, and massive variation in the use of drugs used to execute someone, and reflects on how finding out about his ancestor meant to him in this process.</p>
]]></description>
                                                            <content:encoded><![CDATA[On the 7th of June, 1753, Dr Archibald Cameron was executed at Tyburn. "The body, after hanging twenty minutes, was cut down: it was not quartered; but the heart was taken out and burnt. "

250 years later, his sixth great grandson, Robert Syned found himself deeply involved in the process of execution, as an expert witness in a case about the use of a new drug for lethal injection in the USA.

<p>In this podcast, Robert joins us to talk about the dearth of evidence, and massive variation in the use of drugs used to execute someone, and reflects on how finding out about his ancestor meant to him in this process.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/j2lzeq/stream_603421995-bmjgroup-capital-punishment-my-sixth-great-grandfather-and-me.mp3" length="28711228" type="audio/mpeg"/>
        <itunes:summary><![CDATA[On the 7th of June, 1753, Dr Archibald Cameron was executed at Tyburn. "The body, after hanging twenty minutes, was cut down: it was not quartered; but the heart was taken out and burnt. "

250 years later, his sixth great grandson, Robert Syned found himself deeply involved in the process of execution, as an expert witness in a case about the use of a new drug for lethal injection in the USA.

In this podcast, Robert joins us to talk about the dearth of evidence, and massive variation in the use of drugs used to execute someone, and reflects on how finding out about his ancestor meant to him in this process.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1197</itunes:duration>
                                    </item>
    <item>
        <title>How to have joy at work</title>
        <itunes:title>How to have joy at work</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/how-to-have-joy-at-work/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/how-to-have-joy-at-work/#comments</comments>        <pubDate>Fri, 05 Apr 2019 15:56:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/how-to-have-joy-at-work</guid>
                                    <description><![CDATA[Jessica Perlo is the Director for Joy at Work at the Institute for Healthcare Improverment, and James Mountford is direct or of quality at the Royal Free London NHS Foundation Trust. 

Together they joined us at the International Forum on Quality and Safety in Healthcare to discuss joy at work - what that concept actually means, and practically, how hospitals can start implementing it.

Watch Jessica’s session at the forum
https://internationalforum.bmj.com/glasgow/2018/09/20/a1-leadership-models-for-co-producing-a-joyful-workforce/

BMJ's wellbeing campaign
https://www.bmj.com/wellbeing
<p>https://www.facebook.com/groups/569230966796440/</p>
]]></description>
                                                            <content:encoded><![CDATA[Jessica Perlo is the Director for Joy at Work at the Institute for Healthcare Improverment, and James Mountford is direct or of quality at the Royal Free London NHS Foundation Trust. 

Together they joined us at the International Forum on Quality and Safety in Healthcare to discuss joy at work - what that concept actually means, and practically, how hospitals can start implementing it.

Watch Jessica’s session at the forum
https://internationalforum.bmj.com/glasgow/2018/09/20/a1-leadership-models-for-co-producing-a-joyful-workforce/

BMJ's wellbeing campaign
https://www.bmj.com/wellbeing
<p>https://www.facebook.com/groups/569230966796440/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8do0nt/stream_601449768-bmjgroup-how-to-have-joy-at-work.mp3" length="27279540" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Jessica Perlo is the Director for Joy at Work at the Institute for Healthcare Improverment, and James Mountford is direct or of quality at the Royal Free London NHS Foundation Trust. 

Together they joined us at the International Forum on Quality and Safety in Healthcare to discuss joy at work - what that concept actually means, and practically, how hospitals can start implementing it.

Watch Jessica’s session at the forum
https://internationalforum.bmj.com/glasgow/2018/09/20/a1-leadership-models-for-co-producing-a-joyful-workforce/

BMJ's wellbeing campaign
https://www.bmj.com/wellbeing
https://www.facebook.com/groups/569230966796440/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1138</itunes:duration>
                                    </item>
    <item>
        <title>Social prescribing</title>
        <itunes:title>Social prescribing</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/social-prescribing-1684835859/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/social-prescribing-1684835859/#comments</comments>        <pubDate>Thu, 04 Apr 2019 15:04:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/social-prescribing</guid>
                                    <description><![CDATA[Non-medical interventions are increasingly being proposed to address wider determinants of health and to help patients improve health behaviours and better manage their conditions - this is known as social prescribing. In England, the NHS Long Term Plan states that nearly one million people will qualify for referral to social prescribing schemes by 2024.

In this podcast, Chris Drinkwater, emeritus professor of primary care and Louise Cook, a link worker, both at Newcastle University's Ways to Wellness -  who provide social prescribing support. 

They describe the evidence base for the service, how they work with patients to coordinate their non-medical interventions, and how they measure success.

Read the full clinical update:
<p>https://www.bmj.com/content/364/bmj.l1285</p>
]]></description>
                                                            <content:encoded><![CDATA[Non-medical interventions are increasingly being proposed to address wider determinants of health and to help patients improve health behaviours and better manage their conditions - this is known as social prescribing. In England, the NHS Long Term Plan states that nearly one million people will qualify for referral to social prescribing schemes by 2024.

In this podcast, Chris Drinkwater, emeritus professor of primary care and Louise Cook, a link worker, both at Newcastle University's Ways to Wellness -  who provide social prescribing support. 

They describe the evidence base for the service, how they work with patients to coordinate their non-medical interventions, and how they measure success.

Read the full clinical update:
<p>https://www.bmj.com/content/364/bmj.l1285</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/a0xrly/stream_600876135-bmjgroup-social-prescribing.mp3" length="29093895" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Non-medical interventions are increasingly being proposed to address wider determinants of health and to help patients improve health behaviours and better manage their conditions - this is known as social prescribing. In England, the NHS Long Term Plan states that nearly one million people will qualify for referral to social prescribing schemes by 2024.

In this podcast, Chris Drinkwater, emeritus professor of primary care and Louise Cook, a link worker, both at Newcastle University's Ways to Wellness -  who provide social prescribing support. 

They describe the evidence base for the service, how they work with patients to coordinate their non-medical interventions, and how they measure success.

Read the full clinical update:
https://www.bmj.com/content/364/bmj.l1285]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1214</itunes:duration>
                                    </item>
    <item>
        <title>Applying new power in medicine</title>
        <itunes:title>Applying new power in medicine</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/applying-new-power-in-medicine/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/applying-new-power-in-medicine/#comments</comments>        <pubDate>Mon, 01 Apr 2019 11:41:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/applying-new-power-in-medicine</guid>
                                    <description><![CDATA[Change requires the application of power -  the way in which individuals can accrue power has shifted in our digitally connected world. Traditional ways of influencing change in healthcare (getting the chief executive on side, having a quiet chat with the medical director) are not the only way to build a momentum.

Henry Timms - author of “New Power” the internationally best selling book joins us to talk about about how much of his thinking on these power structures has come from healthcare.

https://thisisnewpower.com/
https://twitter.com/hashtag/newpower
Henry Timms onstage at the International Forum on Quality and Safety in Healthcare
<p>https://livestream.com/IFQSH/Glasgow2019/videos/189271449</p>
]]></description>
                                                            <content:encoded><![CDATA[Change requires the application of power -  the way in which individuals can accrue power has shifted in our digitally connected world. Traditional ways of influencing change in healthcare (getting the chief executive on side, having a quiet chat with the medical director) are not the only way to build a momentum.

Henry Timms - author of “New Power” the internationally best selling book joins us to talk about about how much of his thinking on these power structures has come from healthcare.

https://thisisnewpower.com/
https://twitter.com/hashtag/newpower
Henry Timms onstage at the International Forum on Quality and Safety in Healthcare
<p>https://livestream.com/IFQSH/Glasgow2019/videos/189271449</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jl6dss/stream_599197578-bmjgroup-applying-new-power-in-medicine.mp3" length="52890099" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Change requires the application of power -  the way in which individuals can accrue power has shifted in our digitally connected world. Traditional ways of influencing change in healthcare (getting the chief executive on side, having a quiet chat with the medical director) are not the only way to build a momentum.

Henry Timms - author of “New Power” the internationally best selling book joins us to talk about about how much of his thinking on these power structures has come from healthcare.

https://thisisnewpower.com/
https://twitter.com/hashtag/newpower
Henry Timms onstage at the International Forum on Quality and Safety in Healthcare
https://livestream.com/IFQSH/Glasgow2019/videos/189271449]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2206</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence - Shoulders, statins and doctors messes</title>
        <itunes:title>Talk Evidence - Shoulders, statins and doctors messes</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-shoulders-statins-and-doctors-messes/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-shoulders-statins-and-doctors-messes/#comments</comments>        <pubDate>Thu, 28 Mar 2019 08:37:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-shoulders-etc-mixdown</guid>
                                    <description><![CDATA[Helen Macdonald and Carl Heneghan are back again talking about what's happened in the world of evidence this month.

They start by talking about shoulders - what does the evidence say about treating subacromial pain, and why the potential for a subgroup effect shouldn't change our views about stop surgery (for now, more research needed).

(16.00) Statins - more uncertainty about statins, this is now looking at older people. Age is a big risk factor for cardiovascular disease - at what point does that risk overwhelm any potential benefit from taking statins?

(20.30)Carl explains his rule-of-thumb for turning relative risks into absolute risks, in a way can help doctors talk to patients about new evidence.

(25.46)What's the evidence for doctors messes? Carl's rant of the week focuses on the calls (including the BMJ's campaign) to have spaces for doctors to relax in hospitals. He asks, is that better than putting in a gym? What's the evidence for that. 

Reading list:
Subacromial decompression surgery for adults with shoulder pain
https://www.bmj.com/content/364/bmj.l294

Efficacy and safety of statin therapy in older people
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)31942-1/fulltext

The future of doctor's messes
<p>https://www.bmj.com/content/364/bmj.k5367.abstract</p>
]]></description>
                                                            <content:encoded><![CDATA[Helen Macdonald and Carl Heneghan are back again talking about what's happened in the world of evidence this month.

They start by talking about shoulders - what does the evidence say about treating subacromial pain, and why the potential for a subgroup effect shouldn't change our views about stop surgery (for now, more research needed).

(16.00) Statins - more uncertainty about statins, this is now looking at older people. Age is a big risk factor for cardiovascular disease - at what point does that risk overwhelm any potential benefit from taking statins?

(20.30)Carl explains his rule-of-thumb for turning relative risks into absolute risks, in a way can help doctors talk to patients about new evidence.

(25.46)What's the evidence for doctors messes? Carl's rant of the week focuses on the calls (including the BMJ's campaign) to have spaces for doctors to relax in hospitals. He asks, is that better than putting in a gym? What's the evidence for that. 

Reading list:
Subacromial decompression surgery for adults with shoulder pain
https://www.bmj.com/content/364/bmj.l294

Efficacy and safety of statin therapy in older people
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)31942-1/fulltext

The future of doctor's messes
<p>https://www.bmj.com/content/364/bmj.k5367.abstract</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7d1ri7/stream_597169293-bmjgroup-talk-evidence-shoulders-etc-mixdown.mp3" length="60465177" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Helen Macdonald and Carl Heneghan are back again talking about what's happened in the world of evidence this month.

They start by talking about shoulders - what does the evidence say about treating subacromial pain, and why the potential for a subgroup effect shouldn't change our views about stop surgery (for now, more research needed).

(16.00) Statins - more uncertainty about statins, this is now looking at older people. Age is a big risk factor for cardiovascular disease - at what point does that risk overwhelm any potential benefit from taking statins?

(20.30)Carl explains his rule-of-thumb for turning relative risks into absolute risks, in a way can help doctors talk to patients about new evidence.

(25.46)What's the evidence for doctors messes? Carl's rant of the week focuses on the calls (including the BMJ's campaign) to have spaces for doctors to relax in hospitals. He asks, is that better than putting in a gym? What's the evidence for that. 

Reading list:
Subacromial decompression surgery for adults with shoulder pain
https://www.bmj.com/content/364/bmj.l294

Efficacy and safety of statin therapy in older people
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)31942-1/fulltext

The future of doctor's messes
https://www.bmj.com/content/364/bmj.k5367.abstract]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2519</itunes:duration>
                                    </item>
    <item>
        <title>Is opt-out the best way to increase organ donation?</title>
        <itunes:title>Is opt-out the best way to increase organ donation?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/is-opt-out-the-best-way-to-increase-organ-donation/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/is-opt-out-the-best-way-to-increase-organ-donation/#comments</comments>        <pubDate>Fri, 22 Mar 2019 16:43:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/is-opt-out-the-best-way-to-increase-organ-donation</guid>
                                    <description><![CDATA[As England’s presumed consent law for 2020 clears parliament, Veronica English,  head of medical ethics and human rights at the BMA, say that evidence from Wales and other countries shows that it could increase transplantation rates. But Blair L Sadler, physician and senior adviser to California State University,  consider such legal changes a distraction lacking strong evidence: they say that public education and trained staff would have a proven impact.

We also hear from Erin Walker, the recipient of 2 liver transplants, about her concerns on families over-ruling donor's wishes.

Read the full debate, and Erin's commentary:
<p>https://www.bmj.com/content/364/bmj.l967</p>
]]></description>
                                                            <content:encoded><![CDATA[As England’s presumed consent law for 2020 clears parliament, Veronica English,  head of medical ethics and human rights at the BMA, say that evidence from Wales and other countries shows that it could increase transplantation rates. But Blair L Sadler, physician and senior adviser to California State University,  consider such legal changes a distraction lacking strong evidence: they say that public education and trained staff would have a proven impact.

We also hear from Erin Walker, the recipient of 2 liver transplants, about her concerns on families over-ruling donor's wishes.

Read the full debate, and Erin's commentary:
<p>https://www.bmj.com/content/364/bmj.l967</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qne4xp/stream_594173310-bmjgroup-is-opt-out-the-best-way-to-increase-organ-donation.mp3" length="36418035" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As England’s presumed consent law for 2020 clears parliament, Veronica English,  head of medical ethics and human rights at the BMA, say that evidence from Wales and other countries shows that it could increase transplantation rates. But Blair L Sadler, physician and senior adviser to California State University,  consider such legal changes a distraction lacking strong evidence: they say that public education and trained staff would have a proven impact.

We also hear from Erin Walker, the recipient of 2 liver transplants, about her concerns on families over-ruling donor's wishes.

Read the full debate, and Erin's commentary:
https://www.bmj.com/content/364/bmj.l967]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1518</itunes:duration>
                                    </item>
    <item>
        <title>An acutely disturbed person in the community</title>
        <itunes:title>An acutely disturbed person in the community</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/an-acutely-disturbed-person-in-the-community/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/an-acutely-disturbed-person-in-the-community/#comments</comments>        <pubDate>Thu, 21 Mar 2019 17:46:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/an-acutely-disturbed-person-in-the-community</guid>
                                    <description><![CDATA[It can be difficult to know what to do when a person in severe psychological distress presents to a general practice or community clinic, particularly if they are behaving aggressively, or if they are refusing help.

Most patients who are acutely disturbed present no danger to others, however situations can evolve rapidly. Frontline staff need to know how to call for help, how to assess and manage physical risk, and how to de-escalate such situations.

In this podcast Aileen O’Brien, reader in psychiatry and education at St George’s University of London joins us to give some advice on what to do in that situation - why deescalation is useful, and who else to involve.

We also hear from someone who lives with bipolar disorder, and has had experiences of being acutely unwell in a public places, which have lead to police and psychiatric intervention.

Read the full practice article:
<p>https://www.bmj.com/content/364/bmj.l578</p>
]]></description>
                                                            <content:encoded><![CDATA[It can be difficult to know what to do when a person in severe psychological distress presents to a general practice or community clinic, particularly if they are behaving aggressively, or if they are refusing help.

Most patients who are acutely disturbed present no danger to others, however situations can evolve rapidly. Frontline staff need to know how to call for help, how to assess and manage physical risk, and how to de-escalate such situations.

In this podcast Aileen O’Brien, reader in psychiatry and education at St George’s University of London joins us to give some advice on what to do in that situation - why deescalation is useful, and who else to involve.

We also hear from someone who lives with bipolar disorder, and has had experiences of being acutely unwell in a public places, which have lead to police and psychiatric intervention.

Read the full practice article:
<p>https://www.bmj.com/content/364/bmj.l578</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ie9dgr/stream_593652300-bmjgroup-an-acutely-disturbed-person-in-the-community.mp3" length="36900264" type="audio/mpeg"/>
        <itunes:summary><![CDATA[It can be difficult to know what to do when a person in severe psychological distress presents to a general practice or community clinic, particularly if they are behaving aggressively, or if they are refusing help.

Most patients who are acutely disturbed present no danger to others, however situations can evolve rapidly. Frontline staff need to know how to call for help, how to assess and manage physical risk, and how to de-escalate such situations.

In this podcast Aileen O’Brien, reader in psychiatry and education at St George’s University of London joins us to give some advice on what to do in that situation - why deescalation is useful, and who else to involve.

We also hear from someone who lives with bipolar disorder, and has had experiences of being acutely unwell in a public places, which have lead to police and psychiatric intervention.

Read the full practice article:
https://www.bmj.com/content/364/bmj.l578]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1539</itunes:duration>
                                    </item>
    <item>
        <title>Passing on the secret knowledge of loop diuretics</title>
        <itunes:title>Passing on the secret knowledge of loop diuretics</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/passing-on-the-secret-knowledge-of-loop-diuretics/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/passing-on-the-secret-knowledge-of-loop-diuretics/#comments</comments>        <pubDate>Fri, 15 Mar 2019 17:07:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/passing-on-the-secret-of-loop-diuretics</guid>
                                    <description><![CDATA[In every generation there are a few that know the secret; the counterintuitive effects of loop diuretics. 

In this podcast Steven Anisman, cardiologist at the Dartmouth Hitchcock Department of Cardiovascular Medicine, joins us to explain about the threshold effects of these drugs, and why that might change the way in which you think about prescribing them.

<p>Read the full article on treatment of oedema with loop diuretics, and contribute to the discussion: https://www.bmj.com/content/364/bmj.l359</p>
]]></description>
                                                            <content:encoded><![CDATA[In every generation there are a few that know the secret; the counterintuitive effects of loop diuretics. 

In this podcast Steven Anisman, cardiologist at the Dartmouth Hitchcock Department of Cardiovascular Medicine, joins us to explain about the threshold effects of these drugs, and why that might change the way in which you think about prescribing them.

<p>Read the full article on treatment of oedema with loop diuretics, and contribute to the discussion: https://www.bmj.com/content/364/bmj.l359</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fjn2op/stream_590586501-bmjgroup-passing-on-the-secret-of-loop-diuretics.mp3" length="38002034" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In every generation there are a few that know the secret; the counterintuitive effects of loop diuretics. 

In this podcast Steven Anisman, cardiologist at the Dartmouth Hitchcock Department of Cardiovascular Medicine, joins us to explain about the threshold effects of these drugs, and why that might change the way in which you think about prescribing them.

Read the full article on treatment of oedema with loop diuretics, and contribute to the discussion: https://www.bmj.com/content/364/bmj.l359]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1585</itunes:duration>
                                    </item>
    <item>
        <title>#talkaboutcomplications</title>
        <itunes:title>#talkaboutcomplications</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talkaboutcomplications/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talkaboutcomplications/#comments</comments>        <pubDate>Thu, 14 Mar 2019 15:25:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talkaboutcomplications</guid>
                                    <description><![CDATA[Renza Scibilia and Chris Aldred have diabetes, and their introduction to the idea of complications arising from the condition were terrifying.

Because of this early experience, and Chris's later development of complications, they have campaigned to make doctors really think about the way in which they talk about complications with patients. Challenging the use of "non-compliant" and other stigmatising language.

Chris has also documented his experience of developing an ulcer, and having it successfully treated, on social media, to open up the conversation and make us all #talkaboutcomplications.

<p>Chris Aldred is @grumpy_pumper on twitter, and blogs at http://www.the-grumpy-pumper.com. Renza Scibilia is @RenzaS on twitter and blogs at https://diabetogenic.wordpress.com/</p>
]]></description>
                                                            <content:encoded><![CDATA[Renza Scibilia and Chris Aldred have diabetes, and their introduction to the idea of complications arising from the condition were terrifying.

Because of this early experience, and Chris's later development of complications, they have campaigned to make doctors really think about the way in which they talk about complications with patients. Challenging the use of "non-compliant" and other stigmatising language.

Chris has also documented his experience of developing an ulcer, and having it successfully treated, on social media, to open up the conversation and make us all #talkaboutcomplications.

<p>Chris Aldred is @grumpy_pumper on twitter, and blogs at http://www.the-grumpy-pumper.com. Renza Scibilia is @RenzaS on twitter and blogs at https://diabetogenic.wordpress.com/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xk2in2/stream_589980252-bmjgroup-talkaboutcomplications.mp3" length="39743006" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Renza Scibilia and Chris Aldred have diabetes, and their introduction to the idea of complications arising from the condition were terrifying.

Because of this early experience, and Chris's later development of complications, they have campaigned to make doctors really think about the way in which they talk about complications with patients. Challenging the use of "non-compliant" and other stigmatising language.

Chris has also documented his experience of developing an ulcer, and having it successfully treated, on social media, to open up the conversation and make us all #talkaboutcomplications.

Chris Aldred is @grumpy_pumper on twitter, and blogs at http://www.the-grumpy-pumper.com. Renza Scibilia is @RenzaS on twitter and blogs at https://diabetogenic.wordpress.com/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1658</itunes:duration>
                                    </item>
    <item>
        <title>Ebola - Stepping up in Sierre Leone</title>
        <itunes:title>Ebola - Stepping up in Sierre Leone</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/ebola-stepping-up-in-sierre-leone/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/ebola-stepping-up-in-sierre-leone/#comments</comments>        <pubDate>Fri, 08 Mar 2019 16:36:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/ebola-stepping-up-in-sierre-leone</guid>
                                    <description><![CDATA[In 2014, Oliver Johnson was a 28 year old British doctor, working on health policy in Sierre Leone after finishing medical school.  Also working in Freetown was Sinead Walsh, then the Irish Ambassador to the country.

Then the biggest outbreak of Ebola on record happened in West Africa, starting in Guinea and quickly spreading to Liberia, Sierre Leone and Nigeria.

Oliver and Sinead have co-authored a book about the change that wrought on their lives, how they stepped into roles coordinating the international response to the disease and running a treatment centre. They join us today to talk about their experiences there.

For more information about Ebola, including the current outbreak in the Democratic Republic of Congo visit https://www.bmj.com/ebola.

For Sinead and Oliver's book - Getting to Zero: A Doctor and a Diplomat on the Ebola Frontline is available now.

<p>https://www.amazon.co.uk/dp/B07DFLFF9P/ref=dp-kindle-redirect?_encoding=UTF8&btkr=1</p>
]]></description>
                                                            <content:encoded><![CDATA[In 2014, Oliver Johnson was a 28 year old British doctor, working on health policy in Sierre Leone after finishing medical school.  Also working in Freetown was Sinead Walsh, then the Irish Ambassador to the country.

Then the biggest outbreak of Ebola on record happened in West Africa, starting in Guinea and quickly spreading to Liberia, Sierre Leone and Nigeria.

Oliver and Sinead have co-authored a book about the change that wrought on their lives, how they stepped into roles coordinating the international response to the disease and running a treatment centre. They join us today to talk about their experiences there.

For more information about Ebola, including the current outbreak in the Democratic Republic of Congo visit https://www.bmj.com/ebola.

For Sinead and Oliver's book - Getting to Zero: A Doctor and a Diplomat on the Ebola Frontline is available now.

<p>https://www.amazon.co.uk/dp/B07DFLFF9P/ref=dp-kindle-redirect?_encoding=UTF8&btkr=1</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/og7mq2/stream_586946652-bmjgroup-ebola-stepping-up-in-sierre-leone.mp3" length="44194564" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In 2014, Oliver Johnson was a 28 year old British doctor, working on health policy in Sierre Leone after finishing medical school.  Also working in Freetown was Sinead Walsh, then the Irish Ambassador to the country.

Then the biggest outbreak of Ebola on record happened in West Africa, starting in Guinea and quickly spreading to Liberia, Sierre Leone and Nigeria.

Oliver and Sinead have co-authored a book about the change that wrought on their lives, how they stepped into roles coordinating the international response to the disease and running a treatment centre. They join us today to talk about their experiences there.

For more information about Ebola, including the current outbreak in the Democratic Republic of Congo visit https://www.bmj.com/ebola.

For Sinead and Oliver's book - Getting to Zero: A Doctor and a Diplomat on the Ebola Frontline is available now.

https://www.amazon.co.uk/dp/B07DFLFF9P/ref=dp-kindle-redirect?_encoding=UTF8&btkr=1]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1844</itunes:duration>
                                    </item>
    <item>
        <title>Signals from the NIHR</title>
        <itunes:title>Signals from the NIHR</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/signals-from-the-nihr/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/signals-from-the-nihr/#comments</comments>        <pubDate>Thu, 07 Mar 2019 18:02:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/signals-from-the-nihr</guid>
                                    <description><![CDATA[If you've been keeping up to day with The BMJ - online on in print, you might have noticed that we've got a new type of article - NIHR Signals - and they are here to give busy clinicians a quick overview of practice changing research that has come out of the UK's National Institute for Health Research.

Tara Lamont, director of the NIHR dissemination centre, joins us to talk a bit more about the research underpinning these articles.

You can find the full list of articles:
<p>https://www.bmj.com/NIHR-signals</p>
]]></description>
                                                            <content:encoded><![CDATA[If you've been keeping up to day with The BMJ - online on in print, you might have noticed that we've got a new type of article - NIHR Signals - and they are here to give busy clinicians a quick overview of practice changing research that has come out of the UK's National Institute for Health Research.

Tara Lamont, director of the NIHR dissemination centre, joins us to talk a bit more about the research underpinning these articles.

You can find the full list of articles:
<p>https://www.bmj.com/NIHR-signals</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/zk0ykv/stream_586439496-bmjgroup-signals-from-the-nihr.mp3" length="20523734" type="audio/mpeg"/>
        <itunes:summary><![CDATA[If you've been keeping up to day with The BMJ - online on in print, you might have noticed that we've got a new type of article - NIHR Signals - and they are here to give busy clinicians a quick overview of practice changing research that has come out of the UK's National Institute for Health Research.

Tara Lamont, director of the NIHR dissemination centre, joins us to talk a bit more about the research underpinning these articles.

You can find the full list of articles:
https://www.bmj.com/NIHR-signals]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>856</itunes:duration>
                                    </item>
    <item>
        <title>Nuffield 2019 - How can the NHS provide a fulfilling lifelong career</title>
        <itunes:title>Nuffield 2019 - How can the NHS provide a fulfilling lifelong career</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/nuffield-2019-how-can-the-nhs-provide-a-fulfilling-lifelong-career/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/nuffield-2019-how-can-the-nhs-provide-a-fulfilling-lifelong-career/#comments</comments>        <pubDate>Wed, 06 Mar 2019 18:23:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/nuffield-2019-how-can-the-nhs-provide-a-fulfilling-lifelong-career</guid>
                                    <description><![CDATA[More doctors are choosing to retire early, doctors who take career breaks find it hard to return to practice, and doctors at all stages of their careers are frustrated by the lack of support given to training and development in today’s NHS. 

Each year the BMJ holds a roundtable discussion at the Nuffield Summit - where health leaders come together to talk about the NHS. We wanted to know what more the NHS can do to provide fulfilling careers for staff and to improve support for doctors who want to keep working and those seeking to return to practice.

Taking part in the discussion were:

Tom Moberly - UK editor for The BMJ
Rahkee Shah - paediatric registrar
Ronny Cheung - consultant general paedatrician
Claire Lemer -  consultant paediatrician
Candace Imison - Director of Workforce Strategy at the Nuffield Trust
<p>James Morrow - GP partner</p>
]]></description>
                                                            <content:encoded><![CDATA[More doctors are choosing to retire early, doctors who take career breaks find it hard to return to practice, and doctors at all stages of their careers are frustrated by the lack of support given to training and development in today’s NHS. 

Each year the BMJ holds a roundtable discussion at the Nuffield Summit - where health leaders come together to talk about the NHS. We wanted to know what more the NHS can do to provide fulfilling careers for staff and to improve support for doctors who want to keep working and those seeking to return to practice.

Taking part in the discussion were:

Tom Moberly - UK editor for The BMJ
Rahkee Shah - paediatric registrar
Ronny Cheung - consultant general paedatrician
Claire Lemer -  consultant paediatrician
Candace Imison - Director of Workforce Strategy at the Nuffield Trust
<p>James Morrow - GP partner</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qcgzld/stream_585933378-bmjgroup-nuffield-2019-how-can-the-nhs-provide-a-fulfilling-lifelong-career.mp3" length="67847367" type="audio/mpeg"/>
        <itunes:summary><![CDATA[More doctors are choosing to retire early, doctors who take career breaks find it hard to return to practice, and doctors at all stages of their careers are frustrated by the lack of support given to training and development in today’s NHS. 

Each year the BMJ holds a roundtable discussion at the Nuffield Summit - where health leaders come together to talk about the NHS. We wanted to know what more the NHS can do to provide fulfilling careers for staff and to improve support for doctors who want to keep working and those seeking to return to practice.

Taking part in the discussion were:

Tom Moberly - UK editor for The BMJ
Rahkee Shah - paediatric registrar
Ronny Cheung - consultant general paedatrician
Claire Lemer -  consultant paediatrician
Candace Imison - Director of Workforce Strategy at the Nuffield Trust
James Morrow - GP partner]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2829</itunes:duration>
                                    </item>
    <item>
        <title>Diabetes Insipidus - the danger of misunderstanding diabetes</title>
        <itunes:title>Diabetes Insipidus - the danger of misunderstanding diabetes</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/diabetes-insipidus-the-danger-of-misunderstanding-diabetes/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/diabetes-insipidus-the-danger-of-misunderstanding-diabetes/#comments</comments>        <pubDate>Fri, 01 Mar 2019 18:10:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/diabetes-insipidus-the-danger-of-misunderstanding-diabetes</guid>
                                    <description><![CDATA[Diabetes is synonymous with sugar, but diabetes insipidus, "water diabetes", can't be forgotten. Between 2009 and 2016, 4 people died in hospital in England, when lifesaving treatment for the condition was not given.

In this podcast, we hear some practical tips for non-specialists to aid diagnosis, and how patients should be managed during hospital admission.

On the podcast are
Miles Levy, consultant endocrinologist from Leicester Royal Infirmary
Pat McBride, head of family services at the Pituitary Foundation
John Wass, professor of endocrinology at Oxford University
Malcolm Prentice, consultant endocrinologist at Croydon University Hospital.

Read the full practice article:
<p>https://www.bmj.com/content/364/bmj.l321</p>
]]></description>
                                                            <content:encoded><![CDATA[Diabetes is synonymous with sugar, but diabetes insipidus, "water diabetes", can't be forgotten. Between 2009 and 2016, 4 people died in hospital in England, when lifesaving treatment for the condition was not given.

In this podcast, we hear some practical tips for non-specialists to aid diagnosis, and how patients should be managed during hospital admission.

On the podcast are
Miles Levy, consultant endocrinologist from Leicester Royal Infirmary
Pat McBride, head of family services at the Pituitary Foundation
John Wass, professor of endocrinology at Oxford University
Malcolm Prentice, consultant endocrinologist at Croydon University Hospital.

Read the full practice article:
<p>https://www.bmj.com/content/364/bmj.l321</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/q6r0p3/stream_583437735-bmjgroup-diabetes-insipidus-the-danger-of-misunderstanding-diabetes.mp3" length="63957598" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Diabetes is synonymous with sugar, but diabetes insipidus, "water diabetes", can't be forgotten. Between 2009 and 2016, 4 people died in hospital in England, when lifesaving treatment for the condition was not given.

In this podcast, we hear some practical tips for non-specialists to aid diagnosis, and how patients should be managed during hospital admission.

On the podcast are
Miles Levy, consultant endocrinologist from Leicester Royal Infirmary
Pat McBride, head of family services at the Pituitary Foundation
John Wass, professor of endocrinology at Oxford University
Malcolm Prentice, consultant endocrinologist at Croydon University Hospital.

Read the full practice article:
https://www.bmj.com/content/364/bmj.l321]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2668</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence - Radiation, fertility, and pneumonia</title>
        <itunes:title>Talk Evidence - Radiation, fertility, and pneumonia</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-radiation-fertility-and-pneumonia/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-radiation-fertility-and-pneumonia/#comments</comments>        <pubDate>Wed, 27 Feb 2019 09:54:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talk-evidence-jan-2019</guid>
                                    <description><![CDATA[Helen Macdonald and Carl Heneghan are back again talking about what's happened in the world of evidence this month.

They start by talking about how difficult a task it is to find evidence that's definitely practice changing, what GPs can learn from Malawian children with nonsevere fast-breathing pneumonia, how radiation dosage varies substantially - and consultant radiologist Amy Davies what that means for patients. 

They also rail against add-on tests for fertility, and the lack of evidence underpinning their use - will the traffic light system suggested help patients make treatment choices.

Carl's rant this week is based on a new study by Steve Woloshin and Lisa Schwartz which documented 20 years of medical marketing in the USA. 

Reading list:
Pneumonia in Malawi - https://www.ncbi.nlm.nih.gov/pubmed/30419120
Variation in radiation dose - https://www.bmj.com/content/364/bmj.k4931
Traffic light fertility tests - https://www.bmj.com/content/364/bmj.l226
<p>Medical marketing - https://jamanetwork.com/journals/jama/fullarticle/2720029</p>
]]></description>
                                                            <content:encoded><![CDATA[Helen Macdonald and Carl Heneghan are back again talking about what's happened in the world of evidence this month.

They start by talking about how difficult a task it is to find evidence that's definitely practice changing, what GPs can learn from Malawian children with nonsevere fast-breathing pneumonia, how radiation dosage varies substantially - and consultant radiologist Amy Davies what that means for patients. 

They also rail against add-on tests for fertility, and the lack of evidence underpinning their use - will the traffic light system suggested help patients make treatment choices.

Carl's rant this week is based on a new study by Steve Woloshin and Lisa Schwartz which documented 20 years of medical marketing in the USA. 

Reading list:
Pneumonia in Malawi - https://www.ncbi.nlm.nih.gov/pubmed/30419120
Variation in radiation dose - https://www.bmj.com/content/364/bmj.k4931
Traffic light fertility tests - https://www.bmj.com/content/364/bmj.l226
<p>Medical marketing - https://jamanetwork.com/journals/jama/fullarticle/2720029</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/tcm2n2/stream_582084351-bmjgroup-talk-evidence-jan-2019.mp3" length="30925952" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Helen Macdonald and Carl Heneghan are back again talking about what's happened in the world of evidence this month.

They start by talking about how difficult a task it is to find evidence that's definitely practice changing, what GPs can learn from Malawian children with nonsevere fast-breathing pneumonia, how radiation dosage varies substantially - and consultant radiologist Amy Davies what that means for patients. 

They also rail against add-on tests for fertility, and the lack of evidence underpinning their use - will the traffic light system suggested help patients make treatment choices.

Carl's rant this week is based on a new study by Steve Woloshin and Lisa Schwartz which documented 20 years of medical marketing in the USA. 

Reading list:
Pneumonia in Malawi - https://www.ncbi.nlm.nih.gov/pubmed/30419120
Variation in radiation dose - https://www.bmj.com/content/364/bmj.k4931
Traffic light fertility tests - https://www.bmj.com/content/364/bmj.l226
Medical marketing - https://jamanetwork.com/journals/jama/fullarticle/2720029]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1933</itunes:duration>
                                    </item>
    <item>
        <title>Sorry for the interruption in service</title>
        <itunes:title>Sorry for the interruption in service</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/sorry-for-the-interruption-in-service/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/sorry-for-the-interruption-in-service/#comments</comments>        <pubDate>Fri, 22 Feb 2019 15:58:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/sorry-for-the-interruption-in-service</guid>
                                    <description><![CDATA[The problem we had publishing our feed has been fixed, and normal service has resumed.

Thank you for subscribing to the podcast, if you have thoughts you'd like to express, we'd love to hear them. 

<p>https://www.bmj.com/podcasts</p>
]]></description>
                                                            <content:encoded><![CDATA[The problem we had publishing our feed has been fixed, and normal service has resumed.

Thank you for subscribing to the podcast, if you have thoughts you'd like to express, we'd love to hear them. 

<p>https://www.bmj.com/podcasts</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/1z0mhq/stream_579577413-bmjgroup-sorry-for-the-interruption-in-service.mp3" length="1887789" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The problem we had publishing our feed has been fixed, and normal service has resumed.

Thank you for subscribing to the podcast, if you have thoughts you'd like to express, we'd love to hear them. 

https://www.bmj.com/podcasts]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>78</itunes:duration>
                                    </item>
    <item>
        <title>Safeguarding LGBT+ young people</title>
        <itunes:title>Safeguarding LGBT+ young people</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/safeguarding-lgbt-young-people/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/safeguarding-lgbt-young-people/#comments</comments>        <pubDate>Fri, 15 Feb 2019 19:33:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/safeguarding-lgbt-young-people</guid>
                                    <description><![CDATA[Recent years have seen political and social progress for people who identify as LGBT+ (lesbian, gay, bisexual, and transgender; the “+” indicating inclusion of other minority sexual and gender identities). 

Yet international evidence shows ongoing health and social inequalities in this group, many of which emerge during adolescence and represent unique safeguarding risks.

In this podcast, Kate Addlington, psychiatry trainee and associate editor at The BMJ is joined by Ginger Drage, expert patient educator at University College London, Jessica Salkind, academic clinical fellow in paediatrics & teaching lead for LGBT+, at Imperial College London and Rosanna Bevan, psychiatry trainee from East London Foundation Trust 

They discuss the the risks faced by LGBT+ young people, which include increased rates of self harm, suicide, and family rejection or abuse, and what steps clinicians can take to support and intervene if necessary.

Read the full practice article:
<p>https://www.bmj.com/content/364/bmj.l245</p>
]]></description>
                                                            <content:encoded><![CDATA[Recent years have seen political and social progress for people who identify as LGBT+ (lesbian, gay, bisexual, and transgender; the “+” indicating inclusion of other minority sexual and gender identities). 

Yet international evidence shows ongoing health and social inequalities in this group, many of which emerge during adolescence and represent unique safeguarding risks.

In this podcast, Kate Addlington, psychiatry trainee and associate editor at The BMJ is joined by Ginger Drage, expert patient educator at University College London, Jessica Salkind, academic clinical fellow in paediatrics & teaching lead for LGBT+, at Imperial College London and Rosanna Bevan, psychiatry trainee from East London Foundation Trust 

They discuss the the risks faced by LGBT+ young people, which include increased rates of self harm, suicide, and family rejection or abuse, and what steps clinicians can take to support and intervene if necessary.

Read the full practice article:
<p>https://www.bmj.com/content/364/bmj.l245</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/sl0zt5/stream_575999634-bmjgroup-safeguarding-lgbt-young-people.mp3" length="41095076" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Recent years have seen political and social progress for people who identify as LGBT+ (lesbian, gay, bisexual, and transgender; the “+” indicating inclusion of other minority sexual and gender identities). 

Yet international evidence shows ongoing health and social inequalities in this group, many of which emerge during adolescence and represent unique safeguarding risks.

In this podcast, Kate Addlington, psychiatry trainee and associate editor at The BMJ is joined by Ginger Drage, expert patient educator at University College London, Jessica Salkind, academic clinical fellow in paediatrics & teaching lead for LGBT+, at Imperial College London and Rosanna Bevan, psychiatry trainee from East London Foundation Trust 

They discuss the the risks faced by LGBT+ young people, which include increased rates of self harm, suicide, and family rejection or abuse, and what steps clinicians can take to support and intervene if necessary.

Read the full practice article:
https://www.bmj.com/content/364/bmj.l245]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1714</itunes:duration>
                                    </item>
    <item>
        <title>Should we be screening for AF?</title>
        <itunes:title>Should we be screening for AF?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/should-we-be-screening-for-af/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/should-we-be-screening-for-af/#comments</comments>        <pubDate>Thu, 14 Feb 2019 17:38:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/should-we-be-screening-for-af</guid>
                                    <description><![CDATA[Current evidence is sufficient to justify a national screening programme, argues Mark Lown clinical lecturer at the University of Southampton, but Patrick Moran,  senior research fellow in health economics at Trinity College Dublin, thinks there are too many unanswered questions and evidence from randomised trials is needed to avoid overdiagnosis

Read the full debate:
<p>https://www.bmj.com/content/364/bmj.l43</p>
]]></description>
                                                            <content:encoded><![CDATA[Current evidence is sufficient to justify a national screening programme, argues Mark Lown clinical lecturer at the University of Southampton, but Patrick Moran,  senior research fellow in health economics at Trinity College Dublin, thinks there are too many unanswered questions and evidence from randomised trials is needed to avoid overdiagnosis

Read the full debate:
<p>https://www.bmj.com/content/364/bmj.l43</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/63k40p/stream_575364978-bmjgroup-should-we-be-screening-for-af.mp3" length="30319205" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Current evidence is sufficient to justify a national screening programme, argues Mark Lown clinical lecturer at the University of Southampton, but Patrick Moran,  senior research fellow in health economics at Trinity College Dublin, thinks there are too many unanswered questions and evidence from randomised trials is needed to avoid overdiagnosis

Read the full debate:
https://www.bmj.com/content/364/bmj.l43]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1265</itunes:duration>
                                    </item>
    <item>
        <title>Chronic Rhinosinusitis</title>
        <itunes:title>Chronic Rhinosinusitis</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/chronic-rhinosinusitis/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/chronic-rhinosinusitis/#comments</comments>        <pubDate>Fri, 08 Feb 2019 13:58:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/chronic-rhinosinusitis</guid>
                                    <description><![CDATA[Patients who experience chronic rhinosinusitis may way for a considerable period of time before presenting, because they believe the condition to be trivial.

<p>In this podcast, Alam Hannan, ENT Consultant at the Royal Throat Nose and Ear Hospital in London, explains why that belief is not founded, and describes which treatments can be effective at providing relief.</p>
]]></description>
                                                            <content:encoded><![CDATA[Patients who experience chronic rhinosinusitis may way for a considerable period of time before presenting, because they believe the condition to be trivial.

<p>In this podcast, Alam Hannan, ENT Consultant at the Royal Throat Nose and Ear Hospital in London, explains why that belief is not founded, and describes which treatments can be effective at providing relief.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/i8l1qp/stream_572133807-bmjgroup-chronic-rhinosinusitis.mp3" length="52480395" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Patients who experience chronic rhinosinusitis may way for a considerable period of time before presenting, because they believe the condition to be trivial.

In this podcast, Alam Hannan, ENT Consultant at the Royal Throat Nose and Ear Hospital in London, explains why that belief is not founded, and describes which treatments can be effective at providing relief.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2189</itunes:duration>
                                    </item>
    <item>
        <title>Assisted dying: should doctors help patients to die?</title>
        <itunes:title>Assisted dying: should doctors help patients to die?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/assisted-dying-should-doctors-help-patients-to-die/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/assisted-dying-should-doctors-help-patients-to-die/#comments</comments>        <pubDate>Mon, 04 Feb 2019 15:28:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/assisted-dying-should-doctors-help-patients-to-die</guid>
                                    <description><![CDATA[The Royal College of Physicians will survey all its members in February on this most controversial question. It says that it will move from opposition to neutrality on assisted dying unless 60% vote otherwise. 

The BMJ explores several conflicting views. From Canada, palliative care doctor Sandy Buchman explains why he sees medical aid in dying as a compassionate treatment that fully respects patient autonomy. The Canadian Medical Association is neutral on the issue, and Jeff Blackmer, its vice president for international health, shares how that stance enabled it to represent all its members, including doctors with conscientious objections. 

But many are unconvinced to say the least. Rob George, a UK palliative care doctor and professor at King's College London, says assisted suicide has no place in medicine. Tony Baldwinson, from the UK campaign group Not Dead Yet, worries for disabled people were society to endorse doctors actively ending lives. And Zoe Fritz, a consultant physician in acute medicine at Addenbrooke’s Hospital, Cambridge, has a proposal that she says would protect the doctor-patient relationship.

Read all our content at https://www.bmj.com/assisted-dying

"Why I decided to provide assisted dying: it is truly patient centred care" by Sandy Buchman https://www.bmj.com/content/364/bmj.l412
"How the Canadian Medical Association found a third way to support all its members on assisted dying" by Jeff Blackmer https://www.bmj.com/content/364/bmj.l415
"Religious and non-religious people share objections to assisted suicide" by Mark Pickering https://blogs.bmj.com/bmj/2019/01/30/religious-and-non-religious-people-share-objections-to-assisted-suicide/
<p>"The courts should judge applications for assisted suicide, sparing the doctor-patient relationship" by Zoe Fritz https://blogs.bmj.com/bmj/2019/01/30/the-courts-should-judge-applications-for-assisted-suicide-sparing-the-doctor-patient-relationship/</p>
]]></description>
                                                            <content:encoded><![CDATA[The Royal College of Physicians will survey all its members in February on this most controversial question. It says that it will move from opposition to neutrality on assisted dying unless 60% vote otherwise. 

The BMJ explores several conflicting views. From Canada, palliative care doctor Sandy Buchman explains why he sees medical aid in dying as a compassionate treatment that fully respects patient autonomy. The Canadian Medical Association is neutral on the issue, and Jeff Blackmer, its vice president for international health, shares how that stance enabled it to represent all its members, including doctors with conscientious objections. 

But many are unconvinced to say the least. Rob George, a UK palliative care doctor and professor at King's College London, says assisted suicide has no place in medicine. Tony Baldwinson, from the UK campaign group Not Dead Yet, worries for disabled people were society to endorse doctors actively ending lives. And Zoe Fritz, a consultant physician in acute medicine at Addenbrooke’s Hospital, Cambridge, has a proposal that she says would protect the doctor-patient relationship.

Read all our content at https://www.bmj.com/assisted-dying

"Why I decided to provide assisted dying: it is truly patient centred care" by Sandy Buchman https://www.bmj.com/content/364/bmj.l412
"How the Canadian Medical Association found a third way to support all its members on assisted dying" by Jeff Blackmer https://www.bmj.com/content/364/bmj.l415
"Religious and non-religious people share objections to assisted suicide" by Mark Pickering https://blogs.bmj.com/bmj/2019/01/30/religious-and-non-religious-people-share-objections-to-assisted-suicide/
<p>"The courts should judge applications for assisted suicide, sparing the doctor-patient relationship" by Zoe Fritz https://blogs.bmj.com/bmj/2019/01/30/the-courts-should-judge-applications-for-assisted-suicide-sparing-the-doctor-patient-relationship/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/euikb5/stream_569950740-bmjgroup-assisted-dying-should-doctors-help-patients-to-die.mp3" length="28178816" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The Royal College of Physicians will survey all its members in February on this most controversial question. It says that it will move from opposition to neutrality on assisted dying unless 60% vote otherwise. 

The BMJ explores several conflicting views. From Canada, palliative care doctor Sandy Buchman explains why he sees medical aid in dying as a compassionate treatment that fully respects patient autonomy. The Canadian Medical Association is neutral on the issue, and Jeff Blackmer, its vice president for international health, shares how that stance enabled it to represent all its members, including doctors with conscientious objections. 

But many are unconvinced to say the least. Rob George, a UK palliative care doctor and professor at King's College London, says assisted suicide has no place in medicine. Tony Baldwinson, from the UK campaign group Not Dead Yet, worries for disabled people were society to endorse doctors actively ending lives. And Zoe Fritz, a consultant physician in acute medicine at Addenbrooke’s Hospital, Cambridge, has a proposal that she says would protect the doctor-patient relationship.

Read all our content at https://www.bmj.com/assisted-dying

"Why I decided to provide assisted dying: it is truly patient centred care" by Sandy Buchman https://www.bmj.com/content/364/bmj.l412
"How the Canadian Medical Association found a third way to support all its members on assisted dying" by Jeff Blackmer https://www.bmj.com/content/364/bmj.l415
"Religious and non-religious people share objections to assisted suicide" by Mark Pickering https://blogs.bmj.com/bmj/2019/01/30/religious-and-non-religious-people-share-objections-to-assisted-suicide/
"The courts should judge applications for assisted suicide, sparing the doctor-patient relationship" by Zoe Fritz https://blogs.bmj.com/bmj/2019/01/30/the-courts-should-judge-applications-for-assisted-suicide-sparing-the-doctor-patient-relationship/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1761</itunes:duration>
                                    </item>
    <item>
        <title>Goran Henriks - How an 80 year old woman called Esther shaped Swedish Healthcare</title>
        <itunes:title>Goran Henriks - How an 80 year old woman called Esther shaped Swedish Healthcare</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/goran-henriks-how-an-80-year-old-woman-called-esther-shaped-swedish-healthcare/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/goran-henriks-how-an-80-year-old-woman-called-esther-shaped-swedish-healthcare/#comments</comments>        <pubDate>Fri, 25 Jan 2019 06:11:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/goran-henriks-how-an-80-year-old-woman-called-esther-shaped-swedish-healthcare</guid>
                                    <description><![CDATA[<p>Jönköping has been at the centre of the healthcare quality improvement movement for years - but how did a forested region of Sweden, situated between it's main cities, come to embrace the philosophy of improvement so fervently? Goran Henriks, chief executive of learning and innovation at Qulturum  in Jönköping  joins us to explain. He also tells us about Esther, and why she figures so centrally in their planning.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Jönköping has been at the centre of the healthcare quality improvement movement for years - but how did a forested region of Sweden, situated between it's main cities, come to embrace the philosophy of improvement so fervently? Goran Henriks, chief executive of learning and innovation at Qulturum  in Jönköping  joins us to explain. He also tells us about Esther, and why she figures so centrally in their planning.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kwx1yx/stream_564298854-bmjgroup-goran-henriks-how-an-80-year-old-woman-called-esther-shaped-swedish-healthcare.mp3" length="23241248" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Jönköping has been at the centre of the healthcare quality improvement movement for years - but how did a forested region of Sweden, situated between it's main cities, come to embrace the philosophy of improvement so fervently? Goran Henriks, chief executive of learning and innovation at Qulturum  in Jönköping  joins us to explain. He also tells us about Esther, and why she figures so centrally in their planning.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>969</itunes:duration>
                                    </item>
    <item>
        <title>Talk evidence - TIAs, aging in Japan and women in medicine</title>
        <itunes:title>Talk evidence - TIAs, aging in Japan and women in medicine</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-tias-aging-in-japan-and-women-in-medicine/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-tias-aging-in-japan-and-women-in-medicine/#comments</comments>        <pubDate>Wed, 23 Jan 2019 10:16:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/ebm-roundup-january-2019</guid>
                                    <description><![CDATA[In this EBM round-up, Carl Heneghan, Helen Macdonald and Duncan Jarvies are back to give you an update 

Dual vs single therapy for prevention of TIA or minor stroke - how does the advice that dual work better translate in the UK?

Carl explains why Japan can teach us to get active and, how GPs can use that information to "drop a decade" in aging.

Finally, Helen took some time to relax over Christmas - until she read a story in the Christmas edition about gender discrimination in medicine, and it reminded her of her time on the ward. 

Reading list:

The BMJ Practice: Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke
https://www.bmj.com/content/363/bmj.k4169

Delaying and reversing frailty: a systematic review of primary care interventions
<p>https://bjgp.org/content/early/2018/11/30/bjgp18X700241</p>
]]></description>
                                                            <content:encoded><![CDATA[In this EBM round-up, Carl Heneghan, Helen Macdonald and Duncan Jarvies are back to give you an update 

Dual vs single therapy for prevention of TIA or minor stroke - how does the advice that dual work better translate in the UK?

Carl explains why Japan can teach us to get active and, how GPs can use that information to "drop a decade" in aging.

Finally, Helen took some time to relax over Christmas - until she read a story in the Christmas edition about gender discrimination in medicine, and it reminded her of her time on the ward. 

Reading list:

The BMJ Practice: Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke
https://www.bmj.com/content/363/bmj.k4169

Delaying and reversing frailty: a systematic review of primary care interventions
<p>https://bjgp.org/content/early/2018/11/30/bjgp18X700241</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/csts9p/stream_563328729-bmjgroup-ebm-roundup-january-2019.mp3" length="34924160" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this EBM round-up, Carl Heneghan, Helen Macdonald and Duncan Jarvies are back to give you an update 

Dual vs single therapy for prevention of TIA or minor stroke - how does the advice that dual work better translate in the UK?

Carl explains why Japan can teach us to get active and, how GPs can use that information to "drop a decade" in aging.

Finally, Helen took some time to relax over Christmas - until she read a story in the Christmas edition about gender discrimination in medicine, and it reminded her of her time on the ward. 

Reading list:

The BMJ Practice: Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke
https://www.bmj.com/content/363/bmj.k4169

Delaying and reversing frailty: a systematic review of primary care interventions
https://bjgp.org/content/early/2018/11/30/bjgp18X700241]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2183</itunes:duration>
                                    </item>
    <item>
        <title>HIV - everything you wanted to know about PeP and PreP</title>
        <itunes:title>HIV - everything you wanted to know about PeP and PreP</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/hiv-everything-you-wanted-to-know-about-pep-and-prep/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/hiv-everything-you-wanted-to-know-about-pep-and-prep/#comments</comments>        <pubDate>Tue, 15 Jan 2019 23:12:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/hiv-everything-you-wanted-to-know-about-pep-and-prep</guid>
                                    <description><![CDATA[We have had two articles published recently on bmj.com, looking at drug prevention of HIV;  PeP - Post-exposure Prophylaxis and PreP - Pre-exposure Prophylaxis, neither prevent the virus from entering the body, but they do prevent the infection from taking hold.

There are lots of questions that doctors have about these - what are the risk profiles of patients who should be offered the treatments? How can they be prescribed? What are the side effects? And if you're in England, where PreP is not yet available on the NHS, can doctors advise their patients to buy it online?

Michael Brady, Sexual health and HIV consultant at Kings College Hospital and Medical Director of the Terrence Higgins Trust, joins us to help answer those questions.

Further reading
BMJ article on PeP https://www.bmj.com/content/363/bmj.k4928
BMJ article on PreP
BASHH guidelines on PreP - https://www.bashhguidelines.org/media/1189/prep-2018.pdf
https://iwantprepnow.co.uk
<p>http://www.aidsmap.com/</p>
]]></description>
                                                            <content:encoded><![CDATA[We have had two articles published recently on bmj.com, looking at drug prevention of HIV;  PeP - Post-exposure Prophylaxis and PreP - Pre-exposure Prophylaxis, neither prevent the virus from entering the body, but they do prevent the infection from taking hold.

There are lots of questions that doctors have about these - what are the risk profiles of patients who should be offered the treatments? How can they be prescribed? What are the side effects? And if you're in England, where PreP is not yet available on the NHS, can doctors advise their patients to buy it online?

Michael Brady, Sexual health and HIV consultant at Kings College Hospital and Medical Director of the Terrence Higgins Trust, joins us to help answer those questions.

Further reading
BMJ article on PeP https://www.bmj.com/content/363/bmj.k4928
BMJ article on PreP
BASHH guidelines on PreP - https://www.bashhguidelines.org/media/1189/prep-2018.pdf
https://iwantprepnow.co.uk
<p>http://www.aidsmap.com/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/w51909/stream_559644747-bmjgroup-hiv-everything-you-wanted-to-know-about-pep-and-prep.mp3" length="95695588" type="audio/mpeg"/>
        <itunes:summary><![CDATA[We have had two articles published recently on bmj.com, looking at drug prevention of HIV;  PeP - Post-exposure Prophylaxis and PreP - Pre-exposure Prophylaxis, neither prevent the virus from entering the body, but they do prevent the infection from taking hold.

There are lots of questions that doctors have about these - what are the risk profiles of patients who should be offered the treatments? How can they be prescribed? What are the side effects? And if you're in England, where PreP is not yet available on the NHS, can doctors advise their patients to buy it online?

Michael Brady, Sexual health and HIV consultant at Kings College Hospital and Medical Director of the Terrence Higgins Trust, joins us to help answer those questions.

Further reading
BMJ article on PeP https://www.bmj.com/content/363/bmj.k4928
BMJ article on PreP
BASHH guidelines on PreP - https://www.bashhguidelines.org/media/1189/prep-2018.pdf
https://iwantprepnow.co.uk
http://www.aidsmap.com/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3992</itunes:duration>
                                    </item>
    <item>
        <title>HbA1c - when it might not be accurately measuring glycemic control</title>
        <itunes:title>HbA1c - when it might not be accurately measuring glycemic control</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/hba1c-when-it-might-not-be-accurately-measuring-glycemic-control/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/hba1c-when-it-might-not-be-accurately-measuring-glycemic-control/#comments</comments>        <pubDate>Tue, 15 Jan 2019 06:16:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/hba1c-when-it-might-not-be-accurately-measuring-glycemic-control</guid>
                                    <description><![CDATA[HbA1c concentration is used as the biomarker for long term glycaemic control, however if the lifespan of red blood cells is altered, that may lead to an over, or under estimation of that control.

In this podcast Ravinder Sodi, consultant clinical biochemist at  University Hospitals of Morecambe Bay NHS Foundation Trust, explains when to suspect HbA1c is not an accurate measure of glycemic control, and what alternative tests are available.

Read the full article:
<p>https://www.bmj.com/content/363/bmj.k4723</p>
]]></description>
                                                            <content:encoded><![CDATA[HbA1c concentration is used as the biomarker for long term glycaemic control, however if the lifespan of red blood cells is altered, that may lead to an over, or under estimation of that control.

In this podcast Ravinder Sodi, consultant clinical biochemist at  University Hospitals of Morecambe Bay NHS Foundation Trust, explains when to suspect HbA1c is not an accurate measure of glycemic control, and what alternative tests are available.

Read the full article:
<p>https://www.bmj.com/content/363/bmj.k4723</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/zd160v/stream_559273239-bmjgroup-hba1c-when-it-might-not-be-accurately-measuring-glycemic-control.mp3" length="25721692" type="audio/mpeg"/>
        <itunes:summary><![CDATA[HbA1c concentration is used as the biomarker for long term glycaemic control, however if the lifespan of red blood cells is altered, that may lead to an over, or under estimation of that control.

In this podcast Ravinder Sodi, consultant clinical biochemist at  University Hospitals of Morecambe Bay NHS Foundation Trust, explains when to suspect HbA1c is not an accurate measure of glycemic control, and what alternative tests are available.

Read the full article:
https://www.bmj.com/content/363/bmj.k4723]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1073</itunes:duration>
                                    </item>
    <item>
        <title>Terence Stephenson - looking back at chairing the GMC</title>
        <itunes:title>Terence Stephenson - looking back at chairing the GMC</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/terence-stephenson-looking-back-at-chairing-the-gmc/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/terence-stephenson-looking-back-at-chairing-the-gmc/#comments</comments>        <pubDate>Tue, 15 Jan 2019 06:14:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/terence-stephenson-looking-back-at-chairing-the-gmc</guid>
                                    <description><![CDATA[Terence Stephenson is a consultant paediatrician who became been chair of the General Medical Council in 2015. 

His 4 year tenure has now come to an end, but during his time with the regulator the medical profession faced a number of challenges - the case of Hadiza Bawa Garba and a growing recruitment crisis in the  NHS - the GMC is the gatekeeper for foreign doctors who who wish to work here. As the rules on EU doctors change, the GMC’s regulatory practice may have to change too.

In this podcast, Abi Rimmer, a report and editor for The BMJ, went to Terrence’s office to talk to him about his career at the GMC, and his perspective on how the organisation has responded to those challenges.

Read the related article:
<p>https://www.bmj.com/content/363/bmj.k5402</p>
]]></description>
                                                            <content:encoded><![CDATA[Terence Stephenson is a consultant paediatrician who became been chair of the General Medical Council in 2015. 

His 4 year tenure has now come to an end, but during his time with the regulator the medical profession faced a number of challenges - the case of Hadiza Bawa Garba and a growing recruitment crisis in the  NHS - the GMC is the gatekeeper for foreign doctors who who wish to work here. As the rules on EU doctors change, the GMC’s regulatory practice may have to change too.

In this podcast, Abi Rimmer, a report and editor for The BMJ, went to Terrence’s office to talk to him about his career at the GMC, and his perspective on how the organisation has responded to those challenges.

Read the related article:
<p>https://www.bmj.com/content/363/bmj.k5402</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/14c6i6/stream_559272681-bmjgroup-terence-stephenson-looking-back-at-chairing-the-gmc.mp3" length="33027968" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Terence Stephenson is a consultant paediatrician who became been chair of the General Medical Council in 2015. 

His 4 year tenure has now come to an end, but during his time with the regulator the medical profession faced a number of challenges - the case of Hadiza Bawa Garba and a growing recruitment crisis in the  NHS - the GMC is the gatekeeper for foreign doctors who who wish to work here. As the rules on EU doctors change, the GMC’s regulatory practice may have to change too.

In this podcast, Abi Rimmer, a report and editor for The BMJ, went to Terrence’s office to talk to him about his career at the GMC, and his perspective on how the organisation has responded to those challenges.

Read the related article:
https://www.bmj.com/content/363/bmj.k5402]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1378</itunes:duration>
                                    </item>
    <item>
        <title>How Coca-Cola shaped obesity science and policy in China</title>
        <itunes:title>How Coca-Cola shaped obesity science and policy in China</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/how-coca-cola-shaped-obesity-science-and-policy-in-china/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/how-coca-cola-shaped-obesity-science-and-policy-in-china/#comments</comments>        <pubDate>Wed, 09 Jan 2019 17:25:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/how-coca-cola-shaped-obesity-science-and-policy-in-china</guid>
                                    <description><![CDATA[Susan Greenhalg is a research professor of chinese society in Harvard’s department of anthropology  - not a natural fit for a medical journal you may think, but recently she has been looking at the influence of Coca Cola on obesity policy in China.

She has written up her investigation in an article published on bmj.com this week, and joins us in the podcast to talk about why a communist country would embrace a message from an icon of capitalism, and what attitudes toward financial conflicts of interest exist in the country.

Read the full feature:
https://www.bmj.com/content/364/bmj.k5050

Accompanying editorial:
<p>https://www.bmj.com/content/364/bmj.l4</p>
]]></description>
                                                            <content:encoded><![CDATA[Susan Greenhalg is a research professor of chinese society in Harvard’s department of anthropology  - not a natural fit for a medical journal you may think, but recently she has been looking at the influence of Coca Cola on obesity policy in China.

She has written up her investigation in an article published on bmj.com this week, and joins us in the podcast to talk about why a communist country would embrace a message from an icon of capitalism, and what attitudes toward financial conflicts of interest exist in the country.

Read the full feature:
https://www.bmj.com/content/364/bmj.k5050

Accompanying editorial:
<p>https://www.bmj.com/content/364/bmj.l4</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jzuecg/stream_556440213-bmjgroup-how-coca-cola-shaped-obesity-science-and-policy-in-china.mp3" length="35709664" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Susan Greenhalg is a research professor of chinese society in Harvard’s department of anthropology  - not a natural fit for a medical journal you may think, but recently she has been looking at the influence of Coca Cola on obesity policy in China.

She has written up her investigation in an article published on bmj.com this week, and joins us in the podcast to talk about why a communist country would embrace a message from an icon of capitalism, and what attitudes toward financial conflicts of interest exist in the country.

Read the full feature:
https://www.bmj.com/content/364/bmj.k5050

Accompanying editorial:
https://www.bmj.com/content/364/bmj.l4]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1489</itunes:duration>
                                    </item>
    <item>
        <title>Coding at Christmas</title>
        <itunes:title>Coding at Christmas</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/coding-at-christmas/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/coding-at-christmas/#comments</comments>        <pubDate>Fri, 04 Jan 2019 18:41:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/coding-at-christmas</guid>
                                    <description><![CDATA[For many of you Christmas is over and, you’re back to work. Admin piled up over christmas? Feeling resentful for all those forms, and the weird codes they make you put in them?

In this podcast I hope we can explain why that’s important, with 17th century death, the esoteria of reed codes, and why the WHO cares about spaceship accidents.


Consumption, flux, and dropsy: counting deaths in 17th century London
https://www.bmj.com/content/363/bmj.k5014

Christmas guide to clinical coding
<p>https://www.bmj.com/content/363/bmj.k5209</p>
]]></description>
                                                            <content:encoded><![CDATA[For many of you Christmas is over and, you’re back to work. Admin piled up over christmas? Feeling resentful for all those forms, and the weird codes they make you put in them?

In this podcast I hope we can explain why that’s important, with 17th century death, the esoteria of reed codes, and why the WHO cares about spaceship accidents.


Consumption, flux, and dropsy: counting deaths in 17th century London
https://www.bmj.com/content/363/bmj.k5014

Christmas guide to clinical coding
<p>https://www.bmj.com/content/363/bmj.k5209</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/60fkx7/stream_554099715-bmjgroup-coding-at-christmas.mp3" length="51110786" type="audio/mpeg"/>
        <itunes:summary><![CDATA[For many of you Christmas is over and, you’re back to work. Admin piled up over christmas? Feeling resentful for all those forms, and the weird codes they make you put in them?

In this podcast I hope we can explain why that’s important, with 17th century death, the esoteria of reed codes, and why the WHO cares about spaceship accidents.


Consumption, flux, and dropsy: counting deaths in 17th century London
https://www.bmj.com/content/363/bmj.k5014

Christmas guide to clinical coding
https://www.bmj.com/content/363/bmj.k5209]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2132</itunes:duration>
                                    </item>
    <item>
        <title>Women in medicine at Christmas</title>
        <itunes:title>Women in medicine at Christmas</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/women-in-medicine-at-christmas/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/women-in-medicine-at-christmas/#comments</comments>        <pubDate>Fri, 21 Dec 2018 15:44:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/women-in-medicine-at-christmas</guid>
                                    <description><![CDATA[2018 will go down in history as a year of reckoning as the year that that some men’s behaviour came back to bite them. The continuing impact of #MeToo across the world has prompted another round of thinking about women’s experiences in medicine, which can be seen this year’s christmas journal

In this podcast, Esther Choo and Eleni Lenos, join us to discuss their research into mother's experiences of being doctors - and how discrimination is still rife against them.

Also Sarah Lowry, from the Royal College of Physicians brings us some other women's voices - this time from the RCP exhibition "This vexed Question: 500 years of women in medicine"

Visit the exhibition:
https://www.rcplondon.ac.uk/events/vexed-question-500-years-women-medicine

Physician mothers’ experience of workplace discrimination: a qualitative analysis
https://www.bmj.com/content/363/bmj.k4926


A lexicon for gender bias in academia and medicine
<p>https://www.bmj.com/content/363/bmj.k5218</p>
]]></description>
                                                            <content:encoded><![CDATA[2018 will go down in history as a year of reckoning as the year that that some men’s behaviour came back to bite them. The continuing impact of #MeToo across the world has prompted another round of thinking about women’s experiences in medicine, which can be seen this year’s christmas journal

In this podcast, Esther Choo and Eleni Lenos, join us to discuss their research into mother's experiences of being doctors - and how discrimination is still rife against them.

Also Sarah Lowry, from the Royal College of Physicians brings us some other women's voices - this time from the RCP exhibition "This vexed Question: 500 years of women in medicine"

Visit the exhibition:
https://www.rcplondon.ac.uk/events/vexed-question-500-years-women-medicine

Physician mothers’ experience of workplace discrimination: a qualitative analysis
https://www.bmj.com/content/363/bmj.k4926


A lexicon for gender bias in academia and medicine
<p>https://www.bmj.com/content/363/bmj.k5218</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/sejzug/stream_548272425-bmjgroup-women-in-medicine-at-christmas.mp3" length="59760013" type="audio/mpeg"/>
        <itunes:summary><![CDATA[2018 will go down in history as a year of reckoning as the year that that some men’s behaviour came back to bite them. The continuing impact of #MeToo across the world has prompted another round of thinking about women’s experiences in medicine, which can be seen this year’s christmas journal

In this podcast, Esther Choo and Eleni Lenos, join us to discuss their research into mother's experiences of being doctors - and how discrimination is still rife against them.

Also Sarah Lowry, from the Royal College of Physicians brings us some other women's voices - this time from the RCP exhibition "This vexed Question: 500 years of women in medicine"

Visit the exhibition:
https://www.rcplondon.ac.uk/events/vexed-question-500-years-women-medicine

Physician mothers’ experience of workplace discrimination: a qualitative analysis
https://www.bmj.com/content/363/bmj.k4926


A lexicon for gender bias in academia and medicine
https://www.bmj.com/content/363/bmj.k5218]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2493</itunes:duration>
                                    </item>
    <item>
        <title>Christmas Food 2018</title>
        <itunes:title>Christmas Food 2018</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/christmas-food-2018/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/christmas-food-2018/#comments</comments>        <pubDate>Sun, 16 Dec 2018 13:12:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/christmas-food-2018</guid>
                                    <description><![CDATA[the Christmas BMJ season is upon us - if you’re to go to our website now, you’ll see that it’s been a bumper year. In the podcast, we’re going to be bringing you a select few - we’ll be looking at motherhood. Trying to figure out what 17th Century causes of death were, and - as it’s christmas - in this pod we’ll be looking at food.

We talk to Frances Mason and Amanda Farley, from the University of Birmingham, about their RCT examining the “Effectiveness of a brief behavioural intervention to prevent weight gain over the Christmas holiday period"
https://www.bmj.com/content/363/bmj.k4867

We also have Eric Robinson from the University of Liverpool explains how calorific restaurant food from his observational study, 
"(Over)eating out at major UK restaurant chains"
<p>https://www.bmj.com/content/363/bmj.k4982</p>
]]></description>
                                                            <content:encoded><![CDATA[the Christmas BMJ season is upon us - if you’re to go to our website now, you’ll see that it’s been a bumper year. In the podcast, we’re going to be bringing you a select few - we’ll be looking at motherhood. Trying to figure out what 17th Century causes of death were, and - as it’s christmas - in this pod we’ll be looking at food.

We talk to Frances Mason and Amanda Farley, from the University of Birmingham, about their RCT examining the “Effectiveness of a brief behavioural intervention to prevent weight gain over the Christmas holiday period"
https://www.bmj.com/content/363/bmj.k4867

We also have Eric Robinson from the University of Liverpool explains how calorific restaurant food from his observational study, 
"(Over)eating out at major UK restaurant chains"
<p>https://www.bmj.com/content/363/bmj.k4982</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gwbb08/stream_545731686-bmjgroup-christmas-food-2018.mp3" length="33473096" type="audio/mpeg"/>
        <itunes:summary><![CDATA[the Christmas BMJ season is upon us - if you’re to go to our website now, you’ll see that it’s been a bumper year. In the podcast, we’re going to be bringing you a select few - we’ll be looking at motherhood. Trying to figure out what 17th Century causes of death were, and - as it’s christmas - in this pod we’ll be looking at food.

We talk to Frances Mason and Amanda Farley, from the University of Birmingham, about their RCT examining the “Effectiveness of a brief behavioural intervention to prevent weight gain over the Christmas holiday period"
https://www.bmj.com/content/363/bmj.k4867

We also have Eric Robinson from the University of Liverpool explains how calorific restaurant food from his observational study, 
"(Over)eating out at major UK restaurant chains"
https://www.bmj.com/content/363/bmj.k4982]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2092</itunes:duration>
                                    </item>
    <item>
        <title>Talk Evidence  - Devices and facebook vaccines</title>
        <itunes:title>Talk Evidence  - Devices and facebook vaccines</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-devices-and-facebook-vaccines/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-devices-and-facebook-vaccines/#comments</comments>        <pubDate>Wed, 12 Dec 2018 11:11:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/ebm-roundup-devices-and-facebook-vaccines</guid>
                                    <description><![CDATA[In the second of our EBM round-ups, Carl Heneghan, Helen Macdonald and Duncan Jarvies are joined by Deborah Cohen, investigative journalist and scourge of device manufacturers. 

We're giving our verdict on the  sensitivity and specificity of ketone testing for hyperemesis, and the advice to drinking more water to prevent recurrent UTIs in women.

Deb joins us to talk about the massive, international, investigation into failing regulation for implantable devices - and shares some of the stories where these have harmed patients.

Finally, Carl is excised about antivaxer ads on facebook - but Helen has seen some pro-vaccine ones which are poor science too.


Reading list:

Diagnostic markers for hyperemesis gravidarum
https://www.ncbi.nlm.nih.gov/pubmed/24530975

Effect of Increased Daily Water Intake in Premenopausal Women With Recurrent Urinary Tract Infections
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2705079

The great implant scandle
https://www.bbc.co.uk/iplayer/episode/b0btjr55/panorama-the-great-implant-scandal

Facebook antivaccine ads
<p>https://www.independent.co.uk/news/uk/home-news/anti-vaccination-antivaxxers-uk-advert-banned-facebook-post-vaccines-kill-babies-a8620831.html</p>
]]></description>
                                                            <content:encoded><![CDATA[In the second of our EBM round-ups, Carl Heneghan, Helen Macdonald and Duncan Jarvies are joined by Deborah Cohen, investigative journalist and scourge of device manufacturers. 

We're giving our verdict on the  sensitivity and specificity of ketone testing for hyperemesis, and the advice to drinking more water to prevent recurrent UTIs in women.

Deb joins us to talk about the massive, international, investigation into failing regulation for implantable devices - and shares some of the stories where these have harmed patients.

Finally, Carl is excised about antivaxer ads on facebook - but Helen has seen some pro-vaccine ones which are poor science too.


Reading list:

Diagnostic markers for hyperemesis gravidarum
https://www.ncbi.nlm.nih.gov/pubmed/24530975

Effect of Increased Daily Water Intake in Premenopausal Women With Recurrent Urinary Tract Infections
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2705079

The great implant scandle
https://www.bbc.co.uk/iplayer/episode/b0btjr55/panorama-the-great-implant-scandal

Facebook antivaccine ads
<p>https://www.independent.co.uk/news/uk/home-news/anti-vaccination-antivaxxers-uk-advert-banned-facebook-post-vaccines-kill-babies-a8620831.html</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4p3mm0/stream_543840327-bmjgroup-ebm-roundup-devices-and-facebook-vaccines.mp3" length="51389398" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In the second of our EBM round-ups, Carl Heneghan, Helen Macdonald and Duncan Jarvies are joined by Deborah Cohen, investigative journalist and scourge of device manufacturers. 

We're giving our verdict on the  sensitivity and specificity of ketone testing for hyperemesis, and the advice to drinking more water to prevent recurrent UTIs in women.

Deb joins us to talk about the massive, international, investigation into failing regulation for implantable devices - and shares some of the stories where these have harmed patients.

Finally, Carl is excised about antivaxer ads on facebook - but Helen has seen some pro-vaccine ones which are poor science too.


Reading list:

Diagnostic markers for hyperemesis gravidarum
https://www.ncbi.nlm.nih.gov/pubmed/24530975

Effect of Increased Daily Water Intake in Premenopausal Women With Recurrent Urinary Tract Infections
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2705079

The great implant scandle
https://www.bbc.co.uk/iplayer/episode/b0btjr55/panorama-the-great-implant-scandal

Facebook antivaccine ads
https://www.independent.co.uk/news/uk/home-news/anti-vaccination-antivaxxers-uk-advert-banned-facebook-post-vaccines-kill-babies-a8620831.html]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2144</itunes:duration>
                                    </item>
    <item>
        <title>Making multisectoral collaboration work</title>
        <itunes:title>Making multisectoral collaboration work</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/making-multisectoral-collaboration-work/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/making-multisectoral-collaboration-work/#comments</comments>        <pubDate>Fri, 07 Dec 2018 22:30:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/making-multisectoral-collaboration-work</guid>
                                    <description><![CDATA[A new collection of articles published by The BMJ includes twelve country case studies, each an evaluation of multisectoral collaboration in action at scale on women’s, children’s, and adolescent’s health. 

Collectively these twelve studies inform an overarching synthesis and accompanying commentaries, drawing together lessons learned in achieving effective multisectoral collaboration.

In this podcast, Wendy Graham, professor of obstetric epidemiology at the London School of Hygiene and Tropical Medicine, and Shyama Kuruvilla, senior strategic advisor to the World Health Organisation, join us to discuss what can be learned from those case studies.

Read all the case studies:
<p>https://www.bmj.com/multisectoral-collaboration</p>
]]></description>
                                                            <content:encoded><![CDATA[A new collection of articles published by The BMJ includes twelve country case studies, each an evaluation of multisectoral collaboration in action at scale on women’s, children’s, and adolescent’s health. 

Collectively these twelve studies inform an overarching synthesis and accompanying commentaries, drawing together lessons learned in achieving effective multisectoral collaboration.

In this podcast, Wendy Graham, professor of obstetric epidemiology at the London School of Hygiene and Tropical Medicine, and Shyama Kuruvilla, senior strategic advisor to the World Health Organisation, join us to discuss what can be learned from those case studies.

Read all the case studies:
<p>https://www.bmj.com/multisectoral-collaboration</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/15gj09/stream_541368468-bmjgroup-making-multisectoral-collaboration-work.mp3" length="66160791" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A new collection of articles published by The BMJ includes twelve country case studies, each an evaluation of multisectoral collaboration in action at scale on women’s, children’s, and adolescent’s health. 

Collectively these twelve studies inform an overarching synthesis and accompanying commentaries, drawing together lessons learned in achieving effective multisectoral collaboration.

In this podcast, Wendy Graham, professor of obstetric epidemiology at the London School of Hygiene and Tropical Medicine, and Shyama Kuruvilla, senior strategic advisor to the World Health Organisation, join us to discuss what can be learned from those case studies.

Read all the case studies:
https://www.bmj.com/multisectoral-collaboration]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2758</itunes:duration>
                                    </item>
    <item>
        <title>Trojan Milk</title>
        <itunes:title>Trojan Milk</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/trojan-milk/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/trojan-milk/#comments</comments>        <pubDate>Wed, 05 Dec 2018 19:23:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/trojan-milk</guid>
                                    <description><![CDATA[Infant formula manufacturers were made pariah in the 70s, because of their marketing practices - this lead to “The Code”, adopted by the WHO, which set out clear guidelines about what those practices should be.

Now an investigation on bmj.com by Chris Van Tulleken, honorary senior lecturer at University College London, examines the practices associated with the marketing of specialist milk formula for children with cow’s milk protein allergy, and asks whether doctors organisations should be receiving money from that industry.

Read the full investigation:
<p>https://www.bmj.com/content/363/bmj.k5056</p>
]]></description>
                                                            <content:encoded><![CDATA[Infant formula manufacturers were made pariah in the 70s, because of their marketing practices - this lead to “The Code”, adopted by the WHO, which set out clear guidelines about what those practices should be.

Now an investigation on bmj.com by Chris Van Tulleken, honorary senior lecturer at University College London, examines the practices associated with the marketing of specialist milk formula for children with cow’s milk protein allergy, and asks whether doctors organisations should be receiving money from that industry.

Read the full investigation:
<p>https://www.bmj.com/content/363/bmj.k5056</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hb9fo6/stream_540287046-bmjgroup-trojan-milk.mp3" length="30754689" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Infant formula manufacturers were made pariah in the 70s, because of their marketing practices - this lead to “The Code”, adopted by the WHO, which set out clear guidelines about what those practices should be.

Now an investigation on bmj.com by Chris Van Tulleken, honorary senior lecturer at University College London, examines the practices associated with the marketing of specialist milk formula for children with cow’s milk protein allergy, and asks whether doctors organisations should be receiving money from that industry.

Read the full investigation:
https://www.bmj.com/content/363/bmj.k5056]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1922</itunes:duration>
                                    </item>
    <item>
        <title>The bone crushing nausea of hyperemesis</title>
        <itunes:title>The bone crushing nausea of hyperemesis</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-bone-crushing-nausea-of-hyperemesis/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-bone-crushing-nausea-of-hyperemesis/#comments</comments>        <pubDate>Sat, 01 Dec 2018 11:40:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-bone-crushing-nausea-of-hyperemesis</guid>
                                    <description><![CDATA[Nausea and vomiting in pregnancy affects around 70% of pregnancies. It is mild for around 40% of women, moderate for 46%, and severe for 14%.

By contrast, hyperemesis gravidarum is a complication of pregnancy rather than a normal part of it and occurs in around 1.5% of pregnancies. The psychosocial burden of HG can be heavy for women and their families.

In this podcast, Caitlin Dean Phd Candidate, Gillian Ostrowski, general practitioner, Rebecca C Painter, consultant obstetrician join us to explain what hyperemesis is like for those who experience it, and discuss what treatment options are available.

Read the full article:
<p>https://www.bmj.com/content/363/bmj.k5000</p>
]]></description>
                                                            <content:encoded><![CDATA[Nausea and vomiting in pregnancy affects around 70% of pregnancies. It is mild for around 40% of women, moderate for 46%, and severe for 14%.

By contrast, hyperemesis gravidarum is a complication of pregnancy rather than a normal part of it and occurs in around 1.5% of pregnancies. The psychosocial burden of HG can be heavy for women and their families.

In this podcast, Caitlin Dean Phd Candidate, Gillian Ostrowski, general practitioner, Rebecca C Painter, consultant obstetrician join us to explain what hyperemesis is like for those who experience it, and discuss what treatment options are available.

Read the full article:
<p>https://www.bmj.com/content/363/bmj.k5000</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/p4f23j/stream_538200060-bmjgroup-the-bone-crushing-nausea-of-hyperemesis.mp3" length="70528884" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Nausea and vomiting in pregnancy affects around 70% of pregnancies. It is mild for around 40% of women, moderate for 46%, and severe for 14%.

By contrast, hyperemesis gravidarum is a complication of pregnancy rather than a normal part of it and occurs in around 1.5% of pregnancies. The psychosocial burden of HG can be heavy for women and their families.

In this podcast, Caitlin Dean Phd Candidate, Gillian Ostrowski, general practitioner, Rebecca C Painter, consultant obstetrician join us to explain what hyperemesis is like for those who experience it, and discuss what treatment options are available.

Read the full article:
https://www.bmj.com/content/363/bmj.k5000]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2942</itunes:duration>
                                    </item>
    <item>
        <title>God is in Operating Room 4</title>
        <itunes:title>God is in Operating Room 4</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/god-is-in-operating-room-4/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/god-is-in-operating-room-4/#comments</comments>        <pubDate>Tue, 27 Nov 2018 17:30:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/god-is-in-operating-room-4</guid>
                                    <description><![CDATA[Healthy self confidence has an important role in surgery, but what came first - the surgeon or the ego?

In this conversation, Christopher Myers, Yemeng Lu-Myers, and Amir Ghaferi join us to talk about the (very few) surgeons who behave badly in theatre, and why that behaviour has persisted, and can be detrimental.

Read their full analysis:
<p>https://www.bmj.com/content/363/bmj.k4537</p>
]]></description>
                                                            <content:encoded><![CDATA[Healthy self confidence has an important role in surgery, but what came first - the surgeon or the ego?

In this conversation, Christopher Myers, Yemeng Lu-Myers, and Amir Ghaferi join us to talk about the (very few) surgeons who behave badly in theatre, and why that behaviour has persisted, and can be detrimental.

Read their full analysis:
<p>https://www.bmj.com/content/363/bmj.k4537</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ox58fa/stream_536309634-bmjgroup-god-is-in-operating-room-4.mp3" length="66044892" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Healthy self confidence has an important role in surgery, but what came first - the surgeon or the ego?

In this conversation, Christopher Myers, Yemeng Lu-Myers, and Amir Ghaferi join us to talk about the (very few) surgeons who behave badly in theatre, and why that behaviour has persisted, and can be detrimental.

Read their full analysis:
https://www.bmj.com/content/363/bmj.k4537]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2755</itunes:duration>
                                    </item>
    <item>
        <title>Carers need a voice in the NHS</title>
        <itunes:title>Carers need a voice in the NHS</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/carers-need-a-voice-in-the-nhs/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/carers-need-a-voice-in-the-nhs/#comments</comments>        <pubDate>Thu, 22 Nov 2018 17:05:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/carers-need-a-voice-in-the-nhs-too</guid>
                                    <description><![CDATA[Until recently, The BMJ had a campaign of patient partnership - now we have a patient and public partnership campaign. The reason for that change is that medicine has an effect beyond the individual being treated - and this podcast interview is a very good example of that.

<p>Anya De Iong, patient editor for The BMJ, talks to Christine Morgan - independent chair of the Greater Manchester Carers Strategic Group. Christine has a mission to bring the needs of carers into thinking and planning about the NHS - and explains how the needs of patients and carers may be similar, and different.</p>
]]></description>
                                                            <content:encoded><![CDATA[Until recently, The BMJ had a campaign of patient partnership - now we have a patient and public partnership campaign. The reason for that change is that medicine has an effect beyond the individual being treated - and this podcast interview is a very good example of that.

<p>Anya De Iong, patient editor for The BMJ, talks to Christine Morgan - independent chair of the Greater Manchester Carers Strategic Group. Christine has a mission to bring the needs of carers into thinking and planning about the NHS - and explains how the needs of patients and carers may be similar, and different.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9xzrxp/stream_533956149-bmjgroup-carers-need-a-voice-in-the-nhs-too.mp3" length="40196161" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Until recently, The BMJ had a campaign of patient partnership - now we have a patient and public partnership campaign. The reason for that change is that medicine has an effect beyond the individual being treated - and this podcast interview is a very good example of that.

Anya De Iong, patient editor for The BMJ, talks to Christine Morgan - independent chair of the Greater Manchester Carers Strategic Group. Christine has a mission to bring the needs of carers into thinking and planning about the NHS - and explains how the needs of patients and carers may be similar, and different.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1677</itunes:duration>
                                    </item>
    <item>
        <title>Acceptable, tolerable, manageable - but not to patients. How drug trials report harms.</title>
        <itunes:title>Acceptable, tolerable, manageable - but not to patients. How drug trials report harms.</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/acceptable-tolerable-manageable-but-not-to-patients-how-drug-trials-report-harms/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/acceptable-tolerable-manageable-but-not-to-patients-how-drug-trials-report-harms/#comments</comments>        <pubDate>Mon, 19 Nov 2018 18:02:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/acceptable-tolerable-manageable-but-not-to-patients-how-drug-trials-report-harms</guid>
                                    <description><![CDATA[You’ll have read in a clinical trial “Most patients had an acceptable adverse-event profile.” Or that a drug “has a manageable and mostly reversible safety profile.” And that “the tolerability was good overall.”

In this podcast, Bishal Gyawali (@oncology_bg) joins us to describe what events those terms were actually describing in cancer drug trials, and how they reduce the readers appreciation of the adverse effects of these novel drugs.

Read the full analysis:
<p>https://www.bmj.com/content/363/bmj.k4383</p>
]]></description>
                                                            <content:encoded><![CDATA[You’ll have read in a clinical trial “Most patients had an acceptable adverse-event profile.” Or that a drug “has a manageable and mostly reversible safety profile.” And that “the tolerability was good overall.”

In this podcast, Bishal Gyawali (@oncology_bg) joins us to describe what events those terms were actually describing in cancer drug trials, and how they reduce the readers appreciation of the adverse effects of these novel drugs.

Read the full analysis:
<p>https://www.bmj.com/content/363/bmj.k4383</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8sw7l8/stream_532473207-bmjgroup-acceptable-tolerable-manageable-but-not-to-patients-how-drug-trials-report-harms.mp3" length="37297000" type="audio/mpeg"/>
        <itunes:summary><![CDATA[You’ll have read in a clinical trial “Most patients had an acceptable adverse-event profile.” Or that a drug “has a manageable and mostly reversible safety profile.” And that “the tolerability was good overall.”

In this podcast, Bishal Gyawali (@oncology_bg) joins us to describe what events those terms were actually describing in cancer drug trials, and how they reduce the readers appreciation of the adverse effects of these novel drugs.

Read the full analysis:
https://www.bmj.com/content/363/bmj.k4383]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1556</itunes:duration>
                                    </item>
    <item>
        <title>Talk evidence - Vitamin D, Oxygen and ethics</title>
        <itunes:title>Talk evidence - Vitamin D, Oxygen and ethics</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talk-evidence-vitamin-d-oxygen-and-ethics/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talk-evidence-vitamin-d-oxygen-and-ethics/#comments</comments>        <pubDate>Fri, 16 Nov 2018 11:30:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/ebm-roundup-nov-2018</guid>
                                    <description><![CDATA[Welcome to this, trial run, of a new kind of BMJ podcast - here we’re going to be focusing on all things EBM. 

Duncan Jarvies, Helen Macdonald and Carl Heneghan - and occasional guests- will be back every month to discuss what's been happening in the world of evidence. 

We'll bring you our Verdict on what you should start or stop doing, geek out about stats, and rant about the unevidence based world in which we live.

This week we talk about:

Vitamin D
https://www.thelancet.com/journals/landia/article/PIIS2213-8587(18)30265-1/fulltext

Oxygen
 https://www.bmj.com/content/363/bmj.k4169

The UK parliament's report on clinical trial transparency
<p>https://publications.parliament.uk/pa/cm201719/cmselect/cmsctech/1480/1480.pdf</p>
]]></description>
                                                            <content:encoded><![CDATA[Welcome to this, trial run, of a new kind of BMJ podcast - here we’re going to be focusing on all things EBM. 

Duncan Jarvies, Helen Macdonald and Carl Heneghan - and occasional guests- will be back every month to discuss what's been happening in the world of evidence. 

We'll bring you our Verdict on what you should start or stop doing, geek out about stats, and rant about the unevidence based world in which we live.

This week we talk about:

Vitamin D
https://www.thelancet.com/journals/landia/article/PIIS2213-8587(18)30265-1/fulltext

Oxygen
 https://www.bmj.com/content/363/bmj.k4169

The UK parliament's report on clinical trial transparency
<p>https://publications.parliament.uk/pa/cm201719/cmselect/cmsctech/1480/1480.pdf</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/k5po71/stream_530784252-bmjgroup-ebm-roundup-nov-2018.mp3" length="59090677" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Welcome to this, trial run, of a new kind of BMJ podcast - here we’re going to be focusing on all things EBM. 

Duncan Jarvies, Helen Macdonald and Carl Heneghan - and occasional guests- will be back every month to discuss what's been happening in the world of evidence. 

We'll bring you our Verdict on what you should start or stop doing, geek out about stats, and rant about the unevidence based world in which we live.

This week we talk about:

Vitamin D
https://www.thelancet.com/journals/landia/article/PIIS2213-8587(18)30265-1/fulltext

Oxygen
 https://www.bmj.com/content/363/bmj.k4169

The UK parliament's report on clinical trial transparency
https://publications.parliament.uk/pa/cm201719/cmselect/cmsctech/1480/1480.pdf]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2465</itunes:duration>
                                    </item>
    <item>
        <title>Adverse drug reactions</title>
        <itunes:title>Adverse drug reactions</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/adverse-drug-reactions/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/adverse-drug-reactions/#comments</comments>        <pubDate>Tue, 06 Nov 2018 15:53:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/adverse-drug-reactions</guid>
                                    <description><![CDATA[Clinical trials for regulatory approval are designed to test efficacy, but new drugs might have adverse reactions - reactions those trials aren’t designed to spot.

To talk about those adverse reactions - how to spot them, how to report them and what to do about them, we're joined by Robin Ferner, from the West Midlands Centre for Adverse Drug Reactions.

Read the full practice article:
<p>https://www.bmj.com/content/363/bmj.k4051</p>
]]></description>
                                                            <content:encoded><![CDATA[Clinical trials for regulatory approval are designed to test efficacy, but new drugs might have adverse reactions - reactions those trials aren’t designed to spot.

To talk about those adverse reactions - how to spot them, how to report them and what to do about them, we're joined by Robin Ferner, from the West Midlands Centre for Adverse Drug Reactions.

Read the full practice article:
<p>https://www.bmj.com/content/363/bmj.k4051</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/yw8aii/stream_525672033-bmjgroup-adverse-drug-reactions.mp3" length="30097239" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Clinical trials for regulatory approval are designed to test efficacy, but new drugs might have adverse reactions - reactions those trials aren’t designed to spot.

To talk about those adverse reactions - how to spot them, how to report them and what to do about them, we're joined by Robin Ferner, from the West Midlands Centre for Adverse Drug Reactions.

Read the full practice article:
https://www.bmj.com/content/363/bmj.k4051]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1881</itunes:duration>
                                    </item>
    <item>
        <title>HAL will see you now</title>
        <itunes:title>HAL will see you now</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/hal-will-see-you-now/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/hal-will-see-you-now/#comments</comments>        <pubDate>Mon, 05 Nov 2018 14:17:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/hal-will-see-you-now</guid>
                                    <description><![CDATA[Machines that can learn and correct themselves already perform better than doctors at some tasks, but not all medicine is task based - but will AI doctors ever be able to have a therapeutic relationship with their patients?

In this debate,  Jörg Goldhahn, deputy head of the Institute for Translational Medicine at ETH Zurich  thinks that the future belongs to robot doctors - but Vanessa Rampton, Branco Weiss fellow at McGill Institute for Health and Social Policy, says they'll never be able to emulate the empathy required.

We're also joined by Michael Mittelman, executive director of the American Living Organ Donor Fund, who has had complex healthcare needs for his whole life - to explain what he feels about the prospect of his care delivered by machine.

Read the full debate:

<p>https://www.bmj.com/content/363/bmj.k4669</p>
]]></description>
                                                            <content:encoded><![CDATA[Machines that can learn and correct themselves already perform better than doctors at some tasks, but not all medicine is task based - but will AI doctors ever be able to have a therapeutic relationship with their patients?

In this debate,  Jörg Goldhahn, deputy head of the Institute for Translational Medicine at ETH Zurich  thinks that the future belongs to robot doctors - but Vanessa Rampton, Branco Weiss fellow at McGill Institute for Health and Social Policy, says they'll never be able to emulate the empathy required.

We're also joined by Michael Mittelman, executive director of the American Living Organ Donor Fund, who has had complex healthcare needs for his whole life - to explain what he feels about the prospect of his care delivered by machine.

Read the full debate:

<p>https://www.bmj.com/content/363/bmj.k4669</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/tovryx/stream_525112887-bmjgroup-hal-will-see-you-now.mp3" length="48059693" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Machines that can learn and correct themselves already perform better than doctors at some tasks, but not all medicine is task based - but will AI doctors ever be able to have a therapeutic relationship with their patients?

In this debate,  Jörg Goldhahn, deputy head of the Institute for Translational Medicine at ETH Zurich  thinks that the future belongs to robot doctors - but Vanessa Rampton, Branco Weiss fellow at McGill Institute for Health and Social Policy, says they'll never be able to emulate the empathy required.

We're also joined by Michael Mittelman, executive director of the American Living Organ Donor Fund, who has had complex healthcare needs for his whole life - to explain what he feels about the prospect of his care delivered by machine.

Read the full debate:

https://www.bmj.com/content/363/bmj.k4669]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2003</itunes:duration>
                                    </item>
    <item>
        <title>How much oxygen is too much oxygen?</title>
        <itunes:title>How much oxygen is too much oxygen?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/how-much-oxygen-is-too-much-oxygen/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/how-much-oxygen-is-too-much-oxygen/#comments</comments>        <pubDate>Thu, 01 Nov 2018 18:05:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/how-much-oxygen-is-too-much-oxygen</guid>
                                    <description><![CDATA[As the accompanying editorial to this article says, "oxygen has long been a friend of the medical profession Even old friendships require reappraisal in the light of new information."

And that’s what a new rapid reccomendation - Oxygen therapy for acutely ill medical patients - does.

To discuss we're joined by two of the authors, Reed Simieniuk, general internist at McMaster University and Gordon Guyatt, distinguished professor at McMaster University.

Read the full recommendation:
<p>https://www.bmj.com/content/363/bmj.k4169</p>
]]></description>
                                                            <content:encoded><![CDATA[As the accompanying editorial to this article says, "oxygen has long been a friend of the medical profession Even old friendships require reappraisal in the light of new information."

And that’s what a new rapid reccomendation - Oxygen therapy for acutely ill medical patients - does.

To discuss we're joined by two of the authors, Reed Simieniuk, general internist at McMaster University and Gordon Guyatt, distinguished professor at McMaster University.

Read the full recommendation:
<p>https://www.bmj.com/content/363/bmj.k4169</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/j3as8u/stream_523304850-bmjgroup-how-much-oxygen-is-too-much-oxygen.mp3" length="46294433" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As the accompanying editorial to this article says, "oxygen has long been a friend of the medical profession Even old friendships require reappraisal in the light of new information."

And that’s what a new rapid reccomendation - Oxygen therapy for acutely ill medical patients - does.

To discuss we're joined by two of the authors, Reed Simieniuk, general internist at McMaster University and Gordon Guyatt, distinguished professor at McMaster University.

Read the full recommendation:
https://www.bmj.com/content/363/bmj.k4169]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1931</itunes:duration>
                                    </item>
    <item>
        <title>How does lifestyle affect genetic risk of stroke?</title>
        <itunes:title>How does lifestyle affect genetic risk of stroke?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/how-does-lifestyle-affect-genetic-risk-of-stroke/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/how-does-lifestyle-affect-genetic-risk-of-stroke/#comments</comments>        <pubDate>Tue, 30 Oct 2018 13:35:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/how-does-lifestyle-affect-genetic-risk-of-stroke</guid>
                                    <description><![CDATA[Cardiovascular factors are associated with risk of stroke - and those factors can be mediated by lifestyle and by genetic make up.

New research published by The BMJ sets out to explore how these risks combine, and we're joined on the podcast by two of the authors - Loes Rutten-Jacobs, senior postdoctoral researcher at the German Center for Neurodegenerative diseases, and Susanna Larsson, associate professor at the Karolinska Institutet.

Read the full open access research:
<p>https://www.bmj.com/content/363/bmj.k4168</p>
]]></description>
                                                            <content:encoded><![CDATA[Cardiovascular factors are associated with risk of stroke - and those factors can be mediated by lifestyle and by genetic make up.

New research published by The BMJ sets out to explore how these risks combine, and we're joined on the podcast by two of the authors - Loes Rutten-Jacobs, senior postdoctoral researcher at the German Center for Neurodegenerative diseases, and Susanna Larsson, associate professor at the Karolinska Institutet.

Read the full open access research:
<p>https://www.bmj.com/content/363/bmj.k4168</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4zmed0/stream_522143058-bmjgroup-how-does-lifestyle-affect-genetic-risk-of-stroke.mp3" length="23765383" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Cardiovascular factors are associated with risk of stroke - and those factors can be mediated by lifestyle and by genetic make up.

New research published by The BMJ sets out to explore how these risks combine, and we're joined on the podcast by two of the authors - Loes Rutten-Jacobs, senior postdoctoral researcher at the German Center for Neurodegenerative diseases, and Susanna Larsson, associate professor at the Karolinska Institutet.

Read the full open access research:
https://www.bmj.com/content/363/bmj.k4168]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>991</itunes:duration>
                                    </item>
    <item>
        <title>Talking honestly about intensive care</title>
        <itunes:title>Talking honestly about intensive care</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/talking-honestly-about-intensive-care/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/talking-honestly-about-intensive-care/#comments</comments>        <pubDate>Fri, 26 Oct 2018 19:35:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/talking-honestly-about-intensive-care</guid>
                                    <description><![CDATA[On the podcast, we’ve talked a lot about the limits of medicine - where treatment doesn’t work, or potentially harms. But in that conversation, we’ve mainly focused on specific treatments.

Now a new analysis, broadens that to talk about patients being admitted to a whole ward - intensive care. The authors of that article contend that, often, patients or their families don’t fully understand the implication of that admission.

To discuss, we're joined by Jamie Gross, consultant in intensive care medicine at London North West University Healthcare NHS Trust, and by  Barry Williams, patient representative at the Intensive Care Society.

Read the full analysis:
<p>https://www.bmj.com/content/363/bmj.k4135</p>
]]></description>
                                                            <content:encoded><![CDATA[On the podcast, we’ve talked a lot about the limits of medicine - where treatment doesn’t work, or potentially harms. But in that conversation, we’ve mainly focused on specific treatments.

Now a new analysis, broadens that to talk about patients being admitted to a whole ward - intensive care. The authors of that article contend that, often, patients or their families don’t fully understand the implication of that admission.

To discuss, we're joined by Jamie Gross, consultant in intensive care medicine at London North West University Healthcare NHS Trust, and by  Barry Williams, patient representative at the Intensive Care Society.

Read the full analysis:
<p>https://www.bmj.com/content/363/bmj.k4135</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/q6zmrz/stream_520382052-bmjgroup-talking-honestly-about-intensive-care.mp3" length="48045131" type="audio/mpeg"/>
        <itunes:summary><![CDATA[On the podcast, we’ve talked a lot about the limits of medicine - where treatment doesn’t work, or potentially harms. But in that conversation, we’ve mainly focused on specific treatments.

Now a new analysis, broadens that to talk about patients being admitted to a whole ward - intensive care. The authors of that article contend that, often, patients or their families don’t fully understand the implication of that admission.

To discuss, we're joined by Jamie Gross, consultant in intensive care medicine at London North West University Healthcare NHS Trust, and by  Barry Williams, patient representative at the Intensive Care Society.

Read the full analysis:
https://www.bmj.com/content/363/bmj.k4135]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2004</itunes:duration>
                                    </item>
    <item>
        <title>Nasal symptoms of the common cold</title>
        <itunes:title>Nasal symptoms of the common cold</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/nasal-symptoms-of-the-common-cold/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/nasal-symptoms-of-the-common-cold/#comments</comments>        <pubDate>Sun, 14 Oct 2018 14:52:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/nasal-symptoms-of-the-common-cold</guid>
                                    <description><![CDATA[The common cold is usually mild and self limiting - but they’re very annoying, especially the runny nose and bunged up feeling that form the nasal symptoms.

A new practice article, published on BMJ.com looks at the available evidence for treatment of those nasal symptoms - both pharmacological and alternative.

In this podcast we're joined by Mieke van Driel - GP in Australia and a professor of primary care at The University of Queensland, and An De Sutter - GP in Belgium and professor of family medicine at Ghent University.

Read the full article, and play with the interactive infographic:
<p>https://www.bmj.com/content/363/bmj.k3786</p>
]]></description>
                                                            <content:encoded><![CDATA[The common cold is usually mild and self limiting - but they’re very annoying, especially the runny nose and bunged up feeling that form the nasal symptoms.

A new practice article, published on BMJ.com looks at the available evidence for treatment of those nasal symptoms - both pharmacological and alternative.

In this podcast we're joined by Mieke van Driel - GP in Australia and a professor of primary care at The University of Queensland, and An De Sutter - GP in Belgium and professor of family medicine at Ghent University.

Read the full article, and play with the interactive infographic:
<p>https://www.bmj.com/content/363/bmj.k3786</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/u2xk60/stream_514170741-bmjgroup-nasal-symptoms-of-the-common-cold.mp3" length="31604361" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The common cold is usually mild and self limiting - but they’re very annoying, especially the runny nose and bunged up feeling that form the nasal symptoms.

A new practice article, published on BMJ.com looks at the available evidence for treatment of those nasal symptoms - both pharmacological and alternative.

In this podcast we're joined by Mieke van Driel - GP in Australia and a professor of primary care at The University of Queensland, and An De Sutter - GP in Belgium and professor of family medicine at Ghent University.

Read the full article, and play with the interactive infographic:
https://www.bmj.com/content/363/bmj.k3786]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1317</itunes:duration>
                                    </item>
    <item>
        <title>What’s it like to live with a vaginal mesh?</title>
        <itunes:title>What’s it like to live with a vaginal mesh?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/what-s-it-like-to-live-with-a-vaginal-mesh/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/what-s-it-like-to-live-with-a-vaginal-mesh/#comments</comments>        <pubDate>Fri, 12 Oct 2018 16:52:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/whats-it-like-to-live-with-a-vaginal-mesh</guid>
                                    <description><![CDATA[What can we learn from the shameful story of vaginal mesh? That thousands of women have been irreversibly harmed; that implants were approved on the flimsiest of evidence; that surgeons weren’t adequately trained and patients weren’t properly informed; that the dash for mesh, fuelled by its manufacturers, stopped the development of alternatives; that surgeons failed to set up mesh registries that would have identified complications sooner; and that the National Institute for Health and Clinical Excellence and the UK regulators let them off the hook.

The BMJ has a published an investigation into vaginal mesh, which charts some of the issues above.

In this podcast The BMJ talked to three women who have had a vaginal mesh implanted, and all suffered the negative consequences that have prompted these investigations.

We bring you these stories to underline how life altering the situation has been for these woman, and to highlight the need for fully informed consent before anyone else has a mesh implanted.

What we must learn from mesh:
<p>https://www.bmj.com/content/363/bmj.k4254</p>
]]></description>
                                                            <content:encoded><![CDATA[What can we learn from the shameful story of vaginal mesh? That thousands of women have been irreversibly harmed; that implants were approved on the flimsiest of evidence; that surgeons weren’t adequately trained and patients weren’t properly informed; that the dash for mesh, fuelled by its manufacturers, stopped the development of alternatives; that surgeons failed to set up mesh registries that would have identified complications sooner; and that the National Institute for Health and Clinical Excellence and the UK regulators let them off the hook.

The BMJ has a published an investigation into vaginal mesh, which charts some of the issues above.

In this podcast The BMJ talked to three women who have had a vaginal mesh implanted, and all suffered the negative consequences that have prompted these investigations.

We bring you these stories to underline how life altering the situation has been for these woman, and to highlight the need for fully informed consent before anyone else has a mesh implanted.

What we must learn from mesh:
<p>https://www.bmj.com/content/363/bmj.k4254</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/lvp2hq/stream_513359556-bmjgroup-whats-it-like-to-live-with-a-vaginal-mesh.mp3" length="42729985" type="audio/mpeg"/>
        <itunes:summary><![CDATA[What can we learn from the shameful story of vaginal mesh? That thousands of women have been irreversibly harmed; that implants were approved on the flimsiest of evidence; that surgeons weren’t adequately trained and patients weren’t properly informed; that the dash for mesh, fuelled by its manufacturers, stopped the development of alternatives; that surgeons failed to set up mesh registries that would have identified complications sooner; and that the National Institute for Health and Clinical Excellence and the UK regulators let them off the hook.

The BMJ has a published an investigation into vaginal mesh, which charts some of the issues above.

In this podcast The BMJ talked to three women who have had a vaginal mesh implanted, and all suffered the negative consequences that have prompted these investigations.

We bring you these stories to underline how life altering the situation has been for these woman, and to highlight the need for fully informed consent before anyone else has a mesh implanted.

What we must learn from mesh:
https://www.bmj.com/content/363/bmj.k4254]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1782</itunes:duration>
                                    </item>
    <item>
        <title>How to taper opioids</title>
        <itunes:title>How to taper opioids</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/how-to-taper-opioids/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/how-to-taper-opioids/#comments</comments>        <pubDate>Thu, 11 Oct 2018 08:10:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/how-to-taper-opioids</guid>
                                    <description><![CDATA[There is very little guidance on withdrawing or tapering opioids in chronic pain (not caused by cancer). People can fear pain, withdrawal symptoms, a lack of social and healthcare support, and they may also distrust non-opioid methods of pain management.

This can mean that patients receive repeat opioid prescriptions for extended periods of time.

In this podcast, Harbinder Sandhu, health psychologist in pain management at Warwick Medical School, Andrea Furlan, associate professor of medicine at University of Toronto, and Sam Eldabe,  consultant in pain medicine at The James Cook University Hospital join us to set out the evidence on tapering opioids - and give practical advice on how to support patients. We're also joined by Colin, who was prescribed opioids for a decade, before he decided to reduce his usage.


What you need to know:

For people with chronic pain and who do not have cancer, the benefits of long term opioids are outweighed by the issues of tolerance, dependence, and the requirement for higher doses

Tapering is the gradual reduction of opioids with the aim of limiting withdrawal symptoms; it may target complete discontinuation of the opioid, or on occasion a reduction of the dose

It is not clear how best to support people to taper their opioids; whether it is best done by interdisciplinary pain management programmes, buprenorphine substitution, or behavioural interventions


Read the full uncertainties paper:
<p>https://www.bmj.com/content/362/bmj.k2990</p>
]]></description>
                                                            <content:encoded><![CDATA[There is very little guidance on withdrawing or tapering opioids in chronic pain (not caused by cancer). People can fear pain, withdrawal symptoms, a lack of social and healthcare support, and they may also distrust non-opioid methods of pain management.

This can mean that patients receive repeat opioid prescriptions for extended periods of time.

In this podcast, Harbinder Sandhu, health psychologist in pain management at Warwick Medical School, Andrea Furlan, associate professor of medicine at University of Toronto, and Sam Eldabe,  consultant in pain medicine at The James Cook University Hospital join us to set out the evidence on tapering opioids - and give practical advice on how to support patients. We're also joined by Colin, who was prescribed opioids for a decade, before he decided to reduce his usage.


What you need to know:

For people with chronic pain and who do not have cancer, the benefits of long term opioids are outweighed by the issues of tolerance, dependence, and the requirement for higher doses

Tapering is the gradual reduction of opioids with the aim of limiting withdrawal symptoms; it may target complete discontinuation of the opioid, or on occasion a reduction of the dose

It is not clear how best to support people to taper their opioids; whether it is best done by interdisciplinary pain management programmes, buprenorphine substitution, or behavioural interventions


Read the full uncertainties paper:
<p>https://www.bmj.com/content/362/bmj.k2990</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kjh13n/stream_512673732-bmjgroup-how-to-taper-opioids.mp3" length="42885708" type="audio/mpeg"/>
        <itunes:summary><![CDATA[There is very little guidance on withdrawing or tapering opioids in chronic pain (not caused by cancer). People can fear pain, withdrawal symptoms, a lack of social and healthcare support, and they may also distrust non-opioid methods of pain management.

This can mean that patients receive repeat opioid prescriptions for extended periods of time.

In this podcast, Harbinder Sandhu, health psychologist in pain management at Warwick Medical School, Andrea Furlan, associate professor of medicine at University of Toronto, and Sam Eldabe,  consultant in pain medicine at The James Cook University Hospital join us to set out the evidence on tapering opioids - and give practical advice on how to support patients. We're also joined by Colin, who was prescribed opioids for a decade, before he decided to reduce his usage.


What you need to know:

For people with chronic pain and who do not have cancer, the benefits of long term opioids are outweighed by the issues of tolerance, dependence, and the requirement for higher doses

Tapering is the gradual reduction of opioids with the aim of limiting withdrawal symptoms; it may target complete discontinuation of the opioid, or on occasion a reduction of the dose

It is not clear how best to support people to taper their opioids; whether it is best done by interdisciplinary pain management programmes, buprenorphine substitution, or behavioural interventions


Read the full uncertainties paper:
https://www.bmj.com/content/362/bmj.k2990]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1787</itunes:duration>
                                    </item>
    <item>
        <title>The counter intuitive effect of open label placebo</title>
        <itunes:title>The counter intuitive effect of open label placebo</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-counter-intuitive-effect-of-open-label-placebo/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-counter-intuitive-effect-of-open-label-placebo/#comments</comments>        <pubDate>Sat, 06 Oct 2018 10:42:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-counter-intuitive-effect-of-open-label-placebo</guid>
                                    <description><![CDATA[Ted Kaptchuk, professor of medicine at Harvard Medical school - and leading placebo researcher, has just published an analysis on bmj.com describing the effect of open label placebo - placebos that patient's know are placebos, but still seem to have some clinical effect.

Ted joins us to speculate about what's going on in the body, what this means for designing a more effective placebo, and asking whether it's time to start honestly prescribing placebos in the clinic.

Read his full analysis:
<p>https://www.bmj.com/content/363/bmj.k3889</p>
]]></description>
                                                            <content:encoded><![CDATA[Ted Kaptchuk, professor of medicine at Harvard Medical school - and leading placebo researcher, has just published an analysis on bmj.com describing the effect of open label placebo - placebos that patient's know are placebos, but still seem to have some clinical effect.

Ted joins us to speculate about what's going on in the body, what this means for designing a more effective placebo, and asking whether it's time to start honestly prescribing placebos in the clinic.

Read his full analysis:
<p>https://www.bmj.com/content/363/bmj.k3889</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ljy07p/stream_510340968-bmjgroup-the-counter-intuitive-effect-of-open-label-placebo.mp3" length="40152639" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Ted Kaptchuk, professor of medicine at Harvard Medical school - and leading placebo researcher, has just published an analysis on bmj.com describing the effect of open label placebo - placebos that patient's know are placebos, but still seem to have some clinical effect.

Ted joins us to speculate about what's going on in the body, what this means for designing a more effective placebo, and asking whether it's time to start honestly prescribing placebos in the clinic.

Read his full analysis:
https://www.bmj.com/content/363/bmj.k3889]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1674</itunes:duration>
                                    </item>
    <item>
        <title>Vinay Prasad - there is overdiagnosis in clinical trials</title>
        <itunes:title>Vinay Prasad - there is overdiagnosis in clinical trials</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/vinay-prasad-there-is-overdiagnosis-in-clinical-trials/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/vinay-prasad-there-is-overdiagnosis-in-clinical-trials/#comments</comments>        <pubDate>Wed, 03 Oct 2018 17:11:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/overdiagnosis-in-clinical-trials</guid>
                                    <description><![CDATA[We want clinical trials to be thorough - but Vinay Prasad, assistant professor of medicine at Oregon Health Science University, argues that the problem of overdiagnosis may be as prevalent, in the way we measure disease in our research, as our practice.

In this podcast he joins us to discuss the problem, and why he thinks what qualifies as disease in clinical trials may be getting so broad that outcomes are becoming less meaningful and harder to interpret.

Read the full analysis:
<p>https://www.bmj.com/content/362/bmj.k3783</p>
]]></description>
                                                            <content:encoded><![CDATA[We want clinical trials to be thorough - but Vinay Prasad, assistant professor of medicine at Oregon Health Science University, argues that the problem of overdiagnosis may be as prevalent, in the way we measure disease in our research, as our practice.

In this podcast he joins us to discuss the problem, and why he thinks what qualifies as disease in clinical trials may be getting so broad that outcomes are becoming less meaningful and harder to interpret.

Read the full analysis:
<p>https://www.bmj.com/content/362/bmj.k3783</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/k0e3e8/stream_509004222-bmjgroup-overdiagnosis-in-clinical-trials.mp3" length="41588272" type="audio/mpeg"/>
        <itunes:summary><![CDATA[We want clinical trials to be thorough - but Vinay Prasad, assistant professor of medicine at Oregon Health Science University, argues that the problem of overdiagnosis may be as prevalent, in the way we measure disease in our research, as our practice.

In this podcast he joins us to discuss the problem, and why he thinks what qualifies as disease in clinical trials may be getting so broad that outcomes are becoming less meaningful and harder to interpret.

Read the full analysis:
https://www.bmj.com/content/362/bmj.k3783]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1735</itunes:duration>
                                    </item>
    <item>
        <title>UK children are drinking less and the importance of a publicly provided NHS</title>
        <itunes:title>UK children are drinking less and the importance of a publicly provided NHS</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/uk-children-are-drinking-less-and-the-importance-of-a-publicly-provided-nhs/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/uk-children-are-drinking-less-and-the-importance-of-a-publicly-provided-nhs/#comments</comments>        <pubDate>Fri, 28 Sep 2018 18:36:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/uk-children-are-drinking-less-and-the-importance-of-a-publicly-provided-nhs</guid>
                                    <description><![CDATA[Brits have a reputation as Europe’s boozers - and for good reason, with alcohol consumption  higher than much of the rest of the continent. That reputation is extended to our young people too - but is it still deserved? Joanna Inchley, senior research fellow at the University of St Andrews, explains new research on decreasing drinking - http://www.hbsc.org/

Also this week, as part of our coverage of the 70th anniversary of the founding of the NHS, we’ve been running a series of articles exploring this unique institution’s future.  Neena Modi, professor of neonatal health, and Jonathan Clarke, clinical research fellow, from Imperial College London, passionately believe that the NHS needs to be publicly financed - and importantly, publicly provided.

<p>https://www.bmj.com/content/362/bmj.k3580</p>
]]></description>
                                                            <content:encoded><![CDATA[Brits have a reputation as Europe’s boozers - and for good reason, with alcohol consumption  higher than much of the rest of the continent. That reputation is extended to our young people too - but is it still deserved? Joanna Inchley, senior research fellow at the University of St Andrews, explains new research on decreasing drinking - http://www.hbsc.org/

Also this week, as part of our coverage of the 70th anniversary of the founding of the NHS, we’ve been running a series of articles exploring this unique institution’s future.  Neena Modi, professor of neonatal health, and Jonathan Clarke, clinical research fellow, from Imperial College London, passionately believe that the NHS needs to be publicly financed - and importantly, publicly provided.

<p>https://www.bmj.com/content/362/bmj.k3580</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mudrow/stream_506608689-bmjgroup-uk-children-are-drinking-less-and-the-importance-of-a-publicly-provided-nhs.mp3" length="50615498" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Brits have a reputation as Europe’s boozers - and for good reason, with alcohol consumption  higher than much of the rest of the continent. That reputation is extended to our young people too - but is it still deserved? Joanna Inchley, senior research fellow at the University of St Andrews, explains new research on decreasing drinking - http://www.hbsc.org/

Also this week, as part of our coverage of the 70th anniversary of the founding of the NHS, we’ve been running a series of articles exploring this unique institution’s future.  Neena Modi, professor of neonatal health, and Jonathan Clarke, clinical research fellow, from Imperial College London, passionately believe that the NHS needs to be publicly financed - and importantly, publicly provided.

https://www.bmj.com/content/362/bmj.k3580]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2111</itunes:duration>
                                    </item>
    <item>
        <title>Don’t save on transport at the cost of the NHS</title>
        <itunes:title>Don’t save on transport at the cost of the NHS</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/don-t-save-on-transport-at-the-cost-of-the-nhs/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/don-t-save-on-transport-at-the-cost-of-the-nhs/#comments</comments>        <pubDate>Mon, 24 Sep 2018 10:49:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/dont-save-on-transport-at-the-cost-of-the-nhs</guid>
                                    <description><![CDATA[Last week we heard about how evidence in policy making is imperilled - but today we’re hearing about a plan to make evidence about health central to all aspects of government.

Laura Webber, director of public health modelling at the UK Health Forum, Susie Morrow, chair of the Wandsworth Living Streets Group and Brian Ferguson, chief economist at Public Health England join us to discuss a “health in all policies” approach, with protected funding for preventive interventions.

Read their full analysis:
<p>https://www.bmj.com/content/362/bmj.k3377</p>
]]></description>
                                                            <content:encoded><![CDATA[Last week we heard about how evidence in policy making is imperilled - but today we’re hearing about a plan to make evidence about health central to all aspects of government.

Laura Webber, director of public health modelling at the UK Health Forum, Susie Morrow, chair of the Wandsworth Living Streets Group and Brian Ferguson, chief economist at Public Health England join us to discuss a “health in all policies” approach, with protected funding for preventive interventions.

Read their full analysis:
<p>https://www.bmj.com/content/362/bmj.k3377</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/km1b7a/stream_504343578-bmjgroup-dont-save-on-transport-at-the-cost-of-the-nhs.mp3" length="27891218" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Last week we heard about how evidence in policy making is imperilled - but today we’re hearing about a plan to make evidence about health central to all aspects of government.

Laura Webber, director of public health modelling at the UK Health Forum, Susie Morrow, chair of the Wandsworth Living Streets Group and Brian Ferguson, chief economist at Public Health England join us to discuss a “health in all policies” approach, with protected funding for preventive interventions.

Read their full analysis:
https://www.bmj.com/content/362/bmj.k3377]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1163</itunes:duration>
                                    </item>
    <item>
        <title>15 Iona Heath</title>
        <itunes:title>15 Iona Heath</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/15-iona-heath/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/15-iona-heath/#comments</comments>        <pubDate>Tue, 18 Sep 2018 04:16:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/therecodo/15-iona-heath</guid>
                                    <description><![CDATA[<p>This week a very different kind of conversation on the Recommended Dose – one that considers the art of medicine more than the science. Iona Heath is a long-time family doctor who has worked in a London GP clinic for over 30 years, and at one time became President of the Royal College of General Practitioners. With an international profile, gained in part through her much-loved writing in the BMJ, Iona is unlike many of our previous guests. For a start, she loves words more than numbers, and literature more than clinical guidelines. Host Ray Moynihan caught up with Iona at a recent conference in Helsinki – where she'd just presented little data but much food for thought from the likes of novelists EM Forster and James Baldwin. Here, she shares more of her love of literature and thoughtful commitment to the best kind of patient care.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week a very different kind of conversation on the Recommended Dose – one that considers the art of medicine more than the science. Iona Heath is a long-time family doctor who has worked in a London GP clinic for over 30 years, and at one time became President of the Royal College of General Practitioners. With an international profile, gained in part through her much-loved writing in the BMJ, Iona is unlike many of our previous guests. For a start, she loves words more than numbers, and literature more than clinical guidelines. Host Ray Moynihan caught up with Iona at a recent conference in Helsinki – where she'd just presented little data but much food for thought from the likes of novelists EM Forster and James Baldwin. Here, she shares more of her love of literature and thoughtful commitment to the best kind of patient care.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/bnqgze/stream_501473517-bmjgroup-15-iona-heath.mp3" length="24328985" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week a very different kind of conversation on the Recommended Dose – one that considers the art of medicine more than the science. Iona Heath is a long-time family doctor who has worked in a London GP clinic for over 30 years, and at one time became President of the Royal College of General Practitioners. With an international profile, gained in part through her much-loved writing in the BMJ, Iona is unlike many of our previous guests. For a start, she loves words more than numbers, and literature more than clinical guidelines. Host Ray Moynihan caught up with Iona at a recent conference in Helsinki – where she'd just presented little data but much food for thought from the likes of novelists EM Forster and James Baldwin. Here, she shares more of her love of literature and thoughtful commitment to the best kind of patient care.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1521</itunes:duration>
                                    </item>
    <item>
        <title>Defending evidence informed policy making from ideological attack</title>
        <itunes:title>Defending evidence informed policy making from ideological attack</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/defending-evidence-informed-policy-making-from-ideological-attack/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/defending-evidence-informed-policy-making-from-ideological-attack/#comments</comments>        <pubDate>Mon, 17 Sep 2018 16:00:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/evidence-based-policy-making</guid>
                                    <description><![CDATA[If you’re of a scientific persuasion, watching policy debates around Brexit, or climate change, or drug prohibition are likely to cause feelings of intense frustration about the dearth of evidence in those discussions.

In this podcast we're joined by Chris Bonell, professor of public health sociology - in this podcast he airs those frustrations, and worries that the rise of populism is pushing evidence even further out of policy decision.

Read the accompanying essay:
<p>https://www.bmj.com/content/362/bmj.k3827</p>
]]></description>
                                                            <content:encoded><![CDATA[If you’re of a scientific persuasion, watching policy debates around Brexit, or climate change, or drug prohibition are likely to cause feelings of intense frustration about the dearth of evidence in those discussions.

In this podcast we're joined by Chris Bonell, professor of public health sociology - in this podcast he airs those frustrations, and worries that the rise of populism is pushing evidence even further out of policy decision.

Read the accompanying essay:
<p>https://www.bmj.com/content/362/bmj.k3827</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/iuk393/stream_501190659-bmjgroup-evidence-based-policy-making.mp3" length="40013019" type="audio/mpeg"/>
        <itunes:summary><![CDATA[If you’re of a scientific persuasion, watching policy debates around Brexit, or climate change, or drug prohibition are likely to cause feelings of intense frustration about the dearth of evidence in those discussions.

In this podcast we're joined by Chris Bonell, professor of public health sociology - in this podcast he airs those frustrations, and worries that the rise of populism is pushing evidence even further out of policy decision.

Read the accompanying essay:
https://www.bmj.com/content/362/bmj.k3827]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1669</itunes:duration>
                                    </item>
    <item>
        <title>How often do hospital doctors change long term medication during an inpatient stay?</title>
        <itunes:title>How often do hospital doctors change long term medication during an inpatient stay?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/how-often-do-hospital-doctors-change-long-term-medication-during-an-inpatient-stay/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/how-often-do-hospital-doctors-change-long-term-medication-during-an-inpatient-stay/#comments</comments>        <pubDate>Fri, 14 Sep 2018 18:00:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/how-often-do-hospital-doctors-change-long-term-medication-during-an-inpatient-stay</guid>
                                    <description><![CDATA[More than ½ of patients leave hospital with changes to four or more of their long-term medications - but how appropriate are those changes? 

New research published on bmj.com looks at antihypertensive medication prescription changes to try and model that - and found that more than half of intensifications occurred in patients with previously well controlled outpatient blood pressure.

To discuss what they found, we're joined by Timothy Anderson, primary care research fellow, and Michael Steinman, professor of medicine, both from UCSF.

Read the open access research:
<p>https://www.bmj.com/content/362/bmj.k3503</p>
]]></description>
                                                            <content:encoded><![CDATA[More than ½ of patients leave hospital with changes to four or more of their long-term medications - but how appropriate are those changes? 

New research published on bmj.com looks at antihypertensive medication prescription changes to try and model that - and found that more than half of intensifications occurred in patients with previously well controlled outpatient blood pressure.

To discuss what they found, we're joined by Timothy Anderson, primary care research fellow, and Michael Steinman, professor of medicine, both from UCSF.

Read the open access research:
<p>https://www.bmj.com/content/362/bmj.k3503</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/t3wk1i/stream_499929198-bmjgroup-how-often-do-hospital-doctors-change-long-term-medication-during-an-inpatient-stay.mp3" length="39092160" type="audio/mpeg"/>
        <itunes:summary><![CDATA[More than ½ of patients leave hospital with changes to four or more of their long-term medications - but how appropriate are those changes? 

New research published on bmj.com looks at antihypertensive medication prescription changes to try and model that - and found that more than half of intensifications occurred in patients with previously well controlled outpatient blood pressure.

To discuss what they found, we're joined by Timothy Anderson, primary care research fellow, and Michael Steinman, professor of medicine, both from UCSF.

Read the open access research:
https://www.bmj.com/content/362/bmj.k3503]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1630</itunes:duration>
                                    </item>
    <item>
        <title>Nutritional science - Is quality more important than quantity?</title>
        <itunes:title>Nutritional science - Is quality more important than quantity?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/nutritional-science-is-quality-more-important-than-quantity/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/nutritional-science-is-quality-more-important-than-quantity/#comments</comments>        <pubDate>Fri, 07 Sep 2018 17:39:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/nutritional-science-is-quality-more-important-than-quantity</guid>
                                    <description><![CDATA[We at The BMJ care about food, and if our listener stats are to be believed, so do you.

In this podcast we’re looking at quality as an important driver of a good diet. At our recent food conference - Food For Thought - hosted in Zurich by Swiss Re we brought researchers in many fields of nutritional science together. We asked people with competing ideas to write articles to elucidate where there’s agreement, and where there is still contention. 
There was lots of disagreement - but one thing that was widely agreed on was that, quality of food matters. Quality is as, if not more, important than quantity.

In this podcast we’ll be exploring what quality is, how industrial food production affects it, and how we conceptualise quality. Joining us are Martin White, Mathilde Touvier, Jean Adams, Nicola Guess and Alan Levinovitz.

For the last podcast in the food series:
https://soundcloud.com/bmjpodcasts/nutritional-science-why-studying-what-we-eat-is-so-difficult?

For more on the Food for Thought series
<p>https://www.bmj.com/food-for-thought</p>
]]></description>
                                                            <content:encoded><![CDATA[We at The BMJ care about food, and if our listener stats are to be believed, so do you.

In this podcast we’re looking at quality as an important driver of a good diet. At our recent food conference - Food For Thought - hosted in Zurich by Swiss Re we brought researchers in many fields of nutritional science together. We asked people with competing ideas to write articles to elucidate where there’s agreement, and where there is still contention. 
There was lots of disagreement - but one thing that was widely agreed on was that, quality of food matters. Quality is as, if not more, important than quantity.

In this podcast we’ll be exploring what quality is, how industrial food production affects it, and how we conceptualise quality. Joining us are Martin White, Mathilde Touvier, Jean Adams, Nicola Guess and Alan Levinovitz.

For the last podcast in the food series:
https://soundcloud.com/bmjpodcasts/nutritional-science-why-studying-what-we-eat-is-so-difficult?

For more on the Food for Thought series
<p>https://www.bmj.com/food-for-thought</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/uidpgw/stream_496682928-bmjgroup-nutritional-science-is-quality-more-important-than-quantity.mp3" length="51219235" type="audio/mpeg"/>
        <itunes:summary><![CDATA[We at The BMJ care about food, and if our listener stats are to be believed, so do you.

In this podcast we’re looking at quality as an important driver of a good diet. At our recent food conference - Food For Thought - hosted in Zurich by Swiss Re we brought researchers in many fields of nutritional science together. We asked people with competing ideas to write articles to elucidate where there’s agreement, and where there is still contention. 
There was lots of disagreement - but one thing that was widely agreed on was that, quality of food matters. Quality is as, if not more, important than quantity.

In this podcast we’ll be exploring what quality is, how industrial food production affects it, and how we conceptualise quality. Joining us are Martin White, Mathilde Touvier, Jean Adams, Nicola Guess and Alan Levinovitz.

For the last podcast in the food series:
https://soundcloud.com/bmjpodcasts/nutritional-science-why-studying-what-we-eat-is-so-difficult?

For more on the Food for Thought series
https://www.bmj.com/food-for-thought]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2134</itunes:duration>
                                    </item>
    <item>
        <title>Preventing Overdiagnosis 2018 - part 2: What opened your eyes to overdiagnosis?</title>
        <itunes:title>Preventing Overdiagnosis 2018 - part 2: What opened your eyes to overdiagnosis?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/preventing-overdiagnosis-2018-part-2-what-opened-your-eyes-to-overdiagnosis/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/preventing-overdiagnosis-2018-part-2-what-opened-your-eyes-to-overdiagnosis/#comments</comments>        <pubDate>Fri, 31 Aug 2018 18:27:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/what-opened-your-eyes-to-overdiagnosis</guid>
                                    <description><![CDATA[The concept of overdiagnosis is pretty hard to get - especially if you’ve been educated in a paradigm where medicine has the answers, and it’s only every a positive intervention in someone’s life - the journey to understanding the flip side - that sometimes medicine can harm often takes what Stacey Carter director of Research for Social Change at Wollongong university described in an preventing overdiagnosis podcast last year as a “moral shock” - https://soundcloud.com/bmjpodcasts/preventing-overdiagnosis-2017-stacy-carter-on-the-culture-of-overmedicalisation

This year, we asked some of the leaders in the field to describe what it was that opened their eyes to overdiagnosis and overtreatment - and recorded the session for you.

You’ll hear from Fiona Godlee, editor in Chief of The BMJ, Steve Woloshin and Lisa Schwartz, directors of the Center for Medicine and Media at The Dartmouth Institute, John Brodersen - professor of general practice at the University of Copenhagen, and Barry Kramer - director of the Division of Cancer Prevention at the U.S. National cancer institute.

<p>The</p>
]]></description>
                                                            <content:encoded><![CDATA[The concept of overdiagnosis is pretty hard to get - especially if you’ve been educated in a paradigm where medicine has the answers, and it’s only every a positive intervention in someone’s life - the journey to understanding the flip side - that sometimes medicine can harm often takes what Stacey Carter director of Research for Social Change at Wollongong university described in an preventing overdiagnosis podcast last year as a “moral shock” - https://soundcloud.com/bmjpodcasts/preventing-overdiagnosis-2017-stacy-carter-on-the-culture-of-overmedicalisation

This year, we asked some of the leaders in the field to describe what it was that opened their eyes to overdiagnosis and overtreatment - and recorded the session for you.

You’ll hear from Fiona Godlee, editor in Chief of The BMJ, Steve Woloshin and Lisa Schwartz, directors of the Center for Medicine and Media at The Dartmouth Institute, John Brodersen - professor of general practice at the University of Copenhagen, and Barry Kramer - director of the Division of Cancer Prevention at the U.S. National cancer institute.

<p>The</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/t68q7y/stream_493404564-bmjgroup-what-opened-your-eyes-to-overdiagnosis.mp3" length="48936751" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The concept of overdiagnosis is pretty hard to get - especially if you’ve been educated in a paradigm where medicine has the answers, and it’s only every a positive intervention in someone’s life - the journey to understanding the flip side - that sometimes medicine can harm often takes what Stacey Carter director of Research for Social Change at Wollongong university described in an preventing overdiagnosis podcast last year as a “moral shock” - https://soundcloud.com/bmjpodcasts/preventing-overdiagnosis-2017-stacy-carter-on-the-culture-of-overmedicalisation

This year, we asked some of the leaders in the field to describe what it was that opened their eyes to overdiagnosis and overtreatment - and recorded the session for you.

You’ll hear from Fiona Godlee, editor in Chief of The BMJ, Steve Woloshin and Lisa Schwartz, directors of the Center for Medicine and Media at The Dartmouth Institute, John Brodersen - professor of general practice at the University of Copenhagen, and Barry Kramer - director of the Division of Cancer Prevention at the U.S. National cancer institute.

The]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2041</itunes:duration>
                                    </item>
    <item>
        <title>Preventing overdiagnosis 2018 - Part 1</title>
        <itunes:title>Preventing overdiagnosis 2018 - Part 1</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/preventing-overdiagnosis-2018-part-1/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/preventing-overdiagnosis-2018-part-1/#comments</comments>        <pubDate>Fri, 24 Aug 2018 15:02:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/preventing-overdiagnosis-2018-part-1</guid>
                                    <description><![CDATA[This week saw the latest Preventing Overdiagnosis conference - this time in Copenhagen.

The conference is a is a forum where researchers and practitioners can present examples of overdiagnosis - and we heard about the various ways which disease definitions are being subtly widened, and diagnostic thresholds lowered.

In this podcast we talk to Allen Frances, psychiatrist and former chair of the Diagnostic and Statistical Manual of Mental Disorders. We also hear from friends of the podcast, Steve Woloshin and Lisa Schwartz about the way in which some disease awareness campaigns fuel inappropriate diagnosis.

https://www.preventingoverdiagnosis.net/
<p>https://www.bmj.com/too-much-medicine</p>
]]></description>
                                                            <content:encoded><![CDATA[This week saw the latest Preventing Overdiagnosis conference - this time in Copenhagen.

The conference is a is a forum where researchers and practitioners can present examples of overdiagnosis - and we heard about the various ways which disease definitions are being subtly widened, and diagnostic thresholds lowered.

In this podcast we talk to Allen Frances, psychiatrist and former chair of the Diagnostic and Statistical Manual of Mental Disorders. We also hear from friends of the podcast, Steve Woloshin and Lisa Schwartz about the way in which some disease awareness campaigns fuel inappropriate diagnosis.

https://www.preventingoverdiagnosis.net/
<p>https://www.bmj.com/too-much-medicine</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ts94ks/stream_490039446-bmjgroup-preventing-overdiagnosis-2018-part-1.mp3" length="44323415" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week saw the latest Preventing Overdiagnosis conference - this time in Copenhagen.

The conference is a is a forum where researchers and practitioners can present examples of overdiagnosis - and we heard about the various ways which disease definitions are being subtly widened, and diagnostic thresholds lowered.

In this podcast we talk to Allen Frances, psychiatrist and former chair of the Diagnostic and Statistical Manual of Mental Disorders. We also hear from friends of the podcast, Steve Woloshin and Lisa Schwartz about the way in which some disease awareness campaigns fuel inappropriate diagnosis.

https://www.preventingoverdiagnosis.net/
https://www.bmj.com/too-much-medicine]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1849</itunes:duration>
                                    </item>
    <item>
        <title>Have we misunderstood TB’s timeline?</title>
        <itunes:title>Have we misunderstood TB’s timeline?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/have-we-misunderstood-tb-s-timeline/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/have-we-misunderstood-tb-s-timeline/#comments</comments>        <pubDate>Thu, 23 Aug 2018 09:46:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/have-we-misunderstood-tbs-timeline</guid>
                                    <description><![CDATA[The number of people estimated to be latently infected with TB - that is infected with TB, which has not yet manifested symptoms -  is around 2 billion. That is 1 in 3 people on the planet are infected by the bacteria. The World Health Organization’s website notes that on average 5-10% of those infected with TB will develop active TB.

That number is terrifying, but a new analysis published in the BMJ, suggests that the assumption that latent TB often has a very long incubation period of many years may be wrong - and that may change how we calculate the number of people affected, and our whole approach to tackling the disease.

This podcast features Lalita Ramakrishnan, professor of immunology and infectious diseases at Cambridge University, Paul Edelstein, professor of pathology and laboratory medicine at the University of Pennsylvania, and Marcel Behr, professor of medicine at McGill university.

<p>Together they discuss the analysis article "Revisiting the timetable of tuberculosis" - https://www.bmj.com/content/362/bmj.k2738</p>
]]></description>
                                                            <content:encoded><![CDATA[The number of people estimated to be latently infected with TB - that is infected with TB, which has not yet manifested symptoms -  is around 2 billion. That is 1 in 3 people on the planet are infected by the bacteria. The World Health Organization’s website notes that on average 5-10% of those infected with TB will develop active TB.

That number is terrifying, but a new analysis published in the BMJ, suggests that the assumption that latent TB often has a very long incubation period of many years may be wrong - and that may change how we calculate the number of people affected, and our whole approach to tackling the disease.

This podcast features Lalita Ramakrishnan, professor of immunology and infectious diseases at Cambridge University, Paul Edelstein, professor of pathology and laboratory medicine at the University of Pennsylvania, and Marcel Behr, professor of medicine at McGill university.

<p>Together they discuss the analysis article "Revisiting the timetable of tuberculosis" - https://www.bmj.com/content/362/bmj.k2738</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/uhnf4a/stream_489446547-bmjgroup-have-we-misunderstood-tbs-timeline.mp3" length="45507719" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The number of people estimated to be latently infected with TB - that is infected with TB, which has not yet manifested symptoms -  is around 2 billion. That is 1 in 3 people on the planet are infected by the bacteria. The World Health Organization’s website notes that on average 5-10% of those infected with TB will develop active TB.

That number is terrifying, but a new analysis published in the BMJ, suggests that the assumption that latent TB often has a very long incubation period of many years may be wrong - and that may change how we calculate the number of people affected, and our whole approach to tackling the disease.

This podcast features Lalita Ramakrishnan, professor of immunology and infectious diseases at Cambridge University, Paul Edelstein, professor of pathology and laboratory medicine at the University of Pennsylvania, and Marcel Behr, professor of medicine at McGill university.

Together they discuss the analysis article "Revisiting the timetable of tuberculosis" - https://www.bmj.com/content/362/bmj.k2738]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1898</itunes:duration>
                                    </item>
    <item>
        <title>13 Iain Chalmers</title>
        <itunes:title>13 Iain Chalmers</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/13-iain-chalmers/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/13-iain-chalmers/#comments</comments>        <pubDate>Wed, 22 Aug 2018 07:50:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/therecodo/13-iain-chalmers</guid>
                                    <description><![CDATA[This week, a very special conversation with a maverick British medico who set up a tiny research centre in Oxford and watched it grow into a global collaboration of over 40,000 people across 130 countries. Three decades on, the Cochrane Collaboration now produces the world's most trusted health evidence that's used by patients, health professionals, researchers and policy makers around the world every day.

<p>Cochrane co-founder Iain Chalmers joins Ray to look back on the origins of the organisation and the extraordinary life of its namesake, Archie Cochrane. Iain also reflects on his work beyond the collaboration - from working in refugee camps in Gaza to teaching children in Uganda how to detect ‘bullshit’ health claims and more recently, establishing the James Lind Alliance. It's no surprise he's received the BMJ’s most prestigious award for a lifetime of achievement in healthcare, along with a knighthood from the Queen.</p>
]]></description>
                                                            <content:encoded><![CDATA[This week, a very special conversation with a maverick British medico who set up a tiny research centre in Oxford and watched it grow into a global collaboration of over 40,000 people across 130 countries. Three decades on, the Cochrane Collaboration now produces the world's most trusted health evidence that's used by patients, health professionals, researchers and policy makers around the world every day.

<p>Cochrane co-founder Iain Chalmers joins Ray to look back on the origins of the organisation and the extraordinary life of its namesake, Archie Cochrane. Iain also reflects on his work beyond the collaboration - from working in refugee camps in Gaza to teaching children in Uganda how to detect ‘bullshit’ health claims and more recently, establishing the James Lind Alliance. It's no surprise he's received the BMJ’s most prestigious award for a lifetime of achievement in healthcare, along with a knighthood from the Queen.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/nr1fjv/stream_488951907-bmjgroup-13-iain-chalmers.mp3" length="30093060" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week, a very special conversation with a maverick British medico who set up a tiny research centre in Oxford and watched it grow into a global collaboration of over 40,000 people across 130 countries. Three decades on, the Cochrane Collaboration now produces the world's most trusted health evidence that's used by patients, health professionals, researchers and policy makers around the world every day.

Cochrane co-founder Iain Chalmers joins Ray to look back on the origins of the organisation and the extraordinary life of its namesake, Archie Cochrane. Iain also reflects on his work beyond the collaboration - from working in refugee camps in Gaza to teaching children in Uganda how to detect ‘bullshit’ health claims and more recently, establishing the James Lind Alliance. It's no surprise he's received the BMJ’s most prestigious award for a lifetime of achievement in healthcare, along with a knighthood from the Queen.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1881</itunes:duration>
                                    </item>
    <item>
        <title>The diagnosis and treatment of dyspareunia</title>
        <itunes:title>The diagnosis and treatment of dyspareunia</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-diagnosis-and-treatment-of-dyspareunia/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-diagnosis-and-treatment-of-dyspareunia/#comments</comments>        <pubDate>Mon, 13 Aug 2018 17:16:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/dysparenuia-mixdown</guid>
                                    <description><![CDATA[Dyspareunia is a common but poorly understood problem affecting around 7.5% of sexually active women. It is an important and neglected area of female health, associated with substantial morbidity and distress.

Women may be seen by several clinicians before a diagnosis is reached, There are also specialist psychosexual clinics, where men and women can be referred for sexual problems. Little has been written on the holistic approach to care for women with dyspareunia, therefore, some of the advice here is based on expert experience.

Joining us to talk about care are Leila Frodsham, consultant gynaecologist and lead for psychosexual medicine, and Nikki Lee, speciality trainee in obstetrics & gynaecology, both at King’s College London. We’re also joined by Poppy, who experienced dyspareunia and has undergone treatment.

Read the full education article: 
<p>https://www.bmj.com/content/361/bmj.k2341</p>
]]></description>
                                                            <content:encoded><![CDATA[Dyspareunia is a common but poorly understood problem affecting around 7.5% of sexually active women. It is an important and neglected area of female health, associated with substantial morbidity and distress.

Women may be seen by several clinicians before a diagnosis is reached, There are also specialist psychosexual clinics, where men and women can be referred for sexual problems. Little has been written on the holistic approach to care for women with dyspareunia, therefore, some of the advice here is based on expert experience.

Joining us to talk about care are Leila Frodsham, consultant gynaecologist and lead for psychosexual medicine, and Nikki Lee, speciality trainee in obstetrics & gynaecology, both at King’s College London. We’re also joined by Poppy, who experienced dyspareunia and has undergone treatment.

Read the full education article: 
<p>https://www.bmj.com/content/361/bmj.k2341</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/isvfsa/stream_485022924-bmjgroup-dysparenuia-mixdown.mp3" length="49469910" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Dyspareunia is a common but poorly understood problem affecting around 7.5% of sexually active women. It is an important and neglected area of female health, associated with substantial morbidity and distress.

Women may be seen by several clinicians before a diagnosis is reached, There are also specialist psychosexual clinics, where men and women can be referred for sexual problems. Little has been written on the holistic approach to care for women with dyspareunia, therefore, some of the advice here is based on expert experience.

Joining us to talk about care are Leila Frodsham, consultant gynaecologist and lead for psychosexual medicine, and Nikki Lee, speciality trainee in obstetrics & gynaecology, both at King’s College London. We’re also joined by Poppy, who experienced dyspareunia and has undergone treatment.

Read the full education article: 
https://www.bmj.com/content/361/bmj.k2341]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2063</itunes:duration>
                                    </item>
    <item>
        <title>Patient information is key to the therapeutic relationship</title>
        <itunes:title>Patient information is key to the therapeutic relationship</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/patient-information-is-key-to-the-therapeutic-relationship/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/patient-information-is-key-to-the-therapeutic-relationship/#comments</comments>        <pubDate>Fri, 10 Aug 2018 11:13:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/patient-information-is-key-to-the-therapeutic-relationship</guid>
                                    <description><![CDATA[Sue Farrington is chair of the Patient Information Forum, a member organisation which promotes best practice in anyone who produces information for patients.

In this podcast, she discusses what makes good patient information, why doctors should be pleased when patients arrive at an appointment with a long list of questions, and why patients are savvy about believing "doctor google".


<p>https://www.pifonline.org.uk/</p>
]]></description>
                                                            <content:encoded><![CDATA[Sue Farrington is chair of the Patient Information Forum, a member organisation which promotes best practice in anyone who produces information for patients.

In this podcast, she discusses what makes good patient information, why doctors should be pleased when patients arrive at an appointment with a long list of questions, and why patients are savvy about believing "doctor google".


<p>https://www.pifonline.org.uk/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/uw9l2k/stream_483668322-bmjgroup-patient-information-is-key-to-the-therapeutic-relationship.mp3" length="37132545" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Sue Farrington is chair of the Patient Information Forum, a member organisation which promotes best practice in anyone who produces information for patients.

In this podcast, she discusses what makes good patient information, why doctors should be pleased when patients arrive at an appointment with a long list of questions, and why patients are savvy about believing "doctor google".


https://www.pifonline.org.uk/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1549</itunes:duration>
                                    </item>
    <item>
        <title>15 seconds to improve your workplace</title>
        <itunes:title>15 seconds to improve your workplace</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/15-seconds-to-improve-your-workplace/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/15-seconds-to-improve-your-workplace/#comments</comments>        <pubDate>Fri, 27 Jul 2018 16:23:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/15-seconds-to-improve-your-workplace</guid>
                                    <description><![CDATA[15s30m is a social movement to reduce frustration & increase joy - the idea is to spend 15 seconds of your time now, and save someone else 30 minutes down the line.

To talk about their movement we're joined by the founders, Rachel Pilling, consultant ophthalmologist, and Dan Wadsworth, transformation manager - both from Bradford Teaching Hospitals NHS Trust. 

They explain why this is quality improvement, but doesn't require a lot of theory or permission to put in place, and why empowering staff to make small changes increases joy and reduces frustration.

Follow them on twitter - https://twitter.com/15s30m
<p>See some of their missions on youtube - https://www.youtube.com/channel/UCg6ECK8oq_-pYMTgAR6pt7w</p>
]]></description>
                                                            <content:encoded><![CDATA[15s30m is a social movement to reduce frustration & increase joy - the idea is to spend 15 seconds of your time now, and save someone else 30 minutes down the line.

To talk about their movement we're joined by the founders, Rachel Pilling, consultant ophthalmologist, and Dan Wadsworth, transformation manager - both from Bradford Teaching Hospitals NHS Trust. 

They explain why this is quality improvement, but doesn't require a lot of theory or permission to put in place, and why empowering staff to make small changes increases joy and reduces frustration.

Follow them on twitter - https://twitter.com/15s30m
<p>See some of their missions on youtube - https://www.youtube.com/channel/UCg6ECK8oq_-pYMTgAR6pt7w</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/irbiqk/stream_477523338-bmjgroup-15-seconds-to-improve-your-workplace.mp3" length="34371982" type="audio/mpeg"/>
        <itunes:summary><![CDATA[15s30m is a social movement to reduce frustration & increase joy - the idea is to spend 15 seconds of your time now, and save someone else 30 minutes down the line.

To talk about their movement we're joined by the founders, Rachel Pilling, consultant ophthalmologist, and Dan Wadsworth, transformation manager - both from Bradford Teaching Hospitals NHS Trust. 

They explain why this is quality improvement, but doesn't require a lot of theory or permission to put in place, and why empowering staff to make small changes increases joy and reduces frustration.

Follow them on twitter - https://twitter.com/15s30m
See some of their missions on youtube - https://www.youtube.com/channel/UCg6ECK8oq_-pYMTgAR6pt7w]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1433</itunes:duration>
                                    </item>
    <item>
        <title>Mendelian Randomisation  - for the moderately intelligent</title>
        <itunes:title>Mendelian Randomisation  - for the moderately intelligent</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/mendelian-randomisation-for-the-moderately-intelligent/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/mendelian-randomisation-for-the-moderately-intelligent/#comments</comments>        <pubDate>Mon, 16 Jul 2018 18:47:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/mendelian-randomisation-for-the-moderately-intelligent</guid>
                                    <description><![CDATA[Mendelian randomisation - it’s a technique that uses the chance distribution of genes in a population, combined with big data sets, to investigate causative relationships.

But there are a lot of questions we have in The BMJ about how the technique works - the association between genes and apparently non-biologically mediated behaviours, how much the strict rule of not claiming causation based on observational data has actually been overturned, and general confusion about how the non-methodologists amongst us can read these studies.

Neil Davies and George Davey Smith from University of Bristol, and Michael Holmes from the University of Oxford, join us to explain how the technique works, where it can be applied, and what readers should look out for when they're trying to assess the quality of a mendelian randomisation study.

Read their full research methods and reporting paper:
<p>https://www.bmj.com/content/362/bmj.k601</p>
]]></description>
                                                            <content:encoded><![CDATA[Mendelian randomisation - it’s a technique that uses the chance distribution of genes in a population, combined with big data sets, to investigate causative relationships.

But there are a lot of questions we have in The BMJ about how the technique works - the association between genes and apparently non-biologically mediated behaviours, how much the strict rule of not claiming causation based on observational data has actually been overturned, and general confusion about how the non-methodologists amongst us can read these studies.

Neil Davies and George Davey Smith from University of Bristol, and Michael Holmes from the University of Oxford, join us to explain how the technique works, where it can be applied, and what readers should look out for when they're trying to assess the quality of a mendelian randomisation study.

Read their full research methods and reporting paper:
<p>https://www.bmj.com/content/362/bmj.k601</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/tnc1c6/stream_472484736-bmjgroup-mendelian-randomisation-for-the-moderately-intelligent.mp3" length="48378185" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Mendelian randomisation - it’s a technique that uses the chance distribution of genes in a population, combined with big data sets, to investigate causative relationships.

But there are a lot of questions we have in The BMJ about how the technique works - the association between genes and apparently non-biologically mediated behaviours, how much the strict rule of not claiming causation based on observational data has actually been overturned, and general confusion about how the non-methodologists amongst us can read these studies.

Neil Davies and George Davey Smith from University of Bristol, and Michael Holmes from the University of Oxford, join us to explain how the technique works, where it can be applied, and what readers should look out for when they're trying to assess the quality of a mendelian randomisation study.

Read their full research methods and reporting paper:
https://www.bmj.com/content/362/bmj.k601]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2017</itunes:duration>
                                    </item>
    <item>
        <title>What does the public think of the NHS?</title>
        <itunes:title>What does the public think of the NHS?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/what-does-the-public-think-of-the-nhs/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/what-does-the-public-think-of-the-nhs/#comments</comments>        <pubDate>Thu, 12 Jul 2018 17:02:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/what-does-the-public-think-of-the-nhs</guid>
                                    <description><![CDATA[It’s been quite a year for the NHS - it just turned 70, had a winter crisis like never before, got over junior doctor strikes, but then was hit by a series of scandals about breast screening, and now opiate prescriptions. 

At the same time, we’ve seen demonstrations in favour of the service and even widespread public backing for more money. So how do all of these things mix into the way in which the British public view the NHS?

In this podcast, Ben Page - chief exec of Ipsos MORI, the polling company, joins us to discuss the fluctuations in public opinion.

Read the provocation:
https://www.bmj.com/content/361/bmj.k2663

More NHS at 70 coverage:
<p>https://www.bmj.com/nhs-at-70</p>
]]></description>
                                                            <content:encoded><![CDATA[It’s been quite a year for the NHS - it just turned 70, had a winter crisis like never before, got over junior doctor strikes, but then was hit by a series of scandals about breast screening, and now opiate prescriptions. 

At the same time, we’ve seen demonstrations in favour of the service and even widespread public backing for more money. So how do all of these things mix into the way in which the British public view the NHS?

In this podcast, Ben Page - chief exec of Ipsos MORI, the polling company, joins us to discuss the fluctuations in public opinion.

Read the provocation:
https://www.bmj.com/content/361/bmj.k2663

More NHS at 70 coverage:
<p>https://www.bmj.com/nhs-at-70</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mhjgq2/stream_470755131-bmjgroup-what-does-the-public-think-of-the-nhs.mp3" length="25628341" type="audio/mpeg"/>
        <itunes:summary><![CDATA[It’s been quite a year for the NHS - it just turned 70, had a winter crisis like never before, got over junior doctor strikes, but then was hit by a series of scandals about breast screening, and now opiate prescriptions. 

At the same time, we’ve seen demonstrations in favour of the service and even widespread public backing for more money. So how do all of these things mix into the way in which the British public view the NHS?

In this podcast, Ben Page - chief exec of Ipsos MORI, the polling company, joins us to discuss the fluctuations in public opinion.

Read the provocation:
https://www.bmj.com/content/361/bmj.k2663

More NHS at 70 coverage:
https://www.bmj.com/nhs-at-70]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1069</itunes:duration>
                                    </item>
    <item>
        <title>10 Rita Redberg</title>
        <itunes:title>10 Rita Redberg</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/10-rita-redberg/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/10-rita-redberg/#comments</comments>        <pubDate>Thu, 12 Jul 2018 05:48:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/therecodo/10-rita-redberg</guid>
                                    <description><![CDATA[This week influential Editor-in-Chief of JAMA Internal Medicine Dr Rita Redberg joins Ray for a wide ranging conversation on all things health. A Professor at the University of California San Francisco and high profile contributor to The Washington Post and New York Times, Rita is also a practising cardiologist who loves to see patients. She says that ‘being a doctor is really a privilege’.

<p>Together, Ray and Rita canvas many topics including shared decision making between doctors and patients, the tricky territory of medical device approvals, the controversy surrounding both statins and CT scans, and the implications of not including enough women in clinical trials.</p>
]]></description>
                                                            <content:encoded><![CDATA[This week influential Editor-in-Chief of JAMA Internal Medicine Dr Rita Redberg joins Ray for a wide ranging conversation on all things health. A Professor at the University of California San Francisco and high profile contributor to The Washington Post and New York Times, Rita is also a practising cardiologist who loves to see patients. She says that ‘being a doctor is really a privilege’.

<p>Together, Ray and Rita canvas many topics including shared decision making between doctors and patients, the tricky territory of medical device approvals, the controversy surrounding both statins and CT scans, and the implications of not including enough women in clinical trials.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/37xnd8/stream_470571516-bmjgroup-10-rita-redberg.mp3" length="31484028" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week influential Editor-in-Chief of JAMA Internal Medicine Dr Rita Redberg joins Ray for a wide ranging conversation on all things health. A Professor at the University of California San Francisco and high profile contributor to The Washington Post and New York Times, Rita is also a practising cardiologist who loves to see patients. She says that ‘being a doctor is really a privilege’.

Together, Ray and Rita canvas many topics including shared decision making between doctors and patients, the tricky territory of medical device approvals, the controversy surrounding both statins and CT scans, and the implications of not including enough women in clinical trials.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1968</itunes:duration>
                                    </item>
    <item>
        <title>Doctors and vets working together for antibiotic stewardship</title>
        <itunes:title>Doctors and vets working together for antibiotic stewardship</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/doctors-and-vets-working-together-for-antibiotic-stewardship/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/doctors-and-vets-working-together-for-antibiotic-stewardship/#comments</comments>        <pubDate>Wed, 11 Jul 2018 15:00:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/doctors-and-vets-working-together-for-antibiotic-stewardship</guid>
                                    <description><![CDATA[Doctors and the farming industry are often blamed for overuse of antibiotics that spurs the growing problem of antimicrobial resistance - but the professions are using different methods to combat resistance and reduce overuse. 

In this roundtable, we bring medics and vets together to discuss the problem - where antibiotic resistance arises, how resistance genes propagate through the environment and between countries, and what non-drug approaches can be used to reduce the need for antibiotics.


Sandy Trees, Vet Record editor in chief, and retired veterinary surgeon
Stuart Reid, principal of the Royal Veterinary College
Jenny Bellini, cattle and dairy vet, Friars Moor Livestock Health in Dorset
Peter Hawkey, professor of clinical and public health bacteriology, University of Birmingham
Tim McHugh, professor of medical microbiology at University College London
<p>Emmanuel Wey, consultant in infection, Royal Free Hospital, London</p>
]]></description>
                                                            <content:encoded><![CDATA[Doctors and the farming industry are often blamed for overuse of antibiotics that spurs the growing problem of antimicrobial resistance - but the professions are using different methods to combat resistance and reduce overuse. 

In this roundtable, we bring medics and vets together to discuss the problem - where antibiotic resistance arises, how resistance genes propagate through the environment and between countries, and what non-drug approaches can be used to reduce the need for antibiotics.


Sandy Trees, Vet Record editor in chief, and retired veterinary surgeon
Stuart Reid, principal of the Royal Veterinary College
Jenny Bellini, cattle and dairy vet, Friars Moor Livestock Health in Dorset
Peter Hawkey, professor of clinical and public health bacteriology, University of Birmingham
Tim McHugh, professor of medical microbiology at University College London
<p>Emmanuel Wey, consultant in infection, Royal Free Hospital, London</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ft3naf/stream_470262765-bmjgroup-doctors-and-vets-working-together-for-antibiotic-stewardship.mp3" length="89939151" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Doctors and the farming industry are often blamed for overuse of antibiotics that spurs the growing problem of antimicrobial resistance - but the professions are using different methods to combat resistance and reduce overuse. 

In this roundtable, we bring medics and vets together to discuss the problem - where antibiotic resistance arises, how resistance genes propagate through the environment and between countries, and what non-drug approaches can be used to reduce the need for antibiotics.


Sandy Trees, Vet Record editor in chief, and retired veterinary surgeon
Stuart Reid, principal of the Royal Veterinary College
Jenny Bellini, cattle and dairy vet, Friars Moor Livestock Health in Dorset
Peter Hawkey, professor of clinical and public health bacteriology, University of Birmingham
Tim McHugh, professor of medical microbiology at University College London
Emmanuel Wey, consultant in infection, Royal Free Hospital, London]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3752</itunes:duration>
                                    </item>
    <item>
        <title>James Munro cares about patients opinions.</title>
        <itunes:title>James Munro cares about patients opinions.</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/james-munro-cares-about-patients-opinions/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/james-munro-cares-about-patients-opinions/#comments</comments>        <pubDate>Thu, 05 Jul 2018 16:00:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/james-munro-cares-about-patients-opinions</guid>
                                    <description><![CDATA[Getting feedback from people who use NHS services is  essential to
assessing their value -  and improving their quality.  Hospitals and general practices widely post information about patient's satisfaction with their services on their websites, but approach tells us little about how feedback changes things on the ground .

In this podcast, James Munro, former doctor and academic and current CEO of Care Opinion, explains how their online platform works, how Trusts are using it as a quality improvement tool, and  how  health systems can  capitalise on the learning potential of this large scale data collection.


<p>This is part of the series of interviews with people who are making partnership between health professional and patients work in the real world. Listen to Katherine Cowen, from the James Lind Alliance, talk about how to broker an agreement about research priorities. https://soundcloud.com/bmjpodcasts/katherine-cowan-reaching-a-priority</p>
]]></description>
                                                            <content:encoded><![CDATA[Getting feedback from people who use NHS services is  essential to
assessing their value -  and improving their quality.  Hospitals and general practices widely post information about patient's satisfaction with their services on their websites, but approach tells us little about how feedback changes things on the ground .

In this podcast, James Munro, former doctor and academic and current CEO of Care Opinion, explains how their online platform works, how Trusts are using it as a quality improvement tool, and  how  health systems can  capitalise on the learning potential of this large scale data collection.


<p>This is part of the series of interviews with people who are making partnership between health professional and patients work in the real world. Listen to Katherine Cowen, from the James Lind Alliance, talk about how to broker an agreement about research priorities. https://soundcloud.com/bmjpodcasts/katherine-cowan-reaching-a-priority</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7e4h0e/stream_467682261-bmjgroup-james-munro-cares-about-patients-opinions.mp3" length="27811247" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Getting feedback from people who use NHS services is  essential to
assessing their value -  and improving their quality.  Hospitals and general practices widely post information about patient's satisfaction with their services on their websites, but approach tells us little about how feedback changes things on the ground .

In this podcast, James Munro, former doctor and academic and current CEO of Care Opinion, explains how their online platform works, how Trusts are using it as a quality improvement tool, and  how  health systems can  capitalise on the learning potential of this large scale data collection.


This is part of the series of interviews with people who are making partnership between health professional and patients work in the real world. Listen to Katherine Cowen, from the James Lind Alliance, talk about how to broker an agreement about research priorities. https://soundcloud.com/bmjpodcasts/katherine-cowan-reaching-a-priority]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1160</itunes:duration>
                                    </item>
    <item>
        <title>Prof. Wendy Burn - the changing focus of psychiatry.</title>
        <itunes:title>Prof. Wendy Burn - the changing focus of psychiatry.</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/prof-wendy-burn-the-changing-focus-of-psychiatry/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/prof-wendy-burn-the-changing-focus-of-psychiatry/#comments</comments>        <pubDate>Fri, 29 Jun 2018 14:21:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/prof-wendy-burn-the-changing-focus-of-psychiatry</guid>
                                    <description><![CDATA[Wendy Burn is a consultant old age psychiatrist, and new president of the Royal College of Psychiatrists. Her work on dementia has given her an affinity for the neurobiological basis of psychiatry - and her tenure at the college is seeing a move to wards this neurobiological model in the teaching of the profession. 

<p>In this interview she talks about her work, how the profession is changing, and why she thinks Kanye can be a model for mental health.</p>
]]></description>
                                                            <content:encoded><![CDATA[Wendy Burn is a consultant old age psychiatrist, and new president of the Royal College of Psychiatrists. Her work on dementia has given her an affinity for the neurobiological basis of psychiatry - and her tenure at the college is seeing a move to wards this neurobiological model in the teaching of the profession. 

<p>In this interview she talks about her work, how the profession is changing, and why she thinks Kanye can be a model for mental health.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mj13on/stream_465112539-bmjgroup-prof-wendy-burn-the-changing-focus-of-psychiatry.mp3" length="39122031" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Wendy Burn is a consultant old age psychiatrist, and new president of the Royal College of Psychiatrists. Her work on dementia has given her an affinity for the neurobiological basis of psychiatry - and her tenure at the college is seeing a move to wards this neurobiological model in the teaching of the profession. 

In this interview she talks about her work, how the profession is changing, and why she thinks Kanye can be a model for mental health.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1632</itunes:duration>
                                    </item>
    <item>
        <title>Your recommended dose of Ray Moynihan</title>
        <itunes:title>Your recommended dose of Ray Moynihan</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/your-recommended-dose-of-ray-moynihan/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/your-recommended-dose-of-ray-moynihan/#comments</comments>        <pubDate>Thu, 28 Jun 2018 14:22:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/your-recommended-dose-of-ray-moynihan</guid>
                                    <description><![CDATA[Ray Moynihan is a senior research assistant at Bond University,  a journalist, champion of rolling back too much medicine, and host of a new series “The Recommended Dose” from Cochrane Australia.

In the series, Ray has talked to some of the people who shape the medical evidence that underpin healthcare around the world - the series aim is to elucidating their worldview, and how their thinking shapes their work.

<p>Over the next couple of months, we’ll be co-publishing the series - so keep an ear out for those interviews in your podcast feed.</p>
]]></description>
                                                            <content:encoded><![CDATA[Ray Moynihan is a senior research assistant at Bond University,  a journalist, champion of rolling back too much medicine, and host of a new series “The Recommended Dose” from Cochrane Australia.

In the series, Ray has talked to some of the people who shape the medical evidence that underpin healthcare around the world - the series aim is to elucidating their worldview, and how their thinking shapes their work.

<p>Over the next couple of months, we’ll be co-publishing the series - so keep an ear out for those interviews in your podcast feed.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dtz15t/stream_464622054-bmjgroup-your-recommended-dose-of-ray-moynihan.mp3" length="23424632" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Ray Moynihan is a senior research assistant at Bond University,  a journalist, champion of rolling back too much medicine, and host of a new series “The Recommended Dose” from Cochrane Australia.

In the series, Ray has talked to some of the people who shape the medical evidence that underpin healthcare around the world - the series aim is to elucidating their worldview, and how their thinking shapes their work.

Over the next couple of months, we’ll be co-publishing the series - so keep an ear out for those interviews in your podcast feed.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>977</itunes:duration>
                                    </item>
    <item>
        <title>Evidence in a humanitarian emergency</title>
        <itunes:title>Evidence in a humanitarian emergency</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/evidence-in-a-humanitarian-emergency/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/evidence-in-a-humanitarian-emergency/#comments</comments>        <pubDate>Mon, 25 Jun 2018 09:52:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/evidence-in-a-humanitarian-emergency</guid>
                                    <description><![CDATA[At evidence live this year, one of the sessions was about the work of Evidence Aid - and their attempt to bring high quality evidence to the frontline of a humanitarian crisis.

<p>In that situation, it’s very difficult to know what will work - a conflict, or even immediately post-conflict situation is characterised by chaos - and merely doing something is vital. But though each situation is unique, sharing what’s worked elsewhere can be key to maximising the help given to vulnerable people.</p>
]]></description>
                                                            <content:encoded><![CDATA[At evidence live this year, one of the sessions was about the work of Evidence Aid - and their attempt to bring high quality evidence to the frontline of a humanitarian crisis.

<p>In that situation, it’s very difficult to know what will work - a conflict, or even immediately post-conflict situation is characterised by chaos - and merely doing something is vital. But though each situation is unique, sharing what’s worked elsewhere can be key to maximising the help given to vulnerable people.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/d69429/stream_463131315-bmjgroup-evidence-in-a-humanitarian-emergency.mp3" length="41706867" type="audio/mpeg"/>
        <itunes:summary><![CDATA[At evidence live this year, one of the sessions was about the work of Evidence Aid - and their attempt to bring high quality evidence to the frontline of a humanitarian crisis.

In that situation, it’s very difficult to know what will work - a conflict, or even immediately post-conflict situation is characterised by chaos - and merely doing something is vital. But though each situation is unique, sharing what’s worked elsewhere can be key to maximising the help given to vulnerable people.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1740</itunes:duration>
                                    </item>
    <item>
        <title>When an investigative journalist calls</title>
        <itunes:title>When an investigative journalist calls</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/when-an-investigative-journalist-calls/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/when-an-investigative-journalist-calls/#comments</comments>        <pubDate>Fri, 22 Jun 2018 17:11:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/when-an-investigative-journalist-calls</guid>
                                    <description><![CDATA[At Evidence Live this year, the focus of the conference was on communication of evidence - both academically, and to the public. And part of that is the role that investigative journalism has to play in that. 

At the BMJ we’ve used investigative journalistic techniques to try and expose  wrong doing on the part of government and industry - always in collaboration with clinicians and researchers.

<p>To explain a bit more about the world of journalism and campaigning, we're joined by to Shelley Jofre - from the BBC, Jet Schouten - from Radar, Kath Sansom - who started the online sling the mesh campaign & Deb Cohen, former investigations editor at The BMJ.</p>
]]></description>
                                                            <content:encoded><![CDATA[At Evidence Live this year, the focus of the conference was on communication of evidence - both academically, and to the public. And part of that is the role that investigative journalism has to play in that. 

At the BMJ we’ve used investigative journalistic techniques to try and expose  wrong doing on the part of government and industry - always in collaboration with clinicians and researchers.

<p>To explain a bit more about the world of journalism and campaigning, we're joined by to Shelley Jofre - from the BBC, Jet Schouten - from Radar, Kath Sansom - who started the online sling the mesh campaign & Deb Cohen, former investigations editor at The BMJ.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/q5fcaf/stream_461968788-bmjgroup-when-an-investigative-journalist-calls.mp3" length="46608972" type="audio/mpeg"/>
        <itunes:summary><![CDATA[At Evidence Live this year, the focus of the conference was on communication of evidence - both academically, and to the public. And part of that is the role that investigative journalism has to play in that. 

At the BMJ we’ve used investigative journalistic techniques to try and expose  wrong doing on the part of government and industry - always in collaboration with clinicians and researchers.

To explain a bit more about the world of journalism and campaigning, we're joined by to Shelley Jofre - from the BBC, Jet Schouten - from Radar, Kath Sansom - who started the online sling the mesh campaign & Deb Cohen, former investigations editor at The BMJ.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1944</itunes:duration>
                                    </item>
    <item>
        <title>Don Berwick - you can break the rules to help patients</title>
        <itunes:title>Don Berwick - you can break the rules to help patients</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/don-berwick-you-can-break-the-rules-to-help-patients/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/don-berwick-you-can-break-the-rules-to-help-patients/#comments</comments>        <pubDate>Fri, 15 Jun 2018 12:52:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/don-berwick</guid>
                                    <description><![CDATA[Don Berwick, president emeritus of the Institute of Healthcare Improvement, and former Administrator of the Centers for Medicare and Medicaid Services.

In this conversation he discusses how he went from being a paediatrician to running Medicare for Obama, how we can create headroom in stressed systems, and breaking the rules to make things better for patients and staff.

<p>Quality improvement series:</p>
]]></description>
                                                            <content:encoded><![CDATA[Don Berwick, president emeritus of the Institute of Healthcare Improvement, and former Administrator of the Centers for Medicare and Medicaid Services.

In this conversation he discusses how he went from being a paediatrician to running Medicare for Obama, how we can create headroom in stressed systems, and breaking the rules to make things better for patients and staff.

<p>Quality improvement series:</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/y21pv9/stream_458760771-bmjgroup-don-berwick.mp3" length="38735297" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Don Berwick, president emeritus of the Institute of Healthcare Improvement, and former Administrator of the Centers for Medicare and Medicaid Services.

In this conversation he discusses how he went from being a paediatrician to running Medicare for Obama, how we can create headroom in stressed systems, and breaking the rules to make things better for patients and staff.

Quality improvement series:]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1616</itunes:duration>
                                    </item>
    <item>
        <title>Darknet Opioids</title>
        <itunes:title>Darknet Opioids</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/darknet-opioids/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/darknet-opioids/#comments</comments>        <pubDate>Fri, 15 Jun 2018 09:07:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/darknet-opioids</guid>
                                    <description><![CDATA[When tackling societal problems - like the opioid epidemic in the US - there are two ways of approaching it. One is to reduce demand - by organising treatment programmes, or reducing the underlying reasons why people may become addicted in the first place - but that’s hard. So governments often turn to the other route - reducing supply - and that’s what the US government did in 2014 when it rescheduled oxycodone combination products from schedule 3 to schedual 2 - essentially making it harder for people to obtain a prescription. 


Now reducing that legal supply, without in hand reducing the demand, led to fears that those people with an opioid addiction would just turn to illicit routes to obtain their drugs  -  and new research published on bmj.com has attempted to find out if that happened.

We're joined by 3 of the authors, James Martin, associate professor of criminology at Swinburne University; Judith Aldridge, professor of criminology at the University of Manchester; and Jack Cunliffe, lecturer in quantitative methods and criminology at the University of Kent.

Read the full research:
<p>https://www.bmj.com/content/361/bmj.k2480</p>
]]></description>
                                                            <content:encoded><![CDATA[When tackling societal problems - like the opioid epidemic in the US - there are two ways of approaching it. One is to reduce demand - by organising treatment programmes, or reducing the underlying reasons why people may become addicted in the first place - but that’s hard. So governments often turn to the other route - reducing supply - and that’s what the US government did in 2014 when it rescheduled oxycodone combination products from schedule 3 to schedual 2 - essentially making it harder for people to obtain a prescription. 


Now reducing that legal supply, without in hand reducing the demand, led to fears that those people with an opioid addiction would just turn to illicit routes to obtain their drugs  -  and new research published on bmj.com has attempted to find out if that happened.

We're joined by 3 of the authors, James Martin, associate professor of criminology at Swinburne University; Judith Aldridge, professor of criminology at the University of Manchester; and Jack Cunliffe, lecturer in quantitative methods and criminology at the University of Kent.

Read the full research:
<p>https://www.bmj.com/content/361/bmj.k2480</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vbf7sx/stream_458700669-bmjgroup-darknet-opioids.mp3" length="41638946" type="audio/mpeg"/>
        <itunes:summary><![CDATA[When tackling societal problems - like the opioid epidemic in the US - there are two ways of approaching it. One is to reduce demand - by organising treatment programmes, or reducing the underlying reasons why people may become addicted in the first place - but that’s hard. So governments often turn to the other route - reducing supply - and that’s what the US government did in 2014 when it rescheduled oxycodone combination products from schedule 3 to schedual 2 - essentially making it harder for people to obtain a prescription. 


Now reducing that legal supply, without in hand reducing the demand, led to fears that those people with an opioid addiction would just turn to illicit routes to obtain their drugs  -  and new research published on bmj.com has attempted to find out if that happened.

We're joined by 3 of the authors, James Martin, associate professor of criminology at Swinburne University; Judith Aldridge, professor of criminology at the University of Manchester; and Jack Cunliffe, lecturer in quantitative methods and criminology at the University of Kent.

Read the full research:
https://www.bmj.com/content/361/bmj.k2480]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1737</itunes:duration>
                                    </item>
    <item>
        <title>09 John Ioannidis</title>
        <itunes:title>09 John Ioannidis</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/09-john-ioannidis/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/09-john-ioannidis/#comments</comments>        <pubDate>Fri, 15 Jun 2018 02:09:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/therecodo/09-john-ioannidis</guid>
                                    <description><![CDATA[Series two of The Recommended Dose kicks off with polymath and poet, Dr John Ioannidis. Recognised by The Atlantic as one the most influential scientists alive today, he’s a global authority on genetics, medical research and the nature of scientific inquiry itself – among many other things.

A professor at Stanford University, John has authored close to 1,000 academic papers and served on the editorial boards of 30 of the world's top journals. He is best known for seriously challenging the status quo. His trailblazing 2005 paper 'Why Most Published Research Findings Are False' has been viewed over 2.5 million times and is the most cited article in the history of PLoS Medicine. In it, he argues that most medical research is biased, overblown or simply wrong. Here, he talks to Ray about the far-reaching implications of these findings for people both inside and outside the world of health.

While most closely associated with exploring cutting-edge conundrums across science, genomics and even economics, John is also something of a humanist. He’d be right at home with the philosophers of ancient Greece, seeking as he does to find answers to the big questions of the day in science and medicine, as well as in nature and narratives. 

A voracious reader himself, John has a lifelong love of ‘swimming in books’ and has penned seven literary works of his own in Greek – two of which have been nominated for prestigious literary prizes. And fittingly, he finds inspiration for his myriad of multi-disciplinary pursuits on Antipaxi, one of Greece’s most beautiful and secluded islands. 

He shares some of his distinctive logic, reason - and even a little of his poetry - on this very special episode of The Recommended Dose, produced by Cochrane Australia and co-published with the BMJ.

<p>You'll find our show notes and a full transcript of the show at http://australia.cochrane.org/trd</p>
]]></description>
                                                            <content:encoded><![CDATA[Series two of The Recommended Dose kicks off with polymath and poet, Dr John Ioannidis. Recognised by The Atlantic as one the most influential scientists alive today, he’s a global authority on genetics, medical research and the nature of scientific inquiry itself – among many other things.

A professor at Stanford University, John has authored close to 1,000 academic papers and served on the editorial boards of 30 of the world's top journals. He is best known for seriously challenging the status quo. His trailblazing 2005 paper 'Why Most Published Research Findings Are False' has been viewed over 2.5 million times and is the most cited article in the history of PLoS Medicine. In it, he argues that most medical research is biased, overblown or simply wrong. Here, he talks to Ray about the far-reaching implications of these findings for people both inside and outside the world of health.

While most closely associated with exploring cutting-edge conundrums across science, genomics and even economics, John is also something of a humanist. He’d be right at home with the philosophers of ancient Greece, seeking as he does to find answers to the big questions of the day in science and medicine, as well as in nature and narratives. 

A voracious reader himself, John has a lifelong love of ‘swimming in books’ and has penned seven literary works of his own in Greek – two of which have been nominated for prestigious literary prizes. And fittingly, he finds inspiration for his myriad of multi-disciplinary pursuits on Antipaxi, one of Greece’s most beautiful and secluded islands. 

He shares some of his distinctive logic, reason - and even a little of his poetry - on this very special episode of The Recommended Dose, produced by Cochrane Australia and co-published with the BMJ.

<p>You'll find our show notes and a full transcript of the show at http://australia.cochrane.org/trd</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/pyza3p/stream_458572731-bmjgroup-09-john-ioannidis.mp3" length="59972544" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Series two of The Recommended Dose kicks off with polymath and poet, Dr John Ioannidis. Recognised by The Atlantic as one the most influential scientists alive today, he’s a global authority on genetics, medical research and the nature of scientific inquiry itself – among many other things.

A professor at Stanford University, John has authored close to 1,000 academic papers and served on the editorial boards of 30 of the world's top journals. He is best known for seriously challenging the status quo. His trailblazing 2005 paper 'Why Most Published Research Findings Are False' has been viewed over 2.5 million times and is the most cited article in the history of PLoS Medicine. In it, he argues that most medical research is biased, overblown or simply wrong. Here, he talks to Ray about the far-reaching implications of these findings for people both inside and outside the world of health.

While most closely associated with exploring cutting-edge conundrums across science, genomics and even economics, John is also something of a humanist. He’d be right at home with the philosophers of ancient Greece, seeking as he does to find answers to the big questions of the day in science and medicine, as well as in nature and narratives. 

A voracious reader himself, John has a lifelong love of ‘swimming in books’ and has penned seven literary works of his own in Greek – two of which have been nominated for prestigious literary prizes. And fittingly, he finds inspiration for his myriad of multi-disciplinary pursuits on Antipaxi, one of Greece’s most beautiful and secluded islands. 

He shares some of his distinctive logic, reason - and even a little of his poetry - on this very special episode of The Recommended Dose, produced by Cochrane Australia and co-published with the BMJ.

You'll find our show notes and a full transcript of the show at http://australia.cochrane.org/trd]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3749</itunes:duration>
                                    </item>
    <item>
        <title>Ashish Jha tries to see the world as it is.</title>
        <itunes:title>Ashish Jha tries to see the world as it is.</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/ashish-jha-tries-to-see-the-world-as-it-is/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/ashish-jha-tries-to-see-the-world-as-it-is/#comments</comments>        <pubDate>Fri, 08 Jun 2018 17:02:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/ashish-jha-tries-to-see-the-world-as-it-is</guid>
                                    <description><![CDATA[There’s a lot going on in the world at the moment - Ebola’s back, Puerto Rico is without power and the official estimations of death following the hurricane are being challenged. The WHO’s just met to decide what to do about it all, as well as sorting out universal healthcare, access to medicines, eradicating polio, etc etc.

To make sense of that a little, we grabbed Ashish Jha - Director of the Harvard Global Health Institute to shed some light into how decisions about global health are made, and why he tries to see the world as it actually is - not how he wishes it would be.


Reading list:
Mortality in Puerto Rico after Hurricane Maria
https://www.nejm.org/doi/full/10.1056/NEJMsa1803972

<p>https://www.bmj.com/universal-health-coverage</p>
]]></description>
                                                            <content:encoded><![CDATA[There’s a lot going on in the world at the moment - Ebola’s back, Puerto Rico is without power and the official estimations of death following the hurricane are being challenged. The WHO’s just met to decide what to do about it all, as well as sorting out universal healthcare, access to medicines, eradicating polio, etc etc.

To make sense of that a little, we grabbed Ashish Jha - Director of the Harvard Global Health Institute to shed some light into how decisions about global health are made, and why he tries to see the world as it actually is - not how he wishes it would be.


Reading list:
Mortality in Puerto Rico after Hurricane Maria
https://www.nejm.org/doi/full/10.1056/NEJMsa1803972

<p>https://www.bmj.com/universal-health-coverage</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/0z71g3/stream_455670702-bmjgroup-ashish-jha-tries-to-see-the-world-as-it-is.mp3" length="69162869" type="audio/mpeg"/>
        <itunes:summary><![CDATA[There’s a lot going on in the world at the moment - Ebola’s back, Puerto Rico is without power and the official estimations of death following the hurricane are being challenged. The WHO’s just met to decide what to do about it all, as well as sorting out universal healthcare, access to medicines, eradicating polio, etc etc.

To make sense of that a little, we grabbed Ashish Jha - Director of the Harvard Global Health Institute to shed some light into how decisions about global health are made, and why he tries to see the world as it actually is - not how he wishes it would be.


Reading list:
Mortality in Puerto Rico after Hurricane Maria
https://www.nejm.org/doi/full/10.1056/NEJMsa1803972

https://www.bmj.com/universal-health-coverage]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2886</itunes:duration>
                                    </item>
    <item>
        <title>Nutritional science - why studying what we eat is so difficult.</title>
        <itunes:title>Nutritional science - why studying what we eat is so difficult.</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/nutritional-science-why-studying-what-we-eat-is-so-difficult/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/nutritional-science-why-studying-what-we-eat-is-so-difficult/#comments</comments>        <pubDate>Fri, 08 Jun 2018 16:54:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/nutritional-science-why-studying-what-we-eat-is-so-difficult</guid>
                                    <description><![CDATA[We at The BMJ care about food, and if our listener stats are to be believed, so do you.

In this podcast we talk to a few of the authors of a new series, published next week on bmj.com, which tries to provide some insight into the current state of nutritional science - where the controversies lie, where there’s broad agreement,  and the journey of our understanding of nutrition.

The open access fees for those articles has been paid for by Swiss Re - a wholesale provider of reinsurance, insurance and other insurance-based forms of risk transfer - they have not had any input into the editorial process, which has gone through the same peer review as any of our other analysis articles. Swiss Re are also co-hosting a conference where we’ll be bringing together a lot of these researchers - and which will be live streamed next week - you’ll be able to access that for free on bmj.com

For more on the conference:
<p>http://institute.swissre.com/events/food_for_thought_bmj.html</p>
]]></description>
                                                            <content:encoded><![CDATA[We at The BMJ care about food, and if our listener stats are to be believed, so do you.

In this podcast we talk to a few of the authors of a new series, published next week on bmj.com, which tries to provide some insight into the current state of nutritional science - where the controversies lie, where there’s broad agreement,  and the journey of our understanding of nutrition.

The open access fees for those articles has been paid for by Swiss Re - a wholesale provider of reinsurance, insurance and other insurance-based forms of risk transfer - they have not had any input into the editorial process, which has gone through the same peer review as any of our other analysis articles. Swiss Re are also co-hosting a conference where we’ll be bringing together a lot of these researchers - and which will be live streamed next week - you’ll be able to access that for free on bmj.com

For more on the conference:
<p>http://institute.swissre.com/events/food_for_thought_bmj.html</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qhl06w/stream_455667405-bmjgroup-nutritional-science-why-studying-what-we-eat-is-so-difficult.mp3" length="75003228" type="audio/mpeg"/>
        <itunes:summary><![CDATA[We at The BMJ care about food, and if our listener stats are to be believed, so do you.

In this podcast we talk to a few of the authors of a new series, published next week on bmj.com, which tries to provide some insight into the current state of nutritional science - where the controversies lie, where there’s broad agreement,  and the journey of our understanding of nutrition.

The open access fees for those articles has been paid for by Swiss Re - a wholesale provider of reinsurance, insurance and other insurance-based forms of risk transfer - they have not had any input into the editorial process, which has gone through the same peer review as any of our other analysis articles. Swiss Re are also co-hosting a conference where we’ll be bringing together a lot of these researchers - and which will be live streamed next week - you’ll be able to access that for free on bmj.com

For more on the conference:
http://institute.swissre.com/events/food_for_thought_bmj.html]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3128</itunes:duration>
                                    </item>
    <item>
        <title>The misunderstanding of overdiagnosis</title>
        <itunes:title>The misunderstanding of overdiagnosis</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-misunderstanding-of-overdiagnosis/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-misunderstanding-of-overdiagnosis/#comments</comments>        <pubDate>Thu, 31 May 2018 15:19:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-misunderstanding-of-overdiagnosis</guid>
                                    <description><![CDATA[In December 2017, the NEJM’s national corespondent, Lisa Rosenbaum, published an article “The Less-Is-More Crusade — Are We Overmedicalizing or Oversimplifying?”



The article aimed a broadside against those who are campaigning against the overuse of medicine, and the over diagnosis of treatment.



This week in the BMJ we’ve published a rebuttal to that article, and in this podcast we talk to Steve Woloshin and Lisa Schwartz - both professors at the Dartmouth Institute for Health Policy and Clinical Practice. 



Steve and Lisa’s article carefully deconstructs some of the ideas advanced by Rosenbaum, but in this podcast we discuss how much separate camps are forming in this debate - and how to have a constructive dialogue across that divide.



Read Steve and Lisa's essay

https://www.bmj.com/content/361/bmj.k2035



Iona Heath's essay - The role of fear in overdiagnosis

https://www.bmj.com/content/349/bmj.g6123



Stacy Carter's interview about moral shocks

<p>https://soundcloud.com/bmjpodcasts/preventing-overdiagnosis-2017-stacy-carter-on-the-culture-of-overmedicalisation</p>
]]></description>
                                                            <content:encoded><![CDATA[In December 2017, the NEJM’s national corespondent, Lisa Rosenbaum, published an article “The Less-Is-More Crusade — Are We Overmedicalizing or Oversimplifying?”



The article aimed a broadside against those who are campaigning against the overuse of medicine, and the over diagnosis of treatment.



This week in the BMJ we’ve published a rebuttal to that article, and in this podcast we talk to Steve Woloshin and Lisa Schwartz - both professors at the Dartmouth Institute for Health Policy and Clinical Practice. 



Steve and Lisa’s article carefully deconstructs some of the ideas advanced by Rosenbaum, but in this podcast we discuss how much separate camps are forming in this debate - and how to have a constructive dialogue across that divide.



Read Steve and Lisa's essay

https://www.bmj.com/content/361/bmj.k2035



Iona Heath's essay - The role of fear in overdiagnosis

https://www.bmj.com/content/349/bmj.g6123



Stacy Carter's interview about moral shocks

<p>https://soundcloud.com/bmjpodcasts/preventing-overdiagnosis-2017-stacy-carter-on-the-culture-of-overmedicalisation</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/36dmrl/stream_451764069-bmjgroup-the-misunderstanding-of-overdiagnosis.mp3" length="27065714" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In December 2017, the NEJM’s national corespondent, Lisa Rosenbaum, published an article “The Less-Is-More Crusade — Are We Overmedicalizing or Oversimplifying?”



The article aimed a broadside against those who are campaigning against the overuse of medicine, and the over diagnosis of treatment.



This week in the BMJ we’ve published a rebuttal to that article, and in this podcast we talk to Steve Woloshin and Lisa Schwartz - both professors at the Dartmouth Institute for Health Policy and Clinical Practice. 



Steve and Lisa’s article carefully deconstructs some of the ideas advanced by Rosenbaum, but in this podcast we discuss how much separate camps are forming in this debate - and how to have a constructive dialogue across that divide.



Read Steve and Lisa's essay

https://www.bmj.com/content/361/bmj.k2035



Iona Heath's essay - The role of fear in overdiagnosis

https://www.bmj.com/content/349/bmj.g6123



Stacy Carter's interview about moral shocks

https://soundcloud.com/bmjpodcasts/preventing-overdiagnosis-2017-stacy-carter-on-the-culture-of-overmedicalisation]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1695</itunes:duration>
                                    </item>
    <item>
        <title>Biochem for kids</title>
        <itunes:title>Biochem for kids</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/biochem-for-kids/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/biochem-for-kids/#comments</comments>        <pubDate>Fri, 25 May 2018 17:24:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/biochem-for-kids</guid>
                                    <description><![CDATA[Each time you order a test for a child, do you think the population that makes up the baseline against which the results are measured?  It turns out that that historically those reference intervals have been based on adults - but children, especially neonates and adolescents, are undergoing physiological changes that mean those reference intervals may not be appropriate.

To get around this Khosrow Adeli, head and professor of clinical biochemistry at the Hospital for Sick Children, and the University of Toronto, and colleagues have undertaken a mission to recruit children and young people into a study of their test results.

Read the full practice article:
<p>https://www.bmj.com/content/361/bmj.k1950</p>
]]></description>
                                                            <content:encoded><![CDATA[Each time you order a test for a child, do you think the population that makes up the baseline against which the results are measured?  It turns out that that historically those reference intervals have been based on adults - but children, especially neonates and adolescents, are undergoing physiological changes that mean those reference intervals may not be appropriate.

To get around this Khosrow Adeli, head and professor of clinical biochemistry at the Hospital for Sick Children, and the University of Toronto, and colleagues have undertaken a mission to recruit children and young people into a study of their test results.

Read the full practice article:
<p>https://www.bmj.com/content/361/bmj.k1950</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/uxoyxw/stream_449098914-bmjgroup-biochem-for-kids.mp3" length="32507160" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Each time you order a test for a child, do you think the population that makes up the baseline against which the results are measured?  It turns out that that historically those reference intervals have been based on adults - but children, especially neonates and adolescents, are undergoing physiological changes that mean those reference intervals may not be appropriate.

To get around this Khosrow Adeli, head and professor of clinical biochemistry at the Hospital for Sick Children, and the University of Toronto, and colleagues have undertaken a mission to recruit children and young people into a study of their test results.

Read the full practice article:
https://www.bmj.com/content/361/bmj.k1950]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1355</itunes:duration>
                                    </item>
    <item>
        <title>Antidepressants and weight gain</title>
        <itunes:title>Antidepressants and weight gain</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/antidepressants-and-weight-gain/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/antidepressants-and-weight-gain/#comments</comments>        <pubDate>Fri, 25 May 2018 16:56:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/antidepressants-and-weight-gain</guid>
                                    <description><![CDATA[Patients who are depressed and prescribed antidepressants may report weight gain, but there has been limited research into the association between the two. However new observational research published on bmj.com aims to identify that association. 

Rafael Gafoor, a psychiatrist and researcher at Kings College London, and one of the authors of that research joins us to talk about the potential mechanism of action - is it a physiological response to the drug, is it to do with the underlying reason for the prescription; how they studied the association; and what this might mean for individual prescriptions.

You can read the full research on bmj.com;
<p>https://www.bmj.com/content/361/bmj.k1951</p>
]]></description>
                                                            <content:encoded><![CDATA[Patients who are depressed and prescribed antidepressants may report weight gain, but there has been limited research into the association between the two. However new observational research published on bmj.com aims to identify that association. 

Rafael Gafoor, a psychiatrist and researcher at Kings College London, and one of the authors of that research joins us to talk about the potential mechanism of action - is it a physiological response to the drug, is it to do with the underlying reason for the prescription; how they studied the association; and what this might mean for individual prescriptions.

You can read the full research on bmj.com;
<p>https://www.bmj.com/content/361/bmj.k1951</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/zzxml5/stream_449087565-bmjgroup-antidepressants-and-weight-gain.mp3" length="24536521" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Patients who are depressed and prescribed antidepressants may report weight gain, but there has been limited research into the association between the two. However new observational research published on bmj.com aims to identify that association. 

Rafael Gafoor, a psychiatrist and researcher at Kings College London, and one of the authors of that research joins us to talk about the potential mechanism of action - is it a physiological response to the drug, is it to do with the underlying reason for the prescription; how they studied the association; and what this might mean for individual prescriptions.

You can read the full research on bmj.com;
https://www.bmj.com/content/361/bmj.k1951]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1023</itunes:duration>
                                    </item>
    <item>
        <title>Think of healthcare is an ecosystem, not a machine</title>
        <itunes:title>Think of healthcare is an ecosystem, not a machine</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/think-of-healthcare-is-an-ecosystem-not-a-machine/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/think-of-healthcare-is-an-ecosystem-not-a-machine/#comments</comments>        <pubDate>Sat, 19 May 2018 10:32:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/think-of-healthcare-is-an-ecosystem-not-a-machine</guid>
                                    <description><![CDATA[Complexity science offers ways to change our collective mindset about healthcare systems, enabling us to improve performance that is otherwise stagnant, argues Jeffrey Braithwaite, professor of health systems research and president elect of the International Society for Quality in Health Care.

Read the full analysis:
https://www.bmj.com/content/361/bmj.k2014

Quality improvement series:
https://www.bmj.com/quality-improvement


<p>The BMJ in partnership with and funded by The Health Foundation are launching a joint series of papers exploring how to improve the quality of healthcare delivery. The series aims to discuss the evidence for systematic quality improvement, provide knowledge and support to clinicians and ultimately to help improve care for patients.</p>
]]></description>
                                                            <content:encoded><![CDATA[Complexity science offers ways to change our collective mindset about healthcare systems, enabling us to improve performance that is otherwise stagnant, argues Jeffrey Braithwaite, professor of health systems research and president elect of the International Society for Quality in Health Care.

Read the full analysis:
https://www.bmj.com/content/361/bmj.k2014

Quality improvement series:
https://www.bmj.com/quality-improvement


<p>The BMJ in partnership with and funded by The Health Foundation are launching a joint series of papers exploring how to improve the quality of healthcare delivery. The series aims to discuss the evidence for systematic quality improvement, provide knowledge and support to clinicians and ultimately to help improve care for patients.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kux1tv/stream_446212407-bmjgroup-think-of-healthcare-is-an-ecosystem-not-a-machine.mp3" length="53245975" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Complexity science offers ways to change our collective mindset about healthcare systems, enabling us to improve performance that is otherwise stagnant, argues Jeffrey Braithwaite, professor of health systems research and president elect of the International Society for Quality in Health Care.

Read the full analysis:
https://www.bmj.com/content/361/bmj.k2014

Quality improvement series:
https://www.bmj.com/quality-improvement


The BMJ in partnership with and funded by The Health Foundation are launching a joint series of papers exploring how to improve the quality of healthcare delivery. The series aims to discuss the evidence for systematic quality improvement, provide knowledge and support to clinicians and ultimately to help improve care for patients.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2221</itunes:duration>
                                    </item>
    <item>
        <title>New antivirals for Hepatitis C - what does the evidence prove?</title>
        <itunes:title>New antivirals for Hepatitis C - what does the evidence prove?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/new-antivirals-for-hepatitis-c-what-does-the-evidence-prove/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/new-antivirals-for-hepatitis-c-what-does-the-evidence-prove/#comments</comments>        <pubDate>Sat, 12 May 2018 11:44:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/new-antivirals-for-hepatitis-c-what-does-the-evidence-prove</guid>
                                    <description><![CDATA[There’s been a lot of attention given to the new antirviral drugs which target Hepatitis C - partly because of the burden of infection of the disease, and the lack of a treatment that can be made easily accessible to around the world, and partly because of the incredible cost of a course of treatment.

But a new article on BMJ talks about the uncertainly of that treatment - do we know that the drugs actually clear a HepC infection, and that this will lead to a corresponding decrease in mortality and morbidity?

Janus Jakobsen from the Copenhagen Clinical Trial Unit joins us to discuss what the literature proves.

Read the full article:
<p>https://www.bmj.com/content/361/bmj.k1382</p>
]]></description>
                                                            <content:encoded><![CDATA[There’s been a lot of attention given to the new antirviral drugs which target Hepatitis C - partly because of the burden of infection of the disease, and the lack of a treatment that can be made easily accessible to around the world, and partly because of the incredible cost of a course of treatment.

But a new article on BMJ talks about the uncertainly of that treatment - do we know that the drugs actually clear a HepC infection, and that this will lead to a corresponding decrease in mortality and morbidity?

Janus Jakobsen from the Copenhagen Clinical Trial Unit joins us to discuss what the literature proves.

Read the full article:
<p>https://www.bmj.com/content/361/bmj.k1382</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/psfj8r/stream_442987737-bmjgroup-new-antivirals-for-hepatitis-c-what-does-the-evidence-prove.mp3" length="23999892" type="audio/mpeg"/>
        <itunes:summary><![CDATA[There’s been a lot of attention given to the new antirviral drugs which target Hepatitis C - partly because of the burden of infection of the disease, and the lack of a treatment that can be made easily accessible to around the world, and partly because of the incredible cost of a course of treatment.

But a new article on BMJ talks about the uncertainly of that treatment - do we know that the drugs actually clear a HepC infection, and that this will lead to a corresponding decrease in mortality and morbidity?

Janus Jakobsen from the Copenhagen Clinical Trial Unit joins us to discuss what the literature proves.

Read the full article:
https://www.bmj.com/content/361/bmj.k1382]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1001</itunes:duration>
                                    </item>
    <item>
        <title>What forced migration can tell us about diabetes</title>
        <itunes:title>What forced migration can tell us about diabetes</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/what-forced-migration-can-tell-us-about-diabetes/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/what-forced-migration-can-tell-us-about-diabetes/#comments</comments>        <pubDate>Tue, 08 May 2018 17:04:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/what-forced-migration-can-tell-us-about-diabetes</guid>
                                    <description><![CDATA[Worldwide, the rate of type II diabetes is estimated to be around 1 in 11 people - about 9%. For the Pima people of Arizona, 38% of the adult population have the condition - but across the border in Mexico, the rate drops down to 7%. 

The difference between the groups is their life experience - one side displaced, the other on their traditional lands - and their experience is being replicated elsewhere.

Lauren Carruth, assistant professor at The American University, joins us to talk about the Pima people, where else displacement is changing patterns of non-communicable disease, and what this might tell us about economic migrations effect on health.

Read the full editorial:
<p>https://www.bmj.com/content/361/bmj.k1795</p>
]]></description>
                                                            <content:encoded><![CDATA[Worldwide, the rate of type II diabetes is estimated to be around 1 in 11 people - about 9%. For the Pima people of Arizona, 38% of the adult population have the condition - but across the border in Mexico, the rate drops down to 7%. 

The difference between the groups is their life experience - one side displaced, the other on their traditional lands - and their experience is being replicated elsewhere.

Lauren Carruth, assistant professor at The American University, joins us to talk about the Pima people, where else displacement is changing patterns of non-communicable disease, and what this might tell us about economic migrations effect on health.

Read the full editorial:
<p>https://www.bmj.com/content/361/bmj.k1795</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/a5y8sj/stream_441189603-bmjgroup-what-forced-migration-can-tell-us-about-diabetes.mp3" length="33271943" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Worldwide, the rate of type II diabetes is estimated to be around 1 in 11 people - about 9%. For the Pima people of Arizona, 38% of the adult population have the condition - but across the border in Mexico, the rate drops down to 7%. 

The difference between the groups is their life experience - one side displaced, the other on their traditional lands - and their experience is being replicated elsewhere.

Lauren Carruth, assistant professor at The American University, joins us to talk about the Pima people, where else displacement is changing patterns of non-communicable disease, and what this might tell us about economic migrations effect on health.

Read the full editorial:
https://www.bmj.com/content/361/bmj.k1795]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1388</itunes:duration>
                                    </item>
    <item>
        <title>Big Metadata</title>
        <itunes:title>Big Metadata</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/big-metadata/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/big-metadata/#comments</comments>        <pubDate>Fri, 04 May 2018 17:09:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/big-metadata</guid>
                                    <description><![CDATA[We’re in an era of big data - and hospitals and GPs are generating an inordinate amount of it that has potential to improve everyone’s health. But only if it’s used properly. New research published on www.bmj.com this week describes another set of information, about that data, that the authors believe could be just as important as the data itself.

Griffin weber, and Isaac Kohane, from the Department of Biomedical informatics at Harvard medical school join us to discuss.

Read the full research:
<p>https://www.bmj.com/content/361/bmj.k1479</p>
]]></description>
                                                            <content:encoded><![CDATA[We’re in an era of big data - and hospitals and GPs are generating an inordinate amount of it that has potential to improve everyone’s health. But only if it’s used properly. New research published on www.bmj.com this week describes another set of information, about that data, that the authors believe could be just as important as the data itself.

Griffin weber, and Isaac Kohane, from the Department of Biomedical informatics at Harvard medical school join us to discuss.

Read the full research:
<p>https://www.bmj.com/content/361/bmj.k1479</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/f9v1qd/stream_439379736-bmjgroup-big-metadata.mp3" length="28475066" type="audio/mpeg"/>
        <itunes:summary><![CDATA[We’re in an era of big data - and hospitals and GPs are generating an inordinate amount of it that has potential to improve everyone’s health. But only if it’s used properly. New research published on www.bmj.com this week describes another set of information, about that data, that the authors believe could be just as important as the data itself.

Griffin weber, and Isaac Kohane, from the Department of Biomedical informatics at Harvard medical school join us to discuss.

Read the full research:
https://www.bmj.com/content/361/bmj.k1479]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1187</itunes:duration>
                                    </item>
    <item>
        <title>WHO can tackle pharma advertising</title>
        <itunes:title>WHO can tackle pharma advertising</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/who-can-tackle-pharma-advertising/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/who-can-tackle-pharma-advertising/#comments</comments>        <pubDate>Thu, 03 May 2018 16:35:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/who-can-tackle-pharma-advertising</guid>
                                    <description><![CDATA[The array of options available to pharmaceutical companies, to advertise their drugs, is incredibly broad - and the amount that they spend is increasing, with some reports saying it’s up 60% in the last five years.  In most countries, there are pretty strict rules to limit the ways in which Pharma can spend their advertising dollars - but the WHO guidelines which have informed many of those rules are now 30 years out of date.

A new analysis on bmj.com “Ethical drug marketing criteria for the 21st century“ proposes some ways in which those guidelines should be updated, we're joined two of the authors - Lisa Parker and Lisa Bero - from the Charles Perkins centre at the faculty of pharmacy at the university of Sydney to discuss.

Read the full analysis:
<p>https://www.bmj.com/content/361/bmj.k1809</p>
]]></description>
                                                            <content:encoded><![CDATA[The array of options available to pharmaceutical companies, to advertise their drugs, is incredibly broad - and the amount that they spend is increasing, with some reports saying it’s up 60% in the last five years.  In most countries, there are pretty strict rules to limit the ways in which Pharma can spend their advertising dollars - but the WHO guidelines which have informed many of those rules are now 30 years out of date.

A new analysis on bmj.com “Ethical drug marketing criteria for the 21st century“ proposes some ways in which those guidelines should be updated, we're joined two of the authors - Lisa Parker and Lisa Bero - from the Charles Perkins centre at the faculty of pharmacy at the university of Sydney to discuss.

Read the full analysis:
<p>https://www.bmj.com/content/361/bmj.k1809</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2xy3y8/stream_438854841-bmjgroup-who-can-tackle-pharma-advertising.mp3" length="37700569" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The array of options available to pharmaceutical companies, to advertise their drugs, is incredibly broad - and the amount that they spend is increasing, with some reports saying it’s up 60% in the last five years.  In most countries, there are pretty strict rules to limit the ways in which Pharma can spend their advertising dollars - but the WHO guidelines which have informed many of those rules are now 30 years out of date.

A new analysis on bmj.com “Ethical drug marketing criteria for the 21st century“ proposes some ways in which those guidelines should be updated, we're joined two of the authors - Lisa Parker and Lisa Bero - from the Charles Perkins centre at the faculty of pharmacy at the university of Sydney to discuss.

Read the full analysis:
https://www.bmj.com/content/361/bmj.k1809]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1573</itunes:duration>
                                    </item>
    <item>
        <title>The complexities of depression in cancer</title>
        <itunes:title>The complexities of depression in cancer</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-complexities-of-depression-in-cancer/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-complexities-of-depression-in-cancer/#comments</comments>        <pubDate>Thu, 26 Apr 2018 17:35:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-complexities-of-depression-in-cancer</guid>
                                    <description><![CDATA[For many people, cancer is now survivable and has become a long term condition, and depression and anxiety are more common in cancer survivors than in the general population. Despite this, 73% of patients don't receive effective psychiatric treatment. 

Alexandra Pitman, consultant liaison psychiatrist at St George’s University Hospitals NHS Foundation Trust, and Andrew Hodgkiss, consultant liaison psychiatrist, at the Institute of Psychiatry, Psychology & Neuroscience  join us to dispel some of the concern clinicians may have about the complexities of diagnosing depression in cancer - what is biopsychosocial, what is the organic result of the cancer or treatment - and some of the concern about treatment interactions.

Read the two education articles:
https://www.bmj.com/content/361/bmj.k1415
<p>https://www.bmj.com/content/361/bmj.k1488</p>
]]></description>
                                                            <content:encoded><![CDATA[For many people, cancer is now survivable and has become a long term condition, and depression and anxiety are more common in cancer survivors than in the general population. Despite this, 73% of patients don't receive effective psychiatric treatment. 

Alexandra Pitman, consultant liaison psychiatrist at St George’s University Hospitals NHS Foundation Trust, and Andrew Hodgkiss, consultant liaison psychiatrist, at the Institute of Psychiatry, Psychology & Neuroscience  join us to dispel some of the concern clinicians may have about the complexities of diagnosing depression in cancer - what is biopsychosocial, what is the organic result of the cancer or treatment - and some of the concern about treatment interactions.

Read the two education articles:
https://www.bmj.com/content/361/bmj.k1415
<p>https://www.bmj.com/content/361/bmj.k1488</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/nd8ufe/stream_435584592-bmjgroup-the-complexities-of-depression-in-cancer.mp3" length="54035556" type="audio/mpeg"/>
        <itunes:summary><![CDATA[For many people, cancer is now survivable and has become a long term condition, and depression and anxiety are more common in cancer survivors than in the general population. Despite this, 73% of patients don't receive effective psychiatric treatment. 

Alexandra Pitman, consultant liaison psychiatrist at St George’s University Hospitals NHS Foundation Trust, and Andrew Hodgkiss, consultant liaison psychiatrist, at the Institute of Psychiatry, Psychology & Neuroscience  join us to dispel some of the concern clinicians may have about the complexities of diagnosing depression in cancer - what is biopsychosocial, what is the organic result of the cancer or treatment - and some of the concern about treatment interactions.

Read the two education articles:
https://www.bmj.com/content/361/bmj.k1415
https://www.bmj.com/content/361/bmj.k1488]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2254</itunes:duration>
                                    </item>
    <item>
        <title>E-cigarettes - debating the evidence</title>
        <itunes:title>E-cigarettes - debating the evidence</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/e-cigarettes-debating-the-evidence/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/e-cigarettes-debating-the-evidence/#comments</comments>        <pubDate>Mon, 23 Apr 2018 14:54:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/e-cigarettes-debating-the-evidence</guid>
                                    <description><![CDATA[Smokers want to vape, it can help them quit, and it’s less harmful than smoking, say Paul Aveyard professor of behavioural medicine at the University of Oxford. 

But Kenneth C Johnson, adjunct professor at the University of Ottawa,  argues that smokers who vape are generally less likely to quit and is concerned about youth vaping as a gateway to smoking, dual use, and potential harms from long term use.

Read the debate:
<p>https://www.bmj.com/content/361/bmj.k1759</p>
]]></description>
                                                            <content:encoded><![CDATA[Smokers want to vape, it can help them quit, and it’s less harmful than smoking, say Paul Aveyard professor of behavioural medicine at the University of Oxford. 

But Kenneth C Johnson, adjunct professor at the University of Ottawa,  argues that smokers who vape are generally less likely to quit and is concerned about youth vaping as a gateway to smoking, dual use, and potential harms from long term use.

Read the debate:
<p>https://www.bmj.com/content/361/bmj.k1759</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/c91j2u/stream_433935180-bmjgroup-e-cigarettes-debating-the-evidence.mp3" length="47103779" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Smokers want to vape, it can help them quit, and it’s less harmful than smoking, say Paul Aveyard professor of behavioural medicine at the University of Oxford. 

But Kenneth C Johnson, adjunct professor at the University of Ottawa,  argues that smokers who vape are generally less likely to quit and is concerned about youth vaping as a gateway to smoking, dual use, and potential harms from long term use.

Read the debate:
https://www.bmj.com/content/361/bmj.k1759]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1965</itunes:duration>
                                    </item>
    <item>
        <title>Harry Burns - the social determinants of Scotland</title>
        <itunes:title>Harry Burns - the social determinants of Scotland</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/harry-burns-the-social-determinants-of-scotland/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/harry-burns-the-social-determinants-of-scotland/#comments</comments>        <pubDate>Fri, 20 Apr 2018 17:45:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/harry-burns-the-social-determinants-of-scotland</guid>
                                    <description><![CDATA[Harry Burns was a surgeon, who gave up his career in that discipline to become a public health doctor. Eventually that lead to him being the last Chief Medical Officer of Scotland, and now he’s professor of global public health at the University of Strathclyde.

Scotland has always had a separate NHS, but since devolution, the parliament there has had much more autonomy in running the country - and Harry has seemed to manage to convince them that improving health means improving the social determinants of health.

In this conversation we talk about that link, how his philosophy has affected policy up there, some of the experiments which are going on in the country, and what he thinks is the most exciting change.

Read the editorial on GDP and wellness:
<p>https://www.bmj.com/content/360/bmj.k1239</p>
]]></description>
                                                            <content:encoded><![CDATA[Harry Burns was a surgeon, who gave up his career in that discipline to become a public health doctor. Eventually that lead to him being the last Chief Medical Officer of Scotland, and now he’s professor of global public health at the University of Strathclyde.

Scotland has always had a separate NHS, but since devolution, the parliament there has had much more autonomy in running the country - and Harry has seemed to manage to convince them that improving health means improving the social determinants of health.

In this conversation we talk about that link, how his philosophy has affected policy up there, some of the experiments which are going on in the country, and what he thinks is the most exciting change.

Read the editorial on GDP and wellness:
<p>https://www.bmj.com/content/360/bmj.k1239</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/1fvbvk/stream_432696126-bmjgroup-harry-burns-the-social-determinants-of-scotland.mp3" length="62009386" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Harry Burns was a surgeon, who gave up his career in that discipline to become a public health doctor. Eventually that lead to him being the last Chief Medical Officer of Scotland, and now he’s professor of global public health at the University of Strathclyde.

Scotland has always had a separate NHS, but since devolution, the parliament there has had much more autonomy in running the country - and Harry has seemed to manage to convince them that improving health means improving the social determinants of health.

In this conversation we talk about that link, how his philosophy has affected policy up there, some of the experiments which are going on in the country, and what he thinks is the most exciting change.

Read the editorial on GDP and wellness:
https://www.bmj.com/content/360/bmj.k1239]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2587</itunes:duration>
                                    </item>
    <item>
        <title>Can we regulate intellectual interests like financial ones?</title>
        <itunes:title>Can we regulate intellectual interests like financial ones?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/can-we-regulate-intellectual-interests-like-financial-ones/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/can-we-regulate-intellectual-interests-like-financial-ones/#comments</comments>        <pubDate>Fri, 13 Apr 2018 19:07:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/can-we-regulate-intellectual-interests-like-financial-ones</guid>
                                    <description><![CDATA[We talk about financial conflicts of interest a lot atThe BMJ - and have take taken the decision that our educational content should be without them. 

We also talk a lot about non-financial conflicts of interest, but the choppy waters of those are much more difficult to navigate.

In this podcast, we discuss whether we should, or if we could even could, make people’s intellectual positions transparent.

Arguing that it’s important to tackle this issue, are Wendy Lipworth and Ian Kerridge from Sydney health Ethics at the University of Sydney - and arguing that it’s not as easy as we think is Marc Rodwin, from Suffolk University Law School in Boston.

Read the full head to head:
<p>https://www.bmj.com/content/361/bmj.k1240</p>
]]></description>
                                                            <content:encoded><![CDATA[We talk about financial conflicts of interest a lot atThe BMJ - and have take taken the decision that our educational content should be without them. 

We also talk a lot about non-financial conflicts of interest, but the choppy waters of those are much more difficult to navigate.

In this podcast, we discuss whether we should, or if we could even could, make people’s intellectual positions transparent.

Arguing that it’s important to tackle this issue, are Wendy Lipworth and Ian Kerridge from Sydney health Ethics at the University of Sydney - and arguing that it’s not as easy as we think is Marc Rodwin, from Suffolk University Law School in Boston.

Read the full head to head:
<p>https://www.bmj.com/content/361/bmj.k1240</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ctx7ll/stream_429293247-bmjgroup-can-we-regulate-intellectual-interests-like-financial-ones.mp3" length="50771709" type="audio/mpeg"/>
        <itunes:summary><![CDATA[We talk about financial conflicts of interest a lot atThe BMJ - and have take taken the decision that our educational content should be without them. 

We also talk a lot about non-financial conflicts of interest, but the choppy waters of those are much more difficult to navigate.

In this podcast, we discuss whether we should, or if we could even could, make people’s intellectual positions transparent.

Arguing that it’s important to tackle this issue, are Wendy Lipworth and Ian Kerridge from Sydney health Ethics at the University of Sydney - and arguing that it’s not as easy as we think is Marc Rodwin, from Suffolk University Law School in Boston.

Read the full head to head:
https://www.bmj.com/content/361/bmj.k1240]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2118</itunes:duration>
                                    </item>
    <item>
        <title>Civilians under siege in Eastern Ghouta</title>
        <itunes:title>Civilians under siege in Eastern Ghouta</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/civilians-under-siege-in-eastern-ghouta/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/civilians-under-siege-in-eastern-ghouta/#comments</comments>        <pubDate>Tue, 03 Apr 2018 10:03:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/civilians-under-siege-in-eastern-ghouta</guid>
                                    <description><![CDATA[In 2016, from an estimated pre-war population of 22 million, the United Nations (UN) identified 13.5 million Syrians requiring humanitarian assistance, of which more than 6 million are internally displaced within Syria, and around 5 million are refugees outside of Syria.

In this podcast, Aula Abarra, consultant in infectious disease from London, joins us to discuss what's happening now in Eastern Ghouta, and area of Damascus, where civilians are being held under siege, where humanitarian aid is unable to reach.

Read the full editorial:
<p>https://www.bmj.com/content/360/bmj.k1368</p>
]]></description>
                                                            <content:encoded><![CDATA[In 2016, from an estimated pre-war population of 22 million, the United Nations (UN) identified 13.5 million Syrians requiring humanitarian assistance, of which more than 6 million are internally displaced within Syria, and around 5 million are refugees outside of Syria.

In this podcast, Aula Abarra, consultant in infectious disease from London, joins us to discuss what's happening now in Eastern Ghouta, and area of Damascus, where civilians are being held under siege, where humanitarian aid is unable to reach.

Read the full editorial:
<p>https://www.bmj.com/content/360/bmj.k1368</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qyhaxq/stream_424092969-bmjgroup-civilians-under-siege-in-eastern-ghouta.mp3" length="20977081" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In 2016, from an estimated pre-war population of 22 million, the United Nations (UN) identified 13.5 million Syrians requiring humanitarian assistance, of which more than 6 million are internally displaced within Syria, and around 5 million are refugees outside of Syria.

In this podcast, Aula Abarra, consultant in infectious disease from London, joins us to discuss what's happening now in Eastern Ghouta, and area of Damascus, where civilians are being held under siege, where humanitarian aid is unable to reach.

Read the full editorial:
https://www.bmj.com/content/360/bmj.k1368]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>875</itunes:duration>
                                    </item>
    <item>
        <title>Online Consultations - general practice is primed for a fight</title>
        <itunes:title>Online Consultations - general practice is primed for a fight</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/online-consultations-general-practice-is-primed-for-a-fight/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/online-consultations-general-practice-is-primed-for-a-fight/#comments</comments>        <pubDate>Wed, 28 Mar 2018 15:28:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/online-consultations-general-practice-is-primed-for-a-fight</guid>
                                    <description><![CDATA[The first digital banking in the UK was launched in 1983, Skype turns 15 this year, but 2017 finally saw panic over the impact that online consultations may have on general practices.

In this podcast Martin Marshall, professor of healthcare improvement at University College London joins us to discuss whether video conference actually is a disruptor, or whether it’s actually the whole business model of general practice that needs to change.

Read the full analysis:
<p>https://www.bmj.com/content/360/bmj.k1195</p>
]]></description>
                                                            <content:encoded><![CDATA[The first digital banking in the UK was launched in 1983, Skype turns 15 this year, but 2017 finally saw panic over the impact that online consultations may have on general practices.

In this podcast Martin Marshall, professor of healthcare improvement at University College London joins us to discuss whether video conference actually is a disruptor, or whether it’s actually the whole business model of general practice that needs to change.

Read the full analysis:
<p>https://www.bmj.com/content/360/bmj.k1195</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/u4puhx/stream_421362561-bmjgroup-online-consultations-general-practice-is-primed-for-a-fight.mp3" length="30282501" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The first digital banking in the UK was launched in 1983, Skype turns 15 this year, but 2017 finally saw panic over the impact that online consultations may have on general practices.

In this podcast Martin Marshall, professor of healthcare improvement at University College London joins us to discuss whether video conference actually is a disruptor, or whether it’s actually the whole business model of general practice that needs to change.

Read the full analysis:
https://www.bmj.com/content/360/bmj.k1195]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1263</itunes:duration>
                                    </item>
    <item>
        <title>Evidence for off label prescribing - explore less, confirm more</title>
        <itunes:title>Evidence for off label prescribing - explore less, confirm more</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/evidence-for-off-label-prescribing-explore-less-confirm-more/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/evidence-for-off-label-prescribing-explore-less-confirm-more/#comments</comments>        <pubDate>Fri, 23 Mar 2018 18:37:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/evidence-for-off-label-prescribing-explore-less-confirm-more</guid>
                                    <description><![CDATA[When a new drug reaches market, the race is on to find more indications for its use - exploratory trials are set up, and positive results can lead to the off label prescriptions (eg Pregabalin for lower back pain. However, these initial indications are rarely confirmed with further, better quality, evidence. 

Jonathan Kimmelman is an associate professor at MCgill University in Canada, thinks it's time to explore less, and confirm more - and joins us to explain why.

Read the full analysis:
<p>http://www.bmj.com/content/360/bmj.k959</p>
]]></description>
                                                            <content:encoded><![CDATA[When a new drug reaches market, the race is on to find more indications for its use - exploratory trials are set up, and positive results can lead to the off label prescriptions (eg Pregabalin for lower back pain. However, these initial indications are rarely confirmed with further, better quality, evidence. 

Jonathan Kimmelman is an associate professor at MCgill University in Canada, thinks it's time to explore less, and confirm more - and joins us to explain why.

Read the full analysis:
<p>http://www.bmj.com/content/360/bmj.k959</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/v121n4/stream_418448428-bmjgroup-evidence-for-off-label-prescribing-explore-less-confirm-more.mp3" length="34737039" type="audio/mpeg"/>
        <itunes:summary><![CDATA[When a new drug reaches market, the race is on to find more indications for its use - exploratory trials are set up, and positive results can lead to the off label prescriptions (eg Pregabalin for lower back pain. However, these initial indications are rarely confirmed with further, better quality, evidence. 

Jonathan Kimmelman is an associate professor at MCgill University in Canada, thinks it's time to explore less, and confirm more - and joins us to explain why.

Read the full analysis:
http://www.bmj.com/content/360/bmj.k959]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1449</itunes:duration>
                                    </item>
    <item>
        <title>How to stop generic drug price hikes (or at least reduce them)</title>
        <itunes:title>How to stop generic drug price hikes (or at least reduce them)</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/how-to-stop-generic-drug-price-hikes-or-at-least-reduce-them/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/how-to-stop-generic-drug-price-hikes-or-at-least-reduce-them/#comments</comments>        <pubDate>Fri, 23 Mar 2018 16:27:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/how-to-stop-generic-drug-price-hikes-or-at-least-reduce-them</guid>
                                    <description><![CDATA[Ravi Gupta, is a resident in internal medicine at Johns Hopkins in Baltimore - and as he said has seen the influence of sudden price hikes on his patients - between 2010 and 2015 more than 300 drugs in the U.S. have seen sudden increases of over %100.

Ravi and his co-authors have suggested, and tested the feasibility of, a possible answer to those price hikes - a small tweak that should protect patients from the possibility that they’ll suddenly be unable to afford their essential medication.

Read the full research:
<p>http://www.bmj.com/content/360/bmj.k831</p>
]]></description>
                                                            <content:encoded><![CDATA[Ravi Gupta, is a resident in internal medicine at Johns Hopkins in Baltimore - and as he said has seen the influence of sudden price hikes on his patients - between 2010 and 2015 more than 300 drugs in the U.S. have seen sudden increases of over %100.

Ravi and his co-authors have suggested, and tested the feasibility of, a possible answer to those price hikes - a small tweak that should protect patients from the possibility that they’ll suddenly be unable to afford their essential medication.

Read the full research:
<p>http://www.bmj.com/content/360/bmj.k831</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6xlu3x/stream_418368776-bmjgroup-how-to-stop-generic-drug-price-hikes-or-at-least-reduce-them.mp3" length="27239541" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Ravi Gupta, is a resident in internal medicine at Johns Hopkins in Baltimore - and as he said has seen the influence of sudden price hikes on his patients - between 2010 and 2015 more than 300 drugs in the U.S. have seen sudden increases of over %100.

Ravi and his co-authors have suggested, and tested the feasibility of, a possible answer to those price hikes - a small tweak that should protect patients from the possibility that they’ll suddenly be unable to afford their essential medication.

Read the full research:
http://www.bmj.com/content/360/bmj.k831]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1136</itunes:duration>
                                    </item>
    <item>
        <title>Dorling on decreasing life expectancy - ”the DOH have lost their credibility”</title>
        <itunes:title>Dorling on decreasing life expectancy - ”the DOH have lost their credibility”</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/dorling-on-decreasing-life-expectancy-the-doh-have-lost-their-credibility/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/dorling-on-decreasing-life-expectancy-the-doh-have-lost-their-credibility/#comments</comments>        <pubDate>Fri, 16 Mar 2018 16:23:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/dorling-on-decreasing-life-expectancy-the-doh-have-lost-their-credibility</guid>
                                    <description><![CDATA[”An additional person died every seven minutes during the first 49 days of 2018 compared with what had been usual in the previous five years. Why?

In this podcast, Danny Dorling, Halford Mackinder professor of geography at the university of Oxford, talks about the spike in mortality, what that means for overall life expectancy in the UK (spoiler, it’s not great) and what he thinks could be fuelling the change.


Read the full editorial
http://www.bmj.com/content/360/bmj.k1090

For more information, this article by Dorling and Hiam has further analysis:
<p>https://theconversation.com/rapid-rise-in-mortality-in-england-and-wales-in-early-2018-an-investigation-is-needed-93311</p>
]]></description>
                                                            <content:encoded><![CDATA[”An additional person died every seven minutes during the first 49 days of 2018 compared with what had been usual in the previous five years. Why?

In this podcast, Danny Dorling, Halford Mackinder professor of geography at the university of Oxford, talks about the spike in mortality, what that means for overall life expectancy in the UK (spoiler, it’s not great) and what he thinks could be fuelling the change.


Read the full editorial
http://www.bmj.com/content/360/bmj.k1090

For more information, this article by Dorling and Hiam has further analysis:
<p>https://theconversation.com/rapid-rise-in-mortality-in-england-and-wales-in-early-2018-an-investigation-is-needed-93311</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/h4ta4x/stream_414662739-bmjgroup-dorling-on-decreasing-life-expectancy-the-doh-have-lost-their-credibility.mp3" length="29359611" type="audio/mpeg"/>
        <itunes:summary><![CDATA[”An additional person died every seven minutes during the first 49 days of 2018 compared with what had been usual in the previous five years. Why?

In this podcast, Danny Dorling, Halford Mackinder professor of geography at the university of Oxford, talks about the spike in mortality, what that means for overall life expectancy in the UK (spoiler, it’s not great) and what he thinks could be fuelling the change.


Read the full editorial
http://www.bmj.com/content/360/bmj.k1090

For more information, this article by Dorling and Hiam has further analysis:
https://theconversation.com/rapid-rise-in-mortality-in-england-and-wales-in-early-2018-an-investigation-is-needed-93311]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1224</itunes:duration>
                                    </item>
    <item>
        <title>Unprofessionalism - ”blaming other people, I put that at the top of the impact list”</title>
        <itunes:title>Unprofessionalism - ”blaming other people, I put that at the top of the impact list”</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/unprofessionalism-blaming-other-people-i-put-that-at-the-top-of-the-impact-list/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/unprofessionalism-blaming-other-people-i-put-that-at-the-top-of-the-impact-list/#comments</comments>        <pubDate>Mon, 12 Mar 2018 12:16:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/unprofessionalism-blaming-other-people-i-put-that-at-the-top-of-the-impact-list</guid>
                                    <description><![CDATA[That’s Jo Shapiro is a surgeon and manager in Brigham and Women’s hospital,  she’s also director of the Center for Professionalism and Peer Support, and has written an editorial for The BMJ on tackling unprofessional behaviour.

In this discussion, she and I talked about what she thinks (beyond the illegal) are the most damaging behaviours seen around a hospital, what needs to be done to set up an environment that allows the victims of unprofessional behaviour to speak out about senior members of staff, and how she goes about confronting perpetrators about their behaviour.

Read the full editorial:
<p>http://www.bmj.com/content/360/bmj.k1025</p>
]]></description>
                                                            <content:encoded><![CDATA[That’s Jo Shapiro is a surgeon and manager in Brigham and Women’s hospital,  she’s also director of the Center for Professionalism and Peer Support, and has written an editorial for The BMJ on tackling unprofessional behaviour.

In this discussion, she and I talked about what she thinks (beyond the illegal) are the most damaging behaviours seen around a hospital, what needs to be done to set up an environment that allows the victims of unprofessional behaviour to speak out about senior members of staff, and how she goes about confronting perpetrators about their behaviour.

Read the full editorial:
<p>http://www.bmj.com/content/360/bmj.k1025</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ky0xy4/stream_412463571-bmjgroup-unprofessionalism-blaming-other-people-i-put-that-at-the-top-of-the-impact-list.mp3" length="68409624" type="audio/mpeg"/>
        <itunes:summary><![CDATA[That’s Jo Shapiro is a surgeon and manager in Brigham and Women’s hospital,  she’s also director of the Center for Professionalism and Peer Support, and has written an editorial for The BMJ on tackling unprofessional behaviour.

In this discussion, she and I talked about what she thinks (beyond the illegal) are the most damaging behaviours seen around a hospital, what needs to be done to set up an environment that allows the victims of unprofessional behaviour to speak out about senior members of staff, and how she goes about confronting perpetrators about their behaviour.

Read the full editorial:
http://www.bmj.com/content/360/bmj.k1025]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2854</itunes:duration>
                                    </item>
    <item>
        <title>Should doctors prescribe acupuncture for pain?</title>
        <itunes:title>Should doctors prescribe acupuncture for pain?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/should-doctors-prescribe-acupuncture-for-pain/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/should-doctors-prescribe-acupuncture-for-pain/#comments</comments>        <pubDate>Thu, 08 Mar 2018 18:00:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/should-doctors-prescribe-acupuncture-for-pain</guid>
                                    <description><![CDATA[Our latest debate asks, should doctors recommend acupuncture for pain? Asbjørn Hróbjartsson from the Center for Evidence-based Medicine at University of Southern Denmark argues no - evidence show's it's no worse than placebo. Mike Cummings, medical director of the British Medical Acupuncture Society argues yes - that there is evidence of efficacy, and trials haven't been designed to accurately measure that.

We also hear from Kumari Manickasamy, a GP in north London, and someone who used acupuncture to control her pain during pregnancy despite knowing the lack of evidence. 

Read the debate and commentary:
http://www.bmj.com/content/360/bmj.k970
<p>http://www.bmj.com/content/360/bmj.k990</p>
]]></description>
                                                            <content:encoded><![CDATA[Our latest debate asks, should doctors recommend acupuncture for pain? Asbjørn Hróbjartsson from the Center for Evidence-based Medicine at University of Southern Denmark argues no - evidence show's it's no worse than placebo. Mike Cummings, medical director of the British Medical Acupuncture Society argues yes - that there is evidence of efficacy, and trials haven't been designed to accurately measure that.

We also hear from Kumari Manickasamy, a GP in north London, and someone who used acupuncture to control her pain during pregnancy despite knowing the lack of evidence. 

Read the debate and commentary:
http://www.bmj.com/content/360/bmj.k970
<p>http://www.bmj.com/content/360/bmj.k990</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/00vaum/stream_410628513-bmjgroup-should-doctors-prescribe-acupuncture-for-pain.mp3" length="24395776" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Our latest debate asks, should doctors recommend acupuncture for pain? Asbjørn Hróbjartsson from the Center for Evidence-based Medicine at University of Southern Denmark argues no - evidence show's it's no worse than placebo. Mike Cummings, medical director of the British Medical Acupuncture Society argues yes - that there is evidence of efficacy, and trials haven't been designed to accurately measure that.

We also hear from Kumari Manickasamy, a GP in north London, and someone who used acupuncture to control her pain during pregnancy despite knowing the lack of evidence. 

Read the debate and commentary:
http://www.bmj.com/content/360/bmj.k970
http://www.bmj.com/content/360/bmj.k990]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1636</itunes:duration>
                                    </item>
    <item>
        <title>Nuffield Summit 2018 - HR in all policies, how the NHS can become a good employer</title>
        <itunes:title>Nuffield Summit 2018 - HR in all policies, how the NHS can become a good employer</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/nuffield-summit-2018-hr-in-all-policies-how-the-nhs-can-become-a-good-employer/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/nuffield-summit-2018-hr-in-all-policies-how-the-nhs-can-become-a-good-employer/#comments</comments>        <pubDate>Wed, 07 Mar 2018 17:25:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/nuffield-summit-2018-hr-in-all-policies-how-can-the-nhs-be-a-good-employer</guid>
                                    <description><![CDATA[In this year's Nuffield Summit round table we're asking, how can the NHS become a good employer?

At the moment, there is a recruitment and retention crisis across the workforce, doctors and nurses are leaving the NHS in droves, rota gaps are prevalent. A recent BMA survey showed that the majority of junior doctors are now planning to take a career break.

So against this backdrop, what can the NHS do to nurture it's employees, and make medicine an exciting proposition for the millennial, and subsequent, generations.

Taking part are:

Fiona Godlee (Chair), editor-in-chief, The BMJ

Candace Imison, director of policy, The Nuffield Trust 

Bob Klaber, consultant paediatrician and associate medical director, Imperial College Healthcare NHS Trust

Claire Lemer, consultant in general paediatrics and service transformation, Guys and St Thomas’s NHS Foundation Trust

Nishma Manek, GP trainee in London, national medical director’s clinical fellow

<p>Clifford Mann, consultant in Emergency Medicine, Taunton and Somerset NHS Foundation Trust, national clinical advisor for NHS England’s Accident and Emergency Improvement Plan</p>
]]></description>
                                                            <content:encoded><![CDATA[In this year's Nuffield Summit round table we're asking, how can the NHS become a good employer?

At the moment, there is a recruitment and retention crisis across the workforce, doctors and nurses are leaving the NHS in droves, rota gaps are prevalent. A recent BMA survey showed that the majority of junior doctors are now planning to take a career break.

So against this backdrop, what can the NHS do to nurture it's employees, and make medicine an exciting proposition for the millennial, and subsequent, generations.

Taking part are:

Fiona Godlee (Chair), editor-in-chief, The BMJ

Candace Imison, director of policy, The Nuffield Trust 

Bob Klaber, consultant paediatrician and associate medical director, Imperial College Healthcare NHS Trust

Claire Lemer, consultant in general paediatrics and service transformation, Guys and St Thomas’s NHS Foundation Trust

Nishma Manek, GP trainee in London, national medical director’s clinical fellow

<p>Clifford Mann, consultant in Emergency Medicine, Taunton and Somerset NHS Foundation Trust, national clinical advisor for NHS England’s Accident and Emergency Improvement Plan</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ykhn11/stream_410102595-bmjgroup-nuffield-summit-2018-hr-in-all-policies-how-can-the-nhs-be-a-good-employer.mp3" length="61563391" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this year's Nuffield Summit round table we're asking, how can the NHS become a good employer?

At the moment, there is a recruitment and retention crisis across the workforce, doctors and nurses are leaving the NHS in droves, rota gaps are prevalent. A recent BMA survey showed that the majority of junior doctors are now planning to take a career break.

So against this backdrop, what can the NHS do to nurture it's employees, and make medicine an exciting proposition for the millennial, and subsequent, generations.

Taking part are:

Fiona Godlee (Chair), editor-in-chief, The BMJ

Candace Imison, director of policy, The Nuffield Trust 

Bob Klaber, consultant paediatrician and associate medical director, Imperial College Healthcare NHS Trust

Claire Lemer, consultant in general paediatrics and service transformation, Guys and St Thomas’s NHS Foundation Trust

Nishma Manek, GP trainee in London, national medical director’s clinical fellow

Clifford Mann, consultant in Emergency Medicine, Taunton and Somerset NHS Foundation Trust, national clinical advisor for NHS England’s Accident and Emergency Improvement Plan]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2568</itunes:duration>
                                    </item>
    <item>
        <title>Katherine Cowan - Reaching A Priority</title>
        <itunes:title>Katherine Cowan - Reaching A Priority</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/katherine-cowan-reaching-a-priority/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/katherine-cowan-reaching-a-priority/#comments</comments>        <pubDate>Fri, 02 Mar 2018 15:59:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/katherine-cowan-reaching-a-priority</guid>
                                    <description><![CDATA[Its now widely agreed that one of the key ways of reducing  the current  high level of "waste " in  biomedical research is to focus it more squarely on addressing  the questions that matter to patients  - and the people and medical staff that care for them. 

In this interview, Tessa Richards - the BMJ's patient partnership editor, talks to Katherine Cowan, independent consultant and a senior advisor the the James Lind Alliance, which  has pioneered patient involvement with their research priority setting partnerships.

<p>In this conversation they talk about how these work, the challenge of navigating between different groups with what are often very different views and agendas, and why she thinks healthy debate on divergent views is no bad thing</p>
]]></description>
                                                            <content:encoded><![CDATA[Its now widely agreed that one of the key ways of reducing  the current  high level of "waste " in  biomedical research is to focus it more squarely on addressing  the questions that matter to patients  - and the people and medical staff that care for them. 

In this interview, Tessa Richards - the BMJ's patient partnership editor, talks to Katherine Cowan, independent consultant and a senior advisor the the James Lind Alliance, which  has pioneered patient involvement with their research priority setting partnerships.

<p>In this conversation they talk about how these work, the challenge of navigating between different groups with what are often very different views and agendas, and why she thinks healthy debate on divergent views is no bad thing</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/it2yvo/stream_407621220-bmjgroup-katherine-cowan-reaching-a-priority.mp3" length="40001309" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Its now widely agreed that one of the key ways of reducing  the current  high level of "waste " in  biomedical research is to focus it more squarely on addressing  the questions that matter to patients  - and the people and medical staff that care for them. 

In this interview, Tessa Richards - the BMJ's patient partnership editor, talks to Katherine Cowan, independent consultant and a senior advisor the the James Lind Alliance, which  has pioneered patient involvement with their research priority setting partnerships.

In this conversation they talk about how these work, the challenge of navigating between different groups with what are often very different views and agendas, and why she thinks healthy debate on divergent views is no bad thing]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1668</itunes:duration>
                                    </item>
    <item>
        <title>Should universal distribution of high dose vitamin A to children cease?</title>
        <itunes:title>Should universal distribution of high dose vitamin A to children cease?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/should-universal-distribution-of-high-dose-vitamin-a-to-children-cease/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/should-universal-distribution-of-high-dose-vitamin-a-to-children-cease/#comments</comments>        <pubDate>Thu, 01 Mar 2018 14:49:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/vitamin-a-mixdown</guid>
                                    <description><![CDATA[Up to $500m a year could be put to better use by stopping ineffective and potentially harmful supplementation programmes in poorer countries, argues John Mason, professor emeritus at Tulane University School of Public Health and Tropical Medicine. 

However Keith West,  professor of infant and child nutrition at Johns Hopkins Bloomberg School of Public Health disagrees, saying that such programmes have been proved to save millions of lives and should be withdrawn only when robust evidence permits.

Read the full head to head debate:
<p>http://www.bmj.com/content/360/bmj.k927</p>
]]></description>
                                                            <content:encoded><![CDATA[Up to $500m a year could be put to better use by stopping ineffective and potentially harmful supplementation programmes in poorer countries, argues John Mason, professor emeritus at Tulane University School of Public Health and Tropical Medicine. 

However Keith West,  professor of infant and child nutrition at Johns Hopkins Bloomberg School of Public Health disagrees, saying that such programmes have been proved to save millions of lives and should be withdrawn only when robust evidence permits.

Read the full head to head debate:
<p>http://www.bmj.com/content/360/bmj.k927</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/pgyj69/stream_407042373-bmjgroup-vitamin-a-mixdown.mp3" length="25546436" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Up to $500m a year could be put to better use by stopping ineffective and potentially harmful supplementation programmes in poorer countries, argues John Mason, professor emeritus at Tulane University School of Public Health and Tropical Medicine. 

However Keith West,  professor of infant and child nutrition at Johns Hopkins Bloomberg School of Public Health disagrees, saying that such programmes have been proved to save millions of lives and should be withdrawn only when robust evidence permits.

Read the full head to head debate:
http://www.bmj.com/content/360/bmj.k927]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1065</itunes:duration>
                                    </item>
    <item>
        <title>Fever in the returning traveller</title>
        <itunes:title>Fever in the returning traveller</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/fever-in-the-returning-traveller/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/fever-in-the-returning-traveller/#comments</comments>        <pubDate>Tue, 20 Feb 2018 17:32:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/fever-in-the-returning-traveller</guid>
                                    <description><![CDATA[International travel is increasingly common. Between 10% and 42% of travellers to any destination, and 15%-70% of travellers to tropical settings experience ill health, either while abroad or on returning home,

Malaria is the commonest specific diagnosis, accounting for 5%-29% of all individuals presenting to specialist clinic, followed by dengue, enteric fever, and rickettsial infections .

In this podcast Doug Fink specialist registrar, and Victoria Johnston consultant,  in infectious diseases at The Hospital for Tropical Diseases join us to discuss diagnosis, and treatment - and why the clinically most interesting diagnosis is rarely the right one.

Read the full practice article:
<p>http://www.bmj.com/content/360/bmj.j5773</p>
]]></description>
                                                            <content:encoded><![CDATA[International travel is increasingly common. Between 10% and 42% of travellers to any destination, and 15%-70% of travellers to tropical settings experience ill health, either while abroad or on returning home,

Malaria is the commonest specific diagnosis, accounting for 5%-29% of all individuals presenting to specialist clinic, followed by dengue, enteric fever, and rickettsial infections .

In this podcast Doug Fink specialist registrar, and Victoria Johnston consultant,  in infectious diseases at The Hospital for Tropical Diseases join us to discuss diagnosis, and treatment - and why the clinically most interesting diagnosis is rarely the right one.

Read the full practice article:
<p>http://www.bmj.com/content/360/bmj.j5773</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wq426y/stream_402555240-bmjgroup-fever-in-the-returning-traveller.mp3" length="45412445" type="audio/mpeg"/>
        <itunes:summary><![CDATA[International travel is increasingly common. Between 10% and 42% of travellers to any destination, and 15%-70% of travellers to tropical settings experience ill health, either while abroad or on returning home,

Malaria is the commonest specific diagnosis, accounting for 5%-29% of all individuals presenting to specialist clinic, followed by dengue, enteric fever, and rickettsial infections .

In this podcast Doug Fink specialist registrar, and Victoria Johnston consultant,  in infectious diseases at The Hospital for Tropical Diseases join us to discuss diagnosis, and treatment - and why the clinically most interesting diagnosis is rarely the right one.

Read the full practice article:
http://www.bmj.com/content/360/bmj.j5773]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1894</itunes:duration>
                                    </item>
    <item>
        <title>SDGs - How many lives are at stake?</title>
        <itunes:title>SDGs - How many lives are at stake?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/sdgs-how-many-lives-are-at-stake/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/sdgs-how-many-lives-are-at-stake/#comments</comments>        <pubDate>Sat, 17 Feb 2018 12:58:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/sdgs-how-many-lives-are-at-stake</guid>
                                    <description><![CDATA[In a new analysis  John McArthur and Krista Rasmussen, from the Global Economy and Development Program at the Brookings Institution, and Gavin Yamey from Duke University, have set out to analyse the potential for lives saved by the goals set in the Sustainable Development Goals

In this conversation I talked to Gavin and John about the numbers, which countries have to accelerate their development to meet those goals - and we also address some of the criticisms of the SDGs - that they’re too wide ranging, that they lack a political dimension, and that they are unrealistic.

Read the full analysis and more on the SDGs:
http://www.bmj.com/content/360/bmj.k373
<p>http://www.bmj.com/content/sustainable-development-goals</p>
]]></description>
                                                            <content:encoded><![CDATA[In a new analysis  John McArthur and Krista Rasmussen, from the Global Economy and Development Program at the Brookings Institution, and Gavin Yamey from Duke University, have set out to analyse the potential for lives saved by the goals set in the Sustainable Development Goals

In this conversation I talked to Gavin and John about the numbers, which countries have to accelerate their development to meet those goals - and we also address some of the criticisms of the SDGs - that they’re too wide ranging, that they lack a political dimension, and that they are unrealistic.

Read the full analysis and more on the SDGs:
http://www.bmj.com/content/360/bmj.k373
<p>http://www.bmj.com/content/sustainable-development-goals</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jezn63/stream_400993893-bmjgroup-sdgs-how-many-lives-are-at-stake.mp3" length="62583149" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In a new analysis  John McArthur and Krista Rasmussen, from the Global Economy and Development Program at the Brookings Institution, and Gavin Yamey from Duke University, have set out to analyse the potential for lives saved by the goals set in the Sustainable Development Goals

In this conversation I talked to Gavin and John about the numbers, which countries have to accelerate their development to meet those goals - and we also address some of the criticisms of the SDGs - that they’re too wide ranging, that they lack a political dimension, and that they are unrealistic.

Read the full analysis and more on the SDGs:
http://www.bmj.com/content/360/bmj.k373
http://www.bmj.com/content/sustainable-development-goals]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2610</itunes:duration>
                                    </item>
    <item>
        <title>”We don’t really know the impact of these products on our health”: Ultraprocessed food &amp; cancer risk</title>
        <itunes:title>”We don’t really know the impact of these products on our health”: Ultraprocessed food &amp; cancer risk</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/we-don-t-really-know-the-impact-of-these-products-on-our-health-ultraprocessed-food-cancer-risk/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/we-don-t-really-know-the-impact-of-these-products-on-our-health-ultraprocessed-food-cancer-risk/#comments</comments>        <pubDate>Thu, 15 Feb 2018 10:47:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/ultraprocessed-food-and-increased-cancer-risk</guid>
                                    <description><![CDATA[A study published by The BMJ today reports a possible association between intake of highly processed (“ultra-processed”) food in the diet and cancer. 

Ultra-processed foods include packaged baked goods and snacks, fizzy drinks, sugary cereals, ready meals and reconstituted meat products - often containing high levels of sugar, fat, and salt, but lacking in vitamins and fibre. They are thought to account for up to 50% of total daily energy intake in several developed countries.

Mathilde Touvier, senior researcher in nutritional epidemiology and Bernard Srour, pharmacist and PhD Candidate, both at INSERM, join us to discuss what ultra processed foods actually are, why it is they could be leading to cancer, and what their cohort study tells us about that potential risk.

Read the full open access research:
<p>http://www.bmj.com/content/360/bmj.k322</p>
]]></description>
                                                            <content:encoded><![CDATA[A study published by The BMJ today reports a possible association between intake of highly processed (“ultra-processed”) food in the diet and cancer. 

Ultra-processed foods include packaged baked goods and snacks, fizzy drinks, sugary cereals, ready meals and reconstituted meat products - often containing high levels of sugar, fat, and salt, but lacking in vitamins and fibre. They are thought to account for up to 50% of total daily energy intake in several developed countries.

Mathilde Touvier, senior researcher in nutritional epidemiology and Bernard Srour, pharmacist and PhD Candidate, both at INSERM, join us to discuss what ultra processed foods actually are, why it is they could be leading to cancer, and what their cohort study tells us about that potential risk.

Read the full open access research:
<p>http://www.bmj.com/content/360/bmj.k322</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7z01i4/stream_399962433-bmjgroup-ultraprocessed-food-and-increased-cancer-risk.mp3" length="31163904" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A study published by The BMJ today reports a possible association between intake of highly processed (“ultra-processed”) food in the diet and cancer. 

Ultra-processed foods include packaged baked goods and snacks, fizzy drinks, sugary cereals, ready meals and reconstituted meat products - often containing high levels of sugar, fat, and salt, but lacking in vitamins and fibre. They are thought to account for up to 50% of total daily energy intake in several developed countries.

Mathilde Touvier, senior researcher in nutritional epidemiology and Bernard Srour, pharmacist and PhD Candidate, both at INSERM, join us to discuss what ultra processed foods actually are, why it is they could be leading to cancer, and what their cohort study tells us about that potential risk.

Read the full open access research:
http://www.bmj.com/content/360/bmj.k322]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1300</itunes:duration>
                                    </item>
    <item>
        <title>How does it feel, to help your patient die?</title>
        <itunes:title>How does it feel, to help your patient die?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/how-does-it-feel-to-help-your-patient-die/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/how-does-it-feel-to-help-your-patient-die/#comments</comments>        <pubDate>Thu, 08 Feb 2018 11:55:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/how-does-it-feel-to-help-your-patient-die</guid>
                                    <description><![CDATA[Sabine Netters is an oncologist in The Netherlands - where assisted dying is legal. There doctors actually administer the drugs to help their patients die (unlike proposed legislation in the UK).

In this moving interview, Sabine explains what was going through her head, the first time she helped her patient die - and how in the subsequent years, the emotional toll hasn't lessened. She explains why she believes that in certain circumstances, euthanasia can be the ultimate caring act.

Read her essay:
<p>http://www.bmj.com/content/360/bmj.k116</p>
]]></description>
                                                            <content:encoded><![CDATA[Sabine Netters is an oncologist in The Netherlands - where assisted dying is legal. There doctors actually administer the drugs to help their patients die (unlike proposed legislation in the UK).

In this moving interview, Sabine explains what was going through her head, the first time she helped her patient die - and how in the subsequent years, the emotional toll hasn't lessened. She explains why she believes that in certain circumstances, euthanasia can be the ultimate caring act.

Read her essay:
<p>http://www.bmj.com/content/360/bmj.k116</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/a15skt/stream_396294450-bmjgroup-how-does-it-feel-to-help-your-patient-die.mp3" length="38707872" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Sabine Netters is an oncologist in The Netherlands - where assisted dying is legal. There doctors actually administer the drugs to help their patients die (unlike proposed legislation in the UK).

In this moving interview, Sabine explains what was going through her head, the first time she helped her patient die - and how in the subsequent years, the emotional toll hasn't lessened. She explains why she believes that in certain circumstances, euthanasia can be the ultimate caring act.

Read her essay:
http://www.bmj.com/content/360/bmj.k116]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1614</itunes:duration>
                                    </item>
    <item>
        <title>The tone of the debate around assisted dying</title>
        <itunes:title>The tone of the debate around assisted dying</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-tone-of-the-debate-around-assisted-dying/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-tone-of-the-debate-around-assisted-dying/#comments</comments>        <pubDate>Thu, 08 Feb 2018 11:47:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-tone-of-the-debate-around-assisted-dying</guid>
                                    <description><![CDATA[Bobbie Farsides is professor of clinical and biomedical ethics at Brighton and Sussex Medical School. She’s been described as one of the few people that is acceptable to “both sides” of the assisted dying debate.

This week she joins us to talk about the way in which the debate on euthanasia has played out in the UK - and hear why she thinks it’s now time for all individual doctors to make up their own mind, and not let either camp own the argument for them.

Read her commentary on the debate:
<p>http://www.bmj.com/content/360/bmj.k544</p>
]]></description>
                                                            <content:encoded><![CDATA[Bobbie Farsides is professor of clinical and biomedical ethics at Brighton and Sussex Medical School. She’s been described as one of the few people that is acceptable to “both sides” of the assisted dying debate.

This week she joins us to talk about the way in which the debate on euthanasia has played out in the UK - and hear why she thinks it’s now time for all individual doctors to make up their own mind, and not let either camp own the argument for them.

Read her commentary on the debate:
<p>http://www.bmj.com/content/360/bmj.k544</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/54l00x/stream_396292668-bmjgroup-the-tone-of-the-debate-around-assisted-dying.mp3" length="30223408" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Bobbie Farsides is professor of clinical and biomedical ethics at Brighton and Sussex Medical School. She’s been described as one of the few people that is acceptable to “both sides” of the assisted dying debate.

This week she joins us to talk about the way in which the debate on euthanasia has played out in the UK - and hear why she thinks it’s now time for all individual doctors to make up their own mind, and not let either camp own the argument for them.

Read her commentary on the debate:
http://www.bmj.com/content/360/bmj.k544]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1260</itunes:duration>
                                    </item>
    <item>
        <title>Torture - What declassified guidelines tell us about medical complicity</title>
        <itunes:title>Torture - What declassified guidelines tell us about medical complicity</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/torture-what-declassified-guidelines-tell-us-about-medical-complicity/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/torture-what-declassified-guidelines-tell-us-about-medical-complicity/#comments</comments>        <pubDate>Mon, 05 Feb 2018 10:19:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/torture-what-declassified-guidelines-tell-us-about-medical-complicity</guid>
                                    <description><![CDATA[The UN Convention against Torture defines torture as “any act by which severe pain or suffering, whether physical or mental, is intentionally inflicted on a person” by someone acting in an official capacity for purposes such as obtaining a confession or punishing or intimidating that person.

It is unethical for healthcare professionals to participate in torture, including any use of medical knowledge or skill to facilitate torture or allow it to continue, or to be present during torture. Yet medical participation in torture has taken place throughout the world and was a prominent feature of the US interrogation practice in military and Central Intelligence Agency (CIA) detention facilities in the years after the attacks of 11 September 2001. Little attention has been paid, however, to how a regime of torture affects the ability of health professionals to meet their obligations regarding routine clinical care for detainees.

The 2016 release of previously classified portions of guidelines from the CIA regarding medical practice in its secret detention facilities sheds light on that question. These show that the CIA instructed healthcare professions to subordinate their fundamental ethical obligations regarding professional standards of care to further the objectives of the torturers.

In this podcast, Zackary Berger, associate professor at Johns Hopkins School of Medicine, joins us to discuss what those guidelines have revealed.

Read the full analysis:
<p>http://www.bmj.com/content/360/bmj.k449</p>
]]></description>
                                                            <content:encoded><![CDATA[The UN Convention against Torture defines torture as “any act by which severe pain or suffering, whether physical or mental, is intentionally inflicted on a person” by someone acting in an official capacity for purposes such as obtaining a confession or punishing or intimidating that person.

It is unethical for healthcare professionals to participate in torture, including any use of medical knowledge or skill to facilitate torture or allow it to continue, or to be present during torture. Yet medical participation in torture has taken place throughout the world and was a prominent feature of the US interrogation practice in military and Central Intelligence Agency (CIA) detention facilities in the years after the attacks of 11 September 2001. Little attention has been paid, however, to how a regime of torture affects the ability of health professionals to meet their obligations regarding routine clinical care for detainees.

The 2016 release of previously classified portions of guidelines from the CIA regarding medical practice in its secret detention facilities sheds light on that question. These show that the CIA instructed healthcare professions to subordinate their fundamental ethical obligations regarding professional standards of care to further the objectives of the torturers.

In this podcast, Zackary Berger, associate professor at Johns Hopkins School of Medicine, joins us to discuss what those guidelines have revealed.

Read the full analysis:
<p>http://www.bmj.com/content/360/bmj.k449</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/37cgvp/stream_394747773-bmjgroup-torture-what-declassified-guidelines-tell-us-about-medical-complicity.mp3" length="25372548" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The UN Convention against Torture defines torture as “any act by which severe pain or suffering, whether physical or mental, is intentionally inflicted on a person” by someone acting in an official capacity for purposes such as obtaining a confession or punishing or intimidating that person.

It is unethical for healthcare professionals to participate in torture, including any use of medical knowledge or skill to facilitate torture or allow it to continue, or to be present during torture. Yet medical participation in torture has taken place throughout the world and was a prominent feature of the US interrogation practice in military and Central Intelligence Agency (CIA) detention facilities in the years after the attacks of 11 September 2001. Little attention has been paid, however, to how a regime of torture affects the ability of health professionals to meet their obligations regarding routine clinical care for detainees.

The 2016 release of previously classified portions of guidelines from the CIA regarding medical practice in its secret detention facilities sheds light on that question. These show that the CIA instructed healthcare professions to subordinate their fundamental ethical obligations regarding professional standards of care to further the objectives of the torturers.

In this podcast, Zackary Berger, associate professor at Johns Hopkins School of Medicine, joins us to discuss what those guidelines have revealed.

Read the full analysis:
http://www.bmj.com/content/360/bmj.k449]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1058</itunes:duration>
                                    </item>
    <item>
        <title>We must not get to the stage of thinking that [homelessness] is normal</title>
        <itunes:title>We must not get to the stage of thinking that [homelessness] is normal</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/we-must-not-get-to-the-stage-of-thinking-that-homelessness-is-normal/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/we-must-not-get-to-the-stage-of-thinking-that-homelessness-is-normal/#comments</comments>        <pubDate>Fri, 02 Feb 2018 13:20:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/we-must-not-get-to-the-stage-of-thinking-that-homelessness-is-normal</guid>
                                    <description><![CDATA[The number of people officially recorded as sleeping on the streets of England rose from 1768 in 2010 to 4751 in autumn 2017.1 Charities estimate the true figure to be more than double this.

Danny Dorling, Halford Mackinder professor of geography at the University of Oxford joins us to explain what's fuelling that rise, why the true extent of the problem is far larger, and what steps need to be taken to tackle the epidemic.

Read the editorial:
<p>http://www.bmj.com/content/360/bmj.k214</p>
]]></description>
                                                            <content:encoded><![CDATA[The number of people officially recorded as sleeping on the streets of England rose from 1768 in 2010 to 4751 in autumn 2017.1 Charities estimate the true figure to be more than double this.

Danny Dorling, Halford Mackinder professor of geography at the University of Oxford joins us to explain what's fuelling that rise, why the true extent of the problem is far larger, and what steps need to be taken to tackle the epidemic.

Read the editorial:
<p>http://www.bmj.com/content/360/bmj.k214</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7c856z/stream_393401430-bmjgroup-we-must-not-get-to-the-stage-of-thinking-that-homelessness-is-normal.mp3" length="24807411" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The number of people officially recorded as sleeping on the streets of England rose from 1768 in 2010 to 4751 in autumn 2017.1 Charities estimate the true figure to be more than double this.

Danny Dorling, Halford Mackinder professor of geography at the University of Oxford joins us to explain what's fuelling that rise, why the true extent of the problem is far larger, and what steps need to be taken to tackle the epidemic.

Read the editorial:
http://www.bmj.com/content/360/bmj.k214]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1034</itunes:duration>
                                    </item>
    <item>
        <title>Public health - time for pragmatism or knowledge production?</title>
        <itunes:title>Public health - time for pragmatism or knowledge production?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/public-health-time-for-pragmatism-or-knowledge-production/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/public-health-time-for-pragmatism-or-knowledge-production/#comments</comments>        <pubDate>Thu, 01 Feb 2018 15:58:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/public-health-time-for-pragmatism-or-knowledge-production</guid>
                                    <description><![CDATA[We have evidence on which to act, and inaction costs lives, argues Simon Capewell, Professor of Public Health and Policy, at the University of Liverpool. But Aileen Clarke, professor of public health and health services research at Warwick Medical School, says our understanding of the human behaviour that leads to unhealthy choices is still lacking

Read the head to head
<p>http://www.bmj.com/content/360/bmj.k292</p>
]]></description>
                                                            <content:encoded><![CDATA[We have evidence on which to act, and inaction costs lives, argues Simon Capewell, Professor of Public Health and Policy, at the University of Liverpool. But Aileen Clarke, professor of public health and health services research at Warwick Medical School, says our understanding of the human behaviour that leads to unhealthy choices is still lacking

Read the head to head
<p>http://www.bmj.com/content/360/bmj.k292</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fanknk/stream_392961681-bmjgroup-public-health-time-for-pragmatism-or-knowledge-production.mp3" length="31908981" type="audio/mpeg"/>
        <itunes:summary><![CDATA[We have evidence on which to act, and inaction costs lives, argues Simon Capewell, Professor of Public Health and Policy, at the University of Liverpool. But Aileen Clarke, professor of public health and health services research at Warwick Medical School, says our understanding of the human behaviour that leads to unhealthy choices is still lacking

Read the head to head
http://www.bmj.com/content/360/bmj.k292]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1331</itunes:duration>
                                    </item>
    <item>
        <title>Smoking one a day can’t hurt, can it?</title>
        <itunes:title>Smoking one a day can’t hurt, can it?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/smoking-one-a-day-can-t-hurt-can-it/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/smoking-one-a-day-can-t-hurt-can-it/#comments</comments>        <pubDate>Thu, 25 Jan 2018 14:59:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/smoking-one-a-day-cant-hurt-can-it</guid>
                                    <description><![CDATA[We know that smoking 20 cigarettes a day increases your risk of CHD and stroke - but what happens if you cut down to 1, do you have 1/20th of that risk?

Allan Hackshaw, professor of epidemiology at UCL joins us to discuss a new systematic review and meta analysis published on bmj.com, examining the risk of smoking just one or two cigarettes a day.

Read the full review:
<p>http://www.bmj.com/content/360/bmj.j5855</p>
]]></description>
                                                            <content:encoded><![CDATA[We know that smoking 20 cigarettes a day increases your risk of CHD and stroke - but what happens if you cut down to 1, do you have 1/20th of that risk?

Allan Hackshaw, professor of epidemiology at UCL joins us to discuss a new systematic review and meta analysis published on bmj.com, examining the risk of smoking just one or two cigarettes a day.

Read the full review:
<p>http://www.bmj.com/content/360/bmj.j5855</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/173ptc/stream_388928649-bmjgroup-smoking-one-a-day-cant-hurt-can-it.mp3" length="20200475" type="audio/mpeg"/>
        <itunes:summary><![CDATA[We know that smoking 20 cigarettes a day increases your risk of CHD and stroke - but what happens if you cut down to 1, do you have 1/20th of that risk?

Allan Hackshaw, professor of epidemiology at UCL joins us to discuss a new systematic review and meta analysis published on bmj.com, examining the risk of smoking just one or two cigarettes a day.

Read the full review:
http://www.bmj.com/content/360/bmj.j5855]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>842</itunes:duration>
                                    </item>
    <item>
        <title>Virginia Murray - the science of disaster risk reduction</title>
        <itunes:title>Virginia Murray - the science of disaster risk reduction</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/virginia-murray-the-science-of-disaster-risk-reduction/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/virginia-murray-the-science-of-disaster-risk-reduction/#comments</comments>        <pubDate>Wed, 24 Jan 2018 10:42:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/virginia-murray-the-science-of-disaster-risk-reduction</guid>
                                    <description><![CDATA[Virginia Murray, public health consultant in global disaster risk reduction at Public Health England, was instrumental in putting together the Sendai Framework for Disaster Risk Reduction - an international agreement which aims to move the world from reacting to disasters, to proactively preventing them.

In this podcast, she explains what they learned in the process, and why science had to become storytelling, in order to make politicians pay attention.

Read the editorial on creating a set of indicators for disaster preparedness.
<p>http://www.bmj.com/content/359/bmj.j5279</p>
]]></description>
                                                            <content:encoded><![CDATA[Virginia Murray, public health consultant in global disaster risk reduction at Public Health England, was instrumental in putting together the Sendai Framework for Disaster Risk Reduction - an international agreement which aims to move the world from reacting to disasters, to proactively preventing them.

In this podcast, she explains what they learned in the process, and why science had to become storytelling, in order to make politicians pay attention.

Read the editorial on creating a set of indicators for disaster preparedness.
<p>http://www.bmj.com/content/359/bmj.j5279</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qdfhr0/stream_388352600-bmjgroup-virginia-murray-the-science-of-disaster-risk-reduction.mp3" length="35854064" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Virginia Murray, public health consultant in global disaster risk reduction at Public Health England, was instrumental in putting together the Sendai Framework for Disaster Risk Reduction - an international agreement which aims to move the world from reacting to disasters, to proactively preventing them.

In this podcast, she explains what they learned in the process, and why science had to become storytelling, in order to make politicians pay attention.

Read the editorial on creating a set of indicators for disaster preparedness.
http://www.bmj.com/content/359/bmj.j5279]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1496</itunes:duration>
                                    </item>
    <item>
        <title>Education round-up - January 2018</title>
        <itunes:title>Education round-up - January 2018</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/education-round-up-january-2018/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/education-round-up-january-2018/#comments</comments>        <pubDate>Mon, 22 Jan 2018 17:30:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/education-round-up-january-2018</guid>
                                    <description><![CDATA[The BMJ publishes a variety of education articles, to help doctors improve their practice. Often authors join us in our podcast to give tips on putting their recommendations into practice.

In this audio round-up The BMJ’s clinical editors discuss what they have learned, and how they may alter their practice. Kate Addlington, associate editor and trainee psychiatrist is joined by Cat Chatfield, quality editor and GP.

They discuss acute respiratory distress syndrome:
http://www.bmj.com/content/359/bmj.j5055

Why it’s important to have early diagnosis of psychotic symptoms, and the evidence for improved outcomes:
http://www.bmj.com/content/357/bmj.j4578

And finally, why it’s important to consider hearing-loss on the ward:
<p>http://www.bmj.com/content/360/bmj.k21</p>
]]></description>
                                                            <content:encoded><![CDATA[The BMJ publishes a variety of education articles, to help doctors improve their practice. Often authors join us in our podcast to give tips on putting their recommendations into practice.

In this audio round-up The BMJ’s clinical editors discuss what they have learned, and how they may alter their practice. Kate Addlington, associate editor and trainee psychiatrist is joined by Cat Chatfield, quality editor and GP.

They discuss acute respiratory distress syndrome:
http://www.bmj.com/content/359/bmj.j5055

Why it’s important to have early diagnosis of psychotic symptoms, and the evidence for improved outcomes:
http://www.bmj.com/content/357/bmj.j4578

And finally, why it’s important to consider hearing-loss on the ward:
<p>http://www.bmj.com/content/360/bmj.k21</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/nutqb8/stream_387463295-bmjgroup-education-round-up-january-2018.mp3" length="56158375" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The BMJ publishes a variety of education articles, to help doctors improve their practice. Often authors join us in our podcast to give tips on putting their recommendations into practice.

In this audio round-up The BMJ’s clinical editors discuss what they have learned, and how they may alter their practice. Kate Addlington, associate editor and trainee psychiatrist is joined by Cat Chatfield, quality editor and GP.

They discuss acute respiratory distress syndrome:
http://www.bmj.com/content/359/bmj.j5055

Why it’s important to have early diagnosis of psychotic symptoms, and the evidence for improved outcomes:
http://www.bmj.com/content/357/bmj.j4578

And finally, why it’s important to consider hearing-loss on the ward:
http://www.bmj.com/content/360/bmj.k21]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2342</itunes:duration>
                                    </item>
    <item>
        <title>They can’t hear you - how hearing loss can affect care.</title>
        <itunes:title>They can’t hear you - how hearing loss can affect care.</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/they-can-t-hear-you-how-hearing-loss-can-affect-care/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/they-can-t-hear-you-how-hearing-loss-can-affect-care/#comments</comments>        <pubDate>Fri, 19 Jan 2018 12:31:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/they-cant-hear-you-how-deafness-on-the-ward-can-affect-care</guid>
                                    <description><![CDATA[Many older adults have difficulty understanding speech in acute healthcare settings owing to hearing loss, but the effect on patient care is often overlooked.

Jan Blustein professor of health policy and medicine at New York University, and who has also experienced the affects of hearing loss, joins us to explain what that's like, and gives some tips on making it easier to communicate.

Read the full analysis:
http://www.bmj.com/content/360/bmj.k21

Full transcript of the interview:
<p>https://docs.google.com/document/d/1Rp7zvRlnTG5KRVLgmR-PFt-0fVRLBqINU5EmOrT5RDU/edit?usp=sharing</p>
]]></description>
                                                            <content:encoded><![CDATA[Many older adults have difficulty understanding speech in acute healthcare settings owing to hearing loss, but the effect on patient care is often overlooked.

Jan Blustein professor of health policy and medicine at New York University, and who has also experienced the affects of hearing loss, joins us to explain what that's like, and gives some tips on making it easier to communicate.

Read the full analysis:
http://www.bmj.com/content/360/bmj.k21

Full transcript of the interview:
<p>https://docs.google.com/document/d/1Rp7zvRlnTG5KRVLgmR-PFt-0fVRLBqINU5EmOrT5RDU/edit?usp=sharing</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/zao7xj/stream_385943342-bmjgroup-they-cant-hear-you-how-deafness-on-the-ward-can-affect-care.mp3" length="22394483" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Many older adults have difficulty understanding speech in acute healthcare settings owing to hearing loss, but the effect on patient care is often overlooked.

Jan Blustein professor of health policy and medicine at New York University, and who has also experienced the affects of hearing loss, joins us to explain what that's like, and gives some tips on making it easier to communicate.

Read the full analysis:
http://www.bmj.com/content/360/bmj.k21

Full transcript of the interview:
https://docs.google.com/document/d/1Rp7zvRlnTG5KRVLgmR-PFt-0fVRLBqINU5EmOrT5RDU/edit?usp=sharing]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>933</itunes:duration>
                                    </item>
    <item>
        <title>MVA85A trial investigation - press conference.</title>
        <itunes:title>MVA85A trial investigation - press conference.</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/mva85a-trial-investigation-press-conference/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/mva85a-trial-investigation-press-conference/#comments</comments>        <pubDate>Thu, 11 Jan 2018 18:34:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/mva85a-trial-investigation-press-conference</guid>
                                    <description><![CDATA[Trial MVA85A - monkey trials for a booster vaccine for BCG, developed by researchers at Oxford University, is the subject of an investigation published on bmj.com.

Experts warn that today’s investigation is just one example of “a systematic failure” afflicting preclinical research and call for urgent action “to make animal research more fit for purpose as a valuable and reliable forerunner to clinical research in humans.”

The press conference is led by Dr Fiona Godlee, the editor-in-chief of the BMJ, who provides a background to the investigation. The panel members are:

Dr Deborah Cohen, author of the investigation and associate editor at the BMJ, talking about carrying out the investigation and the difficulty to obtain basic information 

Professor Paul Garner from the Liverpool School of Tropical Medicine, addressing the ineffectiveness of the current TB vaccine and also talking about the backlash he experienced after publishing a systematic review concluding that the animal studies results had been overstated

Malcolm Macleod, from the University of Edinburgh, talking about the broader public health aspect

Merel Ritskes-Hoitinga from the Department for Health Evidence in The Netherlands, addressing the quality of animal studies and the need for systematic reviews

<p>and Jonathan Kimmelman, from McGill University in Canada analysing the story from the perspective of biomedical ethics.</p>
]]></description>
                                                            <content:encoded><![CDATA[Trial MVA85A - monkey trials for a booster vaccine for BCG, developed by researchers at Oxford University, is the subject of an investigation published on bmj.com.

Experts warn that today’s investigation is just one example of “a systematic failure” afflicting preclinical research and call for urgent action “to make animal research more fit for purpose as a valuable and reliable forerunner to clinical research in humans.”

The press conference is led by Dr Fiona Godlee, the editor-in-chief of the BMJ, who provides a background to the investigation. The panel members are:

Dr Deborah Cohen, author of the investigation and associate editor at the BMJ, talking about carrying out the investigation and the difficulty to obtain basic information 

Professor Paul Garner from the Liverpool School of Tropical Medicine, addressing the ineffectiveness of the current TB vaccine and also talking about the backlash he experienced after publishing a systematic review concluding that the animal studies results had been overstated

Malcolm Macleod, from the University of Edinburgh, talking about the broader public health aspect

Merel Ritskes-Hoitinga from the Department for Health Evidence in The Netherlands, addressing the quality of animal studies and the need for systematic reviews

<p>and Jonathan Kimmelman, from McGill University in Canada analysing the story from the perspective of biomedical ethics.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9fyy0f/stream_382131272-bmjgroup-mva85a-trial-investigation-press-conference.mp3" length="71113598" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Trial MVA85A - monkey trials for a booster vaccine for BCG, developed by researchers at Oxford University, is the subject of an investigation published on bmj.com.

Experts warn that today’s investigation is just one example of “a systematic failure” afflicting preclinical research and call for urgent action “to make animal research more fit for purpose as a valuable and reliable forerunner to clinical research in humans.”

The press conference is led by Dr Fiona Godlee, the editor-in-chief of the BMJ, who provides a background to the investigation. The panel members are:

Dr Deborah Cohen, author of the investigation and associate editor at the BMJ, talking about carrying out the investigation and the difficulty to obtain basic information 

Professor Paul Garner from the Liverpool School of Tropical Medicine, addressing the ineffectiveness of the current TB vaccine and also talking about the backlash he experienced after publishing a systematic review concluding that the animal studies results had been overstated

Malcolm Macleod, from the University of Edinburgh, talking about the broader public health aspect

Merel Ritskes-Hoitinga from the Department for Health Evidence in The Netherlands, addressing the quality of animal studies and the need for systematic reviews

and Jonathan Kimmelman, from McGill University in Canada analysing the story from the perspective of biomedical ethics.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2967</itunes:duration>
                                    </item>
    <item>
        <title>neoadjuvant treatment for breast cancer - not living up to the promise</title>
        <itunes:title>neoadjuvant treatment for breast cancer - not living up to the promise</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/neoadjuvant-treatment-for-breast-cancer-not-living-up-to-the-promise/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/neoadjuvant-treatment-for-breast-cancer-not-living-up-to-the-promise/#comments</comments>        <pubDate>Thu, 11 Jan 2018 18:07:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/neoadjuvant-treatment-for-breast-cancer-not-living-up-to-the-promise</guid>
                                    <description><![CDATA[Neoadjuvant chemotherapy for breast cancer is a new strategy that was introduced towards the end of the 20th century with the aim of reducing tumour size - rendering an otherwise inoperable tumour operable, allowing more conservative surgery, and hopefully improving overall survival.

Although data indicate that the first rationale remains valid, the others have not led to the desired outcomes. More conservative surgery after neoadjuvant chemotherapy can result in a higher rate of local recurrence, and, despite the earlier initiation of systemic treatment, no improvement in survival has been seen.

Jayant Vaidya, professor of surgery and oncology and consultant breast cancer surgeon at University College London, joins us to explain why he is rethinking the use of neoadjuvant chemotherapy for breast cancer.

Read the full analysis:
<p>http://www.bmj.com/content/360/bmj.j5913</p>
]]></description>
                                                            <content:encoded><![CDATA[Neoadjuvant chemotherapy for breast cancer is a new strategy that was introduced towards the end of the 20th century with the aim of reducing tumour size - rendering an otherwise inoperable tumour operable, allowing more conservative surgery, and hopefully improving overall survival.

Although data indicate that the first rationale remains valid, the others have not led to the desired outcomes. More conservative surgery after neoadjuvant chemotherapy can result in a higher rate of local recurrence, and, despite the earlier initiation of systemic treatment, no improvement in survival has been seen.

Jayant Vaidya, professor of surgery and oncology and consultant breast cancer surgeon at University College London, joins us to explain why he is rethinking the use of neoadjuvant chemotherapy for breast cancer.

Read the full analysis:
<p>http://www.bmj.com/content/360/bmj.j5913</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/84exeq/stream_382120310-bmjgroup-neoadjuvant-treatment-for-breast-cancer-not-living-up-to-the-promise.mp3" length="27818452" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Neoadjuvant chemotherapy for breast cancer is a new strategy that was introduced towards the end of the 20th century with the aim of reducing tumour size - rendering an otherwise inoperable tumour operable, allowing more conservative surgery, and hopefully improving overall survival.

Although data indicate that the first rationale remains valid, the others have not led to the desired outcomes. More conservative surgery after neoadjuvant chemotherapy can result in a higher rate of local recurrence, and, despite the earlier initiation of systemic treatment, no improvement in survival has been seen.

Jayant Vaidya, professor of surgery and oncology and consultant breast cancer surgeon at University College London, joins us to explain why he is rethinking the use of neoadjuvant chemotherapy for breast cancer.

Read the full analysis:
http://www.bmj.com/content/360/bmj.j5913]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1160</itunes:duration>
                                    </item>
    <item>
        <title>Winter pressures - ”You run the risk of dropping the ball”</title>
        <itunes:title>Winter pressures - ”You run the risk of dropping the ball”</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/winter-pressures-you-run-the-risk-of-dropping-the-ball/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/winter-pressures-you-run-the-risk-of-dropping-the-ball/#comments</comments>        <pubDate>Wed, 10 Jan 2018 17:35:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/winter-pressures-you-run-the-risk-of-dropping-the-ball</guid>
                                    <description><![CDATA[Winter pressures on NHS services have kicked in a little bit earlier than usual. So here to discuss that, and also the issue of how local NHS leaders can support staff in times of extreme pressure.

<p>Discussing that with Rebecca Coombes, The BMJ’s head of news and views, are Matthew Inada-Kim, a consultant in acute and general medicine at Hampshire Hospitals NHS Foundation Trust, and Joe Harrison, CEO of Milton Keynes Hospital NHS Foundation Trust.</p>
]]></description>
                                                            <content:encoded><![CDATA[Winter pressures on NHS services have kicked in a little bit earlier than usual. So here to discuss that, and also the issue of how local NHS leaders can support staff in times of extreme pressure.

<p>Discussing that with Rebecca Coombes, The BMJ’s head of news and views, are Matthew Inada-Kim, a consultant in acute and general medicine at Hampshire Hospitals NHS Foundation Trust, and Joe Harrison, CEO of Milton Keynes Hospital NHS Foundation Trust.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8akir5/stream_381605036-bmjgroup-winter-pressures-you-run-the-risk-of-dropping-the-ball.mp3" length="55887091" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Winter pressures on NHS services have kicked in a little bit earlier than usual. So here to discuss that, and also the issue of how local NHS leaders can support staff in times of extreme pressure.

Discussing that with Rebecca Coombes, The BMJ’s head of news and views, are Matthew Inada-Kim, a consultant in acute and general medicine at Hampshire Hospitals NHS Foundation Trust, and Joe Harrison, CEO of Milton Keynes Hospital NHS Foundation Trust.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2332</itunes:duration>
                                    </item>
    <item>
        <title>Suspect, investigate, and diagnose acute respiratory distress syndrome</title>
        <itunes:title>Suspect, investigate, and diagnose acute respiratory distress syndrome</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/suspect-investigate-and-diagnose-acute-respiratory-distress-syndrome/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/suspect-investigate-and-diagnose-acute-respiratory-distress-syndrome/#comments</comments>        <pubDate>Wed, 03 Jan 2018 14:42:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/suspect-investigate-and-diagnose-acute-respiratory-distress-syndrome</guid>
                                    <description><![CDATA[Acute respiratory distress syndrome was first described in 1967 and has become a defining condition in critical care. Around 40% of patients with ARDS will die, and survivors experience long term sequelae. No drug treatments exist for ARDS, however good supportive management reduces harm and improves outcome.

In this podcast, John Laffey, professor of anaesthesiology at St Michael’s Hospital, Toronto and Brian Kavanagh, clinician-scientist, intensive care medicine at the University of Toronto take us through the background to diagnosis and treatment of ARDS.

Cheryl Misak, professor of philosophy at the University of Toronto, and survivor of ARDS, also joins us to explain how she has faired in recovery.

Read the full easily missed article:
<p>http://www.bmj.com/content/359/bmj.j5055</p>
]]></description>
                                                            <content:encoded><![CDATA[Acute respiratory distress syndrome was first described in 1967 and has become a defining condition in critical care. Around 40% of patients with ARDS will die, and survivors experience long term sequelae. No drug treatments exist for ARDS, however good supportive management reduces harm and improves outcome.

In this podcast, John Laffey, professor of anaesthesiology at St Michael’s Hospital, Toronto and Brian Kavanagh, clinician-scientist, intensive care medicine at the University of Toronto take us through the background to diagnosis and treatment of ARDS.

Cheryl Misak, professor of philosophy at the University of Toronto, and survivor of ARDS, also joins us to explain how she has faired in recovery.

Read the full easily missed article:
<p>http://www.bmj.com/content/359/bmj.j5055</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/57844l/stream_378199712-bmjgroup-suspect-investigate-and-diagnose-acute-respiratory-distress-syndrome.mp3" length="62700824" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Acute respiratory distress syndrome was first described in 1967 and has become a defining condition in critical care. Around 40% of patients with ARDS will die, and survivors experience long term sequelae. No drug treatments exist for ARDS, however good supportive management reduces harm and improves outcome.

In this podcast, John Laffey, professor of anaesthesiology at St Michael’s Hospital, Toronto and Brian Kavanagh, clinician-scientist, intensive care medicine at the University of Toronto take us through the background to diagnosis and treatment of ARDS.

Cheryl Misak, professor of philosophy at the University of Toronto, and survivor of ARDS, also joins us to explain how she has faired in recovery.

Read the full easily missed article:
http://www.bmj.com/content/359/bmj.j5055]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2616</itunes:duration>
                                    </item>
    <item>
        <title>Hope is important -  early psychosis for the non-specialist doctor</title>
        <itunes:title>Hope is important -  early psychosis for the non-specialist doctor</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/hope-is-important-early-psychosis-for-the-non-specialist-doctor/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/hope-is-important-early-psychosis-for-the-non-specialist-doctor/#comments</comments>        <pubDate>Sun, 31 Dec 2017 16:13:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/hope-is-important-early-psychosis-for-the-non-specialist-doctor</guid>
                                    <description><![CDATA[Psychosis often emerges for the first time in adolescence and young adulthood. In around four out of five patients symptoms remit, but most experience relapses and further difficulties.

Psychosis can be a frightening and bewildering experience for both patients and families. Early proactive support and intervention improves clinical outcomes, avoids costly and traumatic hospital admissions, and is preferred by patients and their families

In this podcast,Sagnik Bhattacharyya, consultant psychiatrist at the  Lambeth Hospital South London and Maudsley NHS Foundation Trust, and David Shiers, former GP, honorary reader in early psychosis at at Manchester University, join us to discuss early treatment - and why hope is important for both GPs and patients.

Read the full practice article:
http://www.bmj.com/content/357/bmj.j4578

And see the infographic on identification and management of psychotic disorders.
<p>http://www.bmj.com/content/bmj/suppl/2017/11/08/bmj.j4578.DC1/psychosis_v28.pdf</p>
]]></description>
                                                            <content:encoded><![CDATA[Psychosis often emerges for the first time in adolescence and young adulthood. In around four out of five patients symptoms remit, but most experience relapses and further difficulties.

Psychosis can be a frightening and bewildering experience for both patients and families. Early proactive support and intervention improves clinical outcomes, avoids costly and traumatic hospital admissions, and is preferred by patients and their families

In this podcast,Sagnik Bhattacharyya, consultant psychiatrist at the  Lambeth Hospital South London and Maudsley NHS Foundation Trust, and David Shiers, former GP, honorary reader in early psychosis at at Manchester University, join us to discuss early treatment - and why hope is important for both GPs and patients.

Read the full practice article:
http://www.bmj.com/content/357/bmj.j4578

And see the infographic on identification and management of psychotic disorders.
<p>http://www.bmj.com/content/bmj/suppl/2017/11/08/bmj.j4578.DC1/psychosis_v28.pdf</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/r8n3sn/stream_376994888-bmjgroup-hope-is-important-early-psychosis-for-the-non-specialist-doctor.mp3" length="59792923" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Psychosis often emerges for the first time in adolescence and young adulthood. In around four out of five patients symptoms remit, but most experience relapses and further difficulties.

Psychosis can be a frightening and bewildering experience for both patients and families. Early proactive support and intervention improves clinical outcomes, avoids costly and traumatic hospital admissions, and is preferred by patients and their families

In this podcast,Sagnik Bhattacharyya, consultant psychiatrist at the  Lambeth Hospital South London and Maudsley NHS Foundation Trust, and David Shiers, former GP, honorary reader in early psychosis at at Manchester University, join us to discuss early treatment - and why hope is important for both GPs and patients.

Read the full practice article:
http://www.bmj.com/content/357/bmj.j4578

And see the infographic on identification and management of psychotic disorders.
http://www.bmj.com/content/bmj/suppl/2017/11/08/bmj.j4578.DC1/psychosis_v28.pdf]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2494</itunes:duration>
                                    </item>
    <item>
        <title>Cats, dogs, and biomarkers of ageing.</title>
        <itunes:title>Cats, dogs, and biomarkers of ageing.</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/cats-dogs-and-biomarkers-of-ageing/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/cats-dogs-and-biomarkers-of-ageing/#comments</comments>        <pubDate>Fri, 15 Dec 2017 15:40:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/cats-and-dogs</guid>
                                    <description><![CDATA[The notion that animal companionship might be linked to human health can be traced to ancient writings and, with the first population based study conducted at least four decades ago.

Although some empirical evidence links animal companionship with apparent protection against a series of important health outcomes in middle aged populations, including premature mortality, obesity, hypertension, and hyperlipidaemia, systematic reviews and position statements suggest that these associations are not universal. 

To investigate this further, the authors of this observational study, looked at the prospective link between pet ownership and a selected range of objective biomarkers of ageing proposed for use in large scale population based studies of older people.

Richard Watt, professor of dental public health at University College London joins us to discuss their results.

<p>http://www.bmj.com/content/359/bmj.j5558</p>
]]></description>
                                                            <content:encoded><![CDATA[The notion that animal companionship might be linked to human health can be traced to ancient writings and, with the first population based study conducted at least four decades ago.

Although some empirical evidence links animal companionship with apparent protection against a series of important health outcomes in middle aged populations, including premature mortality, obesity, hypertension, and hyperlipidaemia, systematic reviews and position statements suggest that these associations are not universal. 

To investigate this further, the authors of this observational study, looked at the prospective link between pet ownership and a selected range of objective biomarkers of ageing proposed for use in large scale population based studies of older people.

Richard Watt, professor of dental public health at University College London joins us to discuss their results.

<p>http://www.bmj.com/content/359/bmj.j5558</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rj2d5b/stream_369961211-bmjgroup-cats-and-dogs.mp3" length="30597327" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The notion that animal companionship might be linked to human health can be traced to ancient writings and, with the first population based study conducted at least four decades ago.

Although some empirical evidence links animal companionship with apparent protection against a series of important health outcomes in middle aged populations, including premature mortality, obesity, hypertension, and hyperlipidaemia, systematic reviews and position statements suggest that these associations are not universal. 

To investigate this further, the authors of this observational study, looked at the prospective link between pet ownership and a selected range of objective biomarkers of ageing proposed for use in large scale population based studies of older people.

Richard Watt, professor of dental public health at University College London joins us to discuss their results.

http://www.bmj.com/content/359/bmj.j5558]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1276</itunes:duration>
                                    </item>
    <item>
        <title>Small, medium, or a pint of wine?</title>
        <itunes:title>Small, medium, or a pint of wine?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/small-medium-or-a-pint-of-wine/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/small-medium-or-a-pint-of-wine/#comments</comments>        <pubDate>Thu, 14 Dec 2017 13:48:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/small-medium-or-a-pint-of-wine</guid>
                                    <description><![CDATA[Wine glasses come in a range of sizes, but the average wine glass in the UK today can hold almost ½ a litre.

That wasn’t always the case - and a new analysis, on bmj.com takes a look at the changing size of wineglasses from 1700 until now.  

To discuss how the size of glass affects consumption we're joined by Theresa Marteau, director of the Behaviour and Health Research Unit at the University of Cambridge and Zorana Zupan, a research associate in the Unit.

We're also joined by Matthew Winterbottom, curator of decorative arts at the Ashmolean Museum in Oxford, to tell us about the history of wine drinking in the UK.

Read the full analysis:
<p>http://www.bmj.com/content/359/bmj.j5623</p>
]]></description>
                                                            <content:encoded><![CDATA[Wine glasses come in a range of sizes, but the average wine glass in the UK today can hold almost ½ a litre.

That wasn’t always the case - and a new analysis, on bmj.com takes a look at the changing size of wineglasses from 1700 until now.  

To discuss how the size of glass affects consumption we're joined by Theresa Marteau, director of the Behaviour and Health Research Unit at the University of Cambridge and Zorana Zupan, a research associate in the Unit.

We're also joined by Matthew Winterbottom, curator of decorative arts at the Ashmolean Museum in Oxford, to tell us about the history of wine drinking in the UK.

Read the full analysis:
<p>http://www.bmj.com/content/359/bmj.j5623</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/tc2df0/stream_369431402-bmjgroup-small-medium-or-a-pint-of-wine.mp3" length="47874092" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Wine glasses come in a range of sizes, but the average wine glass in the UK today can hold almost ½ a litre.

That wasn’t always the case - and a new analysis, on bmj.com takes a look at the changing size of wineglasses from 1700 until now.  

To discuss how the size of glass affects consumption we're joined by Theresa Marteau, director of the Behaviour and Health Research Unit at the University of Cambridge and Zorana Zupan, a research associate in the Unit.

We're also joined by Matthew Winterbottom, curator of decorative arts at the Ashmolean Museum in Oxford, to tell us about the history of wine drinking in the UK.

Read the full analysis:
http://www.bmj.com/content/359/bmj.j5623]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1997</itunes:duration>
                                    </item>
    <item>
        <title>Taking the temperature of 37°C</title>
        <itunes:title>Taking the temperature of 37°C</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/taking-the-temperature-of-37%c2%b0c/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/taking-the-temperature-of-37%c2%b0c/#comments</comments>        <pubDate>Wed, 13 Dec 2017 17:00:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/taking-the-temperature-of-37c</guid>
                                    <description><![CDATA[Average body temperature is 37°C, right? 

That was the conclusion of Carl Wunderlich in his magnum opus, The Course of Temperature in Diseases - Wunderlich published that in 1868, following his extensive collection of body temperature readings - and 37°C stuck. But, it’s not as simple as that

Philip Mackowiak, emeritus professor of medicine, and now history of medicine scholar in residence, at the University of Maryland School of Medicine, has been interested in temperature for a long time. He joins us to explain how Wunderlich measured temperature, and what he actually found.

Read his editorial:
<p>http://www.bmj.com/content/359/bmj.j5697</p>
]]></description>
                                                            <content:encoded><![CDATA[Average body temperature is 37°C, right? 

That was the conclusion of Carl Wunderlich in his magnum opus, The Course of Temperature in Diseases - Wunderlich published that in 1868, following his extensive collection of body temperature readings - and 37°C stuck. But, it’s not as simple as that

Philip Mackowiak, emeritus professor of medicine, and now history of medicine scholar in residence, at the University of Maryland School of Medicine, has been interested in temperature for a long time. He joins us to explain how Wunderlich measured temperature, and what he actually found.

Read his editorial:
<p>http://www.bmj.com/content/359/bmj.j5697</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5oj175/stream_369018470-bmjgroup-taking-the-temperature-of-37c.mp3" length="36440751" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Average body temperature is 37°C, right? 

That was the conclusion of Carl Wunderlich in his magnum opus, The Course of Temperature in Diseases - Wunderlich published that in 1868, following his extensive collection of body temperature readings - and 37°C stuck. But, it’s not as simple as that

Philip Mackowiak, emeritus professor of medicine, and now history of medicine scholar in residence, at the University of Maryland School of Medicine, has been interested in temperature for a long time. He joins us to explain how Wunderlich measured temperature, and what he actually found.

Read his editorial:
http://www.bmj.com/content/359/bmj.j5697]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1520</itunes:duration>
                                    </item>
    <item>
        <title>Manflu - are men immunologically inferior?</title>
        <itunes:title>Manflu - are men immunologically inferior?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/manflu-are-men-immunologically-inferior/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/manflu-are-men-immunologically-inferior/#comments</comments>        <pubDate>Tue, 12 Dec 2017 16:26:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/manflu</guid>
                                    <description><![CDATA[Manflu, the phenomenon that men experience the symptoms of viral illness more than woman, is usually used with derision - but a new review, published in the Christmas edition, is asking - is there a plausible biological basis for this sex difference?

Kyle Sue is a  clinical assistant professor in family medicine at Memorial University of Newfoundland, and a GP in northern Canada - and has been looking at the research on sex difference in immune response.

Read the full article:
<p>http://www.bmj.com/content/359/bmj.j5560</p>
]]></description>
                                                            <content:encoded><![CDATA[Manflu, the phenomenon that men experience the symptoms of viral illness more than woman, is usually used with derision - but a new review, published in the Christmas edition, is asking - is there a plausible biological basis for this sex difference?

Kyle Sue is a  clinical assistant professor in family medicine at Memorial University of Newfoundland, and a GP in northern Canada - and has been looking at the research on sex difference in immune response.

Read the full article:
<p>http://www.bmj.com/content/359/bmj.j5560</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qejy2b/stream_368526710-bmjgroup-manflu.mp3" length="29650941" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Manflu, the phenomenon that men experience the symptoms of viral illness more than woman, is usually used with derision - but a new review, published in the Christmas edition, is asking - is there a plausible biological basis for this sex difference?

Kyle Sue is a  clinical assistant professor in family medicine at Memorial University of Newfoundland, and a GP in northern Canada - and has been looking at the research on sex difference in immune response.

Read the full article:
http://www.bmj.com/content/359/bmj.j5560]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1236</itunes:duration>
                                    </item>
    <item>
        <title>I thought I wasn’t thin enough to be anorexic</title>
        <itunes:title>I thought I wasn’t thin enough to be anorexic</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/i-thought-i-wasn-t-thin-enough-to-be-anorexic/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/i-thought-i-wasn-t-thin-enough-to-be-anorexic/#comments</comments>        <pubDate>Sun, 10 Dec 2017 16:57:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/i-thought-i-wasnt-thin-enough-to-be-anorexic</guid>
                                    <description><![CDATA[Assessing young people with possible eating disorders can be complex for a variety of reasons. Building a therapeutic relationship with a young person with a possible eating disorder and their family is key to enabling a thorough assessment and ongoing management, but it introduces difficult issues regarding confidentiality and risk.

In this podcast we speak to the mother and daughter authors of a What you patient is thinking article, who describe what it's like for a family to experience a child with an eating disorder.

In a linked podcast, we talk with the authors of two practice articles, which give advice on spotting and treating eating disorders in young people.


Read the articles:
http://www.bmj.com/content/359/bmj.j5328
http://www.bmj.com/content/359/bmj.j5378
<p>http://www.bmj.com/content/359/bmj.j5245</p>
]]></description>
                                                            <content:encoded><![CDATA[Assessing young people with possible eating disorders can be complex for a variety of reasons. Building a therapeutic relationship with a young person with a possible eating disorder and their family is key to enabling a thorough assessment and ongoing management, but it introduces difficult issues regarding confidentiality and risk.

In this podcast we speak to the mother and daughter authors of a What you patient is thinking article, who describe what it's like for a family to experience a child with an eating disorder.

In a linked podcast, we talk with the authors of two practice articles, which give advice on spotting and treating eating disorders in young people.


Read the articles:
http://www.bmj.com/content/359/bmj.j5328
http://www.bmj.com/content/359/bmj.j5378
<p>http://www.bmj.com/content/359/bmj.j5245</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/q24kzx/stream_367593416-bmjgroup-i-thought-i-wasnt-thin-enough-to-be-anorexic.mp3" length="62281734" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Assessing young people with possible eating disorders can be complex for a variety of reasons. Building a therapeutic relationship with a young person with a possible eating disorder and their family is key to enabling a thorough assessment and ongoing management, but it introduces difficult issues regarding confidentiality and risk.

In this podcast we speak to the mother and daughter authors of a What you patient is thinking article, who describe what it's like for a family to experience a child with an eating disorder.

In a linked podcast, we talk with the authors of two practice articles, which give advice on spotting and treating eating disorders in young people.


Read the articles:
http://www.bmj.com/content/359/bmj.j5328
http://www.bmj.com/content/359/bmj.j5378
http://www.bmj.com/content/359/bmj.j5245]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2598</itunes:duration>
                                    </item>
    <item>
        <title>Early detection of eating disorders</title>
        <itunes:title>Early detection of eating disorders</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/early-detection-of-eating-disorders/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/early-detection-of-eating-disorders/#comments</comments>        <pubDate>Sun, 10 Dec 2017 16:56:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/early-detection-of-eating-disorders</guid>
                                    <description><![CDATA[Assessing young people with possible eating disorders can be complex for a variety of reasons. Building a therapeutic relationship with a young person with a possible eating disorder and their family is key to enabling a thorough assessment and ongoing management, but it introduces difficult issues regarding confidentiality and risk.

In this podcast we talk with the authors of two practice articles, which give advice on spotting and treating eating disorders in young people.

In a linked podcast, we speak to the mother and daughter authors of a What you patient is thinking article, who describe what it's like for a family to experience a child with an eating disorder.

Read the articles:
http://www.bmj.com/content/359/bmj.j5328
http://www.bmj.com/content/359/bmj.j5378
<p>http://www.bmj.com/content/359/bmj.j5245</p>
]]></description>
                                                            <content:encoded><![CDATA[Assessing young people with possible eating disorders can be complex for a variety of reasons. Building a therapeutic relationship with a young person with a possible eating disorder and their family is key to enabling a thorough assessment and ongoing management, but it introduces difficult issues regarding confidentiality and risk.

In this podcast we talk with the authors of two practice articles, which give advice on spotting and treating eating disorders in young people.

In a linked podcast, we speak to the mother and daughter authors of a What you patient is thinking article, who describe what it's like for a family to experience a child with an eating disorder.

Read the articles:
http://www.bmj.com/content/359/bmj.j5328
http://www.bmj.com/content/359/bmj.j5378
<p>http://www.bmj.com/content/359/bmj.j5245</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6454tz/stream_367593143-bmjgroup-early-detection-of-eating-disorders.mp3" length="62323455" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Assessing young people with possible eating disorders can be complex for a variety of reasons. Building a therapeutic relationship with a young person with a possible eating disorder and their family is key to enabling a thorough assessment and ongoing management, but it introduces difficult issues regarding confidentiality and risk.

In this podcast we talk with the authors of two practice articles, which give advice on spotting and treating eating disorders in young people.

In a linked podcast, we speak to the mother and daughter authors of a What you patient is thinking article, who describe what it's like for a family to experience a child with an eating disorder.

Read the articles:
http://www.bmj.com/content/359/bmj.j5328
http://www.bmj.com/content/359/bmj.j5378
http://www.bmj.com/content/359/bmj.j5245]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2600</itunes:duration>
                                    </item>
    <item>
        <title>Should all fetuses be monitored electronically during birth?</title>
        <itunes:title>Should all fetuses be monitored electronically during birth?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/should-all-fetuses-be-monitored-electronically-during-birth/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/should-all-fetuses-be-monitored-electronically-during-birth/#comments</comments>        <pubDate>Thu, 07 Dec 2017 17:38:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/continuous-fetal-monitoring-birth</guid>
                                    <description><![CDATA[Our latest H2H debate asks: Is continuous electronic fetal monitoring useful for all women in labour?

Peter Brocklehurst is professor of women’s health at the University of Birmingham. He argues that continuous electronic fetal monitoring during labour can lead to harm and increase the risk of caesarean section. 

<p>Christoph Lees is reader in obstetrics and fetal medicine at Imperial College London. He argues that continuous electronic fetal monitoring is useful for all women in labour as it helps avoid fetal and neonatal morbidity</p>
]]></description>
                                                            <content:encoded><![CDATA[Our latest H2H debate asks: Is continuous electronic fetal monitoring useful for all women in labour?

Peter Brocklehurst is professor of women’s health at the University of Birmingham. He argues that continuous electronic fetal monitoring during labour can lead to harm and increase the risk of caesarean section. 

<p>Christoph Lees is reader in obstetrics and fetal medicine at Imperial College London. He argues that continuous electronic fetal monitoring is useful for all women in labour as it helps avoid fetal and neonatal morbidity</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/j42sfe/stream_366318083-bmjgroup-continuous-fetal-monitoring-birth.mp3" length="41761144" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Our latest H2H debate asks: Is continuous electronic fetal monitoring useful for all women in labour?

Peter Brocklehurst is professor of women’s health at the University of Birmingham. He argues that continuous electronic fetal monitoring during labour can lead to harm and increase the risk of caesarean section. 

Christoph Lees is reader in obstetrics and fetal medicine at Imperial College London. He argues that continuous electronic fetal monitoring is useful for all women in labour as it helps avoid fetal and neonatal morbidity]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1742</itunes:duration>
                                    </item>
    <item>
        <title>”Obesity is the last thing it’s OK to discriminate on the basis of”</title>
        <itunes:title>”Obesity is the last thing it’s OK to discriminate on the basis of”</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/obesity-is-the-last-thing-it-s-ok-to-discriminate-on-the-basis-of/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/obesity-is-the-last-thing-it-s-ok-to-discriminate-on-the-basis-of/#comments</comments>        <pubDate>Fri, 24 Nov 2017 17:14:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/obesity-is-the-last-thing-its-ok-to-discriminate-on-the-basis-of</guid>
                                    <description><![CDATA[We have a problem in obesity research — clinical trials continue to prioritise weight loss as a primary outcome and rarely consider patients’ experience, quality of life, or adverse events - and now a new analysis article, "Challenging assumptions in obesity research"  questions that focus on weight.

Navjoyt Ladher discusses this thorny topic with Liz Sturgiss, GP, obesity researcher at Australian National University Medical School, and one of the authors of that paper.

Read the full analysis:
<p>http://www.bmj.com/content/359/bmj.j5303</p>
]]></description>
                                                            <content:encoded><![CDATA[We have a problem in obesity research — clinical trials continue to prioritise weight loss as a primary outcome and rarely consider patients’ experience, quality of life, or adverse events - and now a new analysis article, "Challenging assumptions in obesity research"  questions that focus on weight.

Navjoyt Ladher discusses this thorny topic with Liz Sturgiss, GP, obesity researcher at Australian National University Medical School, and one of the authors of that paper.

Read the full analysis:
<p>http://www.bmj.com/content/359/bmj.j5303</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mkyar0/stream_360377657-bmjgroup-obesity-is-the-last-thing-its-ok-to-discriminate-on-the-basis-of.mp3" length="29028824" type="audio/mpeg"/>
        <itunes:summary><![CDATA[We have a problem in obesity research — clinical trials continue to prioritise weight loss as a primary outcome and rarely consider patients’ experience, quality of life, or adverse events - and now a new analysis article, "Challenging assumptions in obesity research"  questions that focus on weight.

Navjoyt Ladher discusses this thorny topic with Liz Sturgiss, GP, obesity researcher at Australian National University Medical School, and one of the authors of that paper.

Read the full analysis:
http://www.bmj.com/content/359/bmj.j5303]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1211</itunes:duration>
                                    </item>
    <item>
        <title>Dieting, cardiovascular disease, cancer, and mortality</title>
        <itunes:title>Dieting, cardiovascular disease, cancer, and mortality</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/dieting-cardiovascular-disease-cancer-and-mortality/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/dieting-cardiovascular-disease-cancer-and-mortality/#comments</comments>        <pubDate>Tue, 21 Nov 2017 15:57:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/dieting-cardiovascular-disease-cancer-and-mortality</guid>
                                    <description><![CDATA[We know that adults with obesity have an increased risk of premature mortality, cardiovascular disease, some cancers, type 2 diabetes, and many other diseases.

However, the effect of dieting on 3 of those outcomes (cancer, cvd, and mortality) is surprisingly little studied.

However a new systematic review and meta-analysis does bring together what we know of that effect, and to explain the evidence we're joined by Alison Avenell, professor in the Health Services Research Unit, University of Aberdeen.

<p>Read the full systematic review and meta-analysis: http://www.bmj.com/content/359/bmj.j4849</p>
]]></description>
                                                            <content:encoded><![CDATA[We know that adults with obesity have an increased risk of premature mortality, cardiovascular disease, some cancers, type 2 diabetes, and many other diseases.

However, the effect of dieting on 3 of those outcomes (cancer, cvd, and mortality) is surprisingly little studied.

However a new systematic review and meta-analysis does bring together what we know of that effect, and to explain the evidence we're joined by Alison Avenell, professor in the Health Services Research Unit, University of Aberdeen.

<p>Read the full systematic review and meta-analysis: http://www.bmj.com/content/359/bmj.j4849</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qvlw46/stream_358947983-bmjgroup-dieting-cardiovascular-disease-cancer-and-mortality.mp3" length="25165824" type="audio/mpeg"/>
        <itunes:summary><![CDATA[We know that adults with obesity have an increased risk of premature mortality, cardiovascular disease, some cancers, type 2 diabetes, and many other diseases.

However, the effect of dieting on 3 of those outcomes (cancer, cvd, and mortality) is surprisingly little studied.

However a new systematic review and meta-analysis does bring together what we know of that effect, and to explain the evidence we're joined by Alison Avenell, professor in the Health Services Research Unit, University of Aberdeen.

Read the full systematic review and meta-analysis: http://www.bmj.com/content/359/bmj.j4849]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1582</itunes:duration>
                                    </item>
    <item>
        <title>Antibiotic prescription course - an update</title>
        <itunes:title>Antibiotic prescription course - an update</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/antibiotic-prescription-course-an-update/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/antibiotic-prescription-course-an-update/#comments</comments>        <pubDate>Fri, 17 Nov 2017 15:37:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/antibiotic-prescription-course-an-update</guid>
                                    <description><![CDATA[In July, The BMJ published an analysis article called “The Antibiotic Course has had it’s day” -  a provocative title that turned out the garner a lot of debate on our site. The article said that the convention for the length of a course of antibiotics was set by Flemming, in his Nobel Prize acceptance speech - “If you use penicillin, use enough!” - and that the evidence base hasn’t moved on since then.

 The article has had over 40 substantive responses, both agreeing and vehemently not - and so we thought it worth revisiting that argument, now the dust has settled.

Discussing that are Martin Llewellyn, professor of infectious disease at Brighton and Sussex Medical School, and Paul Little, professor of primary care at the University of Southampton.

Read the original analysis:
<p>http://www.bmj.com/content/358/bmj.j3418</p>
]]></description>
                                                            <content:encoded><![CDATA[In July, The BMJ published an analysis article called “The Antibiotic Course has had it’s day” -  a provocative title that turned out the garner a lot of debate on our site. The article said that the convention for the length of a course of antibiotics was set by Flemming, in his Nobel Prize acceptance speech - “If you use penicillin, use enough!” - and that the evidence base hasn’t moved on since then.

 The article has had over 40 substantive responses, both agreeing and vehemently not - and so we thought it worth revisiting that argument, now the dust has settled.

Discussing that are Martin Llewellyn, professor of infectious disease at Brighton and Sussex Medical School, and Paul Little, professor of primary care at the University of Southampton.

Read the original analysis:
<p>http://www.bmj.com/content/358/bmj.j3418</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/r5b0gw/stream_357139505-bmjgroup-antibiotic-prescription-course-an-update.mp3" length="43477896" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In July, The BMJ published an analysis article called “The Antibiotic Course has had it’s day” -  a provocative title that turned out the garner a lot of debate on our site. The article said that the convention for the length of a course of antibiotics was set by Flemming, in his Nobel Prize acceptance speech - “If you use penicillin, use enough!” - and that the evidence base hasn’t moved on since then.

 The article has had over 40 substantive responses, both agreeing and vehemently not - and so we thought it worth revisiting that argument, now the dust has settled.

Discussing that are Martin Llewellyn, professor of infectious disease at Brighton and Sussex Medical School, and Paul Little, professor of primary care at the University of Southampton.

Read the original analysis:
http://www.bmj.com/content/358/bmj.j3418]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1813</itunes:duration>
                                    </item>
    <item>
        <title>Is it time to scrap the UK’s mental health act?</title>
        <itunes:title>Is it time to scrap the UK’s mental health act?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/is-it-time-to-scrap-the-uk-s-mental-health-act/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/is-it-time-to-scrap-the-uk-s-mental-health-act/#comments</comments>        <pubDate>Fri, 17 Nov 2017 14:57:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/mental-capacity-act-mixdown</guid>
                                    <description><![CDATA[Unjust discrimination against people with mental ill health should be replaced with universal rules based on decision making ability, argues George Szmukler, emeritus professor of psychiatry and society at King’s College, London.

However Scott Weich, professor of mental health at the University of Sheffield, worries about legal distractions that won’t improve outcomes while services are so thinly stretched.

Read the full debate:
<p>http://www.bmj.com/content/359/bmj.j5248</p>
]]></description>
                                                            <content:encoded><![CDATA[Unjust discrimination against people with mental ill health should be replaced with universal rules based on decision making ability, argues George Szmukler, emeritus professor of psychiatry and society at King’s College, London.

However Scott Weich, professor of mental health at the University of Sheffield, worries about legal distractions that won’t improve outcomes while services are so thinly stretched.

Read the full debate:
<p>http://www.bmj.com/content/359/bmj.j5248</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/bpr4sq/stream_357123257-bmjgroup-mental-capacity-act-mixdown.mp3" length="9195520" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Unjust discrimination against people with mental ill health should be replaced with universal rules based on decision making ability, argues George Szmukler, emeritus professor of psychiatry and society at King’s College, London.

However Scott Weich, professor of mental health at the University of Sheffield, worries about legal distractions that won’t improve outcomes while services are so thinly stretched.

Read the full debate:
http://www.bmj.com/content/359/bmj.j5248]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1566</itunes:duration>
                                    </item>
    <item>
        <title>Three talks to  good decision making</title>
        <itunes:title>Three talks to  good decision making</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/three-talks-to-good-decision-making/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/three-talks-to-good-decision-making/#comments</comments>        <pubDate>Fri, 10 Nov 2017 17:59:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/three-talks-to-good-decision-making</guid>
                                    <description><![CDATA[The Three Talk Model of shared decision is a framework to help clinicians to think about how to structure their consultation to ensure that shared decision making can most usefully take place.

The model is based around 3 concepts - option talk, decision talk, and team talk - with active listening at the centre. 

Three Talk was first proposed in 2012, now new research published on bmj.com updates that model. Professor Glynn Elwyn, from The Dartmouth Institute for Health Policy and Clinical Practice, joins us to explain how that was done, and what it's creators learned from the process.

Read the full research:
<p>http://www.bmj.com/content/359/bmj.j4891</p>
]]></description>
                                                            <content:encoded><![CDATA[The Three Talk Model of shared decision is a framework to help clinicians to think about how to structure their consultation to ensure that shared decision making can most usefully take place.

The model is based around 3 concepts - option talk, decision talk, and team talk - with active listening at the centre. 

Three Talk was first proposed in 2012, now new research published on bmj.com updates that model. Professor Glynn Elwyn, from The Dartmouth Institute for Health Policy and Clinical Practice, joins us to explain how that was done, and what it's creators learned from the process.

Read the full research:
<p>http://www.bmj.com/content/359/bmj.j4891</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/avcoep/stream_353896109-bmjgroup-three-talks-to-good-decision-making.mp3" length="34338702" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The Three Talk Model of shared decision is a framework to help clinicians to think about how to structure their consultation to ensure that shared decision making can most usefully take place.

The model is based around 3 concepts - option talk, decision talk, and team talk - with active listening at the centre. 

Three Talk was first proposed in 2012, now new research published on bmj.com updates that model. Professor Glynn Elwyn, from The Dartmouth Institute for Health Policy and Clinical Practice, joins us to explain how that was done, and what it's creators learned from the process.

Read the full research:
http://www.bmj.com/content/359/bmj.j4891]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1432</itunes:duration>
                                    </item>
    <item>
        <title>Education round up October 2017</title>
        <itunes:title>Education round up October 2017</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/education-round-up-october-2017/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/education-round-up-october-2017/#comments</comments>        <pubDate>Tue, 31 Oct 2017 15:47:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/education-round-up-october-2017</guid>
                                    <description><![CDATA[The BMJ publishes a variety of education articles, to help doctors improve their practice. Often authors join us in our podcast to give tips on putting their recommendations into practice.

In this new monthly audio round-up The BMJ’s clinical editors discuss what they have learned, and how they may alter their practice.

In this edition, GP Cat Chatfield, psychiatric trainee Kate Addlington and Gastrology trainee Robin Baddeley discuss the articles;

Diagnosis and management of postpartum haemorrhage
http://www.bmj.com/content/358/bmj.j3875

Indications for anticoagulant and antiplatelet combined therapy
http://www.bmj.com/content/356/bmj.j1128

Safe Handover
http://www.bmj.com/content/359/bmj.j4328

and why fixing the broken medical ward round is in everyone’s interests
<p>http://blogs.bmj.com/bmj/2017/10/13/robin-baddeley-fixing-the-broken-medical-ward-round-is-in-everyones-interests/</p>
]]></description>
                                                            <content:encoded><![CDATA[The BMJ publishes a variety of education articles, to help doctors improve their practice. Often authors join us in our podcast to give tips on putting their recommendations into practice.

In this new monthly audio round-up The BMJ’s clinical editors discuss what they have learned, and how they may alter their practice.

In this edition, GP Cat Chatfield, psychiatric trainee Kate Addlington and Gastrology trainee Robin Baddeley discuss the articles;

Diagnosis and management of postpartum haemorrhage
http://www.bmj.com/content/358/bmj.j3875

Indications for anticoagulant and antiplatelet combined therapy
http://www.bmj.com/content/356/bmj.j1128

Safe Handover
http://www.bmj.com/content/359/bmj.j4328

and why fixing the broken medical ward round is in everyone’s interests
<p>http://blogs.bmj.com/bmj/2017/10/13/robin-baddeley-fixing-the-broken-medical-ward-round-is-in-everyones-interests/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ipi61q/stream_349460140-bmjgroup-education-round-up-october-2017.mp3" length="69088703" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The BMJ publishes a variety of education articles, to help doctors improve their practice. Often authors join us in our podcast to give tips on putting their recommendations into practice.

In this new monthly audio round-up The BMJ’s clinical editors discuss what they have learned, and how they may alter their practice.

In this edition, GP Cat Chatfield, psychiatric trainee Kate Addlington and Gastrology trainee Robin Baddeley discuss the articles;

Diagnosis and management of postpartum haemorrhage
http://www.bmj.com/content/358/bmj.j3875

Indications for anticoagulant and antiplatelet combined therapy
http://www.bmj.com/content/356/bmj.j1128

Safe Handover
http://www.bmj.com/content/359/bmj.j4328

and why fixing the broken medical ward round is in everyone’s interests
http://blogs.bmj.com/bmj/2017/10/13/robin-baddeley-fixing-the-broken-medical-ward-round-is-in-everyones-interests/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2882</itunes:duration>
                                    </item>
    <item>
        <title>Money for editors</title>
        <itunes:title>Money for editors</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/money-for-editors/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/money-for-editors/#comments</comments>        <pubDate>Fri, 27 Oct 2017 16:45:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/money-for-editors</guid>
                                    <description><![CDATA[As journal editors, we’re aware of the fact that we have a role to play in scientific discourse - that’s why The BMJ has been so keen to talk about the way in which scientific knowledge is constructed, through our Evidence Manifesto.

We also know that money has influence in the scientific literature - which is why we have a zero tolerance policy for financial conflicts of interest in our educational content.

Where do journal editors fit into this? 

The first step into investigating that is to find out if journal editors receive payments from pharma and device companies - and new research, published on bmj.com does that.

Jessica Liu - internist and assistant professor at the university of Toronto, and one of the authors of that study joins us to discuss.

Read the full research:
<p>http://www.bmj.com/content/359/bmj.j4619</p>
]]></description>
                                                            <content:encoded><![CDATA[As journal editors, we’re aware of the fact that we have a role to play in scientific discourse - that’s why The BMJ has been so keen to talk about the way in which scientific knowledge is constructed, through our Evidence Manifesto.

We also know that money has influence in the scientific literature - which is why we have a zero tolerance policy for financial conflicts of interest in our educational content.

Where do journal editors fit into this? 

The first step into investigating that is to find out if journal editors receive payments from pharma and device companies - and new research, published on bmj.com does that.

Jessica Liu - internist and assistant professor at the university of Toronto, and one of the authors of that study joins us to discuss.

Read the full research:
<p>http://www.bmj.com/content/359/bmj.j4619</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/bht7np/stream_348872724-bmjgroup-money-for-editors.mp3" length="23332227" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As journal editors, we’re aware of the fact that we have a role to play in scientific discourse - that’s why The BMJ has been so keen to talk about the way in which scientific knowledge is constructed, through our Evidence Manifesto.

We also know that money has influence in the scientific literature - which is why we have a zero tolerance policy for financial conflicts of interest in our educational content.

Where do journal editors fit into this? 

The first step into investigating that is to find out if journal editors receive payments from pharma and device companies - and new research, published on bmj.com does that.

Jessica Liu - internist and assistant professor at the university of Toronto, and one of the authors of that study joins us to discuss.

Read the full research:
http://www.bmj.com/content/359/bmj.j4619]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>973</itunes:duration>
                                    </item>
    <item>
        <title>The death of QOF?</title>
        <itunes:title>The death of QOF?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-death-of-qof/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-death-of-qof/#comments</comments>        <pubDate>Thu, 26 Oct 2017 14:29:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-death-of-qof</guid>
                                    <description><![CDATA[The Quality and Outcomes Framework (QOF) is one of the most ambitious pay-for-performance schemes introduced into any health system. It's now being scrapped by bits of the NHS, and is under reform elsewhere.

Martin Marshall, GP and professor of Health Improvement at University College London, thinks it's time to rethink the experiment. He joins us to discuss how we got here, what we've learned, and what will replace QOF.

Read the editorial:
<p>http://www.bmj.com/content/359/bmj.j4681</p>
]]></description>
                                                            <content:encoded><![CDATA[The Quality and Outcomes Framework (QOF) is one of the most ambitious pay-for-performance schemes introduced into any health system. It's now being scrapped by bits of the NHS, and is under reform elsewhere.

Martin Marshall, GP and professor of Health Improvement at University College London, thinks it's time to rethink the experiment. He joins us to discuss how we got here, what we've learned, and what will replace QOF.

Read the editorial:
<p>http://www.bmj.com/content/359/bmj.j4681</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/bg2r0u/stream_348685409-bmjgroup-the-death-of-qof.mp3" length="30120983" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The Quality and Outcomes Framework (QOF) is one of the most ambitious pay-for-performance schemes introduced into any health system. It's now being scrapped by bits of the NHS, and is under reform elsewhere.

Martin Marshall, GP and professor of Health Improvement at University College London, thinks it's time to rethink the experiment. He joins us to discuss how we got here, what we've learned, and what will replace QOF.

Read the editorial:
http://www.bmj.com/content/359/bmj.j4681]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1256</itunes:duration>
                                    </item>
    <item>
        <title>70% rise in incidence of self harm in teenagers</title>
        <itunes:title>70% rise in incidence of self harm in teenagers</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/70-rise-in-incidence-of-self-harm-in-teenagers/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/70-rise-in-incidence-of-self-harm-in-teenagers/#comments</comments>        <pubDate>Thu, 19 Oct 2017 12:54:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/70-rise-in-incidence-of-self-harm-in-teenagers</guid>
                                    <description><![CDATA[Half of adolescents who die by suicide have a history of self harm. And in the UK, the rates of adolescents who commit suicide jumped from 3.2, to 5.4 per 100 000 between 2010 and 2015. The national suicide prevention strategy recently expanded its scope by aiming to reduce self harm rates as a common precursor to suicide.

Therefore it's important that we have an accurate measure of rates of self harm in the population, and new research published on bmj.com aims to do that. 

To discuss we're joined by one of the authors of that paper - Navneet Kapur, professor of psychiatry and population health at the University of Manchester.

Read the full research:
<p>http://www.bmj.com/content/359/bmj.j4351</p>
]]></description>
                                                            <content:encoded><![CDATA[Half of adolescents who die by suicide have a history of self harm. And in the UK, the rates of adolescents who commit suicide jumped from 3.2, to 5.4 per 100 000 between 2010 and 2015. The national suicide prevention strategy recently expanded its scope by aiming to reduce self harm rates as a common precursor to suicide.

Therefore it's important that we have an accurate measure of rates of self harm in the population, and new research published on bmj.com aims to do that. 

To discuss we're joined by one of the authors of that paper - Navneet Kapur, professor of psychiatry and population health at the University of Manchester.

Read the full research:
<p>http://www.bmj.com/content/359/bmj.j4351</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/eqtf7w/stream_347613811-bmjgroup-70-rise-in-incidence-of-self-harm-in-teenagers.mp3" length="34945395" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Half of adolescents who die by suicide have a history of self harm. And in the UK, the rates of adolescents who commit suicide jumped from 3.2, to 5.4 per 100 000 between 2010 and 2015. The national suicide prevention strategy recently expanded its scope by aiming to reduce self harm rates as a common precursor to suicide.

Therefore it's important that we have an accurate measure of rates of self harm in the population, and new research published on bmj.com aims to do that. 

To discuss we're joined by one of the authors of that paper - Navneet Kapur, professor of psychiatry and population health at the University of Manchester.

Read the full research:
http://www.bmj.com/content/359/bmj.j4351]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1458</itunes:duration>
                                    </item>
    <item>
        <title>Exercise in old age - ”we need kendo classes in Huddersfield”</title>
        <itunes:title>Exercise in old age - ”we need kendo classes in Huddersfield”</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/exercise-in-old-age-we-need-kendo-classes-in-huddersfield/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/exercise-in-old-age-we-need-kendo-classes-in-huddersfield/#comments</comments>        <pubDate>Wed, 18 Oct 2017 16:24:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/exercise-in-old-age-we-need-kendo-classes-in-huddersfield</guid>
                                    <description><![CDATA[There's a crisis in old age care - not just in the UK, around the world, as population demographics shift, and the proportion of older people increase - there's a worry about who's going to look after them, and how much is it going to cost?

However, a new analysis on bmj.com says this picture need not be so gloomy - they say that encouraging exercise in older people could save billions - by keeping frailty at bay and increasing healthy life expectancy.

We're joined by two of the authors of that analysis - Scarlett McNally, consultant orthopedic surgeon at Eastbourne District General Hospital, and Muir Gray, public health doctor.

Read the full analysis:
<p>http://www.bmj.com/content/359/bmj.j4609</p>
]]></description>
                                                            <content:encoded><![CDATA[There's a crisis in old age care - not just in the UK, around the world, as population demographics shift, and the proportion of older people increase - there's a worry about who's going to look after them, and how much is it going to cost?

However, a new analysis on bmj.com says this picture need not be so gloomy - they say that encouraging exercise in older people could save billions - by keeping frailty at bay and increasing healthy life expectancy.

We're joined by two of the authors of that analysis - Scarlett McNally, consultant orthopedic surgeon at Eastbourne District General Hospital, and Muir Gray, public health doctor.

Read the full analysis:
<p>http://www.bmj.com/content/359/bmj.j4609</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/cf5kiw/stream_347484685-bmjgroup-exercise-in-old-age-we-need-kendo-classes-in-huddersfield.mp3" length="45002993" type="audio/mpeg"/>
        <itunes:summary><![CDATA[There's a crisis in old age care - not just in the UK, around the world, as population demographics shift, and the proportion of older people increase - there's a worry about who's going to look after them, and how much is it going to cost?

However, a new analysis on bmj.com says this picture need not be so gloomy - they say that encouraging exercise in older people could save billions - by keeping frailty at bay and increasing healthy life expectancy.

We're joined by two of the authors of that analysis - Scarlett McNally, consultant orthopedic surgeon at Eastbourne District General Hospital, and Muir Gray, public health doctor.

Read the full analysis:
http://www.bmj.com/content/359/bmj.j4609]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1877</itunes:duration>
                                    </item>
    <item>
        <title>Sex in surgery</title>
        <itunes:title>Sex in surgery</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/sex-in-surgery/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/sex-in-surgery/#comments</comments>        <pubDate>Fri, 13 Oct 2017 16:37:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/sex-in-surgery</guid>
                                    <description><![CDATA[New research published on bmj.com has evaluated how well women surgeons operate, when compared to their male colleagues - and shows that there is a marginal improvement in patient outcomes.

To discuss how that was studied, and what the findings mean, we're joined by Chris Wallis, a resident at the University of Toronto, and Raj Satkunasivam, a urologic-surgeon and assistant professor at the Houston methodist hospital in Texas.

Also joining us, to contextualise that research, is  Clare Marx - associate medical director of Ipswich Hospital NHS Ttrust, and former president of the Royal College of Surgeons. 

Read the open access research:
http://www.bmj.com/content/359/bmj.j4366

and editorial:
<p>http://www.bmj.com/content/359/bmj.j4580</p>
]]></description>
                                                            <content:encoded><![CDATA[New research published on bmj.com has evaluated how well women surgeons operate, when compared to their male colleagues - and shows that there is a marginal improvement in patient outcomes.

To discuss how that was studied, and what the findings mean, we're joined by Chris Wallis, a resident at the University of Toronto, and Raj Satkunasivam, a urologic-surgeon and assistant professor at the Houston methodist hospital in Texas.

Also joining us, to contextualise that research, is  Clare Marx - associate medical director of Ipswich Hospital NHS Ttrust, and former president of the Royal College of Surgeons. 

Read the open access research:
http://www.bmj.com/content/359/bmj.j4366

and editorial:
<p>http://www.bmj.com/content/359/bmj.j4580</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rkpbnf/stream_346739272-bmjgroup-sex-in-surgery.mp3" length="53417148" type="audio/mpeg"/>
        <itunes:summary><![CDATA[New research published on bmj.com has evaluated how well women surgeons operate, when compared to their male colleagues - and shows that there is a marginal improvement in patient outcomes.

To discuss how that was studied, and what the findings mean, we're joined by Chris Wallis, a resident at the University of Toronto, and Raj Satkunasivam, a urologic-surgeon and assistant professor at the Houston methodist hospital in Texas.

Also joining us, to contextualise that research, is  Clare Marx - associate medical director of Ipswich Hospital NHS Ttrust, and former president of the Royal College of Surgeons. 

Read the open access research:
http://www.bmj.com/content/359/bmj.j4366

and editorial:
http://www.bmj.com/content/359/bmj.j4580]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2229</itunes:duration>
                                    </item>
    <item>
        <title>Vinay Prasad - Cancer drugs from an oncologist point of view</title>
        <itunes:title>Vinay Prasad - Cancer drugs from an oncologist point of view</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/vinay-prasad-cancer-drugs-from-an-oncologist-point-of-view/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/vinay-prasad-cancer-drugs-from-an-oncologist-point-of-view/#comments</comments>        <pubDate>Fri, 13 Oct 2017 13:02:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/vinay-prasad-cancer-drugs-from-an-oncologist-point-of-view</guid>
                                    <description><![CDATA[Last week we published some new research which showed that 2/3 of new cancer drugs approved by the European Medicines Agency - the drug regulator for Europe - didn’t have any evidence of improved life expectancy or quality of life.

In this interview, Vinau Prasad, ematologist-oncologist and Assistant Professor of Medicine at the Oregon Health and Sciences University, explains how we came to accept surrogate measures in oncology trials, and how he tries to navigate the evidence for his patients.

Read his editorial:
<p>http://www.bmj.com/content/359/bmj.j4528</p>
]]></description>
                                                            <content:encoded><![CDATA[Last week we published some new research which showed that 2/3 of new cancer drugs approved by the European Medicines Agency - the drug regulator for Europe - didn’t have any evidence of improved life expectancy or quality of life.

In this interview, Vinau Prasad, ematologist-oncologist and Assistant Professor of Medicine at the Oregon Health and Sciences University, explains how we came to accept surrogate measures in oncology trials, and how he tries to navigate the evidence for his patients.

Read his editorial:
<p>http://www.bmj.com/content/359/bmj.j4528</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xg6rmi/stream_346711534-bmjgroup-vinay-prasad-cancer-drugs-from-an-oncologist-point-of-view.mp3" length="33839348" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Last week we published some new research which showed that 2/3 of new cancer drugs approved by the European Medicines Agency - the drug regulator for Europe - didn’t have any evidence of improved life expectancy or quality of life.

In this interview, Vinau Prasad, ematologist-oncologist and Assistant Professor of Medicine at the Oregon Health and Sciences University, explains how we came to accept surrogate measures in oncology trials, and how he tries to navigate the evidence for his patients.

Read his editorial:
http://www.bmj.com/content/359/bmj.j4528]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1412</itunes:duration>
                                    </item>
    <item>
        <title>There’s no clear evidence that most new cancer drugs extend or improve life</title>
        <itunes:title>There’s no clear evidence that most new cancer drugs extend or improve life</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/there-s-no-clear-evidence-that-most-new-cancer-drugs-extend-or-improve-life/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/there-s-no-clear-evidence-that-most-new-cancer-drugs-extend-or-improve-life/#comments</comments>        <pubDate>Thu, 05 Oct 2017 16:33:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/theres-no-clear-evidence-that-most-new-cancer-drugs-extend-or-improve-life</guid>
                                    <description><![CDATA[The majority of cancer drugs approved in Europe between 2009 and 2013 entered the market without clear evidence that they improved survival or quality of life for patients, finds a study published by The BMJ today.
 
Even where drugs did show survival gains over existing treatments, these were often marginal.

To discuss that, we're joined by Huseyin Naci, assistant professor of health policy at the London School of Economics.

<p>Read the open access study: http://www.bmj.com/content/359/bmj.j4530</p>
]]></description>
                                                            <content:encoded><![CDATA[The majority of cancer drugs approved in Europe between 2009 and 2013 entered the market without clear evidence that they improved survival or quality of life for patients, finds a study published by The BMJ today.
 
Even where drugs did show survival gains over existing treatments, these were often marginal.

To discuss that, we're joined by Huseyin Naci, assistant professor of health policy at the London School of Economics.

<p>Read the open access study: http://www.bmj.com/content/359/bmj.j4530</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jse70d/stream_345498216-bmjgroup-theres-no-clear-evidence-that-most-new-cancer-drugs-extend-or-improve-life.mp3" length="34406178" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The majority of cancer drugs approved in Europe between 2009 and 2013 entered the market without clear evidence that they improved survival or quality of life for patients, finds a study published by The BMJ today.
 
Even where drugs did show survival gains over existing treatments, these were often marginal.

To discuss that, we're joined by Huseyin Naci, assistant professor of health policy at the London School of Economics.

Read the open access study: http://www.bmj.com/content/359/bmj.j4530]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1435</itunes:duration>
                                    </item>
    <item>
        <title>Telephone consultations - no cost savings, but increased GP workload</title>
        <itunes:title>Telephone consultations - no cost savings, but increased GP workload</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/telephone-consultations-no-cost-savings-but-increased-gp-workload/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/telephone-consultations-no-cost-savings-but-increased-gp-workload/#comments</comments>        <pubDate>Thu, 28 Sep 2017 15:02:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/telephone-consultations-increase-gp-workload</guid>
                                    <description><![CDATA[If you're a patient in the UK, increasingly, your first interaction with the healthcare system won't be the traditional face to fact chat with your doctor - instead you'll have a telephone consultation.

The prevalence of these telephone consultations is increasing, and being promoted by CCGs and private companies who administer them - usually as a cost saving measure.

Now new research published on bmj.com looks at these phone consultation - how often they happen, how patients feel about them, and how much money they actually save.

In this podcast we're joined by Martin Roland, emeritus professor of health services research at Cambridge University, to find out more.

Read the full research:
<p>http://www.bmj.com/content/358/bmj.j4197</p>
]]></description>
                                                            <content:encoded><![CDATA[If you're a patient in the UK, increasingly, your first interaction with the healthcare system won't be the traditional face to fact chat with your doctor - instead you'll have a telephone consultation.

The prevalence of these telephone consultations is increasing, and being promoted by CCGs and private companies who administer them - usually as a cost saving measure.

Now new research published on bmj.com looks at these phone consultation - how often they happen, how patients feel about them, and how much money they actually save.

In this podcast we're joined by Martin Roland, emeritus professor of health services research at Cambridge University, to find out more.

Read the full research:
<p>http://www.bmj.com/content/358/bmj.j4197</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xr64q6/stream_344426800-bmjgroup-telephone-consultations-increase-gp-workload.mp3" length="32572021" type="audio/mpeg"/>
        <itunes:summary><![CDATA[If you're a patient in the UK, increasingly, your first interaction with the healthcare system won't be the traditional face to fact chat with your doctor - instead you'll have a telephone consultation.

The prevalence of these telephone consultations is increasing, and being promoted by CCGs and private companies who administer them - usually as a cost saving measure.

Now new research published on bmj.com looks at these phone consultation - how often they happen, how patients feel about them, and how much money they actually save.

In this podcast we're joined by Martin Roland, emeritus professor of health services research at Cambridge University, to find out more.

Read the full research:
http://www.bmj.com/content/358/bmj.j4197]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1359</itunes:duration>
                                    </item>
    <item>
        <title>Selling off NHS silver?</title>
        <itunes:title>Selling off NHS silver?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/selling-off-nhs-silver/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/selling-off-nhs-silver/#comments</comments>        <pubDate>Wed, 27 Sep 2017 16:04:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/selling-off-nhs-silver</guid>
                                    <description><![CDATA[Should we welcome plans to sell off NHS land?

The government seems likely to back the recommendations of Robert Naylor (national adviser on NHS property and estates) to raise capital by selling off inefficiently used assets, but Kailash Chand (GP) worries that services could be threatened and that public consultation is lacking.

<p>Read the Head To Head article: https://www.bmj.com/content/358/bmj.j4290</p>
]]></description>
                                                            <content:encoded><![CDATA[Should we welcome plans to sell off NHS land?

The government seems likely to back the recommendations of Robert Naylor (national adviser on NHS property and estates) to raise capital by selling off inefficiently used assets, but Kailash Chand (GP) worries that services could be threatened and that public consultation is lacking.

<p>Read the Head To Head article: https://www.bmj.com/content/358/bmj.j4290</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ae18kh/stream_344281186-bmjgroup-selling-off-nhs-silver.mp3" length="21658088" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Should we welcome plans to sell off NHS land?

The government seems likely to back the recommendations of Robert Naylor (national adviser on NHS property and estates) to raise capital by selling off inefficiently used assets, but Kailash Chand (GP) worries that services could be threatened and that public consultation is lacking.

Read the Head To Head article: https://www.bmj.com/content/358/bmj.j4290]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>903</itunes:duration>
                                    </item>
    <item>
        <title>What Choosing Wisely looks like in the UK</title>
        <itunes:title>What Choosing Wisely looks like in the UK</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/what-choosing-wisely-looks-like-in-the-uk/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/what-choosing-wisely-looks-like-in-the-uk/#comments</comments>        <pubDate>Wed, 27 Sep 2017 10:36:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/choosing-wisely-looks-like-in-the-uk</guid>
                                    <description><![CDATA[Choosing Wisely was launched in the US, to much fanfare. Since then the movement has spread around the world, with successful chapters set up in Canada, Australia Brazil, Italy, Japan, new Zealand -  and most recently the UK.
 
The campaigns have not been without criticism – from how individual recommendations were chosen, to the way in which patients have been involved.
 
In this podcast, we're joined by  joined by 3 of Choosing Wisely UK’s steering group, professor Sue Bailey,  head of the steering committee, Ramai Santhirapala, honorary consultant in anaesthesia and perioperative medicine, and, Richard Lehman, GP.

<p>http://www.choosingwisely.co.uk/</p>
]]></description>
                                                            <content:encoded><![CDATA[Choosing Wisely was launched in the US, to much fanfare. Since then the movement has spread around the world, with successful chapters set up in Canada, Australia Brazil, Italy, Japan, new Zealand -  and most recently the UK.
 
The campaigns have not been without criticism – from how individual recommendations were chosen, to the way in which patients have been involved.
 
In this podcast, we're joined by  joined by 3 of Choosing Wisely UK’s steering group, professor Sue Bailey,  head of the steering committee, Ramai Santhirapala, honorary consultant in anaesthesia and perioperative medicine, and, Richard Lehman, GP.

<p>http://www.choosingwisely.co.uk/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qeryok/stream_344245076-bmjgroup-choosing-wisely-looks-like-in-the-uk.mp3" length="57997959" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Choosing Wisely was launched in the US, to much fanfare. Since then the movement has spread around the world, with successful chapters set up in Canada, Australia Brazil, Italy, Japan, new Zealand -  and most recently the UK.
 
The campaigns have not been without criticism – from how individual recommendations were chosen, to the way in which patients have been involved.
 
In this podcast, we're joined by  joined by 3 of Choosing Wisely UK’s steering group, professor Sue Bailey,  head of the steering committee, Ramai Santhirapala, honorary consultant in anaesthesia and perioperative medicine, and, Richard Lehman, GP.

http://www.choosingwisely.co.uk/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2420</itunes:duration>
                                    </item>
    <item>
        <title>Diabetes remission - ”treating blood glucose, when the disease process is to do with body fat”</title>
        <itunes:title>Diabetes remission - ”treating blood glucose, when the disease process is to do with body fat”</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/diabetes-remission-treating-blood-glucose-when-the-disease-process-is-to-do-with-body-fat/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/diabetes-remission-treating-blood-glucose-when-the-disease-process-is-to-do-with-body-fat/#comments</comments>        <pubDate>Fri, 22 Sep 2017 15:25:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/diabetes-remission-treating-blood-glucose-when-the-disease-process-is-to-do-with-body-fat</guid>
                                    <description><![CDATA[In the UK - type 2 diabetes now affects between 5-10% of the population - and accounts for around 10% of our total NHS budget.  For the individuals affected, treatments are effective at helping control glucose levels - however, the sequela associated with the disease - vascular problems, and a life expectancy that’s 6 years shorter - are still an issue.

However, for some, remission seems to be a possibility.

To discuss we're joined by Mike Lean, professor of human nutrition at the university if Glasgow, and co-author of an analysis, published on bmj.com, which impels doctors to make sure that type to diabetes remission is coded properly.

Read the full analysis:
<p>http://www.bmj.com/content/358/bmj.j4030</p>
]]></description>
                                                            <content:encoded><![CDATA[In the UK - type 2 diabetes now affects between 5-10% of the population - and accounts for around 10% of our total NHS budget.  For the individuals affected, treatments are effective at helping control glucose levels - however, the sequela associated with the disease - vascular problems, and a life expectancy that’s 6 years shorter - are still an issue.

However, for some, remission seems to be a possibility.

To discuss we're joined by Mike Lean, professor of human nutrition at the university if Glasgow, and co-author of an analysis, published on bmj.com, which impels doctors to make sure that type to diabetes remission is coded properly.

Read the full analysis:
<p>http://www.bmj.com/content/358/bmj.j4030</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2poner/stream_343550655-bmjgroup-diabetes-remission-treating-blood-glucose-when-the-disease-process-is-to-do-with-body-fat.mp3" length="33937915" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In the UK - type 2 diabetes now affects between 5-10% of the population - and accounts for around 10% of our total NHS budget.  For the individuals affected, treatments are effective at helping control glucose levels - however, the sequela associated with the disease - vascular problems, and a life expectancy that’s 6 years shorter - are still an issue.

However, for some, remission seems to be a possibility.

To discuss we're joined by Mike Lean, professor of human nutrition at the university if Glasgow, and co-author of an analysis, published on bmj.com, which impels doctors to make sure that type to diabetes remission is coded properly.

Read the full analysis:
http://www.bmj.com/content/358/bmj.j4030]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1415</itunes:duration>
                                    </item>
    <item>
        <title>The problems with peer review</title>
        <itunes:title>The problems with peer review</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-problems-with-peer-review/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-problems-with-peer-review/#comments</comments>        <pubDate>Tue, 19 Sep 2017 14:10:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-problems-with-peer-review</guid>
                                    <description><![CDATA[One of the hurdles that anyone who submits research or analysis to The BMJ has to deal with is peer review.

The problems  of the process, and some of the potential solutions, was a big part of the Peer Review Congress which took place last week.

<p>In this interview, Sophie Cook, The BMJ's UK research editor, talks to Lisa Bero, who’s a professor of evidence based medicine at Sydney University, and spends a lot of time investigating the integrity of health research.</p>
]]></description>
                                                            <content:encoded><![CDATA[One of the hurdles that anyone who submits research or analysis to The BMJ has to deal with is peer review.

The problems  of the process, and some of the potential solutions, was a big part of the Peer Review Congress which took place last week.

<p>In this interview, Sophie Cook, The BMJ's UK research editor, talks to Lisa Bero, who’s a professor of evidence based medicine at Sydney University, and spends a lot of time investigating the integrity of health research.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5kym4t/stream_343060321-bmjgroup-the-problems-with-peer-review.mp3" length="20485993" type="audio/mpeg"/>
        <itunes:summary><![CDATA[One of the hurdles that anyone who submits research or analysis to The BMJ has to deal with is peer review.

The problems  of the process, and some of the potential solutions, was a big part of the Peer Review Congress which took place last week.

In this interview, Sophie Cook, The BMJ's UK research editor, talks to Lisa Bero, who’s a professor of evidence based medicine at Sydney University, and spends a lot of time investigating the integrity of health research.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>854</itunes:duration>
                                    </item>
    <item>
        <title>HIV in pregnancy -  ”without the big picture, people aren’t going to be able to take the medication”</title>
        <itunes:title>HIV in pregnancy -  ”without the big picture, people aren’t going to be able to take the medication”</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/hiv-in-pregnancy-without-the-big-picture-people-aren-t-going-to-be-able-to-take-the-medication/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/hiv-in-pregnancy-without-the-big-picture-people-aren-t-going-to-be-able-to-take-the-medication/#comments</comments>        <pubDate>Fri, 15 Sep 2017 17:11:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/hiv-in-pregnancy-without-the-big-picture-people-arent-going-to-be-able-to-take-the-medication</guid>
                                    <description><![CDATA[A new Rapid Recommendation from The BMJ suggests that for pregnant women, they may wish to avoid certain antiviral treatments for HIV. 

This recommendation differs from the WHO's, and to discuss why that is, and what makes that difference important, we're joined by Reed Siemieniuk, a physician and methodologist from McMaster University, and Alice Welbourn, campaigner for gender and sexual and reproductive health rights, in the context of HIV and violence against women.

Read the full rapid recommendation:
http://www.bmj.com/content/358/bmj.j3961

And Alice Welborn's opinion article:
<p>http://blogs.bmj.com/bmj/2017/09/11/alice-welbourn-who-and-the-rights-of-women-living-with-hiv/</p>
]]></description>
                                                            <content:encoded><![CDATA[A new Rapid Recommendation from The BMJ suggests that for pregnant women, they may wish to avoid certain antiviral treatments for HIV. 

This recommendation differs from the WHO's, and to discuss why that is, and what makes that difference important, we're joined by Reed Siemieniuk, a physician and methodologist from McMaster University, and Alice Welbourn, campaigner for gender and sexual and reproductive health rights, in the context of HIV and violence against women.

Read the full rapid recommendation:
http://www.bmj.com/content/358/bmj.j3961

And Alice Welborn's opinion article:
<p>http://blogs.bmj.com/bmj/2017/09/11/alice-welbourn-who-and-the-rights-of-women-living-with-hiv/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/aexnls/stream_342512469-bmjgroup-hiv-in-pregnancy-without-the-big-picture-people-arent-going-to-be-able-to-take-the-medication.mp3" length="29364224" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A new Rapid Recommendation from The BMJ suggests that for pregnant women, they may wish to avoid certain antiviral treatments for HIV. 

This recommendation differs from the WHO's, and to discuss why that is, and what makes that difference important, we're joined by Reed Siemieniuk, a physician and methodologist from McMaster University, and Alice Welbourn, campaigner for gender and sexual and reproductive health rights, in the context of HIV and violence against women.

Read the full rapid recommendation:
http://www.bmj.com/content/358/bmj.j3961

And Alice Welborn's opinion article:
http://blogs.bmj.com/bmj/2017/09/11/alice-welbourn-who-and-the-rights-of-women-living-with-hiv/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1577</itunes:duration>
                                    </item>
    <item>
        <title>Googling depression</title>
        <itunes:title>Googling depression</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/googling-depression/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/googling-depression/#comments</comments>        <pubDate>Mon, 11 Sep 2017 13:41:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/googling-depression</guid>
                                    <description><![CDATA[In the USA, when googling "depression" patients will be presented with a link to the PHQ-9 screening test.

Google has developed this in collaboration with the National Alliance on Mental Illness - and Ken Duckworth, the alliance's medical director, debates the merits of this approach with Simon Gilbody, from the Department of Health Sciences at the University of York.

Also joining this podcast is David Gilbert, mental health services user and director of InHealth Associates, who argues that it's only through patient involvement that real improvements to mental health can be obtained.

Read the debate and commentary:
http://www.bmj.com/content/358/bmj.j4144
<p>http://www.bmj.com/content/358/bmj.j4207</p>
]]></description>
                                                            <content:encoded><![CDATA[In the USA, when googling "depression" patients will be presented with a link to the PHQ-9 screening test.

Google has developed this in collaboration with the National Alliance on Mental Illness - and Ken Duckworth, the alliance's medical director, debates the merits of this approach with Simon Gilbody, from the Department of Health Sciences at the University of York.

Also joining this podcast is David Gilbert, mental health services user and director of InHealth Associates, who argues that it's only through patient involvement that real improvements to mental health can be obtained.

Read the debate and commentary:
http://www.bmj.com/content/358/bmj.j4144
<p>http://www.bmj.com/content/358/bmj.j4207</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vjpwnv/stream_341875774-bmjgroup-googling-depression.mp3" length="50238568" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In the USA, when googling "depression" patients will be presented with a link to the PHQ-9 screening test.

Google has developed this in collaboration with the National Alliance on Mental Illness - and Ken Duckworth, the alliance's medical director, debates the merits of this approach with Simon Gilbody, from the Department of Health Sciences at the University of York.

Also joining this podcast is David Gilbert, mental health services user and director of InHealth Associates, who argues that it's only through patient involvement that real improvements to mental health can be obtained.

Read the debate and commentary:
http://www.bmj.com/content/358/bmj.j4144
http://www.bmj.com/content/358/bmj.j4207]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2096</itunes:duration>
                                    </item>
    <item>
        <title>Nigel Crisp - The NHS isn’t just a cost to society, it’s a benefit</title>
        <itunes:title>Nigel Crisp - The NHS isn’t just a cost to society, it’s a benefit</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/nigel-crisp-the-nhs-isn-t-just-a-cost-to-society-it-s-a-benefit/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/nigel-crisp-the-nhs-isn-t-just-a-cost-to-society-it-s-a-benefit/#comments</comments>        <pubDate>Fri, 08 Sep 2017 17:18:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/nigel-crisp-the-nhs-isnt-just-a-cost-to-society-its-a-benefit</guid>
                                    <description><![CDATA[If you google "The NHS" you'll see screaming headlines from the Daily Mail about cost and waste - debate in parliament is about how much of our GDP we should be spending - and each year, hospital trusts go cap in hand to ask for more funding. 

Against this backdrop, a new analysis, and a first in a series, published on bmj.com, looks at what it takes to have sustainable healthcare - and cruically, talks about this from the point of view of benefit, not cost.

<p>I'm Duncan Jarvies, and I'm Navjoyt Ladher, and today we've come to the House of Lords to speak to Baron Nigel Crisp - cross-bench peer, former NHS trust executive, and health system guru.</p>
]]></description>
                                                            <content:encoded><![CDATA[If you google "The NHS" you'll see screaming headlines from the Daily Mail about cost and waste - debate in parliament is about how much of our GDP we should be spending - and each year, hospital trusts go cap in hand to ask for more funding. 

Against this backdrop, a new analysis, and a first in a series, published on bmj.com, looks at what it takes to have sustainable healthcare - and cruically, talks about this from the point of view of benefit, not cost.

<p>I'm Duncan Jarvies, and I'm Navjoyt Ladher, and today we've come to the House of Lords to speak to Baron Nigel Crisp - cross-bench peer, former NHS trust executive, and health system guru.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6vh7zp/stream_341498656-bmjgroup-nigel-crisp-the-nhs-isnt-just-a-cost-to-society-its-a-benefit.mp3" length="37478352" type="audio/mpeg"/>
        <itunes:summary><![CDATA[If you google "The NHS" you'll see screaming headlines from the Daily Mail about cost and waste - debate in parliament is about how much of our GDP we should be spending - and each year, hospital trusts go cap in hand to ask for more funding. 

Against this backdrop, a new analysis, and a first in a series, published on bmj.com, looks at what it takes to have sustainable healthcare - and cruically, talks about this from the point of view of benefit, not cost.

I'm Duncan Jarvies, and I'm Navjoyt Ladher, and today we've come to the House of Lords to speak to Baron Nigel Crisp - cross-bench peer, former NHS trust executive, and health system guru.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1563</itunes:duration>
                                    </item>
    <item>
        <title>The World Bank - creating a market in pandemic risk</title>
        <itunes:title>The World Bank - creating a market in pandemic risk</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-world-bank-creating-a-market-in-pandemic-risk/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-world-bank-creating-a-market-in-pandemic-risk/#comments</comments>        <pubDate>Fri, 01 Sep 2017 09:06:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-world-bank-creating-a-market-in-pandemic-risk</guid>
                                    <description><![CDATA[The world bank was set up in 1944. In the aftermath of the second world war, the institution was there to give loans to countries rebuilding after the conflict. Their first loan went to France - but with stipulations about repayment that set a tone for future funds.

A new series, authored by Devi Sridhar, and her team from the  University of Edinburgh, and published on bmj.com, looks at where the World Bank has come.  The series is , and the articles will cover;

Why the World Bank matters to global health
The World Bank’s turn to Universal health coverage
How the Bank’s trust funds are being used to fund specific projects - and why it’s hard to know what those are
The Global Financing Facility - grants and loans supplied together, 
and finally, creating a market out of pandemic risk

In this final interview, Felix Stein a postdoctoral research fellow at the University of Edinburgh describes the bank's move to create a market for pandemic insurance.

Read the full analysis:
<p>http://www.bmj.com/content/358/bmj.j3397</p>
]]></description>
                                                            <content:encoded><![CDATA[The world bank was set up in 1944. In the aftermath of the second world war, the institution was there to give loans to countries rebuilding after the conflict. Their first loan went to France - but with stipulations about repayment that set a tone for future funds.

A new series, authored by Devi Sridhar, and her team from the  University of Edinburgh, and published on bmj.com, looks at where the World Bank has come.  The series is , and the articles will cover;

Why the World Bank matters to global health
The World Bank’s turn to Universal health coverage
How the Bank’s trust funds are being used to fund specific projects - and why it’s hard to know what those are
The Global Financing Facility - grants and loans supplied together, 
and finally, creating a market out of pandemic risk

In this final interview, Felix Stein a postdoctoral research fellow at the University of Edinburgh describes the bank's move to create a market for pandemic insurance.

Read the full analysis:
<p>http://www.bmj.com/content/358/bmj.j3397</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xav5mb/stream_340430948-bmjgroup-the-world-bank-creating-a-market-in-pandemic-risk.mp3" length="31131826" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The world bank was set up in 1944. In the aftermath of the second world war, the institution was there to give loans to countries rebuilding after the conflict. Their first loan went to France - but with stipulations about repayment that set a tone for future funds.

A new series, authored by Devi Sridhar, and her team from the  University of Edinburgh, and published on bmj.com, looks at where the World Bank has come.  The series is , and the articles will cover;

Why the World Bank matters to global health
The World Bank’s turn to Universal health coverage
How the Bank’s trust funds are being used to fund specific projects - and why it’s hard to know what those are
The Global Financing Facility - grants and loans supplied together, 
and finally, creating a market out of pandemic risk

In this final interview, Felix Stein a postdoctoral research fellow at the University of Edinburgh describes the bank's move to create a market for pandemic insurance.

Read the full analysis:
http://www.bmj.com/content/358/bmj.j3397]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1299</itunes:duration>
                                    </item>
    <item>
        <title>The World Bank - the Global Financing Facility</title>
        <itunes:title>The World Bank - the Global Financing Facility</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-world-bank-the-global-financing-facility/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-world-bank-the-global-financing-facility/#comments</comments>        <pubDate>Fri, 01 Sep 2017 09:05:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-world-bank-the-global-financing-facility</guid>
                                    <description><![CDATA[The world bank was set up in 1944. In the aftermath of the second world war, the institution was there to give loans to countries rebuilding after the conflict. Their first loan went to France - but with stipulations about repayment that set a tone for future funds.

A new series, authored by Devi Sridhar, and her team from the  University of Edinburgh, and published on bmj.com, looks at where the World Bank has come.  The series is , and the articles will cover;

Why the World Bank matters to global health
The World Bank’s turn to Universal health coverage
How the Bank’s trust funds are being used to fund specific projects - and why it’s hard to know what those are
The Global Financing Facility - grants and loans supplied together, 
and finally, creating a market out of pandemic risk

In this fourth interview, Genevie Fernandes a PhD student at the University of Edinburgh discusses a new model of combing grants and loans in the Global Financing Facility.

Read the full analysis:
<p>http://www.bmj.com/content/358/bmj.j3395</p>
]]></description>
                                                            <content:encoded><![CDATA[The world bank was set up in 1944. In the aftermath of the second world war, the institution was there to give loans to countries rebuilding after the conflict. Their first loan went to France - but with stipulations about repayment that set a tone for future funds.

A new series, authored by Devi Sridhar, and her team from the  University of Edinburgh, and published on bmj.com, looks at where the World Bank has come.  The series is , and the articles will cover;

Why the World Bank matters to global health
The World Bank’s turn to Universal health coverage
How the Bank’s trust funds are being used to fund specific projects - and why it’s hard to know what those are
The Global Financing Facility - grants and loans supplied together, 
and finally, creating a market out of pandemic risk

In this fourth interview, Genevie Fernandes a PhD student at the University of Edinburgh discusses a new model of combing grants and loans in the Global Financing Facility.

Read the full analysis:
<p>http://www.bmj.com/content/358/bmj.j3395</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/cnlltz/stream_340430843-bmjgroup-the-world-bank-the-global-financing-facility.mp3" length="19077013" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The world bank was set up in 1944. In the aftermath of the second world war, the institution was there to give loans to countries rebuilding after the conflict. Their first loan went to France - but with stipulations about repayment that set a tone for future funds.

A new series, authored by Devi Sridhar, and her team from the  University of Edinburgh, and published on bmj.com, looks at where the World Bank has come.  The series is , and the articles will cover;

Why the World Bank matters to global health
The World Bank’s turn to Universal health coverage
How the Bank’s trust funds are being used to fund specific projects - and why it’s hard to know what those are
The Global Financing Facility - grants and loans supplied together, 
and finally, creating a market out of pandemic risk

In this fourth interview, Genevie Fernandes a PhD student at the University of Edinburgh discusses a new model of combing grants and loans in the Global Financing Facility.

Read the full analysis:
http://www.bmj.com/content/358/bmj.j3395]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>795</itunes:duration>
                                    </item>
    <item>
        <title>The World Bank - trust funds</title>
        <itunes:title>The World Bank - trust funds</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-world-bank-trust-funds/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-world-bank-trust-funds/#comments</comments>        <pubDate>Fri, 01 Sep 2017 09:03:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-world-bank-trust-funds</guid>
                                    <description><![CDATA[The world bank was set up in 1944. In the aftermath of the second world war, the institution was there to give loans to countries rebuilding after the conflict. Their first loan went to France - but with stipulations about repayment that set a tone for future funds.

A new series, authored by Devi Sridhar, and her team from the  University of Edinburgh, and published on bmj.com, looks at where the World Bank has come.  The series is , and the articles will cover;

Why the World Bank matters to global health
The World Bank’s turn to Universal health coverage
How the Bank’s trust funds are being used to fund specific projects - and why it’s hard to know what those are
The Global Financing Facility - grants and loans supplied together, 
and finally, creating a market out of pandemic risk

In this third interview, Janelle Winters a PhD student at the University of Edinburgh explains what the bank's trust funds are, and why it can be hard to tell what they're funding.

Read the full analysis:
<p>http://www.bmj.com/content/358/bmj.j3394</p>
]]></description>
                                                            <content:encoded><![CDATA[The world bank was set up in 1944. In the aftermath of the second world war, the institution was there to give loans to countries rebuilding after the conflict. Their first loan went to France - but with stipulations about repayment that set a tone for future funds.

A new series, authored by Devi Sridhar, and her team from the  University of Edinburgh, and published on bmj.com, looks at where the World Bank has come.  The series is , and the articles will cover;

Why the World Bank matters to global health
The World Bank’s turn to Universal health coverage
How the Bank’s trust funds are being used to fund specific projects - and why it’s hard to know what those are
The Global Financing Facility - grants and loans supplied together, 
and finally, creating a market out of pandemic risk

In this third interview, Janelle Winters a PhD student at the University of Edinburgh explains what the bank's trust funds are, and why it can be hard to tell what they're funding.

Read the full analysis:
<p>http://www.bmj.com/content/358/bmj.j3394</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/r3lf0y/stream_340430773-bmjgroup-the-world-bank-trust-funds.mp3" length="27924798" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The world bank was set up in 1944. In the aftermath of the second world war, the institution was there to give loans to countries rebuilding after the conflict. Their first loan went to France - but with stipulations about repayment that set a tone for future funds.

A new series, authored by Devi Sridhar, and her team from the  University of Edinburgh, and published on bmj.com, looks at where the World Bank has come.  The series is , and the articles will cover;

Why the World Bank matters to global health
The World Bank’s turn to Universal health coverage
How the Bank’s trust funds are being used to fund specific projects - and why it’s hard to know what those are
The Global Financing Facility - grants and loans supplied together, 
and finally, creating a market out of pandemic risk

In this third interview, Janelle Winters a PhD student at the University of Edinburgh explains what the bank's trust funds are, and why it can be hard to tell what they're funding.

Read the full analysis:
http://www.bmj.com/content/358/bmj.j3394]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1164</itunes:duration>
                                    </item>
    <item>
        <title>The World Bank - Universal Healthcare</title>
        <itunes:title>The World Bank - Universal Healthcare</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-world-bank-universal-healthcare/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-world-bank-universal-healthcare/#comments</comments>        <pubDate>Fri, 01 Sep 2017 09:01:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-world-bank-universal-healthcare</guid>
                                    <description><![CDATA[The world bank was set up in 1944. In the aftermath of the second world war, the institution was there to give loans to countries rebuilding after the conflict. Their first loan went to France - but with stipulations about repayment that set a tone for future funds.

A new series, authored by Devi Sridhar, and her team from the  University of Edinburgh, and published on bmj.com, looks at where the World Bank has come.  The series is , and the articles will cover;

Why the World Bank matters to global health
The World Bank’s turn to Universal health coverage
How the Bank’s trust funds are being used to fund specific projects - and why it’s hard to know what those are
The Global Financing Facility - grants and loans supplied together, 
and finally, creating a market out of pandemic risk

In this second interview, Marlee Tichenor, postdoctoral research fellow at the University of Edinburgh explains why the bank has embraced universal healthcare.

Read the full analysis:
<p>http://www.bmj.com/content/358/bmj.j3347</p>
]]></description>
                                                            <content:encoded><![CDATA[The world bank was set up in 1944. In the aftermath of the second world war, the institution was there to give loans to countries rebuilding after the conflict. Their first loan went to France - but with stipulations about repayment that set a tone for future funds.

A new series, authored by Devi Sridhar, and her team from the  University of Edinburgh, and published on bmj.com, looks at where the World Bank has come.  The series is , and the articles will cover;

Why the World Bank matters to global health
The World Bank’s turn to Universal health coverage
How the Bank’s trust funds are being used to fund specific projects - and why it’s hard to know what those are
The Global Financing Facility - grants and loans supplied together, 
and finally, creating a market out of pandemic risk

In this second interview, Marlee Tichenor, postdoctoral research fellow at the University of Edinburgh explains why the bank has embraced universal healthcare.

Read the full analysis:
<p>http://www.bmj.com/content/358/bmj.j3347</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6p2jck/stream_340430656-bmjgroup-the-world-bank-universal-healthcare.mp3" length="24170330" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The world bank was set up in 1944. In the aftermath of the second world war, the institution was there to give loans to countries rebuilding after the conflict. Their first loan went to France - but with stipulations about repayment that set a tone for future funds.

A new series, authored by Devi Sridhar, and her team from the  University of Edinburgh, and published on bmj.com, looks at where the World Bank has come.  The series is , and the articles will cover;

Why the World Bank matters to global health
The World Bank’s turn to Universal health coverage
How the Bank’s trust funds are being used to fund specific projects - and why it’s hard to know what those are
The Global Financing Facility - grants and loans supplied together, 
and finally, creating a market out of pandemic risk

In this second interview, Marlee Tichenor, postdoctoral research fellow at the University of Edinburgh explains why the bank has embraced universal healthcare.

Read the full analysis:
http://www.bmj.com/content/358/bmj.j3347]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1008</itunes:duration>
                                    </item>
    <item>
        <title>The World Bank - why it matters for global health</title>
        <itunes:title>The World Bank - why it matters for global health</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-world-bank-why-it-matters-for-global-health/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-world-bank-why-it-matters-for-global-health/#comments</comments>        <pubDate>Fri, 01 Sep 2017 08:59:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-world-bank-why-it-matters-for-global-health</guid>
                                    <description><![CDATA[The world bank was set up in 1944. In the aftermath of the second world war, the institution was there to give loans to countries rebuilding after the conflict. Their first loan went to France - but with stipulations about repayment that set a tone for future funds.

A new series, authored by Devi Sridhar, and her team from the  University of Edinburgh, and published on bmj.com, looks at where the World Bank has come.  The series is , and the articles will cover;

Why the World Bank matters to global health
The World Bank’s turn to Universal health coverage
How the Bank’s trust funds are being used to fund specific projects - and why it’s hard to know what those are
The Global Financing Facility - grants and loans supplied together, 
and finally, creating a market out of pandemic risk

In this first interview, Devi Sridhar, professor of global health at the University of Edinburgh explains why the bank matters for global health.

Read the full analysis:
<p>http://www.bmj.com/content/358/bmj.j3339</p>
]]></description>
                                                            <content:encoded><![CDATA[The world bank was set up in 1944. In the aftermath of the second world war, the institution was there to give loans to countries rebuilding after the conflict. Their first loan went to France - but with stipulations about repayment that set a tone for future funds.

A new series, authored by Devi Sridhar, and her team from the  University of Edinburgh, and published on bmj.com, looks at where the World Bank has come.  The series is , and the articles will cover;

Why the World Bank matters to global health
The World Bank’s turn to Universal health coverage
How the Bank’s trust funds are being used to fund specific projects - and why it’s hard to know what those are
The Global Financing Facility - grants and loans supplied together, 
and finally, creating a market out of pandemic risk

In this first interview, Devi Sridhar, professor of global health at the University of Edinburgh explains why the bank matters for global health.

Read the full analysis:
<p>http://www.bmj.com/content/358/bmj.j3339</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/f3r6hk/stream_340430541-bmjgroup-the-world-bank-why-it-matters-for-global-health.mp3" length="24436012" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The world bank was set up in 1944. In the aftermath of the second world war, the institution was there to give loans to countries rebuilding after the conflict. Their first loan went to France - but with stipulations about repayment that set a tone for future funds.

A new series, authored by Devi Sridhar, and her team from the  University of Edinburgh, and published on bmj.com, looks at where the World Bank has come.  The series is , and the articles will cover;

Why the World Bank matters to global health
The World Bank’s turn to Universal health coverage
How the Bank’s trust funds are being used to fund specific projects - and why it’s hard to know what those are
The Global Financing Facility - grants and loans supplied together, 
and finally, creating a market out of pandemic risk

In this first interview, Devi Sridhar, professor of global health at the University of Edinburgh explains why the bank matters for global health.

Read the full analysis:
http://www.bmj.com/content/358/bmj.j3339]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1019</itunes:duration>
                                    </item>
    <item>
        <title>Preventing Overdiagnosis 2017 - from theory to practice</title>
        <itunes:title>Preventing Overdiagnosis 2017 - from theory to practice</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/preventing-overdiagnosis-2017-from-theory-to-practice/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/preventing-overdiagnosis-2017-from-theory-to-practice/#comments</comments>        <pubDate>Thu, 24 Aug 2017 21:49:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/preventing-overdiagnosis-2017-from-theory-to-practice</guid>
                                    <description><![CDATA[In our last podcast from Preventing Overdiagnosis 2017, we convened an impromptu roundtable of clinicians who are attending the conference to see how some of the big themes that were discussed at the conference are going to impact their everyday practice.

Joining us were;
Jessica Otte - Family physician from Canada
David Warriner  - Cardiologist from the UK.
Jack O’Sullivan - Junior doctor from Australia
Imran Sajid - GP from the UK 

<p>To read more, have a look at our Too much medicine campaign - bmj.com/too-much-medicine.</p>
]]></description>
                                                            <content:encoded><![CDATA[In our last podcast from Preventing Overdiagnosis 2017, we convened an impromptu roundtable of clinicians who are attending the conference to see how some of the big themes that were discussed at the conference are going to impact their everyday practice.

Joining us were;
Jessica Otte - Family physician from Canada
David Warriner  - Cardiologist from the UK.
Jack O’Sullivan - Junior doctor from Australia
Imran Sajid - GP from the UK 

<p>To read more, have a look at our Too much medicine campaign - bmj.com/too-much-medicine.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/sgn9ar/stream_339361830-bmjgroup-preventing-overdiagnosis-2017-from-theory-to-practice.mp3" length="34273118" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In our last podcast from Preventing Overdiagnosis 2017, we convened an impromptu roundtable of clinicians who are attending the conference to see how some of the big themes that were discussed at the conference are going to impact their everyday practice.

Joining us were;
Jessica Otte - Family physician from Canada
David Warriner  - Cardiologist from the UK.
Jack O’Sullivan - Junior doctor from Australia
Imran Sajid - GP from the UK 

To read more, have a look at our Too much medicine campaign - bmj.com/too-much-medicine.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1429</itunes:duration>
                                    </item>
    <item>
        <title>Preventing Overdiagnosis 2017 - Citizen juries</title>
        <itunes:title>Preventing Overdiagnosis 2017 - Citizen juries</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/preventing-overdiagnosis-2017-citizen-juries/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/preventing-overdiagnosis-2017-citizen-juries/#comments</comments>        <pubDate>Sat, 19 Aug 2017 19:27:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/preventing-overdiagnosis-2017-citizen-juries</guid>
                                    <description><![CDATA[This week we’re at the over diagnosis conference in Quebec Canada,  Preventing overdiangosis is a forum to discuss the harms associated with using uncertain methods to look for disease in apparently healthy people - and is part of the BMJ’s too much medicine campaign.

One of the ways in which the public’s attitudes and wishes around health is measured are citizen or community juries - set up in a similar way to a criminal jury - with an information gathering,  and a deliberation phase - recently one of these citizen juries discussed, whether abortion should be allowed in Ireland (they decided “yes”).

<p>We're joined by Rae Thomas, from Bond University and Chris Degeling, from the University of Sydney, who have both been using citizen juries to look at over diagnosis.</p>
]]></description>
                                                            <content:encoded><![CDATA[This week we’re at the over diagnosis conference in Quebec Canada,  Preventing overdiangosis is a forum to discuss the harms associated with using uncertain methods to look for disease in apparently healthy people - and is part of the BMJ’s too much medicine campaign.

One of the ways in which the public’s attitudes and wishes around health is measured are citizen or community juries - set up in a similar way to a criminal jury - with an information gathering,  and a deliberation phase - recently one of these citizen juries discussed, whether abortion should be allowed in Ireland (they decided “yes”).

<p>We're joined by Rae Thomas, from Bond University and Chris Degeling, from the University of Sydney, who have both been using citizen juries to look at over diagnosis.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3j5xl8/stream_338597186-bmjgroup-preventing-overdiagnosis-2017-citizen-juries.mp3" length="21359464" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week we’re at the over diagnosis conference in Quebec Canada,  Preventing overdiangosis is a forum to discuss the harms associated with using uncertain methods to look for disease in apparently healthy people - and is part of the BMJ’s too much medicine campaign.

One of the ways in which the public’s attitudes and wishes around health is measured are citizen or community juries - set up in a similar way to a criminal jury - with an information gathering,  and a deliberation phase - recently one of these citizen juries discussed, whether abortion should be allowed in Ireland (they decided “yes”).

We're joined by Rae Thomas, from Bond University and Chris Degeling, from the University of Sydney, who have both been using citizen juries to look at over diagnosis.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>891</itunes:duration>
                                    </item>
    <item>
        <title>Preventing Overdiagnosis 2017 - Vinay Prasad</title>
        <itunes:title>Preventing Overdiagnosis 2017 - Vinay Prasad</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/preventing-overdiagnosis-2017-vinay-prasad/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/preventing-overdiagnosis-2017-vinay-prasad/#comments</comments>        <pubDate>Sat, 19 Aug 2017 15:56:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/preventing-overdiagnosis-2017-vinay-prasad</guid>
                                    <description><![CDATA[The Preventing overdiagnosis conference covers how physicians, researchers and patients can implement solutions to the problems of over diagnosis and overuse in healthcare.

<p>If you’re a doctor on twitter, you’ve probably come across our guest - Vinay Prasad, assistant prof. of medicine at Oregon Health and Science University, and author of the book Ending Medical Reversal.</p>
]]></description>
                                                            <content:encoded><![CDATA[The Preventing overdiagnosis conference covers how physicians, researchers and patients can implement solutions to the problems of over diagnosis and overuse in healthcare.

<p>If you’re a doctor on twitter, you’ve probably come across our guest - Vinay Prasad, assistant prof. of medicine at Oregon Health and Science University, and author of the book Ending Medical Reversal.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/v9feci/stream_338573599-bmjgroup-preventing-overdiagnosis-2017-vinay-prasad.mp3" length="46668762" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The Preventing overdiagnosis conference covers how physicians, researchers and patients can implement solutions to the problems of over diagnosis and overuse in healthcare.

If you’re a doctor on twitter, you’ve probably come across our guest - Vinay Prasad, assistant prof. of medicine at Oregon Health and Science University, and author of the book Ending Medical Reversal.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1947</itunes:duration>
                                    </item>
    <item>
        <title>Preventing Overdiagnosis 2017 - Rita Redberg</title>
        <itunes:title>Preventing Overdiagnosis 2017 - Rita Redberg</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/preventing-overdiagnosis-2017-rita-redberg/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/preventing-overdiagnosis-2017-rita-redberg/#comments</comments>        <pubDate>Fri, 18 Aug 2017 20:29:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/preventing-overdiagnosis-2017-rita-redberg</guid>
                                    <description><![CDATA[This week we’re at the Preventing Overdiagnosis conference in Quebec Canada,  The conference is a forum to discuss the harms associated with using uncertain methods to look for disease in apparently healthy people - and is part of the BMJ’s too much medicine campaign.

<p>The literature on overdiagnosis has mostly been published since 2013 - partly because of The BMJ, but in large part because of the work of Rita Redberg, professor of clinical medicine, and a working cardiologist, at UCSF, and editor of JAMA internal medicine who joins us to discuss why less is more.</p>
]]></description>
                                                            <content:encoded><![CDATA[This week we’re at the Preventing Overdiagnosis conference in Quebec Canada,  The conference is a forum to discuss the harms associated with using uncertain methods to look for disease in apparently healthy people - and is part of the BMJ’s too much medicine campaign.

<p>The literature on overdiagnosis has mostly been published since 2013 - partly because of The BMJ, but in large part because of the work of Rita Redberg, professor of clinical medicine, and a working cardiologist, at UCSF, and editor of JAMA internal medicine who joins us to discuss why less is more.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rg82w8/stream_338474985-bmjgroup-preventing-overdiagnosis-2017-rita-redberg.mp3" length="31417404" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week we’re at the Preventing Overdiagnosis conference in Quebec Canada,  The conference is a forum to discuss the harms associated with using uncertain methods to look for disease in apparently healthy people - and is part of the BMJ’s too much medicine campaign.

The literature on overdiagnosis has mostly been published since 2013 - partly because of The BMJ, but in large part because of the work of Rita Redberg, professor of clinical medicine, and a working cardiologist, at UCSF, and editor of JAMA internal medicine who joins us to discuss why less is more.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1310</itunes:duration>
                                    </item>
    <item>
        <title>Preventing Overdiagnosis 2017 - Stacy Carter on the culture of overmedicalisation</title>
        <itunes:title>Preventing Overdiagnosis 2017 - Stacy Carter on the culture of overmedicalisation</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/preventing-overdiagnosis-2017-stacy-carter-on-the-culture-of-overmedicalisation/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/preventing-overdiagnosis-2017-stacy-carter-on-the-culture-of-overmedicalisation/#comments</comments>        <pubDate>Thu, 17 Aug 2017 18:17:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/preventing-overdiagnosis-2017-stacy-carter-on-the-culture-of-overmedicalisation</guid>
                                    <description><![CDATA[In this interview from Preventing Overdiagnosis 2017 (preventingoverdiagnosis.net) Stacy Carter,  associate professor at Sydney Health Ethics - and the author of a recently written BMJ essay the ethical aspects of overdiagnosis, joins us to talk about how the cultural context of medicine seeps into our decision making processes and affects how people conceptualise the risks of too much medicine.

Read Stacy's full essay:
<p>http://www.bmj.com/content/358/bmj.j3872</p>
]]></description>
                                                            <content:encoded><![CDATA[In this interview from Preventing Overdiagnosis 2017 (preventingoverdiagnosis.net) Stacy Carter,  associate professor at Sydney Health Ethics - and the author of a recently written BMJ essay the ethical aspects of overdiagnosis, joins us to talk about how the cultural context of medicine seeps into our decision making processes and affects how people conceptualise the risks of too much medicine.

Read Stacy's full essay:
<p>http://www.bmj.com/content/358/bmj.j3872</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/zia8m4/stream_338303261-bmjgroup-preventing-overdiagnosis-2017-stacy-carter-on-the-culture-of-overmedicalisation.mp3" length="34085428" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this interview from Preventing Overdiagnosis 2017 (preventingoverdiagnosis.net) Stacy Carter,  associate professor at Sydney Health Ethics - and the author of a recently written BMJ essay the ethical aspects of overdiagnosis, joins us to talk about how the cultural context of medicine seeps into our decision making processes and affects how people conceptualise the risks of too much medicine.

Read Stacy's full essay:
http://www.bmj.com/content/358/bmj.j3872]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1422</itunes:duration>
                                    </item>
    <item>
        <title>What’s driving overdiagnosis?</title>
        <itunes:title>What’s driving overdiagnosis?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/what-s-driving-overdiagnosis/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/what-s-driving-overdiagnosis/#comments</comments>        <pubDate>Wed, 16 Aug 2017 21:45:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/whats-driving-overdiagnosis</guid>
                                    <description><![CDATA[This week the annual Preventing over diagnosis conference is happening in Quebec, Canada. The conference is put together with a wide range of partners, including The BMJ, and aims to tackle the some of the problems of Too Much Medicine.

To kick off our content for the conference, this week we’ve published an article looking at some of the drivers - and hence potential solutions for over diagnosis. 

<p>Two of the authors of that paper. Thanya Pathirana, and Ray Moynihan, both from Bond University’s Centre fro Research in Evidence Based Practice, join us to discuss.</p>
]]></description>
                                                            <content:encoded><![CDATA[This week the annual Preventing over diagnosis conference is happening in Quebec, Canada. The conference is put together with a wide range of partners, including The BMJ, and aims to tackle the some of the problems of Too Much Medicine.

To kick off our content for the conference, this week we’ve published an article looking at some of the drivers - and hence potential solutions for over diagnosis. 

<p>Two of the authors of that paper. Thanya Pathirana, and Ray Moynihan, both from Bond University’s Centre fro Research in Evidence Based Practice, join us to discuss.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/nmylqo/stream_338185838-bmjgroup-whats-driving-overdiagnosis.mp3" length="25368987" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week the annual Preventing over diagnosis conference is happening in Quebec, Canada. The conference is put together with a wide range of partners, including The BMJ, and aims to tackle the some of the problems of Too Much Medicine.

To kick off our content for the conference, this week we’ve published an article looking at some of the drivers - and hence potential solutions for over diagnosis. 

Two of the authors of that paper. Thanya Pathirana, and Ray Moynihan, both from Bond University’s Centre fro Research in Evidence Based Practice, join us to discuss.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1058</itunes:duration>
                                    </item>
    <item>
        <title>Helping Bereaved people</title>
        <itunes:title>Helping Bereaved people</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/helping-bereaved-people/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/helping-bereaved-people/#comments</comments>        <pubDate>Thu, 03 Aug 2017 15:11:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/helping-bereaved-people</guid>
                                    <description><![CDATA[Loss of a loved one can be very painful. When seeking support, some people turn to their doctor. Because of their pivotal role in the community, physicians can provide excellent support for bereaved people and can often direct them to additional resources.

Katherine Shear, a physician, and Stephanie Muldberg, a bereaved mother, join us to discuss how grief can play out in the consultation, and explain the importance of doctors acknowledging the death of a patient's loved one.

Read their full practice article:
<p>http://www.bmj.com/content/358/bmj.j2854</p>
]]></description>
                                                            <content:encoded><![CDATA[Loss of a loved one can be very painful. When seeking support, some people turn to their doctor. Because of their pivotal role in the community, physicians can provide excellent support for bereaved people and can often direct them to additional resources.

Katherine Shear, a physician, and Stephanie Muldberg, a bereaved mother, join us to discuss how grief can play out in the consultation, and explain the importance of doctors acknowledging the death of a patient's loved one.

Read their full practice article:
<p>http://www.bmj.com/content/358/bmj.j2854</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/j8ut01/stream_336099714-bmjgroup-helping-bereaved-people.mp3" length="36806938" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Loss of a loved one can be very painful. When seeking support, some people turn to their doctor. Because of their pivotal role in the community, physicians can provide excellent support for bereaved people and can often direct them to additional resources.

Katherine Shear, a physician, and Stephanie Muldberg, a bereaved mother, join us to discuss how grief can play out in the consultation, and explain the importance of doctors acknowledging the death of a patient's loved one.

Read their full practice article:
http://www.bmj.com/content/358/bmj.j2854]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1534</itunes:duration>
                                    </item>
    <item>
        <title>Auditing the transparency policies of pharma</title>
        <itunes:title>Auditing the transparency policies of pharma</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/auditing-the-transparency-policies-of-pharma/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/auditing-the-transparency-policies-of-pharma/#comments</comments>        <pubDate>Fri, 28 Jul 2017 15:39:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/auditing-the-transparency-policies-of-pharma</guid>
                                    <description><![CDATA[If you’ve listened to more than one of our podcasts, you’ll probably be aware of the problem of the opacity of clinical trial data - trials which are conducted by never see the light of day, or results within those trials which are never published.

Pharmaceutical companies have their own policies on what they are willing to make public, when, and for the first time a new audit, published on bmj.com, collates and analyses those policies.

To discuss that study I’m joined by two of the authors - Ben Goldacre, senior clinical research fellow at, and Carl Heneghan, director of, Oxford's Centre for Evidence Based Medicine.

Read the full audit:
<p>http://www.bmj.com/content/358/bmj.j3334</p>
]]></description>
                                                            <content:encoded><![CDATA[If you’ve listened to more than one of our podcasts, you’ll probably be aware of the problem of the opacity of clinical trial data - trials which are conducted by never see the light of day, or results within those trials which are never published.

Pharmaceutical companies have their own policies on what they are willing to make public, when, and for the first time a new audit, published on bmj.com, collates and analyses those policies.

To discuss that study I’m joined by two of the authors - Ben Goldacre, senior clinical research fellow at, and Carl Heneghan, director of, Oxford's Centre for Evidence Based Medicine.

Read the full audit:
<p>http://www.bmj.com/content/358/bmj.j3334</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/anmzot/stream_335242142-bmjgroup-auditing-the-transparency-policies-of-pharma.mp3" length="46001655" type="audio/mpeg"/>
        <itunes:summary><![CDATA[If you’ve listened to more than one of our podcasts, you’ll probably be aware of the problem of the opacity of clinical trial data - trials which are conducted by never see the light of day, or results within those trials which are never published.

Pharmaceutical companies have their own policies on what they are willing to make public, when, and for the first time a new audit, published on bmj.com, collates and analyses those policies.

To discuss that study I’m joined by two of the authors - Ben Goldacre, senior clinical research fellow at, and Carl Heneghan, director of, Oxford's Centre for Evidence Based Medicine.

Read the full audit:
http://www.bmj.com/content/358/bmj.j3334]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1918</itunes:duration>
                                    </item>
    <item>
        <title>Mike Richards has ”never been politically interfered with”</title>
        <itunes:title>Mike Richards has ”never been politically interfered with”</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/mike-richards-has-never-been-politically-interfered-with/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/mike-richards-has-never-been-politically-interfered-with/#comments</comments>        <pubDate>Fri, 28 Jul 2017 13:43:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/mike-richards-has-never-been-politically-interfered-with</guid>
                                    <description><![CDATA[Mike Richards is well known in the UK - former Cancer Tzar, he now heads up the Care Quality Commission - regulator of all health and social care services, and therefore the body responsible for inspecting hospitals and GP practices.

In this interview, BMJ’s head of news and views, Rebecca Coombes went to the CQC’s headquarters in London, and spoke to Mike Richards - who defends the record of hospital inspection on his watch.

This is an edited version of the interview - read the full write up:
<p>http://www.bmj.com/content/358/bmj.j3567</p>
]]></description>
                                                            <content:encoded><![CDATA[Mike Richards is well known in the UK - former Cancer Tzar, he now heads up the Care Quality Commission - regulator of all health and social care services, and therefore the body responsible for inspecting hospitals and GP practices.

In this interview, BMJ’s head of news and views, Rebecca Coombes went to the CQC’s headquarters in London, and spoke to Mike Richards - who defends the record of hospital inspection on his watch.

This is an edited version of the interview - read the full write up:
<p>http://www.bmj.com/content/358/bmj.j3567</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5nmiaq/stream_335228477-bmjgroup-mike-richards-has-never-been-politically-interfered-with.mp3" length="28257515" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Mike Richards is well known in the UK - former Cancer Tzar, he now heads up the Care Quality Commission - regulator of all health and social care services, and therefore the body responsible for inspecting hospitals and GP practices.

In this interview, BMJ’s head of news and views, Rebecca Coombes went to the CQC’s headquarters in London, and spoke to Mike Richards - who defends the record of hospital inspection on his watch.

This is an edited version of the interview - read the full write up:
http://www.bmj.com/content/358/bmj.j3567]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1178</itunes:duration>
                                    </item>
    <item>
        <title>”For the first time in 15 years the quitting rate has gone up” - ecigarettes smoking cessation</title>
        <itunes:title>”For the first time in 15 years the quitting rate has gone up” - ecigarettes smoking cessation</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/for-the-first-time-in-15-years-the-quitting-rate-has-gone-up-ecigarettes-smoking-cessation/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/for-the-first-time-in-15-years-the-quitting-rate-has-gone-up-ecigarettes-smoking-cessation/#comments</comments>        <pubDate>Thu, 27 Jul 2017 10:54:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/for-the-first-time-in-15-years-the-quitting-rate-has-gone-up-ecigarettes-smoking-cessation</guid>
                                    <description><![CDATA[It’s been 10 years since electronic cigarettes hit the shelves in a big way - and since there controversy has reigned about their health effects - are they less unhealthy than smoking traditional tobacco cigarettes, and will they increase nicotine dependence?

Its to that last point that new research, published on BMJ.com is looking into - specifically, do e-cigarettes help people quit tobacco?

Professor Shu-Hong Zhu, Director of the Center for Research & Intervention in Tobacco Control at the university of California San Diego joins us to discuss what effect ecigarettes have had, at a population level, on smoking cessation rates.

Read the open access research:
<p>http://www.bmj.com/content/358/bmj.j3262</p>
]]></description>
                                                            <content:encoded><![CDATA[It’s been 10 years since electronic cigarettes hit the shelves in a big way - and since there controversy has reigned about their health effects - are they less unhealthy than smoking traditional tobacco cigarettes, and will they increase nicotine dependence?

Its to that last point that new research, published on BMJ.com is looking into - specifically, do e-cigarettes help people quit tobacco?

Professor Shu-Hong Zhu, Director of the Center for Research & Intervention in Tobacco Control at the university of California San Diego joins us to discuss what effect ecigarettes have had, at a population level, on smoking cessation rates.

Read the open access research:
<p>http://www.bmj.com/content/358/bmj.j3262</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6c1uil/stream_335057258-bmjgroup-for-the-first-time-in-15-years-the-quitting-rate-has-gone-up-ecigarettes-smoking-cessation.mp3" length="36457025" type="audio/mpeg"/>
        <itunes:summary><![CDATA[It’s been 10 years since electronic cigarettes hit the shelves in a big way - and since there controversy has reigned about their health effects - are they less unhealthy than smoking traditional tobacco cigarettes, and will they increase nicotine dependence?

Its to that last point that new research, published on BMJ.com is looking into - specifically, do e-cigarettes help people quit tobacco?

Professor Shu-Hong Zhu, Director of the Center for Research & Intervention in Tobacco Control at the university of California San Diego joins us to discuss what effect ecigarettes have had, at a population level, on smoking cessation rates.

Read the open access research:
http://www.bmj.com/content/358/bmj.j3262]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1520</itunes:duration>
                                    </item>
    <item>
        <title>What’s going on with life expectancy?</title>
        <itunes:title>What’s going on with life expectancy?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/what-s-going-on-with-life-expectancy/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/what-s-going-on-with-life-expectancy/#comments</comments>        <pubDate>Fri, 21 Jul 2017 13:35:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/whats-going-on-with-life-expectancy</guid>
                                    <description><![CDATA[The increase in life expectancy in England has almost “ground to a halt” since 2010 and austerity measures are likely to be a significant contributor.

In this podcast Michael Marmot, director at University College London’s Institute of Health Equity, joins us to discuss what might be causing that drop off, and why a decrease in early life chances is particularly problematic.

Read more about the report:
<p>http://www.bmj.com/content/358/bmj.j3473</p>
]]></description>
                                                            <content:encoded><![CDATA[The increase in life expectancy in England has almost “ground to a halt” since 2010 and austerity measures are likely to be a significant contributor.

In this podcast Michael Marmot, director at University College London’s Institute of Health Equity, joins us to discuss what might be causing that drop off, and why a decrease in early life chances is particularly problematic.

Read more about the report:
<p>http://www.bmj.com/content/358/bmj.j3473</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hgevud/stream_334173429-bmjgroup-whats-going-on-with-life-expectancy.mp3" length="12095488" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The increase in life expectancy in England has almost “ground to a halt” since 2010 and austerity measures are likely to be a significant contributor.

In this podcast Michael Marmot, director at University College London’s Institute of Health Equity, joins us to discuss what might be causing that drop off, and why a decrease in early life chances is particularly problematic.

Read more about the report:
http://www.bmj.com/content/358/bmj.j3473]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1784</itunes:duration>
                                    </item>
    <item>
        <title>Biomarkers - miracle or marketing?</title>
        <itunes:title>Biomarkers - miracle or marketing?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/biomarkers-miracle-or-marketing/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/biomarkers-miracle-or-marketing/#comments</comments>        <pubDate>Tue, 18 Jul 2017 16:20:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/biomarkers-miracle-or-marketing</guid>
                                    <description><![CDATA[The BMJ has been campaigning for an end to “too much medicine” - the pernicious effect of marketing on the range of tests and treatments that doctors offer patients - tests and treatments which are motivated by the financial reward to the system, than the health of the individual.

A new analysis on BMJ.com takes a look at what’s happening in the the first part of that - testing. New biomarkers for disease, and new ways of monitoring, have the potential to diagnose disease more quickly, but is the hype backed by science?

Bjorn Hoffman professor of medical ethics at Norwegian University of Science and Technology  and one of the authors of that article doesn’t think so - and joins us on the podcast to discuss. 

Read the full analysis:
<p>http://www.bmj.com/content/358/bmj.j3314</p>
]]></description>
                                                            <content:encoded><![CDATA[The BMJ has been campaigning for an end to “too much medicine” - the pernicious effect of marketing on the range of tests and treatments that doctors offer patients - tests and treatments which are motivated by the financial reward to the system, than the health of the individual.

A new analysis on BMJ.com takes a look at what’s happening in the the first part of that - testing. New biomarkers for disease, and new ways of monitoring, have the potential to diagnose disease more quickly, but is the hype backed by science?

Bjorn Hoffman professor of medical ethics at Norwegian University of Science and Technology  and one of the authors of that article doesn’t think so - and joins us on the podcast to discuss. 

Read the full analysis:
<p>http://www.bmj.com/content/358/bmj.j3314</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vx8ztd/stream_333735063-bmjgroup-biomarkers-miracle-or-marketing.mp3" length="26017085" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The BMJ has been campaigning for an end to “too much medicine” - the pernicious effect of marketing on the range of tests and treatments that doctors offer patients - tests and treatments which are motivated by the financial reward to the system, than the health of the individual.

A new analysis on BMJ.com takes a look at what’s happening in the the first part of that - testing. New biomarkers for disease, and new ways of monitoring, have the potential to diagnose disease more quickly, but is the hype backed by science?

Bjorn Hoffman professor of medical ethics at Norwegian University of Science and Technology  and one of the authors of that article doesn’t think so - and joins us on the podcast to discuss. 

Read the full analysis:
http://www.bmj.com/content/358/bmj.j3314]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1084</itunes:duration>
                                    </item>
    <item>
        <title>James Kinross and Chris Hankin WannCry about NHS IT</title>
        <itunes:title>James Kinross and Chris Hankin WannCry about NHS IT</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/james-kinross-and-chris-hankin-wanncry-about-nhs-it/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/james-kinross-and-chris-hankin-wanncry-about-nhs-it/#comments</comments>        <pubDate>Fri, 14 Jul 2017 16:13:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/james-kinross-and-chris-hankin-wanncry-about-nhs-it</guid>
                                    <description><![CDATA[Earlier this year, the WannaCry ransomeware attack took control of computers in 40 NHS trusts, blocking access to the data held on them.

This wasn’t the first time that NHS computers had been infected by malware, but it brought the danger of cyber attack into the consciousness of doctors and patients.

In this podcast we hear from two people who have been thinking hard about cyber security in the NHS - James Kinross, a surgeon and lecturer at Imperial College London, and Chris Hankin, director of Imperial’s Institute for Security Science and Technology.

Read the analysis:
<p>http://www.bmj.com/content/358/bmj.j3179</p>
]]></description>
                                                            <content:encoded><![CDATA[Earlier this year, the WannaCry ransomeware attack took control of computers in 40 NHS trusts, blocking access to the data held on them.

This wasn’t the first time that NHS computers had been infected by malware, but it brought the danger of cyber attack into the consciousness of doctors and patients.

In this podcast we hear from two people who have been thinking hard about cyber security in the NHS - James Kinross, a surgeon and lecturer at Imperial College London, and Chris Hankin, director of Imperial’s Institute for Security Science and Technology.

Read the analysis:
<p>http://www.bmj.com/content/358/bmj.j3179</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/913cuw/stream_333190344-bmjgroup-james-kinross-and-chris-hankin-wanncry-about-nhs-it.mp3" length="53478981" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Earlier this year, the WannaCry ransomeware attack took control of computers in 40 NHS trusts, blocking access to the data held on them.

This wasn’t the first time that NHS computers had been infected by malware, but it brought the danger of cyber attack into the consciousness of doctors and patients.

In this podcast we hear from two people who have been thinking hard about cyber security in the NHS - James Kinross, a surgeon and lecturer at Imperial College London, and Chris Hankin, director of Imperial’s Institute for Security Science and Technology.

Read the analysis:
http://www.bmj.com/content/358/bmj.j3179]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2231</itunes:duration>
                                    </item>
    <item>
        <title>Is the FDA really too slow?</title>
        <itunes:title>Is the FDA really too slow?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/is-the-fda-really-too-slow/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/is-the-fda-really-too-slow/#comments</comments>        <pubDate>Tue, 11 Jul 2017 17:26:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/is-the-fda-really-too-slow</guid>
                                    <description><![CDATA[The FDA faces perpetual criticism that it is too slow in it’s approval process for getting drugs to market, but one former FDA employee Tom Marciniak, and one professor, Victor Serebruany from Johns Hopkins University have analysed that process and disagree.

Tom Marciniak has been a commentator on the approval process, both critical of industry and the FDA in The BMJ - and in this interview he talks about that process, his new analysis, and how he thinks we could be more sure about the safety and efficacy of drugs coming onto the market.

Read this full analysis:
<p>http://www.bmj.com/content/357/bmj.j2867</p>
]]></description>
                                                            <content:encoded><![CDATA[The FDA faces perpetual criticism that it is too slow in it’s approval process for getting drugs to market, but one former FDA employee Tom Marciniak, and one professor, Victor Serebruany from Johns Hopkins University have analysed that process and disagree.

Tom Marciniak has been a commentator on the approval process, both critical of industry and the FDA in The BMJ - and in this interview he talks about that process, his new analysis, and how he thinks we could be more sure about the safety and efficacy of drugs coming onto the market.

Read this full analysis:
<p>http://www.bmj.com/content/357/bmj.j2867</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/sfr0yv/stream_332734895-bmjgroup-is-the-fda-really-too-slow.mp3" length="31908581" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The FDA faces perpetual criticism that it is too slow in it’s approval process for getting drugs to market, but one former FDA employee Tom Marciniak, and one professor, Victor Serebruany from Johns Hopkins University have analysed that process and disagree.

Tom Marciniak has been a commentator on the approval process, both critical of industry and the FDA in The BMJ - and in this interview he talks about that process, his new analysis, and how he thinks we could be more sure about the safety and efficacy of drugs coming onto the market.

Read this full analysis:
http://www.bmj.com/content/357/bmj.j2867]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1331</itunes:duration>
                                    </item>
    <item>
        <title>”For the public good, not for careers” - Iain Chalmers and Doug Altman on research waste</title>
        <itunes:title>”For the public good, not for careers” - Iain Chalmers and Doug Altman on research waste</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/for-the-public-good-not-for-careers-iain-chalmers-and-doug-altman-on-research-waste/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/for-the-public-good-not-for-careers-iain-chalmers-and-doug-altman-on-research-waste/#comments</comments>        <pubDate>Fri, 07 Jul 2017 15:19:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/for-the-public-good-not-for-careers-ian-chalmers-and-doug-altman-on-research-waste</guid>
                                    <description><![CDATA[Twenty years ago the statistician Doug Altman railed against, “The Scandal of Poor Medical Research,” in an editorial in The BMJ. 

10 years later, Iain Chalmers and Paul Glaziou calculated that costs $170 billion annually in wasted research grants.

In this podcast, recorded at Evidence Live, we spoke to Altman and Chalmers about their campaigns to improve the design, conduct, and reporting of clinical trials, and why that level of waste still occurs.

Reward Alliance - http://rewardalliance.net/
Equator Network - http://www.equator-network.org/
<p>Research publication audit "Getting our house in order" - http://bmjopen.bmj.com/content/6/3/e009285</p>
]]></description>
                                                            <content:encoded><![CDATA[Twenty years ago the statistician Doug Altman railed against, “The Scandal of Poor Medical Research,” in an editorial in The BMJ. 

10 years later, Iain Chalmers and Paul Glaziou calculated that costs $170 billion annually in wasted research grants.

In this podcast, recorded at Evidence Live, we spoke to Altman and Chalmers about their campaigns to improve the design, conduct, and reporting of clinical trials, and why that level of waste still occurs.

Reward Alliance - http://rewardalliance.net/
Equator Network - http://www.equator-network.org/
<p>Research publication audit "Getting our house in order" - http://bmjopen.bmj.com/content/6/3/e009285</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dg46yc/stream_332106211-bmjgroup-for-the-public-good-not-for-careers-ian-chalmers-and-doug-altman-on-research-waste.mp3" length="38583664" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Twenty years ago the statistician Doug Altman railed against, “The Scandal of Poor Medical Research,” in an editorial in The BMJ. 

10 years later, Iain Chalmers and Paul Glaziou calculated that costs $170 billion annually in wasted research grants.

In this podcast, recorded at Evidence Live, we spoke to Altman and Chalmers about their campaigns to improve the design, conduct, and reporting of clinical trials, and why that level of waste still occurs.

Reward Alliance - http://rewardalliance.net/
Equator Network - http://www.equator-network.org/
Research publication audit "Getting our house in order" - http://bmjopen.bmj.com/content/6/3/e009285]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1608</itunes:duration>
                                    </item>
    <item>
        <title>Dementia prevalance in 2040</title>
        <itunes:title>Dementia prevalance in 2040</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/dementia-prevalance-in-2040/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/dementia-prevalance-in-2040/#comments</comments>        <pubDate>Wed, 05 Jul 2017 17:07:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/dementia-prevalance-in-2040</guid>
                                    <description><![CDATA[The Alzheimer’s society, in the UK, predicts that if the rates of dementia remain constant there’ll be 1.7 million people in the country living with the condition by 2050. We also know that things like improvements in cardiovascular health are changing those rates. 

New research published on bmj.com attempts to model what the outcomes of those changing factors might be, and Sara Ahmadi - Abhari, a research associate in the Department of Epidemiology and Public Health at the University College London, joins us to discuss that model.

Read the open access research:
<p>http://www.bmj.com/content/358/bmj.j2856</p>
]]></description>
                                                            <content:encoded><![CDATA[The Alzheimer’s society, in the UK, predicts that if the rates of dementia remain constant there’ll be 1.7 million people in the country living with the condition by 2050. We also know that things like improvements in cardiovascular health are changing those rates. 

New research published on bmj.com attempts to model what the outcomes of those changing factors might be, and Sara Ahmadi - Abhari, a research associate in the Department of Epidemiology and Public Health at the University College London, joins us to discuss that model.

Read the open access research:
<p>http://www.bmj.com/content/358/bmj.j2856</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fl17h8/stream_331713794-bmjgroup-dementia-prevalance-in-2040.mp3" length="28824641" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The Alzheimer’s society, in the UK, predicts that if the rates of dementia remain constant there’ll be 1.7 million people in the country living with the condition by 2050. We also know that things like improvements in cardiovascular health are changing those rates. 

New research published on bmj.com attempts to model what the outcomes of those changing factors might be, and Sara Ahmadi - Abhari, a research associate in the Department of Epidemiology and Public Health at the University College London, joins us to discuss that model.

Read the open access research:
http://www.bmj.com/content/358/bmj.j2856]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1202</itunes:duration>
                                    </item>
    <item>
        <title>Transhealth - how to talk to patients about pronouns</title>
        <itunes:title>Transhealth - how to talk to patients about pronouns</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/transhealth-how-to-talk-to-patients-about-pronouns/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/transhealth-how-to-talk-to-patients-about-pronouns/#comments</comments>        <pubDate>Fri, 30 Jun 2017 13:34:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/transhealth-how-to-talk-to-patients-about-pronouns</guid>
                                    <description><![CDATA[Two articles published on the bmj.com aim to help doctors treat patients who request support with their gender identity. 

Firstly a practice pointer on how to refer to gender clinic, and secondly a What Your Patient Is Thinking article about trans people's experiences in the healthcare system.

In this podcast, two of the authors of that patient experience article, Emma-Ben and Reubs, join us to discuss identity, pronouns and what genderqueer means.

I am your trans patient
http://www.bmj.com/content/357/bmj.j2963

Gender dysphoria: assessment and management for non-specialists
<p>http://www.bmj.com/content/357/bmj.j2866</p>
]]></description>
                                                            <content:encoded><![CDATA[Two articles published on the bmj.com aim to help doctors treat patients who request support with their gender identity. 

Firstly a practice pointer on how to refer to gender clinic, and secondly a What Your Patient Is Thinking article about trans people's experiences in the healthcare system.

In this podcast, two of the authors of that patient experience article, Emma-Ben and Reubs, join us to discuss identity, pronouns and what genderqueer means.

I am your trans patient
http://www.bmj.com/content/357/bmj.j2963

Gender dysphoria: assessment and management for non-specialists
<p>http://www.bmj.com/content/357/bmj.j2866</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xdadh3/stream_330899723-bmjgroup-transhealth-how-to-talk-to-patients-about-pronouns.mp3" length="44712573" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Two articles published on the bmj.com aim to help doctors treat patients who request support with their gender identity. 

Firstly a practice pointer on how to refer to gender clinic, and secondly a What Your Patient Is Thinking article about trans people's experiences in the healthcare system.

In this podcast, two of the authors of that patient experience article, Emma-Ben and Reubs, join us to discuss identity, pronouns and what genderqueer means.

I am your trans patient
http://www.bmj.com/content/357/bmj.j2963

Gender dysphoria: assessment and management for non-specialists
http://www.bmj.com/content/357/bmj.j2866]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1864</itunes:duration>
                                    </item>
    <item>
        <title>Childhood IQ and cause of death</title>
        <itunes:title>Childhood IQ and cause of death</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/childhood-iq-and-cause-of-death/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/childhood-iq-and-cause-of-death/#comments</comments>        <pubDate>Thu, 29 Jun 2017 11:23:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/childhood-iq-and-cause-of-death</guid>
                                    <description><![CDATA[Findings from a range of prospective cohort studies based around the world indicate that higher intelligence in children is related to a lower risk of all cause mortality in adulthood - and now a new study, published on bmj.com, is trying to dig into that association further, with a whole population cohort and data on cause specific mortality.

Ian J Deary, professor of differential psychology at the  University of Edinburgh and one of the authors of that study, joins us to discuss what this tells us, and what might be causing that association.

Read the full open access study:
<p>http://www.bmj.com/content/357/bmj.j2708</p>
]]></description>
                                                            <content:encoded><![CDATA[Findings from a range of prospective cohort studies based around the world indicate that higher intelligence in children is related to a lower risk of all cause mortality in adulthood - and now a new study, published on bmj.com, is trying to dig into that association further, with a whole population cohort and data on cause specific mortality.

Ian J Deary, professor of differential psychology at the  University of Edinburgh and one of the authors of that study, joins us to discuss what this tells us, and what might be causing that association.

Read the full open access study:
<p>http://www.bmj.com/content/357/bmj.j2708</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/oe2xl1/stream_330703719-bmjgroup-childhood-iq-and-cause-of-death.mp3" length="27250015" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Findings from a range of prospective cohort studies based around the world indicate that higher intelligence in children is related to a lower risk of all cause mortality in adulthood - and now a new study, published on bmj.com, is trying to dig into that association further, with a whole population cohort and data on cause specific mortality.

Ian J Deary, professor of differential psychology at the  University of Edinburgh and one of the authors of that study, joins us to discuss what this tells us, and what might be causing that association.

Read the full open access study:
http://www.bmj.com/content/357/bmj.j2708]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1136</itunes:duration>
                                    </item>
    <item>
        <title>The Evidence Manifesto - it’s time to fix the E in EBM</title>
        <itunes:title>The Evidence Manifesto - it’s time to fix the E in EBM</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-evidence-manifesto-it-s-time-to-fix-the-e-in-ebm/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-evidence-manifesto-it-s-time-to-fix-the-e-in-ebm/#comments</comments>        <pubDate>Fri, 23 Jun 2017 17:06:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-evidence-manifesto-its-time-to-fix-the-e-in-ebm</guid>
                                    <description><![CDATA["Too many research studies are poorly designed or executed. Too much of the resulting research evidence is withheld or disseminated piecemeal. As the volume of clinical research activity has grown the quality of evidence has often worsened, which has compromised the ability of all health professionals to provide affordable, effective, high value care for patients.”

Evidence is in crisis, and Carl Heneghan, director for the Centre for Evidence Based Medicine, and Fiona Godlee, editor in chief of The BMJ set out the 9 points of the Evidence manifesto, which tries to set a road map for strengthening the evidence base.

1) Expand the role of patients, health professionals and policy makers in research
2) Increase the systematic use of existing evidence
3) Make research evidence relevant, replicable and accessible to end users.
4) Reduce questionable research practices, bias, and conflicts of interests
5) Ensure drug and device regulation is robust, transparent and independent
6) Produce better usable clinical guidelines.
7) Support innovation, quality improvement, and safety through the better use of real world data.
8) Educate professionals, policy makers and the public in evidence-based healthcare to make informed choices.
9) Encourage the next generation of leaders in evidence-based medicine.

<p>http://www.bmj.com/content/357/bmj.j2973</p>
]]></description>
                                                            <content:encoded><![CDATA["Too many research studies are poorly designed or executed. Too much of the resulting research evidence is withheld or disseminated piecemeal. As the volume of clinical research activity has grown the quality of evidence has often worsened, which has compromised the ability of all health professionals to provide affordable, effective, high value care for patients.”

Evidence is in crisis, and Carl Heneghan, director for the Centre for Evidence Based Medicine, and Fiona Godlee, editor in chief of The BMJ set out the 9 points of the Evidence manifesto, which tries to set a road map for strengthening the evidence base.

1) Expand the role of patients, health professionals and policy makers in research
2) Increase the systematic use of existing evidence
3) Make research evidence relevant, replicable and accessible to end users.
4) Reduce questionable research practices, bias, and conflicts of interests
5) Ensure drug and device regulation is robust, transparent and independent
6) Produce better usable clinical guidelines.
7) Support innovation, quality improvement, and safety through the better use of real world data.
8) Educate professionals, policy makers and the public in evidence-based healthcare to make informed choices.
9) Encourage the next generation of leaders in evidence-based medicine.

<p>http://www.bmj.com/content/357/bmj.j2973</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/834yyh/stream_329677590-bmjgroup-the-evidence-manifesto-its-time-to-fix-the-e-in-ebm.mp3" length="60151674" type="audio/mpeg"/>
        <itunes:summary><![CDATA["Too many research studies are poorly designed or executed. Too much of the resulting research evidence is withheld or disseminated piecemeal. As the volume of clinical research activity has grown the quality of evidence has often worsened, which has compromised the ability of all health professionals to provide affordable, effective, high value care for patients.”

Evidence is in crisis, and Carl Heneghan, director for the Centre for Evidence Based Medicine, and Fiona Godlee, editor in chief of The BMJ set out the 9 points of the Evidence manifesto, which tries to set a road map for strengthening the evidence base.

1) Expand the role of patients, health professionals and policy makers in research
2) Increase the systematic use of existing evidence
3) Make research evidence relevant, replicable and accessible to end users.
4) Reduce questionable research practices, bias, and conflicts of interests
5) Ensure drug and device regulation is robust, transparent and independent
6) Produce better usable clinical guidelines.
7) Support innovation, quality improvement, and safety through the better use of real world data.
8) Educate professionals, policy makers and the public in evidence-based healthcare to make informed choices.
9) Encourage the next generation of leaders in evidence-based medicine.

http://www.bmj.com/content/357/bmj.j2973]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2509</itunes:duration>
                                    </item>
    <item>
        <title>Stress at work</title>
        <itunes:title>Stress at work</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/stress-at-work-1680599003/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/stress-at-work-1680599003/#comments</comments>        <pubDate>Fri, 16 Jun 2017 15:59:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/stress-at-work</guid>
                                    <description><![CDATA[Stress is one of the leading causes of work absence, recently overtaking back-pain, and an increasing part of a GPs workload. However good quality evidence about how to deal with stress is hard to come by. 

Alexis Descatha, an occupational/emergency practitioner, at the University hospital of Poincaré, gives some practical advice on what to do when you suspect stress is the underlying cause of a consultation, and what to do once you have confirmed that. 

Read the full practice article:
<p>http://www.bmj.com/content/357/bmj.j2489</p>
]]></description>
                                                            <content:encoded><![CDATA[Stress is one of the leading causes of work absence, recently overtaking back-pain, and an increasing part of a GPs workload. However good quality evidence about how to deal with stress is hard to come by. 

Alexis Descatha, an occupational/emergency practitioner, at the University hospital of Poincaré, gives some practical advice on what to do when you suspect stress is the underlying cause of a consultation, and what to do once you have confirmed that. 

Read the full practice article:
<p>http://www.bmj.com/content/357/bmj.j2489</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/680ds4/stream_328386233-bmjgroup-stress-at-work.mp3" length="24624264" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Stress is one of the leading causes of work absence, recently overtaking back-pain, and an increasing part of a GPs workload. However good quality evidence about how to deal with stress is hard to come by. 

Alexis Descatha, an occupational/emergency practitioner, at the University hospital of Poincaré, gives some practical advice on what to do when you suspect stress is the underlying cause of a consultation, and what to do once you have confirmed that. 

Read the full practice article:
http://www.bmj.com/content/357/bmj.j2489]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1027</itunes:duration>
                                    </item>
    <item>
        <title>”The interest of diesel drivers over the interest of the public” - tackling air pollution</title>
        <itunes:title>”The interest of diesel drivers over the interest of the public” - tackling air pollution</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-interest-of-diesel-drivers-over-the-interest-of-the-public-tackling-air-pollution/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-interest-of-diesel-drivers-over-the-interest-of-the-public-tackling-air-pollution/#comments</comments>        <pubDate>Thu, 15 Jun 2017 16:47:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-interest-of-diesel-drivers-over-the-interest-of-the-public-tackling-air-pollution</guid>
                                    <description><![CDATA[Air pollution is  a truly damaging environmental insult to the human body. The numbers of premature deaths, in the UK alone, that can be attributed to it are calculated to be 40,000 a year.

Yet despite this, action to tackle the problem - as with the other huge environmental issue of our time, climate change - is distinctly lacking.

Robin Russel-Jones dermatologist and chair of Help Rescue the Planet - joins us to discuss what should be done to tackle the problem.

Read the full analysis:
<p>http://www.bmj.com/content/357/bmj.j2713</p>
]]></description>
                                                            <content:encoded><![CDATA[Air pollution is  a truly damaging environmental insult to the human body. The numbers of premature deaths, in the UK alone, that can be attributed to it are calculated to be 40,000 a year.

Yet despite this, action to tackle the problem - as with the other huge environmental issue of our time, climate change - is distinctly lacking.

Robin Russel-Jones dermatologist and chair of Help Rescue the Planet - joins us to discuss what should be done to tackle the problem.

Read the full analysis:
<p>http://www.bmj.com/content/357/bmj.j2713</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ncsxly/stream_328226523-bmjgroup-the-interest-of-diesel-drivers-over-the-interest-of-the-public-tackling-air-pollution.mp3" length="19523911" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Air pollution is  a truly damaging environmental insult to the human body. The numbers of premature deaths, in the UK alone, that can be attributed to it are calculated to be 40,000 a year.

Yet despite this, action to tackle the problem - as with the other huge environmental issue of our time, climate change - is distinctly lacking.

Robin Russel-Jones dermatologist and chair of Help Rescue the Planet - joins us to discuss what should be done to tackle the problem.

Read the full analysis:
http://www.bmj.com/content/357/bmj.j2713]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>814</itunes:duration>
                                    </item>
    <item>
        <title>How to build a resillient health system</title>
        <itunes:title>How to build a resillient health system</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/how-to-build-a-resillient-health-system/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/how-to-build-a-resillient-health-system/#comments</comments>        <pubDate>Thu, 08 Jun 2017 11:02:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/how-to-build-a-resillient-health-system</guid>
                                    <description><![CDATA[The 2014 west African Ebola epidemic shone a harsh light on the health systems of Guinea, Liberia, and Sierra Leone. While decades of domestic and international investment had contributed to substantial progress on the Millennium Development Goals, national health systems remained weak and were unable to cope with the epidemic.

Margaret Kruk associate professor of global health at the Harvard TH Chan School of Public Health, joins us to discuss what makes a health system resilient, and how Liberia in particular has learned lessons from Ebola.

Read the full analysis:
<p>http://www.bmj.com/content/357/bmj.j2323</p>
]]></description>
                                                            <content:encoded><![CDATA[The 2014 west African Ebola epidemic shone a harsh light on the health systems of Guinea, Liberia, and Sierra Leone. While decades of domestic and international investment had contributed to substantial progress on the Millennium Development Goals, national health systems remained weak and were unable to cope with the epidemic.

Margaret Kruk associate professor of global health at the Harvard TH Chan School of Public Health, joins us to discuss what makes a health system resilient, and how Liberia in particular has learned lessons from Ebola.

Read the full analysis:
<p>http://www.bmj.com/content/357/bmj.j2323</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/thuvmm/stream_327111650-bmjgroup-how-to-build-a-resillient-health-system.mp3" length="38969750" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The 2014 west African Ebola epidemic shone a harsh light on the health systems of Guinea, Liberia, and Sierra Leone. While decades of domestic and international investment had contributed to substantial progress on the Millennium Development Goals, national health systems remained weak and were unable to cope with the epidemic.

Margaret Kruk associate professor of global health at the Harvard TH Chan School of Public Health, joins us to discuss what makes a health system resilient, and how Liberia in particular has learned lessons from Ebola.

Read the full analysis:
http://www.bmj.com/content/357/bmj.j2323]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1626</itunes:duration>
                                    </item>
    <item>
        <title>Your brain on booze</title>
        <itunes:title>Your brain on booze</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/your-brain-on-booze/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/your-brain-on-booze/#comments</comments>        <pubDate>Wed, 07 Jun 2017 15:36:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-brain-on-booze</guid>
                                    <description><![CDATA[A new study on BMJ.com, examines the effect of moderate drinking on brain structure.  We know that heavy drinking has a deleterious effect on our brains, and is linked to dementias. However, for sometime it’s been thought that moderate drinking is actually protective.

Anya Topiwala, clinical lecturer in old age psychiatry at the University of Oxford, joins us to discuss the association between alcohol consumption and those structural elements.

Read the full research:
<p>http://www.bmj.com/content/357/bmj.j2353</p>
]]></description>
                                                            <content:encoded><![CDATA[A new study on BMJ.com, examines the effect of moderate drinking on brain structure.  We know that heavy drinking has a deleterious effect on our brains, and is linked to dementias. However, for sometime it’s been thought that moderate drinking is actually protective.

Anya Topiwala, clinical lecturer in old age psychiatry at the University of Oxford, joins us to discuss the association between alcohol consumption and those structural elements.

Read the full research:
<p>http://www.bmj.com/content/357/bmj.j2353</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ddu6si/stream_326983508-bmjgroup-the-brain-on-booze.mp3" length="22158366" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A new study on BMJ.com, examines the effect of moderate drinking on brain structure.  We know that heavy drinking has a deleterious effect on our brains, and is linked to dementias. However, for sometime it’s been thought that moderate drinking is actually protective.

Anya Topiwala, clinical lecturer in old age psychiatry at the University of Oxford, joins us to discuss the association between alcohol consumption and those structural elements.

Read the full research:
http://www.bmj.com/content/357/bmj.j2353]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>924</itunes:duration>
                                    </item>
    <item>
        <title>Future Earth - linking health and environmental research</title>
        <itunes:title>Future Earth - linking health and environmental research</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/future-earth-linking-health-and-environmental-research/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/future-earth-linking-health-and-environmental-research/#comments</comments>        <pubDate>Fri, 02 Jun 2017 15:02:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/future-earth-linking-health-and-environmental-research</guid>
                                    <description><![CDATA[The rapid changes in the global environment have led many scientists to conclude that we are living in a new geological epoch—the Anthropocene—in which human activities have become the dominant driving force transforming the Earth’s natural systems.

A recent joint publication by the World Health Organization and Convention on Biological Diversity articulated the myriad connections between biodiversity and health and the threats to both posed by environmental change.

Andy Haines, professor of public health and primary care, at the London School of Hygiene and Tropical Medicine joins us to talk about a new research platforms present an opportunity to advance understanding of how to safeguard health in the face of global environmental change.

Read more:
<p>http://www.bmj.com/content/357/bmj.j2358</p>
]]></description>
                                                            <content:encoded><![CDATA[The rapid changes in the global environment have led many scientists to conclude that we are living in a new geological epoch—the Anthropocene—in which human activities have become the dominant driving force transforming the Earth’s natural systems.

A recent joint publication by the World Health Organization and Convention on Biological Diversity articulated the myriad connections between biodiversity and health and the threats to both posed by environmental change.

Andy Haines, professor of public health and primary care, at the London School of Hygiene and Tropical Medicine joins us to talk about a new research platforms present an opportunity to advance understanding of how to safeguard health in the face of global environmental change.

Read more:
<p>http://www.bmj.com/content/357/bmj.j2358</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5eb2sh/stream_325706715-bmjgroup-future-earth-linking-health-and-environmental-research.mp3" length="26086112" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The rapid changes in the global environment have led many scientists to conclude that we are living in a new geological epoch—the Anthropocene—in which human activities have become the dominant driving force transforming the Earth’s natural systems.

A recent joint publication by the World Health Organization and Convention on Biological Diversity articulated the myriad connections between biodiversity and health and the threats to both posed by environmental change.

Andy Haines, professor of public health and primary care, at the London School of Hygiene and Tropical Medicine joins us to talk about a new research platforms present an opportunity to advance understanding of how to safeguard health in the face of global environmental change.

Read more:
http://www.bmj.com/content/357/bmj.j2358]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1088</itunes:duration>
                                    </item>
    <item>
        <title>Government and evidence</title>
        <itunes:title>Government and evidence</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/government-and-evidence/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/government-and-evidence/#comments</comments>        <pubDate>Fri, 02 Jun 2017 14:58:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/government-and-evidence</guid>
                                    <description><![CDATA[We're creating a manifesto for better evidence. The centre for Evidence Based Medicine at the University of Oxford, and the BMJ, are asking what are the problem with medical evidence, and how can we fix them?

In this third discussion we went to Scotland, to find out what the people who create policy think about the issues with evidence synthesis, and how the information they create is being used in practice.

<p>evidencelive.org/manifesto/ - join the discussion, read, and comment on our manifesto.</p>
]]></description>
                                                            <content:encoded><![CDATA[We're creating a manifesto for better evidence. The centre for Evidence Based Medicine at the University of Oxford, and the BMJ, are asking what are the problem with medical evidence, and how can we fix them?

In this third discussion we went to Scotland, to find out what the people who create policy think about the issues with evidence synthesis, and how the information they create is being used in practice.

<p>evidencelive.org/manifesto/ - join the discussion, read, and comment on our manifesto.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/0u2jom/stream_325706022-bmjgroup-government-and-evidence.mp3" length="49006044" type="audio/mpeg"/>
        <itunes:summary><![CDATA[We're creating a manifesto for better evidence. The centre for Evidence Based Medicine at the University of Oxford, and the BMJ, are asking what are the problem with medical evidence, and how can we fix them?

In this third discussion we went to Scotland, to find out what the people who create policy think about the issues with evidence synthesis, and how the information they create is being used in practice.

evidencelive.org/manifesto/ - join the discussion, read, and comment on our manifesto.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2042</itunes:duration>
                                    </item>
    <item>
        <title>50% of delirium is hypoactive - how to spot it</title>
        <itunes:title>50% of delirium is hypoactive - how to spot it</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/50-of-delirium-is-hypoactive-how-to-spot-it/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/50-of-delirium-is-hypoactive-how-to-spot-it/#comments</comments>        <pubDate>Fri, 26 May 2017 10:24:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/50-of-delirium-is-hypoactive-how-to-spot-it</guid>
                                    <description><![CDATA[Available data suggest about 50% of delirium is hypoactive; this and the mixed motor subtype account for 80% of all cases of delirium. 
It can be more difficult to recognise, and is associated with worse outcomes, than hyperactive delirium. 

In this podcast, Christian Hosker, consultant liaison psychiatrist at the Leeds Liaison Psychiatry Service outlines when to suspect hypoactive delirium, how to assess, and appropriately manage patients.

Infographic explaining diagnosis:
http://www.bmj.com/content/bmj/suppl/2017/05/25/bmj.j2047.DC1/hosc038261.wi.pdf

Read the full article:
<p>http://www.bmj.com/content/357/bmj.j2047</p>
]]></description>
                                                            <content:encoded><![CDATA[Available data suggest about 50% of delirium is hypoactive; this and the mixed motor subtype account for 80% of all cases of delirium. 
It can be more difficult to recognise, and is associated with worse outcomes, than hyperactive delirium. 

In this podcast, Christian Hosker, consultant liaison psychiatrist at the Leeds Liaison Psychiatry Service outlines when to suspect hypoactive delirium, how to assess, and appropriately manage patients.

Infographic explaining diagnosis:
http://www.bmj.com/content/bmj/suppl/2017/05/25/bmj.j2047.DC1/hosc038261.wi.pdf

Read the full article:
<p>http://www.bmj.com/content/357/bmj.j2047</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kkvml3/stream_324586204-bmjgroup-50-of-delirium-is-hypoactive-how-to-spot-it.mp3" length="33518739" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Available data suggest about 50% of delirium is hypoactive; this and the mixed motor subtype account for 80% of all cases of delirium. 
It can be more difficult to recognise, and is associated with worse outcomes, than hyperactive delirium. 

In this podcast, Christian Hosker, consultant liaison psychiatrist at the Leeds Liaison Psychiatry Service outlines when to suspect hypoactive delirium, how to assess, and appropriately manage patients.

Infographic explaining diagnosis:
http://www.bmj.com/content/bmj/suppl/2017/05/25/bmj.j2047.DC1/hosc038261.wi.pdf

Read the full article:
http://www.bmj.com/content/357/bmj.j2047]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1398</itunes:duration>
                                    </item>
    <item>
        <title>Helping patients with complex grief</title>
        <itunes:title>Helping patients with complex grief</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/helping-patients-with-complex-grief/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/helping-patients-with-complex-grief/#comments</comments>        <pubDate>Thu, 18 May 2017 16:44:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/helping-patients-with-complex-grief</guid>
                                    <description><![CDATA[Each individual’s grief process is unique, when confronted with the death of a loved one, most people experience transient rather than persistent distress - however 10% of bereaved individuals, with an increased risk following the death of a partner or child and loss to unnatural or violent circumstances, experience prolonged grief disorder.

In this podcast, Paul Boelen, a professor of psychiatry at Utrecht University, and Geert Smid, psychiatrist and senior researcher from the Dutch National Psychotrauma Centre, join us to discuss what constitutes complex grief, how to recognise it, and some strategies for helping patients cope.

Read the full practice pointer:
<p>http://www.bmj.com/content/357/bmj.j2016</p>
]]></description>
                                                            <content:encoded><![CDATA[Each individual’s grief process is unique, when confronted with the death of a loved one, most people experience transient rather than persistent distress - however 10% of bereaved individuals, with an increased risk following the death of a partner or child and loss to unnatural or violent circumstances, experience prolonged grief disorder.

In this podcast, Paul Boelen, a professor of psychiatry at Utrecht University, and Geert Smid, psychiatrist and senior researcher from the Dutch National Psychotrauma Centre, join us to discuss what constitutes complex grief, how to recognise it, and some strategies for helping patients cope.

Read the full practice pointer:
<p>http://www.bmj.com/content/357/bmj.j2016</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jl0es7/stream_323240328-bmjgroup-helping-patients-with-complex-grief.mp3" length="27405445" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Each individual’s grief process is unique, when confronted with the death of a loved one, most people experience transient rather than persistent distress - however 10% of bereaved individuals, with an increased risk following the death of a partner or child and loss to unnatural or violent circumstances, experience prolonged grief disorder.

In this podcast, Paul Boelen, a professor of psychiatry at Utrecht University, and Geert Smid, psychiatrist and senior researcher from the Dutch National Psychotrauma Centre, join us to discuss what constitutes complex grief, how to recognise it, and some strategies for helping patients cope.

Read the full practice pointer:
http://www.bmj.com/content/357/bmj.j2016]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1143</itunes:duration>
                                    </item>
    <item>
        <title>NHS must “get its act together” to secure cash for new buildings</title>
        <itunes:title>NHS must “get its act together” to secure cash for new buildings</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/nhs-must-get-its-act-together-to-secure-cash-for-new-buildings/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/nhs-must-get-its-act-together-to-secure-cash-for-new-buildings/#comments</comments>        <pubDate>Mon, 15 May 2017 10:04:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/nhs-estates-mixdown</guid>
                                    <description><![CDATA[NHS hospitals must be willing to dispose of surplus land to help convince the Treasury to invest in new premises that are fit for purpose, the head of a major government review has urged.

Robert Naylor, former chief executive of University College London Hospitals, who was asked by the health secretary, Jeremy Hunt, to produce a review of NHS property and estates - and in this interview we asked him how his plans would work, and what would be done with the land sold.

Read Gareth Iacobucci's report:
<p>http://www.bmj.com/content/357/bmj.j2072</p>
]]></description>
                                                            <content:encoded><![CDATA[NHS hospitals must be willing to dispose of surplus land to help convince the Treasury to invest in new premises that are fit for purpose, the head of a major government review has urged.

Robert Naylor, former chief executive of University College London Hospitals, who was asked by the health secretary, Jeremy Hunt, to produce a review of NHS property and estates - and in this interview we asked him how his plans would work, and what would be done with the land sold.

Read Gareth Iacobucci's report:
<p>http://www.bmj.com/content/357/bmj.j2072</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fzgpky/stream_322701182-bmjgroup-nhs-estates-mixdown.mp3" length="32498343" type="audio/mpeg"/>
        <itunes:summary><![CDATA[NHS hospitals must be willing to dispose of surplus land to help convince the Treasury to invest in new premises that are fit for purpose, the head of a major government review has urged.

Robert Naylor, former chief executive of University College London Hospitals, who was asked by the health secretary, Jeremy Hunt, to produce a review of NHS property and estates - and in this interview we asked him how his plans would work, and what would be done with the land sold.

Read Gareth Iacobucci's report:
http://www.bmj.com/content/357/bmj.j2072]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1355</itunes:duration>
                                    </item>
    <item>
        <title>Education Round - Exercising too much, microbiome, suicide and translation</title>
        <itunes:title>Education Round - Exercising too much, microbiome, suicide and translation</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/education-round-exercising-too-much-microbiome-suicide-and-translation/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/education-round-exercising-too-much-microbiome-suicide-and-translation/#comments</comments>        <pubDate>Mon, 15 May 2017 09:31:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/education-round-up-may</guid>
                                    <description><![CDATA[The BMJ publishes a lot of educational articles, and in an attempt to help you with your CPD, we have put together this round-up. Our authors and editors will reflect on the key learning points in the articles we discuss, and explain how they may change their practice in light of that new understanding.

In this month's round up we're discussing:

Addiction to exercise
http://www.bmj.com/content/357/bmj.j1745

If your patient doesn’t speak the same language as you . . .
http://www.bmj.com/content/357/bmj.j1511

Exploring thoughts of suicide
http://www.bmj.com/content/356/bmj.j1128

The role of the microbiome in human health and disease
<p>http://www.bmj.com/content/356/bmj.j831</p>
]]></description>
                                                            <content:encoded><![CDATA[The BMJ publishes a lot of educational articles, and in an attempt to help you with your CPD, we have put together this round-up. Our authors and editors will reflect on the key learning points in the articles we discuss, and explain how they may change their practice in light of that new understanding.

In this month's round up we're discussing:

Addiction to exercise
http://www.bmj.com/content/357/bmj.j1745

If your patient doesn’t speak the same language as you . . .
http://www.bmj.com/content/357/bmj.j1511

Exploring thoughts of suicide
http://www.bmj.com/content/356/bmj.j1128

The role of the microbiome in human health and disease
<p>http://www.bmj.com/content/356/bmj.j831</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/nvth6a/stream_322698199-bmjgroup-education-round-up-may.mp3" length="44958664" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The BMJ publishes a lot of educational articles, and in an attempt to help you with your CPD, we have put together this round-up. Our authors and editors will reflect on the key learning points in the articles we discuss, and explain how they may change their practice in light of that new understanding.

In this month's round up we're discussing:

Addiction to exercise
http://www.bmj.com/content/357/bmj.j1745

If your patient doesn’t speak the same language as you . . .
http://www.bmj.com/content/357/bmj.j1511

Exploring thoughts of suicide
http://www.bmj.com/content/356/bmj.j1128

The role of the microbiome in human health and disease
http://www.bmj.com/content/356/bmj.j831]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1875</itunes:duration>
                                    </item>
    <item>
        <title>The magic of shared decision making</title>
        <itunes:title>The magic of shared decision making</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-magic-of-shared-decision-making/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-magic-of-shared-decision-making/#comments</comments>        <pubDate>Tue, 09 May 2017 09:48:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-magic-of-shared-decision-making</guid>
                                    <description><![CDATA[Adoption of shared decision making into routine practice has been remarkably slow, despite 40 years of research and considerable policy support.

 In 2010, the Health Foundation in the UK commissioned the MAGIC (Making Good Decisions in Collaboration) programme to design, test, and identify the best ways to embed shared decision making into routine primary and secondary care using quality improvement methods.

In this podcast, Natalie Joseph-Williams from Cardiff University and Richard Thomson from Newcastle University, join us to discuss how the project went, and what key lessons they learned from the pilot.

Read their full analysis:
<p>http://www.bmj.com/content/357/bmj.j1744</p>
]]></description>
                                                            <content:encoded><![CDATA[Adoption of shared decision making into routine practice has been remarkably slow, despite 40 years of research and considerable policy support.

 In 2010, the Health Foundation in the UK commissioned the MAGIC (Making Good Decisions in Collaboration) programme to design, test, and identify the best ways to embed shared decision making into routine primary and secondary care using quality improvement methods.

In this podcast, Natalie Joseph-Williams from Cardiff University and Richard Thomson from Newcastle University, join us to discuss how the project went, and what key lessons they learned from the pilot.

Read their full analysis:
<p>http://www.bmj.com/content/357/bmj.j1744</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/c6cltt/stream_321708656-bmjgroup-the-magic-of-shared-decision-making.mp3" length="30655721" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Adoption of shared decision making into routine practice has been remarkably slow, despite 40 years of research and considerable policy support.

 In 2010, the Health Foundation in the UK commissioned the MAGIC (Making Good Decisions in Collaboration) programme to design, test, and identify the best ways to embed shared decision making into routine primary and secondary care using quality improvement methods.

In this podcast, Natalie Joseph-Williams from Cardiff University and Richard Thomson from Newcastle University, join us to discuss how the project went, and what key lessons they learned from the pilot.

Read their full analysis:
http://www.bmj.com/content/357/bmj.j1744]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1278</itunes:duration>
                                    </item>
    <item>
        <title>Drug promotion, prescription, and value</title>
        <itunes:title>Drug promotion, prescription, and value</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/drug-promotion-prescription-and-value/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/drug-promotion-prescription-and-value/#comments</comments>        <pubDate>Thu, 04 May 2017 09:55:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/drug-promotion-prescription-value</guid>
                                    <description><![CDATA[Pharma companies say that money spent on promotion is essential to educate doctors about the best drugs - but when a medical student asked Joseph Ross, associate professor of medicine and public health at Yale, if those companies are promoting the right drugs for that message to be true, the answer wasn't available.

Ross and Tyler Greenaway, his medical student,  then sat down and used the data from the US  Physician Payments Sunshine Act to find out which drugs have the highest promotional budgets. 

They cross referenced that against prescription databases and measures of value to assess the effectiveness, usefulness, and affordability of the drugs that get the heaviest promotion.

Read the full analysis:
<p>http://www.bmj.com/content/357/bmj.j1855</p>
]]></description>
                                                            <content:encoded><![CDATA[Pharma companies say that money spent on promotion is essential to educate doctors about the best drugs - but when a medical student asked Joseph Ross, associate professor of medicine and public health at Yale, if those companies are promoting the right drugs for that message to be true, the answer wasn't available.

Ross and Tyler Greenaway, his medical student,  then sat down and used the data from the US  Physician Payments Sunshine Act to find out which drugs have the highest promotional budgets. 

They cross referenced that against prescription databases and measures of value to assess the effectiveness, usefulness, and affordability of the drugs that get the heaviest promotion.

Read the full analysis:
<p>http://www.bmj.com/content/357/bmj.j1855</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6ledjl/stream_320891374-bmjgroup-drug-promotion-prescription-value.mp3" length="17834116" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Pharma companies say that money spent on promotion is essential to educate doctors about the best drugs - but when a medical student asked Joseph Ross, associate professor of medicine and public health at Yale, if those companies are promoting the right drugs for that message to be true, the answer wasn't available.

Ross and Tyler Greenaway, his medical student,  then sat down and used the data from the US  Physician Payments Sunshine Act to find out which drugs have the highest promotional budgets. 

They cross referenced that against prescription databases and measures of value to assess the effectiveness, usefulness, and affordability of the drugs that get the heaviest promotion.

Read the full analysis:
http://www.bmj.com/content/357/bmj.j1855]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>744</itunes:duration>
                                    </item>
    <item>
        <title>How established biologics become less safe</title>
        <itunes:title>How established biologics become less safe</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/how-established-biologics-become-less-safe/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/how-established-biologics-become-less-safe/#comments</comments>        <pubDate>Fri, 28 Apr 2017 16:05:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/biologics</guid>
                                    <description><![CDATA[Biologics have revolutionised healthcare for some conditions - but have been expensive because of the multistep manufacturing processes required to create these complex molecules.

Changes to the manufacturing of biological agents make them more affordable, but can lead to drugs with different components from the original medicine tested in clinical trials, challenging assumptions about safety. 

David Hunt, honorary consultant neurologist and Wellcome Trust intermediate clinical fellow, at the University of Edinburgh, joins us to describe how that happens and what the result can be.

Read the full analysis:
<p>http://www.bmj.com/content/357/bmj.j1707</p>
]]></description>
                                                            <content:encoded><![CDATA[Biologics have revolutionised healthcare for some conditions - but have been expensive because of the multistep manufacturing processes required to create these complex molecules.

Changes to the manufacturing of biological agents make them more affordable, but can lead to drugs with different components from the original medicine tested in clinical trials, challenging assumptions about safety. 

David Hunt, honorary consultant neurologist and Wellcome Trust intermediate clinical fellow, at the University of Edinburgh, joins us to describe how that happens and what the result can be.

Read the full analysis:
<p>http://www.bmj.com/content/357/bmj.j1707</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mfyqzk/stream_319915711-bmjgroup-biologics.mp3" length="23924135" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Biologics have revolutionised healthcare for some conditions - but have been expensive because of the multistep manufacturing processes required to create these complex molecules.

Changes to the manufacturing of biological agents make them more affordable, but can lead to drugs with different components from the original medicine tested in clinical trials, challenging assumptions about safety. 

David Hunt, honorary consultant neurologist and Wellcome Trust intermediate clinical fellow, at the University of Edinburgh, joins us to describe how that happens and what the result can be.

Read the full analysis:
http://www.bmj.com/content/357/bmj.j1707]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>997</itunes:duration>
                                    </item>
    <item>
        <title>“I had two herniated discs in my back, and I was still running” - addicted to exercise</title>
        <itunes:title>“I had two herniated discs in my back, and I was still running” - addicted to exercise</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/i-had-two-herniated-discs-in-my-back-and-i-was-still-running-addicted-to-exercise/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/i-had-two-herniated-discs-in-my-back-and-i-was-still-running-addicted-to-exercise/#comments</comments>        <pubDate>Thu, 27 Apr 2017 10:05:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/i-had-two-herniated-discs-in-my-back-and-i-was-still-running-addicted-to-exercise</guid>
                                    <description><![CDATA[It’s been called “the universal panacea” - exercise has a positive effect on almost all health measures, and governments are actively campaigning for us to do more. But at the opposite end of the scale, the realisation that some people may be addicted to exercise is gaining traction.

In this podcast we're joined by Heather Hausenblas - professor of kinesiology at Jacksonville University, James Smoliga - associate professor of physiology at highpoint University, and Katherine Schreiber - who’s experienced exercise addiction, and written about her experience.

They describe the condition, and what drives people to become addicted to exercise. They also outline the key indicators of the addiction, and what options there are for treatment.


Read their article:
<p>http://www.bmj.com/content/357/bmj.j1745</p>
]]></description>
                                                            <content:encoded><![CDATA[It’s been called “the universal panacea” - exercise has a positive effect on almost all health measures, and governments are actively campaigning for us to do more. But at the opposite end of the scale, the realisation that some people may be addicted to exercise is gaining traction.

In this podcast we're joined by Heather Hausenblas - professor of kinesiology at Jacksonville University, James Smoliga - associate professor of physiology at highpoint University, and Katherine Schreiber - who’s experienced exercise addiction, and written about her experience.

They describe the condition, and what drives people to become addicted to exercise. They also outline the key indicators of the addiction, and what options there are for treatment.


Read their article:
<p>http://www.bmj.com/content/357/bmj.j1745</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9lrq84/stream_319709804-bmjgroup-i-had-two-herniated-discs-in-my-back-and-i-was-still-running-addicted-to-exercise.mp3" length="28411228" type="audio/mpeg"/>
        <itunes:summary><![CDATA[It’s been called “the universal panacea” - exercise has a positive effect on almost all health measures, and governments are actively campaigning for us to do more. But at the opposite end of the scale, the realisation that some people may be addicted to exercise is gaining traction.

In this podcast we're joined by Heather Hausenblas - professor of kinesiology at Jacksonville University, James Smoliga - associate professor of physiology at highpoint University, and Katherine Schreiber - who’s experienced exercise addiction, and written about her experience.

They describe the condition, and what drives people to become addicted to exercise. They also outline the key indicators of the addiction, and what options there are for treatment.


Read their article:
http://www.bmj.com/content/357/bmj.j1745]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1185</itunes:duration>
                                    </item>
    <item>
        <title>The evidence manifesto - better trials, better use of trial data</title>
        <itunes:title>The evidence manifesto - better trials, better use of trial data</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-evidence-manifesto-better-trials-better-use-of-trial-data/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-evidence-manifesto-better-trials-better-use-of-trial-data/#comments</comments>        <pubDate>Fri, 21 Apr 2017 15:48:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-evidence-manifesto-better-trials-better-use-of-trial-data</guid>
                                    <description><![CDATA[We're creating a manifesto for better evidence.  The centre for Evidence Based Medicine at the University of Oxford, and the BMJ, are asking what are the problem with medical evidence, and how can we fix them?

In this second discussion we went to Nottingham​ University, to find out what the people who create the bread and butter of EBM - randomised control trials - think about the issues with evidence synthesis, and how the information they create is being used in practice.

<p>http://evidencelive.org/manifesto/  - join the discussion, read, and comment on our manifesto.</p>
]]></description>
                                                            <content:encoded><![CDATA[We're creating a manifesto for better evidence.  The centre for Evidence Based Medicine at the University of Oxford, and the BMJ, are asking what are the problem with medical evidence, and how can we fix them?

In this second discussion we went to Nottingham​ University, to find out what the people who create the bread and butter of EBM - randomised control trials - think about the issues with evidence synthesis, and how the information they create is being used in practice.

<p>http://evidencelive.org/manifesto/  - join the discussion, read, and comment on our manifesto.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/34vzlt/stream_318812610-bmjgroup-the-evidence-manifesto-better-trials-better-use-of-trial-data.mp3" length="40090807" type="audio/mpeg"/>
        <itunes:summary><![CDATA[We're creating a manifesto for better evidence.  The centre for Evidence Based Medicine at the University of Oxford, and the BMJ, are asking what are the problem with medical evidence, and how can we fix them?

In this second discussion we went to Nottingham​ University, to find out what the people who create the bread and butter of EBM - randomised control trials - think about the issues with evidence synthesis, and how the information they create is being used in practice.

http://evidencelive.org/manifesto/  - join the discussion, read, and comment on our manifesto.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1671</itunes:duration>
                                    </item>
    <item>
        <title>Assessing and treating an electrical injury</title>
        <itunes:title>Assessing and treating an electrical injury</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/assessing-and-treating-an-electrical-injury/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/assessing-and-treating-an-electrical-injury/#comments</comments>        <pubDate>Thu, 13 Apr 2017 15:14:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/assessing-and-treating-an-electrical-injury</guid>
                                    <description><![CDATA[Thankfully, electrical injuries are relatively uncommon - but that means that lack of evidence regarding the management of patients who have been electrocuted, which can cause concern for clinicians when these patients present.

In this podcast, Cath Brizzel, clinical editor for The BMJ, is joined by one of the authors of a clinical update on the management of electrical injury  - Kumar Narayanan, a Consultant Cardiologist and Electrophysiologist at MaxCure Hospitals in India.

Read that full update, including the free infographic:
<p>http://www.bmj.com/content/357/bmj.j1418</p>
]]></description>
                                                            <content:encoded><![CDATA[Thankfully, electrical injuries are relatively uncommon - but that means that lack of evidence regarding the management of patients who have been electrocuted, which can cause concern for clinicians when these patients present.

In this podcast, Cath Brizzel, clinical editor for The BMJ, is joined by one of the authors of a clinical update on the management of electrical injury  - Kumar Narayanan, a Consultant Cardiologist and Electrophysiologist at MaxCure Hospitals in India.

Read that full update, including the free infographic:
<p>http://www.bmj.com/content/357/bmj.j1418</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8plfpa/stream_317508441-bmjgroup-assessing-and-treating-an-electrical-injury.mp3" length="13723935" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Thankfully, electrical injuries are relatively uncommon - but that means that lack of evidence regarding the management of patients who have been electrocuted, which can cause concern for clinicians when these patients present.

In this podcast, Cath Brizzel, clinical editor for The BMJ, is joined by one of the authors of a clinical update on the management of electrical injury  - Kumar Narayanan, a Consultant Cardiologist and Electrophysiologist at MaxCure Hospitals in India.

Read that full update, including the free infographic:
http://www.bmj.com/content/357/bmj.j1418]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>572</itunes:duration>
                                    </item>
    <item>
        <title>”We’re kicking the can down the road” - how to get agreement on the future of the NHS</title>
        <itunes:title>”We’re kicking the can down the road” - how to get agreement on the future of the NHS</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/we-re-kicking-the-can-down-the-road-how-to-get-agreement-on-the-future-of-the-nhs/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/we-re-kicking-the-can-down-the-road-how-to-get-agreement-on-the-future-of-the-nhs/#comments</comments>        <pubDate>Wed, 12 Apr 2017 14:54:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/were-kicking-the-can-down-the-road-how-to-get-agreement-on-the-future-of-the-nhs</guid>
                                    <description><![CDATA[Our latest debate asks whether there should be a Royal Commission (a high level enquiry, with statutory powers) into the future of the NHS.

A high level inquiry could detoxify the radical changes needed and command wide support, say Maurice Saatchi, conservative peer, and Paul Buchanan, The BMJ's patient editor; but Nigel Crisp, independent peer, thinks that a less formal, more flexible and collaborative approach could be quicker.

Read the debate:
<p>http://www.bmj.com/content/357/bmj.j1621</p>
]]></description>
                                                            <content:encoded><![CDATA[Our latest debate asks whether there should be a Royal Commission (a high level enquiry, with statutory powers) into the future of the NHS.

A high level inquiry could detoxify the radical changes needed and command wide support, say Maurice Saatchi, conservative peer, and Paul Buchanan, The BMJ's patient editor; but Nigel Crisp, independent peer, thinks that a less formal, more flexible and collaborative approach could be quicker.

Read the debate:
<p>http://www.bmj.com/content/357/bmj.j1621</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/82hsi9/stream_317354739-bmjgroup-were-kicking-the-can-down-the-road-how-to-get-agreement-on-the-future-of-the-nhs.mp3" length="26588690" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Our latest debate asks whether there should be a Royal Commission (a high level enquiry, with statutory powers) into the future of the NHS.

A high level inquiry could detoxify the radical changes needed and command wide support, say Maurice Saatchi, conservative peer, and Paul Buchanan, The BMJ's patient editor; but Nigel Crisp, independent peer, thinks that a less formal, more flexible and collaborative approach could be quicker.

Read the debate:
http://www.bmj.com/content/357/bmj.j1621]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1109</itunes:duration>
                                    </item>
    <item>
        <title>Fighting inequality, corruption, and conflict - how to improve South Asia’s health</title>
        <itunes:title>Fighting inequality, corruption, and conflict - how to improve South Asia’s health</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/fighting-inequality-corruption-and-conflict-how-to-improve-south-asia-s-health/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/fighting-inequality-corruption-and-conflict-how-to-improve-south-asia-s-health/#comments</comments>        <pubDate>Tue, 11 Apr 2017 15:29:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/key-health-issues-in-south-asia</guid>
                                    <description><![CDATA[The BMJ has published a series of articles, taking an in-depth look at health in South Asia. In this collection, authors from India, Pakistan, Nepal, Bangladesh, Sri Lanka, and Afghanistan collaborate to identify evidence-based solutions to shape health policy and interventions, and drive innovations and research in the region.

In this podcast, two of the driving forces behind the series - Dr Zulfiqar Bhutta, from Aga Khan University, and Dr Samiran Nundy from the Ganga Ram Postgraduate institute for Medical Education and research - join Anita Jain to discuss the key issues affecting the region now.

Read all of the open access articles:
<p>http://www.bmj.com/health-in-south-asia</p>
]]></description>
                                                            <content:encoded><![CDATA[The BMJ has published a series of articles, taking an in-depth look at health in South Asia. In this collection, authors from India, Pakistan, Nepal, Bangladesh, Sri Lanka, and Afghanistan collaborate to identify evidence-based solutions to shape health policy and interventions, and drive innovations and research in the region.

In this podcast, two of the driving forces behind the series - Dr Zulfiqar Bhutta, from Aga Khan University, and Dr Samiran Nundy from the Ganga Ram Postgraduate institute for Medical Education and research - join Anita Jain to discuss the key issues affecting the region now.

Read all of the open access articles:
<p>http://www.bmj.com/health-in-south-asia</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/msoc7t/stream_317198861-bmjgroup-key-health-issues-in-south-asia.mp3" length="17370109" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The BMJ has published a series of articles, taking an in-depth look at health in South Asia. In this collection, authors from India, Pakistan, Nepal, Bangladesh, Sri Lanka, and Afghanistan collaborate to identify evidence-based solutions to shape health policy and interventions, and drive innovations and research in the region.

In this podcast, two of the driving forces behind the series - Dr Zulfiqar Bhutta, from Aga Khan University, and Dr Samiran Nundy from the Ganga Ram Postgraduate institute for Medical Education and research - join Anita Jain to discuss the key issues affecting the region now.

Read all of the open access articles:
http://www.bmj.com/health-in-south-asia]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>724</itunes:duration>
                                    </item>
    <item>
        <title>STPs - who, what, why, when, where.</title>
        <itunes:title>STPs - who, what, why, when, where.</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/stps-who-what-why-when-where/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/stps-who-what-why-when-where/#comments</comments>        <pubDate>Fri, 07 Apr 2017 14:43:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/what-are-stps-and-whats-happening-with-them</guid>
                                    <description><![CDATA[The NHS Delivery Plan - setting out what’s in store of the English NHS in the coming years, has been delivered by Simon Stevens the chief executive. Key to those are the sustainability and transformation plans (STPs) which have been made in 44 areas, and yet again reorganise care - crucially, this time, with social care included in the mix.

In this podcast Hugh Alderwick, senior policy advisor at the King’s Fund explains what STPs are, and what they're planning, and crucially, the cash involved.

Read the full analysis:
<p>http://www.bmj.com/content/356/bmj.j1541</p>
]]></description>
                                                            <content:encoded><![CDATA[The NHS Delivery Plan - setting out what’s in store of the English NHS in the coming years, has been delivered by Simon Stevens the chief executive. Key to those are the sustainability and transformation plans (STPs) which have been made in 44 areas, and yet again reorganise care - crucially, this time, with social care included in the mix.

In this podcast Hugh Alderwick, senior policy advisor at the King’s Fund explains what STPs are, and what they're planning, and crucially, the cash involved.

Read the full analysis:
<p>http://www.bmj.com/content/356/bmj.j1541</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/swo3da/stream_316572789-bmjgroup-what-are-stps-and-whats-happening-with-them.mp3" length="26262406" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The NHS Delivery Plan - setting out what’s in store of the English NHS in the coming years, has been delivered by Simon Stevens the chief executive. Key to those are the sustainability and transformation plans (STPs) which have been made in 44 areas, and yet again reorganise care - crucially, this time, with social care included in the mix.

In this podcast Hugh Alderwick, senior policy advisor at the King’s Fund explains what STPs are, and what they're planning, and crucially, the cash involved.

Read the full analysis:
http://www.bmj.com/content/356/bmj.j1541]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1095</itunes:duration>
                                    </item>
    <item>
        <title>High integrity child mental healthcare</title>
        <itunes:title>High integrity child mental healthcare</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/high-integrity-child-mental-healthcare/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/high-integrity-child-mental-healthcare/#comments</comments>        <pubDate>Thu, 06 Apr 2017 14:54:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/high-integrity-child-mental-healthcare</guid>
                                    <description><![CDATA[Around 1 in 10 children and young people worldwide have mental health difficulties that substantially affect their lives.

Child mental health services often concentrate on risk reduction, at the expense of the wider aspects of a child's wellbeing.

As part of the high integrity healthcare series, this podcast focuses on novel ways of providing support to children and adolescents, and particularly Pause - a city centre drop in centre in Birmingham, England.

Read the full analysis:
<p>http://www.bmj.com/content/357/bmj.j1500</p>
]]></description>
                                                            <content:encoded><![CDATA[Around 1 in 10 children and young people worldwide have mental health difficulties that substantially affect their lives.

Child mental health services often concentrate on risk reduction, at the expense of the wider aspects of a child's wellbeing.

As part of the high integrity healthcare series, this podcast focuses on novel ways of providing support to children and adolescents, and particularly Pause - a city centre drop in centre in Birmingham, England.

Read the full analysis:
<p>http://www.bmj.com/content/357/bmj.j1500</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/d1kq25/stream_316399561-bmjgroup-high-integrity-child-mental-healthcare.mp3" length="24515476" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Around 1 in 10 children and young people worldwide have mental health difficulties that substantially affect their lives.

Child mental health services often concentrate on risk reduction, at the expense of the wider aspects of a child's wellbeing.

As part of the high integrity healthcare series, this podcast focuses on novel ways of providing support to children and adolescents, and particularly Pause - a city centre drop in centre in Birmingham, England.

Read the full analysis:
http://www.bmj.com/content/357/bmj.j1500]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1022</itunes:duration>
                                    </item>
    <item>
        <title>What is high integrity healthcare?</title>
        <itunes:title>What is high integrity healthcare?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/what-is-high-integrity-healthcare/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/what-is-high-integrity-healthcare/#comments</comments>        <pubDate>Fri, 31 Mar 2017 17:09:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/what-is-high-integrity-healthcare</guid>
                                    <description><![CDATA[This week, a new series starts in The BMJ - the aim is to rethink how hospitals, clinics, community services and public health work - with the aim of stopping the perverse blocks and incentives that prevent doctors, and other healthcare professionals, from providing the care that patients want and need.

Talking to Navjoyt Ladher, are Albert Mulley - professor of medicine at the Dartmouth Institute, and Jane Druce, an evaluations manger, and Donal Collins, a GP - both of whom work in an NHS Vanguard area, where new ways of delivering care are being tested.

Read the full analysis:
<p>http://www.bmj.com/content/356/bmj.j1401</p>
]]></description>
                                                            <content:encoded><![CDATA[This week, a new series starts in The BMJ - the aim is to rethink how hospitals, clinics, community services and public health work - with the aim of stopping the perverse blocks and incentives that prevent doctors, and other healthcare professionals, from providing the care that patients want and need.

Talking to Navjoyt Ladher, are Albert Mulley - professor of medicine at the Dartmouth Institute, and Jane Druce, an evaluations manger, and Donal Collins, a GP - both of whom work in an NHS Vanguard area, where new ways of delivering care are being tested.

Read the full analysis:
<p>http://www.bmj.com/content/356/bmj.j1401</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ppfof3/stream_315424079-bmjgroup-what-is-high-integrity-healthcare.mp3" length="26239286" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week, a new series starts in The BMJ - the aim is to rethink how hospitals, clinics, community services and public health work - with the aim of stopping the perverse blocks and incentives that prevent doctors, and other healthcare professionals, from providing the care that patients want and need.

Talking to Navjoyt Ladher, are Albert Mulley - professor of medicine at the Dartmouth Institute, and Jane Druce, an evaluations manger, and Donal Collins, a GP - both of whom work in an NHS Vanguard area, where new ways of delivering care are being tested.

Read the full analysis:
http://www.bmj.com/content/356/bmj.j1401]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1094</itunes:duration>
                                    </item>
    <item>
        <title>”Watching the world through a clear fog” - recognising depersonalisation and derealisation</title>
        <itunes:title>”Watching the world through a clear fog” - recognising depersonalisation and derealisation</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/watching-the-world-through-a-clear-fog-recognising-depersonalisation-and-derealisation/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/watching-the-world-through-a-clear-fog-recognising-depersonalisation-and-derealisation/#comments</comments>        <pubDate>Fri, 31 Mar 2017 11:02:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/watching-the-world-through-a-clear-fog-recognising-depersonalisation-and-derealisation</guid>
                                    <description><![CDATA[Transient symptoms of depersonalisation and derealisation - feeling detached from the world, and feeling as if you are watching events at a remove - are common. However for some, persistent symptoms can make the disorder extremely distressing.

In this podcast, Kate Adlington is joined by Elaine Hunter, consultant clinical psychologist, Anthony David, professor of cognitive neuropsychiatry, and by Jane Charlton and Fiona Godlee - who have both experienced depersonalisation/derealisation over a number of years.

Read the full education article:
<p>http://www.bmj.com/content/356/bmj.j745</p>
]]></description>
                                                            <content:encoded><![CDATA[Transient symptoms of depersonalisation and derealisation - feeling detached from the world, and feeling as if you are watching events at a remove - are common. However for some, persistent symptoms can make the disorder extremely distressing.

In this podcast, Kate Adlington is joined by Elaine Hunter, consultant clinical psychologist, Anthony David, professor of cognitive neuropsychiatry, and by Jane Charlton and Fiona Godlee - who have both experienced depersonalisation/derealisation over a number of years.

Read the full education article:
<p>http://www.bmj.com/content/356/bmj.j745</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/p11rqr/stream_315379410-bmjgroup-watching-the-world-through-a-clear-fog-recognising-depersonalisation-and-derealisation.mp3" length="45873000" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Transient symptoms of depersonalisation and derealisation - feeling detached from the world, and feeling as if you are watching events at a remove - are common. However for some, persistent symptoms can make the disorder extremely distressing.

In this podcast, Kate Adlington is joined by Elaine Hunter, consultant clinical psychologist, Anthony David, professor of cognitive neuropsychiatry, and by Jane Charlton and Fiona Godlee - who have both experienced depersonalisation/derealisation over a number of years.

Read the full education article:
http://www.bmj.com/content/356/bmj.j745]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1913</itunes:duration>
                                    </item>
    <item>
        <title>American healthcare - what next?</title>
        <itunes:title>American healthcare - what next?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/american-healthcare-what-next/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/american-healthcare-what-next/#comments</comments>        <pubDate>Wed, 29 Mar 2017 09:10:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/american-healthcare-what-next</guid>
                                    <description><![CDATA[For seven years, Republicans have vowed to repeal the Affordable Healthcare Act (Obamacare), and that promise took a central place in President Trump's campaign. The first major vote to replace it was due to happen last week, but was cancelled at the 11th hour.

In advance of the potential vote, The BMJ published a debate asking "Should US doctors mourn for Obamacare?". Now we're asking the authors of that debate, what next?

Joining Peter Doshi are Adam Gaffney, from Harvard Medical School and Saurabh Jha from the Hospital of the University of Pennsylvania.

Read their original debate:
<p>http://www.bmj.com/content/356/bmj.j1441</p>
]]></description>
                                                            <content:encoded><![CDATA[For seven years, Republicans have vowed to repeal the Affordable Healthcare Act (Obamacare), and that promise took a central place in President Trump's campaign. The first major vote to replace it was due to happen last week, but was cancelled at the 11th hour.

In advance of the potential vote, The BMJ published a debate asking "Should US doctors mourn for Obamacare?". Now we're asking the authors of that debate, what next?

Joining Peter Doshi are Adam Gaffney, from Harvard Medical School and Saurabh Jha from the Hospital of the University of Pennsylvania.

Read their original debate:
<p>http://www.bmj.com/content/356/bmj.j1441</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2rwr4u/stream_315013841-bmjgroup-american-healthcare-what-next.mp3" length="28620021" type="audio/mpeg"/>
        <itunes:summary><![CDATA[For seven years, Republicans have vowed to repeal the Affordable Healthcare Act (Obamacare), and that promise took a central place in President Trump's campaign. The first major vote to replace it was due to happen last week, but was cancelled at the 11th hour.

In advance of the potential vote, The BMJ published a debate asking "Should US doctors mourn for Obamacare?". Now we're asking the authors of that debate, what next?

Joining Peter Doshi are Adam Gaffney, from Harvard Medical School and Saurabh Jha from the Hospital of the University of Pennsylvania.

Read their original debate:
http://www.bmj.com/content/356/bmj.j1441]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1194</itunes:duration>
                                    </item>
    <item>
        <title>Dying on the canal</title>
        <itunes:title>Dying on the canal</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/dying-on-the-canal/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/dying-on-the-canal/#comments</comments>        <pubDate>Fri, 24 Mar 2017 11:51:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/dying-on-the-canal</guid>
                                    <description><![CDATA[Lady-Jacqueline Aster lives on a 72 foot canal boat. She's been diagnosed with adrenocortical cancer, and is receiving palliative care and is planning to die in the home she loves.

In this interview The BMJ's patient editor, Rosamund Snow, talks to Lady-Jacqueline about her cancer, her care and her funeral plans - and why planning one's own death can be fun.

Read more about healthcare on the water
http://www.bmj.com/content/356/bmj.j245

Since this recording, Rosamund died by suicide, making these discussions about planning for death more poignant. You can read more about Rosamund's life and work in her obituary.
<p>http://www.bmj.com/content/346/bmj.j850</p>
]]></description>
                                                            <content:encoded><![CDATA[Lady-Jacqueline Aster lives on a 72 foot canal boat. She's been diagnosed with adrenocortical cancer, and is receiving palliative care and is planning to die in the home she loves.

In this interview The BMJ's patient editor, Rosamund Snow, talks to Lady-Jacqueline about her cancer, her care and her funeral plans - and why planning one's own death can be fun.

Read more about healthcare on the water
http://www.bmj.com/content/356/bmj.j245

Since this recording, Rosamund died by suicide, making these discussions about planning for death more poignant. You can read more about Rosamund's life and work in her obituary.
<p>http://www.bmj.com/content/346/bmj.j850</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xl1sdg/stream_314239138-bmjgroup-dying-on-the-canal.mp3" length="13438976" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Lady-Jacqueline Aster lives on a 72 foot canal boat. She's been diagnosed with adrenocortical cancer, and is receiving palliative care and is planning to die in the home she loves.

In this interview The BMJ's patient editor, Rosamund Snow, talks to Lady-Jacqueline about her cancer, her care and her funeral plans - and why planning one's own death can be fun.

Read more about healthcare on the water
http://www.bmj.com/content/356/bmj.j245

Since this recording, Rosamund died by suicide, making these discussions about planning for death more poignant. You can read more about Rosamund's life and work in her obituary.
http://www.bmj.com/content/346/bmj.j850]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>611</itunes:duration>
                                    </item>
    <item>
        <title>Education round up - HIV testing, legal highs and care for relatives of the dying</title>
        <itunes:title>Education round up - HIV testing, legal highs and care for relatives of the dying</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/education-round-up-hiv-testing-legal-highs-and-care-for-relatives-of-the-dying/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/education-round-up-hiv-testing-legal-highs-and-care-for-relatives-of-the-dying/#comments</comments>        <pubDate>Fri, 17 Mar 2017 15:44:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/education-round-up-hiv-testing-legal-highs-care-for-relatives-of-the-dying</guid>
                                    <description><![CDATA[The BMJ publishes a lot of educational articles, and in an attempt to help you with your CPD, we have put together this round-up.  Our authors and editors will reflect on the key learning points in the articles we discuss, and explain how they may change their practice in light of that new understanding.

In this week's round up we're discussing:

The offer of an HIV screen for an asymptomatic adult
http://www.bmj.com/content/356/bmj.i6656

Two articles on legal highs
Novel psychoactive substances: types, mechanisms of action, and effects
http://www.bmj.com/content/356/bmj.i6848
Novel psychoactive substances: identifying and managing acute and chronic harmful use
http://www.bmj.com/content/356/bmj.i6814

and how to become better at supporting relatives and carers at the end of a patient’s life
<p>http://www.bmj.com/content/356/bmj.j367</p>
]]></description>
                                                            <content:encoded><![CDATA[The BMJ publishes a lot of educational articles, and in an attempt to help you with your CPD, we have put together this round-up.  Our authors and editors will reflect on the key learning points in the articles we discuss, and explain how they may change their practice in light of that new understanding.

In this week's round up we're discussing:

The offer of an HIV screen for an asymptomatic adult
http://www.bmj.com/content/356/bmj.i6656

Two articles on legal highs
Novel psychoactive substances: types, mechanisms of action, and effects
http://www.bmj.com/content/356/bmj.i6848
Novel psychoactive substances: identifying and managing acute and chronic harmful use
http://www.bmj.com/content/356/bmj.i6814

and how to become better at supporting relatives and carers at the end of a patient’s life
<p>http://www.bmj.com/content/356/bmj.j367</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/73s12v/stream_312965853-bmjgroup-education-round-up-hiv-testing-legal-highs-care-for-relatives-of-the-dying.mp3" length="50839824" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The BMJ publishes a lot of educational articles, and in an attempt to help you with your CPD, we have put together this round-up.  Our authors and editors will reflect on the key learning points in the articles we discuss, and explain how they may change their practice in light of that new understanding.

In this week's round up we're discussing:

The offer of an HIV screen for an asymptomatic adult
http://www.bmj.com/content/356/bmj.i6656

Two articles on legal highs
Novel psychoactive substances: types, mechanisms of action, and effects
http://www.bmj.com/content/356/bmj.i6848
Novel psychoactive substances: identifying and managing acute and chronic harmful use
http://www.bmj.com/content/356/bmj.i6814

and how to become better at supporting relatives and carers at the end of a patient’s life
http://www.bmj.com/content/356/bmj.j367]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2120</itunes:duration>
                                    </item>
    <item>
        <title>Identifying a viral rash in pregnancy</title>
        <itunes:title>Identifying a viral rash in pregnancy</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/identifying-a-viral-rash-in-pregnancy/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/identifying-a-viral-rash-in-pregnancy/#comments</comments>        <pubDate>Fri, 17 Mar 2017 15:33:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/identifying-a-viral-rash-in-pregnancy</guid>
                                    <description><![CDATA[Viral exanthema can cause rash in a pregnant woman and should be considered even in countries that have comprehensive vaccination programmes.  Measles and rubella can cause intrauterine death. Intrauterine infection with rubella can lead to congenital rubella syndrome in the liveborn baby.

In this podcast, Jack Carruthers, honorary clinical research fellow at Imperial College London joins us to discuss spotting a viral rash, what steps to take to assess cause, and what advice to give a worried parent.

Read the full clinical review:
<p>http://www.bmj.com/content/356/bmj.j512</p>
]]></description>
                                                            <content:encoded><![CDATA[Viral exanthema can cause rash in a pregnant woman and should be considered even in countries that have comprehensive vaccination programmes.  Measles and rubella can cause intrauterine death. Intrauterine infection with rubella can lead to congenital rubella syndrome in the liveborn baby.

In this podcast, Jack Carruthers, honorary clinical research fellow at Imperial College London joins us to discuss spotting a viral rash, what steps to take to assess cause, and what advice to give a worried parent.

Read the full clinical review:
<p>http://www.bmj.com/content/356/bmj.j512</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hmybns/stream_312963854-bmjgroup-identifying-a-viral-rash-in-pregnancy.mp3" length="16755141" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Viral exanthema can cause rash in a pregnant woman and should be considered even in countries that have comprehensive vaccination programmes.  Measles and rubella can cause intrauterine death. Intrauterine infection with rubella can lead to congenital rubella syndrome in the liveborn baby.

In this podcast, Jack Carruthers, honorary clinical research fellow at Imperial College London joins us to discuss spotting a viral rash, what steps to take to assess cause, and what advice to give a worried parent.

Read the full clinical review:
http://www.bmj.com/content/356/bmj.j512]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>698</itunes:duration>
                                    </item>
    <item>
        <title>Nuffield Summit 2017 - Reducing Demand</title>
        <itunes:title>Nuffield Summit 2017 - Reducing Demand</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/nuffield-summit-2017-reducing-demand/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/nuffield-summit-2017-reducing-demand/#comments</comments>        <pubDate>Thu, 16 Mar 2017 13:47:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/nuffield-summit-2017-reducing-demand</guid>
                                    <description><![CDATA[As the NHS strains under pressure from rising patient activity, an ageing population, and financial constraints, The BMJ hosted a discussion on how clinicians should be helping to manage demand at last week’s Nuffield Trust health policy summit.


Taking part are:

 - Eileen Burns, president of the British Geriatrics Society
 - Andrew Fernando, GP and medical director of North Hampshire Urgent Care
 - Candace Imison, director of policy at the Nuffield Trust
 - Martin Marshall, vice chair of the Royal College of General Practitioners
 - Amanda Philpott, chief officer of two clinical commissioning groups
 - Maxine Power, director of innovation and improvement science at Salford        Royal NHS Foundation Trust
 - Jeremy Taylor, chief executive of the charities’ coalition National Voices
 - Judith Smith, director of the Health Services Management Centre
 - Ashok Soni, chair of NHS England’s local professional network for pharmacy in London

Listen to all of our other Nuffield Summit Roundtables:
<p>http://www.bmj.com/nuffieldsummit</p>
]]></description>
                                                            <content:encoded><![CDATA[As the NHS strains under pressure from rising patient activity, an ageing population, and financial constraints, The BMJ hosted a discussion on how clinicians should be helping to manage demand at last week’s Nuffield Trust health policy summit.


Taking part are:

 - Eileen Burns, president of the British Geriatrics Society
 - Andrew Fernando, GP and medical director of North Hampshire Urgent Care
 - Candace Imison, director of policy at the Nuffield Trust
 - Martin Marshall, vice chair of the Royal College of General Practitioners
 - Amanda Philpott, chief officer of two clinical commissioning groups
 - Maxine Power, director of innovation and improvement science at Salford        Royal NHS Foundation Trust
 - Jeremy Taylor, chief executive of the charities’ coalition National Voices
 - Judith Smith, director of the Health Services Management Centre
 - Ashok Soni, chair of NHS England’s local professional network for pharmacy in London

Listen to all of our other Nuffield Summit Roundtables:
<p>http://www.bmj.com/nuffieldsummit</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/uj34dp/stream_312702920-bmjgroup-nuffield-summit-2017-reducing-demand.mp3" length="76332986" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As the NHS strains under pressure from rising patient activity, an ageing population, and financial constraints, The BMJ hosted a discussion on how clinicians should be helping to manage demand at last week’s Nuffield Trust health policy summit.


Taking part are:

 - Eileen Burns, president of the British Geriatrics Society
 - Andrew Fernando, GP and medical director of North Hampshire Urgent Care
 - Candace Imison, director of policy at the Nuffield Trust
 - Martin Marshall, vice chair of the Royal College of General Practitioners
 - Amanda Philpott, chief officer of two clinical commissioning groups
 - Maxine Power, director of innovation and improvement science at Salford        Royal NHS Foundation Trust
 - Jeremy Taylor, chief executive of the charities’ coalition National Voices
 - Judith Smith, director of the Health Services Management Centre
 - Ashok Soni, chair of NHS England’s local professional network for pharmacy in London

Listen to all of our other Nuffield Summit Roundtables:
http://www.bmj.com/nuffieldsummit]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3184</itunes:duration>
                                    </item>
    <item>
        <title>Emergency care plans at the end of life</title>
        <itunes:title>Emergency care plans at the end of life</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/emergency-care-plans-at-the-end-of-life/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/emergency-care-plans-at-the-end-of-life/#comments</comments>        <pubDate>Wed, 08 Mar 2017 16:48:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/emergency-care-plans-at-the-end-of-life</guid>
                                    <description><![CDATA[When a person’s heart or breathing stops and the cause is reversible, immediate cardiopulmonary resuscitation (CPR) offers a chance of life. However, when a person is dying—for example, from organ failure, frailty, or advanced cancer—and his or her heart stops as a final part of a dying process, CPR will not prevent death and may do harm. But conversations around that distinction are difficult. 

In a this podcast, we explore the ways in which these conversations go wrong, and give some practical advice on carrying them out better. Joining Helen Macdonald are Zoe Fritz, consultant acute physician, and Wellcome Fellow, David Pitcher, former president of the Resuscitation Council, and Kate Masters, whose mothers death led to a change in the law around DNACPR orders.

Read the articles discussed in this podcast:

Emergency care and resuscitation plans http://www.bmj.com/content/356/bmj.j876

Resuscitation policy should focus on the patient, not the decision
http://www.bmj.com/content/356/bmj.j813

My mum’s care means that decisions not to resuscitate must now be discussed with patients
<p>http://www.bmj.com/content/356/bmj.j1084</p>
]]></description>
                                                            <content:encoded><![CDATA[When a person’s heart or breathing stops and the cause is reversible, immediate cardiopulmonary resuscitation (CPR) offers a chance of life. However, when a person is dying—for example, from organ failure, frailty, or advanced cancer—and his or her heart stops as a final part of a dying process, CPR will not prevent death and may do harm. But conversations around that distinction are difficult. 

In a this podcast, we explore the ways in which these conversations go wrong, and give some practical advice on carrying them out better. Joining Helen Macdonald are Zoe Fritz, consultant acute physician, and Wellcome Fellow, David Pitcher, former president of the Resuscitation Council, and Kate Masters, whose mothers death led to a change in the law around DNACPR orders.

Read the articles discussed in this podcast:

Emergency care and resuscitation plans http://www.bmj.com/content/356/bmj.j876

Resuscitation policy should focus on the patient, not the decision
http://www.bmj.com/content/356/bmj.j813

My mum’s care means that decisions not to resuscitate must now be discussed with patients
<p>http://www.bmj.com/content/356/bmj.j1084</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9y22wq/stream_311374113-bmjgroup-emergency-care-plans-at-the-end-of-life.mp3" length="48458611" type="audio/mpeg"/>
        <itunes:summary><![CDATA[When a person’s heart or breathing stops and the cause is reversible, immediate cardiopulmonary resuscitation (CPR) offers a chance of life. However, when a person is dying—for example, from organ failure, frailty, or advanced cancer—and his or her heart stops as a final part of a dying process, CPR will not prevent death and may do harm. But conversations around that distinction are difficult. 

In a this podcast, we explore the ways in which these conversations go wrong, and give some practical advice on carrying them out better. Joining Helen Macdonald are Zoe Fritz, consultant acute physician, and Wellcome Fellow, David Pitcher, former president of the Resuscitation Council, and Kate Masters, whose mothers death led to a change in the law around DNACPR orders.

Read the articles discussed in this podcast:

Emergency care and resuscitation plans http://www.bmj.com/content/356/bmj.j876

Resuscitation policy should focus on the patient, not the decision
http://www.bmj.com/content/356/bmj.j813

My mum’s care means that decisions not to resuscitate must now be discussed with patients
http://www.bmj.com/content/356/bmj.j1084]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2021</itunes:duration>
                                    </item>
    <item>
        <title>Should malaria be eradicated?</title>
        <itunes:title>Should malaria be eradicated?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/should-malaria-be-eradicated/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/should-malaria-be-eradicated/#comments</comments>        <pubDate>Tue, 07 Mar 2017 14:53:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/should-malaria-be-eradicated</guid>
                                    <description><![CDATA[The World Health Organization, the Roll Back Malaria Partnership, and the United Nations, all have a vision of a malaria-free world. The world has already committed to malaria eradication, albeit without a target date.

Bruno Moonen, deputy director for malaria at the Bill and Melinda Gates Foundation, thinks that for malaria, eradication is the only equitable and sustainable solution.

Where as Clive Shiff, associate professor at the Johns Hopkins Bloomberg School of Public Health, thinks this is a top-down strategy, dependent on massive concentrated funding until finished - funding which could be more effectively spent elsewhere.

In this podcast they debate whether malaria should be eliminated, or eradicated, and how that might work.

Read the full debate:
<p>http://www.bmj.com/content/356/bmj.j916</p>
]]></description>
                                                            <content:encoded><![CDATA[The World Health Organization, the Roll Back Malaria Partnership, and the United Nations, all have a vision of a malaria-free world. The world has already committed to malaria eradication, albeit without a target date.

Bruno Moonen, deputy director for malaria at the Bill and Melinda Gates Foundation, thinks that for malaria, eradication is the only equitable and sustainable solution.

Where as Clive Shiff, associate professor at the Johns Hopkins Bloomberg School of Public Health, thinks this is a top-down strategy, dependent on massive concentrated funding until finished - funding which could be more effectively spent elsewhere.

In this podcast they debate whether malaria should be eliminated, or eradicated, and how that might work.

Read the full debate:
<p>http://www.bmj.com/content/356/bmj.j916</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/frknal/stream_311177070-bmjgroup-should-malaria-be-eradicated.mp3" length="22265181" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The World Health Organization, the Roll Back Malaria Partnership, and the United Nations, all have a vision of a malaria-free world. The world has already committed to malaria eradication, albeit without a target date.

Bruno Moonen, deputy director for malaria at the Bill and Melinda Gates Foundation, thinks that for malaria, eradication is the only equitable and sustainable solution.

Where as Clive Shiff, associate professor at the Johns Hopkins Bloomberg School of Public Health, thinks this is a top-down strategy, dependent on massive concentrated funding until finished - funding which could be more effectively spent elsewhere.

In this podcast they debate whether malaria should be eliminated, or eradicated, and how that might work.

Read the full debate:
http://www.bmj.com/content/356/bmj.j916]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>928</itunes:duration>
                                    </item>
    <item>
        <title>Palliative care is about life, not death</title>
        <itunes:title>Palliative care is about life, not death</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/palliative-care-is-about-life-not-death/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/palliative-care-is-about-life-not-death/#comments</comments>        <pubDate>Fri, 03 Mar 2017 17:04:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/palliative-care-is-about-life-not-death</guid>
                                    <description><![CDATA[Scott Murray, professor of primary palliative care at the University of Edinburgh, has written, and talked in this podcast before, about the benefits of early palliative care - and today he’s back to explain how illness trajectory, and the pattern of decline at the end of life, affects 4 main areas of wellness - physical, social, psychological and spiritual or existential.

Read his full analysis article:
<p>http://www.bmj.com/content/356/bmj.j878</p>
]]></description>
                                                            <content:encoded><![CDATA[Scott Murray, professor of primary palliative care at the University of Edinburgh, has written, and talked in this podcast before, about the benefits of early palliative care - and today he’s back to explain how illness trajectory, and the pattern of decline at the end of life, affects 4 main areas of wellness - physical, social, psychological and spiritual or existential.

Read his full analysis article:
<p>http://www.bmj.com/content/356/bmj.j878</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rfnldn/stream_310541576-bmjgroup-palliative-care-is-about-life-not-death.mp3" length="21411264" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Scott Murray, professor of primary palliative care at the University of Edinburgh, has written, and talked in this podcast before, about the benefits of early palliative care - and today he’s back to explain how illness trajectory, and the pattern of decline at the end of life, affects 4 main areas of wellness - physical, social, psychological and spiritual or existential.

Read his full analysis article:
http://www.bmj.com/content/356/bmj.j878]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>893</itunes:duration>
                                    </item>
    <item>
        <title>Community acquired pneumonia in children</title>
        <itunes:title>Community acquired pneumonia in children</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/community-acquired-pneumonia-in-children/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/community-acquired-pneumonia-in-children/#comments</comments>        <pubDate>Thu, 02 Mar 2017 17:45:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/community-acquired-pneumonia-in-children</guid>
                                    <description><![CDATA[In 2015, community acquired pneumonia (CAP) accounted for 15% of deaths in children under 5 years old globally and 922 000 deaths globally in children of all ages.

In this podcast Iram Haq, a registrar and clinical research associate in paediatric respiratory medicine, joins us to discuss the definition of pneumonia, how to assess  for the infection, and what treatments are effective.

Read the full clinical update:
<p>http://www.bmj.com/content/356/bmj.j686</p>
]]></description>
                                                            <content:encoded><![CDATA[In 2015, community acquired pneumonia (CAP) accounted for 15% of deaths in children under 5 years old globally and 922 000 deaths globally in children of all ages.

In this podcast Iram Haq, a registrar and clinical research associate in paediatric respiratory medicine, joins us to discuss the definition of pneumonia, how to assess  for the infection, and what treatments are effective.

Read the full clinical update:
<p>http://www.bmj.com/content/356/bmj.j686</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4mzwh3/stream_310364376-bmjgroup-community-acquired-pneumonia-in-children.mp3" length="15941782" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In 2015, community acquired pneumonia (CAP) accounted for 15% of deaths in children under 5 years old globally and 922 000 deaths globally in children of all ages.

In this podcast Iram Haq, a registrar and clinical research associate in paediatric respiratory medicine, joins us to discuss the definition of pneumonia, how to assess  for the infection, and what treatments are effective.

Read the full clinical update:
http://www.bmj.com/content/356/bmj.j686]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>665</itunes:duration>
                                    </item>
    <item>
        <title>The inadequacy of the UK’s childhood obesity strategy</title>
        <itunes:title>The inadequacy of the UK’s childhood obesity strategy</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-inadequacy-of-the-uk-s-childhood-obesity-strategy/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-inadequacy-of-the-uk-s-childhood-obesity-strategy/#comments</comments>        <pubDate>Thu, 02 Mar 2017 17:39:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/childhood-obesity-strategy</guid>
                                    <description><![CDATA[The UK government published its report Childhood Obesity: a Plan for Action, in August 2016. A new analysis article takes them to task for the inadequacy of that response to a growing problem.

Neena Modi is a professor of neonatal medicine, at Imperial College London, and president of the Royal College of Paediatrics and Child Health, and joins us to discuss what that report should have contained.

Read the full analysis:
<p>http://www.bmj.com/content/356/bmj.j762</p>
]]></description>
                                                            <content:encoded><![CDATA[The UK government published its report Childhood Obesity: a Plan for Action, in August 2016. A new analysis article takes them to task for the inadequacy of that response to a growing problem.

Neena Modi is a professor of neonatal medicine, at Imperial College London, and president of the Royal College of Paediatrics and Child Health, and joins us to discuss what that report should have contained.

Read the full analysis:
<p>http://www.bmj.com/content/356/bmj.j762</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xq1xh7/stream_310363443-bmjgroup-childhood-obesity-strategy.mp3" length="20025828" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The UK government published its report Childhood Obesity: a Plan for Action, in August 2016. A new analysis article takes them to task for the inadequacy of that response to a growing problem.

Neena Modi is a professor of neonatal medicine, at Imperial College London, and president of the Royal College of Paediatrics and Child Health, and joins us to discuss what that report should have contained.

Read the full analysis:
http://www.bmj.com/content/356/bmj.j762]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>835</itunes:duration>
                                    </item>
    <item>
        <title>Low intensity pulsed ultrasound - no difference for bone healing</title>
        <itunes:title>Low intensity pulsed ultrasound - no difference for bone healing</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/low-intensity-pulsed-ultrasound-no-difference-for-bone-healing/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/low-intensity-pulsed-ultrasound-no-difference-for-bone-healing/#comments</comments>        <pubDate>Fri, 24 Feb 2017 20:36:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/low-intensity-pulsed-ultrasound-no-difference-for-bone-healing</guid>
                                    <description><![CDATA[A new rapid recommendation had concluded that LIPUS makes no different to patients experience of bone healing, and therefore shouldn't be used.

In this podcast, we talk to three of those panel members - Rudolf Poolman, orthopaedic surgeon from The Netherlands, Stefan Schandelmaier, a methodologist from McMaster University, and Maureen Smith, a patient representative.

Read the full recommendation:
<p>http://www.bmj.com/content/356/bmj.j576</p>
]]></description>
                                                            <content:encoded><![CDATA[A new rapid recommendation had concluded that LIPUS makes no different to patients experience of bone healing, and therefore shouldn't be used.

In this podcast, we talk to three of those panel members - Rudolf Poolman, orthopaedic surgeon from The Netherlands, Stefan Schandelmaier, a methodologist from McMaster University, and Maureen Smith, a patient representative.

Read the full recommendation:
<p>http://www.bmj.com/content/356/bmj.j576</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/uuauz5/stream_309393247-bmjgroup-low-intensity-pulsed-ultrasound-no-difference-for-bone-healing.mp3" length="26244451" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A new rapid recommendation had concluded that LIPUS makes no different to patients experience of bone healing, and therefore shouldn't be used.

In this podcast, we talk to three of those panel members - Rudolf Poolman, orthopaedic surgeon from The Netherlands, Stefan Schandelmaier, a methodologist from McMaster University, and Maureen Smith, a patient representative.

Read the full recommendation:
http://www.bmj.com/content/356/bmj.j576]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1095</itunes:duration>
                                    </item>
    <item>
        <title>How people die remains in the memory of those who live on - supporting the relatives of the dying</title>
        <itunes:title>How people die remains in the memory of those who live on - supporting the relatives of the dying</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/how-people-die-remains-in-the-memory-of-those-who-live-on-supporting-the-relatives-of-the-dying/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/how-people-die-remains-in-the-memory-of-those-who-live-on-supporting-the-relatives-of-the-dying/#comments</comments>        <pubDate>Tue, 21 Feb 2017 11:00:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/how-people-die-remains-in-the-memory-of-those-who-live-on-supporting-the-relatives-of-the-dying</guid>
                                    <description><![CDATA[All doctors, irrespective of their specialty or the setting in which they work, will care for patients who die. Around half of all deaths occur in hospitals.

Evidence suggests that the quality of communication around this process is poorer in hospitals than in other settings, according to responses from relatives who have experienced bereavement. Over half of NHS complaints concern care of the dying.

In this podcast, Katherine Sleeman, clinician scientist and honorary consultant in palliative medicine at King's College London, and Jane Harris, counselling and psychotherapy practitioner, and bereaved mother and daughter join us to discuss what support the carers and relatives of a dying patient need, and give practical advice on how to become better at having those difficult conversations.

Read the full essentials article:
<p>http://www.bmj.com/content/356/bmj.j367</p>
]]></description>
                                                            <content:encoded><![CDATA[All doctors, irrespective of their specialty or the setting in which they work, will care for patients who die. Around half of all deaths occur in hospitals.

Evidence suggests that the quality of communication around this process is poorer in hospitals than in other settings, according to responses from relatives who have experienced bereavement. Over half of NHS complaints concern care of the dying.

In this podcast, Katherine Sleeman, clinician scientist and honorary consultant in palliative medicine at King's College London, and Jane Harris, counselling and psychotherapy practitioner, and bereaved mother and daughter join us to discuss what support the carers and relatives of a dying patient need, and give practical advice on how to become better at having those difficult conversations.

Read the full essentials article:
<p>http://www.bmj.com/content/356/bmj.j367</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8xk7a1/stream_308808266-bmjgroup-how-people-die-remains-in-the-memory-of-those-who-live-on-supporting-the-relatives-of-the-dying.mp3" length="32574791" type="audio/mpeg"/>
        <itunes:summary><![CDATA[All doctors, irrespective of their specialty or the setting in which they work, will care for patients who die. Around half of all deaths occur in hospitals.

Evidence suggests that the quality of communication around this process is poorer in hospitals than in other settings, according to responses from relatives who have experienced bereavement. Over half of NHS complaints concern care of the dying.

In this podcast, Katherine Sleeman, clinician scientist and honorary consultant in palliative medicine at King's College London, and Jane Harris, counselling and psychotherapy practitioner, and bereaved mother and daughter join us to discuss what support the carers and relatives of a dying patient need, and give practical advice on how to become better at having those difficult conversations.

Read the full essentials article:
http://www.bmj.com/content/356/bmj.j367]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1358</itunes:duration>
                                    </item>
    <item>
        <title>Helping patients with medically unexplained symptoms</title>
        <itunes:title>Helping patients with medically unexplained symptoms</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/helping-patients-with-medically-unexplained-symptoms/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/helping-patients-with-medically-unexplained-symptoms/#comments</comments>        <pubDate>Fri, 17 Feb 2017 16:59:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/helping-patients-with-medically-unexplained-symptoms</guid>
                                    <description><![CDATA[Persistent physical symptoms are common and include those symptoms that last at least three months and are insufficiently explained by a medical condition after adequate examination and investigation.

 Observational studies in primary care report that women, especially those aged 35-45 years, more commonly present with these symptoms.

In this podcast, Madelon den Boeft, a GP and, Nikki Claassen-van Dessel,  a GP trainee, both in The Netherlands, join us to explain why listening to a patient is important, and making sure that regular follow up is essential.

Read the full uncertainties article:
<p>http://www.bmj.com/content/356/bmj.j268</p>
]]></description>
                                                            <content:encoded><![CDATA[Persistent physical symptoms are common and include those symptoms that last at least three months and are insufficiently explained by a medical condition after adequate examination and investigation.

 Observational studies in primary care report that women, especially those aged 35-45 years, more commonly present with these symptoms.

In this podcast, Madelon den Boeft, a GP and, Nikki Claassen-van Dessel,  a GP trainee, both in The Netherlands, join us to explain why listening to a patient is important, and making sure that regular follow up is essential.

Read the full uncertainties article:
<p>http://www.bmj.com/content/356/bmj.j268</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ufnc87/stream_308232664-bmjgroup-helping-patients-with-medically-unexplained-symptoms.mp3" length="20396518" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Persistent physical symptoms are common and include those symptoms that last at least three months and are insufficiently explained by a medical condition after adequate examination and investigation.

 Observational studies in primary care report that women, especially those aged 35-45 years, more commonly present with these symptoms.

In this podcast, Madelon den Boeft, a GP and, Nikki Claassen-van Dessel,  a GP trainee, both in The Netherlands, join us to explain why listening to a patient is important, and making sure that regular follow up is essential.

Read the full uncertainties article:
http://www.bmj.com/content/356/bmj.j268]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>850</itunes:duration>
                                    </item>
    <item>
        <title>US Surgeon General - “For far too long addiction has been looked at as a moral failing”</title>
        <itunes:title>US Surgeon General - “For far too long addiction has been looked at as a moral failing”</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/us-surgeon-general-for-far-too-long-addiction-has-been-looked-at-as-a-moral-failing/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/us-surgeon-general-for-far-too-long-addiction-has-been-looked-at-as-a-moral-failing/#comments</comments>        <pubDate>Wed, 15 Feb 2017 14:17:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/us-surgeon-general-for-far-too-long-addiction-has-been-looked-at-as-a-moral-failing</guid>
                                    <description><![CDATA[Vivek Murthy, the US surgeon general, has highlighted prescription opioid misuse as a serious public health problem. 

In this podcast, Richard Hurley speaks to him about what he thinks needs to be done to tackle the issue.

<p>http://www.bmj.com/content/356/bmj.j715</p>
]]></description>
                                                            <content:encoded><![CDATA[Vivek Murthy, the US surgeon general, has highlighted prescription opioid misuse as a serious public health problem. 

In this podcast, Richard Hurley speaks to him about what he thinks needs to be done to tackle the issue.

<p>http://www.bmj.com/content/356/bmj.j715</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/p979pf/stream_307865800-bmjgroup-us-surgeon-general-for-far-too-long-addiction-has-been-looked-at-as-a-moral-failing.mp3" length="46508808" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Vivek Murthy, the US surgeon general, has highlighted prescription opioid misuse as a serious public health problem. 

In this podcast, Richard Hurley speaks to him about what he thinks needs to be done to tackle the issue.

http://www.bmj.com/content/356/bmj.j715]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1941</itunes:duration>
                                    </item>
    <item>
        <title>Should all American doctors be using electronic medical records?</title>
        <itunes:title>Should all American doctors be using electronic medical records?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/should-all-american-doctors-be-using-electronic-medical-records/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/should-all-american-doctors-be-using-electronic-medical-records/#comments</comments>        <pubDate>Thu, 19 Jan 2017 17:40:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/should-all-american-doctors-be-using-electronic-medical-records</guid>
                                    <description><![CDATA[Evidence shows using electronic health records can increase efficiency, and reduce preventable medical errors - but only if they are used properly. However, in the US, the president of the American Medical Association calls them almost unusable.

In this debate, Richard Hurley is joined by George Gellert, Regional Medical Informatics Officer at CHRISTUS Santa Rosa Health System and Edward Melnick, Assistant Professor of Emergency Medicine at Yale, who debate whether US doctors should be using electronic medical records.

Read the related article:
<p>http://www.bmj.com/content/356/bmj.j242.</p>
]]></description>
                                                            <content:encoded><![CDATA[Evidence shows using electronic health records can increase efficiency, and reduce preventable medical errors - but only if they are used properly. However, in the US, the president of the American Medical Association calls them almost unusable.

In this debate, Richard Hurley is joined by George Gellert, Regional Medical Informatics Officer at CHRISTUS Santa Rosa Health System and Edward Melnick, Assistant Professor of Emergency Medicine at Yale, who debate whether US doctors should be using electronic medical records.

Read the related article:
<p>http://www.bmj.com/content/356/bmj.j242.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/h0xg7f/stream_303515262-bmjgroup-should-all-american-doctors-be-using-electronic-medical-records.mp3" length="18912362" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Evidence shows using electronic health records can increase efficiency, and reduce preventable medical errors - but only if they are used properly. However, in the US, the president of the American Medical Association calls them almost unusable.

In this debate, Richard Hurley is joined by George Gellert, Regional Medical Informatics Officer at CHRISTUS Santa Rosa Health System and Edward Melnick, Assistant Professor of Emergency Medicine at Yale, who debate whether US doctors should be using electronic medical records.

Read the related article:
http://www.bmj.com/content/356/bmj.j242.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>788</itunes:duration>
                                    </item>
    <item>
        <title>Expanding your mind about novel psychoactives</title>
        <itunes:title>Expanding your mind about novel psychoactives</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/expanding-your-mind-about-novel-psychoactives/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/expanding-your-mind-about-novel-psychoactives/#comments</comments>        <pubDate>Thu, 19 Jan 2017 17:37:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/expanding-your-mind-about-novel-psychoactives</guid>
                                    <description><![CDATA[The use of novel psychoactive substances is increasing, however there is little information about what these are, and how they work. 

Dr Derek Tracy, consultant psychiatrist at Oxleas NHS Foundation Trust, and David Wood, consultant physician and toxicologist at Guy's and St Thomas' NHS Foundation Trust join us to explain that doctors already know how to deal with these, if they think about them in terms of traditional drug use.

Read the two related articles: 
http://www.bmj.com/content/356/bmj.i6814
<p>http://www.bmj.com/content/356/bmj.i6848</p>
]]></description>
                                                            <content:encoded><![CDATA[The use of novel psychoactive substances is increasing, however there is little information about what these are, and how they work. 

Dr Derek Tracy, consultant psychiatrist at Oxleas NHS Foundation Trust, and David Wood, consultant physician and toxicologist at Guy's and St Thomas' NHS Foundation Trust join us to explain that doctors already know how to deal with these, if they think about them in terms of traditional drug use.

Read the two related articles: 
http://www.bmj.com/content/356/bmj.i6814
<p>http://www.bmj.com/content/356/bmj.i6848</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/t89m5j/stream_303514830-bmjgroup-expanding-your-mind-about-novel-psychoactives.mp3" length="36583116" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The use of novel psychoactive substances is increasing, however there is little information about what these are, and how they work. 

Dr Derek Tracy, consultant psychiatrist at Oxleas NHS Foundation Trust, and David Wood, consultant physician and toxicologist at Guy's and St Thomas' NHS Foundation Trust join us to explain that doctors already know how to deal with these, if they think about them in terms of traditional drug use.

Read the two related articles: 
http://www.bmj.com/content/356/bmj.i6814
http://www.bmj.com/content/356/bmj.i6848]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1525</itunes:duration>
                                    </item>
    <item>
        <title>Big Data - what effect is it going to have on EBM</title>
        <itunes:title>Big Data - what effect is it going to have on EBM</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/big-data-what-effect-is-it-going-to-have-on-ebm/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/big-data-what-effect-is-it-going-to-have-on-ebm/#comments</comments>        <pubDate>Thu, 19 Jan 2017 17:30:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/big-data-what-effect-is-it-going-to-have-on-ebm</guid>
                                    <description><![CDATA[http://evidencelive.org/manifesto/

The BMJ, and the Centre for Evidence Based Medicine in Oxford have long collaborated to document the problems with the creation and use of Evidence based medicine - and together we host evidence gatherers, synthesisers and users in the conference Evidence Live.

We know what the problems are - but what would positive change, when it comes to the creation and use of medical evidence look like? To find out we’re doing a series of discussions at various places around the world - where we’re talking to people who have a particular insight into one area of the evidence ecosystem. Ultimately we’re collating this into what we’re calling the evidence manifesto.

<p>In this discussion we went to the The Farr Institute which is a  of 21 academic institutions and health partners in the UK - whose mission is to deliver high-quality, cutting-edge research using ‘big data”.</p>
]]></description>
                                                            <content:encoded><![CDATA[http://evidencelive.org/manifesto/

The BMJ, and the Centre for Evidence Based Medicine in Oxford have long collaborated to document the problems with the creation and use of Evidence based medicine - and together we host evidence gatherers, synthesisers and users in the conference Evidence Live.

We know what the problems are - but what would positive change, when it comes to the creation and use of medical evidence look like? To find out we’re doing a series of discussions at various places around the world - where we’re talking to people who have a particular insight into one area of the evidence ecosystem. Ultimately we’re collating this into what we’re calling the evidence manifesto.

<p>In this discussion we went to the The Farr Institute which is a  of 21 academic institutions and health partners in the UK - whose mission is to deliver high-quality, cutting-edge research using ‘big data”.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gl432n/stream_303513772-bmjgroup-big-data-what-effect-is-it-going-to-have-on-ebm.mp3" length="25897773" type="audio/mpeg"/>
        <itunes:summary><![CDATA[http://evidencelive.org/manifesto/

The BMJ, and the Centre for Evidence Based Medicine in Oxford have long collaborated to document the problems with the creation and use of Evidence based medicine - and together we host evidence gatherers, synthesisers and users in the conference Evidence Live.

We know what the problems are - but what would positive change, when it comes to the creation and use of medical evidence look like? To find out we’re doing a series of discussions at various places around the world - where we’re talking to people who have a particular insight into one area of the evidence ecosystem. Ultimately we’re collating this into what we’re calling the evidence manifesto.

In this discussion we went to the The Farr Institute which is a  of 21 academic institutions and health partners in the UK - whose mission is to deliver high-quality, cutting-edge research using ‘big data”.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1079</itunes:duration>
                                    </item>
    <item>
        <title>Gluten free on the NHS</title>
        <itunes:title>Gluten free on the NHS</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/gluten-free-on-the-nhs/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/gluten-free-on-the-nhs/#comments</comments>        <pubDate>Fri, 13 Jan 2017 18:08:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/gluten-free-on-the-nhs</guid>
                                    <description><![CDATA[Should gluten-free foods be available on prescription?

A gluten free diet is the main treatment for celiac disease, and gluten-free food has been available on prescription from the NHS. However, as finances become tighter, in some areas patients no longer have that option.

Prescriptions of gluten free food is the same as a prescription for a drug, argues David  Sanders, professor of gastroenterology from Royal Hallamshire Hospital, but James Cave lambasts a costly system that frustrates patients and doctors alike. Gemma Gleed is the mother of a child with coeliac disease, who has had her prescriptions cancelled.

Read the debate:
<p>http://www.bmj.com/content/356/bmj.i6810</p>
]]></description>
                                                            <content:encoded><![CDATA[Should gluten-free foods be available on prescription?

A gluten free diet is the main treatment for celiac disease, and gluten-free food has been available on prescription from the NHS. However, as finances become tighter, in some areas patients no longer have that option.

Prescriptions of gluten free food is the same as a prescription for a drug, argues David  Sanders, professor of gastroenterology from Royal Hallamshire Hospital, but James Cave lambasts a costly system that frustrates patients and doctors alike. Gemma Gleed is the mother of a child with coeliac disease, who has had her prescriptions cancelled.

Read the debate:
<p>http://www.bmj.com/content/356/bmj.i6810</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7mnsbi/stream_302540476-bmjgroup-gluten-free-on-the-nhs.mp3" length="27592906" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Should gluten-free foods be available on prescription?

A gluten free diet is the main treatment for celiac disease, and gluten-free food has been available on prescription from the NHS. However, as finances become tighter, in some areas patients no longer have that option.

Prescriptions of gluten free food is the same as a prescription for a drug, argues David  Sanders, professor of gastroenterology from Royal Hallamshire Hospital, but James Cave lambasts a costly system that frustrates patients and doctors alike. Gemma Gleed is the mother of a child with coeliac disease, who has had her prescriptions cancelled.

Read the debate:
http://www.bmj.com/content/356/bmj.i6810]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1150</itunes:duration>
                                    </item>
    <item>
        <title>Surrogate outcomes distorting medicine</title>
        <itunes:title>Surrogate outcomes distorting medicine</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/surrogate-outcomes-distorting-medicine/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/surrogate-outcomes-distorting-medicine/#comments</comments>        <pubDate>Fri, 06 Jan 2017 18:47:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/surrogate-outcomes-distorting-medicine</guid>
                                    <description><![CDATA[Surrogate endpoints are commonly used in clinical trials to get quicker results, however Michael Baum, emeritus professor at University College London, worries that by not focusing on real outcomes - length of life, and quality of life - that these are being used to justify expensive treatments which may not benefit patients.

Read the full analysis:
<p>http://www.bmj.com/content/355/bmj.i6286</p>
]]></description>
                                                            <content:encoded><![CDATA[Surrogate endpoints are commonly used in clinical trials to get quicker results, however Michael Baum, emeritus professor at University College London, worries that by not focusing on real outcomes - length of life, and quality of life - that these are being used to justify expensive treatments which may not benefit patients.

Read the full analysis:
<p>http://www.bmj.com/content/355/bmj.i6286</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/013uv9/stream_301247258-bmjgroup-surrogate-outcomes-distorting-medicine.mp3" length="19842730" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Surrogate endpoints are commonly used in clinical trials to get quicker results, however Michael Baum, emeritus professor at University College London, worries that by not focusing on real outcomes - length of life, and quality of life - that these are being used to justify expensive treatments which may not benefit patients.

Read the full analysis:
http://www.bmj.com/content/355/bmj.i6286]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>826</itunes:duration>
                                    </item>
    <item>
        <title>Nanny state knows best</title>
        <itunes:title>Nanny state knows best</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/nanny-state-knows-best/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/nanny-state-knows-best/#comments</comments>        <pubDate>Tue, 03 Jan 2017 11:44:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/nanny-state-knows-best</guid>
                                    <description><![CDATA[State regulation is necessary for safety, says Simon Capewell, professor of public health and policy at the University of Liverpool.  Richard Lilford, professor of public health at the University of Warwick, argues that restricting adults’ choice can undermine such aims.

Read the debate:
<p>http://www.bmj.com/content/355/bmj.i6341</p>
]]></description>
                                                            <content:encoded><![CDATA[State regulation is necessary for safety, says Simon Capewell, professor of public health and policy at the University of Liverpool.  Richard Lilford, professor of public health at the University of Warwick, argues that restricting adults’ choice can undermine such aims.

Read the debate:
<p>http://www.bmj.com/content/355/bmj.i6341</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/daz6n4/stream_300710799-bmjgroup-nanny-state-knows-best.mp3" length="21062521" type="audio/mpeg"/>
        <itunes:summary><![CDATA[State regulation is necessary for safety, says Simon Capewell, professor of public health and policy at the University of Liverpool.  Richard Lilford, professor of public health at the University of Warwick, argues that restricting adults’ choice can undermine such aims.

Read the debate:
http://www.bmj.com/content/355/bmj.i6341]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>878</itunes:duration>
                                    </item>
    <item>
        <title>Christmas 2016 - War</title>
        <itunes:title>Christmas 2016 - War</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/christmas-2016-war/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/christmas-2016-war/#comments</comments>        <pubDate>Fri, 23 Dec 2016 15:05:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/christmas-2016-war</guid>
                                    <description><![CDATA[In this year's Christmas BMJ 2016 podcasts, we’ve been discussing morality, compassion, truth. In this final one, it's time for war.

After the second world war, there was an attempt to bring a moral sense to conflict - and Julian Sheather, specialist adviser on ethics and human rights to the BMA, and author of the christmas editorial “medicine under fire” is worried about the retrenchment of those ideals.
http://www.bmj.com/content/355/bmj.i6464

Peter Wever is a doctor in The Netherlands, and has been uncovering the story of the number 10 stationary hospital, in st-omer in northern france -  a British army hospital that was targeted and destroyed during the first world war.
<p>http://www.bmj.com/content/355/bmj.i6509</p>
]]></description>
                                                            <content:encoded><![CDATA[In this year's Christmas BMJ 2016 podcasts, we’ve been discussing morality, compassion, truth. In this final one, it's time for war.

After the second world war, there was an attempt to bring a moral sense to conflict - and Julian Sheather, specialist adviser on ethics and human rights to the BMA, and author of the christmas editorial “medicine under fire” is worried about the retrenchment of those ideals.
http://www.bmj.com/content/355/bmj.i6464

Peter Wever is a doctor in The Netherlands, and has been uncovering the story of the number 10 stationary hospital, in st-omer in northern france -  a British army hospital that was targeted and destroyed during the first world war.
<p>http://www.bmj.com/content/355/bmj.i6509</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/uk72eg/stream_299298723-bmjgroup-christmas-2016-war.mp3" length="39026527" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this year's Christmas BMJ 2016 podcasts, we’ve been discussing morality, compassion, truth. In this final one, it's time for war.

After the second world war, there was an attempt to bring a moral sense to conflict - and Julian Sheather, specialist adviser on ethics and human rights to the BMA, and author of the christmas editorial “medicine under fire” is worried about the retrenchment of those ideals.
http://www.bmj.com/content/355/bmj.i6464

Peter Wever is a doctor in The Netherlands, and has been uncovering the story of the number 10 stationary hospital, in st-omer in northern france -  a British army hospital that was targeted and destroyed during the first world war.
http://www.bmj.com/content/355/bmj.i6509]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1627</itunes:duration>
                                    </item>
    <item>
        <title>Christmas 2016 - truth, post truth, nothing like the truth</title>
        <itunes:title>Christmas 2016 - truth, post truth, nothing like the truth</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/christmas-2016-truth-post-truth-nothing-like-the-truth/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/christmas-2016-truth-post-truth-nothing-like-the-truth/#comments</comments>        <pubDate>Thu, 22 Dec 2016 17:11:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/christmas-2016-truth-post-truth-nothing-like-the-truth</guid>
                                    <description><![CDATA[In response to the turmoil of 2016, with political campaigns being run on, and won on, misinformation -  many commentators are disparing that we’ve become a post-truth society. And what is truth anyway?

Tracy Brown, director of Sense about Science, the charity set up to champion evidence in everyday life, is less pessimistic about the public's appetite for evidence.
http://www.bmj.com/content/355/bmj.i6467

Anders Huitfeldt, a postdoctoral scholar at Stanford University School of Medicine, and has been trying to puzzle out “Is caviar a risk factor for being a millionaire?”
<p>http://www.bmj.com/content/355/bmj.i6536</p>
]]></description>
                                                            <content:encoded><![CDATA[In response to the turmoil of 2016, with political campaigns being run on, and won on, misinformation -  many commentators are disparing that we’ve become a post-truth society. And what is truth anyway?

Tracy Brown, director of Sense about Science, the charity set up to champion evidence in everyday life, is less pessimistic about the public's appetite for evidence.
http://www.bmj.com/content/355/bmj.i6467

Anders Huitfeldt, a postdoctoral scholar at Stanford University School of Medicine, and has been trying to puzzle out “Is caviar a risk factor for being a millionaire?”
<p>http://www.bmj.com/content/355/bmj.i6536</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9d35zz/stream_299168100-bmjgroup-christmas-2016-truth-post-truth-nothing-like-the-truth.mp3" length="38591155" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In response to the turmoil of 2016, with political campaigns being run on, and won on, misinformation -  many commentators are disparing that we’ve become a post-truth society. And what is truth anyway?

Tracy Brown, director of Sense about Science, the charity set up to champion evidence in everyday life, is less pessimistic about the public's appetite for evidence.
http://www.bmj.com/content/355/bmj.i6467

Anders Huitfeldt, a postdoctoral scholar at Stanford University School of Medicine, and has been trying to puzzle out “Is caviar a risk factor for being a millionaire?”
http://www.bmj.com/content/355/bmj.i6536]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1610</itunes:duration>
                                    </item>
    <item>
        <title>Christmas 2016 - Health and happiness</title>
        <itunes:title>Christmas 2016 - Health and happiness</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/christmas-2016-health-and-happiness/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/christmas-2016-health-and-happiness/#comments</comments>        <pubDate>Wed, 21 Dec 2016 11:59:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/christmas-2016-health-happiness</guid>
                                    <description><![CDATA[Underneath all of our civilisation and science, we’re still primates - and the connection between patient and doctor can be reinforced by simply taking a hand.

Robin Youngson, cofounder of hearts in healthcare, and Mitzi Blennerhassett, who has written extensively on patient engagement, have co-authored an editorial calling for the humanisation of medicine, and we talk to them about the power of touch.

Read the editorial:
www.bmj.com/content/355/bmj.i6262

Andrew Steptoe is the British Heart Foundation professor of psychology, at University College London. He and colleagues have been using a large cohort study to measure the link between overall happiness and health.

Read the full research:
<p>www.bmj.com/content/355/bmj.i6267</p>
]]></description>
                                                            <content:encoded><![CDATA[Underneath all of our civilisation and science, we’re still primates - and the connection between patient and doctor can be reinforced by simply taking a hand.

Robin Youngson, cofounder of hearts in healthcare, and Mitzi Blennerhassett, who has written extensively on patient engagement, have co-authored an editorial calling for the humanisation of medicine, and we talk to them about the power of touch.

Read the editorial:
www.bmj.com/content/355/bmj.i6262

Andrew Steptoe is the British Heart Foundation professor of psychology, at University College London. He and colleagues have been using a large cohort study to measure the link between overall happiness and health.

Read the full research:
<p>www.bmj.com/content/355/bmj.i6267</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3jjsfz/stream_298947292-bmjgroup-christmas-2016-health-happiness.mp3" length="34307923" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Underneath all of our civilisation and science, we’re still primates - and the connection between patient and doctor can be reinforced by simply taking a hand.

Robin Youngson, cofounder of hearts in healthcare, and Mitzi Blennerhassett, who has written extensively on patient engagement, have co-authored an editorial calling for the humanisation of medicine, and we talk to them about the power of touch.

Read the editorial:
www.bmj.com/content/355/bmj.i6262

Andrew Steptoe is the British Heart Foundation professor of psychology, at University College London. He and colleagues have been using a large cohort study to measure the link between overall happiness and health.

Read the full research:
www.bmj.com/content/355/bmj.i6267]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1431</itunes:duration>
                                    </item>
    <item>
        <title>Christmas 2016 - ideologies and moralities</title>
        <itunes:title>Christmas 2016 - ideologies and moralities</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/christmas-2016-ideologies-and-moralities/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/christmas-2016-ideologies-and-moralities/#comments</comments>        <pubDate>Fri, 16 Dec 2016 18:10:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/christmas-2016-ideologies-and-moralities</guid>
                                    <description><![CDATA[In an ideal world, policies would be evidence based - but governments are made of humans, who have positions and ideologies and moral bases. 

In this podcast Anthony Painter, from the RSA will be talking about why universal basic income may work, but who’s proponents cross ideological barriers, and writer and philosopher AC Grayling explains how economic arguments become moral crusades.


A universal basic income: the answer to poverty, insecurity, and health inequality?
http://www.bmj.com/content/355/bmj.i6473

Morality and non-medical drug use
<p>http://www.bmj.com/content/355/bmj.i5850</p>
]]></description>
                                                            <content:encoded><![CDATA[In an ideal world, policies would be evidence based - but governments are made of humans, who have positions and ideologies and moral bases. 

In this podcast Anthony Painter, from the RSA will be talking about why universal basic income may work, but who’s proponents cross ideological barriers, and writer and philosopher AC Grayling explains how economic arguments become moral crusades.


A universal basic income: the answer to poverty, insecurity, and health inequality?
http://www.bmj.com/content/355/bmj.i6473

Morality and non-medical drug use
<p>http://www.bmj.com/content/355/bmj.i5850</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ingugl/stream_298238823-bmjgroup-christmas-2016-ideologies-and-moralities.mp3" length="46883000" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In an ideal world, policies would be evidence based - but governments are made of humans, who have positions and ideologies and moral bases. 

In this podcast Anthony Painter, from the RSA will be talking about why universal basic income may work, but who’s proponents cross ideological barriers, and writer and philosopher AC Grayling explains how economic arguments become moral crusades.


A universal basic income: the answer to poverty, insecurity, and health inequality?
http://www.bmj.com/content/355/bmj.i6473

Morality and non-medical drug use
http://www.bmj.com/content/355/bmj.i5850]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1955</itunes:duration>
                                    </item>
    <item>
        <title>Education round up - November</title>
        <itunes:title>Education round up - November</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/education-round-up-november/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/education-round-up-november/#comments</comments>        <pubDate>Wed, 07 Dec 2016 17:40:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/education-round-up-november</guid>
                                    <description><![CDATA[The BMJ publishes a variety of education articles, to help doctors improve their practice. Often authors join us in our podcast to give tips on putting their recommendations into practice.

In this new monthly audio round-up The BMJ’s clinical editors discuss what they have learned, and how they may alter their practice.

In our second audio edition, GPs Sophie Cook and Helen Macdonald, surgical trainee Jessamy Baganel, and internalist and methodologist Reed Siemieniuk, talk about the evidence for vitamin D supplements.
http://www.bmj.com/content/355/bmj.i6201

The new Rapid Recommendation series in the BMJ
http://www.bmj.com/content/354/bmj.i5085 

Communication with patients who have learning difficulties, or others who have experienced torture.
http://www.bmj.com/content/355/bmj.i5296
http://www.bmj.com/content/355/bmj.i5019

And safety netting of people with low, but not no, risk of cancer.
<p>Can safety-netting improve cancer detection in patients with vague symptoms?</p>
]]></description>
                                                            <content:encoded><![CDATA[The BMJ publishes a variety of education articles, to help doctors improve their practice. Often authors join us in our podcast to give tips on putting their recommendations into practice.

In this new monthly audio round-up The BMJ’s clinical editors discuss what they have learned, and how they may alter their practice.

In our second audio edition, GPs Sophie Cook and Helen Macdonald, surgical trainee Jessamy Baganel, and internalist and methodologist Reed Siemieniuk, talk about the evidence for vitamin D supplements.
http://www.bmj.com/content/355/bmj.i6201

The new Rapid Recommendation series in the BMJ
http://www.bmj.com/content/354/bmj.i5085 

Communication with patients who have learning difficulties, or others who have experienced torture.
http://www.bmj.com/content/355/bmj.i5296
http://www.bmj.com/content/355/bmj.i5019

And safety netting of people with low, but not no, risk of cancer.
<p>Can safety-netting improve cancer detection in patients with vague symptoms?</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/edjv1c/stream_296691064-bmjgroup-education-round-up-november.mp3" length="52118022" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The BMJ publishes a variety of education articles, to help doctors improve their practice. Often authors join us in our podcast to give tips on putting their recommendations into practice.

In this new monthly audio round-up The BMJ’s clinical editors discuss what they have learned, and how they may alter their practice.

In our second audio edition, GPs Sophie Cook and Helen Macdonald, surgical trainee Jessamy Baganel, and internalist and methodologist Reed Siemieniuk, talk about the evidence for vitamin D supplements.
http://www.bmj.com/content/355/bmj.i6201

The new Rapid Recommendation series in the BMJ
http://www.bmj.com/content/354/bmj.i5085 

Communication with patients who have learning difficulties, or others who have experienced torture.
http://www.bmj.com/content/355/bmj.i5296
http://www.bmj.com/content/355/bmj.i5019

And safety netting of people with low, but not no, risk of cancer.
Can safety-netting improve cancer detection in patients with vague symptoms?]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2174</itunes:duration>
                                    </item>
    <item>
        <title>Caring for renal transplant patients</title>
        <itunes:title>Caring for renal transplant patients</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/caring-for-renal-transplant-patients/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/caring-for-renal-transplant-patients/#comments</comments>        <pubDate>Fri, 02 Dec 2016 18:28:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/caring-for-renal-transplant-patients</guid>
                                    <description><![CDATA[Renal transplantation improves quantity and quality of life compared with chronic dialysis. A UK general practice with 8000 patients will have around four patients with a functioning renal transplant, one patient on the transplant waiting list, and several under consideration for transplantation.

Many medical problems in renal transplant recipients will be managed by non-specialist clinicians, and this article provides advice for the non-specialist on managing renal transplant patients.

In this podcast, Tom Nieto, and Paul Cockwell from the Renal Services unit in the, College of Medical and Dental Sciences at the University of Birmingham, join us to discuss how non-specialists can spot problems early, and when it’s appropriate to talk about the potential for transplantation.

Read their full clinical update:
<p>http://www.bmj.com/content/355/bmj.i6158</p>
]]></description>
                                                            <content:encoded><![CDATA[Renal transplantation improves quantity and quality of life compared with chronic dialysis. A UK general practice with 8000 patients will have around four patients with a functioning renal transplant, one patient on the transplant waiting list, and several under consideration for transplantation.

Many medical problems in renal transplant recipients will be managed by non-specialist clinicians, and this article provides advice for the non-specialist on managing renal transplant patients.

In this podcast, Tom Nieto, and Paul Cockwell from the Renal Services unit in the, College of Medical and Dental Sciences at the University of Birmingham, join us to discuss how non-specialists can spot problems early, and when it’s appropriate to talk about the potential for transplantation.

Read their full clinical update:
<p>http://www.bmj.com/content/355/bmj.i6158</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ts9cxv/stream_295903178-bmjgroup-caring-for-renal-transplant-patients.mp3" length="44273010" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Renal transplantation improves quantity and quality of life compared with chronic dialysis. A UK general practice with 8000 patients will have around four patients with a functioning renal transplant, one patient on the transplant waiting list, and several under consideration for transplantation.

Many medical problems in renal transplant recipients will be managed by non-specialist clinicians, and this article provides advice for the non-specialist on managing renal transplant patients.

In this podcast, Tom Nieto, and Paul Cockwell from the Renal Services unit in the, College of Medical and Dental Sciences at the University of Birmingham, join us to discuss how non-specialists can spot problems early, and when it’s appropriate to talk about the potential for transplantation.

Read their full clinical update:
http://www.bmj.com/content/355/bmj.i6158]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1845</itunes:duration>
                                    </item>
    <item>
        <title>Margaret McCartney wants to fix the NHS</title>
        <itunes:title>Margaret McCartney wants to fix the NHS</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/margaret-mccartney-wants-to-fix-the-nhs/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/margaret-mccartney-wants-to-fix-the-nhs/#comments</comments>        <pubDate>Mon, 28 Nov 2016 17:15:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/margaret-mccartney-wants-to-fix-the-nhs</guid>
                                    <description><![CDATA[Glasgow GP, writer, broadcaster, and The BMJ's weekly columnist Margaret McCartney joins us to talk about her new book "The State of Medicine: Keeping the Promise of the NHS".

Read all of Margaret's columns:
<p>goo.gl/iKmmie</p>
]]></description>
                                                            <content:encoded><![CDATA[Glasgow GP, writer, broadcaster, and The BMJ's weekly columnist Margaret McCartney joins us to talk about her new book "The State of Medicine: Keeping the Promise of the NHS".

Read all of Margaret's columns:
<p>goo.gl/iKmmie</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3spx5x/stream_295165548-bmjgroup-margaret-mccartney-wants-to-fix-the-nhs.mp3" length="31127468" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Glasgow GP, writer, broadcaster, and The BMJ's weekly columnist Margaret McCartney joins us to talk about her new book "The State of Medicine: Keeping the Promise of the NHS".

Read all of Margaret's columns:
goo.gl/iKmmie]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1298</itunes:duration>
                                    </item>
    <item>
        <title>Evidence for vitamin D supplimentation</title>
        <itunes:title>Evidence for vitamin D supplimentation</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/evidence-for-vitamin-d-supplimentation/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/evidence-for-vitamin-d-supplimentation/#comments</comments>        <pubDate>Fri, 25 Nov 2016 16:15:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/evidence-for-vitamin-d-supplimentation</guid>
                                    <description><![CDATA[Despite high quality systematic reviews reporting ineffectiveness, many guideline groups continue to recommend vitamin D supplementation (with or without calcium) for fall or fracture prevention. Recently Public Health England recommended that everyone needs vitamin D equivalent to an average daily intake of 10 μg (400 IU) to protect bone and muscle health,

In this podcast, Andrew Grey, associate professor of medicine at the University of Aukland joins us to discuss what the evidence says for who should, and who shouldn't take vitamin D supplimentation.

Read the full uncertainties article:
<p>http://www.bmj.com/content/355/bmj.i6201</p>
]]></description>
                                                            <content:encoded><![CDATA[Despite high quality systematic reviews reporting ineffectiveness, many guideline groups continue to recommend vitamin D supplementation (with or without calcium) for fall or fracture prevention. Recently Public Health England recommended that everyone needs vitamin D equivalent to an average daily intake of 10 μg (400 IU) to protect bone and muscle health,

In this podcast, Andrew Grey, associate professor of medicine at the University of Aukland joins us to discuss what the evidence says for who should, and who shouldn't take vitamin D supplimentation.

Read the full uncertainties article:
<p>http://www.bmj.com/content/355/bmj.i6201</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/o3b8g8/stream_294739789-bmjgroup-evidence-for-vitamin-d-supplimentation.mp3" length="19000342" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Despite high quality systematic reviews reporting ineffectiveness, many guideline groups continue to recommend vitamin D supplementation (with or without calcium) for fall or fracture prevention. Recently Public Health England recommended that everyone needs vitamin D equivalent to an average daily intake of 10 μg (400 IU) to protect bone and muscle health,

In this podcast, Andrew Grey, associate professor of medicine at the University of Aukland joins us to discuss what the evidence says for who should, and who shouldn't take vitamin D supplimentation.

Read the full uncertainties article:
http://www.bmj.com/content/355/bmj.i6201]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>792</itunes:duration>
                                    </item>
    <item>
        <title>Blinding the randomisation</title>
        <itunes:title>Blinding the randomisation</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/blinding-the-randomisation/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/blinding-the-randomisation/#comments</comments>        <pubDate>Fri, 18 Nov 2016 15:58:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/blinding-the-randomisation</guid>
                                    <description><![CDATA[Allocation concealment - blinding which arm of a trial a patient is randomised to - is being questioned in an analysis published on thebmj.com.

David Torgerson, director of the York Trials Unit at the university of York and colleagues have been looking at the way in which trials do this randomisation, and how they subsequently report it - and have found both lacking.

Read the full analysis:
<p>http://www.bmj.com/content/355/bmj.i5663</p>
]]></description>
                                                            <content:encoded><![CDATA[Allocation concealment - blinding which arm of a trial a patient is randomised to - is being questioned in an analysis published on thebmj.com.

David Torgerson, director of the York Trials Unit at the university of York and colleagues have been looking at the way in which trials do this randomisation, and how they subsequently report it - and have found both lacking.

Read the full analysis:
<p>http://www.bmj.com/content/355/bmj.i5663</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jeogx6/stream_293653167-bmjgroup-blinding-the-randomisation.mp3" length="17230402" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Allocation concealment - blinding which arm of a trial a patient is randomised to - is being questioned in an analysis published on thebmj.com.

David Torgerson, director of the York Trials Unit at the university of York and colleagues have been looking at the way in which trials do this randomisation, and how they subsequently report it - and have found both lacking.

Read the full analysis:
http://www.bmj.com/content/355/bmj.i5663]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>717</itunes:duration>
                                    </item>
    <item>
        <title>What to do after a concussion</title>
        <itunes:title>What to do after a concussion</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/what-to-do-after-a-concussion/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/what-to-do-after-a-concussion/#comments</comments>        <pubDate>Fri, 18 Nov 2016 15:50:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/what-to-do-after-a-concussion</guid>
                                    <description><![CDATA[Concussion is a clinical diagnosis made after a head injury with consequent associated signs, symptoms, and neurological or cognitive impairment (infographic - http://bmj.co/conrecG). In the absence of strong evidence, most recommendations on the management and recovery from concussion are based on international expert consensus.

In this podcast John Brooks, academic clinical fellow in general practice, and Simon Kemp, chief medical officer for the Rugby Football Union take us through the process of guiding a patient through recovery and back into everyday life, including sport.

Read the full 10 minute consultation:
<p>http://www.bmj.com/content/355/bmj.i5629</p>
]]></description>
                                                            <content:encoded><![CDATA[Concussion is a clinical diagnosis made after a head injury with consequent associated signs, symptoms, and neurological or cognitive impairment (infographic - http://bmj.co/conrecG). In the absence of strong evidence, most recommendations on the management and recovery from concussion are based on international expert consensus.

In this podcast John Brooks, academic clinical fellow in general practice, and Simon Kemp, chief medical officer for the Rugby Football Union take us through the process of guiding a patient through recovery and back into everyday life, including sport.

Read the full 10 minute consultation:
<p>http://www.bmj.com/content/355/bmj.i5629</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/c5f097/stream_293652172-bmjgroup-what-to-do-after-a-concussion.mp3" length="26136228" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Concussion is a clinical diagnosis made after a head injury with consequent associated signs, symptoms, and neurological or cognitive impairment (infographic - http://bmj.co/conrecG). In the absence of strong evidence, most recommendations on the management and recovery from concussion are based on international expert consensus.

In this podcast John Brooks, academic clinical fellow in general practice, and Simon Kemp, chief medical officer for the Rugby Football Union take us through the process of guiding a patient through recovery and back into everyday life, including sport.

Read the full 10 minute consultation:
http://www.bmj.com/content/355/bmj.i5629]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1088</itunes:duration>
                                    </item>
    <item>
        <title>Non-drug treatments for chronic insomnia</title>
        <itunes:title>Non-drug treatments for chronic insomnia</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/non-drug-treatments-for-chronic-insomnia/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/non-drug-treatments-for-chronic-insomnia/#comments</comments>        <pubDate>Thu, 17 Nov 2016 15:24:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/non-drug-treatments-for-chronic-insomnia</guid>
                                    <description><![CDATA[Between 13 & 33% of the adult population have regular difficulty in getting to sleep, or staying asleep. It's important to recognise the difference between acute and chronic insomnia, as treatment strategies differ.

David Cunnington, director of the Melbourne Sleep Disorders Centre, joins us to explain what non-drug interventions are available to help those with chronic insomnia.

Read the full clinical review:
<p>http://www.bmj.com/content/355/bmj.i5819</p>
]]></description>
                                                            <content:encoded><![CDATA[Between 13 & 33% of the adult population have regular difficulty in getting to sleep, or staying asleep. It's important to recognise the difference between acute and chronic insomnia, as treatment strategies differ.

David Cunnington, director of the Melbourne Sleep Disorders Centre, joins us to explain what non-drug interventions are available to help those with chronic insomnia.

Read the full clinical review:
<p>http://www.bmj.com/content/355/bmj.i5819</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/053nxi/stream_293485506-bmjgroup-non-drug-treatments-for-chronic-insomnia.mp3" length="30265246" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Between 13 & 33% of the adult population have regular difficulty in getting to sleep, or staying asleep. It's important to recognise the difference between acute and chronic insomnia, as treatment strategies differ.

David Cunnington, director of the Melbourne Sleep Disorders Centre, joins us to explain what non-drug interventions are available to help those with chronic insomnia.

Read the full clinical review:
http://www.bmj.com/content/355/bmj.i5819]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1262</itunes:duration>
                                    </item>
    <item>
        <title>Cancer drugs, survival, and ethics</title>
        <itunes:title>Cancer drugs, survival, and ethics</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/cancer-drugs-survival-and-ethics/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/cancer-drugs-survival-and-ethics/#comments</comments>        <pubDate>Fri, 11 Nov 2016 18:13:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/cancer-drugs-survival-and-ethics</guid>
                                    <description><![CDATA[Despite considerable investment and innovation, chemotherapy drugs have had little effect on survival in adults with metastatic cancer. 

In this podcast, Navjoyt Ladher, clinical editor for The BMJ, talks to Peter Wise, former consultant physician and senior lecturer Imperial College School of Medicine, and author of a recent analysis on TheBMJ.com

Read the full analysis:
<p>http://www.bmj.com/content/355/bmj.i5792</p>
]]></description>
                                                            <content:encoded><![CDATA[Despite considerable investment and innovation, chemotherapy drugs have had little effect on survival in adults with metastatic cancer. 

In this podcast, Navjoyt Ladher, clinical editor for The BMJ, talks to Peter Wise, former consultant physician and senior lecturer Imperial College School of Medicine, and author of a recent analysis on TheBMJ.com

Read the full analysis:
<p>http://www.bmj.com/content/355/bmj.i5792</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jrtrv0/stream_292580583-bmjgroup-cancer-drugs-survival-and-ethics.mp3" length="18862080" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Despite considerable investment and innovation, chemotherapy drugs have had little effect on survival in adults with metastatic cancer. 

In this podcast, Navjoyt Ladher, clinical editor for The BMJ, talks to Peter Wise, former consultant physician and senior lecturer Imperial College School of Medicine, and author of a recent analysis on TheBMJ.com

Read the full analysis:
http://www.bmj.com/content/355/bmj.i5792]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1017</itunes:duration>
                                    </item>
    <item>
        <title>Advertising junk food to children</title>
        <itunes:title>Advertising junk food to children</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/advertising-junk-food-to-children/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/advertising-junk-food-to-children/#comments</comments>        <pubDate>Fri, 04 Nov 2016 17:18:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/advertising-junk-food-to-children</guid>
                                    <description><![CDATA[In the UK, junk food advertising is banned on children’s TV - but manufactures are still able to target children in other ways.  A recent report from the WHO  "Tackling food marketing to children in a digital world", takes a look at the issue.

In this podcast we're joined by João Breda, programme manager for nutrition physical activity and obesity at the regional office for Europe of the World Health Organisation, and Mimi Tatlow-Golden, lecturer in childhood studies and developmental psychology at the open university, and the lead author on the report.

Read the full report:
<p>http://www.euro.who.int/en/health-topics/disease-prevention/nutrition/publications/2016/tackling-food-marketing-to-children-in-a-digital-world-trans-disciplinary-perspectives-2016</p>
]]></description>
                                                            <content:encoded><![CDATA[In the UK, junk food advertising is banned on children’s TV - but manufactures are still able to target children in other ways.  A recent report from the WHO  "Tackling food marketing to children in a digital world", takes a look at the issue.

In this podcast we're joined by João Breda, programme manager for nutrition physical activity and obesity at the regional office for Europe of the World Health Organisation, and Mimi Tatlow-Golden, lecturer in childhood studies and developmental psychology at the open university, and the lead author on the report.

Read the full report:
<p>http://www.euro.who.int/en/health-topics/disease-prevention/nutrition/publications/2016/tackling-food-marketing-to-children-in-a-digital-world-trans-disciplinary-perspectives-2016</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ii11tx/stream_291505268-bmjgroup-advertising-junk-food-to-children.mp3" length="26685177" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In the UK, junk food advertising is banned on children’s TV - but manufactures are still able to target children in other ways.  A recent report from the WHO  "Tackling food marketing to children in a digital world", takes a look at the issue.

In this podcast we're joined by João Breda, programme manager for nutrition physical activity and obesity at the regional office for Europe of the World Health Organisation, and Mimi Tatlow-Golden, lecturer in childhood studies and developmental psychology at the open university, and the lead author on the report.

Read the full report:
http://www.euro.who.int/en/health-topics/disease-prevention/nutrition/publications/2016/tackling-food-marketing-to-children-in-a-digital-world-trans-disciplinary-perspectives-2016]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1113</itunes:duration>
                                    </item>
    <item>
        <title>Research before researching</title>
        <itunes:title>Research before researching</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/research-before-researching/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/research-before-researching/#comments</comments>        <pubDate>Fri, 04 Nov 2016 17:13:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/research-before-researching</guid>
                                    <description><![CDATA[To avoid waste of research, no new studies should be done without a systematic review of existing evidence. That argument has been made for 20 years, yet the lack of reference to a systematic review before designing new studies is still a problem.

Hand Lund, professor at the University of Southern Denmark joins us to explain why research before researching is still an issue.

Read the full analysis:
<p>http://www.bmj.com/content/355/bmj.i5440</p>
]]></description>
                                                            <content:encoded><![CDATA[To avoid waste of research, no new studies should be done without a systematic review of existing evidence. That argument has been made for 20 years, yet the lack of reference to a systematic review before designing new studies is still a problem.

Hand Lund, professor at the University of Southern Denmark joins us to explain why research before researching is still an issue.

Read the full analysis:
<p>http://www.bmj.com/content/355/bmj.i5440</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4bfu8j/stream_291504588-bmjgroup-research-before-researching.mp3" length="17880260" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To avoid waste of research, no new studies should be done without a systematic review of existing evidence. That argument has been made for 20 years, yet the lack of reference to a systematic review before designing new studies is still a problem.

Hand Lund, professor at the University of Southern Denmark joins us to explain why research before researching is still an issue.

Read the full analysis:
http://www.bmj.com/content/355/bmj.i5440]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>745</itunes:duration>
                                    </item>
    <item>
        <title>Rapid Recs - patient preference in heart valve replacement</title>
        <itunes:title>Rapid Recs - patient preference in heart valve replacement</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/rapid-recs-patient-preference-in-heart-valve-replacement/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/rapid-recs-patient-preference-in-heart-valve-replacement/#comments</comments>        <pubDate>Tue, 01 Nov 2016 17:30:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/rapid-recs-patient-preference-in-heart-valve-replacement</guid>
                                    <description><![CDATA[In patients with symptomatic severe aortic stenosis but at lower risk of perioperative death, how do minimally invasive techniques compare with open surgery? Prompted by a recent trial, an expert panel produced these recommendations based on three linked rapid systematic reviews.

In this podcast we talk to Michael Shapiro who was a patient representative on that panel about what matters to patients, and how he found taking part in creating the recommendation.

Read the recommendation in full:
<p>http://www.bmj.com/content/354/bmj.i5085</p>
]]></description>
                                                            <content:encoded><![CDATA[In patients with symptomatic severe aortic stenosis but at lower risk of perioperative death, how do minimally invasive techniques compare with open surgery? Prompted by a recent trial, an expert panel produced these recommendations based on three linked rapid systematic reviews.

In this podcast we talk to Michael Shapiro who was a patient representative on that panel about what matters to patients, and how he found taking part in creating the recommendation.

Read the recommendation in full:
<p>http://www.bmj.com/content/354/bmj.i5085</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dx2hl9/stream_290990088-bmjgroup-rapid-recs-patient-preference-in-heart-valve-replacement.mp3" length="19529863" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In patients with symptomatic severe aortic stenosis but at lower risk of perioperative death, how do minimally invasive techniques compare with open surgery? Prompted by a recent trial, an expert panel produced these recommendations based on three linked rapid systematic reviews.

In this podcast we talk to Michael Shapiro who was a patient representative on that panel about what matters to patients, and how he found taking part in creating the recommendation.

Read the recommendation in full:
http://www.bmj.com/content/354/bmj.i5085]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>814</itunes:duration>
                                    </item>
    <item>
        <title>Catherine Calderwood’s realistic medicine</title>
        <itunes:title>Catherine Calderwood’s realistic medicine</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/catherine-calderwood-s-realistic-medicine/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/catherine-calderwood-s-realistic-medicine/#comments</comments>        <pubDate>Fri, 28 Oct 2016 15:53:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/catherine-calderwoods-realistic-medicine</guid>
                                    <description><![CDATA[Catherine Calderwood has been chief medical officer for Scotland since March 2015 - her first CMO report, which she titled “Realistic Medicine” has created a stir beyond the borders of Scotland. The BMJ, sat down with Catherine at a the Preventing Overdiagnosis conference to find out what she intended with that report.

Read more:
<p>http://www.bmj.com/content/355/bmj.i5455</p>
]]></description>
                                                            <content:encoded><![CDATA[Catherine Calderwood has been chief medical officer for Scotland since March 2015 - her first CMO report, which she titled “Realistic Medicine” has created a stir beyond the borders of Scotland. The BMJ, sat down with Catherine at a the Preventing Overdiagnosis conference to find out what she intended with that report.

Read more:
<p>http://www.bmj.com/content/355/bmj.i5455</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/erwchw/stream_290405079-bmjgroup-catherine-calderwoods-realistic-medicine.mp3" length="28586803" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Catherine Calderwood has been chief medical officer for Scotland since March 2015 - her first CMO report, which she titled “Realistic Medicine” has created a stir beyond the borders of Scotland. The BMJ, sat down with Catherine at a the Preventing Overdiagnosis conference to find out what she intended with that report.

Read more:
http://www.bmj.com/content/355/bmj.i5455]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1192</itunes:duration>
                                    </item>
    <item>
        <title>Middle East respiratory syndrome</title>
        <itunes:title>Middle East respiratory syndrome</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/middle-east-respiratory-syndrome/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/middle-east-respiratory-syndrome/#comments</comments>        <pubDate>Fri, 21 Oct 2016 15:25:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/middle-east-respiratory-syndrome</guid>
                                    <description><![CDATA[Middle East respiratory syndrome (MERS) is an acute viral respiratory tract infection caused by the novel betacoronavirus. 

Cases have been limited to the Arabian Peninsula and its surrounding countries, and to travellers from the Middle East or their contacts. 

The clinical spectrum of infection varies from no symptoms or mild respiratory symptoms to severe, rapidly progressive pneumonia, acute respiratory distress syndrome, septic shock, or multiorgan failure resulting in death.

In this podcast Sarah Shalhoub, infectious diseases consultant at King Fahad Armed Forces Hospital, in Saudi Arabia joins us to discuss the history of the disease, clinical presentation, and what can be done to support those infected.

Read the full clinical update:
<p>http://www.bmj.com/content/355/bmj.i5281</p>
]]></description>
                                                            <content:encoded><![CDATA[Middle East respiratory syndrome (MERS) is an acute viral respiratory tract infection caused by the novel betacoronavirus. 

Cases have been limited to the Arabian Peninsula and its surrounding countries, and to travellers from the Middle East or their contacts. 

The clinical spectrum of infection varies from no symptoms or mild respiratory symptoms to severe, rapidly progressive pneumonia, acute respiratory distress syndrome, septic shock, or multiorgan failure resulting in death.

In this podcast Sarah Shalhoub, infectious diseases consultant at King Fahad Armed Forces Hospital, in Saudi Arabia joins us to discuss the history of the disease, clinical presentation, and what can be done to support those infected.

Read the full clinical update:
<p>http://www.bmj.com/content/355/bmj.i5281</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/25u7tl/stream_289325473-bmjgroup-middle-east-respiratory-syndrome.mp3" length="29058457" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Middle East respiratory syndrome (MERS) is an acute viral respiratory tract infection caused by the novel betacoronavirus. 

Cases have been limited to the Arabian Peninsula and its surrounding countries, and to travellers from the Middle East or their contacts. 

The clinical spectrum of infection varies from no symptoms or mild respiratory symptoms to severe, rapidly progressive pneumonia, acute respiratory distress syndrome, septic shock, or multiorgan failure resulting in death.

In this podcast Sarah Shalhoub, infectious diseases consultant at King Fahad Armed Forces Hospital, in Saudi Arabia joins us to discuss the history of the disease, clinical presentation, and what can be done to support those infected.

Read the full clinical update:
http://www.bmj.com/content/355/bmj.i5281]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1212</itunes:duration>
                                    </item>
    <item>
        <title>Beyond data sharing - ”It was me who got my research team out of jail... that’s my data”</title>
        <itunes:title>Beyond data sharing - ”It was me who got my research team out of jail... that’s my data”</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/beyond-data-sharing-it-was-me-who-got-my-research-team-out-of-jail-that-s-my-data/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/beyond-data-sharing-it-was-me-who-got-my-research-team-out-of-jail-that-s-my-data/#comments</comments>        <pubDate>Tue, 11 Oct 2016 14:58:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/beyond-data-sharing</guid>
                                    <description><![CDATA[Elizabeth Pisani, visiting senior research fellow at King's College London, collects data on sex workers and injecting drug users in low and middle income countries. 

For years she has been sharing her data, and joins us to explain why she went from being protective of her research to to making it freely available - and talk about some of the practicalities of keeping participants anonymous.

Read the full analysis:
<p>http://www.bmj.com/content/355/bmj.i5295</p>
]]></description>
                                                            <content:encoded><![CDATA[Elizabeth Pisani, visiting senior research fellow at King's College London, collects data on sex workers and injecting drug users in low and middle income countries. 

For years she has been sharing her data, and joins us to explain why she went from being protective of her research to to making it freely available - and talk about some of the practicalities of keeping participants anonymous.

Read the full analysis:
<p>http://www.bmj.com/content/355/bmj.i5295</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ir8w5d/stream_287157572-bmjgroup-beyond-data-sharing.mp3" length="32332627" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Elizabeth Pisani, visiting senior research fellow at King's College London, collects data on sex workers and injecting drug users in low and middle income countries. 

For years she has been sharing her data, and joins us to explain why she went from being protective of her research to to making it freely available - and talk about some of the practicalities of keeping participants anonymous.

Read the full analysis:
http://www.bmj.com/content/355/bmj.i5295]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1348</itunes:duration>
                                    </item>
    <item>
        <title>Head to head - Should all GPs be NHS employees?</title>
        <itunes:title>Head to head - Should all GPs be NHS employees?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/head-to-head-should-all-gps-be-nhs-employees/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/head-to-head-should-all-gps-be-nhs-employees/#comments</comments>        <pubDate>Fri, 07 Oct 2016 15:44:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/head-to-head-should-all-gps-be-nhs-employees</guid>
                                    <description><![CDATA[Independent contractor status creates unnecessary stress, argues Azeem Majeed, GP partner and professor of primary care at Imperial College London.

Laurence Buckman, GP partner and former head of the BMA GP committee, values his autonomy and distance from a non-benign employer.

Read the full head to head:
http://www.bmj.com/content/355/bmj.i5064

We also hear from former columnist and current partner in a federated practice, Des Spence, who thinks that the days of small GP surgeries are numbered.

Independent or employed? There is a third way. . .
<p>http://www.bmj.com/content/355/bmj.i5329</p>
]]></description>
                                                            <content:encoded><![CDATA[Independent contractor status creates unnecessary stress, argues Azeem Majeed, GP partner and professor of primary care at Imperial College London.

Laurence Buckman, GP partner and former head of the BMA GP committee, values his autonomy and distance from a non-benign employer.

Read the full head to head:
http://www.bmj.com/content/355/bmj.i5064

We also hear from former columnist and current partner in a federated practice, Des Spence, who thinks that the days of small GP surgeries are numbered.

Independent or employed? There is a third way. . .
<p>http://www.bmj.com/content/355/bmj.i5329</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/yrkht3/stream_286590794-bmjgroup-head-to-head-should-all-gps-be-nhs-employees.mp3" length="24242305" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Independent contractor status creates unnecessary stress, argues Azeem Majeed, GP partner and professor of primary care at Imperial College London.

Laurence Buckman, GP partner and former head of the BMA GP committee, values his autonomy and distance from a non-benign employer.

Read the full head to head:
http://www.bmj.com/content/355/bmj.i5064

We also hear from former columnist and current partner in a federated practice, Des Spence, who thinks that the days of small GP surgeries are numbered.

Independent or employed? There is a third way. . .
http://www.bmj.com/content/355/bmj.i5329]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1010</itunes:duration>
                                    </item>
    <item>
        <title>Preventing Overdiagnosis In Barcelona</title>
        <itunes:title>Preventing Overdiagnosis In Barcelona</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/preventing-overdiagnosis-in-barcelona/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/preventing-overdiagnosis-in-barcelona/#comments</comments>        <pubDate>Thu, 06 Oct 2016 13:37:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/preventing-overdiagnosis-in-barcelona</guid>
                                    <description><![CDATA[The Preventing Overdiagnosis conference is part of The BMJ's campaign against Too Much Medicine.

Helen Macdonald clinical editor for The BMJ was at the conference, and talked to some of the key speakers there about what they believe the key issues are, and what's being done to roll back the harms of too much medicine.

http://www.bmj.com/too-much-medicine
<p>http://www.preventingoverdiagnosis.net/</p>
]]></description>
                                                            <content:encoded><![CDATA[The Preventing Overdiagnosis conference is part of The BMJ's campaign against Too Much Medicine.

Helen Macdonald clinical editor for The BMJ was at the conference, and talked to some of the key speakers there about what they believe the key issues are, and what's being done to roll back the harms of too much medicine.

http://www.bmj.com/too-much-medicine
<p>http://www.preventingoverdiagnosis.net/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8y8ln8/stream_286313577-bmjgroup-preventing-overdiagnosis-in-barcelona.mp3" length="71752061" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The Preventing Overdiagnosis conference is part of The BMJ's campaign against Too Much Medicine.

Helen Macdonald clinical editor for The BMJ was at the conference, and talked to some of the key speakers there about what they believe the key issues are, and what's being done to roll back the harms of too much medicine.

http://www.bmj.com/too-much-medicine
http://www.preventingoverdiagnosis.net/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2992</itunes:duration>
                                    </item>
    <item>
        <title>Living kidney donation</title>
        <itunes:title>Living kidney donation</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/living-kidney-donation/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/living-kidney-donation/#comments</comments>        <pubDate>Fri, 23 Sep 2016 15:54:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/living-kidney-donation</guid>
                                    <description><![CDATA[Globally each year more than 30 000 people become living kidney donors. Living kidney donation is constantly evolving, with new ways of pooling donors and recipients to maximise opportunity. With increased numbers, there is increasing information regarding the long term outcomes associated with donation. 

Pippa Bailey, clinical lecturer in renal medicine at the University of Bristol, and Aisling Courtney, consultant nephrologist at Belfast City Hospital join us to explain who can donate, to whom, and the possible impact of donation on the donor’s health.

Read the full update:
<p>http://www.bmj.com/content/354/bmj.i4746</p>
]]></description>
                                                            <content:encoded><![CDATA[Globally each year more than 30 000 people become living kidney donors. Living kidney donation is constantly evolving, with new ways of pooling donors and recipients to maximise opportunity. With increased numbers, there is increasing information regarding the long term outcomes associated with donation. 

Pippa Bailey, clinical lecturer in renal medicine at the University of Bristol, and Aisling Courtney, consultant nephrologist at Belfast City Hospital join us to explain who can donate, to whom, and the possible impact of donation on the donor’s health.

Read the full update:
<p>http://www.bmj.com/content/354/bmj.i4746</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/k1s6l8/stream_284301991-bmjgroup-living-kidney-donation.mp3" length="28044115" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Globally each year more than 30 000 people become living kidney donors. Living kidney donation is constantly evolving, with new ways of pooling donors and recipients to maximise opportunity. With increased numbers, there is increasing information regarding the long term outcomes associated with donation. 

Pippa Bailey, clinical lecturer in renal medicine at the University of Bristol, and Aisling Courtney, consultant nephrologist at Belfast City Hospital join us to explain who can donate, to whom, and the possible impact of donation on the donor’s health.

Read the full update:
http://www.bmj.com/content/354/bmj.i4746]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1169</itunes:duration>
                                    </item>
    <item>
        <title>The ethics of placebo</title>
        <itunes:title>The ethics of placebo</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-ethics-of-placebo/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-ethics-of-placebo/#comments</comments>        <pubDate>Fri, 16 Sep 2016 09:02:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-ethics-of-placebo-controlled-trials-mixdown</guid>
                                    <description><![CDATA[In a clinical trial, we usually think of risk in terms of the new active compound - will it have unwanted effects. However, two analyses in The BMJ are concerned about the risk associated with the control arm.

Robin Emsley is a professor of psychiatry at Stellenbosch University in South Africa, he and colleagues have written about the risk associated with forgoing treatment in patients with schizophrenia.
Read the full analysis: http://www.bmj.com/content/354/bmj.i4728


Jonathan Mendel, lecturer in human geography at the University of Dundee, and Ben Goldacre, senior clinical research fellow at the University of Oxford, have examined the ethical approval given to trials, and are concerned that identified risks are not adequately communicated to patients.
<p>Read the full analysis: http://www.bmj.com/content/354/bmj.i4626</p>
]]></description>
                                                            <content:encoded><![CDATA[In a clinical trial, we usually think of risk in terms of the new active compound - will it have unwanted effects. However, two analyses in The BMJ are concerned about the risk associated with the control arm.

Robin Emsley is a professor of psychiatry at Stellenbosch University in South Africa, he and colleagues have written about the risk associated with forgoing treatment in patients with schizophrenia.
Read the full analysis: http://www.bmj.com/content/354/bmj.i4728


Jonathan Mendel, lecturer in human geography at the University of Dundee, and Ben Goldacre, senior clinical research fellow at the University of Oxford, have examined the ethical approval given to trials, and are concerned that identified risks are not adequately communicated to patients.
<p>Read the full analysis: http://www.bmj.com/content/354/bmj.i4626</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/pxkysq/stream_283163000-bmjgroup-the-ethics-of-placebo-controlled-trials-mixdown.mp3" length="27888999" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In a clinical trial, we usually think of risk in terms of the new active compound - will it have unwanted effects. However, two analyses in The BMJ are concerned about the risk associated with the control arm.

Robin Emsley is a professor of psychiatry at Stellenbosch University in South Africa, he and colleagues have written about the risk associated with forgoing treatment in patients with schizophrenia.
Read the full analysis: http://www.bmj.com/content/354/bmj.i4728


Jonathan Mendel, lecturer in human geography at the University of Dundee, and Ben Goldacre, senior clinical research fellow at the University of Oxford, have examined the ethical approval given to trials, and are concerned that identified risks are not adequately communicated to patients.
Read the full analysis: http://www.bmj.com/content/354/bmj.i4626]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1162</itunes:duration>
                                    </item>
    <item>
        <title>Ghostwriting redefined</title>
        <itunes:title>Ghostwriting redefined</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/ghostwriting-redefined/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/ghostwriting-redefined/#comments</comments>        <pubDate>Fri, 09 Sep 2016 13:09:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/ghostwriting-redefined</guid>
                                    <description><![CDATA[Alastair Matheson, independant consultant and former ghostwriter, describes how the pharmaceutical publications industry seeks to legitimise ghostwriting by changing its definition while deflecting attention from wider marketing practices in academic publishing.

Read his full analysis:
<p>http://www.bmj.com/content/354/bmj.i4578</p>
]]></description>
                                                            <content:encoded><![CDATA[Alastair Matheson, independant consultant and former ghostwriter, describes how the pharmaceutical publications industry seeks to legitimise ghostwriting by changing its definition while deflecting attention from wider marketing practices in academic publishing.

Read his full analysis:
<p>http://www.bmj.com/content/354/bmj.i4578</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rk3of3/stream_282108064-bmjgroup-ghostwriting-redefined.mp3" length="16871492" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Alastair Matheson, independant consultant and former ghostwriter, describes how the pharmaceutical publications industry seeks to legitimise ghostwriting by changing its definition while deflecting attention from wider marketing practices in academic publishing.

Read his full analysis:
http://www.bmj.com/content/354/bmj.i4578]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>703</itunes:duration>
                                    </item>
    <item>
        <title>Reprehensible, but the people carrying out atrocities have very low rates of mental disorders</title>
        <itunes:title>Reprehensible, but the people carrying out atrocities have very low rates of mental disorders</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/reprehensible-but-the-people-carrying-out-atrocities-have-very-low-rates-of-mental-disorders/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/reprehensible-but-the-people-carrying-out-atrocities-have-very-low-rates-of-mental-disorders/#comments</comments>        <pubDate>Thu, 08 Sep 2016 14:46:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/terrorism-and-mental-health</guid>
                                    <description><![CDATA[Oversimplification and lack of evidence stigmatise people with mental illness and impede prevention efforts, says Simon Wessley, professor of psychiatry at King's College London, in an editorial published on thebmj.com.

Read the full editorial:
http://www.bmj.com/content/354/bmj.i4869
<p></p>
<p></p>
]]></description>
                                                            <content:encoded><![CDATA[Oversimplification and lack of evidence stigmatise people with mental illness and impede prevention efforts, says Simon Wessley, professor of psychiatry at King's College London, in an editorial published on thebmj.com.

Read the full editorial:
http://www.bmj.com/content/354/bmj.i4869
<p></p>
<p></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/96a9i9/stream_281961603-bmjgroup-terrorism-and-mental-health.mp3" length="16446647" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Oversimplification and lack of evidence stigmatise people with mental illness and impede prevention efforts, says Simon Wessley, professor of psychiatry at King's College London, in an editorial published on thebmj.com.

Read the full editorial:
http://www.bmj.com/content/354/bmj.i4869

]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>686</itunes:duration>
                                    </item>
    <item>
        <title>Late effects of anticancer chemotherapy: It’s hard to trust your body, after it’s betrayed you</title>
        <itunes:title>Late effects of anticancer chemotherapy: It’s hard to trust your body, after it’s betrayed you</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/late-effects-of-anticancer-chemotherapy-it-s-hard-to-trust-your-body-after-it-s-betrayed-you/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/late-effects-of-anticancer-chemotherapy-it-s-hard-to-trust-your-body-after-it-s-betrayed-you/#comments</comments>        <pubDate>Thu, 08 Sep 2016 13:30:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/late-effects-of-anticancer-chemotherapy-its-hard-to-trust-your-body-after-its-betrayed-you</guid>
                                    <description><![CDATA[Lily was diagnosed at 14 years old with stage four Hodgkin's lymphoma and received six rounds of chemotherapy and two weeks of radiotherapy. She survived but now lives with the long term effects of that therapy - and joins us to discuss how it has impacted her quality of life.
 
We're also joined by Saif Ahmad and Thankamma Ajithkumar, oncologists from Cambridge University Hospitals NHS Foundation Trust, who give advice for generalists on late effects of anticancer chemotherapy that may affect quality of life. 

Read the full clinical review:
http://www.bmj.com/content/354/bmj.i4567
<p></p>
<p></p>
]]></description>
                                                            <content:encoded><![CDATA[Lily was diagnosed at 14 years old with stage four Hodgkin's lymphoma and received six rounds of chemotherapy and two weeks of radiotherapy. She survived but now lives with the long term effects of that therapy - and joins us to discuss how it has impacted her quality of life.
 
We're also joined by Saif Ahmad and Thankamma Ajithkumar, oncologists from Cambridge University Hospitals NHS Foundation Trust, who give advice for generalists on late effects of anticancer chemotherapy that may affect quality of life. 

Read the full clinical review:
http://www.bmj.com/content/354/bmj.i4567
<p></p>
<p></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vbrnau/stream_281951995-bmjgroup-late-effects-of-anticancer-chemotherapy-its-hard-to-trust-your-body-after-its-betrayed-you.mp3" length="35081953" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Lily was diagnosed at 14 years old with stage four Hodgkin's lymphoma and received six rounds of chemotherapy and two weeks of radiotherapy. She survived but now lives with the long term effects of that therapy - and joins us to discuss how it has impacted her quality of life.
 
We're also joined by Saif Ahmad and Thankamma Ajithkumar, oncologists from Cambridge University Hospitals NHS Foundation Trust, who give advice for generalists on late effects of anticancer chemotherapy that may affect quality of life. 

Read the full clinical review:
http://www.bmj.com/content/354/bmj.i4567

]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1462</itunes:duration>
                                    </item>
    <item>
        <title>”It suggests that older people have a lower value in society” - Ageism in global development</title>
        <itunes:title>”It suggests that older people have a lower value in society” - Ageism in global development</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/it-suggests-that-older-people-have-a-lower-value-in-society-ageism-in-global-development/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/it-suggests-that-older-people-have-a-lower-value-in-society-ageism-in-global-development/#comments</comments>        <pubDate>Fri, 02 Sep 2016 16:20:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/ageism-in-global-development</guid>
                                    <description><![CDATA[The United Nation's Millennium Development Goals, and the subsequent Sustainable Development Goals, define premature mortality as being a death under the age of 70. 

As demographic change means more people are living longer than this,  Peter Lloyd-Sherlock, professor of social policy and international development at the University of East Anglia, argues that this will lead to discrimination against older people.

Read the full analysis:
<p>http://www.bmj.com/content/354/bmj.i4514</p>
]]></description>
                                                            <content:encoded><![CDATA[The United Nation's Millennium Development Goals, and the subsequent Sustainable Development Goals, define premature mortality as being a death under the age of 70. 

As demographic change means more people are living longer than this,  Peter Lloyd-Sherlock, professor of social policy and international development at the University of East Anglia, argues that this will lead to discrimination against older people.

Read the full analysis:
<p>http://www.bmj.com/content/354/bmj.i4514</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gdogw2/stream_281081138-bmjgroup-ageism-in-global-development.mp3" length="17145220" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The United Nation's Millennium Development Goals, and the subsequent Sustainable Development Goals, define premature mortality as being a death under the age of 70. 

As demographic change means more people are living longer than this,  Peter Lloyd-Sherlock, professor of social policy and international development at the University of East Anglia, argues that this will lead to discrimination against older people.

Read the full analysis:
http://www.bmj.com/content/354/bmj.i4514]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>715</itunes:duration>
                                    </item>
    <item>
        <title>Not just our ethical credibility as a profession, but our shared humanity</title>
        <itunes:title>Not just our ethical credibility as a profession, but our shared humanity</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/not-just-our-ethical-credibility-as-a-profession-but-our-shared-humanity/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/not-just-our-ethical-credibility-as-a-profession-but-our-shared-humanity/#comments</comments>        <pubDate>Tue, 30 Aug 2016 10:30:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/berger-detention-camps</guid>
                                    <description><![CDATA["I say to all Australian doctors - young, old, the political and the apolitical - that on this depends not just our ethical credibility as a profession, but our shared humanity. "

Following the leaked emails published in The Guardian newspaper, alleging abuse of asylum seekers detained by the Australian government on the Pacific island of Nauru, David Berger joins us again to say it is time that doctors take a stand and march to protest against this treatment.

Read his full editorial:
http://www.bmj.com/content/354/bmj.i4606

Listen to the head to head debating if doctors should boycott working at the detention centres: 
<p>https://soundcloud.com/bmjpodcasts/should-doctors-boycott-working-in-australias-immigration-detention-centres</p>
]]></description>
                                                            <content:encoded><![CDATA["I say to all Australian doctors - young, old, the political and the apolitical - that on this depends not just our ethical credibility as a profession, but our shared humanity. "

Following the leaked emails published in The Guardian newspaper, alleging abuse of asylum seekers detained by the Australian government on the Pacific island of Nauru, David Berger joins us again to say it is time that doctors take a stand and march to protest against this treatment.

Read his full editorial:
http://www.bmj.com/content/354/bmj.i4606

Listen to the head to head debating if doctors should boycott working at the detention centres: 
<p>https://soundcloud.com/bmjpodcasts/should-doctors-boycott-working-in-australias-immigration-detention-centres</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mhpfly/stream_280563327-bmjgroup-berger-detention-camps.mp3" length="19221878" type="audio/mpeg"/>
        <itunes:summary><![CDATA["I say to all Australian doctors - young, old, the political and the apolitical - that on this depends not just our ethical credibility as a profession, but our shared humanity. "

Following the leaked emails published in The Guardian newspaper, alleging abuse of asylum seekers detained by the Australian government on the Pacific island of Nauru, David Berger joins us again to say it is time that doctors take a stand and march to protest against this treatment.

Read his full editorial:
http://www.bmj.com/content/354/bmj.i4606

Listen to the head to head debating if doctors should boycott working at the detention centres: 
https://soundcloud.com/bmjpodcasts/should-doctors-boycott-working-in-australias-immigration-detention-centres]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>801</itunes:duration>
                                    </item>
    <item>
        <title>Education round up - ICE, examinations, and adherence</title>
        <itunes:title>Education round up - ICE, examinations, and adherence</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/education-round-up-ice-examinations-and-adherence/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/education-round-up-ice-examinations-and-adherence/#comments</comments>        <pubDate>Thu, 25 Aug 2016 16:53:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/education-round-up-aug-2016</guid>
                                    <description><![CDATA[The BMJ publishes a variety of education articles, to help doctors improve their practice. Often authors join us in our podcast to give tips on putting their recommendations into practice.
 
In this new monthly audio round-up The BMJ’s clinical editors discuss what they have learned, and how they may alter their practice.
 
In our first audio edition, GPs Sophie Cook and Helen Macdonald, psychiatry trainee Kate Adlington, and HIV and sexual health trainee Deborah Kirkham talk about communication skills –  ICE - obtaining a patient’s ideas, concerns and expectations about their health.
http://www.bmj.com/content/354/bmj.i3729
 
They also examine the lack of evidence for cardiovascular examination.
http://www.bmj.com/content/354/bmj.i3309
 
And finally, they talk about how 50% of patients with treatment resistant hypertension may actually be treatment non-adherent, and what that could mean for other conditions.
<p>http://www.bmj.com/content/354/bmj.i3268</p>
]]></description>
                                                            <content:encoded><![CDATA[The BMJ publishes a variety of education articles, to help doctors improve their practice. Often authors join us in our podcast to give tips on putting their recommendations into practice.
 
In this new monthly audio round-up The BMJ’s clinical editors discuss what they have learned, and how they may alter their practice.
 
In our first audio edition, GPs Sophie Cook and Helen Macdonald, psychiatry trainee Kate Adlington, and HIV and sexual health trainee Deborah Kirkham talk about communication skills –  ICE - obtaining a patient’s ideas, concerns and expectations about their health.
http://www.bmj.com/content/354/bmj.i3729
 
They also examine the lack of evidence for cardiovascular examination.
http://www.bmj.com/content/354/bmj.i3309
 
And finally, they talk about how 50% of patients with treatment resistant hypertension may actually be treatment non-adherent, and what that could mean for other conditions.
<p>http://www.bmj.com/content/354/bmj.i3268</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/0xg41l/stream_279858282-bmjgroup-education-round-up-aug-2016.mp3" length="29851452" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The BMJ publishes a variety of education articles, to help doctors improve their practice. Often authors join us in our podcast to give tips on putting their recommendations into practice.
 
In this new monthly audio round-up The BMJ’s clinical editors discuss what they have learned, and how they may alter their practice.
 
In our first audio edition, GPs Sophie Cook and Helen Macdonald, psychiatry trainee Kate Adlington, and HIV and sexual health trainee Deborah Kirkham talk about communication skills –  ICE - obtaining a patient’s ideas, concerns and expectations about their health.
http://www.bmj.com/content/354/bmj.i3729
 
They also examine the lack of evidence for cardiovascular examination.
http://www.bmj.com/content/354/bmj.i3309
 
And finally, they talk about how 50% of patients with treatment resistant hypertension may actually be treatment non-adherent, and what that could mean for other conditions.
http://www.bmj.com/content/354/bmj.i3268]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1244</itunes:duration>
                                    </item>
    <item>
        <title>A maladaptive pathway to drug approval</title>
        <itunes:title>A maladaptive pathway to drug approval</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/a-maladaptive-pathway-to-drug-approval/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/a-maladaptive-pathway-to-drug-approval/#comments</comments>        <pubDate>Fri, 19 Aug 2016 14:04:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/a-maladaptive-pathway-to-drug-approval</guid>
                                    <description><![CDATA[The European Medicines Agency (EMA) has embraced a new model of drug testing and marketing called “adaptive pathways”, allowing new drugs for “unmet medical needs” to be launched on the market faster, on the basis of fewer data.

While industry claims this is necessary, an analysis on thebmj.com looks at the assumptions underlying the new pathway, and raises concerns about the negative impact on patient safety and the cost of healthcare.

To discuss, we're joined by  Courtney Davis, senior lecturer at King’s College London, Peter Gøtzsche, director of the Nordic Cochrane Centre and Joel Lexchin, a professor at York University in Toronto.

Read the full analysis:
<p>http://www.bmj.com/content/354/bmj.i4437</p>
]]></description>
                                                            <content:encoded><![CDATA[The European Medicines Agency (EMA) has embraced a new model of drug testing and marketing called “adaptive pathways”, allowing new drugs for “unmet medical needs” to be launched on the market faster, on the basis of fewer data.

While industry claims this is necessary, an analysis on thebmj.com looks at the assumptions underlying the new pathway, and raises concerns about the negative impact on patient safety and the cost of healthcare.

To discuss, we're joined by  Courtney Davis, senior lecturer at King’s College London, Peter Gøtzsche, director of the Nordic Cochrane Centre and Joel Lexchin, a professor at York University in Toronto.

Read the full analysis:
<p>http://www.bmj.com/content/354/bmj.i4437</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jyqog3/stream_278961505-bmjgroup-a-maladaptive-pathway-to-drug-approval.mp3" length="24451107" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The European Medicines Agency (EMA) has embraced a new model of drug testing and marketing called “adaptive pathways”, allowing new drugs for “unmet medical needs” to be launched on the market faster, on the basis of fewer data.

While industry claims this is necessary, an analysis on thebmj.com looks at the assumptions underlying the new pathway, and raises concerns about the negative impact on patient safety and the cost of healthcare.

To discuss, we're joined by  Courtney Davis, senior lecturer at King’s College London, Peter Gøtzsche, director of the Nordic Cochrane Centre and Joel Lexchin, a professor at York University in Toronto.

Read the full analysis:
http://www.bmj.com/content/354/bmj.i4437]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1019</itunes:duration>
                                    </item>
    <item>
        <title>Evidence for examination</title>
        <itunes:title>Evidence for examination</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/evidence-for-examination/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/evidence-for-examination/#comments</comments>        <pubDate>Tue, 16 Aug 2016 15:24:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/evidence-for-examination</guid>
                                    <description><![CDATA[You may have spent hours practicing for your examination exams, but how evidence based are the techniques taught?

Andrew Elder, a professor at the University of Edinburgh, and author of the clinical review “How valuable is physical examination of the cardiovascular system?” joins us to discuss.

Read the full review:
http://www.bmj.com/content/354/bmj.i3309

Andrew also discussed likelihood ratios; which are useful in understanding the relative use of tests in different clinical scenarios: https://soundcloud.com/bmjpodcasts/likelyhood-ratios-in-diagnostic-tests

<p></p>
<p></p>
]]></description>
                                                            <content:encoded><![CDATA[You may have spent hours practicing for your examination exams, but how evidence based are the techniques taught?

Andrew Elder, a professor at the University of Edinburgh, and author of the clinical review “How valuable is physical examination of the cardiovascular system?” joins us to discuss.

Read the full review:
http://www.bmj.com/content/354/bmj.i3309

Andrew also discussed likelihood ratios; which are useful in understanding the relative use of tests in different clinical scenarios: https://soundcloud.com/bmjpodcasts/likelyhood-ratios-in-diagnostic-tests

<p></p>
<p></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rdvv6w/stream_278510894-bmjgroup-evidence-for-examination.mp3" length="22709888" type="audio/mpeg"/>
        <itunes:summary><![CDATA[You may have spent hours practicing for your examination exams, but how evidence based are the techniques taught?

Andrew Elder, a professor at the University of Edinburgh, and author of the clinical review “How valuable is physical examination of the cardiovascular system?” joins us to discuss.

Read the full review:
http://www.bmj.com/content/354/bmj.i3309

Andrew also discussed likelihood ratios; which are useful in understanding the relative use of tests in different clinical scenarios: https://soundcloud.com/bmjpodcasts/likelyhood-ratios-in-diagnostic-tests


]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>947</itunes:duration>
                                    </item>
    <item>
        <title>Likelihood ratios in diagnostic tests</title>
        <itunes:title>Likelihood ratios in diagnostic tests</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/likelihood-ratios-in-diagnostic-tests/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/likelihood-ratios-in-diagnostic-tests/#comments</comments>        <pubDate>Tue, 16 Aug 2016 15:24:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/likelyhood-ratios-in-diagnostic-tests</guid>
                                    <description><![CDATA[Andrew Elder, a professor at the University of Edinburgh talks about likelihood ratios in diagnostic testing, and how they’re helpful in thinking about how context changes the predictive value of a test.

This is part of a wider discussion on the evidence behind clinical examination of the cardiovascular system https://soundcloud.com/bmjpodcasts/evidence-for-examination 

Read the full clinical review:
<p>http://www.bmj.com/content/354/bmj.i3309</p>
]]></description>
                                                            <content:encoded><![CDATA[Andrew Elder, a professor at the University of Edinburgh talks about likelihood ratios in diagnostic testing, and how they’re helpful in thinking about how context changes the predictive value of a test.

This is part of a wider discussion on the evidence behind clinical examination of the cardiovascular system https://soundcloud.com/bmjpodcasts/evidence-for-examination 

Read the full clinical review:
<p>http://www.bmj.com/content/354/bmj.i3309</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/x74qjo/stream_278510893-bmjgroup-likelyhood-ratios-in-diagnostic-tests.mp3" length="10816121" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Andrew Elder, a professor at the University of Edinburgh talks about likelihood ratios in diagnostic testing, and how they’re helpful in thinking about how context changes the predictive value of a test.

This is part of a wider discussion on the evidence behind clinical examination of the cardiovascular system https://soundcloud.com/bmjpodcasts/evidence-for-examination 

Read the full clinical review:
http://www.bmj.com/content/354/bmj.i3309]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>450</itunes:duration>
                                    </item>
    <item>
        <title>Poor adherence to antihypertensives</title>
        <itunes:title>Poor adherence to antihypertensives</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/poor-adherence-to-antihypertensives/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/poor-adherence-to-antihypertensives/#comments</comments>        <pubDate>Tue, 16 Aug 2016 14:04:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/non-adherence-to-antihypertensives</guid>
                                    <description><![CDATA[It is estimated that 50% of patients who have what appears to be treatment resistant hypertension are actually not taking their drugs as prescribed.

Indranil Dasgupta, a consultant nephrologist at the Heart of England NHS Foundation Trust joins us to discuss what factors may influence non-adherence, and how to encourage patients to divulge that information.

Read the full article:
<p>http://www.bmj.com/content/354/bmj.i3268</p>
]]></description>
                                                            <content:encoded><![CDATA[It is estimated that 50% of patients who have what appears to be treatment resistant hypertension are actually not taking their drugs as prescribed.

Indranil Dasgupta, a consultant nephrologist at the Heart of England NHS Foundation Trust joins us to discuss what factors may influence non-adherence, and how to encourage patients to divulge that information.

Read the full article:
<p>http://www.bmj.com/content/354/bmj.i3268</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/frwp5t/stream_278501005-bmjgroup-non-adherence-to-antihypertensives.mp3" length="24474505" type="audio/mpeg"/>
        <itunes:summary><![CDATA[It is estimated that 50% of patients who have what appears to be treatment resistant hypertension are actually not taking their drugs as prescribed.

Indranil Dasgupta, a consultant nephrologist at the Heart of England NHS Foundation Trust joins us to discuss what factors may influence non-adherence, and how to encourage patients to divulge that information.

Read the full article:
http://www.bmj.com/content/354/bmj.i3268]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1019</itunes:duration>
                                    </item>
    <item>
        <title>Anticipatory care</title>
        <itunes:title>Anticipatory care</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/anticipatory-care/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/anticipatory-care/#comments</comments>        <pubDate>Fri, 05 Aug 2016 15:49:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/anticipatory-care</guid>
                                    <description><![CDATA[“How long have I got, doc” is a TV medical drama cliche  -  but like all cliches has it’s feet in real life - and it’s medicine’s attempt to answer these questions that the authors of an analysis article on TheBMJ.com are questioning.

Kirsty Boyd is a consultant in palliative care in NHS lothian, a trainer and a researcher with the University of Edinburgh. Scott Murray is a GP, and St Columba's Hospice Chair of Primary Palliative Care, also at the University of edinburgh. They argue that it’s time to rethink how we talk about prognosis, and what conversations to have as patients become more unwell.

Read the full analysis:
<p>http://www.bmj.com/content/354/bmj.i3802</p>
<p></p>
]]></description>
                                                            <content:encoded><![CDATA[“How long have I got, doc” is a TV medical drama cliche  -  but like all cliches has it’s feet in real life - and it’s medicine’s attempt to answer these questions that the authors of an analysis article on TheBMJ.com are questioning.

Kirsty Boyd is a consultant in palliative care in NHS lothian, a trainer and a researcher with the University of Edinburgh. Scott Murray is a GP, and St Columba's Hospice Chair of Primary Palliative Care, also at the University of edinburgh. They argue that it’s time to rethink how we talk about prognosis, and what conversations to have as patients become more unwell.

Read the full analysis:
<p>http://www.bmj.com/content/354/bmj.i3802</p>
<p></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6xrjxx/stream_276965898-bmjgroup-anticipatory-care.mp3" length="24357003" type="audio/mpeg"/>
        <itunes:summary><![CDATA[“How long have I got, doc” is a TV medical drama cliche  -  but like all cliches has it’s feet in real life - and it’s medicine’s attempt to answer these questions that the authors of an analysis article on TheBMJ.com are questioning.

Kirsty Boyd is a consultant in palliative care in NHS lothian, a trainer and a researcher with the University of Edinburgh. Scott Murray is a GP, and St Columba's Hospice Chair of Primary Palliative Care, also at the University of edinburgh. They argue that it’s time to rethink how we talk about prognosis, and what conversations to have as patients become more unwell.

Read the full analysis:
http://www.bmj.com/content/354/bmj.i3802
]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1015</itunes:duration>
                                    </item>
    <item>
        <title>Ivan Oransky watching retractions</title>
        <itunes:title>Ivan Oransky watching retractions</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/ivan-oransky-watching-retractions/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/ivan-oransky-watching-retractions/#comments</comments>        <pubDate>Fri, 29 Jul 2016 15:21:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/30-minutes-with-ivan-oransky</guid>
                                    <description><![CDATA[<p>Ivan Oransky, co-founder of Retraction Watch and global editorial director at MedPage Today, discusses which areas of science are most affected by research fraud, and what motivates individuals to risk their careers by fabricating data.</p>
<p></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Ivan Oransky, co-founder of Retraction Watch and global editorial director at MedPage Today, discusses which areas of science are most affected by research fraud, and what motivates individuals to risk their careers by fabricating data.</p>
<p></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ceikdc/stream_275926676-bmjgroup-30-minutes-with-ivan-oransky.mp3" length="47555163" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Ivan Oransky, co-founder of Retraction Watch and global editorial director at MedPage Today, discusses which areas of science are most affected by research fraud, and what motivates individuals to risk their careers by fabricating data.
]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1984</itunes:duration>
                                    </item>
    <item>
        <title>How does maximizing shareholder value distort drug development?</title>
        <itunes:title>How does maximizing shareholder value distort drug development?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/how-does-maximizing-shareholder-value-distort-drug-development/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/how-does-maximizing-shareholder-value-distort-drug-development/#comments</comments>        <pubDate>Thu, 28 Jul 2016 09:01:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/have-drug-companies-become-investment-funds</guid>
                                    <description><![CDATA[With the emergence of sofobuvir, a new direct acting antiviral, treatment for Hepatitis C infection is currently undergoing it's greatest change since the discovery of the virus 25 years ago.

However Gilead, who manufacture the treatment, are under fire for the cost of the druge - around $90 000 for a course of treatment.

Victor Roy, doctoral researcher at the University of Cambridge, discusses how the new drug was discovered and came to market, and what happened to the profits from sale.

Read the full analysis:
<p>http://www.bmj.com/content/354/bmj.i3718</p>
]]></description>
                                                            <content:encoded><![CDATA[With the emergence of sofobuvir, a new direct acting antiviral, treatment for Hepatitis C infection is currently undergoing it's greatest change since the discovery of the virus 25 years ago.

However Gilead, who manufacture the treatment, are under fire for the cost of the druge - around $90 000 for a course of treatment.

Victor Roy, doctoral researcher at the University of Cambridge, discusses how the new drug was discovered and came to market, and what happened to the profits from sale.

Read the full analysis:
<p>http://www.bmj.com/content/354/bmj.i3718</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/cm9prs/stream_275736626-bmjgroup-have-drug-companies-become-investment-funds.mp3" length="25924584" type="audio/mpeg"/>
        <itunes:summary><![CDATA[With the emergence of sofobuvir, a new direct acting antiviral, treatment for Hepatitis C infection is currently undergoing it's greatest change since the discovery of the virus 25 years ago.

However Gilead, who manufacture the treatment, are under fire for the cost of the druge - around $90 000 for a course of treatment.

Victor Roy, doctoral researcher at the University of Cambridge, discusses how the new drug was discovered and came to market, and what happened to the profits from sale.

Read the full analysis:
http://www.bmj.com/content/354/bmj.i3718]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1081</itunes:duration>
                                    </item>
    <item>
        <title>What went wrong with care.data?</title>
        <itunes:title>What went wrong with care.data?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/what-went-wrong-with-caredata/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/what-went-wrong-with-caredata/#comments</comments>        <pubDate>Fri, 22 Jul 2016 16:20:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/what-went-wrong-with-caredata</guid>
                                    <description><![CDATA[Failures in implementation of data sharing projects have eroded public trust.

In the wake of NHS England’s decision to close down its care.data programme, Tjeerd-Pieter van Staa professor of health e-research at the University of Manchester, examines what lessons must be learnt, and what we can do better next time.

Read the full analysis:
<p>http://www.bmj.com/content/354/bmj.i3636</p>
]]></description>
                                                            <content:encoded><![CDATA[Failures in implementation of data sharing projects have eroded public trust.

In the wake of NHS England’s decision to close down its care.data programme, Tjeerd-Pieter van Staa professor of health e-research at the University of Manchester, examines what lessons must be learnt, and what we can do better next time.

Read the full analysis:
<p>http://www.bmj.com/content/354/bmj.i3636</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/v8xvop/stream_274881837-bmjgroup-what-went-wrong-with-caredata.mp3" length="18985155" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Failures in implementation of data sharing projects have eroded public trust.

In the wake of NHS England’s decision to close down its care.data programme, Tjeerd-Pieter van Staa professor of health e-research at the University of Manchester, examines what lessons must be learnt, and what we can do better next time.

Read the full analysis:
http://www.bmj.com/content/354/bmj.i3636]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>792</itunes:duration>
                                    </item>
    <item>
        <title>You’ve been ICE’d</title>
        <itunes:title>You’ve been ICE’d</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/you-ve-been-ice-d/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/you-ve-been-ice-d/#comments</comments>        <pubDate>Fri, 22 Jul 2016 11:24:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/youve-been-iced</guid>
                                    <description><![CDATA[We’re taught that patients' ideas, concerns, and expectations are central to a successful consultation, but has ICEing gone too far?

A “What your patient is thinking” article published this week talks about the pressure that asking questions in the wrong way can put on a patient.

Sophie Cook, education editor for The BMJ, is joined by the author of that article - The BMJ’s patient editor, Rosamund Snow, and by Roger Neighbour, former president of the royal college of general practice, and author of "The Inner Consultation".

<p>http://www.bmj.com/content/354/bmj.i3729</p>
<p></p>
]]></description>
                                                            <content:encoded><![CDATA[We’re taught that patients' ideas, concerns, and expectations are central to a successful consultation, but has ICEing gone too far?

A “What your patient is thinking” article published this week talks about the pressure that asking questions in the wrong way can put on a patient.

Sophie Cook, education editor for The BMJ, is joined by the author of that article - The BMJ’s patient editor, Rosamund Snow, and by Roger Neighbour, former president of the royal college of general practice, and author of "The Inner Consultation".

<p>http://www.bmj.com/content/354/bmj.i3729</p>
<p></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/00d8wb/stream_274846148-bmjgroup-youve-been-iced.mp3" length="31842032" type="audio/mpeg"/>
        <itunes:summary><![CDATA[We’re taught that patients' ideas, concerns, and expectations are central to a successful consultation, but has ICEing gone too far?

A “What your patient is thinking” article published this week talks about the pressure that asking questions in the wrong way can put on a patient.

Sophie Cook, education editor for The BMJ, is joined by the author of that article - The BMJ’s patient editor, Rosamund Snow, and by Roger Neighbour, former president of the royal college of general practice, and author of "The Inner Consultation".

http://www.bmj.com/content/354/bmj.i3729
]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1328</itunes:duration>
                                    </item>
    <item>
        <title>Should we scrap the internal market in England’s NHS</title>
        <itunes:title>Should we scrap the internal market in England’s NHS</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/should-we-scrap-the-internal-market-in-england-s-nhs/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/should-we-scrap-the-internal-market-in-england-s-nhs/#comments</comments>        <pubDate>Fri, 15 Jul 2016 13:45:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/should-we-scrap-the-internal-market-in-englands-nhs</guid>
                                    <description><![CDATA[The "internal market" was created after the 1987 UK general election focused attention on inadequate funding in the NHS, long waiting lists for elective surgery, and large unwarranted variations in clinical care.

Economists attributed these problems to a lack of incentives for efficiency, and the remedies offered included increasing competition in the NHS.

Twenty nine years later, this interesting experiment is not likely to have been worth it, says Alan Maynard, professor emeritus of health economics at the University of York. But Michael Dixon, a GP and commissioner in Devon, says that if properly funded and liberated from some of the administrative burdens of "red tape," the internal market could increase accountability.

Read their full debate:
<p>http://www.bmj.com/content/354/bmj.i3825</p>
]]></description>
                                                            <content:encoded><![CDATA[The "internal market" was created after the 1987 UK general election focused attention on inadequate funding in the NHS, long waiting lists for elective surgery, and large unwarranted variations in clinical care.

Economists attributed these problems to a lack of incentives for efficiency, and the remedies offered included increasing competition in the NHS.

Twenty nine years later, this interesting experiment is not likely to have been worth it, says Alan Maynard, professor emeritus of health economics at the University of York. But Michael Dixon, a GP and commissioner in Devon, says that if properly funded and liberated from some of the administrative burdens of "red tape," the internal market could increase accountability.

Read their full debate:
<p>http://www.bmj.com/content/354/bmj.i3825</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rzdrs3/stream_273811898-bmjgroup-should-we-scrap-the-internal-market-in-englands-nhs.mp3" length="27014800" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The "internal market" was created after the 1987 UK general election focused attention on inadequate funding in the NHS, long waiting lists for elective surgery, and large unwarranted variations in clinical care.

Economists attributed these problems to a lack of incentives for efficiency, and the remedies offered included increasing competition in the NHS.

Twenty nine years later, this interesting experiment is not likely to have been worth it, says Alan Maynard, professor emeritus of health economics at the University of York. But Michael Dixon, a GP and commissioner in Devon, says that if properly funded and liberated from some of the administrative burdens of "red tape," the internal market could increase accountability.

Read their full debate:
http://www.bmj.com/content/354/bmj.i3825]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1127</itunes:duration>
                                    </item>
    <item>
        <title>Treating hip osteoarthritis</title>
        <itunes:title>Treating hip osteoarthritis</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/treating-hip-osteoarthritis/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/treating-hip-osteoarthritis/#comments</comments>        <pubDate>Fri, 08 Jul 2016 16:26:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/treating-hip-osteoarthritis</guid>
                                    <description><![CDATA[2.46 million people in England have osteoarthritis of the hip, and many of those go on to eventually have a hip replacement - which is now widely considered one of the most commonly performed and successful operations in the world. 

Jessamy Bagenal, clinical fellow with The BMJ, talks to Nick Aresti, a specialist registrar in trauma and orthopaedic surgery and one of the authors of a clinical update on hip osteoarthritis, recently published on thebmj.com

In a linked podcast, Nick Nicholas, a patient who has hip OA gives us his perspective.

Read the full article:
http://www.bmj.com/content/354/bmj.i3405

Listen to the linked podcast:
<p>https://soundcloud.com/bmjpodcasts/having-hip-osteoarthritis</p>
]]></description>
                                                            <content:encoded><![CDATA[2.46 million people in England have osteoarthritis of the hip, and many of those go on to eventually have a hip replacement - which is now widely considered one of the most commonly performed and successful operations in the world. 

Jessamy Bagenal, clinical fellow with The BMJ, talks to Nick Aresti, a specialist registrar in trauma and orthopaedic surgery and one of the authors of a clinical update on hip osteoarthritis, recently published on thebmj.com

In a linked podcast, Nick Nicholas, a patient who has hip OA gives us his perspective.

Read the full article:
http://www.bmj.com/content/354/bmj.i3405

Listen to the linked podcast:
<p>https://soundcloud.com/bmjpodcasts/having-hip-osteoarthritis</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/b9viue/stream_272759134-bmjgroup-treating-hip-osteoarthritis.mp3" length="34047367" type="audio/mpeg"/>
        <itunes:summary><![CDATA[2.46 million people in England have osteoarthritis of the hip, and many of those go on to eventually have a hip replacement - which is now widely considered one of the most commonly performed and successful operations in the world. 

Jessamy Bagenal, clinical fellow with The BMJ, talks to Nick Aresti, a specialist registrar in trauma and orthopaedic surgery and one of the authors of a clinical update on hip osteoarthritis, recently published on thebmj.com

In a linked podcast, Nick Nicholas, a patient who has hip OA gives us his perspective.

Read the full article:
http://www.bmj.com/content/354/bmj.i3405

Listen to the linked podcast:
https://soundcloud.com/bmjpodcasts/having-hip-osteoarthritis]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1420</itunes:duration>
                                    </item>
    <item>
        <title>Having hip osteoarthritis</title>
        <itunes:title>Having hip osteoarthritis</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/having-hip-osteoarthritis/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/having-hip-osteoarthritis/#comments</comments>        <pubDate>Fri, 08 Jul 2016 16:25:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/having-hip-osteoarthritis</guid>
                                    <description><![CDATA[2.46 million people in England have osteoarthritis of the hip, and many of those go on to eventually have a hip replacement - which is now widely considered one of the most commonly performed and successful operations in the world. 

Jessamy Bagenal, clinical fellow with The BMJ, talks to Nick Nicholas, an obstetrician who has had OA and one of the authors of a clinical update on hip osteoarthritis, recently published on thebmj.com

In a linked podcast, Nick Aresti, a specialist registrar in trauma and orthopaedic surgery to talks about management of the condition.

Read the full article:
http://www.bmj.com/content/354/bmj.i3405

Listen to the linked podcast:
<p>https://soundcloud.com/bmjpodcasts/treating-hip-osteoarthritis</p>
]]></description>
                                                            <content:encoded><![CDATA[2.46 million people in England have osteoarthritis of the hip, and many of those go on to eventually have a hip replacement - which is now widely considered one of the most commonly performed and successful operations in the world. 

Jessamy Bagenal, clinical fellow with The BMJ, talks to Nick Nicholas, an obstetrician who has had OA and one of the authors of a clinical update on hip osteoarthritis, recently published on thebmj.com

In a linked podcast, Nick Aresti, a specialist registrar in trauma and orthopaedic surgery to talks about management of the condition.

Read the full article:
http://www.bmj.com/content/354/bmj.i3405

Listen to the linked podcast:
<p>https://soundcloud.com/bmjpodcasts/treating-hip-osteoarthritis</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/egu46z/stream_272759006-bmjgroup-having-hip-osteoarthritis.mp3" length="18278873" type="audio/mpeg"/>
        <itunes:summary><![CDATA[2.46 million people in England have osteoarthritis of the hip, and many of those go on to eventually have a hip replacement - which is now widely considered one of the most commonly performed and successful operations in the world. 

Jessamy Bagenal, clinical fellow with The BMJ, talks to Nick Nicholas, an obstetrician who has had OA and one of the authors of a clinical update on hip osteoarthritis, recently published on thebmj.com

In a linked podcast, Nick Aresti, a specialist registrar in trauma and orthopaedic surgery to talks about management of the condition.

Read the full article:
http://www.bmj.com/content/354/bmj.i3405

Listen to the linked podcast:
https://soundcloud.com/bmjpodcasts/treating-hip-osteoarthritis]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>762</itunes:duration>
                                    </item>
    <item>
        <title>PreP And public health</title>
        <itunes:title>PreP And public health</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/prep-and-public-health/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/prep-and-public-health/#comments</comments>        <pubDate>Fri, 08 Jul 2016 13:54:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/prep-and-public-health</guid>
                                    <description><![CDATA[The drug Truvada, licenced for HIV PrEP, costs £350 a month but is shown to be cost effective in preventing infection. However, in the English NHS, a row has broken out about which body should fund the treatment - NHS England claims local authorities have responsibility, local authorities believe NHS England does.

In this podcast Jim McManus, director of public health at Hertfordshire County Council, explains why he believes local authorities cannot afford the treatment, and describes the pressure that public health budgets are under.

Read the full editorial:
<p>http://www.bmj.com/content/354/bmj.i3515</p>
]]></description>
                                                            <content:encoded><![CDATA[The drug Truvada, licenced for HIV PrEP, costs £350 a month but is shown to be cost effective in preventing infection. However, in the English NHS, a row has broken out about which body should fund the treatment - NHS England claims local authorities have responsibility, local authorities believe NHS England does.

In this podcast Jim McManus, director of public health at Hertfordshire County Council, explains why he believes local authorities cannot afford the treatment, and describes the pressure that public health budgets are under.

Read the full editorial:
<p>http://www.bmj.com/content/354/bmj.i3515</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kns3ym/stream_272740981-bmjgroup-prep-and-public-health.mp3" length="24526897" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The drug Truvada, licenced for HIV PrEP, costs £350 a month but is shown to be cost effective in preventing infection. However, in the English NHS, a row has broken out about which body should fund the treatment - NHS England claims local authorities have responsibility, local authorities believe NHS England does.

In this podcast Jim McManus, director of public health at Hertfordshire County Council, explains why he believes local authorities cannot afford the treatment, and describes the pressure that public health budgets are under.

Read the full editorial:
http://www.bmj.com/content/354/bmj.i3515]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1023</itunes:duration>
                                    </item>
    <item>
        <title>Can guidelines be reformulated to account for how doctors actually use information?</title>
        <itunes:title>Can guidelines be reformulated to account for how doctors actually use information?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/can-guidelines-be-reformulated-to-account-for-how-doctors-actually-use-information/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/can-guidelines-be-reformulated-to-account-for-how-doctors-actually-use-information/#comments</comments>        <pubDate>Fri, 01 Jul 2016 16:49:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/can-guidelines-be-reformulated-to-account-for-how-doctors-actually-use-information</guid>
                                    <description><![CDATA[Guidelines usually assume a rational comprehensive decision model in which all values, means, and ends are known and considered. In clinical encounters, however, patients and doctors most often follow “the science of muddling through. 

Given that clinical knowledge does not follow the narrow rationality of “if-then” algorithms contained in guidelines, alternatives are desperately needed.

Glyn Elwyn, professor at the Dartmouth Institute for Health Policy and Clinical Practice, joins us to discuss what we know about how doctors and patients use evidence, and what the alternative to guidelines could look like.

Read the full analysis:
<p>http://www.bmj.com/content/353/bmj.i3200</p>
]]></description>
                                                            <content:encoded><![CDATA[Guidelines usually assume a rational comprehensive decision model in which all values, means, and ends are known and considered. In clinical encounters, however, patients and doctors most often follow “the science of muddling through. 

Given that clinical knowledge does not follow the narrow rationality of “if-then” algorithms contained in guidelines, alternatives are desperately needed.

Glyn Elwyn, professor at the Dartmouth Institute for Health Policy and Clinical Practice, joins us to discuss what we know about how doctors and patients use evidence, and what the alternative to guidelines could look like.

Read the full analysis:
<p>http://www.bmj.com/content/353/bmj.i3200</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/g65p8a/stream_271742098-bmjgroup-can-guidelines-be-reformulated-to-account-for-how-doctors-actually-use-information.mp3" length="28172479" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guidelines usually assume a rational comprehensive decision model in which all values, means, and ends are known and considered. In clinical encounters, however, patients and doctors most often follow “the science of muddling through. 

Given that clinical knowledge does not follow the narrow rationality of “if-then” algorithms contained in guidelines, alternatives are desperately needed.

Glyn Elwyn, professor at the Dartmouth Institute for Health Policy and Clinical Practice, joins us to discuss what we know about how doctors and patients use evidence, and what the alternative to guidelines could look like.

Read the full analysis:
http://www.bmj.com/content/353/bmj.i3200]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1175</itunes:duration>
                                    </item>
    <item>
        <title>Evidence live - Emily Sena on closing the gap between clinical and basic science</title>
        <itunes:title>Evidence live - Emily Sena on closing the gap between clinical and basic science</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/evidence-live-emily-sena-on-closing-the-gap-between-clinical-and-basic-science/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/evidence-live-emily-sena-on-closing-the-gap-between-clinical-and-basic-science/#comments</comments>        <pubDate>Fri, 24 Jun 2016 11:27:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/evidence-live-emily-sena-on-closing-the-gap-between-clinical-and-basic-science</guid>
                                    <description><![CDATA[When we think about medical evidence, we think of RCTs, registries and meta-analysis. But these EBM tools have yet to filter into the basic science that underpins clinical science. 

<p>One person changing that is Emily Sena, research fellow in clinical brain sciences at the University of Edinburgh - and one of the few people who’s trying to meta-analyse animal studies.</p>
]]></description>
                                                            <content:encoded><![CDATA[When we think about medical evidence, we think of RCTs, registries and meta-analysis. But these EBM tools have yet to filter into the basic science that underpins clinical science. 

<p>One person changing that is Emily Sena, research fellow in clinical brain sciences at the University of Edinburgh - and one of the few people who’s trying to meta-analyse animal studies.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/aagnef/stream_270635952-bmjgroup-evidence-live-emily-sena-on-closing-the-gap-between-clinical-and-basic-science.mp3" length="23827031" type="audio/mpeg"/>
        <itunes:summary><![CDATA[When we think about medical evidence, we think of RCTs, registries and meta-analysis. But these EBM tools have yet to filter into the basic science that underpins clinical science. 

One person changing that is Emily Sena, research fellow in clinical brain sciences at the University of Edinburgh - and one of the few people who’s trying to meta-analyse animal studies.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>994</itunes:duration>
                                    </item>
    <item>
        <title>Julia Beluz And Victor Montori - Journalists And doctors; separated by a common evidence</title>
        <itunes:title>Julia Beluz And Victor Montori - Journalists And doctors; separated by a common evidence</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/julia-beluz-and-victor-montori-journalists-and-doctors-separated-by-a-common-evidence/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/julia-beluz-and-victor-montori-journalists-and-doctors-separated-by-a-common-evidence/#comments</comments>        <pubDate>Thu, 23 Jun 2016 15:52:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/julia-beluz-and-victor-montori-journalists-and-doctors-separated-by-a-common-evidence</guid>
                                    <description><![CDATA[The same piece of evidence may reach you via a journalist, or via your doctor - but the way in which that evidence is communicated is changed by your relationship between that person.

<p>Julia Beluz from Vox and Victor Montori from the Mayo Clinic join us to discuss if it's possible to reconcile those competing points of view.</p>
]]></description>
                                                            <content:encoded><![CDATA[The same piece of evidence may reach you via a journalist, or via your doctor - but the way in which that evidence is communicated is changed by your relationship between that person.

<p>Julia Beluz from Vox and Victor Montori from the Mayo Clinic join us to discuss if it's possible to reconcile those competing points of view.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/h4vd9j/stream_270503087-bmjgroup-julia-beluz-and-victor-montori-journalists-and-doctors-separated-by-a-common-evidence.mp3" length="24371972" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The same piece of evidence may reach you via a journalist, or via your doctor - but the way in which that evidence is communicated is changed by your relationship between that person.

Julia Beluz from Vox and Victor Montori from the Mayo Clinic join us to discuss if it's possible to reconcile those competing points of view.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1017</itunes:duration>
                                    </item>
    <item>
        <title>Epilepsy in pregnancy</title>
        <itunes:title>Epilepsy in pregnancy</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/epilepsy-in-pregnancy/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/epilepsy-in-pregnancy/#comments</comments>        <pubDate>Tue, 21 Jun 2016 16:12:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/epilepsy-in-pregnancy</guid>
                                    <description><![CDATA[In every 1000 pregnancies, between two and five infants are born to women with epilepsy. For such women, pregnancy can be a time of anxiety over maternal and fetal wellbeing.

In 96% of pregnancies they will deliver a healthy child. However, some women will experience an increase in seizure frequency, which can be harmful for the mother or fetus, and evidence comes from observational study and registry data suggests some antiepileptic drugs are associated with an increased risk of congenital and neurodevelopmental abnormalities.

Michael Kinney, specialist registrar in neurology, and James Morrow, principal investigator of the UK and Ireland Epilepsy and Pregnancy Register, both based at the Royal Group of Hospitals in Belfast, join us to discuss how to manage epilepsy in pregnancy.

Read the review:
http://www.bmj.com/content/353/bmj.i2880

<p>For information on joining the UK epilepsy and pregnancy register, call 0800 389 1248 or visit http://www.epilepsyandpregnancy.co.uk/</p>
]]></description>
                                                            <content:encoded><![CDATA[In every 1000 pregnancies, between two and five infants are born to women with epilepsy. For such women, pregnancy can be a time of anxiety over maternal and fetal wellbeing.

In 96% of pregnancies they will deliver a healthy child. However, some women will experience an increase in seizure frequency, which can be harmful for the mother or fetus, and evidence comes from observational study and registry data suggests some antiepileptic drugs are associated with an increased risk of congenital and neurodevelopmental abnormalities.

Michael Kinney, specialist registrar in neurology, and James Morrow, principal investigator of the UK and Ireland Epilepsy and Pregnancy Register, both based at the Royal Group of Hospitals in Belfast, join us to discuss how to manage epilepsy in pregnancy.

Read the review:
http://www.bmj.com/content/353/bmj.i2880

<p>For information on joining the UK epilepsy and pregnancy register, call 0800 389 1248 or visit http://www.epilepsyandpregnancy.co.uk/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/pydejj/stream_270190967-bmjgroup-epilepsy-in-pregnancy.mp3" length="25251490" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In every 1000 pregnancies, between two and five infants are born to women with epilepsy. For such women, pregnancy can be a time of anxiety over maternal and fetal wellbeing.

In 96% of pregnancies they will deliver a healthy child. However, some women will experience an increase in seizure frequency, which can be harmful for the mother or fetus, and evidence comes from observational study and registry data suggests some antiepileptic drugs are associated with an increased risk of congenital and neurodevelopmental abnormalities.

Michael Kinney, specialist registrar in neurology, and James Morrow, principal investigator of the UK and Ireland Epilepsy and Pregnancy Register, both based at the Royal Group of Hospitals in Belfast, join us to discuss how to manage epilepsy in pregnancy.

Read the review:
http://www.bmj.com/content/353/bmj.i2880

For information on joining the UK epilepsy and pregnancy register, call 0800 389 1248 or visit http://www.epilepsyandpregnancy.co.uk/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1052</itunes:duration>
                                    </item>
    <item>
        <title>Caring for patients with delirium at the end of their life</title>
        <itunes:title>Caring for patients with delirium at the end of their life</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/caring-for-patients-with-delirium-at-the-end-of-their-life/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/caring-for-patients-with-delirium-at-the-end-of-their-life/#comments</comments>        <pubDate>Tue, 14 Jun 2016 16:15:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/caring-for-patients-with-delirium-at-the-end-of-their-life</guid>
                                    <description><![CDATA[Delirium is common in the last weeks or days of life. It can be distressing for patients and those around them. A clinical update explains why successful management involves excluding reversible causes of delirium and balancing drugs that may provoke or maintain delirium while appreciating that most patients want to retain clear cognition at the end of life.

Kate Adlington, clinical editor at The BMJ, is joined by the authors of the paper -  Christian Hosker, consultant liaison psychiatrist at Leeds and York Partnership Foundation Trust, and Michael Bennett, professor of palliative medicine at the University of Leeds.

http://www.bmj.com/content/353/bmj.i3085
<p></p>
<p></p>
]]></description>
                                                            <content:encoded><![CDATA[Delirium is common in the last weeks or days of life. It can be distressing for patients and those around them. A clinical update explains why successful management involves excluding reversible causes of delirium and balancing drugs that may provoke or maintain delirium while appreciating that most patients want to retain clear cognition at the end of life.

Kate Adlington, clinical editor at The BMJ, is joined by the authors of the paper -  Christian Hosker, consultant liaison psychiatrist at Leeds and York Partnership Foundation Trust, and Michael Bennett, professor of palliative medicine at the University of Leeds.

http://www.bmj.com/content/353/bmj.i3085
<p></p>
<p></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/e67l6d/stream_269057979-bmjgroup-caring-for-patients-with-delirium-at-the-end-of-their-life.mp3" length="26352599" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Delirium is common in the last weeks or days of life. It can be distressing for patients and those around them. A clinical update explains why successful management involves excluding reversible causes of delirium and balancing drugs that may provoke or maintain delirium while appreciating that most patients want to retain clear cognition at the end of life.

Kate Adlington, clinical editor at The BMJ, is joined by the authors of the paper -  Christian Hosker, consultant liaison psychiatrist at Leeds and York Partnership Foundation Trust, and Michael Bennett, professor of palliative medicine at the University of Leeds.

http://www.bmj.com/content/353/bmj.i3085

]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1097</itunes:duration>
                                    </item>
    <item>
        <title>”What has convinced me is the evidence” - why mandatory treatment for drug use is a bad idea</title>
        <itunes:title>”What has convinced me is the evidence” - why mandatory treatment for drug use is a bad idea</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/what-has-convinced-me-is-the-evidence-why-mandatory-treatment-for-drug-use-is-a-bad-idea/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/what-has-convinced-me-is-the-evidence-why-mandatory-treatment-for-drug-use-is-a-bad-idea/#comments</comments>        <pubDate>Fri, 10 Jun 2016 15:07:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/what-has-convinced-me-is-the-evidence-why-mandatory-treatment-for-drug-use-is-a-bad-idea</guid>
                                    <description><![CDATA[Global evidence indicates that mandated treatment of drug dependence conflicts with drug users’ human rights and is not effective in treating addiction. 

Karsten Lunze, associate professor at the Boston University School of Medicine, joins us to describe the evidence, and why he is convinced seemingly counter intuitive hard reduction works.

<p>http://www.bmj.com/content/353/bmj.i2943</p>
]]></description>
                                                            <content:encoded><![CDATA[Global evidence indicates that mandated treatment of drug dependence conflicts with drug users’ human rights and is not effective in treating addiction. 

Karsten Lunze, associate professor at the Boston University School of Medicine, joins us to describe the evidence, and why he is convinced seemingly counter intuitive hard reduction works.

<p>http://www.bmj.com/content/353/bmj.i2943</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/k6v7an/stream_268466955-bmjgroup-what-has-convinced-me-is-the-evidence-why-mandatory-treatment-for-drug-use-is-a-bad-idea.mp3" length="17629359" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Global evidence indicates that mandated treatment of drug dependence conflicts with drug users’ human rights and is not effective in treating addiction. 

Karsten Lunze, associate professor at the Boston University School of Medicine, joins us to describe the evidence, and why he is convinced seemingly counter intuitive hard reduction works.

http://www.bmj.com/content/353/bmj.i2943]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>734</itunes:duration>
                                    </item>
    <item>
        <title>Tell me a story</title>
        <itunes:title>Tell me a story</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/tell-me-a-story-1680599489/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/tell-me-a-story-1680599489/#comments</comments>        <pubDate>Fri, 03 Jun 2016 15:22:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/tell-me-a-story</guid>
                                    <description><![CDATA[How can asking patient to tell us their story improve healthcare? Helen Morant, content lead at BMJ, talks us through her project getting healthcare professionals to sit down with patients and record their conversations, and what on earth this has to do with quality improvement.

We also hear some of the recordings she has gathered through the project.

Here are links to the other podcasts and projects Helen mentions:

Story Corps - https://storycorps.org/

The Listening Project - http://goo.gl/3auSHX

<p>Beautiful stories from anonymous people - http://goo.gl/78QSjU</p>
]]></description>
                                                            <content:encoded><![CDATA[How can asking patient to tell us their story improve healthcare? Helen Morant, content lead at BMJ, talks us through her project getting healthcare professionals to sit down with patients and record their conversations, and what on earth this has to do with quality improvement.

We also hear some of the recordings she has gathered through the project.

Here are links to the other podcasts and projects Helen mentions:

Story Corps - https://storycorps.org/

The Listening Project - http://goo.gl/3auSHX

<p>Beautiful stories from anonymous people - http://goo.gl/78QSjU</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/l8psyc/stream_267283048-bmjgroup-tell-me-a-story.mp3" length="37133036" type="audio/mpeg"/>
        <itunes:summary><![CDATA[How can asking patient to tell us their story improve healthcare? Helen Morant, content lead at BMJ, talks us through her project getting healthcare professionals to sit down with patients and record their conversations, and what on earth this has to do with quality improvement.

We also hear some of the recordings she has gathered through the project.

Here are links to the other podcasts and projects Helen mentions:

Story Corps - https://storycorps.org/

The Listening Project - http://goo.gl/3auSHX

Beautiful stories from anonymous people - http://goo.gl/78QSjU]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1549</itunes:duration>
                                    </item>
    <item>
        <title>Guidelines Not Tramlines</title>
        <itunes:title>Guidelines Not Tramlines</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/guidelines-not-tramlines/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/guidelines-not-tramlines/#comments</comments>        <pubDate>Fri, 27 May 2016 15:18:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/guidelines-not-tramlines</guid>
                                    <description><![CDATA[Julian Treadwell, Neal Maskrey and Richard Lehman join us in the studio to argue that new models of evidence synthesis and shared decision making are needed to accelerate a move from guideline driven care to individualised care.

Read the full analysis:
<p>www.bmj.com/content/353/bmj.i2452</p>
]]></description>
                                                            <content:encoded><![CDATA[Julian Treadwell, Neal Maskrey and Richard Lehman join us in the studio to argue that new models of evidence synthesis and shared decision making are needed to accelerate a move from guideline driven care to individualised care.

Read the full analysis:
<p>www.bmj.com/content/353/bmj.i2452</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/nrwbwj/stream_266198603-bmjgroup-guidelines-not-tramlines.mp3" length="31294871" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Julian Treadwell, Neal Maskrey and Richard Lehman join us in the studio to argue that new models of evidence synthesis and shared decision making are needed to accelerate a move from guideline driven care to individualised care.

Read the full analysis:
www.bmj.com/content/353/bmj.i2452]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1304</itunes:duration>
                                    </item>
    <item>
        <title>Uncovering the uncertainty on wound dressing</title>
        <itunes:title>Uncovering the uncertainty on wound dressing</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/uncovering-the-uncertainty-on-wound-dressing/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/uncovering-the-uncertainty-on-wound-dressing/#comments</comments>        <pubDate>Thu, 26 May 2016 14:30:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/uncovering-the-uncertainty-on-wound-dressing</guid>
                                    <description><![CDATA[There is insufficient evidence to know whether dressings reduce the risk of surgical site infection in closed primary surgical wounds. 

Jane Blazeby, professor of surgery at the University of Bristol, and Thomas Pinkney, consultant colorectal surgeon at the University of Birmingham, join us to  discusses why there is a lack of evidence, and the implications for patient care.

read the full article:
<p>http://www.bmj.com/content/353/bmj.i2270</p>
]]></description>
                                                            <content:encoded><![CDATA[There is insufficient evidence to know whether dressings reduce the risk of surgical site infection in closed primary surgical wounds. 

Jane Blazeby, professor of surgery at the University of Bristol, and Thomas Pinkney, consultant colorectal surgeon at the University of Birmingham, join us to  discusses why there is a lack of evidence, and the implications for patient care.

read the full article:
<p>http://www.bmj.com/content/353/bmj.i2270</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/lb4zd2/stream_266025942-bmjgroup-uncovering-the-uncertainty-on-wound-dressing.mp3" length="17725429" type="audio/mpeg"/>
        <itunes:summary><![CDATA[There is insufficient evidence to know whether dressings reduce the risk of surgical site infection in closed primary surgical wounds. 

Jane Blazeby, professor of surgery at the University of Bristol, and Thomas Pinkney, consultant colorectal surgeon at the University of Birmingham, join us to  discusses why there is a lack of evidence, and the implications for patient care.

read the full article:
http://www.bmj.com/content/353/bmj.i2270]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>739</itunes:duration>
                                    </item>
    <item>
        <title>Women and the Zika Virus</title>
        <itunes:title>Women and the Zika Virus</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/women-and-the-zika-virus/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/women-and-the-zika-virus/#comments</comments>        <pubDate>Wed, 25 May 2016 11:01:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/women-and-the-zika-virus</guid>
                                    <description><![CDATA[Interviews from the Women deliver conference in Copenhagen.

<p>Donna McCarraher, director of reproductive, maternal, newborn and child health at FHI 360, explains why women should be at the centre of efforts to mitigate the effect of Zika Virus in Brazil.</p>
]]></description>
                                                            <content:encoded><![CDATA[Interviews from the Women deliver conference in Copenhagen.

<p>Donna McCarraher, director of reproductive, maternal, newborn and child health at FHI 360, explains why women should be at the centre of efforts to mitigate the effect of Zika Virus in Brazil.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/u9bpj7/stream_265831315-bmjgroup-women-and-the-zika-virus.mp3" length="12089284" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Interviews from the Women deliver conference in Copenhagen.

Donna McCarraher, director of reproductive, maternal, newborn and child health at FHI 360, explains why women should be at the centre of efforts to mitigate the effect of Zika Virus in Brazil.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>504</itunes:duration>
                                    </item>
    <item>
        <title>Abortion as a development issue</title>
        <itunes:title>Abortion as a development issue</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/abortion-as-a-development-issue/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/abortion-as-a-development-issue/#comments</comments>        <pubDate>Wed, 25 May 2016 11:01:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/abortion-as-a-development-issue</guid>
                                    <description><![CDATA[Interviews from the Women deliver conference in Copenhagen.

<p>Catrin Schulte-Hillen, co-ordinator of reproductive health and sexual violence care at Medecins Sans Frontieres, explains why the development community shouldn't conflate sexual violence and access to abortion.</p>
]]></description>
                                                            <content:encoded><![CDATA[Interviews from the Women deliver conference in Copenhagen.

<p>Catrin Schulte-Hillen, co-ordinator of reproductive health and sexual violence care at Medecins Sans Frontieres, explains why the development community shouldn't conflate sexual violence and access to abortion.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/z8azqp/stream_265831317-bmjgroup-abortion-as-a-development-issue.mp3" length="2543616" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Interviews from the Women deliver conference in Copenhagen.

Catrin Schulte-Hillen, co-ordinator of reproductive health and sexual violence care at Medecins Sans Frontieres, explains why the development community shouldn't conflate sexual violence and access to abortion.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>653</itunes:duration>
                                    </item>
    <item>
        <title>What are they on?</title>
        <itunes:title>What are they on?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/what-are-they-on/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/what-are-they-on/#comments</comments>        <pubDate>Fri, 20 May 2016 16:42:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/what-are-they-on</guid>
                                    <description><![CDATA[This week, we look at medication reconciliation.

Joshua Pevnick, health services researcher and hospital physician at Cedars-Sinai Hospital, LA, US, talks us through what it is and why it can be so hard to get right. 

And Emma Iddles, a junior doctor in general surgery at Hairmyres Hospital, Lanarkshire, UK, explains how her project improved medicines reconciliation in the surgical admissions unit of the hospital.

<p>For more, read Joshua's full paper, http://goo.gl/O59BWo, and Emma's project write up http://goo.gl/znrNGQ.</p>
]]></description>
                                                            <content:encoded><![CDATA[This week, we look at medication reconciliation.

Joshua Pevnick, health services researcher and hospital physician at Cedars-Sinai Hospital, LA, US, talks us through what it is and why it can be so hard to get right. 

And Emma Iddles, a junior doctor in general surgery at Hairmyres Hospital, Lanarkshire, UK, explains how her project improved medicines reconciliation in the surgical admissions unit of the hospital.

<p>For more, read Joshua's full paper, http://goo.gl/O59BWo, and Emma's project write up http://goo.gl/znrNGQ.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/m61go0/stream_265083450-bmjgroup-what-are-they-on.mp3" length="20276176" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week, we look at medication reconciliation.

Joshua Pevnick, health services researcher and hospital physician at Cedars-Sinai Hospital, LA, US, talks us through what it is and why it can be so hard to get right. 

And Emma Iddles, a junior doctor in general surgery at Hairmyres Hospital, Lanarkshire, UK, explains how her project improved medicines reconciliation in the surgical admissions unit of the hospital.

For more, read Joshua's full paper, http://goo.gl/O59BWo, and Emma's project write up http://goo.gl/znrNGQ.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>844</itunes:duration>
                                    </item>
    <item>
        <title>The Weekend Effect - what’s (un)knowable, and what next?</title>
        <itunes:title>The Weekend Effect - what’s (un)knowable, and what next?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-weekend-effect-what-s-unknowable-and-what-next/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-weekend-effect-what-s-unknowable-and-what-next/#comments</comments>        <pubDate>Fri, 20 May 2016 16:09:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-weekend-effect-what-can-research-tell-us</guid>
                                    <description><![CDATA[We do we know about the weekend effect? As Martin McKee puts it in an editorial on thebmj.com, "almost nothing is clear in this tangled tale" 

In this roundtable, Navjoyt Ladher, Analysis editor for The BMJ is joined by some of the key academics who have published research and commented on the weekend effect to make sense of what we know and don’t know about weekend care in hospitals.

http://www.bmj.com/weekend

Taking part in the discussion are:
Cassie Aldridge, HiSLAC study project manager at the University of Birmingham
Rachel Meacock, research fellow in health economics at Manchester University
Nick Black, professor of health services research at the London School of Hygiene and Tropical Medicine
Paul Aylin, professor of epidemiology and public health at Imperial College London
Nick Freemantle, professor of clinical epidemiology and biostatistics at University College London
<p>Peter Rothwell, professor of neurology at the University of Oxford</p>
]]></description>
                                                            <content:encoded><![CDATA[We do we know about the weekend effect? As Martin McKee puts it in an editorial on thebmj.com, "almost nothing is clear in this tangled tale" 

In this roundtable, Navjoyt Ladher, Analysis editor for The BMJ is joined by some of the key academics who have published research and commented on the weekend effect to make sense of what we know and don’t know about weekend care in hospitals.

http://www.bmj.com/weekend

Taking part in the discussion are:
Cassie Aldridge, HiSLAC study project manager at the University of Birmingham
Rachel Meacock, research fellow in health economics at Manchester University
Nick Black, professor of health services research at the London School of Hygiene and Tropical Medicine
Paul Aylin, professor of epidemiology and public health at Imperial College London
Nick Freemantle, professor of clinical epidemiology and biostatistics at University College London
<p>Peter Rothwell, professor of neurology at the University of Oxford</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/b78cms/stream_265078422-bmjgroup-the-weekend-effect-what-can-research-tell-us.mp3" length="78145993" type="audio/mpeg"/>
        <itunes:summary><![CDATA[We do we know about the weekend effect? As Martin McKee puts it in an editorial on thebmj.com, "almost nothing is clear in this tangled tale" 

In this roundtable, Navjoyt Ladher, Analysis editor for The BMJ is joined by some of the key academics who have published research and commented on the weekend effect to make sense of what we know and don’t know about weekend care in hospitals.

http://www.bmj.com/weekend

Taking part in the discussion are:
Cassie Aldridge, HiSLAC study project manager at the University of Birmingham
Rachel Meacock, research fellow in health economics at Manchester University
Nick Black, professor of health services research at the London School of Hygiene and Tropical Medicine
Paul Aylin, professor of epidemiology and public health at Imperial College London
Nick Freemantle, professor of clinical epidemiology and biostatistics at University College London
Peter Rothwell, professor of neurology at the University of Oxford]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3260</itunes:duration>
                                    </item>
    <item>
        <title>”Women deliver, and not only babies”</title>
        <itunes:title>”Women deliver, and not only babies”</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/women-deliver-and-not-only-babies/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/women-deliver-and-not-only-babies/#comments</comments>        <pubDate>Mon, 16 May 2016 10:34:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/women-deliver-and-not-only-babies</guid>
                                    <description><![CDATA[Katja Iversen, CEO of Women Deliver, joins Rebecca Coombes to explain why the UN sustainable development goals are unachievable if we don't empower women and girls to take control of their health, wellbeing, and reproductive rights.

<p>http://womendeliver.org/</p>
]]></description>
                                                            <content:encoded><![CDATA[Katja Iversen, CEO of Women Deliver, joins Rebecca Coombes to explain why the UN sustainable development goals are unachievable if we don't empower women and girls to take control of their health, wellbeing, and reproductive rights.

<p>http://womendeliver.org/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/i1l003/stream_264363450-bmjgroup-women-deliver-and-not-only-babies.mp3" length="33966796" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Katja Iversen, CEO of Women Deliver, joins Rebecca Coombes to explain why the UN sustainable development goals are unachievable if we don't empower women and girls to take control of their health, wellbeing, and reproductive rights.

http://womendeliver.org/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1416</itunes:duration>
                                    </item>
    <item>
        <title>Travellers’ diarrhoea</title>
        <itunes:title>Travellers’ diarrhoea</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/travellers-diarrhoea/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/travellers-diarrhoea/#comments</comments>        <pubDate>Fri, 13 May 2016 15:23:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/travellers-diarrhoea</guid>
                                    <description><![CDATA[Travellers’ diarrhoea is one of the most common illnesses in people who travel internationally, and depending on destination affects 20-60% of the more than 800 million travellers each year. In most cases the diarrhoea occurs in people who travel to areas with poor food and water hygiene.

Mike Brown, consultant in infectious diseases and tropical medicine at the London School of Hygiene and Tropical Medicine, explains the approach to the prevention and treatment of diarrhoea in travellers.

Read the full review:
<p>http://www.bmj.com/content/353/bmj.i1937</p>
]]></description>
                                                            <content:encoded><![CDATA[Travellers’ diarrhoea is one of the most common illnesses in people who travel internationally, and depending on destination affects 20-60% of the more than 800 million travellers each year. In most cases the diarrhoea occurs in people who travel to areas with poor food and water hygiene.

Mike Brown, consultant in infectious diseases and tropical medicine at the London School of Hygiene and Tropical Medicine, explains the approach to the prevention and treatment of diarrhoea in travellers.

Read the full review:
<p>http://www.bmj.com/content/353/bmj.i1937</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4341yw/stream_263953579-bmjgroup-travellers-diarrhoea.mp3" length="26298826" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Travellers’ diarrhoea is one of the most common illnesses in people who travel internationally, and depending on destination affects 20-60% of the more than 800 million travellers each year. In most cases the diarrhoea occurs in people who travel to areas with poor food and water hygiene.

Mike Brown, consultant in infectious diseases and tropical medicine at the London School of Hygiene and Tropical Medicine, explains the approach to the prevention and treatment of diarrhoea in travellers.

Read the full review:
http://www.bmj.com/content/353/bmj.i1937]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1097</itunes:duration>
                                    </item>
    <item>
        <title>”The information we get can be harmfull”; Informed consent is not a panacea</title>
        <itunes:title>”The information we get can be harmfull”; Informed consent is not a panacea</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-information-we-get-can-be-harmfull-informed-consent-is-not-a-panacea/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-information-we-get-can-be-harmfull-informed-consent-is-not-a-panacea/#comments</comments>        <pubDate>Mon, 09 May 2016 17:01:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-information-we-get-can-be-harmfull-informed-consent-is-not-a-panacea</guid>
                                    <description><![CDATA[Providing information to enable informed choices about healthcare sounds immediately appealing to most of us. 

But Minna Johansson, GP trainee and PhD student at the University of Gothenburg, argues that preventive medicine and expanding disease definitions have changed the ethical premises of informed choice and our good intentions may inadvertently advance overmedicalisation.

Read the full analysis:
<p>http://www.bmj.com/content/353/bmj.i2230</p>
]]></description>
                                                            <content:encoded><![CDATA[Providing information to enable informed choices about healthcare sounds immediately appealing to most of us. 

But Minna Johansson, GP trainee and PhD student at the University of Gothenburg, argues that preventive medicine and expanding disease definitions have changed the ethical premises of informed choice and our good intentions may inadvertently advance overmedicalisation.

Read the full analysis:
<p>http://www.bmj.com/content/353/bmj.i2230</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/k4pg10/stream_263239563-bmjgroup-the-information-we-get-can-be-harmfull-informed-consent-is-not-a-panacea.mp3" length="12737526" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Providing information to enable informed choices about healthcare sounds immediately appealing to most of us. 

But Minna Johansson, GP trainee and PhD student at the University of Gothenburg, argues that preventive medicine and expanding disease definitions have changed the ethical premises of informed choice and our good intentions may inadvertently advance overmedicalisation.

Read the full analysis:
http://www.bmj.com/content/353/bmj.i2230]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>530</itunes:duration>
                                    </item>
    <item>
        <title>The science of improvement</title>
        <itunes:title>The science of improvement</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-science-of-improvement/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-science-of-improvement/#comments</comments>        <pubDate>Fri, 06 May 2016 15:50:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-science-of-improvement</guid>
                                    <description><![CDATA[Or, the one where Fiona Moss and Don Berwick tells us what they think quality improvement is.

Fiona Moss is dean, Royal Society of Medicine, and Don Berwick is president emeritus and senior fellow, Institute for Healthcare Improvement.

Don's talk and the interview with Fiona were both recorded at the International Forum on Quality and Safety in Healthcare, Gothenburg, April 2016. Watch out for the extended versions of these recordings, up next Friday.
<p></p>
<p></p>
]]></description>
                                                            <content:encoded><![CDATA[Or, the one where Fiona Moss and Don Berwick tells us what they think quality improvement is.

Fiona Moss is dean, Royal Society of Medicine, and Don Berwick is president emeritus and senior fellow, Institute for Healthcare Improvement.

Don's talk and the interview with Fiona were both recorded at the International Forum on Quality and Safety in Healthcare, Gothenburg, April 2016. Watch out for the extended versions of these recordings, up next Friday.
<p></p>
<p></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mbt5vl/stream_262802022-bmjgroup-the-science-of-improvement.mp3" length="20837549" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Or, the one where Fiona Moss and Don Berwick tells us what they think quality improvement is.

Fiona Moss is dean, Royal Society of Medicine, and Don Berwick is president emeritus and senior fellow, Institute for Healthcare Improvement.

Don's talk and the interview with Fiona were both recorded at the International Forum on Quality and Safety in Healthcare, Gothenburg, April 2016. Watch out for the extended versions of these recordings, up next Friday.

]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>867</itunes:duration>
                                    </item>
    <item>
        <title>Medical error—the third leading cause of death in the US</title>
        <itunes:title>Medical error—the third leading cause of death in the US</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/medical-error%e2%80%94the-third-leading-cause-of-death-in-the-us/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/medical-error%e2%80%94the-third-leading-cause-of-death-in-the-us/#comments</comments>        <pubDate>Wed, 04 May 2016 09:29:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/medical-errorthe-third-leading-cause-of-death-in-the-us</guid>
                                    <description><![CDATA[Medical error is not included on death certificates or in rankings of cause of death. Martin Makary, professor of surgery at Johns Hopkins University School of Medicine, joins us to explain why we don't measure medical error, and why it is so important that we start.

Read the full analysis:
<p>http://www.bmj.com/content/353/bmj.i2139</p>
]]></description>
                                                            <content:encoded><![CDATA[Medical error is not included on death certificates or in rankings of cause of death. Martin Makary, professor of surgery at Johns Hopkins University School of Medicine, joins us to explain why we don't measure medical error, and why it is so important that we start.

Read the full analysis:
<p>http://www.bmj.com/content/353/bmj.i2139</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rvgbv5/stream_262431193-bmjgroup-medical-errorthe-third-leading-cause-of-death-in-the-us.mp3" length="17694814" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Medical error is not included on death certificates or in rankings of cause of death. Martin Makary, professor of surgery at Johns Hopkins University School of Medicine, joins us to explain why we don't measure medical error, and why it is so important that we start.

Read the full analysis:
http://www.bmj.com/content/353/bmj.i2139]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>737</itunes:duration>
                                    </item>
    <item>
        <title>Ecigarettes; ”...the risk is 5% of that caused by smoking”</title>
        <itunes:title>Ecigarettes; ”...the risk is 5% of that caused by smoking”</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/ecigarettes-the-risk-is-5-of-that-caused-by-smoking/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/ecigarettes-the-risk-is-5-of-that-caused-by-smoking/#comments</comments>        <pubDate>Fri, 29 Apr 2016 15:09:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/ecigarettes-the-risk-is-5-of-that-caused-by-smoking</guid>
                                    <description><![CDATA[Nicholas Hopkinson, reader in respiratory medicine at Imperial College London, joins us to explain why a new report from the Royal College of Physicians supports the role of electronic cigarettes as part of a comprehensive tobacco control strategy.

Read the full analysis:
<p>http://www.bmj.com/content/353/bmj.i1745</p>
]]></description>
                                                            <content:encoded><![CDATA[Nicholas Hopkinson, reader in respiratory medicine at Imperial College London, joins us to explain why a new report from the Royal College of Physicians supports the role of electronic cigarettes as part of a comprehensive tobacco control strategy.

Read the full analysis:
<p>http://www.bmj.com/content/353/bmj.i1745</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fb2g7g/stream_261508394-bmjgroup-ecigarettes-the-risk-is-5-of-that-caused-by-smoking.mp3" length="21595608" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Nicholas Hopkinson, reader in respiratory medicine at Imperial College London, joins us to explain why a new report from the Royal College of Physicians supports the role of electronic cigarettes as part of a comprehensive tobacco control strategy.

Read the full analysis:
http://www.bmj.com/content/353/bmj.i1745]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>900</itunes:duration>
                                    </item>
    <item>
        <title>BMJ roundtable: How to fix out of hours care</title>
        <itunes:title>BMJ roundtable: How to fix out of hours care</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/bmj-roundtable-how-to-fix-out-of-hours-care/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/bmj-roundtable-how-to-fix-out-of-hours-care/#comments</comments>        <pubDate>Wed, 27 Apr 2016 14:39:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/how-to-fix-out-of-hours-care</guid>
                                    <description><![CDATA[The BMJ recently held a discussion between experts in the fields of general practice, emergency medicine, and paediatrics about the state of out of hours care in the UK, and crucially offered their vision for a better service. 

Are children a special case, can urgent care ‘hubs’ be a silver bullet, is NHS 111 up to the job of triaging patients, do there enough clinicians involved in out of hours care, and are other countries doing a better job? 

The state of out of hours care can best be described as ‘patchy,’ with some, even most, people receiving good and timely care although from a confusing plethora of different bodies - walk-in centres, urgent care centres, out of hours centres, telephone consultation and - that most recognisable of all NHS brands - Accident and Emergency. But there are  also very serious deficiencies attributed to core  problems identified by our experts below. 

Around the table were: Clifford Mann, president of The Royal College of Emergency Medicine and an emergency medicine consultant in Taunton in Somerset; Neena Modi, professor of Neonatal Medicine in the Imperial College, London and president of Royal College of Paediatrics and Child Health; and Professor Martin Roland, professor of Health Service Research at the University of Cambridge and who has 35 years experience as a GP.

<p>Read the write up:</p>
<p></p>
]]></description>
                                                            <content:encoded><![CDATA[The BMJ recently held a discussion between experts in the fields of general practice, emergency medicine, and paediatrics about the state of out of hours care in the UK, and crucially offered their vision for a better service. 

Are children a special case, can urgent care ‘hubs’ be a silver bullet, is NHS 111 up to the job of triaging patients, do there enough clinicians involved in out of hours care, and are other countries doing a better job? 

The state of out of hours care can best be described as ‘patchy,’ with some, even most, people receiving good and timely care although from a confusing plethora of different bodies - walk-in centres, urgent care centres, out of hours centres, telephone consultation and - that most recognisable of all NHS brands - Accident and Emergency. But there are  also very serious deficiencies attributed to core  problems identified by our experts below. 

Around the table were: Clifford Mann, president of The Royal College of Emergency Medicine and an emergency medicine consultant in Taunton in Somerset; Neena Modi, professor of Neonatal Medicine in the Imperial College, London and president of Royal College of Paediatrics and Child Health; and Professor Martin Roland, professor of Health Service Research at the University of Cambridge and who has 35 years experience as a GP.

<p>Read the write up:</p>
<p></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fn2s0c/stream_261161588-bmjgroup-how-to-fix-out-of-hours-care.mp3" length="33576886" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The BMJ recently held a discussion between experts in the fields of general practice, emergency medicine, and paediatrics about the state of out of hours care in the UK, and crucially offered their vision for a better service. 

Are children a special case, can urgent care ‘hubs’ be a silver bullet, is NHS 111 up to the job of triaging patients, do there enough clinicians involved in out of hours care, and are other countries doing a better job? 

The state of out of hours care can best be described as ‘patchy,’ with some, even most, people receiving good and timely care although from a confusing plethora of different bodies - walk-in centres, urgent care centres, out of hours centres, telephone consultation and - that most recognisable of all NHS brands - Accident and Emergency. But there are  also very serious deficiencies attributed to core  problems identified by our experts below. 

Around the table were: Clifford Mann, president of The Royal College of Emergency Medicine and an emergency medicine consultant in Taunton in Somerset; Neena Modi, professor of Neonatal Medicine in the Imperial College, London and president of Royal College of Paediatrics and Child Health; and Professor Martin Roland, professor of Health Service Research at the University of Cambridge and who has 35 years experience as a GP.

Read the write up:
]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1399</itunes:duration>
                                    </item>
    <item>
        <title>Bad with names</title>
        <itunes:title>Bad with names</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/bad-with-names/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/bad-with-names/#comments</comments>        <pubDate>Fri, 22 Apr 2016 16:22:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/bad-with-names</guid>
                                    <description><![CDATA[It's bad practice to prescribe a brand name drug when a cheaper, viable and approved generic is available. But, particularly in the US, this happens too much, at major cost to the health system.

The team behind Michigan State University's paediatric clinics set out to increase their prescribing of generics, and found that much of the problem was that whilst brand names lodged in staff and patient's minds, generic names were easily forgotten.

Sath Sudhanthar, paediatrician and assistant professor in paediatrics, and Kari Chandler, nurse manager, tell Harriet Vickers how they overcame this and tripled the team's generic medication prescription rate.

<p>Read their full report: http://qir.bmj.com/content/4/1/u209517.w3931.full</p>
]]></description>
                                                            <content:encoded><![CDATA[It's bad practice to prescribe a brand name drug when a cheaper, viable and approved generic is available. But, particularly in the US, this happens too much, at major cost to the health system.

The team behind Michigan State University's paediatric clinics set out to increase their prescribing of generics, and found that much of the problem was that whilst brand names lodged in staff and patient's minds, generic names were easily forgotten.

Sath Sudhanthar, paediatrician and assistant professor in paediatrics, and Kari Chandler, nurse manager, tell Harriet Vickers how they overcame this and tripled the team's generic medication prescription rate.

<p>Read their full report: http://qir.bmj.com/content/4/1/u209517.w3931.full</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4i2jcv/stream_260366436-bmjgroup-bad-with-names.mp3" length="16346679" type="audio/mpeg"/>
        <itunes:summary><![CDATA[It's bad practice to prescribe a brand name drug when a cheaper, viable and approved generic is available. But, particularly in the US, this happens too much, at major cost to the health system.

The team behind Michigan State University's paediatric clinics set out to increase their prescribing of generics, and found that much of the problem was that whilst brand names lodged in staff and patient's minds, generic names were easily forgotten.

Sath Sudhanthar, paediatrician and assistant professor in paediatrics, and Kari Chandler, nurse manager, tell Harriet Vickers how they overcame this and tripled the team's generic medication prescription rate.

Read their full report: http://qir.bmj.com/content/4/1/u209517.w3931.full]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>680</itunes:duration>
                                    </item>
    <item>
        <title>”The harm and the benefit of treatment is about the same” - cardiac screening for athletes</title>
        <itunes:title>”The harm and the benefit of treatment is about the same” - cardiac screening for athletes</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-harm-and-the-benefit-of-treatment-is-about-the-same-cardiac-screening-for-athletes/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-harm-and-the-benefit-of-treatment-is-about-the-same-cardiac-screening-for-athletes/#comments</comments>        <pubDate>Fri, 22 Apr 2016 11:07:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-harm-and-the-benefit-of-treatment-is-about-the-same-cardiac-screening-for-athletes</guid>
                                    <description><![CDATA[Sudden cardiac death of young athletes needs to be avoided but does screening really help? Hans Van Braband, researcher at the Belgian Health Care Knowledge Centre, joins us to explain that the evidence for screening doesn't show benefit, and may lead to harm.

Read the full analysis:
<p>http://www.bmj.com/content/353/bmj.i1156</p>
]]></description>
                                                            <content:encoded><![CDATA[Sudden cardiac death of young athletes needs to be avoided but does screening really help? Hans Van Braband, researcher at the Belgian Health Care Knowledge Centre, joins us to explain that the evidence for screening doesn't show benefit, and may lead to harm.

Read the full analysis:
<p>http://www.bmj.com/content/353/bmj.i1156</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wbwqvh/stream_260328727-bmjgroup-the-harm-and-the-benefit-of-treatment-is-about-the-same-cardiac-screening-for-athletes.mp3" length="24375113" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Sudden cardiac death of young athletes needs to be avoided but does screening really help? Hans Van Braband, researcher at the Belgian Health Care Knowledge Centre, joins us to explain that the evidence for screening doesn't show benefit, and may lead to harm.

Read the full analysis:
http://www.bmj.com/content/353/bmj.i1156]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1016</itunes:duration>
                                    </item>
    <item>
        <title>Doctors in spaaaaaace</title>
        <itunes:title>Doctors in spaaaaaace</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/doctors-in-spaaaaaace/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/doctors-in-spaaaaaace/#comments</comments>        <pubDate>Fri, 15 Apr 2016 15:03:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/doctors-in-spaaaaaace</guid>
                                    <description><![CDATA[Sheyna Gifford has an unusual claim to fame—she is the first doctor ever to work on Mars. Not the planet Mars, of course, but Mauna Loa, a volcano in Hawaii, whose dusty, rust coloured landscape is probably the closest on earth to the red planet. She is serving on the Hi-Seas programme, a mission run the University of Hawaii and funded by NASA, whose purpose is to simulate a three year voyage to Mars and back.

Since last August Gifford and six other scientists have been living in a 1000 square foot solar powered dome, which they rarely leave. The project is treated as a real mission to Mars so the crew have all the supplies for their year long stay and, because of the time delay between Mars and Earth, they cannot speak to the outside world. They can, however, communicate by email, so Sheyna sent The BMJ this voice file to answer 15 of our questions.


Questions: Anne Gulland
<p>Copyright: Sheyna Gifford, MD, 2016.</p>
]]></description>
                                                            <content:encoded><![CDATA[Sheyna Gifford has an unusual claim to fame—she is the first doctor ever to work on Mars. Not the planet Mars, of course, but Mauna Loa, a volcano in Hawaii, whose dusty, rust coloured landscape is probably the closest on earth to the red planet. She is serving on the Hi-Seas programme, a mission run the University of Hawaii and funded by NASA, whose purpose is to simulate a three year voyage to Mars and back.

Since last August Gifford and six other scientists have been living in a 1000 square foot solar powered dome, which they rarely leave. The project is treated as a real mission to Mars so the crew have all the supplies for their year long stay and, because of the time delay between Mars and Earth, they cannot speak to the outside world. They can, however, communicate by email, so Sheyna sent The BMJ this voice file to answer 15 of our questions.


Questions: Anne Gulland
<p>Copyright: Sheyna Gifford, MD, 2016.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/lxdq0w/stream_259238305-bmjgroup-doctors-in-spaaaaaace.mp3" length="43110560" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Sheyna Gifford has an unusual claim to fame—she is the first doctor ever to work on Mars. Not the planet Mars, of course, but Mauna Loa, a volcano in Hawaii, whose dusty, rust coloured landscape is probably the closest on earth to the red planet. She is serving on the Hi-Seas programme, a mission run the University of Hawaii and funded by NASA, whose purpose is to simulate a three year voyage to Mars and back.

Since last August Gifford and six other scientists have been living in a 1000 square foot solar powered dome, which they rarely leave. The project is treated as a real mission to Mars so the crew have all the supplies for their year long stay and, because of the time delay between Mars and Earth, they cannot speak to the outside world. They can, however, communicate by email, so Sheyna sent The BMJ this voice file to answer 15 of our questions.


Questions: Anne Gulland
Copyright: Sheyna Gifford, MD, 2016.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1799</itunes:duration>
                                    </item>
    <item>
        <title>The pattern of damage caused by Zika virus in the brains of 23 foetuses</title>
        <itunes:title>The pattern of damage caused by Zika virus in the brains of 23 foetuses</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-pattern-of-damage-caused-by-zika-virus-in-the-brains-of-23-foetuses/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-pattern-of-damage-caused-by-zika-virus-in-the-brains-of-23-foetuses/#comments</comments>        <pubDate>Thu, 14 Apr 2016 17:47:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/what-does-zika-virus-do-the-brain-of-an-infected-foetus</guid>
                                    <description><![CDATA[In February World Health Organization (WHO) declared the microcephaly epidemic in South America an international public health emergency. Today, the US Centers for Disease Control and Prevention, the CDC, has confirmed that it’s is Zika virus which is causing that microcephaly. 

The outbreak was originally spotted in Recife, in Brazil, and it’s from there that the authors of this research paper have been carrying out imaging of the skulls of babies born with microcephaly and probable Zika virus infection - to establish patterns of damage in the brain.

We're joined by Maria de Fatima Vasco Aragao, professor of radiology and scientific director of Multimagem Radiology Clinic, Recife. Also, Vanessa Van Der Linden, paediatric neurologist and clinic director of Association for Assistance of Disabled Children Recife.

Read the full research:
<p>http://www.bmj.com/content/353/bmj.i1901</p>
]]></description>
                                                            <content:encoded><![CDATA[In February World Health Organization (WHO) declared the microcephaly epidemic in South America an international public health emergency. Today, the US Centers for Disease Control and Prevention, the CDC, has confirmed that it’s is Zika virus which is causing that microcephaly. 

The outbreak was originally spotted in Recife, in Brazil, and it’s from there that the authors of this research paper have been carrying out imaging of the skulls of babies born with microcephaly and probable Zika virus infection - to establish patterns of damage in the brain.

We're joined by Maria de Fatima Vasco Aragao, professor of radiology and scientific director of Multimagem Radiology Clinic, Recife. Also, Vanessa Van Der Linden, paediatric neurologist and clinic director of Association for Assistance of Disabled Children Recife.

Read the full research:
<p>http://www.bmj.com/content/353/bmj.i1901</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/65qtfo/stream_258993770-bmjgroup-what-does-zika-virus-do-the-brain-of-an-infected-foetus.mp3" length="27983920" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In February World Health Organization (WHO) declared the microcephaly epidemic in South America an international public health emergency. Today, the US Centers for Disease Control and Prevention, the CDC, has confirmed that it’s is Zika virus which is causing that microcephaly. 

The outbreak was originally spotted in Recife, in Brazil, and it’s from there that the authors of this research paper have been carrying out imaging of the skulls of babies born with microcephaly and probable Zika virus infection - to establish patterns of damage in the brain.

We're joined by Maria de Fatima Vasco Aragao, professor of radiology and scientific director of Multimagem Radiology Clinic, Recife. Also, Vanessa Van Der Linden, paediatric neurologist and clinic director of Association for Assistance of Disabled Children Recife.

Read the full research:
http://www.bmj.com/content/353/bmj.i1901]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1167</itunes:duration>
                                    </item>
    <item>
        <title>”What’s the point in living, in a body I don’t want” - how the NHS treats trans people</title>
        <itunes:title>”What’s the point in living, in a body I don’t want” - how the NHS treats trans people</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/what-s-the-point-in-living-in-a-body-i-don-t-want-how-the-nhs-treats-trans-people/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/what-s-the-point-in-living-in-a-body-i-don-t-want-how-the-nhs-treats-trans-people/#comments</comments>        <pubDate>Mon, 11 Apr 2016 16:45:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/trans-health-in-the-nhs</guid>
                                    <description><![CDATA[James Barrett, president of the British Association of Gender Identity Specialists, and Nina, a trans woman, join us to discuss how difficult it can be for trans people to access gender clinics, and what barriers are faced by the community after their transition has been completed. 

Read James Barrett's personal view:
<p>http://www.bmj.com/content/352/bmj.i1694</p>
]]></description>
                                                            <content:encoded><![CDATA[James Barrett, president of the British Association of Gender Identity Specialists, and Nina, a trans woman, join us to discuss how difficult it can be for trans people to access gender clinics, and what barriers are faced by the community after their transition has been completed. 

Read James Barrett's personal view:
<p>http://www.bmj.com/content/352/bmj.i1694</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/i07uji/stream_258471438-bmjgroup-trans-health-in-the-nhs.mp3" length="25082515" type="audio/mpeg"/>
        <itunes:summary><![CDATA[James Barrett, president of the British Association of Gender Identity Specialists, and Nina, a trans woman, join us to discuss how difficult it can be for trans people to access gender clinics, and what barriers are faced by the community after their transition has been completed. 

Read James Barrett's personal view:
http://www.bmj.com/content/352/bmj.i1694]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1046</itunes:duration>
                                    </item>
    <item>
        <title>Budget decisions can decrease alcohol deaths in less than 18 months</title>
        <itunes:title>Budget decisions can decrease alcohol deaths in less than 18 months</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/budget-decisions-can-decrease-alcohol-deaths-in-less-than-18-months/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/budget-decisions-can-decrease-alcohol-deaths-in-less-than-18-months/#comments</comments>        <pubDate>Fri, 08 Apr 2016 15:57:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/budget-decisions-can-decrease-alcohol-deaths-in-less-than-18-months</guid>
                                    <description><![CDATA[Alcohol consumption has been a perennial problem, but recently The economic downturn and rises in alcohol taxation seem to have stemmed the persistent rise in associated mortality.

Nick Sheron, head of clinical herpetology at Southampton university, and one of the authors of an analysis article, explains how government fiscal policy has the ability to immediately reduce alcohol related deaths.
<p></p>
<p></p>
]]></description>
                                                            <content:encoded><![CDATA[Alcohol consumption has been a perennial problem, but recently The economic downturn and rises in alcohol taxation seem to have stemmed the persistent rise in associated mortality.

Nick Sheron, head of clinical herpetology at Southampton university, and one of the authors of an analysis article, explains how government fiscal policy has the ability to immediately reduce alcohol related deaths.
<p></p>
<p></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gzoox2/stream_257986066-bmjgroup-budget-decisions-can-decrease-alcohol-deaths-in-less-than-18-months.mp3" length="33170186" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Alcohol consumption has been a perennial problem, but recently The economic downturn and rises in alcohol taxation seem to have stemmed the persistent rise in associated mortality.

Nick Sheron, head of clinical herpetology at Southampton university, and one of the authors of an analysis article, explains how government fiscal policy has the ability to immediately reduce alcohol related deaths.

]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1383</itunes:duration>
                                    </item>
    <item>
        <title>Why the junior doctors are striking again</title>
        <itunes:title>Why the junior doctors are striking again</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/why-the-junior-doctors-are-striking-again/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/why-the-junior-doctors-are-striking-again/#comments</comments>        <pubDate>Fri, 08 Apr 2016 15:49:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/why-the-junior-doctors-are-striking-again</guid>
                                    <description><![CDATA[Abi Rimmer, BMJ Careers reporter, talks to junior doctors on the picket line at Northwick Park Hospital.

Read her report:
<p>http://bmj.co/1qydmFq</p>
]]></description>
                                                            <content:encoded><![CDATA[Abi Rimmer, BMJ Careers reporter, talks to junior doctors on the picket line at Northwick Park Hospital.

Read her report:
<p>http://bmj.co/1qydmFq</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/orz730/stream_257984821-bmjgroup-why-the-junior-doctors-are-striking-again.mp3" length="9245818" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Abi Rimmer, BMJ Careers reporter, talks to junior doctors on the picket line at Northwick Park Hospital.

Read her report:
http://bmj.co/1qydmFq]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>384</itunes:duration>
                                    </item>
    <item>
        <title>Greenwing cast explain why they’re with the junior doctors</title>
        <itunes:title>Greenwing cast explain why they’re with the junior doctors</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/greenwing-cast-explain-why-they-re-with-the-junior-doctors/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/greenwing-cast-explain-why-they-re-with-the-junior-doctors/#comments</comments>        <pubDate>Fri, 08 Apr 2016 15:49:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/greenwing-cast-explain-why-theyre-with-the-junior-doctors</guid>
                                    <description><![CDATA[Abi Rimmer, BMJ careers reporter, talks to the cast of hospital comedy Greenwing, who explain why they're supporting junior doctors on the picket line.

Read her report:
<p>http://bmj.co/1oJ2W41</p>
]]></description>
                                                            <content:encoded><![CDATA[Abi Rimmer, BMJ careers reporter, talks to the cast of hospital comedy Greenwing, who explain why they're supporting junior doctors on the picket line.

Read her report:
<p>http://bmj.co/1oJ2W41</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/eyo0mi/stream_257984824-bmjgroup-greenwing-cast-explain-why-theyre-with-the-junior-doctors.mp3" length="11278947" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Abi Rimmer, BMJ careers reporter, talks to the cast of hospital comedy Greenwing, who explain why they're supporting junior doctors on the picket line.

Read her report:
http://bmj.co/1oJ2W41]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>469</itunes:duration>
                                    </item>
    <item>
        <title>Plan, do, study, act</title>
        <itunes:title>Plan, do, study, act</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/plan-do-study-act/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/plan-do-study-act/#comments</comments>        <pubDate>Fri, 08 Apr 2016 13:43:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/plan-do-study-act</guid>
                                    <description><![CDATA[Plan, do, study, act cycles, or PDSA cycles, are the basis of many quality improvement projects, they're a model to trial changes and feed the lessons from each test into the next.

Why are they a popular method, and how do you get the best out of them? And what on earth happens when they explode?

Harriet Vickers asks Julie Reed, National Institute for Healthcare Research CLAHRC (Collaboration for Leadership in Applied Health Research and Care) for north west London.

Read all of Julie's paper (for free): http://qualitysafety.bmj.com/content/25/3/147

<p>Check out BMJ Quality: http://quality.bmj.com</p>
]]></description>
                                                            <content:encoded><![CDATA[Plan, do, study, act cycles, or PDSA cycles, are the basis of many quality improvement projects, they're a model to trial changes and feed the lessons from each test into the next.

Why are they a popular method, and how do you get the best out of them? And what on earth happens when they explode?

Harriet Vickers asks Julie Reed, National Institute for Healthcare Research CLAHRC (Collaboration for Leadership in Applied Health Research and Care) for north west London.

Read all of Julie's paper (for free): http://qualitysafety.bmj.com/content/25/3/147

<p>Check out BMJ Quality: http://quality.bmj.com</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hy6t2y/stream_257965020-bmjgroup-plan-do-study-act.mp3" length="20650123" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Plan, do, study, act cycles, or PDSA cycles, are the basis of many quality improvement projects, they're a model to trial changes and feed the lessons from each test into the next.

Why are they a popular method, and how do you get the best out of them? And what on earth happens when they explode?

Harriet Vickers asks Julie Reed, National Institute for Healthcare Research CLAHRC (Collaboration for Leadership in Applied Health Research and Care) for north west London.

Read all of Julie's paper (for free): http://qualitysafety.bmj.com/content/25/3/147

Check out BMJ Quality: http://quality.bmj.com]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>860</itunes:duration>
                                    </item>
    <item>
        <title>Mistakes were made</title>
        <itunes:title>Mistakes were made</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/mistakes-were-made-1680599101/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/mistakes-were-made-1680599101/#comments</comments>        <pubDate>Fri, 08 Apr 2016 13:43:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/mistakes-were-made</guid>
                                    <description><![CDATA[The Francis report, the Berwick report, the Keogh review - all of these have highlighted how important learning from mistakes is in healthcare.

Reporting incidents is key to this, and in this podcast Jen Perry, from BMJ Quality, tells Harriet Vickers the whats, hows and whys of incident reporting. 

And Emily Hotton, previously a foundation doctor at Royal United Hospital Bath, UK, talks about how her project helped junior doctors at the hospital become more confident at incident reporting, and bumped up the number of incidents they logged.

Read Emily's full report: http://qir.bmj.com/content/3/1/u202381.w2481.full

<p>Check out BMJ Quality: http://quality.bmj.com</p>
]]></description>
                                                            <content:encoded><![CDATA[The Francis report, the Berwick report, the Keogh review - all of these have highlighted how important learning from mistakes is in healthcare.

Reporting incidents is key to this, and in this podcast Jen Perry, from BMJ Quality, tells Harriet Vickers the whats, hows and whys of incident reporting. 

And Emily Hotton, previously a foundation doctor at Royal United Hospital Bath, UK, talks about how her project helped junior doctors at the hospital become more confident at incident reporting, and bumped up the number of incidents they logged.

Read Emily's full report: http://qir.bmj.com/content/3/1/u202381.w2481.full

<p>Check out BMJ Quality: http://quality.bmj.com</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/0f3ji3/stream_257965016-bmjgroup-mistakes-were-made.mp3" length="23101500" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The Francis report, the Berwick report, the Keogh review - all of these have highlighted how important learning from mistakes is in healthcare.

Reporting incidents is key to this, and in this podcast Jen Perry, from BMJ Quality, tells Harriet Vickers the whats, hows and whys of incident reporting. 

And Emily Hotton, previously a foundation doctor at Royal United Hospital Bath, UK, talks about how her project helped junior doctors at the hospital become more confident at incident reporting, and bumped up the number of incidents they logged.

Read Emily's full report: http://qir.bmj.com/content/3/1/u202381.w2481.full

Check out BMJ Quality: http://quality.bmj.com]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>963</itunes:duration>
                                    </item>
    <item>
        <title>Médecins Sans Frontières’s Dunkirk spirit</title>
        <itunes:title>Médecins Sans Frontières’s Dunkirk spirit</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/medecins-sans-frontieres-s-dunkirk-spirit/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/medecins-sans-frontieres-s-dunkirk-spirit/#comments</comments>        <pubDate>Thu, 31 Mar 2016 13:50:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/medecins-sans-frontieress-dunkirk-spirit</guid>
                                    <description><![CDATA[As France has moved in recent weeks to clear camps where migrants stay while trying to cross illegally into Britain, Médecins Sans Frontières has just opened a new one. 

Sophie Arie talks to Caroline Gollé, medical coordinator at the Médecins Sans Frontières​ La Linière camp​.

Read more about the camp:
<p>http://www.bmj.com/content/352/bmj.i1696</p>
]]></description>
                                                            <content:encoded><![CDATA[As France has moved in recent weeks to clear camps where migrants stay while trying to cross illegally into Britain, Médecins Sans Frontières has just opened a new one. 

Sophie Arie talks to Caroline Gollé, medical coordinator at the Médecins Sans Frontières​ La Linière camp​.

Read more about the camp:
<p>http://www.bmj.com/content/352/bmj.i1696</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/i0z8sh/stream_256479671-bmjgroup-medecins-sans-frontieress-dunkirk-spirit.mp3" length="3337403" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As France has moved in recent weeks to clear camps where migrants stay while trying to cross illegally into Britain, Médecins Sans Frontières has just opened a new one. 

Sophie Arie talks to Caroline Gollé, medical coordinator at the Médecins Sans Frontières​ La Linière camp​.

Read more about the camp:
http://www.bmj.com/content/352/bmj.i1696]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>209</itunes:duration>
                                    </item>
    <item>
        <title>How and when to treat depression in pregnancy</title>
        <itunes:title>How and when to treat depression in pregnancy</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/how-and-when-to-treat-depression-in-pregnancy/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/how-and-when-to-treat-depression-in-pregnancy/#comments</comments>        <pubDate>Thu, 24 Mar 2016 16:51:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/how-and-when-to-treat-depression-in-pregnancy</guid>
                                    <description><![CDATA[Depression in pregnancy affects up to 10% of women, a rate only slightly lower than in the postpartum period. Yet, as few as 20% of pregnant women with depression receive adequate treatment.

Louise Howard, professor in women’s mental health at King's College London, joins us to discuss the clinical review on depression in pregnancy.

Read the full article:
<p>http://www.bmj.com/content/352/bmj.i1547</p>
]]></description>
                                                            <content:encoded><![CDATA[Depression in pregnancy affects up to 10% of women, a rate only slightly lower than in the postpartum period. Yet, as few as 20% of pregnant women with depression receive adequate treatment.

Louise Howard, professor in women’s mental health at King's College London, joins us to discuss the clinical review on depression in pregnancy.

Read the full article:
<p>http://www.bmj.com/content/352/bmj.i1547</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fmwzxz/stream_254834456-bmjgroup-how-and-when-to-treat-depression-in-pregnancy.mp3" length="24015150" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Depression in pregnancy affects up to 10% of women, a rate only slightly lower than in the postpartum period. Yet, as few as 20% of pregnant women with depression receive adequate treatment.

Louise Howard, professor in women’s mental health at King's College London, joins us to discuss the clinical review on depression in pregnancy.

Read the full article:
http://www.bmj.com/content/352/bmj.i1547]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1002</itunes:duration>
                                    </item>
    <item>
        <title>Should doctors boycott working in Australia’s immigration detention centres?</title>
        <itunes:title>Should doctors boycott working in Australia’s immigration detention centres?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/should-doctors-boycott-working-in-australia-s-immigration-detention-centres/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/should-doctors-boycott-working-in-australia-s-immigration-detention-centres/#comments</comments>        <pubDate>Thu, 24 Mar 2016 16:48:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/should-doctors-boycott-working-in-australias-immigration-detention-centres</guid>
                                    <description><![CDATA[However well intentioned, working in detention centres amounts to complicity in torture, says David Berger, a district medical officer in emergency medicine at Broome Hospital in Australia.

However, Steven Miles, chair in bioethics at the University of Minnesota thinks that they play an important role in telling the world about conditions in these camps.

Read the full debate:
<p>http://www.bmj.com/content/352/bmj.i1600</p>
]]></description>
                                                            <content:encoded><![CDATA[However well intentioned, working in detention centres amounts to complicity in torture, says David Berger, a district medical officer in emergency medicine at Broome Hospital in Australia.

However, Steven Miles, chair in bioethics at the University of Minnesota thinks that they play an important role in telling the world about conditions in these camps.

Read the full debate:
<p>http://www.bmj.com/content/352/bmj.i1600</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/j1b7af/stream_254833948-bmjgroup-should-doctors-boycott-working-in-australias-immigration-detention-centres.mp3" length="22665504" type="audio/mpeg"/>
        <itunes:summary><![CDATA[However well intentioned, working in detention centres amounts to complicity in torture, says David Berger, a district medical officer in emergency medicine at Broome Hospital in Australia.

However, Steven Miles, chair in bioethics at the University of Minnesota thinks that they play an important role in telling the world about conditions in these camps.

Read the full debate:
http://www.bmj.com/content/352/bmj.i1600]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>945</itunes:duration>
                                    </item>
    <item>
        <title>Jeremy Hunt Interview</title>
        <itunes:title>Jeremy Hunt Interview</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/jeremy-hunt-interview/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/jeremy-hunt-interview/#comments</comments>        <pubDate>Wed, 23 Mar 2016 11:14:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/jeremy-hunt-interview</guid>
                                    <description><![CDATA[Jeremy Hunt is a health secretary under pressure. In this exclusive interview with The BMJ’s editor in chief Fiona Godlee, the man who could soon become England's longest serving health secretary insists he has more to give. 

The steady hand brought in to steer the NHS away from the front pages has been shaking in recent months, but the grip seems to be intact. As he greets The BMJ in his Whitehall office, Jeremy Hunt does not betray the signs of a man buckling under the pressure despite a tumultuous few months that have left many NHS staff feeling downtrodden, battered, and 
bruised—and that have brought calls for his resignation after he was rebuked for misrepresenting data published in The BMJ to support the case for seven day working in the NHS.

Read Gareth Iacobucci's report of the interview:
http://www.bmj.com/content/352/bmj.i1632
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[Jeremy Hunt is a health secretary under pressure. In this exclusive interview with The BMJ’s editor in chief Fiona Godlee, the man who could soon become England's longest serving health secretary insists he has more to give. 

The steady hand brought in to steer the NHS away from the front pages has been shaking in recent months, but the grip seems to be intact. As he greets The BMJ in his Whitehall office, Jeremy Hunt does not betray the signs of a man buckling under the pressure despite a tumultuous few months that have left many NHS staff feeling downtrodden, battered, and 
bruised—and that have brought calls for his resignation after he was rebuked for misrepresenting data published in The BMJ to support the case for seven day working in the NHS.

Read Gareth Iacobucci's report of the interview:
http://www.bmj.com/content/352/bmj.i1632
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9pm9s1/stream_254402623-bmjgroup-jeremy-hunt-interview.mp3" length="28378980" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Jeremy Hunt is a health secretary under pressure. In this exclusive interview with The BMJ’s editor in chief Fiona Godlee, the man who could soon become England's longest serving health secretary insists he has more to give. 

The steady hand brought in to steer the NHS away from the front pages has been shaking in recent months, but the grip seems to be intact. As he greets The BMJ in his Whitehall office, Jeremy Hunt does not betray the signs of a man buckling under the pressure despite a tumultuous few months that have left many NHS staff feeling downtrodden, battered, and 
bruised—and that have brought calls for his resignation after he was rebuked for misrepresenting data published in The BMJ to support the case for seven day working in the NHS.

Read Gareth Iacobucci's report of the interview:
http://www.bmj.com/content/352/bmj.i1632
 ]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1183</itunes:duration>
                                    </item>
    <item>
        <title>”I thought I was the worst person with type I...” - Self management of diabetes</title>
        <itunes:title>”I thought I was the worst person with type I...” - Self management of diabetes</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/i-thought-i-was-the-worst-person-with-type-i-self-management-of-diabetes/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/i-thought-i-was-the-worst-person-with-type-i-self-management-of-diabetes/#comments</comments>        <pubDate>Mon, 14 Mar 2016 11:20:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/self-management-of-diabetes</guid>
                                    <description><![CDATA[Nick Oliver, consultant diabetologist at Imperial Healthcare NHS Trust and Philippa Cooper, who has type I diabetes, join us to explain how structured education works for patients, and give tips on self management.

Read the full review:
<p>http://www.bmj.com/content/352/bmj.i998</p>
]]></description>
                                                            <content:encoded><![CDATA[Nick Oliver, consultant diabetologist at Imperial Healthcare NHS Trust and Philippa Cooper, who has type I diabetes, join us to explain how structured education works for patients, and give tips on self management.

Read the full review:
<p>http://www.bmj.com/content/352/bmj.i998</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/bcc5gg/stream_251794931-bmjgroup-self-management-of-diabetes.mp3" length="40109617" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Nick Oliver, consultant diabetologist at Imperial Healthcare NHS Trust and Philippa Cooper, who has type I diabetes, join us to explain how structured education works for patients, and give tips on self management.

Read the full review:
http://www.bmj.com/content/352/bmj.i998]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1672</itunes:duration>
                                    </item>
    <item>
        <title>”We’re pulling the rug out from under the feet of [GPs]”</title>
        <itunes:title>”We’re pulling the rug out from under the feet of [GPs]”</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/we-re-pulling-the-rug-out-from-under-the-feet-of-gps/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/we-re-pulling-the-rug-out-from-under-the-feet-of-gps/#comments</comments>        <pubDate>Mon, 14 Mar 2016 10:30:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/were-pulling-the-rug-out-from-under-the-feet-of-gps</guid>
                                    <description><![CDATA[Gareth Iacobucci talks to Candace Imison, director of policy at The Nuffield Trust, about the problems facing GPs, and how primary care could be changed.

<p>"5 minutes with... Candace Imison": http://www.bmj.com/content/352/bmj.i1378</p>
]]></description>
                                                            <content:encoded><![CDATA[Gareth Iacobucci talks to Candace Imison, director of policy at The Nuffield Trust, about the problems facing GPs, and how primary care could be changed.

<p>"5 minutes with... Candace Imison": http://www.bmj.com/content/352/bmj.i1378</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2lvqzp/stream_251790908-bmjgroup-were-pulling-the-rug-out-from-under-the-feet-of-gps.mp3" length="15445204" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Gareth Iacobucci talks to Candace Imison, director of policy at The Nuffield Trust, about the problems facing GPs, and how primary care could be changed.

"5 minutes with... Candace Imison": http://www.bmj.com/content/352/bmj.i1378]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>644</itunes:duration>
                                    </item>
    <item>
        <title>”It’s the workforce, stupid” - is the NHS workforce in crisis?</title>
        <itunes:title>”It’s the workforce, stupid” - is the NHS workforce in crisis?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/it-s-the-workforce-stupid-is-the-nhs-workforce-in-crisis/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/it-s-the-workforce-stupid-is-the-nhs-workforce-in-crisis/#comments</comments>        <pubDate>Wed, 09 Mar 2016 10:36:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/its-the-workforce-stupid</guid>
                                    <description><![CDATA[As the junior doctors in England strike, concerns for the workforce are foremost in the minds of those running the NHS.

A summary is available here: http://www.bmj.com/content/352/bmj.i1510

In The BMJ roundtable, recorded at the Nuffield Trust Health Policy Summit on Friday 4 March 2016, we asked our participants if they think the NHS is in crisis, and what they think can be done to help those working across the system.

<p>The participants were Clifford Mann, president of the Royal College of Emergency Medicine, Samantha Barrell, chief executive at Taunton and Somerset NHS Foundation Trust, Candace Imison, director of policy at the Nuffield Trust, Richard Jones, consultant cardiologist, Saira Ghafur, specialist registrar, Neena Modi, president of the Royal College of Paediatrics and Child Health, Claire Lemer, consultant in general paediatrics, Ben Mearns , chief of medicine at Surrey & Sussex Healthcare NHS Trust, Sarah Pickup, deputy chief executive at the Local Government Association, and Jeremy Taylor, chief executive of National Voices.</p>
]]></description>
                                                            <content:encoded><![CDATA[As the junior doctors in England strike, concerns for the workforce are foremost in the minds of those running the NHS.

A summary is available here: http://www.bmj.com/content/352/bmj.i1510

In The BMJ roundtable, recorded at the Nuffield Trust Health Policy Summit on Friday 4 March 2016, we asked our participants if they think the NHS is in crisis, and what they think can be done to help those working across the system.

<p>The participants were Clifford Mann, president of the Royal College of Emergency Medicine, Samantha Barrell, chief executive at Taunton and Somerset NHS Foundation Trust, Candace Imison, director of policy at the Nuffield Trust, Richard Jones, consultant cardiologist, Saira Ghafur, specialist registrar, Neena Modi, president of the Royal College of Paediatrics and Child Health, Claire Lemer, consultant in general paediatrics, Ben Mearns , chief of medicine at Surrey & Sussex Healthcare NHS Trust, Sarah Pickup, deputy chief executive at the Local Government Association, and Jeremy Taylor, chief executive of National Voices.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/m61qpa/stream_250984296-bmjgroup-its-the-workforce-stupid.mp3" length="52709012" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As the junior doctors in England strike, concerns for the workforce are foremost in the minds of those running the NHS.

A summary is available here: http://www.bmj.com/content/352/bmj.i1510

In The BMJ roundtable, recorded at the Nuffield Trust Health Policy Summit on Friday 4 March 2016, we asked our participants if they think the NHS is in crisis, and what they think can be done to help those working across the system.

The participants were Clifford Mann, president of the Royal College of Emergency Medicine, Samantha Barrell, chief executive at Taunton and Somerset NHS Foundation Trust, Candace Imison, director of policy at the Nuffield Trust, Richard Jones, consultant cardiologist, Saira Ghafur, specialist registrar, Neena Modi, president of the Royal College of Paediatrics and Child Health, Claire Lemer, consultant in general paediatrics, Ben Mearns , chief of medicine at Surrey & Sussex Healthcare NHS Trust, Sarah Pickup, deputy chief executive at the Local Government Association, and Jeremy Taylor, chief executive of National Voices.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2197</itunes:duration>
                                    </item>
    <item>
        <title>Zika virus - ”it really felt like having bad sunburn, all over your body”</title>
        <itunes:title>Zika virus - ”it really felt like having bad sunburn, all over your body”</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/zika-virus-it-really-felt-like-having-bad-sunburn-all-over-your-body/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/zika-virus-it-really-felt-like-having-bad-sunburn-all-over-your-body/#comments</comments>        <pubDate>Fri, 26 Feb 2016 15:07:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/zika-virus</guid>
                                    <description><![CDATA[“Juliet”, a woman living in London, was diagnosed with a mysterious illness in November 2015, Ian Cropley, a consultant in infectious disease from The Royal Free London NHS Foundation Trust, was there to investigate.

In this podcast, we find out how Zika, once a little known virus causing a rash and fever, has subsequently become a global health emergency. We also discuss how the infection is linked to microcephaly, and what we still need to understand to control the disease.

<p>All Zika virus resources from BMJ are now freely available on www.bmj.com/freezikaresources.</p>
<p></p>
]]></description>
                                                            <content:encoded><![CDATA[“Juliet”, a woman living in London, was diagnosed with a mysterious illness in November 2015, Ian Cropley, a consultant in infectious disease from The Royal Free London NHS Foundation Trust, was there to investigate.

In this podcast, we find out how Zika, once a little known virus causing a rash and fever, has subsequently become a global health emergency. We also discuss how the infection is linked to microcephaly, and what we still need to understand to control the disease.

<p>All Zika virus resources from BMJ are now freely available on www.bmj.com/freezikaresources.</p>
<p></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/cxpbie/stream_249016722-bmjgroup-zika-virus.mp3" length="39981376" type="audio/mpeg"/>
        <itunes:summary><![CDATA[“Juliet”, a woman living in London, was diagnosed with a mysterious illness in November 2015, Ian Cropley, a consultant in infectious disease from The Royal Free London NHS Foundation Trust, was there to investigate.

In this podcast, we find out how Zika, once a little known virus causing a rash and fever, has subsequently become a global health emergency. We also discuss how the infection is linked to microcephaly, and what we still need to understand to control the disease.

All Zika virus resources from BMJ are now freely available on www.bmj.com/freezikaresources.
]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1667</itunes:duration>
                                    </item>
    <item>
        <title>What is vaginal seeding - and is it safe?</title>
        <itunes:title>What is vaginal seeding - and is it safe?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/what-is-vaginal-seeding-and-is-it-safe/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/what-is-vaginal-seeding-and-is-it-safe/#comments</comments>        <pubDate>Tue, 23 Feb 2016 16:13:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/what-is-vaginal-seeding-and-is-it-safe</guid>
                                    <description><![CDATA[How should health professionals engage with this increasingly popular but unproved practice?

Aubrey Cunnington, a consultant paediatrician from Imperial College London joins us to discuss.

Read the full editorial:
<p>http://www.bmj.com/content/352/bmj.i227</p>
]]></description>
                                                            <content:encoded><![CDATA[How should health professionals engage with this increasingly popular but unproved practice?

Aubrey Cunnington, a consultant paediatrician from Imperial College London joins us to discuss.

Read the full editorial:
<p>http://www.bmj.com/content/352/bmj.i227</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/j6dnv4/stream_248513030-bmjgroup-what-is-vaginal-seeding-and-is-it-safe.mp3" length="14455284" type="audio/mpeg"/>
        <itunes:summary><![CDATA[How should health professionals engage with this increasingly popular but unproved practice?

Aubrey Cunnington, a consultant paediatrician from Imperial College London joins us to discuss.

Read the full editorial:
http://www.bmj.com/content/352/bmj.i227]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>602</itunes:duration>
                                    </item>
    <item>
        <title>Frontline NHS charges for migrants will harm the most vulnerable</title>
        <itunes:title>Frontline NHS charges for migrants will harm the most vulnerable</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/frontline-nhs-charges-for-migrants-will-harm-the-most-vulnerable/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/frontline-nhs-charges-for-migrants-will-harm-the-most-vulnerable/#comments</comments>        <pubDate>Fri, 19 Feb 2016 16:40:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/migrant-health-charges</guid>
                                    <description><![CDATA[The Department of Health is proposing to extend charging for migrants into some NHS primary care services and emergency departments.

Although the government asserts that the NHS is “overly generous to those who have only a temporary relationship with the UK,” Lucy Jones, UK lead for Doctors of the World says these proposals will disproportionately harm vulnerable undocumented migrants.

Read the full editorial:
<p>http://www.bmj.com/content/352/bmj.i685</p>
]]></description>
                                                            <content:encoded><![CDATA[The Department of Health is proposing to extend charging for migrants into some NHS primary care services and emergency departments.

Although the government asserts that the NHS is “overly generous to those who have only a temporary relationship with the UK,” Lucy Jones, UK lead for Doctors of the World says these proposals will disproportionately harm vulnerable undocumented migrants.

Read the full editorial:
<p>http://www.bmj.com/content/352/bmj.i685</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/naeenl/stream_247873562-bmjgroup-migrant-health-charges.mp3" length="20990724" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The Department of Health is proposing to extend charging for migrants into some NHS primary care services and emergency departments.

Although the government asserts that the NHS is “overly generous to those who have only a temporary relationship with the UK,” Lucy Jones, UK lead for Doctors of the World says these proposals will disproportionately harm vulnerable undocumented migrants.

Read the full editorial:
http://www.bmj.com/content/352/bmj.i685]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>875</itunes:duration>
                                    </item>
    <item>
        <title>Time to end the federal ban on gun violence research funding</title>
        <itunes:title>Time to end the federal ban on gun violence research funding</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/time-to-end-the-federal-ban-on-gun-violence-research-funding/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/time-to-end-the-federal-ban-on-gun-violence-research-funding/#comments</comments>        <pubDate>Thu, 11 Feb 2016 11:17:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/time-to-end-the-ban-on-gun-violence-research-funding</guid>
                                    <description><![CDATA[In recent weeks, the firearms controversy has again lit up the media in the United States, with clarification that anyone engaged in the business of selling firearms must get a license and conduct background checks. 

But, argues Fred Rivara from the Seattle Children’s Research Institute and Harborview Injury Prevention and Research Center, we may never know its effects because of the continuing ban on federal funding of research into gun violence.

<p>http://www.bmj.com/content/352/bmj.i578</p>
]]></description>
                                                            <content:encoded><![CDATA[In recent weeks, the firearms controversy has again lit up the media in the United States, with clarification that anyone engaged in the business of selling firearms must get a license and conduct background checks. 

But, argues Fred Rivara from the Seattle Children’s Research Institute and Harborview Injury Prevention and Research Center, we may never know its effects because of the continuing ban on federal funding of research into gun violence.

<p>http://www.bmj.com/content/352/bmj.i578</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8u10hg/stream_246512322-bmjgroup-time-to-end-the-ban-on-gun-violence-research-funding.mp3" length="19334736" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In recent weeks, the firearms controversy has again lit up the media in the United States, with clarification that anyone engaged in the business of selling firearms must get a license and conduct background checks. 

But, argues Fred Rivara from the Seattle Children’s Research Institute and Harborview Injury Prevention and Research Center, we may never know its effects because of the continuing ban on federal funding of research into gun violence.

http://www.bmj.com/content/352/bmj.i578]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>806</itunes:duration>
                                    </item>
    <item>
        <title>Junior doctors second strike - from the picket line</title>
        <itunes:title>Junior doctors second strike - from the picket line</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/junior-doctors-second-strike-from-the-picket-line/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/junior-doctors-second-strike-from-the-picket-line/#comments</comments>        <pubDate>Wed, 10 Feb 2016 17:13:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/junior-doctors-second-strike</guid>
                                    <description><![CDATA[This week, junior doctors in England have taken industrial action for the second time in as many months after failing to reach agreement with the government over their proposed new contract. 

Tom Moberley and Abi Rimmer, from BMJ Careers, went to the picket lines at Northwick Park Hospital, and University Hospital Lewisham to talk to the doctors, and their supporters.

Keep up to date with the junior doctor's continuing industrial action with our live blog:
<p>http://blogs.bmj.com/bmj/2016/02/08/junior-doctors-strike-february-2016-live-blog/</p>
]]></description>
                                                            <content:encoded><![CDATA[This week, junior doctors in England have taken industrial action for the second time in as many months after failing to reach agreement with the government over their proposed new contract. 

Tom Moberley and Abi Rimmer, from BMJ Careers, went to the picket lines at Northwick Park Hospital, and University Hospital Lewisham to talk to the doctors, and their supporters.

Keep up to date with the junior doctor's continuing industrial action with our live blog:
<p>http://blogs.bmj.com/bmj/2016/02/08/junior-doctors-strike-february-2016-live-blog/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/k813qc/stream_246389082-bmjgroup-junior-doctors-second-strike.mp3" length="20110607" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week, junior doctors in England have taken industrial action for the second time in as many months after failing to reach agreement with the government over their proposed new contract. 

Tom Moberley and Abi Rimmer, from BMJ Careers, went to the picket lines at Northwick Park Hospital, and University Hospital Lewisham to talk to the doctors, and their supporters.

Keep up to date with the junior doctor's continuing industrial action with our live blog:
http://blogs.bmj.com/bmj/2016/02/08/junior-doctors-strike-february-2016-live-blog/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>838</itunes:duration>
                                    </item>
    <item>
        <title>Stopping the overtreatment of malaria</title>
        <itunes:title>Stopping the overtreatment of malaria</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/stopping-the-overtreatment-of-malaria/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/stopping-the-overtreatment-of-malaria/#comments</comments>        <pubDate>Fri, 05 Feb 2016 17:00:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/stopping-the-overtreatment-of-malaria</guid>
                                    <description><![CDATA[The Rapid diagnostic tests have the potential to reduce the overtreatment of malaria by 95%, but time and extensive logistical, behavioural, and technical interventions may be required to achieve this.

Eleanor Ochodo from the Centre for Evidence-Based Health Care, at Stellenbosch University, joins us to discuss.

Read the full article:
<p>http://www.bmj.com/content/352/bmj.i107</p>
]]></description>
                                                            <content:encoded><![CDATA[The Rapid diagnostic tests have the potential to reduce the overtreatment of malaria by 95%, but time and extensive logistical, behavioural, and technical interventions may be required to achieve this.

Eleanor Ochodo from the Centre for Evidence-Based Health Care, at Stellenbosch University, joins us to discuss.

Read the full article:
<p>http://www.bmj.com/content/352/bmj.i107</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wuywmk/stream_245599972-bmjgroup-stopping-the-overtreatment-of-malaria.mp3" length="25839306" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The Rapid diagnostic tests have the potential to reduce the overtreatment of malaria by 95%, but time and extensive logistical, behavioural, and technical interventions may be required to achieve this.

Eleanor Ochodo from the Centre for Evidence-Based Health Care, at Stellenbosch University, joins us to discuss.

Read the full article:
http://www.bmj.com/content/352/bmj.i107]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1077</itunes:duration>
                                    </item>
    <item>
        <title>The role of stenting in stable angina</title>
        <itunes:title>The role of stenting in stable angina</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-role-of-stenting-in-stable-angina/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-role-of-stenting-in-stable-angina/#comments</comments>        <pubDate>Fri, 05 Feb 2016 09:27:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/stenting-stable-angina</guid>
                                    <description><![CDATA[Iqbal  Malik, consultant cardiologist at Imperial College Healthcare NHS Trust in London, joins Mabel Chew to discuss the role of angioplasty and stenting in patients with stable angina.


Read the full article online:
<p>http://www.bmj.com/content/352/bmj.i205</p>
<p></p>
]]></description>
                                                            <content:encoded><![CDATA[Iqbal  Malik, consultant cardiologist at Imperial College Healthcare NHS Trust in London, joins Mabel Chew to discuss the role of angioplasty and stenting in patients with stable angina.


Read the full article online:
<p>http://www.bmj.com/content/352/bmj.i205</p>
<p></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/tombxj/stream_245551067-bmjgroup-stenting-stable-angina.mp3" length="17448859" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Iqbal  Malik, consultant cardiologist at Imperial College Healthcare NHS Trust in London, joins Mabel Chew to discuss the role of angioplasty and stenting in patients with stable angina.


Read the full article online:
http://www.bmj.com/content/352/bmj.i205
]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>727</itunes:duration>
                                    </item>
    <item>
        <title>Could campaigns like Dry January do more harm than good?</title>
        <itunes:title>Could campaigns like Dry January do more harm than good?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/could-campaigns-like-dry-january-do-more-harm-than-good/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/could-campaigns-like-dry-january-do-more-harm-than-good/#comments</comments>        <pubDate>Sat, 09 Jan 2016 16:17:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/dry-january</guid>
                                    <description><![CDATA[Are you having a dry January?

In this podcast Ian Gilmore, honorary professor at Liverpool University, and Ian Hamilton, a lecturer in the Department of Health Sciences at York University, debate whether campaigns such as this have any public health benefit.

<p>Read the full head to head article: http://www.bmj.com/content/352/bmj.i143</p>
<p></p>
]]></description>
                                                            <content:encoded><![CDATA[Are you having a dry January?

In this podcast Ian Gilmore, honorary professor at Liverpool University, and Ian Hamilton, a lecturer in the Department of Health Sciences at York University, debate whether campaigns such as this have any public health benefit.

<p>Read the full head to head article: http://www.bmj.com/content/352/bmj.i143</p>
<p></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ctaw3a/stream_241134615-bmjgroup-dry-january.mp3" length="30315539" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Are you having a dry January?

In this podcast Ian Gilmore, honorary professor at Liverpool University, and Ian Hamilton, a lecturer in the Department of Health Sciences at York University, debate whether campaigns such as this have any public health benefit.

Read the full head to head article: http://www.bmj.com/content/352/bmj.i143
]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1264</itunes:duration>
                                    </item>
    <item>
        <title>Exercise induced bronchoconstriction</title>
        <itunes:title>Exercise induced bronchoconstriction</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/exercise-induced-bronchoconstriction/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/exercise-induced-bronchoconstriction/#comments</comments>        <pubDate>Sat, 09 Jan 2016 16:17:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/exercise-induced-broncoconstriction</guid>
                                    <description><![CDATA[<p>James Smoliga, from High Point University, North Carolina, and Ken Rundell, from The Commonwealth Medical College, Pennsylvania, join us to discuss how to test for, and manage, exercise induced bronchoconstriction, and particularly how to distinguish it from other respiratory conditions.</p>
<p>Read the full review at http://www.bmj.com/content/352/bmj.h6951</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>James Smoliga, from High Point University, North Carolina, and Ken Rundell, from The Commonwealth Medical College, Pennsylvania, join us to discuss how to test for, and manage, exercise induced bronchoconstriction, and particularly how to distinguish it from other respiratory conditions.</p>
<p>Read the full review at http://www.bmj.com/content/352/bmj.h6951</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/zhawmn/stream_241134644-bmjgroup-exercise-induced-broncoconstriction.mp3" length="32811894" type="audio/mpeg"/>
        <itunes:summary><![CDATA[James Smoliga, from High Point University, North Carolina, and Ken Rundell, from The Commonwealth Medical College, Pennsylvania, join us to discuss how to test for, and manage, exercise induced bronchoconstriction, and particularly how to distinguish it from other respiratory conditions.Read the full review at http://www.bmj.com/content/352/bmj.h6951]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1369</itunes:duration>
                                    </item>
    <item>
        <title>CKD In the elderly - disease, or disease label</title>
        <itunes:title>CKD In the elderly - disease, or disease label</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/ckd-in-the-elderly-disease-or-disease-label/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/ckd-in-the-elderly-disease-or-disease-label/#comments</comments>        <pubDate>Sat, 09 Jan 2016 16:16:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/ckd-in-the-elderly-disease-or-disease-label-mixdown</guid>
                                    <description><![CDATA[Around half of people aged over 75 meet the diagnostic criteria for chronic kidney disease (CKD), but there is  debate about what this means for patients as only a proportion of elderly people with CKD will have clinically important outcomes as a result. 

In this podcast, Dr Arif Khwaja argues that for CKD in the elderly, we should focus on patient centered outcomes rather than applying population risks.

<p>Read the full Analysis article: http://www.bmj.com/content/352/bmj.h6559</p>
]]></description>
                                                            <content:encoded><![CDATA[Around half of people aged over 75 meet the diagnostic criteria for chronic kidney disease (CKD), but there is  debate about what this means for patients as only a proportion of elderly people with CKD will have clinically important outcomes as a result. 

In this podcast, Dr Arif Khwaja argues that for CKD in the elderly, we should focus on patient centered outcomes rather than applying population risks.

<p>Read the full Analysis article: http://www.bmj.com/content/352/bmj.h6559</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/tfdbhu/stream_241134569-bmjgroup-ckd-in-the-elderly-disease-or-disease-label-mixdown.mp3" length="21475444" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Around half of people aged over 75 meet the diagnostic criteria for chronic kidney disease (CKD), but there is  debate about what this means for patients as only a proportion of elderly people with CKD will have clinically important outcomes as a result. 

In this podcast, Dr Arif Khwaja argues that for CKD in the elderly, we should focus on patient centered outcomes rather than applying population risks.

Read the full Analysis article: http://www.bmj.com/content/352/bmj.h6559]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>896</itunes:duration>
                                    </item>
    <item>
        <title>Cancer screening - does it save lives?</title>
        <itunes:title>Cancer screening - does it save lives?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/cancer-screening-does-it-save-lives/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/cancer-screening-does-it-save-lives/#comments</comments>        <pubDate>Fri, 08 Jan 2016 15:02:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/cancer-screening-does-it-save-lives</guid>
                                    <description><![CDATA[The claim that cancer screening saves lives is based on fewer deaths due to the target cancer. Vinay Prasad, assistant professor at Oregon Health and Science University, joins us to argue that reductions in overall mortality should be the benchmark and call for higher standards of evidence for cancer screening.

Read the full analysis:
<p>http://www.bmj.com/content/352/bmj.h6080</p>
]]></description>
                                                            <content:encoded><![CDATA[The claim that cancer screening saves lives is based on fewer deaths due to the target cancer. Vinay Prasad, assistant professor at Oregon Health and Science University, joins us to argue that reductions in overall mortality should be the benchmark and call for higher standards of evidence for cancer screening.

Read the full analysis:
<p>http://www.bmj.com/content/352/bmj.h6080</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/iyaiqr/stream_240975881-bmjgroup-cancer-screening-does-it-save-lives.mp3" length="20098806" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The claim that cancer screening saves lives is based on fewer deaths due to the target cancer. Vinay Prasad, assistant professor at Oregon Health and Science University, joins us to argue that reductions in overall mortality should be the benchmark and call for higher standards of evidence for cancer screening.

Read the full analysis:
http://www.bmj.com/content/352/bmj.h6080]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>838</itunes:duration>
                                    </item>
    <item>
        <title>Why are Dutch GPs happier than British ones?</title>
        <itunes:title>Why are Dutch GPs happier than British ones?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/why-are-dutch-gps-happier-than-british-ones/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/why-are-dutch-gps-happier-than-british-ones/#comments</comments>        <pubDate>Fri, 08 Jan 2016 14:53:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/why-are-dutch-gps-happier-than-british-ones</guid>
                                    <description><![CDATA[General practice is similar in the Netherlands and the UK yet it appeals far more to young Dutch doctors than to their British counterparts. In collaboration with the Dutch medical journal Nederlands Tijdschrift voor Geneeskunde, Roger Damoiseaux, professor of general practice, and Margaret McCartney, Glasgow GP and The BMJ columnist, met to try to work out why. Sophie Arie reports

Read the feature:
<p>http://www.bmj.com/content/351/bmj.h6870</p>
]]></description>
                                                            <content:encoded><![CDATA[General practice is similar in the Netherlands and the UK yet it appeals far more to young Dutch doctors than to their British counterparts. In collaboration with the Dutch medical journal Nederlands Tijdschrift voor Geneeskunde, Roger Damoiseaux, professor of general practice, and Margaret McCartney, Glasgow GP and The BMJ columnist, met to try to work out why. Sophie Arie reports

Read the feature:
<p>http://www.bmj.com/content/351/bmj.h6870</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dzebol/stream_240974844-bmjgroup-why-are-dutch-gps-happier-than-british-ones.mp3" length="44158344" type="audio/mpeg"/>
        <itunes:summary><![CDATA[General practice is similar in the Netherlands and the UK yet it appeals far more to young Dutch doctors than to their British counterparts. In collaboration with the Dutch medical journal Nederlands Tijdschrift voor Geneeskunde, Roger Damoiseaux, professor of general practice, and Margaret McCartney, Glasgow GP and The BMJ columnist, met to try to work out why. Sophie Arie reports

Read the feature:
http://www.bmj.com/content/351/bmj.h6870]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1841</itunes:duration>
                                    </item>
    <item>
        <title>In search of the Christmas spirit</title>
        <itunes:title>In search of the Christmas spirit</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/in-search-of-the-christmas-spirit-1680599117/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/in-search-of-the-christmas-spirit-1680599117/#comments</comments>        <pubDate>Tue, 15 Dec 2015 21:05:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/in-search-of-the-christmas-spirit</guid>
                                    <description><![CDATA[Is the Christmas sprit divinely inspired, or does it reside within the body? Researchers from Denmark have tried to answer that age-old philosophical question with fMRI. Bryan Haddock, medical physicist at Rigshospitalet in Copenhagen joins us to explain what they found.

Read the full research:
<p>http://www.bmj.com/cgi/doi/10.1136/bmj.h6266</p>
]]></description>
                                                            <content:encoded><![CDATA[Is the Christmas sprit divinely inspired, or does it reside within the body? Researchers from Denmark have tried to answer that age-old philosophical question with fMRI. Bryan Haddock, medical physicist at Rigshospitalet in Copenhagen joins us to explain what they found.

Read the full research:
<p>http://www.bmj.com/cgi/doi/10.1136/bmj.h6266</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jag09l/stream_237718926-bmjgroup-in-search-of-the-christmas-spirit.mp3" length="21077498" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Is the Christmas sprit divinely inspired, or does it reside within the body? Researchers from Denmark have tried to answer that age-old philosophical question with fMRI. Bryan Haddock, medical physicist at Rigshospitalet in Copenhagen joins us to explain what they found.

Read the full research:
http://www.bmj.com/cgi/doi/10.1136/bmj.h6266]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>879</itunes:duration>
                                    </item>
    <item>
        <title>The big (research) book of British teeth</title>
        <itunes:title>The big (research) book of British teeth</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-big-research-book-of-british-teeth/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-big-research-book-of-british-teeth/#comments</comments>        <pubDate>Tue, 15 Dec 2015 20:59:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-big-research-book-of-british-teeth</guid>
                                    <description><![CDATA[Despite what hollywood says, science has proven that British teeth are actually better than American. Richard Watt, head of the Research Department of Epidemiology and Public Health at UCL explains how they came to that conclusion.

Read the full research:
<p>http://www.bmj.com/cgi/doi/10.1136/bmj.h6543</p>
]]></description>
                                                            <content:encoded><![CDATA[Despite what hollywood says, science has proven that British teeth are actually better than American. Richard Watt, head of the Research Department of Epidemiology and Public Health at UCL explains how they came to that conclusion.

Read the full research:
<p>http://www.bmj.com/cgi/doi/10.1136/bmj.h6543</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/p4vwex/stream_237718109-bmjgroup-the-big-research-book-of-british-teeth.mp3" length="12195460" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Despite what hollywood says, science has proven that British teeth are actually better than American. Richard Watt, head of the Research Department of Epidemiology and Public Health at UCL explains how they came to that conclusion.

Read the full research:
http://www.bmj.com/cgi/doi/10.1136/bmj.h6543]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>508</itunes:duration>
                                    </item>
    <item>
        <title>Gunslingers gait</title>
        <itunes:title>Gunslingers gait</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/gunslingers-gait/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/gunslingers-gait/#comments</comments>        <pubDate>Tue, 15 Dec 2015 20:48:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/gunslingers-gate</guid>
                                    <description><![CDATA[A lot of attention has been paid to Russian president Vladimir Putin recently, but a group of researchers from The Netherlands are more interested in his walk than his intervention in Syria. Bastiaan Bloem, medical director of the Parkinson's Centre in Nijmegen, joins us to explain more.

<p>http://www.bmj.com/content/351/bmj.h6141</p>
<p></p>
]]></description>
                                                            <content:encoded><![CDATA[A lot of attention has been paid to Russian president Vladimir Putin recently, but a group of researchers from The Netherlands are more interested in his walk than his intervention in Syria. Bastiaan Bloem, medical director of the Parkinson's Centre in Nijmegen, joins us to explain more.

<p>http://www.bmj.com/content/351/bmj.h6141</p>
<p></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/h66od2/stream_237716449-bmjgroup-gunslingers-gate.mp3" length="15423091" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A lot of attention has been paid to Russian president Vladimir Putin recently, but a group of researchers from The Netherlands are more interested in his walk than his intervention in Syria. Bastiaan Bloem, medical director of the Parkinson's Centre in Nijmegen, joins us to explain more.

http://www.bmj.com/content/351/bmj.h6141
]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>643</itunes:duration>
                                    </item>
    <item>
        <title>Diagnosing COPD in primary care</title>
        <itunes:title>Diagnosing COPD in primary care</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/diagnosing-copd-in-primary-care/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/diagnosing-copd-in-primary-care/#comments</comments>        <pubDate>Fri, 04 Dec 2015 10:04:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/diagnosing-copd-in-primary</guid>
                                    <description><![CDATA[Francesca Conway, from the Department of Primary Care and Public Health at Imperial College London is co-author of an article on diagnosis of COPD. She joins us to discuss the major guideline recommendations, and highlights where they concur and where they differ.

Read the full article:
<p>http://www.bmj.com/content/351/bmj.h6171</p>
]]></description>
                                                            <content:encoded><![CDATA[Francesca Conway, from the Department of Primary Care and Public Health at Imperial College London is co-author of an article on diagnosis of COPD. She joins us to discuss the major guideline recommendations, and highlights where they concur and where they differ.

Read the full article:
<p>http://www.bmj.com/content/351/bmj.h6171</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8il6nr/stream_236030587-bmjgroup-diagnosing-copd-in-primary.mp3" length="37795608" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Francesca Conway, from the Department of Primary Care and Public Health at Imperial College London is co-author of an article on diagnosis of COPD. She joins us to discuss the major guideline recommendations, and highlights where they concur and where they differ.

Read the full article:
http://www.bmj.com/content/351/bmj.h6171]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>945</itunes:duration>
                                    </item>
    <item>
        <title>The more you see, the more you eat</title>
        <itunes:title>The more you see, the more you eat</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-more-you-see-the-more-you-eat/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-more-you-see-the-more-you-eat/#comments</comments>        <pubDate>Thu, 03 Dec 2015 15:34:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/portion-size-obesity</guid>
                                    <description><![CDATA[Larger portions of food increase consumption. Theresa Marteau, director of the Behaviour and Health Research Unit at the University of Cambridge, joins us to discuss how government action to tackle portion size and packaging could help reset our appetites and make us thinner.

Read the full analysis:
<p>http://www.bmj.com/content/351/bmj.h5863</p>
]]></description>
                                                            <content:encoded><![CDATA[Larger portions of food increase consumption. Theresa Marteau, director of the Behaviour and Health Research Unit at the University of Cambridge, joins us to discuss how government action to tackle portion size and packaging could help reset our appetites and make us thinner.

Read the full analysis:
<p>http://www.bmj.com/content/351/bmj.h5863</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7nls3a/stream_235904963-bmjgroup-portion-size-obesity.mp3" length="20010456" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Larger portions of food increase consumption. Theresa Marteau, director of the Behaviour and Health Research Unit at the University of Cambridge, joins us to discuss how government action to tackle portion size and packaging could help reset our appetites and make us thinner.

Read the full analysis:
http://www.bmj.com/content/351/bmj.h5863]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>834</itunes:duration>
                                    </item>
    <item>
        <title>Sarah Wollaston - obesity, not a sugary drinks tax, is regressive</title>
        <itunes:title>Sarah Wollaston - obesity, not a sugary drinks tax, is regressive</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/sarah-wollaston-obesity-not-a-sugary-drinks-tax-is-regressive/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/sarah-wollaston-obesity-not-a-sugary-drinks-tax-is-regressive/#comments</comments>        <pubDate>Wed, 02 Dec 2015 11:28:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/sarah-wollaston-obesity-not-a-sugary-drinks-tax-is-regressive</guid>
                                    <description><![CDATA[The UK Parliament's Health Select Committee's recent report on childhood obesity says 1 in 5 children are obese by the time they leave school. The committee calls for legislation to turn the tide by taxing sugary drinks, a pre-watershed ban on junk food advertising, and investment in public health.

<p>We joined Sarah Wollaston, conservative MP for Totnes, and chair of the committee for lunch (thai chicken soup) to discuss their recommendations.</p>
]]></description>
                                                            <content:encoded><![CDATA[The UK Parliament's Health Select Committee's recent report on childhood obesity says 1 in 5 children are obese by the time they leave school. The committee calls for legislation to turn the tide by taxing sugary drinks, a pre-watershed ban on junk food advertising, and investment in public health.

<p>We joined Sarah Wollaston, conservative MP for Totnes, and chair of the committee for lunch (thai chicken soup) to discuss their recommendations.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/bdatlg/stream_235722421-bmjgroup-sarah-wollaston-obesity-not-a-sugary-drinks-tax-is-regressive.mp3" length="39017636" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The UK Parliament's Health Select Committee's recent report on childhood obesity says 1 in 5 children are obese by the time they leave school. The committee calls for legislation to turn the tide by taxing sugary drinks, a pre-watershed ban on junk food advertising, and investment in public health.

We joined Sarah Wollaston, conservative MP for Totnes, and chair of the committee for lunch (thai chicken soup) to discuss their recommendations.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>976</itunes:duration>
                                    </item>
    <item>
        <title>The diagnosis and treatment of post-traumatic stress disorder</title>
        <itunes:title>The diagnosis and treatment of post-traumatic stress disorder</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-diagnosis-and-treatment-of-post-traumatic-stress-disorder/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-diagnosis-and-treatment-of-post-traumatic-stress-disorder/#comments</comments>        <pubDate>Fri, 27 Nov 2015 12:33:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-diagnosis-and-treatment-of-post-traumatic-stress-disorder</guid>
                                    <description><![CDATA[PTSD may develop after exposure to exceptionally threatening or horrifying events. About 3% of the adult population has PTSD at any one time, and more than 50% in survivors of rape.

In this podcast Jonathan Bisson, professor of psychiatry at the  School of Medicine in Cardiff joins us to talk about the evidence for diagnosis and treatment, and Sarah Cosgrove, the patient author of the paper, discusses her experience of treatment.

Read the full clinical review:
<p>http://www.bmj.com/content/351/bmj.h6161</p>
]]></description>
                                                            <content:encoded><![CDATA[PTSD may develop after exposure to exceptionally threatening or horrifying events. About 3% of the adult population has PTSD at any one time, and more than 50% in survivors of rape.

In this podcast Jonathan Bisson, professor of psychiatry at the  School of Medicine in Cardiff joins us to talk about the evidence for diagnosis and treatment, and Sarah Cosgrove, the patient author of the paper, discusses her experience of treatment.

Read the full clinical review:
<p>http://www.bmj.com/content/351/bmj.h6161</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mj8174/stream_234944847-bmjgroup-the-diagnosis-and-treatment-of-post-traumatic-stress-disorder.mp3" length="35478851" type="audio/mpeg"/>
        <itunes:summary><![CDATA[PTSD may develop after exposure to exceptionally threatening or horrifying events. About 3% of the adult population has PTSD at any one time, and more than 50% in survivors of rape.

In this podcast Jonathan Bisson, professor of psychiatry at the  School of Medicine in Cardiff joins us to talk about the evidence for diagnosis and treatment, and Sarah Cosgrove, the patient author of the paper, discusses her experience of treatment.

Read the full clinical review:
http://www.bmj.com/content/351/bmj.h6161]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1478</itunes:duration>
                                    </item>
    <item>
        <title>The evidence on doctors strikes and patient harm</title>
        <itunes:title>The evidence on doctors strikes and patient harm</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-evidence-on-doctors-strikes-and-patient-harm/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-evidence-on-doctors-strikes-and-patient-harm/#comments</comments>        <pubDate>Fri, 27 Nov 2015 12:23:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-evidence-on-doctors-strikes-and-patient-harm</guid>
                                    <description><![CDATA[Doctors considering strike action may worry about the effect on patients. David Metcalfe and colleagues examine the evidence and find that “patients do not come to serious harm during industrial action provided that provisions are made for emergency care.”

Read the full analysis:
<p>http://www.bmj.com/content/351/bmj.h6231</p>
]]></description>
                                                            <content:encoded><![CDATA[Doctors considering strike action may worry about the effect on patients. David Metcalfe and colleagues examine the evidence and find that “patients do not come to serious harm during industrial action provided that provisions are made for emergency care.”

Read the full analysis:
<p>http://www.bmj.com/content/351/bmj.h6231</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kvf8pb/stream_234944105-bmjgroup-the-evidence-on-doctors-strikes-and-patient-harm.mp3" length="14246189" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Doctors considering strike action may worry about the effect on patients. David Metcalfe and colleagues examine the evidence and find that “patients do not come to serious harm during industrial action provided that provisions are made for emergency care.”

Read the full analysis:
http://www.bmj.com/content/351/bmj.h6231]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>592</itunes:duration>
                                    </item>
    <item>
        <title>Revisiting the bridge</title>
        <itunes:title>Revisiting the bridge</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/revisiting-the-bridge/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/revisiting-the-bridge/#comments</comments>        <pubDate>Fri, 13 Nov 2015 16:55:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/revisiting-the-bridge</guid>
                                    <description><![CDATA[In the podcast, we’ll hear from Kevin Hines the survivor of such an attempt, and Alys Cole-King, a psychiatrist who wants to break down the stigma of suicide.

Originally broadcast in 2010

For more on suicide risk assessment and prevention, read our latest clinical review:
<p>http://www.bmj.com/content/351/bmj.h4978</p>
<p></p>
]]></description>
                                                            <content:encoded><![CDATA[In the podcast, we’ll hear from Kevin Hines the survivor of such an attempt, and Alys Cole-King, a psychiatrist who wants to break down the stigma of suicide.

Originally broadcast in 2010

For more on suicide risk assessment and prevention, read our latest clinical review:
<p>http://www.bmj.com/content/351/bmj.h4978</p>
<p></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8h2iom/stream_232919116-bmjgroup-revisiting-the-bridge.mp3" length="16890964" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In the podcast, we’ll hear from Kevin Hines the survivor of such an attempt, and Alys Cole-King, a psychiatrist who wants to break down the stigma of suicide.

Originally broadcast in 2010

For more on suicide risk assessment and prevention, read our latest clinical review:
http://www.bmj.com/content/351/bmj.h4978
]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>704</itunes:duration>
                                    </item>
    <item>
        <title>Unexpected findings, with uncertain implications, in research imaging</title>
        <itunes:title>Unexpected findings, with uncertain implications, in research imaging</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/unexpected-findings-with-uncertain-implications-in-research-imaging/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/unexpected-findings-with-uncertain-implications-in-research-imaging/#comments</comments>        <pubDate>Fri, 13 Nov 2015 16:20:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/incidental-findings-on-a-brain</guid>
                                    <description><![CDATA[When healthy volunteers are scanned as part of a research project, unexpected findings, with uncertain implications, can be thrown up. 

Joanna Wardlaw,  professor of applied neuroimaging and honorary consultant neuroradiologist at the University of Edinburgh, joins us to discuss how her group deals with these incidental findings, and what volunteers and patients want to happen when they are found.

Read the full analysis:
<p>http://www.bmj.com/content/351/bmj.h5190</p>
]]></description>
                                                            <content:encoded><![CDATA[When healthy volunteers are scanned as part of a research project, unexpected findings, with uncertain implications, can be thrown up. 

Joanna Wardlaw,  professor of applied neuroimaging and honorary consultant neuroradiologist at the University of Edinburgh, joins us to discuss how her group deals with these incidental findings, and what volunteers and patients want to happen when they are found.

Read the full analysis:
<p>http://www.bmj.com/content/351/bmj.h5190</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qtko41/stream_232914511-bmjgroup-incidental-findings-on-a-brain.mp3" length="18875482" type="audio/mpeg"/>
        <itunes:summary><![CDATA[When healthy volunteers are scanned as part of a research project, unexpected findings, with uncertain implications, can be thrown up. 

Joanna Wardlaw,  professor of applied neuroimaging and honorary consultant neuroradiologist at the University of Edinburgh, joins us to discuss how her group deals with these incidental findings, and what volunteers and patients want to happen when they are found.

Read the full analysis:
http://www.bmj.com/content/351/bmj.h5190]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>786</itunes:duration>
                                    </item>
    <item>
        <title>This house believes that medicine is the best career in the world.</title>
        <itunes:title>This house believes that medicine is the best career in the world.</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/this-house-believes-that-medicine-is-the-best-career-in-the-world/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/this-house-believes-that-medicine-is-the-best-career-in-the-world/#comments</comments>        <pubDate>Mon, 02 Nov 2015 12:36:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/this-house-believes-that-medicine-is-the-best-career-in-the-world</guid>
                                    <description><![CDATA[Medicine has long been a rewarding career, but doctors say the profession needs to overcome the frustrations of working in the NHS to ensure it remains so. 

During the Big Debate at BMJ Live in London last week six speakers argued for and against the motion, “This house believes that medicine is the best career in the world.” After presentations from the six speakers and questions from the floor, the audience voted in favour of the motion.

Arguing the motions are:

Jennie Watson, medical student, Imperial College (for)
Janis Burns, junior clinical fellow, Royal Brompton and Harefield NHS Foundation Trust (against)
Helgi Johannsson, anaesthetic consultant, Imperial College Healthcare NHS Trust(for)
Pete Deveson, GP, Epsom, Surrey(against)
Clare Gerada, medical director, Practitioner Health Programme(for)
Partha Kar, diabetes and endocrinology consultant, Portsmouth Hospitals NHS Trust(against)

edit: To see Pete Devesons slides - check out https://www.youtube.com/watch?v=cfRezS1dZJY
<p></p>
<p></p>
]]></description>
                                                            <content:encoded><![CDATA[Medicine has long been a rewarding career, but doctors say the profession needs to overcome the frustrations of working in the NHS to ensure it remains so. 

During the Big Debate at BMJ Live in London last week six speakers argued for and against the motion, “This house believes that medicine is the best career in the world.” After presentations from the six speakers and questions from the floor, the audience voted in favour of the motion.

Arguing the motions are:

Jennie Watson, medical student, Imperial College (for)
Janis Burns, junior clinical fellow, Royal Brompton and Harefield NHS Foundation Trust (against)
Helgi Johannsson, anaesthetic consultant, Imperial College Healthcare NHS Trust(for)
Pete Deveson, GP, Epsom, Surrey(against)
Clare Gerada, medical director, Practitioner Health Programme(for)
Partha Kar, diabetes and endocrinology consultant, Portsmouth Hospitals NHS Trust(against)

edit: To see Pete Devesons slides - check out https://www.youtube.com/watch?v=cfRezS1dZJY
<p></p>
<p></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/yju7tt/stream_231190844-bmjgroup-this-house-believes-that-medicine-is-the-best-career-in-the-world.mp3" length="65179108" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Medicine has long been a rewarding career, but doctors say the profession needs to overcome the frustrations of working in the NHS to ensure it remains so. 

During the Big Debate at BMJ Live in London last week six speakers argued for and against the motion, “This house believes that medicine is the best career in the world.” After presentations from the six speakers and questions from the floor, the audience voted in favour of the motion.

Arguing the motions are:

Jennie Watson, medical student, Imperial College (for)
Janis Burns, junior clinical fellow, Royal Brompton and Harefield NHS Foundation Trust (against)
Helgi Johannsson, anaesthetic consultant, Imperial College Healthcare NHS Trust(for)
Pete Deveson, GP, Epsom, Surrey(against)
Clare Gerada, medical director, Practitioner Health Programme(for)
Partha Kar, diabetes and endocrinology consultant, Portsmouth Hospitals NHS Trust(against)

edit: To see Pete Devesons slides - check out https://www.youtube.com/watch?v=cfRezS1dZJY

]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2719</itunes:duration>
                                    </item>
    <item>
        <title>Diagnosis and treatment of diabetic ketoacidosis in adults</title>
        <itunes:title>Diagnosis and treatment of diabetic ketoacidosis in adults</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/diagnosis-and-treatment-of-diabetic-ketoacidosis-in-adults/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/diagnosis-and-treatment-of-diabetic-ketoacidosis-in-adults/#comments</comments>        <pubDate>Fri, 30 Oct 2015 14:01:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/diagnosis-and-treatment-of-diabetic-ketoacidosis-in-adults</guid>
                                    <description><![CDATA[Shivani Misra, clinical research fellow and specialist trainee in metabolic medicine from Imperial College London, joins us to discuss diagnosis and management of diabetic ketoacidosis in adults. She talks us through UK and US guidelines, and explains what the latest evidence tells us about prescribing fluid and insulin.

Read the full clinical review:
<p>http://www.bmj.com/content/351/bmj.h5660</p>
<p></p>
]]></description>
                                                            <content:encoded><![CDATA[Shivani Misra, clinical research fellow and specialist trainee in metabolic medicine from Imperial College London, joins us to discuss diagnosis and management of diabetic ketoacidosis in adults. She talks us through UK and US guidelines, and explains what the latest evidence tells us about prescribing fluid and insulin.

Read the full clinical review:
<p>http://www.bmj.com/content/351/bmj.h5660</p>
<p></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/zcnptm/stream_230784681-bmjgroup-diagnosis-and-treatment-of-diabetic-ketoacidosis-in-adults.mp3" length="26401338" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Shivani Misra, clinical research fellow and specialist trainee in metabolic medicine from Imperial College London, joins us to discuss diagnosis and management of diabetic ketoacidosis in adults. She talks us through UK and US guidelines, and explains what the latest evidence tells us about prescribing fluid and insulin.

Read the full clinical review:
http://www.bmj.com/content/351/bmj.h5660
]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1101</itunes:duration>
                                    </item>
    <item>
        <title>Europe’s impending syrup tsunami</title>
        <itunes:title>Europe’s impending syrup tsunami</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/europe-s-impending-syrup-tsunami/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/europe-s-impending-syrup-tsunami/#comments</comments>        <pubDate>Thu, 29 Oct 2015 10:41:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/syrup-tsunami</guid>
                                    <description><![CDATA[Europe's common agricultural policy (CAP) on sugar is due to change, and Emilie Aguirre, from the UKCRC Centre for Diet and Activity Research at the University of Cambridge, argues that an influx of cheap high fructose corn syrup (HFCS, isoglucose) into the European market will have a negative effect on on the health of the continent.

Read the full analysis here:
<p>http://www.bmj.com/content/351/bmj.h5085</p>
]]></description>
                                                            <content:encoded><![CDATA[Europe's common agricultural policy (CAP) on sugar is due to change, and Emilie Aguirre, from the UKCRC Centre for Diet and Activity Research at the University of Cambridge, argues that an influx of cheap high fructose corn syrup (HFCS, isoglucose) into the European market will have a negative effect on on the health of the continent.

Read the full analysis here:
<p>http://www.bmj.com/content/351/bmj.h5085</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/f7krai/stream_230608896-bmjgroup-syrup-tsunami.mp3" length="27864765" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Europe's common agricultural policy (CAP) on sugar is due to change, and Emilie Aguirre, from the UKCRC Centre for Diet and Activity Research at the University of Cambridge, argues that an influx of cheap high fructose corn syrup (HFCS, isoglucose) into the European market will have a negative effect on on the health of the continent.

Read the full analysis here:
http://www.bmj.com/content/351/bmj.h5085]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1162</itunes:duration>
                                    </item>
    <item>
        <title>Mark Britnell - You have to value your workforce</title>
        <itunes:title>Mark Britnell - You have to value your workforce</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/mark-britnell-you-have-to-value-your-workforce/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/mark-britnell-you-have-to-value-your-workforce/#comments</comments>        <pubDate>Thu, 22 Oct 2015 15:26:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/mark-britnel</guid>
                                    <description><![CDATA[“The people of the UK are right to treasure their NHS,” writes Mark Britnell in his new book In Search of the Perfect Health System (Palgrave Macmillan). Currently chairman of KPMG Global Health, Britnell has worked in healthcare systems in over 60 countries. For his book he analysed 25 healthcare systems in search of what was working and what wasn’t in times of challenging demographic and economic change. He doesn’t find perfection, but against the others the NHS measures up pretty well.

Buy the book:
<p>http://www.amazon.co.uk/In-Search-Perfect-Health-System/dp/1137496614</p>
]]></description>
                                                            <content:encoded><![CDATA[“The people of the UK are right to treasure their NHS,” writes Mark Britnell in his new book In Search of the Perfect Health System (Palgrave Macmillan). Currently chairman of KPMG Global Health, Britnell has worked in healthcare systems in over 60 countries. For his book he analysed 25 healthcare systems in search of what was working and what wasn’t in times of challenging demographic and economic change. He doesn’t find perfection, but against the others the NHS measures up pretty well.

Buy the book:
<p>http://www.amazon.co.uk/In-Search-Perfect-Health-System/dp/1137496614</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/nkhxav/stream_229582927-bmjgroup-mark-britnel.mp3" length="37380534" type="audio/mpeg"/>
        <itunes:summary><![CDATA[“The people of the UK are right to treasure their NHS,” writes Mark Britnell in his new book In Search of the Perfect Health System (Palgrave Macmillan). Currently chairman of KPMG Global Health, Britnell has worked in healthcare systems in over 60 countries. For his book he analysed 25 healthcare systems in search of what was working and what wasn’t in times of challenging demographic and economic change. He doesn’t find perfection, but against the others the NHS measures up pretty well.

Buy the book:
http://www.amazon.co.uk/In-Search-Perfect-Health-System/dp/1137496614]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1559</itunes:duration>
                                    </item>
    <item>
        <title>The junior doctor protest</title>
        <itunes:title>The junior doctor protest</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-junior-doctor-protest/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-junior-doctor-protest/#comments</comments>        <pubDate>Wed, 21 Oct 2015 09:23:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/junior-doctor-protest</guid>
                                    <description><![CDATA[Thousands of NHS staff have demonstrated against the government’s threatened “imposition” of an “unsafe and unfair” contract for junior doctors.

At a London rally on Saturday 17 October junior doctors and supporters noisily defended their trade union, as speakers accused England’s health secretary, Jeremy Hunt, of misleading the public about research evidence on weekend mortality rates in hospitals and the nature of contract negotiations.

Matt Limb was there for the BMJ, finding out why junior doctors are so angry.

Read more:
<p>http://www.bmj.com/content/351/bmj.h5572</p>
]]></description>
                                                            <content:encoded><![CDATA[Thousands of NHS staff have demonstrated against the government’s threatened “imposition” of an “unsafe and unfair” contract for junior doctors.

At a London rally on Saturday 17 October junior doctors and supporters noisily defended their trade union, as speakers accused England’s health secretary, Jeremy Hunt, of misleading the public about research evidence on weekend mortality rates in hospitals and the nature of contract negotiations.

Matt Limb was there for the BMJ, finding out why junior doctors are so angry.

Read more:
<p>http://www.bmj.com/content/351/bmj.h5572</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/n9ri6r/stream_229386495-bmjgroup-junior-doctor-protest.mp3" length="10824602" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Thousands of NHS staff have demonstrated against the government’s threatened “imposition” of an “unsafe and unfair” contract for junior doctors.

At a London rally on Saturday 17 October junior doctors and supporters noisily defended their trade union, as speakers accused England’s health secretary, Jeremy Hunt, of misleading the public about research evidence on weekend mortality rates in hospitals and the nature of contract negotiations.

Matt Limb was there for the BMJ, finding out why junior doctors are so angry.

Read more:
http://www.bmj.com/content/351/bmj.h5572]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>451</itunes:duration>
                                    </item>
    <item>
        <title>Are new diabetes drugs approved too easily?</title>
        <itunes:title>Are new diabetes drugs approved too easily?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/are-new-diabetes-drugs-approved-too-easily/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/are-new-diabetes-drugs-approved-too-easily/#comments</comments>        <pubDate>Mon, 19 Oct 2015 14:18:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/diabetes-regulation</guid>
                                    <description><![CDATA[<p>Given the number of effective treatments for type II diabetes, which have good evidence about safety and efficacy, should any new drugs for the condition be subject to a higher regulatory bar?</p>
<p>In this podcast, Huseyin Naci from the London School of Economics, John Yudkin from Univerity College London, and Ben Goldacre from the University of Oxford, explain why they believe the current process is inadequate, and suggest some ways in which it could be improved.</p>
<p>Read the full analysis article:</p>
<p>http://www.bmj.com/content/351/bmj.h5260</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Given the number of effective treatments for type II diabetes, which have good evidence about safety and efficacy, should any new drugs for the condition be subject to a higher regulatory bar?</p>
<p>In this podcast, Huseyin Naci from the London School of Economics, John Yudkin from Univerity College London, and Ben Goldacre from the University of Oxford, explain why they believe the current process is inadequate, and suggest some ways in which it could be improved.</p>
<p>Read the full analysis article:</p>
<p>http://www.bmj.com/content/351/bmj.h5260</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/cu1xzf/stream_229093978-bmjgroup-diabetes-regulation.mp3" length="36564182" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Given the number of effective treatments for type II diabetes, which have good evidence about safety and efficacy, should any new drugs for the condition be subject to a higher regulatory bar?In this podcast, Huseyin Naci from the London School of Economics, John Yudkin from Univerity College London, and Ben Goldacre from the University of Oxford, explain why they believe the current process is inadequate, and suggest some ways in which it could be improved.Read the full analysis article:http://www.bmj.com/content/351/bmj.h5260]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1524</itunes:duration>
                                    </item>
    <item>
        <title>Is place of death important to patients?</title>
        <itunes:title>Is place of death important to patients?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/is-place-of-death-important-to-patients/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/is-place-of-death-important-to-patients/#comments</comments>        <pubDate>Mon, 12 Oct 2015 13:41:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/place-of-death</guid>
                                    <description><![CDATA[The current orthodoxy is that home is the best and preferred place of death for most people, but in this podcast, Kristian Pollock a sociologist from Nottingham University questions these assumptions and calls for greater attention to improving the experience of dying in hospital and elsewhere.

Read the full analysis:
<p>http://www.bmj.com/content/351/bmj.h4855</p>
]]></description>
                                                            <content:encoded><![CDATA[The current orthodoxy is that home is the best and preferred place of death for most people, but in this podcast, Kristian Pollock a sociologist from Nottingham University questions these assumptions and calls for greater attention to improving the experience of dying in hospital and elsewhere.

Read the full analysis:
<p>http://www.bmj.com/content/351/bmj.h4855</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2ild0k/stream_228046317-bmjgroup-place-of-death.mp3" length="26660563" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The current orthodoxy is that home is the best and preferred place of death for most people, but in this podcast, Kristian Pollock a sociologist from Nottingham University questions these assumptions and calls for greater attention to improving the experience of dying in hospital and elsewhere.

Read the full analysis:
http://www.bmj.com/content/351/bmj.h4855]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1112</itunes:duration>
                                    </item>
    <item>
        <title>Why do the Scottish do fewer knee arthroscopies?</title>
        <itunes:title>Why do the Scottish do fewer knee arthroscopies?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/why-do-the-scottish-do-fewer-knee-arthroscopies/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/why-do-the-scottish-do-fewer-knee-arthroscopies/#comments</comments>        <pubDate>Sat, 26 Sep 2015 15:34:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/knee-arthroscopy</guid>
                                    <description><![CDATA[The “correct” rates of discretional interventions are difficult to define. However, David Hamilton and Colin Howie point out that discrepancies in usage of knee arthroscopy within the UK suggest the organisation of the care pathway may be an important determinant

Read their full analysis:
<p>http://www.bmj.com/content/351/bmj.h4720</p>
]]></description>
                                                            <content:encoded><![CDATA[The “correct” rates of discretional interventions are difficult to define. However, David Hamilton and Colin Howie point out that discrepancies in usage of knee arthroscopy within the UK suggest the organisation of the care pathway may be an important determinant

Read their full analysis:
<p>http://www.bmj.com/content/351/bmj.h4720</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4mk0x2/stream_225678771-bmjgroup-knee-arthroscopy.mp3" length="25874809" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The “correct” rates of discretional interventions are difficult to define. However, David Hamilton and Colin Howie point out that discrepancies in usage of knee arthroscopy within the UK suggest the organisation of the care pathway may be an important determinant

Read their full analysis:
http://www.bmj.com/content/351/bmj.h4720]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1079</itunes:duration>
                                    </item>
    <item>
        <title>Cardiac rehab</title>
        <itunes:title>Cardiac rehab</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/cardiac-rehab/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/cardiac-rehab/#comments</comments>        <pubDate>Sat, 26 Sep 2015 14:52:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/cardiac-rehab</guid>
                                    <description><![CDATA[With improved survival and and ageing population, the number of people living with coronary heart disease in the UK has increased to an estimated 2.3 million. There is increasing evidence that cardiac rehabilitation benefits these patients, and as such it has been included in international clinical guidelines.

To discuss cardiac rehabilitation in this podcast, we're joined by Hasnain Dalal, a GP and honorary clinical associate professor at the University of Exeter Medical School, Rod Taylor, academic lead for Exeter Clinical Trials Support Network and NIHR senior investigator, and Jenny Wingham, a senior clinical researcher in cardiac rehabilitation.

Read the full clinical review online:
http://www.bmj.com/content/351/bmj.h5000

<p>Listen to our podcast with a patient who's been through cardiac rehabilitation: https://soundcloud.com/bmjpodcasts/cardiac-rehab-patient</p>
]]></description>
                                                            <content:encoded><![CDATA[With improved survival and and ageing population, the number of people living with coronary heart disease in the UK has increased to an estimated 2.3 million. There is increasing evidence that cardiac rehabilitation benefits these patients, and as such it has been included in international clinical guidelines.

To discuss cardiac rehabilitation in this podcast, we're joined by Hasnain Dalal, a GP and honorary clinical associate professor at the University of Exeter Medical School, Rod Taylor, academic lead for Exeter Clinical Trials Support Network and NIHR senior investigator, and Jenny Wingham, a senior clinical researcher in cardiac rehabilitation.

Read the full clinical review online:
http://www.bmj.com/content/351/bmj.h5000

<p>Listen to our podcast with a patient who's been through cardiac rehabilitation: https://soundcloud.com/bmjpodcasts/cardiac-rehab-patient</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/be6q96/stream_225674002-bmjgroup-cardiac-rehab.mp3" length="36248885" type="audio/mpeg"/>
        <itunes:summary><![CDATA[With improved survival and and ageing population, the number of people living with coronary heart disease in the UK has increased to an estimated 2.3 million. There is increasing evidence that cardiac rehabilitation benefits these patients, and as such it has been included in international clinical guidelines.

To discuss cardiac rehabilitation in this podcast, we're joined by Hasnain Dalal, a GP and honorary clinical associate professor at the University of Exeter Medical School, Rod Taylor, academic lead for Exeter Clinical Trials Support Network and NIHR senior investigator, and Jenny Wingham, a senior clinical researcher in cardiac rehabilitation.

Read the full clinical review online:
http://www.bmj.com/content/351/bmj.h5000

Listen to our podcast with a patient who's been through cardiac rehabilitation: https://soundcloud.com/bmjpodcasts/cardiac-rehab-patient]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1512</itunes:duration>
                                    </item>
    <item>
        <title>What it’s like to receive cardiac rehabilitation</title>
        <itunes:title>What it’s like to receive cardiac rehabilitation</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/what-it-s-like-to-receive-cardiac-rehabilitation/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/what-it-s-like-to-receive-cardiac-rehabilitation/#comments</comments>        <pubDate>Sat, 26 Sep 2015 14:09:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/cardiac-rehab-patient</guid>
                                    <description><![CDATA[With improved survival and and ageing population, the number of people living with coronary heart disease in the UK has increased to an estimated 2.3 million. There is increasing evidence that cardiac rehabilitation benefits these patients, and as such it has been included in international clinical guidelines.

​In this podcast, we're joined by Kevin Paul, who explains what it's like to receive cardiac rehabilitation, and what doctors should be aware of when they recommend it to patients.

<p>Read the full clinical review online: http://www.bmj.com/content/351/bmj.h5000</p>
]]></description>
                                                            <content:encoded><![CDATA[With improved survival and and ageing population, the number of people living with coronary heart disease in the UK has increased to an estimated 2.3 million. There is increasing evidence that cardiac rehabilitation benefits these patients, and as such it has been included in international clinical guidelines.

​In this podcast, we're joined by Kevin Paul, who explains what it's like to receive cardiac rehabilitation, and what doctors should be aware of when they recommend it to patients.

<p>Read the full clinical review online: http://www.bmj.com/content/351/bmj.h5000</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ot7ntc/stream_225669374-bmjgroup-cardiac-rehab-patient.mp3" length="18012147" type="audio/mpeg"/>
        <itunes:summary><![CDATA[With improved survival and and ageing population, the number of people living with coronary heart disease in the UK has increased to an estimated 2.3 million. There is increasing evidence that cardiac rehabilitation benefits these patients, and as such it has been included in international clinical guidelines.

​In this podcast, we're joined by Kevin Paul, who explains what it's like to receive cardiac rehabilitation, and what doctors should be aware of when they recommend it to patients.

Read the full clinical review online: http://www.bmj.com/content/351/bmj.h5000]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>751</itunes:duration>
                                    </item>
    <item>
        <title>How scientific are US dietary guidelines?</title>
        <itunes:title>How scientific are US dietary guidelines?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/how-scientific-are-us-dietary-guidelines/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/how-scientific-are-us-dietary-guidelines/#comments</comments>        <pubDate>Fri, 25 Sep 2015 09:56:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/how-scientific-are-us-dietary-guidelines</guid>
                                    <description><![CDATA[They have a big impact on the diet of American citizens, and those of most Western nations, so why does the expert advice underpinning US government dietary guidelines not take account of all the relevant scientific evidence asks Nina Teicholz.

Read the full investigation:
<p>http://www.bmj.com/content/351/bmj.h4962</p>
]]></description>
                                                            <content:encoded><![CDATA[They have a big impact on the diet of American citizens, and those of most Western nations, so why does the expert advice underpinning US government dietary guidelines not take account of all the relevant scientific evidence asks Nina Teicholz.

Read the full investigation:
<p>http://www.bmj.com/content/351/bmj.h4962</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/202eow/stream_225503708-bmjgroup-how-scientific-are-us-dietary-guidelines.mp3" length="21443357" type="audio/mpeg"/>
        <itunes:summary><![CDATA[They have a big impact on the diet of American citizens, and those of most Western nations, so why does the expert advice underpinning US government dietary guidelines not take account of all the relevant scientific evidence asks Nina Teicholz.

Read the full investigation:
http://www.bmj.com/content/351/bmj.h4962]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>894</itunes:duration>
                                    </item>
    <item>
        <title>Dengue fever</title>
        <itunes:title>Dengue fever</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/dengue-fever-1680599500/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/dengue-fever-1680599500/#comments</comments>        <pubDate>Thu, 24 Sep 2015 14:15:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/dengue-fever</guid>
                                    <description><![CDATA[Around two fifths of the world’s population (those in tropical and subtropical countries), or up to 2.5 billion people, are at risk of dengue infection.

An estimated 50 million infections occur annually worldwide, with 0.5 million of these cases being admitted to hospital for dengue haemorrhagic fever. Approximately 90% of these cases are in children aged less than 5 years. The epidemiology is, however, changing both regionally and globally. 

In this podcast, Senanayake A M Kularatne, senior professor of medicine at the University of Peradeniya in Sri Lanka, joins us to discuss which symptoms should make doctors consider a diagnosis of Dengue fever.

Read the full clinical review:
http://www.bmj.com/content/351/bmj.h4661

Read the best practice monograph:
<p>http://bestpractice.bmj.com/best-practice/monograph/1197.html</p>
]]></description>
                                                            <content:encoded><![CDATA[Around two fifths of the world’s population (those in tropical and subtropical countries), or up to 2.5 billion people, are at risk of dengue infection.

An estimated 50 million infections occur annually worldwide, with 0.5 million of these cases being admitted to hospital for dengue haemorrhagic fever. Approximately 90% of these cases are in children aged less than 5 years. The epidemiology is, however, changing both regionally and globally. 

In this podcast, Senanayake A M Kularatne, senior professor of medicine at the University of Peradeniya in Sri Lanka, joins us to discuss which symptoms should make doctors consider a diagnosis of Dengue fever.

Read the full clinical review:
http://www.bmj.com/content/351/bmj.h4661

Read the best practice monograph:
<p>http://bestpractice.bmj.com/best-practice/monograph/1197.html</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vzxs2r/stream_225369000-bmjgroup-dengue-fever.mp3" length="12004094" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Around two fifths of the world’s population (those in tropical and subtropical countries), or up to 2.5 billion people, are at risk of dengue infection.

An estimated 50 million infections occur annually worldwide, with 0.5 million of these cases being admitted to hospital for dengue haemorrhagic fever. Approximately 90% of these cases are in children aged less than 5 years. The epidemiology is, however, changing both regionally and globally. 

In this podcast, Senanayake A M Kularatne, senior professor of medicine at the University of Peradeniya in Sri Lanka, joins us to discuss which symptoms should make doctors consider a diagnosis of Dengue fever.

Read the full clinical review:
http://www.bmj.com/content/351/bmj.h4661

Read the best practice monograph:
http://bestpractice.bmj.com/best-practice/monograph/1197.html]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>500</itunes:duration>
                                    </item>
    <item>
        <title>They drained 92L from me - diagnosis and management of pleural effusion</title>
        <itunes:title>They drained 92L from me - diagnosis and management of pleural effusion</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/they-drained-92l-from-me-diagnosis-and-management-of-pleural-effusion/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/they-drained-92l-from-me-diagnosis-and-management-of-pleural-effusion/#comments</comments>        <pubDate>Thu, 10 Sep 2015 10:56:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/pleural-effusion</guid>
                                    <description><![CDATA[Pleural effusions are common, with an estimated 1-1.5 million new cases in the United States and 200 000-250 000 in the United Kingdom each year.

Rahul Bhatnagar, academic clinical lecturer at the University of Bristol, describes how pleural effusions may be investigated and treated in the community and secondary care, with a particular focus on the emerging phenomenon of ambulatory management.

We're also joined by Ron who boasts that he could have filled his car twice over, with the fluid drained over the two years he had a catheter in situ.

Read the full clinical review:
<p>http://www.bmj.com/content/351/bmj.h4520</p>
]]></description>
                                                            <content:encoded><![CDATA[Pleural effusions are common, with an estimated 1-1.5 million new cases in the United States and 200 000-250 000 in the United Kingdom each year.

Rahul Bhatnagar, academic clinical lecturer at the University of Bristol, describes how pleural effusions may be investigated and treated in the community and secondary care, with a particular focus on the emerging phenomenon of ambulatory management.

We're also joined by Ron who boasts that he could have filled his car twice over, with the fluid drained over the two years he had a catheter in situ.

Read the full clinical review:
<p>http://www.bmj.com/content/351/bmj.h4520</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7u7izv/stream_223207805-bmjgroup-pleural-effusion.mp3" length="32413871" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Pleural effusions are common, with an estimated 1-1.5 million new cases in the United States and 200 000-250 000 in the United Kingdom each year.

Rahul Bhatnagar, academic clinical lecturer at the University of Bristol, describes how pleural effusions may be investigated and treated in the community and secondary care, with a particular focus on the emerging phenomenon of ambulatory management.

We're also joined by Ron who boasts that he could have filled his car twice over, with the fluid drained over the two years he had a catheter in situ.

Read the full clinical review:
http://www.bmj.com/content/351/bmj.h4520]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1352</itunes:duration>
                                    </item>
    <item>
        <title>Being diagnosed with ovarian cancer</title>
        <itunes:title>Being diagnosed with ovarian cancer</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/being-diagnosed-with-ovarian-cancer/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/being-diagnosed-with-ovarian-cancer/#comments</comments>        <pubDate>Wed, 09 Sep 2015 10:55:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/being-diagnosed-with-ovarian-cancer</guid>
                                    <description><![CDATA[Ovarian cancer is the 7th most common cancer in women world wide, and 5 year survival continues to remain low - in the UK this has been attributed to delayed diagnosis.  

In this podcast Sophie Cook is joined today by two women who have had, and been treated for, ovarian cancer. Adele and Rosemary describe their experience, and what they think doctors should know about what patients are feeling.

Read the full clinical review:
www.bmj.com/content/351/bmj.h4443

Listen to the podcast on diagnosing ovarian cancer:
<p>https://soundcloud.com/bmjpodcasts/diagnosing-ovarian-cancer</p>
]]></description>
                                                            <content:encoded><![CDATA[Ovarian cancer is the 7th most common cancer in women world wide, and 5 year survival continues to remain low - in the UK this has been attributed to delayed diagnosis.  

In this podcast Sophie Cook is joined today by two women who have had, and been treated for, ovarian cancer. Adele and Rosemary describe their experience, and what they think doctors should know about what patients are feeling.

Read the full clinical review:
www.bmj.com/content/351/bmj.h4443

Listen to the podcast on diagnosing ovarian cancer:
<p>https://soundcloud.com/bmjpodcasts/diagnosing-ovarian-cancer</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/h5lx4r/stream_223049495-bmjgroup-being-diagnosed-with-ovarian-cancer.mp3" length="37577975" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Ovarian cancer is the 7th most common cancer in women world wide, and 5 year survival continues to remain low - in the UK this has been attributed to delayed diagnosis.  

In this podcast Sophie Cook is joined today by two women who have had, and been treated for, ovarian cancer. Adele and Rosemary describe their experience, and what they think doctors should know about what patients are feeling.

Read the full clinical review:
www.bmj.com/content/351/bmj.h4443

Listen to the podcast on diagnosing ovarian cancer:
https://soundcloud.com/bmjpodcasts/diagnosing-ovarian-cancer]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1567</itunes:duration>
                                    </item>
    <item>
        <title>Diagnosing ovarian cancer</title>
        <itunes:title>Diagnosing ovarian cancer</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/diagnosing-ovarian-cancer-1680599145/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/diagnosing-ovarian-cancer-1680599145/#comments</comments>        <pubDate>Tue, 08 Sep 2015 09:52:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/diagnosing-ovarian-cancer</guid>
                                    <description><![CDATA[Ovarian cancer is the 7th most common cancer in women world wide, and 5 year survival continues to remain low -  in the UK this has been attributed to delayed diagnosis.

In this podcast Sudha Sundar, senior lecturer in gynaecological oncology at the University of Birmingham, discusses how doctors can identify women at risk, and who to refer for specialist evaluation.

Read the full clinical review:
http://www.bmj.com/content/351/bmj.h4443

Find out what patients are experiencing:
<p>https://soundcloud.com/bmjpodcasts/being-diagnosed-with-ovarian-cancer</p>
]]></description>
                                                            <content:encoded><![CDATA[Ovarian cancer is the 7th most common cancer in women world wide, and 5 year survival continues to remain low -  in the UK this has been attributed to delayed diagnosis.

In this podcast Sudha Sundar, senior lecturer in gynaecological oncology at the University of Birmingham, discusses how doctors can identify women at risk, and who to refer for specialist evaluation.

Read the full clinical review:
http://www.bmj.com/content/351/bmj.h4443

Find out what patients are experiencing:
<p>https://soundcloud.com/bmjpodcasts/being-diagnosed-with-ovarian-cancer</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4bity6/stream_222884196-bmjgroup-diagnosing-ovarian-cancer.mp3" length="23686661" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Ovarian cancer is the 7th most common cancer in women world wide, and 5 year survival continues to remain low -  in the UK this has been attributed to delayed diagnosis.

In this podcast Sudha Sundar, senior lecturer in gynaecological oncology at the University of Birmingham, discusses how doctors can identify women at risk, and who to refer for specialist evaluation.

Read the full clinical review:
http://www.bmj.com/content/351/bmj.h4443

Find out what patients are experiencing:
https://soundcloud.com/bmjpodcasts/being-diagnosed-with-ovarian-cancer]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>987</itunes:duration>
                                    </item>
    <item>
        <title>A research agenda for medical overuse</title>
        <itunes:title>A research agenda for medical overuse</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/a-research-agenda-for-medical-overuse/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/a-research-agenda-for-medical-overuse/#comments</comments>        <pubDate>Wed, 02 Sep 2015 11:08:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/a-research-agenda-for-overdiagnosis</guid>
                                    <description><![CDATA[Although overuse in medicine is gaining increased attention, many questions remain unanswered. 

At the Preventing Overdiagnosis conference in Washington, Dan Morgan, associate professor at the University of Maryland School of Medicine, and Sanket Dhruva, research fellow at Yale University, propose an agenda for coordinated research to improve our understanding of the problem.

Read the full agenda at:
<p>http://www.bmj.com/content/351/bmj.h4534</p>
]]></description>
                                                            <content:encoded><![CDATA[Although overuse in medicine is gaining increased attention, many questions remain unanswered. 

At the Preventing Overdiagnosis conference in Washington, Dan Morgan, associate professor at the University of Maryland School of Medicine, and Sanket Dhruva, research fellow at Yale University, propose an agenda for coordinated research to improve our understanding of the problem.

Read the full agenda at:
<p>http://www.bmj.com/content/351/bmj.h4534</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/pc4qfe/stream_222000050-bmjgroup-a-research-agenda-for-overdiagnosis.mp3" length="14934206" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Although overuse in medicine is gaining increased attention, many questions remain unanswered. 

At the Preventing Overdiagnosis conference in Washington, Dan Morgan, associate professor at the University of Maryland School of Medicine, and Sanket Dhruva, research fellow at Yale University, propose an agenda for coordinated research to improve our understanding of the problem.

Read the full agenda at:
http://www.bmj.com/content/351/bmj.h4534]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>623</itunes:duration>
                                    </item>
    <item>
        <title>Diagnosis and treatment of hepatic encephalopathy</title>
        <itunes:title>Diagnosis and treatment of hepatic encephalopathy</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/diagnosis-and-treatment-of-hepatic-encephalopathy/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/diagnosis-and-treatment-of-hepatic-encephalopathy/#comments</comments>        <pubDate>Fri, 14 Aug 2015 16:41:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/hepatic-encephalopathy</guid>
                                    <description><![CDATA[Hepatic encephalopathy constitutes a spectrum of neuropsychiatric abnormalities, beginning with subtle psychomotor changes and progressing to confusion with asterixis, somnolence, and then coma, arising in patients with impaired liver function.

In this podcast, Tim Cross, a consultant hepatologist from the Royal Liverpool University Hospital, describes how to diagnose and manage the condition.

We're also joined by Ralph Crawford, who suffers from hepatic encephalopathy, to talk about the burden of the disease and the treatment from a patient's perspective.

Read the full review:
<p>http://www.bmj.com/content/351/bmj.h4187</p>
]]></description>
                                                            <content:encoded><![CDATA[Hepatic encephalopathy constitutes a spectrum of neuropsychiatric abnormalities, beginning with subtle psychomotor changes and progressing to confusion with asterixis, somnolence, and then coma, arising in patients with impaired liver function.

In this podcast, Tim Cross, a consultant hepatologist from the Royal Liverpool University Hospital, describes how to diagnose and manage the condition.

We're also joined by Ralph Crawford, who suffers from hepatic encephalopathy, to talk about the burden of the disease and the treatment from a patient's perspective.

Read the full review:
<p>http://www.bmj.com/content/351/bmj.h4187</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/b78hbw/stream_219241958-bmjgroup-hepatic-encephalopathy.mp3" length="33870055" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Hepatic encephalopathy constitutes a spectrum of neuropsychiatric abnormalities, beginning with subtle psychomotor changes and progressing to confusion with asterixis, somnolence, and then coma, arising in patients with impaired liver function.

In this podcast, Tim Cross, a consultant hepatologist from the Royal Liverpool University Hospital, describes how to diagnose and manage the condition.

We're also joined by Ralph Crawford, who suffers from hepatic encephalopathy, to talk about the burden of the disease and the treatment from a patient's perspective.

Read the full review:
http://www.bmj.com/content/351/bmj.h4187]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1413</itunes:duration>
                                    </item>
    <item>
        <title>Open Doors For Sex Workers</title>
        <itunes:title>Open Doors For Sex Workers</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/open-doors-for-sex-workers/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/open-doors-for-sex-workers/#comments</comments>        <pubDate>Fri, 14 Aug 2015 15:46:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/open-doors-for-sex-workers</guid>
                                    <description><![CDATA[Following on from the clinical review "Caring for sex workers", we spoke to the team at Open Doors, a sex worker outreach clinic in east London, run from the Homerton University Hospital NHS Foundation Trust.

Kim Leveret and Anca Doczi join us to give practical advice on reaching out to sex workers, what barriers exist to them accessing care, and how to take a sex worker sexual history.

Listen to the author of the clinical review, Michael Rekart, talk about the infectious disease side of sex worker health in our accompanying podcast:
https://soundcloud.com/bmjpodcasts/sex-worker-health

Read the full review:
http://www.bmj.com/content/351/bmj.h4011

Practical advice for sex workers and health professionals, including links to Ugly Mugs:
http://www.opendoors.nhs.uk/

The historic reasons for high abortion rates in Romania, from the journal of family planning and reproductive healthcare:
<p>https://soundcloud.com/bmjpodcasts/romanian-womens-fertility</p>
]]></description>
                                                            <content:encoded><![CDATA[Following on from the clinical review "Caring for sex workers", we spoke to the team at Open Doors, a sex worker outreach clinic in east London, run from the Homerton University Hospital NHS Foundation Trust.

Kim Leveret and Anca Doczi join us to give practical advice on reaching out to sex workers, what barriers exist to them accessing care, and how to take a sex worker sexual history.

Listen to the author of the clinical review, Michael Rekart, talk about the infectious disease side of sex worker health in our accompanying podcast:
https://soundcloud.com/bmjpodcasts/sex-worker-health

Read the full review:
http://www.bmj.com/content/351/bmj.h4011

Practical advice for sex workers and health professionals, including links to Ugly Mugs:
http://www.opendoors.nhs.uk/

The historic reasons for high abortion rates in Romania, from the journal of family planning and reproductive healthcare:
<p>https://soundcloud.com/bmjpodcasts/romanian-womens-fertility</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/etuejc/stream_219234411-bmjgroup-open-doors-for-sex-workers.mp3" length="24590013" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Following on from the clinical review "Caring for sex workers", we spoke to the team at Open Doors, a sex worker outreach clinic in east London, run from the Homerton University Hospital NHS Foundation Trust.

Kim Leveret and Anca Doczi join us to give practical advice on reaching out to sex workers, what barriers exist to them accessing care, and how to take a sex worker sexual history.

Listen to the author of the clinical review, Michael Rekart, talk about the infectious disease side of sex worker health in our accompanying podcast:
https://soundcloud.com/bmjpodcasts/sex-worker-health

Read the full review:
http://www.bmj.com/content/351/bmj.h4011

Practical advice for sex workers and health professionals, including links to Ugly Mugs:
http://www.opendoors.nhs.uk/

The historic reasons for high abortion rates in Romania, from the journal of family planning and reproductive healthcare:
https://soundcloud.com/bmjpodcasts/romanian-womens-fertility]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1025</itunes:duration>
                                    </item>
    <item>
        <title>Sex worker health</title>
        <itunes:title>Sex worker health</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/sex-worker-health/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/sex-worker-health/#comments</comments>        <pubDate>Mon, 10 Aug 2015 14:30:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/sex-worker-health</guid>
                                    <description><![CDATA[Sex workers are unique population with specific health needs, caring for them can present non-specialists with a challenge, and there are important health promotion opportunities which should no be missed.

Michael Rekart, clinical professor of infectious disease at the University of British Columbia, joins us to discuss his clinical review on caring for sex workers.

Read the full article:
http://www.bmj.com/content/351/bmj.h4011

Listen to outreach workers from Open Doors, a sex worker healthcare initiative in east London, give practical tips on caring for sex workers:
<p>https://soundcloud.com/bmjpodcasts/open-doors-for-sex-workers</p>
]]></description>
                                                            <content:encoded><![CDATA[Sex workers are unique population with specific health needs, caring for them can present non-specialists with a challenge, and there are important health promotion opportunities which should no be missed.

Michael Rekart, clinical professor of infectious disease at the University of British Columbia, joins us to discuss his clinical review on caring for sex workers.

Read the full article:
http://www.bmj.com/content/351/bmj.h4011

Listen to outreach workers from Open Doors, a sex worker healthcare initiative in east London, give practical tips on caring for sex workers:
<p>https://soundcloud.com/bmjpodcasts/open-doors-for-sex-workers</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/r0pmiy/stream_218597143-bmjgroup-sex-worker-health.mp3" length="21668470" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Sex workers are unique population with specific health needs, caring for them can present non-specialists with a challenge, and there are important health promotion opportunities which should no be missed.

Michael Rekart, clinical professor of infectious disease at the University of British Columbia, joins us to discuss his clinical review on caring for sex workers.

Read the full article:
http://www.bmj.com/content/351/bmj.h4011

Listen to outreach workers from Open Doors, a sex worker healthcare initiative in east London, give practical tips on caring for sex workers:
https://soundcloud.com/bmjpodcasts/open-doors-for-sex-workers]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>904</itunes:duration>
                                    </item>
    <item>
        <title>The system can abuse older people too</title>
        <itunes:title>The system can abuse older people too</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-system-can-abuse-older-people-too/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-system-can-abuse-older-people-too/#comments</comments>        <pubDate>Fri, 24 Jul 2015 16:20:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-system-can-abuse-older-people-too</guid>
                                    <description><![CDATA[Elder abuse is often the result of the organisation of health systems rather than the fault of individuals, argue Jolanda Lindenberg and Rudi Westendorp, two authors of a recent analysis paper. 

They call for system abuse to be acknowledged and addressed by incorporating older people’s views when designing health services.

Read the full analysis:
<p>http://www.bmj.com/content/350/bmj.h2697</p>
]]></description>
                                                            <content:encoded><![CDATA[Elder abuse is often the result of the organisation of health systems rather than the fault of individuals, argue Jolanda Lindenberg and Rudi Westendorp, two authors of a recent analysis paper. 

They call for system abuse to be acknowledged and addressed by incorporating older people’s views when designing health services.

Read the full analysis:
<p>http://www.bmj.com/content/350/bmj.h2697</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wxj9y2/stream_216168174-bmjgroup-the-system-can-abuse-older-people-too.mp3" length="24385280" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Elder abuse is often the result of the organisation of health systems rather than the fault of individuals, argue Jolanda Lindenberg and Rudi Westendorp, two authors of a recent analysis paper. 

They call for system abuse to be acknowledged and addressed by incorporating older people’s views when designing health services.

Read the full analysis:
http://www.bmj.com/content/350/bmj.h2697]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1017</itunes:duration>
                                    </item>
    <item>
        <title>Tackling racism in the NHS</title>
        <itunes:title>Tackling racism in the NHS</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/tackling-racism-in-the-nhs/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/tackling-racism-in-the-nhs/#comments</comments>        <pubDate>Thu, 23 Jul 2015 10:45:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/racism-in-the-nhs</guid>
                                    <description><![CDATA[<p>For decades research has shown that discrimination, harassment, and exclusion are pervasive experiences for staff from black and minority ethnic (BME) backgrounds in the National Health Service.</p>
<p>In this podcast, the authors of a recent analysis article in The BMJ talk about the evidence for discrimination, what the NHS has done and is doing, and what has worked to promote equality in the wider world.</p>
<p>Read their full analysis at:</p>
<p>http://www.bmj.com/content/351/bmj.h3297</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>For decades research has shown that discrimination, harassment, and exclusion are pervasive experiences for staff from black and minority ethnic (BME) backgrounds in the National Health Service.</p>
<p>In this podcast, the authors of a recent analysis article in The BMJ talk about the evidence for discrimination, what the NHS has done and is doing, and what has worked to promote equality in the wider world.</p>
<p>Read their full analysis at:</p>
<p>http://www.bmj.com/content/351/bmj.h3297</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fmlm9o/stream_215979529-bmjgroup-racism-in-the-nhs.mp3" length="32426770" type="audio/mpeg"/>
        <itunes:summary><![CDATA[For decades research has shown that discrimination, harassment, and exclusion are pervasive experiences for staff from black and minority ethnic (BME) backgrounds in the National Health Service.In this podcast, the authors of a recent analysis article in The BMJ talk about the evidence for discrimination, what the NHS has done and is doing, and what has worked to promote equality in the wider world.Read their full analysis at:http://www.bmj.com/content/351/bmj.h3297]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1349</itunes:duration>
                                    </item>
    <item>
        <title>Should doctors recommend homeopathy?</title>
        <itunes:title>Should doctors recommend homeopathy?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/should-doctors-recommend-homeopathy/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/should-doctors-recommend-homeopathy/#comments</comments>        <pubDate>Tue, 14 Jul 2015 15:16:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/should-doctors-recommend</guid>
                                    <description><![CDATA[A recent review by the Australian National Health and Medical Research Council concluded that “there are no health conditions for which there is reliable evidence that homeopathy is effective”, but Europe currently spends €1bn annually on such remedies - often at the recommendation of doctors.

So a recent head to head debate in The BMJ asks, should doctors recommend homeopathy? Peter Fisher, director of research, Royal London Hospital for Integrated Medicine argues yes, and Edzard Ernst, emeritus professor of complementary medicine at the University of Exeter argues no.

Read their full arguments:
<p>http://www.bmj.com/content/351/bmj.h3735</p>
]]></description>
                                                            <content:encoded><![CDATA[A recent review by the Australian National Health and Medical Research Council concluded that “there are no health conditions for which there is reliable evidence that homeopathy is effective”, but Europe currently spends €1bn annually on such remedies - often at the recommendation of doctors.

So a recent head to head debate in The BMJ asks, should doctors recommend homeopathy? Peter Fisher, director of research, Royal London Hospital for Integrated Medicine argues yes, and Edzard Ernst, emeritus professor of complementary medicine at the University of Exeter argues no.

Read their full arguments:
<p>http://www.bmj.com/content/351/bmj.h3735</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xb28zu/stream_214685304-bmjgroup-should-doctors-recommend.mp3" length="25039862" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A recent review by the Australian National Health and Medical Research Council concluded that “there are no health conditions for which there is reliable evidence that homeopathy is effective”, but Europe currently spends €1bn annually on such remedies - often at the recommendation of doctors.

So a recent head to head debate in The BMJ asks, should doctors recommend homeopathy? Peter Fisher, director of research, Royal London Hospital for Integrated Medicine argues yes, and Edzard Ernst, emeritus professor of complementary medicine at the University of Exeter argues no.

Read their full arguments:
http://www.bmj.com/content/351/bmj.h3735]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1044</itunes:duration>
                                    </item>
    <item>
        <title>Rheumatic fever - diagnosis and treatment</title>
        <itunes:title>Rheumatic fever - diagnosis and treatment</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/rheumatic-fever-diagnosis-and-treatment/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/rheumatic-fever-diagnosis-and-treatment/#comments</comments>        <pubDate>Tue, 14 Jul 2015 10:15:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/rheumatic-fever</guid>
                                    <description><![CDATA[Many doctors may believe that acute rheumatic fever is a disease of the past, but it's estimated that, worldwide, there are 500,000 new annual cases, and that 15 million have chronic rheumatic heart disease.

Rachel Helena Webb, paediatric infectious diseases specialist at the Starship Children’s Hospital in Auckland, joins us to discuss diagnosis and management of this condition.

Read the full clinical review:
<p>http://www.bmj.com/content/351/bmj.h3443</p>
]]></description>
                                                            <content:encoded><![CDATA[Many doctors may believe that acute rheumatic fever is a disease of the past, but it's estimated that, worldwide, there are 500,000 new annual cases, and that 15 million have chronic rheumatic heart disease.

Rachel Helena Webb, paediatric infectious diseases specialist at the Starship Children’s Hospital in Auckland, joins us to discuss diagnosis and management of this condition.

Read the full clinical review:
<p>http://www.bmj.com/content/351/bmj.h3443</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3veqpl/stream_214653399-bmjgroup-rheumatic-fever.mp3" length="8990720" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Many doctors may believe that acute rheumatic fever is a disease of the past, but it's estimated that, worldwide, there are 500,000 new annual cases, and that 15 million have chronic rheumatic heart disease.

Rachel Helena Webb, paediatric infectious diseases specialist at the Starship Children’s Hospital in Auckland, joins us to discuss diagnosis and management of this condition.

Read the full clinical review:
http://www.bmj.com/content/351/bmj.h3443]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>808</itunes:duration>
                                    </item>
    <item>
        <title>Tarnished GOLD - diagnosing COPD</title>
        <itunes:title>Tarnished GOLD - diagnosing COPD</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/tarnished-gold-diagnosing-copd/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/tarnished-gold-diagnosing-copd/#comments</comments>        <pubDate>Mon, 13 Jul 2015 16:55:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/tarnished-gold-copd</guid>
                                    <description><![CDATA[Read the full analysis:
http://www.bmj.com/content/351/bmj.h3021

The prevalence and mortality of chronic obstructive pulmonary disease (COPD) is increasing globally.

<p>However, Martin Miller, honorary professor of medicine at the University of Birmingham, and Mark Levy, GP with a special interest in respiratory medicine, argue that the GOLD (Global Initiative for Obstructive Lung Disease) criteria used for diagnosis may be leading to misdiagnosis.</p>
]]></description>
                                                            <content:encoded><![CDATA[Read the full analysis:
http://www.bmj.com/content/351/bmj.h3021

The prevalence and mortality of chronic obstructive pulmonary disease (COPD) is increasing globally.

<p>However, Martin Miller, honorary professor of medicine at the University of Birmingham, and Mark Levy, GP with a special interest in respiratory medicine, argue that the GOLD (Global Initiative for Obstructive Lung Disease) criteria used for diagnosis may be leading to misdiagnosis.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5txymn/stream_214539612-bmjgroup-tarnished-gold-copd.mp3" length="27494559" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Read the full analysis:
http://www.bmj.com/content/351/bmj.h3021

The prevalence and mortality of chronic obstructive pulmonary disease (COPD) is increasing globally.

However, Martin Miller, honorary professor of medicine at the University of Birmingham, and Mark Levy, GP with a special interest in respiratory medicine, argue that the GOLD (Global Initiative for Obstructive Lung Disease) criteria used for diagnosis may be leading to misdiagnosis.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1147</itunes:duration>
                                    </item>
    <item>
        <title>GI bleeding, slow to diagnose, slow to treat</title>
        <itunes:title>GI bleeding, slow to diagnose, slow to treat</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/gi-bleeding-slow-to-diagnose-slow-to-treat/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/gi-bleeding-slow-to-diagnose-slow-to-treat/#comments</comments>        <pubDate>Fri, 03 Jul 2015 15:16:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/gi-bleeding-slow-to-diagnose</guid>
                                    <description><![CDATA[The National Confidential Enquiry into Patient Outcome and Death (NCEPOD) has been examining the treatment of acute GI bleeds in England's NHS.

Two of the authors, Martin Sinclair, consultant surgeon, and Simon McPherson, consultant vascular radiologist, join us to talk about their findings.

Read the full report:
http://www.ncepod.org.uk/gih.htm

Read The BMJ news story:
<p>http://www.bmj.com/content/351/bmj.h3488</p>
]]></description>
                                                            <content:encoded><![CDATA[The National Confidential Enquiry into Patient Outcome and Death (NCEPOD) has been examining the treatment of acute GI bleeds in England's NHS.

Two of the authors, Martin Sinclair, consultant surgeon, and Simon McPherson, consultant vascular radiologist, join us to talk about their findings.

Read the full report:
http://www.ncepod.org.uk/gih.htm

Read The BMJ news story:
<p>http://www.bmj.com/content/351/bmj.h3488</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5m1w7l/stream_213107396-bmjgroup-gi-bleeding-slow-to-diagnose.mp3" length="12706763" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The National Confidential Enquiry into Patient Outcome and Death (NCEPOD) has been examining the treatment of acute GI bleeds in England's NHS.

Two of the authors, Martin Sinclair, consultant surgeon, and Simon McPherson, consultant vascular radiologist, join us to talk about their findings.

Read the full report:
http://www.ncepod.org.uk/gih.htm

Read The BMJ news story:
http://www.bmj.com/content/351/bmj.h3488]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>529</itunes:duration>
                                    </item>
    <item>
        <title>The trials and tribulations of peer review</title>
        <itunes:title>The trials and tribulations of peer review</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-trials-and-tribulations-of-peer-review/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-trials-and-tribulations-of-peer-review/#comments</comments>        <pubDate>Tue, 30 Jun 2015 16:21:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-trials-and-tribulations-of-peer-review</guid>
                                    <description><![CDATA[Bias and peer review are of universal importance to all those that produce scholarly work.  Fiona Godlee and Rob Tarr, editors in chief of The BMJ and JNIS respectively, share their insights and experience on these highly topical issues with Joshua Hirsch.

<p>Read the related paper: http://jnis.bmj.com/content/early/2015/04/17/neurintsurg-2015-011781.full</p>
]]></description>
                                                            <content:encoded><![CDATA[Bias and peer review are of universal importance to all those that produce scholarly work.  Fiona Godlee and Rob Tarr, editors in chief of The BMJ and JNIS respectively, share their insights and experience on these highly topical issues with Joshua Hirsch.

<p>Read the related paper: http://jnis.bmj.com/content/early/2015/04/17/neurintsurg-2015-011781.full</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/w0v9bn/stream_212659846-bmjgroup-the-trials-and-tribulations-of-peer-review.mp3" length="22254295" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Bias and peer review are of universal importance to all those that produce scholarly work.  Fiona Godlee and Rob Tarr, editors in chief of The BMJ and JNIS respectively, share their insights and experience on these highly topical issues with Joshua Hirsch.

Read the related paper: http://jnis.bmj.com/content/early/2015/04/17/neurintsurg-2015-011781.full]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1856</itunes:duration>
                                    </item>
    <item>
        <title>How GPs can help carers looking after patients with</title>
        <itunes:title>How GPs can help carers looking after patients with</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/how-gps-can-help-carers-looking-after-patients-with/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/how-gps-can-help-carers-looking-after-patients-with/#comments</comments>        <pubDate>Tue, 23 Jun 2015 12:53:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/how-gps-can-help-dementia-carers</guid>
                                    <description><![CDATA[By 2050 an estimated 135 million people worldwide will have dementia. Of all chronic diseases, dementia is one of the most important contributors to dependence and disability.

In this part of a 2-part podcast, Sue, who cared for her mother who had dementia, and Louise Robinson, GP and professor of primary care at Newcastle University, join us to discuss what GPs can do to support carers.

Listen to part 1 of the podcast:
https://soundcloud.com/bmjpodcasts/diagnosis-and-management-of-dementia

Read the full clinical review:
<p>http://www.bmj.com/content/350/bmj.h3029</p>
]]></description>
                                                            <content:encoded><![CDATA[By 2050 an estimated 135 million people worldwide will have dementia. Of all chronic diseases, dementia is one of the most important contributors to dependence and disability.

In this part of a 2-part podcast, Sue, who cared for her mother who had dementia, and Louise Robinson, GP and professor of primary care at Newcastle University, join us to discuss what GPs can do to support carers.

Listen to part 1 of the podcast:
https://soundcloud.com/bmjpodcasts/diagnosis-and-management-of-dementia

Read the full clinical review:
<p>http://www.bmj.com/content/350/bmj.h3029</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4mh2v2/stream_211608908-bmjgroup-how-gps-can-help-dementia-carers.mp3" length="13809246" type="audio/mpeg"/>
        <itunes:summary><![CDATA[By 2050 an estimated 135 million people worldwide will have dementia. Of all chronic diseases, dementia is one of the most important contributors to dependence and disability.

In this part of a 2-part podcast, Sue, who cared for her mother who had dementia, and Louise Robinson, GP and professor of primary care at Newcastle University, join us to discuss what GPs can do to support carers.

Listen to part 1 of the podcast:
https://soundcloud.com/bmjpodcasts/diagnosis-and-management-of-dementia

Read the full clinical review:
http://www.bmj.com/content/350/bmj.h3029]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>575</itunes:duration>
                                    </item>
    <item>
        <title>Time to target older women for cervical cancer screening?</title>
        <itunes:title>Time to target older women for cervical cancer screening?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/time-to-target-older-women-for-cervical-cancer-screening/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/time-to-target-older-women-for-cervical-cancer-screening/#comments</comments>        <pubDate>Tue, 23 Jun 2015 12:45:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/cervical-cancer-not-just-young-women</guid>
                                    <description><![CDATA[Cervical screening programmes in many countries stop at around the age of 65 and much of the focus is often on younger women. However, comparatively little attention has been given to older women despite the fact that they account for about a fifth of cases each year and half of deaths.

In this podcast Susan Sherman, a senior lecturer in psychology at Keele University, and Esther Moss, consultant gynaecological oncologist at University Hospitals of Leicester NHS Trust, argue that the upper age limit for cervical screening needs revisiting and call for awareness campaigns to target older as well as younger women.

Read the full analysis:
<p>http://www.bmj.com/content/350/bmj.h2729</p>
]]></description>
                                                            <content:encoded><![CDATA[Cervical screening programmes in many countries stop at around the age of 65 and much of the focus is often on younger women. However, comparatively little attention has been given to older women despite the fact that they account for about a fifth of cases each year and half of deaths.

In this podcast Susan Sherman, a senior lecturer in psychology at Keele University, and Esther Moss, consultant gynaecological oncologist at University Hospitals of Leicester NHS Trust, argue that the upper age limit for cervical screening needs revisiting and call for awareness campaigns to target older as well as younger women.

Read the full analysis:
<p>http://www.bmj.com/content/350/bmj.h2729</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/anebnv/stream_211607996-bmjgroup-cervical-cancer-not-just-young-women.mp3" length="21221633" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Cervical screening programmes in many countries stop at around the age of 65 and much of the focus is often on younger women. However, comparatively little attention has been given to older women despite the fact that they account for about a fifth of cases each year and half of deaths.

In this podcast Susan Sherman, a senior lecturer in psychology at Keele University, and Esther Moss, consultant gynaecological oncologist at University Hospitals of Leicester NHS Trust, argue that the upper age limit for cervical screening needs revisiting and call for awareness campaigns to target older as well as younger women.

Read the full analysis:
http://www.bmj.com/content/350/bmj.h2729]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>885</itunes:duration>
                                    </item>
    <item>
        <title>Diagnosis and management of dementia</title>
        <itunes:title>Diagnosis and management of dementia</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/diagnosis-and-management-of-dementia/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/diagnosis-and-management-of-dementia/#comments</comments>        <pubDate>Tue, 23 Jun 2015 10:23:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/diagnosis-and-management-of-dementia</guid>
                                    <description><![CDATA[By 2050 an estimated 135 million people worldwide will have dementia. However, increasing evidence showing that dementia may be preventable.

In this part of a 2-part podcast, Sue, who cared for her mother who had dementia, and Louise Robinson, GP and professor of primary care at Newcastle University, join us to discuss how to diagnose and manage the condition.

Listen to part 2 of the podcast:
https://soundcloud.com/bmjpodcasts/how-gps-can-help-dementia-carers

Read the full clinical review:
<p>http://www.bmj.com/content/350/bmj.h3029</p>
]]></description>
                                                            <content:encoded><![CDATA[By 2050 an estimated 135 million people worldwide will have dementia. However, increasing evidence showing that dementia may be preventable.

In this part of a 2-part podcast, Sue, who cared for her mother who had dementia, and Louise Robinson, GP and professor of primary care at Newcastle University, join us to discuss how to diagnose and manage the condition.

Listen to part 2 of the podcast:
https://soundcloud.com/bmjpodcasts/how-gps-can-help-dementia-carers

Read the full clinical review:
<p>http://www.bmj.com/content/350/bmj.h3029</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8c8xs8/stream_211595049-bmjgroup-diagnosis-and-management-of-dementia.mp3" length="22627707" type="audio/mpeg"/>
        <itunes:summary><![CDATA[By 2050 an estimated 135 million people worldwide will have dementia. However, increasing evidence showing that dementia may be preventable.

In this part of a 2-part podcast, Sue, who cared for her mother who had dementia, and Louise Robinson, GP and professor of primary care at Newcastle University, join us to discuss how to diagnose and manage the condition.

Listen to part 2 of the podcast:
https://soundcloud.com/bmjpodcasts/how-gps-can-help-dementia-carers

Read the full clinical review:
http://www.bmj.com/content/350/bmj.h3029]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>943</itunes:duration>
                                    </item>
    <item>
        <title>QOF, what is it good for?</title>
        <itunes:title>QOF, what is it good for?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/qof-what-is-it-good-for/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/qof-what-is-it-good-for/#comments</comments>        <pubDate>Mon, 15 Jun 2015 12:58:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/qof-what-is-it-good-for</guid>
                                    <description><![CDATA[Martin McShane, medical director of long term conditions at NHS England, questions the validity of the Quality and Outcomes Framework and suggests how it should change in the future.

Read the related article:
<p>http://www.bmj.com/content/350/bmj.h2540</p>
]]></description>
                                                            <content:encoded><![CDATA[Martin McShane, medical director of long term conditions at NHS England, questions the validity of the Quality and Outcomes Framework and suggests how it should change in the future.

Read the related article:
<p>http://www.bmj.com/content/350/bmj.h2540</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xkp9nu/stream_210417065-bmjgroup-qof-what-is-it-good-for.mp3" length="19057756" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Martin McShane, medical director of long term conditions at NHS England, questions the validity of the Quality and Outcomes Framework and suggests how it should change in the future.

Read the related article:
http://www.bmj.com/content/350/bmj.h2540]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>795</itunes:duration>
                                    </item>
    <item>
        <title>Rethinking caesarean delivery</title>
        <itunes:title>Rethinking caesarean delivery</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/rethinking-caesarean-delivery/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/rethinking-caesarean-delivery/#comments</comments>        <pubDate>Fri, 12 Jun 2015 12:30:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/rethinking-caesarean-delivery</guid>
                                    <description><![CDATA[Caesarean delivery can improve maternal and child health, and even save lives. But recent research points to latent risks for chronic disease: children delivered by caesarean have a higher incidence of type diabetes, obesity, and asthma.

Jan Blustein, from New York University, joins us to discuss why she and colleage Jainmeng Liu believe this evidence should be examined and taken into account when considering elective caesarean.

Read their full analysis:
http://www.bmj.com/content/350/bmj.h2410
<p></p>
<p></p>
]]></description>
                                                            <content:encoded><![CDATA[Caesarean delivery can improve maternal and child health, and even save lives. But recent research points to latent risks for chronic disease: children delivered by caesarean have a higher incidence of type diabetes, obesity, and asthma.

Jan Blustein, from New York University, joins us to discuss why she and colleage Jainmeng Liu believe this evidence should be examined and taken into account when considering elective caesarean.

Read their full analysis:
http://www.bmj.com/content/350/bmj.h2410
<p></p>
<p></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mcq2dv/stream_209997827-bmjgroup-rethinking-caesarean-delivery.mp3" length="24045231" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Caesarean delivery can improve maternal and child health, and even save lives. But recent research points to latent risks for chronic disease: children delivered by caesarean have a higher incidence of type diabetes, obesity, and asthma.

Jan Blustein, from New York University, joins us to discuss why she and colleage Jainmeng Liu believe this evidence should be examined and taken into account when considering elective caesarean.

Read their full analysis:
http://www.bmj.com/content/350/bmj.h2410

]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1002</itunes:duration>
                                    </item>
    <item>
        <title>Methodological gloss won’t fix a rubbish evidence base</title>
        <itunes:title>Methodological gloss won’t fix a rubbish evidence base</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/methodological-gloss-won-t-fix-a-rubbish-evidence-base/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/methodological-gloss-won-t-fix-a-rubbish-evidence-base/#comments</comments>        <pubDate>Thu, 11 Jun 2015 14:43:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/meta-analysis-is-broken</guid>
                                    <description><![CDATA[Information on the effectiveness and safety of healthcare should be valid, precise, up to date, clear, and freely available. Currently none of these criteria are fully satisfied, and Cochrane systematic reviews are not the solution.

Ian Roberts, co-director of the clinical trials unit at the London School of Hygiene and Tropical Medicine, joins us to describe what the Cochrane Injuries Group is doing to address some of these problems.

Read the full analysis article:
<p>http://www.bmj.com/content/350/bmj.h2463 </p>
]]></description>
                                                            <content:encoded><![CDATA[Information on the effectiveness and safety of healthcare should be valid, precise, up to date, clear, and freely available. Currently none of these criteria are fully satisfied, and Cochrane systematic reviews are not the solution.

Ian Roberts, co-director of the clinical trials unit at the London School of Hygiene and Tropical Medicine, joins us to describe what the Cochrane Injuries Group is doing to address some of these problems.

Read the full analysis article:
<p>http://www.bmj.com/content/350/bmj.h2463 </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/63c2o6/stream_209858280-bmjgroup-meta-analysis-is-broken.mp3" length="17351715" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Information on the effectiveness and safety of healthcare should be valid, precise, up to date, clear, and freely available. Currently none of these criteria are fully satisfied, and Cochrane systematic reviews are not the solution.

Ian Roberts, co-director of the clinical trials unit at the London School of Hygiene and Tropical Medicine, joins us to describe what the Cochrane Injuries Group is doing to address some of these problems.

Read the full analysis article:
http://www.bmj.com/content/350/bmj.h2463 ]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>723</itunes:duration>
                                    </item>
    <item>
        <title>They want to say something on health . . . so what can you fish up?</title>
        <itunes:title>They want to say something on health . . . so what can you fish up?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/they-want-to-say-something-on-health-so-what-can-you-fish-up/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/they-want-to-say-something-on-health-so-what-can-you-fish-up/#comments</comments>        <pubDate>Wed, 03 Jun 2015 11:05:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/10-ways-to-be-a-health-secretary</guid>
                                    <description><![CDATA[In Glaziers and Window Breakers: the Role of the Secretary of State for Health in Their Own Words, published by the Health Foundation, Nicholas Timmins and Edward Davies find out what 10 of our recent health secretaries think the job is about.

Read the feature on The BMJ
http://www.bmj.com/content/350/bmj.h2954
<p></p>
<p></p>
]]></description>
                                                            <content:encoded><![CDATA[In Glaziers and Window Breakers: the Role of the Secretary of State for Health in Their Own Words, published by the Health Foundation, Nicholas Timmins and Edward Davies find out what 10 of our recent health secretaries think the job is about.

Read the feature on The BMJ
http://www.bmj.com/content/350/bmj.h2954
<p></p>
<p></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3y2ls1/stream_208589883-bmjgroup-10-ways-to-be-a-health-secretary.mp3" length="23214412" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In Glaziers and Window Breakers: the Role of the Secretary of State for Health in Their Own Words, published by the Health Foundation, Nicholas Timmins and Edward Davies find out what 10 of our recent health secretaries think the job is about.

Read the feature on The BMJ
http://www.bmj.com/content/350/bmj.h2954

]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>968</itunes:duration>
                                    </item>
    <item>
        <title>bmj.com at 20</title>
        <itunes:title>bmj.com at 20</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/bmjcom-at-20/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/bmjcom-at-20/#comments</comments>        <pubDate>Fri, 22 May 2015 14:36:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/bmj-com-at-20</guid>
                                    <description><![CDATA[The BMJ website is 20 years old this week - the first general medical journal online. Launch editor Tony Delamothe discusses with fellow digital pioneers Richard Smith and John Sack how the internet transformed doctors’ reading habits and the journal’s international reach. David Payne reports

<p>www.bmj.com/twenty</p>
<p></p>
]]></description>
                                                            <content:encoded><![CDATA[The BMJ website is 20 years old this week - the first general medical journal online. Launch editor Tony Delamothe discusses with fellow digital pioneers Richard Smith and John Sack how the internet transformed doctors’ reading habits and the journal’s international reach. David Payne reports

<p>www.bmj.com/twenty</p>
<p></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/65lasl/stream_206705765-bmjgroup-bmj-com-at-20.mp3" length="29028154" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The BMJ website is 20 years old this week - the first general medical journal online. Launch editor Tony Delamothe discusses with fellow digital pioneers Richard Smith and John Sack how the internet transformed doctors’ reading habits and the journal’s international reach. David Payne reports

www.bmj.com/twenty
]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1210</itunes:duration>
                                    </item>
    <item>
        <title>The BMJ requires data sharing on request for all trials</title>
        <itunes:title>The BMJ requires data sharing on request for all trials</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-bmj-requires-data-sharing-on-request-for-all-trials/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-bmj-requires-data-sharing-on-request-for-all-trials/#comments</comments>        <pubDate>Fri, 22 May 2015 13:22:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-bmj-requires-data-sharing</guid>
                                    <description><![CDATA[The movement to make data from clinical trials widely accessible has achieved enormous success, and it is now time for medical journals to play their part. From 1 July The BMJ will extend its requirements for data sharing to apply to all submitted clinical trials, not just those that test drugs or devices.

The BMJ's Elizabeth Loder explains what this means for authors, and how we expect researchers to make their data available.

Read the full editorial:
<p>http://www.bmj.com/content/350/bmj.h2373</p>
]]></description>
                                                            <content:encoded><![CDATA[The movement to make data from clinical trials widely accessible has achieved enormous success, and it is now time for medical journals to play their part. From 1 July The BMJ will extend its requirements for data sharing to apply to all submitted clinical trials, not just those that test drugs or devices.

The BMJ's Elizabeth Loder explains what this means for authors, and how we expect researchers to make their data available.

Read the full editorial:
<p>http://www.bmj.com/content/350/bmj.h2373</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/omtcgy/stream_206695390-bmjgroup-the-bmj-requires-data-sharing.mp3" length="16845398" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The movement to make data from clinical trials widely accessible has achieved enormous success, and it is now time for medical journals to play their part. From 1 July The BMJ will extend its requirements for data sharing to apply to all submitted clinical trials, not just those that test drugs or devices.

The BMJ's Elizabeth Loder explains what this means for authors, and how we expect researchers to make their data available.

Read the full editorial:
http://www.bmj.com/content/350/bmj.h2373]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>702</itunes:duration>
                                    </item>
    <item>
        <title>ADHD in childhood - diagnosis</title>
        <itunes:title>ADHD in childhood - diagnosis</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/adhd-in-childhood-diagnosis/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/adhd-in-childhood-diagnosis/#comments</comments>        <pubDate>Thu, 21 May 2015 09:34:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/adhd-in-childhood-diagnosis</guid>
                                    <description><![CDATA[Attention deficit hyperactivity disorder, or ADHD, presents with persistent symptoms of inattention, hyperactivity, and impulsivity causing impairment in multiple settings. It is a disorder that attracts considerable debate and controversy. 

The this part of this podcast, focused on the diagnosis of ADHD,  two of the authors of the review, Mina Fazel, consultant psychiatrist at Oxford University Hospitals NHS Trust, and Nienke Verkuijl, specialty trainee at the University of Oxford and Rachel, a parent of a child who has a diagnosis of ADHD.

Read the full review:
http://www.bmj.com/content/350/bmj.h2168
Listen to the second part of the podcast:
<p>https://soundcloud.com/bmjpodcasts/adhd-in-childhood-treatment</p>
]]></description>
                                                            <content:encoded><![CDATA[Attention deficit hyperactivity disorder, or ADHD, presents with persistent symptoms of inattention, hyperactivity, and impulsivity causing impairment in multiple settings. It is a disorder that attracts considerable debate and controversy. 

The this part of this podcast, focused on the diagnosis of ADHD,  two of the authors of the review, Mina Fazel, consultant psychiatrist at Oxford University Hospitals NHS Trust, and Nienke Verkuijl, specialty trainee at the University of Oxford and Rachel, a parent of a child who has a diagnosis of ADHD.

Read the full review:
http://www.bmj.com/content/350/bmj.h2168
Listen to the second part of the podcast:
<p>https://soundcloud.com/bmjpodcasts/adhd-in-childhood-treatment</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5lu545/stream_206512247-bmjgroup-adhd-in-childhood-diagnosis.mp3" length="17254253" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Attention deficit hyperactivity disorder, or ADHD, presents with persistent symptoms of inattention, hyperactivity, and impulsivity causing impairment in multiple settings. It is a disorder that attracts considerable debate and controversy. 

The this part of this podcast, focused on the diagnosis of ADHD,  two of the authors of the review, Mina Fazel, consultant psychiatrist at Oxford University Hospitals NHS Trust, and Nienke Verkuijl, specialty trainee at the University of Oxford and Rachel, a parent of a child who has a diagnosis of ADHD.

Read the full review:
http://www.bmj.com/content/350/bmj.h2168
Listen to the second part of the podcast:
https://soundcloud.com/bmjpodcasts/adhd-in-childhood-treatment]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>719</itunes:duration>
                                    </item>
    <item>
        <title>ADHD in childhood - treatment</title>
        <itunes:title>ADHD in childhood - treatment</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/adhd-in-childhood-treatment/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/adhd-in-childhood-treatment/#comments</comments>        <pubDate>Thu, 21 May 2015 09:32:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/adhd-in-childhood-treatment</guid>
                                    <description><![CDATA[Attention deficit hyperactivity disorder, or ADHD, presents with persistent symptoms of inattention, hyperactivity, and impulsivity causing impairment in multiple settings. It is a disorder that attracts considerable debate and controversy. 

The this part of this podcast, focused on the treatment of ADHD,  two of the authors of the review, Mina Fazel, consultant psychiatrist at Oxford University Hospitals NHS Trust, and Nienke Verkuijl, specialty trainee at the University of Oxford and Rachel, a parent of a child who has a diagnosis of ADHD.

Read the full review:
http://www.bmj.com/content/350/bmj.h2168
Listen to the second part of the podcast:
<p>https://soundcloud.com/bmjpodcasts/adhd-in-childhood-diagnosis</p>
]]></description>
                                                            <content:encoded><![CDATA[Attention deficit hyperactivity disorder, or ADHD, presents with persistent symptoms of inattention, hyperactivity, and impulsivity causing impairment in multiple settings. It is a disorder that attracts considerable debate and controversy. 

The this part of this podcast, focused on the treatment of ADHD,  two of the authors of the review, Mina Fazel, consultant psychiatrist at Oxford University Hospitals NHS Trust, and Nienke Verkuijl, specialty trainee at the University of Oxford and Rachel, a parent of a child who has a diagnosis of ADHD.

Read the full review:
http://www.bmj.com/content/350/bmj.h2168
Listen to the second part of the podcast:
<p>https://soundcloud.com/bmjpodcasts/adhd-in-childhood-diagnosis</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9rew9q/stream_206512103-bmjgroup-adhd-in-childhood-treatment.mp3" length="34925614" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Attention deficit hyperactivity disorder, or ADHD, presents with persistent symptoms of inattention, hyperactivity, and impulsivity causing impairment in multiple settings. It is a disorder that attracts considerable debate and controversy. 

The this part of this podcast, focused on the treatment of ADHD,  two of the authors of the review, Mina Fazel, consultant psychiatrist at Oxford University Hospitals NHS Trust, and Nienke Verkuijl, specialty trainee at the University of Oxford and Rachel, a parent of a child who has a diagnosis of ADHD.

Read the full review:
http://www.bmj.com/content/350/bmj.h2168
Listen to the second part of the podcast:
https://soundcloud.com/bmjpodcasts/adhd-in-childhood-diagnosis]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1456</itunes:duration>
                                    </item>
    <item>
        <title>Speech difficulties in preschool children</title>
        <itunes:title>Speech difficulties in preschool children</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/speech-difficulties-in-preschool-children/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/speech-difficulties-in-preschool-children/#comments</comments>        <pubDate>Fri, 15 May 2015 14:07:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/speech-difficulties-in-children</guid>
                                    <description><![CDATA[Speech and language therapists Cristina McKean and Angela Morgan join us to discuss their clinical review "Identifying and managing common childhood language and speech impairments", published on thebmj.com. 

They talk about the prevalence, the steps to take if parents believes their child has a speech problem, and the importance of knowing which resources are locally available to support children.

Read the full review:
<p>http://www.bmj.com/content/350/bmj.h2318 </p>
]]></description>
                                                            <content:encoded><![CDATA[Speech and language therapists Cristina McKean and Angela Morgan join us to discuss their clinical review "Identifying and managing common childhood language and speech impairments", published on thebmj.com. 

They talk about the prevalence, the steps to take if parents believes their child has a speech problem, and the importance of knowing which resources are locally available to support children.

Read the full review:
<p>http://www.bmj.com/content/350/bmj.h2318 </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dvhcef/stream_205601617-bmjgroup-speech-difficulties-in-children.mp3" length="24856172" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Speech and language therapists Cristina McKean and Angela Morgan join us to discuss their clinical review "Identifying and managing common childhood language and speech impairments", published on thebmj.com. 

They talk about the prevalence, the steps to take if parents believes their child has a speech problem, and the importance of knowing which resources are locally available to support children.

Read the full review:
http://www.bmj.com/content/350/bmj.h2318 ]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1035</itunes:duration>
                                    </item>
    <item>
        <title>Infectious mononucleosis FAQs</title>
        <itunes:title>Infectious mononucleosis FAQs</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/infectious-mononucleosis-faqs/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/infectious-mononucleosis-faqs/#comments</comments>        <pubDate>Wed, 29 Apr 2015 15:03:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/infectious-mononucleosis-faqs</guid>
                                    <description><![CDATA[Paul Lennon, a specialist registrar at University Hospital Limerick, and  Michael Crotty, general practitioner from the Synergy Medical Clinic in Canada, join Emma Parish to answer some frequently asked questions about  infectious mononucleosis.

Read their full clinical review:
<p>http://www.bmj.com/content/350/bmj.h1825</p>
]]></description>
                                                            <content:encoded><![CDATA[Paul Lennon, a specialist registrar at University Hospital Limerick, and  Michael Crotty, general practitioner from the Synergy Medical Clinic in Canada, join Emma Parish to answer some frequently asked questions about  infectious mononucleosis.

Read their full clinical review:
<p>http://www.bmj.com/content/350/bmj.h1825</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xy4y4f/stream_203120873-bmjgroup-infectious-mononucleosis-faqs.mp3" length="30727788" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Paul Lennon, a specialist registrar at University Hospital Limerick, and  Michael Crotty, general practitioner from the Synergy Medical Clinic in Canada, join Emma Parish to answer some frequently asked questions about  infectious mononucleosis.

Read their full clinical review:
http://www.bmj.com/content/350/bmj.h1825]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1281</itunes:duration>
                                    </item>
    <item>
        <title>The health debate - the analysis</title>
        <itunes:title>The health debate - the analysis</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-health-debate-the-analysis/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-health-debate-the-analysis/#comments</comments>        <pubDate>Thu, 23 Apr 2015 13:46:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-health-debate-analysis</guid>
                                    <description><![CDATA[The future of health and social care looks certain to be a defining issue in the forthcoming UK general election. Social care has been subject to deep public spending cuts, raising concerns about the sustainability of services in the future. Whoever wins the next election will need to grapple with providing joined up health and social care services in an era of continued austerity.

A recent debate (heathdebate.net) with key spokespeople from across the political spectrum took place this week, and we assembled a panel of experts to discuss how they think the debate went, and the key promises and gaps in the parties plans for the NHS.

Taking part were:
Fiona Godlee, editor in chief of The BMJ
Jeremy Taylor - chief executive of National Voices
Johnny Marshall - director of policy at the NHS Confederation
Jane Dacre - president of the Royal College of Physicians
Anita Charlesworth - chief economist at the Health Foundation 
Mark Porter - chair of council at the BMA
Nigel Edwards - chief executive of the Nuffield Trust
Chris Ham - chief executive of The King's Fund

<p>For more analysis of the election's health promises, read Gareth Iacobucci's Election Watch column: http://www.bmj.com/content/350/bmj.h2165</p>
<p></p>
]]></description>
                                                            <content:encoded><![CDATA[The future of health and social care looks certain to be a defining issue in the forthcoming UK general election. Social care has been subject to deep public spending cuts, raising concerns about the sustainability of services in the future. Whoever wins the next election will need to grapple with providing joined up health and social care services in an era of continued austerity.

A recent debate (heathdebate.net) with key spokespeople from across the political spectrum took place this week, and we assembled a panel of experts to discuss how they think the debate went, and the key promises and gaps in the parties plans for the NHS.

Taking part were:
Fiona Godlee, editor in chief of The BMJ
Jeremy Taylor - chief executive of National Voices
Johnny Marshall - director of policy at the NHS Confederation
Jane Dacre - president of the Royal College of Physicians
Anita Charlesworth - chief economist at the Health Foundation 
Mark Porter - chair of council at the BMA
Nigel Edwards - chief executive of the Nuffield Trust
Chris Ham - chief executive of The King's Fund

<p>For more analysis of the election's health promises, read Gareth Iacobucci's Election Watch column: http://www.bmj.com/content/350/bmj.h2165</p>
<p></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wdf9xf/stream_202181619-bmjgroup-the-health-debate-analysis.mp3" length="64647229" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The future of health and social care looks certain to be a defining issue in the forthcoming UK general election. Social care has been subject to deep public spending cuts, raising concerns about the sustainability of services in the future. Whoever wins the next election will need to grapple with providing joined up health and social care services in an era of continued austerity.

A recent debate (heathdebate.net) with key spokespeople from across the political spectrum took place this week, and we assembled a panel of experts to discuss how they think the debate went, and the key promises and gaps in the parties plans for the NHS.

Taking part were:
Fiona Godlee, editor in chief of The BMJ
Jeremy Taylor - chief executive of National Voices
Johnny Marshall - director of policy at the NHS Confederation
Jane Dacre - president of the Royal College of Physicians
Anita Charlesworth - chief economist at the Health Foundation 
Mark Porter - chair of council at the BMA
Nigel Edwards - chief executive of the Nuffield Trust
Chris Ham - chief executive of The King's Fund

For more analysis of the election's health promises, read Gareth Iacobucci's Election Watch column: http://www.bmj.com/content/350/bmj.h2165
]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2696</itunes:duration>
                                    </item>
    <item>
        <title>Management of a multiple sclerosis relapse</title>
        <itunes:title>Management of a multiple sclerosis relapse</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/management-of-a-multiple-sclerosis-relapse/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/management-of-a-multiple-sclerosis-relapse/#comments</comments>        <pubDate>Thu, 16 Apr 2015 15:12:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/ms-relapse</guid>
                                    <description><![CDATA[Nicki Ward-Abel, a lecturer practitioner in MS at Birmingham City University, joins us to explain how to treat patients who are experiencing a relapse of their MS symptoms. She discusses what constitutes a relapse, which treatments are available, and what effect a relapse can have on a patient.

Read more at: 
<p>http://www.bmj.com/content/350/bmj.h1765</p>
]]></description>
                                                            <content:encoded><![CDATA[Nicki Ward-Abel, a lecturer practitioner in MS at Birmingham City University, joins us to explain how to treat patients who are experiencing a relapse of their MS symptoms. She discusses what constitutes a relapse, which treatments are available, and what effect a relapse can have on a patient.

Read more at: 
<p>http://www.bmj.com/content/350/bmj.h1765</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/bsskpa/stream_201094856-bmjgroup-ms-relapse.mp3" length="28358233" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Nicki Ward-Abel, a lecturer practitioner in MS at Birmingham City University, joins us to explain how to treat patients who are experiencing a relapse of their MS symptoms. She discusses what constitutes a relapse, which treatments are available, and what effect a relapse can have on a patient.

Read more at: 
http://www.bmj.com/content/350/bmj.h1765]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1182</itunes:duration>
                                    </item>
    <item>
        <title>Health apps for well people - problematic or panacea?</title>
        <itunes:title>Health apps for well people - problematic or panacea?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/health-apps-for-well-people-problematic-or-panacea/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/health-apps-for-well-people-problematic-or-panacea/#comments</comments>        <pubDate>Wed, 15 Apr 2015 15:41:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/health-apps-problematic-or</guid>
                                    <description><![CDATA[Some apps have the potential to encourage healthier habits and are accessible to most people, argues Iltifat Husain, but Des Spence notes the lack of any evidence of effectiveness and the potential for encouraging unnecessary anxiety.

<p>Read more about in our head to head "Can healthy people benefit from health apps?" - http://www.bmj.com/content/350/bmj.h1887</p>
]]></description>
                                                            <content:encoded><![CDATA[Some apps have the potential to encourage healthier habits and are accessible to most people, argues Iltifat Husain, but Des Spence notes the lack of any evidence of effectiveness and the potential for encouraging unnecessary anxiety.

<p>Read more about in our head to head "Can healthy people benefit from health apps?" - http://www.bmj.com/content/350/bmj.h1887</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dfuxv4/stream_200941135-bmjgroup-health-apps-problematic-or.mp3" length="25525237" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Some apps have the potential to encourage healthier habits and are accessible to most people, argues Iltifat Husain, but Des Spence notes the lack of any evidence of effectiveness and the potential for encouraging unnecessary anxiety.

Read more about in our head to head "Can healthy people benefit from health apps?" - http://www.bmj.com/content/350/bmj.h1887]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1064</itunes:duration>
                                    </item>
    <item>
        <title>Foodbanks - is supply or demand increasing their usage</title>
        <itunes:title>Foodbanks - is supply or demand increasing their usage</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/foodbanks-is-supply-or-demand-increasing-their-usage/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/foodbanks-is-supply-or-demand-increasing-their-usage/#comments</comments>        <pubDate>Thu, 09 Apr 2015 10:44:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/foodbanks-is-supply-or-demand</guid>
                                    <description><![CDATA[Doctors are witnessing increasing numbers of patients seeking referrals to food banks in the United Kingdom. Rachel Loopstra, a post-doctoral researcher at the University of Oxford and colleagues have been asking if that rise is due to supply or demand?

Read their full analysis:
<p>http://www.bmj.com/content/350/bmj.h1775</p>
]]></description>
                                                            <content:encoded><![CDATA[Doctors are witnessing increasing numbers of patients seeking referrals to food banks in the United Kingdom. Rachel Loopstra, a post-doctoral researcher at the University of Oxford and colleagues have been asking if that rise is due to supply or demand?

Read their full analysis:
<p>http://www.bmj.com/content/350/bmj.h1775</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ypoiut/stream_199979316-bmjgroup-foodbanks-is-supply-or-demand.mp3" length="20765992" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Doctors are witnessing increasing numbers of patients seeking referrals to food banks in the United Kingdom. Rachel Loopstra, a post-doctoral researcher at the University of Oxford and colleagues have been asking if that rise is due to supply or demand?

Read their full analysis:
http://www.bmj.com/content/350/bmj.h1775]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>866</itunes:duration>
                                    </item>
    <item>
        <title>How to talk to a patient about delusional infestation</title>
        <itunes:title>How to talk to a patient about delusional infestation</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/how-to-talk-to-a-patient-about-delusional-infestation/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/how-to-talk-to-a-patient-about-delusional-infestation/#comments</comments>        <pubDate>Thu, 02 Apr 2015 12:56:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/delisional-infestation</guid>
                                    <description><![CDATA[Peter Lepping, consultant psychiatrist and honorary professor at Betsi Cadwaladr University Health Board in North Wales, joins us to discuss his experience dealing with patients who have delusional infestations. He talks about how to broach the diagnosis, and gives practical tips on how to investigate this difficult condition.

Read his practice pointer:
<p>http://www.bmj.com/content/350/bmj.h1328</p>
]]></description>
                                                            <content:encoded><![CDATA[Peter Lepping, consultant psychiatrist and honorary professor at Betsi Cadwaladr University Health Board in North Wales, joins us to discuss his experience dealing with patients who have delusional infestations. He talks about how to broach the diagnosis, and gives practical tips on how to investigate this difficult condition.

Read his practice pointer:
<p>http://www.bmj.com/content/350/bmj.h1328</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/sxtxtb/stream_198898455-bmjgroup-delisional-infestation.mp3" length="36001185" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Peter Lepping, consultant psychiatrist and honorary professor at Betsi Cadwaladr University Health Board in North Wales, joins us to discuss his experience dealing with patients who have delusional infestations. He talks about how to broach the diagnosis, and gives practical tips on how to investigate this difficult condition.

Read his practice pointer:
http://www.bmj.com/content/350/bmj.h1328]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1501</itunes:duration>
                                    </item>
    <item>
        <title>Withdraw the interim report on the UK’s billion unit pledge</title>
        <itunes:title>Withdraw the interim report on the UK’s billion unit pledge</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/withdraw-the-interim-report-on-the-uk-s-billion-unit-pledge/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/withdraw-the-interim-report-on-the-uk-s-billion-unit-pledge/#comments</comments>        <pubDate>Thu, 26 Mar 2015 16:54:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/withdraw-billion-unit-pledge-report</guid>
                                    <description><![CDATA[Flaws in the Department of Health’s interim evaluation of an alcohol industry pledge to remove one billion alcohol units from the market raise questions about the claimed success argue John Holmes, Colin Angus and Petra Meier from the Sheffield Alcohol Research Group at the University of Sheffileld. They say that the report should be withdrawn and revised targets set

Read the full analysis:
<p>http://www.bmj.com/content/350/bmj.h1301</p>
]]></description>
                                                            <content:encoded><![CDATA[Flaws in the Department of Health’s interim evaluation of an alcohol industry pledge to remove one billion alcohol units from the market raise questions about the claimed success argue John Holmes, Colin Angus and Petra Meier from the Sheffield Alcohol Research Group at the University of Sheffileld. They say that the report should be withdrawn and revised targets set

Read the full analysis:
<p>http://www.bmj.com/content/350/bmj.h1301</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vl5mk5/stream_197805828-bmjgroup-withdraw-billion-unit-pledge-report.mp3" length="29996214" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Flaws in the Department of Health’s interim evaluation of an alcohol industry pledge to remove one billion alcohol units from the market raise questions about the claimed success argue John Holmes, Colin Angus and Petra Meier from the Sheffield Alcohol Research Group at the University of Sheffileld. They say that the report should be withdrawn and revised targets set

Read the full analysis:
http://www.bmj.com/content/350/bmj.h1301]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1251</itunes:duration>
                                    </item>
    <item>
        <title>Preventing sudden cardiac death in athletes</title>
        <itunes:title>Preventing sudden cardiac death in athletes</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/preventing-sudden-cardiac-death-in-athletes/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/preventing-sudden-cardiac-death-in-athletes/#comments</comments>        <pubDate>Fri, 20 Mar 2015 14:05:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/sudden-cardiac-death-athletes</guid>
                                    <description><![CDATA[Sudden cardiac death in athletes aged less than 35 years is the leading cause of medical death in this subgroup, with an estimated incidence of 1 in 50 000 to 1 in 80 000 athletes per year. it is most commonly caused by an underlying genetic heart disorder, such as hypertrophic cardiomyopathy.

In this podcast Christopher Semsarian, professor of medicine at the University of Sydney, joins us to discuss the diagnosis of cardiac changes and prevention of death in this population.

Read the full clinical review:
<p>http://www.bmj.com/content/350/bmj.h1218</p>
]]></description>
                                                            <content:encoded><![CDATA[Sudden cardiac death in athletes aged less than 35 years is the leading cause of medical death in this subgroup, with an estimated incidence of 1 in 50 000 to 1 in 80 000 athletes per year. it is most commonly caused by an underlying genetic heart disorder, such as hypertrophic cardiomyopathy.

In this podcast Christopher Semsarian, professor of medicine at the University of Sydney, joins us to discuss the diagnosis of cardiac changes and prevention of death in this population.

Read the full clinical review:
<p>http://www.bmj.com/content/350/bmj.h1218</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/akcsw1/stream_196812543-bmjgroup-sudden-cardiac-death-athletes.mp3" length="23856577" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Sudden cardiac death in athletes aged less than 35 years is the leading cause of medical death in this subgroup, with an estimated incidence of 1 in 50 000 to 1 in 80 000 athletes per year. it is most commonly caused by an underlying genetic heart disorder, such as hypertrophic cardiomyopathy.

In this podcast Christopher Semsarian, professor of medicine at the University of Sydney, joins us to discuss the diagnosis of cardiac changes and prevention of death in this population.

Read the full clinical review:
http://www.bmj.com/content/350/bmj.h1218]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>995</itunes:duration>
                                    </item>
    <item>
        <title>Trigeminal neuralgia - the evidence base for medical and surgical treatments</title>
        <itunes:title>Trigeminal neuralgia - the evidence base for medical and surgical treatments</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/trigeminal-neuralgia-the-evidence-base-for-medical-and-surgical-treatments/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/trigeminal-neuralgia-the-evidence-base-for-medical-and-surgical-treatments/#comments</comments>        <pubDate>Wed, 18 Mar 2015 17:35:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/trigeminal-neuralgia-the-evidence-base-for-medical-and-surgical-treatments</guid>
                                    <description><![CDATA[A BMJ Clinical Evidence systematic overview looks at the evidence for medical and surgical treatments of trigeminal neuralgia, and the uncertainties that exist due to gaps in the evidence. This has been summarised in The BMJ.

The authors of the overview and bmj.comsummary, Prof. Joanna Zakrzewska from the Facial Pain Unit at the Eastman Dental Hospital, London, and Mark Linskey, Professor of Neurological Surgery at the University of California Irvine, discuss the evidence, the issues around it, and put this all into a clinical context.

Read the full systematic overview: 
http://clinicalevidence.bmj.com/x/systematic-review/1207/overview.html

Disclaimer:
The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions.
By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.  
<p>BMJ does not warrant the accuracy of the information contained in the podcast and to the fullest extent permitted by law, BMJ Publishing Group Limited is not responsible for any loss whatsoever resulting from the application of, or reliance upon, the information contained in this podcast.</p>
]]></description>
                                                            <content:encoded><![CDATA[A BMJ Clinical Evidence systematic overview looks at the evidence for medical and surgical treatments of trigeminal neuralgia, and the uncertainties that exist due to gaps in the evidence. This has been summarised in The BMJ.

The authors of the overview and bmj.comsummary, Prof. Joanna Zakrzewska from the Facial Pain Unit at the Eastman Dental Hospital, London, and Mark Linskey, Professor of Neurological Surgery at the University of California Irvine, discuss the evidence, the issues around it, and put this all into a clinical context.

Read the full systematic overview: 
http://clinicalevidence.bmj.com/x/systematic-review/1207/overview.html

Disclaimer:
The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions.
By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.  
<p>BMJ does not warrant the accuracy of the information contained in the podcast and to the fullest extent permitted by law, BMJ Publishing Group Limited is not responsible for any loss whatsoever resulting from the application of, or reliance upon, the information contained in this podcast.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/nkei70/stream_196509017-bmjgroup-trigeminal-neuralgia-the-evidence-base-for-medical-and-surgical-treatments.mp3" length="19269384" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A BMJ Clinical Evidence systematic overview looks at the evidence for medical and surgical treatments of trigeminal neuralgia, and the uncertainties that exist due to gaps in the evidence. This has been summarised in The BMJ.

The authors of the overview and bmj.comsummary, Prof. Joanna Zakrzewska from the Facial Pain Unit at the Eastman Dental Hospital, London, and Mark Linskey, Professor of Neurological Surgery at the University of California Irvine, discuss the evidence, the issues around it, and put this all into a clinical context.

Read the full systematic overview: 
http://clinicalevidence.bmj.com/x/systematic-review/1207/overview.html

Disclaimer:
The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions.
By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.  
BMJ does not warrant the accuracy of the information contained in the podcast and to the fullest extent permitted by law, BMJ Publishing Group Limited is not responsible for any loss whatsoever resulting from the application of, or reliance upon, the information contained in this podcast.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1607</itunes:duration>
                                    </item>
    <item>
        <title>Thrombolysis in acute ischaemic stroke - time for a rethink?</title>
        <itunes:title>Thrombolysis in acute ischaemic stroke - time for a rethink?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/thrombolysis-in-acute-ischaemic-stroke-time-for-a-rethink/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/thrombolysis-in-acute-ischaemic-stroke-time-for-a-rethink/#comments</comments>        <pubDate>Wed, 18 Mar 2015 16:39:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/thrombolysis-in-acute-ischaemic-stroke-time-for-a-rethink</guid>
                                    <description><![CDATA[In the US the licence, or marketing authorisation, for alteplase is limited to 0-3 hours after onset of stroke, but some other countries - including the UK and Australia - have extended the licence to 4.5 hours.

In an analysis article on thebmj.com Brian Alper, vice president of evidence based medicine research and development at Dynamed, and colleagues, interpret the evidence to suggest increased mortality with uncertain benefit for its use beyond three hours.

Read their full analysis:
<p>http://www.bmj.com/content/350/bmj.h1075</p>
]]></description>
                                                            <content:encoded><![CDATA[In the US the licence, or marketing authorisation, for alteplase is limited to 0-3 hours after onset of stroke, but some other countries - including the UK and Australia - have extended the licence to 4.5 hours.

In an analysis article on thebmj.com Brian Alper, vice president of evidence based medicine research and development at Dynamed, and colleagues, interpret the evidence to suggest increased mortality with uncertain benefit for its use beyond three hours.

Read their full analysis:
<p>http://www.bmj.com/content/350/bmj.h1075</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/lu0vel/stream_196500360-bmjgroup-thrombolysis-in-acute-ischaemic-stroke-time-for-a-rethink.mp3" length="23751734" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In the US the licence, or marketing authorisation, for alteplase is limited to 0-3 hours after onset of stroke, but some other countries - including the UK and Australia - have extended the licence to 4.5 hours.

In an analysis article on thebmj.com Brian Alper, vice president of evidence based medicine research and development at Dynamed, and colleagues, interpret the evidence to suggest increased mortality with uncertain benefit for its use beyond three hours.

Read their full analysis:
http://www.bmj.com/content/350/bmj.h1075]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>988</itunes:duration>
                                    </item>
    <item>
        <title>Chris Moulton A and E - patients are usually justified in presenting as an emergency</title>
        <itunes:title>Chris Moulton A and E - patients are usually justified in presenting as an emergency</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/chris-moulton-a-and-e-patients-are-usually-justified-in-presenting-as-an-emergency/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/chris-moulton-a-and-e-patients-are-usually-justified-in-presenting-as-an-emergency/#comments</comments>        <pubDate>Wed, 11 Mar 2015 14:56:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/chris-moulton-mixdown</guid>
                                    <description><![CDATA[Chris Moulton is VP of the Royal College of Emergency Medicine and an A&E consultant in the Royal Bolton Hospital.

He believes that the majority of patients who attend A&E cannot be adequately treated elsewhere, and that measures to try and reduce emergency presentations may be counterproductive.

<p>If you would like to contribute to this collection, please email a brief audio recording to voices@bmj.com or phone +44 (20) 3058 7427 and tell us what your main concern for the NHS is. Please include your name, job title, and place of work.</p>
]]></description>
                                                            <content:encoded><![CDATA[Chris Moulton is VP of the Royal College of Emergency Medicine and an A&E consultant in the Royal Bolton Hospital.

He believes that the majority of patients who attend A&E cannot be adequately treated elsewhere, and that measures to try and reduce emergency presentations may be counterproductive.

<p>If you would like to contribute to this collection, please email a brief audio recording to voices@bmj.com or phone +44 (20) 3058 7427 and tell us what your main concern for the NHS is. Please include your name, job title, and place of work.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/v53y83/stream_195348413-bmjgroup-chris-moulton-mixdown.mp3" length="3162793" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Chris Moulton is VP of the Royal College of Emergency Medicine and an A&E consultant in the Royal Bolton Hospital.

He believes that the majority of patients who attend A&E cannot be adequately treated elsewhere, and that measures to try and reduce emergency presentations may be counterproductive.

If you would like to contribute to this collection, please email a brief audio recording to voices@bmj.com or phone +44 (20) 3058 7427 and tell us what your main concern for the NHS is. Please include your name, job title, and place of work.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>132</itunes:duration>
                                    </item>
    <item>
        <title>Patrick Keating GP - under pressure to increase list size</title>
        <itunes:title>Patrick Keating GP - under pressure to increase list size</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/patrick-keating-gp-under-pressure-to-increase-list-size/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/patrick-keating-gp-under-pressure-to-increase-list-size/#comments</comments>        <pubDate>Wed, 11 Mar 2015 14:55:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/patrick-keating-gp</guid>
                                    <description><![CDATA[BMJ Voices is a collection of readers’ experiences of working in the NHS. For this, The BMJ is seeking short audio submissions from UK listeners. These submissions will be published on thebmj.com.

Patrick Keating, a GP from Enfield, is concerned that small practices are under pressure to increase list size, but aren't able to muster resources to meet this increased demand.

If you would like to contribute to this collection, please email a brief audio recording to voices@bmj.com or phone +44 (20) 3058 7427 and tell us what your main concern for the NHS is. Please include your name, job title, and place of work.
<p></p>
<p></p>
]]></description>
                                                            <content:encoded><![CDATA[BMJ Voices is a collection of readers’ experiences of working in the NHS. For this, The BMJ is seeking short audio submissions from UK listeners. These submissions will be published on thebmj.com.

Patrick Keating, a GP from Enfield, is concerned that small practices are under pressure to increase list size, but aren't able to muster resources to meet this increased demand.

If you would like to contribute to this collection, please email a brief audio recording to voices@bmj.com or phone +44 (20) 3058 7427 and tell us what your main concern for the NHS is. Please include your name, job title, and place of work.
<p></p>
<p></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/76msgf/stream_195348343-bmjgroup-patrick-keating-gp.mp3" length="1555639" type="audio/mpeg"/>
        <itunes:summary><![CDATA[BMJ Voices is a collection of readers’ experiences of working in the NHS. For this, The BMJ is seeking short audio submissions from UK listeners. These submissions will be published on thebmj.com.

Patrick Keating, a GP from Enfield, is concerned that small practices are under pressure to increase list size, but aren't able to muster resources to meet this increased demand.

If you would like to contribute to this collection, please email a brief audio recording to voices@bmj.com or phone +44 (20) 3058 7427 and tell us what your main concern for the NHS is. Please include your name, job title, and place of work.

]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>65</itunes:duration>
                                    </item>
    <item>
        <title>Obioma Ezekobe GP  - patients need to be educated about resources</title>
        <itunes:title>Obioma Ezekobe GP  - patients need to be educated about resources</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/obioma-ezekobe-gp-patients-need-to-be-educated-about-resources/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/obioma-ezekobe-gp-patients-need-to-be-educated-about-resources/#comments</comments>        <pubDate>Wed, 11 Mar 2015 14:55:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/obioma-ezekobe-mixdown</guid>
                                    <description><![CDATA[Obioma Ezekobe is a GP in an urgent care centre in Central Middlesex Hospital. 

She believes that the public need to be educated about the use of NHS resources, and be taught when it is appropriate to seek care.

<p>If you would like to contribute to this collection, please email a brief audio recording to voices@bmj.com or phone +44 (20) 3058 7427 and tell us what your main concern for the NHS is. Please include your name, job title, and place of work.</p>
<p></p>
]]></description>
                                                            <content:encoded><![CDATA[Obioma Ezekobe is a GP in an urgent care centre in Central Middlesex Hospital. 

She believes that the public need to be educated about the use of NHS resources, and be taught when it is appropriate to seek care.

<p>If you would like to contribute to this collection, please email a brief audio recording to voices@bmj.com or phone +44 (20) 3058 7427 and tell us what your main concern for the NHS is. Please include your name, job title, and place of work.</p>
<p></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hibrc3/stream_195348353-bmjgroup-obioma-ezekobe-mixdown.mp3" length="2227059" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Obioma Ezekobe is a GP in an urgent care centre in Central Middlesex Hospital. 

She believes that the public need to be educated about the use of NHS resources, and be taught when it is appropriate to seek care.

If you would like to contribute to this collection, please email a brief audio recording to voices@bmj.com or phone +44 (20) 3058 7427 and tell us what your main concern for the NHS is. Please include your name, job title, and place of work.
]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>93</itunes:duration>
                                    </item>
    <item>
        <title>Katherine Henderson  A and E consultant - lack of ward beds is hitting A and E the hardest</title>
        <itunes:title>Katherine Henderson  A and E consultant - lack of ward beds is hitting A and E the hardest</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/katherine-henderson-a-and-e-consultant-lack-of-ward-beds-is-hitting-a-and-e-the-hardest/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/katherine-henderson-a-and-e-consultant-lack-of-ward-beds-is-hitting-a-and-e-the-hardest/#comments</comments>        <pubDate>Wed, 11 Mar 2015 14:55:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/katherine-henderson-mixdown</guid>
                                    <description><![CDATA[Katherine Henderson is the clinical lead of the emergency department at St Thomas's hospital in London.

She worries that lack of ward space is having a domino effect throughout A and E and is the cause of increased waiting time for both patients and ambulances.

<p>If you would like to contribute to this collection, please email a brief audio recording to voices@bmj.com or phone +44 (20) 3058 7427 and tell us what your main concern for the NHS is. Please include your name, job title, and place of work.</p>
]]></description>
                                                            <content:encoded><![CDATA[Katherine Henderson is the clinical lead of the emergency department at St Thomas's hospital in London.

She worries that lack of ward space is having a domino effect throughout A and E and is the cause of increased waiting time for both patients and ambulances.

<p>If you would like to contribute to this collection, please email a brief audio recording to voices@bmj.com or phone +44 (20) 3058 7427 and tell us what your main concern for the NHS is. Please include your name, job title, and place of work.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/zm02v4/stream_195348364-bmjgroup-katherine-henderson-mixdown.mp3" length="4878181" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Katherine Henderson is the clinical lead of the emergency department at St Thomas's hospital in London.

She worries that lack of ward space is having a domino effect throughout A and E and is the cause of increased waiting time for both patients and ambulances.

If you would like to contribute to this collection, please email a brief audio recording to voices@bmj.com or phone +44 (20) 3058 7427 and tell us what your main concern for the NHS is. Please include your name, job title, and place of work.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>203</itunes:duration>
                                    </item>
    <item>
        <title>Has the balance of screening for AAA tipped towards harm?</title>
        <itunes:title>Has the balance of screening for AAA tipped towards harm?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/has-the-balance-of-screening-for-aaa-tipped-towards-harm/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/has-the-balance-of-screening-for-aaa-tipped-towards-harm/#comments</comments>        <pubDate>Fri, 06 Mar 2015 16:32:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/overdiagnosis_aaa</guid>
                                    <description><![CDATA[Abdominal aortic aneurysms (AAA) are usually asymptomatic until they rupture, which is fatal in more than 80% of cases.

Screening aims to detect the aneurysm before it ruptures, enabling preventive surgery and hence reducing morbidity and mortality. However, preventive surgery has a mortality of 3.9-4.5%.

As the prevalence of risk factors, ie smoking, decreases and the definition of the condition is expanded, Minna Johansson from the University of Gothenburg and colleagues wonder if the balance of benefit and harm may have tipped.

Read the full analysis:
<p>http://www.bmj.com/content/350/bmj.h825</p>
]]></description>
                                                            <content:encoded><![CDATA[Abdominal aortic aneurysms (AAA) are usually asymptomatic until they rupture, which is fatal in more than 80% of cases.

Screening aims to detect the aneurysm before it ruptures, enabling preventive surgery and hence reducing morbidity and mortality. However, preventive surgery has a mortality of 3.9-4.5%.

As the prevalence of risk factors, ie smoking, decreases and the definition of the condition is expanded, Minna Johansson from the University of Gothenburg and colleagues wonder if the balance of benefit and harm may have tipped.

Read the full analysis:
<p>http://www.bmj.com/content/350/bmj.h825</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/77wddp/stream_194550852-bmjgroup-overdiagnosis_aaa.mp3" length="10931678" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Abdominal aortic aneurysms (AAA) are usually asymptomatic until they rupture, which is fatal in more than 80% of cases.

Screening aims to detect the aneurysm before it ruptures, enabling preventive surgery and hence reducing morbidity and mortality. However, preventive surgery has a mortality of 3.9-4.5%.

As the prevalence of risk factors, ie smoking, decreases and the definition of the condition is expanded, Minna Johansson from the University of Gothenburg and colleagues wonder if the balance of benefit and harm may have tipped.

Read the full analysis:
http://www.bmj.com/content/350/bmj.h825]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>455</itunes:duration>
                                    </item>
    <item>
        <title>Nuffield summit - Ashish Jha explains Acountable Care Organisations</title>
        <itunes:title>Nuffield summit - Ashish Jha explains Acountable Care Organisations</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/nuffield-summit-ashish-jha-explains-acountable-care-organisations/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/nuffield-summit-ashish-jha-explains-acountable-care-organisations/#comments</comments>        <pubDate>Thu, 05 Mar 2015 16:23:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/nuffield-summit-ashish-jha</guid>
                                    <description><![CDATA[Ashish Jha, professor of health policy and management at Harvard School of Public Health, talking about how the Affordable Care Act has fostered new models of integrated service delivery in the United States 

Read more from the summit:
<p>http://www.bmj.com/content/350/bmj.h1172</p>
]]></description>
                                                            <content:encoded><![CDATA[Ashish Jha, professor of health policy and management at Harvard School of Public Health, talking about how the Affordable Care Act has fostered new models of integrated service delivery in the United States 

Read more from the summit:
<p>http://www.bmj.com/content/350/bmj.h1172</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3ezuz8/stream_194372736-bmjgroup-nuffield-summit-ashish-jha.mp3" length="9863636" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Ashish Jha, professor of health policy and management at Harvard School of Public Health, talking about how the Affordable Care Act has fostered new models of integrated service delivery in the United States 

Read more from the summit:
http://www.bmj.com/content/350/bmj.h1172]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>411</itunes:duration>
                                    </item>
    <item>
        <title>Nuffield summit - Bastiaan Bloem on parkinsons.net</title>
        <itunes:title>Nuffield summit - Bastiaan Bloem on parkinsons.net</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/nuffield-summit-bastiaan-bloem-on-parkinsonsnet/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/nuffield-summit-bastiaan-bloem-on-parkinsonsnet/#comments</comments>        <pubDate>Thu, 05 Mar 2015 16:22:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/nuffield-summit-baastian-bloem</guid>
                                    <description><![CDATA[Bastiaan Bloem, consultant neurologist at Radboud University Nijmegen Medical Centre, Netherlands, discussing his revolutionary approach to patient centred care.

Read more from the summit:
<p>http://www.bmj.com/content/350/bmj.h1172</p>
]]></description>
                                                            <content:encoded><![CDATA[Bastiaan Bloem, consultant neurologist at Radboud University Nijmegen Medical Centre, Netherlands, discussing his revolutionary approach to patient centred care.

Read more from the summit:
<p>http://www.bmj.com/content/350/bmj.h1172</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7feom6/stream_194372626-bmjgroup-nuffield-summit-baastian-bloem.mp3" length="20003822" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Bastiaan Bloem, consultant neurologist at Radboud University Nijmegen Medical Centre, Netherlands, discussing his revolutionary approach to patient centred care.

Read more from the summit:
http://www.bmj.com/content/350/bmj.h1172]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>834</itunes:duration>
                                    </item>
    <item>
        <title>How to diagnose overdiagnosis</title>
        <itunes:title>How to diagnose overdiagnosis</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/how-to-diagnose-overdiagnosis/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/how-to-diagnose-overdiagnosis/#comments</comments>        <pubDate>Thu, 05 Mar 2015 14:35:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/how-to-diagnose-overdiagnosis</guid>
                                    <description><![CDATA[Overdiagnosis means different things to different people. Stacy Carter, associate professor at the Centre for Values, Ethics and the Law in Medicine at the University of Sydney argues that we should use a broad term such as too much medicine for advocacy and develop precise, case by case definitions of overdiagnosis for research and clinical purposes.

Read the full analysis article:
http://www.bmj.com/content/350/bmj.h869

For the full overdiagnosis digital edition:
<p>http://www.bmj.com/specialties/digital-theme-issue-overdiagnosis</p>
]]></description>
                                                            <content:encoded><![CDATA[Overdiagnosis means different things to different people. Stacy Carter, associate professor at the Centre for Values, Ethics and the Law in Medicine at the University of Sydney argues that we should use a broad term such as too much medicine for advocacy and develop precise, case by case definitions of overdiagnosis for research and clinical purposes.

Read the full analysis article:
http://www.bmj.com/content/350/bmj.h869

For the full overdiagnosis digital edition:
<p>http://www.bmj.com/specialties/digital-theme-issue-overdiagnosis</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/0sl8u4/stream_194357781-bmjgroup-how-to-diagnose-overdiagnosis.mp3" length="24582017" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Overdiagnosis means different things to different people. Stacy Carter, associate professor at the Centre for Values, Ethics and the Law in Medicine at the University of Sydney argues that we should use a broad term such as too much medicine for advocacy and develop precise, case by case definitions of overdiagnosis for research and clinical purposes.

Read the full analysis article:
http://www.bmj.com/content/350/bmj.h869

For the full overdiagnosis digital edition:
http://www.bmj.com/specialties/digital-theme-issue-overdiagnosis]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1025</itunes:duration>
                                    </item>
    <item>
        <title>Overdiagnosis in breast cancer - 45 years to become a mainstream idea</title>
        <itunes:title>Overdiagnosis in breast cancer - 45 years to become a mainstream idea</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/overdiagnosis-in-breast-cancer-45-years-to-become-a-mainstream-idea/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/overdiagnosis-in-breast-cancer-45-years-to-become-a-mainstream-idea/#comments</comments>        <pubDate>Wed, 04 Mar 2015 10:34:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/overdiagnosis-in-breast-cancer-45-years-to-become-a-mainstream-idea</guid>
                                    <description><![CDATA[In this podcast Alexandra Barratt, professor of public health at the University of Sydney, discusses how questions about overdiagnosis in breast cancer screening programmes were first raised 45 years ago, and why it has taken so long for the concept to become mainstream.

Read her full analysis:
<p>http://www.bmj.com/content/350/bmj.h867</p>
<p></p>
]]></description>
                                                            <content:encoded><![CDATA[In this podcast Alexandra Barratt, professor of public health at the University of Sydney, discusses how questions about overdiagnosis in breast cancer screening programmes were first raised 45 years ago, and why it has taken so long for the concept to become mainstream.

Read her full analysis:
<p>http://www.bmj.com/content/350/bmj.h867</p>
<p></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/bv22bg/stream_194161257-bmjgroup-overdiagnosis-in-breast-cancer-45-years-to-become-a-mainstream-idea.mp3" length="30109106" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast Alexandra Barratt, professor of public health at the University of Sydney, discusses how questions about overdiagnosis in breast cancer screening programmes were first raised 45 years ago, and why it has taken so long for the concept to become mainstream.

Read her full analysis:
http://www.bmj.com/content/350/bmj.h867
]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1256</itunes:duration>
                                    </item>
    <item>
        <title>Roundtable: Hopes for the NHS, the election and beyond</title>
        <itunes:title>Roundtable: Hopes for the NHS, the election and beyond</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/roundtable-hopes-for-the-nhs-the-election-and-beyond/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/roundtable-hopes-for-the-nhs-the-election-and-beyond/#comments</comments>        <pubDate>Fri, 27 Feb 2015 16:55:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/nuffield-roundtable-2015</guid>
                                    <description><![CDATA[The BMJ held a breakfast roundtable at the annual health policy summit held by the Nuffield Trust think tank to explore some of the key policy discussions that took place during the ​proceeding day. These included NHS England chief executive Simon Stevens' five year plan, whether politics can be removed from the NHS, and what the creation of a central unit to coordinate care for Manchester means for the rest of the ​NHS in England.

Chaired by Fiona Godlee, editor in chief of The BMJ, the particpants were: 

Richard Jones - Clinical director of the Wessex Cardiovascular Strategic Clinical Network
Suzie Bailey - Development director at health service regulator Monitor
Jonathan Michael​ - ​chief executive of Oxford University Hospital NHS Trust
Steve Field - Chief inspector of general practice for the Care Quality Commission
Nigel Edwards - Chief executive of The Nuffield Trust
Jeremy Taylor - Chief executive of health and care charity National Voices
Massoud Fouladi - Chief medical officer of Circle Partnership
Rebecca Rosen - GP and clinical commissioner of Greenwich Clinical Commissioning Group, London
<p>Jennifer Dixon - Chief executive of the Health Foundation</p>
]]></description>
                                                            <content:encoded><![CDATA[The BMJ held a breakfast roundtable at the annual health policy summit held by the Nuffield Trust think tank to explore some of the key policy discussions that took place during the ​proceeding day. These included NHS England chief executive Simon Stevens' five year plan, whether politics can be removed from the NHS, and what the creation of a central unit to coordinate care for Manchester means for the rest of the ​NHS in England.

Chaired by Fiona Godlee, editor in chief of The BMJ, the particpants were: 

Richard Jones - Clinical director of the Wessex Cardiovascular Strategic Clinical Network
Suzie Bailey - Development director at health service regulator Monitor
Jonathan Michael​ - ​chief executive of Oxford University Hospital NHS Trust
Steve Field - Chief inspector of general practice for the Care Quality Commission
Nigel Edwards - Chief executive of The Nuffield Trust
Jeremy Taylor - Chief executive of health and care charity National Voices
Massoud Fouladi - Chief medical officer of Circle Partnership
Rebecca Rosen - GP and clinical commissioner of Greenwich Clinical Commissioning Group, London
<p>Jennifer Dixon - Chief executive of the Health Foundation</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/oveir2/stream_193369297-bmjgroup-nuffield-roundtable-2015.mp3" length="64811525" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The BMJ held a breakfast roundtable at the annual health policy summit held by the Nuffield Trust think tank to explore some of the key policy discussions that took place during the ​proceeding day. These included NHS England chief executive Simon Stevens' five year plan, whether politics can be removed from the NHS, and what the creation of a central unit to coordinate care for Manchester means for the rest of the ​NHS in England.

Chaired by Fiona Godlee, editor in chief of The BMJ, the particpants were: 

Richard Jones - Clinical director of the Wessex Cardiovascular Strategic Clinical Network
Suzie Bailey - Development director at health service regulator Monitor
Jonathan Michael​ - ​chief executive of Oxford University Hospital NHS Trust
Steve Field - Chief inspector of general practice for the Care Quality Commission
Nigel Edwards - Chief executive of The Nuffield Trust
Jeremy Taylor - Chief executive of health and care charity National Voices
Massoud Fouladi - Chief medical officer of Circle Partnership
Rebecca Rosen - GP and clinical commissioner of Greenwich Clinical Commissioning Group, London
Jennifer Dixon - Chief executive of the Health Foundation]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2704</itunes:duration>
                                    </item>
    <item>
        <title>Assessment and management of alcohol use disorders</title>
        <itunes:title>Assessment and management of alcohol use disorders</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/assessment-and-management-of-alcohol-use-disorders/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/assessment-and-management-of-alcohol-use-disorders/#comments</comments>        <pubDate>Thu, 19 Feb 2015 16:27:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/alcohol-misuse</guid>
                                    <description><![CDATA[As the level of alcohol consumption goes up, so the risk of physical, psychological, and social problems increases. 

In this podcast we’re joined by Ed Day, consultant addiction psychiatrist at Kings College London, Alex Copello, professor of addiction research at the University of Birmingham, and Martyn Hull, GP with a special interest in substance misuse at the Ridgacre Medical Centres in Birmingham.

They discuss practical aspects of the assessment and treatment of alcohol use disorders from the perspective of the non-specialist hospital doctor or general practitioner.

Read the full clinical review:
<p>http://www.bmj.com/content/350/bmj.h715</p>
]]></description>
                                                            <content:encoded><![CDATA[As the level of alcohol consumption goes up, so the risk of physical, psychological, and social problems increases. 

In this podcast we’re joined by Ed Day, consultant addiction psychiatrist at Kings College London, Alex Copello, professor of addiction research at the University of Birmingham, and Martyn Hull, GP with a special interest in substance misuse at the Ridgacre Medical Centres in Birmingham.

They discuss practical aspects of the assessment and treatment of alcohol use disorders from the perspective of the non-specialist hospital doctor or general practitioner.

Read the full clinical review:
<p>http://www.bmj.com/content/350/bmj.h715</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xc4vdc/stream_191951284-bmjgroup-alcohol-misuse.mp3" length="25096192" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As the level of alcohol consumption goes up, so the risk of physical, psychological, and social problems increases. 

In this podcast we’re joined by Ed Day, consultant addiction psychiatrist at Kings College London, Alex Copello, professor of addiction research at the University of Birmingham, and Martyn Hull, GP with a special interest in substance misuse at the Ridgacre Medical Centres in Birmingham.

They discuss practical aspects of the assessment and treatment of alcohol use disorders from the perspective of the non-specialist hospital doctor or general practitioner.

Read the full clinical review:
http://www.bmj.com/content/350/bmj.h715]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2028</itunes:duration>
                                    </item>
    <item>
        <title>Jackie Applebee GP - the funding formula is hurting deprived practices</title>
        <itunes:title>Jackie Applebee GP - the funding formula is hurting deprived practices</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/jackie-applebee-gp-the-funding-formula-is-hurting-deprived-practices/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/jackie-applebee-gp-the-funding-formula-is-hurting-deprived-practices/#comments</comments>        <pubDate>Fri, 13 Feb 2015 16:27:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/jackie-applebee-gp-the-funding-formula-is-hurting-deprived-practices</guid>
                                    <description><![CDATA[Jackie Applebee is a GP in Tower Hamlets in London, and is concerned that the way the GP funding formula is working doesn't take account of the earlier health needs of people in deprived areas.

For more about the Tower Hamlets Save Our Surgery campaign, visit their facebook page https://www.facebook.com/SaveOurGPsurgeries

BMJ Voices is a collection of readers’ experiences of working in the NHS. For this, The BMJ is seeking short audio submissions from UK listeners. These submissions will be published on thebmj.com.

<p>If you would like to contribute to this collection, please email a brief audio recording to voices@bmj.com or phone +44 (20) 3058 7427 and tell us what your main concern for the NHS is. Please include your name, job title, and place of work.</p>
]]></description>
                                                            <content:encoded><![CDATA[Jackie Applebee is a GP in Tower Hamlets in London, and is concerned that the way the GP funding formula is working doesn't take account of the earlier health needs of people in deprived areas.

For more about the Tower Hamlets Save Our Surgery campaign, visit their facebook page https://www.facebook.com/SaveOurGPsurgeries

BMJ Voices is a collection of readers’ experiences of working in the NHS. For this, The BMJ is seeking short audio submissions from UK listeners. These submissions will be published on thebmj.com.

<p>If you would like to contribute to this collection, please email a brief audio recording to voices@bmj.com or phone +44 (20) 3058 7427 and tell us what your main concern for the NHS is. Please include your name, job title, and place of work.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mbyzfl/stream_190952296-bmjgroup-jackie-applebee-gp-the-funding-formula-is-hurting-deprived-practices.mp3" length="6609140" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Jackie Applebee is a GP in Tower Hamlets in London, and is concerned that the way the GP funding formula is working doesn't take account of the earlier health needs of people in deprived areas.

For more about the Tower Hamlets Save Our Surgery campaign, visit their facebook page https://www.facebook.com/SaveOurGPsurgeries

BMJ Voices is a collection of readers’ experiences of working in the NHS. For this, The BMJ is seeking short audio submissions from UK listeners. These submissions will be published on thebmj.com.

If you would like to contribute to this collection, please email a brief audio recording to voices@bmj.com or phone +44 (20) 3058 7427 and tell us what your main concern for the NHS is. Please include your name, job title, and place of work.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>275</itunes:duration>
                                    </item>
    <item>
        <title>Mark Folman GP - time pressure and patient care</title>
        <itunes:title>Mark Folman GP - time pressure and patient care</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/mark-folman-gp-time-pressure-and-patient-care/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/mark-folman-gp-time-pressure-and-patient-care/#comments</comments>        <pubDate>Fri, 13 Feb 2015 16:17:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/mike-folman</guid>
                                    <description><![CDATA[Mark Folman, a GP in Nottinghamshire, is concerned that more and more work, with more and more patients, means less time with those who really need him.

BMJ Voices is a collection of readers’ experiences of working in the NHS. For this, The BMJ is seeking short audio submissions from UK listeners. These submissions will be published on thebmj.com.

<p>If you would like to contribute to this collection, please email a brief audio recording to voices@bmj.com or phone +44 (20) 3058 7427 and tell us what your main concern for the NHS is. Please include your name, job title, and place of work.</p>
]]></description>
                                                            <content:encoded><![CDATA[Mark Folman, a GP in Nottinghamshire, is concerned that more and more work, with more and more patients, means less time with those who really need him.

BMJ Voices is a collection of readers’ experiences of working in the NHS. For this, The BMJ is seeking short audio submissions from UK listeners. These submissions will be published on thebmj.com.

<p>If you would like to contribute to this collection, please email a brief audio recording to voices@bmj.com or phone +44 (20) 3058 7427 and tell us what your main concern for the NHS is. Please include your name, job title, and place of work.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wu0q0m/stream_190950724-bmjgroup-mike-folman.mp3" length="4155836" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Mark Folman, a GP in Nottinghamshire, is concerned that more and more work, with more and more patients, means less time with those who really need him.

BMJ Voices is a collection of readers’ experiences of working in the NHS. For this, The BMJ is seeking short audio submissions from UK listeners. These submissions will be published on thebmj.com.

If you would like to contribute to this collection, please email a brief audio recording to voices@bmj.com or phone +44 (20) 3058 7427 and tell us what your main concern for the NHS is. Please include your name, job title, and place of work.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>173</itunes:duration>
                                    </item>
    <item>
        <title>Michelle Sinclair GP - surgery buildings are not up to scratch</title>
        <itunes:title>Michelle Sinclair GP - surgery buildings are not up to scratch</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/michelle-sinclair-gp-surgery-buildings-are-not-up-to-scratch/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/michelle-sinclair-gp-surgery-buildings-are-not-up-to-scratch/#comments</comments>        <pubDate>Fri, 13 Feb 2015 16:17:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/bmj-voices-gp-surgeries</guid>
                                    <description><![CDATA[Michelle Sinclar, a GP in Hampshire who is concerned that GP premises aren't fit for purpose and limit her ability to provide fully rounded patient care.

BMJ Voices is a collection of readers’ experiences of working in the NHS. For this, The BMJ is seeking short audio submissions from UK listeners. These submissions will be published on thebmj.com.

<p>If you would like to contribute to this collection, please email a brief audio recording to voices@bmj.com or phone +44 (20) 3058 7427 and tell us what your main concern for the NHS is. Please include your name, job title, and place of work.</p>
]]></description>
                                                            <content:encoded><![CDATA[Michelle Sinclar, a GP in Hampshire who is concerned that GP premises aren't fit for purpose and limit her ability to provide fully rounded patient care.

BMJ Voices is a collection of readers’ experiences of working in the NHS. For this, The BMJ is seeking short audio submissions from UK listeners. These submissions will be published on thebmj.com.

<p>If you would like to contribute to this collection, please email a brief audio recording to voices@bmj.com or phone +44 (20) 3058 7427 and tell us what your main concern for the NHS is. Please include your name, job title, and place of work.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7v8xoy/stream_190950727-bmjgroup-bmj-voices-gp-surgeries.mp3"  type="audio/mpeg"/>
        <itunes:summary><![CDATA[Michelle Sinclar, a GP in Hampshire who is concerned that GP premises aren't fit for purpose and limit her ability to provide fully rounded patient care.

BMJ Voices is a collection of readers’ experiences of working in the NHS. For this, The BMJ is seeking short audio submissions from UK listeners. These submissions will be published on thebmj.com.

If you would like to contribute to this collection, please email a brief audio recording to voices@bmj.com or phone +44 (20) 3058 7427 and tell us what your main concern for the NHS is. Please include your name, job title, and place of work.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>170</itunes:duration>
                                    </item>
    <item>
        <title>Patient spotlight - How can we get better at providing patient centred care?</title>
        <itunes:title>Patient spotlight - How can we get better at providing patient centred care?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/patient-spotlight-how-can-we-get-better-at-providing-patient-centred-care/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/patient-spotlight-how-can-we-get-better-at-providing-patient-centred-care/#comments</comments>        <pubDate>Tue, 10 Feb 2015 12:04:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/patient-spotlight-roundtable</guid>
                                    <description><![CDATA[Participants in our discussion on person centred care in January
agreed that a change in culture and better use of technology
could benefit both patients and doctors.

At the roundtable:

Fiona Godlee (chair), editor in chief, The BMJ
Tessa Richards, senior editor, patient partnership, The BMJ
Rosamund Snow, patient editor, The BMJ
Navjoyt Ladher, clinical editor, The BMJ
Angela Coulter, director of global initiatives, Informed Medical Decisions Foundation (www.informedmedicaldecisions.org)
Paul Wicks, vice president of innovation, PatientsLikeMe (www.patientslikeme.com)
Michael Seres, founder, 11 Health (www.11health.com)
Alf Collins, clinical associate in person centred care, Health Foundation (www.health.org.uk)
Jeremy Taylor, chief executive, National Voices (www.nationalvoices.org.uk)
Dave deBronkart, cochair, Society for Participatory Medicine (www.participatorymedicine.org)
Amir Hannan, general practitioner and member of clinical commissioning group board
Alexander Silverstein, past president, International Diabetes Federation’s young leaders in diabetes project
Paul Hodgkin, founder, Patient Opinion (www.patientopinion.org.uk)
Ben Mearns, consultant in acute care and elderly medicine, Surrey and Sussex Healthcare NHS Trust
Sara Riggare, PhD student in health informatics, Karolinska Institute
Rupert Whitaker, founder, Tuke Institute (www.tukeinstitute.org)
<p>Stephen Leyshon (observer), DNV Healthcare</p>
]]></description>
                                                            <content:encoded><![CDATA[Participants in our discussion on person centred care in January
agreed that a change in culture and better use of technology
could benefit both patients and doctors.

At the roundtable:

Fiona Godlee (chair), editor in chief, The BMJ
Tessa Richards, senior editor, patient partnership, The BMJ
Rosamund Snow, patient editor, The BMJ
Navjoyt Ladher, clinical editor, The BMJ
Angela Coulter, director of global initiatives, Informed Medical Decisions Foundation (www.informedmedicaldecisions.org)
Paul Wicks, vice president of innovation, PatientsLikeMe (www.patientslikeme.com)
Michael Seres, founder, 11 Health (www.11health.com)
Alf Collins, clinical associate in person centred care, Health Foundation (www.health.org.uk)
Jeremy Taylor, chief executive, National Voices (www.nationalvoices.org.uk)
Dave deBronkart, cochair, Society for Participatory Medicine (www.participatorymedicine.org)
Amir Hannan, general practitioner and member of clinical commissioning group board
Alexander Silverstein, past president, International Diabetes Federation’s young leaders in diabetes project
Paul Hodgkin, founder, Patient Opinion (www.patientopinion.org.uk)
Ben Mearns, consultant in acute care and elderly medicine, Surrey and Sussex Healthcare NHS Trust
Sara Riggare, PhD student in health informatics, Karolinska Institute
Rupert Whitaker, founder, Tuke Institute (www.tukeinstitute.org)
<p>Stephen Leyshon (observer), DNV Healthcare</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ho05fa/stream_190405625-bmjgroup-patient-spotlight-roundtable.mp3" length="111456322" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Participants in our discussion on person centred care in January
agreed that a change in culture and better use of technology
could benefit both patients and doctors.

At the roundtable:

Fiona Godlee (chair), editor in chief, The BMJ
Tessa Richards, senior editor, patient partnership, The BMJ
Rosamund Snow, patient editor, The BMJ
Navjoyt Ladher, clinical editor, The BMJ
Angela Coulter, director of global initiatives, Informed Medical Decisions Foundation (www.informedmedicaldecisions.org)
Paul Wicks, vice president of innovation, PatientsLikeMe (www.patientslikeme.com)
Michael Seres, founder, 11 Health (www.11health.com)
Alf Collins, clinical associate in person centred care, Health Foundation (www.health.org.uk)
Jeremy Taylor, chief executive, National Voices (www.nationalvoices.org.uk)
Dave deBronkart, cochair, Society for Participatory Medicine (www.participatorymedicine.org)
Amir Hannan, general practitioner and member of clinical commissioning group board
Alexander Silverstein, past president, International Diabetes Federation’s young leaders in diabetes project
Paul Hodgkin, founder, Patient Opinion (www.patientopinion.org.uk)
Ben Mearns, consultant in acute care and elderly medicine, Surrey and Sussex Healthcare NHS Trust
Sara Riggare, PhD student in health informatics, Karolinska Institute
Rupert Whitaker, founder, Tuke Institute (www.tukeinstitute.org)
Stephen Leyshon (observer), DNV Healthcare]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>4651</itunes:duration>
                                    </item>
    <item>
        <title>Patient spotlight - Doing it for themselves</title>
        <itunes:title>Patient spotlight - Doing it for themselves</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/patient-spotlight-doing-it-for-themselves/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/patient-spotlight-doing-it-for-themselves/#comments</comments>        <pubDate>Tue, 10 Feb 2015 11:45:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/patients-doing-it-for-themselves</guid>
                                    <description><![CDATA[In our accompanying roundtable discussion,we hear views from a group of patients and clinicians based largely in the UK on the  actions required  to advance  progress towards providing patient centred care.

To extend the conversation we talked to members of the BMJ's international patient advisory panel and other patient advocates - and what follows are short clips of hour long conversations with people in the US, Europe, India, Equador and Uganda. 

While the quality of the recordings vary there is no mistaking
the passion of these advocates to improve care for fellow patients and the barriers which need to be overcome to make it happen.

Taking part in this discussion in order are:
Dominck Frosch,associate professor, University of California
Maggie Breslin US designer, researcher and writer
Matthew Maleska, designer, Patient Revolution Project
Cristin Lind, patient advocate, Rare Diseases Sweden
Corine Jansen, cheif listening officer, JoConnect
Jonas Gonseth, chief executive, Gaerente en Hospital de Especialidades Guayaquil, Equador
Rakhal Gaitonde chair, community advisory board of the National
Institute for Research on Tuberculosis
Robinah Alambuya, president of the Pan African Network of People with Psychosocial Disabilities, Uganda
<p>Daniel Iga Mwesigwa, executive medical director, Mwesigwa Medical Centre, Uganda</p>
]]></description>
                                                            <content:encoded><![CDATA[In our accompanying roundtable discussion,we hear views from a group of patients and clinicians based largely in the UK on the  actions required  to advance  progress towards providing patient centred care.

To extend the conversation we talked to members of the BMJ's international patient advisory panel and other patient advocates - and what follows are short clips of hour long conversations with people in the US, Europe, India, Equador and Uganda. 

While the quality of the recordings vary there is no mistaking
the passion of these advocates to improve care for fellow patients and the barriers which need to be overcome to make it happen.

Taking part in this discussion in order are:
Dominck Frosch,associate professor, University of California
Maggie Breslin US designer, researcher and writer
Matthew Maleska, designer, Patient Revolution Project
Cristin Lind, patient advocate, Rare Diseases Sweden
Corine Jansen, cheif listening officer, JoConnect
Jonas Gonseth, chief executive, Gaerente en Hospital de Especialidades Guayaquil, Equador
Rakhal Gaitonde chair, community advisory board of the National
Institute for Research on Tuberculosis
Robinah Alambuya, president of the Pan African Network of People with Psychosocial Disabilities, Uganda
<p>Daniel Iga Mwesigwa, executive medical director, Mwesigwa Medical Centre, Uganda</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/un47s7/stream_190403874-bmjgroup-patients-doing-it-for-themselves.mp3" length="75175012" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In our accompanying roundtable discussion,we hear views from a group of patients and clinicians based largely in the UK on the  actions required  to advance  progress towards providing patient centred care.

To extend the conversation we talked to members of the BMJ's international patient advisory panel and other patient advocates - and what follows are short clips of hour long conversations with people in the US, Europe, India, Equador and Uganda. 

While the quality of the recordings vary there is no mistaking
the passion of these advocates to improve care for fellow patients and the barriers which need to be overcome to make it happen.

Taking part in this discussion in order are:
Dominck Frosch,associate professor, University of California
Maggie Breslin US designer, researcher and writer
Matthew Maleska, designer, Patient Revolution Project
Cristin Lind, patient advocate, Rare Diseases Sweden
Corine Jansen, cheif listening officer, JoConnect
Jonas Gonseth, chief executive, Gaerente en Hospital de Especialidades Guayaquil, Equador
Rakhal Gaitonde chair, community advisory board of the National
Institute for Research on Tuberculosis
Robinah Alambuya, president of the Pan African Network of People with Psychosocial Disabilities, Uganda
Daniel Iga Mwesigwa, executive medical director, Mwesigwa Medical Centre, Uganda]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3135</itunes:duration>
                                    </item>
    <item>
        <title>International donations to the Ebola virus outbreak: too little, too late?</title>
        <itunes:title>International donations to the Ebola virus outbreak: too little, too late?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/international-donations-to-the-ebola-virus-outbreak-too-little-too-late/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/international-donations-to-the-ebola-virus-outbreak-too-little-too-late/#comments</comments>        <pubDate>Wed, 04 Feb 2015 11:19:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/ebola-donations-too-little-too-late</guid>
                                    <description><![CDATA[Karen Grépin, assistant professor of global health policy at New York University, has been examining the pledges made by the international community to help fight the ebola virus outbreak - was it really too little, too late?

Read her full analysis:
<p>http://www.bmj.com/content/350/bmj.h376</p>
]]></description>
                                                            <content:encoded><![CDATA[Karen Grépin, assistant professor of global health policy at New York University, has been examining the pledges made by the international community to help fight the ebola virus outbreak - was it really too little, too late?

Read her full analysis:
<p>http://www.bmj.com/content/350/bmj.h376</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/93l05r/stream_189431002-bmjgroup-ebola-donations-too-little-too-late.mp3" length="20938778" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Karen Grépin, assistant professor of global health policy at New York University, has been examining the pledges made by the international community to help fight the ebola virus outbreak - was it really too little, too late?

Read her full analysis:
http://www.bmj.com/content/350/bmj.h376]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>872</itunes:duration>
                                    </item>
    <item>
        <title>Helping Eddie Redmayne play Stephen Hawking</title>
        <itunes:title>Helping Eddie Redmayne play Stephen Hawking</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/helping-eddie-redmayne-play-stephen-hawking/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/helping-eddie-redmayne-play-stephen-hawking/#comments</comments>        <pubDate>Tue, 03 Feb 2015 11:05:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/helping-eddie-redmayne-in-the</guid>
                                    <description><![CDATA[Katie Sidle is a consultant neurologist at the National Hospital for Neurology and Neurosurgery, in London. She helped actor Eddie Redmayne in his portrayal of theoretical physicist and cosmologist Stephen Hawking in the film The Theory of Everything.

She joins us to describe how that process worked, and what Motor Neurone Disease patients thought about how their condition was depicted.

Read the feature:
<p>http://www.bmj.com/content/350/bmj.h483</p>
]]></description>
                                                            <content:encoded><![CDATA[Katie Sidle is a consultant neurologist at the National Hospital for Neurology and Neurosurgery, in London. She helped actor Eddie Redmayne in his portrayal of theoretical physicist and cosmologist Stephen Hawking in the film The Theory of Everything.

She joins us to describe how that process worked, and what Motor Neurone Disease patients thought about how their condition was depicted.

Read the feature:
<p>http://www.bmj.com/content/350/bmj.h483</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/pk8fzt/stream_189257731-bmjgroup-helping-eddie-redmayne-in-the.mp3" length="9916583" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Katie Sidle is a consultant neurologist at the National Hospital for Neurology and Neurosurgery, in London. She helped actor Eddie Redmayne in his portrayal of theoretical physicist and cosmologist Stephen Hawking in the film The Theory of Everything.

She joins us to describe how that process worked, and what Motor Neurone Disease patients thought about how their condition was depicted.

Read the feature:
http://www.bmj.com/content/350/bmj.h483]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>413</itunes:duration>
                                    </item>
    <item>
        <title>Management of cancer induced bone pain</title>
        <itunes:title>Management of cancer induced bone pain</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/management-of-cancer-induced-bone-pain/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/management-of-cancer-induced-bone-pain/#comments</comments>        <pubDate>Fri, 30 Jan 2015 17:07:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/management-of-cancer-induced-bone-pain</guid>
                                    <description><![CDATA[Bone pain is the most common type of pain from cancer and is present in around one third of patients with bone metastases, currently, improvements in cancer treatments mean that many patients are living with metastatic cancer for several years. 

Christopher Kane, NIHR academic clinical fellow in palliative medicine at Leeds University School of Medicine, and Michael Bennett, St Gemma’s professor of palliative medicine at University College London join us to discuss the management of cancer induced bone pain.

Read the full clinical review:
<p>http://www.bmj.com/content/350/bmj.h315</p>
]]></description>
                                                            <content:encoded><![CDATA[Bone pain is the most common type of pain from cancer and is present in around one third of patients with bone metastases, currently, improvements in cancer treatments mean that many patients are living with metastatic cancer for several years. 

Christopher Kane, NIHR academic clinical fellow in palliative medicine at Leeds University School of Medicine, and Michael Bennett, St Gemma’s professor of palliative medicine at University College London join us to discuss the management of cancer induced bone pain.

Read the full clinical review:
<p>http://www.bmj.com/content/350/bmj.h315</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2xww3c/stream_188660463-bmjgroup-management-of-cancer-induced-bone-pain.mp3" length="27666186" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Bone pain is the most common type of pain from cancer and is present in around one third of patients with bone metastases, currently, improvements in cancer treatments mean that many patients are living with metastatic cancer for several years. 

Christopher Kane, NIHR academic clinical fellow in palliative medicine at Leeds University School of Medicine, and Michael Bennett, St Gemma’s professor of palliative medicine at University College London join us to discuss the management of cancer induced bone pain.

Read the full clinical review:
http://www.bmj.com/content/350/bmj.h315]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1154</itunes:duration>
                                    </item>
    <item>
        <title>Cash for referrals</title>
        <itunes:title>Cash for referrals</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/cash-for-referrals/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/cash-for-referrals/#comments</comments>        <pubDate>Thu, 29 Jan 2015 15:50:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/cash-for-referrals</guid>
                                    <description><![CDATA[Private hospital chains have been “buying” referrals by offering clinicians lucrative packages, including free facilities in sought after locations. And the doctors’ regulator is turning a blind eye to those who are tempted, Reporter Jonathan Gornall joins us to discuss the investigation.

Read the full report:
<p>http://www.bmj.com/content/350/bmj.h396</p>
]]></description>
                                                            <content:encoded><![CDATA[Private hospital chains have been “buying” referrals by offering clinicians lucrative packages, including free facilities in sought after locations. And the doctors’ regulator is turning a blind eye to those who are tempted, Reporter Jonathan Gornall joins us to discuss the investigation.

Read the full report:
<p>http://www.bmj.com/content/350/bmj.h396</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/0s317m/stream_188480343-bmjgroup-cash-for-referrals.mp3" length="20155911" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Private hospital chains have been “buying” referrals by offering clinicians lucrative packages, including free facilities in sought after locations. And the doctors’ regulator is turning a blind eye to those who are tempted, Reporter Jonathan Gornall joins us to discuss the investigation.

Read the full report:
http://www.bmj.com/content/350/bmj.h396]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>841</itunes:duration>
                                    </item>
    <item>
        <title>Managing multimorbidity in primary care</title>
        <itunes:title>Managing multimorbidity in primary care</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/managing-multimorbidity-in-primary-care/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/managing-multimorbidity-in-primary-care/#comments</comments>        <pubDate>Fri, 23 Jan 2015 11:56:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/managing-multimorbidity</guid>
                                    <description><![CDATA[Multimorbidity presents a number of different challenges, for the patients living with the conditions, but also for the health professionals caring for them in systems that often are not designed with these more complex needs in mind.

Emma Wallace, general practice lecturer, and Susan Smith, a professor of general practice at the Royal College of Surgeons in Ireland Medical School join us to discuss how to work within the system, and what their dream scenario for care would be.

Read the full clinical review:
<p>http://www.bmj.com/content/350/bmj.h176</p>
]]></description>
                                                            <content:encoded><![CDATA[Multimorbidity presents a number of different challenges, for the patients living with the conditions, but also for the health professionals caring for them in systems that often are not designed with these more complex needs in mind.

Emma Wallace, general practice lecturer, and Susan Smith, a professor of general practice at the Royal College of Surgeons in Ireland Medical School join us to discuss how to work within the system, and what their dream scenario for care would be.

Read the full clinical review:
<p>http://www.bmj.com/content/350/bmj.h176</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/sl15to/stream_187464386-bmjgroup-managing-multimorbidity.mp3" length="26460224" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Multimorbidity presents a number of different challenges, for the patients living with the conditions, but also for the health professionals caring for them in systems that often are not designed with these more complex needs in mind.

Emma Wallace, general practice lecturer, and Susan Smith, a professor of general practice at the Royal College of Surgeons in Ireland Medical School join us to discuss how to work within the system, and what their dream scenario for care would be.

Read the full clinical review:
http://www.bmj.com/content/350/bmj.h176]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1103</itunes:duration>
                                    </item>
    <item>
        <title>WHO needs exercise?</title>
        <itunes:title>WHO needs exercise?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/who-needs-exercise/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/who-needs-exercise/#comments</comments>        <pubDate>Thu, 22 Jan 2015 13:10:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/who-exercises</guid>
                                    <description><![CDATA[Philipe de Souto Barreto argues that, to reduce premature mortality, policies should focus on getting fully inactive people to do a little physical activity rather than strive for the entire population to meet current physical activity recommendations.

Read the full analysis paper:
<p>http://www.bmj.com/content/350/bmj.h23</p>
]]></description>
                                                            <content:encoded><![CDATA[Philipe de Souto Barreto argues that, to reduce premature mortality, policies should focus on getting fully inactive people to do a little physical activity rather than strive for the entire population to meet current physical activity recommendations.

Read the full analysis paper:
<p>http://www.bmj.com/content/350/bmj.h23</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jvpmbj/stream_187304293-bmjgroup-who-exercises.mp3" length="15106505" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Philipe de Souto Barreto argues that, to reduce premature mortality, policies should focus on getting fully inactive people to do a little physical activity rather than strive for the entire population to meet current physical activity recommendations.

Read the full analysis paper:
http://www.bmj.com/content/350/bmj.h23]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>629</itunes:duration>
                                    </item>
    <item>
        <title>Dominique Thompson GP - Young people’s health is overlooked</title>
        <itunes:title>Dominique Thompson GP - Young people’s health is overlooked</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/dominique-thompson-gp-young-people-s-health-is-overlooked/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/dominique-thompson-gp-young-people-s-health-is-overlooked/#comments</comments>        <pubDate>Mon, 19 Jan 2015 11:11:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/dominique-thompson-gp</guid>
                                    <description><![CDATA[Dominique Thompson, GP and director of the Students’ Health Service at the University of Bristol, is concerned that young people's health is being neglected.

BMJ Voices is a collection of readers’ experiences of working in the NHS. For this, The BMJ is seeking short audio submissions from UK listeners. These submissions will be published on thebmj.com. 

<p>If you would like to contribute to this collection, please email a brief audio recording to voices@bmj.com or phone +44 (20) 3058 7427 and tell us what your main concern for the NHS is. Please include your name, job title, and place of work.</p>
]]></description>
                                                            <content:encoded><![CDATA[Dominique Thompson, GP and director of the Students’ Health Service at the University of Bristol, is concerned that young people's health is being neglected.

BMJ Voices is a collection of readers’ experiences of working in the NHS. For this, The BMJ is seeking short audio submissions from UK listeners. These submissions will be published on thebmj.com. 

<p>If you would like to contribute to this collection, please email a brief audio recording to voices@bmj.com or phone +44 (20) 3058 7427 and tell us what your main concern for the NHS is. Please include your name, job title, and place of work.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/85shuk/stream_186776664-bmjgroup-dominique-thompson-gp.mp3" length="4682397" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Dominique Thompson, GP and director of the Students’ Health Service at the University of Bristol, is concerned that young people's health is being neglected.

BMJ Voices is a collection of readers’ experiences of working in the NHS. For this, The BMJ is seeking short audio submissions from UK listeners. These submissions will be published on thebmj.com. 

If you would like to contribute to this collection, please email a brief audio recording to voices@bmj.com or phone +44 (20) 3058 7427 and tell us what your main concern for the NHS is. Please include your name, job title, and place of work.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>195</itunes:duration>
                                    </item>
    <item>
        <title>Rabies in animals</title>
        <itunes:title>Rabies in animals</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/rabies-in-animals/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/rabies-in-animals/#comments</comments>        <pubDate>Fri, 16 Jan 2015 17:42:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/rabies-in-animals</guid>
                                    <description><![CDATA[Rabies is the archytypical zoonotic disease, and only by vaccination in animals will we prevent infections in people. In two podcasts linked to our latest clinical review "The prevention and management of rabies"​ we'll be discussing how we can get there.

In this podcast Sarah Cleaveland, professor of comparative epidemiology at the University of Glasgow discusses control​ling the disease in animals​.​ To find out about the clincial presentation listen to the accompanying podcast with ​Natasha Crowcroft, chief of infectious disease at Public Health Ontario 

Listen to the accompanying podcast:
https://soundcloud.com/bmjpodcasts/rabies-in-humans

Read the full clinical review:
<p>http://www.bmj.com/content/350/bmj.g7827</p>
]]></description>
                                                            <content:encoded><![CDATA[Rabies is the archytypical zoonotic disease, and only by vaccination in animals will we prevent infections in people. In two podcasts linked to our latest clinical review "The prevention and management of rabies"​ we'll be discussing how we can get there.

In this podcast Sarah Cleaveland, professor of comparative epidemiology at the University of Glasgow discusses control​ling the disease in animals​.​ To find out about the clincial presentation listen to the accompanying podcast with ​Natasha Crowcroft, chief of infectious disease at Public Health Ontario 

Listen to the accompanying podcast:
https://soundcloud.com/bmjpodcasts/rabies-in-humans

Read the full clinical review:
<p>http://www.bmj.com/content/350/bmj.g7827</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/l93dpw/stream_186367306-bmjgroup-rabies-in-animals.mp3" length="21873263" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Rabies is the archytypical zoonotic disease, and only by vaccination in animals will we prevent infections in people. In two podcasts linked to our latest clinical review "The prevention and management of rabies"​ we'll be discussing how we can get there.

In this podcast Sarah Cleaveland, professor of comparative epidemiology at the University of Glasgow discusses control​ling the disease in animals​.​ To find out about the clincial presentation listen to the accompanying podcast with ​Natasha Crowcroft, chief of infectious disease at Public Health Ontario 

Listen to the accompanying podcast:
https://soundcloud.com/bmjpodcasts/rabies-in-humans

Read the full clinical review:
http://www.bmj.com/content/350/bmj.g7827]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>912</itunes:duration>
                                    </item>
    <item>
        <title>Rabies in humans</title>
        <itunes:title>Rabies in humans</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/rabies-in-humans/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/rabies-in-humans/#comments</comments>        <pubDate>Fri, 16 Jan 2015 17:38:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/rabies-in-humans</guid>
                                    <description><![CDATA[Rabies is the archytypical zoonotic disease, and only by vaccination in animals will we prevent infections in people. In two podcasts linked to our latest clinical review "The prevention and management of rabies"​ we'll be discussing how we can get there.


In this podcast Natasha Crowcroft, chief of infectious disease at Public Health Ontario to discuss the human aspect of the disease, and in the second Sarah Cleaveland, professor of comparative epidemiology at the University of Glasgow explains animal control.

Listen to the accompanying podcast:
https://soundcloud.com/bmjpodcasts/rabies-in-animals

Read the full clinical review:
<p>http://www.bmj.com/content/350/bmj.g7827</p>
]]></description>
                                                            <content:encoded><![CDATA[Rabies is the archytypical zoonotic disease, and only by vaccination in animals will we prevent infections in people. In two podcasts linked to our latest clinical review "The prevention and management of rabies"​ we'll be discussing how we can get there.


In this podcast Natasha Crowcroft, chief of infectious disease at Public Health Ontario to discuss the human aspect of the disease, and in the second Sarah Cleaveland, professor of comparative epidemiology at the University of Glasgow explains animal control.

Listen to the accompanying podcast:
https://soundcloud.com/bmjpodcasts/rabies-in-animals

Read the full clinical review:
<p>http://www.bmj.com/content/350/bmj.g7827</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/u1gmly/stream_186366686-bmjgroup-rabies-in-humans.mp3" length="28782787" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Rabies is the archytypical zoonotic disease, and only by vaccination in animals will we prevent infections in people. In two podcasts linked to our latest clinical review "The prevention and management of rabies"​ we'll be discussing how we can get there.


In this podcast Natasha Crowcroft, chief of infectious disease at Public Health Ontario to discuss the human aspect of the disease, and in the second Sarah Cleaveland, professor of comparative epidemiology at the University of Glasgow explains animal control.

Listen to the accompanying podcast:
https://soundcloud.com/bmjpodcasts/rabies-in-animals

Read the full clinical review:
http://www.bmj.com/content/350/bmj.g7827]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1201</itunes:duration>
                                    </item>
    <item>
        <title>Is the Hep C screening expansion justified?</title>
        <itunes:title>Is the Hep C screening expansion justified?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/is-the-hep-c-screening-expansion-justified/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/is-the-hep-c-screening-expansion-justified/#comments</comments>        <pubDate>Wed, 14 Jan 2015 11:56:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/hep-c-screening</guid>
                                    <description><![CDATA[Until recently, hepatitis C screening was offered to people at increased risk of infection - such as intravenous drug users - but now, the US Centers for Disease Control and Prevention has recommended screening all people born between 1945 and 1965.
 
Kenny Lin, associate professor of family medicine at Georgetown University in Washington, DC, and Jeanne Lenzer, an investigative health journalist from New York, explain why they worry that the evidence doesn't support this expansion.

ead their analysis article:
<p>http://www.bmj.com/content/350/bmj.g7809</p>
]]></description>
                                                            <content:encoded><![CDATA[Until recently, hepatitis C screening was offered to people at increased risk of infection - such as intravenous drug users - but now, the US Centers for Disease Control and Prevention has recommended screening all people born between 1945 and 1965.
 
Kenny Lin, associate professor of family medicine at Georgetown University in Washington, DC, and Jeanne Lenzer, an investigative health journalist from New York, explain why they worry that the evidence doesn't support this expansion.

ead their analysis article:
<p>http://www.bmj.com/content/350/bmj.g7809</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/o8aa6d/stream_185993444-bmjgroup-hep-c-screening.mp3" length="23660970" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Until recently, hepatitis C screening was offered to people at increased risk of infection - such as intravenous drug users - but now, the US Centers for Disease Control and Prevention has recommended screening all people born between 1945 and 1965.
 
Kenny Lin, associate professor of family medicine at Georgetown University in Washington, DC, and Jeanne Lenzer, an investigative health journalist from New York, explain why they worry that the evidence doesn't support this expansion.

ead their analysis article:
http://www.bmj.com/content/350/bmj.g7809]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>987</itunes:duration>
                                    </item>
    <item>
        <title>Being a human guinea pig</title>
        <itunes:title>Being a human guinea pig</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/being-a-human-guinea-pig/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/being-a-human-guinea-pig/#comments</comments>        <pubDate>Thu, 08 Jan 2015 17:02:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/being-a-human-guinea-pig</guid>
                                    <description><![CDATA[Drug development happens in stages – pre-clinical, phase I, II, 
III, and so on. But how much do trial participants know about what has happened before their enrolment to test for safety, and how much should they be told?
 
Holger Pedersen from Denmark was one trial participant who tried to find information about the drug he was on, and was surprised at how little data had actually been collected, let alone shared – which has been detailed in an analysis article on thebmj.com
 
He talks to Helen Macdonald, analysis editor for the BMJ about his experience.

Read the analysis article:
<p> http://www.bmj.com/content/349/bmj.g6714</p>
]]></description>
                                                            <content:encoded><![CDATA[Drug development happens in stages – pre-clinical, phase I, II, 
III, and so on. But how much do trial participants know about what has happened before their enrolment to test for safety, and how much should they be told?
 
Holger Pedersen from Denmark was one trial participant who tried to find information about the drug he was on, and was surprised at how little data had actually been collected, let alone shared – which has been detailed in an analysis article on thebmj.com
 
He talks to Helen Macdonald, analysis editor for the BMJ about his experience.

Read the analysis article:
<p> http://www.bmj.com/content/349/bmj.g6714</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/05bxvj/stream_185075625-bmjgroup-being-a-human-guinea-pig.mp3" length="13677094" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Drug development happens in stages – pre-clinical, phase I, II, 
III, and so on. But how much do trial participants know about what has happened before their enrolment to test for safety, and how much should they be told?
 
Holger Pedersen from Denmark was one trial participant who tried to find information about the drug he was on, and was surprised at how little data had actually been collected, let alone shared – which has been detailed in an analysis article on thebmj.com
 
He talks to Helen Macdonald, analysis editor for the BMJ about his experience.

Read the analysis article:
 http://www.bmj.com/content/349/bmj.g6714]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>569</itunes:duration>
                                    </item>
    <item>
        <title>Operating theatre time, where does it all go?</title>
        <itunes:title>Operating theatre time, where does it all go?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/operating-theatre-time-where-does-it-all-go/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/operating-theatre-time-where-does-it-all-go/#comments</comments>        <pubDate>Fri, 19 Dec 2014 15:45:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/operating-theatre-time-where</guid>
                                    <description><![CDATA[Waiting times in theatre can be a source of friction – but is the delay due to mandatory anaesthetic faff around time (MAFAT), or AWOL surgeons? 

Elizabeth Travis, and orthopaedic house officer in New Zealand and colleagues, have been trying to create and evidence base to argue the toss, and she joins me now to discuss her study, Operating theatre time, where does it all go? 

Read the full research:
<p>http://www.bmj.com/content/349/bmj.g7182</p>
<p></p>
]]></description>
                                                            <content:encoded><![CDATA[Waiting times in theatre can be a source of friction – but is the delay due to mandatory anaesthetic faff around time (MAFAT), or AWOL surgeons? 

Elizabeth Travis, and orthopaedic house officer in New Zealand and colleagues, have been trying to create and evidence base to argue the toss, and she joins me now to discuss her study, Operating theatre time, where does it all go? 

Read the full research:
<p>http://www.bmj.com/content/349/bmj.g7182</p>
<p></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/uqvqgk/stream_182262467-bmjgroup-operating-theatre-time-where.mp3" length="9068439" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Waiting times in theatre can be a source of friction – but is the delay due to mandatory anaesthetic faff around time (MAFAT), or AWOL surgeons? 

Elizabeth Travis, and orthopaedic house officer in New Zealand and colleagues, have been trying to create and evidence base to argue the toss, and she joins me now to discuss her study, Operating theatre time, where does it all go? 

Read the full research:
http://www.bmj.com/content/349/bmj.g7182
]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>378</itunes:duration>
                                    </item>
    <item>
        <title>Grumpy old doctors</title>
        <itunes:title>Grumpy old doctors</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/grumpy-old-doctors/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/grumpy-old-doctors/#comments</comments>        <pubDate>Thu, 18 Dec 2014 12:57:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/grumpy-old-doctors</guid>
                                    <description><![CDATA[Those who rise to the top in medicine see themselves as hardworking extroverts with a caring nature, suggests an unscientific analysis of the answers given by contributors to BMJ Confidential.

But ask about their pet hates and another, less nurturing, side emerges. We gathered 6 former confidentialists in The BMJ studio to moan over mince pies.

<p>Read Doctors: caring extroverts or self deluded chocoholics?: http://www.bmj.com/content/349/bmj.g7623</p>
]]></description>
                                                            <content:encoded><![CDATA[Those who rise to the top in medicine see themselves as hardworking extroverts with a caring nature, suggests an unscientific analysis of the answers given by contributors to BMJ Confidential.

But ask about their pet hates and another, less nurturing, side emerges. We gathered 6 former confidentialists in The BMJ studio to moan over mince pies.

<p>Read Doctors: caring extroverts or self deluded chocoholics?: http://www.bmj.com/content/349/bmj.g7623</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wuflht/stream_182086641-bmjgroup-grumpy-old-doctors.mp3" length="30567823" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Those who rise to the top in medicine see themselves as hardworking extroverts with a caring nature, suggests an unscientific analysis of the answers given by contributors to BMJ Confidential.

But ask about their pet hates and another, less nurturing, side emerges. We gathered 6 former confidentialists in The BMJ studio to moan over mince pies.

Read Doctors: caring extroverts or self deluded chocoholics?: http://www.bmj.com/content/349/bmj.g7623]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1275</itunes:duration>
                                    </item>
    <item>
        <title>Can you trust the advice of TV doctors?</title>
        <itunes:title>Can you trust the advice of TV doctors?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/can-you-trust-the-advice-of-tv-doctors/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/can-you-trust-the-advice-of-tv-doctors/#comments</comments>        <pubDate>Wed, 17 Dec 2014 17:48:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/can-you-trust-the-advice-of-tv-doctors</guid>
                                    <description><![CDATA[How much can you trust the advice given by TV doctors? A new research paper on thebmj.com has analysed over 40 episodes of popular American TV shows, to see if health claims are evidence based.

This podcast is a bit different, as the authors host their own show - The BS Medicine Podcast, which tops the charts around the world - and they've given us permission to repost on The BMJ.

Read the​​ full research:
<p>http://www.bmj.com/content/349/bmj.g7346</p>
<p></p>
]]></description>
                                                            <content:encoded><![CDATA[How much can you trust the advice given by TV doctors? A new research paper on thebmj.com has analysed over 40 episodes of popular American TV shows, to see if health claims are evidence based.

This podcast is a bit different, as the authors host their own show - The BS Medicine Podcast, which tops the charts around the world - and they've given us permission to repost on The BMJ.

Read the​​ full research:
<p>http://www.bmj.com/content/349/bmj.g7346</p>
<p></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/53b7th/stream_181963591-bmjgroup-can-you-trust-the-advice-of-tv-doctors.mp3" length="32943590" type="audio/mpeg"/>
        <itunes:summary><![CDATA[How much can you trust the advice given by TV doctors? A new research paper on thebmj.com has analysed over 40 episodes of popular American TV shows, to see if health claims are evidence based.

This podcast is a bit different, as the authors host their own show - The BS Medicine Podcast, which tops the charts around the world - and they've given us permission to repost on The BMJ.

Read the​​ full research:
http://www.bmj.com/content/349/bmj.g7346
]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2749</itunes:duration>
                                    </item>
    <item>
        <title>Turning back the tide of appointments</title>
        <itunes:title>Turning back the tide of appointments</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/turning-back-the-tide-of-appointments/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/turning-back-the-tide-of-appointments/#comments</comments>        <pubDate>Tue, 16 Dec 2014 17:45:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/rolling-back-the-tide</guid>
                                    <description><![CDATA[In AD 1028 King Canute tried to command the tide to turn back. History records that the king of all lands surrounding the North Sea got very cross, wet, and made a hasty retreat. Every day, in general practices across the country, dedicated practice teams get very cross when they are yet again unsuccessful at meeting the daily demand for appointments and the incoming tide of patient demand and expectation. 

Ron Neville, a partner in the Westgate Health Centre in Dundee joins us to discuss what his new appointment system learned from the soggy monarch.

<p>http://www.bmj.com/content/349/bmj.g7228</p>
]]></description>
                                                            <content:encoded><![CDATA[In AD 1028 King Canute tried to command the tide to turn back. History records that the king of all lands surrounding the North Sea got very cross, wet, and made a hasty retreat. Every day, in general practices across the country, dedicated practice teams get very cross when they are yet again unsuccessful at meeting the daily demand for appointments and the incoming tide of patient demand and expectation. 

Ron Neville, a partner in the Westgate Health Centre in Dundee joins us to discuss what his new appointment system learned from the soggy monarch.

<p>http://www.bmj.com/content/349/bmj.g7228</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/u9r8u4/stream_181801919-bmjgroup-rolling-back-the-tide.mp3" length="18138357" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In AD 1028 King Canute tried to command the tide to turn back. History records that the king of all lands surrounding the North Sea got very cross, wet, and made a hasty retreat. Every day, in general practices across the country, dedicated practice teams get very cross when they are yet again unsuccessful at meeting the daily demand for appointments and the incoming tide of patient demand and expectation. 

Ron Neville, a partner in the Westgate Health Centre in Dundee joins us to discuss what his new appointment system learned from the soggy monarch.

http://www.bmj.com/content/349/bmj.g7228]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>756</itunes:duration>
                                    </item>
    <item>
        <title>Men are idiots</title>
        <itunes:title>Men are idiots</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/men-are-idiots-1684836014/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/men-are-idiots-1684836014/#comments</comments>        <pubDate>Mon, 15 Dec 2014 16:02:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/men-are-idiots</guid>
                                    <description><![CDATA[Winners of the Darwin Award must eliminate themselves from the gene pool in such an idiotic manner that their action ensures one less idiot will survive.

Ben and Dennis Lendrem, and colleagues, have reviewed the data on winners of the Darwin Award over a 20 year period and they join us to discuss why men are idiots, and why their team is not the only ones to have noticed.

<p>www.bmj.com/content/349/bmj.g7094</p>
]]></description>
                                                            <content:encoded><![CDATA[Winners of the Darwin Award must eliminate themselves from the gene pool in such an idiotic manner that their action ensures one less idiot will survive.

Ben and Dennis Lendrem, and colleagues, have reviewed the data on winners of the Darwin Award over a 20 year period and they join us to discuss why men are idiots, and why their team is not the only ones to have noticed.

<p>www.bmj.com/content/349/bmj.g7094</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/b3k1tx/stream_181621522-bmjgroup-men-are-idiots.mp3" length="10618921" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Winners of the Darwin Award must eliminate themselves from the gene pool in such an idiotic manner that their action ensures one less idiot will survive.

Ben and Dennis Lendrem, and colleagues, have reviewed the data on winners of the Darwin Award over a 20 year period and they join us to discuss why men are idiots, and why their team is not the only ones to have noticed.

www.bmj.com/content/349/bmj.g7094]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>443</itunes:duration>
                                    </item>
    <item>
        <title>Musical (operating) theatre</title>
        <itunes:title>Musical (operating) theatre</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/musical-operating-theatre/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/musical-operating-theatre/#comments</comments>        <pubDate>Fri, 12 Dec 2014 16:15:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/medical-music</guid>
                                    <description><![CDATA[One hundred years ago, Pennsylvanian surgeon Evan Kane penned a brief letter to JAMA in which he declared himself a rigorous proponent of the “benefic [sic] effects of the phonograph within the operating room.”

Now David Bosenquet, a surgeon from University Hospital of Wales in Cardiff has written a Christmas editorial about the evidence for the benefit of music to patients.

Read his editorial here:
http://www.bmj.com/content/349/bmj.g7436

<p>And share your perfect playlist with us at bmj.com/playlists</p>
]]></description>
                                                            <content:encoded><![CDATA[One hundred years ago, Pennsylvanian surgeon Evan Kane penned a brief letter to JAMA in which he declared himself a rigorous proponent of the “benefic [sic] effects of the phonograph within the operating room.”

Now David Bosenquet, a surgeon from University Hospital of Wales in Cardiff has written a Christmas editorial about the evidence for the benefit of music to patients.

Read his editorial here:
http://www.bmj.com/content/349/bmj.g7436

<p>And share your perfect playlist with us at bmj.com/playlists</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9pgiq6/stream_181196866-bmjgroup-medical-music.mp3" length="8708228" type="audio/mpeg"/>
        <itunes:summary><![CDATA[One hundred years ago, Pennsylvanian surgeon Evan Kane penned a brief letter to JAMA in which he declared himself a rigorous proponent of the “benefic [sic] effects of the phonograph within the operating room.”

Now David Bosenquet, a surgeon from University Hospital of Wales in Cardiff has written a Christmas editorial about the evidence for the benefit of music to patients.

Read his editorial here:
http://www.bmj.com/content/349/bmj.g7436

And share your perfect playlist with us at bmj.com/playlists]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>363</itunes:duration>
                                    </item>
    <item>
        <title>Great leap backwards - austerity measures are hitting the vulnerable hardest</title>
        <itunes:title>Great leap backwards - austerity measures are hitting the vulnerable hardest</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/great-leap-backwards-austerity-measures-are-hitting-the-vulnerable-hardest/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/great-leap-backwards-austerity-measures-are-hitting-the-vulnerable-hardest/#comments</comments>        <pubDate>Wed, 10 Dec 2014 17:19:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/great-leap-backwards-austerity</guid>
                                    <description><![CDATA[The UK’s austerity programme has disproportionately affected children and people with disabilities, says David Taylor-Robinson, a senior clinical lecturer in public health at the University of Liverpool. 

He joins us to discuss why the evidence shows the vulnerable are hit hardest by the cuts to public services, despite the UN conventions on human rights giving children and people with disabilities special protection.

<p>Read his full editorial: http://www.bmj.com/content/349/bmj.g7350</p>
]]></description>
                                                            <content:encoded><![CDATA[The UK’s austerity programme has disproportionately affected children and people with disabilities, says David Taylor-Robinson, a senior clinical lecturer in public health at the University of Liverpool. 

He joins us to discuss why the evidence shows the vulnerable are hit hardest by the cuts to public services, despite the UN conventions on human rights giving children and people with disabilities special protection.

<p>Read his full editorial: http://www.bmj.com/content/349/bmj.g7350</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/v6iffj/stream_180885926-bmjgroup-great-leap-backwards-austerity.mp3" length="14232369" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The UK’s austerity programme has disproportionately affected children and people with disabilities, says David Taylor-Robinson, a senior clinical lecturer in public health at the University of Liverpool. 

He joins us to discuss why the evidence shows the vulnerable are hit hardest by the cuts to public services, despite the UN conventions on human rights giving children and people with disabilities special protection.

Read his full editorial: http://www.bmj.com/content/349/bmj.g7350]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>891</itunes:duration>
                                    </item>
    <item>
        <title>Too much blood: when transfusions do more harm than good</title>
        <itunes:title>Too much blood: when transfusions do more harm than good</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/too-much-blood-when-transfusions-do-more-harm-than-good/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/too-much-blood-when-transfusions-do-more-harm-than-good/#comments</comments>        <pubDate>Fri, 05 Dec 2014 16:13:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/too-much-blood</guid>
                                    <description><![CDATA[Blood transfusions have been identified as one of the most overused therapies both in the United States and the UK. 

In this podcast Lawrence Tim Goodnough, from Stanford University Medical Center's Transfusion Service, and Michael Murphy, from NHS Blood and Transplant, explain the physiological reasons why
liberal blood transfusion will not benefit patients, and can potentially harm them.

Read their full analysis:
<p>http://www.bmj.com/content/349/bmj.g6897</p>
<p></p>
]]></description>
                                                            <content:encoded><![CDATA[Blood transfusions have been identified as one of the most overused therapies both in the United States and the UK. 

In this podcast Lawrence Tim Goodnough, from Stanford University Medical Center's Transfusion Service, and Michael Murphy, from NHS Blood and Transplant, explain the physiological reasons why
liberal blood transfusion will not benefit patients, and can potentially harm them.

Read their full analysis:
<p>http://www.bmj.com/content/349/bmj.g6897</p>
<p></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/bogl7v/stream_180113553-bmjgroup-too-much-blood.mp3" length="26026054" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Blood transfusions have been identified as one of the most overused therapies both in the United States and the UK. 

In this podcast Lawrence Tim Goodnough, from Stanford University Medical Center's Transfusion Service, and Michael Murphy, from NHS Blood and Transplant, explain the physiological reasons why
liberal blood transfusion will not benefit patients, and can potentially harm them.

Read their full analysis:
http://www.bmj.com/content/349/bmj.g6897
]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1085</itunes:duration>
                                    </item>
    <item>
        <title>Zero tolerance for competing interests</title>
        <itunes:title>Zero tolerance for competing interests</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/zero-tolerance-for-competing-interests/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/zero-tolerance-for-competing-interests/#comments</comments>        <pubDate>Thu, 04 Dec 2014 17:21:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/zero-tolerence-for-competing</guid>
                                    <description><![CDATA[The BMJ has a new policy on competing interestings - from 2015 we will have zero tolerance for them in authors who write education articles or editorials.

<p>Cath Brizzell and Mabel Chew explain what that policy is about, and why we think it's important.</p>
]]></description>
                                                            <content:encoded><![CDATA[The BMJ has a new policy on competing interestings - from 2015 we will have zero tolerance for them in authors who write education articles or editorials.

<p>Cath Brizzell and Mabel Chew explain what that policy is about, and why we think it's important.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/x2qrma/stream_179962481-bmjgroup-zero-tolerence-for-competing.mp3" length="13934636" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The BMJ has a new policy on competing interestings - from 2015 we will have zero tolerance for them in authors who write education articles or editorials.

Cath Brizzell and Mabel Chew explain what that policy is about, and why we think it's important.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>581</itunes:duration>
                                    </item>
    <item>
        <title>Simon Stevens - saving the NHS?</title>
        <itunes:title>Simon Stevens - saving the NHS?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/simon-stevens-saving-the-nhs/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/simon-stevens-saving-the-nhs/#comments</comments>        <pubDate>Tue, 02 Dec 2014 11:07:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/simon-stevens-saving-the-nhs</guid>
                                    <description><![CDATA[<p>Eight months into the NHS’s top job, Simon Stevens’s intelligent refusal to enforce a “one size fits all” solution on the service’s ills is, so far, winning him the backing of staff. He talks to Gareth Iacobucci</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Eight months into the NHS’s top job, Simon Stevens’s intelligent refusal to enforce a “one size fits all” solution on the service’s ills is, so far, winning him the backing of staff. He talks to Gareth Iacobucci</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hleshu/stream_179598001-bmjgroup-simon-stevens-saving-the-nhs.mp3" length="4479754" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Eight months into the NHS’s top job, Simon Stevens’s intelligent refusal to enforce a “one size fits all” solution on the service’s ills is, so far, winning him the backing of staff. He talks to Gareth Iacobucci]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>187</itunes:duration>
                                    </item>
    <item>
        <title>Self monitoring of hypertension in pregnancy</title>
        <itunes:title>Self monitoring of hypertension in pregnancy</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/self-monitoring-of-hypertension-in-pregnancy/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/self-monitoring-of-hypertension-in-pregnancy/#comments</comments>        <pubDate>Thu, 20 Nov 2014 18:02:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/self-monitoring-of</guid>
                                    <description><![CDATA[Guidelines encourage the use of self monitoring of blood pressure in pregnancy, and research suggests that women prefer it. But Richard McManus, GP and professor of primary care at the University of Oxford explains that our enthusiasm may run ahead of the evidence and call for more research before it is routinely adopted.

Read the full analysis:
<p>http://www.bmj.com/content/349/bmj.g6616</p>
]]></description>
                                                            <content:encoded><![CDATA[Guidelines encourage the use of self monitoring of blood pressure in pregnancy, and research suggests that women prefer it. But Richard McManus, GP and professor of primary care at the University of Oxford explains that our enthusiasm may run ahead of the evidence and call for more research before it is routinely adopted.

Read the full analysis:
<p>http://www.bmj.com/content/349/bmj.g6616</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rpfwpj/stream_177842716-bmjgroup-self-monitoring-of.mp3" length="23924518" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guidelines encourage the use of self monitoring of blood pressure in pregnancy, and research suggests that women prefer it. But Richard McManus, GP and professor of primary care at the University of Oxford explains that our enthusiasm may run ahead of the evidence and call for more research before it is routinely adopted.

Read the full analysis:
http://www.bmj.com/content/349/bmj.g6616]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>998</itunes:duration>
                                    </item>
    <item>
        <title>Crohn’s disease - a patient’s perspective</title>
        <itunes:title>Crohn’s disease - a patient’s perspective</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/crohn-s-disease-a-patient-s-perspective/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/crohn-s-disease-a-patient-s-perspective/#comments</comments>        <pubDate>Thu, 20 Nov 2014 17:21:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/crohns-disease-a-patients-perspective</guid>
                                    <description><![CDATA[The incidence and prevalence of Crohn’s disease is increasing worldwide, and a clinical review on thebmj.com provides a practical approach to the diagnosis, management, and long term care of patients with Crohn’s disease.
 
To help us understand what it’s like to have this condition, we're joined by Sarah, who was diagnosed with Crohn’s 13 years ago when she was 18.

Read the full clinical review:
<p>http://www.bmj.com/content/349/bmj.g6670</p>
]]></description>
                                                            <content:encoded><![CDATA[The incidence and prevalence of Crohn’s disease is increasing worldwide, and a clinical review on thebmj.com provides a practical approach to the diagnosis, management, and long term care of patients with Crohn’s disease.
 
To help us understand what it’s like to have this condition, we're joined by Sarah, who was diagnosed with Crohn’s 13 years ago when she was 18.

Read the full clinical review:
<p>http://www.bmj.com/content/349/bmj.g6670</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/lsrrpc/stream_177837130-bmjgroup-crohns-disease-a-patients-perspective.mp3" length="29634787" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The incidence and prevalence of Crohn’s disease is increasing worldwide, and a clinical review on thebmj.com provides a practical approach to the diagnosis, management, and long term care of patients with Crohn’s disease.
 
To help us understand what it’s like to have this condition, we're joined by Sarah, who was diagnosed with Crohn’s 13 years ago when she was 18.

Read the full clinical review:
http://www.bmj.com/content/349/bmj.g6670]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1235</itunes:duration>
                                    </item>
    <item>
        <title>The diagnosis and management of Menieres disease</title>
        <itunes:title>The diagnosis and management of Menieres disease</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-diagnosis-and-management-of-menieres-disease/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-diagnosis-and-management-of-menieres-disease/#comments</comments>        <pubDate>Thu, 13 Nov 2014 14:25:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/menieres-disease</guid>
                                    <description><![CDATA[A clinical review on thebmj.com looks at Meniere’s disease. One of the review's authors, Jonny Harcourt, a consultant otologist at Charing Cross Hospital in London, takes us through the pathogenic process and clinical presentation of the disease, its clinical course and prognosis, and what clinical features help to discriminate the condition from other diagnoses. He also discusses the evidence for treatment.

In a second interview Corine from The Netherlands discusses her experience of having the disease, and offers her tips to others with the condition.

https://soundcloud.com/bmjpodcasts/menieres-disease-patient

Read the full review:
<p>http://www.bmj.com/content/349/bmj.g6544</p>
]]></description>
                                                            <content:encoded><![CDATA[A clinical review on thebmj.com looks at Meniere’s disease. One of the review's authors, Jonny Harcourt, a consultant otologist at Charing Cross Hospital in London, takes us through the pathogenic process and clinical presentation of the disease, its clinical course and prognosis, and what clinical features help to discriminate the condition from other diagnoses. He also discusses the evidence for treatment.

In a second interview Corine from The Netherlands discusses her experience of having the disease, and offers her tips to others with the condition.

https://soundcloud.com/bmjpodcasts/menieres-disease-patient

Read the full review:
<p>http://www.bmj.com/content/349/bmj.g6544</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ikvnhs/stream_176723349-bmjgroup-menieres-disease.mp3" length="23004485" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A clinical review on thebmj.com looks at Meniere’s disease. One of the review's authors, Jonny Harcourt, a consultant otologist at Charing Cross Hospital in London, takes us through the pathogenic process and clinical presentation of the disease, its clinical course and prognosis, and what clinical features help to discriminate the condition from other diagnoses. He also discusses the evidence for treatment.

In a second interview Corine from The Netherlands discusses her experience of having the disease, and offers her tips to others with the condition.

https://soundcloud.com/bmjpodcasts/menieres-disease-patient

Read the full review:
http://www.bmj.com/content/349/bmj.g6544]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>959</itunes:duration>
                                    </item>
    <item>
        <title>Menieres disease - a patient perspective</title>
        <itunes:title>Menieres disease - a patient perspective</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/menieres-disease-a-patient-perspective/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/menieres-disease-a-patient-perspective/#comments</comments>        <pubDate>Thu, 13 Nov 2014 11:52:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/menieres-disease-patient</guid>
                                    <description><![CDATA[A clinical review on thebmj.com looks at Meniere's disease. Corine from The Netherlands discusses her experience of having the disease and explains how the symptoms of vertigo and tinnitus have affected her everyday life. She also offers her top tips on coping with the disease to others with the condition.


In a second podcast, Jonny Harcourt, a consultant otologist at Charing Cross Hospital in London and one of the authors of the review, takes us through the clinical course and prognosis of the disease.
https://soundcloud.com/bmjpodcasts/menieres-disease

Read the full review:
<p>http://www.bmj.com/content/349/bmj.g6544</p>
<p></p>
]]></description>
                                                            <content:encoded><![CDATA[A clinical review on thebmj.com looks at Meniere's disease. Corine from The Netherlands discusses her experience of having the disease and explains how the symptoms of vertigo and tinnitus have affected her everyday life. She also offers her top tips on coping with the disease to others with the condition.


In a second podcast, Jonny Harcourt, a consultant otologist at Charing Cross Hospital in London and one of the authors of the review, takes us through the clinical course and prognosis of the disease.
https://soundcloud.com/bmjpodcasts/menieres-disease

Read the full review:
<p>http://www.bmj.com/content/349/bmj.g6544</p>
<p></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/u2xmyy/stream_176708033-bmjgroup-menieres-disease-patient.mp3" length="25096519" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A clinical review on thebmj.com looks at Meniere's disease. Corine from The Netherlands discusses her experience of having the disease and explains how the symptoms of vertigo and tinnitus have affected her everyday life. She also offers her top tips on coping with the disease to others with the condition.


In a second podcast, Jonny Harcourt, a consultant otologist at Charing Cross Hospital in London and one of the authors of the review, takes us through the clinical course and prognosis of the disease.
https://soundcloud.com/bmjpodcasts/menieres-disease

Read the full review:
http://www.bmj.com/content/349/bmj.g6544
]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1047</itunes:duration>
                                    </item>
    <item>
        <title>Should we still be using hydroxyethyl starch?</title>
        <itunes:title>Should we still be using hydroxyethyl starch?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/should-we-still-be-using-hydroxyethyl-starch/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/should-we-still-be-using-hydroxyethyl-starch/#comments</comments>        <pubDate>Tue, 11 Nov 2014 15:26:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/hydroxy-ethyl-starch-solution</guid>
                                    <description><![CDATA[Large trials show that hydroxyethyl starch increases the risk of death, kidney injury, and bleeding. So why does the European Medicines Agency still allow its use?

Helen Macdonald, analysis editor for The BMJ, discusses the issue with Christiane Hartog, a lecturer in intensive care medicine at Jena University Hospital in Germany, and one of the authors of an analysis paper on thebmj.com

Read the full analysis paper:
<p>www.bmj.com/content/349/bmj.g5981</p>
]]></description>
                                                            <content:encoded><![CDATA[Large trials show that hydroxyethyl starch increases the risk of death, kidney injury, and bleeding. So why does the European Medicines Agency still allow its use?

Helen Macdonald, analysis editor for The BMJ, discusses the issue with Christiane Hartog, a lecturer in intensive care medicine at Jena University Hospital in Germany, and one of the authors of an analysis paper on thebmj.com

Read the full analysis paper:
<p>www.bmj.com/content/349/bmj.g5981</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/zrnt4t/stream_176401079-bmjgroup-hydroxy-ethyl-starch-solution.mp3" length="23216037" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Large trials show that hydroxyethyl starch increases the risk of death, kidney injury, and bleeding. So why does the European Medicines Agency still allow its use?

Helen Macdonald, analysis editor for The BMJ, discusses the issue with Christiane Hartog, a lecturer in intensive care medicine at Jena University Hospital in Germany, and one of the authors of an analysis paper on thebmj.com

Read the full analysis paper:
www.bmj.com/content/349/bmj.g5981]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>967</itunes:duration>
                                    </item>
    <item>
        <title>Atul Gawande - It’s about having a good life not a good death</title>
        <itunes:title>Atul Gawande - It’s about having a good life not a good death</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/atul-gawande-it-s-about-having-a-good-life-not-a-good-death/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/atul-gawande-it-s-about-having-a-good-life-not-a-good-death/#comments</comments>        <pubDate>Fri, 07 Nov 2014 11:09:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/atul-gawande-good-life-not-good-death</guid>
                                    <description><![CDATA[Surgeon, writer, and researcher, Atul Gawande is best known for the development of surgical checklists, but the death of his father has inspired him to write his latest book exploring medical and societal attitudes to death.

<p>We joined him for breakfast during his whistle stop tour of the UK recording this year's BBC Reith Lectures, to discuss Being Mortal.</p>
]]></description>
                                                            <content:encoded><![CDATA[Surgeon, writer, and researcher, Atul Gawande is best known for the development of surgical checklists, but the death of his father has inspired him to write his latest book exploring medical and societal attitudes to death.

<p>We joined him for breakfast during his whistle stop tour of the UK recording this year's BBC Reith Lectures, to discuss Being Mortal.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8n4wtz/stream_175772097-bmjgroup-atul-gawande-good-life-not-good-death.mp3" length="33943261" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Surgeon, writer, and researcher, Atul Gawande is best known for the development of surgical checklists, but the death of his father has inspired him to write his latest book exploring medical and societal attitudes to death.

We joined him for breakfast during his whistle stop tour of the UK recording this year's BBC Reith Lectures, to discuss Being Mortal.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1416</itunes:duration>
                                    </item>
    <item>
        <title>It’s time to change surgical training in the UK</title>
        <itunes:title>It’s time to change surgical training in the UK</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/it-s-time-to-change-surgical-training-in-the-uk/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/it-s-time-to-change-surgical-training-in-the-uk/#comments</comments>        <pubDate>Fri, 31 Oct 2014 16:44:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/its-time-to-change-surgical</guid>
                                    <description><![CDATA[In a GMC survey last year, the UK’s surgical trainees came bottom of the list when it came to satisfaction about their training. 

Today, Craig McIlhenny, Director of the faculty of surgical training at the Royal college of surgeons of Edinburgh has released a report with a series of recommendations to improve standards of training, and he hopes, help it come inline with the European Working Time Directive

Read his full report 
<p>http://goo.gl/kH55lW</p>
<p></p>
]]></description>
                                                            <content:encoded><![CDATA[In a GMC survey last year, the UK’s surgical trainees came bottom of the list when it came to satisfaction about their training. 

Today, Craig McIlhenny, Director of the faculty of surgical training at the Royal college of surgeons of Edinburgh has released a report with a series of recommendations to improve standards of training, and he hopes, help it come inline with the European Working Time Directive

Read his full report 
<p>http://goo.gl/kH55lW</p>
<p></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/zkcgdo/stream_174734692-bmjgroup-its-time-to-change-surgical.mp3" length="17797953" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In a GMC survey last year, the UK’s surgical trainees came bottom of the list when it came to satisfaction about their training. 

Today, Craig McIlhenny, Director of the faculty of surgical training at the Royal college of surgeons of Edinburgh has released a report with a series of recommendations to improve standards of training, and he hopes, help it come inline with the European Working Time Directive

Read his full report 
http://goo.gl/kH55lW
]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>742</itunes:duration>
                                    </item>
    <item>
        <title>Update on malaria - new technologies helping to tackle the disease</title>
        <itunes:title>Update on malaria - new technologies helping to tackle the disease</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/update-on-malaria-new-technologies-helping-to-tackle-the-disease/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/update-on-malaria-new-technologies-helping-to-tackle-the-disease/#comments</comments>        <pubDate>Fri, 24 Oct 2014 16:27:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/update-on-malaria-new-technologies-helping-to-tackle-the-disease</guid>
                                    <description><![CDATA[<p>Fatoumata Nafo-Traoré is the executive director of the Roll Back Malaria Partnership. In this podcast, she updates us on recent successes in the global effort to control the disease. A second podcast examines the effect of the current ebola outbreak on the prevention and treatment of malaria, and other diseases, in affected regions. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Fatoumata Nafo-Traoré is the executive director of the Roll Back Malaria Partnership. In this podcast, she updates us on recent successes in the global effort to control the disease. A second podcast examines the effect of the current ebola outbreak on the prevention and treatment of malaria, and other diseases, in affected regions. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/g8zwtf/stream_173658604-bmjgroup-update-on-malaria-new-technologies-helping-to-tackle-the-disease.mp3" length="18374475" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Fatoumata Nafo-Traoré is the executive director of the Roll Back Malaria Partnership. In this podcast, she updates us on recent successes in the global effort to control the disease. A second podcast examines the effect of the current ebola outbreak on the prevention and treatment of malaria, and other diseases, in affected regions. ]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>766</itunes:duration>
                                    </item>
    <item>
        <title>Fighting on many fronts - how tackling ebola is effecting other diseases</title>
        <itunes:title>Fighting on many fronts - how tackling ebola is effecting other diseases</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/fighting-on-many-fronts-how-tackling-ebola-is-effecting-other-diseases/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/fighting-on-many-fronts-how-tackling-ebola-is-effecting-other-diseases/#comments</comments>        <pubDate>Fri, 24 Oct 2014 16:27:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/fighting-on-many-fronts-how-tackling-ebola-is-effecting-other-diseases</guid>
                                    <description><![CDATA[<p>Fatoumata Nafo-Traoré is the executive director of the Roll Back Malaria Partnership, and has just returned from Sierra Leone and Guinea. In this podcast, she describes the effect of the west African ebola outbreak on the prevention and treatment of malaria, and other diseases, in affected regions.  In an earlier podcast, Dr Nafo examined recent successes in the global effort to control malaria.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Fatoumata Nafo-Traoré is the executive director of the Roll Back Malaria Partnership, and has just returned from Sierra Leone and Guinea. In this podcast, she describes the effect of the west African ebola outbreak on the prevention and treatment of malaria, and other diseases, in affected regions.  In an earlier podcast, Dr Nafo examined recent successes in the global effort to control malaria.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mjog4o/stream_173658608-bmjgroup-fighting-on-many-fronts-how-tackling-ebola-is-effecting-other-diseases.mp3" length="16488204" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Fatoumata Nafo-Traoré is the executive director of the Roll Back Malaria Partnership, and has just returned from Sierra Leone and Guinea. In this podcast, she describes the effect of the west African ebola outbreak on the prevention and treatment of malaria, and other diseases, in affected regions.  In an earlier podcast, Dr Nafo examined recent successes in the global effort to control malaria.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>687</itunes:duration>
                                    </item>
    <item>
        <title>The blockbuster sex drug for women; creating a feminist issue</title>
        <itunes:title>The blockbuster sex drug for women; creating a feminist issue</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-blockbuster-sex-drug-for-women-creating-a-feminist-issue/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-blockbuster-sex-drug-for-women-creating-a-feminist-issue/#comments</comments>        <pubDate>Thu, 16 Oct 2014 11:20:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-sex-drug-for-women</guid>
                                    <description><![CDATA[A thrice failed antidepressant is at the centre of a new marketing campaign to win approval for what could become the world’s first blockbuster sex pill for women. Frustrated by the drug’s repeated rejection, proponents have orchestrated a fierce attack, accusing the regulator of unfairness, and enlisting support from several well connected women’s organisations in the US. 

Critics counter that the campaign is exceedingly misleading, that it targets a desire disorder that does not exist, and that approval could see widespread overprescribing of a drug with marginal benefits and real safety concerns.

Ray Moynihan has investigated for The BMJ, and talks to Rebecca Coombes about the way this publicity campaign has been orchestrated.

Read the full feature:
<p>http://www.bmj.com/content/349/bmj.g6246</p>
<p></p>
]]></description>
                                                            <content:encoded><![CDATA[A thrice failed antidepressant is at the centre of a new marketing campaign to win approval for what could become the world’s first blockbuster sex pill for women. Frustrated by the drug’s repeated rejection, proponents have orchestrated a fierce attack, accusing the regulator of unfairness, and enlisting support from several well connected women’s organisations in the US. 

Critics counter that the campaign is exceedingly misleading, that it targets a desire disorder that does not exist, and that approval could see widespread overprescribing of a drug with marginal benefits and real safety concerns.

Ray Moynihan has investigated for The BMJ, and talks to Rebecca Coombes about the way this publicity campaign has been orchestrated.

Read the full feature:
<p>http://www.bmj.com/content/349/bmj.g6246</p>
<p></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xn9ife/stream_172404390-bmjgroup-the-sex-drug-for-women.mp3" length="30018598" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A thrice failed antidepressant is at the centre of a new marketing campaign to win approval for what could become the world’s first blockbuster sex pill for women. Frustrated by the drug’s repeated rejection, proponents have orchestrated a fierce attack, accusing the regulator of unfairness, and enlisting support from several well connected women’s organisations in the US. 

Critics counter that the campaign is exceedingly misleading, that it targets a desire disorder that does not exist, and that approval could see widespread overprescribing of a drug with marginal benefits and real safety concerns.

Ray Moynihan has investigated for The BMJ, and talks to Rebecca Coombes about the way this publicity campaign has been orchestrated.

Read the full feature:
http://www.bmj.com/content/349/bmj.g6246
]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1250</itunes:duration>
                                    </item>
    <item>
        <title>”Death is not inevitable”; why society’s beliefs fuel overtreatment</title>
        <itunes:title>”Death is not inevitable”; why society’s beliefs fuel overtreatment</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/death-is-not-inevitable-why-society-s-beliefs-fuel-overtreatment/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/death-is-not-inevitable-why-society-s-beliefs-fuel-overtreatment/#comments</comments>        <pubDate>Wed, 15 Oct 2014 09:39:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/whats-fuelling-overtreatment</guid>
                                    <description><![CDATA[Our whole society views risk in medicine wrongly, argue Jerome Hoffman and Hemal Kanzaria from the University of California Los Angeles. In this podcast they slay some strongly held myths about medicine's ability to heal, and say that one of our big beliefs, that death is not inevitable, is leading to overtreatment.

Read their full analysis of the situation:
http://www.bmj.com/content/349/bmj.g5702

<p>For more information about overdiagnosis and overtreatment, visit www.bmj.com/too-much-medicine</p>
]]></description>
                                                            <content:encoded><![CDATA[Our whole society views risk in medicine wrongly, argue Jerome Hoffman and Hemal Kanzaria from the University of California Los Angeles. In this podcast they slay some strongly held myths about medicine's ability to heal, and say that one of our big beliefs, that death is not inevitable, is leading to overtreatment.

Read their full analysis of the situation:
http://www.bmj.com/content/349/bmj.g5702

<p>For more information about overdiagnosis and overtreatment, visit www.bmj.com/too-much-medicine</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/u01xzl/stream_172240557-bmjgroup-whats-fuelling-overtreatment.mp3" length="26877522" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Our whole society views risk in medicine wrongly, argue Jerome Hoffman and Hemal Kanzaria from the University of California Los Angeles. In this podcast they slay some strongly held myths about medicine's ability to heal, and say that one of our big beliefs, that death is not inevitable, is leading to overtreatment.

Read their full analysis of the situation:
http://www.bmj.com/content/349/bmj.g5702

For more information about overdiagnosis and overtreatment, visit www.bmj.com/too-much-medicine]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1120</itunes:duration>
                                    </item>
    <item>
        <title>Is NHS England being whittled down to a core service?</title>
        <itunes:title>Is NHS England being whittled down to a core service?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/is-nhs-england-being-whittled-down-to-a-core-service/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/is-nhs-england-being-whittled-down-to-a-core-service/#comments</comments>        <pubDate>Thu, 09 Oct 2014 15:12:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/is-nhs-england-being-whittled</guid>
                                    <description><![CDATA[Allyson Pollock, professor of global health, and Peter Roderick, a barrister and senior research fellow, both at Queen Mary University of London, argue that, through various mechanisms in the 2012 Health and Social Care Act, the NHS in England could be turned into a small core service. For full healthcare coverage, will we have to turn to commercial medicine?

Read their analysis article:
http://www.bmj.com/content/349/bmj.g5603

The NHS Reinstatement Bill Campaign:
<p>http://www.nhsbill2015.org/</p>
<p></p>
]]></description>
                                                            <content:encoded><![CDATA[Allyson Pollock, professor of global health, and Peter Roderick, a barrister and senior research fellow, both at Queen Mary University of London, argue that, through various mechanisms in the 2012 Health and Social Care Act, the NHS in England could be turned into a small core service. For full healthcare coverage, will we have to turn to commercial medicine?

Read their analysis article:
http://www.bmj.com/content/349/bmj.g5603

The NHS Reinstatement Bill Campaign:
<p>http://www.nhsbill2015.org/</p>
<p></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ehxjw6/stream_171352789-bmjgroup-is-nhs-england-being-whittled.mp3" length="27551512" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Allyson Pollock, professor of global health, and Peter Roderick, a barrister and senior research fellow, both at Queen Mary University of London, argue that, through various mechanisms in the 2012 Health and Social Care Act, the NHS in England could be turned into a small core service. For full healthcare coverage, will we have to turn to commercial medicine?

Read their analysis article:
http://www.bmj.com/content/349/bmj.g5603

The NHS Reinstatement Bill Campaign:
http://www.nhsbill2015.org/
]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1149</itunes:duration>
                                    </item>
    <item>
        <title>How to manage cerebral palsy in children</title>
        <itunes:title>How to manage cerebral palsy in children</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/how-to-manage-cerebral-palsy-in-children/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/how-to-manage-cerebral-palsy-in-children/#comments</comments>        <pubDate>Mon, 29 Sep 2014 16:38:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/how-to-manage-cerebral-palsy</guid>
                                    <description><![CDATA[Cerebral palsy is a clinical diagnosis, which describes a wide spectrum of neurological disability – all as a result of some sort of trauma to the developing brain, either pre or post natally.

Neil Wimalasundera, a consultant in paediatric neurodisability at Great Ormond Street Hospital, and one of the authors of The BMJ clinical review discusses how to diagnose and manage cerebral palsy in children.

Read the full clinical review:
<p>http://www.bmj.com/content/349/bmj.g5474</p>
]]></description>
                                                            <content:encoded><![CDATA[Cerebral palsy is a clinical diagnosis, which describes a wide spectrum of neurological disability – all as a result of some sort of trauma to the developing brain, either pre or post natally.

Neil Wimalasundera, a consultant in paediatric neurodisability at Great Ormond Street Hospital, and one of the authors of The BMJ clinical review discusses how to diagnose and manage cerebral palsy in children.

Read the full clinical review:
<p>http://www.bmj.com/content/349/bmj.g5474</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kdvbea/stream_169886856-bmjgroup-how-to-manage-cerebral-palsy.mp3" length="30010851" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Cerebral palsy is a clinical diagnosis, which describes a wide spectrum of neurological disability – all as a result of some sort of trauma to the developing brain, either pre or post natally.

Neil Wimalasundera, a consultant in paediatric neurodisability at Great Ormond Street Hospital, and one of the authors of The BMJ clinical review discusses how to diagnose and manage cerebral palsy in children.

Read the full clinical review:
http://www.bmj.com/content/349/bmj.g5474]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1251</itunes:duration>
                                    </item>
    <item>
        <title>Are we overmedicalising global health?</title>
        <itunes:title>Are we overmedicalising global health?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/are-we-overmedicalising-global-health/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/are-we-overmedicalising-global-health/#comments</comments>        <pubDate>Fri, 26 Sep 2014 11:06:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/are-we-overmedicalising-global</guid>
                                    <description><![CDATA[Jocalyn Clarke, executive editor at icdd,b, argues the solutions proposed to improve global health are too focused on the medical, and fail to tackle the underlying socioeconomic factors which will undermine those efforts.

Read her full analysis of the situation:
<p>http://www.bmj.com/content/349/bmj.g5457</p>
]]></description>
                                                            <content:encoded><![CDATA[Jocalyn Clarke, executive editor at icdd,b, argues the solutions proposed to improve global health are too focused on the medical, and fail to tackle the underlying socioeconomic factors which will undermine those efforts.

Read her full analysis of the situation:
<p>http://www.bmj.com/content/349/bmj.g5457</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/r3gdq7/stream_169434890-bmjgroup-are-we-overmedicalising-global.mp3" length="18835796" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Jocalyn Clarke, executive editor at icdd,b, argues the solutions proposed to improve global health are too focused on the medical, and fail to tackle the underlying socioeconomic factors which will undermine those efforts.

Read her full analysis of the situation:
http://www.bmj.com/content/349/bmj.g5457]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>785</itunes:duration>
                                    </item>
    <item>
        <title>Listen to patients, how Radboud UMC changed quality and care</title>
        <itunes:title>Listen to patients, how Radboud UMC changed quality and care</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/listen-to-patients-how-radboud-umc-changed-quality-and-care/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/listen-to-patients-how-radboud-umc-changed-quality-and-care/#comments</comments>        <pubDate>Thu, 25 Sep 2014 13:41:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/listen-to-patients-how-radboud</guid>
                                    <description><![CDATA[In April 2006 one of the largest hospitals in the Netherlands hit the national headlines with the exposure of “scandalously” poor results for cardiac surgery.

Melvin Samsom, CEO of the hospital, explains how the high death rates galvanised quality improvement and innovative change, transforming it into a model for patient participation.

Read more about the transformation at:
<p>http://www.bmj.com/content/349/bmj.g5765</p>
]]></description>
                                                            <content:encoded><![CDATA[In April 2006 one of the largest hospitals in the Netherlands hit the national headlines with the exposure of “scandalously” poor results for cardiac surgery.

Melvin Samsom, CEO of the hospital, explains how the high death rates galvanised quality improvement and innovative change, transforming it into a model for patient participation.

Read more about the transformation at:
<p>http://www.bmj.com/content/349/bmj.g5765</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/c37urt/stream_169310907-bmjgroup-listen-to-patients-how-radboud.mp3" length="24478002" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In April 2006 one of the largest hospitals in the Netherlands hit the national headlines with the exposure of “scandalously” poor results for cardiac surgery.

Melvin Samsom, CEO of the hospital, explains how the high death rates galvanised quality improvement and innovative change, transforming it into a model for patient participation.

Read more about the transformation at:
http://www.bmj.com/content/349/bmj.g5765]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1020</itunes:duration>
                                    </item>
    <item>
        <title>How not to miss kawasaki disease</title>
        <itunes:title>How not to miss kawasaki disease</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/how-not-to-miss-kawasaki-disease/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/how-not-to-miss-kawasaki-disease/#comments</comments>        <pubDate>Fri, 19 Sep 2014 13:53:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/how-not-to-miss-kawasaki</guid>
                                    <description><![CDATA[Kawasaki Disease presents as fever and rash, which makes diagnosis difficult. 

In this podcast, Anthony Harnden, professor of primary care at the University of Oxford, describes what to watch out for to ensure you don’t miss the diagnosis.

Read the full article:
<p>http://www.bmj.com/content/349/bmj.g5336</p>
]]></description>
                                                            <content:encoded><![CDATA[Kawasaki Disease presents as fever and rash, which makes diagnosis difficult. 

In this podcast, Anthony Harnden, professor of primary care at the University of Oxford, describes what to watch out for to ensure you don’t miss the diagnosis.

Read the full article:
<p>http://www.bmj.com/content/349/bmj.g5336</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9w8oij/stream_168437276-bmjgroup-how-not-to-miss-kawasaki.mp3" length="17779921" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Kawasaki Disease presents as fever and rash, which makes diagnosis difficult. 

In this podcast, Anthony Harnden, professor of primary care at the University of Oxford, describes what to watch out for to ensure you don’t miss the diagnosis.

Read the full article:
http://www.bmj.com/content/349/bmj.g5336]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>741</itunes:duration>
                                    </item>
    <item>
        <title>Risky Business - Kevin Fong -  learning too much from aviation?</title>
        <itunes:title>Risky Business - Kevin Fong -  learning too much from aviation?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/risky-business-kevin-fong-learning-too-much-from-aviation/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/risky-business-kevin-fong-learning-too-much-from-aviation/#comments</comments>        <pubDate>Thu, 18 Sep 2014 14:34:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/risky-business-kevin-fong</guid>
                                    <description><![CDATA[Is medicine trying to learn too much from aviation?

<p>Kevin Fong, consultant anaesthetist at UCLH is currently working with Kent, Surrey and Sussex air ambulance. At Risky Business he talked to The BMJ about why he thinks medicine is trying to learn too much from aviation.</p>
]]></description>
                                                            <content:encoded><![CDATA[Is medicine trying to learn too much from aviation?

<p>Kevin Fong, consultant anaesthetist at UCLH is currently working with Kent, Surrey and Sussex air ambulance. At Risky Business he talked to The BMJ about why he thinks medicine is trying to learn too much from aviation.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5o0fnb/stream_168292225-bmjgroup-risky-business-kevin-fong.mp3" length="8186439" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Is medicine trying to learn too much from aviation?

Kevin Fong, consultant anaesthetist at UCLH is currently working with Kent, Surrey and Sussex air ambulance. At Risky Business he talked to The BMJ about why he thinks medicine is trying to learn too much from aviation.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>341</itunes:duration>
                                    </item>
    <item>
        <title>Preventing overdiagnosis - the problems with screening</title>
        <itunes:title>Preventing overdiagnosis - the problems with screening</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/preventing-overdiagnosis-the-problems-with-screening/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/preventing-overdiagnosis-the-problems-with-screening/#comments</comments>        <pubDate>Wed, 17 Sep 2014 15:58:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/preventing-overdiagnosis-the</guid>
                                    <description><![CDATA[Screening tests were central to many of the discussions taking place at the Preventing Overdiagnosis conference (preventingoverdiagnosis.net)  

To sum up some of the problems with screening we’re joined by Carl Heneghan, director of the Centre for Evidence Based Medicine at the University of Oxford, and John Broderson, associate professor in the Research Unit and Section of General Practice at the University of Copenhagen.

For more on over diagnosis, visit 
<p>www.bmj.com/too-much-medicine</p>
]]></description>
                                                            <content:encoded><![CDATA[Screening tests were central to many of the discussions taking place at the Preventing Overdiagnosis conference (preventingoverdiagnosis.net)  

To sum up some of the problems with screening we’re joined by Carl Heneghan, director of the Centre for Evidence Based Medicine at the University of Oxford, and John Broderson, associate professor in the Research Unit and Section of General Practice at the University of Copenhagen.

For more on over diagnosis, visit 
<p>www.bmj.com/too-much-medicine</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2pu474/stream_168154584-bmjgroup-preventing-overdiagnosis-the.mp3" length="21104512" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Screening tests were central to many of the discussions taking place at the Preventing Overdiagnosis conference (preventingoverdiagnosis.net)  

To sum up some of the problems with screening we’re joined by Carl Heneghan, director of the Centre for Evidence Based Medicine at the University of Oxford, and John Broderson, associate professor in the Research Unit and Section of General Practice at the University of Copenhagen.

For more on over diagnosis, visit 
www.bmj.com/too-much-medicine]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>880</itunes:duration>
                                    </item>
    <item>
        <title>Trans-sphenoidal surgery, a patient’s experience</title>
        <itunes:title>Trans-sphenoidal surgery, a patient’s experience</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/trans-sphenoidal-surgery-a-patient-s-experience/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/trans-sphenoidal-surgery-a-patient-s-experience/#comments</comments>        <pubDate>Fri, 12 Sep 2014 15:13:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/trans-sphenoidal-surgery-a-patients-experience</guid>
                                    <description><![CDATA[A recent clinical review in The BMJ discusses diagnosis and management of prolactinomas and non-functioning pituitary adenomas.

One management option is surgery to remove the tumour, often this can done trans-sphenoidally. Though major complications of this type of surgery are low (~1%), there are still effects that can be distressing to patients, and should be discussed.

In this interview the patient wished to remain anonymous, so we have re-recorded her words. She describes the way in which attempts to reassure her about the surgery made he under-estimate the risks involved.

Read the full review:
<p>http://www.bmj.com/content/349/bmj.g5390</p>
]]></description>
                                                            <content:encoded><![CDATA[A recent clinical review in The BMJ discusses diagnosis and management of prolactinomas and non-functioning pituitary adenomas.

One management option is surgery to remove the tumour, often this can done trans-sphenoidally. Though major complications of this type of surgery are low (~1%), there are still effects that can be distressing to patients, and should be discussed.

In this interview the patient wished to remain anonymous, so we have re-recorded her words. She describes the way in which attempts to reassure her about the surgery made he under-estimate the risks involved.

Read the full review:
<p>http://www.bmj.com/content/349/bmj.g5390</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/oim5ea/stream_167411519-bmjgroup-trans-sphenoidal-surgery-a-patients-experience.mp3" length="7968620" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A recent clinical review in The BMJ discusses diagnosis and management of prolactinomas and non-functioning pituitary adenomas.

One management option is surgery to remove the tumour, often this can done trans-sphenoidally. Though major complications of this type of surgery are low (~1%), there are still effects that can be distressing to patients, and should be discussed.

In this interview the patient wished to remain anonymous, so we have re-recorded her words. She describes the way in which attempts to reassure her about the surgery made he under-estimate the risks involved.

Read the full review:
http://www.bmj.com/content/349/bmj.g5390]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>332</itunes:duration>
                                    </item>
    <item>
        <title>Overtreating mild hypertension, are we doing more harm than good?</title>
        <itunes:title>Overtreating mild hypertension, are we doing more harm than good?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/overtreating-mild-hypertension-are-we-doing-more-harm-than-good/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/overtreating-mild-hypertension-are-we-doing-more-harm-than-good/#comments</comments>        <pubDate>Fri, 12 Sep 2014 10:14:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/overtreating-mild-hypertension-are-we-doing-more-harm-than-good</guid>
                                    <description><![CDATA[Stephen Martin, an associate professor at the University of Massachusetts Medical School, thinks we're overtreating otherwise healthy patients who have mild hypertension.

In this podcast he sets out his argument, and explains why prescribing drugs to these people may actually be doing more harm than good.

Read the full analysis article:
<p> http://www.bmj.com/cgi/doi/10.1136/bmj.g5432</p>
]]></description>
                                                            <content:encoded><![CDATA[Stephen Martin, an associate professor at the University of Massachusetts Medical School, thinks we're overtreating otherwise healthy patients who have mild hypertension.

In this podcast he sets out his argument, and explains why prescribing drugs to these people may actually be doing more harm than good.

Read the full analysis article:
<p> http://www.bmj.com/cgi/doi/10.1136/bmj.g5432</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9prd50/stream_167380910-bmjgroup-overtreating-mild-hypertension-are-we-doing-more-harm-than-good.mp3" length="30690407" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Stephen Martin, an associate professor at the University of Massachusetts Medical School, thinks we're overtreating otherwise healthy patients who have mild hypertension.

In this podcast he sets out his argument, and explains why prescribing drugs to these people may actually be doing more harm than good.

Read the full analysis article:
 http://www.bmj.com/cgi/doi/10.1136/bmj.g5432]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1280</itunes:duration>
                                    </item>
    <item>
        <title>Should patients be able to email their doctor?</title>
        <itunes:title>Should patients be able to email their doctor?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/should-patients-be-able-to-email-their-doctor/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/should-patients-be-able-to-email-their-doctor/#comments</comments>        <pubDate>Thu, 04 Sep 2014 15:10:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/should-patients-be-able-to-email-their-doctor</guid>
                                    <description><![CDATA[Demand for better access to primary care is ever rising, but is email the answer? In this podcast, Elinor Gunning, a clinical teaching fellow in London says that patients want it and that careful planning can mitigate worries about safety and security. Emma Richards, trainee academic GP, is not so sure and thinks clearer guidance and resourcing are needed first.

Read the head to head online:
<p>http://www.bmj.com/content/349/bmj.g5338</p>
<p></p>
]]></description>
                                                            <content:encoded><![CDATA[Demand for better access to primary care is ever rising, but is email the answer? In this podcast, Elinor Gunning, a clinical teaching fellow in London says that patients want it and that careful planning can mitigate worries about safety and security. Emma Richards, trainee academic GP, is not so sure and thinks clearer guidance and resourcing are needed first.

Read the head to head online:
<p>http://www.bmj.com/content/349/bmj.g5338</p>
<p></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/r4txik/stream_166208844-bmjgroup-should-patients-be-able-to-email-their-doctor.mp3" length="24267376" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Demand for better access to primary care is ever rising, but is email the answer? In this podcast, Elinor Gunning, a clinical teaching fellow in London says that patients want it and that careful planning can mitigate worries about safety and security. Emma Richards, trainee academic GP, is not so sure and thinks clearer guidance and resourcing are needed first.

Read the head to head online:
http://www.bmj.com/content/349/bmj.g5338
]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1012</itunes:duration>
                                    </item>
    <item>
        <title>Ebola virus disease, a long terms perspective</title>
        <itunes:title>Ebola virus disease, a long terms perspective</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/ebola-virus-disease-a-long-terms-perspective/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/ebola-virus-disease-a-long-terms-perspective/#comments</comments>        <pubDate>Wed, 20 Aug 2014 16:04:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/ebola-virus-disease-a-long-terms-perspective</guid>
                                    <description><![CDATA[David Heymann, professor of infectious disease epidemiology, and head and senior fellow, at the Chatham House Centre on Global Health Security was sent to investigate the first outbreaks of Ebola in 1976. In this podcast he gives a longer term perspective on the disease, and talks about the importance and challenges of introducing novel treatments.

For more information on ebola virus disease, including working in a front line clinic, visit bmj.com/ebola

<p>David Heymann's analysis article, Prevention is better than cure for emerging infectious diseases: http://www.bmj.com/content/348/bmj.g1499</p>
]]></description>
                                                            <content:encoded><![CDATA[David Heymann, professor of infectious disease epidemiology, and head and senior fellow, at the Chatham House Centre on Global Health Security was sent to investigate the first outbreaks of Ebola in 1976. In this podcast he gives a longer term perspective on the disease, and talks about the importance and challenges of introducing novel treatments.

For more information on ebola virus disease, including working in a front line clinic, visit bmj.com/ebola

<p>David Heymann's analysis article, Prevention is better than cure for emerging infectious diseases: http://www.bmj.com/content/348/bmj.g1499</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/afmbld/stream_163986371-bmjgroup-ebola-virus-disease-a-long-terms-perspective.mp3" length="3207168" type="audio/mpeg"/>
        <itunes:summary><![CDATA[David Heymann, professor of infectious disease epidemiology, and head and senior fellow, at the Chatham House Centre on Global Health Security was sent to investigate the first outbreaks of Ebola in 1976. In this podcast he gives a longer term perspective on the disease, and talks about the importance and challenges of introducing novel treatments.

For more information on ebola virus disease, including working in a front line clinic, visit bmj.com/ebola

David Heymann's analysis article, Prevention is better than cure for emerging infectious diseases: http://www.bmj.com/content/348/bmj.g1499]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1080</itunes:duration>
                                    </item>
    <item>
        <title>How to test for an immediate food allergy</title>
        <itunes:title>How to test for an immediate food allergy</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/how-to-test-for-an-immediate-food-allergy/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/how-to-test-for-an-immediate-food-allergy/#comments</comments>        <pubDate>Fri, 08 Aug 2014 13:57:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/how-to-test-for-an-immediate-food-allergy</guid>
                                    <description><![CDATA[<p>A new rational testing article, published on thebmj.com, looks at how to diagnose an immediate food allergy. Mabel Chew, The BMJ's practice editor, is joined by Cathal Steele from the Belfast Trust Regional Immunology Service - they discuss which tests are appropriate, and the common pitfalls in diagnosis.</p>
<p>Read the full article:</p>
<p>http://www.bmj.com/content/349/bmj.g3695</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>A new rational testing article, published on thebmj.com, looks at how to diagnose an immediate food allergy. Mabel Chew, The BMJ's practice editor, is joined by Cathal Steele from the Belfast Trust Regional Immunology Service - they discuss which tests are appropriate, and the common pitfalls in diagnosis.</p>
<p>Read the full article:</p>
<p>http://www.bmj.com/content/349/bmj.g3695</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/pzbl70/stream_162264040-bmjgroup-how-to-test-for-an-immediate-food-allergy.mp3" length="25014296" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A new rational testing article, published on thebmj.com, looks at how to diagnose an immediate food allergy. Mabel Chew, The BMJ's practice editor, is joined by Cathal Steele from the Belfast Trust Regional Immunology Service - they discuss which tests are appropriate, and the common pitfalls in diagnosis.Read the full article:http://www.bmj.com/content/349/bmj.g3695]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1043</itunes:duration>
                                    </item>
    <item>
        <title>Diagnosing and managing spasticity in adults</title>
        <itunes:title>Diagnosing and managing spasticity in adults</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/diagnosing-and-managing-spasticity-in-adults/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/diagnosing-and-managing-spasticity-in-adults/#comments</comments>        <pubDate>Tue, 05 Aug 2014 13:33:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/diagnosing-and-managing-spasticity-in-adults</guid>
                                    <description><![CDATA[<p>Management of spasticity requires a balanced approach, weighing the benefits of treatment against the usefulness of the spasticity. Current interventions to treat spasticity lack a robust evidence base, and guidelines often depend on expert recommendations. A new clinical review published on thebmj.com discusses the assessment and treatment of spasticity in adults.</p>
<p>In this podcast we're joined by one of the authors of that review, Siva Nair, from the Department of Neurology at The Royal Hallamshire Hospital, and by a patient with spasticity, Ian, who is chairman of the Hereditary Spastic Paraplegia (HSP) Support Group.</p>
<p>Read the clinical review: http://www.bmj.com/content/349/bmj.g4737</p>
<p>For more information on HSP visit http://hspgroup.org/</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Management of spasticity requires a balanced approach, weighing the benefits of treatment against the usefulness of the spasticity. Current interventions to treat spasticity lack a robust evidence base, and guidelines often depend on expert recommendations. A new clinical review published on thebmj.com discusses the assessment and treatment of spasticity in adults.</p>
<p>In this podcast we're joined by one of the authors of that review, Siva Nair, from the Department of Neurology at The Royal Hallamshire Hospital, and by a patient with spasticity, Ian, who is chairman of the Hereditary Spastic Paraplegia (HSP) Support Group.</p>
<p>Read the clinical review: http://www.bmj.com/content/349/bmj.g4737</p>
<p>For more information on HSP visit http://hspgroup.org/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wffbhe/stream_161799150-bmjgroup-diagnosing-and-managing-spasticity-in-adults.mp3" length="37474717" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Management of spasticity requires a balanced approach, weighing the benefits of treatment against the usefulness of the spasticity. Current interventions to treat spasticity lack a robust evidence base, and guidelines often depend on expert recommendations. A new clinical review published on thebmj.com discusses the assessment and treatment of spasticity in adults.In this podcast we're joined by one of the authors of that review, Siva Nair, from the Department of Neurology at The Royal Hallamshire Hospital, and by a patient with spasticity, Ian, who is chairman of the Hereditary Spastic Paraplegia (HSP) Support Group.Read the clinical review: http://www.bmj.com/content/349/bmj.g4737For more information on HSP visit http://hspgroup.org/]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1562</itunes:duration>
                                    </item>
    <item>
        <title>Are essential medicines essential?</title>
        <itunes:title>Are essential medicines essential?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/are-essential-medicines-essential/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/are-essential-medicines-essential/#comments</comments>        <pubDate>Fri, 01 Aug 2014 10:57:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/are-essential-medicines-essential</guid>
                                    <description><![CDATA[Global endorsement as a WHO essential medicine is big step. But Corrado Barbui, from the Department of Public Health and Community Medicine at the University of Verona, has found that the quality of applications for antidepressants and antipsychotics is poor and calls on applicants and WHO to raise standards.

Read the analysis article:
<p>http://www.bmj.com/content/349/bmj.g4798</p>
]]></description>
                                                            <content:encoded><![CDATA[Global endorsement as a WHO essential medicine is big step. But Corrado Barbui, from the Department of Public Health and Community Medicine at the University of Verona, has found that the quality of applications for antidepressants and antipsychotics is poor and calls on applicants and WHO to raise standards.

Read the analysis article:
<p>http://www.bmj.com/content/349/bmj.g4798</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/q337zu/stream_161234081-bmjgroup-are-essential-medicines-essential.mp3" length="16086011" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Global endorsement as a WHO essential medicine is big step. But Corrado Barbui, from the Department of Public Health and Community Medicine at the University of Verona, has found that the quality of applications for antidepressants and antipsychotics is poor and calls on applicants and WHO to raise standards.

Read the analysis article:
http://www.bmj.com/content/349/bmj.g4798]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>670</itunes:duration>
                                    </item>
    <item>
        <title>Pre-diabetes - epidemic or emperor’s new clothes?</title>
        <itunes:title>Pre-diabetes - epidemic or emperor’s new clothes?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/pre-diabetes-epidemic-or-emperor-s-new-clothes/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/pre-diabetes-epidemic-or-emperor-s-new-clothes/#comments</comments>        <pubDate>Thu, 17 Jul 2014 15:59:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/pre-diabetes-epidemic-or-emperors-new-clothes</guid>
                                    <description><![CDATA[Pre-diabetes is an umbrella term and the most widely used phrase to describe a blood concentration of glucose or glycated haemoglobin (HbA1c) that lies above normal but below that defined for diabetes. 

John S Yudkin, emeritus professor of diabetes at University College London, thinks this is over-medicalisation and will only increase the burden on individuals and the health system.

Read the full analysis article:
<p>http://www.bmj.com/content/349/bmj.g4485</p>
]]></description>
                                                            <content:encoded><![CDATA[Pre-diabetes is an umbrella term and the most widely used phrase to describe a blood concentration of glucose or glycated haemoglobin (HbA1c) that lies above normal but below that defined for diabetes. 

John S Yudkin, emeritus professor of diabetes at University College London, thinks this is over-medicalisation and will only increase the burden on individuals and the health system.

Read the full analysis article:
<p>http://www.bmj.com/content/349/bmj.g4485</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7po720/stream_159119998-bmjgroup-pre-diabetes-epidemic-or-emperors-new-clothes.mp3" length="9388032" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Pre-diabetes is an umbrella term and the most widely used phrase to describe a blood concentration of glucose or glycated haemoglobin (HbA1c) that lies above normal but below that defined for diabetes. 

John S Yudkin, emeritus professor of diabetes at University College London, thinks this is over-medicalisation and will only increase the burden on individuals and the health system.

Read the full analysis article:
http://www.bmj.com/content/349/bmj.g4485]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>910</itunes:duration>
                                    </item>
    <item>
        <title>Should research fraud be a criminal offence?</title>
        <itunes:title>Should research fraud be a criminal offence?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/should-research-fraud-be-a-criminal-offence/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/should-research-fraud-be-a-criminal-offence/#comments</comments>        <pubDate>Tue, 15 Jul 2014 14:35:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/should-research-fraud-be-a-criminal-offence</guid>
                                    <description><![CDATA[<p>Research fraud, the deliberate falsification of research data, undermines science and can lead to horrible outcomes, as exemplified by Andrew Wakefield and the MMR/Autism scandal.</p>
<p>A new Head to Head in The BMJ sets out the case for and against making research fraud a crime. </p>
<p>Arguing yes is Prof. Zulfiqar Bhutta, from the Hospital for Sick Children in Toronto, who says that criminal sanctions are necessary to deter growing deliberate research misconduct, which can ultimately harm patients. </p>
<p>Prof. Julian Crane, from the University of Otago Wellington, disagrees: he doubts that sanctions will have any deterrent effect and worries that criminalisation would undermine trust.</p>
<p>Read the full debate:</p>
<p>http://www.bmj.com/content/349/bmj.g4532</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Research fraud, the deliberate falsification of research data, undermines science and can lead to horrible outcomes, as exemplified by Andrew Wakefield and the MMR/Autism scandal.</p>
<p>A new Head to Head in The BMJ sets out the case for and against making research fraud a crime. </p>
<p>Arguing yes is Prof. Zulfiqar Bhutta, from the Hospital for Sick Children in Toronto, who says that criminal sanctions are necessary to deter growing deliberate research misconduct, which can ultimately harm patients. </p>
<p>Prof. Julian Crane, from the University of Otago Wellington, disagrees: he doubts that sanctions will have any deterrent effect and worries that criminalisation would undermine trust.</p>
<p>Read the full debate:</p>
<p>http://www.bmj.com/content/349/bmj.g4532</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/1s13ld/stream_158806647-bmjgroup-should-research-fraud-be-a-criminal-offence.mp3" length="19832747" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Research fraud, the deliberate falsification of research data, undermines science and can lead to horrible outcomes, as exemplified by Andrew Wakefield and the MMR/Autism scandal.A new Head to Head in The BMJ sets out the case for and against making research fraud a crime. Arguing yes is Prof. Zulfiqar Bhutta, from the Hospital for Sick Children in Toronto, who says that criminal sanctions are necessary to deter growing deliberate research misconduct, which can ultimately harm patients. Prof. Julian Crane, from the University of Otago Wellington, disagrees: he doubts that sanctions will have any deterrent effect and worries that criminalisation would undermine trust.Read the full debate:http://www.bmj.com/content/349/bmj.g4532]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>826</itunes:duration>
                                    </item>
    <item>
        <title>Newly diagnosed HIV</title>
        <itunes:title>Newly diagnosed HIV</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/newly-diagnosed-hiv/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/newly-diagnosed-hiv/#comments</comments>        <pubDate>Fri, 11 Jul 2014 14:29:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/newly-diagnosed-hiv</guid>
                                    <description><![CDATA[HIV testing is now being routinely offered in increasingly diverse health settings, including primary care. In this podcast we talk to HIV consultant Mike Rayment, from Chelsea and Westminster NHS Foundation Trust, and Paul, a patient diagnosed with HIV infection 4 years ago. 

They discuss how to go about offering testing, and what matters to patients when they receive the diagnosis.

Read the clinical review discussed:
<p>http://www.bmj.com/content/349/bmj.g4275</p>
]]></description>
                                                            <content:encoded><![CDATA[HIV testing is now being routinely offered in increasingly diverse health settings, including primary care. In this podcast we talk to HIV consultant Mike Rayment, from Chelsea and Westminster NHS Foundation Trust, and Paul, a patient diagnosed with HIV infection 4 years ago. 

They discuss how to go about offering testing, and what matters to patients when they receive the diagnosis.

Read the clinical review discussed:
<p>http://www.bmj.com/content/349/bmj.g4275</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/aonnyk/stream_158259784-bmjgroup-newly-diagnosed-hiv.mp3" length="43727291" type="audio/mpeg"/>
        <itunes:summary><![CDATA[HIV testing is now being routinely offered in increasingly diverse health settings, including primary care. In this podcast we talk to HIV consultant Mike Rayment, from Chelsea and Westminster NHS Foundation Trust, and Paul, a patient diagnosed with HIV infection 4 years ago. 

They discuss how to go about offering testing, and what matters to patients when they receive the diagnosis.

Read the clinical review discussed:
http://www.bmj.com/content/349/bmj.g4275]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1824</itunes:duration>
                                    </item>
    <item>
        <title>Why we need an independent WHO</title>
        <itunes:title>Why we need an independent WHO</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/why-we-need-an-independent-who/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/why-we-need-an-independent-who/#comments</comments>        <pubDate>Fri, 20 Jun 2014 17:15:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/why-we-need-an-independent-who</guid>
                                    <description><![CDATA[<p>Devi Sridhar, population health researcher and lecturer, joins us to discuss why an independent organisation to co-ordinate international health concerns is absolutely necessary.</p>
<p>Read more in her analysis article, </p>
<p>Global rules for global health: Why we need an independent, impartial WHO</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Devi Sridhar, population health researcher and lecturer, joins us to discuss why an independent organisation to co-ordinate international health concerns is absolutely necessary.</p>
<p>Read more in her analysis article, </p>
<p>Global rules for global health: Why we need an independent, impartial WHO</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6f6aon/stream_155256736-bmjgroup-why-we-need-an-independent-who.mp3" length="21754162" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Devi Sridhar, population health researcher and lecturer, joins us to discuss why an independent organisation to co-ordinate international health concerns is absolutely necessary.Read more in her analysis article, Global rules for global health: Why we need an independent, impartial WHO]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>907</itunes:duration>
                                    </item>
    <item>
        <title>FiFA, the World Cup, and the disappearing alcohol ban</title>
        <itunes:title>FiFA, the World Cup, and the disappearing alcohol ban</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/fifa-the-world-cup-and-the-disappearing-alcohol-ban/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/fifa-the-world-cup-and-the-disappearing-alcohol-ban/#comments</comments>        <pubDate>Fri, 13 Jun 2014 16:10:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/fifa-the-world-cup-and-the-disappearing-alcohol-ban</guid>
                                    <description><![CDATA[<p>Whichever country hoists aloft the World Cup trophy on 13 July, the real winner will be the alcohol industry. </p>
<p>In this podcast Jonathan Gornall explains why FIFA promotes the interests of the alcohol industry, and the extraordinary demands countries comply with in order to host the World Cup.</p>
<p>World Cup 2014: festival of football or alcohol?</p>
<p>http://www.bmj.com/content/348/bmj.g3772</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Whichever country hoists aloft the World Cup trophy on 13 July, the real winner will be the alcohol industry. </p>
<p>In this podcast Jonathan Gornall explains why FIFA promotes the interests of the alcohol industry, and the extraordinary demands countries comply with in order to host the World Cup.</p>
<p>World Cup 2014: festival of football or alcohol?</p>
<p>http://www.bmj.com/content/348/bmj.g3772</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/r4v81x/stream_154210925-bmjgroup-fifa-the-world-cup-and-the-disappearing-alcohol-ban.mp3" length="10708360" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Whichever country hoists aloft the World Cup trophy on 13 July, the real winner will be the alcohol industry. In this podcast Jonathan Gornall explains why FIFA promotes the interests of the alcohol industry, and the extraordinary demands countries comply with in order to host the World Cup.World Cup 2014: festival of football or alcohol?http://www.bmj.com/content/348/bmj.g3772]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>446</itunes:duration>
                                    </item>
    <item>
        <title>Drugs for weight loss</title>
        <itunes:title>Drugs for weight loss</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/drugs-for-weight-loss/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/drugs-for-weight-loss/#comments</comments>        <pubDate>Fri, 06 Jun 2014 16:06:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/drugs-for-weight-loss</guid>
                                    <description><![CDATA[<p>Drugs to encourage weight loss have a chequered past, with many of them having been withdrawn from the market due to increased morbidity and mortality.</p>
<p>In this podcast Raj Padwal, associate professor of medicine at the University of Alberta, takes us through the remaining therapy Orlistat, and discusses the potential for two new therapies, Phentermine-ER topiramate, and Lorcaserin, which are being licensed in some countries</p>
<p>Read the full article: http://www.bmj.com/content/348/bmj.g3526</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Drugs to encourage weight loss have a chequered past, with many of them having been withdrawn from the market due to increased morbidity and mortality.</p>
<p>In this podcast Raj Padwal, associate professor of medicine at the University of Alberta, takes us through the remaining therapy Orlistat, and discusses the potential for two new therapies, Phentermine-ER topiramate, and Lorcaserin, which are being licensed in some countries</p>
<p>Read the full article: http://www.bmj.com/content/348/bmj.g3526</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/zbgd3c/stream_153129914-bmjgroup-drugs-for-weight-loss.mp3" length="33577379" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Drugs to encourage weight loss have a chequered past, with many of them having been withdrawn from the market due to increased morbidity and mortality.In this podcast Raj Padwal, associate professor of medicine at the University of Alberta, takes us through the remaining therapy Orlistat, and discusses the potential for two new therapies, Phentermine-ER topiramate, and Lorcaserin, which are being licensed in some countriesRead the full article: http://www.bmj.com/content/348/bmj.g3526]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1400</itunes:duration>
                                    </item>
    <item>
        <title>Helicobacter pylori - new evidence, and when to test and treat</title>
        <itunes:title>Helicobacter pylori - new evidence, and when to test and treat</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/helicobacter-pylori-new-evidence-and-when-to-test-and-treat/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/helicobacter-pylori-new-evidence-and-when-to-test-and-treat/#comments</comments>        <pubDate>Tue, 27 May 2014 13:12:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/helicobacter-pylori-new-evidence-and-when-to-test-and-treat</guid>
                                    <description><![CDATA[<p>Two articles on bmj.com look at helicobacter pylori; a systematic review and meta-analysis examines if eradication treatment reduces rates of gastric cancer, and an uncertainties article asks who we should be testing and treating for the infection.</p>
<p>Two of the authors of those articles, Alex Ford from the Leeds Gastroenterology Institute, and Paul Moayyedi from the Gastroenterology Division of McMaster University, join us to discuss the bacterium.</p>
<p>Read the full articles</p>
<p>www.bmj.com/content/348/bmj.g3174</p>
<p>www.bmj.com/content/348/bmj.g3320</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Two articles on bmj.com look at helicobacter pylori; a systematic review and meta-analysis examines if eradication treatment reduces rates of gastric cancer, and an uncertainties article asks who we should be testing and treating for the infection.</p>
<p>Two of the authors of those articles, Alex Ford from the Leeds Gastroenterology Institute, and Paul Moayyedi from the Gastroenterology Division of McMaster University, join us to discuss the bacterium.</p>
<p>Read the full articles</p>
<p>www.bmj.com/content/348/bmj.g3174</p>
<p>www.bmj.com/content/348/bmj.g3320</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kiw98y/stream_151497074-bmjgroup-helicobacter-pylori-new-evidence-and-when-to-test-and-treat.mp3" length="31723689" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Two articles on bmj.com look at helicobacter pylori; a systematic review and meta-analysis examines if eradication treatment reduces rates of gastric cancer, and an uncertainties article asks who we should be testing and treating for the infection.Two of the authors of those articles, Alex Ford from the Leeds Gastroenterology Institute, and Paul Moayyedi from the Gastroenterology Division of McMaster University, join us to discuss the bacterium.Read the full articleswww.bmj.com/content/348/bmj.g3174www.bmj.com/content/348/bmj.g3320]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1323</itunes:duration>
                                    </item>
    <item>
        <title>Is advice to cut down smoking wrong?</title>
        <itunes:title>Is advice to cut down smoking wrong?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/is-advice-to-cut-down-smoking-wrong/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/is-advice-to-cut-down-smoking-wrong/#comments</comments>        <pubDate>Fri, 23 May 2014 15:06:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/is-advice-to-cut-down-smoking-wrong</guid>
                                    <description><![CDATA[<p>New NICE guidance says that smokers should be encouraged to cut down on the number of cigarettes they smoke, as well as trying to quit.</p>
<p>In a head to head, published on bmj.com, Paul Aveyard, professor of behavioural medicine at the University of Oxford, says that reducing smoking is a worthwhile step towards cessation, but Gerard Hastings, professor of social marketing at Stirling and Open Universities,  argues that the lifelong nicotine replacement therapy being recommended in support may benefit industry more than public health.</p>
<p>Read the full head to head:</p>
<p>http://www.bmj.com/content/348/bmj.g2787</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>New NICE guidance says that smokers should be encouraged to cut down on the number of cigarettes they smoke, as well as trying to quit.</p>
<p>In a head to head, published on bmj.com, Paul Aveyard, professor of behavioural medicine at the University of Oxford, says that reducing smoking is a worthwhile step towards cessation, but Gerard Hastings, professor of social marketing at Stirling and Open Universities,  argues that the lifelong nicotine replacement therapy being recommended in support may benefit industry more than public health.</p>
<p>Read the full head to head:</p>
<p>http://www.bmj.com/content/348/bmj.g2787</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/zmdsix/stream_150918825-bmjgroup-is-advice-to-cut-down-smoking-wrong.mp3" length="24198255" type="audio/mpeg"/>
        <itunes:summary><![CDATA[New NICE guidance says that smokers should be encouraged to cut down on the number of cigarettes they smoke, as well as trying to quit.In a head to head, published on bmj.com, Paul Aveyard, professor of behavioural medicine at the University of Oxford, says that reducing smoking is a worthwhile step towards cessation, but Gerard Hastings, professor of social marketing at Stirling and Open Universities,  argues that the lifelong nicotine replacement therapy being recommended in support may benefit industry more than public health.Read the full head to head:http://www.bmj.com/content/348/bmj.g2787]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1009</itunes:duration>
                                    </item>
    <item>
        <title>Investigating UTIs in older adults</title>
        <itunes:title>Investigating UTIs in older adults</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/investigating-utis-in-older-adults/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/investigating-utis-in-older-adults/#comments</comments>        <pubDate>Thu, 22 May 2014 13:56:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/investigating-utis-mixdown</guid>
                                    <description><![CDATA[<p>UTIs are often diagnosed in secondary care, but often that diagnosis isn't accurate. In this podcast Gavin Barlow from the Department of infection and tropical medicine at Hull & East Yorkshire Hospitals NHS Trust joins us to discuss when and how to test for the infection​.</p>
<p>Read the full clinical review</p>
<p>Investigation of suspected urinary tract infection in older people http://www.bmj.com/content/348/bmj.g3861</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>UTIs are often diagnosed in secondary care, but often that diagnosis isn't accurate. In this podcast Gavin Barlow from the Department of infection and tropical medicine at Hull & East Yorkshire Hospitals NHS Trust joins us to discuss when and how to test for the infection​.</p>
<p>Read the full clinical review</p>
<p>Investigation of suspected urinary tract infection in older people http://www.bmj.com/content/348/bmj.g3861</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9px1fl/stream_150742823-bmjgroup-investigating-utis-mixdown.mp3" length="15942274" type="audio/mpeg"/>
        <itunes:summary><![CDATA[UTIs are often diagnosed in secondary care, but often that diagnosis isn't accurate. In this podcast Gavin Barlow from the Department of infection and tropical medicine at Hull & East Yorkshire Hospitals NHS Trust joins us to discuss when and how to test for the infection​.Read the full clinical reviewInvestigation of suspected urinary tract infection in older people http://www.bmj.com/content/348/bmj.g3861]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>665</itunes:duration>
                                    </item>
    <item>
        <title>Alcohol - The UK’s billion unit pledge is worthless</title>
        <itunes:title>Alcohol - The UK’s billion unit pledge is worthless</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/alcohol-the-uk-s-billion-unit-pledge-is-worthless/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/alcohol-the-uk-s-billion-unit-pledge-is-worthless/#comments</comments>        <pubDate>Wed, 21 May 2014 16:30:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/alcohol-the-billion-unit-pledge-is-worthless</guid>
                                    <description><![CDATA[<p>The BMJ has been investigating the  “cosy relationship” between the alcohol industry and the British government.</p>
<p>In a series of articles Under the influence, journalist Jonathan Gornall has been looking into UK government’s consultation into introducing a minimum unit price for alcohol in England and Wales, and also at the wider responsibility deal between government and industry which is meant to champion public health.</p>
<p>In his latest article, he looks at the billion unit pledge, and how it's actually being used as a marketing tool to attract new drinkers.</p>
<p>Read all of the articles discussed on www.bmj.com/alcohol</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The BMJ has been investigating the  “cosy relationship” between the alcohol industry and the British government.</p>
<p>In a series of articles Under the influence, journalist Jonathan Gornall has been looking into UK government’s consultation into introducing a minimum unit price for alcohol in England and Wales, and also at the wider responsibility deal between government and industry which is meant to champion public health.</p>
<p>In his latest article, he looks at the billion unit pledge, and how it's actually being used as a marketing tool to attract new drinkers.</p>
<p>Read all of the articles discussed on www.bmj.com/alcohol</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ttbesy/stream_150601415-bmjgroup-alcohol-the-billion-unit-pledge-is-worthless.mp3" length="28415073" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The BMJ has been investigating the  “cosy relationship” between the alcohol industry and the British government.In a series of articles Under the influence, journalist Jonathan Gornall has been looking into UK government’s consultation into introducing a minimum unit price for alcohol in England and Wales, and also at the wider responsibility deal between government and industry which is meant to champion public health.In his latest article, he looks at the billion unit pledge, and how it's actually being used as a marketing tool to attract new drinkers.Read all of the articles discussed on www.bmj.com/alcohol]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1185</itunes:duration>
                                    </item>
    <item>
        <title>Operating to remove recurrent colorectal cancer: have we got it right?</title>
        <itunes:title>Operating to remove recurrent colorectal cancer: have we got it right?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/operating-to-remove-recurrent-colorectal-cancer-have-we-got-it-right/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/operating-to-remove-recurrent-colorectal-cancer-have-we-got-it-right/#comments</comments>        <pubDate>Thu, 15 May 2014 16:52:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/surgery-for-colorectal-cancer</guid>
                                    <description><![CDATA[<p>A new analysis article on bmj.com discusses the story of a surgical colon cancer trial, that was started 30 years ago and then abandoned, and the data lost. </p>
<p>In this podcast Helen Macdonald talks to Tom Treasure from Imperial College London, who has unearthed the data and now published the research. Also joining the discussion is Peter Doshi, one of the instigators of the RIAT initiative set up to encourage this kind of work to correct the scientific record.</p>
<p>Read the full article: http://www.bmj.com/content/348/bmj.g2085</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>A new analysis article on bmj.com discusses the story of a surgical colon cancer trial, that was started 30 years ago and then abandoned, and the data lost. </p>
<p>In this podcast Helen Macdonald talks to Tom Treasure from Imperial College London, who has unearthed the data and now published the research. Also joining the discussion is Peter Doshi, one of the instigators of the RIAT initiative set up to encourage this kind of work to correct the scientific record.</p>
<p>Read the full article: http://www.bmj.com/content/348/bmj.g2085</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jvjmt3/stream_149687103-bmjgroup-surgery-for-colorectal-cancer.mp3" length="27536140" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A new analysis article on bmj.com discusses the story of a surgical colon cancer trial, that was started 30 years ago and then abandoned, and the data lost. In this podcast Helen Macdonald talks to Tom Treasure from Imperial College London, who has unearthed the data and now published the research. Also joining the discussion is Peter Doshi, one of the instigators of the RIAT initiative set up to encourage this kind of work to correct the scientific record.Read the full article: http://www.bmj.com/content/348/bmj.g2085]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1148</itunes:duration>
                                    </item>
    <item>
        <title>Patient confidentiality in the digital age</title>
        <itunes:title>Patient confidentiality in the digital age</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/patient-confidentiality-in-the-digital-age/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/patient-confidentiality-in-the-digital-age/#comments</comments>        <pubDate>Fri, 09 May 2014 13:41:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/patient-confidentiality-in-the-digital-age</guid>
                                    <description><![CDATA[<p>Digital technology introduces new concerns for confidentiality and information security. In this podcast Bradley Crotty and Arash Mostaghimi, both from Harvard Medical School,  outline the regulations governing confidentiality and medical privacy and provide practical advice on how to safeguard patient information</p>
<p>Read their article for more details:</p>
<p>http://www.bmj.com/content/348/bmj.g2943</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Digital technology introduces new concerns for confidentiality and information security. In this podcast Bradley Crotty and Arash Mostaghimi, both from Harvard Medical School,  outline the regulations governing confidentiality and medical privacy and provide practical advice on how to safeguard patient information</p>
<p>Read their article for more details:</p>
<p>http://www.bmj.com/content/348/bmj.g2943</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/u1unxx/stream_148681984-bmjgroup-patient-confidentiality-in-the-digital-age.mp3" length="25879398" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Digital technology introduces new concerns for confidentiality and information security. In this podcast Bradley Crotty and Arash Mostaghimi, both from Harvard Medical School,  outline the regulations governing confidentiality and medical privacy and provide practical advice on how to safeguard patient informationRead their article for more details:http://www.bmj.com/content/348/bmj.g2943]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1079</itunes:duration>
                                    </item>
    <item>
        <title>The problems with testosterone testing in female athletes</title>
        <itunes:title>The problems with testosterone testing in female athletes</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-problems-with-testosterone-testing-in-female-athletes/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-problems-with-testosterone-testing-in-female-athletes/#comments</comments>        <pubDate>Wed, 30 Apr 2014 16:08:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-problems-with-testosterone-testing-in-female-athletes</guid>
                                    <description><![CDATA[<p>The International Olympic Committee (IOC) and other international sports federations have recently introduced policies which require a medical investigation of women athletes known or suspected to have hyperandrogenism. </p>
<p>Women who are found to have naturally high testosterone levels and tissue sensitivity are banned from competition unless they have surgical or pharmaceutical interventions to lower their testosterone levels. </p>
<p>But a recent analysis published on bmj.com says that these tests and procedures are at best not medically necessary, and at worst totally unethical. </p>
<p>In this podcast we're joined by two of the authors, Rebecca Jordan-Young,  professor women’s gender and sexuality studies at Barnard College, and Katrina Karkazis, bioethicist at Stanford centre for biomedical ethics.</p>
<p>Read the full analysis article online:</p>
<p>http://www.bmj.com/content/348/bmj.g2926</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The International Olympic Committee (IOC) and other international sports federations have recently introduced policies which require a medical investigation of women athletes known or suspected to have hyperandrogenism. </p>
<p>Women who are found to have naturally high testosterone levels and tissue sensitivity are banned from competition unless they have surgical or pharmaceutical interventions to lower their testosterone levels. </p>
<p>But a recent analysis published on bmj.com says that these tests and procedures are at best not medically necessary, and at worst totally unethical. </p>
<p>In this podcast we're joined by two of the authors, Rebecca Jordan-Young,  professor women’s gender and sexuality studies at Barnard College, and Katrina Karkazis, bioethicist at Stanford centre for biomedical ethics.</p>
<p>Read the full analysis article online:</p>
<p>http://www.bmj.com/content/348/bmj.g2926</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/li2oi7/stream_147240243-bmjgroup-the-problems-with-testosterone-testing-in-female-athletes.mp3" length="25804679" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The International Olympic Committee (IOC) and other international sports federations have recently introduced policies which require a medical investigation of women athletes known or suspected to have hyperandrogenism. Women who are found to have naturally high testosterone levels and tissue sensitivity are banned from competition unless they have surgical or pharmaceutical interventions to lower their testosterone levels. But a recent analysis published on bmj.com says that these tests and procedures are at best not medically necessary, and at worst totally unethical. In this podcast we're joined by two of the authors, Rebecca Jordan-Young,  professor women’s gender and sexuality studies at Barnard College, and Katrina Karkazis, bioethicist at Stanford centre for biomedical ethics.Read the full analysis article online:http://www.bmj.com/content/348/bmj.g2926]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1076</itunes:duration>
                                    </item>
    <item>
        <title>Should doctors be prescribing cannabinoids?</title>
        <itunes:title>Should doctors be prescribing cannabinoids?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/should-doctors-be-prescribing-cannabinoids/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/should-doctors-be-prescribing-cannabinoids/#comments</comments>        <pubDate>Fri, 25 Apr 2014 14:35:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/should-drs-prescrbe-cannabinoids</guid>
                                    <description><![CDATA[<p>Michael Farrell, professor and director of the National Drug and Alcohol Research Centre at the University of New South Wales in Sydney, talks to Mabel Chew, The BMJ's practice editor, about prescription of cannabinoids.</p>
<p>They discuss the latest evidence on nausea and appetite, when cannabinoids may be effective for chronic pain, and which common problems to watch out for.</p>
<p>Read the full article:</p>
<p>http://www.bmj.com/content/348/bmj.g2737</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Michael Farrell, professor and director of the National Drug and Alcohol Research Centre at the University of New South Wales in Sydney, talks to Mabel Chew, The BMJ's practice editor, about prescription of cannabinoids.</p>
<p>They discuss the latest evidence on nausea and appetite, when cannabinoids may be effective for chronic pain, and which common problems to watch out for.</p>
<p>Read the full article:</p>
<p>http://www.bmj.com/content/348/bmj.g2737</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xat08x/stream_146422567-bmjgroup-should-drs-prescrbe-cannabinoids.mp3" length="27216820" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Michael Farrell, professor and director of the National Drug and Alcohol Research Centre at the University of New South Wales in Sydney, talks to Mabel Chew, The BMJ's practice editor, about prescription of cannabinoids.They discuss the latest evidence on nausea and appetite, when cannabinoids may be effective for chronic pain, and which common problems to watch out for.Read the full article:http://www.bmj.com/content/348/bmj.g2737]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1134</itunes:duration>
                                    </item>
    <item>
        <title>Using HbA1c to diagnose type 2 diabetes</title>
        <itunes:title>Using HbA1c to diagnose type 2 diabetes</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/using-hba1c-to-diagnose-type-2-diabetes/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/using-hba1c-to-diagnose-type-2-diabetes/#comments</comments>        <pubDate>Thu, 24 Apr 2014 14:40:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/using-hba1c-to-diagnose-type-2-diabetes</guid>
                                    <description><![CDATA[<p>Glycated Haemoglobin (HbA1c) is used to measure glucose control in patients with diabetes, but can now be used as an alternative test to glucose concentration for diagnosing type 2 diabetes or identifying people at high risk of developing the disease.</p>
<p>in this podcast Eric Kilpatrick, from the Department of Clinical Biochemistry at Hull York Medical School, and Stephen Atkin, from Weill Cornell Medical College Qatar, describe when testing HbA1c may be appropriate for diagnosis, and what comorbidities would rule it out.</p>
<p>Read the full rational testing article: http://www.bmj.com/content/348/bmj.g2867</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Glycated Haemoglobin (HbA1c) is used to measure glucose control in patients with diabetes, but can now be used as an alternative test to glucose concentration for diagnosing type 2 diabetes or identifying people at high risk of developing the disease.</p>
<p>in this podcast Eric Kilpatrick, from the Department of Clinical Biochemistry at Hull York Medical School, and Stephen Atkin, from Weill Cornell Medical College Qatar, describe when testing HbA1c may be appropriate for diagnosis, and what comorbidities would rule it out.</p>
<p>Read the full rational testing article: http://www.bmj.com/content/348/bmj.g2867</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/o2qrdp/stream_146255443-bmjgroup-using-hba1c-to-diagnose-type-2-diabetes.mp3" length="21491924" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Glycated Haemoglobin (HbA1c) is used to measure glucose control in patients with diabetes, but can now be used as an alternative test to glucose concentration for diagnosing type 2 diabetes or identifying people at high risk of developing the disease.in this podcast Eric Kilpatrick, from the Department of Clinical Biochemistry at Hull York Medical School, and Stephen Atkin, from Weill Cornell Medical College Qatar, describe when testing HbA1c may be appropriate for diagnosis, and what comorbidities would rule it out.Read the full rational testing article: http://www.bmj.com/content/348/bmj.g2867]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>896</itunes:duration>
                                    </item>
    <item>
        <title>How to manage the first seizure in an adult</title>
        <itunes:title>How to manage the first seizure in an adult</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/how-to-manage-the-first-seizure-in-an-adult/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/how-to-manage-the-first-seizure-in-an-adult/#comments</comments>        <pubDate>Mon, 14 Apr 2014 13:33:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/managing-first-seizure-adult</guid>
                                    <description><![CDATA[<p>First seizure covers a wide range of manifestations, but picking up the minor events can prevent a patient from experiencing a major event, so early diagnosis is key.</p>
<p>Heather Angus-Leppan, consultant neurologist and epilepsy lead at the Royal Free Hospital in London, talks to Navjoyt Ladher about how to manage the first seizure in an adult. </p>
<p>Read the full clinical review at:</p>
<p>http://www.bmj.com/content/348/bmj.g2470</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>First seizure covers a wide range of manifestations, but picking up the minor events can prevent a patient from experiencing a major event, so early diagnosis is key.</p>
<p>Heather Angus-Leppan, consultant neurologist and epilepsy lead at the Royal Free Hospital in London, talks to Navjoyt Ladher about how to manage the first seizure in an adult. </p>
<p>Read the full clinical review at:</p>
<p>http://www.bmj.com/content/348/bmj.g2470</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/h7pywr/stream_144646330-bmjgroup-managing-first-seizure-adult.mp3" length="42747348" type="audio/mpeg"/>
        <itunes:summary><![CDATA[First seizure covers a wide range of manifestations, but picking up the minor events can prevent a patient from experiencing a major event, so early diagnosis is key.Heather Angus-Leppan, consultant neurologist and epilepsy lead at the Royal Free Hospital in London, talks to Navjoyt Ladher about how to manage the first seizure in an adult. Read the full clinical review at:http://www.bmj.com/content/348/bmj.g2470]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1783</itunes:duration>
                                    </item>
    <item>
        <title>Tamiflu US Press Conference</title>
        <itunes:title>Tamiflu US Press Conference</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/tamiflu-us-press-conference/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/tamiflu-us-press-conference/#comments</comments>        <pubDate>Wed, 09 Apr 2014 13:53:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/tamiflu-press-conference</guid>
                                    <description><![CDATA[<p>Tamiflu (oseltamivir) is a neuraminidase inhibitor, developed by Roche, for the treatment of seasonal and pandemic influenza. Yet for the first time a comprehensive review of the data, by independent researchers, has shown that the claims for Tamiflu’s effectiveness have been overestimated, and that harms have been underreported.</p>
<p>Here is the audio of a recent press conference where researchers and the BMJ's editors describe the findings of that research, and the systematic regulatory failures those findings expose.</p>
<p>Taking part were:</p>
<p>Fiona Godlee - BMJ editor in chief</p>
<p>Carl Heneghan - Director of Oxford University's Centre for Evidence Based Medicine</p>
<p>Peter Doshi - Assistant Professor of Pharmaceutical Health Services Research</p>
<p>Elizabeth Loder - The BMJ clinical epidemiology editor </p>
<p>David Tovey - Editor in chief, Cochrane Library</p>
<p>Ben Goldacre - Founder of the AllTrials campaign</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Tamiflu (oseltamivir) is a neuraminidase inhibitor, developed by Roche, for the treatment of seasonal and pandemic influenza. Yet for the first time a comprehensive review of the data, by independent researchers, has shown that the claims for Tamiflu’s effectiveness have been overestimated, and that harms have been underreported.</p>
<p>Here is the audio of a recent press conference where researchers and the BMJ's editors describe the findings of that research, and the systematic regulatory failures those findings expose.</p>
<p>Taking part were:</p>
<p>Fiona Godlee - BMJ editor in chief</p>
<p>Carl Heneghan - Director of Oxford University's Centre for Evidence Based Medicine</p>
<p>Peter Doshi - Assistant Professor of Pharmaceutical Health Services Research</p>
<p>Elizabeth Loder - The BMJ clinical epidemiology editor </p>
<p>David Tovey - Editor in chief, Cochrane Library</p>
<p>Ben Goldacre - Founder of the AllTrials campaign</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/79crkf/stream_143868224-bmjgroup-tamiflu-press-conference.mp3" length="46855720" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Tamiflu (oseltamivir) is a neuraminidase inhibitor, developed by Roche, for the treatment of seasonal and pandemic influenza. Yet for the first time a comprehensive review of the data, by independent researchers, has shown that the claims for Tamiflu’s effectiveness have been overestimated, and that harms have been underreported.Here is the audio of a recent press conference where researchers and the BMJ's editors describe the findings of that research, and the systematic regulatory failures those findings expose.Taking part were:Fiona Godlee - BMJ editor in chiefCarl Heneghan - Director of Oxford University's Centre for Evidence Based MedicinePeter Doshi - Assistant Professor of Pharmaceutical Health Services ResearchElizabeth Loder - The BMJ clinical epidemiology editor David Tovey - Editor in chief, Cochrane LibraryBen Goldacre - Founder of the AllTrials campaign]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1955</itunes:duration>
                                    </item>
    <item>
        <title>Triptans for the acute treatment of migraine</title>
        <itunes:title>Triptans for the acute treatment of migraine</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/triptans-for-the-acute-treatment-of-migraine/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/triptans-for-the-acute-treatment-of-migraine/#comments</comments>        <pubDate>Mon, 07 Apr 2014 12:54:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/triptans-for-the-acute</guid>
                                    <description><![CDATA[<p>Mabel Chew talks to Tamara Pringsheim, from the University of Calgary, about the use of triptans for acute treatment of migraine. When, how, and what contraindications a physician should be aware of.</p>
<p>Read the full article:</p>
<p>http://www.bmj.com/content/348/bmj.g2285</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Mabel Chew talks to Tamara Pringsheim, from the University of Calgary, about the use of triptans for acute treatment of migraine. When, how, and what contraindications a physician should be aware of.</p>
<p>Read the full article:</p>
<p>http://www.bmj.com/content/348/bmj.g2285</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qzgzj4/stream_143510658-bmjgroup-triptans-for-the-acute.mp3" length="25240205" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Mabel Chew talks to Tamara Pringsheim, from the University of Calgary, about the use of triptans for acute treatment of migraine. When, how, and what contraindications a physician should be aware of.Read the full article:http://www.bmj.com/content/348/bmj.g2285]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1052</itunes:duration>
                                    </item>
    <item>
        <title>Friends and family test: Don’t just collect data, use it</title>
        <itunes:title>Friends and family test: Don’t just collect data, use it</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/friends-and-family-test-don-t-just-collect-data-use-it/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/friends-and-family-test-don-t-just-collect-data-use-it/#comments</comments>        <pubDate>Thu, 27 Mar 2014 17:43:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/friends-and-family-test-dont</guid>
                                    <description><![CDATA[<p>The NHS has been collecting data on patients’ experience of care for over 10 years but few providers are systematically using the information to improve services. </p>
<p>Angela Coulter joins us to discuss the new Friends and Family test, and why it will fail to change services until it asks the right questions.</p>
<p>read the full paper:</p>
<p>http://www.bmj.com/content/348/bmj.g2225</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The NHS has been collecting data on patients’ experience of care for over 10 years but few providers are systematically using the information to improve services. </p>
<p>Angela Coulter joins us to discuss the new Friends and Family test, and why it will fail to change services until it asks the right questions.</p>
<p>read the full paper:</p>
<p>http://www.bmj.com/content/348/bmj.g2225</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/0zivzl/stream_141718234-bmjgroup-friends-and-family-test-dont.mp3" length="20265121" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The NHS has been collecting data on patients’ experience of care for over 10 years but few providers are systematically using the information to improve services. Angela Coulter joins us to discuss the new Friends and Family test, and why it will fail to change services until it asks the right questions.read the full paper:http://www.bmj.com/content/348/bmj.g2225]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>845</itunes:duration>
                                    </item>
    <item>
        <title>Who, when and how: Screening for MRSA</title>
        <itunes:title>Who, when and how: Screening for MRSA</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/who-when-and-how-screening-for-mrsa/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/who-when-and-how-screening-for-mrsa/#comments</comments>        <pubDate>Fri, 21 Mar 2014 16:51:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/who-when-and-how-screening-for</guid>
                                    <description><![CDATA[<p>Meticillin resistant Staphylococcus aureus (MRSA) remains one of the foremost hospital acquired pathogens. </p>
<p>Patients colonised or infected with MRSA provide a reservoir within hospitals, although infection prevention and control measures minimise the risk of transmission. </p>
<p>Although there is broad agreement on the control measures required for patients colonised or infected with MRSA, there is considerable controversy over who, when and how to screen for the bacteria.</p>
<p> John Coia, a consultant microbiologist at Glasgow Royal Infirmary, discusses when screening may be appropriate, how it should be carried out, and the best strategy for decolonisation.</p>
<p>Read the full article: http://www.bmj.com/content/348/bmj.g1697</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Meticillin resistant Staphylococcus aureus (MRSA) remains one of the foremost hospital acquired pathogens. </p>
<p>Patients colonised or infected with MRSA provide a reservoir within hospitals, although infection prevention and control measures minimise the risk of transmission. </p>
<p>Although there is broad agreement on the control measures required for patients colonised or infected with MRSA, there is considerable controversy over who, when and how to screen for the bacteria.</p>
<p> John Coia, a consultant microbiologist at Glasgow Royal Infirmary, discusses when screening may be appropriate, how it should be carried out, and the best strategy for decolonisation.</p>
<p>Read the full article: http://www.bmj.com/content/348/bmj.g1697</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/0lhadt/stream_140717310-bmjgroup-who-when-and-how-screening-for.mp3" length="19099197" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Meticillin resistant Staphylococcus aureus (MRSA) remains one of the foremost hospital acquired pathogens. Patients colonised or infected with MRSA provide a reservoir within hospitals, although infection prevention and control measures minimise the risk of transmission. Although there is broad agreement on the control measures required for patients colonised or infected with MRSA, there is considerable controversy over who, when and how to screen for the bacteria. John Coia, a consultant microbiologist at Glasgow Royal Infirmary, discusses when screening may be appropriate, how it should be carried out, and the best strategy for decolonisation.Read the full article: http://www.bmj.com/content/348/bmj.g1697]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>796</itunes:duration>
                                    </item>
    <item>
        <title>ParkinsonNet: a new approach to management of chronic disease</title>
        <itunes:title>ParkinsonNet: a new approach to management of chronic disease</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/parkinsonnet-a-new-approach-to-management-of-chronic-disease/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/parkinsonnet-a-new-approach-to-management-of-chronic-disease/#comments</comments>        <pubDate>Thu, 20 Mar 2014 10:52:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/parkinsonnet-a-new-approach-to</guid>
                                    <description><![CDATA[Read the full analysis of ParkinsonNet: http://www.bmj.com/content/348/bmj.g1838

<p>Patients with Parkinson’s disease need long term support to manage their condition. In this podcast Bastiaan Bloem, medical director at the Parkinsons Institute in Nijmegen, and Marko van der Vegt, a Parkinsons patient, describe the benefits of ParkinsonNet; a model of integrated care provided by a network of specialists and suggest it has promise for other long term conditions</p>
]]></description>
                                                            <content:encoded><![CDATA[Read the full analysis of ParkinsonNet: http://www.bmj.com/content/348/bmj.g1838

<p>Patients with Parkinson’s disease need long term support to manage their condition. In this podcast Bastiaan Bloem, medical director at the Parkinsons Institute in Nijmegen, and Marko van der Vegt, a Parkinsons patient, describe the benefits of ParkinsonNet; a model of integrated care provided by a network of specialists and suggest it has promise for other long term conditions</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7iq2ju/stream_140505461-bmjgroup-parkinsonnet-a-new-approach-to.mp3" length="21188869" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Read the full analysis of ParkinsonNet: http://www.bmj.com/content/348/bmj.g1838

Patients with Parkinson’s disease need long term support to manage their condition. In this podcast Bastiaan Bloem, medical director at the Parkinsons Institute in Nijmegen, and Marko van der Vegt, a Parkinsons patient, describe the benefits of ParkinsonNet; a model of integrated care provided by a network of specialists and suggest it has promise for other long term conditions]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>883</itunes:duration>
                                    </item>
    <item>
        <title>Recognising a subdural haematoma in the elderly</title>
        <itunes:title>Recognising a subdural haematoma in the elderly</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/recognising-a-subdural-haematoma-in-the-elderly/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/recognising-a-subdural-haematoma-in-the-elderly/#comments</comments>        <pubDate>Tue, 11 Mar 2014 10:48:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/recognising-a-subdural</guid>
                                    <description><![CDATA[<p>Subdural haematoma is more common in elderly patients, yet the condition is easy to miss in this group.</p>
<p>John Young, a consultant geriatrician at Bradford Teaching Hospitals NHS Foundation Trust, describes what clinical signs to look out for, and what tests can confirm a diagnosis of subdural haematoma.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Subdural haematoma is more common in elderly patients, yet the condition is easy to miss in this group.</p>
<p>John Young, a consultant geriatrician at Bradford Teaching Hospitals NHS Foundation Trust, describes what clinical signs to look out for, and what tests can confirm a diagnosis of subdural haematoma.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kib49c/stream_139013762-bmjgroup-recognising-a-subdural.mp3" length="27472342" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Subdural haematoma is more common in elderly patients, yet the condition is easy to miss in this group.John Young, a consultant geriatrician at Bradford Teaching Hospitals NHS Foundation Trust, describes what clinical signs to look out for, and what tests can confirm a diagnosis of subdural haematoma.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1146</itunes:duration>
                                    </item>
    <item>
        <title>The Health and Social Care bill: An end of year report</title>
        <itunes:title>The Health and Social Care bill: An end of year report</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-health-and-social-care-bill-an-end-of-year-report/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-health-and-social-care-bill-an-end-of-year-report/#comments</comments>        <pubDate>Fri, 07 Mar 2014 12:17:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-health-and-social-care</guid>
                                    <description><![CDATA[<p>Each year at the Nuffield Trust Health Policy Summit, The BMJ hosts a breakfast roundtable. It has been one year since the Health and Social Care Bill for England was enacted, and the reconfiguration of the NHS continues, so this year we asked our panel to give the bill an end of year report.</p>
<p>Taking part were:</p>
<p>John Richards – Southampton Clinical Commissioning Group</p>
<p>Nigel Edwards - CEO Nuffield Trust</p>
<p>Jennifer Dixon - CEO Health Foundation</p>
<p>Terence Stephenson - president Academy of Medical Royal Colleges</p>
<p>Maureen Baker - Chair RCGP</p>
<p>Hugh Taylor - Chairman Guys and St Thomas' Foundation Trust</p>
<p>Nick Hicks - CEO COBIC Ltd</p>
<p>Jeremy Taylor - National Voices</p>
<p>Tim Ferris - VP for population health management, Partners Healthcare, MA</p>
<p>Nick Timmins - Senior Associate Nuffield Trust</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Each year at the Nuffield Trust Health Policy Summit, The BMJ hosts a breakfast roundtable. It has been one year since the Health and Social Care Bill for England was enacted, and the reconfiguration of the NHS continues, so this year we asked our panel to give the bill an end of year report.</p>
<p>Taking part were:</p>
<p>John Richards – Southampton Clinical Commissioning Group</p>
<p>Nigel Edwards - CEO Nuffield Trust</p>
<p>Jennifer Dixon - CEO Health Foundation</p>
<p>Terence Stephenson - president Academy of Medical Royal Colleges</p>
<p>Maureen Baker - Chair RCGP</p>
<p>Hugh Taylor - Chairman Guys and St Thomas' Foundation Trust</p>
<p>Nick Hicks - CEO COBIC Ltd</p>
<p>Jeremy Taylor - National Voices</p>
<p>Tim Ferris - VP for population health management, Partners Healthcare, MA</p>
<p>Nick Timmins - Senior Associate Nuffield Trust</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/v9v0cf/stream_138371888-bmjgroup-the-health-and-social-care.mp3" length="32493167" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Each year at the Nuffield Trust Health Policy Summit, The BMJ hosts a breakfast roundtable. It has been one year since the Health and Social Care Bill for England was enacted, and the reconfiguration of the NHS continues, so this year we asked our panel to give the bill an end of year report.Taking part were:John Richards – Southampton Clinical Commissioning GroupNigel Edwards - CEO Nuffield TrustJennifer Dixon - CEO Health FoundationTerence Stephenson - president Academy of Medical Royal CollegesMaureen Baker - Chair RCGPHugh Taylor - Chairman Guys and St Thomas' Foundation TrustNick Hicks - CEO COBIC LtdJeremy Taylor - National VoicesTim Ferris - VP for population health management, Partners Healthcare, MANick Timmins - Senior Associate Nuffield Trust]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2704</itunes:duration>
                                    </item>
    <item>
        <title>HPV vaccination and cervical cancer screening in Australia</title>
        <itunes:title>HPV vaccination and cervical cancer screening in Australia</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/hpv-vaccination-and-cervical-cancer-screening-in-australia/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/hpv-vaccination-and-cervical-cancer-screening-in-australia/#comments</comments>        <pubDate>Thu, 06 Mar 2014 14:46:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/hpv-vaccination-and-cervical</guid>
                                    <description><![CDATA[Read the open access research: http://www.bmj.com/cgi/doi/10.1136/bmj.g1458

Australia was one of the first countries to introduce HPV vaccination, and due to it's cervical cancer screening programme, is one of the first to be able to measure the effectiveness of the vaccine.

<p>In this podcast, 3 of the authors of a new paper on bmj.com discuss their findings and talk about implications for cervical cancer screening in Australia.</p>
]]></description>
                                                            <content:encoded><![CDATA[Read the open access research: http://www.bmj.com/cgi/doi/10.1136/bmj.g1458

Australia was one of the first countries to introduce HPV vaccination, and due to it's cervical cancer screening programme, is one of the first to be able to measure the effectiveness of the vaccine.

<p>In this podcast, 3 of the authors of a new paper on bmj.com discuss their findings and talk about implications for cervical cancer screening in Australia.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/igubc7/stream_138217269-bmjgroup-hpv-vaccination-and-cervical.mp3" length="31836266" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Read the open access research: http://www.bmj.com/cgi/doi/10.1136/bmj.g1458

Australia was one of the first countries to introduce HPV vaccination, and due to it's cervical cancer screening programme, is one of the first to be able to measure the effectiveness of the vaccine.

In this podcast, 3 of the authors of a new paper on bmj.com discuss their findings and talk about implications for cervical cancer screening in Australia.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1328</itunes:duration>
                                    </item>
    <item>
        <title>Recognising and treating fibromyalgia</title>
        <itunes:title>Recognising and treating fibromyalgia</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/recognising-and-treating-fibromyalgia/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/recognising-and-treating-fibromyalgia/#comments</comments>        <pubDate>Mon, 24 Feb 2014 14:00:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/fibromyalgia</guid>
                                    <description><![CDATA[<p>Most doctors are familiar with patients who describe chronic pain all over the body, which is associated with a range of other symptoms including poor sleep, fatigue, and depression. This complex of symptoms is sometimes referred to as fibromyalgia. </p>
<p>Management of patients with this condition is often complex and challenging. The diagnosis of fibromyalgia has long been controversial, with some experts questioning whether it exists as a separate entity</p>
<p>In this podcast Anisur Rahman, professor of rheumatology at University College London, joins us to discuss diagnosis and management of the condition.</p>
<p>Read the full clinical review article:</p>
<p>http://goo.gl/MYryTJ</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Most doctors are familiar with patients who describe chronic pain all over the body, which is associated with a range of other symptoms including poor sleep, fatigue, and depression. This complex of symptoms is sometimes referred to as fibromyalgia. </p>
<p>Management of patients with this condition is often complex and challenging. The diagnosis of fibromyalgia has long been controversial, with some experts questioning whether it exists as a separate entity</p>
<p>In this podcast Anisur Rahman, professor of rheumatology at University College London, joins us to discuss diagnosis and management of the condition.</p>
<p>Read the full clinical review article:</p>
<p>http://goo.gl/MYryTJ</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6qfnfd/stream_136483852-bmjgroup-fibromyalgia.mp3" length="13295616" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Most doctors are familiar with patients who describe chronic pain all over the body, which is associated with a range of other symptoms including poor sleep, fatigue, and depression. This complex of symptoms is sometimes referred to as fibromyalgia. Management of patients with this condition is often complex and challenging. The diagnosis of fibromyalgia has long been controversial, with some experts questioning whether it exists as a separate entityIn this podcast Anisur Rahman, professor of rheumatology at University College London, joins us to discuss diagnosis and management of the condition.Read the full clinical review article:http://goo.gl/MYryTJ]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1141</itunes:duration>
                                    </item>
    <item>
        <title>Steps to limit smoking in China could save 13,000,000 lives in 35 years</title>
        <itunes:title>Steps to limit smoking in China could save 13,000,000 lives in 35 years</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/steps-to-limit-smoking-in-china-could-save-13000000-lives-in-35-years/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/steps-to-limit-smoking-in-china-could-save-13000000-lives-in-35-years/#comments</comments>        <pubDate>Mon, 17 Feb 2014 16:23:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/smoking-in-china</guid>
                                    <description><![CDATA[<p> Complete implementation of the World Health Organization Framework Convention on Tobacco Control (WHO FCTC) recommends policies in China that would prevent almost 13m smoking related deaths by 2050, suggests a paper published on bmj.com.</p>
<p>China is home to about one third of the world’s smokers and reducing smoking in China could have an enormous public health impact, even on a global scale.</p>
<p>To discuss their research, we are joined by three of the paper's authors, David Levy from Georgetown University, Teh-Wei Hu from University of California at Berkeley, and Andrew Moran from Columbia University Medical Center.</p>
<p>Read the full open access research: http://www.bmj.com/cgi/doi/10.1136/bmj.g1134</p>
]]></description>
                                                            <content:encoded><![CDATA[<p> Complete implementation of the World Health Organization Framework Convention on Tobacco Control (WHO FCTC) recommends policies in China that would prevent almost 13m smoking related deaths by 2050, suggests a paper published on bmj.com.</p>
<p>China is home to about one third of the world’s smokers and reducing smoking in China could have an enormous public health impact, even on a global scale.</p>
<p>To discuss their research, we are joined by three of the paper's authors, David Levy from Georgetown University, Teh-Wei Hu from University of California at Berkeley, and Andrew Moran from Columbia University Medical Center.</p>
<p>Read the full open access research: http://www.bmj.com/cgi/doi/10.1136/bmj.g1134</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xn48m5/stream_135302552-bmjgroup-smoking-in-china.mp3" length="29050879" type="audio/mpeg"/>
        <itunes:summary><![CDATA[ Complete implementation of the World Health Organization Framework Convention on Tobacco Control (WHO FCTC) recommends policies in China that would prevent almost 13m smoking related deaths by 2050, suggests a paper published on bmj.com.China is home to about one third of the world’s smokers and reducing smoking in China could have an enormous public health impact, even on a global scale.To discuss their research, we are joined by three of the paper's authors, David Levy from Georgetown University, Teh-Wei Hu from University of California at Berkeley, and Andrew Moran from Columbia University Medical Center.Read the full open access research: http://www.bmj.com/cgi/doi/10.1136/bmj.g1134]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1211</itunes:duration>
                                    </item>
    <item>
        <title>Twenty-five Year Follow-up of the Canadian National Breast Screening Study</title>
        <itunes:title>Twenty-five Year Follow-up of the Canadian National Breast Screening Study</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/twenty-five-year-follow-up-of-the-canadian-national-breast-screening-study/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/twenty-five-year-follow-up-of-the-canadian-national-breast-screening-study/#comments</comments>        <pubDate>Fri, 07 Feb 2014 15:31:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/twenty-five-year-follow-up-of</guid>
                                    <description><![CDATA[<p>Controversy rages over the relative benefits or harms of screening for breast cancer, with evidence suggesting that in younger women at least it does more harm than good.</p>
<p>Now a new paper on bmj.com reports the results of 25 years of follow up of women who have taken part in a breast cancer screening trial in Canada, and suggests that annual screening does not cut breast cancer deaths.</p>
<p>Anthony Miller, Professor Emeritus at the Dalla Lana School of Public Health, University of Toronto, lead author on the paper, and director of the trial, joins us to discuss the results.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Controversy rages over the relative benefits or harms of screening for breast cancer, with evidence suggesting that in younger women at least it does more harm than good.</p>
<p>Now a new paper on bmj.com reports the results of 25 years of follow up of women who have taken part in a breast cancer screening trial in Canada, and suggests that annual screening does not cut breast cancer deaths.</p>
<p>Anthony Miller, Professor Emeritus at the Dalla Lana School of Public Health, University of Toronto, lead author on the paper, and director of the trial, joins us to discuss the results.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qz70pk/stream_133552989-bmjgroup-twenty-five-year-follow-up-of.mp3" length="24030638" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Controversy rages over the relative benefits or harms of screening for breast cancer, with evidence suggesting that in younger women at least it does more harm than good.Now a new paper on bmj.com reports the results of 25 years of follow up of women who have taken part in a breast cancer screening trial in Canada, and suggests that annual screening does not cut breast cancer deaths.Anthony Miller, Professor Emeritus at the Dalla Lana School of Public Health, University of Toronto, lead author on the paper, and director of the trial, joins us to discuss the results.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1002</itunes:duration>
                                    </item>
    <item>
        <title>Veggie drugs</title>
        <itunes:title>Veggie drugs</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/veggie-drugs/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/veggie-drugs/#comments</comments>        <pubDate>Wed, 05 Feb 2014 11:44:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/veggie-drugs</guid>
                                    <description><![CDATA[<p>Read the full article online: http://www.bmj.com/content/348/bmj.g401 </p>
<p>When you prescribe a drug, do you ever stop to wonder if it's suitable for vegetarians? Kinesh Patel and Kate Tatham from Imperial College London have found that 74 of the 100 drugs most commonly prescribed by GPs in the UK contain ingredients which may have been derived from animals. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Read the full article online: http://www.bmj.com/content/348/bmj.g401 </p>
<p>When you prescribe a drug, do you ever stop to wonder if it's suitable for vegetarians? Kinesh Patel and Kate Tatham from Imperial College London have found that 74 of the 100 drugs most commonly prescribed by GPs in the UK contain ingredients which may have been derived from animals. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/v6vq3z/stream_133175267-bmjgroup-veggie-drugs.mp3" length="17713454" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Read the full article online: http://www.bmj.com/content/348/bmj.g401 When you prescribe a drug, do you ever stop to wonder if it's suitable for vegetarians? Kinesh Patel and Kate Tatham from Imperial College London have found that 74 of the 100 drugs most commonly prescribed by GPs in the UK contain ingredients which may have been derived from animals. ]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>739</itunes:duration>
                                    </item>
    <item>
        <title>BMJ podcast: Treating erectile dysfunction</title>
        <itunes:title>BMJ podcast: Treating erectile dysfunction</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/bmj-podcast-treating-erectile-dysfunction/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/bmj-podcast-treating-erectile-dysfunction/#comments</comments>        <pubDate>Mon, 27 Jan 2014 16:52:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/treating-erectile-dysfunction</guid>
                                    <description><![CDATA[<p>Read the full article: http://www.bmj.com/content/348/bmj.g129</p>
<p>Erectile dysfunction is a common problem, and novel treatments mean that patient’s options have widened. In this podcast Asif Muneer, consultant urological surgeon and andrologist at University College Hospital in London, explains the aetiology, treatment, and prognosis for the condition.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Read the full article: http://www.bmj.com/content/348/bmj.g129</p>
<p>Erectile dysfunction is a common problem, and novel treatments mean that patient’s options have widened. In this podcast Asif Muneer, consultant urological surgeon and andrologist at University College Hospital in London, explains the aetiology, treatment, and prognosis for the condition.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/tlzsyj/stream_131658473-bmjgroup-treating-erectile-dysfunction.mp3" length="25055601" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Read the full article: http://www.bmj.com/content/348/bmj.g129Erectile dysfunction is a common problem, and novel treatments mean that patient’s options have widened. In this podcast Asif Muneer, consultant urological surgeon and andrologist at University College Hospital in London, explains the aetiology, treatment, and prognosis for the condition.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1045</itunes:duration>
                                    </item>
    <item>
        <title>BMJ podcast - high risk devices for rare conditions</title>
        <itunes:title>BMJ podcast - high risk devices for rare conditions</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/bmj-podcast-high-risk-devices-for-rare-conditions/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/bmj-podcast-high-risk-devices-for-rare-conditions/#comments</comments>        <pubDate>Fri, 24 Jan 2014 17:40:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/bmj-podcast-high-risk-devices</guid>
                                    <description><![CDATA[Two articles on bmj.com look at high risk devices for rare conditions, and how the US Food and Drug Administration regulates them.

Joining us to discuss the problems are Rita Redberg, professor of medicine at the University of California San Francisco, and Aaron Kesselheim, assistant professor of medicine at the Harvard School of Public health.

Read the articles
Presumed safe no more: lessons from the Wingspan saga on regulation of devices
http://www.bmj.com/content/348/bmj.g93

<p>Assessment of US pathway for approving medical devices for rare conditions http://www.bmj.com/content/348/bmj.g217</p>
]]></description>
                                                            <content:encoded><![CDATA[Two articles on bmj.com look at high risk devices for rare conditions, and how the US Food and Drug Administration regulates them.

Joining us to discuss the problems are Rita Redberg, professor of medicine at the University of California San Francisco, and Aaron Kesselheim, assistant professor of medicine at the Harvard School of Public health.

Read the articles
Presumed safe no more: lessons from the Wingspan saga on regulation of devices
http://www.bmj.com/content/348/bmj.g93

<p>Assessment of US pathway for approving medical devices for rare conditions http://www.bmj.com/content/348/bmj.g217</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9oz5xu/stream_131175804-bmjgroup-bmj-podcast-high-risk-devices.mp3" length="19911309" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Two articles on bmj.com look at high risk devices for rare conditions, and how the US Food and Drug Administration regulates them.

Joining us to discuss the problems are Rita Redberg, professor of medicine at the University of California San Francisco, and Aaron Kesselheim, assistant professor of medicine at the Harvard School of Public health.

Read the articles
Presumed safe no more: lessons from the Wingspan saga on regulation of devices
http://www.bmj.com/content/348/bmj.g93

Assessment of US pathway for approving medical devices for rare conditions http://www.bmj.com/content/348/bmj.g217]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>830</itunes:duration>
                                    </item>
    <item>
        <title>Why don’t WHO guidelines on fluid resuscitation in children include the FEAST trial results?</title>
        <itunes:title>Why don’t WHO guidelines on fluid resuscitation in children include the FEAST trial results?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/why-don-t-who-guidelines-on-fluid-resuscitation-in-children-include-the-feast-trial-results/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/why-don-t-who-guidelines-on-fluid-resuscitation-in-children-include-the-feast-trial-results/#comments</comments>        <pubDate>Fri, 17 Jan 2014 16:55:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/why-dont-who-guidelines-on</guid>
                                    <description><![CDATA[<p>Read the article: http://www.bmj.com/content/348/bmj.f7003</p>
<p>The 2013 World Health Organization guidelines continue to recommend rapid fluid resuscitation for children with shock, despite evidence from the FEAST trial that this can increase mortality.</p>
<p>Katheryn Maitland, professor of tropical paediatric infectious disease at Imperial College London, who led the FEAST trial, joins us to discuss it.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Read the article: http://www.bmj.com/content/348/bmj.f7003</p>
<p>The 2013 World Health Organization guidelines continue to recommend rapid fluid resuscitation for children with shock, despite evidence from the FEAST trial that this can increase mortality.</p>
<p>Katheryn Maitland, professor of tropical paediatric infectious disease at Imperial College London, who led the FEAST trial, joins us to discuss it.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xg7tim/stream_129994926-bmjgroup-why-dont-who-guidelines-on.mp3" length="21346676" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Read the article: http://www.bmj.com/content/348/bmj.f7003The 2013 World Health Organization guidelines continue to recommend rapid fluid resuscitation for children with shock, despite evidence from the FEAST trial that this can increase mortality.Katheryn Maitland, professor of tropical paediatric infectious disease at Imperial College London, who led the FEAST trial, joins us to discuss it.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>890</itunes:duration>
                                    </item>
    <item>
        <title>Should journals stop publishing research funded by the drug industry?</title>
        <itunes:title>Should journals stop publishing research funded by the drug industry?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/should-journals-stop-publishing-research-funded-by-the-drug-industry/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/should-journals-stop-publishing-research-funded-by-the-drug-industry/#comments</comments>        <pubDate>Wed, 15 Jan 2014 10:42:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/publishing-drug-funded-research</guid>
                                    <description><![CDATA[<p>Read the head to head:</p>
<p>http://www.bmj.com/content/348/bmj.g171</p>
<p>The BMJ no longer publishes research funded by tobacco companies. Richard Smith says that research funded by drug companies is also flawed and published to encourage sales, but Trish Groves says that the industries are fundamentally different and that moves are afoot to increase integrity</p>
<p>Join the authors live on Twitter to debate the issue on 21 January, 1200-1230 GMT at #pharmaban.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Read the head to head:</p>
<p>http://www.bmj.com/content/348/bmj.g171</p>
<p>The BMJ no longer publishes research funded by tobacco companies. Richard Smith says that research funded by drug companies is also flawed and published to encourage sales, but Trish Groves says that the industries are fundamentally different and that moves are afoot to increase integrity</p>
<p>Join the authors live on Twitter to debate the issue on 21 January, 1200-1230 GMT at #pharmaban.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ksztne/stream_129619574-bmjgroup-publishing-drug-funded-research.mp3" length="23267477" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Read the head to head:http://www.bmj.com/content/348/bmj.g171The BMJ no longer publishes research funded by tobacco companies. Richard Smith says that research funded by drug companies is also flawed and published to encourage sales, but Trish Groves says that the industries are fundamentally different and that moves are afoot to increase integrityJoin the authors live on Twitter to debate the issue on 21 January, 1200-1230 GMT at #pharmaban.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>970</itunes:duration>
                                    </item>
    <item>
        <title>Solving the case, making the diagnosis: Neurology and detective writing</title>
        <itunes:title>Solving the case, making the diagnosis: Neurology and detective writing</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/solving-the-case-making-the-diagnosis-neurology-and-detective-writing/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/solving-the-case-making-the-diagnosis-neurology-and-detective-writing/#comments</comments>        <pubDate>Fri, 03 Jan 2014 16:13:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/solving-the-case-making-the-1</guid>
                                    <description><![CDATA[<p>When searching for clues to reach a diagnosis, neurologists often empathise with the detective who is trying to solve a case, write Peter Kempster and Andrew Lees in BMJ sister journal Practical Neurology bit.ly/1dqReQq.</p>
<p>In this podcast, journal editor Phil Smith and Andrew Lees, director of the Queen Square Brain Bank in London, discuss how neurologists draw upon detective skills. They also talk about neurologists who have turned these skills to crime fiction writing, and the use of narrative in clinical case histories.</p>
<p>The expert witnesses called upon are:</p>
<p>- Oliver Sacks, best selling author and professor of neurology at NYU School of Medicine</p>
<p>- Peter Gautier Smith, now retired from consulting at Queen Square and author of 31 detective novels</p>
<p>- Chris Goetz, who worked at Rush University Medical Centre with Harold Klawans, crime fiction writer and authority on Parkinson’s disease</p>
<p>Listen to the full interviews here:</p>
<p>Andrew Lees bit.ly/1cPaoxM</p>
<p>Peter Gautier-Smith bit.ly/1d5HhKj</p>
<p>Harold Klawans bit.ly/19cXR</p>
<p>Oliver Sacks bit.ly/1hBsbgz</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>When searching for clues to reach a diagnosis, neurologists often empathise with the detective who is trying to solve a case, write Peter Kempster and Andrew Lees in BMJ sister journal Practical Neurology bit.ly/1dqReQq.</p>
<p>In this podcast, journal editor Phil Smith and Andrew Lees, director of the Queen Square Brain Bank in London, discuss how neurologists draw upon detective skills. They also talk about neurologists who have turned these skills to crime fiction writing, and the use of narrative in clinical case histories.</p>
<p>The expert witnesses called upon are:</p>
<p>- Oliver Sacks, best selling author and professor of neurology at NYU School of Medicine</p>
<p>- Peter Gautier Smith, now retired from consulting at Queen Square and author of 31 detective novels</p>
<p>- Chris Goetz, who worked at Rush University Medical Centre with Harold Klawans, crime fiction writer and authority on Parkinson’s disease</p>
<p>Listen to the full interviews here:</p>
<p>Andrew Lees bit.ly/1cPaoxM</p>
<p>Peter Gautier-Smith bit.ly/1d5HhKj</p>
<p>Harold Klawans bit.ly/19cXR</p>
<p>Oliver Sacks bit.ly/1hBsbgz</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jqbzhx/stream_127704337-bmjgroup-solving-the-case-making-the-1.mp3" length="14189914" type="audio/mpeg"/>
        <itunes:summary><![CDATA[When searching for clues to reach a diagnosis, neurologists often empathise with the detective who is trying to solve a case, write Peter Kempster and Andrew Lees in BMJ sister journal Practical Neurology bit.ly/1dqReQq.In this podcast, journal editor Phil Smith and Andrew Lees, director of the Queen Square Brain Bank in London, discuss how neurologists draw upon detective skills. They also talk about neurologists who have turned these skills to crime fiction writing, and the use of narrative in clinical case histories.The expert witnesses called upon are:- Oliver Sacks, best selling author and professor of neurology at NYU School of Medicine- Peter Gautier Smith, now retired from consulting at Queen Square and author of 31 detective novels- Chris Goetz, who worked at Rush University Medical Centre with Harold Klawans, crime fiction writer and authority on Parkinson’s diseaseListen to the full interviews here:Andrew Lees bit.ly/1cPaoxMPeter Gautier-Smith bit.ly/1d5HhKjHarold Klawans bit.ly/19cXROliver Sacks bit.ly/1hBsbgz]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1176</itunes:duration>
                                    </item>
    <item>
        <title>Virgin births, poor house hospital and right or happy</title>
        <itunes:title>Virgin births, poor house hospital and right or happy</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/virgin-births-poor-house-hospital-and-right-or-happy/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/virgin-births-poor-house-hospital-and-right-or-happy/#comments</comments>        <pubDate>Fri, 20 Dec 2013 16:27:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/virgin-births-poor-house</guid>
                                    <description><![CDATA[<p>It is generally agreed that sex is useful when getting pregnant, but is it necessary? Professors Amy Herring, and Carolyn Halpern from the University of North Carolina explain how they found virgin births in the US for their Christmas BMJ paper.</p>
<p>Also Gareth Jones, emeritus professor of anaesthesia at Cambridge University, recalls his early life in the City Lodge Hospital – formerly Cardiff Union Workhouse</p>
<p>Finally, does being right always make you happy? Bruce Aroll, professor of primary care at the University of Auckland wanted to know, and so designed a pilot study.</p>
<p>See also:</p>
<p>Like a virgin (mother): analysis of data from a longitudinal, US population representative sample survey (http://www.bmj.com/content/347/bmj.f7102)</p>
<p>Being right or being happy: pilot study (http://www.bmj.com/content/347/bmj.f7398)</p>
<p>Growing up over the shop (http://www.bmj.com/content/347/bmj.f6922)</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>It is generally agreed that sex is useful when getting pregnant, but is it necessary? Professors Amy Herring, and Carolyn Halpern from the University of North Carolina explain how they found virgin births in the US for their Christmas BMJ paper.</p>
<p>Also Gareth Jones, emeritus professor of anaesthesia at Cambridge University, recalls his early life in the City Lodge Hospital – formerly Cardiff Union Workhouse</p>
<p>Finally, does being right always make you happy? Bruce Aroll, professor of primary care at the University of Auckland wanted to know, and so designed a pilot study.</p>
<p>See also:</p>
<p>Like a virgin (mother): analysis of data from a longitudinal, US population representative sample survey (http://www.bmj.com/content/347/bmj.f7102)</p>
<p>Being right or being happy: pilot study (http://www.bmj.com/content/347/bmj.f7398)</p>
<p>Growing up over the shop (http://www.bmj.com/content/347/bmj.f6922)</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/me7dav/stream_125751535-bmjgroup-virgin-births-poor-house.mp3" length="27579871" type="audio/mpeg"/>
        <itunes:summary><![CDATA[It is generally agreed that sex is useful when getting pregnant, but is it necessary? Professors Amy Herring, and Carolyn Halpern from the University of North Carolina explain how they found virgin births in the US for their Christmas BMJ paper.Also Gareth Jones, emeritus professor of anaesthesia at Cambridge University, recalls his early life in the City Lodge Hospital – formerly Cardiff Union WorkhouseFinally, does being right always make you happy? Bruce Aroll, professor of primary care at the University of Auckland wanted to know, and so designed a pilot study.See also:Like a virgin (mother): analysis of data from a longitudinal, US population representative sample survey (http://www.bmj.com/content/347/bmj.f7102)Being right or being happy: pilot study (http://www.bmj.com/content/347/bmj.f7398)Growing up over the shop (http://www.bmj.com/content/347/bmj.f6922)]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1724</itunes:duration>
                                    </item>
    <item>
        <title>James Bond’s drinking and caring for undocumented migrants</title>
        <itunes:title>James Bond’s drinking and caring for undocumented migrants</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/james-bond-s-drinking-and-caring-for-undocumented-migrants/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/james-bond-s-drinking-and-caring-for-undocumented-migrants/#comments</comments>        <pubDate>Fri, 13 Dec 2013 17:10:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/james-bonds-drinking-and-other</guid>
                                    <description><![CDATA[<p>James Bond, legendary secret agent, marksman, womaniser, smoker, but perhaps most famously, drinker. Neil Guha and Patrick Davies from Nottingham University Hospitals NHS Trust, and Graham Johnson from the Royal Derby Hospital, have documented Commander Bond's drinking in a Christmas BMJ paper, and join us to discuss its findings.</p>
<p>Also this week, Doctors of the World, The BMJ's Christmas charity, has a role beyond emergency response to humanitarian crises, helping undocumented migrants in the UK access healthcare. Richard Hurley visits its clinic in the east end of London to find out out more. </p>
<p>See also</p>
<p>Were James Bond’s drinks shaken because of alcohol induced tremor?</p>
<p>http://www.bmj.com/content/347/bmj.f7255</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>James Bond, legendary secret agent, marksman, womaniser, smoker, but perhaps most famously, drinker. Neil Guha and Patrick Davies from Nottingham University Hospitals NHS Trust, and Graham Johnson from the Royal Derby Hospital, have documented Commander Bond's drinking in a Christmas BMJ paper, and join us to discuss its findings.</p>
<p>Also this week, Doctors of the World, The BMJ's Christmas charity, has a role beyond emergency response to humanitarian crises, helping undocumented migrants in the UK access healthcare. Richard Hurley visits its clinic in the east end of London to find out out more. </p>
<p>See also</p>
<p>Were James Bond’s drinks shaken because of alcohol induced tremor?</p>
<p>http://www.bmj.com/content/347/bmj.f7255</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wgz4e3/stream_124677449-bmjgroup-james-bonds-drinking-and-other.mp3" length="28263723" type="audio/mpeg"/>
        <itunes:summary><![CDATA[James Bond, legendary secret agent, marksman, womaniser, smoker, but perhaps most famously, drinker. Neil Guha and Patrick Davies from Nottingham University Hospitals NHS Trust, and Graham Johnson from the Royal Derby Hospital, have documented Commander Bond's drinking in a Christmas BMJ paper, and join us to discuss its findings.Also this week, Doctors of the World, The BMJ's Christmas charity, has a role beyond emergency response to humanitarian crises, helping undocumented migrants in the UK access healthcare. Richard Hurley visits its clinic in the east end of London to find out out more. See alsoWere James Bond’s drinks shaken because of alcohol induced tremor?http://www.bmj.com/content/347/bmj.f7255]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1178</itunes:duration>
                                    </item>
    <item>
        <title>Christmas charity appeal and treating polymyalgia rheumatica</title>
        <itunes:title>Christmas charity appeal and treating polymyalgia rheumatica</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/christmas-charity-appeal-and-treating-polymyalgia-rheumatica/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/christmas-charity-appeal-and-treating-polymyalgia-rheumatica/#comments</comments>        <pubDate>Fri, 06 Dec 2013 17:14:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/christmas-charity-appeal-and</guid>
                                    <description><![CDATA[<p>This year The BMJ has chosen Doctors of the World as it's Christmas appeal. This week we hear about the charity's international work.  Deputy magazine editor Richard Hurley talks to some of the doctors who are working in Syria and the camps surrounding the stricken country.</p>
<p> </p>
<p>Also this week, a clinical review on BMJ.com looks at polymyalgia rheumatica. Clinical reviews editor Sophie Cook asks Sarah Mackie, from the Leeds Institute of Rheumatic and Musculoskeletal Medicine, how she explains this difficult condition to patients.</p>
<p>After the typhoon: how volunteer doctors are bringing medical care to those most in need</p>
<p>http://www.bmj.com/content/347/bmj.f7193</p>
<p>Polymyalgia rheumatica</p>
<p>http://www.bmj.com/content/347/bmj.f6937</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This year The BMJ has chosen Doctors of the World as it's Christmas appeal. This week we hear about the charity's international work.  Deputy magazine editor Richard Hurley talks to some of the doctors who are working in Syria and the camps surrounding the stricken country.</p>
<p> </p>
<p>Also this week, a clinical review on BMJ.com looks at polymyalgia rheumatica. Clinical reviews editor Sophie Cook asks Sarah Mackie, from the Leeds Institute of Rheumatic and Musculoskeletal Medicine, how she explains this difficult condition to patients.</p>
<p>After the typhoon: how volunteer doctors are bringing medical care to those most in need</p>
<p>http://www.bmj.com/content/347/bmj.f7193</p>
<p>Polymyalgia rheumatica</p>
<p>http://www.bmj.com/content/347/bmj.f6937</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dtkw35/stream_123547430-bmjgroup-christmas-charity-appeal-and.mp3" length="32754559" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This year The BMJ has chosen Doctors of the World as it's Christmas appeal. This week we hear about the charity's international work.  Deputy magazine editor Richard Hurley talks to some of the doctors who are working in Syria and the camps surrounding the stricken country. Also this week, a clinical review on BMJ.com looks at polymyalgia rheumatica. Clinical reviews editor Sophie Cook asks Sarah Mackie, from the Leeds Institute of Rheumatic and Musculoskeletal Medicine, how she explains this difficult condition to patients.After the typhoon: how volunteer doctors are bringing medical care to those most in needhttp://www.bmj.com/content/347/bmj.f7193Polymyalgia rheumaticahttp://www.bmj.com/content/347/bmj.f6937]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1364</itunes:duration>
                                    </item>
    <item>
        <title>Patient centred research and doctors burnout</title>
        <itunes:title>Patient centred research and doctors burnout</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/patient-centred-research-and-doctors-burnout/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/patient-centred-research-and-doctors-burnout/#comments</comments>        <pubDate>Fri, 29 Nov 2013 17:30:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/patient-centred-research-and</guid>
                                    <description><![CDATA[<p>Professor Sir John Oldham, from the Institute of Global Health Innovation at Imperial College London, talks about reforming reform, and why he worries that research agendas are more influenced by career aspirations than patient care.</p>
<p> Tom Kenny, director of external relations at the Evaluation, Trials, and Studies Coordinating Centre at the National Institute for Health Research, explains how the NIHR is trying to put patients at the centre of the research it funds.</p>
<p>Finally doctors' health - Michael Peters from the BMA's Doctors for Doctors Unit, explains why life's everyday struggles are hard for doctors to cope with.</p>
<p>See also:</p>
<p>Reform reform: an essay by John Oldham </p>
<p>http://www.bmj.com/content/347/bmj.f6716</p>
<p>Doctors’ health: taking the lifecycle approach</p>
<p>http://www.bmj.com/content/347/bmj.f7086</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Professor Sir John Oldham, from the Institute of Global Health Innovation at Imperial College London, talks about reforming reform, and why he worries that research agendas are more influenced by career aspirations than patient care.</p>
<p> Tom Kenny, director of external relations at the Evaluation, Trials, and Studies Coordinating Centre at the National Institute for Health Research, explains how the NIHR is trying to put patients at the centre of the research it funds.</p>
<p>Finally doctors' health - Michael Peters from the BMA's Doctors for Doctors Unit, explains why life's everyday struggles are hard for doctors to cope with.</p>
<p>See also:</p>
<p>Reform reform: an essay by John Oldham </p>
<p>http://www.bmj.com/content/347/bmj.f6716</p>
<p>Doctors’ health: taking the lifecycle approach</p>
<p>http://www.bmj.com/content/347/bmj.f7086</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wedc3g/stream_122468188-bmjgroup-patient-centred-research-and.mp3" length="40169029" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Professor Sir John Oldham, from the Institute of Global Health Innovation at Imperial College London, talks about reforming reform, and why he worries that research agendas are more influenced by career aspirations than patient care. Tom Kenny, director of external relations at the Evaluation, Trials, and Studies Coordinating Centre at the National Institute for Health Research, explains how the NIHR is trying to put patients at the centre of the research it funds.Finally doctors' health - Michael Peters from the BMA's Doctors for Doctors Unit, explains why life's everyday struggles are hard for doctors to cope with.See also:Reform reform: an essay by John Oldham http://www.bmj.com/content/347/bmj.f6716Doctors’ health: taking the lifecycle approachhttp://www.bmj.com/content/347/bmj.f7086]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1675</itunes:duration>
                                    </item>
    <item>
        <title>Aneurysmal subarachnoid haermorrhage</title>
        <itunes:title>Aneurysmal subarachnoid haermorrhage</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/aneurysmal-subarachnoid-haermorrhage/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/aneurysmal-subarachnoid-haermorrhage/#comments</comments>        <pubDate>Fri, 22 Nov 2013 17:21:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/aneurysmal-sah</guid>
                                    <description><![CDATA[<p>The latest NCEPOD (National Confidential Enquiry into Patient Outcome and Death) report examines the management of aneurysmal subarachnoid haemorrhage, in England's National Health Service.</p>
<p>Two of the report's clinical co-ordinators, Mike Gough, a vascular surgeon at Leeds General Hospital, and Alex Goodwin, anaesthetist at the Royal United Hospital in Bath, join us to discuss the reports findings and recommendations.</p>
<p>Read the full report: http://www.ncepod.org.uk/sah.htm</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The latest NCEPOD (National Confidential Enquiry into Patient Outcome and Death) report examines the management of aneurysmal subarachnoid haemorrhage, in England's National Health Service.</p>
<p>Two of the report's clinical co-ordinators, Mike Gough, a vascular surgeon at Leeds General Hospital, and Alex Goodwin, anaesthetist at the Royal United Hospital in Bath, join us to discuss the reports findings and recommendations.</p>
<p>Read the full report: http://www.ncepod.org.uk/sah.htm</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fjm2tb/stream_121388472-bmjgroup-aneurysmal-sah.mp3" length="27910446" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The latest NCEPOD (National Confidential Enquiry into Patient Outcome and Death) report examines the management of aneurysmal subarachnoid haemorrhage, in England's National Health Service.Two of the report's clinical co-ordinators, Mike Gough, a vascular surgeon at Leeds General Hospital, and Alex Goodwin, anaesthetist at the Royal United Hospital in Bath, join us to discuss the reports findings and recommendations.Read the full report: http://www.ncepod.org.uk/sah.htm]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1164</itunes:duration>
                                    </item>
    <item>
        <title>Population ageing, the timebomb that isn’t</title>
        <itunes:title>Population ageing, the timebomb that isn’t</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/population-ageing-the-timebomb-that-isn-t/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/population-ageing-the-timebomb-that-isn-t/#comments</comments>        <pubDate>Fri, 15 Nov 2013 17:04:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/population-ageing-the-timebomb</guid>
                                    <description><![CDATA[The population timebomb: The idea that an ageing population is making it harder and harder to fund pensions, social care, and healthcare, as the number of older people grows in proportion to the working population. Jeroen Spijker, senior research fellow at the School of Social and Political Science in the University of Edinburgh, explains why he thinks the risk has been overblown.


Also, Michael Kidd, current president of WONCA – the world organisation of family doctors - talks about the pressures on primary care, and how he would like to attract the best medical talent to the specialty.


<p>http://www.bmj.com/content/347/bmj.f6598</p>
]]></description>
                                                            <content:encoded><![CDATA[The population timebomb: The idea that an ageing population is making it harder and harder to fund pensions, social care, and healthcare, as the number of older people grows in proportion to the working population. Jeroen Spijker, senior research fellow at the School of Social and Political Science in the University of Edinburgh, explains why he thinks the risk has been overblown.


Also, Michael Kidd, current president of WONCA – the world organisation of family doctors - talks about the pressures on primary care, and how he would like to attract the best medical talent to the specialty.


<p>http://www.bmj.com/content/347/bmj.f6598</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mysidr/stream_120287898-bmjgroup-population-ageing-the-timebomb.mp3" length="30302393" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The population timebomb: The idea that an ageing population is making it harder and harder to fund pensions, social care, and healthcare, as the number of older people grows in proportion to the working population. Jeroen Spijker, senior research fellow at the School of Social and Political Science in the University of Edinburgh, explains why he thinks the risk has been overblown.


Also, Michael Kidd, current president of WONCA – the world organisation of family doctors - talks about the pressures on primary care, and how he would like to attract the best medical talent to the specialty.


http://www.bmj.com/content/347/bmj.f6598]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1264</itunes:duration>
                                    </item>
    <item>
        <title>A sugary drinks tax, liver tests in pregnancy</title>
        <itunes:title>A sugary drinks tax, liver tests in pregnancy</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/a-sugary-drinks-tax-liver-tests-in-pregnancy/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/a-sugary-drinks-tax-liver-tests-in-pregnancy/#comments</comments>        <pubDate>Fri, 08 Nov 2013 16:50:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/a-sugary-drinks-tax-liver</guid>
                                    <description><![CDATA[<p>A modelling study on bmj.com suggests that a 20% tax on sugar sweetened drinks would reduce the number of obese adults in the UK by 1.3%, and by 0.9 for those who are overweight. The health gains are fairly similar across all income groups. Oliver Mytton, one of the study's authors, describes why a 20% figure was chosen and how the modelling was done. </p>
<p>Also, liver function tests follow a different normal range during pregnancy. Catherine Williamson, professor of women’s health at King's College London, explains why.</p>
<p>Read the articles:</p>
<p>Overall and income specific effect on prevalence of overweight and obesity of 20% sugar sweetened drink tax in UK - http://www.bmj.com/content/347/bmj.f6189</p>
<p>Abnormal liver function tests in pregnancy - http://www.bmj.com/content/347/bmj.f6055</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>A modelling study on bmj.com suggests that a 20% tax on sugar sweetened drinks would reduce the number of obese adults in the UK by 1.3%, and by 0.9 for those who are overweight. The health gains are fairly similar across all income groups. Oliver Mytton, one of the study's authors, describes why a 20% figure was chosen and how the modelling was done. </p>
<p>Also, liver function tests follow a different normal range during pregnancy. Catherine Williamson, professor of women’s health at King's College London, explains why.</p>
<p>Read the articles:</p>
<p>Overall and income specific effect on prevalence of overweight and obesity of 20% sugar sweetened drink tax in UK - http://www.bmj.com/content/347/bmj.f6189</p>
<p>Abnormal liver function tests in pregnancy - http://www.bmj.com/content/347/bmj.f6055</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ebt7nu/stream_119179694-bmjgroup-a-sugary-drinks-tax-liver.mp3" length="40669870" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A modelling study on bmj.com suggests that a 20% tax on sugar sweetened drinks would reduce the number of obese adults in the UK by 1.3%, and by 0.9 for those who are overweight. The health gains are fairly similar across all income groups. Oliver Mytton, one of the study's authors, describes why a 20% figure was chosen and how the modelling was done. Also, liver function tests follow a different normal range during pregnancy. Catherine Williamson, professor of women’s health at King's College London, explains why.Read the articles:Overall and income specific effect on prevalence of overweight and obesity of 20% sugar sweetened drink tax in UK - http://www.bmj.com/content/347/bmj.f6189Abnormal liver function tests in pregnancy - http://www.bmj.com/content/347/bmj.f6055]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1697</itunes:duration>
                                    </item>
    <item>
        <title>Heath in Europe, When to order ANA tests</title>
        <itunes:title>Heath in Europe, When to order ANA tests</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/heath-in-europe-when-to-order-ana-tests/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/heath-in-europe-when-to-order-ana-tests/#comments</comments>        <pubDate>Fri, 01 Nov 2013 12:39:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/heath-in-europe-ana-test</guid>
                                    <description><![CDATA[<p>Professor Michael Marmot has spearheaded WHO Europe’s Health 2020 report, which looks at the disparity in the social determinants of health across the region. He joins us to explain why he’s hopeful for change.</p>
<p>Also, Spencer Ellis, consultant rheumatologist at Lister Hospital in Stevenage, explains when and why to order antinuclear antibody (ANA) tests.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Professor Michael Marmot has spearheaded WHO Europe’s Health 2020 report, which looks at the disparity in the social determinants of health across the region. He joins us to explain why he’s hopeful for change.</p>
<p>Also, Spencer Ellis, consultant rheumatologist at Lister Hospital in Stevenage, explains when and why to order antinuclear antibody (ANA) tests.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/uqxq9l/stream_118083848-bmjgroup-heath-in-europe-ana-test.mp3" length="40213450" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Professor Michael Marmot has spearheaded WHO Europe’s Health 2020 report, which looks at the disparity in the social determinants of health across the region. He joins us to explain why he’s hopeful for change.Also, Spencer Ellis, consultant rheumatologist at Lister Hospital in Stevenage, explains when and why to order antinuclear antibody (ANA) tests.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1677</itunes:duration>
                                    </item>
    <item>
        <title>Statins: benefits and harms for low risk patients</title>
        <itunes:title>Statins: benefits and harms for low risk patients</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/statins-benefits-and-harms-for-low-risk-patients/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/statins-benefits-and-harms-for-low-risk-patients/#comments</comments>        <pubDate>Fri, 25 Oct 2013 16:09:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/statins-benefits-and-harms-for</guid>
                                    <description><![CDATA[<p>NB: In our interview about statins, Abramson quotes the figure of an 18% relative increase in risk of adverse effects of statins. This figure should be couched in uncertainty, and a correction has been posted on bmj.com to reflect that - http://www.bmj.com/content/348/bmj.g3329</p>
<p>--------------------------------------------------------------------</p>
<p>It may soon be recommended that statins are prescribed to patients with a low risk of cardiovascular disease. John Abramson from the Department of Health Care Policy at Harvard Medical School explains why the risks associated with taking the drug may have been underplayed.</p>
<p>Also this week, interviews with Steve Field, the new chief inspector of hospitals, and Richard Vautry, deputy chairman of the BMA's GP committee, recorded at the National Association of Primary Care's annual Best Practice conference.</p>
<p>See also:</p>
<p>Should people at low risk of cardiovascular disease take a statin?</p>
<p>http://www.bmj.com/content/347/bmj.f6123</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>NB: In our interview about statins, Abramson quotes the figure of an 18% relative increase in risk of adverse effects of statins. This figure should be couched in uncertainty, and a correction has been posted on bmj.com to reflect that - http://www.bmj.com/content/348/bmj.g3329</p>
<p>--------------------------------------------------------------------</p>
<p>It may soon be recommended that statins are prescribed to patients with a low risk of cardiovascular disease. John Abramson from the Department of Health Care Policy at Harvard Medical School explains why the risks associated with taking the drug may have been underplayed.</p>
<p>Also this week, interviews with Steve Field, the new chief inspector of hospitals, and Richard Vautry, deputy chairman of the BMA's GP committee, recorded at the National Association of Primary Care's annual Best Practice conference.</p>
<p>See also:</p>
<p>Should people at low risk of cardiovascular disease take a statin?</p>
<p>http://www.bmj.com/content/347/bmj.f6123</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/js9gqo/stream_117022121-bmjgroup-statins-benefits-and-harms-for.mp3" length="28006708" type="audio/mpeg"/>
        <itunes:summary><![CDATA[NB: In our interview about statins, Abramson quotes the figure of an 18% relative increase in risk of adverse effects of statins. This figure should be couched in uncertainty, and a correction has been posted on bmj.com to reflect that - http://www.bmj.com/content/348/bmj.g3329--------------------------------------------------------------------It may soon be recommended that statins are prescribed to patients with a low risk of cardiovascular disease. John Abramson from the Department of Health Care Policy at Harvard Medical School explains why the risks associated with taking the drug may have been underplayed.Also this week, interviews with Steve Field, the new chief inspector of hospitals, and Richard Vautry, deputy chairman of the BMA's GP committee, recorded at the National Association of Primary Care's annual Best Practice conference.See also:Should people at low risk of cardiovascular disease take a statin?http://www.bmj.com/content/347/bmj.f6123]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1168</itunes:duration>
                                    </item>
    <item>
        <title>Tobacco industry vs science, vCJD in the UK</title>
        <itunes:title>Tobacco industry vs science, vCJD in the UK</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/tobacco-industry-vs-science-vcjd-in-the-uk/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/tobacco-industry-vs-science-vcjd-in-the-uk/#comments</comments>        <pubDate>Fri, 18 Oct 2013 17:06:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/tobacco-industry-vs-science</guid>
                                    <description><![CDATA[The BMJ, BMJ Open, Heart, Thorax, and Tobacco control – all journals in BMJ’s stable, have announced they will no longer carry research funded in part, or in whole, by the tobacco industry. Fiona Godlee, BMJ Editor in chief, explains what that means, and Allen Brandt, professor of the history of science at Harvard University, gives us a potted history of the way in which the tobacco industry has manipulated science.

Also this week, Sebastian Brandner, professor of neuropathology at UCL, explains his research into the population prevalence of the prion which causes vCJD.

See also
Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic
http://www.bmj.com/content/347/bmj.f5675
Journal policy on research funded by the tobacco industry
<p>http://www.bmj.com/content/347/bmj.f5193</p>
]]></description>
                                                            <content:encoded><![CDATA[The BMJ, BMJ Open, Heart, Thorax, and Tobacco control – all journals in BMJ’s stable, have announced they will no longer carry research funded in part, or in whole, by the tobacco industry. Fiona Godlee, BMJ Editor in chief, explains what that means, and Allen Brandt, professor of the history of science at Harvard University, gives us a potted history of the way in which the tobacco industry has manipulated science.

Also this week, Sebastian Brandner, professor of neuropathology at UCL, explains his research into the population prevalence of the prion which causes vCJD.

See also
Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic
http://www.bmj.com/content/347/bmj.f5675
Journal policy on research funded by the tobacco industry
<p>http://www.bmj.com/content/347/bmj.f5193</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/59cfdw/stream_115958986-bmjgroup-tobacco-industry-vs-science.mp3" length="46742139" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The BMJ, BMJ Open, Heart, Thorax, and Tobacco control – all journals in BMJ’s stable, have announced they will no longer carry research funded in part, or in whole, by the tobacco industry. Fiona Godlee, BMJ Editor in chief, explains what that means, and Allen Brandt, professor of the history of science at Harvard University, gives us a potted history of the way in which the tobacco industry has manipulated science.

Also this week, Sebastian Brandner, professor of neuropathology at UCL, explains his research into the population prevalence of the prion which causes vCJD.

See also
Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic
http://www.bmj.com/content/347/bmj.f5675
Journal policy on research funded by the tobacco industry
http://www.bmj.com/content/347/bmj.f5193]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1950</itunes:duration>
                                    </item>
    <item>
        <title>Brain tumours in children, and why all polyps are not equal</title>
        <itunes:title>Brain tumours in children, and why all polyps are not equal</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/brain-tumours-in-children-and-why-all-polyps-are-not-equal/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/brain-tumours-in-children-and-why-all-polyps-are-not-equal/#comments</comments>        <pubDate>Tue, 15 Oct 2013 08:23:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/brain-tumours-in-children-and</guid>
                                    <description><![CDATA[There are many overlapping classifications for bowel polyps. Geir Hoff, professor of gastroenterology at the University of Oslo, explains why he fears screening for one type has lead to overtreatment of another.

Also, Sophie Wilne, consultant paediatric oncologist at Nottingham University Hospitals NHS Trust, discusses the clinical signs of brain tumours in children and young adults, and what treatment should follow.

See also:

Identifying brain tumours in children and young adults
www.bmj.com/content/347/bmj.f5844

New polyps, old tricks: controversy about removing benign bowel lesions
<p>www.bmj.com/content/347/bmj.f5843</p>
]]></description>
                                                            <content:encoded><![CDATA[There are many overlapping classifications for bowel polyps. Geir Hoff, professor of gastroenterology at the University of Oslo, explains why he fears screening for one type has lead to overtreatment of another.

Also, Sophie Wilne, consultant paediatric oncologist at Nottingham University Hospitals NHS Trust, discusses the clinical signs of brain tumours in children and young adults, and what treatment should follow.

See also:

Identifying brain tumours in children and young adults
www.bmj.com/content/347/bmj.f5844

New polyps, old tricks: controversy about removing benign bowel lesions
<p>www.bmj.com/content/347/bmj.f5843</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7o5ldt/stream_115424037-bmjgroup-brain-tumours-in-children-and.mp3" length="42755779" type="audio/mpeg"/>
        <itunes:summary><![CDATA[There are many overlapping classifications for bowel polyps. Geir Hoff, professor of gastroenterology at the University of Oslo, explains why he fears screening for one type has lead to overtreatment of another.

Also, Sophie Wilne, consultant paediatric oncologist at Nottingham University Hospitals NHS Trust, discusses the clinical signs of brain tumours in children and young adults, and what treatment should follow.

See also:

Identifying brain tumours in children and young adults
www.bmj.com/content/347/bmj.f5844

New polyps, old tricks: controversy about removing benign bowel lesions
www.bmj.com/content/347/bmj.f5843]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1783</itunes:duration>
                                    </item>
    <item>
        <title>Leaving the RCGP</title>
        <itunes:title>Leaving the RCGP</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/leaving-the-rcgp/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/leaving-the-rcgp/#comments</comments>        <pubDate>Fri, 04 Oct 2013 16:48:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/leaving-the-rcgp</guid>
                                    <description><![CDATA[As Clare Gerada's stint as RCGP chair comes to a close, she gives BMJ news reporter Gareth Iacobucci a typically honest exit interview.

And David Loxterkamp, a primary care physician in Belfast, Maine, tells us why he thinks metrics are obscuring humanism in medical care.

See also:
Clare Gerada: “It’s like the wild west in healthcare” http://goo.gl/SiWZ5y
<p>Humanism in the time of metrics—an essay by David Loxterkamp http://goo.gl/FRD0xC</p>
]]></description>
                                                            <content:encoded><![CDATA[As Clare Gerada's stint as RCGP chair comes to a close, she gives BMJ news reporter Gareth Iacobucci a typically honest exit interview.

And David Loxterkamp, a primary care physician in Belfast, Maine, tells us why he thinks metrics are obscuring humanism in medical care.

See also:
Clare Gerada: “It’s like the wild west in healthcare” http://goo.gl/SiWZ5y
<p>Humanism in the time of metrics—an essay by David Loxterkamp http://goo.gl/FRD0xC</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/f9yw68/stream_113823210-bmjgroup-leaving-the-rcgp.mp3" length="18207118" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As Clare Gerada's stint as RCGP chair comes to a close, she gives BMJ news reporter Gareth Iacobucci a typically honest exit interview.

And David Loxterkamp, a primary care physician in Belfast, Maine, tells us why he thinks metrics are obscuring humanism in medical care.

See also:
Clare Gerada: “It’s like the wild west in healthcare” http://goo.gl/SiWZ5y
Humanism in the time of metrics—an essay by David Loxterkamp http://goo.gl/FRD0xC]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1519</itunes:duration>
                                    </item>
    <item>
        <title>Possible racial bias in the RCGP exam</title>
        <itunes:title>Possible racial bias in the RCGP exam</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/possible-racial-bias-in-the-rcgp-exam/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/possible-racial-bias-in-the-rcgp-exam/#comments</comments>        <pubDate>Mon, 30 Sep 2013 09:55:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/possible-racial-bias-in-the-mrcgp-exams</guid>
                                    <description><![CDATA[<p>A study on bmj.com raises raises concerns over possible “subjective bias owing to racial discrimination” in the MRCGP - the Royal College of General Practitioner''s postgraduate exams required to become a registered GP in the UK. Aneez Esmail, professor of primary care at the University of Manchester and the paper's lead author, explains the background to the study and its findings. Read the accompanying editorial and news story, which includes a response from RCGP chairwoman Claire Gerada.</p>
<p>See also:</p>
<p>Academic performance of ethnic minority candidates and discrimination in the MRCGP examinations between 2010 and 2012: analysis of data</p>
<p>http://www.bmj.com/content/347/bmj.f5662</p>
<p>BMJ author hits out at attempts to dismiss findings of possible racial bias in RCGP exam</p>
<p>http://www.bmj.com/content/347/bmj.f5871</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>A study on bmj.com raises raises concerns over possible “subjective bias owing to racial discrimination” in the MRCGP - the Royal College of General Practitioner''s postgraduate exams required to become a registered GP in the UK. Aneez Esmail, professor of primary care at the University of Manchester and the paper's lead author, explains the background to the study and its findings. Read the accompanying editorial and news story, which includes a response from RCGP chairwoman Claire Gerada.</p>
<p>See also:</p>
<p>Academic performance of ethnic minority candidates and discrimination in the MRCGP examinations between 2010 and 2012: analysis of data</p>
<p>http://www.bmj.com/content/347/bmj.f5662</p>
<p>BMJ author hits out at attempts to dismiss findings of possible racial bias in RCGP exam</p>
<p>http://www.bmj.com/content/347/bmj.f5871</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ubs7xf/stream_113177334-bmjgroup-possible-racial-bias-in-the-mrcgp-exams.mp3" length="43333439" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A study on bmj.com raises raises concerns over possible “subjective bias owing to racial discrimination” in the MRCGP - the Royal College of General Practitioner''s postgraduate exams required to become a registered GP in the UK. Aneez Esmail, professor of primary care at the University of Manchester and the paper's lead author, explains the background to the study and its findings. Read the accompanying editorial and news story, which includes a response from RCGP chairwoman Claire Gerada.See also:Academic performance of ethnic minority candidates and discrimination in the MRCGP examinations between 2010 and 2012: analysis of datahttp://www.bmj.com/content/347/bmj.f5662BMJ author hits out at attempts to dismiss findings of possible racial bias in RCGP examhttp://www.bmj.com/content/347/bmj.f5871]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1806</itunes:duration>
                                    </item>
    <item>
        <title>A new chief inspector of hospitals</title>
        <itunes:title>A new chief inspector of hospitals</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/a-new-chief-inspector-of-hospitals/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/a-new-chief-inspector-of-hospitals/#comments</comments>        <pubDate>Mon, 30 Sep 2013 09:52:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/a-new-chief-inspector-of</guid>
                                    <description><![CDATA[<p>Professor Sir Mike Richards, previously National Cancer Director at the Department of Health, and former head of the Academic Division of Oncology at King's College London, is the new chief inspector of hospitals in England.</p>
<p>In his new role he will have the power to enter hospitals, both in planned and unplanned inspections, to highlight problems before they develop into another scandal of the kind that happened in Mid-Staffordshire. He talks about his new role to Nigel Hawkes.</p>
<p>See also:</p>
<p>“We know where to probe,” says Mike Richards, the new chief inspector of hospitals http://www.bmj.com/content/347/bmj.f5557</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Professor Sir Mike Richards, previously National Cancer Director at the Department of Health, and former head of the Academic Division of Oncology at King's College London, is the new chief inspector of hospitals in England.</p>
<p>In his new role he will have the power to enter hospitals, both in planned and unplanned inspections, to highlight problems before they develop into another scandal of the kind that happened in Mid-Staffordshire. He talks about his new role to Nigel Hawkes.</p>
<p>See also:</p>
<p>“We know where to probe,” says Mike Richards, the new chief inspector of hospitals http://www.bmj.com/content/347/bmj.f5557</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/d11l2j/stream_113177157-bmjgroup-a-new-chief-inspector-of.mp3" length="18725714" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Professor Sir Mike Richards, previously National Cancer Director at the Department of Health, and former head of the Academic Division of Oncology at King's College London, is the new chief inspector of hospitals in England.In his new role he will have the power to enter hospitals, both in planned and unplanned inspections, to highlight problems before they develop into another scandal of the kind that happened in Mid-Staffordshire. He talks about his new role to Nigel Hawkes.See also:“We know where to probe,” says Mike Richards, the new chief inspector of hospitals http://www.bmj.com/content/347/bmj.f5557]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>780</itunes:duration>
                                    </item>
    <item>
        <title>Safety from Syria</title>
        <itunes:title>Safety from Syria</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/safety-from-syria/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/safety-from-syria/#comments</comments>        <pubDate>Mon, 30 Sep 2013 09:47:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/safety-from-syria</guid>
                                    <description><![CDATA[<p>UN Refugee Agency High Commissioner António Guterres described the Syrian crisis this week as the great tragedy of the century, a "disgraceful humanitarian calamity with suffering and displacement unparalleled in recent history." Every 15 seconds a Syrian seeks refuge in neighbouring countries. UNHCR spokesperson Andrej Mahecic describes a typical refugee's journey from the stricken country and how their health needs are addressed when they reach refugee camps and host communities in Jordan, Lebanon, and Turkey.</p>
<p>See also:</p>
<p>http://www.bmj.com/content/347/bmj.f5413</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>UN Refugee Agency High Commissioner António Guterres described the Syrian crisis this week as the great tragedy of the century, a "disgraceful humanitarian calamity with suffering and displacement unparalleled in recent history." Every 15 seconds a Syrian seeks refuge in neighbouring countries. UNHCR spokesperson Andrej Mahecic describes a typical refugee's journey from the stricken country and how their health needs are addressed when they reach refugee camps and host communities in Jordan, Lebanon, and Turkey.</p>
<p>See also:</p>
<p>http://www.bmj.com/content/347/bmj.f5413</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/g7ylru/stream_113176656-bmjgroup-safety-from-syria.mp3" length="1522884" type="audio/mpeg"/>
        <itunes:summary><![CDATA[UN Refugee Agency High Commissioner António Guterres described the Syrian crisis this week as the great tragedy of the century, a "disgraceful humanitarian calamity with suffering and displacement unparalleled in recent history." Every 15 seconds a Syrian seeks refuge in neighbouring countries. UNHCR spokesperson Andrej Mahecic describes a typical refugee's journey from the stricken country and how their health needs are addressed when they reach refugee camps and host communities in Jordan, Lebanon, and Turkey.See also:http://www.bmj.com/content/347/bmj.f5413]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>63</itunes:duration>
                                    </item>
    <item>
        <title>Treating childhood autism, and cardiac imaging for stable chest pain</title>
        <itunes:title>Treating childhood autism, and cardiac imaging for stable chest pain</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/treating-childhood-autism-and-cardiac-imaging-for-stable-chest-pain/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/treating-childhood-autism-and-cardiac-imaging-for-stable-chest-pain/#comments</comments>        <pubDate>Mon, 30 Sep 2013 09:44:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/treating-childhood-autism-and</guid>
                                    <description><![CDATA[<p>NICE has published now guidelines on the treatment of children with autism. Mabel Chew BMJ practice editor talks to Tim Kendall, director of the National Collaborating Centre for Mental Health at the Royal College of Psychiatrists, who helped draw up the guidelines.</p>
<p>Mabel also talks to Declan P O’Regan, consultant radiologist at the MRC Clinical Sciences Centre in London, and an author of our rational imaging article on investigating stable chest pain</p>
<p>See also:</p>
<p>http://www.bmj.com/content/347/bmj.f3940</p>
<p>http://www.bmj.com/content/347/bmj.f4865</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>NICE has published now guidelines on the treatment of children with autism. Mabel Chew BMJ practice editor talks to Tim Kendall, director of the National Collaborating Centre for Mental Health at the Royal College of Psychiatrists, who helped draw up the guidelines.</p>
<p>Mabel also talks to Declan P O’Regan, consultant radiologist at the MRC Clinical Sciences Centre in London, and an author of our rational imaging article on investigating stable chest pain</p>
<p>See also:</p>
<p>http://www.bmj.com/content/347/bmj.f3940</p>
<p>http://www.bmj.com/content/347/bmj.f4865</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5rz989/stream_113176439-bmjgroup-treating-childhood-autism-and.mp3" length="43354733" type="audio/mpeg"/>
        <itunes:summary><![CDATA[NICE has published now guidelines on the treatment of children with autism. Mabel Chew BMJ practice editor talks to Tim Kendall, director of the National Collaborating Centre for Mental Health at the Royal College of Psychiatrists, who helped draw up the guidelines.Mabel also talks to Declan P O’Regan, consultant radiologist at the MRC Clinical Sciences Centre in London, and an author of our rational imaging article on investigating stable chest painSee also:http://www.bmj.com/content/347/bmj.f3940http://www.bmj.com/content/347/bmj.f4865]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1809</itunes:duration>
                                    </item>
    <item>
        <title>HPV testing in preventing cervical cancer</title>
        <itunes:title>HPV testing in preventing cervical cancer</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/hpv-testing-in-preventing-cervical-cancer/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/hpv-testing-in-preventing-cervical-cancer/#comments</comments>        <pubDate>Mon, 30 Sep 2013 09:42:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/hpv-testing-in-preventing</guid>
                                    <description><![CDATA[<p>What do clinicians need to know about the developing role of HPV in cervical cancer prevention? BMJ clinical reviews editor Sophie Cook speaks to Henry Kitchener, professor of gynaecological oncology, and Emma Crosbie, senior lecturer and honorary consultant in gynaecological oncology, both at the University of Manchester.</p>
<p>Read the full clinical review:</p>
<p>http://www.bmj.com/content/347/bmj.f4781</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>What do clinicians need to know about the developing role of HPV in cervical cancer prevention? BMJ clinical reviews editor Sophie Cook speaks to Henry Kitchener, professor of gynaecological oncology, and Emma Crosbie, senior lecturer and honorary consultant in gynaecological oncology, both at the University of Manchester.</p>
<p>Read the full clinical review:</p>
<p>http://www.bmj.com/content/347/bmj.f4781</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/98uo8i/stream_113176322-bmjgroup-hpv-testing-in-preventing.mp3" length="23608361" type="audio/mpeg"/>
        <itunes:summary><![CDATA[What do clinicians need to know about the developing role of HPV in cervical cancer prevention? BMJ clinical reviews editor Sophie Cook speaks to Henry Kitchener, professor of gynaecological oncology, and Emma Crosbie, senior lecturer and honorary consultant in gynaecological oncology, both at the University of Manchester.Read the full clinical review:http://www.bmj.com/content/347/bmj.f4781]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>984</itunes:duration>
                                    </item>
    <item>
        <title>Diagnosing dementia, treating personality disorder</title>
        <itunes:title>Diagnosing dementia, treating personality disorder</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/diagnosing-dementia-treating-personality-disorder/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/diagnosing-dementia-treating-personality-disorder/#comments</comments>        <pubDate>Mon, 16 Sep 2013 09:34:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/diagnosing-dementia-treating</guid>
                                    <description><![CDATA[<p>inda Gask, professor of primary care psychiatry at the University of Manchester, explains why a personality disorder diagnosis is not as hopeless as many patients and doctors fear.</p>
<p>Also Carol Brayne, professor of public health at the University of Cambridge, discusses how to make the most of the UK government’s push to diagnose dementia, even though the evidence is limited.</p>
<p>See also:</p>
<p>http://www.bmj.com/content/347/bmj.f5276</p>
<p>http://www.bmj.com/content/347/bmj.f5125</p>
<p>http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(13)61570-6/fulltext</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>inda Gask, professor of primary care psychiatry at the University of Manchester, explains why a personality disorder diagnosis is not as hopeless as many patients and doctors fear.</p>
<p>Also Carol Brayne, professor of public health at the University of Cambridge, discusses how to make the most of the UK government’s push to diagnose dementia, even though the evidence is limited.</p>
<p>See also:</p>
<p>http://www.bmj.com/content/347/bmj.f5276</p>
<p>http://www.bmj.com/content/347/bmj.f5125</p>
<p>http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(13)61570-6/fulltext</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/uav8i2/stream_110707343-bmjgroup-diagnosing-dementia-treating.mp3" length="13557760" type="audio/mpeg"/>
        <itunes:summary><![CDATA[inda Gask, professor of primary care psychiatry at the University of Manchester, explains why a personality disorder diagnosis is not as hopeless as many patients and doctors fear.Also Carol Brayne, professor of public health at the University of Cambridge, discusses how to make the most of the UK government’s push to diagnose dementia, even though the evidence is limited.See also:http://www.bmj.com/content/347/bmj.f5276http://www.bmj.com/content/347/bmj.f5125http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(13)61570-6/fulltext]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1479</itunes:duration>
                                    </item>
    <item>
        <title>Looking forward</title>
        <itunes:title>Looking forward</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/looking-forward-1680600725/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/looking-forward-1680600725/#comments</comments>        <pubDate>Thu, 29 Aug 2013 11:30:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/looking-forward</guid>
                                    <description><![CDATA[<p>For our first podcast of 2010, we’ll be asking various medical professionals what they’d like to see happen to healthcare in the next decade.</p>
<p>Also, Chris Grundy tells us how effective 20 mph zones really are at preventing accidents.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>For our first podcast of 2010, we’ll be asking various medical professionals what they’d like to see happen to healthcare in the next decade.</p>
<p>Also, Chris Grundy tells us how effective 20 mph zones really are at preventing accidents.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ql388v/stream_107820026-bmjgroup-looking-forward.mp3" length="17074992" type="audio/mpeg"/>
        <itunes:summary><![CDATA[For our first podcast of 2010, we’ll be asking various medical professionals what they’d like to see happen to healthcare in the next decade.Also, Chris Grundy tells us how effective 20 mph zones really are at preventing accidents.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1064</itunes:duration>
                                    </item>
    <item>
        <title>Retrained to eat</title>
        <itunes:title>Retrained to eat</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/retrained-to-eat/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/retrained-to-eat/#comments</comments>        <pubDate>Thu, 29 Aug 2013 11:29:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/retrained-to-eat</guid>
                                    <description><![CDATA[<p>This week, research published on bmj.com shows that overweight and obese teenagers can be taught to eat more sensibly by using a device called a mandometer. Professor Julian Shield, who led the study, talks about the results.</p>
<p>Also this week, the response to one of the articles in the latest Christmas BMJ was enormous. Duncan Jarvies talks to Nathan Grills, the author of the article, about the storm in a sleigh.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week, research published on bmj.com shows that overweight and obese teenagers can be taught to eat more sensibly by using a device called a mandometer. Professor Julian Shield, who led the study, talks about the results.</p>
<p>Also this week, the response to one of the articles in the latest Christmas BMJ was enormous. Duncan Jarvies talks to Nathan Grills, the author of the article, about the storm in a sleigh.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mp9dgl/stream_107819891-bmjgroup-retrained-to-eat.mp3" length="21006480" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week, research published on bmj.com shows that overweight and obese teenagers can be taught to eat more sensibly by using a device called a mandometer. Professor Julian Shield, who led the study, talks about the results.Also this week, the response to one of the articles in the latest Christmas BMJ was enormous. Duncan Jarvies talks to Nathan Grills, the author of the article, about the storm in a sleigh.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1310</itunes:duration>
                                    </item>
    <item>
        <title>Disaster and dementia</title>
        <itunes:title>Disaster and dementia</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/disaster-and-dementia/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/disaster-and-dementia/#comments</comments>        <pubDate>Thu, 29 Aug 2013 11:26:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/disaster-and-dementia</guid>
                                    <description><![CDATA[<p>Haiti this week suffered its worst earthquake in 200 years. Marc Dubois, general director of aid charity MSF UK, talks about how his organisation is responding to the disaster and how doctors can help.</p>
<p>Also, BMJ clinical editor Elizabeth Loder interviews Benjamin Wolozin about the link between cardiovascular disease and dementia.</p>
<p>Krishna Moorthy talks to Helen Morant about what medicine can learn from aviation.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Haiti this week suffered its worst earthquake in 200 years. Marc Dubois, general director of aid charity MSF UK, talks about how his organisation is responding to the disaster and how doctors can help.</p>
<p>Also, BMJ clinical editor Elizabeth Loder interviews Benjamin Wolozin about the link between cardiovascular disease and dementia.</p>
<p>Krishna Moorthy talks to Helen Morant about what medicine can learn from aviation.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/w1q0qs/stream_107819682-bmjgroup-disaster-and-dementia.mp3" length="22151171" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Haiti this week suffered its worst earthquake in 200 years. Marc Dubois, general director of aid charity MSF UK, talks about how his organisation is responding to the disaster and how doctors can help.Also, BMJ clinical editor Elizabeth Loder interviews Benjamin Wolozin about the link between cardiovascular disease and dementia.Krishna Moorthy talks to Helen Morant about what medicine can learn from aviation.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1381</itunes:duration>
                                    </item>
    <item>
        <title>12 steps to public health</title>
        <itunes:title>12 steps to public health</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/12-steps-to-public-health/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/12-steps-to-public-health/#comments</comments>        <pubDate>Thu, 29 Aug 2013 11:24:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/12-steps-to-public-health</guid>
                                    <description><![CDATA[<p>This week the Faculty of Public Health has released its manifesto tor a healthier Britain. Duncan Jarvies speaks to the faculty’s president, Professor Alan Maryon-Davis, about the manifesto’s recommendations.</p>
<p>Also new online this week, we have a clinical review on depression in adolescents. We talk to one of the authors, Professor Anita Thapar, about one aspect of it - prevention - and the promising research that is under way.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week the Faculty of Public Health has released its manifesto tor a healthier Britain. Duncan Jarvies speaks to the faculty’s president, Professor Alan Maryon-Davis, about the manifesto’s recommendations.</p>
<p>Also new online this week, we have a clinical review on depression in adolescents. We talk to one of the authors, Professor Anita Thapar, about one aspect of it - prevention - and the promising research that is under way.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5tc3bd/stream_107819438-bmjgroup-12-steps-to-public-health.mp3" length="20334623" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week the Faculty of Public Health has released its manifesto tor a healthier Britain. Duncan Jarvies speaks to the faculty’s president, Professor Alan Maryon-Davis, about the manifesto’s recommendations.Also new online this week, we have a clinical review on depression in adolescents. We talk to one of the authors, Professor Anita Thapar, about one aspect of it - prevention - and the promising research that is under way.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1268</itunes:duration>
                                    </item>
    <item>
        <title>Clubfoot</title>
        <itunes:title>Clubfoot</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/clubfoot/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/clubfoot/#comments</comments>        <pubDate>Thu, 29 Aug 2013 11:19:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/clubfoot</guid>
                                    <description><![CDATA[<p>Several articles on bmj.com deal with clubfoot disorder. Kirsten Patrick gives us a quick history of the condition, and talks to Andrew Hogg - a GP trainee - about a film he made in South Africa to help Zulu parents understand it. Also this week, Trish Groves tells Duncan Jarvies about the importance of sharing data - and the possible problems that may arise. Deborah Cohen takes us through the news.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Several articles on bmj.com deal with clubfoot disorder. Kirsten Patrick gives us a quick history of the condition, and talks to Andrew Hogg - a GP trainee - about a film he made in South Africa to help Zulu parents understand it. Also this week, Trish Groves tells Duncan Jarvies about the importance of sharing data - and the possible problems that may arise. Deborah Cohen takes us through the news.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/lg6jka/stream_107818990-bmjgroup-clubfoot.mp3" length="16975061" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Several articles on bmj.com deal with clubfoot disorder. Kirsten Patrick gives us a quick history of the condition, and talks to Andrew Hogg - a GP trainee - about a film he made in South Africa to help Zulu parents understand it. Also this week, Trish Groves tells Duncan Jarvies about the importance of sharing data - and the possible problems that may arise. Deborah Cohen takes us through the news.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1061</itunes:duration>
                                    </item>
    <item>
        <title>Urinary tract infections</title>
        <itunes:title>Urinary tract infections</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/urinary-tract-infections-1680600732/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/urinary-tract-infections-1680600732/#comments</comments>        <pubDate>Thu, 29 Aug 2013 11:17:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/urinary-tract-infections</guid>
                                    <description><![CDATA[<p>Urinary tract infections are commonly seen in primary care, particularly in women, yet there are gaps in the evidence about their treatment. Trish Groves talks to Paul Little about a group of papers that compare management approaches for the condition, look at their cost effectiveness, and analyse patients’ reactions to them.</p>
<p>Duncan Jarvies takes us through the news.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Urinary tract infections are commonly seen in primary care, particularly in women, yet there are gaps in the evidence about their treatment. Trish Groves talks to Paul Little about a group of papers that compare management approaches for the condition, look at their cost effectiveness, and analyse patients’ reactions to them.</p>
<p>Duncan Jarvies takes us through the news.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7br7hw/stream_107818843-bmjgroup-urinary-tract-infections.mp3" length="11780637" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Urinary tract infections are commonly seen in primary care, particularly in women, yet there are gaps in the evidence about their treatment. Trish Groves talks to Paul Little about a group of papers that compare management approaches for the condition, look at their cost effectiveness, and analyse patients’ reactions to them.Duncan Jarvies takes us through the news.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>733</itunes:duration>
                                    </item>
    <item>
        <title>Transmuting tamoxifen</title>
        <itunes:title>Transmuting tamoxifen</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/transmuting-tamoxifen/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/transmuting-tamoxifen/#comments</comments>        <pubDate>Thu, 29 Aug 2013 11:15:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/transmuting-tamoxifen</guid>
                                    <description><![CDATA[<p>This week new research was published on the use of the SSRI (selective serotonin re-uptake inhibitor) antidepressants, in combination with the drug tamoxifen. For some time there have been concerns about prescribing them together, and a new study finally quantifies that, David Juurlink explains how.</p>
<p>Also this week, a child’s early years will affect the rest of their life, in terms of medical as well as social and educational outcomes. Clyde Hertzman talks about what governments are, and should be, doing to help build a solid foundation.</p>
<p>Juliet Walker and Birte Twisselmann takes us through the week’s news.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week new research was published on the use of the SSRI (selective serotonin re-uptake inhibitor) antidepressants, in combination with the drug tamoxifen. For some time there have been concerns about prescribing them together, and a new study finally quantifies that, David Juurlink explains how.</p>
<p>Also this week, a child’s early years will affect the rest of their life, in terms of medical as well as social and educational outcomes. Clyde Hertzman talks about what governments are, and should be, doing to help build a solid foundation.</p>
<p>Juliet Walker and Birte Twisselmann takes us through the week’s news.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jy4mvg/stream_107818671-bmjgroup-transmuting-tamoxifen.mp3" length="20687450" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week new research was published on the use of the SSRI (selective serotonin re-uptake inhibitor) antidepressants, in combination with the drug tamoxifen. For some time there have been concerns about prescribing them together, and a new study finally quantifies that, David Juurlink explains how.Also this week, a child’s early years will affect the rest of their life, in terms of medical as well as social and educational outcomes. Clyde Hertzman talks about what governments are, and should be, doing to help build a solid foundation.Juliet Walker and Birte Twisselmann takes us through the week’s news.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1290</itunes:duration>
                                    </item>
    <item>
        <title>Personal care</title>
        <itunes:title>Personal care</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/personal-care/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/personal-care/#comments</comments>        <pubDate>Thu, 29 Aug 2013 11:11:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/personal-care</guid>
                                    <description><![CDATA[<p>In this week’s podcast Sam Lister, health editor of the Times, explains the political fight that’s emerging around provision of free home health care for elderly people.</p>
<p>Duncan Jarvies talks to Iain Chalmers, from the the James Lind Initiative, about the importance of making information about clinical trials available to the public.</p>
<p>Sabreena Malik takes us through this week’s news.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this week’s podcast Sam Lister, health editor of the Times, explains the political fight that’s emerging around provision of free home health care for elderly people.</p>
<p>Duncan Jarvies talks to Iain Chalmers, from the the James Lind Initiative, about the importance of making information about clinical trials available to the public.</p>
<p>Sabreena Malik takes us through this week’s news.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jco10j/stream_107818234-bmjgroup-personal-care.mp3" length="22298642" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this week’s podcast Sam Lister, health editor of the Times, explains the political fight that’s emerging around provision of free home health care for elderly people.Duncan Jarvies talks to Iain Chalmers, from the the James Lind Initiative, about the importance of making information about clinical trials available to the public.Sabreena Malik takes us through this week’s news.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1390</itunes:duration>
                                    </item>
    <item>
        <title>Disinvestment</title>
        <itunes:title>Disinvestment</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/disinvestment/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/disinvestment/#comments</comments>        <pubDate>Thu, 29 Aug 2013 11:09:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/disinvestment</guid>
                                    <description><![CDATA[<p>Estimates of HIV are just that, estimates – but in order to research the progression of the virus, and the effectiveness of intervention strategies, those estimates have to be as accurate as possible. Professor Prabhat Jha joins us to explain the novel way in which he and his team have collected data in India to provide a more accurate picture about the spread of the virus.</p>
<p>Also this week, as spending cuts are planned across public services, the financial strain on the UK health service is increasing. One way in which some money can be saved is through disinvestment; ceasing treatments which have been superseded, or shown ineffective. Peter Littlejohns, the clinical and public health director of the National Institute for Health and Clinical Excellence (NICE), joins us to explain what NICE is doing in that arena.</p>
<p>Annabel Ferriman takes us through the news.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Estimates of HIV are just that, estimates – but in order to research the progression of the virus, and the effectiveness of intervention strategies, those estimates have to be as accurate as possible. Professor Prabhat Jha joins us to explain the novel way in which he and his team have collected data in India to provide a more accurate picture about the spread of the virus.</p>
<p>Also this week, as spending cuts are planned across public services, the financial strain on the UK health service is increasing. One way in which some money can be saved is through disinvestment; ceasing treatments which have been superseded, or shown ineffective. Peter Littlejohns, the clinical and public health director of the National Institute for Health and Clinical Excellence (NICE), joins us to explain what NICE is doing in that arena.</p>
<p>Annabel Ferriman takes us through the news.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/u2n2go/stream_107818047-bmjgroup-disinvestment.mp3" length="20246427" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Estimates of HIV are just that, estimates – but in order to research the progression of the virus, and the effectiveness of intervention strategies, those estimates have to be as accurate as possible. Professor Prabhat Jha joins us to explain the novel way in which he and his team have collected data in India to provide a more accurate picture about the spread of the virus.Also this week, as spending cuts are planned across public services, the financial strain on the UK health service is increasing. One way in which some money can be saved is through disinvestment; ceasing treatments which have been superseded, or shown ineffective. Peter Littlejohns, the clinical and public health director of the National Institute for Health and Clinical Excellence (NICE), joins us to explain what NICE is doing in that arena.Annabel Ferriman takes us through the news.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1265</itunes:duration>
                                    </item>
    <item>
        <title>Chronic fatigue syndrome</title>
        <itunes:title>Chronic fatigue syndrome</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/chronic-fatigue-syndrome/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/chronic-fatigue-syndrome/#comments</comments>        <pubDate>Thu, 29 Aug 2013 11:07:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/chronic-fatigue-syndrome</guid>
                                    <description><![CDATA[<p>This week’s hot topic is chronic fatigue syndrome. The journal Science published a paper in October 2009, which suggested a possible link between a new virus (xenotrophic murine leukaemia virus-like virus) and the syndrome. Duncan Jarvies is looking at the evidence behind this link, and finding out more about the history and treatment of the condition. Richard Hurley takes us through what caught his eye on bmj.com week.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week’s hot topic is chronic fatigue syndrome. The journal Science published a paper in October 2009, which suggested a possible link between a new virus (xenotrophic murine leukaemia virus-like virus) and the syndrome. Duncan Jarvies is looking at the evidence behind this link, and finding out more about the history and treatment of the condition. Richard Hurley takes us through what caught his eye on bmj.com week.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/u6wc0p/stream_107817869-bmjgroup-chronic-fatigue-syndrome.mp3" length="24071658" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week’s hot topic is chronic fatigue syndrome. The journal Science published a paper in October 2009, which suggested a possible link between a new virus (xenotrophic murine leukaemia virus-like virus) and the syndrome. Duncan Jarvies is looking at the evidence behind this link, and finding out more about the history and treatment of the condition. Richard Hurley takes us through what caught his eye on bmj.com week.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1501</itunes:duration>
                                    </item>
    <item>
        <title>Sex life - from soup to nuts</title>
        <itunes:title>Sex life - from soup to nuts</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/sex-life-from-soup-to-nuts/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/sex-life-from-soup-to-nuts/#comments</comments>        <pubDate>Thu, 29 Aug 2013 11:02:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/sex-life-from-soup-to-nuts</guid>
                                    <description><![CDATA[<p>This week, Duncan Jarvies talks to Stacy Lindau and Natalia Garilova about their new sex life expectancy measure, and what it could mean for patients and public health.</p>
<p>Zosia Kmietowicz talks to Douglas Gwatidzo and Rutendo Bonde about the health care system in Zimbabwe, and how the situation there has changed since its nadir in 2008.</p>
<p>David Payne takes us through this week’s news.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week, Duncan Jarvies talks to Stacy Lindau and Natalia Garilova about their new sex life expectancy measure, and what it could mean for patients and public health.</p>
<p>Zosia Kmietowicz talks to Douglas Gwatidzo and Rutendo Bonde about the health care system in Zimbabwe, and how the situation there has changed since its nadir in 2008.</p>
<p>David Payne takes us through this week’s news.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rhosaa/stream_107817442-bmjgroup-sex-life-from-soup-to-nuts.mp3" length="18987546" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week, Duncan Jarvies talks to Stacy Lindau and Natalia Garilova about their new sex life expectancy measure, and what it could mean for patients and public health.Zosia Kmietowicz talks to Douglas Gwatidzo and Rutendo Bonde about the health care system in Zimbabwe, and how the situation there has changed since its nadir in 2008.David Payne takes us through this week’s news.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1183</itunes:duration>
                                    </item>
    <item>
        <title>Variolae Vaccina</title>
        <itunes:title>Variolae Vaccina</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/variolae-vaccina/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/variolae-vaccina/#comments</comments>        <pubDate>Thu, 29 Aug 2013 11:00:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/variolae-vaccina</guid>
                                    <description><![CDATA[<p>If you visited Trafalgar Square in central London today you’d see Admiral Nelson gazing down from his column. What you won’t see is a statue to celebrate the work of Edward Jenner – although once there was one.</p>
<p>Gareth Williams, a professor of medicine at the University of Bristol, is backing a campaign to have Jenner’s statue reinstated. Mabel Chew talks to him about the life and times of the father of vaccination.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>If you visited Trafalgar Square in central London today you’d see Admiral Nelson gazing down from his column. What you won’t see is a statue to celebrate the work of Edward Jenner – although once there was one.</p>
<p>Gareth Williams, a professor of medicine at the University of Bristol, is backing a campaign to have Jenner’s statue reinstated. Mabel Chew talks to him about the life and times of the father of vaccination.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/lnsdta/stream_107817332-bmjgroup-variolae-vaccina.mp3" length="24134766" type="audio/mpeg"/>
        <itunes:summary><![CDATA[If you visited Trafalgar Square in central London today you’d see Admiral Nelson gazing down from his column. What you won’t see is a statue to celebrate the work of Edward Jenner – although once there was one.Gareth Williams, a professor of medicine at the University of Bristol, is backing a campaign to have Jenner’s statue reinstated. Mabel Chew talks to him about the life and times of the father of vaccination.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1505</itunes:duration>
                                    </item>
    <item>
        <title>Sunbeds and spotlights</title>
        <itunes:title>Sunbeds and spotlights</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/sunbeds-and-spotlights/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/sunbeds-and-spotlights/#comments</comments>        <pubDate>Thu, 29 Aug 2013 10:59:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/sunbeds-and-spotlights</guid>
                                    <description><![CDATA[<p>This week the BMJ published research into the use of sunbeds. Cancer Research UK surveyed teenagers across the country to find out how often they top up their tan. Duncan Jarvies talks to Catherine Thomson, from Cancer Research UK, and Madeleine Brindley, a journalist who’s often campaigned on the dangers of solariums, about the results.</p>
<p>Also this week, recent revelations from a group of stem cell scientists shone a light on some of the problems with peer review. Modern science often holds it sacrosanct, but in a feature in this week’s BMJ, Mark Henderson - science editor of the Times newspaper -  highlights various ways in which it might not work. Trish Groves, the BMJ’s research editor, talks to Liz Wager, an independent researcher into peer review, about the process and the ways in which it might be improved.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week the BMJ published research into the use of sunbeds. Cancer Research UK surveyed teenagers across the country to find out how often they top up their tan. Duncan Jarvies talks to Catherine Thomson, from Cancer Research UK, and Madeleine Brindley, a journalist who’s often campaigned on the dangers of solariums, about the results.</p>
<p>Also this week, recent revelations from a group of stem cell scientists shone a light on some of the problems with peer review. Modern science often holds it sacrosanct, but in a feature in this week’s BMJ, Mark Henderson - science editor of the Times newspaper -  highlights various ways in which it might not work. Trish Groves, the BMJ’s research editor, talks to Liz Wager, an independent researcher into peer review, about the process and the ways in which it might be improved.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/s93tgy/stream_107817194-bmjgroup-sunbeds-and-spotlights.mp3" length="18973349" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week the BMJ published research into the use of sunbeds. Cancer Research UK surveyed teenagers across the country to find out how often they top up their tan. Duncan Jarvies talks to Catherine Thomson, from Cancer Research UK, and Madeleine Brindley, a journalist who’s often campaigned on the dangers of solariums, about the results.Also this week, recent revelations from a group of stem cell scientists shone a light on some of the problems with peer review. Modern science often holds it sacrosanct, but in a feature in this week’s BMJ, Mark Henderson - science editor of the Times newspaper -  highlights various ways in which it might not work. Trish Groves, the BMJ’s research editor, talks to Liz Wager, an independent researcher into peer review, about the process and the ways in which it might be improved.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1182</itunes:duration>
                                    </item>
    <item>
        <title>Cannabis conversations</title>
        <itunes:title>Cannabis conversations</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/cannabis-conversations/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/cannabis-conversations/#comments</comments>        <pubDate>Thu, 29 Aug 2013 10:55:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/cannabis-conversations</guid>
                                    <description><![CDATA[<p>This week Duncan Jarvies discusses with London GP Chris Ford how to talk to patients about their cannabis use.</p>
<p>Rebecca Coombes talks to Jim Swire, a retired GP whose daughter Flora died in the Lockerbie bombing. Dr Swire has written an article for the BMJ about the role of Abdelbaset Al-Megrahi’s doctors in his early release.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week Duncan Jarvies discusses with London GP Chris Ford how to talk to patients about their cannabis use.</p>
<p>Rebecca Coombes talks to Jim Swire, a retired GP whose daughter Flora died in the Lockerbie bombing. Dr Swire has written an article for the BMJ about the role of Abdelbaset Al-Megrahi’s doctors in his early release.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/m3x473/stream_107816817-bmjgroup-cannabis-conversations.mp3" length="10302978" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week Duncan Jarvies discusses with London GP Chris Ford how to talk to patients about their cannabis use.Rebecca Coombes talks to Jim Swire, a retired GP whose daughter Flora died in the Lockerbie bombing. Dr Swire has written an article for the BMJ about the role of Abdelbaset Al-Megrahi’s doctors in his early release.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1281</itunes:duration>
                                    </item>
    <item>
        <title>Regulating herbal medicines</title>
        <itunes:title>Regulating herbal medicines</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/regulating-herbal-medicines/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/regulating-herbal-medicines/#comments</comments>        <pubDate>Thu, 29 Aug 2013 10:53:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/regulating-herbal-medicines</guid>
                                    <description><![CDATA[<p>This week Ike Iheanacho investigates the role of herbal remedies in modern medicine. He speaks to Dr Linda Anderson, Principal Pharmaceutical Assessor at the Medicines and Healthcare products Regulatory Agency (MHRA), and Michael Mcintyre, chair of the European Herbal Practitioners Association.</p>
<p>Sabreena Malik and David Payne take us through the week’s news.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week Ike Iheanacho investigates the role of herbal remedies in modern medicine. He speaks to Dr Linda Anderson, Principal Pharmaceutical Assessor at the Medicines and Healthcare products Regulatory Agency (MHRA), and Michael Mcintyre, chair of the European Herbal Practitioners Association.</p>
<p>Sabreena Malik and David Payne take us through the week’s news.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4qksks/stream_107816678-bmjgroup-regulating-herbal-medicines.mp3" length="14283907" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week Ike Iheanacho investigates the role of herbal remedies in modern medicine. He speaks to Dr Linda Anderson, Principal Pharmaceutical Assessor at the Medicines and Healthcare products Regulatory Agency (MHRA), and Michael Mcintyre, chair of the European Herbal Practitioners Association.Sabreena Malik and David Payne take us through the week’s news.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1020</itunes:duration>
                                    </item>
    <item>
        <title>Sudden death</title>
        <itunes:title>Sudden death</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/sudden-death-1680600746/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/sudden-death-1680600746/#comments</comments>        <pubDate>Thu, 29 Aug 2013 10:52:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/sudden-death</guid>
                                    <description><![CDATA[<p>This week’s podcast is based on the BMJ series Competent Novice.Junior doctors play an important part in verifying sudden deaths in hospital and communicating with the family of the deceased. Unexpected, and often premature, deaths can be challenging to manage.</p>
<p>In this podcast Mabel Chew talks to Paul Frost, a consultant in intensive care medicine at the University of Wales. Paul gives practical step by step advice on dealing with sudden death, illustraded by a case study of a 19 year old stab victim who has died in the accident and emergency department.</p>
<p>Also this week, Annabel Ferriman takes us through the news.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week’s podcast is based on the BMJ series Competent Novice.Junior doctors play an important part in verifying sudden deaths in hospital and communicating with the family of the deceased. Unexpected, and often premature, deaths can be challenging to manage.</p>
<p>In this podcast Mabel Chew talks to Paul Frost, a consultant in intensive care medicine at the University of Wales. Paul gives practical step by step advice on dealing with sudden death, illustraded by a case study of a 19 year old stab victim who has died in the accident and emergency department.</p>
<p>Also this week, Annabel Ferriman takes us through the news.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kpiilv/stream_107816563-bmjgroup-sudden-death.mp3" length="18131624" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week’s podcast is based on the BMJ series Competent Novice.Junior doctors play an important part in verifying sudden deaths in hospital and communicating with the family of the deceased. Unexpected, and often premature, deaths can be challenging to manage.In this podcast Mabel Chew talks to Paul Frost, a consultant in intensive care medicine at the University of Wales. Paul gives practical step by step advice on dealing with sudden death, illustraded by a case study of a 19 year old stab victim who has died in the accident and emergency department.Also this week, Annabel Ferriman takes us through the news.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1291</itunes:duration>
                                    </item>
    <item>
        <title>Seeing the body</title>
        <itunes:title>Seeing the body</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/seeing-the-body/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/seeing-the-body/#comments</comments>        <pubDate>Thu, 29 Aug 2013 10:50:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/seeing-the-body</guid>
                                    <description><![CDATA[<p>A traumatic death can be very difficult for friends and family to deal with. A clinician’s instinct may be to protect them from seeing the extent of the damage to the body. However this may not be best in the long run. Duncan Jarvies talks to Alison Chapple about her research into people’s experiences of viewing a body after a traumatic death.</p>
<p>Also this week, the National Patient Safety Agency regularly issue alerts about clinical problems that can be averted. Mabel Chew talks to the NPSA about its latest alert featuring digital tourniquets.</p>
<p>Birte Twisselmann takes us through the news.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>A traumatic death can be very difficult for friends and family to deal with. A clinician’s instinct may be to protect them from seeing the extent of the damage to the body. However this may not be best in the long run. Duncan Jarvies talks to Alison Chapple about her research into people’s experiences of viewing a body after a traumatic death.</p>
<p>Also this week, the National Patient Safety Agency regularly issue alerts about clinical problems that can be averted. Mabel Chew talks to the NPSA about its latest alert featuring digital tourniquets.</p>
<p>Birte Twisselmann takes us through the news.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8ykiyq/stream_107816396-bmjgroup-seeing-the-body.mp3" length="16771637" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A traumatic death can be very difficult for friends and family to deal with. A clinician’s instinct may be to protect them from seeing the extent of the damage to the body. However this may not be best in the long run. Duncan Jarvies talks to Alison Chapple about her research into people’s experiences of viewing a body after a traumatic death.Also this week, the National Patient Safety Agency regularly issue alerts about clinical problems that can be averted. Mabel Chew talks to the NPSA about its latest alert featuring digital tourniquets.Birte Twisselmann takes us through the news.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1393</itunes:duration>
                                    </item>
    <item>
        <title>Cambodia</title>
        <itunes:title>Cambodia</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/cambodia-1680600748/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/cambodia-1680600748/#comments</comments>        <pubDate>Thu, 29 Aug 2013 10:45:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/cambodia</guid>
                                    <description><![CDATA[<p>This week David Payne talks to Emily Friedman, a health policy and ethics analyst, about Cambodia – a country with a difficult past that is now rebuilding its healthcare system to try to meet some of the particular needs of its population.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week David Payne talks to Emily Friedman, a health policy and ethics analyst, about Cambodia – a country with a difficult past that is now rebuilding its healthcare system to try to meet some of the particular needs of its population.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xl9f8y/stream_107815967-bmjgroup-cambodia.mp3" length="13254197" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week David Payne talks to Emily Friedman, a health policy and ethics analyst, about Cambodia – a country with a difficult past that is now rebuilding its healthcare system to try to meet some of the particular needs of its population.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1100</itunes:duration>
                                    </item>
    <item>
        <title>Screening and serodiscordance</title>
        <itunes:title>Screening and serodiscordance</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/screening-and-serodiscordance/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/screening-and-serodiscordance/#comments</comments>        <pubDate>Thu, 29 Aug 2013 10:43:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/screening-and-serodiscordance</guid>
                                    <description><![CDATA[<p>In this week’s podcast Duncan Jarvies talks to Theresa Marteau about screening for diabetes; can patients be given too much information? Also Anne Buvé discusses the likelihood of HIV transmission in serodiscordant couples when the infected partner is receiving antiretroviral treatment.</p>
<p>Annabel Ferriman takes us through the news.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this week’s podcast Duncan Jarvies talks to Theresa Marteau about screening for diabetes; can patients be given too much information? Also Anne Buvé discusses the likelihood of HIV transmission in serodiscordant couples when the infected partner is receiving antiretroviral treatment.</p>
<p>Annabel Ferriman takes us through the news.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xt49o5/stream_107815787-bmjgroup-screening-and-serodiscordance.mp3" length="16528384" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this week’s podcast Duncan Jarvies talks to Theresa Marteau about screening for diabetes; can patients be given too much information? Also Anne Buvé discusses the likelihood of HIV transmission in serodiscordant couples when the infected partner is receiving antiretroviral treatment.Annabel Ferriman takes us through the news.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1373</itunes:duration>
                                    </item>
    <item>
        <title>Legacy of the games</title>
        <itunes:title>Legacy of the games</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/legacy-of-the-games/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/legacy-of-the-games/#comments</comments>        <pubDate>Thu, 29 Aug 2013 10:40:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/legacy-of-the-games</guid>
                                    <description><![CDATA[<p>This week we’ re looking at the legacy of large sports events - with the 2012 Olympic games costing £9bn, and that cost being justified by saying how great an impact the games will have on the health of the nation. We talk to Gerry McCartney about his systematic review of the evidence for those claims.</p>
<p>Antibiotic resistance is a major problem, and we increasingly have to turn to second line drugs as bacteria become immune. We have just published a systematic review on bmj.com that looks at the link between prescribed antibiotics in primary care and antimicrobial resistance. Coauthor Alastair Hay tells us about his findings.</p>
<p>Annabel Ferriman, takes us through the news.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week we’ re looking at the legacy of large sports events - with the 2012 Olympic games costing £9bn, and that cost being justified by saying how great an impact the games will have on the health of the nation. We talk to Gerry McCartney about his systematic review of the evidence for those claims.</p>
<p>Antibiotic resistance is a major problem, and we increasingly have to turn to second line drugs as bacteria become immune. We have just published a systematic review on bmj.com that looks at the link between prescribed antibiotics in primary care and antimicrobial resistance. Coauthor Alastair Hay tells us about his findings.</p>
<p>Annabel Ferriman, takes us through the news.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dkrt7u/stream_107815538-bmjgroup-legacy-of-the-games.mp3" length="16456600" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week we’ re looking at the legacy of large sports events - with the 2012 Olympic games costing £9bn, and that cost being justified by saying how great an impact the games will have on the health of the nation. We talk to Gerry McCartney about his systematic review of the evidence for those claims.Antibiotic resistance is a major problem, and we increasingly have to turn to second line drugs as bacteria become immune. We have just published a systematic review on bmj.com that looks at the link between prescribed antibiotics in primary care and antimicrobial resistance. Coauthor Alastair Hay tells us about his findings.Annabel Ferriman, takes us through the news.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1367</itunes:duration>
                                    </item>
    <item>
        <title>Healthy heart, happy smile</title>
        <itunes:title>Healthy heart, happy smile</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/healthy-heart-happy-smile/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/healthy-heart-happy-smile/#comments</comments>        <pubDate>Thu, 29 Aug 2013 10:39:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/healthy-heart-happy-smile</guid>
                                    <description><![CDATA[<p>In this week’s podcast we examine the link between toothbrushing and cardiovascular disease – Richard Watts talks about his research in Scotland.</p>
<p>Also this week the Department of Health issued a statement that has made some people wonder about the future of NICE. Fiona Godlee discusses the statement with health economist James Raftery.</p>
<p>Finally this week, Evan Harris may have recently lost his seat in parliament, but one thing that’ll keep him busy is his new job as a columnist for the BMJ. Trevor Jackson talks to him about his first column on Wakefield and MMR.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this week’s podcast we examine the link between toothbrushing and cardiovascular disease – Richard Watts talks about his research in Scotland.</p>
<p>Also this week the Department of Health issued a statement that has made some people wonder about the future of NICE. Fiona Godlee discusses the statement with health economist James Raftery.</p>
<p>Finally this week, Evan Harris may have recently lost his seat in parliament, but one thing that’ll keep him busy is his new job as a columnist for the BMJ. Trevor Jackson talks to him about his first column on Wakefield and MMR.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2wm1cl/stream_107815374-bmjgroup-healthy-heart-happy-smile.mp3" length="17469419" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this week’s podcast we examine the link between toothbrushing and cardiovascular disease – Richard Watts talks about his research in Scotland.Also this week the Department of Health issued a statement that has made some people wonder about the future of NICE. Fiona Godlee discusses the statement with health economist James Raftery.Finally this week, Evan Harris may have recently lost his seat in parliament, but one thing that’ll keep him busy is his new job as a columnist for the BMJ. Trevor Jackson talks to him about his first column on Wakefield and MMR.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1451</itunes:duration>
                                    </item>
    <item>
        <title>Suicide, sport, and CME</title>
        <itunes:title>Suicide, sport, and CME</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/suicide-sport-and-cme/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/suicide-sport-and-cme/#comments</comments>        <pubDate>Thu, 29 Aug 2013 10:37:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/suicide-sport-and-cme</guid>
                                    <description><![CDATA[<p>What is the association between IQ and attempted suicide? David Batty talks to us about his research in Sweden.</p>
<p>Also this week, Steven Kawczak, associate director of the Cleveland Clinic’s Center for Continuing Education, outlines the clinic’s new CME partnership with the BMJ and BMJ Learning.</p>
<p>And finally, Richard Budgett, chief medical officer of the London 2012 Olympics, speaks about how scientists are hoping to beat the cheats. He also discusses a recent BMJ research paper about the limited health and economic benefits that big sporting events have on their host nations. The recent Legacy of the games podcast includes an interview with the lead author of that paper.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>What is the association between IQ and attempted suicide? David Batty talks to us about his research in Sweden.</p>
<p>Also this week, Steven Kawczak, associate director of the Cleveland Clinic’s Center for Continuing Education, outlines the clinic’s new CME partnership with the BMJ and BMJ Learning.</p>
<p>And finally, Richard Budgett, chief medical officer of the London 2012 Olympics, speaks about how scientists are hoping to beat the cheats. He also discusses a recent BMJ research paper about the limited health and economic benefits that big sporting events have on their host nations. The recent Legacy of the games podcast includes an interview with the lead author of that paper.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/glc8x5/stream_107815206-bmjgroup-suicide-sport-and-cme.mp3" length="17895111" type="audio/mpeg"/>
        <itunes:summary><![CDATA[What is the association between IQ and attempted suicide? David Batty talks to us about his research in Sweden.Also this week, Steven Kawczak, associate director of the Cleveland Clinic’s Center for Continuing Education, outlines the clinic’s new CME partnership with the BMJ and BMJ Learning.And finally, Richard Budgett, chief medical officer of the London 2012 Olympics, speaks about how scientists are hoping to beat the cheats. He also discusses a recent BMJ research paper about the limited health and economic benefits that big sporting events have on their host nations. The recent Legacy of the games podcast includes an interview with the lead author of that paper.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1487</itunes:duration>
                                    </item>
    <item>
        <title>I ♥ the smoking ban</title>
        <itunes:title>I ♥ the smoking ban</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/i-%e2%99%a5-the-smoking-ban/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/i-%e2%99%a5-the-smoking-ban/#comments</comments>        <pubDate>Thu, 29 Aug 2013 10:36:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/i-the-smoking-ban</guid>
                                    <description><![CDATA[<p>This week research published on bmj.com looks at the association between the smoking ban and a drop in acute myocardial infarctions. Anna Gilmore, director of the Tobacco Control Centre at the University of Bath, talks to us about her findings. We also hear from the London Health Observatory about how much money the drop has saved the NHS.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week research published on bmj.com looks at the association between the smoking ban and a drop in acute myocardial infarctions. Anna Gilmore, director of the Tobacco Control Centre at the University of Bath, talks to us about her findings. We also hear from the London Health Observatory about how much money the drop has saved the NHS.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6htps5/stream_107815081-bmjgroup-i-the-smoking-ban.mp3" length="9285361" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week research published on bmj.com looks at the association between the smoking ban and a drop in acute myocardial infarctions. Anna Gilmore, director of the Tobacco Control Centre at the University of Bath, talks to us about her findings. We also hear from the London Health Observatory about how much money the drop has saved the NHS.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>769</itunes:duration>
                                    </item>
    <item>
        <title>Radios and retinas</title>
        <itunes:title>Radios and retinas</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/radios-and-retinas/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/radios-and-retinas/#comments</comments>        <pubDate>Thu, 29 Aug 2013 10:33:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/radios-and-retinas</guid>
                                    <description><![CDATA[<p>Since mobile phones have been around there has been public concern about their safety - fears over radiation exposure causing cancer have been particularly trenchant. This week Paul Elliott and his colleagues published research looking for an increase in the incidence of childhood cancers around mobile phone base stations. Paul joins us in the studio.</p>
<p>NCEPOD (the National Confidential Enquiry into Patient Outcome and Death) have published a report on parenteral nutrition. Kayte McCann talks to gastroenterologist Jim Stewart about the findings.</p>
<p>Finally, bevacizumab (traded as Avastin) has been used for off-label treatment of age related macular degeneration for some time. The BMJ published research looking at the effectiveness of this monoclonal antibody compared with what was formerly the standard NHS treatment. Adnan Tufail, one of the study’s authors, joins us in the studio.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Since mobile phones have been around there has been public concern about their safety - fears over radiation exposure causing cancer have been particularly trenchant. This week Paul Elliott and his colleagues published research looking for an increase in the incidence of childhood cancers around mobile phone base stations. Paul joins us in the studio.</p>
<p>NCEPOD (the National Confidential Enquiry into Patient Outcome and Death) have published a report on parenteral nutrition. Kayte McCann talks to gastroenterologist Jim Stewart about the findings.</p>
<p>Finally, bevacizumab (traded as Avastin) has been used for off-label treatment of age related macular degeneration for some time. The BMJ published research looking at the effectiveness of this monoclonal antibody compared with what was formerly the standard NHS treatment. Adnan Tufail, one of the study’s authors, joins us in the studio.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/46a2ap/stream_107814792-bmjgroup-radios-and-retinas.mp3" length="17840881" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Since mobile phones have been around there has been public concern about their safety - fears over radiation exposure causing cancer have been particularly trenchant. This week Paul Elliott and his colleagues published research looking for an increase in the incidence of childhood cancers around mobile phone base stations. Paul joins us in the studio.NCEPOD (the National Confidential Enquiry into Patient Outcome and Death) have published a report on parenteral nutrition. Kayte McCann talks to gastroenterologist Jim Stewart about the findings.Finally, bevacizumab (traded as Avastin) has been used for off-label treatment of age related macular degeneration for some time. The BMJ published research looking at the effectiveness of this monoclonal antibody compared with what was formerly the standard NHS treatment. Adnan Tufail, one of the study’s authors, joins us in the studio.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1482</itunes:duration>
                                    </item>
    <item>
        <title>BMA-on-Sea</title>
        <itunes:title>BMA-on-Sea</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/bma-on-sea/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/bma-on-sea/#comments</comments>        <pubDate>Thu, 29 Aug 2013 10:31:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/bma-on-sea</guid>
                                    <description><![CDATA[<p>This week saw the British Medial Association’s Annual Representatives Meeting. Deborah Cohen and Helen Morant tell us what was going on in Brighton. Also this week we have the second part of Sophie Arie’s special report on Haiti.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week saw the British Medial Association’s Annual Representatives Meeting. Deborah Cohen and Helen Morant tell us what was going on in Brighton. Also this week we have the second part of Sophie Arie’s special report on Haiti.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qo18os/stream_107814656-bmjgroup-bma-on-sea.mp3" length="12237969" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week saw the British Medial Association’s Annual Representatives Meeting. Deborah Cohen and Helen Morant tell us what was going on in Brighton. Also this week we have the second part of Sophie Arie’s special report on Haiti.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1015</itunes:duration>
                                    </item>
    <item>
        <title>Methado, methadon’t, methadone</title>
        <itunes:title>Methado, methadon’t, methadone</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/methado-methadon-t-methadone/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/methado-methadon-t-methadone/#comments</comments>        <pubDate>Thu, 29 Aug 2013 10:29:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/methado-methadont-methadone</guid>
                                    <description><![CDATA[<p>Later this month sees the 17th International AIDS Conference in Vienna. One of the topics that will be discussed there is harm reduction, and the political will to embrace it.In this podcast, we look at the effects of long term opiate substitution programmes in Muirhouse, Edinburgh. Local GP Roy Robertson discusses the research he conducted there. We also travel to Kiev in Ukraine, where Richard Hurley talks to NGOs and injecting drug users about local harm reduction programmes.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Later this month sees the 17th International AIDS Conference in Vienna. One of the topics that will be discussed there is harm reduction, and the political will to embrace it.In this podcast, we look at the effects of long term opiate substitution programmes in Muirhouse, Edinburgh. Local GP Roy Robertson discusses the research he conducted there. We also travel to Kiev in Ukraine, where Richard Hurley talks to NGOs and injecting drug users about local harm reduction programmes.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vhb0k0/stream_107814448-bmjgroup-methado-methadont-methadone.mp3" length="20248221" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Later this month sees the 17th International AIDS Conference in Vienna. One of the topics that will be discussed there is harm reduction, and the political will to embrace it.In this podcast, we look at the effects of long term opiate substitution programmes in Muirhouse, Edinburgh. Local GP Roy Robertson discusses the research he conducted there. We also travel to Kiev in Ukraine, where Richard Hurley talks to NGOs and injecting drug users about local harm reduction programmes.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1262</itunes:duration>
                                    </item>
    <item>
        <title>The white paper</title>
        <itunes:title>The white paper</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-white-paper/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-white-paper/#comments</comments>        <pubDate>Thu, 29 Aug 2013 10:26:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-white-paper</guid>
                                    <description><![CDATA[<p>The new coalition government’s white paper on health – encompassing the future of the NHS - was published this week. Chris Ham, chief executive of the health policy think-tank the King’s Fund and professor of health policy and management at the University of Birmingham, and Edward Davies, editor of BMJ Careers, discuss their immediate impressions with Ashley McKimm.</p>
<p>Also this week a paper on www.bmj.com looks at suicide, and how the method of an attempted suicide relates to a later successful attempt. Professor Bo Runeson from the Karolinska Institutet in Sweden joins us on the phone to discuss his research.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The new coalition government’s white paper on health – encompassing the future of the NHS - was published this week. Chris Ham, chief executive of the health policy think-tank the King’s Fund and professor of health policy and management at the University of Birmingham, and Edward Davies, editor of BMJ Careers, discuss their immediate impressions with Ashley McKimm.</p>
<p>Also this week a paper on www.bmj.com looks at suicide, and how the method of an attempted suicide relates to a later successful attempt. Professor Bo Runeson from the Karolinska Institutet in Sweden joins us on the phone to discuss his research.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/yegsac/stream_107814208-bmjgroup-the-white-paper.mp3" length="23543411" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The new coalition government’s white paper on health – encompassing the future of the NHS - was published this week. Chris Ham, chief executive of the health policy think-tank the King’s Fund and professor of health policy and management at the University of Birmingham, and Edward Davies, editor of BMJ Careers, discuss their immediate impressions with Ashley McKimm.Also this week a paper on www.bmj.com looks at suicide, and how the method of an attempted suicide relates to a later successful attempt. Professor Bo Runeson from the Karolinska Institutet in Sweden joins us on the phone to discuss his research.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1468</itunes:duration>
                                    </item>
    <item>
        <title>The bridge</title>
        <itunes:title>The bridge</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-bridge-1680600762/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-bridge-1680600762/#comments</comments>        <pubDate>Thu, 29 Aug 2013 10:24:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-bridge</guid>
                                    <description><![CDATA[<p>This week the print BMJ has a cluster of articles on suicide – one of which talks about the efficacy of physical barriers to prevent suicide from bridges. In the podcast, we’ll hear from Kevin Hines the survivor of such an attempt, and Alys Cole-King, a psychiatrist who wants to break down the stigma of suicide.</p>
<p>We’ll also hear from Gordon Smith, one of the authors of a study looking at a link between the time when a mother gives birth – whether it’s in the normal working week, or out of hours - and the risk of neonatal death.</p>
<p>Finally Richard Hurley tells us about AIDS 2010, the 25 000 delegate conference in Vienna.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week the print BMJ has a cluster of articles on suicide – one of which talks about the efficacy of physical barriers to prevent suicide from bridges. In the podcast, we’ll hear from Kevin Hines the survivor of such an attempt, and Alys Cole-King, a psychiatrist who wants to break down the stigma of suicide.</p>
<p>We’ll also hear from Gordon Smith, one of the authors of a study looking at a link between the time when a mother gives birth – whether it’s in the normal working week, or out of hours - and the risk of neonatal death.</p>
<p>Finally Richard Hurley tells us about AIDS 2010, the 25 000 delegate conference in Vienna.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hpndl5/stream_107814065-bmjgroup-the-bridge.mp3" length="24299437" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week the print BMJ has a cluster of articles on suicide – one of which talks about the efficacy of physical barriers to prevent suicide from bridges. In the podcast, we’ll hear from Kevin Hines the survivor of such an attempt, and Alys Cole-King, a psychiatrist who wants to break down the stigma of suicide.We’ll also hear from Gordon Smith, one of the authors of a study looking at a link between the time when a mother gives birth – whether it’s in the normal working week, or out of hours - and the risk of neonatal death.Finally Richard Hurley tells us about AIDS 2010, the 25 000 delegate conference in Vienna.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1515</itunes:duration>
                                    </item>
    <item>
        <title>The NHS market place</title>
        <itunes:title>The NHS market place</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-nhs-market-place/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-nhs-market-place/#comments</comments>        <pubDate>Thu, 29 Aug 2013 10:20:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-nhs-market-place</guid>
                                    <description><![CDATA[<p>The new coalition government’s plans for the NHS in England put GPs firmly in the driving seat - how do their secondary care colleagues feel about that?</p>
<p>Jacky Davis, co-chair of the NHS Consultants’ Association and a founder member of the “Keep our NHS Public” campaign, shares her views with Duncan Jarvies. Duncan also  talks to Professor Julian Le Grand from the London School of Economics about how market pressures can help make health care more efficient and what GP fundholding taught us.</p>
<p>To see all BMJ Group’s articles about the NHS white paper for England, including discussion threads, podcasts, blogs, and learning modules, visit doc2doc.bmj.com/whitepaper</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The new coalition government’s plans for the NHS in England put GPs firmly in the driving seat - how do their secondary care colleagues feel about that?</p>
<p>Jacky Davis, co-chair of the NHS Consultants’ Association and a founder member of the “Keep our NHS Public” campaign, shares her views with Duncan Jarvies. Duncan also  talks to Professor Julian Le Grand from the London School of Economics about how market pressures can help make health care more efficient and what GP fundholding taught us.</p>
<p>To see all BMJ Group’s articles about the NHS white paper for England, including discussion threads, podcasts, blogs, and learning modules, visit doc2doc.bmj.com/whitepaper</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vhijrp/stream_107813758-bmjgroup-the-nhs-market-place.mp3" length="20574188" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The new coalition government’s plans for the NHS in England put GPs firmly in the driving seat - how do their secondary care colleagues feel about that?Jacky Davis, co-chair of the NHS Consultants’ Association and a founder member of the “Keep our NHS Public” campaign, shares her views with Duncan Jarvies. Duncan also  talks to Professor Julian Le Grand from the London School of Economics about how market pressures can help make health care more efficient and what GP fundholding taught us.To see all BMJ Group’s articles about the NHS white paper for England, including discussion threads, podcasts, blogs, and learning modules, visit doc2doc.bmj.com/whitepaper]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1283</itunes:duration>
                                    </item>
    <item>
        <title>Musical lithotomy</title>
        <itunes:title>Musical lithotomy</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/musical-lithotomy/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/musical-lithotomy/#comments</comments>        <pubDate>Thu, 29 Aug 2013 10:16:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/musical-lithotomy</guid>
                                    <description><![CDATA[<p>In June 2010 the drug company Novo Nordisk announced that its only conventional human biphasic insulin, human Mixtard 30, would no longer be available in the UK from January 2011, a decision that affects an estimated 90,000 patients  Drug and Theraputics Bulletin (DTB), one of the BMJ’s sister journals, is campaigning against that decision. DTB editor Ike Ihenacho talks about the campaign.</p>
<p>Mabel Chew talks to the authors of a rational testing article on what to do about  mildly abnormal serum amine transferase levels, what to suspect, and how to diagnose.</p>
<p>Finally, we have a musical interlude.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In June 2010 the drug company Novo Nordisk announced that its only conventional human biphasic insulin, human Mixtard 30, would no longer be available in the UK from January 2011, a decision that affects an estimated 90,000 patients  Drug and Theraputics Bulletin (DTB), one of the BMJ’s sister journals, is campaigning against that decision. DTB editor Ike Ihenacho talks about the campaign.</p>
<p>Mabel Chew talks to the authors of a rational testing article on what to do about  mildly abnormal serum amine transferase levels, what to suspect, and how to diagnose.</p>
<p>Finally, we have a musical interlude.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/n557sr/stream_107813451-bmjgroup-musical-lithotomy.mp3" length="12281710" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In June 2010 the drug company Novo Nordisk announced that its only conventional human biphasic insulin, human Mixtard 30, would no longer be available in the UK from January 2011, a decision that affects an estimated 90,000 patients  Drug and Theraputics Bulletin (DTB), one of the BMJ’s sister journals, is campaigning against that decision. DTB editor Ike Ihenacho talks about the campaign.Mabel Chew talks to the authors of a rational testing article on what to do about  mildly abnormal serum amine transferase levels, what to suspect, and how to diagnose.Finally, we have a musical interlude.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1528</itunes:duration>
                                    </item>
    <item>
        <title>Heavy weather</title>
        <itunes:title>Heavy weather</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/heavy-weather/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/heavy-weather/#comments</comments>        <pubDate>Thu, 29 Aug 2013 10:15:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/heavy-weather</guid>
                                    <description><![CDATA[<p>In this week’s podcast we discover the link between the weather and the risk of heart attacks - Krishnan Bhaskaran tells us about his research.</p>
<p>Also, criticism and response are crucial parts of the scientific process, but how well do authors of research papers respond to critics of their work? Peter Gøtzsche and Tony Delamothe discuss their work looking at that in the BMJ.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this week’s podcast we discover the link between the weather and the risk of heart attacks - Krishnan Bhaskaran tells us about his research.</p>
<p>Also, criticism and response are crucial parts of the scientific process, but how well do authors of research papers respond to critics of their work? Peter Gøtzsche and Tony Delamothe discuss their work looking at that in the BMJ.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/p76bfc/stream_107813369-bmjgroup-heavy-weather.mp3" length="9907911" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this week’s podcast we discover the link between the weather and the risk of heart attacks - Krishnan Bhaskaran tells us about his research.Also, criticism and response are crucial parts of the scientific process, but how well do authors of research papers respond to critics of their work? Peter Gøtzsche and Tony Delamothe discuss their work looking at that in the BMJ.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1232</itunes:duration>
                                    </item>
    <item>
        <title>The hidden eunuch</title>
        <itunes:title>The hidden eunuch</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-hidden-eunuch/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-hidden-eunuch/#comments</comments>        <pubDate>Thu, 29 Aug 2013 10:14:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-hidden-eunuch</guid>
                                    <description><![CDATA[<p>Jill Morrison talks about how people on long term incapacity benefit because of mental health problems could be identified by their GPs three years before they stop working.</p>
<p>BMJ Deputy editor Trish Groves explains more about the journal’s new policy of asking authors of eligible research articles to pay a publication fee.</p>
<p>And, finally, why does the modern eunuch remain invisible?</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Jill Morrison talks about how people on long term incapacity benefit because of mental health problems could be identified by their GPs three years before they stop working.</p>
<p>BMJ Deputy editor Trish Groves explains more about the journal’s new policy of asking authors of eligible research articles to pay a publication fee.</p>
<p>And, finally, why does the modern eunuch remain invisible?</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gd465p/stream_107813245-bmjgroup-the-hidden-eunuch.mp3" length="10453766" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Jill Morrison talks about how people on long term incapacity benefit because of mental health problems could be identified by their GPs three years before they stop working.BMJ Deputy editor Trish Groves explains more about the journal’s new policy of asking authors of eligible research articles to pay a publication fee.And, finally, why does the modern eunuch remain invisible?]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1300</itunes:duration>
                                    </item>
    <item>
        <title>Shit happens</title>
        <itunes:title>Shit happens</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/shit-happens-1680600769/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/shit-happens-1680600769/#comments</comments>        <pubDate>Wed, 28 Aug 2013 14:19:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/shit-happens</guid>
                                    <description><![CDATA[<p>This week, to steal a line from the latest BMJ editor’s choice, we’ll be talking shit. The millennium development goal on sanitation is way off track; Lyla Mehta, a sociologist from the Institute of Development Studies, tells us why, and Kamal Kar, a development consultant from India, explains how his grass roots initiative changes the way people view sanitation.</p>
<p>Also, National confidential enquiry into patient outcome and death reported on cosmetic surgery this week. Dr Alex Goodwin, anaesthetist and clinical coordinator of the report, tells us about the problems they had collecting data, and some of the implications of their findings.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week, to steal a line from the latest BMJ editor’s choice, we’ll be talking shit. The millennium development goal on sanitation is way off track; Lyla Mehta, a sociologist from the Institute of Development Studies, tells us why, and Kamal Kar, a development consultant from India, explains how his grass roots initiative changes the way people view sanitation.</p>
<p>Also, National confidential enquiry into patient outcome and death reported on cosmetic surgery this week. Dr Alex Goodwin, anaesthetist and clinical coordinator of the report, tells us about the problems they had collecting data, and some of the implications of their findings.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hbj39d/stream_107663113-bmjgroup-shit-happens.mp3" length="15897347" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week, to steal a line from the latest BMJ editor’s choice, we’ll be talking shit. The millennium development goal on sanitation is way off track; Lyla Mehta, a sociologist from the Institute of Development Studies, tells us why, and Kamal Kar, a development consultant from India, explains how his grass roots initiative changes the way people view sanitation.Also, National confidential enquiry into patient outcome and death reported on cosmetic surgery this week. Dr Alex Goodwin, anaesthetist and clinical coordinator of the report, tells us about the problems they had collecting data, and some of the implications of their findings.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>990</itunes:duration>
                                    </item>
    <item>
        <title>NICE in America</title>
        <itunes:title>NICE in America</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/nice-in-america/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/nice-in-america/#comments</comments>        <pubDate>Wed, 28 Aug 2013 14:16:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/nice-in-america</guid>
                                    <description><![CDATA[<p>In this week’s podcast we find out from Sean Tunis about the future of comparative effectiveness research in the USA, and how the new institute created to champion it will differ from the UK’s National Institute of Clinical Excellence.</p>
<p>Also, Claudia Cooper talks about her research that could support carers in the decisions they have to make for dementia sufferers.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this week’s podcast we find out from Sean Tunis about the future of comparative effectiveness research in the USA, and how the new institute created to champion it will differ from the UK’s National Institute of Clinical Excellence.</p>
<p>Also, Claudia Cooper talks about her research that could support carers in the decisions they have to make for dementia sufferers.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3mfuid/stream_107662710-bmjgroup-nice-in-america.mp3" length="8141615" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this week’s podcast we find out from Sean Tunis about the future of comparative effectiveness research in the USA, and how the new institute created to champion it will differ from the UK’s National Institute of Clinical Excellence.Also, Claudia Cooper talks about her research that could support carers in the decisions they have to make for dementia sufferers.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1011</itunes:duration>
                                    </item>
    <item>
        <title>Rational suicide</title>
        <itunes:title>Rational suicide</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/rational-suicide/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/rational-suicide/#comments</comments>        <pubDate>Wed, 28 Aug 2013 14:14:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/rational-suicide</guid>
                                    <description><![CDATA[<p>A person’s right to refuse treatment is based on their capacity to make a rational decision – but what is the situation when someone is admitted after a suicide attempt? Can you be simultaneously rational and suicidal? Anthony David from the Institute of Psychiatry gives us his views.</p>
<p>A second interview deals with Barrett’s oesophagus, which is on the increase. The same is true for adenocarcinoma of the oesophagus, which can arise from the condition. We talked to Rebecca Fitzgerald from the Hutchison/MRC Research Centre how developments in treatment, and a new method of sampling, could make a national screening test a possibility.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>A person’s right to refuse treatment is based on their capacity to make a rational decision – but what is the situation when someone is admitted after a suicide attempt? Can you be simultaneously rational and suicidal? Anthony David from the Institute of Psychiatry gives us his views.</p>
<p>A second interview deals with Barrett’s oesophagus, which is on the increase. The same is true for adenocarcinoma of the oesophagus, which can arise from the condition. We talked to Rebecca Fitzgerald from the Hutchison/MRC Research Centre how developments in treatment, and a new method of sampling, could make a national screening test a possibility.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/0ekzbj/stream_107662553-bmjgroup-rational-suicide.mp3" length="7840466" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A person’s right to refuse treatment is based on their capacity to make a rational decision – but what is the situation when someone is admitted after a suicide attempt? Can you be simultaneously rational and suicidal? Anthony David from the Institute of Psychiatry gives us his views.A second interview deals with Barrett’s oesophagus, which is on the increase. The same is true for adenocarcinoma of the oesophagus, which can arise from the condition. We talked to Rebecca Fitzgerald from the Hutchison/MRC Research Centre how developments in treatment, and a new method of sampling, could make a national screening test a possibility.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1245</itunes:duration>
                                    </item>
    <item>
        <title>Spotlight on palliative care beyond cancer</title>
        <itunes:title>Spotlight on palliative care beyond cancer</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/spotlight-on-palliative-care-beyond-cancer/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/spotlight-on-palliative-care-beyond-cancer/#comments</comments>        <pubDate>Wed, 28 Aug 2013 14:12:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/spotlight-on-palliative-care</guid>
                                    <description><![CDATA[<p>In a series of articles, this spotlight focuses on recognising and managing the end of life, having the difficult conversations with patients about their death, and the importance of taking into account the spiritual aspects of death. In this podcast Duncan Jarvies talks to the authors of 2 of those articles.</p>
<p>Professor Jane Maher, oncologist and CMO of Macmillan Cancer Support, talks about the importance of end of life care.  Dr Mike Knapton, GP and CMO of the British Heart Foundation, talks about their move into palliation.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In a series of articles, this spotlight focuses on recognising and managing the end of life, having the difficult conversations with patients about their death, and the importance of taking into account the spiritual aspects of death. In this podcast Duncan Jarvies talks to the authors of 2 of those articles.</p>
<p>Professor Jane Maher, oncologist and CMO of Macmillan Cancer Support, talks about the importance of end of life care.  Dr Mike Knapton, GP and CMO of the British Heart Foundation, talks about their move into palliation.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/0ypghp/stream_107662287-bmjgroup-spotlight-on-palliative-care.mp3" length="15251651" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In a series of articles, this spotlight focuses on recognising and managing the end of life, having the difficult conversations with patients about their death, and the importance of taking into account the spiritual aspects of death. In this podcast Duncan Jarvies talks to the authors of 2 of those articles.Professor Jane Maher, oncologist and CMO of Macmillan Cancer Support, talks about the importance of end of life care.  Dr Mike Knapton, GP and CMO of the British Heart Foundation, talks about their move into palliation.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>950</itunes:duration>
                                    </item>
    <item>
        <title>Radical reforms</title>
        <itunes:title>Radical reforms</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/radical-reforms/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/radical-reforms/#comments</comments>        <pubDate>Wed, 28 Aug 2013 14:11:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/radical-reforms</guid>
                                    <description><![CDATA[<p>This week we’re joined by Martin McKee, professor of European public health at the Loncon School of Hygiene and Tropical Medicine. He’s also research director of the European observatory on health systems and policies, a group that promotes evidence based healthcare policies in Europe.</p>
<p>We’ll be discussing the effect the squeeze in funding is having on health care in Europe, and the various strategies different countries are using to save money.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week we’re joined by Martin McKee, professor of European public health at the Loncon School of Hygiene and Tropical Medicine. He’s also research director of the European observatory on health systems and policies, a group that promotes evidence based healthcare policies in Europe.</p>
<p>We’ll be discussing the effect the squeeze in funding is having on health care in Europe, and the various strategies different countries are using to save money.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/v33zgd/stream_107662162-bmjgroup-radical-reforms.mp3" length="17190222" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week we’re joined by Martin McKee, professor of European public health at the Loncon School of Hygiene and Tropical Medicine. He’s also research director of the European observatory on health systems and policies, a group that promotes evidence based healthcare policies in Europe.We’ll be discussing the effect the squeeze in funding is having on health care in Europe, and the various strategies different countries are using to save money.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1071</itunes:duration>
                                    </item>
    <item>
        <title>Safety comes second</title>
        <itunes:title>Safety comes second</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/safety-comes-second/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/safety-comes-second/#comments</comments>        <pubDate>Wed, 28 Aug 2013 14:09:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/safety-comes-second</guid>
                                    <description><![CDATA[<p>Last week saw Safety 2010, the international conference on preventable accidents. We hear from some of the speakers there why safety comes second when it comes to global health.</p>
<p>Also this week, female sexual dysfunction - fact or fiction. In advance of a BMJ debate on the topic, we get to the heart of the issue.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Last week saw Safety 2010, the international conference on preventable accidents. We hear from some of the speakers there why safety comes second when it comes to global health.</p>
<p>Also this week, female sexual dysfunction - fact or fiction. In advance of a BMJ debate on the topic, we get to the heart of the issue.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/tzniay/stream_107661974-bmjgroup-safety-comes-second.mp3" length="16370574" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Last week saw Safety 2010, the international conference on preventable accidents. We hear from some of the speakers there why safety comes second when it comes to global health.Also this week, female sexual dysfunction - fact or fiction. In advance of a BMJ debate on the topic, we get to the heart of the issue.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1020</itunes:duration>
                                    </item>
    <item>
        <title>The new lost tribe</title>
        <itunes:title>The new lost tribe</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-new-lost-tribe/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-new-lost-tribe/#comments</comments>        <pubDate>Wed, 28 Aug 2013 14:02:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-new-lost-tribe</guid>
                                    <description><![CDATA[<p>Last week BMJ Careers published “The new lost tribe,” describing the cohort of surgical trainees moving from ST2 to ST3. In this podcast Edward Davies, BMJ Careers editor, and Tom Dolphin, a member of the BMA junior doctors’ committee, describe how competition for training places is affecting career progression.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Last week BMJ Careers published “The new lost tribe,” describing the cohort of surgical trainees moving from ST2 to ST3. In this podcast Edward Davies, BMJ Careers editor, and Tom Dolphin, a member of the BMA junior doctors’ committee, describe how competition for training places is affecting career progression.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5r26cd/stream_107661199-bmjgroup-the-new-lost-tribe.mp3" length="12558054" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Last week BMJ Careers published “The new lost tribe,” describing the cohort of surgical trainees moving from ST2 to ST3. In this podcast Edward Davies, BMJ Careers editor, and Tom Dolphin, a member of the BMA junior doctors’ committee, describe how competition for training places is affecting career progression.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>781</itunes:duration>
                                    </item>
    <item>
        <title>Reboxetine and the missing data</title>
        <itunes:title>Reboxetine and the missing data</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/reboxetine-and-the-missing-data/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/reboxetine-and-the-missing-data/#comments</comments>        <pubDate>Wed, 28 Aug 2013 14:00:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/reboxetine-and-the-missing</guid>
                                    <description><![CDATA[<p>This week Beate Wieseler from IQWiG (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen) tells us how they uncovered data on the antidepressant reboxetine.</p>
<p>Also Angela Thomas and Julia Anderson, haematologists from the Comprehensive Care Haemophilia and Thrombosis Centre, Royal Infirmary of Edinburgh, explain how to investigate a child who bruises easily.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week Beate Wieseler from IQWiG (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen) tells us how they uncovered data on the antidepressant reboxetine.</p>
<p>Also Angela Thomas and Julia Anderson, haematologists from the Comprehensive Care Haemophilia and Thrombosis Centre, Royal Infirmary of Edinburgh, explain how to investigate a child who bruises easily.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/458oni/stream_107661080-bmjgroup-reboxetine-and-the-missing.mp3" length="23754563" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week Beate Wieseler from IQWiG (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen) tells us how they uncovered data on the antidepressant reboxetine.Also Angela Thomas and Julia Anderson, haematologists from the Comprehensive Care Haemophilia and Thrombosis Centre, Royal Infirmary of Edinburgh, explain how to investigate a child who bruises easily.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1481</itunes:duration>
                                    </item>
    <item>
        <title>Hyper hypo</title>
        <itunes:title>Hyper hypo</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/hyper-hypo/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/hyper-hypo/#comments</comments>        <pubDate>Wed, 28 Aug 2013 12:42:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/hyper-hypo</guid>
                                    <description><![CDATA[<p>In this week’s podcast Jayati Das-Munshi, from the Institute of Psychiatry, London, talks about her study into the mental health effects of ethnic density.</p>
<p>Also, hyper/hypo - antonyms that can sound almost identical. Adam Frankel and Phillip Vecchio from the Princess Alexandra Hospital in Woolloongabba, Australia, explain their their plan to do away with these troublesome prefixes.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this week’s podcast Jayati Das-Munshi, from the Institute of Psychiatry, London, talks about her study into the mental health effects of ethnic density.</p>
<p>Also, hyper/hypo - antonyms that can sound almost identical. Adam Frankel and Phillip Vecchio from the Princess Alexandra Hospital in Woolloongabba, Australia, explain their their plan to do away with these troublesome prefixes.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gguvji/stream_107653091-bmjgroup-hyper-hypo.mp3" length="18041574" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this week’s podcast Jayati Das-Munshi, from the Institute of Psychiatry, London, talks about her study into the mental health effects of ethnic density.Also, hyper/hypo - antonyms that can sound almost identical. Adam Frankel and Phillip Vecchio from the Princess Alexandra Hospital in Woolloongabba, Australia, explain their their plan to do away with these troublesome prefixes.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1124</itunes:duration>
                                    </item>
    <item>
        <title>China</title>
        <itunes:title>China</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/china-1680600782/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/china-1680600782/#comments</comments>        <pubDate>Wed, 28 Aug 2013 12:41:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/china</guid>
                                    <description><![CDATA[<p>China’s New Rural Cooperative Medical Scheme, aims to provide health insurance to 800 million rural citizens. We’ll be finding out from Scott Rozelle, from Stanford University and Qingye Meng from Peking University, the background to the formation of the scheme, and its place in the wider Chinese medical system.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>China’s New Rural Cooperative Medical Scheme, aims to provide health insurance to 800 million rural citizens. We’ll be finding out from Scott Rozelle, from Stanford University and Qingye Meng from Peking University, the background to the formation of the scheme, and its place in the wider Chinese medical system.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/729rog/stream_107652968-bmjgroup-china.mp3" length="16709716" type="audio/mpeg"/>
        <itunes:summary><![CDATA[China’s New Rural Cooperative Medical Scheme, aims to provide health insurance to 800 million rural citizens. We’ll be finding out from Scott Rozelle, from Stanford University and Qingye Meng from Peking University, the background to the formation of the scheme, and its place in the wider Chinese medical system.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1041</itunes:duration>
                                    </item>
    <item>
        <title>Regulation, regulation, regulation</title>
        <itunes:title>Regulation, regulation, regulation</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/regulation-regulation-regulation/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/regulation-regulation-regulation/#comments</comments>        <pubDate>Wed, 28 Aug 2013 12:39:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/regulation-regulation</guid>
                                    <description><![CDATA[<p>A BMJ investigation this week raises concerns about the ability of the US Food and Drug Administration to monitor the safety of medical devices through post-approval surveillance. We ask: is the FDA giving device manufacturers an easy regulatory ride?</p>
<p>Also, the National Institute for Health and Clinical Excellence (NICE) is set to lose the power to restrict the use of any drug that exceeds its £30k cost per quality adjusted life year ceiling. Alan Maynard, professor of health economics at the University of York, discusses what this will mean.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>A BMJ investigation this week raises concerns about the ability of the US Food and Drug Administration to monitor the safety of medical devices through post-approval surveillance. We ask: is the FDA giving device manufacturers an easy regulatory ride?</p>
<p>Also, the National Institute for Health and Clinical Excellence (NICE) is set to lose the power to restrict the use of any drug that exceeds its £30k cost per quality adjusted life year ceiling. Alan Maynard, professor of health economics at the University of York, discusses what this will mean.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/nejvcc/stream_107652825-bmjgroup-regulation-regulation.mp3" length="15649416" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A BMJ investigation this week raises concerns about the ability of the US Food and Drug Administration to monitor the safety of medical devices through post-approval surveillance. We ask: is the FDA giving device manufacturers an easy regulatory ride?Also, the National Institute for Health and Clinical Excellence (NICE) is set to lose the power to restrict the use of any drug that exceeds its £30k cost per quality adjusted life year ceiling. Alan Maynard, professor of health economics at the University of York, discusses what this will mean.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>975</itunes:duration>
                                    </item>
    <item>
        <title>Risky business 2010</title>
        <itunes:title>Risky business 2010</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/risky-business-2010/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/risky-business-2010/#comments</comments>        <pubDate>Wed, 28 Aug 2013 12:37:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/risky-business-2010</guid>
                                    <description><![CDATA[<p>This week the podcast’s all about risk, as we bring you two reports from Risky Business, the conference where speakers from a wide range of hazardous industries came together to share ideas.</p>
<p>Pat Crosskerry tells Rebecca Coombes how his work shows thinking more analytically, and less intuitively, could help doctors make better diagnostic decisions, and save lives.</p>
<p>We also look at the contentious subject of medical litigation, and ask if it improves patient safety.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week the podcast’s all about risk, as we bring you two reports from Risky Business, the conference where speakers from a wide range of hazardous industries came together to share ideas.</p>
<p>Pat Crosskerry tells Rebecca Coombes how his work shows thinking more analytically, and less intuitively, could help doctors make better diagnostic decisions, and save lives.</p>
<p>We also look at the contentious subject of medical litigation, and ask if it improves patient safety.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/unm93s/stream_107652625-bmjgroup-risky-business-2010.mp3" length="21635846" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week the podcast’s all about risk, as we bring you two reports from Risky Business, the conference where speakers from a wide range of hazardous industries came together to share ideas.Pat Crosskerry tells Rebecca Coombes how his work shows thinking more analytically, and less intuitively, could help doctors make better diagnostic decisions, and save lives.We also look at the contentious subject of medical litigation, and ask if it improves patient safety.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1349</itunes:duration>
                                    </item>
    <item>
        <title>Refer, or not to refer...</title>
        <itunes:title>Refer, or not to refer...</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/refer-or-not-to-refer/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/refer-or-not-to-refer/#comments</comments>        <pubDate>Wed, 28 Aug 2013 12:36:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/refer-or-not-to-refer</guid>
                                    <description><![CDATA[<p>This week Dulcie McBride, a consultant in public health at University College London, joins us to talk about the UK’s practice variation in referring to secondary care.</p>
<p>Also Simon Wright, head of health at Save the Children, the BMJ’s Christmas charity, talks to Rebecca Coombes about how the money you donate helps health care in some of the world’s poorest countries.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week Dulcie McBride, a consultant in public health at University College London, joins us to talk about the UK’s practice variation in referring to secondary care.</p>
<p>Also Simon Wright, head of health at Save the Children, the BMJ’s Christmas charity, talks to Rebecca Coombes about how the money you donate helps health care in some of the world’s poorest countries.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/d14k0l/stream_107652444-bmjgroup-refer-or-not-to-refer.mp3" length="19974040" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week Dulcie McBride, a consultant in public health at University College London, joins us to talk about the UK’s practice variation in referring to secondary care.Also Simon Wright, head of health at Save the Children, the BMJ’s Christmas charity, talks to Rebecca Coombes about how the money you donate helps health care in some of the world’s poorest countries.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1245</itunes:duration>
                                    </item>
    <item>
        <title>A tale of two cycles</title>
        <itunes:title>A tale of two cycles</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/a-tale-of-two-cycles/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/a-tale-of-two-cycles/#comments</comments>        <pubDate>Wed, 28 Aug 2013 12:34:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/a-tale-of-two-cycles</guid>
                                    <description><![CDATA[<p>This week we’re joined by Jack Wennberg, author of the Dartmoth Atlas of Healthcare. He and Fiona Godlee discuss his work, and what the UK can learn from the US.</p>
<p>Also this week what do you buy a MAMIL (Middle Aged Man in Lycra) for Christmas?</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week we’re joined by Jack Wennberg, author of the Dartmoth Atlas of Healthcare. He and Fiona Godlee discuss his work, and what the UK can learn from the US.</p>
<p>Also this week what do you buy a MAMIL (Middle Aged Man in Lycra) for Christmas?</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/klcw38/stream_107652323-bmjgroup-a-tale-of-two-cycles.mp3" length="22528606" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week we’re joined by Jack Wennberg, author of the Dartmoth Atlas of Healthcare. He and Fiona Godlee discuss his work, and what the UK can learn from the US.Also this week what do you buy a MAMIL (Middle Aged Man in Lycra) for Christmas?]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1405</itunes:duration>
                                    </item>
    <item>
        <title>Christmas 2010</title>
        <itunes:title>Christmas 2010</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/christmas-2010-1680600789/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/christmas-2010-1680600789/#comments</comments>        <pubDate>Wed, 28 Aug 2013 12:27:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/christmas-2010</guid>
                                    <description><![CDATA[<p>In this week’s cracker of a show…</p>
<p>Firstly, could how you park your car indicate your choice of specialty?</p>
<p>Secondly, how a team of scientists managed to solve the mystery of the missing French monarch.</p>
<p>And are doctors in ITU more likely to be oliguric, and at greater risk of acute kidney injury than their patients?</p>
<p>We read a modern fable, which has an important message for the management of complex clinical collaborations.</p>
<p>And finally, how much beauty is there in beauty sleep?</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this week’s cracker of a show…</p>
<p>Firstly, could how you park your car indicate your choice of specialty?</p>
<p>Secondly, how a team of scientists managed to solve the mystery of the missing French monarch.</p>
<p>And are doctors in ITU more likely to be oliguric, and at greater risk of acute kidney injury than their patients?</p>
<p>We read a modern fable, which has an important message for the management of complex clinical collaborations.</p>
<p>And finally, how much beauty is there in beauty sleep?</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ts49ed/stream_107651663-bmjgroup-christmas-2010.mp3" length="25173452" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this week’s cracker of a show…Firstly, could how you park your car indicate your choice of specialty?Secondly, how a team of scientists managed to solve the mystery of the missing French monarch.And are doctors in ITU more likely to be oliguric, and at greater risk of acute kidney injury than their patients?We read a modern fable, which has an important message for the management of complex clinical collaborations.And finally, how much beauty is there in beauty sleep?]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1570</itunes:duration>
                                    </item>
    <item>
        <title>And that was 2010</title>
        <itunes:title>And that was 2010</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/and-that-was-2010/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/and-that-was-2010/#comments</comments>        <pubDate>Wed, 28 Aug 2013 12:24:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/and-that-was-2010</guid>
                                    <description><![CDATA[<p>In the final BMJ podcast of 2010, David Payne asks the Independent’s Jeremy Laurance about the year past, and BMJ authors how they feel going into the one ahead.</p>
<p>Also, Adama Traore tells us about the work Save the Children are doing in Sierra Leone. The charity has been instrumental in implementing free healthcare for women and children there, and we hear about their success.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In the final BMJ podcast of 2010, David Payne asks the Independent’s Jeremy Laurance about the year past, and BMJ authors how they feel going into the one ahead.</p>
<p>Also, Adama Traore tells us about the work Save the Children are doing in Sierra Leone. The charity has been instrumental in implementing free healthcare for women and children there, and we hear about their success.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3483yc/stream_107651356-bmjgroup-and-that-was-2010.mp3" length="19667690" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In the final BMJ podcast of 2010, David Payne asks the Independent’s Jeremy Laurance about the year past, and BMJ authors how they feel going into the one ahead.Also, Adama Traore tells us about the work Save the Children are doing in Sierra Leone. The charity has been instrumental in implementing free healthcare for women and children there, and we hear about their success.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1226</itunes:duration>
                                    </item>
    <item>
        <title>Sting in the tale</title>
        <itunes:title>Sting in the tale</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/sting-in-the-tale/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/sting-in-the-tale/#comments</comments>        <pubDate>Wed, 28 Aug 2013 12:13:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/sting-in-the-tale</guid>
                                    <description><![CDATA[<p>This week we find out the best way to treat a Mesobuthus tamulus (indian red scorpion) sting. We also discuss the current state of healthcare in Iraq; and how Andrew Wakefield’s article linking the MMR vaccine and autism was not bad science, but deliberate fraud.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week we find out the best way to treat a Mesobuthus tamulus (indian red scorpion) sting. We also discuss the current state of healthcare in Iraq; and how Andrew Wakefield’s article linking the MMR vaccine and autism was not bad science, but deliberate fraud.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/v00g2d/stream_107650102-bmjgroup-sting-in-the-tale.mp3" length="18364061" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week we find out the best way to treat a Mesobuthus tamulus (indian red scorpion) sting. We also discuss the current state of healthcare in Iraq; and how Andrew Wakefield’s article linking the MMR vaccine and autism was not bad science, but deliberate fraud.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1144</itunes:duration>
                                    </item>
    <item>
        <title>Dowsing for data</title>
        <itunes:title>Dowsing for data</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/dowsing-for-data/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/dowsing-for-data/#comments</comments>        <pubDate>Wed, 28 Aug 2013 12:11:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/dowsing-for-data</guid>
                                    <description><![CDATA[<p>In this week’s podcast we hear from Tom Jefferson of the Cochrane Collaboration about the problem of publication bias – and a tool that could help researchers dowse for hidden data.</p>
<p>Also, Brian Deer discusses his features and explains why it’s been so long from the original publication of Wakefield’s work in the Lancet to the revelations just published in the BMJ.</p>
<p>And David Payne talks to us about the new BMJ iPad app.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this week’s podcast we hear from Tom Jefferson of the Cochrane Collaboration about the problem of publication bias – and a tool that could help researchers dowse for hidden data.</p>
<p>Also, Brian Deer discusses his features and explains why it’s been so long from the original publication of Wakefield’s work in the Lancet to the revelations just published in the BMJ.</p>
<p>And David Payne talks to us about the new BMJ iPad app.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/puzz95/stream_107649926-bmjgroup-dowsing-for-data.mp3" length="12252697" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this week’s podcast we hear from Tom Jefferson of the Cochrane Collaboration about the problem of publication bias – and a tool that could help researchers dowse for hidden data.Also, Brian Deer discusses his features and explains why it’s been so long from the original publication of Wakefield’s work in the Lancet to the revelations just published in the BMJ.And David Payne talks to us about the new BMJ iPad app.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1202</itunes:duration>
                                    </item>
    <item>
        <title>Andrew Lansley’s apples and oranges</title>
        <itunes:title>Andrew Lansley’s apples and oranges</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/andrew-lansley-s-apples-and-oranges/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/andrew-lansley-s-apples-and-oranges/#comments</comments>        <pubDate>Wed, 28 Aug 2013 12:08:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/andrew-lansleys-apples-and</guid>
                                    <description><![CDATA[<p>Andrew Lansley said this week his NHS reforms are needed because the UK’s health outcomes are amongst the poorest in Europe. However John Appleby, chief economist at the King’s Fund, tells us why the comparisons are flawed.</p>
<p>We also hear from Turkey’s minister of health, Recep Akdağ, on the strides his country has made in providing healthcare.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Andrew Lansley said this week his NHS reforms are needed because the UK’s health outcomes are amongst the poorest in Europe. However John Appleby, chief economist at the King’s Fund, tells us why the comparisons are flawed.</p>
<p>We also hear from Turkey’s minister of health, Recep Akdağ, on the strides his country has made in providing healthcare.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/h42o4b/stream_107649558-bmjgroup-andrew-lansleys-apples-and.mp3" length="9910530" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Andrew Lansley said this week his NHS reforms are needed because the UK’s health outcomes are amongst the poorest in Europe. However John Appleby, chief economist at the King’s Fund, tells us why the comparisons are flawed.We also hear from Turkey’s minister of health, Recep Akdağ, on the strides his country has made in providing healthcare.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1001</itunes:duration>
                                    </item>
    <item>
        <title>Judging the nudging</title>
        <itunes:title>Judging the nudging</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/judging-the-nudging/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/judging-the-nudging/#comments</comments>        <pubDate>Wed, 28 Aug 2013 12:06:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/judging-the-nudging</guid>
                                    <description><![CDATA[<p>In this week’s podcast Theresa Marteau, director of the Behaviour and Health Research Unit at the University of Cambridge, wonders if a nudge is enough to change our health behaviours.</p>
<p>Also this week, Aziz Sheikh, from the E-medicine Group at The University of Edinburgh, explains how telemedicine is going to be an integral part of future healthcare.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this week’s podcast Theresa Marteau, director of the Behaviour and Health Research Unit at the University of Cambridge, wonders if a nudge is enough to change our health behaviours.</p>
<p>Also this week, Aziz Sheikh, from the E-medicine Group at The University of Edinburgh, explains how telemedicine is going to be an integral part of future healthcare.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/r13x3n/stream_107649389-bmjgroup-judging-the-nudging.mp3" length="9690531" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this week’s podcast Theresa Marteau, director of the Behaviour and Health Research Unit at the University of Cambridge, wonders if a nudge is enough to change our health behaviours.Also this week, Aziz Sheikh, from the E-medicine Group at The University of Edinburgh, explains how telemedicine is going to be an integral part of future healthcare.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1004</itunes:duration>
                                    </item>
    <item>
        <title>Overusing oxygen</title>
        <itunes:title>Overusing oxygen</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/overusing-oxygen/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/overusing-oxygen/#comments</comments>        <pubDate>Wed, 28 Aug 2013 12:04:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/overusing-oxygen</guid>
                                    <description><![CDATA[<p>In this week’s podcast Andrew Farmer from the National Institute of Health Research, Health Technology Assessment programme (NIHR HTA), tackles uncertainty.</p>
<p>Also, Andrew Clark from the University of Hull tells us that the case for administering oxygen isn’t air tight.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this week’s podcast Andrew Farmer from the National Institute of Health Research, Health Technology Assessment programme (NIHR HTA), tackles uncertainty.</p>
<p>Also, Andrew Clark from the University of Hull tells us that the case for administering oxygen isn’t air tight.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/1s1pnm/stream_107649237-bmjgroup-overusing-oxygen.mp3" length="12077466" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this week’s podcast Andrew Farmer from the National Institute of Health Research, Health Technology Assessment programme (NIHR HTA), tackles uncertainty.Also, Andrew Clark from the University of Hull tells us that the case for administering oxygen isn’t air tight.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1295</itunes:duration>
                                    </item>
    <item>
        <title>Diabetes</title>
        <itunes:title>Diabetes</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/diabetes-1680600434/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/diabetes-1680600434/#comments</comments>        <pubDate>Wed, 28 Aug 2013 12:03:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/diabetes</guid>
                                    <description><![CDATA[<p>This week we find out about diabetes. Mabel Chew, our Sydney based associate editor, discovers why it’s important not to miss the diagnosis of type I diabetes in children. And we learn about a new therapeutic agent for type II diabetes: glucagon-like peptide-1 analogues.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week we find out about diabetes. Mabel Chew, our Sydney based associate editor, discovers why it’s important not to miss the diagnosis of type I diabetes in children. And we learn about a new therapeutic agent for type II diabetes: glucagon-like peptide-1 analogues.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6a3qvx/stream_107649057-bmjgroup-diabetes.mp3" length="9190767" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week we find out about diabetes. Mabel Chew, our Sydney based associate editor, discovers why it’s important not to miss the diagnosis of type I diabetes in children. And we learn about a new therapeutic agent for type II diabetes: glucagon-like peptide-1 analogues.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1052</itunes:duration>
                                    </item>
    <item>
        <title>A hearty drink</title>
        <itunes:title>A hearty drink</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/a-hearty-drink/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/a-hearty-drink/#comments</comments>        <pubDate>Wed, 28 Aug 2013 12:01:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/a-hearty-drink</guid>
                                    <description><![CDATA[<p>In this week’s podcast we find out from Susan Brien and Paul Ronksley about the cardioprotective effects of alcohol.</p>
<p>Also, Annabel Ferriman tells us about the nominees for the BMJ Group lifetime achievement award.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this week’s podcast we find out from Susan Brien and Paul Ronksley about the cardioprotective effects of alcohol.</p>
<p>Also, Annabel Ferriman tells us about the nominees for the BMJ Group lifetime achievement award.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3m5l16/stream_107648898-bmjgroup-a-hearty-drink.mp3" length="14618121" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this week’s podcast we find out from Susan Brien and Paul Ronksley about the cardioprotective effects of alcohol.Also, Annabel Ferriman tells us about the nominees for the BMJ Group lifetime achievement award.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1517</itunes:duration>
                                    </item>
    <item>
        <title>Food for thought</title>
        <itunes:title>Food for thought</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/food-for-thought-1680600437/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/food-for-thought-1680600437/#comments</comments>        <pubDate>Wed, 28 Aug 2013 11:58:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/food-for-thought</guid>
                                    <description><![CDATA[<p>Between March 2010 and March 2011 the cost of maize and wheat doubled. This is just the latest in a series of price hikes in food staples. In an editorial this week, Joachim Von Braun sets out some of the problems that this price rise is going to cause. David Nabarro, UN special representative of the secretary-general on food security and nutrition, describes why and how we should control the price rise.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Between March 2010 and March 2011 the cost of maize and wheat doubled. This is just the latest in a series of price hikes in food staples. In an editorial this week, Joachim Von Braun sets out some of the problems that this price rise is going to cause. David Nabarro, UN special representative of the secretary-general on food security and nutrition, describes why and how we should control the price rise.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8uwlfq/stream_107648655-bmjgroup-food-for-thought.mp3" length="10947840" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Between March 2010 and March 2011 the cost of maize and wheat doubled. This is just the latest in a series of price hikes in food staples. In an editorial this week, Joachim Von Braun sets out some of the problems that this price rise is going to cause. David Nabarro, UN special representative of the secretary-general on food security and nutrition, describes why and how we should control the price rise.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1371</itunes:duration>
                                    </item>
    <item>
        <title>Watching waiting times</title>
        <itunes:title>Watching waiting times</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/watching-waiting-times/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/watching-waiting-times/#comments</comments>        <pubDate>Wed, 28 Aug 2013 11:57:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/watching-waiting-times</guid>
                                    <description><![CDATA[<p>In this week’s podcast,  Johan Sundstrom explains how blood pressure in adolescents effects mortality in adults. And John Appleby, chief economist of the King’s Fund, talks waiting times.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this week’s podcast,  Johan Sundstrom explains how blood pressure in adolescents effects mortality in adults. And John Appleby, chief economist of the King’s Fund, talks waiting times.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/csf4o1/stream_107648512-bmjgroup-watching-waiting-times.mp3" length="8776435" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this week’s podcast,  Johan Sundstrom explains how blood pressure in adolescents effects mortality in adults. And John Appleby, chief economist of the King’s Fund, talks waiting times.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>964</itunes:duration>
                                    </item>
    <item>
        <title>30 years of AIDS</title>
        <itunes:title>30 years of AIDS</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/30-years-of-aids/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/30-years-of-aids/#comments</comments>        <pubDate>Wed, 28 Aug 2013 11:49:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/30-years-of-aids</guid>
                                    <description><![CDATA[<p>This month marks the 30th anniversary of the first diagnosed case of AIDS. Bertrand Audoin, from the International AIDS Society, brings us up to date with the latest developments in the fight against the disease.</p>
<p>Also this week, Francesco Capuccio from Warwick University explains the importance of sleep as a “health commodity” and the problems with its sacrifice,  in our increasingly busy lives.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This month marks the 30th anniversary of the first diagnosed case of AIDS. Bertrand Audoin, from the International AIDS Society, brings us up to date with the latest developments in the fight against the disease.</p>
<p>Also this week, Francesco Capuccio from Warwick University explains the importance of sleep as a “health commodity” and the problems with its sacrifice,  in our increasingly busy lives.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rewaaw/stream_107647685-bmjgroup-30-years-of-aids.mp3" length="23055612" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This month marks the 30th anniversary of the first diagnosed case of AIDS. Bertrand Audoin, from the International AIDS Society, brings us up to date with the latest developments in the fight against the disease.Also this week, Francesco Capuccio from Warwick University explains the importance of sleep as a “health commodity” and the problems with its sacrifice,  in our increasingly busy lives.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1438</itunes:duration>
                                    </item>
    <item>
        <title>From Fukushima</title>
        <itunes:title>From Fukushima</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/from-fukushima/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/from-fukushima/#comments</comments>        <pubDate>Wed, 28 Aug 2013 11:48:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/from-fukushima</guid>
                                    <description><![CDATA[<p>As the world’s attention turns to Fukushima, we hear from Ryuki Kassai, Director of Community and Family Medicine at Fukushima Medical University, about the situation on the ground there. He tells us about the difficulties they currently face, and the uncertainty of the next few days and weeks.</p>
<p>Also this week, Paul Mackin of Newcastle University discusses the use and efficacy of atypical antipsychotic</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>As the world’s attention turns to Fukushima, we hear from Ryuki Kassai, Director of Community and Family Medicine at Fukushima Medical University, about the situation on the ground there. He tells us about the difficulties they currently face, and the uncertainty of the next few days and weeks.</p>
<p>Also this week, Paul Mackin of Newcastle University discusses the use and efficacy of atypical antipsychotic</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fqpkui/stream_107647587-bmjgroup-from-fukushima.mp3" length="11076141" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As the world’s attention turns to Fukushima, we hear from Ryuki Kassai, Director of Community and Family Medicine at Fukushima Medical University, about the situation on the ground there. He tells us about the difficulties they currently face, and the uncertainty of the next few days and weeks.Also this week, Paul Mackin of Newcastle University discusses the use and efficacy of atypical antipsychotic]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1284</itunes:duration>
                                    </item>
    <item>
        <title>NHS reforms round table</title>
        <itunes:title>NHS reforms round table</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/nhs-reforms-round-table/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/nhs-reforms-round-table/#comments</comments>        <pubDate>Wed, 28 Aug 2013 11:48:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/nhs-reforms-round-table</guid>
                                    <description><![CDATA[<p>This week the British government has tabled an amendment to remove maximum pricing from the Health and Social Care Bill. We convened a round table discussion to find out what other elements of the bill need re-examining.</p>
<p>Joining us in the studio at BMA house were:</p>
<p>John Black - president of the Royal College of Surgeons.</p>
<p>Clare Gerada - chair of the Royal College of General Practitioners</p>
<p>Michelle Drage - chief executive of the London Wide LMCs</p>
<p>Nigel Edwards – acting chief executive of the NHS Confederation</p>
<p>Anna Dixon - director of policy at the King’s Fund</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week the British government has tabled an amendment to remove maximum pricing from the Health and Social Care Bill. We convened a round table discussion to find out what other elements of the bill need re-examining.</p>
<p>Joining us in the studio at BMA house were:</p>
<p>John Black - president of the Royal College of Surgeons.</p>
<p>Clare Gerada - chair of the Royal College of General Practitioners</p>
<p>Michelle Drage - chief executive of the London Wide LMCs</p>
<p>Nigel Edwards – acting chief executive of the NHS Confederation</p>
<p>Anna Dixon - director of policy at the King’s Fund</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6odse8/stream_107647659-bmjgroup-nhs-reforms-round-table.mp3" length="11656057" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week the British government has tabled an amendment to remove maximum pricing from the Health and Social Care Bill. We convened a round table discussion to find out what other elements of the bill need re-examining.Joining us in the studio at BMA house were:John Black - president of the Royal College of Surgeons.Clare Gerada - chair of the Royal College of General PractitionersMichelle Drage - chief executive of the London Wide LMCsNigel Edwards – acting chief executive of the NHS ConfederationAnna Dixon - director of policy at the King’s Fund]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1127</itunes:duration>
                                    </item>
    <item>
        <title>Trade in generics</title>
        <itunes:title>Trade in generics</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/trade-in-generics/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/trade-in-generics/#comments</comments>        <pubDate>Wed, 28 Aug 2013 11:45:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/trade-in-generics</guid>
                                    <description><![CDATA[<p>Jamie Love, Knowledge Ecology International, and Hans Hogerzeil, director of essential medicines and pharmaceutical policies at the World Health Organization (WHO), discuss the ongoing EU trade negotiations with India.  They set out their concerns that it may lead to an interruption in the supply of new generic drugs to the developing world.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Jamie Love, Knowledge Ecology International, and Hans Hogerzeil, director of essential medicines and pharmaceutical policies at the World Health Organization (WHO), discuss the ongoing EU trade negotiations with India.  They set out their concerns that it may lead to an interruption in the supply of new generic drugs to the developing world.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kxmclm/stream_107647323-bmjgroup-trade-in-generics.mp3" length="5814259" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Jamie Love, Knowledge Ecology International, and Hans Hogerzeil, director of essential medicines and pharmaceutical policies at the World Health Organization (WHO), discuss the ongoing EU trade negotiations with India.  They set out their concerns that it may lead to an interruption in the supply of new generic drugs to the developing world.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>693</itunes:duration>
                                    </item>
    <item>
        <title>BMJ Round Table Shared Decision - Making Patients</title>
        <itunes:title>BMJ Round Table Shared Decision - Making Patients</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/bmj-round-table-shared-decision-making-patients/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/bmj-round-table-shared-decision-making-patients/#comments</comments>        <pubDate>Wed, 28 Aug 2013 11:44:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/bmj-round-table-shared-2</guid>
                                    <description><![CDATA[<p>At BMA house, we convened a group of world experts in shared decision making. Inspired by the Salzburg Global Summit meeting we discussed the background, practical challenges, and how to engage patients with their health</p>
<p>The participants were:</p>
<p>Fiona Godlee , editor in chief, BMJ </p>
<p>Angela Coulter , director of global initiatives, Foundation for Informed Medical Decision Making </p>
<p>Albert Mulley , co-founder, Foundation for Informed Medical Decision Making, and director, Dartmouth Center for Health Care Delivery Science </p>
<p>Glyn Elwyn, research professor with an interest in shared decision making, Cardiff University </p>
<p>Muir Gray , chair of the Information Standard, Department of Health, and co-editor (with Gerd Gigerenzer of the new book Better Doctors, Better Patients, Better Decisions: Envisioning Health Care 2020 </p>
<p>Marion Collict, national programme manager, shared decision making, NHS (UK’s National Health System) </p>
<p>Alf Collins , consultant in pain medicine, Taunton and Somerset NHS Foundation Trust, and national clinical lead for Co-Creating Health </p>
<p>Margaret McCartney , writer and GP </p>
<p>Anu Dhir , junior surgical trainee and co-signatory of the Salzburg Statement </p>
<p>Gerd Gigerenzer , director, Center for Adaptive Behaviour and Cognition, Max Planck Institute for Human Behaviour </p>
<p>Lisa Schwartz , professor of medicine, Dartmouth Medical School, author (with Steve Woloshin (see below)) of Know Your Chances available free online. </p>
<p>Steve Woloshin , professor of medicine, Dartmouth Medical School </p>
<p>“e-Patient Dave” deBronkart , co-chair, Society for Participatory Medicine </p>
<p>Tessa Richards , analysis editor, BMJ </p>
<p>Sue Ziebland , research director of the Health Experiences Research Group and a reader in qualitative health research, Department of Primary Health Care, University of Oxford</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>At BMA house, we convened a group of world experts in shared decision making. Inspired by the Salzburg Global Summit meeting we discussed the background, practical challenges, and how to engage patients with their health</p>
<p>The participants were:</p>
<p>Fiona Godlee , editor in chief, BMJ </p>
<p>Angela Coulter , director of global initiatives, Foundation for Informed Medical Decision Making </p>
<p>Albert Mulley , co-founder, Foundation for Informed Medical Decision Making, and director, Dartmouth Center for Health Care Delivery Science </p>
<p>Glyn Elwyn, research professor with an interest in shared decision making, Cardiff University </p>
<p>Muir Gray , chair of the Information Standard, Department of Health, and co-editor (with Gerd Gigerenzer of the new book Better Doctors, Better Patients, Better Decisions: Envisioning Health Care 2020 </p>
<p>Marion Collict, national programme manager, shared decision making, NHS (UK’s National Health System) </p>
<p>Alf Collins , consultant in pain medicine, Taunton and Somerset NHS Foundation Trust, and national clinical lead for Co-Creating Health </p>
<p>Margaret McCartney , writer and GP </p>
<p>Anu Dhir , junior surgical trainee and co-signatory of the Salzburg Statement </p>
<p>Gerd Gigerenzer , director, Center for Adaptive Behaviour and Cognition, Max Planck Institute for Human Behaviour </p>
<p>Lisa Schwartz , professor of medicine, Dartmouth Medical School, author (with Steve Woloshin (see below)) of Know Your Chances available free online. </p>
<p>Steve Woloshin , professor of medicine, Dartmouth Medical School </p>
<p>“e-Patient Dave” deBronkart , co-chair, Society for Participatory Medicine </p>
<p>Tessa Richards , analysis editor, BMJ </p>
<p>Sue Ziebland , research director of the Health Experiences Research Group and a reader in qualitative health research, Department of Primary Health Care, University of Oxford</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/42vion/stream_107647231-bmjgroup-bmj-round-table-shared-2.mp3" length="21366918" type="audio/mpeg"/>
        <itunes:summary><![CDATA[At BMA house, we convened a group of world experts in shared decision making. Inspired by the Salzburg Global Summit meeting we discussed the background, practical challenges, and how to engage patients with their healthThe participants were:Fiona Godlee , editor in chief, BMJ Angela Coulter , director of global initiatives, Foundation for Informed Medical Decision Making Albert Mulley , co-founder, Foundation for Informed Medical Decision Making, and director, Dartmouth Center for Health Care Delivery Science Glyn Elwyn, research professor with an interest in shared decision making, Cardiff University Muir Gray , chair of the Information Standard, Department of Health, and co-editor (with Gerd Gigerenzer of the new book Better Doctors, Better Patients, Better Decisions: Envisioning Health Care 2020 Marion Collict, national programme manager, shared decision making, NHS (UK’s National Health System) Alf Collins , consultant in pain medicine, Taunton and Somerset NHS Foundation Trust, and national clinical lead for Co-Creating Health Margaret McCartney , writer and GP Anu Dhir , junior surgical trainee and co-signatory of the Salzburg Statement Gerd Gigerenzer , director, Center for Adaptive Behaviour and Cognition, Max Planck Institute for Human Behaviour Lisa Schwartz , professor of medicine, Dartmouth Medical School, author (with Steve Woloshin (see below)) of Know Your Chances available free online. Steve Woloshin , professor of medicine, Dartmouth Medical School “e-Patient Dave” deBronkart , co-chair, Society for Participatory Medicine Tessa Richards , analysis editor, BMJ Sue Ziebland , research director of the Health Experiences Research Group and a reader in qualitative health research, Department of Primary Health Care, University of Oxford]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2148</itunes:duration>
                                    </item>
    <item>
        <title>BMJ Round Table Shared Decision - Making Practicalities</title>
        <itunes:title>BMJ Round Table Shared Decision - Making Practicalities</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/bmj-round-table-shared-decision-making-practicalities/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/bmj-round-table-shared-decision-making-practicalities/#comments</comments>        <pubDate>Wed, 28 Aug 2013 11:42:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/bmj-round-table-shared-1</guid>
                                    <description><![CDATA[<p>At BMA house, we convened a group of world experts in shared decision making. Inspired by the Salzburg Global Summit meeting we discussed the background, practical challenges, and how to engage patients with their health</p>
<p>The participants were:</p>
<p>Fiona Godlee , editor in chief, BMJ </p>
<p>Angela Coulter , director of global initiatives, Foundation for Informed Medical Decision Making </p>
<p>Albert Mulley , co-founder, Foundation for Informed Medical Decision Making, and director, Dartmouth Center for Health Care Delivery Science </p>
<p>Glyn Elwyn, research professor with an interest in shared decision making, Cardiff University </p>
<p>Muir Gray , chair of the Information Standard, Department of Health, and co-editor (with Gerd Gigerenzer of the new book Better Doctors, Better Patients, Better Decisions: Envisioning Health Care 2020 </p>
<p>Marion Collict, national programme manager, shared decision making, NHS (UK’s National Health System) </p>
<p>Alf Collins , consultant in pain medicine, Taunton and Somerset NHS Foundation Trust, and national clinical lead for Co-Creating Health </p>
<p>Margaret McCartney , writer and GP </p>
<p>Anu Dhir , junior surgical trainee and co-signatory of the Salzburg Statement </p>
<p>Gerd Gigerenzer , director, Center for Adaptive Behaviour and Cognition, Max Planck Institute for Human Behaviour </p>
<p>Lisa Schwartz , professor of medicine, Dartmouth Medical School, author (with Steve Woloshin (see below)) of Know Your Chances available free online. </p>
<p>Steve Woloshin , professor of medicine, Dartmouth Medical School </p>
<p>“e-Patient Dave” deBronkart , co-chair, Society for Participatory Medicine </p>
<p>Tessa Richards , analysis editor, BMJ </p>
<p>Sue Ziebland , research director of the Health Experiences Research Group and a reader in qualitative health research, Department of Primary Health Care, University of Oxford</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>At BMA house, we convened a group of world experts in shared decision making. Inspired by the Salzburg Global Summit meeting we discussed the background, practical challenges, and how to engage patients with their health</p>
<p>The participants were:</p>
<p>Fiona Godlee , editor in chief, BMJ </p>
<p>Angela Coulter , director of global initiatives, Foundation for Informed Medical Decision Making </p>
<p>Albert Mulley , co-founder, Foundation for Informed Medical Decision Making, and director, Dartmouth Center for Health Care Delivery Science </p>
<p>Glyn Elwyn, research professor with an interest in shared decision making, Cardiff University </p>
<p>Muir Gray , chair of the Information Standard, Department of Health, and co-editor (with Gerd Gigerenzer of the new book Better Doctors, Better Patients, Better Decisions: Envisioning Health Care 2020 </p>
<p>Marion Collict, national programme manager, shared decision making, NHS (UK’s National Health System) </p>
<p>Alf Collins , consultant in pain medicine, Taunton and Somerset NHS Foundation Trust, and national clinical lead for Co-Creating Health </p>
<p>Margaret McCartney , writer and GP </p>
<p>Anu Dhir , junior surgical trainee and co-signatory of the Salzburg Statement </p>
<p>Gerd Gigerenzer , director, Center for Adaptive Behaviour and Cognition, Max Planck Institute for Human Behaviour </p>
<p>Lisa Schwartz , professor of medicine, Dartmouth Medical School, author (with Steve Woloshin (see below)) of Know Your Chances available free online. </p>
<p>Steve Woloshin , professor of medicine, Dartmouth Medical School </p>
<p>“e-Patient Dave” deBronkart , co-chair, Society for Participatory Medicine </p>
<p>Tessa Richards , analysis editor, BMJ </p>
<p>Sue Ziebland , research director of the Health Experiences Research Group and a reader in qualitative health research, Department of Primary Health Care, University of Oxford</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7dvlh8/stream_107647054-bmjgroup-bmj-round-table-shared-1.mp3" length="14232381" type="audio/mpeg"/>
        <itunes:summary><![CDATA[At BMA house, we convened a group of world experts in shared decision making. Inspired by the Salzburg Global Summit meeting we discussed the background, practical challenges, and how to engage patients with their healthThe participants were:Fiona Godlee , editor in chief, BMJ Angela Coulter , director of global initiatives, Foundation for Informed Medical Decision Making Albert Mulley , co-founder, Foundation for Informed Medical Decision Making, and director, Dartmouth Center for Health Care Delivery Science Glyn Elwyn, research professor with an interest in shared decision making, Cardiff University Muir Gray , chair of the Information Standard, Department of Health, and co-editor (with Gerd Gigerenzer of the new book Better Doctors, Better Patients, Better Decisions: Envisioning Health Care 2020 Marion Collict, national programme manager, shared decision making, NHS (UK’s National Health System) Alf Collins , consultant in pain medicine, Taunton and Somerset NHS Foundation Trust, and national clinical lead for Co-Creating Health Margaret McCartney , writer and GP Anu Dhir , junior surgical trainee and co-signatory of the Salzburg Statement Gerd Gigerenzer , director, Center for Adaptive Behaviour and Cognition, Max Planck Institute for Human Behaviour Lisa Schwartz , professor of medicine, Dartmouth Medical School, author (with Steve Woloshin (see below)) of Know Your Chances available free online. Steve Woloshin , professor of medicine, Dartmouth Medical School “e-Patient Dave” deBronkart , co-chair, Society for Participatory Medicine Tessa Richards , analysis editor, BMJ Sue Ziebland , research director of the Health Experiences Research Group and a reader in qualitative health research, Department of Primary Health Care, University of Oxford]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1411</itunes:duration>
                                    </item>
    <item>
        <title>BMJ Round Table Shared Decision - Making Background</title>
        <itunes:title>BMJ Round Table Shared Decision - Making Background</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/bmj-round-table-shared-decision-making-background/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/bmj-round-table-shared-decision-making-background/#comments</comments>        <pubDate>Wed, 28 Aug 2013 11:41:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/bmj-round-table-shared</guid>
                                    <description><![CDATA[<p>At BMA house, we convened a group of world experts in shared decision making. Inspired by the Salzburg Global Summit meeting we discussed the background, practical challenges, and how to engage patients with their health</p>
<p>The participants were:</p>
<p>Fiona Godlee , editor in chief, BMJ </p>
<p>Angela Coulter , director of global initiatives, Foundation for Informed Medical Decision Making </p>
<p>Albert Mulley , co-founder, Foundation for Informed Medical Decision Making, and director, Dartmouth Center for Health Care Delivery Science </p>
<p>Glyn Elwyn, research professor with an interest in shared decision making, Cardiff University </p>
<p>Muir Gray , chair of the Information Standard, Department of Health, and co-editor (with Gerd Gigerenzer of the new book Better Doctors, Better Patients, Better Decisions: Envisioning Health Care 2020 </p>
<p>Marion Collict, national programme manager, shared decision making, NHS (UK’s National Health System) </p>
<p>Alf Collins , consultant in pain medicine, Taunton and Somerset NHS Foundation Trust, and national clinical lead for Co-Creating Health </p>
<p>Margaret McCartney , writer and GP </p>
<p>Anu Dhir , junior surgical trainee and co-signatory of the Salzburg Statement </p>
<p>Gerd Gigerenzer , director, Center for Adaptive Behaviour and Cognition, Max Planck Institute for Human Behaviour </p>
<p>Lisa Schwartz , professor of medicine, Dartmouth Medical School, author (with Steve Woloshin (see below)) of Know Your Chances available free online. </p>
<p>Steve Woloshin , professor of medicine, Dartmouth Medical School </p>
<p>“e-Patient Dave” deBronkart , co-chair, Society for Participatory Medicine </p>
<p>Tessa Richards , analysis editor, BMJ </p>
<p>Sue Ziebland , research director of the Health Experiences Research Group and a reader in qualitative health research, Department of Primary Health Care, University of Oxford</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>At BMA house, we convened a group of world experts in shared decision making. Inspired by the Salzburg Global Summit meeting we discussed the background, practical challenges, and how to engage patients with their health</p>
<p>The participants were:</p>
<p>Fiona Godlee , editor in chief, BMJ </p>
<p>Angela Coulter , director of global initiatives, Foundation for Informed Medical Decision Making </p>
<p>Albert Mulley , co-founder, Foundation for Informed Medical Decision Making, and director, Dartmouth Center for Health Care Delivery Science </p>
<p>Glyn Elwyn, research professor with an interest in shared decision making, Cardiff University </p>
<p>Muir Gray , chair of the Information Standard, Department of Health, and co-editor (with Gerd Gigerenzer of the new book Better Doctors, Better Patients, Better Decisions: Envisioning Health Care 2020 </p>
<p>Marion Collict, national programme manager, shared decision making, NHS (UK’s National Health System) </p>
<p>Alf Collins , consultant in pain medicine, Taunton and Somerset NHS Foundation Trust, and national clinical lead for Co-Creating Health </p>
<p>Margaret McCartney , writer and GP </p>
<p>Anu Dhir , junior surgical trainee and co-signatory of the Salzburg Statement </p>
<p>Gerd Gigerenzer , director, Center for Adaptive Behaviour and Cognition, Max Planck Institute for Human Behaviour </p>
<p>Lisa Schwartz , professor of medicine, Dartmouth Medical School, author (with Steve Woloshin (see below)) of Know Your Chances available free online. </p>
<p>Steve Woloshin , professor of medicine, Dartmouth Medical School </p>
<p>“e-Patient Dave” deBronkart , co-chair, Society for Participatory Medicine </p>
<p>Tessa Richards , analysis editor, BMJ </p>
<p>Sue Ziebland , research director of the Health Experiences Research Group and a reader in qualitative health research, Department of Primary Health Care, University of Oxford</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4409ke/stream_107646883-bmjgroup-bmj-round-table-shared.mp3" length="15919585" type="audio/mpeg"/>
        <itunes:summary><![CDATA[At BMA house, we convened a group of world experts in shared decision making. Inspired by the Salzburg Global Summit meeting we discussed the background, practical challenges, and how to engage patients with their healthThe participants were:Fiona Godlee , editor in chief, BMJ Angela Coulter , director of global initiatives, Foundation for Informed Medical Decision Making Albert Mulley , co-founder, Foundation for Informed Medical Decision Making, and director, Dartmouth Center for Health Care Delivery Science Glyn Elwyn, research professor with an interest in shared decision making, Cardiff University Muir Gray , chair of the Information Standard, Department of Health, and co-editor (with Gerd Gigerenzer of the new book Better Doctors, Better Patients, Better Decisions: Envisioning Health Care 2020 Marion Collict, national programme manager, shared decision making, NHS (UK’s National Health System) Alf Collins , consultant in pain medicine, Taunton and Somerset NHS Foundation Trust, and national clinical lead for Co-Creating Health Margaret McCartney , writer and GP Anu Dhir , junior surgical trainee and co-signatory of the Salzburg Statement Gerd Gigerenzer , director, Center for Adaptive Behaviour and Cognition, Max Planck Institute for Human Behaviour Lisa Schwartz , professor of medicine, Dartmouth Medical School, author (with Steve Woloshin (see below)) of Know Your Chances available free online. Steve Woloshin , professor of medicine, Dartmouth Medical School “e-Patient Dave” deBronkart , co-chair, Society for Participatory Medicine Tessa Richards , analysis editor, BMJ Sue Ziebland , research director of the Health Experiences Research Group and a reader in qualitative health research, Department of Primary Health Care, University of Oxford]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1564</itunes:duration>
                                    </item>
    <item>
        <title>Shared decision making</title>
        <itunes:title>Shared decision making</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/shared-decision-making/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/shared-decision-making/#comments</comments>        <pubDate>Wed, 28 Aug 2013 11:32:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/shared-decision-making</guid>
                                    <description><![CDATA[<p>This week’s podcast is a summary of the shared decision making round table - looking at it’s history, practicalities of implementation and how to get patients involved.</p>
<p>The full round table can be found on bmj.com/podcasts.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week’s podcast is a summary of the shared decision making round table - looking at it’s history, practicalities of implementation and how to get patients involved.</p>
<p>The full round table can be found on bmj.com/podcasts.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/lk13dn/stream_107646135-bmjgroup-shared-decision-making.mp3" length="12204786" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week’s podcast is a summary of the shared decision making round table - looking at it’s history, practicalities of implementation and how to get patients involved.The full round table can be found on bmj.com/podcasts.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1202</itunes:duration>
                                    </item>
    <item>
        <title>ACE to ARB</title>
        <itunes:title>ACE to ARB</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/ace-to-arb/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/ace-to-arb/#comments</comments>        <pubDate>Wed, 28 Aug 2013 11:29:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/ace-to-arb</guid>
                                    <description><![CDATA[<p>Should we screen for prostate cancer? A study published on bmj.com suggests that it doesn’t improve survival rates, and could lead to over treatment. Gabriel Sandblom, of the Karolinska Institute, tells us about his research.</p>
<p>Also, James Ritter, emeritus professor of pharmacology at King’s College London, explains the As in the ABCD of hypertension treatment.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Should we screen for prostate cancer? A study published on bmj.com suggests that it doesn’t improve survival rates, and could lead to over treatment. Gabriel Sandblom, of the Karolinska Institute, tells us about his research.</p>
<p>Also, James Ritter, emeritus professor of pharmacology at King’s College London, explains the As in the ABCD of hypertension treatment.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/lkbyrq/stream_107645903-bmjgroup-ace-to-arb.mp3" length="12431890" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Should we screen for prostate cancer? A study published on bmj.com suggests that it doesn’t improve survival rates, and could lead to over treatment. Gabriel Sandblom, of the Karolinska Institute, tells us about his research.Also, James Ritter, emeritus professor of pharmacology at King’s College London, explains the As in the ABCD of hypertension treatment.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1302</itunes:duration>
                                    </item>
    <item>
        <title>Understanding information</title>
        <itunes:title>Understanding information</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/understanding-information/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/understanding-information/#comments</comments>        <pubDate>Wed, 28 Aug 2013 11:28:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/understanding-information</guid>
                                    <description><![CDATA[<p>Information abounds in our burgeoning knowledge economy, but how much is useful - let alone essential? Martin Dawes from the University of British Colombia tells us about the hierachy of evidence.</p>
<p>Also this week, data journalist and author of Information is Beautiful, David McCandless, talks to us about the power and the pitfalls of graphically representing data.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Information abounds in our burgeoning knowledge economy, but how much is useful - let alone essential? Martin Dawes from the University of British Colombia tells us about the hierachy of evidence.</p>
<p>Also this week, data journalist and author of Information is Beautiful, David McCandless, talks to us about the power and the pitfalls of graphically representing data.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/cd4zwp/stream_107645776-bmjgroup-understanding-information.mp3" length="8656264" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Information abounds in our burgeoning knowledge economy, but how much is useful - let alone essential? Martin Dawes from the University of British Colombia tells us about the hierachy of evidence.Also this week, data journalist and author of Information is Beautiful, David McCandless, talks to us about the power and the pitfalls of graphically representing data.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>900</itunes:duration>
                                    </item>
    <item>
        <title>Artificial pancreas and a genetic ISO</title>
        <itunes:title>Artificial pancreas and a genetic ISO</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/artificial-pancreas-and-a-genetic-iso/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/artificial-pancreas-and-a-genetic-iso/#comments</comments>        <pubDate>Wed, 28 Aug 2013 11:25:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/artificial-pancreas-and-a</guid>
                                    <description><![CDATA[<p>Regulation of genetic testing kits is difficult, so how do we start to control this growing market? Christine Hauskeller, from the ESRC Centre for Genomics in Society at the University of Exeter, discusses her idea for an international standard which will help consumers make the right choices. Also this week, management of type 2 diabetes could be improved using an “artificial pancreas”. Roman Hovorka, principal research associate at the Institute of Metabolic Science, University of Cambridge, describes his new intelligent system for insulin delivery.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Regulation of genetic testing kits is difficult, so how do we start to control this growing market? Christine Hauskeller, from the ESRC Centre for Genomics in Society at the University of Exeter, discusses her idea for an international standard which will help consumers make the right choices. Also this week, management of type 2 diabetes could be improved using an “artificial pancreas”. Roman Hovorka, principal research associate at the Institute of Metabolic Science, University of Cambridge, describes his new intelligent system for insulin delivery.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/i2iy3e/stream_107645565-bmjgroup-artificial-pancreas-and-a.mp3" length="7542815" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Regulation of genetic testing kits is difficult, so how do we start to control this growing market? Christine Hauskeller, from the ESRC Centre for Genomics in Society at the University of Exeter, discusses her idea for an international standard which will help consumers make the right choices. Also this week, management of type 2 diabetes could be improved using an “artificial pancreas”. Roman Hovorka, principal research associate at the Institute of Metabolic Science, University of Cambridge, describes his new intelligent system for insulin delivery.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>765</itunes:duration>
                                    </item>
    <item>
        <title>Travelling when pregnant</title>
        <itunes:title>Travelling when pregnant</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/travelling-when-pregnant/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/travelling-when-pregnant/#comments</comments>        <pubDate>Wed, 28 Aug 2013 11:18:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/travelling-when-pregnant</guid>
                                    <description><![CDATA[<p>The problems associated with arsenic in drinking water have been known for some time, but new research published in the BMJ helps quantify that risk with respect to cardiovascular disease. Yu Chen, New York University School of Medicine, joins us to discuss her research.</p>
<p>Also this week, requests for travel information for pregnant women are on the increase, but the available information is patchy. Lucy Chappell, a lecturer at Kings College London School of Medicine and one of the authors of a new clinical review on the subject, joins us in the studio to talk about the evidence and how to assess risk.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The problems associated with arsenic in drinking water have been known for some time, but new research published in the BMJ helps quantify that risk with respect to cardiovascular disease. Yu Chen, New York University School of Medicine, joins us to discuss her research.</p>
<p>Also this week, requests for travel information for pregnant women are on the increase, but the available information is patchy. Lucy Chappell, a lecturer at Kings College London School of Medicine and one of the authors of a new clinical review on the subject, joins us in the studio to talk about the evidence and how to assess risk.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ta6jmw/stream_107644918-bmjgroup-travelling-when-pregnant.mp3" length="9651183" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The problems associated with arsenic in drinking water have been known for some time, but new research published in the BMJ helps quantify that risk with respect to cardiovascular disease. Yu Chen, New York University School of Medicine, joins us to discuss her research.Also this week, requests for travel information for pregnant women are on the increase, but the available information is patchy. Lucy Chappell, a lecturer at Kings College London School of Medicine and one of the authors of a new clinical review on the subject, joins us in the studio to talk about the evidence and how to assess risk.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>981</itunes:duration>
                                    </item>
    <item>
        <title>Cold homes cost lives</title>
        <itunes:title>Cold homes cost lives</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/cold-homes-cost-lives/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/cold-homes-cost-lives/#comments</comments>        <pubDate>Wed, 28 Aug 2013 11:17:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/cold-homes-cost-lives</guid>
                                    <description><![CDATA[<p>What are the health impacts of cold homes and fuel poverty? Michael Marmot, professor of epidemiology and public health at University College London, talks about findings of the report he co- authored for environmental charity Friends of the Earth.</p>
<p>BMJ editor in chief Fiona Godlee and deputy editor Trish Groves talk about the BMJ Group’s evidence to the UK parliamentary science and technology select committee inquiry into peer review.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>What are the health impacts of cold homes and fuel poverty? Michael Marmot, professor of epidemiology and public health at University College London, talks about findings of the report he co- authored for environmental charity Friends of the Earth.</p>
<p>BMJ editor in chief Fiona Godlee and deputy editor Trish Groves talk about the BMJ Group’s evidence to the UK parliamentary science and technology select committee inquiry into peer review.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jtaaru/stream_107644784-bmjgroup-cold-homes-cost-lives.mp3" length="10338099" type="audio/mpeg"/>
        <itunes:summary><![CDATA[What are the health impacts of cold homes and fuel poverty? Michael Marmot, professor of epidemiology and public health at University College London, talks about findings of the report he co- authored for environmental charity Friends of the Earth.BMJ editor in chief Fiona Godlee and deputy editor Trish Groves talk about the BMJ Group’s evidence to the UK parliamentary science and technology select committee inquiry into peer review.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1054</itunes:duration>
                                    </item>
    <item>
        <title>Prophylaxis for endocarditis</title>
        <itunes:title>Prophylaxis for endocarditis</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/prophylaxis-for-endocarditis/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/prophylaxis-for-endocarditis/#comments</comments>        <pubDate>Wed, 28 Aug 2013 11:15:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/prophylaxis-for-endocarditis</guid>
                                    <description><![CDATA[<p>Richard Peto, renowned epidemiologist at Oxford University, won the BMJ Group lifetime achievement award this week. We hear from him about his work, and some of impact it has had.</p>
<p>Also this week, Martin Thornhill, from the University of Sheffield, talks about his research, which shows the effect of a change to NICE guidance on antibiotic prophylaxis for endocarditis.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Richard Peto, renowned epidemiologist at Oxford University, won the BMJ Group lifetime achievement award this week. We hear from him about his work, and some of impact it has had.</p>
<p>Also this week, Martin Thornhill, from the University of Sheffield, talks about his research, which shows the effect of a change to NICE guidance on antibiotic prophylaxis for endocarditis.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/f3l055/stream_107644617-bmjgroup-prophylaxis-for-endocarditis.mp3" length="7808687" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Richard Peto, renowned epidemiologist at Oxford University, won the BMJ Group lifetime achievement award this week. We hear from him about his work, and some of impact it has had.Also this week, Martin Thornhill, from the University of Sheffield, talks about his research, which shows the effect of a change to NICE guidance on antibiotic prophylaxis for endocarditis.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>860</itunes:duration>
                                    </item>
    <item>
        <title>Climate change and population, sleep and obesity</title>
        <itunes:title>Climate change and population, sleep and obesity</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/climate-change-and-population-sleep-and-obesity/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/climate-change-and-population-sleep-and-obesity/#comments</comments>        <pubDate>Wed, 28 Aug 2013 11:14:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/climate-change-and-population</guid>
                                    <description><![CDATA[<p>In this week’s podcast Babatunde Osotimehin, executive director of the UN population fund, joins us in the studio to talk about climate change and reproductive rights.</p>
<p>Also, Barry Taylor from the University of Otago in New Zealand, describes his research into the link between sleep, BMI, and body fat in children.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this week’s podcast Babatunde Osotimehin, executive director of the UN population fund, joins us in the studio to talk about climate change and reproductive rights.</p>
<p>Also, Barry Taylor from the University of Otago in New Zealand, describes his research into the link between sleep, BMI, and body fat in children.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6niqp7/stream_107644509-bmjgroup-climate-change-and-population.mp3" length="16265906" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this week’s podcast Babatunde Osotimehin, executive director of the UN population fund, joins us in the studio to talk about climate change and reproductive rights.Also, Barry Taylor from the University of Otago in New Zealand, describes his research into the link between sleep, BMI, and body fat in children.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1013</itunes:duration>
                                    </item>
    <item>
        <title>Immunisation and ectopic pregnancy</title>
        <itunes:title>Immunisation and ectopic pregnancy</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/immunisation-and-ectopic-pregnancy/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/immunisation-and-ectopic-pregnancy/#comments</comments>        <pubDate>Wed, 28 Aug 2013 11:12:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/immunisation-and-ectopic</guid>
                                    <description><![CDATA[<p>In this week’s podcast Trish Groves talks to Marzio Babille, UNICEF representative in Chad, about the country with the lowest immunisation rates in the world.</p>
<p>Sophie Cook finds out from Davor Jurkovic, from University College Hospital London, about clinical signs of ectopic pregnancy that may be easy to miss.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this week’s podcast Trish Groves talks to Marzio Babille, UNICEF representative in Chad, about the country with the lowest immunisation rates in the world.</p>
<p>Sophie Cook finds out from Davor Jurkovic, from University College Hospital London, about clinical signs of ectopic pregnancy that may be easy to miss.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/57pp5f/stream_107644359-bmjgroup-immunisation-and-ectopic.mp3" length="13481654" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this week’s podcast Trish Groves talks to Marzio Babille, UNICEF representative in Chad, about the country with the lowest immunisation rates in the world.Sophie Cook finds out from Davor Jurkovic, from University College Hospital London, about clinical signs of ectopic pregnancy that may be easy to miss.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1311</itunes:duration>
                                    </item>
    <item>
        <title>Sharing the pain</title>
        <itunes:title>Sharing the pain</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/sharing-the-pain/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/sharing-the-pain/#comments</comments>        <pubDate>Wed, 28 Aug 2013 11:10:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/sharing-the-pain</guid>
                                    <description><![CDATA[<p>How can doctors and police sharing information help stop violent crime? Jonathan Shepherd, from Cardiff University, explains the Cardiff Violence Prevention Programme - and his research into its effectiveness.</p>
<p>Also this week, as a new antiplatelet agent is being considered by the National Institute for Health and Clinical Excellence (NICE), Albert Ferro, from King’s College London, takes us through this class of drugs, their effectiveness, and their indications.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>How can doctors and police sharing information help stop violent crime? Jonathan Shepherd, from Cardiff University, explains the Cardiff Violence Prevention Programme - and his research into its effectiveness.</p>
<p>Also this week, as a new antiplatelet agent is being considered by the National Institute for Health and Clinical Excellence (NICE), Albert Ferro, from King’s College London, takes us through this class of drugs, their effectiveness, and their indications.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8vvz3h/stream_107644088-bmjgroup-sharing-the-pain.mp3" length="12435068" type="audio/mpeg"/>
        <itunes:summary><![CDATA[How can doctors and police sharing information help stop violent crime? Jonathan Shepherd, from Cardiff University, explains the Cardiff Violence Prevention Programme - and his research into its effectiveness.Also this week, as a new antiplatelet agent is being considered by the National Institute for Health and Clinical Excellence (NICE), Albert Ferro, from King’s College London, takes us through this class of drugs, their effectiveness, and their indications.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1474</itunes:duration>
                                    </item>
    <item>
        <title>Beansprouts and blood pressure</title>
        <itunes:title>Beansprouts and blood pressure</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/beansprouts-and-blood-pressure/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/beansprouts-and-blood-pressure/#comments</comments>        <pubDate>Wed, 28 Aug 2013 11:08:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/beansprouts-and-blood-pressure</guid>
                                    <description><![CDATA[<p>In this week’s podcast, we look at the ups and downs of postural hypotension.</p>
<p>Also, beansprouts have been fingered as the cause of the recent E coli outbreak in Germany, David Payne investigates this microbiological detective story.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this week’s podcast, we look at the ups and downs of postural hypotension.</p>
<p>Also, beansprouts have been fingered as the cause of the recent E coli outbreak in Germany, David Payne investigates this microbiological detective story.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/pllwvu/stream_107643932-bmjgroup-beansprouts-and-blood-pressure.mp3" length="10062434" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this week’s podcast, we look at the ups and downs of postural hypotension.Also, beansprouts have been fingered as the cause of the recent E coli outbreak in Germany, David Payne investigates this microbiological detective story.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1226</itunes:duration>
                                    </item>
    <item>
        <title>A world without smoking</title>
        <itunes:title>A world without smoking</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/a-world-without-smoking/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/a-world-without-smoking/#comments</comments>        <pubDate>Wed, 28 Aug 2013 11:07:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/a-world-without-smoking</guid>
                                    <description><![CDATA[<p>If everyone were to stop smoking, what would be the major public health hazards, and what would happen to health inequalities? Laurence Gruer, director of public health science at NHS Health Scotland, tells podcast producer Duncan Jarvies what his cohort study, examining Scottish women who have never smoked, reveals.</p>
<p>And BMJ web editor David Payne talks to editor-in-chief Fiona Godlee about what came to pass at the BMA Annual Representatives Meeting this week.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>If everyone were to stop smoking, what would be the major public health hazards, and what would happen to health inequalities? Laurence Gruer, director of public health science at NHS Health Scotland, tells podcast producer Duncan Jarvies what his cohort study, examining Scottish women who have never smoked, reveals.</p>
<p>And BMJ web editor David Payne talks to editor-in-chief Fiona Godlee about what came to pass at the BMA Annual Representatives Meeting this week.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gjlna0/stream_107643807-bmjgroup-a-world-without-smoking.mp3" length="7495926" type="audio/mpeg"/>
        <itunes:summary><![CDATA[If everyone were to stop smoking, what would be the major public health hazards, and what would happen to health inequalities? Laurence Gruer, director of public health science at NHS Health Scotland, tells podcast producer Duncan Jarvies what his cohort study, examining Scottish women who have never smoked, reveals.And BMJ web editor David Payne talks to editor-in-chief Fiona Godlee about what came to pass at the BMA Annual Representatives Meeting this week.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1063</itunes:duration>
                                    </item>
    <item>
        <title>Bed blues</title>
        <itunes:title>Bed blues</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/bed-blues/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/bed-blues/#comments</comments>        <pubDate>Wed, 28 Aug 2013 11:05:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/bed-blues</guid>
                                    <description><![CDATA[<p>In this week’s podcast, Margaret McCartney examines Hydration for Health,  Quentin Anstee explains how big a problem non-alcoholic fatty liver disease is, and Patrick Keown explains the association between provision of mental health beds and the involuntary admission of mental health patients.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this week’s podcast, Margaret McCartney examines Hydration for Health,  Quentin Anstee explains how big a problem non-alcoholic fatty liver disease is, and Patrick Keown explains the association between provision of mental health beds and the involuntary admission of mental health patients.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xa2sxy/stream_107643648-bmjgroup-bed-blues.mp3" length="8954355" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this week’s podcast, Margaret McCartney examines Hydration for Health,  Quentin Anstee explains how big a problem non-alcoholic fatty liver disease is, and Patrick Keown explains the association between provision of mental health beds and the involuntary admission of mental health patients.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1215</itunes:duration>
                                    </item>
    <item>
        <title>Artificial organs and surgical research</title>
        <itunes:title>Artificial organs and surgical research</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/artificial-organs-and-surgical-research/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/artificial-organs-and-surgical-research/#comments</comments>        <pubDate>Wed, 28 Aug 2013 11:03:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/artificial-organs-and-surgical</guid>
                                    <description><![CDATA[<p>In this week’s podcast, Duncan Jarvies speaks to Alexander Seifalian, professor of nanotechnology and regenerative medicine, about a groundbreaking procedure that enabled a multinational surgical team to implant an entirely synthetic organ—a trachea—into a patient. And Norman Williams, president of the Royal College of Surgeons, talks about the college’s plans for improving the quality of surgical research.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this week’s podcast, Duncan Jarvies speaks to Alexander Seifalian, professor of nanotechnology and regenerative medicine, about a groundbreaking procedure that enabled a multinational surgical team to implant an entirely synthetic organ—a trachea—into a patient. And Norman Williams, president of the Royal College of Surgeons, talks about the college’s plans for improving the quality of surgical research.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/twn0vw/stream_107643477-bmjgroup-artificial-organs-and-surgical.mp3" length="7542815" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this week’s podcast, Duncan Jarvies speaks to Alexander Seifalian, professor of nanotechnology and regenerative medicine, about a groundbreaking procedure that enabled a multinational surgical team to implant an entirely synthetic organ—a trachea—into a patient. And Norman Williams, president of the Royal College of Surgeons, talks about the college’s plans for improving the quality of surgical research.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>765</itunes:duration>
                                    </item>
    <item>
        <title>Designed for health</title>
        <itunes:title>Designed for health</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/designed-for-health/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/designed-for-health/#comments</comments>        <pubDate>Wed, 28 Aug 2013 11:01:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/designed-for-health</guid>
                                    <description><![CDATA[<p>In this week’s podcast Jeremy Myerson, from the Royal College of Art, tells us how good design techniques can make cities more friendly places to grow old gracefully. Clive Ballard, from Kings College London, explains how important pain relief is for dementia patients.  Elizabeth Draper, from the University of Leicester,  talks us through her investigation into how socioeconomic class affects how women deal with severe congenital abnormalities during pregnancy.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this week’s podcast Jeremy Myerson, from the Royal College of Art, tells us how good design techniques can make cities more friendly places to grow old gracefully. Clive Ballard, from Kings College London, explains how important pain relief is for dementia patients.  Elizabeth Draper, from the University of Leicester,  talks us through her investigation into how socioeconomic class affects how women deal with severe congenital abnormalities during pregnancy.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2snktd/stream_107643326-bmjgroup-designed-for-health.mp3" length="12059462" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this week’s podcast Jeremy Myerson, from the Royal College of Art, tells us how good design techniques can make cities more friendly places to grow old gracefully. Clive Ballard, from Kings College London, explains how important pain relief is for dementia patients.  Elizabeth Draper, from the University of Leicester,  talks us through her investigation into how socioeconomic class affects how women deal with severe congenital abnormalities during pregnancy.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1180</itunes:duration>
                                    </item>
    <item>
        <title>Sharing decisions and data</title>
        <itunes:title>Sharing decisions and data</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/sharing-decisions-and-data/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/sharing-decisions-and-data/#comments</comments>        <pubDate>Wed, 28 Aug 2013 10:59:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/sharing-decisions-and-data</guid>
                                    <description><![CDATA[<p>In this week’s podcast we discuss publishing medical details with former health editor of The Sun, Jacqui Thornton.  Rogaia Abuelgasim Abdelrahim, the UN Population Fund’s deputy representative in Somalia, explains how the drought and subsequent crop failure there has been exacerbated by existing political problems and led to widespread famine. And Natalie Grazin, Assistant Director of the Health Foundation, talks about making shared decision making a reality.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this week’s podcast we discuss publishing medical details with former health editor of The Sun, Jacqui Thornton.  Rogaia Abuelgasim Abdelrahim, the UN Population Fund’s deputy representative in Somalia, explains how the drought and subsequent crop failure there has been exacerbated by existing political problems and led to widespread famine. And Natalie Grazin, Assistant Director of the Health Foundation, talks about making shared decision making a reality.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3ew5uw/stream_107643125-bmjgroup-sharing-decisions-and-data.mp3" length="19333489" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this week’s podcast we discuss publishing medical details with former health editor of The Sun, Jacqui Thornton.  Rogaia Abuelgasim Abdelrahim, the UN Population Fund’s deputy representative in Somalia, explains how the drought and subsequent crop failure there has been exacerbated by existing political problems and led to widespread famine. And Natalie Grazin, Assistant Director of the Health Foundation, talks about making shared decision making a reality.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1609</itunes:duration>
                                    </item>
    <item>
        <title>Tracking down TB</title>
        <itunes:title>Tracking down TB</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/tracking-down-tb/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/tracking-down-tb/#comments</comments>        <pubDate>Wed, 28 Aug 2013 10:57:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/tracking-down-tb</guid>
                                    <description><![CDATA[<p>In this week’s podcast, Sue Rabbit Roff describes how she thinks a system of paid for kidney donations could work in practice.  Al Story, clinical lead of the Find and Treat programme – a travelling team who scour the streets of London for tuberculosis – explains the programme’s mission.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this week’s podcast, Sue Rabbit Roff describes how she thinks a system of paid for kidney donations could work in practice.  Al Story, clinical lead of the Find and Treat programme – a travelling team who scour the streets of London for tuberculosis – explains the programme’s mission.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/1h1qk2/stream_107643022-bmjgroup-tracking-down-tb.mp3" length="12546084" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this week’s podcast, Sue Rabbit Roff describes how she thinks a system of paid for kidney donations could work in practice.  Al Story, clinical lead of the Find and Treat programme – a travelling team who scour the streets of London for tuberculosis – explains the programme’s mission.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1042</itunes:duration>
                                    </item>
    <item>
        <title>Doctors in the danger zone</title>
        <itunes:title>Doctors in the danger zone</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/doctors-in-the-danger-zone/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/doctors-in-the-danger-zone/#comments</comments>        <pubDate>Wed, 28 Aug 2013 10:55:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/doctors-in-the-danger-zone</guid>
                                    <description><![CDATA[<p>A recent study compared cost efficiency of different healthcare systems around the world. We hear from Colin Pritchard, from Bournemouth University,  about how the NHS came out near the top.  Also this week, the International Committee of the Red Cross has a mandate under the Geneva convention to protect the victims of both international and internal armed conflict. Head of mission Geoff Loane explains why they’re finding that increasingly difficult to do.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>A recent study compared cost efficiency of different healthcare systems around the world. We hear from Colin Pritchard, from Bournemouth University,  about how the NHS came out near the top.  Also this week, the International Committee of the Red Cross has a mandate under the Geneva convention to protect the victims of both international and internal armed conflict. Head of mission Geoff Loane explains why they’re finding that increasingly difficult to do.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/0t7y9j/stream_107642854-bmjgroup-doctors-in-the-danger-zone.mp3" length="11503684" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A recent study compared cost efficiency of different healthcare systems around the world. We hear from Colin Pritchard, from Bournemouth University,  about how the NHS came out near the top.  Also this week, the International Committee of the Red Cross has a mandate under the Geneva convention to protect the victims of both international and internal armed conflict. Head of mission Geoff Loane explains why they’re finding that increasingly difficult to do.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>955</itunes:duration>
                                    </item>
    <item>
        <title>Global Health and TB</title>
        <itunes:title>Global Health and TB</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/global-health-and-tb/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/global-health-and-tb/#comments</comments>        <pubDate>Wed, 28 Aug 2013 10:50:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/global-health-and-tb</guid>
                                    <description><![CDATA[<p>Last week BMJ Group held an inaugural global health conference http://globalhealth.bmj.com/ in London, looking at policies for sustainable and effective healthcare. David Heymann, chair of the UK Health Protection Agency, and Martha Gyansa-Lutterodt, Director of Pharmaceuticals at the Ministry of Health, Ghana, discuss how vertical aid programmes can lead to systemic improvements in lower income countries.  And, Kalipso Chalkidou, Director of NICE International, explains a bit more about its work.</p>
<p>Also, smoking is known to increase TB mortality. A modelling study this week suggests that the number of excess deaths from TB, caused by tobacco consumption, could be as high as 40 million over the next 40 years.  Stanton Glantz, Director of the Centre for Tobacco Control Research and Education at the University of California, San Francisco, joins us to set out the numbers.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Last week BMJ Group held an inaugural global health conference http://globalhealth.bmj.com/ in London, looking at policies for sustainable and effective healthcare. David Heymann, chair of the UK Health Protection Agency, and Martha Gyansa-Lutterodt, Director of Pharmaceuticals at the Ministry of Health, Ghana, discuss how vertical aid programmes can lead to systemic improvements in lower income countries.  And, Kalipso Chalkidou, Director of NICE International, explains a bit more about its work.</p>
<p>Also, smoking is known to increase TB mortality. A modelling study this week suggests that the number of excess deaths from TB, caused by tobacco consumption, could be as high as 40 million over the next 40 years.  Stanton Glantz, Director of the Centre for Tobacco Control Research and Education at the University of California, San Francisco, joins us to set out the numbers.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/w6nel2/stream_107642313-bmjgroup-global-health-and-tb.mp3" length="17855731" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Last week BMJ Group held an inaugural global health conference http://globalhealth.bmj.com/ in London, looking at policies for sustainable and effective healthcare. David Heymann, chair of the UK Health Protection Agency, and Martha Gyansa-Lutterodt, Director of Pharmaceuticals at the Ministry of Health, Ghana, discuss how vertical aid programmes can lead to systemic improvements in lower income countries.  And, Kalipso Chalkidou, Director of NICE International, explains a bit more about its work.Also, smoking is known to increase TB mortality. A modelling study this week suggests that the number of excess deaths from TB, caused by tobacco consumption, could be as high as 40 million over the next 40 years.  Stanton Glantz, Director of the Centre for Tobacco Control Research and Education at the University of California, San Francisco, joins us to set out the numbers.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1484</itunes:duration>
                                    </item>
    <item>
        <title>Drink, drugs, and comic book villains</title>
        <itunes:title>Drink, drugs, and comic book villains</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/drink-drugs-and-comic-book-villains/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/drink-drugs-and-comic-book-villains/#comments</comments>        <pubDate>Wed, 28 Aug 2013 10:48:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/drink-drugs-and-comic-book</guid>
                                    <description><![CDATA[<p>In this week’s podcast, Shaun Walker reports on alcohol consumption in Russia. Ewan Hoyle explains why he wants the Lib Dems to discuss drug policy. And we found out how realistic comic book villains’ mental health problems are.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this week’s podcast, Shaun Walker reports on alcohol consumption in Russia. Ewan Hoyle explains why he wants the Lib Dems to discuss drug policy. And we found out how realistic comic book villains’ mental health problems are.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/1j585w/stream_107642138-bmjgroup-drink-drugs-and-comic-book.mp3" length="14804069" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this week’s podcast, Shaun Walker reports on alcohol consumption in Russia. Ewan Hoyle explains why he wants the Lib Dems to discuss drug policy. And we found out how realistic comic book villains’ mental health problems are.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1231</itunes:duration>
                                    </item>
    <item>
        <title>Facing the dragon</title>
        <itunes:title>Facing the dragon</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/facing-the-dragon/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/facing-the-dragon/#comments</comments>        <pubDate>Wed, 28 Aug 2013 10:47:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/facing-the-dragon</guid>
                                    <description><![CDATA[<p>This week, chocolate is good for your emotional heart, but what about your physical one? Oscar Franco, clinical lecturer in public health at the University of Cambridge, tells us about the results of his recent meta-analysis.</p>
<p>Also, Irfan Dhalla , an internist and lecturer at the University of Toronto, highlights the problem of opioid related death in the USA, and how he thinks we can avoid a crisis.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week, chocolate is good for your emotional heart, but what about your physical one? Oscar Franco, clinical lecturer in public health at the University of Cambridge, tells us about the results of his recent meta-analysis.</p>
<p>Also, Irfan Dhalla , an internist and lecturer at the University of Toronto, highlights the problem of opioid related death in the USA, and how he thinks we can avoid a crisis.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/nlx42i/stream_107642017-bmjgroup-facing-the-dragon.mp3" length="14390909" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week, chocolate is good for your emotional heart, but what about your physical one? Oscar Franco, clinical lecturer in public health at the University of Cambridge, tells us about the results of his recent meta-analysis.Also, Irfan Dhalla , an internist and lecturer at the University of Toronto, highlights the problem of opioid related death in the USA, and how he thinks we can avoid a crisis.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1197</itunes:duration>
                                    </item>
    <item>
        <title>Unprecedented access</title>
        <itunes:title>Unprecedented access</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/unprecedented-access/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/unprecedented-access/#comments</comments>        <pubDate>Wed, 28 Aug 2013 10:45:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/unprecedented-access</guid>
                                    <description><![CDATA[<p>John Young, professor of elderly care medicine at Leeds University, gives Mabel Chew tips on carrying out a cognitive assessment of an older person. Also this week, Harlan Krumholz explains to Deborah Cohen how he got Medtronic to agree to independent scrutiny of their data that is “unprecedented in the medical industry”.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>John Young, professor of elderly care medicine at Leeds University, gives Mabel Chew tips on carrying out a cognitive assessment of an older person. Also this week, Harlan Krumholz explains to Deborah Cohen how he got Medtronic to agree to independent scrutiny of their data that is “unprecedented in the medical industry”.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/r3a2ck/stream_107641838-bmjgroup-unprecedented-access.mp3" length="15033332" type="audio/mpeg"/>
        <itunes:summary><![CDATA[John Young, professor of elderly care medicine at Leeds University, gives Mabel Chew tips on carrying out a cognitive assessment of an older person. Also this week, Harlan Krumholz explains to Deborah Cohen how he got Medtronic to agree to independent scrutiny of their data that is “unprecedented in the medical industry”.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1249</itunes:duration>
                                    </item>
    <item>
        <title>Mental health and mortality</title>
        <itunes:title>Mental health and mortality</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/mental-health-and-mortality/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/mental-health-and-mortality/#comments</comments>        <pubDate>Wed, 28 Aug 2013 10:44:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/mental-health-and-mortality</guid>
                                    <description><![CDATA[<p>Research has found that the gap in all-cause mortality between psychiatric patients after discharge, and the general population, is growing. Uy Hoang (Oxford University) tells us what his paper reveals about the trend, and we discuss possible ways to tackle the disparity with Fiona Gaughran and Shubulade Smith  (Institute of Psychiatry, South London and Maudsley NHS Foundation Trust).</p>
<p>Also, a UN conference this week aims to tackle non-communicable disease. Rebecca Coombes, BMJ features editor, explains how they’re doing that, and some of the problems with the negotiations.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Research has found that the gap in all-cause mortality between psychiatric patients after discharge, and the general population, is growing. Uy Hoang (Oxford University) tells us what his paper reveals about the trend, and we discuss possible ways to tackle the disparity with Fiona Gaughran and Shubulade Smith  (Institute of Psychiatry, South London and Maudsley NHS Foundation Trust).</p>
<p>Also, a UN conference this week aims to tackle non-communicable disease. Rebecca Coombes, BMJ features editor, explains how they’re doing that, and some of the problems with the negotiations.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/szthyx/stream_107641690-bmjgroup-mental-health-and-mortality.mp3" length="12915427" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Research has found that the gap in all-cause mortality between psychiatric patients after discharge, and the general population, is growing. Uy Hoang (Oxford University) tells us what his paper reveals about the trend, and we discuss possible ways to tackle the disparity with Fiona Gaughran and Shubulade Smith  (Institute of Psychiatry, South London and Maudsley NHS Foundation Trust).Also, a UN conference this week aims to tackle non-communicable disease. Rebecca Coombes, BMJ features editor, explains how they’re doing that, and some of the problems with the negotiations.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1074</itunes:duration>
                                    </item>
    <item>
        <title>Caring for the carers</title>
        <itunes:title>Caring for the carers</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/caring-for-the-carers/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/caring-for-the-carers/#comments</comments>        <pubDate>Wed, 28 Aug 2013 10:41:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/caring-for-the-carers</guid>
                                    <description><![CDATA[<p>This week, the UK’s General Medical Council is reviewing its standards of good medical practice. Helen Jaques quizzes Niall Dickson, the council’s chief executive, about the possible changes.</p>
<p>Also this week, Ian Cameron, head of the rehabilitation studies unit at the University of Sydney, explains how doctors should care for the carers of older patients.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week, the UK’s General Medical Council is reviewing its standards of good medical practice. Helen Jaques quizzes Niall Dickson, the council’s chief executive, about the possible changes.</p>
<p>Also this week, Ian Cameron, head of the rehabilitation studies unit at the University of Sydney, explains how doctors should care for the carers of older patients.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dcle7g/stream_107641475-bmjgroup-caring-for-the-carers.mp3" length="12193998" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week, the UK’s General Medical Council is reviewing its standards of good medical practice. Helen Jaques quizzes Niall Dickson, the council’s chief executive, about the possible changes.Also this week, Ian Cameron, head of the rehabilitation studies unit at the University of Sydney, explains how doctors should care for the carers of older patients.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1012</itunes:duration>
                                    </item>
    <item>
        <title>10 Lords revolting</title>
        <itunes:title>10 Lords revolting</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/10-lords-revolting/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/10-lords-revolting/#comments</comments>        <pubDate>Tue, 27 Aug 2013 17:44:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/10-lords-revolting</guid>
                                    <description><![CDATA[<p>Seth Berkley, CEO of GAVI (formerly the “Global Alliance for Vaccines and Immunisation”), talks to Rebecca Coombes about the future of vaccination funding.  Also this week, the Health and Social Care bill, set to change the English NHS, is about to enter the House of Lords before becoming law.  We find out which areas will receive most scrutiny from members of the Upper House from liberal democrat peer Baroness Shirley Williams of Crosby, a leading critic of the changes.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Seth Berkley, CEO of GAVI (formerly the “Global Alliance for Vaccines and Immunisation”), talks to Rebecca Coombes about the future of vaccination funding.  Also this week, the Health and Social Care bill, set to change the English NHS, is about to enter the House of Lords before becoming law.  We find out which areas will receive most scrutiny from members of the Upper House from liberal democrat peer Baroness Shirley Williams of Crosby, a leading critic of the changes.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/z4ek7o/stream_107518870-bmjgroup-10-lords-revolting.mp3" length="12273517" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Seth Berkley, CEO of GAVI (formerly the “Global Alliance for Vaccines and Immunisation”), talks to Rebecca Coombes about the future of vaccination funding.  Also this week, the Health and Social Care bill, set to change the English NHS, is about to enter the House of Lords before becoming law.  We find out which areas will receive most scrutiny from members of the Upper House from liberal democrat peer Baroness Shirley Williams of Crosby, a leading critic of the changes.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1021</itunes:duration>
                                    </item>
    <item>
        <title>Regulating education, and respiratory infections</title>
        <itunes:title>Regulating education, and respiratory infections</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/regulating-education-and-respiratory-infections/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/regulating-education-and-respiratory-infections/#comments</comments>        <pubDate>Tue, 27 Aug 2013 17:39:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/regulating-education-and</guid>
                                    <description><![CDATA[<p>The Health and Social Care Bill for England has now reached the House of Lords. With the proposed demise of deaneries, questions still remain about how medical training will be carried out in the future. Niall Dickson, chief executive of the General Medical Council, explains how the council hopes to maintain professional standards whatever the outcome, and what changes to postgraduate education are on the horizon. Also this week, James Chalmers takes us through the steps in treating a non-responding presumed lower respiratory tract infection.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The Health and Social Care Bill for England has now reached the House of Lords. With the proposed demise of deaneries, questions still remain about how medical training will be carried out in the future. Niall Dickson, chief executive of the General Medical Council, explains how the council hopes to maintain professional standards whatever the outcome, and what changes to postgraduate education are on the horizon. Also this week, James Chalmers takes us through the steps in treating a non-responding presumed lower respiratory tract infection.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/0ef37n/stream_107518174-bmjgroup-regulating-education-and.mp3" length="13374908" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The Health and Social Care Bill for England has now reached the House of Lords. With the proposed demise of deaneries, questions still remain about how medical training will be carried out in the future. Niall Dickson, chief executive of the General Medical Council, explains how the council hopes to maintain professional standards whatever the outcome, and what changes to postgraduate education are on the horizon. Also this week, James Chalmers takes us through the steps in treating a non-responding presumed lower respiratory tract infection.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1112</itunes:duration>
                                    </item>
    <item>
        <title>Climate, health, and security</title>
        <itunes:title>Climate, health, and security</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/climate-health-and-security/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/climate-health-and-security/#comments</comments>        <pubDate>Tue, 27 Aug 2013 17:37:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/climate-health-and-security</guid>
                                    <description><![CDATA[<p>Hugh Montgomery, director of the University College London Institute for Human Health & Performance, talks about the space where climate, health, and international security meet.  Christabel Owens, head of mental health research at the Devon Partnership NHS Trust, explains why warning signs for suicidal thoughts may not be visible to those best placed to spot them.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Hugh Montgomery, director of the University College London Institute for Human Health & Performance, talks about the space where climate, health, and international security meet.  Christabel Owens, head of mental health research at the Devon Partnership NHS Trust, explains why warning signs for suicidal thoughts may not be visible to those best placed to spot them.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wnf1wc/stream_107517958-bmjgroup-climate-health-and-security.mp3" length="10319032" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Hugh Montgomery, director of the University College London Institute for Human Health & Performance, talks about the space where climate, health, and international security meet.  Christabel Owens, head of mental health research at the Devon Partnership NHS Trust, explains why warning signs for suicidal thoughts may not be visible to those best placed to spot them.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>856</itunes:duration>
                                    </item>
    <item>
        <title>Decriminalisation of drugs in Portugal</title>
        <itunes:title>Decriminalisation of drugs in Portugal</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/decriminalisation-of-drugs-in-portugal/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/decriminalisation-of-drugs-in-portugal/#comments</comments>        <pubDate>Tue, 27 Aug 2013 17:35:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/decriminalisation-of-drugs-in</guid>
                                    <description><![CDATA[<p>In 2001 Portugal abolished all criminal penalties for personal possession of drugs – effectively decriminalising their use. Health journalist Nigel Hawkes talks to João Goulão, Portugal’s drug tsar, to find out how effective this policy change has been.</p>
<p>Also, the General Medical Council is introducing revalidation for doctors. Part of that revalidation will require input from a doctor’s colleagues and patients. We hear from John Campbell, Peninsula College of Medicine and Dentistry, about possible independent factors that could affect the scores.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In 2001 Portugal abolished all criminal penalties for personal possession of drugs – effectively decriminalising their use. Health journalist Nigel Hawkes talks to João Goulão, Portugal’s drug tsar, to find out how effective this policy change has been.</p>
<p>Also, the General Medical Council is introducing revalidation for doctors. Part of that revalidation will require input from a doctor’s colleagues and patients. We hear from John Campbell, Peninsula College of Medicine and Dentistry, about possible independent factors that could affect the scores.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3nr9do/stream_107517709-bmjgroup-decriminalisation-of-drugs-in.mp3" length="13270682" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In 2001 Portugal abolished all criminal penalties for personal possession of drugs – effectively decriminalising their use. Health journalist Nigel Hawkes talks to João Goulão, Portugal’s drug tsar, to find out how effective this policy change has been.Also, the General Medical Council is introducing revalidation for doctors. Part of that revalidation will require input from a doctor’s colleagues and patients. We hear from John Campbell, Peninsula College of Medicine and Dentistry, about possible independent factors that could affect the scores.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1103</itunes:duration>
                                    </item>
    <item>
        <title>Watching receptionists, watching weight</title>
        <itunes:title>Watching receptionists, watching weight</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/watching-receptionists-watching-weight/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/watching-receptionists-watching-weight/#comments</comments>        <pubDate>Tue, 27 Aug 2013 17:32:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/watching-receptionists</guid>
                                    <description><![CDATA[<p>One way of tackling obesity is by attending a weight loss club, such as WeightWatchers . There are many such schemes available on the NHS, but which one is the most effective? We find out the results of an RCT that aims to find out.  Also this week, ethnographic studies aren’t just limited to lost tribes. We find out what observation of receptionists in general practice surgeries uncovered.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>One way of tackling obesity is by attending a weight loss club, such as WeightWatchers . There are many such schemes available on the NHS, but which one is the most effective? We find out the results of an RCT that aims to find out.  Also this week, ethnographic studies aren’t just limited to lost tribes. We find out what observation of receptionists in general practice surgeries uncovered.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/v6kg30/stream_107517352-bmjgroup-watching-receptionists.mp3" length="12690815" type="audio/mpeg"/>
        <itunes:summary><![CDATA[One way of tackling obesity is by attending a weight loss club, such as WeightWatchers . There are many such schemes available on the NHS, but which one is the most effective? We find out the results of an RCT that aims to find out.  Also this week, ethnographic studies aren’t just limited to lost tribes. We find out what observation of receptionists in general practice surgeries uncovered.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1054</itunes:duration>
                                    </item>
    <item>
        <title>Undernutrition in India</title>
        <itunes:title>Undernutrition in India</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/undernutrition-in-india/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/undernutrition-in-india/#comments</comments>        <pubDate>Tue, 27 Aug 2013 17:30:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/undernutrition-in-india</guid>
                                    <description><![CDATA[<p>Tessa Richards (BMJ’s analysis editor) and Duncan Jarvies (BMJ’s multimedia producer) talk to Veena Rao (adviser at Karnataka Nutrition Mission, India) about the issue of undernutrion in the country.</p>
<p>And David Payne (BMJ’s web editor) gives us a run-down of the new bmj.com.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Tessa Richards (BMJ’s analysis editor) and Duncan Jarvies (BMJ’s multimedia producer) talk to Veena Rao (adviser at Karnataka Nutrition Mission, India) about the issue of undernutrion in the country.</p>
<p>And David Payne (BMJ’s web editor) gives us a run-down of the new bmj.com.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/37d9la/stream_107517160-bmjgroup-undernutrition-in-india.mp3" length="13544868" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Tessa Richards (BMJ’s analysis editor) and Duncan Jarvies (BMJ’s multimedia producer) talk to Veena Rao (adviser at Karnataka Nutrition Mission, India) about the issue of undernutrion in the country.And David Payne (BMJ’s web editor) gives us a run-down of the new bmj.com.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1122</itunes:duration>
                                    </item>
    <item>
        <title>Sudden death in epilepsy; NAFLD mortality</title>
        <itunes:title>Sudden death in epilepsy; NAFLD mortality</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/sudden-death-in-epilepsy-nafld-mortality/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/sudden-death-in-epilepsy-nafld-mortality/#comments</comments>        <pubDate>Tue, 27 Aug 2013 17:29:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/sudden-death-in-epilepsy-nafld</guid>
                                    <description><![CDATA[<p>Mariana Lazo, from Johns Hopkins Bloomberg School of Public Health, tells us how non-alcoholic fatty liver disease has affected all cause mortality in the US. Also, Ley Sander, from University College London, discusses the problem of sudden death in epilepsy.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Mariana Lazo, from Johns Hopkins Bloomberg School of Public Health, tells us how non-alcoholic fatty liver disease has affected all cause mortality in the US. Also, Ley Sander, from University College London, discusses the problem of sudden death in epilepsy.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/pan56i/stream_107516954-bmjgroup-sudden-death-in-epilepsy-nafld.mp3" length="11001683" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Mariana Lazo, from Johns Hopkins Bloomberg School of Public Health, tells us how non-alcoholic fatty liver disease has affected all cause mortality in the US. Also, Ley Sander, from University College London, discusses the problem of sudden death in epilepsy.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>913</itunes:duration>
                                    </item>
    <item>
        <title>Evolved to run</title>
        <itunes:title>Evolved to run</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/evolved-to-run/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/evolved-to-run/#comments</comments>        <pubDate>Tue, 27 Aug 2013 17:27:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/evolved-to-run</guid>
                                    <description><![CDATA[<p>This week’s podcast is from UKSEM, the big sports and exercise medicine conference in London. Daniel Lieberman, an evolutionary biologist from Harvard, explains how we have evolved to run. Steven Blair, University of South Carolina, explains how physical inactivity is having serious effects on our health. Finally Karim Khan, BJSM’s editor, tells us how much exercise gives you the most bang for your buck.</p>
<p>If you’re interested in sports medicine, then have a listen to the BJSM podcast, where your can find more interviews with world leaders in sports medicine - http://podcasts.bmj.com/bjsm</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week’s podcast is from UKSEM, the big sports and exercise medicine conference in London. Daniel Lieberman, an evolutionary biologist from Harvard, explains how we have evolved to run. Steven Blair, University of South Carolina, explains how physical inactivity is having serious effects on our health. Finally Karim Khan, BJSM’s editor, tells us how much exercise gives you the most bang for your buck.</p>
<p>If you’re interested in sports medicine, then have a listen to the BJSM podcast, where your can find more interviews with world leaders in sports medicine - http://podcasts.bmj.com/bjsm</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/k6f363/stream_107516784-bmjgroup-evolved-to-run.mp3" length="11764763" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week’s podcast is from UKSEM, the big sports and exercise medicine conference in London. Daniel Lieberman, an evolutionary biologist from Harvard, explains how we have evolved to run. Steven Blair, University of South Carolina, explains how physical inactivity is having serious effects on our health. Finally Karim Khan, BJSM’s editor, tells us how much exercise gives you the most bang for your buck.If you’re interested in sports medicine, then have a listen to the BJSM podcast, where your can find more interviews with world leaders in sports medicine - http://podcasts.bmj.com/bjsm]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>982</itunes:duration>
                                    </item>
    <item>
        <title>AIDS at 30</title>
        <itunes:title>AIDS at 30</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/aids-at-30/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/aids-at-30/#comments</comments>        <pubDate>Tue, 27 Aug 2013 17:25:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/aids-at-30</guid>
                                    <description><![CDATA[<p>To mark World AIDS Day, the WHO has issued a report outlining policy successes and failures in the diagnosis and treatment of HIV/AIDS. Yves Souteyrand, the co-ordinator of the report, joins us to discuss its findings and how to combat the disease in the future.</p>
<p>Alan White, professor of men's health at Leeds Metropolitan University and the author of a new European report into men's health, explains why we need to look at men differently.</p>
<p>Finally, renowned surgeon Atul Gawande launches the BMJ's 2011 Christmas appeal, in aid of charity Lifebox, by describing how a cheap reliable pulse oximeter costing £160 should be available in all operating theatres. You can donate at www.lifebox.org/donations</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To mark World AIDS Day, the WHO has issued a report outlining policy successes and failures in the diagnosis and treatment of HIV/AIDS. Yves Souteyrand, the co-ordinator of the report, joins us to discuss its findings and how to combat the disease in the future.</p>
<p>Alan White, professor of men's health at Leeds Metropolitan University and the author of a new European report into men's health, explains why we need to look at men differently.</p>
<p>Finally, renowned surgeon Atul Gawande launches the BMJ's 2011 Christmas appeal, in aid of charity Lifebox, by describing how a cheap reliable pulse oximeter costing £160 should be available in all operating theatres. You can donate at www.lifebox.org/donations</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/yhpgex/stream_107516504-bmjgroup-aids-at-30.mp3" length="18819944" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To mark World AIDS Day, the WHO has issued a report outlining policy successes and failures in the diagnosis and treatment of HIV/AIDS. Yves Souteyrand, the co-ordinator of the report, joins us to discuss its findings and how to combat the disease in the future.Alan White, professor of men's health at Leeds Metropolitan University and the author of a new European report into men's health, explains why we need to look at men differently.Finally, renowned surgeon Atul Gawande launches the BMJ's 2011 Christmas appeal, in aid of charity Lifebox, by describing how a cheap reliable pulse oximeter costing £160 should be available in all operating theatres. You can donate at www.lifebox.org/donations]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1565</itunes:duration>
                                    </item>
    <item>
        <title>Brain drain</title>
        <itunes:title>Brain drain</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/brain-drain-1680600494/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/brain-drain-1680600494/#comments</comments>        <pubDate>Tue, 27 Aug 2013 17:19:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/brain-drain</guid>
                                    <description><![CDATA[<p>How much does it cost sub-Saharan countries to train all the doctors who end up working in the UK, US, Canada, and Australia? Edward Mills from the University of Ottawa explains his economic analysis of healthcare migration. Also Hungarian health minister Miklós Szócska talks about his country's challenges and plans when it comes to improving health outcomes, currently among the worst in Europe.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>How much does it cost sub-Saharan countries to train all the doctors who end up working in the UK, US, Canada, and Australia? Edward Mills from the University of Ottawa explains his economic analysis of healthcare migration. Also Hungarian health minister Miklós Szócska talks about his country's challenges and plans when it comes to improving health outcomes, currently among the worst in Europe.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qjjpih/stream_107515843-bmjgroup-brain-drain.mp3" length="15272625" type="audio/mpeg"/>
        <itunes:summary><![CDATA[How much does it cost sub-Saharan countries to train all the doctors who end up working in the UK, US, Canada, and Australia? Edward Mills from the University of Ottawa explains his economic analysis of healthcare migration. Also Hungarian health minister Miklós Szócska talks about his country's challenges and plans when it comes to improving health outcomes, currently among the worst in Europe.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1269</itunes:duration>
                                    </item>
    <item>
        <title>Death in Borsetshire</title>
        <itunes:title>Death in Borsetshire</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/death-in-borsetshire/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/death-in-borsetshire/#comments</comments>        <pubDate>Tue, 27 Aug 2013 17:17:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/death-in-borsetshire</guid>
                                    <description><![CDATA[<p>Vanessa Whitburn, editor of BBC Radio 4’s The Archers, talks morbidity and mortality in Ambridge. James Raftery, University of Southampton, updates the Forrest Report – whose evidence prompted the breast cancer screening programme in the UK.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Vanessa Whitburn, editor of BBC Radio 4’s The Archers, talks morbidity and mortality in Ambridge. James Raftery, University of Southampton, updates the Forrest Report – whose evidence prompted the breast cancer screening programme in the UK.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/z2qcgl/stream_107515628-bmjgroup-death-in-borsetshire.mp3" length="14092058" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Vanessa Whitburn, editor of BBC Radio 4’s The Archers, talks morbidity and mortality in Ambridge. James Raftery, University of Southampton, updates the Forrest Report – whose evidence prompted the breast cancer screening programme in the UK.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1171</itunes:duration>
                                    </item>
    <item>
        <title>2011    </title>
        <itunes:title>2011    </itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/2011-1680600497/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/2011-1680600497/#comments</comments>        <pubDate>Tue, 27 Aug 2013 17:16:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/2011-1</guid>
                                    <description><![CDATA[<p>Somehow we've come to the end of another year. The Independent's health editor Jeremy Laurance talks us through the big health stories from 2011.</p>
<p>And Greg Scott discusses his Christmas paper on the phrase "obs stable", and what it's revealed these two words have actually come to mean to hospital doctors.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Somehow we've come to the end of another year. The Independent's health editor Jeremy Laurance talks us through the big health stories from 2011.</p>
<p>And Greg Scott discusses his Christmas paper on the phrase "obs stable", and what it's revealed these two words have actually come to mean to hospital doctors.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/k27k1q/stream_107515417-bmjgroup-2011-1.mp3" length="18252108" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Somehow we've come to the end of another year. The Independent's health editor Jeremy Laurance talks us through the big health stories from 2011.And Greg Scott discusses his Christmas paper on the phrase "obs stable", and what it's revealed these two words have actually come to mean to hospital doctors.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1518</itunes:duration>
                                    </item>
    <item>
        <title>Missing data</title>
        <itunes:title>Missing data</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/missing-data/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/missing-data/#comments</comments>        <pubDate>Tue, 27 Aug 2013 17:13:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/missing-data</guid>
                                    <description><![CDATA[<p>The problem of missing data is well known, especially in cases where drug companies conceal evidence. However pharmaceutical industry misconduct is not the only cause, and a cluster of papers in this week's BMJ show how aspects of the culture of medical science contribute to the problem.</p>
<p>Elizabeth Loder, BMJ's clinical editor, talks to Harlan Krumholz (Harold H Hines Jr professor of medicine at Yale University) and Joseph Ross (assistant professor of medicine, also at Yale) about missing data from US publicly funded trials. Lisa Bero (professor at the Department of Clinical Pharmacy, University of California) describes how adding missing data to meta-analyses of drug trials can change the results, and Richard Riley (senior lecturer in medical statistics at Birmingham University) explains why individual participant meta-analyses aren't as balanced as we may think.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The problem of missing data is well known, especially in cases where drug companies conceal evidence. However pharmaceutical industry misconduct is not the only cause, and a cluster of papers in this week's BMJ show how aspects of the culture of medical science contribute to the problem.</p>
<p>Elizabeth Loder, BMJ's clinical editor, talks to Harlan Krumholz (Harold H Hines Jr professor of medicine at Yale University) and Joseph Ross (assistant professor of medicine, also at Yale) about missing data from US publicly funded trials. Lisa Bero (professor at the Department of Clinical Pharmacy, University of California) describes how adding missing data to meta-analyses of drug trials can change the results, and Richard Riley (senior lecturer in medical statistics at Birmingham University) explains why individual participant meta-analyses aren't as balanced as we may think.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5hnj8d/stream_107515144-bmjgroup-missing-data.mp3" length="16926926" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The problem of missing data is well known, especially in cases where drug companies conceal evidence. However pharmaceutical industry misconduct is not the only cause, and a cluster of papers in this week's BMJ show how aspects of the culture of medical science contribute to the problem.Elizabeth Loder, BMJ's clinical editor, talks to Harlan Krumholz (Harold H Hines Jr professor of medicine at Yale University) and Joseph Ross (assistant professor of medicine, also at Yale) about missing data from US publicly funded trials. Lisa Bero (professor at the Department of Clinical Pharmacy, University of California) describes how adding missing data to meta-analyses of drug trials can change the results, and Richard Riley (senior lecturer in medical statistics at Birmingham University) explains why individual participant meta-analyses aren't as balanced as we may think.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1405</itunes:duration>
                                    </item>
    <item>
        <title>Surgical performance</title>
        <itunes:title>Surgical performance</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/surgical-performance/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/surgical-performance/#comments</comments>        <pubDate>Tue, 27 Aug 2013 17:11:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/surgical-performance</guid>
                                    <description><![CDATA[<p>Antoine Declos, Université de Lyon, explains the performance curve of surgeons as they become more experienced. Peter Wilmshurst, Royal Shrewsbury Hospital, and veteran whistleblower explains why it may be harder to expose the truth in a lab, than on the ward.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Antoine Declos, Université de Lyon, explains the performance curve of surgeons as they become more experienced. Peter Wilmshurst, Royal Shrewsbury Hospital, and veteran whistleblower explains why it may be harder to expose the truth in a lab, than on the ward.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8hq972/stream_107514878-bmjgroup-surgical-performance.mp3" length="9817669" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Antoine Declos, Université de Lyon, explains the performance curve of surgeons as they become more experienced. Peter Wilmshurst, Royal Shrewsbury Hospital, and veteran whistleblower explains why it may be harder to expose the truth in a lab, than on the ward.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>814</itunes:duration>
                                    </item>
    <item>
        <title>Antidepressants and tamiflu</title>
        <itunes:title>Antidepressants and tamiflu</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/antidepressants-and-tamiflu/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/antidepressants-and-tamiflu/#comments</comments>        <pubDate>Tue, 27 Aug 2013 17:09:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/antidepressants-and-tamiflu</guid>
                                    <description><![CDATA[<p>Simon Hatcher, associate professor of psychiatry at the University of Aukland, sets out the use of newer antidepressants for the treatment of depression in adults. Deborah Cohen, BMJ's investigations editor, updates us on the Tamiflu saga, and how Roche is still holding onto its full patient data.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Simon Hatcher, associate professor of psychiatry at the University of Aukland, sets out the use of newer antidepressants for the treatment of depression in adults. Deborah Cohen, BMJ's investigations editor, updates us on the Tamiflu saga, and how Roche is still holding onto its full patient data.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/n1n5t7/stream_107514625-bmjgroup-antidepressants-and-tamiflu.mp3" length="14717168" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Simon Hatcher, associate professor of psychiatry at the University of Aukland, sets out the use of newer antidepressants for the treatment of depression in adults. Deborah Cohen, BMJ's investigations editor, updates us on the Tamiflu saga, and how Roche is still holding onto its full patient data.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1223</itunes:duration>
                                    </item>
    <item>
        <title>New antiepileptics and the drop in MI deaths</title>
        <itunes:title>New antiepileptics and the drop in MI deaths</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/new-antiepileptics-and-the-drop-in-mi-deaths/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/new-antiepileptics-and-the-drop-in-mi-deaths/#comments</comments>        <pubDate>Tue, 27 Aug 2013 13:22:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/new-antiepileptics-and-the</guid>
                                    <description><![CDATA[<p>Mabel Chew talks to epileptologists Martin Brodie from the Western Infirmary Glasgow and Patrick Kwan from the University of Melbourne, about the newer drug treatments for the condition. Also, Kate Smolina from Oxford University's Department of Public Health explains what constitutes the drop in deaths from acute myocardial infarction.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Mabel Chew talks to epileptologists Martin Brodie from the Western Infirmary Glasgow and Patrick Kwan from the University of Melbourne, about the newer drug treatments for the condition. Also, Kate Smolina from Oxford University's Department of Public Health explains what constitutes the drop in deaths from acute myocardial infarction.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/f4cxxf/stream_107486766-bmjgroup-new-antiepileptics-and-the.mp3" length="17541195" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Mabel Chew talks to epileptologists Martin Brodie from the Western Infirmary Glasgow and Patrick Kwan from the University of Melbourne, about the newer drug treatments for the condition. Also, Kate Smolina from Oxford University's Department of Public Health explains what constitutes the drop in deaths from acute myocardial infarction.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1459</itunes:duration>
                                    </item>
    <item>
        <title>Healthcare and corruption in Uttar Pradesh</title>
        <itunes:title>Healthcare and corruption in Uttar Pradesh</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/healthcare-and-corruption-in-uttar-pradesh/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/healthcare-and-corruption-in-uttar-pradesh/#comments</comments>        <pubDate>Tue, 27 Aug 2013 13:21:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/healthcare-and-corruption-in</guid>
                                    <description><![CDATA[<p>The Indian government has invested £1.2bn to kick start rural healthcare in its most populous northern state, Uttar Pradesh. Much of that money has now disappeared, and the programme is blighted by corruption and murder. Harriet Vickers hears the details. Also this week, the UK's Department for International Development has to make decisions on sometimes scant evidence. We find out how DFID is trying to improve research into aid programmes.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The Indian government has invested £1.2bn to kick start rural healthcare in its most populous northern state, Uttar Pradesh. Much of that money has now disappeared, and the programme is blighted by corruption and murder. Harriet Vickers hears the details. Also this week, the UK's Department for International Development has to make decisions on sometimes scant evidence. We find out how DFID is trying to improve research into aid programmes.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3lnoib/stream_107486541-bmjgroup-healthcare-and-corruption-in.mp3" length="16979780" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The Indian government has invested £1.2bn to kick start rural healthcare in its most populous northern state, Uttar Pradesh. Much of that money has now disappeared, and the programme is blighted by corruption and murder. Harriet Vickers hears the details. Also this week, the UK's Department for International Development has to make decisions on sometimes scant evidence. We find out how DFID is trying to improve research into aid programmes.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1058</itunes:duration>
                                    </item>
    <item>
        <title>Cannabis in cars</title>
        <itunes:title>Cannabis in cars</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/cannabis-in-cars/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/cannabis-in-cars/#comments</comments>        <pubDate>Tue, 27 Aug 2013 13:20:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/cannabis-in-cars</guid>
                                    <description><![CDATA[<p>Journalist Karen McColl interviews Wendell Potter, US health industry lobbying guru turned critic. Mark Ashbridge, an associate professor at Dalhousie University, explains how cannabis intoxication is an increasingly important factor in motor vehicle collisions.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Journalist Karen McColl interviews Wendell Potter, US health industry lobbying guru turned critic. Mark Ashbridge, an associate professor at Dalhousie University, explains how cannabis intoxication is an increasingly important factor in motor vehicle collisions.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ymb63r/stream_107486413-bmjgroup-cannabis-in-cars.mp3" length="11950607" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Journalist Karen McColl interviews Wendell Potter, US health industry lobbying guru turned critic. Mark Ashbridge, an associate professor at Dalhousie University, explains how cannabis intoxication is an increasingly important factor in motor vehicle collisions.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>989</itunes:duration>
                                    </item>
    <item>
        <title>Menopause, HRT, and cancer</title>
        <itunes:title>Menopause, HRT, and cancer</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/menopause-hrt-and-cancer/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/menopause-hrt-and-cancer/#comments</comments>        <pubDate>Tue, 27 Aug 2013 13:18:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/menopause-hrt-and-cancer</guid>
                                    <description><![CDATA[<p>This week we look at older women's health, Gita Mishra from the School of Population Health, University of Queensland, explains the trajectories of perimenopausal symptoms. Martha Hickey, professor of obstetrics and gynaecology at the University of Melbourne, and Jane Elliott a senior lecturer at the University of Adelaide, give Mabel Chew practical tips on prescribing HRT. Finally Steinar Tretli, research director of the Cancer Registry of Norway, explains the results of their research into how HRT and mammography combine to increase apparent rates of breast cancer.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week we look at older women's health, Gita Mishra from the School of Population Health, University of Queensland, explains the trajectories of perimenopausal symptoms. Martha Hickey, professor of obstetrics and gynaecology at the University of Melbourne, and Jane Elliott a senior lecturer at the University of Adelaide, give Mabel Chew practical tips on prescribing HRT. Finally Steinar Tretli, research director of the Cancer Registry of Norway, explains the results of their research into how HRT and mammography combine to increase apparent rates of breast cancer.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/risdhx/stream_107486254-bmjgroup-menopause-hrt-and-cancer.mp3" length="19836629" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week we look at older women's health, Gita Mishra from the School of Population Health, University of Queensland, explains the trajectories of perimenopausal symptoms. Martha Hickey, professor of obstetrics and gynaecology at the University of Melbourne, and Jane Elliott a senior lecturer at the University of Adelaide, give Mabel Chew practical tips on prescribing HRT. Finally Steinar Tretli, research director of the Cancer Registry of Norway, explains the results of their research into how HRT and mammography combine to increase apparent rates of breast cancer.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1647</itunes:duration>
                                    </item>
    <item>
        <title>After the health bill - what next?</title>
        <itunes:title>After the health bill - what next?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/after-the-health-bill-what-next/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/after-the-health-bill-what-next/#comments</comments>        <pubDate>Tue, 27 Aug 2013 13:17:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/after-the-health-bill-what</guid>
                                    <description><![CDATA[<p>With the future of the Health and Social Care bill more certain, how will the health service react to the legislative changes? At this year's Nuffield Trust Health Policy Summit, the BMJ's editor Fiona Godlee hosted a round table to discuss this question.</p>
<p>Taking part were:</p>
<p>David Bennett, Chairman and CEO, Monitor</p>
<p>Paul Corrigan, Management consultant, Southside</p>
<p>Penny Dash, McKinseys</p>
<p>Nigel Edwards, Kings Fund</p>
<p>Clare Gerada, RCGP</p>
<p>Gareth Goodier, CEO, Cambridge University Hospitals NHS Foundation Trust, Cambridge</p>
<p>Alastair McLellan, Editor, Health Services Journal</p>
<p>James Morrow, GP, Sawston, Cambridge</p>
<p>Judith Smith, Nuffield Trust</p>
<p>Simon Stevens, CEO, Global Health, United Health Group, USA</p>
<p>Helen Thomas, Medical Director, Sentinel Commissioning, Plymouth</p>
<p>For more from the summit, and to watch some of the keynote speeches, go to the Nuffield Trust site.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>With the future of the Health and Social Care bill more certain, how will the health service react to the legislative changes? At this year's Nuffield Trust Health Policy Summit, the BMJ's editor Fiona Godlee hosted a round table to discuss this question.</p>
<p>Taking part were:</p>
<p>David Bennett, Chairman and CEO, Monitor</p>
<p>Paul Corrigan, Management consultant, Southside</p>
<p>Penny Dash, McKinseys</p>
<p>Nigel Edwards, Kings Fund</p>
<p>Clare Gerada, RCGP</p>
<p>Gareth Goodier, CEO, Cambridge University Hospitals NHS Foundation Trust, Cambridge</p>
<p>Alastair McLellan, Editor, Health Services Journal</p>
<p>James Morrow, GP, Sawston, Cambridge</p>
<p>Judith Smith, Nuffield Trust</p>
<p>Simon Stevens, CEO, Global Health, United Health Group, USA</p>
<p>Helen Thomas, Medical Director, Sentinel Commissioning, Plymouth</p>
<p>For more from the summit, and to watch some of the keynote speeches, go to the Nuffield Trust site.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ct9mmh/stream_107486090-bmjgroup-after-the-health-bill-what.mp3" length="59683263" type="audio/mpeg"/>
        <itunes:summary><![CDATA[With the future of the Health and Social Care bill more certain, how will the health service react to the legislative changes? At this year's Nuffield Trust Health Policy Summit, the BMJ's editor Fiona Godlee hosted a round table to discuss this question.Taking part were:David Bennett, Chairman and CEO, MonitorPaul Corrigan, Management consultant, SouthsidePenny Dash, McKinseysNigel Edwards, Kings FundClare Gerada, RCGPGareth Goodier, CEO, Cambridge University Hospitals NHS Foundation Trust, CambridgeAlastair McLellan, Editor, Health Services JournalJames Morrow, GP, Sawston, CambridgeJudith Smith, Nuffield TrustSimon Stevens, CEO, Global Health, United Health Group, USAHelen Thomas, Medical Director, Sentinel Commissioning, PlymouthFor more from the summit, and to watch some of the keynote speeches, go to the Nuffield Trust site.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2490</itunes:duration>
                                    </item>
    <item>
        <title>Tackling NCDs in developing countries</title>
        <itunes:title>Tackling NCDs in developing countries</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/tackling-ncds-in-developing-countries/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/tackling-ncds-in-developing-countries/#comments</comments>        <pubDate>Tue, 27 Aug 2013 13:14:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/tackling-ncds-in-developing</guid>
                                    <description><![CDATA[<p>Dan Chisholm, a health economist with the World Health Organisation talks to Harriet Vickers about a cluster of articles which examines the more cost effective way to tackle non-communicable diseases in sub-Saharan Africa and South East Asia.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Dan Chisholm, a health economist with the World Health Organisation talks to Harriet Vickers about a cluster of articles which examines the more cost effective way to tackle non-communicable diseases in sub-Saharan Africa and South East Asia.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/h3huas/stream_107485823-bmjgroup-tackling-ncds-in-developing.mp3" length="6589269" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Dan Chisholm, a health economist with the World Health Organisation talks to Harriet Vickers about a cluster of articles which examines the more cost effective way to tackle non-communicable diseases in sub-Saharan Africa and South East Asia.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>545</itunes:duration>
                                    </item>
    <item>
        <title>Elective ventilation and the future of medical professionalism</title>
        <itunes:title>Elective ventilation and the future of medical professionalism</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/elective-ventilation-and-the-future-of-medical-professionalism/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/elective-ventilation-and-the-future-of-medical-professionalism/#comments</comments>        <pubDate>Tue, 27 Aug 2013 13:02:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/ymexsboaoxrg</guid>
                                    <description><![CDATA[<p>Is elective ventilation an acceptable way to increase organs available for transplant? Duncan Jarvies discusses the ethics with Dominic Wilkinson (associate professor of neonatal medicine and bioethics, and consultant neonatologist, at the University of Adelaide).</p>
<p>And Harriet Vickers talks to Iona Heath (president of the Royal College of General Practitioners) and David Haslam (president of the British Medical Association) about how the NHS reforms fundamentally threaten medical professionalism.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Is elective ventilation an acceptable way to increase organs available for transplant? Duncan Jarvies discusses the ethics with Dominic Wilkinson (associate professor of neonatal medicine and bioethics, and consultant neonatologist, at the University of Adelaide).</p>
<p>And Harriet Vickers talks to Iona Heath (president of the Royal College of General Practitioners) and David Haslam (president of the British Medical Association) about how the NHS reforms fundamentally threaten medical professionalism.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/pwhp5m/stream_107484548-bmjgroup-ymexsboaoxrg.mp3" length="16725341" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Is elective ventilation an acceptable way to increase organs available for transplant? Duncan Jarvies discusses the ethics with Dominic Wilkinson (associate professor of neonatal medicine and bioethics, and consultant neonatologist, at the University of Adelaide).And Harriet Vickers talks to Iona Heath (president of the Royal College of General Practitioners) and David Haslam (president of the British Medical Association) about how the NHS reforms fundamentally threaten medical professionalism.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1042</itunes:duration>
                                    </item>
    <item>
        <title>Neurodegenerative disease and cancer, and peer led parenting</title>
        <itunes:title>Neurodegenerative disease and cancer, and peer led parenting</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/neurodegenerative-disease-and-cancer-and-peer-led-parenting/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/neurodegenerative-disease-and-cancer-and-peer-led-parenting/#comments</comments>        <pubDate>Tue, 27 Aug 2013 13:00:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/neurodegenerative-disease-and</guid>
                                    <description><![CDATA[<p>A new peer led parenting group is having success in South London, we visit a session to find out why. Also Jane Driver, an associate professor at Brigham and Women’s Hospital in Boston, explains how Alzheimer's disease and cancer maybe opposite sides of the same coin.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>A new peer led parenting group is having success in South London, we visit a session to find out why. Also Jane Driver, an associate professor at Brigham and Women’s Hospital in Boston, explains how Alzheimer's disease and cancer maybe opposite sides of the same coin.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/g6po6q/stream_107484330-bmjgroup-neurodegenerative-disease-and.mp3" length="13528421" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A new peer led parenting group is having success in South London, we visit a session to find out why. Also Jane Driver, an associate professor at Brigham and Women’s Hospital in Boston, explains how Alzheimer's disease and cancer maybe opposite sides of the same coin.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1124</itunes:duration>
                                    </item>
    <item>
        <title>Emergency contraception, and stopping smoking</title>
        <itunes:title>Emergency contraception, and stopping smoking</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/emergency-contraception-and-stopping-smoking/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/emergency-contraception-and-stopping-smoking/#comments</comments>        <pubDate>Tue, 27 Aug 2013 12:58:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/emergency-contraception-and</guid>
                                    <description><![CDATA[<p>Indhu Prabakar, a subspecialty registrar in sexual and reproductive health at Abacus Services for Sexual and Reproductive Healthcare in Liverpool, goes through the options for emergency contraception. Tim Coleman, a professor of primary care at the UK Centre for Tobacco Control Studies, University of Nottingham, explains his research on methods to help smokers quit.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Indhu Prabakar, a subspecialty registrar in sexual and reproductive health at Abacus Services for Sexual and Reproductive Healthcare in Liverpool, goes through the options for emergency contraception. Tim Coleman, a professor of primary care at the UK Centre for Tobacco Control Studies, University of Nottingham, explains his research on methods to help smokers quit.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/x0zqf8/stream_107484124-bmjgroup-emergency-contraception-and.mp3" length="17201890" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Indhu Prabakar, a subspecialty registrar in sexual and reproductive health at Abacus Services for Sexual and Reproductive Healthcare in Liverpool, goes through the options for emergency contraception. Tim Coleman, a professor of primary care at the UK Centre for Tobacco Control Studies, University of Nottingham, explains his research on methods to help smokers quit.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1430</itunes:duration>
                                    </item>
    <item>
        <title>SSRIs in dementia, and exposure to a rash in pregnancy</title>
        <itunes:title>SSRIs in dementia, and exposure to a rash in pregnancy</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/ssris-in-dementia-and-exposure-to-a-rash-in-pregnancy/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/ssris-in-dementia-and-exposure-to-a-rash-in-pregnancy/#comments</comments>        <pubDate>Tue, 27 Aug 2013 12:52:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/ssris-in-dementia-and-exposure</guid>
                                    <description><![CDATA[<p>Eithne MacMahon, consultant and honorary senior lecturer at the Department of Infectious Diseases, Guy’s and St Thomas’ NHS Foundation Trust, explains how to test and treat a pregnant woman exposed to a child with a rash. Sverre Bergh, a researcher at the Centre for Old Age Psychiatric Research, Sanderud Hospital in Norway, discusses the results of his research into stopping SSRIs in dementia patients in Norway.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Eithne MacMahon, consultant and honorary senior lecturer at the Department of Infectious Diseases, Guy’s and St Thomas’ NHS Foundation Trust, explains how to test and treat a pregnant woman exposed to a child with a rash. Sverre Bergh, a researcher at the Centre for Old Age Psychiatric Research, Sanderud Hospital in Norway, discusses the results of his research into stopping SSRIs in dementia patients in Norway.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/psqlvd/stream_107483511-bmjgroup-ssris-in-dementia-and-exposure.mp3" length="14625453" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Eithne MacMahon, consultant and honorary senior lecturer at the Department of Infectious Diseases, Guy’s and St Thomas’ NHS Foundation Trust, explains how to test and treat a pregnant woman exposed to a child with a rash. Sverre Bergh, a researcher at the Centre for Old Age Psychiatric Research, Sanderud Hospital in Norway, discusses the results of his research into stopping SSRIs in dementia patients in Norway.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1215</itunes:duration>
                                    </item>
    <item>
        <title>Stopping the spread of disease at the Olympics and Hajj</title>
        <itunes:title>Stopping the spread of disease at the Olympics and Hajj</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/stopping-the-spread-of-disease-at-the-olympics-and-hajj/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/stopping-the-spread-of-disease-at-the-olympics-and-hajj/#comments</comments>        <pubDate>Tue, 27 Aug 2013 12:37:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/stopping-the-spread-of-disease</guid>
                                    <description><![CDATA[<p>Hopes are high that the 2012 Olympics and Paralympics will have a lasting sports and exercise legacy, but the work done to ensure the health of the millions of attendees could also have an important impact.</p>
<p>Harriet Vickers talks to Brian McCloskey, the Health Protection Agency’s national Olympics and Paralympics lead, about how infectious diseases will be monitored and controlled during the games, and ensuring the knowledge and structures developed are captured. And Ziad Memish, deputy public health minister for Saudi Arabia’s Department of Health, discusses the innovations and interventions his country has pioneered for public health at the Hajj, paving the way for other mass gatherings.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Hopes are high that the 2012 Olympics and Paralympics will have a lasting sports and exercise legacy, but the work done to ensure the health of the millions of attendees could also have an important impact.</p>
<p>Harriet Vickers talks to Brian McCloskey, the Health Protection Agency’s national Olympics and Paralympics lead, about how infectious diseases will be monitored and controlled during the games, and ensuring the knowledge and structures developed are captured. And Ziad Memish, deputy public health minister for Saudi Arabia’s Department of Health, discusses the innovations and interventions his country has pioneered for public health at the Hajj, paving the way for other mass gatherings.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mqltsz/stream_107481839-bmjgroup-stopping-the-spread-of-disease.mp3" length="5253749" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Hopes are high that the 2012 Olympics and Paralympics will have a lasting sports and exercise legacy, but the work done to ensure the health of the millions of attendees could also have an important impact.Harriet Vickers talks to Brian McCloskey, the Health Protection Agency’s national Olympics and Paralympics lead, about how infectious diseases will be monitored and controlled during the games, and ensuring the knowledge and structures developed are captured. And Ziad Memish, deputy public health minister for Saudi Arabia’s Department of Health, discusses the innovations and interventions his country has pioneered for public health at the Hajj, paving the way for other mass gatherings.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>742</itunes:duration>
                                    </item>
    <item>
        <title>Overactive bladder syndrome</title>
        <itunes:title>Overactive bladder syndrome</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/overactive-bladder-syndrome/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/overactive-bladder-syndrome/#comments</comments>        <pubDate>Tue, 27 Aug 2013 12:36:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/overactive-bladder-syndrome</guid>
                                    <description><![CDATA[<p>This week we’re concentrating on the problem of an overactive bladder, the subject of a cluster of articles in this week’s BMJ. Practice editor Mabel Chew is joined by Linda Cardozo, professor of urogynaecology, and Dudley Robinson, consultant urogynaecologist, both from King’s College Hospital, London.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week we’re concentrating on the problem of an overactive bladder, the subject of a cluster of articles in this week’s BMJ. Practice editor Mabel Chew is joined by Linda Cardozo, professor of urogynaecology, and Dudley Robinson, consultant urogynaecologist, both from King’s College Hospital, London.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/nv0gdp/stream_107481718-bmjgroup-overactive-bladder-syndrome.mp3" length="15492244" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week we’re concentrating on the problem of an overactive bladder, the subject of a cluster of articles in this week’s BMJ. Practice editor Mabel Chew is joined by Linda Cardozo, professor of urogynaecology, and Dudley Robinson, consultant urogynaecologist, both from King’s College Hospital, London.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1285</itunes:duration>
                                    </item>
    <item>
        <title>23.5 hours to change behaviour</title>
        <itunes:title>23.5 hours to change behaviour</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/235-hours-to-change-behaviour/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/235-hours-to-change-behaviour/#comments</comments>        <pubDate>Tue, 27 Aug 2013 12:34:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/23-5-hours-to-change-behaviour</guid>
                                    <description><![CDATA[<p>The focus of this week’s programme is health promotion and behaviour change.</p>
<p>Joining Karim Khan, BJSM editor, and Domhnall McAuley, BMJ primary care editor, is Mike Evans, associate professor of family medicine at the University of Toronto and founder of the Health Design Lab. Dan Heath, senior fellow at Duke University’s Center for the Advancement of Social Entrepreneurship, and co-author of a book “Switch – how to change things when change is hard” also joins the panel.</p>
<p>The Health Design Lab’s viral video 23 and 1/2 hours: What is the single best thing we can do for our health? has been watched over 2.5m times, and is freely available on youtube</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The focus of this week’s programme is health promotion and behaviour change.</p>
<p>Joining Karim Khan, BJSM editor, and Domhnall McAuley, BMJ primary care editor, is Mike Evans, associate professor of family medicine at the University of Toronto and founder of the Health Design Lab. Dan Heath, senior fellow at Duke University’s Center for the Advancement of Social Entrepreneurship, and co-author of a book “Switch – how to change things when change is hard” also joins the panel.</p>
<p>The Health Design Lab’s viral video 23 and 1/2 hours: What is the single best thing we can do for our health? has been watched over 2.5m times, and is freely available on youtube</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4jzign/stream_107481576-bmjgroup-23-5-hours-to-change-behaviour.mp3" length="22753818" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The focus of this week’s programme is health promotion and behaviour change.Joining Karim Khan, BJSM editor, and Domhnall McAuley, BMJ primary care editor, is Mike Evans, associate professor of family medicine at the University of Toronto and founder of the Health Design Lab. Dan Heath, senior fellow at Duke University’s Center for the Advancement of Social Entrepreneurship, and co-author of a book “Switch – how to change things when change is hard” also joins the panel.The Health Design Lab’s viral video 23 and 1/2 hours: What is the single best thing we can do for our health? has been watched over 2.5m times, and is freely available on youtube]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1888</itunes:duration>
                                    </item>
    <item>
        <title>SPARX and spirometry</title>
        <itunes:title>SPARX and spirometry</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/sparx-and-spirometry/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/sparx-and-spirometry/#comments</comments>        <pubDate>Tue, 27 Aug 2013 12:33:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/sparx-and-spirometry</guid>
                                    <description><![CDATA[<p>SPARX is a new cognitive behavioural therapy based computer game for young people with depression. Sally Merry, an associate professor of child and adolescent psychiatry at the University of Auckland, joins us to explain how it was created. Also this week Christine Jenkins, thoracic physician at Concord Hospital in Sydney, gives Mabel Chew a masterclass in spirometry.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>SPARX is a new cognitive behavioural therapy based computer game for young people with depression. Sally Merry, an associate professor of child and adolescent psychiatry at the University of Auckland, joins us to explain how it was created. Also this week Christine Jenkins, thoracic physician at Concord Hospital in Sydney, gives Mabel Chew a masterclass in spirometry.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/cz2bj7/stream_107481427-bmjgroup-sparx-and-spirometry.mp3" length="20593463" type="audio/mpeg"/>
        <itunes:summary><![CDATA[SPARX is a new cognitive behavioural therapy based computer game for young people with depression. Sally Merry, an associate professor of child and adolescent psychiatry at the University of Auckland, joins us to explain how it was created. Also this week Christine Jenkins, thoracic physician at Concord Hospital in Sydney, gives Mabel Chew a masterclass in spirometry.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1708</itunes:duration>
                                    </item>
    <item>
        <title>Type 1 or type 2 diabetes?</title>
        <itunes:title>Type 1 or type 2 diabetes?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/type-1-or-type-2-diabetes/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/type-1-or-type-2-diabetes/#comments</comments>        <pubDate>Tue, 27 Aug 2013 12:31:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/type-1-or-type-2-diabetes</guid>
                                    <description><![CDATA[<p>BMJ deputy editor Trish Groves talks to Bianca Hemmingsen, a PhD student at Copenhagen University Hospital, about research comparing metformin and insulin with insulin alone, for the treatment of type 2 diabetes. Also, Dan Lasserson, a senior clinical researcher at the University of Oxford, tells BMJ practice editor Mabel Chew how late onset type 1 diabetes can be easily missed.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>BMJ deputy editor Trish Groves talks to Bianca Hemmingsen, a PhD student at Copenhagen University Hospital, about research comparing metformin and insulin with insulin alone, for the treatment of type 2 diabetes. Also, Dan Lasserson, a senior clinical researcher at the University of Oxford, tells BMJ practice editor Mabel Chew how late onset type 1 diabetes can be easily missed.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/q7rx6u/stream_107481285-bmjgroup-type-1-or-type-2-diabetes.mp3" length="15617028" type="audio/mpeg"/>
        <itunes:summary><![CDATA[BMJ deputy editor Trish Groves talks to Bianca Hemmingsen, a PhD student at Copenhagen University Hospital, about research comparing metformin and insulin with insulin alone, for the treatment of type 2 diabetes. Also, Dan Lasserson, a senior clinical researcher at the University of Oxford, tells BMJ practice editor Mabel Chew how late onset type 1 diabetes can be easily missed.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1294</itunes:duration>
                                    </item>
    <item>
        <title>GAVI in Ghana</title>
        <itunes:title>GAVI in Ghana</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/gavi-in-ghana/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/gavi-in-ghana/#comments</comments>        <pubDate>Tue, 27 Aug 2013 12:29:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/gavi-in-ghana</guid>
                                    <description><![CDATA[<p>BMJ features editor Rebecca Coombes finds out more about a new pneumococcal vaccine being rolled out in Ghana. And David Payne meets Kenneth Kizer, the US doctor who transformed the failing Veteran’s Health Administration and took on the tobacco industry in California.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>BMJ features editor Rebecca Coombes finds out more about a new pneumococcal vaccine being rolled out in Ghana. And David Payne meets Kenneth Kizer, the US doctor who transformed the failing Veteran’s Health Administration and took on the tobacco industry in California.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/s41haf/stream_107481113-bmjgroup-gavi-in-ghana.mp3" length="14238527" type="audio/mpeg"/>
        <itunes:summary><![CDATA[BMJ features editor Rebecca Coombes finds out more about a new pneumococcal vaccine being rolled out in Ghana. And David Payne meets Kenneth Kizer, the US doctor who transformed the failing Veteran’s Health Administration and took on the tobacco industry in California.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1180</itunes:duration>
                                    </item>
    <item>
        <title>Anti vaccination movements</title>
        <itunes:title>Anti vaccination movements</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/anti-vaccination-movements/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/anti-vaccination-movements/#comments</comments>        <pubDate>Tue, 27 Aug 2013 12:27:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/anti-vaccination-movements</guid>
                                    <description><![CDATA[<p>Paul Offit, the author of the yes side of our head to head article "Should childhood vaccination be mandatory", joins us to discuss his book Deadly Choices: How the anti-vaccine movement threatens us all, and explains why he thinks it is wrong to refuse to accept patients who haven't been vaccinated.</p>
<p>Also, in the month when UK prime minister David Cameron said dementia care is a “national crisis” and that he is making it one of his personal priorities, Marcel Olde Rikkert, professor in geriatrics at Radboud University Nijmegen Medical Centre in the Netherlands, discusses his research which looks at the relative effectiveness of dementia follow up care by either dedicated memory clinics or general practitioners.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Paul Offit, the author of the yes side of our head to head article "Should childhood vaccination be mandatory", joins us to discuss his book Deadly Choices: How the anti-vaccine movement threatens us all, and explains why he thinks it is wrong to refuse to accept patients who haven't been vaccinated.</p>
<p>Also, in the month when UK prime minister David Cameron said dementia care is a “national crisis” and that he is making it one of his personal priorities, Marcel Olde Rikkert, professor in geriatrics at Radboud University Nijmegen Medical Centre in the Netherlands, discusses his research which looks at the relative effectiveness of dementia follow up care by either dedicated memory clinics or general practitioners.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/uq5gnf/stream_107480909-bmjgroup-anti-vaccination-movements.mp3" length="13074497" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Paul Offit, the author of the yes side of our head to head article "Should childhood vaccination be mandatory", joins us to discuss his book Deadly Choices: How the anti-vaccine movement threatens us all, and explains why he thinks it is wrong to refuse to accept patients who haven't been vaccinated.Also, in the month when UK prime minister David Cameron said dementia care is a “national crisis” and that he is making it one of his personal priorities, Marcel Olde Rikkert, professor in geriatrics at Radboud University Nijmegen Medical Centre in the Netherlands, discusses his research which looks at the relative effectiveness of dementia follow up care by either dedicated memory clinics or general practitioners.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1086</itunes:duration>
                                    </item>
    <item>
        <title>Doctors on strike</title>
        <itunes:title>Doctors on strike</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/doctors-on-strike/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/doctors-on-strike/#comments</comments>        <pubDate>Tue, 27 Aug 2013 12:25:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/doctors-on-strike</guid>
                                    <description><![CDATA[<p>It's the first time doctors have been polled for strike action since 1975, and we've heard a lot about the moral arguments of doing so, but what about the practicalities? Edward Davies, BMJ Careers editor, talked to Mark Porter, chair of the BMA's consultant committee, about how he thinks doctors can balance industrial action and patient safety.</p>
<p>Also this week, Richard Hurley finds out why Sam Shuster, emeritus professor of dermatology at the University of Newcastle, thinks drug testing for athletes is illogical and immoral.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>It's the first time doctors have been polled for strike action since 1975, and we've heard a lot about the moral arguments of doing so, but what about the practicalities? Edward Davies, BMJ Careers editor, talked to Mark Porter, chair of the BMA's consultant committee, about how he thinks doctors can balance industrial action and patient safety.</p>
<p>Also this week, Richard Hurley finds out why Sam Shuster, emeritus professor of dermatology at the University of Newcastle, thinks drug testing for athletes is illogical and immoral.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/grcja3/stream_107480721-bmjgroup-doctors-on-strike.mp3" length="13797676" type="audio/mpeg"/>
        <itunes:summary><![CDATA[It's the first time doctors have been polled for strike action since 1975, and we've heard a lot about the moral arguments of doing so, but what about the practicalities? Edward Davies, BMJ Careers editor, talked to Mark Porter, chair of the BMA's consultant committee, about how he thinks doctors can balance industrial action and patient safety.Also this week, Richard Hurley finds out why Sam Shuster, emeritus professor of dermatology at the University of Newcastle, thinks drug testing for athletes is illogical and immoral.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1144</itunes:duration>
                                    </item>
    <item>
        <title>It’s time to say sorry</title>
        <itunes:title>It’s time to say sorry</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/it-s-time-to-say-sorry/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/it-s-time-to-say-sorry/#comments</comments>        <pubDate>Tue, 27 Aug 2013 12:23:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/its-time-to-say-sorry</guid>
                                    <description><![CDATA[<p>In this weeks podcast BMJ features editor Rebecca Coombes reports from Risky Business, the patient safety conference held in London last week. She talks to Loretta Evans, a mother who lost her son because of medical negligence, and about her fight to receive an apology from the hospital. Dr Liliane Field, medicolegal adviser at the Medical Protection Society, talks about the importance of a genuine apology, and what doctors should do if they feel prevented from doing so.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this weeks podcast BMJ features editor Rebecca Coombes reports from Risky Business, the patient safety conference held in London last week. She talks to Loretta Evans, a mother who lost her son because of medical negligence, and about her fight to receive an apology from the hospital. Dr Liliane Field, medicolegal adviser at the Medical Protection Society, talks about the importance of a genuine apology, and what doctors should do if they feel prevented from doing so.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/d7rxhl/stream_107480509-bmjgroup-its-time-to-say-sorry.mp3" length="15492280" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this weeks podcast BMJ features editor Rebecca Coombes reports from Risky Business, the patient safety conference held in London last week. She talks to Loretta Evans, a mother who lost her son because of medical negligence, and about her fight to receive an apology from the hospital. Dr Liliane Field, medicolegal adviser at the Medical Protection Society, talks about the importance of a genuine apology, and what doctors should do if they feel prevented from doing so.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1286</itunes:duration>
                                    </item>
    <item>
        <title>Are statins still safe?</title>
        <itunes:title>Are statins still safe?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/are-statins-still-safe/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/are-statins-still-safe/#comments</comments>        <pubDate>Tue, 27 Aug 2013 12:14:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/are-statins-still-safe</guid>
                                    <description><![CDATA[<p>Keith Fox, president of the British Cardiovascular Society, and Rory Collins, co-director of the University of Oxford's Clinical Trial Service Unit and Epidemiological Studies Unit, discuss the safety of statins, and how clever prescribing can overcome worries about myopathy. Also this week, Tony Delamothe, BMJ deputy editor, explains why the sudden interest in atrial fibrillation is making him queasy.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Keith Fox, president of the British Cardiovascular Society, and Rory Collins, co-director of the University of Oxford's Clinical Trial Service Unit and Epidemiological Studies Unit, discuss the safety of statins, and how clever prescribing can overcome worries about myopathy. Also this week, Tony Delamothe, BMJ deputy editor, explains why the sudden interest in atrial fibrillation is making him queasy.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/obd5hi/stream_107479653-bmjgroup-are-statins-still-safe.mp3" length="10992121" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Keith Fox, president of the British Cardiovascular Society, and Rory Collins, co-director of the University of Oxford's Clinical Trial Service Unit and Epidemiological Studies Unit, discuss the safety of statins, and how clever prescribing can overcome worries about myopathy. Also this week, Tony Delamothe, BMJ deputy editor, explains why the sudden interest in atrial fibrillation is making him queasy.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>911</itunes:duration>
                                    </item>
    <item>
        <title>Herpes simplex encephalitis</title>
        <itunes:title>Herpes simplex encephalitis</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/herpes-simplex-encephalitis/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/herpes-simplex-encephalitis/#comments</comments>        <pubDate>Tue, 27 Aug 2013 12:11:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/herpes-simplex-encephalitis</guid>
                                    <description><![CDATA[<p>This week we look at herpes simplex encephalitis, an easily missed central nervous system infection which can have serious consequences.</p>
<p>Our practice editor Mabel Chew discusses the features of the illness with Tom Solomon, professor of neurological science at Walton Centre NHS Foundation Trust, Liverpool. And podcast producer Duncan Jarvies gets advice on diagnosis from Adam Zeman, professor of cognitive and behavioural neurology at Peninsular Medical School.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week we look at herpes simplex encephalitis, an easily missed central nervous system infection which can have serious consequences.</p>
<p>Our practice editor Mabel Chew discusses the features of the illness with Tom Solomon, professor of neurological science at Walton Centre NHS Foundation Trust, Liverpool. And podcast producer Duncan Jarvies gets advice on diagnosis from Adam Zeman, professor of cognitive and behavioural neurology at Peninsular Medical School.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/iah5tu/stream_107479398-bmjgroup-herpes-simplex-encephalitis.mp3" length="7637963" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week we look at herpes simplex encephalitis, an easily missed central nervous system infection which can have serious consequences.Our practice editor Mabel Chew discusses the features of the illness with Tom Solomon, professor of neurological science at Walton Centre NHS Foundation Trust, Liverpool. And podcast producer Duncan Jarvies gets advice on diagnosis from Adam Zeman, professor of cognitive and behavioural neurology at Peninsular Medical School.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1084</itunes:duration>
                                    </item>
    <item>
        <title>Research free for all?</title>
        <itunes:title>Research free for all?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/research-free-for-all/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/research-free-for-all/#comments</comments>        <pubDate>Tue, 27 Aug 2013 12:08:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/research-free-for-all</guid>
                                    <description><![CDATA[<p>For the last year a group commissioned by the UK government has been looking at whether making all published research freely available is attainable or not. BMJ editor Fiona Godlee speaks to Dame Janet Finch, the group's chair, about its conclusions.</p>
<p>We also bring you highlights from a BMJ hosted round table on what the landscape of research publishing could, and should, look like in the future.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>For the last year a group commissioned by the UK government has been looking at whether making all published research freely available is attainable or not. BMJ editor Fiona Godlee speaks to Dame Janet Finch, the group's chair, about its conclusions.</p>
<p>We also bring you highlights from a BMJ hosted round table on what the landscape of research publishing could, and should, look like in the future.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/t6rjev/stream_107479132-bmjgroup-research-free-for-all.mp3" length="9248088" type="audio/mpeg"/>
        <itunes:summary><![CDATA[For the last year a group commissioned by the UK government has been looking at whether making all published research freely available is attainable or not. BMJ editor Fiona Godlee speaks to Dame Janet Finch, the group's chair, about its conclusions.We also bring you highlights from a BMJ hosted round table on what the landscape of research publishing could, and should, look like in the future.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1318</itunes:duration>
                                    </item>
    <item>
        <title>The future of secondary care - full roundtable</title>
        <itunes:title>The future of secondary care - full roundtable</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-future-of-secondary-care-full-roundtable/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-future-of-secondary-care-full-roundtable/#comments</comments>        <pubDate>Tue, 27 Aug 2013 12:06:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-future-of-secondary-care-1</guid>
                                    <description><![CDATA[<p>With changes to the NHS such as cuts, competition and tendering, secondary care will need to adapt. Joining BMJ features editor Rebecca Coombes to discuss how, are:</p>
<p>Yi Mien Koh, chief executive of Whittington Health, London</p>
<p>Jan Filochowski, chief executive of West Hertfordshire Hospitals NHS Trust</p>
<p>Fergus Gleeson, divisional director of Critical Care, Theatres, Diagnostics and Pharmacy at Oxford University Hospitals</p>
<p>Nigel Edwards, senior fellow at the King’s Fund</p>
<p>Derek Greatorex, chair of the South Devon and Torbay Clinical Commissioning Group</p>
<p>Kate Hall, policy advisor, Monitor, London</p>
<p>This is the full version of the roundtable. See the podcast above for highlights.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>With changes to the NHS such as cuts, competition and tendering, secondary care will need to adapt. Joining BMJ features editor Rebecca Coombes to discuss how, are:</p>
<p>Yi Mien Koh, chief executive of Whittington Health, London</p>
<p>Jan Filochowski, chief executive of West Hertfordshire Hospitals NHS Trust</p>
<p>Fergus Gleeson, divisional director of Critical Care, Theatres, Diagnostics and Pharmacy at Oxford University Hospitals</p>
<p>Nigel Edwards, senior fellow at the King’s Fund</p>
<p>Derek Greatorex, chair of the South Devon and Torbay Clinical Commissioning Group</p>
<p>Kate Hall, policy advisor, Monitor, London</p>
<p>This is the full version of the roundtable. See the podcast above for highlights.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/lhvsp7/stream_107478959-bmjgroup-the-future-of-secondary-care-1.mp3" length="33920991" type="audio/mpeg"/>
        <itunes:summary><![CDATA[With changes to the NHS such as cuts, competition and tendering, secondary care will need to adapt. Joining BMJ features editor Rebecca Coombes to discuss how, are:Yi Mien Koh, chief executive of Whittington Health, LondonJan Filochowski, chief executive of West Hertfordshire Hospitals NHS TrustFergus Gleeson, divisional director of Critical Care, Theatres, Diagnostics and Pharmacy at Oxford University HospitalsNigel Edwards, senior fellow at the King’s FundDerek Greatorex, chair of the South Devon and Torbay Clinical Commissioning GroupKate Hall, policy advisor, Monitor, LondonThis is the full version of the roundtable. See the podcast above for highlights.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>4856</itunes:duration>
                                    </item>
    <item>
        <title>The future of secondary care</title>
        <itunes:title>The future of secondary care</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-future-of-secondary-care/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-future-of-secondary-care/#comments</comments>        <pubDate>Tue, 27 Aug 2013 12:04:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-future-of-secondary-care</guid>
                                    <description><![CDATA[<p>The healthcare landscape in the England is shifting, with cuts, competition and tendering some of the major changes. Secondary care must adapt to these, but how? Joining BMJ features editor Rebecca Coombes to discuss the issues are:</p>
<p>Yi Mien Koh, chief executive of Whittington Health, London</p>
<p>Jan Filochowski, chief executive of West Hertfordshire Hospitals NHS Trust</p>
<p>Fergus Gleeson, divisional director of Critical Care, Theatres, Diagnostics and Pharmacy at Oxford University Hospitals</p>
<p>Nigel Edwards, senior fellow at the King’s Fund</p>
<p>Derek Greatorex, chair of the South Devon and Torbay Clinical Commissioning Group</p>
<p>And BMJ practice editor Mabel Chew talks to Ruth Reed (specialty registrar in child and adolescent psychiatry, Warneford Hospital, Oxford) and Mina Fazel (postdoctoral research fellow, Warneford Hospital Oxford) about why post-traumatic stress disorder is easily missed, and what clinicians should look out for.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The healthcare landscape in the England is shifting, with cuts, competition and tendering some of the major changes. Secondary care must adapt to these, but how? Joining BMJ features editor Rebecca Coombes to discuss the issues are:</p>
<p>Yi Mien Koh, chief executive of Whittington Health, London</p>
<p>Jan Filochowski, chief executive of West Hertfordshire Hospitals NHS Trust</p>
<p>Fergus Gleeson, divisional director of Critical Care, Theatres, Diagnostics and Pharmacy at Oxford University Hospitals</p>
<p>Nigel Edwards, senior fellow at the King’s Fund</p>
<p>Derek Greatorex, chair of the South Devon and Torbay Clinical Commissioning Group</p>
<p>And BMJ practice editor Mabel Chew talks to Ruth Reed (specialty registrar in child and adolescent psychiatry, Warneford Hospital, Oxford) and Mina Fazel (postdoctoral research fellow, Warneford Hospital Oxford) about why post-traumatic stress disorder is easily missed, and what clinicians should look out for.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rpyga6/stream_107478766-bmjgroup-the-future-of-secondary-care.mp3" length="9086501" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The healthcare landscape in the England is shifting, with cuts, competition and tendering some of the major changes. Secondary care must adapt to these, but how? Joining BMJ features editor Rebecca Coombes to discuss the issues are:Yi Mien Koh, chief executive of Whittington Health, LondonJan Filochowski, chief executive of West Hertfordshire Hospitals NHS TrustFergus Gleeson, divisional director of Critical Care, Theatres, Diagnostics and Pharmacy at Oxford University HospitalsNigel Edwards, senior fellow at the King’s FundDerek Greatorex, chair of the South Devon and Torbay Clinical Commissioning GroupAnd BMJ practice editor Mabel Chew talks to Ruth Reed (specialty registrar in child and adolescent psychiatry, Warneford Hospital, Oxford) and Mina Fazel (postdoctoral research fellow, Warneford Hospital Oxford) about why post-traumatic stress disorder is easily missed, and what clinicians should look out for.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1295</itunes:duration>
                                    </item>
    <item>
        <title>Obama’s healthcare reforms on trial</title>
        <itunes:title>Obama’s healthcare reforms on trial</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/obama-s-healthcare-reforms-on-trial/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/obama-s-healthcare-reforms-on-trial/#comments</comments>        <pubDate>Tue, 27 Aug 2013 11:57:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/obamas-healthcare-reforms-on</guid>
                                    <description><![CDATA[<p>Barack Obama saw his Affordable Care Act remain law last week, as the US Supreme Court ruled it is constitutional. Ed Davies (BMJ US news and features editor) talks to Janice Hopkins Tanne (freelance journalist based in New York) about the ruling’s implications.</p>
<p>And what are the options for tackling childhood obesity? Li Ming Wen (research and evaluation manager at Sydney University) believes intervention needs to be early, and has demonstrated that giving new mothers simple nutrition messages reduces their child’s BMI at age two. BMJ assistant editor Helen MacDonald speaks to him.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Barack Obama saw his Affordable Care Act remain law last week, as the US Supreme Court ruled it is constitutional. Ed Davies (BMJ US news and features editor) talks to Janice Hopkins Tanne (freelance journalist based in New York) about the ruling’s implications.</p>
<p>And what are the options for tackling childhood obesity? Li Ming Wen (research and evaluation manager at Sydney University) believes intervention needs to be early, and has demonstrated that giving new mothers simple nutrition messages reduces their child’s BMI at age two. BMJ assistant editor Helen MacDonald speaks to him.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/tlquae/stream_107478115-bmjgroup-obamas-healthcare-reforms-on.mp3" length="7040183" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Barack Obama saw his Affordable Care Act remain law last week, as the US Supreme Court ruled it is constitutional. Ed Davies (BMJ US news and features editor) talks to Janice Hopkins Tanne (freelance journalist based in New York) about the ruling’s implications.And what are the options for tackling childhood obesity? Li Ming Wen (research and evaluation manager at Sydney University) believes intervention needs to be early, and has demonstrated that giving new mothers simple nutrition messages reduces their child’s BMI at age two. BMJ assistant editor Helen MacDonald speaks to him.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1000</itunes:duration>
                                    </item>
    <item>
        <title>Telehealth: Running before walking?</title>
        <itunes:title>Telehealth: Running before walking?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/telehealth-running-before-walking/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/telehealth-running-before-walking/#comments</comments>        <pubDate>Tue, 27 Aug 2013 11:53:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/telehealth-running-before</guid>
                                    <description><![CDATA[<p>It seems the race to implement telehealth is on – the UK government’s response to its Whole System Demonstrator pilot has been very positive. But has it been over-hyped? We find out from Jennifer Dixon, Director of the Nuffield Trust, which has evaluated the pilot.</p>
<p>Also, alcohol: beneficial or detrimental? Evidence shows it depends on what aspects of health you look at. Research published on bmj.com this week adds to the picture by looking at the association between alcohol consumption and the risk of developing arthritis. Alicja Wolk, professor of nutritional epidemiology at the Karolinska Institutet, explains her study.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>It seems the race to implement telehealth is on – the UK government’s response to its Whole System Demonstrator pilot has been very positive. But has it been over-hyped? We find out from Jennifer Dixon, Director of the Nuffield Trust, which has evaluated the pilot.</p>
<p>Also, alcohol: beneficial or detrimental? Evidence shows it depends on what aspects of health you look at. Research published on bmj.com this week adds to the picture by looking at the association between alcohol consumption and the risk of developing arthritis. Alicja Wolk, professor of nutritional epidemiology at the Karolinska Institutet, explains her study.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kqzvd5/stream_107477666-bmjgroup-telehealth-running-before.mp3" length="15582323" type="audio/mpeg"/>
        <itunes:summary><![CDATA[It seems the race to implement telehealth is on – the UK government’s response to its Whole System Demonstrator pilot has been very positive. But has it been over-hyped? We find out from Jennifer Dixon, Director of the Nuffield Trust, which has evaluated the pilot.Also, alcohol: beneficial or detrimental? Evidence shows it depends on what aspects of health you look at. Research published on bmj.com this week adds to the picture by looking at the association between alcohol consumption and the risk of developing arthritis. Alicja Wolk, professor of nutritional epidemiology at the Karolinska Institutet, explains her study.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1295</itunes:duration>
                                    </item>
    <item>
        <title>Insanity in the dock</title>
        <itunes:title>Insanity in the dock</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/insanity-in-the-dock/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/insanity-in-the-dock/#comments</comments>        <pubDate>Tue, 27 Aug 2013 11:51:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/insanity-in-the-dock</guid>
                                    <description><![CDATA[<p>It has been almost exactly a year since Anders Breivik bombed government buildings in Oslo, and then carried out a mass shooting on the island of Utøya, where he killed 69 people, mostly teenagers. In that time there has been much discussion about his mental state. Vivienne Nathanson and Julian Sheather from the BMA join us to discuss the moral and ethical problems that a diagnosis of insanity bring to the case.</p>
<p>Also this week, seven articles on bmj.com look at the science behind sports product adverts. We hear from Matthew Thompson, from the Centre for Evidence Based Medicine in Oxford, who criticises the quality of the evidence submitted to the European Food Safety Authority to back these claims</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>It has been almost exactly a year since Anders Breivik bombed government buildings in Oslo, and then carried out a mass shooting on the island of Utøya, where he killed 69 people, mostly teenagers. In that time there has been much discussion about his mental state. Vivienne Nathanson and Julian Sheather from the BMA join us to discuss the moral and ethical problems that a diagnosis of insanity bring to the case.</p>
<p>Also this week, seven articles on bmj.com look at the science behind sports product adverts. We hear from Matthew Thompson, from the Centre for Evidence Based Medicine in Oxford, who criticises the quality of the evidence submitted to the European Food Safety Authority to back these claims</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/d7gady/stream_107477474-bmjgroup-insanity-in-the-dock.mp3" length="10834164" type="audio/mpeg"/>
        <itunes:summary><![CDATA[It has been almost exactly a year since Anders Breivik bombed government buildings in Oslo, and then carried out a mass shooting on the island of Utøya, where he killed 69 people, mostly teenagers. In that time there has been much discussion about his mental state. Vivienne Nathanson and Julian Sheather from the BMA join us to discuss the moral and ethical problems that a diagnosis of insanity bring to the case.Also this week, seven articles on bmj.com look at the science behind sports product adverts. We hear from Matthew Thompson, from the Centre for Evidence Based Medicine in Oxford, who criticises the quality of the evidence submitted to the European Food Safety Authority to back these claims]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>898</itunes:duration>
                                    </item>
    <item>
        <title>Shift workers’ health and assessing risk of violence</title>
        <itunes:title>Shift workers’ health and assessing risk of violence</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/shift-workers-health-and-assessing-risk-of-violence/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/shift-workers-health-and-assessing-risk-of-violence/#comments</comments>        <pubDate>Tue, 27 Aug 2013 11:49:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/shift-workers-health-and</guid>
                                    <description><![CDATA[<p>Daniel Hackam, associate professor at Western University in Canada, explains how shift patterns can have a detrimental effect on the vascular health of workers.</p>
<p>Also this week Seena Fazel, Wellcome Trust senior research fellow in clinical science at the University of Oxford, queries the predictive value of the risk assessment tools routinely used to predict violent behaviour</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Daniel Hackam, associate professor at Western University in Canada, explains how shift patterns can have a detrimental effect on the vascular health of workers.</p>
<p>Also this week Seena Fazel, Wellcome Trust senior research fellow in clinical science at the University of Oxford, queries the predictive value of the risk assessment tools routinely used to predict violent behaviour</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/lggn9m/stream_107477302-bmjgroup-shift-workers-health-and.mp3" length="12881573" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Daniel Hackam, associate professor at Western University in Canada, explains how shift patterns can have a detrimental effect on the vascular health of workers.Also this week Seena Fazel, Wellcome Trust senior research fellow in clinical science at the University of Oxford, queries the predictive value of the risk assessment tools routinely used to predict violent behaviour]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1069</itunes:duration>
                                    </item>
    <item>
        <title>Renal patient records</title>
        <itunes:title>Renal patient records</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/renal-patient-records/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/renal-patient-records/#comments</comments>        <pubDate>Tue, 27 Aug 2013 11:47:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/renal-patient-records</guid>
                                    <description><![CDATA[<p>A feature this week asks "Should patients be able to control their own records?". The website renalpatientview.org allows patients to do exactly that. Neil Turner, a professor of nephrology at Edinburgh Royal Infirmary, explains how he and colleagues developed the resource.</p>
<p>Also Steven Woloshin and Lisa Schwartz, authors of the "Not So Stories" column have turned their statistical scrutiny onto a recent advert by Susan G. Komen for the Cure®, the breast cancer charity. They explain how the case for mammography has been massively oversold.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>A feature this week asks "Should patients be able to control their own records?". The website renalpatientview.org allows patients to do exactly that. Neil Turner, a professor of nephrology at Edinburgh Royal Infirmary, explains how he and colleagues developed the resource.</p>
<p>Also Steven Woloshin and Lisa Schwartz, authors of the "Not So Stories" column have turned their statistical scrutiny onto a recent advert by Susan G. Komen for the Cure®, the breast cancer charity. They explain how the case for mammography has been massively oversold.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/htnco9/stream_107477153-bmjgroup-renal-patient-records.mp3" length="15911221" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A feature this week asks "Should patients be able to control their own records?". The website renalpatientview.org allows patients to do exactly that. Neil Turner, a professor of nephrology at Edinburgh Royal Infirmary, explains how he and colleagues developed the resource.Also Steven Woloshin and Lisa Schwartz, authors of the "Not So Stories" column have turned their statistical scrutiny onto a recent advert by Susan G. Komen for the Cure®, the breast cancer charity. They explain how the case for mammography has been massively oversold.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1320</itunes:duration>
                                    </item>
    <item>
        <title>Is the drug pipeline really drying up?</title>
        <itunes:title>Is the drug pipeline really drying up?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/is-the-drug-pipeline-really-drying-up/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/is-the-drug-pipeline-really-drying-up/#comments</comments>        <pubDate>Tue, 27 Aug 2013 11:45:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/is-the-drug-pipeline-really</guid>
                                    <description><![CDATA[<p>This week we’ll hear why Donald Light, professor of comparative health systems research at the University of Medicine and Dentistry of New Jersey, thinks the innovation crisis in the development of drugs is more marketing rhetoric than reality.</p>
<p>Also this week, a research paper on bmj.com looks at how subclinical psychological distress affects mortality. Tom Russ, Alzheimer Scotland clinical research fellow at the University of Edinburgh and one of the paper's authors, explains what they found.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week we’ll hear why Donald Light, professor of comparative health systems research at the University of Medicine and Dentistry of New Jersey, thinks the innovation crisis in the development of drugs is more marketing rhetoric than reality.</p>
<p>Also this week, a research paper on bmj.com looks at how subclinical psychological distress affects mortality. Tom Russ, Alzheimer Scotland clinical research fellow at the University of Edinburgh and one of the paper's authors, explains what they found.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rk7rhq/stream_107477001-bmjgroup-is-the-drug-pipeline-really.mp3" length="15566461" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week we’ll hear why Donald Light, professor of comparative health systems research at the University of Medicine and Dentistry of New Jersey, thinks the innovation crisis in the development of drugs is more marketing rhetoric than reality.Also this week, a research paper on bmj.com looks at how subclinical psychological distress affects mortality. Tom Russ, Alzheimer Scotland clinical research fellow at the University of Edinburgh and one of the paper's authors, explains what they found.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1299</itunes:duration>
                                    </item>
    <item>
        <title>Fighting the food giants</title>
        <itunes:title>Fighting the food giants</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/fighting-the-food-giants/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/fighting-the-food-giants/#comments</comments>        <pubDate>Tue, 27 Aug 2013 11:44:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/fighting-the-food-giants</guid>
                                    <description><![CDATA[<p>Marion Nestle is the Paulette Goddard Professor of Nutrition, Food Studies, and Public Health at New York University. She has written widely about food and nutrition, and is an iconoclast in the world of food politics. In this podcast she explains how economic forces have changed the food industry, and how that change is fuelling the obesity epidemic.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Marion Nestle is the Paulette Goddard Professor of Nutrition, Food Studies, and Public Health at New York University. She has written widely about food and nutrition, and is an iconoclast in the world of food politics. In this podcast she explains how economic forces have changed the food industry, and how that change is fuelling the obesity epidemic.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wtlwy6/stream_107476838-bmjgroup-fighting-the-food-giants.mp3" length="10759828" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Marion Nestle is the Paulette Goddard Professor of Nutrition, Food Studies, and Public Health at New York University. She has written widely about food and nutrition, and is an iconoclast in the world of food politics. In this podcast she explains how economic forces have changed the food industry, and how that change is fuelling the obesity epidemic.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>892</itunes:duration>
                                    </item>
    <item>
        <title>Ecological public health</title>
        <itunes:title>Ecological public health</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/ecological-public-health/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/ecological-public-health/#comments</comments>        <pubDate>Tue, 27 Aug 2013 11:42:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/ecological-public-health</guid>
                                    <description><![CDATA[<p>Over the decades public health has had many incarnations. Geof Rayner and Tim Lang (Center for Food Policy) argue that public health today needs an overhaul, and to focus on our co-existence with nature and relationships with each other. They explain why, and how.</p>
<p>Many of the issues Dr Rayner and Professor Lang are concerned about are being taken up by the People's Health Movement. Member Jonny Currie explains what he wants the movement to achieve, and others involved talk about actions they are taking.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Over the decades public health has had many incarnations. Geof Rayner and Tim Lang (Center for Food Policy) argue that public health today needs an overhaul, and to focus on our co-existence with nature and relationships with each other. They explain why, and how.</p>
<p>Many of the issues Dr Rayner and Professor Lang are concerned about are being taken up by the People's Health Movement. Member Jonny Currie explains what he wants the movement to achieve, and others involved talk about actions they are taking.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/itzdnc/stream_107476701-bmjgroup-ecological-public-health.mp3" length="8079826" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Over the decades public health has had many incarnations. Geof Rayner and Tim Lang (Center for Food Policy) argue that public health today needs an overhaul, and to focus on our co-existence with nature and relationships with each other. They explain why, and how.Many of the issues Dr Rayner and Professor Lang are concerned about are being taken up by the People's Health Movement. Member Jonny Currie explains what he wants the movement to achieve, and others involved talk about actions they are taking.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1151</itunes:duration>
                                    </item>
    <item>
        <title>Bad for wealth, bad for health?</title>
        <itunes:title>Bad for wealth, bad for health?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/bad-for-wealth-bad-for-health/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/bad-for-wealth-bad-for-health/#comments</comments>        <pubDate>Tue, 27 Aug 2013 11:41:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/bad-for-wealth-bad-for-health</guid>
                                    <description><![CDATA[<p>In 2008 the rates of suicide in the UK began to increase. Is it a coincidence that this was also when the financial crisis hit? Ben Barr, research fellow in the department of Public Health and Policy at the University of Liverpool, explains what his study found.</p>
<p>Those who've attempted to kill themselves once are at high risk of doing so again, but interventions to prevent this have been hard to find. Merete Nordentoft, professor at the Mental Health Centre Copenhagen, University of Copenhagen, talks us through the results of her study examining a promising candidate.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In 2008 the rates of suicide in the UK began to increase. Is it a coincidence that this was also when the financial crisis hit? Ben Barr, research fellow in the department of Public Health and Policy at the University of Liverpool, explains what his study found.</p>
<p>Those who've attempted to kill themselves once are at high risk of doing so again, but interventions to prevent this have been hard to find. Merete Nordentoft, professor at the Mental Health Centre Copenhagen, University of Copenhagen, talks us through the results of her study examining a promising candidate.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fpnop6/stream_107476577-bmjgroup-bad-for-wealth-bad-for-health.mp3" length="6033272" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In 2008 the rates of suicide in the UK began to increase. Is it a coincidence that this was also when the financial crisis hit? Ben Barr, research fellow in the department of Public Health and Policy at the University of Liverpool, explains what his study found.Those who've attempted to kill themselves once are at high risk of doing so again, but interventions to prevent this have been hard to find. Merete Nordentoft, professor at the Mental Health Centre Copenhagen, University of Copenhagen, talks us through the results of her study examining a promising candidate.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>857</itunes:duration>
                                    </item>
    <item>
        <title>Acutely ill patients</title>
        <itunes:title>Acutely ill patients</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/acutely-ill-patients/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/acutely-ill-patients/#comments</comments>        <pubDate>Tue, 27 Aug 2013 11:38:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/acutely-ill-patients</guid>
                                    <description><![CDATA[<p>It's increasingly obvious that acutely ill patients have received less than gold standard care. Deficiencies in training are often blamed. Paul Frost, consultant in intensive care medicine at the University Hospital of Wales, takes us through the admission of an acutely ill patient.</p>
<p>Also this week, BRCA mutations and ionising radiation both increase the risk of developing cancer, but how do these risk factors combine? Anouk Pijpe, an epidemiologist at the Netherlands Cancer Institute, explains the results of her retrospective cohort study.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>It's increasingly obvious that acutely ill patients have received less than gold standard care. Deficiencies in training are often blamed. Paul Frost, consultant in intensive care medicine at the University Hospital of Wales, takes us through the admission of an acutely ill patient.</p>
<p>Also this week, BRCA mutations and ionising radiation both increase the risk of developing cancer, but how do these risk factors combine? Anouk Pijpe, an epidemiologist at the Netherlands Cancer Institute, explains the results of her retrospective cohort study.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jhmza1/stream_107476365-bmjgroup-acutely-ill-patients.mp3" length="17741423" type="audio/mpeg"/>
        <itunes:summary><![CDATA[It's increasingly obvious that acutely ill patients have received less than gold standard care. Deficiencies in training are often blamed. Paul Frost, consultant in intensive care medicine at the University Hospital of Wales, takes us through the admission of an acutely ill patient.Also this week, BRCA mutations and ionising radiation both increase the risk of developing cancer, but how do these risk factors combine? Anouk Pijpe, an epidemiologist at the Netherlands Cancer Institute, explains the results of her retrospective cohort study.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1472</itunes:duration>
                                    </item>
    <item>
        <title>Spotting pre-eclampsia, and debating obesity</title>
        <itunes:title>Spotting pre-eclampsia, and debating obesity</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/spotting-pre-eclampsia-and-debating-obesity/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/spotting-pre-eclampsia-and-debating-obesity/#comments</comments>        <pubDate>Tue, 27 Aug 2013 11:36:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/spotting-pre-eclampsia-and</guid>
                                    <description><![CDATA[<p>A BMJ head to head article this week asks: "Are the causes of obesity primarily environmental?" John Wilding, Head of the Department of Obesity and Endocrinology at the University of Liverpool, and Tim Frayling, professor of human genetics at the University of Exeter, argue their cases.</p>
<p>Also this week, David Williams, a consultant obstetric physician at University College Hospital London, explains why pre-eclampsia is easily missed.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>A BMJ head to head article this week asks: "Are the causes of obesity primarily environmental?" John Wilding, Head of the Department of Obesity and Endocrinology at the University of Liverpool, and Tim Frayling, professor of human genetics at the University of Exeter, argue their cases.</p>
<p>Also this week, David Williams, a consultant obstetric physician at University College Hospital London, explains why pre-eclampsia is easily missed.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/i3n59n/stream_107476188-bmjgroup-spotting-pre-eclampsia-and.mp3" length="21008323" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A BMJ head to head article this week asks: "Are the causes of obesity primarily environmental?" John Wilding, Head of the Department of Obesity and Endocrinology at the University of Liverpool, and Tim Frayling, professor of human genetics at the University of Exeter, argue their cases.Also this week, David Williams, a consultant obstetric physician at University College Hospital London, explains why pre-eclampsia is easily missed.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1743</itunes:duration>
                                    </item>
    <item>
        <title>Newer insulins and stents in diabetic patients</title>
        <itunes:title>Newer insulins and stents in diabetic patients</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/newer-insulins-and-stents-in-diabetic-patients/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/newer-insulins-and-stents-in-diabetic-patients/#comments</comments>        <pubDate>Tue, 27 Aug 2013 11:34:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/newer-insulins-and-stents-in</guid>
                                    <description><![CDATA[<p>This week we concentrate on diabetes</p>
<p>"The difference between insulin management in type 1 and type 2 diabetes is rather like the difference between driving a sports car and driving a lorry," says Edwin Gale, emeritus professor of diabetes at the University of Bristol. He tells us why this means the newer insulins that have benefits in the treatment of type 1 diabetes may not be as good for type 2.</p>
<p>Sripal Bangalore, director of research at the New York University School of Medicine, discusses his research into the relative effectiveness of different types of stents in diabetes patients</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week we concentrate on diabetes</p>
<p>"The difference between insulin management in type 1 and type 2 diabetes is rather like the difference between driving a sports car and driving a lorry," says Edwin Gale, emeritus professor of diabetes at the University of Bristol. He tells us why this means the newer insulins that have benefits in the treatment of type 1 diabetes may not be as good for type 2.</p>
<p>Sripal Bangalore, director of research at the New York University School of Medicine, discusses his research into the relative effectiveness of different types of stents in diabetes patients</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5uva8x/stream_107475986-bmjgroup-newer-insulins-and-stents-in.mp3" length="15907203" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week we concentrate on diabetes"The difference between insulin management in type 1 and type 2 diabetes is rather like the difference between driving a sports car and driving a lorry," says Edwin Gale, emeritus professor of diabetes at the University of Bristol. He tells us why this means the newer insulins that have benefits in the treatment of type 1 diabetes may not be as good for type 2.Sripal Bangalore, director of research at the New York University School of Medicine, discusses his research into the relative effectiveness of different types of stents in diabetes patients]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1321</itunes:duration>
                                    </item>
    <item>
        <title>Reducing emergency admissions: are we on the right track?</title>
        <itunes:title>Reducing emergency admissions: are we on the right track?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/reducing-emergency-admissions-are-we-on-the-right-track/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/reducing-emergency-admissions-are-we-on-the-right-track/#comments</comments>        <pubDate>Tue, 27 Aug 2013 11:32:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/reducing-emergency-admissions</guid>
                                    <description><![CDATA[<p>Schemes which reduce emergency admissions sound like a good thing, but Martin Rowland, professor of health services research, Cambridge Centre for Health Services Research, University of Cambridge, explains how they can go off track.</p>
<p>And Mabel Chew gets some advice on the prognosis of children with acute coughs from Matthew Thompson, a senior clinical scientist in the Department of Primary Care Health Sciences, Oxford University.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Schemes which reduce emergency admissions sound like a good thing, but Martin Rowland, professor of health services research, Cambridge Centre for Health Services Research, University of Cambridge, explains how they can go off track.</p>
<p>And Mabel Chew gets some advice on the prognosis of children with acute coughs from Matthew Thompson, a senior clinical scientist in the Department of Primary Care Health Sciences, Oxford University.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/opr400/stream_107475816-bmjgroup-reducing-emergency-admissions.mp3" length="32046566" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Schemes which reduce emergency admissions sound like a good thing, but Martin Rowland, professor of health services research, Cambridge Centre for Health Services Research, University of Cambridge, explains how they can go off track.And Mabel Chew gets some advice on the prognosis of children with acute coughs from Matthew Thompson, a senior clinical scientist in the Department of Primary Care Health Sciences, Oxford University.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1335</itunes:duration>
                                    </item>
    <item>
        <title>Stayin’ Alive, in the cardboard city</title>
        <itunes:title>Stayin’ Alive, in the cardboard city</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/stayin-alive-in-the-cardboard-city/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/stayin-alive-in-the-cardboard-city/#comments</comments>        <pubDate>Tue, 27 Aug 2013 11:25:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/stayin-alive-in-the-cardboard</guid>
                                    <description><![CDATA[<p>A head to head article this week asks: "Does celebrity involvement in public health campaigns deliver long term benefit?”. The British Heart Foundation’s Hands Only CPR campaign, featuring Hollywood actor Vinnie Jones, seems to be having positive effects. Maura Gillespie, head of policy and advocacy at the BHF, explains why.</p>
<p>Also this week, care for the homeless is often fragmented and transient. A team at University College Hospital in London is trying to unite the disparate agencies involved to ensure long term medical and social care for these vulnerable people. They tell us how their pilot service has improved outcomes and reduced costs.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>A head to head article this week asks: "Does celebrity involvement in public health campaigns deliver long term benefit?”. The British Heart Foundation’s Hands Only CPR campaign, featuring Hollywood actor Vinnie Jones, seems to be having positive effects. Maura Gillespie, head of policy and advocacy at the BHF, explains why.</p>
<p>Also this week, care for the homeless is often fragmented and transient. A team at University College Hospital in London is trying to unite the disparate agencies involved to ensure long term medical and social care for these vulnerable people. They tell us how their pilot service has improved outcomes and reduced costs.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mgtwz6/stream_107475202-bmjgroup-stayin-alive-in-the-cardboard.mp3" length="13359205" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A head to head article this week asks: "Does celebrity involvement in public health campaigns deliver long term benefit?”. The British Heart Foundation’s Hands Only CPR campaign, featuring Hollywood actor Vinnie Jones, seems to be having positive effects. Maura Gillespie, head of policy and advocacy at the BHF, explains why.Also this week, care for the homeless is often fragmented and transient. A team at University College Hospital in London is trying to unite the disparate agencies involved to ensure long term medical and social care for these vulnerable people. They tell us how their pilot service has improved outcomes and reduced costs.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1110</itunes:duration>
                                    </item>
    <item>
        <title>Treating the masses, overtreating the few</title>
        <itunes:title>Treating the masses, overtreating the few</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/treating-the-masses-overtreating-the-few/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/treating-the-masses-overtreating-the-few/#comments</comments>        <pubDate>Tue, 27 Aug 2013 11:23:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/treating-the-masses</guid>
                                    <description><![CDATA[<p>In the US, overly aggressive treatment is estimated to cause 30 000 deaths among Medicare recipients alone each year. Reporter Jeanne Lenzer has investigated the problem for the BMJ, and explains why she thinks profit driven healthcare is to blame.</p>
<p>And, experience of treating rare conditions can take time to build. Rej Bhumbra, a surgical trainee in orthopaedic oncology, explains how his time in India fast tracked his learning.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In the US, overly aggressive treatment is estimated to cause 30 000 deaths among Medicare recipients alone each year. Reporter Jeanne Lenzer has investigated the problem for the BMJ, and explains why she thinks profit driven healthcare is to blame.</p>
<p>And, experience of treating rare conditions can take time to build. Rej Bhumbra, a surgical trainee in orthopaedic oncology, explains how his time in India fast tracked his learning.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rk0tng/stream_107474968-bmjgroup-treating-the-masses.mp3" length="22304272" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In the US, overly aggressive treatment is estimated to cause 30 000 deaths among Medicare recipients alone each year. Reporter Jeanne Lenzer has investigated the problem for the BMJ, and explains why she thinks profit driven healthcare is to blame.And, experience of treating rare conditions can take time to build. Rej Bhumbra, a surgical trainee in orthopaedic oncology, explains how his time in India fast tracked his learning.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>928</itunes:duration>
                                    </item>
    <item>
        <title>Bariatric surgery, neuromuscular blocking agents, and calcium in primary parahyperthyroidism</title>
        <itunes:title>Bariatric surgery, neuromuscular blocking agents, and calcium in primary parahyperthyroidism</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/bariatric-surgery-neuromuscular-blocking-agents-and-calcium-in-primary-parahyperthyroidism/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/bariatric-surgery-neuromuscular-blocking-agents-and-calcium-in-primary-parahyperthyroidism/#comments</comments>        <pubDate>Tue, 27 Aug 2013 11:21:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/bariatric-surgery</guid>
                                    <description><![CDATA[<p>Bariatric surgery is under scrutiny from NCEPOD, the National Confidential Enquiry into Patient Outcome and Death, Ian Martin, NCEPOD's clinical co-ordinator for surgery, takes us through the highlights of its latest report. Also this week, Julie Paik, instructor and physician at Harvard Medical School, tells us about a new risk factor for primary hyperparathyroidism. And finally, some neuromuscular agents may lead to respiratory complications after surgery. Matthias Eikermann, director of research in the surgical intensive care unit at Massachusetts General Hospital, explains how they investigated this vexed problem.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Bariatric surgery is under scrutiny from NCEPOD, the National Confidential Enquiry into Patient Outcome and Death, Ian Martin, NCEPOD's clinical co-ordinator for surgery, takes us through the highlights of its latest report. Also this week, Julie Paik, instructor and physician at Harvard Medical School, tells us about a new risk factor for primary hyperparathyroidism. And finally, some neuromuscular agents may lead to respiratory complications after surgery. Matthias Eikermann, director of research in the surgical intensive care unit at Massachusetts General Hospital, explains how they investigated this vexed problem.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/e4q83t/stream_107474738-bmjgroup-bariatric-surgery.mp3" length="18007848" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Bariatric surgery is under scrutiny from NCEPOD, the National Confidential Enquiry into Patient Outcome and Death, Ian Martin, NCEPOD's clinical co-ordinator for surgery, takes us through the highlights of its latest report. Also this week, Julie Paik, instructor and physician at Harvard Medical School, tells us about a new risk factor for primary hyperparathyroidism. And finally, some neuromuscular agents may lead to respiratory complications after surgery. Matthias Eikermann, director of research in the surgical intensive care unit at Massachusetts General Hospital, explains how they investigated this vexed problem.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1496</itunes:duration>
                                    </item>
    <item>
        <title>Smoking in Japan</title>
        <itunes:title>Smoking in Japan</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/smoking-in-japan/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/smoking-in-japan/#comments</comments>        <pubDate>Tue, 27 Aug 2013 11:15:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/smoking-in-japan</guid>
                                    <description><![CDATA[<p>Deborah Cohen explains how a joint BMJ and Daily Telegraph investigation helped uncover problems with device regulation in Europe. Previous research has shown smoking reduces life expectancy by about a decade, but only by four years if you are Japanese. Sarah Darby, from the University of Oxford, explains why her new research shows they are actually just as unhealthy as their British counterparts.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Deborah Cohen explains how a joint BMJ and Daily Telegraph investigation helped uncover problems with device regulation in Europe. Previous research has shown smoking reduces life expectancy by about a decade, but only by four years if you are Japanese. Sarah Darby, from the University of Oxford, explains why her new research shows they are actually just as unhealthy as their British counterparts.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kn7lkw/stream_107474306-bmjgroup-smoking-in-japan.mp3" length="13343159" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Deborah Cohen explains how a joint BMJ and Daily Telegraph investigation helped uncover problems with device regulation in Europe. Previous research has shown smoking reduces life expectancy by about a decade, but only by four years if you are Japanese. Sarah Darby, from the University of Oxford, explains why her new research shows they are actually just as unhealthy as their British counterparts.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1108</itunes:duration>
                                    </item>
    <item>
        <title>Fishy data</title>
        <itunes:title>Fishy data</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/fishy-data/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/fishy-data/#comments</comments>        <pubDate>Tue, 27 Aug 2013 11:13:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/fishy-data</guid>
                                    <description><![CDATA[<p>Rajiv Chowdury, a research associate from the Department of Public Health and Primary Care at the University of Cambridge, explains why eating whole fish is better than fish oil - at least when it comes to cerebrovascular disease. Also this week Peter Doshi and Tom Jefferson from the Cochrane Collaboration talk about the BMJ's open data campaign, and how publishing correspondence with Roche, the WHO and Centers for Disease Control and Prevention might reveal the missing data on Tamiflu.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Rajiv Chowdury, a research associate from the Department of Public Health and Primary Care at the University of Cambridge, explains why eating whole fish is better than fish oil - at least when it comes to cerebrovascular disease. Also this week Peter Doshi and Tom Jefferson from the Cochrane Collaboration talk about the BMJ's open data campaign, and how publishing correspondence with Roche, the WHO and Centers for Disease Control and Prevention might reveal the missing data on Tamiflu.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wt4c7v/stream_107474106-bmjgroup-fishy-data.mp3" length="28818780" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Rajiv Chowdury, a research associate from the Department of Public Health and Primary Care at the University of Cambridge, explains why eating whole fish is better than fish oil - at least when it comes to cerebrovascular disease. Also this week Peter Doshi and Tom Jefferson from the Cochrane Collaboration talk about the BMJ's open data campaign, and how publishing correspondence with Roche, the WHO and Centers for Disease Control and Prevention might reveal the missing data on Tamiflu.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1198</itunes:duration>
                                    </item>
    <item>
        <title>The silent misdiagnosis</title>
        <itunes:title>The silent misdiagnosis</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-silent-misdiagnosis/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-silent-misdiagnosis/#comments</comments>        <pubDate>Tue, 27 Aug 2013 11:11:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-silent-misdiagnosis</guid>
                                    <description><![CDATA[<p>This week, Al Mulley, Dartmouth Center for Health Care Delivery Science, and Tessa Richards, BMJ associate editor, discuss the silent misdiagnosis: that of patient preferences.</p>
<p>Removing pre-cancerous cells spotted through screening is the foremost defence against cervical cancer. However, a recent BMJ paper has shown that women who go through this have a fourfold risk of going on to develop cancer compared to women who’ve only ever had normal smears, even if they complete follow up and are given the all clear. Matejka Rebolj, postdoctoral researcher, Department of Public Health, University of Copenhagen, and Chris Meijer and Maaike Bleeker, pathologists in the Department of Pathology, VU Medical Centre, Amsterdam, discuss what could be done to mitigate the risk.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week, Al Mulley, Dartmouth Center for Health Care Delivery Science, and Tessa Richards, BMJ associate editor, discuss the silent misdiagnosis: that of patient preferences.</p>
<p>Removing pre-cancerous cells spotted through screening is the foremost defence against cervical cancer. However, a recent BMJ paper has shown that women who go through this have a fourfold risk of going on to develop cancer compared to women who’ve only ever had normal smears, even if they complete follow up and are given the all clear. Matejka Rebolj, postdoctoral researcher, Department of Public Health, University of Copenhagen, and Chris Meijer and Maaike Bleeker, pathologists in the Department of Pathology, VU Medical Centre, Amsterdam, discuss what could be done to mitigate the risk.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8r128b/stream_107473909-bmjgroup-the-silent-misdiagnosis.mp3" length="27831933" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week, Al Mulley, Dartmouth Center for Health Care Delivery Science, and Tessa Richards, BMJ associate editor, discuss the silent misdiagnosis: that of patient preferences.Removing pre-cancerous cells spotted through screening is the foremost defence against cervical cancer. However, a recent BMJ paper has shown that women who go through this have a fourfold risk of going on to develop cancer compared to women who’ve only ever had normal smears, even if they complete follow up and are given the all clear. Matejka Rebolj, postdoctoral researcher, Department of Public Health, University of Copenhagen, and Chris Meijer and Maaike Bleeker, pathologists in the Department of Pathology, VU Medical Centre, Amsterdam, discuss what could be done to mitigate the risk.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1159</itunes:duration>
                                    </item>
    <item>
        <title>Countering counterfeits</title>
        <itunes:title>Countering counterfeits</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/countering-counterfeits/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/countering-counterfeits/#comments</comments>        <pubDate>Tue, 27 Aug 2013 11:03:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/countering-counterfeits</guid>
                                    <description><![CDATA[<p>Last year 125 people died in Pakistan after taking contaminated cardiac medication. The disaster is one example of the dangers of counterfeit and substandard medicines, an issue the WHO is struggling to control.</p>
<p>In this podcast we hear from Amir Attaran, Canada research chair in law, population health, and global development policy at the University of Ottawa, on the international wrangling he sees at the political level. And Sania Nishtar, president of Heartfile, an independent think tank based in India, discusses what went wrong in Pakistan, and how to prevent it happening again.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Last year 125 people died in Pakistan after taking contaminated cardiac medication. The disaster is one example of the dangers of counterfeit and substandard medicines, an issue the WHO is struggling to control.</p>
<p>In this podcast we hear from Amir Attaran, Canada research chair in law, population health, and global development policy at the University of Ottawa, on the international wrangling he sees at the political level. And Sania Nishtar, president of Heartfile, an independent think tank based in India, discusses what went wrong in Pakistan, and how to prevent it happening again.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fh6f9m/stream_107473066-bmjgroup-countering-counterfeits.mp3" length="25760065" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Last year 125 people died in Pakistan after taking contaminated cardiac medication. The disaster is one example of the dangers of counterfeit and substandard medicines, an issue the WHO is struggling to control.In this podcast we hear from Amir Attaran, Canada research chair in law, population health, and global development policy at the University of Ottawa, on the international wrangling he sees at the political level. And Sania Nishtar, president of Heartfile, an independent think tank based in India, discusses what went wrong in Pakistan, and how to prevent it happening again.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1071</itunes:duration>
                                    </item>
    <item>
        <title>Checking out the check-ups</title>
        <itunes:title>Checking out the check-ups</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/checking-out-the-check-ups/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/checking-out-the-check-ups/#comments</comments>        <pubDate>Tue, 27 Aug 2013 10:57:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/checking-out-the-check-ups</guid>
                                    <description><![CDATA[<p>Lasse Krogsbøll, from the Nordic Cochrane Centre, explains research into whether general health checks improve mortality and morbidity in the population. Also, the European Medicines Agency (EMA) this week announced plans to make trial data used as the basis for its decisions publicly available. BMJ Deputy editor Trish Groves finds out more from some of the key players in the campaign for open data.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Lasse Krogsbøll, from the Nordic Cochrane Centre, explains research into whether general health checks improve mortality and morbidity in the population. Also, the European Medicines Agency (EMA) this week announced plans to make trial data used as the basis for its decisions publicly available. BMJ Deputy editor Trish Groves finds out more from some of the key players in the campaign for open data.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/oq56sf/stream_107472541-bmjgroup-checking-out-the-check-ups.mp3" length="23508072" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Lasse Krogsbøll, from the Nordic Cochrane Centre, explains research into whether general health checks improve mortality and morbidity in the population. Also, the European Medicines Agency (EMA) this week announced plans to make trial data used as the basis for its decisions publicly available. BMJ Deputy editor Trish Groves finds out more from some of the key players in the campaign for open data.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>977</itunes:duration>
                                    </item>
    <item>
        <title>Neonatal survival and Lifebox</title>
        <itunes:title>Neonatal survival and Lifebox</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/neonatal-survival-and-lifebox/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/neonatal-survival-and-lifebox/#comments</comments>        <pubDate>Tue, 27 Aug 2013 10:53:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/neonatal-survival-and-lifebox</guid>
                                    <description><![CDATA[<p>Helen Macdonald, assistant editor at the BMJ, talks to Neil Marlow, professor of neonatal medicine at University College London, about his update to the EPICure study looking at outcomes for extremely premature babies.</p>
<p>Jane Feinmann talks to writer and surgeon Atul Gawande, about Lifebox – which has been chosen again as the BMJ’s Christmas appeal for 2012.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Helen Macdonald, assistant editor at the BMJ, talks to Neil Marlow, professor of neonatal medicine at University College London, about his update to the EPICure study looking at outcomes for extremely premature babies.</p>
<p>Jane Feinmann talks to writer and surgeon Atul Gawande, about Lifebox – which has been chosen again as the BMJ’s Christmas appeal for 2012.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kma0vm/stream_107472173-bmjgroup-neonatal-survival-and-lifebox.mp3" length="42603174" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Helen Macdonald, assistant editor at the BMJ, talks to Neil Marlow, professor of neonatal medicine at University College London, about his update to the EPICure study looking at outcomes for extremely premature babies.Jane Feinmann talks to writer and surgeon Atul Gawande, about Lifebox – which has been chosen again as the BMJ’s Christmas appeal for 2012.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1775</itunes:duration>
                                    </item>
    <item>
        <title>Emergency oxygen use</title>
        <itunes:title>Emergency oxygen use</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/emergency-oxygen-use/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/emergency-oxygen-use/#comments</comments>        <pubDate>Tue, 27 Aug 2013 10:51:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/emergency-oxygen-use</guid>
                                    <description><![CDATA[<p>Is too much oxygen a good thing? Christine Roffe, consultant physician, Stoke Stroke Research Group, North Staffordshire Combined Healthcare NHS Trust, talks Mabel Chew, BMJ associate editor, through the evidence for routinely treating stroke patients with oxygen.</p>
<p>And Russell Gruen, professor of surgery and public health, Alfred and Monash University, Melbourne, explains how and when tranexamic acid should be used after trauma.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Is too much oxygen a good thing? Christine Roffe, consultant physician, Stoke Stroke Research Group, North Staffordshire Combined Healthcare NHS Trust, talks Mabel Chew, BMJ associate editor, through the evidence for routinely treating stroke patients with oxygen.</p>
<p>And Russell Gruen, professor of surgery and public health, Alfred and Monash University, Melbourne, explains how and when tranexamic acid should be used after trauma.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mmwe2m/stream_107471948-bmjgroup-emergency-oxygen-use.mp3" length="28101529" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Is too much oxygen a good thing? Christine Roffe, consultant physician, Stoke Stroke Research Group, North Staffordshire Combined Healthcare NHS Trust, talks Mabel Chew, BMJ associate editor, through the evidence for routinely treating stroke patients with oxygen.And Russell Gruen, professor of surgery and public health, Alfred and Monash University, Melbourne, explains how and when tranexamic acid should be used after trauma.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1170</itunes:duration>
                                    </item>
    <item>
        <title>Non-coeliac but gluten sensitive?</title>
        <itunes:title>Non-coeliac but gluten sensitive?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/non-coeliac-but-gluten-sensitive/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/non-coeliac-but-gluten-sensitive/#comments</comments>        <pubDate>Tue, 27 Aug 2013 10:44:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/non-coeliac-but-gluten</guid>
                                    <description><![CDATA[<p>Many patients are following a wheat free diet, which they believe helps with their gastrointestinal symptoms, yet they don't exhibit markers of coeliac disease. Mabel Chew finds out from David Sanders, a professor of gastroenterology at the Royal Hallamshire Hospital, about non-coeliac gluten sensitivity.</p>
<p>Also, Fiona Godlee gives us an update on the open data campaign.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Many patients are following a wheat free diet, which they believe helps with their gastrointestinal symptoms, yet they don't exhibit markers of coeliac disease. Mabel Chew finds out from David Sanders, a professor of gastroenterology at the Royal Hallamshire Hospital, about non-coeliac gluten sensitivity.</p>
<p>Also, Fiona Godlee gives us an update on the open data campaign.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ipu5w7/stream_107470863-bmjgroup-non-coeliac-but-gluten.mp3" length="22737933" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Many patients are following a wheat free diet, which they believe helps with their gastrointestinal symptoms, yet they don't exhibit markers of coeliac disease. Mabel Chew finds out from David Sanders, a professor of gastroenterology at the Royal Hallamshire Hospital, about non-coeliac gluten sensitivity.Also, Fiona Godlee gives us an update on the open data campaign.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>946</itunes:duration>
                                    </item>
    <item>
        <title>Christmas 2012: The speed bump test</title>
        <itunes:title>Christmas 2012: The speed bump test</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/christmas-2012-the-speed-bump-test/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/christmas-2012-the-speed-bump-test/#comments</comments>        <pubDate>Tue, 27 Aug 2013 10:42:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/christmas-2012-the-speed-bump</guid>
                                    <description><![CDATA[<p>We know that speed bumps have an important public health role, but a Christmas BMJ paper shows they're also clinically useful, and can help diagnose appendicitis. Helen Ashdown, academic clinical fellow in general practice, University of Oxford, and Mike Puttick, consultant surgeon, Stoke Mandeville Hospital, explain.</p>
<p>And want to know how many carrots you need to eat to balance out that festive champagne? David Spiegelhalter, Winton professor for the public understanding of risk, University of Cambridge, tells us how to work it out.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>We know that speed bumps have an important public health role, but a Christmas BMJ paper shows they're also clinically useful, and can help diagnose appendicitis. Helen Ashdown, academic clinical fellow in general practice, University of Oxford, and Mike Puttick, consultant surgeon, Stoke Mandeville Hospital, explain.</p>
<p>And want to know how many carrots you need to eat to balance out that festive champagne? David Spiegelhalter, Winton professor for the public understanding of risk, University of Cambridge, tells us how to work it out.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xsn4st/stream_107470573-bmjgroup-christmas-2012-the-speed-bump.mp3" length="29020981" type="audio/mpeg"/>
        <itunes:summary><![CDATA[We know that speed bumps have an important public health role, but a Christmas BMJ paper shows they're also clinically useful, and can help diagnose appendicitis. Helen Ashdown, academic clinical fellow in general practice, University of Oxford, and Mike Puttick, consultant surgeon, Stoke Mandeville Hospital, explain.And want to know how many carrots you need to eat to balance out that festive champagne? David Spiegelhalter, Winton professor for the public understanding of risk, University of Cambridge, tells us how to work it out.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1208</itunes:duration>
                                    </item>
    <item>
        <title>Prison health</title>
        <itunes:title>Prison health</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/prison-health/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/prison-health/#comments</comments>        <pubDate>Tue, 27 Aug 2013 10:34:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/prison-health</guid>
                                    <description><![CDATA[<p>The final article in the analysis series examining prison health in England and Wales is published this week. To sum up, Francis Crook, Director of the Howard League for Penal Reform - the UK's oldest charity examining prison conditions - joins us to discuss prison reform.</p>
<p>Also this week, Myasthenia gravis; Jennifer Spillane, clinical research associate at the Institute of Neurology in London, explains why it's easily missed.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The final article in the analysis series examining prison health in England and Wales is published this week. To sum up, Francis Crook, Director of the Howard League for Penal Reform - the UK's oldest charity examining prison conditions - joins us to discuss prison reform.</p>
<p>Also this week, Myasthenia gravis; Jennifer Spillane, clinical research associate at the Institute of Neurology in London, explains why it's easily missed.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9a3im9/stream_107469434-bmjgroup-prison-health.mp3" length="33603139" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The final article in the analysis series examining prison health in England and Wales is published this week. To sum up, Francis Crook, Director of the Howard League for Penal Reform - the UK's oldest charity examining prison conditions - joins us to discuss prison reform.Also this week, Myasthenia gravis; Jennifer Spillane, clinical research associate at the Institute of Neurology in London, explains why it's easily missed.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1399</itunes:duration>
                                    </item>
    <item>
        <title>Deworming debunked</title>
        <itunes:title>Deworming debunked</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/deworming-debunked/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/deworming-debunked/#comments</comments>        <pubDate>Tue, 27 Aug 2013 10:31:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/deworming-debunked</guid>
                                    <description><![CDATA[<p>You may well assume that a programme supported by organisations such as the World Bank and the World Health Organization does what it says on the tin. However, it turns out this is not the case with deworming initiatives in countries such as Africa and India. Paul Garner, co-author of the Cochrane review on the topic, explains what's going on.</p>
<p>And Michael Wilson, instructor of medicine at the Mayo Clinic, gives us some advice on diagnosing Klinefelter's syndrome.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>You may well assume that a programme supported by organisations such as the World Bank and the World Health Organization does what it says on the tin. However, it turns out this is not the case with deworming initiatives in countries such as Africa and India. Paul Garner, co-author of the Cochrane review on the topic, explains what's going on.</p>
<p>And Michael Wilson, instructor of medicine at the Mayo Clinic, gives us some advice on diagnosing Klinefelter's syndrome.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ovk3uo/stream_107469118-bmjgroup-deworming-debunked.mp3" length="27948563" type="audio/mpeg"/>
        <itunes:summary><![CDATA[You may well assume that a programme supported by organisations such as the World Bank and the World Health Organization does what it says on the tin. However, it turns out this is not the case with deworming initiatives in countries such as Africa and India. Paul Garner, co-author of the Cochrane review on the topic, explains what's going on.And Michael Wilson, instructor of medicine at the Mayo Clinic, gives us some advice on diagnosing Klinefelter's syndrome.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1164</itunes:duration>
                                    </item>
    <item>
        <title>The science of sugar</title>
        <itunes:title>The science of sugar</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-science-of-sugar-1680599904/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-science-of-sugar-1680599904/#comments</comments>        <pubDate>Tue, 27 Aug 2013 10:28:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-science-of-sugar</guid>
                                    <description><![CDATA[<p>The authors of the recent meta-analysis on dietary sugar and body weight, Lisa Te Morenga, and Jim Mann, from the Departments of Human Nutrition and Medicine at the University of Otago, join us to discuss their findings.</p>
<p>Also this week, the BMA wants doctors to be more involved in influencing policy on recreational drugs. Vivienne Nathanson, its director of professional activities, explains its new report, and how individual testimony can combine to convince governments to change policy.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The authors of the recent meta-analysis on dietary sugar and body weight, Lisa Te Morenga, and Jim Mann, from the Departments of Human Nutrition and Medicine at the University of Otago, join us to discuss their findings.</p>
<p>Also this week, the BMA wants doctors to be more involved in influencing policy on recreational drugs. Vivienne Nathanson, its director of professional activities, explains its new report, and how individual testimony can combine to convince governments to change policy.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/o0frf3/stream_107468811-bmjgroup-the-science-of-sugar.mp3" length="26531174" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The authors of the recent meta-analysis on dietary sugar and body weight, Lisa Te Morenga, and Jim Mann, from the Departments of Human Nutrition and Medicine at the University of Otago, join us to discuss their findings.Also this week, the BMA wants doctors to be more involved in influencing policy on recreational drugs. Vivienne Nathanson, its director of professional activities, explains its new report, and how individual testimony can combine to convince governments to change policy.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1104</itunes:duration>
                                    </item>
    <item>
        <title>H7N9, and NHS standardised mortality rates</title>
        <itunes:title>H7N9, and NHS standardised mortality rates</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/h7n9-and-nhs-standardised-mortality-rates/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/h7n9-and-nhs-standardised-mortality-rates/#comments</comments>        <pubDate>Mon, 12 Aug 2013 14:32:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/h7n9-and-nhs-standardised</guid>
                                    <description><![CDATA[An epidemiological investigation on bmj.com discusses the first probable case of human to human transmission of novel avian influenza A (H7N9). The author of the accompanying editorial, James Rudge, from the London School of Hygiene and Tropical Medicine, explains what this means for public health.

Also this week, we know that standardised mortality rates are tricky and have to be interpreted carefully. David Spiegelhater, Winton Professor for the Public Understanding of Risk at the university of Cambridge, explains why a figure of 13 000 excess deaths in NHS hospitals is “number abuse”.

Read the articles:
http://www.bmj.com/content/347/bmj.f4730
<p>http://www.bmj.com/content/347/bmj.f4893</p>
]]></description>
                                                            <content:encoded><![CDATA[An epidemiological investigation on bmj.com discusses the first probable case of human to human transmission of novel avian influenza A (H7N9). The author of the accompanying editorial, James Rudge, from the London School of Hygiene and Tropical Medicine, explains what this means for public health.

Also this week, we know that standardised mortality rates are tricky and have to be interpreted carefully. David Spiegelhater, Winton Professor for the Public Understanding of Risk at the university of Cambridge, explains why a figure of 13 000 excess deaths in NHS hospitals is “number abuse”.

Read the articles:
http://www.bmj.com/content/347/bmj.f4730
<p>http://www.bmj.com/content/347/bmj.f4893</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/nsall7/stream_105088551-bmjgroup-h7n9-and-nhs-standardised.mp3" length="26229626" type="audio/mpeg"/>
        <itunes:summary><![CDATA[An epidemiological investigation on bmj.com discusses the first probable case of human to human transmission of novel avian influenza A (H7N9). The author of the accompanying editorial, James Rudge, from the London School of Hygiene and Tropical Medicine, explains what this means for public health.

Also this week, we know that standardised mortality rates are tricky and have to be interpreted carefully. David Spiegelhater, Winton Professor for the Public Understanding of Risk at the university of Cambridge, explains why a figure of 13 000 excess deaths in NHS hospitals is “number abuse”.

Read the articles:
http://www.bmj.com/content/347/bmj.f4730
http://www.bmj.com/content/347/bmj.f4893]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1091</itunes:duration>
                                    </item>
    <item>
        <title>American life</title>
        <itunes:title>American life</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/american-life/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/american-life/#comments</comments>        <pubDate>Wed, 07 Aug 2013 09:31:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/american-life</guid>
                                    <description><![CDATA[<p>US Health in International Perspective: Shorter Lives, Poorer Health produced by the National Research Council and Institute of Medicine of the National Academies, has found that on almost every comparative measure, Americans fare worse than their counterparts from other developed countries. Steve Woolf, from the Department of Family Medicine at Virginia Commonwealth University, who chaired the report, joins us to discuss its findings, and the implications.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>US Health in International Perspective: Shorter Lives, Poorer Health produced by the National Research Council and Institute of Medicine of the National Academies, has found that on almost every comparative measure, Americans fare worse than their counterparts from other developed countries. Steve Woolf, from the Department of Family Medicine at Virginia Commonwealth University, who chaired the report, joins us to discuss its findings, and the implications.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/h5izoj/stream_104376028-bmjgroup-american-life.mp3" length="36962389" type="audio/mpeg"/>
        <itunes:summary><![CDATA[US Health in International Perspective: Shorter Lives, Poorer Health produced by the National Research Council and Institute of Medicine of the National Academies, has found that on almost every comparative measure, Americans fare worse than their counterparts from other developed countries. Steve Woolf, from the Department of Family Medicine at Virginia Commonwealth University, who chaired the report, joins us to discuss its findings, and the implications.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1540</itunes:duration>
                                    </item>
    <item>
        <title>Screening and treating clinically localised prostate cancer</title>
        <itunes:title>Screening and treating clinically localised prostate cancer</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/screening-and-treating-clinically-localised-prostate-cancer/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/screening-and-treating-clinically-localised-prostate-cancer/#comments</comments>        <pubDate>Wed, 07 Aug 2013 09:30:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/screening-and-treating</guid>
                                    <description><![CDATA[<p>In this practice special podcast, Timothy Wilt, professor of medicine at Minneapolis VA Center for Chronic Disease Outcomes Research, explains how to talk to patients about prostate cancer screening. Benjamin C Thomas, senior clinical fellow at Addenbrooks Hospital in Cambridge then talks us through androgen deprivation therapy.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this practice special podcast, Timothy Wilt, professor of medicine at Minneapolis VA Center for Chronic Disease Outcomes Research, explains how to talk to patients about prostate cancer screening. Benjamin C Thomas, senior clinical fellow at Addenbrooks Hospital in Cambridge then talks us through androgen deprivation therapy.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/n57ktz/stream_104375953-bmjgroup-screening-and-treating.mp3" length="30694455" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this practice special podcast, Timothy Wilt, professor of medicine at Minneapolis VA Center for Chronic Disease Outcomes Research, explains how to talk to patients about prostate cancer screening. Benjamin C Thomas, senior clinical fellow at Addenbrooks Hospital in Cambridge then talks us through androgen deprivation therapy.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1277</itunes:duration>
                                    </item>
    <item>
        <title>Treating early psychosis</title>
        <itunes:title>Treating early psychosis</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/treating-early-psychosis/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/treating-early-psychosis/#comments</comments>        <pubDate>Wed, 07 Aug 2013 09:30:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/treating-early-psychosis</guid>
                                    <description><![CDATA[<p>How can you treat a young person who is exhibiting the first signs of psychosis? Mabel Chew talks to Professor Tim Kendall a consultant psychiatrist and director of the National Collaborating Centre for Mental Health at the Royal College of Psychiatrists. Professor Kendall is co-author of both a systematic review and meta-analysis into early treatments to prevent psychosis, and co-author of a new set of NICE guidelines into management of the condition.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>How can you treat a young person who is exhibiting the first signs of psychosis? Mabel Chew talks to Professor Tim Kendall a consultant psychiatrist and director of the National Collaborating Centre for Mental Health at the Royal College of Psychiatrists. Professor Kendall is co-author of both a systematic review and meta-analysis into early treatments to prevent psychosis, and co-author of a new set of NICE guidelines into management of the condition.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/12hk4t/stream_104375969-bmjgroup-treating-early-psychosis.mp3" length="20143393" type="audio/mpeg"/>
        <itunes:summary><![CDATA[How can you treat a young person who is exhibiting the first signs of psychosis? Mabel Chew talks to Professor Tim Kendall a consultant psychiatrist and director of the National Collaborating Centre for Mental Health at the Royal College of Psychiatrists. Professor Kendall is co-author of both a systematic review and meta-analysis into early treatments to prevent psychosis, and co-author of a new set of NICE guidelines into management of the condition.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>836</itunes:duration>
                                    </item>
    <item>
        <title>Mid Staffs inquiry, and digging for data</title>
        <itunes:title>Mid Staffs inquiry, and digging for data</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/mid-staffs-inquiry-and-digging-for-data/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/mid-staffs-inquiry-and-digging-for-data/#comments</comments>        <pubDate>Wed, 07 Aug 2013 09:22:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/mid-staffs-inquiry-and-digging</guid>
                                    <description><![CDATA[<p>The Francis report into care standards at Mid Staffordshire NHS Foundation Trust was published this week. Triggered by deaths at a hospital in England, Robert Francis QC was appointed by the government to look into why the quality of care in some wards was so low, and what can be done to make sure that this doesn’t happen in other hospitals.</p>
<p>Also this week, research has unearthed data hidden for 40 years on magnetic tapes. It casts new light on the link between consumption of unsaturated fatty acids and secondary prevention of cardiovascular events. We hear from Christopher Ramsden, a clinical investigator at the US National Institutes of Health, who dug up the data.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The Francis report into care standards at Mid Staffordshire NHS Foundation Trust was published this week. Triggered by deaths at a hospital in England, Robert Francis QC was appointed by the government to look into why the quality of care in some wards was so low, and what can be done to make sure that this doesn’t happen in other hospitals.</p>
<p>Also this week, research has unearthed data hidden for 40 years on magnetic tapes. It casts new light on the link between consumption of unsaturated fatty acids and secondary prevention of cardiovascular events. We hear from Christopher Ramsden, a clinical investigator at the US National Institutes of Health, who dug up the data.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/auo5ba/stream_104375400-bmjgroup-mid-staffs-inquiry-and-digging.mp3" length="44102563" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The Francis report into care standards at Mid Staffordshire NHS Foundation Trust was published this week. Triggered by deaths at a hospital in England, Robert Francis QC was appointed by the government to look into why the quality of care in some wards was so low, and what can be done to make sure that this doesn’t happen in other hospitals.Also this week, research has unearthed data hidden for 40 years on magnetic tapes. It casts new light on the link between consumption of unsaturated fatty acids and secondary prevention of cardiovascular events. We hear from Christopher Ramsden, a clinical investigator at the US National Institutes of Health, who dug up the data.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1837</itunes:duration>
                                    </item>
    <item>
        <title>The future of primary care</title>
        <itunes:title>The future of primary care</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-future-of-primary-care/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-future-of-primary-care/#comments</comments>        <pubDate>Wed, 07 Aug 2013 09:12:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-future-of-primary-care</guid>
                                    <description><![CDATA[<p>The BMJ held a round table in January 2013 to discuss the future of primary care in England and Wales. The wide ranging topics included out of hours care, commissioning, education, time management, and integration. This is the full version, lasting one hour and 20 minutes. Edited highlights are available in this week's podcast.</p>
<p>Chair: </p>
<p>Domhnall MacAuley, primary care editor, BMJ.</p>
<p>Participants:</p>
<p>Helen Thomas, former GP partner, and current GP Strategic Health Authority lead for the south west of England </p>
<p>Clare Gerada, chair of the Royal College of General Practitioners.</p>
<p>Nav Chana, postgraduate dean of GP and community based education at the London Deanery.</p>
<p>Judith Smith, director of policy at the policy think tank, the Nuffield Trust.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The BMJ held a round table in January 2013 to discuss the future of primary care in England and Wales. The wide ranging topics included out of hours care, commissioning, education, time management, and integration. This is the full version, lasting one hour and 20 minutes. Edited highlights are available in this week's podcast.</p>
<p>Chair: </p>
<p>Domhnall MacAuley, primary care editor, BMJ.</p>
<p>Participants:</p>
<p>Helen Thomas, former GP partner, and current GP Strategic Health Authority lead for the south west of England </p>
<p>Clare Gerada, chair of the Royal College of General Practitioners.</p>
<p>Nav Chana, postgraduate dean of GP and community based education at the London Deanery.</p>
<p>Judith Smith, director of policy at the policy think tank, the Nuffield Trust.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8rxkha/stream_104374754-bmjgroup-the-future-of-primary-care.mp3" length="113573409" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The BMJ held a round table in January 2013 to discuss the future of primary care in England and Wales. The wide ranging topics included out of hours care, commissioning, education, time management, and integration. This is the full version, lasting one hour and 20 minutes. Edited highlights are available in this week's podcast.Chair: Domhnall MacAuley, primary care editor, BMJ.Participants:Helen Thomas, former GP partner, and current GP Strategic Health Authority lead for the south west of England Clare Gerada, chair of the Royal College of General Practitioners.Nav Chana, postgraduate dean of GP and community based education at the London Deanery.Judith Smith, director of policy at the policy think tank, the Nuffield Trust.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>4737</itunes:duration>
                                    </item>
    <item>
        <title>Start with the basics, food and fluid</title>
        <itunes:title>Start with the basics, food and fluid</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/start-with-the-basics-food-and-fluid/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/start-with-the-basics-food-and-fluid/#comments</comments>        <pubDate>Wed, 07 Aug 2013 08:52:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/start-with-the-basics-food-and</guid>
                                    <description><![CDATA[<p>How involved are doctors in the non medical aspects of patient care? An analysis on bmj.com this week examines the problem of nutrition and fluid balance in hospitalised patients. Helen Macdonald, a junior doctor and editor at the BMJ, asks Richard Leach, clinical director of Guy's and St Thomas' NHS Foundation Trust, about how it should best be handled.</p>
<p>Also this week, a summary of the BMJ round table on the future of primary care, which is available in full on the podcast page.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>How involved are doctors in the non medical aspects of patient care? An analysis on bmj.com this week examines the problem of nutrition and fluid balance in hospitalised patients. Helen Macdonald, a junior doctor and editor at the BMJ, asks Richard Leach, clinical director of Guy's and St Thomas' NHS Foundation Trust, about how it should best be handled.</p>
<p>Also this week, a summary of the BMJ round table on the future of primary care, which is available in full on the podcast page.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xnkqu7/stream_104373417-bmjgroup-start-with-the-basics-food-and.mp3" length="32365850" type="audio/mpeg"/>
        <itunes:summary><![CDATA[How involved are doctors in the non medical aspects of patient care? An analysis on bmj.com this week examines the problem of nutrition and fluid balance in hospitalised patients. Helen Macdonald, a junior doctor and editor at the BMJ, asks Richard Leach, clinical director of Guy's and St Thomas' NHS Foundation Trust, about how it should best be handled.Also this week, a summary of the BMJ round table on the future of primary care, which is available in full on the podcast page.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1347</itunes:duration>
                                    </item>
    <item>
        <title>Health in all policies</title>
        <itunes:title>Health in all policies</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/health-in-all-policies/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/health-in-all-policies/#comments</comments>        <pubDate>Wed, 07 Aug 2013 08:44:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/health-in-all-policies</guid>
                                    <description><![CDATA[<p>Of the myriad of clinical decision support tools, what features actually improve patient outcomes? Pavel Romanov, medical student at Western University in Canada, discusses his research.</p>
<p>Also this week: Is it feasible to get governments to consider the public health impact of every policy decision they make? Politicians in Wales have drafted legislation to make the devolved nation the first in the world to implement this WHO recommendation. Adam Fletcher, senior lecturer in social science and health at Cardiff University, has written an editorial about the plan, and joins us to discuss the practicalities of enshrining public health in law.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Of the myriad of clinical decision support tools, what features actually improve patient outcomes? Pavel Romanov, medical student at Western University in Canada, discusses his research.</p>
<p>Also this week: Is it feasible to get governments to consider the public health impact of every policy decision they make? Politicians in Wales have drafted legislation to make the devolved nation the first in the world to implement this WHO recommendation. Adam Fletcher, senior lecturer in social science and health at Cardiff University, has written an editorial about the plan, and joins us to discuss the practicalities of enshrining public health in law.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dwl3hc/stream_104372804-bmjgroup-health-in-all-policies.mp3" length="26197149" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Of the myriad of clinical decision support tools, what features actually improve patient outcomes? Pavel Romanov, medical student at Western University in Canada, discusses his research.Also this week: Is it feasible to get governments to consider the public health impact of every policy decision they make? Politicians in Wales have drafted legislation to make the devolved nation the first in the world to implement this WHO recommendation. Adam Fletcher, senior lecturer in social science and health at Cardiff University, has written an editorial about the plan, and joins us to discuss the practicalities of enshrining public health in law.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1091</itunes:duration>
                                    </item>
    <item>
        <title>How do we put the compassion back into healthcare?: Full roundtable discussion</title>
        <itunes:title>How do we put the compassion back into healthcare?: Full roundtable discussion</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/how-do-we-put-the-compassion-back-into-healthcare-full-roundtable-discussion/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/how-do-we-put-the-compassion-back-into-healthcare-full-roundtable-discussion/#comments</comments>        <pubDate>Wed, 07 Aug 2013 08:38:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/how-do-we-put-the-compassion</guid>
                                    <description><![CDATA[<p>In the wake of the Francis report, the BMJ gathered experts to discuss compassion in the health service. This is the discussion in full.</p>
<p>Taking part are:</p>
<p>Domhnall MacAuley, BMJ primary care editor</p>
<p>Anthony Silverstone, consultant at UCH </p>
<p>Peter Carter, chief executive for the Royal College of Nursing </p>
<p>Jocelyn Cornwall, director, The Point of Care programme, The King's Fund </p>
<p>Joanne Watson, consultant at Musgrove Park Hospital </p>
<p>Sean O'Brien, head of the patient experience group at Musgrove Park Hospital</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In the wake of the Francis report, the BMJ gathered experts to discuss compassion in the health service. This is the discussion in full.</p>
<p>Taking part are:</p>
<p>Domhnall MacAuley, BMJ primary care editor</p>
<p>Anthony Silverstone, consultant at UCH </p>
<p>Peter Carter, chief executive for the Royal College of Nursing </p>
<p>Jocelyn Cornwall, director, The Point of Care programme, The King's Fund </p>
<p>Joanne Watson, consultant at Musgrove Park Hospital </p>
<p>Sean O'Brien, head of the patient experience group at Musgrove Park Hospital</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/396vk4/stream_104372467-bmjgroup-how-do-we-put-the-compassion.mp3" length="56677179" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In the wake of the Francis report, the BMJ gathered experts to discuss compassion in the health service. This is the discussion in full.Taking part are:Domhnall MacAuley, BMJ primary care editorAnthony Silverstone, consultant at UCH Peter Carter, chief executive for the Royal College of Nursing Jocelyn Cornwall, director, The Point of Care programme, The King's Fund Joanne Watson, consultant at Musgrove Park Hospital Sean O'Brien, head of the patient experience group at Musgrove Park Hospital]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2361</itunes:duration>
                                    </item>
    <item>
        <title>Compassion and variation</title>
        <itunes:title>Compassion and variation</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/compassion-and-variation/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/compassion-and-variation/#comments</comments>        <pubDate>Wed, 07 Aug 2013 08:27:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/compassion-and-variation</guid>
                                    <description><![CDATA[<p>If patients living in one area have more diagnoses than those living in another, use more care, but have similar mortality rates, you would think they were simply sicker, but that the extra care they were receiving must be good and making them better. Not so, says new research published on bmj.com. John Wennberg, emeritus professor of community and family medicine at the Dartmouth Institute in the US, joins us to explains how this flawed logic is harmfully perpetuating overdiagnosis and variation in care.</p>
<p>Also, post Mid Staffs, how do we put compassion back at the heart of care? A BMJ round table discusses this, and we have edited highlights. The full round table is also available on the podcast page.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>If patients living in one area have more diagnoses than those living in another, use more care, but have similar mortality rates, you would think they were simply sicker, but that the extra care they were receiving must be good and making them better. Not so, says new research published on bmj.com. John Wennberg, emeritus professor of community and family medicine at the Dartmouth Institute in the US, joins us to explains how this flawed logic is harmfully perpetuating overdiagnosis and variation in care.</p>
<p>Also, post Mid Staffs, how do we put compassion back at the heart of care? A BMJ round table discusses this, and we have edited highlights. The full round table is also available on the podcast page.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3sdjyz/stream_104371695-bmjgroup-compassion-and-variation.mp3" length="24861219" type="audio/mpeg"/>
        <itunes:summary><![CDATA[If patients living in one area have more diagnoses than those living in another, use more care, but have similar mortality rates, you would think they were simply sicker, but that the extra care they were receiving must be good and making them better. Not so, says new research published on bmj.com. John Wennberg, emeritus professor of community and family medicine at the Dartmouth Institute in the US, joins us to explains how this flawed logic is harmfully perpetuating overdiagnosis and variation in care.Also, post Mid Staffs, how do we put compassion back at the heart of care? A BMJ round table discusses this, and we have edited highlights. The full round table is also available on the podcast page.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1034</itunes:duration>
                                    </item>
    <item>
        <title>Witty words on data</title>
        <itunes:title>Witty words on data</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/witty-words-on-data/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/witty-words-on-data/#comments</comments>        <pubDate>Wed, 07 Aug 2013 08:22:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/witty-words-on-data</guid>
                                    <description><![CDATA[<p>Andrew Witty is the CEO of GlaxoSmithKline. He’s been credited with taking on a pharma company with a history of behaving badly in the past – as shown by a record $3bn fine levied by the US government last year. How much is he able or willing to change the culture of an industry, which is under pressure to alter its practices? Rebecca Coombes finds out.</p>
<p>Also this week, Michael Dowling, president and CEO of the North Shore-LIJ Health System in New York, has built his organisation up from two hospitals undergoing a difficult merger into a giant integrated system. He explains his no-nonsense approach to making change work.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Andrew Witty is the CEO of GlaxoSmithKline. He’s been credited with taking on a pharma company with a history of behaving badly in the past – as shown by a record $3bn fine levied by the US government last year. How much is he able or willing to change the culture of an industry, which is under pressure to alter its practices? Rebecca Coombes finds out.</p>
<p>Also this week, Michael Dowling, president and CEO of the North Shore-LIJ Health System in New York, has built his organisation up from two hospitals undergoing a difficult merger into a giant integrated system. He explains his no-nonsense approach to making change work.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/entlxd/stream_104371238-bmjgroup-witty-words-on-data.mp3" length="27691200" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Andrew Witty is the CEO of GlaxoSmithKline. He’s been credited with taking on a pharma company with a history of behaving badly in the past – as shown by a record $3bn fine levied by the US government last year. How much is he able or willing to change the culture of an industry, which is under pressure to alter its practices? Rebecca Coombes finds out.Also this week, Michael Dowling, president and CEO of the North Shore-LIJ Health System in New York, has built his organisation up from two hospitals undergoing a difficult merger into a giant integrated system. He explains his no-nonsense approach to making change work.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1153</itunes:duration>
                                    </item>
    <item>
        <title>After Francis, what next?</title>
        <itunes:title>After Francis, what next?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/after-francis-what-next/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/after-francis-what-next/#comments</comments>        <pubDate>Tue, 06 Aug 2013 16:42:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/after-francis-what-next</guid>
                                    <description><![CDATA[<p>Recorded at the recent Nuffield health policy summit, this round table asks how to impliment the Francis reports recommendations.</p>
<p>Taking part were:</p>
<p>Robert Francis, chair of The Mid Staffordshire NHS Foundation Trust Public Enquiry</p>
<p>Simon Stevens, president of global health at the UnitedHealth Group</p>
<p>Sam Barrell, chief clinical officer of South Devon and Torbay CCG </p>
<p>Niall Dickson, CEO of the General Medical Council </p>
<p>Stephen Dorrell MP, chair of the HOC Health Select Committee </p>
<p>Nigel Edwards, director of the Global Healthcare Group, KPMG </p>
<p>Jan Filochowski, chief executive, Great Ormond Street Hospital for Children NHS Foundation Trust </p>
<p>Julie Moore, chief executive of University Hospitals Birmingham</p>
<p>Bruce Keogh, medical director of the NHS</p>
<p>Alastair McLellan, Editor of Health Services Journal</p>
<p>Jeremy Taylor, chief executive, National Voices </p>
<p>Ruth Thorlby, senior fellow at the Nuffield Trust.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Recorded at the recent Nuffield health policy summit, this round table asks how to impliment the Francis reports recommendations.</p>
<p>Taking part were:</p>
<p>Robert Francis, chair of The Mid Staffordshire NHS Foundation Trust Public Enquiry</p>
<p>Simon Stevens, president of global health at the UnitedHealth Group</p>
<p>Sam Barrell, chief clinical officer of South Devon and Torbay CCG </p>
<p>Niall Dickson, CEO of the General Medical Council </p>
<p>Stephen Dorrell MP, chair of the HOC Health Select Committee </p>
<p>Nigel Edwards, director of the Global Healthcare Group, KPMG </p>
<p>Jan Filochowski, chief executive, Great Ormond Street Hospital for Children NHS Foundation Trust </p>
<p>Julie Moore, chief executive of University Hospitals Birmingham</p>
<p>Bruce Keogh, medical director of the NHS</p>
<p>Alastair McLellan, Editor of Health Services Journal</p>
<p>Jeremy Taylor, chief executive, National Voices </p>
<p>Ruth Thorlby, senior fellow at the Nuffield Trust.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9ohxr4/stream_104271750-bmjgroup-after-francis-what-next.mp3" length="70779707" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Recorded at the recent Nuffield health policy summit, this round table asks how to impliment the Francis reports recommendations.Taking part were:Robert Francis, chair of The Mid Staffordshire NHS Foundation Trust Public EnquirySimon Stevens, president of global health at the UnitedHealth GroupSam Barrell, chief clinical officer of South Devon and Torbay CCG Niall Dickson, CEO of the General Medical Council Stephen Dorrell MP, chair of the HOC Health Select Committee Nigel Edwards, director of the Global Healthcare Group, KPMG Jan Filochowski, chief executive, Great Ormond Street Hospital for Children NHS Foundation Trust Julie Moore, chief executive of University Hospitals BirminghamBruce Keogh, medical director of the NHSAlastair McLellan, Editor of Health Services JournalJeremy Taylor, chief executive, National Voices Ruth Thorlby, senior fellow at the Nuffield Trust.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2950</itunes:duration>
                                    </item>
    <item>
        <title>Are all calories equal?</title>
        <itunes:title>Are all calories equal?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/are-all-calories-equal-1680599922/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/are-all-calories-equal-1680599922/#comments</comments>        <pubDate>Tue, 06 Aug 2013 16:30:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/are-all-calories-equal</guid>
                                    <description><![CDATA[<p>Are all calories equal? Thermodynamics would say that energy is energy, be it derived from carbohydrate, fat, or protein. But things get more complicated when appetite is taken into consideration , says Robert Lustig, professor of pediatric endocrinology at the University of California, San Francisco.</p>
<p>Also this week, life expectancy in Europe is increasing, but at the same time health inequalities are widening. Claudia Stein, director of the Division of Information, Evidence, Research, and Innovation at the World Health Organization's regional office for Europe, talks about a new report that highlights both the good and the bad of Europe's health.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Are all calories equal? Thermodynamics would say that energy is energy, be it derived from carbohydrate, fat, or protein. But things get more complicated when appetite is taken into consideration , says Robert Lustig, professor of pediatric endocrinology at the University of California, San Francisco.</p>
<p>Also this week, life expectancy in Europe is increasing, but at the same time health inequalities are widening. Claudia Stein, director of the Division of Information, Evidence, Research, and Innovation at the World Health Organization's regional office for Europe, talks about a new report that highlights both the good and the bad of Europe's health.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/m6fut9/stream_104270307-bmjgroup-are-all-calories-equal.mp3" length="32524785" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Are all calories equal? Thermodynamics would say that energy is energy, be it derived from carbohydrate, fat, or protein. But things get more complicated when appetite is taken into consideration , says Robert Lustig, professor of pediatric endocrinology at the University of California, San Francisco.Also this week, life expectancy in Europe is increasing, but at the same time health inequalities are widening. Claudia Stein, director of the Division of Information, Evidence, Research, and Innovation at the World Health Organization's regional office for Europe, talks about a new report that highlights both the good and the bad of Europe's health.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1353</itunes:duration>
                                    </item>
    <item>
        <title>Carotid atherosclerosis and patient participation</title>
        <itunes:title>Carotid atherosclerosis and patient participation</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/carotid-atherosclerosis-and-patient-participation/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/carotid-atherosclerosis-and-patient-participation/#comments</comments>        <pubDate>Tue, 06 Aug 2013 16:17:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/carotid-atherosclerosis-and</guid>
                                    <description><![CDATA[<p>A clinical review this week looks at the diagnosis and treatment of carotid atherosclerosis, including when to screen and the threshold for intervention. Alun Davies, professor of vascular surgery at Imperial College London, also answers how useful or harmful screening offered commercially is.</p>
<p>Also this week, the BMJ’s editorial board met to discuss how patient participation should be represented and encouraged by the journal. We captured some of their views.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>A clinical review this week looks at the diagnosis and treatment of carotid atherosclerosis, including when to screen and the threshold for intervention. Alun Davies, professor of vascular surgery at Imperial College London, also answers how useful or harmful screening offered commercially is.</p>
<p>Also this week, the BMJ’s editorial board met to discuss how patient participation should be represented and encouraged by the journal. We captured some of their views.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7kphdc/stream_104268681-bmjgroup-carotid-atherosclerosis-and.mp3" length="29323345" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A clinical review this week looks at the diagnosis and treatment of carotid atherosclerosis, including when to screen and the threshold for intervention. Alun Davies, professor of vascular surgery at Imperial College London, also answers how useful or harmful screening offered commercially is.Also this week, the BMJ’s editorial board met to discuss how patient participation should be represented and encouraged by the journal. We captured some of their views.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1221</itunes:duration>
                                    </item>
    <item>
        <title>All trials registered | All results reported</title>
        <itunes:title>All trials registered | All results reported</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/all-trials-registered-all-results-reported/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/all-trials-registered-all-results-reported/#comments</comments>        <pubDate>Tue, 06 Aug 2013 16:12:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/all-trials-registered-all</guid>
                                    <description><![CDATA[<p>The issues of hidden data are well known, and the BMJ’s open data campaign page documents some of the problems which have arisen as a result of clinical trial data remaining undisclosed.</p>
<p>At Evidence Live 2013 in Oxford this week, Fiona Godlee, BMJ editor in chief, convened a group of those closely involved with the AllTrials campaign, to discuss where we are now and what still needs to be done</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The issues of hidden data are well known, and the BMJ’s open data campaign page documents some of the problems which have arisen as a result of clinical trial data remaining undisclosed.</p>
<p>At Evidence Live 2013 in Oxford this week, Fiona Godlee, BMJ editor in chief, convened a group of those closely involved with the AllTrials campaign, to discuss where we are now and what still needs to be done</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/m4gav9/stream_104268056-bmjgroup-all-trials-registered-all.mp3" length="21405601" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The issues of hidden data are well known, and the BMJ’s open data campaign page documents some of the problems which have arisen as a result of clinical trial data remaining undisclosed.At Evidence Live 2013 in Oxford this week, Fiona Godlee, BMJ editor in chief, convened a group of those closely involved with the AllTrials campaign, to discuss where we are now and what still needs to be done]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>891</itunes:duration>
                                    </item>
    <item>
        <title>Tackling hypertension in India</title>
        <itunes:title>Tackling hypertension in India</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/tackling-hypertension-in-india/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/tackling-hypertension-in-india/#comments</comments>        <pubDate>Tue, 06 Aug 2013 15:40:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/tackling-hypertension-in-india</guid>
                                    <description><![CDATA[<p>The World Health Organization has chosen hypertension as the public health threat it will focus on for the next year. The problem is particularly pressing in India, and Anita Jain, the BMJ's India editor, spoke to François Decaillet, Coordinator for Health Programs, WHO India, about what needs to be done to tackle hypertension in the country's population.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The World Health Organization has chosen hypertension as the public health threat it will focus on for the next year. The problem is particularly pressing in India, and Anita Jain, the BMJ's India editor, spoke to François Decaillet, Coordinator for Health Programs, WHO India, about what needs to be done to tackle hypertension in the country's population.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wxwb1s/stream_104264014-bmjgroup-tackling-hypertension-in-india.mp3" length="19152523" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The World Health Organization has chosen hypertension as the public health threat it will focus on for the next year. The problem is particularly pressing in India, and Anita Jain, the BMJ's India editor, spoke to François Decaillet, Coordinator for Health Programs, WHO India, about what needs to be done to tackle hypertension in the country's population.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>796</itunes:duration>
                                    </item>
    <item>
        <title>Dealing with delirium</title>
        <itunes:title>Dealing with delirium</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/dealing-with-delirium/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/dealing-with-delirium/#comments</comments>        <pubDate>Tue, 06 Aug 2013 15:02:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/dealing-with-delirium</guid>
                                    <description><![CDATA[<p>Delirium is often missed in primary and secondary care. Edison Vidal, assistant professor in internal medicine at the Universidade Estadual Paulista, Brazil, advises on diagnosing and managing the condition.</p>
<p>Rheumatoid arthritis, non-biological drug treatments, or both, might suppress tumour surveillance and in theory increase the risk of melanoma. Pauline Raaschou, consultant in clinical pharmacology at the Karolinska Institutet, Sweden, explains what she found while investigating the association.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Delirium is often missed in primary and secondary care. Edison Vidal, assistant professor in internal medicine at the Universidade Estadual Paulista, Brazil, advises on diagnosing and managing the condition.</p>
<p>Rheumatoid arthritis, non-biological drug treatments, or both, might suppress tumour surveillance and in theory increase the risk of melanoma. Pauline Raaschou, consultant in clinical pharmacology at the Karolinska Institutet, Sweden, explains what she found while investigating the association.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/v2vs8v/stream_104259663-bmjgroup-dealing-with-delirium.mp3" length="29674067" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Delirium is often missed in primary and secondary care. Edison Vidal, assistant professor in internal medicine at the Universidade Estadual Paulista, Brazil, advises on diagnosing and managing the condition.Rheumatoid arthritis, non-biological drug treatments, or both, might suppress tumour surveillance and in theory increase the risk of melanoma. Pauline Raaschou, consultant in clinical pharmacology at the Karolinska Institutet, Sweden, explains what she found while investigating the association.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1236</itunes:duration>
                                    </item>
    <item>
        <title>Warts and all</title>
        <itunes:title>Warts and all</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/warts-and-all-1680599929/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/warts-and-all-1680599929/#comments</comments>        <pubDate>Tue, 06 Aug 2013 14:57:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/warts-and-all</guid>
                                    <description><![CDATA[<p>This week, we discuss how Australia’s national human papillomavirus (HPV) vaccination programme has caused a dramatic drop in genital warts. Does this foretell elimination of all disease caused by HPV in the country?</p>
<p>And some advice on how to diagnose and manage pulmonary hypertension.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week, we discuss how Australia’s national human papillomavirus (HPV) vaccination programme has caused a dramatic drop in genital warts. Does this foretell elimination of all disease caused by HPV in the country?</p>
<p>And some advice on how to diagnose and manage pulmonary hypertension.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mk2wst/stream_104259018-bmjgroup-warts-and-all.mp3" length="39652141" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week, we discuss how Australia’s national human papillomavirus (HPV) vaccination programme has caused a dramatic drop in genital warts. Does this foretell elimination of all disease caused by HPV in the country?And some advice on how to diagnose and manage pulmonary hypertension.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1652</itunes:duration>
                                    </item>
    <item>
        <title>Dying patients in hospital, e-patients online</title>
        <itunes:title>Dying patients in hospital, e-patients online</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/dying-patients-in-hospital-e-patients-online/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/dying-patients-in-hospital-e-patients-online/#comments</comments>        <pubDate>Tue, 06 Aug 2013 14:50:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/dying-patients-in-hospital-e</guid>
                                    <description><![CDATA[<p>Patients are increasingly going online to find and discuss information about their condition. What are they getting on the web that they’re not getting from clinicians, and how is this changing healthcare?</p>
<p>Also, how to care for a dying patient in hospital.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Patients are increasingly going online to find and discuss information about their condition. What are they getting on the web that they’re not getting from clinicians, and how is this changing healthcare?</p>
<p>Also, how to care for a dying patient in hospital.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/46encd/stream_104258158-bmjgroup-dying-patients-in-hospital-e.mp3" length="39442406" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Patients are increasingly going online to find and discuss information about their condition. What are they getting on the web that they’re not getting from clinicians, and how is this changing healthcare?Also, how to care for a dying patient in hospital.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1641</itunes:duration>
                                    </item>
    <item>
        <title>Suspected heart failure</title>
        <itunes:title>Suspected heart failure</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/suspected-heart-failure/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/suspected-heart-failure/#comments</comments>        <pubDate>Tue, 06 Aug 2013 14:43:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/suspected-heart-failure</guid>
                                    <description><![CDATA[<p>Mabel Chew, practice editor at the BMJ, talks to Tushar Kotecha, a cardiology specialist registrar at Charing Cross Hospital in London, about when to suspect heart failure, and how to diagnose the condition.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Mabel Chew, practice editor at the BMJ, talks to Tushar Kotecha, a cardiology specialist registrar at Charing Cross Hospital in London, about when to suspect heart failure, and how to diagnose the condition.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/oc59xd/stream_104257270-bmjgroup-suspected-heart-failure.mp3" length="20363283" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Mabel Chew, practice editor at the BMJ, talks to Tushar Kotecha, a cardiology specialist registrar at Charing Cross Hospital in London, about when to suspect heart failure, and how to diagnose the condition.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>846</itunes:duration>
                                    </item>
    <item>
        <title>The BMJ Awards: Medical Team of the Year</title>
        <itunes:title>The BMJ Awards: Medical Team of the Year</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/the-bmj-awards-medical-team-of-the-year/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/the-bmj-awards-medical-team-of-the-year/#comments</comments>        <pubDate>Tue, 06 Aug 2013 14:39:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/the-bmj-awards-medical-team-of</guid>
                                    <description><![CDATA[<p>The BMJ Awards were held last Thursday. Fiona Godlee, the BMJ's editor in chief, announced that the Britain Nepal Otology Service (BRINOS) was named Medical Team of the Year.</p>
<p>BRINOS (brinos.org.uk) started out in 1988 by setting up joint British and Nepalese surgical camps to treat ear disease among patients living outside the reach of hospitals in the capital of Kathmandu. A national survey in 1991 found that among the 19m people in Nepal, 2.7m were deaf and 1.5m had abnormal ear drums indicative of ear disease. BRINOS has performed more than 4000 major ear operations at 49 surgical day camps since its first expedition in 1989. Furthermore, there have been many anecdotal stories of improved education and employment opportunities in social isolation after surgery. The organisation expanded in 2000 to introduce community ear assistants, who are specially trained in the diagnosis and treatment of ear disease and dispense hearing aids passed on from the NHS.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The BMJ Awards were held last Thursday. Fiona Godlee, the BMJ's editor in chief, announced that the Britain Nepal Otology Service (BRINOS) was named Medical Team of the Year.</p>
<p>BRINOS (brinos.org.uk) started out in 1988 by setting up joint British and Nepalese surgical camps to treat ear disease among patients living outside the reach of hospitals in the capital of Kathmandu. A national survey in 1991 found that among the 19m people in Nepal, 2.7m were deaf and 1.5m had abnormal ear drums indicative of ear disease. BRINOS has performed more than 4000 major ear operations at 49 surgical day camps since its first expedition in 1989. Furthermore, there have been many anecdotal stories of improved education and employment opportunities in social isolation after surgery. The organisation expanded in 2000 to introduce community ear assistants, who are specially trained in the diagnosis and treatment of ear disease and dispense hearing aids passed on from the NHS.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/pm6w07/stream_104256848-bmjgroup-the-bmj-awards-medical-team-of.mp3" length="13753814" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The BMJ Awards were held last Thursday. Fiona Godlee, the BMJ's editor in chief, announced that the Britain Nepal Otology Service (BRINOS) was named Medical Team of the Year.BRINOS (brinos.org.uk) started out in 1988 by setting up joint British and Nepalese surgical camps to treat ear disease among patients living outside the reach of hospitals in the capital of Kathmandu. A national survey in 1991 found that among the 19m people in Nepal, 2.7m were deaf and 1.5m had abnormal ear drums indicative of ear disease. BRINOS has performed more than 4000 major ear operations at 49 surgical day camps since its first expedition in 1989. Furthermore, there have been many anecdotal stories of improved education and employment opportunities in social isolation after surgery. The organisation expanded in 2000 to introduce community ear assistants, who are specially trained in the diagnosis and treatment of ear disease and dispense hearing aids passed on from the NHS.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>571</itunes:duration>
                                    </item>
    <item>
        <title>Vulnerable adults, and the road to cycle safety</title>
        <itunes:title>Vulnerable adults, and the road to cycle safety</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/vulnerable-adults-and-the-road-to-cycle-safety/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/vulnerable-adults-and-the-road-to-cycle-safety/#comments</comments>        <pubDate>Tue, 06 Aug 2013 14:36:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/vulnerable-adults-and-the-road</guid>
                                    <description><![CDATA[<p>In a drive to improve safety, many cyclists now wear helmets. But how useful is legislation that mandates their use when compared with all the other safety initiatives available? Jessica Dennis, a PhD candidate from the Dalla Lana School of Public Health at the University of Toronto, tells us about her research into accident trends.</p>
<p>Also this week, doctors play a key role in spotting when a vulnerable person is experiencing abuse, but it can be difficult to know how to tackle the issue. A clinical review sets out some advice. We're joined by the authors, Billy Boland, consultant psychiatrist and lead doctor for safeguarding adults, and Jemima Burnage, head of social work and safeguarding, at Hertfordshire Partnership NHS Foundation Trust in the UK.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In a drive to improve safety, many cyclists now wear helmets. But how useful is legislation that mandates their use when compared with all the other safety initiatives available? Jessica Dennis, a PhD candidate from the Dalla Lana School of Public Health at the University of Toronto, tells us about her research into accident trends.</p>
<p>Also this week, doctors play a key role in spotting when a vulnerable person is experiencing abuse, but it can be difficult to know how to tackle the issue. A clinical review sets out some advice. We're joined by the authors, Billy Boland, consultant psychiatrist and lead doctor for safeguarding adults, and Jemima Burnage, head of social work and safeguarding, at Hertfordshire Partnership NHS Foundation Trust in the UK.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/95nrer/stream_104256484-bmjgroup-vulnerable-adults-and-the-road.mp3" length="28290989" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In a drive to improve safety, many cyclists now wear helmets. But how useful is legislation that mandates their use when compared with all the other safety initiatives available? Jessica Dennis, a PhD candidate from the Dalla Lana School of Public Health at the University of Toronto, tells us about her research into accident trends.Also this week, doctors play a key role in spotting when a vulnerable person is experiencing abuse, but it can be difficult to know how to tackle the issue. A clinical review sets out some advice. We're joined by the authors, Billy Boland, consultant psychiatrist and lead doctor for safeguarding adults, and Jemima Burnage, head of social work and safeguarding, at Hertfordshire Partnership NHS Foundation Trust in the UK.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1177</itunes:duration>
                                    </item>
    <item>
        <title>Think then scan, don’t scan then think</title>
        <itunes:title>Think then scan, don’t scan then think</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/think-then-scan-don-t-scan-then-think/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/think-then-scan-don-t-scan-then-think/#comments</comments>        <pubDate>Mon, 05 Aug 2013 20:37:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/think-then-scan-dont-scan-then</guid>
                                    <description><![CDATA[<p>Until now, the increased risk of cancer from CT scans has been modelled from the data gathered from survivors of the Hiroshima and Nagasaki bombings. However, new BMJ research, based on a large Australian cohort, offers new evidence to support the modelling. John Matthews, from the university of Melbourne, joins us to explain what they found.</p>
<p>Also this week, social media is relatively new – but did you realise that doctors had been using social networks to improve health for centuries? Enrico Coiera, director of the Centre for Health Informatics at the University of New South Wales, explains more, and how in the digital age we might try and use virtual networks to do the same job on a larger scale.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Until now, the increased risk of cancer from CT scans has been modelled from the data gathered from survivors of the Hiroshima and Nagasaki bombings. However, new BMJ research, based on a large Australian cohort, offers new evidence to support the modelling. John Matthews, from the university of Melbourne, joins us to explain what they found.</p>
<p>Also this week, social media is relatively new – but did you realise that doctors had been using social networks to improve health for centuries? Enrico Coiera, director of the Centre for Health Informatics at the University of New South Wales, explains more, and how in the digital age we might try and use virtual networks to do the same job on a larger scale.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5rygqy/stream_104155167-bmjgroup-think-then-scan-dont-scan-then.mp3" length="27182633" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Until now, the increased risk of cancer from CT scans has been modelled from the data gathered from survivors of the Hiroshima and Nagasaki bombings. However, new BMJ research, based on a large Australian cohort, offers new evidence to support the modelling. John Matthews, from the university of Melbourne, joins us to explain what they found.Also this week, social media is relatively new – but did you realise that doctors had been using social networks to improve health for centuries? Enrico Coiera, director of the Centre for Health Informatics at the University of New South Wales, explains more, and how in the digital age we might try and use virtual networks to do the same job on a larger scale.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1131</itunes:duration>
                                    </item>
    <item>
        <title>Corporations as vectors of disease</title>
        <itunes:title>Corporations as vectors of disease</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/corporations-as-vectors-of-disease/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/corporations-as-vectors-of-disease/#comments</comments>        <pubDate>Mon, 05 Aug 2013 20:30:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/corporations-as-vectors-of</guid>
                                    <description><![CDATA[<p>This month the UK parliament has been looking at the big accountancy firms' involvement in drafting tax laws. Conversely, the Department of Health has hidden the involvement of tobacco lobbyists in proposed plain packaging legislation.</p>
<p>Jeff Collin, professor of global health policy at the University of Edinburgh, argues that this culture of industry participation is worrying, but the lack of transparency by government is even worse.</p>
<p>Also this week, what day of the week is safest for surgery? Paul Aylin, a clinical reader in epidemiology and public health at Imperial College London, explains his research.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This month the UK parliament has been looking at the big accountancy firms' involvement in drafting tax laws. Conversely, the Department of Health has hidden the involvement of tobacco lobbyists in proposed plain packaging legislation.</p>
<p>Jeff Collin, professor of global health policy at the University of Edinburgh, argues that this culture of industry participation is worrying, but the lack of transparency by government is even worse.</p>
<p>Also this week, what day of the week is safest for surgery? Paul Aylin, a clinical reader in epidemiology and public health at Imperial College London, explains his research.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ra98bs/stream_104154097-bmjgroup-corporations-as-vectors-of.mp3" length="20060953" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This month the UK parliament has been looking at the big accountancy firms' involvement in drafting tax laws. Conversely, the Department of Health has hidden the involvement of tobacco lobbyists in proposed plain packaging legislation.Jeff Collin, professor of global health policy at the University of Edinburgh, argues that this culture of industry participation is worrying, but the lack of transparency by government is even worse.Also this week, what day of the week is safest for surgery? Paul Aylin, a clinical reader in epidemiology and public health at Imperial College London, explains his research.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>835</itunes:duration>
                                    </item>
    <item>
        <title>Bias in clinical guidelines, and giving birth at home</title>
        <itunes:title>Bias in clinical guidelines, and giving birth at home</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/bias-in-clinical-guidelines-and-giving-birth-at-home/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/bias-in-clinical-guidelines-and-giving-birth-at-home/#comments</comments>        <pubDate>Mon, 05 Aug 2013 20:22:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/bias-in-clinical-guidelines</guid>
                                    <description><![CDATA[<p>Despite repeated calls to prohibit or limit conflicts of interests among authors and sponsors of clinical guidelines, the problem persists. Jeanne Lenzer explains what's going wrong.</p>
<p>And is giving birth at home as safe for the mother as giving birth in hospital? New research from the Netherlands suggests that it is, and that risk assessment is key.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Despite repeated calls to prohibit or limit conflicts of interests among authors and sponsors of clinical guidelines, the problem persists. Jeanne Lenzer explains what's going wrong.</p>
<p>And is giving birth at home as safe for the mother as giving birth in hospital? New research from the Netherlands suggests that it is, and that risk assessment is key.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jklv4q/stream_104152893-bmjgroup-bias-in-clinical-guidelines.mp3" length="27414835" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Despite repeated calls to prohibit or limit conflicts of interests among authors and sponsors of clinical guidelines, the problem persists. Jeanne Lenzer explains what's going wrong.And is giving birth at home as safe for the mother as giving birth in hospital? New research from the Netherlands suggests that it is, and that risk assessment is key.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1141</itunes:duration>
                                    </item>
    <item>
        <title>Tackling violence against women</title>
        <itunes:title>Tackling violence against women</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/tackling-violence-against-women-1680599940/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/tackling-violence-against-women-1680599940/#comments</comments>        <pubDate>Mon, 05 Aug 2013 20:13:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/tackling-violence-against</guid>
                                    <description><![CDATA[<p>This week, the World Health Organisation called for healthcare providers to be more aware of intimate partner and sexual violence against women, calling it a "global health problem of epidemic proportions." We look into what doctors need to know.</p>
<p>And we discuss advice on diagnosing and treating first trimester miscarriage.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week, the World Health Organisation called for healthcare providers to be more aware of intimate partner and sexual violence against women, calling it a "global health problem of epidemic proportions." We look into what doctors need to know.</p>
<p>And we discuss advice on diagnosing and treating first trimester miscarriage.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dp187x/stream_104151670-bmjgroup-tackling-violence-against.mp3" length="38101901" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week, the World Health Organisation called for healthcare providers to be more aware of intimate partner and sexual violence against women, calling it a "global health problem of epidemic proportions." We look into what doctors need to know.And we discuss advice on diagnosing and treating first trimester miscarriage.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1587</itunes:duration>
                                    </item>
    <item>
        <title>NSAIDs update</title>
        <itunes:title>NSAIDs update</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/nsaids-update/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/nsaids-update/#comments</comments>        <pubDate>Mon, 05 Aug 2013 19:58:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/nsaids-update</guid>
                                    <description><![CDATA[<p>Recent research shows that some non-steroidal anti-inflammatory drugs increase cardiovascular risk in some patients. Given their widespread use, and breadth of indications for prescription, should clinicians be more circumspect about their practice?</p>
<p>In this podcast, Mabel Chew BMJ's practice editor, talks to Richard O'Day, professor of clinical pharmacology at the University of New South Wales and author of a recent therapeutics article, about the latest research on NSAIDs</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Recent research shows that some non-steroidal anti-inflammatory drugs increase cardiovascular risk in some patients. Given their widespread use, and breadth of indications for prescription, should clinicians be more circumspect about their practice?</p>
<p>In this podcast, Mabel Chew BMJ's practice editor, talks to Richard O'Day, professor of clinical pharmacology at the University of New South Wales and author of a recent therapeutics article, about the latest research on NSAIDs</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dea4wd/stream_104149531-bmjgroup-nsaids-update.mp3" length="26522874" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Recent research shows that some non-steroidal anti-inflammatory drugs increase cardiovascular risk in some patients. Given their widespread use, and breadth of indications for prescription, should clinicians be more circumspect about their practice?In this podcast, Mabel Chew BMJ's practice editor, talks to Richard O'Day, professor of clinical pharmacology at the University of New South Wales and author of a recent therapeutics article, about the latest research on NSAIDs]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1084</itunes:duration>
                                    </item>
    <item>
        <title>Surgical outcome data</title>
        <itunes:title>Surgical outcome data</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/surgical-outcome-data/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/surgical-outcome-data/#comments</comments>        <pubDate>Mon, 05 Aug 2013 19:43:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/surgical-outcome-data</guid>
                                    <description><![CDATA[<p>Last week saw the start of a campaign to publish patient death rates for individual surgeons. Bruce Keogh, medical director of the NHS in England, talks to BMJ editor in chief Fiona Godlee about the initiative and the background to it.</p>
<p>Also, the WHO has launched its Guidelines and Global Progress in HIV/AIDs report. Anne Gulland interviews Gottfried Hirnschall, a Director of the WHO’s HIV/AIDS Department, and his his scientist colleague, Philippa Easterbrook.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Last week saw the start of a campaign to publish patient death rates for individual surgeons. Bruce Keogh, medical director of the NHS in England, talks to BMJ editor in chief Fiona Godlee about the initiative and the background to it.</p>
<p>Also, the WHO has launched its Guidelines and Global Progress in HIV/AIDs report. Anne Gulland interviews Gottfried Hirnschall, a Director of the WHO’s HIV/AIDS Department, and his his scientist colleague, Philippa Easterbrook.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mnssvm/stream_104147303-bmjgroup-surgical-outcome-data.mp3" length="47135889" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Last week saw the start of a campaign to publish patient death rates for individual surgeons. Bruce Keogh, medical director of the NHS in England, talks to BMJ editor in chief Fiona Godlee about the initiative and the background to it.Also, the WHO has launched its Guidelines and Global Progress in HIV/AIDs report. Anne Gulland interviews Gottfried Hirnschall, a Director of the WHO’s HIV/AIDS Department, and his his scientist colleague, Philippa Easterbrook.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1962</itunes:duration>
                                    </item>
    <item>
        <title>Antibiotics in agriculture</title>
        <itunes:title>Antibiotics in agriculture</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/antibiotics-in-agriculture/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/antibiotics-in-agriculture/#comments</comments>        <pubDate>Mon, 05 Aug 2013 19:32:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/antibiotics-in-agriculture</guid>
                                    <description><![CDATA[<p>This week a head to head article asks: "Does adding routine antibiotics to animal feed pose a serious risk to human health? The authors David Wallinga, a physician member of the steering committee of Keep Antibiotics Working: the Campaign to End Antibiotic Overuse in Animal Agriculture, and David Burch, a veterinarian and consultant on antibiotic use in agriculture from Octagon Services, argue their sides.</p>
<p>Also this week, a BMJ investigation looks at changes in rationing patterns in the new NHS in England. News editor Annabel Ferriman talks Gareth Iacobucci, who carried out the investigation, about the squeeze on access to hospital care.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week a head to head article asks: "Does adding routine antibiotics to animal feed pose a serious risk to human health? The authors David Wallinga, a physician member of the steering committee of Keep Antibiotics Working: the Campaign to End Antibiotic Overuse in Animal Agriculture, and David Burch, a veterinarian and consultant on antibiotic use in agriculture from Octagon Services, argue their sides.</p>
<p>Also this week, a BMJ investigation looks at changes in rationing patterns in the new NHS in England. News editor Annabel Ferriman talks Gareth Iacobucci, who carried out the investigation, about the squeeze on access to hospital care.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8frkzi/stream_104145743-bmjgroup-antibiotics-in-agriculture.mp3" length="42174828" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week a head to head article asks: "Does adding routine antibiotics to animal feed pose a serious risk to human health? The authors David Wallinga, a physician member of the steering committee of Keep Antibiotics Working: the Campaign to End Antibiotic Overuse in Animal Agriculture, and David Burch, a veterinarian and consultant on antibiotic use in agriculture from Octagon Services, argue their sides.Also this week, a BMJ investigation looks at changes in rationing patterns in the new NHS in England. News editor Annabel Ferriman talks Gareth Iacobucci, who carried out the investigation, about the squeeze on access to hospital care.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1752</itunes:duration>
                                    </item>
    <item>
        <title>Dying at home</title>
        <itunes:title>Dying at home</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/dying-at-home/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/dying-at-home/#comments</comments>        <pubDate>Mon, 05 Aug 2013 19:11:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/bmj-podcast-dying-at-home</guid>
                                    <description><![CDATA[<p>This week, we look at how to help patients have better deaths at home.</p>
<p>BMJ assistant editor Sophie Cook talks to Emily Collis, a consultant in palliative medicine and the author of a recent clinical review about caring for dying patients in the community.</p>
<p>BMJ columnist Des Spence, a GP in Glasgow, explains why the dying deserve better from GPs.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This week, we look at how to help patients have better deaths at home.</p>
<p>BMJ assistant editor Sophie Cook talks to Emily Collis, a consultant in palliative medicine and the author of a recent clinical review about caring for dying patients in the community.</p>
<p>BMJ columnist Des Spence, a GP in Glasgow, explains why the dying deserve better from GPs.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hriwwv/stream_104142646-bmjgroup-bmj-podcast-dying-at-home.mp3" length="29813059" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This week, we look at how to help patients have better deaths at home.BMJ assistant editor Sophie Cook talks to Emily Collis, a consultant in palliative medicine and the author of a recent clinical review about caring for dying patients in the community.BMJ columnist Des Spence, a GP in Glasgow, explains why the dying deserve better from GPs.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1243</itunes:duration>
                                    </item>
    <item>
        <title>Lost in transfusion?</title>
        <itunes:title>Lost in transfusion?</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/lost-in-transfusion/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/lost-in-transfusion/#comments</comments>        <pubDate>Mon, 05 Aug 2013 18:55:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/bmj-podcast-lost-in</guid>
                                    <description><![CDATA[<p>Blood transfusion is an essential part of modern healthcare and can be lifesaving when used appropriately. In this podcast, Sophie Cook, The BMJ's clinical reviews editor, talks to Michael Murphy, consultant haematologist and professor of blood transfusion medicine at NHS Blood and Transplant at the John Radcliffe Hospital, Oxford, about best practice for the safety of patients receiving blood; including ways to reduce unnecessary transfusion, and the warning signs of an adverse reaction.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Blood transfusion is an essential part of modern healthcare and can be lifesaving when used appropriately. In this podcast, Sophie Cook, The BMJ's clinical reviews editor, talks to Michael Murphy, consultant haematologist and professor of blood transfusion medicine at NHS Blood and Transplant at the John Radcliffe Hospital, Oxford, about best practice for the safety of patients receiving blood; including ways to reduce unnecessary transfusion, and the warning signs of an adverse reaction.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/uhvvun/stream_104140327-bmjgroup-bmj-podcast-lost-in.mp3" length="19901721" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Blood transfusion is an essential part of modern healthcare and can be lifesaving when used appropriately. In this podcast, Sophie Cook, The BMJ's clinical reviews editor, talks to Michael Murphy, consultant haematologist and professor of blood transfusion medicine at NHS Blood and Transplant at the John Radcliffe Hospital, Oxford, about best practice for the safety of patients receiving blood; including ways to reduce unnecessary transfusion, and the warning signs of an adverse reaction.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>822</itunes:duration>
                                    </item>
    <item>
        <title>Plain Packaging</title>
        <itunes:title>Plain Packaging</itunes:title>
        <link>https://thebmjpodcast.podbean.com/e/plain-packaging/</link>
                    <comments>https://thebmjpodcast.podbean.com/e/plain-packaging/#comments</comments>        <pubDate>Mon, 05 Aug 2013 18:42:00 +0000</pubDate>
        <guid isPermaLink="false">https://soundcloud.com/bmjpodcasts/plain-packaging</guid>
                                    <description><![CDATA[<p>Plain packaging on tobacco products is the latest strategy aimed at reducing smoking. Campaigners had hoped the UK would follow Australia’s example. But they have been disappointed as the UK government postpones the plans until “more evidence” is available.</p>
<p>We hear from Linda Bauld, professor of public policy at the University of Stirling, about why she thinks the current evidence is convincing enough.</p>
<p>Also this week, one of the most difficult consultations a doctor can have doesn’t involve a complex diagnosis, but rather a statement of intent: suicide. Richard Morriss, professor of psychiatry and community mental health at the University of Nottingham, explains how to have that conversation.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Plain packaging on tobacco products is the latest strategy aimed at reducing smoking. Campaigners had hoped the UK would follow Australia’s example. But they have been disappointed as the UK government postpones the plans until “more evidence” is available.</p>
<p>We hear from Linda Bauld, professor of public policy at the University of Stirling, about why she thinks the current evidence is convincing enough.</p>
<p>Also this week, one of the most difficult consultations a doctor can have doesn’t involve a complex diagnosis, but rather a statement of intent: suicide. Richard Morriss, professor of psychiatry and community mental health at the University of Nottingham, explains how to have that conversation.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/t3w4ql/stream_104138450-bmjgroup-plain-packaging.mp3" length="38330937" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Plain packaging on tobacco products is the latest strategy aimed at reducing smoking. Campaigners had hoped the UK would follow Australia’s example. But they have been disappointed as the UK government postpones the plans until “more evidence” is available.We hear from Linda Bauld, professor of public policy at the University of Stirling, about why she thinks the current evidence is convincing enough.Also this week, one of the most difficult consultations a doctor can have doesn’t involve a complex diagnosis, but rather a statement of intent: suicide. Richard Morriss, professor of psychiatry and community mental health at the University of Nottingham, explains how to have that conversation.]]></itunes:summary>
        <itunes:author>The BMJ</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1599</itunes:duration>
                                    </item>
</channel>
</rss>
